1	Tissue-specific	_	JJ	JJ	_	2	amod	_	_
2	regulation	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	7	det	_	_
5	rabbit	_	JJ	JJ	_	7	amod	_	_
6	15-lipoxygenase	_	NN	NN	_	7	nn	_	_
7	gene	_	NN	NN	_	3	pobj	_	_
8	in	_	IN	IN	_	2	prep	_	_
9	erythroid	_	JJ	JJ	_	10	amod	_	_
10	cells	_	NNS	NNS	_	8	pobj	_	_
11	by	_	IN	IN	_	2	prep	_	_
12	a	_	DT	DT	_	14	det	_	_
13	transcriptional	_	JJ	JJ	_	14	amod	_	_
14	silencer	_	NN	NN	_	11	pobj	_	_
15	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	6	det	_	_
2	15-lipoxygenase	_	NN	NN	_	6	nn	_	_
3	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
4	lox	_	NN	NN	_	6	nn	_	_
5	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
6	gene	_	NN	NN	_	8	nsubjpass	_	_
7	is	_	VBZ	VBZ	_	8	auxpass	_	_
8	expressed	_	VBN	VBN	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	a	_	DT	DT	_	12	det	_	_
11	tissue-specific	_	JJ	JJ	_	12	amod	_	_
12	manner	_	NN	NN	_	9	pobj	_	_
13	,	_	,	,	_	8	punct	_	_
14	predominantly	_	RB	RB	_	15	advmod	_	_
15	in	_	IN	IN	_	8	prep	_	_
16	erythroid	_	JJ	JJ	_	17	amod	_	_
17	cells	_	NNS	NNS	_	15	pobj	_	_
18	but	_	CC	CC	_	15	cc	_	_
19	also	_	RB	RB	_	20	advmod	_	_
20	in	_	IN	IN	_	15	conj	_	_
21	airway	_	NN	NN	_	23	nn	_	_
22	epithelial	_	JJ	JJ	_	23	amod	_	_
23	cells	_	NNS	NNS	_	20	pobj	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	eosinophils	_	NNS	NNS	_	23	conj	_	_
26	.	_	.	.	_	8	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	demonstrate	_	VBP	VBP	_	0	root	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	this	_	DT	DT	_	5	det	_	_
5	report	_	NN	NN	_	3	pobj	_	_
6	that	_	IN	IN	_	15	mark	_	_
7	the	_	DT	DT	_	10	det	_	_
8	5'	_	JJ	JJ	_	10	amod	_	_
9	flanking	_	JJ	JJ	_	10	amod	_	_
10	DNA	_	NN	NN	_	15	nsubj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	15-lox	_	NN	NN	_	14	nn	_	_
14	gene	_	NN	NN	_	11	pobj	_	_
15	contains	_	VBZ	VBZ	_	2	ccomp	_	_
16	sequences	_	NNS	NNS	_	15	dobj	_	_
17	which	_	WDT	WDT	_	18	nsubj	_	_
18	down-regulate	_	VBP	VBP	_	16	rcmod	_	_
19	its	_	PRP$	PRP$	_	20	poss	_	_
20	activity	_	NN	NN	_	18	dobj	_	_
21	in	_	IN	IN	_	18	prep	_	_
22	a	_	DT	DT	_	23	det	_	_
23	variety	_	NN	NN	_	21	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	non-erythroid	_	JJ	JJ	_	27	amod	_	_
26	cell	_	NN	NN	_	27	nn	_	_
27	lines	_	NNS	NNS	_	24	pobj	_	_
28	but	_	CC	CC	_	21	cc	_	_
29	not	_	RB	RB	_	30	neg	_	_
30	in	_	IN	IN	_	21	conj	_	_
31	two	_	CD	CD	_	34	num	_	_
32	erythroid	_	JJ	JJ	_	34	amod	_	_
33	cell	_	NN	NN	_	34	nn	_	_
34	lines	_	NNS	NNS	_	30	pobj	_	_
35	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	element	_	NN	NN	_	3	nsubj	_	_
3	has	_	VBZ	VBZ	_	0	root	_	_
4	characteristics	_	NNS	NNS	_	3	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	a	_	DT	DT	_	9	det	_	_
7	transcriptional	_	JJ	JJ	_	9	amod	_	_
8	'	_	``	``	_	9	punct	_	_
9	silencer	_	NN	NN	_	5	pobj	_	_
10	'	_	''	''	_	9	punct	_	_
11	since	_	IN	IN	_	13	mark	_	_
12	it	_	PRP	PRP	_	13	nsubj	_	_
13	functions	_	VBZ	VBZ	_	3	advcl	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	both	_	DT	DT	_	16	det	_	_
16	orientations	_	NNS	NNS	_	14	pobj	_	_
17	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	main	_	JJ	JJ	_	3	amod	_	_
3	activity	_	NN	NN	_	9	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	6	det	_	_
6	silencer	_	NN	NN	_	4	pobj	_	_
7	has	_	VBZ	VBZ	_	9	aux	_	_
8	been	_	VBN	VBN	_	9	auxpass	_	_
9	mapped	_	VBN	VBN	_	0	root	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	the	_	DT	DT	_	14	det	_	_
12	first	_	JJ	JJ	_	14	amod	_	_
13	900	_	CD	CD	_	14	num	_	_
14	bp	_	NN	NN	_	10	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	5'	_	JJ	JJ	_	18	amod	_	_
17	flanking	_	JJ	JJ	_	18	amod	_	_
18	DNA	_	NN	NN	_	15	pobj	_	_
19	,	_	,	,	_	18	punct	_	_
20	which	_	WDT	WDT	_	21	nsubj	_	_
21	contains	_	VBZ	VBZ	_	18	rcmod	_	_
22	nine	_	CD	CD	_	24	num	_	_
23	binding	_	VBG	VBG	_	24	amod	_	_
24	sites	_	NNS	NNS	_	21	dobj	_	_
25	for	_	IN	IN	_	24	prep	_	_
26	a	_	DT	DT	_	28	det	_	_
27	nuclear	_	JJ	JJ	_	28	amod	_	_
28	factor	_	NN	NN	_	25	pobj	_	_
29	present	_	JJ	JJ	_	24	amod	_	_
30	in	_	IN	IN	_	29	prep	_	_
31	non-erythroid	_	JJ	JJ	_	32	amod	_	_
32	cells	_	NNS	NNS	_	30	pobj	_	_
33	but	_	CC	CC	_	30	cc	_	_
34	not	_	RB	RB	_	35	neg	_	_
35	in	_	IN	IN	_	30	conj	_	_
36	erythroid	_	JJ	JJ	_	37	amod	_	_
37	cells	_	NNS	NNS	_	35	pobj	_	_
38	.	_	.	.	_	9	punct	_	_

1	These	_	DT	DT	_	3	det	_	_
2	binding	_	VBG	VBG	_	3	amod	_	_
3	sites	_	NNS	NNS	_	4	nsubj	_	_
4	have	_	VBP	VBP	_	0	root	_	_
5	similar	_	JJ	JJ	_	6	amod	_	_
6	sequences	_	NNS	NNS	_	4	dobj	_	_
7	and	_	CC	CC	_	4	cc	_	_
8	multiple	_	JJ	JJ	_	9	amod	_	_
9	copies	_	NNS	NNS	_	14	nsubj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	binding	_	VBG	VBG	_	13	amod	_	_
13	sites	_	NNS	NNS	_	10	pobj	_	_
14	confer	_	VBP	VBP	_	4	conj	_	_
15	tissue-specific	_	JJ	JJ	_	16	amod	_	_
16	down-regulation	_	NN	NN	_	14	dobj	_	_
17	when	_	WRB	WRB	_	18	advmod	_	_
18	attached	_	VBN	VBN	_	14	advcl	_	_
19	to	_	TO	TO	_	18	prep	_	_
20	a	_	DT	DT	_	24	det	_	_
21	minimal	_	JJ	JJ	_	24	amod	_	_
22	lox	_	NN	NN	_	24	nn	_	_
23	promoter	_	NN	NN	_	24	nn	_	_
24	fragment	_	NN	NN	_	19	pobj	_	_
25	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	5'	_	JJ	JJ	_	4	amod	_	_
3	flanking	_	JJ	JJ	_	4	amod	_	_
4	DNA	_	NN	NN	_	6	nsubj	_	_
5	also	_	RB	RB	_	6	advmod	_	_
6	contains	_	VBZ	VBZ	_	0	root	_	_
7	a	_	DT	DT	_	8	det	_	_
8	cluster	_	NN	NN	_	6	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	three	_	CD	CD	_	12	num	_	_
11	binding	_	VBG	VBG	_	12	amod	_	_
12	sites	_	NNS	NNS	_	9	pobj	_	_
13	for	_	IN	IN	_	8	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	GATA	_	NN	NN	_	16	nn	_	_
16	family	_	NN	NN	_	13	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	transcription	_	NN	NN	_	19	nn	_	_
19	factors	_	NNS	NNS	_	17	pobj	_	_
20	.	_	.	.	_	6	punct	_	_

1	Staphylococcal	_	JJ	JJ	_	2	amod	_	_
2	enterotoxins	_	NNS	NNS	_	3	nsubj	_	_
3	modulate	_	VBP	VBP	_	0	root	_	_
4	interleukin	_	NN	NN	_	6	nn	_	_
5	2	_	CD	CD	_	6	num	_	_
6	receptor	_	NN	NN	_	7	nn	_	_
7	expression	_	NN	NN	_	3	dobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	ligand-induced	_	JJ	JJ	_	11	amod	_	_
10	tyrosine	_	NN	NN	_	11	nn	_	_
11	phosphorylation	_	NN	NN	_	7	conj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	16	det	_	_
14	Janus	_	NN	NN	_	16	nn	_	_
15	protein-tyrosine	_	NN	NN	_	16	nn	_	_
16	kinase	_	NN	NN	_	12	pobj	_	_
17	3	_	CD	CD	_	16	num	_	_
18	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
19	Jak3	_	NN	NN	_	16	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	and	_	CC	CC	_	16	cc	_	_
22	signal	_	NN	NN	_	23	nn	_	_
23	transducers	_	NNS	NNS	_	16	conj	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	activators	_	NNS	NNS	_	27	nn	_	_
26	of	_	IN	IN	_	27	amod	_	_
27	transcription	_	NN	NN	_	23	conj	_	_
28	-LRB-	_	-LRB-	-LRB-	_	30	punct	_	_
29	Stat	_	NN	NN	_	30	nn	_	_
30	proteins	_	NNS	NNS	_	23	appos	_	_
31	-RRB-	_	-RRB-	-RRB-	_	30	punct	_	_
32	.	_	.	.	_	3	punct	_	_

1	Staphylococcal	_	JJ	JJ	_	2	amod	_	_
2	enterotoxins	_	NN	NN	_	6	nsubj	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	SE	_	NNS	NNS	_	2	appos	_	_
5	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
6	stimulate	_	VBP	VBP	_	0	root	_	_
7	T	_	NN	NN	_	8	nn	_	_
8	cells	_	NNS	NNS	_	6	dobj	_	_
9	expressing	_	VBG	VBG	_	8	vmod	_	_
10	the	_	DT	DT	_	22	det	_	_
11	appropriate	_	JJ	JJ	_	22	amod	_	_
12	variable	_	JJ	JJ	_	22	amod	_	_
13	region	_	NN	NN	_	22	nn	_	_
14	beta	_	NN	NN	_	22	nn	_	_
15	chain	_	NN	NN	_	22	nn	_	_
16	of	_	IN	IN	_	22	amod	_	_
17	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
18	V	_	NN	NN	_	22	nn	_	_
19	beta	_	NN	NN	_	22	nn	_	_
20	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
21	T-cell	_	NN	NN	_	22	nn	_	_
22	receptors	_	NNS	NNS	_	9	dobj	_	_
23	and	_	CC	CC	_	6	cc	_	_
24	have	_	VBP	VBP	_	26	aux	_	_
25	been	_	VBN	VBN	_	26	auxpass	_	_
26	implicated	_	VBN	VBN	_	6	conj	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	29	det	_	_
29	pathogenesis	_	NN	NN	_	27	pobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	several	_	JJ	JJ	_	33	amod	_	_
32	autoimmune	_	JJ	JJ	_	33	amod	_	_
33	diseases	_	NNS	NNS	_	30	pobj	_	_
34	.	_	.	.	_	6	punct	_	_

1	Depending	_	VBG	VBG	_	7	prep	_	_
2	on	_	IN	IN	_	1	pcomp	_	_
3	costimulatory	_	JJ	JJ	_	4	amod	_	_
4	signals	_	NNS	NNS	_	2	pobj	_	_
5	,	_	,	,	_	7	punct	_	_
6	SE	_	NNS	NNS	_	7	nsubj	_	_
7	induce	_	VBP	VBP	_	0	root	_	_
8	either	_	CC	CC	_	9	preconj	_	_
9	proliferation	_	NN	NN	_	7	dobj	_	_
10	or	_	CC	CC	_	9	cc	_	_
11	anergy	_	NN	NN	_	9	conj	_	_
12	in	_	IN	IN	_	9	prep	_	_
13	T	_	NN	NN	_	14	nn	_	_
14	cells	_	NNS	NNS	_	12	pobj	_	_
15	.	_	.	.	_	7	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	6	punct	_	_
4	SE	_	NNS	NNS	_	6	nsubj	_	_
5	can	_	MD	MD	_	6	aux	_	_
6	induce	_	VB	VB	_	0	root	_	_
7	an	_	DT	DT	_	13	det	_	_
8	interleukin-2	_	NN	NN	_	13	nn	_	_
9	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	IL-2	_	NN	NN	_	8	appos	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	nonresponsive	_	JJ	JJ	_	13	amod	_	_
13	state	_	NN	NN	_	6	dobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	apoptosis	_	NN	NN	_	13	conj	_	_
16	.	_	.	.	_	6	punct	_	_

1	Here	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	show	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	7	mark	_	_
6	SE	_	NNS	NNS	_	7	nsubj	_	_
7	induce	_	VBP	VBP	_	4	ccomp	_	_
8	dynamic	_	JJ	JJ	_	9	amod	_	_
9	changes	_	NNS	NNS	_	7	dobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	expression	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	and	_	CC	CC	_	12	cc	_	_
15	signal	_	NN	NN	_	16	nn	_	_
16	transduction	_	NN	NN	_	12	conj	_	_
17	through	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	dep	_	_
19	IL-2	_	NN	NN	_	20	nn	_	_
20	receptor	_	NN	NN	_	12	dep	_	_
21	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
22	IL-2R	_	NN	NN	_	20	appos	_	_
23	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
24	beta	_	NN	NN	_	20	dep	_	_
25	and	_	CC	CC	_	20	cc	_	_
26	gamma	_	NN	NN	_	20	conj	_	_
27	chains	_	NNS	NNS	_	20	dep	_	_
28	-LRB-	_	-LRB-	-LRB-	_	30	punct	_	_
29	IL-2R	_	NN	NN	_	30	nn	_	_
30	beta	_	NN	NN	_	20	dep	_	_
31	and	_	CC	CC	_	30	cc	_	_
32	IL-2R	_	NN	NN	_	33	nn	_	_
33	gamma	_	NN	NN	_	30	conj	_	_
34	-RRB-	_	-RRB-	-RRB-	_	30	punct	_	_
35	in	_	IN	IN	_	9	prep	_	_
36	human	_	JJ	JJ	_	40	amod	_	_
37	antigen-specific	_	JJ	JJ	_	40	amod	_	_
38	CD4+	_	JJ	JJ	_	40	amod	_	_
39	T-cell	_	NN	NN	_	40	nn	_	_
40	lines	_	NNS	NNS	_	35	pobj	_	_
41	.	_	.	.	_	4	punct	_	_

1	Thus	_	RB	RB	_	19	advmod	_	_
2	,	_	,	,	_	19	punct	_	_
3	after	_	IN	IN	_	19	prep	_	_
4	4	_	CD	CD	_	5	num	_	_
5	hr	_	NN	NN	_	3	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	exposure	_	NN	NN	_	6	pobj	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	SEA	_	NN	NN	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	SEB	_	NN	NN	_	9	conj	_	_
12	,	_	,	,	_	19	punct	_	_
13	the	_	DT	DT	_	14	det	_	_
14	expression	_	NN	NN	_	19	nsubjpass	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	IL-2R	_	NN	NN	_	17	nn	_	_
17	beta	_	NN	NN	_	15	pobj	_	_
18	was	_	VBD	VBD	_	19	auxpass	_	_
19	down-regulated	_	VBN	VBN	_	0	root	_	_
20	,	_	,	,	_	19	punct	_	_
21	IL-2R	_	NN	NN	_	22	nn	_	_
22	gamma	_	NN	NN	_	25	nsubjpass	_	_
23	was	_	VBD	VBD	_	25	auxpass	_	_
24	slightly	_	RB	RB	_	25	advmod	_	_
25	up-regulated	_	VBN	VBN	_	19	parataxis	_	_
26	,	_	,	,	_	25	punct	_	_
27	while	_	IN	IN	_	30	mark	_	_
28	IL-2R	_	NN	NN	_	29	nn	_	_
29	alpha	_	NN	NN	_	30	nsubj	_	_
30	remained	_	VBD	VBD	_	25	advcl	_	_
31	largely	_	RB	RB	_	32	advmod	_	_
32	unaffected	_	JJ	JJ	_	30	acomp	_	_
33	.	_	.	.	_	19	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	changes	_	NNS	NNS	_	9	nsubjpass	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	5	det	_	_
5	composition	_	NN	NN	_	3	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	IL-2Rs	_	NNS	NNS	_	6	pobj	_	_
8	were	_	VBD	VBD	_	9	auxpass	_	_
9	accompanied	_	VBN	VBN	_	0	root	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	inhibition	_	NN	NN	_	10	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	IL-2-induced	_	JJ	JJ	_	15	amod	_	_
14	tyrosine	_	NN	NN	_	15	nn	_	_
15	phosphorylation	_	NN	NN	_	12	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	20	det	_	_
18	Janus	_	NN	NN	_	20	nn	_	_
19	protein-tyrosine	_	NN	NN	_	20	nn	_	_
20	kinase	_	NN	NN	_	16	pobj	_	_
21	3	_	CD	CD	_	20	num	_	_
22	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
23	Jak3	_	NN	NN	_	20	appos	_	_
24	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
25	and	_	CC	CC	_	20	cc	_	_
26	signal	_	NN	NN	_	27	nn	_	_
27	transducers	_	NNS	NNS	_	20	conj	_	_
28	and	_	CC	CC	_	27	cc	_	_
29	activators	_	NNS	NNS	_	31	nn	_	_
30	of	_	IN	IN	_	31	amod	_	_
31	transcription	_	NN	NN	_	27	conj	_	_
32	called	_	VBN	VBN	_	27	vmod	_	_
33	Stat3	_	NN	NN	_	32	dep	_	_
34	and	_	CC	CC	_	33	cc	_	_
35	Stat5	_	NN	NN	_	33	conj	_	_
36	.	_	.	.	_	9	punct	_	_

1	In	_	IN	IN	_	8	prep	_	_
2	parallel	_	JJ	JJ	_	3	amod	_	_
3	experiments	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	8	punct	_	_
5	IL-2-driven	_	JJ	JJ	_	6	amod	_	_
6	proliferation	_	NN	NN	_	8	nsubjpass	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	inhibited	_	VBN	VBN	_	0	root	_	_
9	significantly	_	RB	RB	_	8	advmod	_	_
10	.	_	.	.	_	8	punct	_	_

1	After	_	IN	IN	_	14	prep	_	_
2	16	_	CD	CD	_	3	num	_	_
3	hr	_	NN	NN	_	1	pobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	exposure	_	NN	NN	_	4	pobj	_	_
6	to	_	TO	TO	_	5	prep	_	_
7	SE	_	NNS	NNS	_	6	pobj	_	_
8	,	_	,	,	_	14	punct	_	_
9	the	_	DT	DT	_	10	det	_	_
10	expression	_	NN	NN	_	14	nsubj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	IL-2R	_	NN	NN	_	13	nn	_	_
13	beta	_	NN	NN	_	11	pobj	_	_
14	remained	_	VBD	VBD	_	0	root	_	_
15	low	_	JJ	JJ	_	14	acomp	_	_
16	,	_	,	,	_	14	punct	_	_
17	while	_	IN	IN	_	27	mark	_	_
18	that	_	DT	DT	_	27	nsubjpass	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	IL2R	_	NN	NN	_	21	nn	_	_
21	alpha	_	NN	NN	_	19	pobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	IL2R	_	NN	NN	_	24	nn	_	_
24	gamma	_	NN	NN	_	21	conj	_	_
25	was	_	VBD	VBD	_	27	auxpass	_	_
26	further	_	RB	RB	_	27	advmod	_	_
27	up-regulated	_	VBN	VBN	_	14	advcl	_	_
28	,	_	,	,	_	14	punct	_	_
29	and	_	CC	CC	_	14	cc	_	_
30	ligand-induced	_	JJ	JJ	_	32	amod	_	_
31	tyrosine	_	NN	NN	_	32	nn	_	_
32	phosphorylation	_	NN	NN	_	40	nsubjpass	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	Jak3	_	NN	NN	_	33	pobj	_	_
35	and	_	CC	CC	_	34	cc	_	_
36	Stat	_	NN	NN	_	37	nn	_	_
37	proteins	_	NNS	NNS	_	34	conj	_	_
38	was	_	VBD	VBD	_	40	auxpass	_	_
39	partly	_	RB	RB	_	40	advmod	_	_
40	normalized	_	VBN	VBN	_	14	conj	_	_
41	.	_	.	.	_	14	punct	_	_

1	Yet	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	IL-2-driven	_	JJ	JJ	_	4	amod	_	_
4	proliferation	_	NN	NN	_	5	nsubj	_	_
5	remained	_	VBD	VBD	_	0	root	_	_
6	profoundly	_	RB	RB	_	7	advmod	_	_
7	inhibited	_	JJ	JJ	_	5	acomp	_	_
8	,	_	,	,	_	5	punct	_	_
9	suggesting	_	VBG	VBG	_	5	vmod	_	_
10	that	_	IN	IN	_	20	mark	_	_
11	signaling	_	NN	NN	_	12	nn	_	_
12	events	_	NNS	NNS	_	20	nsubjpass	_	_
13	other	_	JJ	JJ	_	12	cc	_	_
14	than	_	IN	IN	_	13	dep	_	_
15	Jak3/Stat	_	NN	NN	_	16	nn	_	_
16	activation	_	NN	NN	_	12	conj	_	_
17	had	_	VBD	VBD	_	20	aux	_	_
18	also	_	RB	RB	_	20	advmod	_	_
19	been	_	VBN	VBN	_	20	auxpass	_	_
20	changed	_	VBN	VBN	_	9	ccomp	_	_
21	following	_	VBG	VBG	_	20	prep	_	_
22	SE	_	NNS	NNS	_	23	nn	_	_
23	stimulation	_	NN	NN	_	21	pobj	_	_
24	.	_	.	.	_	5	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	conclusion	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	6	punct	_	_
4	our	_	PRP$	PRP$	_	5	poss	_	_
5	data	_	NNS	NNS	_	6	nsubj	_	_
6	suggest	_	VBP	VBP	_	0	root	_	_
7	that	_	IN	IN	_	10	mark	_	_
8	SE	_	NNS	NNS	_	10	nsubj	_	_
9	can	_	MD	MD	_	10	aux	_	_
10	modulate	_	VB	VB	_	6	ccomp	_	_
11	IL-2R	_	NN	NN	_	12	nn	_	_
12	expression	_	NN	NN	_	10	dobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	signal	_	NN	NN	_	15	nn	_	_
15	transduction	_	NN	NN	_	12	conj	_	_
16	involving	_	VBG	VBG	_	15	vmod	_	_
17	the	_	DT	DT	_	19	det	_	_
18	Jak/Stat	_	NN	NN	_	19	nn	_	_
19	pathway	_	NN	NN	_	16	dobj	_	_
20	in	_	IN	IN	_	12	prep	_	_
21	CD4+	_	JJ	JJ	_	23	amod	_	_
22	T-cell	_	NN	NN	_	23	nn	_	_
23	lines	_	NNS	NNS	_	20	pobj	_	_
24	.	_	.	.	_	6	punct	_	_

1	Mutation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	Jak3	_	NN	NN	_	2	pobj	_	_
4	in	_	IN	IN	_	1	prep	_	_
5	a	_	DT	DT	_	6	det	_	_
6	patient	_	NN	NN	_	4	pobj	_	_
7	with	_	IN	IN	_	6	prep	_	_
8	SCID	_	NN	NN	_	7	pobj	_	_
9	:	_	:	:	_	1	punct	_	_
10	essential	_	JJ	JJ	_	11	amod	_	_
11	role	_	NN	NN	_	1	dep	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	Jak3	_	NN	NN	_	12	pobj	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	lymphoid	_	JJ	JJ	_	16	amod	_	_
16	development	_	NN	NN	_	14	pobj	_	_
17	.	_	.	.	_	1	punct	_	_

1	Males	_	NNS	NNS	_	10	nsubj	_	_
2	with	_	IN	IN	_	1	prep	_	_
3	X-linked	_	JJ	JJ	_	6	amod	_	_
4	severe	_	JJ	JJ	_	6	amod	_	_
5	combined	_	JJ	JJ	_	6	amod	_	_
6	immunodeficiency	_	NN	NN	_	2	pobj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	XSCID	_	NN	NN	_	6	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	have	_	VBP	VBP	_	0	root	_	_
11	defects	_	NNS	NNS	_	10	dobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	23	det	_	_
14	common	_	JJ	JJ	_	23	amod	_	_
15	cytokine	_	NN	NN	_	23	nn	_	_
16	receptor	_	NN	NN	_	23	nn	_	_
17	gamma	_	NN	NN	_	23	nn	_	_
18	chain	_	NN	NN	_	23	nn	_	_
19	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
20	gamma	_	NN	NN	_	23	nn	_	_
21	c	_	NN	NN	_	23	nn	_	_
22	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
23	gene	_	NN	NN	_	12	pobj	_	_
24	that	_	WDT	WDT	_	25	nsubj	_	_
25	encodes	_	VBZ	VBZ	_	23	rcmod	_	_
26	a	_	DT	DT	_	30	det	_	_
27	shared	_	JJ	JJ	_	30	amod	_	_
28	,	_	,	,	_	27	punct	_	_
29	essential	_	JJ	JJ	_	27	dep	_	_
30	component	_	NN	NN	_	25	dobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	the	_	DT	DT	_	33	det	_	_
33	receptors	_	NNS	NNS	_	31	pobj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	interleukin-2	_	NN	NN	_	34	pobj	_	_
36	-LRB-	_	-LRB-	-LRB-	_	37	punct	_	_
37	IL-2	_	NN	NN	_	35	appos	_	_
38	-RRB-	_	-RRB-	-RRB-	_	37	punct	_	_
39	,	_	,	,	_	35	punct	_	_
40	IL-4	_	NN	NN	_	35	conj	_	_
41	,	_	,	,	_	35	punct	_	_
42	IL-7	_	NN	NN	_	35	conj	_	_
43	,	_	,	,	_	35	punct	_	_
44	IL-9	_	NN	NN	_	35	conj	_	_
45	,	_	,	,	_	35	punct	_	_
46	and	_	CC	CC	_	35	cc	_	_
47	IL-15	_	NN	NN	_	35	conj	_	_
48	.	_	.	.	_	10	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	Janus	_	NN	NN	_	5	nn	_	_
3	family	_	NN	NN	_	5	nn	_	_
4	tyrosine	_	NN	NN	_	5	nn	_	_
5	kinase	_	NN	NN	_	11	nsubj	_	_
6	Jak3	_	NN	NN	_	5	dep	_	_
7	is	_	VBZ	VBZ	_	11	cop	_	_
8	the	_	DT	DT	_	11	det	_	_
9	only	_	JJ	JJ	_	11	amod	_	_
10	signaling	_	VBG	VBG	_	11	amod	_	_
11	molecule	_	NN	NN	_	0	root	_	_
12	known	_	VBN	VBN	_	11	vmod	_	_
13	to	_	TO	TO	_	15	aux	_	_
14	be	_	VB	VB	_	15	auxpass	_	_
15	associated	_	VBN	VBN	_	12	xcomp	_	_
16	with	_	IN	IN	_	15	prep	_	_
17	gamma	_	NN	NN	_	18	nn	_	_
18	c	_	NN	NN	_	16	pobj	_	_
19	,	_	,	,	_	11	punct	_	_
20	so	_	IN	IN	_	23	mark	_	_
21	it	_	PRP	PRP	_	23	nsubjpass	_	_
22	was	_	VBD	VBD	_	23	auxpass	_	_
23	hypothesized	_	VBN	VBN	_	11	advcl	_	_
24	that	_	IN	IN	_	29	mark	_	_
25	defects	_	NNS	NNS	_	29	nsubj	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	Jak3	_	NN	NN	_	26	pobj	_	_
28	might	_	MD	MD	_	29	aux	_	_
29	cause	_	VB	VB	_	23	ccomp	_	_
30	an	_	DT	DT	_	32	det	_	_
31	XSCID-like	_	JJ	JJ	_	32	amod	_	_
32	phenotype	_	NN	NN	_	29	dobj	_	_
33	.	_	.	.	_	11	punct	_	_

1	A	_	DT	DT	_	2	det	_	_
2	girl	_	NN	NN	_	13	nsubjpass	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	immunological	_	JJ	JJ	_	5	amod	_	_
5	features	_	NNS	NNS	_	3	pobj	_	_
6	indistinguishable	_	JJ	JJ	_	5	amod	_	_
7	from	_	IN	IN	_	6	prep	_	_
8	those	_	DT	DT	_	7	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	XSCID	_	NN	NN	_	9	pobj	_	_
11	was	_	VBD	VBD	_	13	auxpass	_	_
12	therefore	_	RB	RB	_	13	advmod	_	_
13	selected	_	VBN	VBN	_	0	root	_	_
14	for	_	IN	IN	_	13	prep	_	_
15	analysis	_	NN	NN	_	14	pobj	_	_
16	.	_	.	.	_	13	punct	_	_

1	An	_	DT	DT	_	9	det	_	_
2	Epstein-Barr	_	JJ	JJ	_	9	amod	_	_
3	virus	_	NN	NN	_	9	nn	_	_
4	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
5	EBV	_	NN	NN	_	9	nn	_	_
6	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
7	-transformed	_	JJ	JJ	_	9	amod	_	_
8	cell	_	NN	NN	_	9	nn	_	_
9	line	_	NN	NN	_	14	nsubj	_	_
10	derived	_	VBN	VBN	_	9	vmod	_	_
11	from	_	IN	IN	_	10	prep	_	_
12	her	_	PRP$	PRP$	_	13	poss	_	_
13	lymphocytes	_	NNS	NNS	_	11	pobj	_	_
14	had	_	VBD	VBD	_	0	root	_	_
15	normal	_	JJ	JJ	_	18	amod	_	_
16	gamma	_	NN	NN	_	17	nn	_	_
17	c	_	NN	NN	_	18	nn	_	_
18	expression	_	NN	NN	_	14	dobj	_	_
19	but	_	CC	CC	_	14	cc	_	_
20	lacked	_	VBD	VBD	_	14	conj	_	_
21	Jak3	_	NN	NN	_	22	nn	_	_
22	protein	_	NN	NN	_	20	dobj	_	_
23	and	_	CC	CC	_	14	cc	_	_
24	had	_	VBD	VBD	_	14	conj	_	_
25	greatly	_	RB	RB	_	26	advmod	_	_
26	diminished	_	VBN	VBN	_	29	amod	_	_
27	Jak3	_	NN	NN	_	29	nn	_	_
28	messenger	_	NN	NN	_	29	nn	_	_
29	RNA	_	NN	NN	_	24	dobj	_	_
30	.	_	.	.	_	14	punct	_	_

1	Sequencing	_	NN	NN	_	2	nsubj	_	_
2	revealed	_	VBD	VBD	_	0	root	_	_
3	a	_	DT	DT	_	5	det	_	_
4	different	_	JJ	JJ	_	5	amod	_	_
5	mutation	_	NN	NN	_	2	dobj	_	_
6	on	_	IN	IN	_	5	prep	_	_
7	each	_	DT	DT	_	8	det	_	_
8	allele	_	NN	NN	_	6	pobj	_	_
9	:	_	:	:	_	2	punct	_	_
10	a	_	DT	DT	_	13	det	_	_
11	single	_	JJ	JJ	_	13	amod	_	_
12	nucleotide	_	NN	NN	_	13	nn	_	_
13	insertion	_	NN	NN	_	2	dep	_	_
14	resulting	_	VBG	VBG	_	13	vmod	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	a	_	DT	DT	_	18	det	_	_
17	frame	_	NN	NN	_	18	nn	_	_
18	shift	_	NN	NN	_	15	pobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	premature	_	JJ	JJ	_	21	amod	_	_
21	termination	_	NN	NN	_	18	conj	_	_
22	in	_	IN	IN	_	18	prep	_	_
23	the	_	DT	DT	_	26	det	_	_
24	Jak3	_	NN	NN	_	26	nn	_	_
25	JH4	_	NN	NN	_	26	nn	_	_
26	domain	_	NN	NN	_	22	pobj	_	_
27	and	_	CC	CC	_	18	cc	_	_
28	a	_	DT	DT	_	30	det	_	_
29	nonsense	_	JJ	JJ	_	30	amod	_	_
30	mutation	_	NN	NN	_	18	conj	_	_
31	in	_	IN	IN	_	30	prep	_	_
32	the	_	DT	DT	_	35	det	_	_
33	Jak3	_	NN	NN	_	35	nn	_	_
34	JH2	_	NN	NN	_	35	nn	_	_
35	domain	_	NN	NN	_	31	pobj	_	_
36	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	lack	_	NN	NN	_	6	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	Jak3	_	NN	NN	_	5	nn	_	_
5	expression	_	NN	NN	_	3	pobj	_	_
6	correlated	_	VBD	VBD	_	0	root	_	_
7	with	_	IN	IN	_	6	prep	_	_
8	impaired	_	JJ	JJ	_	11	amod	_	_
9	B	_	NN	NN	_	11	nn	_	_
10	cell	_	NN	NN	_	11	nn	_	_
11	signaling	_	NN	NN	_	7	pobj	_	_
12	,	_	,	,	_	6	punct	_	_
13	as	_	IN	IN	_	14	mark	_	_
14	demonstrated	_	VBN	VBN	_	6	advcl	_	_
15	by	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	17	det	_	_
17	inability	_	NN	NN	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	IL-4	_	NN	NN	_	18	pobj	_	_
20	to	_	TO	TO	_	21	aux	_	_
21	activate	_	VB	VB	_	17	vmod	_	_
22	Stat6	_	NN	NN	_	21	dobj	_	_
23	in	_	IN	IN	_	21	prep	_	_
24	the	_	DT	DT	_	27	det	_	_
25	EBV-transformed	_	JJ	JJ	_	27	amod	_	_
26	cell	_	NN	NN	_	27	nn	_	_
27	line	_	NN	NN	_	23	pobj	_	_
28	from	_	IN	IN	_	27	prep	_	_
29	the	_	DT	DT	_	30	det	_	_
30	patient	_	NN	NN	_	28	pobj	_	_
31	.	_	.	.	_	6	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	observations	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	11	mark	_	_
5	the	_	DT	DT	_	6	det	_	_
6	functions	_	NNS	NNS	_	11	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	gamma	_	NN	NN	_	9	nn	_	_
9	c	_	NN	NN	_	7	pobj	_	_
10	are	_	VBP	VBP	_	11	cop	_	_
11	dependent	_	JJ	JJ	_	3	ccomp	_	_
12	on	_	IN	IN	_	11	prep	_	_
13	Jak3	_	NN	NN	_	12	pobj	_	_
14	and	_	CC	CC	_	11	cc	_	_
15	that	_	IN	IN	_	18	mark	_	_
16	Jak3	_	NN	NN	_	18	nsubj	_	_
17	is	_	VBZ	VBZ	_	18	cop	_	_
18	essential	_	JJ	JJ	_	11	conj	_	_
19	for	_	IN	IN	_	18	prep	_	_
20	lymphoid	_	JJ	JJ	_	21	amod	_	_
21	development	_	NN	NN	_	19	pobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	signaling	_	NN	NN	_	21	conj	_	_
24	.	_	.	.	_	3	punct	_	_

1	Costimulation	_	NN	NN	_	2	nn	_	_
2	requirement	_	NN	NN	_	0	root	_	_
3	for	_	IN	IN	_	2	prep	_	_
4	AP-1	_	NN	NN	_	10	nn	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	NF-kappa	_	NN	NN	_	7	nn	_	_
7	B	_	NN	NN	_	4	conj	_	_
8	transcription	_	NN	NN	_	10	nn	_	_
9	factor	_	NN	NN	_	10	nn	_	_
10	activation	_	NN	NN	_	3	pobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	T	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	11	pobj	_	_
14	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	transcriptional	_	JJ	JJ	_	3	amod	_	_
3	activity	_	NN	NN	_	8	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	IL-2	_	NN	NN	_	7	nn	_	_
7	promoter	_	NN	NN	_	4	pobj	_	_
8	requires	_	VBZ	VBZ	_	0	root	_	_
9	T-cell	_	NN	NN	_	10	nn	_	_
10	costimulation	_	NN	NN	_	8	dobj	_	_
11	delivered	_	VBN	VBN	_	10	vmod	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	TCR	_	NN	NN	_	12	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	the	_	DT	DT	_	19	det	_	_
17	auxiliary	_	JJ	JJ	_	19	amod	_	_
18	receptor	_	NN	NN	_	19	nn	_	_
19	CD28	_	NN	NN	_	14	conj	_	_
20	.	_	.	.	_	8	punct	_	_

1	Several	_	JJ	JJ	_	3	amod	_	_
2	transcription	_	NN	NN	_	3	nn	_	_
3	factors	_	NNS	NNS	_	4	nsubj	_	_
4	participate	_	VBP	VBP	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	IL-2	_	NN	NN	_	8	nn	_	_
7	promoter	_	NN	NN	_	8	nn	_	_
8	activation	_	NN	NN	_	5	pobj	_	_
9	,	_	,	,	_	8	punct	_	_
10	among	_	IN	IN	_	14	dep	_	_
11	which	_	WDT	WDT	_	10	pobj	_	_
12	are	_	VBP	VBP	_	14	cop	_	_
13	AP-1-like	_	JJ	JJ	_	14	amod	_	_
14	factors	_	NNS	NNS	_	8	rcmod	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	NF-kappa	_	NN	NN	_	17	nn	_	_
17	B	_	NN	NN	_	14	conj	_	_
18	.	_	.	.	_	4	punct	_	_

1	Protein	_	NN	NN	_	2	nn	_	_
2	phosphorylation	_	NN	NN	_	3	nsubj	_	_
3	has	_	VBZ	VBZ	_	0	root	_	_
4	an	_	DT	DT	_	6	det	_	_
5	important	_	JJ	JJ	_	6	amod	_	_
6	role	_	NN	NN	_	3	dobj	_	_
7	in	_	IN	IN	_	3	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	regulation	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	these	_	DT	DT	_	13	det	_	_
12	two	_	CD	CD	_	13	num	_	_
13	factors	_	NNS	NNS	_	10	pobj	_	_
14	:	_	:	:	_	3	punct	_	_
15	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
16	1	_	LS	LS	_	19	dep	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	it	_	PRP	PRP	_	19	nsubj	_	_
19	induces	_	VBZ	VBZ	_	3	parataxis	_	_
20	the	_	DT	DT	_	22	det	_	_
21	transactivating	_	NN	NN	_	22	nn	_	_
22	capacity	_	NN	NN	_	19	dobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	26	det	_	_
25	AP-1	_	NN	NN	_	26	nn	_	_
26	protein	_	NN	NN	_	23	pobj	_	_
27	c-Jun	_	NN	NN	_	26	dep	_	_
28	;	_	:	:	_	19	punct	_	_
29	and	_	CC	CC	_	19	cc	_	_
30	-LRB-	_	-LRB-	-LRB-	_	31	punct	_	_
31	2	_	LS	LS	_	35	dep	_	_
32	-RRB-	_	-RRB-	-RRB-	_	31	punct	_	_
33	it	_	PRP	PRP	_	35	nsubjpass	_	_
34	is	_	VBZ	VBZ	_	35	auxpass	_	_
35	involved	_	VBN	VBN	_	19	conj	_	_
36	in	_	IN	IN	_	35	prep	_	_
37	the	_	DT	DT	_	38	det	_	_
38	release	_	NN	NN	_	36	pobj	_	_
39	of	_	IN	IN	_	38	prep	_	_
40	the	_	DT	DT	_	42	det	_	_
41	cytoplasmic	_	JJ	JJ	_	42	amod	_	_
42	inhibitor	_	NN	NN	_	39	pobj	_	_
43	,	_	,	,	_	42	punct	_	_
44	I	_	NN	NN	_	46	nn	_	_
45	kappa	_	NN	NN	_	46	nn	_	_
46	B	_	NN	NN	_	42	appos	_	_
47	,	_	,	,	_	38	punct	_	_
48	from	_	IN	IN	_	38	prep	_	_
49	NF-kappa	_	NN	NN	_	50	nn	_	_
50	B	_	NN	NN	_	48	pobj	_	_
51	,	_	,	,	_	35	punct	_	_
52	allowing	_	VBG	VBG	_	35	vmod	_	_
53	translocation	_	NN	NN	_	52	dobj	_	_
54	of	_	IN	IN	_	53	prep	_	_
55	the	_	DT	DT	_	56	det	_	_
56	latter	_	JJ	JJ	_	54	pobj	_	_
57	into	_	IN	IN	_	53	prep	_	_
58	the	_	DT	DT	_	59	det	_	_
59	nucleus	_	NN	NN	_	57	pobj	_	_
60	.	_	.	.	_	3	punct	_	_

1	We	_	PRP	PRP	_	4	nsubj	_	_
2	have	_	VBP	VBP	_	4	aux	_	_
3	recently	_	RB	RB	_	4	advmod	_	_
4	shown	_	VBN	VBN	_	0	root	_	_
5	that	_	IN	IN	_	9	mark	_	_
6	both	_	DT	DT	_	8	det	_	_
7	phosphorylation	_	NN	NN	_	8	nn	_	_
8	processes	_	NNS	NNS	_	9	nsubj	_	_
9	require	_	VBP	VBP	_	4	ccomp	_	_
10	T-cell	_	NN	NN	_	11	nn	_	_
11	costimulation	_	NN	NN	_	9	dobj	_	_
12	.	_	.	.	_	4	punct	_	_

1	Furthermore	_	RB	RB	_	17	advmod	_	_
2	,	_	,	,	_	17	punct	_	_
3	in	_	IN	IN	_	17	prep	_	_
4	activated	_	VBN	VBN	_	6	amod	_	_
5	T	_	NN	NN	_	6	nn	_	_
6	cells	_	NNS	NNS	_	3	pobj	_	_
7	,	_	,	,	_	17	punct	_	_
8	the	_	DT	DT	_	9	det	_	_
9	kinetics	_	NNS	NNS	_	17	nsubj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	14	det	_	_
12	two	_	CD	CD	_	14	num	_	_
13	phosphorylation	_	NN	NN	_	14	nn	_	_
14	events	_	NNS	NNS	_	10	pobj	_	_
15	are	_	VBP	VBP	_	17	cop	_	_
16	essentially	_	RB	RB	_	17	advmod	_	_
17	similar	_	JJ	JJ	_	0	root	_	_
18	.	_	.	.	_	17	punct	_	_

1	According	_	VBG	VBG	_	17	prep	_	_
2	to	_	TO	TO	_	1	pcomp	_	_
3	our	_	PRP$	PRP$	_	4	poss	_	_
4	results	_	NNS	NNS	_	2	pobj	_	_
5	,	_	,	,	_	17	punct	_	_
6	however	_	RB	RB	_	17	advmod	_	_
7	,	_	,	,	_	17	punct	_	_
8	the	_	DT	DT	_	9	det	_	_
9	kinases	_	NNS	NNS	_	17	nsubj	_	_
10	responsible	_	JJ	JJ	_	9	amod	_	_
11	for	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	two	_	CD	CD	_	14	num	_	_
14	processes	_	NNS	NNS	_	11	pobj	_	_
15	are	_	VBP	VBP	_	17	cop	_	_
16	distinct	_	JJ	JJ	_	17	amod	_	_
17	entities	_	NNS	NNS	_	0	root	_	_
18	.	_	.	.	_	17	punct	_	_

1	Whereas	_	IN	IN	_	3	mark	_	_
2	TPCK	_	NN	NN	_	3	nsubj	_	_
3	inhibits	_	VBZ	VBZ	_	20	advcl	_	_
4	phosphorylation	_	NN	NN	_	3	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	I	_	NN	NN	_	8	nn	_	_
7	kappa	_	NN	NN	_	8	nn	_	_
8	B	_	NN	NN	_	5	pobj	_	_
9	and	_	CC	CC	_	4	cc	_	_
10	,	_	,	,	_	4	punct	_	_
11	consequently	_	RB	RB	_	4	advmod	_	_
12	,	_	,	,	_	4	punct	_	_
13	activation	_	NN	NN	_	4	conj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	NF-kappa	_	NN	NN	_	16	nn	_	_
16	B	_	NN	NN	_	14	pobj	_	_
17	,	_	,	,	_	20	punct	_	_
18	it	_	PRP	PRP	_	20	nsubj	_	_
19	markedly	_	RB	RB	_	20	advmod	_	_
20	enhances	_	VBZ	VBZ	_	0	root	_	_
21	the	_	DT	DT	_	22	det	_	_
22	activity	_	NN	NN	_	20	dobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	JNK	_	NN	NN	_	23	pobj	_	_
25	,	_	,	,	_	24	punct	_	_
26	the	_	DT	DT	_	29	det	_	_
27	MAP	_	NN	NN	_	29	nn	_	_
28	kinase-related	_	JJ	JJ	_	29	amod	_	_
29	kinase	_	NN	NN	_	24	appos	_	_
30	that	_	WDT	WDT	_	31	nsubj	_	_
31	phosphorylates	_	VBZ	VBZ	_	29	rcmod	_	_
32	the	_	DT	DT	_	34	det	_	_
33	transactivation	_	NN	NN	_	34	nn	_	_
34	domain	_	NN	NN	_	31	dobj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	c-Jun	_	NN	NN	_	35	pobj	_	_
37	.	_	.	.	_	20	punct	_	_

1	We	_	PRP	PRP	_	5	nsubj	_	_
2	,	_	,	,	_	1	punct	_	_
3	therefore	_	RB	RB	_	5	advmod	_	_
4	,	_	,	,	_	5	punct	_	_
5	propose	_	VBP	VBP	_	0	root	_	_
6	the	_	DT	DT	_	8	det	_	_
7	activation	_	NN	NN	_	8	nn	_	_
8	scheme	_	NN	NN	_	5	dobj	_	_
9	presented	_	VBN	VBN	_	8	vmod	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	FIGURE	_	NN	NN	_	10	pobj	_	_
12	3	_	CD	CD	_	11	num	_	_
13	for	_	IN	IN	_	5	prep	_	_
14	T-cell	_	NN	NN	_	15	nn	_	_
15	costimulation	_	NN	NN	_	13	pobj	_	_
16	.	_	.	.	_	5	punct	_	_

1	Costimulation	_	NN	NN	_	2	nsubj	_	_
2	results	_	VBZ	VBZ	_	0	root	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	5	det	_	_
5	activation	_	NN	NN	_	3	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	a	_	DT	DT	_	9	det	_	_
8	signaling	_	NN	NN	_	9	nn	_	_
9	pathway	_	NN	NN	_	6	pobj	_	_
10	that	_	WDT	WDT	_	11	nsubj	_	_
11	leads	_	VBZ	VBZ	_	5	rcmod	_	_
12	to	_	TO	TO	_	11	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	simultaneous	_	JJ	JJ	_	15	amod	_	_
15	induction	_	NN	NN	_	12	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	20	det	_	_
18	two	_	CD	CD	_	20	num	_	_
19	transcription	_	NN	NN	_	20	nn	_	_
20	factors	_	NNS	NNS	_	16	pobj	_	_
21	,	_	,	,	_	20	punct	_	_
22	AP-1	_	NN	NN	_	20	appos	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	NF-kappa	_	NN	NN	_	25	nn	_	_
25	B	_	NN	NN	_	22	conj	_	_
26	.	_	.	.	_	2	punct	_	_

1	Integration	_	NN	NN	_	11	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	4	det	_	_
4	signals	_	NNS	NNS	_	2	pobj	_	_
5	generated	_	VBN	VBN	_	4	vmod	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	TCR	_	NN	NN	_	10	nn	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	CD28	_	NN	NN	_	7	conj	_	_
10	engagement	_	NN	NN	_	6	pobj	_	_
11	occurs	_	VBZ	VBZ	_	0	root	_	_
12	along	_	IN	IN	_	11	prep	_	_
13	this	_	DT	DT	_	14	det	_	_
14	pathway	_	NN	NN	_	12	pobj	_	_
15	,	_	,	,	_	14	punct	_	_
16	which	_	WDT	WDT	_	18	nsubj	_	_
17	then	_	RB	RB	_	18	advmod	_	_
18	bifurcates	_	VBZ	VBZ	_	14	rcmod	_	_
19	to	_	TO	TO	_	20	aux	_	_
20	induce	_	VB	VB	_	18	xcomp	_	_
21	I	_	NN	NN	_	23	nn	_	_
22	kappa	_	NN	NN	_	23	nn	_	_
23	B	_	NN	NN	_	24	nn	_	_
24	phosphorylation	_	NN	NN	_	20	dobj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	NF-kappa	_	NN	NN	_	27	nn	_	_
27	B	_	NN	NN	_	28	nn	_	_
28	activation	_	NN	NN	_	24	conj	_	_
29	on	_	IN	IN	_	24	prep	_	_
30	the	_	DT	DT	_	32	det	_	_
31	one	_	CD	CD	_	32	num	_	_
32	hand	_	NN	NN	_	29	pobj	_	_
33	,	_	,	,	_	24	punct	_	_
34	and	_	CC	CC	_	24	cc	_	_
35	JNK	_	NN	NN	_	36	nn	_	_
36	activation	_	NN	NN	_	24	conj	_	_
37	and	_	CC	CC	_	36	cc	_	_
38	c-Jun	_	NN	NN	_	39	nn	_	_
39	phosphorylation	_	NN	NN	_	36	conj	_	_
40	on	_	IN	IN	_	24	prep	_	_
41	the	_	DT	DT	_	42	det	_	_
42	other	_	JJ	JJ	_	40	pobj	_	_
43	.	_	.	.	_	11	punct	_	_

1	We	_	PRP	PRP	_	4	nsubjpass	_	_
2	are	_	VBP	VBP	_	4	auxpass	_	_
3	currently	_	RB	RB	_	4	advmod	_	_
4	engaged	_	VBN	VBN	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	defining	_	VBG	VBG	_	5	pcomp	_	_
7	where	_	WRB	WRB	_	11	advmod	_	_
8	the	_	DT	DT	_	10	det	_	_
9	two	_	CD	CD	_	10	num	_	_
10	signals	_	NNS	NNS	_	11	nsubj	_	_
11	integrate	_	VBP	VBP	_	6	advcl	_	_
12	along	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	16	det	_	_
14	AP-1/NF-kappa	_	NN	NN	_	16	nn	_	_
15	B	_	NN	NN	_	16	nn	_	_
16	pathway	_	NN	NN	_	12	pobj	_	_
17	.	_	.	.	_	4	punct	_	_

1	Interleukin-7	_	NN	NN	_	3	nsubj	_	_
2	can	_	MD	MD	_	3	aux	_	_
3	induce	_	VB	VB	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	activation	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	Jak	_	NN	NN	_	6	pobj	_	_
8	1	_	CD	CD	_	7	num	_	_
9	,	_	,	,	_	7	punct	_	_
10	Jak	_	NN	NN	_	7	conj	_	_
11	3	_	CD	CD	_	10	num	_	_
12	and	_	CC	CC	_	7	cc	_	_
13	STAT	_	NN	NN	_	15	nn	_	_
14	5	_	CD	CD	_	15	num	_	_
15	proteins	_	NNS	NNS	_	7	conj	_	_
16	in	_	IN	IN	_	5	prep	_	_
17	murine	_	JJ	JJ	_	19	amod	_	_
18	T	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	16	pobj	_	_
20	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	activation	_	NN	NN	_	25	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	Janus	_	NN	NN	_	7	nn	_	_
5	protein	_	NN	NN	_	7	nn	_	_
6	tyrosine	_	NN	NN	_	7	nn	_	_
7	kinases	_	NNS	NNS	_	3	pobj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	Jak	_	NN	NN	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	and	_	CC	CC	_	7	cc	_	_
12	STAT	_	NN	NN	_	15	nn	_	_
13	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
14	signal	_	NN	NN	_	15	nn	_	_
15	transducer	_	NN	NN	_	7	conj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	activator	_	NN	NN	_	21	nn	_	_
18	of	_	IN	IN	_	21	amod	_	_
19	transcription	_	NN	NN	_	21	nn	_	_
20	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
21	proteins	_	NNS	NNS	_	15	conj	_	_
22	has	_	VBZ	VBZ	_	25	aux	_	_
23	recently	_	RB	RB	_	25	advmod	_	_
24	been	_	VBN	VBN	_	25	auxpass	_	_
25	linked	_	VBN	VBN	_	0	root	_	_
26	to	_	TO	TO	_	25	prep	_	_
27	the	_	DT	DT	_	30	det	_	_
28	signal	_	NN	NN	_	30	nn	_	_
29	transduction	_	NN	NN	_	30	nn	_	_
30	mechanism	_	NN	NN	_	26	pobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	several	_	JJ	JJ	_	33	amod	_	_
33	cytokines	_	NNS	NNS	_	31	pobj	_	_
34	.	_	.	.	_	25	punct	_	_

1	IL-7	_	NN	NN	_	3	nsubjpass	_	_
2	was	_	VBD	VBD	_	3	auxpass	_	_
3	observed	_	VBN	VBN	_	0	root	_	_
4	to	_	TO	TO	_	5	aux	_	_
5	induce	_	VB	VB	_	3	xcomp	_	_
6	a	_	DT	DT	_	11	det	_	_
7	rapid	_	JJ	JJ	_	11	amod	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	dose-dependent	_	JJ	JJ	_	7	conj	_	_
10	tyrosine	_	NN	NN	_	11	nn	_	_
11	phosphorylation	_	NN	NN	_	5	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	Jak	_	NN	NN	_	12	pobj	_	_
14	1	_	CD	CD	_	13	num	_	_
15	and	_	CC	CC	_	13	cc	_	_
16	Jak	_	NN	NN	_	13	conj	_	_
17	3	_	CD	CD	_	16	num	_	_
18	and	_	CC	CC	_	11	cc	_	_
19	concomitantly	_	RB	RB	_	11	advmod	_	_
20	,	_	,	,	_	11	punct	_	_
21	the	_	DT	DT	_	23	dep	_	_
22	tyrosine	_	NN	NN	_	23	nn	_	_
23	phosphorylation	_	NN	NN	_	11	conj	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	DNA	_	NN	NN	_	27	nn	_	_
26	binding	_	NN	NN	_	27	nn	_	_
27	activity	_	NN	NN	_	23	conj	_	_
28	of	_	IN	IN	_	23	prep	_	_
29	multiple	_	JJ	JJ	_	31	amod	_	_
30	STAT	_	NN	NN	_	31	nn	_	_
31	proteins	_	NNS	NNS	_	28	pobj	_	_
32	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	STAT	_	NN	NN	_	3	nn	_	_
3	proteins	_	NNS	NNS	_	8	nsubj	_	_
4	utilized	_	VBN	VBN	_	3	vmod	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	IL-7	_	NN	NN	_	5	pobj	_	_
7	were	_	VBD	VBD	_	8	cop	_	_
8	identical	_	JJ	JJ	_	0	root	_	_
9	to	_	TO	TO	_	8	prep	_	_
10	those	_	DT	DT	_	9	pobj	_	_
11	induced	_	VBN	VBN	_	10	vmod	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	IL-2	_	NN	NN	_	12	pobj	_	_
14	and	_	CC	CC	_	8	cc	_	_
15	could	_	MD	MD	_	17	aux	_	_
16	be	_	VB	VB	_	17	auxpass	_	_
17	identified	_	VBN	VBN	_	8	conj	_	_
18	as	_	IN	IN	_	17	prep	_	_
19	various	_	JJ	JJ	_	22	amod	_	_
20	STAT	_	NN	NN	_	22	nn	_	_
21	5	_	CD	CD	_	22	num	_	_
22	isoforms	_	NNS	NNS	_	18	pobj	_	_
23	.	_	.	.	_	8	punct	_	_

1	Moreover	_	RB	RB	_	17	advmod	_	_
2	,	_	,	,	_	17	punct	_	_
3	the	_	DT	DT	_	4	det	_	_
4	induction	_	NN	NN	_	17	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	both	_	CC	CC	_	7	preconj	_	_
7	Jak	_	NN	NN	_	5	pobj	_	_
8	1	_	CD	CD	_	7	dep	_	_
9	and	_	CC	CC	_	7	cc	_	_
10	3	_	CD	CD	_	7	conj	_	_
11	,	_	,	,	_	4	punct	_	_
12	and	_	CC	CC	_	4	cc	_	_
13	STAT	_	NN	NN	_	15	nn	_	_
14	5	_	CD	CD	_	13	num	_	_
15	activity	_	NN	NN	_	4	conj	_	_
16	strongly	_	RB	RB	_	17	advmod	_	_
17	correlated	_	VBD	VBD	_	0	root	_	_
18	with	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	growth-promoting	_	JJ	JJ	_	21	amod	_	_
21	effects	_	NNS	NNS	_	18	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	IL-7	_	NN	NN	_	22	pobj	_	_
24	,	_	,	,	_	17	punct	_	_
25	suggesting	_	VBG	VBG	_	17	xcomp	_	_
26	that	_	IN	IN	_	32	mark	_	_
27	this	_	DT	DT	_	30	det	_	_
28	signal	_	NN	NN	_	30	nn	_	_
29	transduction	_	NN	NN	_	30	nn	_	_
30	mechanism	_	NN	NN	_	32	nsubj	_	_
31	may	_	MD	MD	_	32	aux	_	_
32	play	_	VB	VB	_	25	ccomp	_	_
33	a	_	DT	DT	_	35	det	_	_
34	key	_	JJ	JJ	_	35	amod	_	_
35	role	_	NN	NN	_	32	dobj	_	_
36	in	_	IN	IN	_	32	prep	_	_
37	IL-7-induced	_	JJ	JJ	_	38	amod	_	_
38	proliferation	_	NN	NN	_	36	pobj	_	_
39	.	_	.	.	_	17	punct	_	_

1	Oncogenicity	_	NN	NN	_	8	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	human	_	JJ	JJ	_	4	amod	_	_
4	papillomavirus-	_	NN	NN	_	2	pobj	_	_
5	or	_	CC	CC	_	4	cc	_	_
6	adenovirus-transformed	_	JJ	JJ	_	4	conj	_	_
7	cells	_	NNS	NNS	_	4	dep	_	_
8	correlates	_	VBZ	VBZ	_	0	root	_	_
9	with	_	IN	IN	_	8	prep	_	_
10	resistance	_	NN	NN	_	9	pobj	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	lysis	_	NN	NN	_	11	pobj	_	_
13	by	_	IN	IN	_	12	prep	_	_
14	natural	_	JJ	JJ	_	16	amod	_	_
15	killer	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	13	pobj	_	_
17	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	reasons	_	NNS	NNS	_	19	nsubj	_	_
3	for	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	dissimilar	_	JJ	JJ	_	6	amod	_	_
6	oncogenicities	_	NNS	NNS	_	3	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	human	_	JJ	JJ	_	9	amod	_	_
9	adenoviruses	_	NNS	NNS	_	7	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	human	_	JJ	JJ	_	12	amod	_	_
12	papillomaviruses	_	NNS	NNS	_	9	conj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	HPV	_	NNS	NNS	_	12	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	in	_	IN	IN	_	6	prep	_	_
17	humans	_	NNS	NNS	_	16	pobj	_	_
18	are	_	VBP	VBP	_	19	cop	_	_
19	unknown	_	JJ	JJ	_	0	root	_	_
20	but	_	CC	CC	_	19	cc	_	_
21	may	_	MD	MD	_	22	aux	_	_
22	relate	_	VB	VB	_	19	conj	_	_
23	to	_	TO	TO	_	22	prep	_	_
24	differences	_	NNS	NNS	_	23	pobj	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	27	det	_	_
27	capacities	_	NNS	NNS	_	25	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	the	_	DT	DT	_	30	dep	_	_
30	E1A	_	NN	NN	_	28	pobj	_	_
31	and	_	CC	CC	_	30	cc	_	_
32	E7	_	NN	NN	_	33	nn	_	_
33	proteins	_	NNS	NNS	_	30	conj	_	_
34	to	_	TO	TO	_	35	aux	_	_
35	target	_	VB	VB	_	27	vmod	_	_
36	cells	_	NNS	NNS	_	35	dobj	_	_
37	for	_	IN	IN	_	35	prep	_	_
38	rejection	_	NN	NN	_	37	pobj	_	_
39	by	_	IN	IN	_	38	prep	_	_
40	the	_	DT	DT	_	48	det	_	_
41	host	_	NN	NN	_	47	nn	_	_
42	natural	_	JJ	JJ	_	47	amod	_	_
43	killer	_	NN	NN	_	47	nn	_	_
44	-LRB-	_	-LRB-	-LRB-	_	47	punct	_	_
45	NK	_	NN	NN	_	47	nn	_	_
46	-RRB-	_	-RRB-	-RRB-	_	47	punct	_	_
47	cell	_	NN	NN	_	48	nn	_	_
48	response	_	NN	NN	_	39	pobj	_	_
49	.	_	.	.	_	19	punct	_	_

1	As	_	IN	IN	_	9	prep	_	_
2	one	_	CD	CD	_	3	num	_	_
3	test	_	NN	NN	_	1	pobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	this	_	DT	DT	_	6	det	_	_
6	hypothesis	_	NN	NN	_	4	pobj	_	_
7	,	_	,	,	_	9	punct	_	_
8	we	_	PRP	PRP	_	9	nsubj	_	_
9	compared	_	VBD	VBD	_	0	root	_	_
10	the	_	DT	DT	_	11	det	_	_
11	abilities	_	NNS	NNS	_	9	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	E1A-	_	NN	NN	_	12	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	E7-expressing	_	JJ	JJ	_	13	conj	_	_
16	human	_	JJ	JJ	_	17	amod	_	_
17	fibroblastic	_	JJ	JJ	_	13	dep	_	_
18	or	_	CC	CC	_	13	cc	_	_
19	keratinocyte-derived	_	JJ	JJ	_	20	amod	_	_
20	human	_	JJ	JJ	_	13	conj	_	_
21	cells	_	NNS	NNS	_	13	dep	_	_
22	to	_	TO	TO	_	25	aux	_	_
23	be	_	VB	VB	_	25	auxpass	_	_
24	selectively	_	RB	RB	_	25	advmod	_	_
25	killed	_	VBN	VBN	_	11	vmod	_	_
26	by	_	IN	IN	_	25	prep	_	_
27	either	_	CC	CC	_	28	preconj	_	_
28	unstimulated	_	JJ	JJ	_	26	pobj	_	_
29	or	_	CC	CC	_	28	cc	_	_
30	interferon	_	NN	NN	_	36	nn	_	_
31	-LRB-	_	-LRB-	-LRB-	_	36	punct	_	_
32	IFN	_	NN	NN	_	36	nn	_	_
33	-RRB-	_	-RRB-	-RRB-	_	36	punct	_	_
34	-activated	_	JJ	JJ	_	36	amod	_	_
35	NK	_	NN	NN	_	36	nn	_	_
36	cells	_	NNS	NNS	_	28	conj	_	_
37	.	_	.	.	_	9	punct	_	_

1	Cells	_	NNS	NNS	_	8	nsubjpass	_	_
2	expressing	_	VBG	VBG	_	1	vmod	_	_
3	the	_	DT	DT	_	5	det	_	_
4	E1A	_	NN	NN	_	5	nn	_	_
5	oncoprotein	_	NN	NN	_	2	dobj	_	_
6	were	_	VBD	VBD	_	8	auxpass	_	_
7	selectively	_	RB	RB	_	8	advmod	_	_
8	killed	_	VBN	VBN	_	0	root	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	unstimulated	_	JJ	JJ	_	12	amod	_	_
11	NK	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	9	pobj	_	_
13	,	_	,	,	_	8	punct	_	_
14	while	_	IN	IN	_	33	mark	_	_
15	the	_	DT	DT	_	18	det	_	_
16	same	_	JJ	JJ	_	18	amod	_	_
17	parental	_	JJ	JJ	_	18	amod	_	_
18	cells	_	NNS	NNS	_	33	nsubj	_	_
19	but	_	CC	CC	_	18	cc	_	_
20	expressing	_	VBG	VBG	_	18	conj	_	_
21	the	_	DT	DT	_	23	dep	_	_
22	HPV	_	NNS	NNS	_	23	nn	_	_
23	type	_	NN	NN	_	20	dobj	_	_
24	16	_	CD	CD	_	23	num	_	_
25	-LRB-	_	-LRB-	-LRB-	_	26	punct	_	_
26	HPV-16	_	NN	NN	_	23	appos	_	_
27	-RRB-	_	-RRB-	-RRB-	_	26	punct	_	_
28	or	_	CC	CC	_	23	cc	_	_
29	HPV-18	_	NN	NN	_	23	conj	_	_
30	E7	_	NN	NN	_	31	nn	_	_
31	oncoprotein	_	NN	NN	_	29	dep	_	_
32	were	_	VBD	VBD	_	33	cop	_	_
33	resistant	_	JJ	JJ	_	8	advcl	_	_
34	to	_	TO	TO	_	33	prep	_	_
35	NK	_	NN	NN	_	37	nn	_	_
36	cell	_	NN	NN	_	37	nn	_	_
37	lysis	_	NN	NN	_	34	pobj	_	_
38	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	ability	_	NN	NN	_	13	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	IFN-activated	_	JJ	JJ	_	6	amod	_	_
5	NK	_	NN	NN	_	6	nn	_	_
6	cells	_	NNS	NNS	_	3	pobj	_	_
7	to	_	TO	TO	_	2	prep	_	_
8	selectively	_	RB	RB	_	7	pcomp	_	_
9	kill	_	VB	VB	_	7	dep	_	_
10	virally	_	RB	RB	_	12	advmod	_	_
11	transformed	_	VBN	VBN	_	12	amod	_	_
12	cells	_	NNS	NNS	_	9	dobj	_	_
13	depends	_	VBZ	VBZ	_	0	root	_	_
14	on	_	IN	IN	_	13	prep	_	_
15	IFN	_	NN	NN	_	17	poss	_	_
16	's	_	POS	POS	_	15	possessive	_	_
17	ability	_	NN	NN	_	14	pobj	_	_
18	to	_	TO	TO	_	19	aux	_	_
19	induce	_	VB	VB	_	17	vmod	_	_
20	resistance	_	NN	NN	_	19	dobj	_	_
21	to	_	TO	TO	_	20	prep	_	_
22	NK	_	NN	NN	_	24	nn	_	_
23	cell	_	NN	NN	_	24	nn	_	_
24	lysis	_	NN	NN	_	21	pobj	_	_
25	in	_	IN	IN	_	19	prep	_	_
26	normal	_	JJ	JJ	_	25	pobj	_	_
27	-LRB-	_	-LRB-	-LRB-	_	31	punct	_	_
28	i.e.	_	FW	FW	_	31	prep	_	_
29	,	_	,	,	_	31	punct	_	_
30	non-viral	_	JJ	JJ	_	31	amod	_	_
31	oncogene-expressing	_	JJ	JJ	_	26	dep	_	_
32	-RRB-	_	-RRB-	-RRB-	_	31	punct	_	_
33	but	_	CC	CC	_	34	cc	_	_
34	not	_	RB	RB	_	26	cc	_	_
35	virally	_	RB	RB	_	37	advmod	_	_
36	transformed	_	VBN	VBN	_	37	amod	_	_
37	cells	_	NNS	NNS	_	26	conj	_	_
38	.	_	.	.	_	13	punct	_	_

1	E1A	_	NN	NN	_	2	nsubj	_	_
2	blocked	_	VBD	VBD	_	0	root	_	_
3	IFN	_	NN	NN	_	5	poss	_	_
4	's	_	POS	POS	_	3	possessive	_	_
5	induction	_	NN	NN	_	2	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	cytolytic	_	JJ	JJ	_	8	amod	_	_
8	resistance	_	NN	NN	_	6	pobj	_	_
9	,	_	,	,	_	2	punct	_	_
10	resulting	_	VBG	VBG	_	2	vmod	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	selective	_	JJ	JJ	_	14	amod	_	_
14	lysis	_	NN	NN	_	11	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	adenovirus-transformed	_	JJ	JJ	_	17	amod	_	_
17	cells	_	NNS	NNS	_	15	pobj	_	_
18	by	_	IN	IN	_	14	prep	_	_
19	IFN-activated	_	JJ	JJ	_	21	amod	_	_
20	NK	_	NN	NN	_	21	nn	_	_
21	cells	_	NNS	NNS	_	18	pobj	_	_
22	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	extent	_	NN	NN	_	12	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	IFN-induced	_	JJ	JJ	_	7	amod	_	_
5	NK	_	NN	NN	_	7	nn	_	_
6	cell	_	NN	NN	_	7	nn	_	_
7	killing	_	NN	NN	_	3	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	E1A-expressing	_	JJ	JJ	_	10	amod	_	_
10	cells	_	NNS	NNS	_	8	pobj	_	_
11	was	_	VBD	VBD	_	12	cop	_	_
12	proportional	_	JJ	JJ	_	0	root	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	level	_	NN	NN	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	E1A	_	NN	NN	_	18	nn	_	_
18	expression	_	NN	NN	_	16	pobj	_	_
19	and	_	CC	CC	_	12	cc	_	_
20	correlated	_	VBN	VBN	_	12	conj	_	_
21	with	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	23	det	_	_
23	ability	_	NN	NN	_	21	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	E1A	_	NN	NN	_	24	pobj	_	_
26	to	_	TO	TO	_	27	aux	_	_
27	block	_	VB	VB	_	23	vmod	_	_
28	IFN-stimulated	_	JJ	JJ	_	30	amod	_	_
29	gene	_	NN	NN	_	30	nn	_	_
30	expression	_	NN	NN	_	27	dobj	_	_
31	in	_	IN	IN	_	30	prep	_	_
32	target	_	NN	NN	_	33	nn	_	_
33	cells	_	NNS	NNS	_	31	pobj	_	_
34	.	_	.	.	_	12	punct	_	_

1	In	_	IN	IN	_	5	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	5	punct	_	_
4	E7	_	NN	NN	_	5	nsubj	_	_
5	blocked	_	VBD	VBD	_	0	root	_	_
6	neither	_	CC	CC	_	9	preconj	_	_
7	IFN-stimulated	_	JJ	JJ	_	9	amod	_	_
8	gene	_	NN	NN	_	9	nn	_	_
9	expression	_	NN	NN	_	5	dobj	_	_
10	nor	_	CC	CC	_	9	cc	_	_
11	IFN	_	NN	NN	_	13	poss	_	_
12	's	_	POS	POS	_	11	possessive	_	_
13	induction	_	NN	NN	_	9	conj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	cytolytic	_	JJ	JJ	_	16	amod	_	_
16	resistance	_	NN	NN	_	14	pobj	_	_
17	,	_	,	,	_	5	punct	_	_
18	thereby	_	RB	RB	_	19	advmod	_	_
19	precluding	_	VBG	VBG	_	5	vmod	_	_
20	the	_	DT	DT	_	22	det	_	_
21	selective	_	JJ	JJ	_	22	amod	_	_
22	lysis	_	NN	NN	_	19	dobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	HPV-transformed	_	JJ	JJ	_	25	amod	_	_
25	cells	_	NNS	NNS	_	23	pobj	_	_
26	by	_	IN	IN	_	22	prep	_	_
27	IFN-activated	_	JJ	JJ	_	29	amod	_	_
28	NK	_	NN	NN	_	29	nn	_	_
29	cells	_	NNS	NNS	_	26	pobj	_	_
30	.	_	.	.	_	5	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	conclusion	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	6	punct	_	_
4	E1A	_	NN	NN	_	5	nn	_	_
5	expression	_	NN	NN	_	6	nsubj	_	_
6	marks	_	VBZ	VBZ	_	0	root	_	_
7	cells	_	NNS	NNS	_	6	dobj	_	_
8	for	_	IN	IN	_	6	prep	_	_
9	destruction	_	NN	NN	_	8	pobj	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	15	det	_	_
12	host	_	NN	NN	_	15	nn	_	_
13	NK	_	NN	NN	_	14	nn	_	_
14	cell	_	NN	NN	_	15	nn	_	_
15	response	_	NN	NN	_	10	pobj	_	_
16	,	_	,	,	_	6	punct	_	_
17	whereas	_	IN	IN	_	21	mark	_	_
18	the	_	DT	DT	_	20	det	_	_
19	E7	_	NN	NN	_	20	nn	_	_
20	oncoprotein	_	NN	NN	_	21	nsubj	_	_
21	lacks	_	VBZ	VBZ	_	6	advcl	_	_
22	this	_	DT	DT	_	23	det	_	_
23	activity	_	NN	NN	_	21	dobj	_	_
24	.	_	.	.	_	6	punct	_	_

1	Identification	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	an	_	DT	DT	_	9	det	_	_
4	I	_	NN	NN	_	9	nn	_	_
5	kappa	_	NN	NN	_	9	nn	_	_
6	B	_	NN	NN	_	9	nn	_	_
7	alpha-associated	_	JJ	JJ	_	9	amod	_	_
8	protein	_	NN	NN	_	9	nn	_	_
9	kinase	_	NN	NN	_	2	pobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	a	_	DT	DT	_	15	det	_	_
12	human	_	JJ	JJ	_	15	amod	_	_
13	monocytic	_	JJ	JJ	_	15	amod	_	_
14	cell	_	NN	NN	_	15	nn	_	_
15	line	_	NN	NN	_	10	pobj	_	_
16	and	_	CC	CC	_	1	cc	_	_
17	determination	_	NN	NN	_	1	conj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	its	_	PRP$	PRP$	_	21	poss	_	_
20	phosphorylation	_	NN	NN	_	21	nn	_	_
21	sites	_	NNS	NNS	_	18	pobj	_	_
22	on	_	IN	IN	_	21	prep	_	_
23	I	_	NN	NN	_	26	nn	_	_
24	kappa	_	NN	NN	_	26	nn	_	_
25	B	_	NN	NN	_	26	nn	_	_
26	alpha	_	NN	NN	_	22	pobj	_	_
27	.	_	.	.	_	1	punct	_	_

1	Nuclear	_	JJ	JJ	_	4	amod	_	_
2	factor	_	NN	NN	_	4	nn	_	_
3	kappa	_	NN	NN	_	4	nn	_	_
4	B	_	NN	NN	_	10	nsubj	_	_
5	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
6	NF-kappa	_	NN	NN	_	7	nn	_	_
7	B	_	NN	NN	_	4	appos	_	_
8	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
9	is	_	VBZ	VBZ	_	10	cop	_	_
10	stored	_	JJ	JJ	_	0	root	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	cytoplasm	_	NN	NN	_	11	pobj	_	_
14	as	_	IN	IN	_	10	prep	_	_
15	an	_	DT	DT	_	17	det	_	_
16	inactive	_	JJ	JJ	_	17	amod	_	_
17	form	_	NN	NN	_	14	pobj	_	_
18	through	_	IN	IN	_	10	prep	_	_
19	interaction	_	NN	NN	_	18	pobj	_	_
20	with	_	IN	IN	_	19	prep	_	_
21	I	_	NN	NN	_	23	nn	_	_
22	kappa	_	NN	NN	_	23	nn	_	_
23	B	_	NN	NN	_	20	pobj	_	_
24	.	_	.	.	_	10	punct	_	_

1	Stimulation	_	NN	NN	_	4	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	cells	_	NNS	NNS	_	2	pobj	_	_
4	leads	_	VBZ	VBZ	_	0	root	_	_
5	to	_	TO	TO	_	4	prep	_	_
6	a	_	DT	DT	_	8	det	_	_
7	rapid	_	JJ	JJ	_	8	amod	_	_
8	phosphorylation	_	NN	NN	_	5	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	I	_	NN	NN	_	13	nn	_	_
11	kappa	_	NN	NN	_	13	nn	_	_
12	B	_	NN	NN	_	13	nn	_	_
13	alpha	_	NN	NN	_	9	pobj	_	_
14	,	_	,	,	_	8	punct	_	_
15	which	_	WDT	WDT	_	17	nsubjpass	_	_
16	is	_	VBZ	VBZ	_	17	auxpass	_	_
17	presumed	_	VBN	VBN	_	8	rcmod	_	_
18	to	_	TO	TO	_	20	aux	_	_
19	be	_	VB	VB	_	20	cop	_	_
20	important	_	JJ	JJ	_	17	xcomp	_	_
21	for	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	24	det	_	_
23	subsequent	_	JJ	JJ	_	24	amod	_	_
24	degradation	_	NN	NN	_	21	pobj	_	_
25	.	_	.	.	_	4	punct	_	_

1	We	_	PRP	PRP	_	4	nsubj	_	_
2	have	_	VBP	VBP	_	4	aux	_	_
3	recently	_	RB	RB	_	4	advmod	_	_
4	reported	_	VBN	VBN	_	0	root	_	_
5	the	_	DT	DT	_	6	det	_	_
6	establishment	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	a	_	DT	DT	_	16	det	_	_
9	lipopolysaccharide	_	NN	NN	_	14	npadvmod	_	_
10	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
11	LPS	_	NN	NN	_	14	npadvmod	_	_
12	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
13	-dependent	_	JJ	JJ	_	14	amod	_	_
14	cell-free	_	JJ	JJ	_	16	amod	_	_
15	activation	_	NN	NN	_	16	nn	_	_
16	system	_	NN	NN	_	7	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	NF-kappa	_	NN	NN	_	19	nn	_	_
19	B	_	NN	NN	_	17	pobj	_	_
20	in	_	IN	IN	_	16	prep	_	_
21	association	_	NN	NN	_	20	pobj	_	_
22	with	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	24	det	_	_
24	induction	_	NN	NN	_	22	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	I	_	NN	NN	_	29	nn	_	_
27	kappa	_	NN	NN	_	29	nn	_	_
28	B	_	NN	NN	_	29	nn	_	_
29	alpha	_	NN	NN	_	30	nn	_	_
30	phosphorylation	_	NN	NN	_	25	pobj	_	_
31	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	study	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	7	punct	_	_
5	we	_	PRP	PRP	_	7	nsubj	_	_
6	have	_	VBP	VBP	_	7	aux	_	_
7	identified	_	VBN	VBN	_	0	root	_	_
8	a	_	DT	DT	_	9	det	_	_
9	kinase	_	NN	NN	_	7	dobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	cell	_	NN	NN	_	12	nn	_	_
12	extracts	_	NNS	NNS	_	10	pobj	_	_
13	from	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	19	det	_	_
15	LPS-stimulated	_	JJ	JJ	_	19	amod	_	_
16	human	_	JJ	JJ	_	19	amod	_	_
17	monocytic	_	JJ	JJ	_	19	amod	_	_
18	cell	_	NN	NN	_	19	nn	_	_
19	line	_	NN	NN	_	13	pobj	_	_
20	,	_	,	,	_	19	punct	_	_
21	THP-1	_	NN	NN	_	19	appos	_	_
22	,	_	,	,	_	9	punct	_	_
23	that	_	WDT	WDT	_	25	nsubj	_	_
24	specifically	_	RB	RB	_	25	advmod	_	_
25	binds	_	VBZ	VBZ	_	9	rcmod	_	_
26	and	_	CC	CC	_	25	cc	_	_
27	phosphorylates	_	VBZ	VBZ	_	25	conj	_	_
28	I	_	NN	NN	_	31	nn	_	_
29	kappa	_	NN	NN	_	31	nn	_	_
30	B	_	NN	NN	_	31	nn	_	_
31	alpha	_	NN	NN	_	25	dobj	_	_
32	.	_	.	.	_	7	punct	_	_

1	LPS	_	NN	NN	_	2	nn	_	_
2	stimulation	_	NN	NN	_	4	nsubj	_	_
3	transiently	_	RB	RB	_	4	advmod	_	_
4	enhanced	_	VBD	VBD	_	0	root	_	_
5	the	_	DT	DT	_	11	det	_	_
6	I	_	NN	NN	_	11	nn	_	_
7	kappa	_	NN	NN	_	11	nn	_	_
8	B	_	NN	NN	_	11	nn	_	_
9	alpha-bound	_	JJ	JJ	_	11	amod	_	_
10	kinase	_	NN	NN	_	11	nn	_	_
11	activity	_	NN	NN	_	4	dobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	THP-1	_	NN	NN	_	14	nn	_	_
14	cells	_	NNS	NNS	_	12	pobj	_	_
15	.	_	.	.	_	4	punct	_	_

1	Mutational	_	JJ	JJ	_	2	amod	_	_
2	analyses	_	NNS	NNS	_	15	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	I	_	NN	NN	_	6	nn	_	_
5	kappa	_	NN	NN	_	6	nn	_	_
6	B	_	NN	NN	_	7	nn	_	_
7	alpha	_	NN	NN	_	3	pobj	_	_
8	and	_	CC	CC	_	2	cc	_	_
9	competition	_	NN	NN	_	10	nn	_	_
10	experiments	_	NNS	NNS	_	2	conj	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	synthetic	_	JJ	JJ	_	14	amod	_	_
14	peptides	_	NNS	NNS	_	11	pobj	_	_
15	identified	_	VBD	VBD	_	0	root	_	_
16	major	_	JJ	JJ	_	18	amod	_	_
17	phosphorylation	_	NN	NN	_	18	nn	_	_
18	sites	_	NNS	NNS	_	15	dobj	_	_
19	by	_	IN	IN	_	15	prep	_	_
20	the	_	DT	DT	_	22	det	_	_
21	bound	_	VBN	VBN	_	22	amod	_	_
22	kinase	_	NN	NN	_	19	pobj	_	_
23	as	_	IN	IN	_	15	prep	_	_
24	Ser	_	NN	NN	_	23	pobj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	Thr	_	NN	NN	_	24	conj	_	_
27	residues	_	NNS	NNS	_	24	dep	_	_
28	in	_	IN	IN	_	15	prep	_	_
29	the	_	DT	DT	_	32	det	_	_
30	C-terminal	_	JJ	JJ	_	32	amod	_	_
31	acidic	_	JJ	JJ	_	32	amod	_	_
32	domain	_	NN	NN	_	28	pobj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	I	_	NN	NN	_	37	nn	_	_
35	kappa	_	NN	NN	_	37	nn	_	_
36	B	_	NN	NN	_	37	nn	_	_
37	alpha	_	NN	NN	_	33	pobj	_	_
38	.	_	.	.	_	15	punct	_	_

1	Moreover	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	show	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	21	mark	_	_
6	the	_	DT	DT	_	7	det	_	_
7	peptide	_	NN	NN	_	21	nsubj	_	_
8	,	_	,	,	_	7	punct	_	_
9	corresponding	_	VBG	VBG	_	21	dep	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	the	_	DT	DT	_	14	det	_	_
12	C-terminal	_	JJ	JJ	_	14	amod	_	_
13	acidic	_	JJ	JJ	_	14	amod	_	_
14	domain	_	NN	NN	_	10	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	I	_	NN	NN	_	19	nn	_	_
17	kappa	_	NN	NN	_	19	nn	_	_
18	B	_	NN	NN	_	19	nn	_	_
19	alpha	_	NN	NN	_	15	pobj	_	_
20	,	_	,	,	_	21	punct	_	_
21	blocked	_	VBD	VBD	_	4	ccomp	_	_
22	the	_	DT	DT	_	26	det	_	_
23	LPS-induced	_	JJ	JJ	_	26	amod	_	_
24	NF-kappa	_	NN	NN	_	25	nn	_	_
25	B	_	NN	NN	_	26	nn	_	_
26	activation	_	NN	NN	_	21	dobj	_	_
27	as	_	RB	RB	_	28	advmod	_	_
28	well	_	RB	RB	_	26	cc	_	_
29	as	_	IN	IN	_	28	mwe	_	_
30	inducible	_	JJ	JJ	_	31	amod	_	_
31	phosphorylation	_	NN	NN	_	26	conj	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	endogenous	_	JJ	JJ	_	37	amod	_	_
34	I	_	NN	NN	_	37	nn	_	_
35	kappa	_	NN	NN	_	37	nn	_	_
36	B	_	NN	NN	_	37	nn	_	_
37	alpha	_	NN	NN	_	32	pobj	_	_
38	in	_	IN	IN	_	21	prep	_	_
39	a	_	DT	DT	_	41	det	_	_
40	cell-free	_	JJ	JJ	_	41	amod	_	_
41	system	_	NN	NN	_	38	pobj	_	_
42	using	_	VBG	VBG	_	41	vmod	_	_
43	THP-1	_	NN	NN	_	44	nn	_	_
44	cells	_	NNS	NNS	_	42	dobj	_	_
45	.	_	.	.	_	4	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggested	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	9	mark	_	_
5	the	_	DT	DT	_	7	det	_	_
6	bound	_	JJ	JJ	_	7	amod	_	_
7	kinase	_	NN	NN	_	9	nsubjpass	_	_
8	is	_	VBZ	VBZ	_	9	auxpass	_	_
9	involved	_	VBN	VBN	_	3	ccomp	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	signaling	_	NN	NN	_	13	nn	_	_
13	pathway	_	NN	NN	_	10	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	LPS	_	NN	NN	_	14	pobj	_	_
16	by	_	IN	IN	_	9	prep	_	_
17	inducing	_	VBG	VBG	_	16	pcomp	_	_
18	the	_	DT	DT	_	19	det	_	_
19	phosphorylation	_	NN	NN	_	17	dobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	C-terminal	_	JJ	JJ	_	23	amod	_	_
23	region	_	NN	NN	_	20	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	I	_	NN	NN	_	28	nn	_	_
26	kappa	_	NN	NN	_	28	nn	_	_
27	B	_	NN	NN	_	28	nn	_	_
28	alpha	_	NN	NN	_	24	pobj	_	_
29	and	_	CC	CC	_	19	cc	_	_
30	subsequent	_	JJ	JJ	_	31	amod	_	_
31	dissociation	_	NN	NN	_	19	conj	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	the	_	DT	DT	_	39	det	_	_
34	NF-kappa	_	NN	NN	_	39	nn	_	_
35	B.I	_	NN	NN	_	39	nn	_	_
36	kappa	_	NN	NN	_	39	nn	_	_
37	B	_	NN	NN	_	39	nn	_	_
38	alpha	_	NN	NN	_	39	nn	_	_
39	complex	_	NN	NN	_	32	pobj	_	_
40	.	_	.	.	_	3	punct	_	_

1	Triggering	_	NN	NN	_	16	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	6	det	_	_
4	human	_	JJ	JJ	_	6	amod	_	_
5	interleukin-6	_	NN	NN	_	6	nn	_	_
6	gene	_	NN	NN	_	2	pobj	_	_
7	by	_	IN	IN	_	1	prep	_	_
8	interferon-gamma	_	NN	NN	_	7	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	tumor	_	NN	NN	_	12	nn	_	_
11	necrosis	_	NN	NN	_	12	nn	_	_
12	factor-alpha	_	NN	NN	_	8	conj	_	_
13	in	_	IN	IN	_	8	prep	_	_
14	monocytic	_	JJ	JJ	_	15	amod	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	involves	_	VBZ	VBZ	_	0	root	_	_
17	cooperation	_	NN	NN	_	16	dobj	_	_
18	between	_	IN	IN	_	17	prep	_	_
19	interferon	_	NN	NN	_	21	nn	_	_
20	regulatory	_	JJ	JJ	_	21	amod	_	_
21	factor-1	_	NN	NN	_	18	pobj	_	_
22	,	_	,	,	_	21	punct	_	_
23	NF	_	NN	NN	_	25	nn	_	_
24	kappa	_	NN	NN	_	25	nn	_	_
25	B	_	NN	NN	_	21	conj	_	_
26	,	_	,	,	_	21	punct	_	_
27	and	_	CC	CC	_	21	cc	_	_
28	Sp1	_	NN	NN	_	21	conj	_	_
29	transcription	_	NN	NN	_	30	nn	_	_
30	factors	_	NNS	NNS	_	21	dep	_	_
31	.	_	.	.	_	16	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	investigated	_	VBD	VBD	_	0	root	_	_
3	the	_	DT	DT	_	5	det	_	_
4	molecular	_	JJ	JJ	_	5	amod	_	_
5	basis	_	NN	NN	_	2	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	synergistic	_	JJ	JJ	_	9	amod	_	_
9	induction	_	NN	NN	_	6	pobj	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	interferon-gamma	_	NN	NN	_	10	pobj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	IFN-gamma	_	NN	NN	_	11	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	/tumor	_	NN	NN	_	17	nn	_	_
16	necrosis	_	NN	NN	_	17	nn	_	_
17	factor-alpha	_	NN	NN	_	11	dep	_	_
18	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
19	TNF-alpha	_	NN	NN	_	17	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	of	_	IN	IN	_	11	prep	_	_
22	human	_	JJ	JJ	_	27	amod	_	_
23	interleukin-6	_	NN	NN	_	27	nn	_	_
24	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
25	IL-6	_	NN	NN	_	27	nn	_	_
26	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
27	gene	_	NN	NN	_	21	pobj	_	_
28	in	_	IN	IN	_	27	prep	_	_
29	THP-1	_	NN	NN	_	31	nn	_	_
30	monocytic	_	JJ	JJ	_	31	amod	_	_
31	cells	_	NNS	NNS	_	28	pobj	_	_
32	,	_	,	,	_	2	punct	_	_
33	and	_	CC	CC	_	2	cc	_	_
34	compared	_	VBD	VBD	_	2	conj	_	_
35	it	_	PRP	PRP	_	34	dobj	_	_
36	with	_	IN	IN	_	34	prep	_	_
37	the	_	DT	DT	_	38	det	_	_
38	basis	_	NN	NN	_	36	pobj	_	_
39	of	_	IN	IN	_	38	prep	_	_
40	this	_	DT	DT	_	41	det	_	_
41	induction	_	NN	NN	_	39	pobj	_	_
42	by	_	IN	IN	_	41	prep	_	_
43	lipopolysaccharide	_	NN	NN	_	42	pobj	_	_
44	-LRB-	_	-LRB-	-LRB-	_	45	punct	_	_
45	LPS	_	NN	NN	_	43	appos	_	_
46	-RRB-	_	-RRB-	-RRB-	_	45	punct	_	_
47	.	_	.	.	_	2	punct	_	_

1	Functional	_	JJ	JJ	_	2	amod	_	_
2	studies	_	NNS	NNS	_	6	nsubj	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	IL-6	_	NN	NN	_	5	nn	_	_
5	promoter	_	NN	NN	_	3	pobj	_	_
6	demonstrated	_	VBD	VBD	_	0	root	_	_
7	that	_	IN	IN	_	12	mark	_	_
8	three	_	CD	CD	_	9	num	_	_
9	regions	_	NNS	NNS	_	12	nsubj	_	_
10	are	_	VBP	VBP	_	12	cop	_	_
11	the	_	DT	DT	_	12	det	_	_
12	targets	_	NNS	NNS	_	6	ccomp	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	18	det	_	_
15	IFN-gamma	_	NN	NN	_	18	nn	_	_
16	and/or	_	CC	CC	_	15	cc	_	_
17	TNF-alpha	_	NN	NN	_	15	conj	_	_
18	action	_	NN	NN	_	13	pobj	_	_
19	,	_	,	,	_	12	punct	_	_
20	whereas	_	IN	IN	_	26	mark	_	_
21	only	_	RB	RB	_	22	advmod	_	_
22	one	_	CD	CD	_	26	nsubj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	these	_	DT	DT	_	25	det	_	_
25	regions	_	NNS	NNS	_	23	pobj	_	_
26	seemed	_	VBD	VBD	_	12	advcl	_	_
27	to	_	TO	TO	_	29	aux	_	_
28	be	_	VB	VB	_	29	auxpass	_	_
29	implicated	_	VBN	VBN	_	26	xcomp	_	_
30	in	_	IN	IN	_	29	prep	_	_
31	LPS	_	NN	NN	_	32	nn	_	_
32	activation	_	NN	NN	_	30	pobj	_	_
33	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	three	_	CD	CD	_	3	num	_	_
3	regions	_	NNS	NNS	_	5	nsubj	_	_
4	concerned	_	VBN	VBN	_	3	vmod	_	_
5	are	_	VBP	VBP	_	0	root	_	_
6	:	_	:	:	_	5	punct	_	_
7	1	_	LS	LS	_	10	dep	_	_
8	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
9	a	_	DT	DT	_	10	det	_	_
10	region	_	NN	NN	_	5	dep	_	_
11	between	_	IN	IN	_	10	prep	_	_
12	-73	_	CD	CD	_	11	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	-36	_	CD	CD	_	12	conj	_	_
15	,	_	,	,	_	10	punct	_	_
16	which	_	WDT	WDT	_	20	nsubj	_	_
17	is	_	VBZ	VBZ	_	20	cop	_	_
18	the	_	DT	DT	_	20	det	_	_
19	minimal	_	JJ	JJ	_	20	amod	_	_
20	element	_	NN	NN	_	10	rcmod	_	_
21	inducible	_	JJ	JJ	_	20	amod	_	_
22	by	_	IN	IN	_	21	prep	_	_
23	LPS	_	NN	NN	_	22	pobj	_	_
24	or	_	CC	CC	_	23	cc	_	_
25	TNF-alpha	_	NN	NN	_	23	conj	_	_
26	;	_	:	:	_	10	punct	_	_
27	2	_	LS	LS	_	30	dep	_	_
28	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
29	an	_	DT	DT	_	30	det	_	_
30	element	_	NN	NN	_	10	conj	_	_
31	located	_	JJ	JJ	_	30	amod	_	_
32	between	_	IN	IN	_	31	prep	_	_
33	-181	_	CD	CD	_	32	pobj	_	_
34	and	_	CC	CC	_	33	cc	_	_
35	-73	_	CD	CD	_	33	conj	_	_
36	,	_	,	,	_	30	punct	_	_
37	which	_	WDT	WDT	_	38	nsubj	_	_
38	appeared	_	VBD	VBD	_	30	rcmod	_	_
39	to	_	TO	TO	_	40	aux	_	_
40	regulate	_	VB	VB	_	38	xcomp	_	_
41	the	_	DT	DT	_	42	det	_	_
42	response	_	NN	NN	_	40	dobj	_	_
43	to	_	TO	TO	_	42	prep	_	_
44	IFN-gamma	_	NN	NN	_	43	pobj	_	_
45	and	_	CC	CC	_	44	cc	_	_
46	TNF-alpha	_	NN	NN	_	44	conj	_	_
47	negatively	_	RB	RB	_	40	advmod	_	_
48	;	_	:	:	_	10	punct	_	_
49	and	_	CC	CC	_	10	cc	_	_
50	3	_	LS	LS	_	54	dep	_	_
51	-RRB-	_	-RRB-	-RRB-	_	50	punct	_	_
52	a	_	DT	DT	_	54	det	_	_
53	distal	_	JJ	JJ	_	54	amod	_	_
54	element	_	NN	NN	_	10	conj	_	_
55	upstream	_	JJ	JJ	_	54	amod	_	_
56	of	_	IN	IN	_	54	prep	_	_
57	-224	_	CD	CD	_	56	pobj	_	_
58	,	_	,	,	_	54	punct	_	_
59	which	_	WDT	WDT	_	61	nsubj	_	_
60	was	_	VBD	VBD	_	61	cop	_	_
61	inducible	_	JJ	JJ	_	54	rcmod	_	_
62	by	_	IN	IN	_	61	prep	_	_
63	IFN-gamma	_	NN	NN	_	62	pobj	_	_
64	alone	_	RB	RB	_	63	advmod	_	_
65	.	_	.	.	_	5	punct	_	_

1	LPS	_	NN	NN	_	2	nn	_	_
2	signaling	_	NN	NN	_	4	nsubjpass	_	_
3	was	_	VBD	VBD	_	4	auxpass	_	_
4	found	_	VBN	VBN	_	0	root	_	_
5	to	_	TO	TO	_	6	aux	_	_
6	involve	_	VB	VB	_	4	xcomp	_	_
7	NF	_	NN	NN	_	9	nn	_	_
8	kappa	_	NN	NN	_	9	nn	_	_
9	B	_	NN	NN	_	10	nn	_	_
10	activation	_	NN	NN	_	6	dobj	_	_
11	by	_	IN	IN	_	6	prep	_	_
12	the	_	DT	DT	_	15	det	_	_
13	p50	_	NN	NN	_	15	nn	_	_
14	/p65	_	NN	NN	_	15	nn	_	_
15	heterodimers	_	NNS	NNS	_	11	pobj	_	_
16	.	_	.	.	_	4	punct	_	_

1	Synergistic	_	JJ	JJ	_	2	amod	_	_
2	induction	_	NN	NN	_	16	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	IL-6	_	NN	NN	_	6	nn	_	_
6	gene	_	NN	NN	_	3	pobj	_	_
7	by	_	IN	IN	_	2	prep	_	_
8	IFN-gamma	_	NN	NN	_	7	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	TNF-alpha	_	NN	NN	_	8	conj	_	_
11	,	_	,	,	_	2	punct	_	_
12	in	_	IN	IN	_	2	prep	_	_
13	monocytic	_	JJ	JJ	_	14	amod	_	_
14	cells	_	NNS	NNS	_	12	pobj	_	_
15	,	_	,	,	_	2	punct	_	_
16	involved	_	VBD	VBD	_	0	root	_	_
17	cooperation	_	NN	NN	_	16	dobj	_	_
18	between	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	20	det	_	_
20	IRF-1	_	NN	NN	_	18	pobj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	NF	_	NN	NN	_	26	nn	_	_
23	kappa	_	NN	NN	_	26	nn	_	_
24	B	_	NN	NN	_	26	nn	_	_
25	p65	_	NN	NN	_	26	nn	_	_
26	homodimers	_	NNS	NNS	_	20	conj	_	_
27	with	_	IN	IN	_	16	prep	_	_
28	concomitant	_	JJ	JJ	_	29	amod	_	_
29	removal	_	NN	NN	_	27	pobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	the	_	DT	DT	_	33	det	_	_
32	negative	_	JJ	JJ	_	33	amod	_	_
33	effect	_	NN	NN	_	30	pobj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	the	_	DT	DT	_	38	det	_	_
36	retinoblastoma	_	NN	NN	_	38	nn	_	_
37	control	_	NN	NN	_	38	nn	_	_
38	element	_	NN	NN	_	34	pobj	_	_
39	present	_	JJ	JJ	_	38	amod	_	_
40	in	_	IN	IN	_	39	prep	_	_
41	the	_	DT	DT	_	43	det	_	_
42	IL-6	_	NN	NN	_	43	nn	_	_
43	promoter	_	NN	NN	_	40	pobj	_	_
44	.	_	.	.	_	16	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	removal	_	NN	NN	_	3	nsubj	_	_
3	occurred	_	VBD	VBD	_	0	root	_	_
4	by	_	IN	IN	_	3	prep	_	_
5	activation	_	NN	NN	_	4	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	10	det	_	_
8	constitutive	_	JJ	JJ	_	10	amod	_	_
9	Sp1	_	NN	NN	_	10	nn	_	_
10	factor	_	NN	NN	_	6	pobj	_	_
11	,	_	,	,	_	10	punct	_	_
12	whose	_	WP$	WP$	_	15	poss	_	_
13	increased	_	VBN	VBN	_	15	amod	_	_
14	binding	_	NN	NN	_	15	nn	_	_
15	activity	_	NN	NN	_	19	nsubjpass	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	phosphorylation	_	NN	NN	_	15	conj	_	_
18	were	_	VBD	VBD	_	19	auxpass	_	_
19	mediated	_	VBN	VBN	_	10	rcmod	_	_
20	by	_	IN	IN	_	19	prep	_	_
21	IFN-gamma	_	NN	NN	_	20	pobj	_	_
22	.	_	.	.	_	3	punct	_	_

1	Steel	_	NN	NN	_	2	nn	_	_
2	factor	_	NN	NN	_	3	nsubj	_	_
3	affects	_	VBZ	VBZ	_	0	root	_	_
4	SCL	_	NN	NN	_	5	nn	_	_
5	expression	_	NN	NN	_	3	dobj	_	_
6	during	_	IN	IN	_	3	prep	_	_
7	normal	_	JJ	JJ	_	9	amod	_	_
8	erythroid	_	JJ	JJ	_	7	dep	_	_
9	differentiation	_	NN	NN	_	6	pobj	_	_
10	.	_	.	.	_	3	punct	_	_

1	Steel	_	NN	NN	_	2	nn	_	_
2	factor	_	NN	NN	_	4	nsubj	_	_
3	is	_	VBZ	VBZ	_	4	cop	_	_
4	one	_	CD	CD	_	0	root	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	growth	_	NN	NN	_	8	nn	_	_
8	factors	_	NNS	NNS	_	5	pobj	_	_
9	that	_	WDT	WDT	_	10	nsubj	_	_
10	controls	_	VBZ	VBZ	_	4	rcmod	_	_
11	the	_	DT	DT	_	12	dep	_	_
12	proliferation	_	NN	NN	_	10	dobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	differentiation	_	NN	NN	_	12	conj	_	_
15	of	_	IN	IN	_	12	prep	_	_
16	hematopoietic	_	JJ	JJ	_	17	amod	_	_
17	cells	_	NNS	NNS	_	15	pobj	_	_
18	and	_	CC	CC	_	4	cc	_	_
19	SCL	_	NN	NN	_	31	nsubj	_	_
20	,	_	,	,	_	19	punct	_	_
21	also	_	RB	RB	_	22	advmod	_	_
22	known	_	VBN	VBN	_	19	vmod	_	_
23	as	_	IN	IN	_	22	prep	_	_
24	Tcl-5	_	NN	NN	_	23	pobj	_	_
25	or	_	CC	CC	_	24	cc	_	_
26	Tal-1	_	NN	NN	_	24	conj	_	_
27	,	_	,	,	_	19	punct	_	_
28	is	_	VBZ	VBZ	_	31	cop	_	_
29	a	_	DT	DT	_	31	det	_	_
30	transcription	_	NN	NN	_	31	nn	_	_
31	factor	_	NN	NN	_	4	conj	_	_
32	involved	_	VBN	VBN	_	31	vmod	_	_
33	in	_	IN	IN	_	32	prep	_	_
34	erythropoiesis	_	NN	NN	_	33	pobj	_	_
35	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	report	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	studied	_	VBD	VBD	_	0	root	_	_
7	the	_	DT	DT	_	8	det	_	_
8	role	_	NN	NN	_	6	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	SCL	_	NN	NN	_	9	pobj	_	_
11	in	_	IN	IN	_	8	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	proliferation	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	human	_	JJ	JJ	_	19	amod	_	_
16	peripheral	_	JJ	JJ	_	19	amod	_	_
17	blood	_	NN	NN	_	19	nn	_	_
18	burst-forming	_	JJ	JJ	_	19	amod	_	_
19	unit-erythroid	_	NN	NN	_	14	pobj	_	_
20	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	BFU-E	_	NN	NN	_	19	appos	_	_
22	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
23	and	_	CC	CC	_	8	cc	_	_
24	the	_	DT	DT	_	25	det	_	_
25	effects	_	NNS	NNS	_	8	conj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	Steel	_	NN	NN	_	28	nn	_	_
28	factor	_	NN	NN	_	26	pobj	_	_
29	on	_	IN	IN	_	25	prep	_	_
30	SCL	_	NN	NN	_	31	nn	_	_
31	expression	_	NN	NN	_	29	pobj	_	_
32	in	_	IN	IN	_	25	prep	_	_
33	proliferating	_	VBG	VBG	_	35	amod	_	_
34	erythroid	_	JJ	JJ	_	35	amod	_	_
35	cells	_	NNS	NNS	_	32	pobj	_	_
36	.	_	.	.	_	6	punct	_	_

1	BFU-E-derived	_	JJ	JJ	_	2	amod	_	_
2	colonies	_	NNS	NNS	_	3	nsubj	_	_
3	increase	_	VBP	VBP	_	0	root	_	_
4	progressively	_	RB	RB	_	3	advmod	_	_
5	in	_	IN	IN	_	3	prep	_	_
6	size	_	NN	NN	_	5	pobj	_	_
7	,	_	,	,	_	3	punct	_	_
8	as	_	IN	IN	_	9	mark	_	_
9	determined	_	VBN	VBN	_	3	advcl	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	cell	_	NN	NN	_	12	nn	_	_
12	number	_	NN	NN	_	10	pobj	_	_
13	,	_	,	,	_	3	punct	_	_
14	from	_	IN	IN	_	3	prep	_	_
15	day	_	NN	NN	_	14	pobj	_	_
16	7	_	CD	CD	_	15	num	_	_
17	to	_	TO	TO	_	14	prep	_	_
18	day	_	NN	NN	_	17	pobj	_	_
19	14	_	CD	CD	_	18	num	_	_
20	of	_	IN	IN	_	14	prep	_	_
21	culture	_	NN	NN	_	20	pobj	_	_
22	,	_	,	,	_	3	punct	_	_
23	with	_	IN	IN	_	3	prep	_	_
24	the	_	DT	DT	_	26	det	_	_
25	greatest	_	JJS	JJS	_	26	amod	_	_
26	increase	_	NN	NN	_	23	pobj	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	colony	_	NN	NN	_	29	nn	_	_
29	size	_	NN	NN	_	27	pobj	_	_
30	-LRB-	_	-LRB-	-LRB-	_	32	punct	_	_
31	10-fold	_	JJ	JJ	_	32	amod	_	_
32	expansion	_	NN	NN	_	26	appos	_	_
33	-RRB-	_	-RRB-	-RRB-	_	32	punct	_	_
34	occurring	_	VBG	VBG	_	26	vmod	_	_
35	between	_	IN	IN	_	34	prep	_	_
36	day	_	NN	NN	_	35	pobj	_	_
37	7	_	CD	CD	_	36	num	_	_
38	and	_	CC	CC	_	36	cc	_	_
39	day	_	NN	NN	_	36	conj	_	_
40	10	_	CD	CD	_	39	num	_	_
41	.	_	.	.	_	3	punct	_	_

1	SCL	_	NN	NN	_	2	nn	_	_
2	protein	_	NN	NN	_	3	nn	_	_
3	levels	_	NNS	NNS	_	8	nsubjpass	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	BFU-E-derived	_	JJ	JJ	_	6	amod	_	_
6	cells	_	NNS	NNS	_	4	pobj	_	_
7	were	_	VBD	VBD	_	8	auxpass	_	_
8	highest	_	JJS	JJS	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	day	_	NN	NN	_	12	nn	_	_
11	7	_	CD	CD	_	12	num	_	_
12	cells	_	NNS	NNS	_	9	pobj	_	_
13	and	_	CC	CC	_	8	cc	_	_
14	decreased	_	VBD	VBD	_	8	conj	_	_
15	progressively	_	RB	RB	_	14	advmod	_	_
16	from	_	IN	IN	_	14	prep	_	_
17	day	_	NN	NN	_	16	pobj	_	_
18	7	_	CD	CD	_	17	num	_	_
19	to	_	TO	TO	_	16	prep	_	_
20	day	_	NN	NN	_	19	pobj	_	_
21	14	_	CD	CD	_	20	num	_	_
22	of	_	IN	IN	_	16	prep	_	_
23	culture	_	NN	NN	_	22	pobj	_	_
24	,	_	,	,	_	8	punct	_	_
25	suggesting	_	VBG	VBG	_	8	xcomp	_	_
26	an	_	DT	DT	_	27	det	_	_
27	association	_	NN	NN	_	25	dobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	SCL	_	NN	NN	_	28	pobj	_	_
30	with	_	IN	IN	_	27	prep	_	_
31	erythroid	_	JJ	JJ	_	32	amod	_	_
32	proliferation	_	NN	NN	_	30	pobj	_	_
33	.	_	.	.	_	8	punct	_	_

1	In	_	IN	IN	_	9	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	9	punct	_	_
4	SCL	_	NN	NN	_	5	nn	_	_
5	mRNA	_	NN	NN	_	6	nn	_	_
6	levels	_	NNS	NNS	_	9	nsubj	_	_
7	did	_	VBD	VBD	_	9	aux	_	_
8	not	_	RB	RB	_	9	neg	_	_
9	decrease	_	VB	VB	_	0	root	_	_
10	significantly	_	RB	RB	_	9	advmod	_	_
11	between	_	IN	IN	_	9	prep	_	_
12	day	_	NN	NN	_	11	pobj	_	_
13	7	_	CD	CD	_	12	num	_	_
14	and	_	CC	CC	_	12	cc	_	_
15	day	_	NN	NN	_	12	conj	_	_
16	14	_	CD	CD	_	15	num	_	_
17	cells	_	NNS	NNS	_	12	dep	_	_
18	,	_	,	,	_	9	punct	_	_
19	suggesting	_	VBG	VBG	_	9	vmod	_	_
20	that	_	IN	IN	_	25	mark	_	_
21	posttranscriptional	_	JJ	JJ	_	22	amod	_	_
22	mechanisms	_	NNS	NNS	_	25	nsubj	_	_
23	are	_	VBP	VBP	_	25	cop	_	_
24	largely	_	RB	RB	_	25	advmod	_	_
25	responsible	_	JJ	JJ	_	19	ccomp	_	_
26	for	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	28	det	_	_
28	decrease	_	NN	NN	_	26	pobj	_	_
29	in	_	IN	IN	_	28	prep	_	_
30	SCL	_	NN	NN	_	31	nn	_	_
31	protein	_	NN	NN	_	29	pobj	_	_
32	observed	_	VBN	VBN	_	31	vmod	_	_
33	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	role	_	NN	NN	_	12	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	SCL	_	NN	NN	_	3	pobj	_	_
5	in	_	IN	IN	_	2	prep	_	_
6	Steel	_	NN	NN	_	9	nn	_	_
7	factor-induced	_	JJ	JJ	_	9	amod	_	_
8	erythroid	_	JJ	JJ	_	9	amod	_	_
9	proliferation	_	NN	NN	_	5	pobj	_	_
10	was	_	VBD	VBD	_	12	auxpass	_	_
11	then	_	RB	RB	_	12	advmod	_	_
12	examined	_	VBN	VBN	_	0	root	_	_
13	.	_	.	.	_	12	punct	_	_

1	In	_	IN	IN	_	13	prep	_	_
2	BFU-E-derived	_	JJ	JJ	_	3	amod	_	_
3	colonies	_	NNS	NNS	_	1	pobj	_	_
4	cultured	_	VBN	VBN	_	3	vmod	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	Steel	_	NN	NN	_	7	nn	_	_
7	factor	_	NN	NN	_	5	pobj	_	_
8	,	_	,	,	_	13	punct	_	_
9	colony	_	NN	NN	_	10	nn	_	_
10	size	_	NN	NN	_	13	nsubjpass	_	_
11	was	_	VBD	VBD	_	13	auxpass	_	_
12	significantly	_	RB	RB	_	13	advmod	_	_
13	increased	_	VBN	VBN	_	0	root	_	_
14	compared	_	VBN	VBN	_	13	prep	_	_
15	to	_	TO	TO	_	14	pcomp	_	_
16	control	_	NN	NN	_	15	pobj	_	_
17	.	_	.	.	_	13	punct	_	_

1	In	_	IN	IN	_	17	prep	_	_
2	day	_	NN	NN	_	1	pobj	_	_
3	7	_	CD	CD	_	2	num	_	_
4	and	_	CC	CC	_	2	cc	_	_
5	day	_	NN	NN	_	2	conj	_	_
6	10	_	CD	CD	_	5	num	_	_
7	erythroid	_	JJ	JJ	_	8	amod	_	_
8	precursors	_	NNS	NNS	_	2	dep	_	_
9	cultured	_	VBN	VBN	_	2	vmod	_	_
10	with	_	IN	IN	_	9	prep	_	_
11	Steel	_	NN	NN	_	12	nn	_	_
12	factor	_	NN	NN	_	10	pobj	_	_
13	,	_	,	,	_	17	punct	_	_
14	SCL	_	NN	NN	_	15	nn	_	_
15	protein	_	NN	NN	_	17	nsubjpass	_	_
16	was	_	VBD	VBD	_	17	auxpass	_	_
17	increased	_	VBN	VBN	_	0	root	_	_
18	significantly	_	RB	RB	_	17	advmod	_	_
19	compared	_	VBN	VBN	_	17	prep	_	_
20	to	_	TO	TO	_	19	pcomp	_	_
21	control	_	NN	NN	_	20	pobj	_	_
22	.	_	.	.	_	17	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	increase	_	NN	NN	_	15	nsubj	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	SCL	_	NN	NN	_	6	nn	_	_
5	protein	_	NN	NN	_	6	nn	_	_
6	levels	_	NNS	NNS	_	3	pobj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	early	_	JJ	JJ	_	10	amod	_	_
9	erythroid	_	JJ	JJ	_	10	amod	_	_
10	precursors	_	NNS	NNS	_	7	pobj	_	_
11	stimulated	_	VBD	VBD	_	10	vmod	_	_
12	with	_	IN	IN	_	11	prep	_	_
13	Steel	_	NN	NN	_	14	nn	_	_
14	factor	_	NN	NN	_	12	pobj	_	_
15	suggests	_	VBZ	VBZ	_	0	root	_	_
16	one	_	CD	CD	_	17	num	_	_
17	mechanism	_	NN	NN	_	15	dobj	_	_
18	through	_	IN	IN	_	23	prep	_	_
19	which	_	WDT	WDT	_	18	pobj	_	_
20	Steel	_	NN	NN	_	21	nn	_	_
21	factor	_	NN	NN	_	23	nsubj	_	_
22	may	_	MD	MD	_	23	aux	_	_
23	enhance	_	VB	VB	_	17	rcmod	_	_
24	normal	_	JJ	JJ	_	26	amod	_	_
25	erythroid	_	JJ	JJ	_	24	dep	_	_
26	proliferation	_	NN	NN	_	23	dobj	_	_
27	.	_	.	.	_	15	punct	_	_

1	SCL	_	NN	NN	_	2	nn	_	_
2	mRNA	_	NN	NN	_	3	nn	_	_
3	levels	_	NNS	NNS	_	14	nsubj	_	_
4	assessed	_	VBN	VBN	_	3	vmod	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	Northern	_	NN	NN	_	7	nn	_	_
7	blot	_	NN	NN	_	5	pobj	_	_
8	in	_	IN	IN	_	4	prep	_	_
9	day	_	NN	NN	_	11	nn	_	_
10	7	_	CD	CD	_	11	num	_	_
11	cells	_	NNS	NNS	_	8	pobj	_	_
12	did	_	VBD	VBD	_	14	aux	_	_
13	not	_	RB	RB	_	14	neg	_	_
14	increase	_	VB	VB	_	0	root	_	_
15	significantly	_	RB	RB	_	14	advmod	_	_
16	in	_	IN	IN	_	14	prep	_	_
17	response	_	NN	NN	_	16	pobj	_	_
18	to	_	TO	TO	_	17	prep	_	_
19	Steel	_	NN	NN	_	20	nn	_	_
20	factor	_	NN	NN	_	21	nn	_	_
21	stimulation	_	NN	NN	_	18	pobj	_	_
22	,	_	,	,	_	14	punct	_	_
23	suggesting	_	VBG	VBG	_	14	vmod	_	_
24	that	_	IN	IN	_	30	mark	_	_
25	posttranscriptional	_	JJ	JJ	_	26	amod	_	_
26	mechanisms	_	NNS	NNS	_	30	nsubj	_	_
27	may	_	MD	MD	_	30	aux	_	_
28	also	_	RB	RB	_	30	advmod	_	_
29	be	_	VB	VB	_	30	cop	_	_
30	important	_	JJ	JJ	_	23	ccomp	_	_
31	in	_	IN	IN	_	30	prep	_	_
32	the	_	DT	DT	_	33	det	_	_
33	increase	_	NN	NN	_	31	pobj	_	_
34	in	_	IN	IN	_	33	prep	_	_
35	SCL	_	NN	NN	_	36	nn	_	_
36	protein	_	NN	NN	_	34	pobj	_	_
37	observed	_	VBN	VBN	_	36	vmod	_	_
38	in	_	IN	IN	_	37	prep	_	_
39	response	_	NN	NN	_	38	pobj	_	_
40	to	_	TO	TO	_	39	prep	_	_
41	Steel	_	NN	NN	_	40	pobj	_	_
42	.	_	.	.	_	14	punct	_	_

1	Cross-linking	_	JJ	JJ	_	2	amod	_	_
2	CD40	_	NN	NN	_	7	nsubj	_	_
3	on	_	IN	IN	_	2	prep	_	_
4	B	_	NN	NN	_	5	nn	_	_
5	cells	_	NNS	NNS	_	3	pobj	_	_
6	rapidly	_	RB	RB	_	7	advmod	_	_
7	activates	_	VBZ	VBZ	_	0	root	_	_
8	nuclear	_	JJ	JJ	_	10	amod	_	_
9	factor-kappa	_	NN	NN	_	10	nn	_	_
10	B	_	NN	NN	_	7	dobj	_	_
11	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	6	det	_	_
2	B	_	NN	NN	_	6	nn	_	_
3	cell-associated	_	JJ	JJ	_	6	amod	_	_
4	surface	_	NN	NN	_	6	nn	_	_
5	molecule	_	NN	NN	_	6	nn	_	_
6	CD40	_	NN	NN	_	7	nsubj	_	_
7	functions	_	VBZ	VBZ	_	0	root	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	regulate	_	VB	VB	_	7	xcomp	_	_
10	B	_	NN	NN	_	12	nn	_	_
11	cell	_	NN	NN	_	12	nn	_	_
12	responses	_	NNS	NNS	_	9	dobj	_	_
13	.	_	.	.	_	7	punct	_	_

1	Cross-linking	_	JJ	JJ	_	2	amod	_	_
2	CD40	_	NN	NN	_	7	nsubj	_	_
3	on	_	IN	IN	_	2	prep	_	_
4	B	_	NN	NN	_	5	nn	_	_
5	cells	_	NNS	NNS	_	3	pobj	_	_
6	can	_	MD	MD	_	7	aux	_	_
7	lead	_	VB	VB	_	0	root	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	homotypic	_	JJ	JJ	_	11	amod	_	_
10	cell	_	NN	NN	_	11	nn	_	_
11	adhesion	_	NN	NN	_	8	pobj	_	_
12	,	_	,	,	_	11	punct	_	_
13	IL-6	_	NN	NN	_	14	nn	_	_
14	production	_	NN	NN	_	11	appos	_	_
15	,	_	,	,	_	8	punct	_	_
16	and	_	CC	CC	_	8	cc	_	_
17	,	_	,	,	_	8	punct	_	_
18	in	_	IN	IN	_	8	conj	_	_
19	combination	_	NN	NN	_	18	pobj	_	_
20	with	_	IN	IN	_	19	prep	_	_
21	cytokines	_	NNS	NNS	_	20	pobj	_	_
22	,	_	,	,	_	8	punct	_	_
23	to	_	TO	TO	_	8	conj	_	_
24	Ig	_	NN	NN	_	26	nn	_	_
25	isotype	_	NN	NN	_	26	nn	_	_
26	switching	_	NN	NN	_	23	pobj	_	_
27	.	_	.	.	_	7	punct	_	_

1	Tyrosine	_	NN	NN	_	3	nn	_	_
2	kinase	_	NN	NN	_	3	nn	_	_
3	activity	_	NN	NN	_	5	nsubjpass	_	_
4	is	_	VBZ	VBZ	_	5	auxpass	_	_
5	increased	_	VBN	VBN	_	0	root	_	_
6	shortly	_	RB	RB	_	5	advmod	_	_
7	after	_	IN	IN	_	5	prep	_	_
8	engagement	_	NN	NN	_	7	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	this	_	DT	DT	_	11	det	_	_
11	receptor	_	NN	NN	_	9	pobj	_	_
12	.	_	.	.	_	5	punct	_	_

1	Little	_	JJ	JJ	_	3	nsubjpass	_	_
2	is	_	VBZ	VBZ	_	3	auxpass	_	_
3	known	_	VBN	VBN	_	0	root	_	_
4	about	_	IN	IN	_	3	dep	_	_
5	how	_	WRB	WRB	_	14	advmod	_	_
6	the	_	DT	DT	_	9	det	_	_
7	very	_	RB	RB	_	8	advmod	_	_
8	early	_	JJ	JJ	_	9	amod	_	_
9	events	_	NNS	NNS	_	14	nsubj	_	_
10	induced	_	VBN	VBN	_	9	vmod	_	_
11	by	_	IN	IN	_	10	prep	_	_
12	CD40	_	NN	NN	_	13	nn	_	_
13	cross-linking	_	NN	NN	_	11	pobj	_	_
14	link	_	VBP	VBP	_	4	pcomp	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	cellular	_	JJ	JJ	_	17	amod	_	_
17	responses	_	NNS	NNS	_	15	pobj	_	_
18	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	study	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	demonstrate	_	VBP	VBP	_	0	root	_	_
7	that	_	IN	IN	_	21	mark	_	_
8	nuclear	_	JJ	JJ	_	14	amod	_	_
9	factor	_	NN	NN	_	14	nn	_	_
10	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
11	NF	_	NN	NN	_	14	nn	_	_
12	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
13	-kappa	_	NN	NN	_	14	nn	_	_
14	B	_	NN	NN	_	21	nsubjpass	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	NF-kappa	_	NN	NN	_	19	nn	_	_
17	B-like	_	JJ	JJ	_	19	amod	_	_
18	transcription	_	NN	NN	_	19	nn	_	_
19	factors	_	NNS	NNS	_	14	conj	_	_
20	are	_	VBP	VBP	_	21	auxpass	_	_
21	activated	_	VBN	VBN	_	6	ccomp	_	_
22	after	_	IN	IN	_	21	prep	_	_
23	cross-linking	_	JJ	JJ	_	24	amod	_	_
24	CD40	_	NN	NN	_	22	pobj	_	_
25	on	_	IN	IN	_	24	prep	_	_
26	resting	_	VBG	VBG	_	30	amod	_	_
27	human	_	JJ	JJ	_	30	amod	_	_
28	tonsillar	_	JJ	JJ	_	30	amod	_	_
29	B	_	NN	NN	_	30	nn	_	_
30	cells	_	NNS	NNS	_	25	pobj	_	_
31	and	_	CC	CC	_	25	cc	_	_
32	on	_	IN	IN	_	25	conj	_	_
33	B	_	NN	NN	_	35	nn	_	_
34	cell	_	NN	NN	_	35	nn	_	_
35	lines	_	NNS	NNS	_	32	pobj	_	_
36	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	activation	_	NN	NN	_	4	nsubj	_	_
3	is	_	VBZ	VBZ	_	4	cop	_	_
4	rapid	_	JJ	JJ	_	0	root	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	is	_	VBZ	VBZ	_	7	auxpass	_	_
7	mediated	_	VBN	VBN	_	4	conj	_	_
8	through	_	IN	IN	_	7	prep	_	_
9	a	_	DT	DT	_	12	det	_	_
10	tyrosine	_	NN	NN	_	12	nn	_	_
11	kinase-dependent	_	JJ	JJ	_	12	amod	_	_
12	pathway	_	NN	NN	_	8	pobj	_	_
13	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	complexes	_	NNS	NNS	_	9	nsubj	_	_
3	detected	_	VBN	VBN	_	2	vmod	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	electrophoretic	_	JJ	JJ	_	8	amod	_	_
6	mobility	_	NN	NN	_	8	nn	_	_
7	shift	_	NN	NN	_	8	nn	_	_
8	assays	_	NNS	NNS	_	4	pobj	_	_
9	contain	_	VBP	VBP	_	0	root	_	_
10	p50	_	NN	NN	_	9	dobj	_	_
11	,	_	,	,	_	10	punct	_	_
12	p65	_	NN	NN	_	10	conj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	RelA	_	NN	NN	_	12	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	,	_	,	,	_	10	punct	_	_
17	c-Rel	_	NN	NN	_	10	conj	_	_
18	,	_	,	,	_	10	punct	_	_
19	and	_	CC	CC	_	10	cc	_	_
20	most	_	RBS	RBS	_	21	advmod	_	_
21	likely	_	RB	RB	_	10	advmod	_	_
22	other	_	JJ	JJ	_	23	amod	_	_
23	components	_	NNS	NNS	_	10	conj	_	_
24	.	_	.	.	_	9	punct	_	_

1	By	_	IN	IN	_	8	prep	_	_
2	using	_	VBG	VBG	_	1	pcomp	_	_
3	transient	_	JJ	JJ	_	5	amod	_	_
4	transfection	_	NN	NN	_	5	nn	_	_
5	assays	_	NNS	NNS	_	2	dobj	_	_
6	,	_	,	,	_	8	punct	_	_
7	we	_	PRP	PRP	_	8	nsubj	_	_
8	found	_	VBD	VBD	_	0	root	_	_
9	that	_	IN	IN	_	12	mark	_	_
10	cross-linking	_	JJ	JJ	_	11	amod	_	_
11	CD40	_	NN	NN	_	12	nsubj	_	_
12	supports	_	VBZ	VBZ	_	8	ccomp	_	_
13	NF-kappa	_	NN	NN	_	16	nn	_	_
14	B-dependent	_	JJ	JJ	_	16	amod	_	_
15	gene	_	NN	NN	_	16	nn	_	_
16	expression	_	NN	NN	_	12	dobj	_	_
17	.	_	.	.	_	8	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	define	_	VBP	VBP	_	0	root	_	_
4	the	_	DT	DT	_	7	det	_	_
5	NF-kappa	_	NN	NN	_	6	nn	_	_
6	B	_	NN	NN	_	7	nn	_	_
7	system	_	NN	NN	_	3	dobj	_	_
8	as	_	IN	IN	_	3	prep	_	_
9	an	_	DT	DT	_	11	det	_	_
10	intermediate	_	JJ	JJ	_	11	amod	_	_
11	event	_	NN	NN	_	8	pobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	CD40	_	NN	NN	_	14	nn	_	_
14	signaling	_	NN	NN	_	12	pobj	_	_
15	and	_	CC	CC	_	3	cc	_	_
16	suggest	_	VBP	VBP	_	3	conj	_	_
17	that	_	IN	IN	_	22	mark	_	_
18	the	_	DT	DT	_	20	det	_	_
19	CD40	_	NN	NN	_	20	nn	_	_
20	pathway	_	NN	NN	_	22	nsubj	_	_
21	can	_	MD	MD	_	22	aux	_	_
22	influence	_	VB	VB	_	16	ccomp	_	_
23	the	_	DT	DT	_	24	det	_	_
24	expression	_	NN	NN	_	22	dobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	B	_	NN	NN	_	28	nn	_	_
27	cell-associated	_	JJ	JJ	_	28	amod	_	_
28	genes	_	NNS	NNS	_	25	pobj	_	_
29	with	_	IN	IN	_	22	prep	_	_
30	NF-kappa	_	NN	NN	_	33	nn	_	_
31	B	_	NN	NN	_	33	nn	_	_
32	consensus	_	NN	NN	_	33	nn	_	_
33	sites	_	NNS	NNS	_	29	pobj	_	_
34	.	_	.	.	_	3	punct	_	_

1	Separation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	oxidant-initiated	_	JJ	JJ	_	2	pobj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	redox-regulated	_	JJ	JJ	_	3	conj	_	_
6	steps	_	NNS	NNS	_	3	dep	_	_
7	in	_	IN	IN	_	3	prep	_	_
8	the	_	DT	DT	_	13	det	_	_
9	NF-kappa	_	NN	NN	_	10	nn	_	_
10	B	_	NN	NN	_	13	nn	_	_
11	signal	_	NN	NN	_	13	nn	_	_
12	transduction	_	NN	NN	_	13	nn	_	_
13	pathway	_	NN	NN	_	7	pobj	_	_
14	.	_	.	.	_	1	punct	_	_

1	Studies	_	NNS	NNS	_	4	nsubj	_	_
2	presented	_	VBN	VBN	_	1	vmod	_	_
3	here	_	RB	RB	_	2	advmod	_	_
4	show	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	11	mark	_	_
6	overall	_	JJ	JJ	_	10	amod	_	_
7	NF-kappa	_	NN	NN	_	8	nn	_	_
8	B	_	NN	NN	_	10	nn	_	_
9	signal	_	NN	NN	_	10	nn	_	_
10	transduction	_	NN	NN	_	11	nsubj	_	_
11	begins	_	VBZ	VBZ	_	4	ccomp	_	_
12	with	_	IN	IN	_	11	prep	_	_
13	a	_	DT	DT	_	15	det	_	_
14	parallel	_	JJ	JJ	_	15	amod	_	_
15	series	_	NN	NN	_	12	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	stimuli-specific	_	JJ	JJ	_	18	amod	_	_
18	pathways	_	NNS	NNS	_	16	pobj	_	_
19	through	_	IN	IN	_	47	prep	_	_
20	which	_	WDT	WDT	_	19	pobj	_	_
21	cytokines	_	NNS	NNS	_	47	nsubj	_	_
22	-LRB-	_	-LRB-	-LRB-	_	26	punct	_	_
23	tumor	_	NN	NN	_	26	nn	_	_
24	necrosis	_	NN	NN	_	26	nn	_	_
25	factor	_	NN	NN	_	26	nn	_	_
26	alpha	_	NN	NN	_	21	appos	_	_
27	-RRB-	_	-RRB-	-RRB-	_	26	punct	_	_
28	,	_	,	,	_	21	punct	_	_
29	oxidants	_	NNS	NNS	_	21	conj	_	_
30	-LRB-	_	-LRB-	-LRB-	_	32	punct	_	_
31	hydrogen	_	NN	NN	_	32	nn	_	_
32	peroxide	_	NN	NN	_	29	dep	_	_
33	and	_	CC	CC	_	32	cc	_	_
34	mitomycin	_	NN	NN	_	35	nn	_	_
35	C	_	NN	NN	_	32	conj	_	_
36	-RRB-	_	-RRB-	-RRB-	_	32	punct	_	_
37	,	_	,	,	_	21	punct	_	_
38	and	_	CC	CC	_	21	cc	_	_
39	phorbol	_	NN	NN	_	40	nn	_	_
40	ester	_	NN	NN	_	21	conj	_	_
41	-LRB-	_	-LRB-	-LRB-	_	44	punct	_	_
42	phorbol	_	NN	NN	_	44	nn	_	_
43	12-myristate	_	NN	NN	_	44	nn	_	_
44	13-acetate	_	NN	NN	_	40	appos	_	_
45	-RRB-	_	-RRB-	-RRB-	_	44	punct	_	_
46	individually	_	RB	RB	_	47	advmod	_	_
47	initiate	_	VBP	VBP	_	15	rcmod	_	_
48	signaling	_	NN	NN	_	47	dobj	_	_
49	.	_	.	.	_	4	punct	_	_

1	These	_	DT	DT	_	3	det	_	_
2	initial	_	JJ	JJ	_	3	amod	_	_
3	pathways	_	NNS	NNS	_	4	nsubj	_	_
4	culminate	_	VBP	VBP	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	a	_	DT	DT	_	8	det	_	_
7	common	_	JJ	JJ	_	8	amod	_	_
8	pathway	_	NN	NN	_	5	pobj	_	_
9	through	_	IN	IN	_	17	prep	_	_
10	which	_	WDT	WDT	_	9	pobj	_	_
11	all	_	DT	DT	_	17	nsubj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	stimulating	_	VBG	VBG	_	15	amod	_	_
15	agents	_	NNS	NNS	_	12	pobj	_	_
16	ultimately	_	RB	RB	_	17	advmod	_	_
17	signal	_	VBP	VBP	_	8	rcmod	_	_
18	NF-kappa	_	NN	NN	_	19	nn	_	_
19	B	_	NN	NN	_	20	nn	_	_
20	activation	_	NN	NN	_	17	dobj	_	_
21	.	_	.	.	_	4	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	distinguish	_	VBP	VBP	_	0	root	_	_
3	the	_	DT	DT	_	5	det	_	_
4	stimuli-specific	_	JJ	JJ	_	5	amod	_	_
5	pathways	_	NNS	NNS	_	2	dobj	_	_
6	by	_	IN	IN	_	2	prep	_	_
7	showing	_	VBG	VBG	_	6	pcomp	_	_
8	that	_	IN	IN	_	12	mark	_	_
9	the	_	DT	DT	_	11	det	_	_
10	oxidative	_	JJ	JJ	_	11	amod	_	_
11	stimuli	_	NNS	NNS	_	12	nsubj	_	_
12	trigger	_	VBP	VBP	_	7	ccomp	_	_
13	NF-kappa	_	NN	NN	_	14	nn	_	_
14	B	_	NN	NN	_	15	nn	_	_
15	activation	_	NN	NN	_	12	dobj	_	_
16	in	_	IN	IN	_	12	prep	_	_
17	only	_	RB	RB	_	18	advmod	_	_
18	one	_	CD	CD	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	two	_	CD	CD	_	23	num	_	_
21	human	_	JJ	JJ	_	23	amod	_	_
22	T-cell	_	NN	NN	_	23	nn	_	_
23	lines	_	NNS	NNS	_	19	pobj	_	_
24	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
25	Wurzburg	_	NN	NN	_	23	dep	_	_
26	but	_	CC	CC	_	27	cc	_	_
27	not	_	RB	RB	_	25	cc	_	_
28	Jurkat	_	NN	NN	_	25	conj	_	_
29	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
30	,	_	,	,	_	12	punct	_	_
31	whereas	_	IN	IN	_	41	mark	_	_
32	tumor	_	NN	NN	_	35	nn	_	_
33	necrosis	_	NN	NN	_	35	nn	_	_
34	factor	_	NN	NN	_	35	nn	_	_
35	alpha	_	NN	NN	_	41	nsubj	_	_
36	and	_	CC	CC	_	35	cc	_	_
37	phorbol	_	NN	NN	_	39	nn	_	_
38	12-myristate	_	NN	NN	_	39	nn	_	_
39	13-acetate	_	NN	NN	_	35	conj	_	_
40	readily	_	RB	RB	_	41	advmod	_	_
41	stimulate	_	VBP	VBP	_	12	advcl	_	_
42	in	_	IN	IN	_	41	prep	_	_
43	both	_	DT	DT	_	44	det	_	_
44	lines	_	NNS	NNS	_	42	pobj	_	_
45	.	_	.	.	_	2	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	propose	_	VBP	VBP	_	0	root	_	_
3	the	_	DT	DT	_	5	det	_	_
4	common	_	JJ	JJ	_	5	amod	_	_
5	pathway	_	NN	NN	_	2	dobj	_	_
6	as	_	IN	IN	_	2	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	simplest	_	JJS	JJS	_	9	amod	_	_
9	way	_	NN	NN	_	6	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	accounting	_	NN	NN	_	10	pcomp	_	_
12	for	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	15	dep	_	_
14	common	_	JJ	JJ	_	15	amod	_	_
15	requirements	_	NNS	NNS	_	12	pobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	properties	_	NNS	NNS	_	15	conj	_	_
18	of	_	IN	IN	_	15	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	signaling	_	NN	NN	_	21	nn	_	_
21	pathway	_	NN	NN	_	18	pobj	_	_
22	.	_	.	.	_	2	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	include	_	VBP	VBP	_	0	root	_	_
3	a	_	DT	DT	_	7	det	_	_
4	redox-regulatory	_	JJ	JJ	_	7	amod	_	_
5	mechanism	_	NN	NN	_	7	nn	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	s	_	NNS	NNS	_	2	dobj	_	_
8	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
9	in	_	IN	IN	_	2	prep	_	_
10	this	_	DT	DT	_	12	det	_	_
11	common	_	JJ	JJ	_	12	amod	_	_
12	pathway	_	NN	NN	_	9	pobj	_	_
13	to	_	TO	TO	_	14	aux	_	_
14	account	_	VB	VB	_	2	vmod	_	_
15	for	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	20	det	_	_
17	previously	_	RB	RB	_	18	advmod	_	_
18	demonstrated	_	VBN	VBN	_	20	amod	_	_
19	redox	_	NN	NN	_	20	nn	_	_
20	regulation	_	NN	NN	_	15	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	NF-kappa	_	NN	NN	_	23	nn	_	_
23	B	_	NN	NN	_	24	nn	_	_
24	activation	_	NN	NN	_	21	pobj	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	Jurkat	_	NN	NN	_	27	nn	_	_
27	cells	_	NNS	NNS	_	25	pobj	_	_
28	-LRB-	_	-LRB-	-LRB-	_	34	punct	_	_
29	in	_	IN	IN	_	34	prep	_	_
30	which	_	WDT	WDT	_	29	pobj	_	_
31	oxidants	_	NNS	NNS	_	34	nsubj	_	_
32	do	_	VBP	VBP	_	34	aux	_	_
33	n't	_	RB	RB	_	34	neg	_	_
34	activate	_	VB	VB	_	27	dep	_	_
35	NF-kappa	_	NN	NN	_	36	nn	_	_
36	B	_	NN	NN	_	34	dobj	_	_
37	-RRB-	_	-RRB-	-RRB-	_	34	punct	_	_
38	;	_	:	:	_	2	punct	_	_
39	we	_	PRP	PRP	_	40	nsubj	_	_
40	put	_	VBP	VBP	_	2	parataxis	_	_
41	tyrosine	_	NN	NN	_	42	nn	_	_
42	phosphorylation	_	NN	NN	_	40	dobj	_	_
43	in	_	IN	IN	_	40	prep	_	_
44	the	_	DT	DT	_	46	det	_	_
45	common	_	JJ	JJ	_	46	amod	_	_
46	pathway	_	NN	NN	_	43	pobj	_	_
47	by	_	IN	IN	_	40	prep	_	_
48	showing	_	VBG	VBG	_	47	pcomp	_	_
49	that	_	IN	IN	_	62	mark	_	_
50	kinase	_	NN	NN	_	51	nn	_	_
51	activity	_	NN	NN	_	62	nsubjpass	_	_
52	-LRB-	_	-LRB-	-LRB-	_	53	punct	_	_
53	inhibitable	_	JJ	JJ	_	51	dep	_	_
54	by	_	IN	IN	_	53	prep	_	_
55	herbimycin	_	NN	NN	_	56	nn	_	_
56	A	_	NN	NN	_	54	pobj	_	_
57	and	_	CC	CC	_	56	cc	_	_
58	tyrphostin	_	NN	NN	_	56	conj	_	_
59	47	_	CD	CD	_	58	num	_	_
60	-RRB-	_	-RRB-	-RRB-	_	53	punct	_	_
61	is	_	VBZ	VBZ	_	62	auxpass	_	_
62	required	_	VBN	VBN	_	48	ccomp	_	_
63	for	_	IN	IN	_	62	prep	_	_
64	NF-kappa	_	NN	NN	_	65	nn	_	_
65	B	_	NN	NN	_	66	nn	_	_
66	activation	_	NN	NN	_	63	pobj	_	_
67	by	_	IN	IN	_	66	prep	_	_
68	all	_	DT	DT	_	69	det	_	_
69	stimuli	_	NNS	NNS	_	67	pobj	_	_
70	tested	_	VBN	VBN	_	69	vmod	_	_
71	in	_	IN	IN	_	70	prep	_	_
72	both	_	DT	DT	_	74	det	_	_
73	cell	_	NN	NN	_	74	nn	_	_
74	lines	_	NNS	NNS	_	71	pobj	_	_
75	.	_	.	.	_	2	punct	_	_

1	Since	_	IN	IN	_	9	mark	_	_
2	internal	_	JJ	JJ	_	3	amod	_	_
3	sites	_	NNS	NNS	_	9	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	oxidant	_	NN	NN	_	6	nn	_	_
6	production	_	NN	NN	_	4	pobj	_	_
7	have	_	VBP	VBP	_	9	aux	_	_
8	been	_	VBN	VBN	_	9	auxpass	_	_
9	shown	_	VBN	VBN	_	40	dep	_	_
10	to	_	TO	TO	_	11	aux	_	_
11	play	_	VB	VB	_	9	xcomp	_	_
12	a	_	DT	DT	_	14	det	_	_
13	key	_	JJ	JJ	_	14	amod	_	_
14	role	_	NN	NN	_	11	dobj	_	_
15	in	_	IN	IN	_	11	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	cytokine-stimulated	_	JJ	JJ	_	18	amod	_	_
18	activation	_	NN	NN	_	15	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	NF-kappa	_	NN	NN	_	21	nn	_	_
21	B	_	NN	NN	_	19	pobj	_	_
22	,	_	,	,	_	9	punct	_	_
23	and	_	CC	CC	_	9	cc	_	_
24	since	_	IN	IN	_	31	mark	_	_
25	tyrosine	_	NN	NN	_	26	nn	_	_
26	kinase	_	NN	NN	_	31	nsubjpass	_	_
27	and	_	CC	CC	_	26	cc	_	_
28	phosphatase	_	NN	NN	_	26	conj	_	_
29	activities	_	NNS	NNS	_	26	dep	_	_
30	are	_	VBP	VBP	_	31	auxpass	_	_
31	known	_	VBN	VBN	_	9	conj	_	_
32	to	_	TO	TO	_	34	aux	_	_
33	be	_	VB	VB	_	34	auxpass	_	_
34	altered	_	VBN	VBN	_	31	xcomp	_	_
35	by	_	IN	IN	_	34	prep	_	_
36	oxidants	_	NNS	NNS	_	35	pobj	_	_
37	,	_	,	,	_	40	punct	_	_
38	these	_	DT	DT	_	39	det	_	_
39	findings	_	NNS	NNS	_	40	nsubj	_	_
40	suggest	_	VBP	VBP	_	0	root	_	_
41	that	_	IN	IN	_	45	mark	_	_
42	intracellular	_	JJ	JJ	_	44	amod	_	_
43	redox	_	NN	NN	_	44	nn	_	_
44	status	_	NN	NN	_	45	nsubj	_	_
45	controls	_	VBZ	VBZ	_	40	ccomp	_	_
46	NF-kappa	_	NN	NN	_	47	nn	_	_
47	B	_	NN	NN	_	48	nn	_	_
48	activation	_	NN	NN	_	45	dobj	_	_
49	by	_	IN	IN	_	45	prep	_	_
50	regulating	_	VBG	VBG	_	49	pcomp	_	_
51	tyrosine	_	NN	NN	_	55	nn	_	_
52	phosphorylation	_	NN	NN	_	55	nn	_	_
53	event	_	NN	NN	_	55	nn	_	_
54	-LRB-	_	-LRB-	-LRB-	_	55	punct	_	_
55	s	_	NNS	NNS	_	50	dobj	_	_
56	-RRB-	_	-RRB-	-RRB-	_	55	punct	_	_
57	within	_	IN	IN	_	50	prep	_	_
58	the	_	DT	DT	_	60	det	_	_
59	common	_	JJ	JJ	_	60	amod	_	_
60	step	_	NN	NN	_	57	pobj	_	_
61	of	_	IN	IN	_	60	prep	_	_
62	the	_	DT	DT	_	67	det	_	_
63	NF-kappa	_	NN	NN	_	64	nn	_	_
64	B	_	NN	NN	_	67	nn	_	_
65	signal	_	NN	NN	_	67	nn	_	_
66	transduction	_	NN	NN	_	67	nn	_	_
67	pathway	_	NN	NN	_	61	pobj	_	_
68	.	_	.	.	_	40	punct	_	_

1	Transcription-independent	_	JJ	JJ	_	2	amod	_	_
2	turnover	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	I	_	NN	NN	_	7	nn	_	_
5	kappa	_	NN	NN	_	7	nn	_	_
6	B	_	NN	NN	_	7	nn	_	_
7	alpha	_	NN	NN	_	3	pobj	_	_
8	during	_	IN	IN	_	2	prep	_	_
9	monocyte	_	NN	NN	_	10	nn	_	_
10	adherence	_	NN	NN	_	8	pobj	_	_
11	:	_	:	:	_	2	punct	_	_
12	implications	_	NNS	NNS	_	2	dep	_	_
13	for	_	IN	IN	_	12	prep	_	_
14	a	_	DT	DT	_	16	det	_	_
15	translational	_	JJ	JJ	_	16	amod	_	_
16	component	_	NN	NN	_	13	pobj	_	_
17	regulating	_	VBG	VBG	_	16	vmod	_	_
18	I	_	NN	NN	_	22	nn	_	_
19	kappa	_	NN	NN	_	22	nn	_	_
20	B	_	NN	NN	_	22	nn	_	_
21	alpha/MAD-3	_	NN	NN	_	22	nn	_	_
22	mRNA	_	NN	NN	_	23	nn	_	_
23	levels	_	NNS	NNS	_	17	dobj	_	_
24	.	_	.	.	_	2	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	identified	_	VBD	VBD	_	0	root	_	_
3	I	_	NN	NN	_	6	nn	_	_
4	kappa	_	NN	NN	_	6	nn	_	_
5	B	_	NN	NN	_	6	nn	_	_
6	alpha/MAD-3	_	NN	NN	_	2	dobj	_	_
7	as	_	IN	IN	_	2	prep	_	_
8	an	_	DT	DT	_	10	det	_	_
9	immediate-early	_	JJ	JJ	_	10	amod	_	_
10	gene	_	NN	NN	_	7	pobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	human	_	JJ	JJ	_	13	amod	_	_
13	monocytes	_	NNS	NNS	_	11	pobj	_	_
14	that	_	WDT	WDT	_	16	nsubjpass	_	_
15	is	_	VBZ	VBZ	_	16	auxpass	_	_
16	expressed	_	VBN	VBN	_	10	rcmod	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	response	_	NN	NN	_	17	pobj	_	_
19	to	_	TO	TO	_	18	prep	_	_
20	a	_	DT	DT	_	21	det	_	_
21	variety	_	NN	NN	_	19	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	signals	_	NNS	NNS	_	22	pobj	_	_
24	,	_	,	,	_	23	punct	_	_
25	including	_	VBG	VBG	_	23	prep	_	_
26	adhesion	_	NN	NN	_	25	pobj	_	_
27	,	_	,	,	_	26	punct	_	_
28	lipopolysaccharide	_	NN	NN	_	26	conj	_	_
29	,	_	,	,	_	26	punct	_	_
30	and	_	CC	CC	_	26	cc	_	_
31	phorbol	_	NN	NN	_	33	nn	_	_
32	myristate	_	NN	NN	_	33	nn	_	_
33	acetate	_	NN	NN	_	26	conj	_	_
34	.	_	.	.	_	2	punct	_	_

1	Within	_	IN	IN	_	19	prep	_	_
2	5	_	CD	CD	_	3	num	_	_
3	min	_	NN	NN	_	1	pobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	monocyte	_	NN	NN	_	6	nn	_	_
6	adhesion	_	NN	NN	_	4	pobj	_	_
7	,	_	,	,	_	19	punct	_	_
8	the	_	DT	DT	_	9	det	_	_
9	level	_	NN	NN	_	19	nsubjpass	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	16	det	_	_
12	I	_	NN	NN	_	16	nn	_	_
13	kappa	_	NN	NN	_	16	nn	_	_
14	B	_	NN	NN	_	16	nn	_	_
15	alpha	_	NN	NN	_	16	nn	_	_
16	protein	_	NN	NN	_	10	pobj	_	_
17	is	_	VBZ	VBZ	_	19	auxpass	_	_
18	markedly	_	RB	RB	_	19	advmod	_	_
19	diminished	_	VBN	VBN	_	0	root	_	_
20	but	_	CC	CC	_	19	cc	_	_
21	is	_	VBZ	VBZ	_	23	auxpass	_	_
22	rapidly	_	RB	RB	_	23	advmod	_	_
23	replaced	_	VBN	VBN	_	19	conj	_	_
24	in	_	IN	IN	_	23	prep	_	_
25	a	_	DT	DT	_	27	det	_	_
26	cycloheximide-sensitive	_	JJ	JJ	_	27	amod	_	_
27	manner	_	NN	NN	_	24	pobj	_	_
28	within	_	IN	IN	_	23	prep	_	_
29	20	_	CD	CD	_	30	num	_	_
30	min	_	NN	NN	_	28	pobj	_	_
31	.	_	.	.	_	19	punct	_	_

1	Accompanying	_	VBG	VBG	_	0	root	_	_
2	the	_	DT	DT	_	4	det	_	_
3	rapid	_	JJ	JJ	_	4	amod	_	_
4	turnover	_	NN	NN	_	1	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	11	det	_	_
7	I	_	NN	NN	_	11	nn	_	_
8	kappa	_	NN	NN	_	11	nn	_	_
9	B	_	NN	NN	_	11	nn	_	_
10	alpha	_	NN	NN	_	11	nn	_	_
11	protein	_	NN	NN	_	5	pobj	_	_
12	is	_	VBZ	VBZ	_	1	aux	_	_
13	simultaneous	_	JJ	JJ	_	14	amod	_	_
14	translocation	_	NN	NN	_	1	nsubj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	NF-kappa	_	NN	NN	_	19	nn	_	_
17	B-related	_	JJ	JJ	_	19	amod	_	_
18	transcription	_	NN	NN	_	19	nn	_	_
19	factors	_	NNS	NNS	_	15	pobj	_	_
20	to	_	TO	TO	_	14	prep	_	_
21	nuclei	_	NNS	NNS	_	20	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	adhered	_	JJ	JJ	_	24	amod	_	_
24	monocytes	_	NNS	NNS	_	22	pobj	_	_
25	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	demonstration	_	NN	NN	_	18	nsubj	_	_
3	that	_	IN	IN	_	7	mark	_	_
4	NF-kappa	_	NN	NN	_	5	nn	_	_
5	B	_	NN	NN	_	7	nsubj	_	_
6	can	_	MD	MD	_	7	aux	_	_
7	regulate	_	VB	VB	_	2	ccomp	_	_
8	I	_	NN	NN	_	12	nn	_	_
9	kappa	_	NN	NN	_	12	nn	_	_
10	B	_	NN	NN	_	12	nn	_	_
11	alpha/MAD-3	_	NN	NN	_	12	nn	_	_
12	gene	_	NN	NN	_	13	nn	_	_
13	transcription	_	NN	NN	_	7	dobj	_	_
14	in	_	IN	IN	_	7	prep	_	_
15	other	_	JJ	JJ	_	17	amod	_	_
16	cell	_	NN	NN	_	17	nn	_	_
17	types	_	NNS	NNS	_	14	pobj	_	_
18	suggested	_	VBD	VBD	_	0	root	_	_
19	that	_	IN	IN	_	40	mark	_	_
20	the	_	DT	DT	_	22	det	_	_
21	rapid	_	JJ	JJ	_	22	amod	_	_
22	increase	_	NN	NN	_	40	nsubj	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	steady-state	_	JJ	JJ	_	30	amod	_	_
25	I	_	NN	NN	_	29	nn	_	_
26	kappa	_	NN	NN	_	29	nn	_	_
27	B	_	NN	NN	_	29	nn	_	_
28	alpha/MAD-3	_	NN	NN	_	29	nn	_	_
29	mRNA	_	NN	NN	_	30	nn	_	_
30	levels	_	NNS	NNS	_	23	pobj	_	_
31	we	_	PRP	PRP	_	32	nsubj	_	_
32	observed	_	VBD	VBD	_	22	rcmod	_	_
33	within	_	IN	IN	_	32	prep	_	_
34	30	_	CD	CD	_	35	num	_	_
35	min	_	NN	NN	_	33	pobj	_	_
36	of	_	IN	IN	_	35	prep	_	_
37	monocyte	_	NN	NN	_	38	nn	_	_
38	adherence	_	NN	NN	_	36	pobj	_	_
39	would	_	MD	MD	_	40	aux	_	_
40	result	_	VB	VB	_	18	ccomp	_	_
41	from	_	IN	IN	_	40	prep	_	_
42	NF-kappa	_	NN	NN	_	45	nn	_	_
43	B-dependent	_	JJ	JJ	_	45	amod	_	_
44	transcriptional	_	JJ	JJ	_	45	amod	_	_
45	stimulation	_	NN	NN	_	41	pobj	_	_
46	of	_	IN	IN	_	45	prep	_	_
47	the	_	DT	DT	_	52	det	_	_
48	I	_	NN	NN	_	52	nn	_	_
49	kappa	_	NN	NN	_	52	nn	_	_
50	B	_	NN	NN	_	52	nn	_	_
51	alpha/MAD-3	_	NN	NN	_	52	nn	_	_
52	gene	_	NN	NN	_	46	pobj	_	_
53	.	_	.	.	_	18	punct	_	_

1	Nuclear	_	JJ	JJ	_	3	amod	_	_
2	run-on	_	JJ	JJ	_	1	dep	_	_
3	analyses	_	NNS	NNS	_	4	nsubj	_	_
4	indicated	_	VBD	VBD	_	0	root	_	_
5	that	_	IN	IN	_	43	mark	_	_
6	,	_	,	,	_	43	punct	_	_
7	instead	_	RB	RB	_	43	advmod	_	_
8	,	_	,	,	_	43	punct	_	_
9	while	_	IN	IN	_	29	mark	_	_
10	several	_	JJ	JJ	_	13	amod	_	_
11	immediate-early	_	JJ	JJ	_	13	amod	_	_
12	cytokine	_	NN	NN	_	13	nn	_	_
13	genes	_	NNS	NNS	_	29	nsubjpass	_	_
14	,	_	,	,	_	13	punct	_	_
15	such	_	JJ	JJ	_	16	mwe	_	_
16	as	_	IN	IN	_	13	prep	_	_
17	the	_	DT	DT	_	25	det	_	_
18	interleukin	_	NN	NN	_	25	nn	_	_
19	1	_	CD	CD	_	25	num	_	_
20	beta	_	NN	NN	_	25	nn	_	_
21	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
22	IL-1	_	NN	NN	_	25	nn	_	_
23	beta	_	NN	NN	_	25	nn	_	_
24	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
25	gene	_	NN	NN	_	16	pobj	_	_
26	,	_	,	,	_	13	punct	_	_
27	were	_	VBD	VBD	_	29	auxpass	_	_
28	transcriptionally	_	RB	RB	_	29	advmod	_	_
29	activated	_	VBN	VBN	_	43	dep	_	_
30	during	_	IN	IN	_	29	prep	_	_
31	monocyte	_	NN	NN	_	32	nn	_	_
32	adhesion	_	NN	NN	_	30	pobj	_	_
33	,	_	,	,	_	43	punct	_	_
34	the	_	DT	DT	_	35	det	_	_
35	rate	_	NN	NN	_	43	nsubj	_	_
36	of	_	IN	IN	_	35	prep	_	_
37	I	_	NN	NN	_	41	nn	_	_
38	kappa	_	NN	NN	_	41	nn	_	_
39	B	_	NN	NN	_	41	nn	_	_
40	alpha/MAD-3	_	NN	NN	_	41	nn	_	_
41	gene	_	NN	NN	_	42	nn	_	_
42	transcription	_	NN	NN	_	36	pobj	_	_
43	remained	_	VBD	VBD	_	4	ccomp	_	_
44	constant	_	JJ	JJ	_	43	acomp	_	_
45	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	adherence-dependent	_	JJ	JJ	_	3	amod	_	_
3	increase	_	NN	NN	_	15	nsubj	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	I	_	NN	NN	_	9	nn	_	_
6	kappa	_	NN	NN	_	9	nn	_	_
7	B	_	NN	NN	_	9	nn	_	_
8	alpha/MAD-3	_	NN	NN	_	9	nn	_	_
9	mRNA	_	NN	NN	_	10	nn	_	_
10	levels	_	NNS	NNS	_	4	pobj	_	_
11	was	_	VBD	VBD	_	15	cop	_	_
12	also	_	RB	RB	_	15	advmod	_	_
13	not	_	RB	RB	_	15	neg	_	_
14	a	_	DT	DT	_	15	det	_	_
15	consequence	_	NN	NN	_	0	root	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	mRNA	_	NN	NN	_	19	nn	_	_
18	stabilization	_	NN	NN	_	19	nn	_	_
19	events	_	NNS	NNS	_	16	pobj	_	_
20	.	_	.	.	_	15	punct	_	_

1	Interestingly	_	RB	RB	_	30	advmod	_	_
2	,	_	,	,	_	30	punct	_	_
3	while	_	IN	IN	_	17	mark	_	_
4	increases	_	NNS	NNS	_	17	nsubjpass	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	both	_	CC	CC	_	8	preconj	_	_
7	IL-1	_	NN	NN	_	8	nn	_	_
8	beta	_	NN	NN	_	5	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	I	_	NN	NN	_	14	nn	_	_
11	kappa	_	NN	NN	_	14	nn	_	_
12	B	_	NN	NN	_	14	nn	_	_
13	alpha/MAD-3	_	NN	NN	_	14	nn	_	_
14	mRNA	_	NN	NN	_	8	conj	_	_
15	levels	_	NNS	NNS	_	8	dep	_	_
16	were	_	VBD	VBD	_	17	auxpass	_	_
17	detected	_	VBN	VBN	_	30	dep	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	nuclei	_	NNS	NNS	_	18	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	adherent	_	JJ	JJ	_	22	amod	_	_
22	monocytes	_	NNS	NNS	_	20	pobj	_	_
23	,	_	,	,	_	30	punct	_	_
24	cytoplasmic	_	JJ	JJ	_	25	amod	_	_
25	levels	_	NNS	NNS	_	30	nsubj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	IL-1	_	NN	NN	_	29	nn	_	_
28	beta	_	NN	NN	_	29	nn	_	_
29	mRNA	_	NN	NN	_	26	pobj	_	_
30	increased	_	VBN	VBN	_	0	root	_	_
31	during	_	IN	IN	_	30	prep	_	_
32	adherence	_	NN	NN	_	31	pobj	_	_
33	whereas	_	IN	IN	_	41	mark	_	_
34	those	_	DT	DT	_	41	nsubj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	I	_	NN	NN	_	40	nn	_	_
37	kappa	_	NN	NN	_	40	nn	_	_
38	B	_	NN	NN	_	40	nn	_	_
39	alpha/MAD-3	_	NN	NN	_	40	nn	_	_
40	mRNA	_	NN	NN	_	35	pobj	_	_
41	did	_	VBD	VBD	_	30	advcl	_	_
42	not	_	RB	RB	_	41	neg	_	_
43	.	_	.	.	_	30	punct	_	_

1	Taken	_	VBN	VBN	_	0	root	_	_
2	together	_	RB	RB	_	1	advmod	_	_
3	,	_	,	,	_	1	punct	_	_
4	our	_	PRP$	PRP$	_	5	poss	_	_
5	data	_	NNS	NNS	_	6	nsubj	_	_
6	suggest	_	VBP	VBP	_	1	parataxis	_	_
7	that	_	IN	IN	_	11	mark	_	_
8	two	_	CD	CD	_	10	num	_	_
9	interactive	_	JJ	JJ	_	10	amod	_	_
10	mechanisms	_	NNS	NNS	_	11	nsubj	_	_
11	regulate	_	VBP	VBP	_	6	ccomp	_	_
12	monocytic	_	JJ	JJ	_	17	amod	_	_
13	I	_	NN	NN	_	17	nn	_	_
14	kappa	_	NN	NN	_	17	nn	_	_
15	B	_	NN	NN	_	17	nn	_	_
16	alpha/MAD-3	_	NN	NN	_	17	nn	_	_
17	mRNA	_	NN	NN	_	18	nn	_	_
18	levels	_	NNS	NNS	_	11	dobj	_	_
19	.	_	.	.	_	1	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	propose	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	6	mark	_	_
4	adherent	_	JJ	JJ	_	5	amod	_	_
5	monocytes	_	NNS	NNS	_	6	nsubj	_	_
6	regulate	_	VBP	VBP	_	2	ccomp	_	_
7	nuclear	_	JJ	JJ	_	8	amod	_	_
8	processing	_	NN	NN	_	6	dobj	_	_
9	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
10	or	_	CC	CC	_	11	cc	_	_
11	decay	_	NN	NN	_	8	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	of	_	IN	IN	_	8	prep	_	_
14	I	_	NN	NN	_	18	nn	_	_
15	kappa	_	NN	NN	_	18	nn	_	_
16	B	_	NN	NN	_	18	nn	_	_
17	alpha/MAD-3	_	NN	NN	_	18	nn	_	_
18	mRNA	_	NN	NN	_	13	pobj	_	_
19	,	_	,	,	_	6	punct	_	_
20	thereby	_	RB	RB	_	21	advmod	_	_
21	increasing	_	VBG	VBG	_	6	vmod	_	_
22	mRNA	_	NN	NN	_	23	nn	_	_
23	levels	_	NNS	NNS	_	21	dobj	_	_
24	without	_	IN	IN	_	21	prep	_	_
25	stimulating	_	VBG	VBG	_	24	pcomp	_	_
26	I	_	NN	NN	_	30	nn	_	_
27	kappa	_	NN	NN	_	30	nn	_	_
28	B	_	NN	NN	_	30	nn	_	_
29	alpha/MAD-3	_	NN	NN	_	30	nn	_	_
30	gene	_	NN	NN	_	31	nn	_	_
31	transcription	_	NN	NN	_	25	dobj	_	_
32	.	_	.	.	_	2	punct	_	_

1	Moreover	_	RB	RB	_	27	advmod	_	_
2	,	_	,	,	_	27	punct	_	_
3	since	_	IN	IN	_	8	mark	_	_
4	inhibition	_	NN	NN	_	8	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	protein	_	NN	NN	_	7	nn	_	_
7	synthesis	_	NN	NN	_	5	pobj	_	_
8	leads	_	VBZ	VBZ	_	27	dep	_	_
9	to	_	TO	TO	_	8	prep	_	_
10	accumulation	_	NN	NN	_	9	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	I	_	NN	NN	_	16	nn	_	_
13	kappa	_	NN	NN	_	16	nn	_	_
14	B	_	NN	NN	_	16	nn	_	_
15	alpha/MAD-3	_	NN	NN	_	16	nn	_	_
16	mRNA	_	NN	NN	_	11	pobj	_	_
17	without	_	IN	IN	_	8	prep	_	_
18	stimulating	_	VBG	VBG	_	17	pcomp	_	_
19	I	_	NN	NN	_	23	nn	_	_
20	kappa	_	NN	NN	_	23	nn	_	_
21	B	_	NN	NN	_	23	nn	_	_
22	alpha/MAD-3	_	NN	NN	_	23	nn	_	_
23	gene	_	NN	NN	_	24	nn	_	_
24	transcription	_	NN	NN	_	18	dobj	_	_
25	,	_	,	,	_	27	punct	_	_
26	we	_	PRP	PRP	_	27	nsubj	_	_
27	suggest	_	VBP	VBP	_	0	root	_	_
28	that	_	IN	IN	_	39	mark	_	_
29	low	_	JJ	JJ	_	31	amod	_	_
30	cytoplasmic	_	JJ	JJ	_	31	amod	_	_
31	levels	_	NNS	NNS	_	39	nsubjpass	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	I	_	NN	NN	_	37	nn	_	_
34	kappa	_	NN	NN	_	37	nn	_	_
35	B	_	NN	NN	_	37	nn	_	_
36	alpha/MAD-3	_	NN	NN	_	37	nn	_	_
37	mRNA	_	NN	NN	_	32	pobj	_	_
38	are	_	VBP	VBP	_	39	auxpass	_	_
39	maintained	_	VBN	VBN	_	27	ccomp	_	_
40	by	_	IN	IN	_	39	prep	_	_
41	a	_	DT	DT	_	44	det	_	_
42	translation-dependent	_	JJ	JJ	_	44	amod	_	_
43	degradation	_	NN	NN	_	44	nn	_	_
44	mechanism	_	NN	NN	_	40	pobj	_	_
45	.	_	.	.	_	27	punct	_	_

1	E2F-1	_	NN	NN	_	12	nsubj	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	a	_	DT	DT	_	7	det	_	_
4	cyclin-like	_	JJ	JJ	_	7	amod	_	_
5	DNA	_	NN	NN	_	7	nn	_	_
6	repair	_	NN	NN	_	7	nn	_	_
7	enzyme	_	NN	NN	_	1	conj	_	_
8	,	_	,	,	_	7	punct	_	_
9	uracil-DNA	_	NN	NN	_	10	nn	_	_
10	glycosylase	_	NN	NN	_	7	appos	_	_
11	,	_	,	,	_	1	punct	_	_
12	provide	_	VBP	VBP	_	0	root	_	_
13	evidence	_	NN	NN	_	12	dobj	_	_
14	for	_	IN	IN	_	13	prep	_	_
15	an	_	DT	DT	_	17	det	_	_
16	autoregulatory	_	JJ	JJ	_	17	amod	_	_
17	mechanism	_	NN	NN	_	14	pobj	_	_
18	for	_	IN	IN	_	17	prep	_	_
19	transcription	_	NN	NN	_	18	pobj	_	_
20	.	_	.	.	_	12	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	cell	_	NN	NN	_	5	nn	_	_
3	cycle-dependent	_	JJ	JJ	_	5	amod	_	_
4	transcription	_	NN	NN	_	5	nn	_	_
5	factor	_	NN	NN	_	9	nsubj	_	_
6	,	_	,	,	_	5	punct	_	_
7	E2F-1	_	NN	NN	_	5	appos	_	_
8	,	_	,	,	_	5	punct	_	_
9	regulates	_	VBZ	VBZ	_	0	root	_	_
10	the	_	DT	DT	_	12	det	_	_
11	cyclin-like	_	JJ	JJ	_	12	amod	_	_
12	species	_	NNS	NNS	_	9	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	17	det	_	_
15	DNA	_	NN	NN	_	17	nn	_	_
16	repair	_	NN	NN	_	17	nn	_	_
17	enzyme	_	NN	NN	_	13	pobj	_	_
18	uracil-DNA	_	NN	NN	_	23	nn	_	_
19	glycosylase	_	NN	NN	_	23	nn	_	_
20	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
21	UDG	_	NN	NN	_	23	nn	_	_
22	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
23	gene	_	NN	NN	_	17	dep	_	_
24	in	_	IN	IN	_	9	prep	_	_
25	human	_	JJ	JJ	_	30	amod	_	_
26	osteosarcoma	_	NN	NN	_	30	nn	_	_
27	-LRB-	_	-LRB-	-LRB-	_	30	punct	_	_
28	Saos-2	_	NN	NN	_	30	nn	_	_
29	-RRB-	_	-RRB-	-RRB-	_	30	punct	_	_
30	cells	_	NNS	NNS	_	24	pobj	_	_
31	.	_	.	.	_	9	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	demonstrate	_	VBP	VBP	_	0	root	_	_
3	,	_	,	,	_	2	punct	_	_
4	through	_	IN	IN	_	2	prep	_	_
5	the	_	DT	DT	_	6	det	_	_
6	deletion	_	NN	NN	_	4	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	12	det	_	_
9	human	_	JJ	JJ	_	12	amod	_	_
10	UDG	_	NN	NN	_	12	nn	_	_
11	promoter	_	NN	NN	_	12	nn	_	_
12	sequences	_	NNS	NNS	_	7	pobj	_	_
13	,	_	,	,	_	2	punct	_	_
14	that	_	IN	IN	_	18	mark	_	_
15	expression	_	NN	NN	_	18	nsubj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	E2F-1	_	NN	NN	_	16	pobj	_	_
18	activates	_	VBZ	VBZ	_	2	ccomp	_	_
19	the	_	DT	DT	_	21	det	_	_
20	UDG	_	NN	NN	_	21	nn	_	_
21	promoter	_	NN	NN	_	18	dobj	_	_
22	through	_	IN	IN	_	18	prep	_	_
23	several	_	JJ	JJ	_	25	amod	_	_
24	E2F	_	NN	NN	_	25	nn	_	_
25	sites	_	NNS	NNS	_	22	pobj	_	_
26	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	major	_	JJ	JJ	_	5	amod	_	_
3	putative	_	JJ	JJ	_	5	amod	_	_
4	downstream	_	JJ	JJ	_	5	amod	_	_
5	site	_	NN	NN	_	15	nsubj	_	_
6	for	_	IN	IN	_	5	prep	_	_
7	E2F	_	NN	NN	_	6	pobj	_	_
8	,	_	,	,	_	5	punct	_	_
9	located	_	JJ	JJ	_	5	amod	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	first	_	JJ	JJ	_	13	amod	_	_
13	exon	_	NN	NN	_	10	pobj	_	_
14	,	_	,	,	_	5	punct	_	_
15	serves	_	VBZ	VBZ	_	0	root	_	_
16	as	_	IN	IN	_	15	prep	_	_
17	a	_	DT	DT	_	18	det	_	_
18	target	_	NN	NN	_	16	pobj	_	_
19	for	_	IN	IN	_	18	prep	_	_
20	E2F-1/DP1	_	NN	NN	_	21	nn	_	_
21	complex	_	NN	NN	_	22	nn	_	_
22	binding	_	NN	NN	_	19	pobj	_	_
23	in	_	FW	FW	_	24	nn	_	_
24	vitro	_	FW	FW	_	22	advmod	_	_
25	.	_	.	.	_	15	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	provide	_	VBP	VBP	_	0	root	_	_
4	evidence	_	NN	NN	_	3	dobj	_	_
5	for	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	functional	_	JJ	JJ	_	8	amod	_	_
8	relationship	_	NN	NN	_	5	pobj	_	_
9	between	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	14	det	_	_
11	cyclin-like	_	JJ	JJ	_	14	amod	_	_
12	UDG	_	NN	NN	_	14	nn	_	_
13	gene	_	NN	NN	_	14	nn	_	_
14	product	_	NN	NN	_	9	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	E2F	_	NN	NN	_	14	conj	_	_
17	.	_	.	.	_	3	punct	_	_

1	High	_	JJ	JJ	_	2	amod	_	_
2	levels	_	NNS	NNS	_	11	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	UDG	_	NN	NN	_	5	nn	_	_
5	expression	_	NN	NN	_	3	pobj	_	_
6	in	_	IN	IN	_	2	prep	_	_
7	a	_	DT	DT	_	10	det	_	_
8	transient	_	JJ	JJ	_	10	amod	_	_
9	transfection	_	NN	NN	_	10	nn	_	_
10	assay	_	NN	NN	_	6	pobj	_	_
11	result	_	VBP	VBP	_	0	root	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	down-regulation	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	transcriptional	_	JJ	JJ	_	17	amod	_	_
17	activity	_	NN	NN	_	15	pobj	_	_
18	through	_	IN	IN	_	17	prep	_	_
19	elements	_	NNS	NNS	_	18	pobj	_	_
20	specific	_	JJ	JJ	_	19	amod	_	_
21	for	_	IN	IN	_	20	prep	_	_
22	E2F-mediated	_	JJ	JJ	_	23	amod	_	_
23	transcription	_	NN	NN	_	21	pobj	_	_
24	.	_	.	.	_	11	punct	_	_

1	Overexpression	_	NN	NN	_	9	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	UDG	_	NN	NN	_	2	pobj	_	_
4	in	_	IN	IN	_	1	prep	_	_
5	Saos	_	NN	NN	_	7	nn	_	_
6	2	_	CD	CD	_	7	num	_	_
7	cells	_	NNS	NNS	_	4	pobj	_	_
8	was	_	VBD	VBD	_	9	auxpass	_	_
9	observed	_	VBN	VBN	_	0	root	_	_
10	to	_	TO	TO	_	11	aux	_	_
11	delay	_	VB	VB	_	9	xcomp	_	_
12	growth	_	NN	NN	_	11	dobj	_	_
13	late	_	RB	RB	_	11	advmod	_	_
14	in	_	IN	IN	_	11	prep	_	_
15	G1	_	NN	NN	_	16	nn	_	_
16	phase	_	NN	NN	_	14	pobj	_	_
17	and	_	CC	CC	_	11	cc	_	_
18	transiently	_	RB	RB	_	19	advmod	_	_
19	arrest	_	VB	VB	_	11	conj	_	_
20	these	_	DT	DT	_	21	det	_	_
21	cells	_	NNS	NNS	_	19	dobj	_	_
22	from	_	IN	IN	_	19	prep	_	_
23	progressing	_	VBG	VBG	_	22	pcomp	_	_
24	into	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	27	det	_	_
26	S	_	NN	NN	_	27	nn	_	_
27	phase	_	NN	NN	_	24	pobj	_	_
28	.	_	.	.	_	9	punct	_	_

1	This	_	DT	DT	_	3	det	_	_
2	hypothetical	_	JJ	JJ	_	3	amod	_	_
3	model	_	NN	NN	_	4	nsubj	_	_
4	integrates	_	VBZ	VBZ	_	0	root	_	_
5	one	_	CD	CD	_	6	num	_	_
6	mechanism	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	DNA	_	NN	NN	_	9	nn	_	_
9	repair	_	NN	NN	_	7	pobj	_	_
10	with	_	IN	IN	_	4	prep	_	_
11	the	_	DT	DT	_	14	det	_	_
12	cell	_	NN	NN	_	14	nn	_	_
13	cycle	_	NN	NN	_	14	nn	_	_
14	control	_	NN	NN	_	10	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	gene	_	NN	NN	_	17	nn	_	_
17	transcription	_	NN	NN	_	15	pobj	_	_
18	,	_	,	,	_	4	punct	_	_
19	likely	_	RB	RB	_	20	advmod	_	_
20	through	_	IN	IN	_	4	prep	_	_
21	E2F	_	NN	NN	_	20	pobj	_	_
22	.	_	.	.	_	4	punct	_	_

1	This	_	DT	DT	_	2	nsubj	_	_
2	implicates	_	VBZ	VBZ	_	0	root	_	_
3	E2F	_	NN	NN	_	2	dobj	_	_
4	as	_	IN	IN	_	2	prep	_	_
5	a	_	DT	DT	_	7	det	_	_
6	multifunctional	_	JJ	JJ	_	7	amod	_	_
7	target	_	NN	NN	_	4	pobj	_	_
8	for	_	IN	IN	_	7	prep	_	_
9	proteins	_	NNS	NNS	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	enzymes	_	NNS	NNS	_	9	conj	_	_
12	,	_	,	,	_	9	punct	_	_
13	possibly	_	RB	RB	_	9	advmod	_	_
14	,	_	,	,	_	9	punct	_	_
15	responsive	_	JJ	JJ	_	9	amod	_	_
16	to	_	TO	TO	_	15	prep	_	_
17	DNA	_	NN	NN	_	18	nn	_	_
18	damage	_	NN	NN	_	16	pobj	_	_
19	through	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	22	det	_	_
21	negative	_	JJ	JJ	_	22	amod	_	_
22	effect	_	NN	NN	_	19	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	UDG	_	NN	NN	_	23	pobj	_	_
25	on	_	IN	IN	_	22	prep	_	_
26	E2F-mediated	_	JJ	JJ	_	28	amod	_	_
27	transcriptional	_	JJ	JJ	_	28	amod	_	_
28	activity	_	NN	NN	_	25	pobj	_	_
29	.	_	.	.	_	2	punct	_	_

1	Aspirin	_	NN	NN	_	2	nsubj	_	_
2	inhibits	_	VBZ	VBZ	_	0	root	_	_
3	nuclear	_	JJ	JJ	_	5	amod	_	_
4	factor-kappa	_	NN	NN	_	5	nn	_	_
5	B	_	NN	NN	_	6	nn	_	_
6	mobilization	_	NN	NN	_	2	dobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	monocyte	_	NN	NN	_	9	nn	_	_
9	adhesion	_	NN	NN	_	6	conj	_	_
10	in	_	IN	IN	_	6	prep	_	_
11	stimulated	_	VBN	VBN	_	14	amod	_	_
12	human	_	JJ	JJ	_	14	amod	_	_
13	endothelial	_	JJ	JJ	_	14	amod	_	_
14	cells	_	NNS	NNS	_	10	pobj	_	_
15	.	_	.	.	_	2	punct	_	_

1	BACKGROUND	_	NN	NN	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	The	_	DT	DT	_	4	det	_	_
4	induction	_	NN	NN	_	23	nsubjpass	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	vascular	_	JJ	JJ	_	9	amod	_	_
7	cell	_	NN	NN	_	9	nn	_	_
8	adhesion	_	NN	NN	_	9	nn	_	_
9	molecule-1	_	NN	NN	_	5	pobj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	VCAM-1	_	NN	NN	_	9	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	and	_	CC	CC	_	9	cc	_	_
14	E-selectin	_	NN	NN	_	9	conj	_	_
15	by	_	IN	IN	_	4	prep	_	_
16	tumor	_	NN	NN	_	18	nn	_	_
17	necrosis	_	NN	NN	_	18	nn	_	_
18	factor-alpha	_	NN	NN	_	15	pobj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	TNF	_	NN	NN	_	18	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	is	_	VBZ	VBZ	_	23	auxpass	_	_
23	mediated	_	VBN	VBN	_	1	dep	_	_
24	by	_	IN	IN	_	23	prep	_	_
25	mobilization	_	NN	NN	_	24	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	29	det	_	_
28	transcription	_	NN	NN	_	29	nn	_	_
29	factor	_	NN	NN	_	26	pobj	_	_
30	nuclear	_	JJ	JJ	_	32	amod	_	_
31	factor-kappa	_	NN	NN	_	32	nn	_	_
32	B	_	NN	NN	_	29	dep	_	_
33	-LRB-	_	-LRB-	-LRB-	_	35	punct	_	_
34	NF-kappa	_	NN	NN	_	35	nn	_	_
35	B	_	NN	NN	_	32	appos	_	_
36	-RRB-	_	-RRB-	-RRB-	_	35	punct	_	_
37	.	_	.	.	_	23	punct	_	_

1	Since	_	IN	IN	_	5	mark	_	_
2	salicylates	_	NNS	NNS	_	5	nsubjpass	_	_
3	have	_	VBP	VBP	_	5	aux	_	_
4	been	_	VBN	VBN	_	5	auxpass	_	_
5	reported	_	VBN	VBN	_	23	advcl	_	_
6	to	_	TO	TO	_	7	aux	_	_
7	inhibit	_	VB	VB	_	5	xcomp	_	_
8	NF-kappa	_	NN	NN	_	9	nn	_	_
9	B	_	NN	NN	_	10	nn	_	_
10	activation	_	NN	NN	_	7	dobj	_	_
11	by	_	IN	IN	_	7	prep	_	_
12	preventing	_	VBG	VBG	_	11	pcomp	_	_
13	the	_	DT	DT	_	14	det	_	_
14	degradation	_	NN	NN	_	12	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	its	_	PRP$	PRP$	_	17	poss	_	_
17	inhibitor	_	NN	NN	_	15	pobj	_	_
18	I	_	NN	NN	_	20	nn	_	_
19	kappa	_	NN	NN	_	20	nn	_	_
20	B	_	NN	NN	_	17	dep	_	_
21	,	_	,	,	_	23	punct	_	_
22	we	_	PRP	PRP	_	23	nsubj	_	_
23	studied	_	VBD	VBD	_	0	root	_	_
24	a	_	DT	DT	_	26	det	_	_
25	potential	_	JJ	JJ	_	26	amod	_	_
26	inhibition	_	NN	NN	_	23	dobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	this	_	DT	DT	_	29	det	_	_
29	pathway	_	NN	NN	_	27	pobj	_	_
30	by	_	IN	IN	_	26	prep	_	_
31	acetylsalicylate	_	NN	NN	_	30	pobj	_	_
32	-LRB-	_	-LRB-	-LRB-	_	33	punct	_	_
33	aspirin	_	NN	NN	_	31	appos	_	_
34	-RRB-	_	-RRB-	-RRB-	_	33	punct	_	_
35	in	_	IN	IN	_	26	prep	_	_
36	human	_	JJ	JJ	_	40	amod	_	_
37	umbilical	_	JJ	JJ	_	40	amod	_	_
38	vein	_	NN	NN	_	40	nn	_	_
39	endothelial	_	JJ	JJ	_	40	amod	_	_
40	cells	_	NNS	NNS	_	35	pobj	_	_
41	-LRB-	_	-LRB-	-LRB-	_	42	punct	_	_
42	HUVECs	_	NNS	NNS	_	40	appos	_	_
43	-RRB-	_	-RRB-	-RRB-	_	42	punct	_	_
44	.	_	.	.	_	23	punct	_	_

1	METHODS	_	NNS	NNS	_	0	root	_	_
2	AND	_	CC	CC	_	1	cc	_	_
3	RESULTS	_	NNS	NNS	_	1	conj	_	_
4	:	_	:	:	_	3	punct	_	_
5	Gel-shift	_	JJ	JJ	_	6	amod	_	_
6	analyses	_	NNS	NNS	_	7	nsubj	_	_
7	demonstrated	_	VBD	VBD	_	1	dep	_	_
8	dose-dependent	_	JJ	JJ	_	9	amod	_	_
9	inhibition	_	NN	NN	_	7	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	TNF-induced	_	JJ	JJ	_	14	amod	_	_
12	NF-kappa	_	NN	NN	_	13	nn	_	_
13	B	_	NN	NN	_	14	nn	_	_
14	mobilization	_	NN	NN	_	10	pobj	_	_
15	by	_	IN	IN	_	9	prep	_	_
16	aspirin	_	NN	NN	_	15	pobj	_	_
17	at	_	IN	IN	_	16	prep	_	_
18	concentrations	_	NNS	NNS	_	17	pobj	_	_
19	ranging	_	VBG	VBG	_	18	vmod	_	_
20	from	_	IN	IN	_	23	quantmod	_	_
21	1	_	CD	CD	_	23	number	_	_
22	to	_	TO	TO	_	23	dep	_	_
23	10	_	CD	CD	_	24	num	_	_
24	mmol/L	_	NN	NN	_	19	dobj	_	_
25	.	_	.	.	_	1	punct	_	_

1	Induction	_	NN	NN	_	12	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	VCAM-1	_	NN	NN	_	2	pobj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	E-selectin	_	NN	NN	_	3	conj	_	_
6	surface	_	NN	NN	_	7	nn	_	_
7	expression	_	NN	NN	_	3	dep	_	_
8	by	_	IN	IN	_	1	prep	_	_
9	TNF	_	NN	NN	_	8	pobj	_	_
10	was	_	VBD	VBD	_	12	auxpass	_	_
11	dose-dependently	_	RB	RB	_	12	advmod	_	_
12	reduced	_	VBN	VBN	_	0	root	_	_
13	by	_	IN	IN	_	12	prep	_	_
14	aspirin	_	NN	NN	_	13	pobj	_	_
15	over	_	IN	IN	_	12	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	same	_	JJ	JJ	_	18	amod	_	_
18	range	_	NN	NN	_	15	pobj	_	_
19	,	_	,	,	_	12	punct	_	_
20	while	_	IN	IN	_	31	mark	_	_
21	induction	_	NN	NN	_	31	nsubjpass	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	intercellular	_	JJ	JJ	_	25	amod	_	_
24	adhesion	_	NN	NN	_	25	nn	_	_
25	molecule-1	_	NN	NN	_	22	pobj	_	_
26	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
27	ICAM-1	_	NN	NN	_	25	appos	_	_
28	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
29	was	_	VBD	VBD	_	31	auxpass	_	_
30	hardly	_	RB	RB	_	31	advmod	_	_
31	affected	_	VBN	VBN	_	12	advcl	_	_
32	.	_	.	.	_	12	punct	_	_

1	Aspirin	_	NN	NN	_	2	nsubj	_	_
2	appeared	_	VBD	VBD	_	0	root	_	_
3	to	_	TO	TO	_	4	aux	_	_
4	prevent	_	VB	VB	_	2	xcomp	_	_
5	VCAM-1	_	NN	NN	_	6	nn	_	_
6	transcription	_	NN	NN	_	4	dobj	_	_
7	,	_	,	,	_	2	punct	_	_
8	since	_	IN	IN	_	11	mark	_	_
9	it	_	PRP	PRP	_	11	nsubj	_	_
10	dose-dependently	_	RB	RB	_	11	advmod	_	_
11	inhibited	_	VBD	VBD	_	2	advcl	_	_
12	induction	_	NN	NN	_	11	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	VCAM-1	_	NN	NN	_	15	nn	_	_
15	mRNA	_	NN	NN	_	13	pobj	_	_
16	by	_	IN	IN	_	12	prep	_	_
17	TNF	_	NN	NN	_	16	pobj	_	_
18	.	_	.	.	_	2	punct	_	_

1	As	_	IN	IN	_	15	prep	_	_
2	a	_	DT	DT	_	4	det	_	_
3	functional	_	JJ	JJ	_	4	amod	_	_
4	consequence	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	15	punct	_	_
6	adhesion	_	NN	NN	_	15	nsubjpass	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	U937	_	NN	NN	_	9	nn	_	_
9	monocytes	_	NNS	NNS	_	7	pobj	_	_
10	to	_	TO	TO	_	6	prep	_	_
11	TNF-stimulated	_	JJ	JJ	_	12	amod	_	_
12	HUVECs	_	NNS	NNS	_	10	pobj	_	_
13	was	_	VBD	VBD	_	15	auxpass	_	_
14	markedly	_	RB	RB	_	15	advmod	_	_
15	reduced	_	VBN	VBN	_	0	root	_	_
16	by	_	IN	IN	_	15	prep	_	_
17	aspirin	_	NN	NN	_	16	pobj	_	_
18	due	_	JJ	JJ	_	19	mwe	_	_
19	to	_	TO	TO	_	15	prep	_	_
20	suppression	_	NN	NN	_	19	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	VCAM-1	_	NN	NN	_	21	pobj	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	E-selectin	_	NN	NN	_	22	conj	_	_
25	upregulation	_	NN	NN	_	24	dep	_	_
26	.	_	.	.	_	15	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	effects	_	NNS	NNS	_	7	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	aspirin	_	NN	NN	_	3	pobj	_	_
5	were	_	VBD	VBD	_	7	cop	_	_
6	not	_	RB	RB	_	7	neg	_	_
7	related	_	JJ	JJ	_	0	root	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	inhibition	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	cyclooxygenase	_	NN	NN	_	13	nn	_	_
13	activity	_	NN	NN	_	11	pobj	_	_
14	,	_	,	,	_	7	punct	_	_
15	since	_	IN	IN	_	18	mark	_	_
16	indomethacin	_	NN	NN	_	18	nsubj	_	_
17	was	_	VBD	VBD	_	18	cop	_	_
18	ineffective	_	JJ	JJ	_	7	advcl	_	_
19	.	_	.	.	_	7	punct	_	_

1	CONCLUSIONS	_	NNS	NNS	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	Our	_	PRP$	PRP$	_	4	poss	_	_
4	data	_	NNS	NNS	_	5	nsubj	_	_
5	suggest	_	VBP	VBP	_	1	dep	_	_
6	that	_	IN	IN	_	8	mark	_	_
7	aspirin	_	NN	NN	_	8	nsubj	_	_
8	inhibits	_	VBZ	VBZ	_	5	ccomp	_	_
9	NF-kappa	_	NN	NN	_	10	nn	_	_
10	B	_	NN	NN	_	11	nn	_	_
11	mobilization	_	NN	NN	_	8	dobj	_	_
12	,	_	,	,	_	11	punct	_	_
13	induction	_	NN	NN	_	11	conj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	VCAM-1	_	NN	NN	_	14	pobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	E-selectin	_	NN	NN	_	15	conj	_	_
18	,	_	,	,	_	11	punct	_	_
19	and	_	CC	CC	_	11	cc	_	_
20	subsequent	_	JJ	JJ	_	22	amod	_	_
21	monocyte	_	NN	NN	_	22	nn	_	_
22	adhesion	_	NN	NN	_	11	conj	_	_
23	in	_	IN	IN	_	11	prep	_	_
24	endothelial	_	JJ	JJ	_	25	amod	_	_
25	cells	_	NNS	NNS	_	23	pobj	_	_
26	stimulated	_	VBN	VBN	_	25	vmod	_	_
27	by	_	IN	IN	_	26	prep	_	_
28	TNF	_	NN	NN	_	27	pobj	_	_
29	,	_	,	,	_	5	punct	_	_
30	thereby	_	RB	RB	_	31	advmod	_	_
31	providing	_	VBG	VBG	_	5	xcomp	_	_
32	an	_	DT	DT	_	34	det	_	_
33	additional	_	JJ	JJ	_	34	amod	_	_
34	mechanism	_	NN	NN	_	31	dobj	_	_
35	for	_	IN	IN	_	34	prep	_	_
36	therapeutic	_	JJ	JJ	_	37	amod	_	_
37	effects	_	NNS	NNS	_	35	pobj	_	_
38	of	_	IN	IN	_	37	prep	_	_
39	aspirin	_	NN	NN	_	38	pobj	_	_
40	.	_	.	.	_	1	punct	_	_

1	Cross-linking	_	NN	NN	_	4	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	CD30	_	NN	NN	_	2	pobj	_	_
4	induces	_	VBZ	VBZ	_	0	root	_	_
5	HIV	_	NN	NN	_	6	nn	_	_
6	expression	_	NN	NN	_	4	dobj	_	_
7	in	_	IN	IN	_	4	prep	_	_
8	chronically	_	RB	RB	_	9	advmod	_	_
9	infected	_	JJ	JJ	_	11	amod	_	_
10	T	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	7	pobj	_	_
12	.	_	.	.	_	4	punct	_	_

1	CD30	_	NN	NN	_	17	nsubjpass	_	_
2	,	_	,	,	_	1	punct	_	_
3	a	_	DT	DT	_	4	det	_	_
4	member	_	NN	NN	_	1	appos	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	14	det	_	_
7	tumor	_	NN	NN	_	9	nn	_	_
8	necrosis	_	NN	NN	_	9	nn	_	_
9	factor	_	NN	NN	_	14	nn	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	TNF	_	NN	NN	_	9	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	receptor	_	NN	NN	_	14	nn	_	_
14	family	_	NN	NN	_	5	pobj	_	_
15	,	_	,	,	_	1	punct	_	_
16	is	_	VBZ	VBZ	_	17	auxpass	_	_
17	expressed	_	VBN	VBN	_	0	root	_	_
18	constitutively	_	RB	RB	_	17	advmod	_	_
19	on	_	IN	IN	_	17	prep	_	_
20	the	_	DT	DT	_	21	det	_	_
21	surface	_	NN	NN	_	19	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	28	det	_	_
24	human	_	JJ	JJ	_	28	amod	_	_
25	T	_	NN	NN	_	28	nn	_	_
26	cell	_	NN	NN	_	28	nn	_	_
27	line	_	NN	NN	_	28	nn	_	_
28	ACH-2	_	NN	NN	_	22	pobj	_	_
29	,	_	,	,	_	28	punct	_	_
30	which	_	WDT	WDT	_	33	nsubjpass	_	_
31	is	_	VBZ	VBZ	_	33	auxpass	_	_
32	chronically	_	RB	RB	_	33	advmod	_	_
33	infected	_	VBN	VBN	_	28	rcmod	_	_
34	with	_	IN	IN	_	33	prep	_	_
35	human	_	JJ	JJ	_	40	amod	_	_
36	immunodeficiency	_	NN	NN	_	40	nn	_	_
37	virus	_	NN	NN	_	40	nn	_	_
38	type-1	_	NN	NN	_	40	nn	_	_
39	-LRB-	_	-LRB-	-LRB-	_	40	punct	_	_
40	HIV	_	NN	NN	_	34	pobj	_	_
41	-RRB-	_	-RRB-	-RRB-	_	40	punct	_	_
42	-1	_	CD	CD	_	40	num	_	_
43	.	_	.	.	_	17	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	demonstrate	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	26	mark	_	_
4	cross-linking	_	JJ	JJ	_	26	ccomp	_	_
5	CD30	_	NN	NN	_	4	dobj	_	_
6	with	_	IN	IN	_	4	prep	_	_
7	an	_	DT	DT	_	10	det	_	_
8	anti-CD30-specific	_	JJ	JJ	_	10	amod	_	_
9	monoclonal	_	JJ	JJ	_	10	amod	_	_
10	antibody	_	NN	NN	_	6	pobj	_	_
11	,	_	,	,	_	10	punct	_	_
12	which	_	WDT	WDT	_	13	nsubj	_	_
13	mimics	_	VBZ	VBZ	_	10	rcmod	_	_
14	the	_	DT	DT	_	17	det	_	_
15	described	_	VBN	VBN	_	17	amod	_	_
16	biological	_	JJ	JJ	_	17	amod	_	_
17	activities	_	NNS	NNS	_	13	dobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	CD30	_	NN	NN	_	21	nn	_	_
21	ligand	_	NN	NN	_	18	pobj	_	_
22	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
23	CD30L	_	NN	NN	_	21	appos	_	_
24	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
25	,	_	,	,	_	26	punct	_	_
26	results	_	VBZ	VBZ	_	2	ccomp	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	HIV	_	NN	NN	_	29	nn	_	_
29	expression	_	NN	NN	_	27	pobj	_	_
30	.	_	.	.	_	2	punct	_	_

1	CD30	_	NN	NN	_	2	nn	_	_
2	cross-linking	_	NN	NN	_	5	nsubj	_	_
3	does	_	VBZ	VBZ	_	5	aux	_	_
4	not	_	RB	RB	_	5	neg	_	_
5	alter	_	VB	VB	_	0	root	_	_
6	proliferation	_	NN	NN	_	5	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	ACH-2	_	NN	NN	_	9	nn	_	_
9	cells	_	NNS	NNS	_	7	pobj	_	_
10	and	_	CC	CC	_	5	cc	_	_
11	the	_	DT	DT	_	12	det	_	_
12	induction	_	NN	NN	_	18	nsubjpass	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	HIV	_	NN	NN	_	15	nn	_	_
15	expression	_	NN	NN	_	13	pobj	_	_
16	is	_	VBZ	VBZ	_	18	auxpass	_	_
17	not	_	RB	RB	_	18	neg	_	_
18	mediated	_	VBN	VBN	_	5	conj	_	_
19	by	_	IN	IN	_	18	prep	_	_
20	endogenous	_	JJ	JJ	_	22	amod	_	_
21	TNF	_	NN	NN	_	22	nn	_	_
22	alpha/beta	_	NN	NN	_	19	pobj	_	_
23	.	_	.	.	_	5	punct	_	_

1	Furthermore	_	RB	RB	_	6	advmod	_	_
2	,	_	,	,	_	6	punct	_	_
3	cross-linking	_	NN	NN	_	6	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	CD30	_	NN	NN	_	4	pobj	_	_
6	leads	_	VBZ	VBZ	_	0	root	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	NF-kappa	_	NN	NN	_	9	nn	_	_
9	B	_	NN	NN	_	10	nn	_	_
10	activation	_	NN	NN	_	7	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	enhanced	_	VBN	VBN	_	14	amod	_	_
13	HIV	_	NN	NN	_	14	nn	_	_
14	transcription	_	NN	NN	_	10	conj	_	_
15	.	_	.	.	_	6	punct	_	_

1	Thus	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	CD30-CD30L	_	JJ	JJ	_	4	amod	_	_
4	interactions	_	NNS	NNS	_	5	nsubj	_	_
5	mediate	_	VBP	VBP	_	0	root	_	_
6	the	_	DT	DT	_	7	det	_	_
7	induction	_	NN	NN	_	5	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	HIV	_	NN	NN	_	10	nn	_	_
10	expression	_	NN	NN	_	8	pobj	_	_
11	by	_	IN	IN	_	5	prep	_	_
12	a	_	DT	DT	_	15	det	_	_
13	kappa	_	NN	NN	_	15	nn	_	_
14	B-dependent	_	JJ	JJ	_	15	amod	_	_
15	pathway	_	NN	NN	_	11	pobj	_	_
16	that	_	WDT	WDT	_	18	nsubj	_	_
17	is	_	VBZ	VBZ	_	18	cop	_	_
18	independent	_	JJ	JJ	_	15	rcmod	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	TNF	_	NN	NN	_	19	pobj	_	_
21	.	_	.	.	_	5	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	mechanism	_	NN	NN	_	5	nsubj	_	_
3	may	_	MD	MD	_	5	aux	_	_
4	be	_	VB	VB	_	5	cop	_	_
5	important	_	JJ	JJ	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	activation	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	HIV	_	NN	NN	_	11	nn	_	_
11	expression	_	NN	NN	_	9	pobj	_	_
12	from	_	IN	IN	_	8	prep	_	_
13	latently	_	RB	RB	_	14	advmod	_	_
14	infected	_	JJ	JJ	_	17	amod	_	_
15	CD4+	_	JJ	JJ	_	17	amod	_	_
16	T	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	12	pobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	especially	_	RB	RB	_	20	advmod	_	_
20	in	_	IN	IN	_	17	prep	_	_
21	lymphoid	_	JJ	JJ	_	22	amod	_	_
22	organs	_	NNS	NNS	_	20	pobj	_	_
23	where	_	WRB	WRB	_	29	advmod	_	_
24	cell	_	NN	NN	_	27	nn	_	_
25	to	_	TO	TO	_	24	prep	_	_
26	cell	_	NN	NN	_	25	pobj	_	_
27	contact	_	NN	NN	_	29	nsubj	_	_
28	is	_	VBZ	VBZ	_	29	cop	_	_
29	conducive	_	JJ	JJ	_	22	rcmod	_	_
30	to	_	TO	TO	_	29	prep	_	_
31	receptor-ligand	_	JJ	JJ	_	32	amod	_	_
32	interactions	_	NNS	NNS	_	30	pobj	_	_
33	.	_	.	.	_	5	punct	_	_

1	Integrin-mediated	_	JJ	JJ	_	3	amod	_	_
2	tyrosine	_	NN	NN	_	3	nn	_	_
3	phosphorylation	_	NN	NN	_	0	root	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	cytokine	_	NN	NN	_	7	nn	_	_
6	message	_	NN	NN	_	7	nn	_	_
7	induction	_	NN	NN	_	3	conj	_	_
8	in	_	IN	IN	_	3	prep	_	_
9	monocytic	_	JJ	JJ	_	10	amod	_	_
10	cells	_	NNS	NNS	_	8	pobj	_	_
11	.	_	.	.	_	3	punct	_	_

1	A	_	DT	DT	_	4	det	_	_
2	possible	_	JJ	JJ	_	4	amod	_	_
3	signaling	_	NN	NN	_	4	nn	_	_
4	role	_	NN	NN	_	0	root	_	_
5	for	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	9	det	_	_
7	Syk	_	NN	NN	_	9	nn	_	_
8	tyrosine	_	NN	NN	_	9	nn	_	_
9	kinase	_	NN	NN	_	5	pobj	_	_
10	.	_	.	.	_	4	punct	_	_

1	Activation	_	NN	NN	_	9	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	cytoplasmic	_	JJ	JJ	_	5	amod	_	_
4	tyrosine	_	NN	NN	_	5	nn	_	_
5	kinases	_	NNS	NNS	_	2	pobj	_	_
6	is	_	VBZ	VBZ	_	9	cop	_	_
7	an	_	DT	DT	_	9	det	_	_
8	important	_	JJ	JJ	_	9	amod	_	_
9	aspect	_	NN	NN	_	0	root	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	signal	_	NN	NN	_	12	nn	_	_
12	transduction	_	NN	NN	_	10	pobj	_	_
13	mediated	_	VBN	VBN	_	12	vmod	_	_
14	by	_	IN	IN	_	13	prep	_	_
15	integrins	_	NNS	NNS	_	14	pobj	_	_
16	.	_	.	.	_	9	punct	_	_

1	In	_	IN	IN	_	23	prep	_	_
2	the	_	DT	DT	_	7	det	_	_
3	human	_	JJ	JJ	_	7	amod	_	_
4	monocytic	_	JJ	JJ	_	7	amod	_	_
5	cell	_	NN	NN	_	7	nn	_	_
6	line	_	NN	NN	_	7	nn	_	_
7	THP-1	_	NN	NN	_	1	pobj	_	_
8	,	_	,	,	_	23	punct	_	_
9	either	_	CC	CC	_	12	preconj	_	_
10	integrin-dependent	_	JJ	JJ	_	12	amod	_	_
11	cell	_	NN	NN	_	12	nn	_	_
12	adhesion	_	NN	NN	_	23	nsubj	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	fibronectin	_	NN	NN	_	13	pobj	_	_
15	or	_	CC	CC	_	12	cc	_	_
16	ligation	_	NN	NN	_	12	conj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	beta	_	NN	NN	_	20	nn	_	_
19	1	_	CD	CD	_	20	num	_	_
20	integrins	_	NNS	NNS	_	17	pobj	_	_
21	with	_	IN	IN	_	16	prep	_	_
22	antibodies	_	NNS	NNS	_	21	pobj	_	_
23	causes	_	VBZ	VBZ	_	0	root	_	_
24	a	_	DT	DT	_	29	det	_	_
25	rapid	_	JJ	JJ	_	29	amod	_	_
26	and	_	CC	CC	_	25	cc	_	_
27	intense	_	JJ	JJ	_	25	conj	_	_
28	tyrosine	_	NN	NN	_	29	nn	_	_
29	phosphorylation	_	NN	NN	_	23	dobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	two	_	CD	CD	_	32	num	_	_
32	sets	_	NNS	NNS	_	30	pobj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	proteins	_	NNS	NNS	_	33	pobj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	about	_	RB	RB	_	37	advmod	_	_
37	65-75	_	CD	CD	_	35	pobj	_	_
38	and	_	CC	CC	_	37	cc	_	_
39	120-125	_	CD	CD	_	37	conj	_	_
40	kDa	_	NN	NN	_	37	dep	_	_
41	.	_	.	.	_	23	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	6	punct	_	_
4	integrin	_	NN	NN	_	5	nn	_	_
5	ligation	_	NN	NN	_	6	nsubj	_	_
6	leads	_	VBZ	VBZ	_	0	root	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	nuclear	_	JJ	JJ	_	9	amod	_	_
9	translocation	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	p50	_	NN	NN	_	10	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	p65	_	NN	NN	_	15	nn	_	_
15	subunits	_	NNS	NNS	_	12	conj	_	_
16	of	_	IN	IN	_	12	prep	_	_
17	the	_	DT	DT	_	21	det	_	_
18	NF-kappa	_	NN	NN	_	21	nn	_	_
19	B	_	NN	NN	_	21	nn	_	_
20	transcription	_	NN	NN	_	21	nn	_	_
21	factor	_	NN	NN	_	16	pobj	_	_
22	,	_	,	,	_	7	punct	_	_
23	to	_	TO	TO	_	7	conj	_	_
24	activation	_	NN	NN	_	23	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	a	_	DT	DT	_	28	det	_	_
27	reporter	_	NN	NN	_	28	nn	_	_
28	gene	_	NN	NN	_	25	pobj	_	_
29	driven	_	VBN	VBN	_	24	vmod	_	_
30	by	_	IN	IN	_	29	prep	_	_
31	a	_	DT	DT	_	32	det	_	_
32	promoter	_	NN	NN	_	30	pobj	_	_
33	containing	_	VBG	VBG	_	32	vmod	_	_
34	NF-kappa	_	NN	NN	_	36	nn	_	_
35	B	_	NN	NN	_	36	nn	_	_
36	sites	_	NNS	NNS	_	33	dobj	_	_
37	,	_	,	,	_	7	punct	_	_
38	and	_	CC	CC	_	7	cc	_	_
39	to	_	TO	TO	_	7	conj	_	_
40	increased	_	VBN	VBN	_	41	amod	_	_
41	levels	_	NNS	NNS	_	39	pobj	_	_
42	of	_	IN	IN	_	41	prep	_	_
43	mRNAs	_	NNS	NNS	_	42	pobj	_	_
44	for	_	IN	IN	_	43	prep	_	_
45	immediate-early	_	JJ	JJ	_	46	amod	_	_
46	genes	_	NNS	NNS	_	44	pobj	_	_
47	,	_	,	,	_	46	punct	_	_
48	including	_	VBG	VBG	_	46	prep	_	_
49	the	_	DT	DT	_	56	det	_	_
50	cytokine	_	NN	NN	_	56	nn	_	_
51	interleukin	_	NN	NN	_	56	nn	_	_
52	-LRB-	_	-LRB-	-LRB-	_	56	punct	_	_
53	IL	_	NN	NN	_	56	nn	_	_
54	-RRB-	_	-RRB-	-RRB-	_	56	punct	_	_
55	-1	_	CD	CD	_	56	num	_	_
56	beta	_	NN	NN	_	48	pobj	_	_
57	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	tyrosine	_	NN	NN	_	4	nn	_	_
3	kinase	_	NN	NN	_	4	nn	_	_
4	inhibitors	_	NNS	NNS	_	9	nsubj	_	_
5	genistein	_	NN	NN	_	4	dep	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	herbimycin	_	NN	NN	_	8	nn	_	_
8	A	_	NN	NN	_	5	conj	_	_
9	block	_	VBP	VBP	_	0	root	_	_
10	both	_	CC	CC	_	13	preconj	_	_
11	integrin-mediated	_	JJ	JJ	_	13	amod	_	_
12	tyrosine	_	NN	NN	_	13	nn	_	_
13	phosphorylation	_	NN	NN	_	9	dobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	increases	_	NNS	NNS	_	13	conj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	IL-1	_	NN	NN	_	18	nn	_	_
18	beta	_	NN	NN	_	20	nn	_	_
19	message	_	NN	NN	_	20	nn	_	_
20	levels	_	NNS	NNS	_	16	pobj	_	_
21	,	_	,	,	_	9	punct	_	_
22	indicating	_	VBG	VBG	_	9	vmod	_	_
23	a	_	DT	DT	_	25	det	_	_
24	causal	_	JJ	JJ	_	25	amod	_	_
25	relationship	_	NN	NN	_	22	dobj	_	_
26	between	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	29	det	_	_
28	two	_	CD	CD	_	29	num	_	_
29	events	_	NNS	NNS	_	26	pobj	_	_
30	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	components	_	NNS	NNS	_	9	nsubj	_	_
3	tyrosine	_	NN	NN	_	4	dep	_	_
4	phosphorylated	_	VBN	VBN	_	2	vmod	_	_
5	subsequent	_	JJ	JJ	_	4	acomp	_	_
6	to	_	TO	TO	_	5	prep	_	_
7	cell	_	NN	NN	_	8	nn	_	_
8	adhesion	_	NN	NN	_	6	pobj	_	_
9	include	_	VBP	VBP	_	0	root	_	_
10	paxillin	_	NN	NN	_	9	dobj	_	_
11	,	_	,	,	_	10	punct	_	_
12	pp125FAK	_	NN	NN	_	10	conj	_	_
13	,	_	,	,	_	10	punct	_	_
14	and	_	CC	CC	_	10	cc	_	_
15	the	_	DT	DT	_	21	det	_	_
16	SH2	_	NN	NN	_	21	nn	_	_
17	domain	_	NN	NN	_	21	nn	_	_
18	containing	_	VBG	VBG	_	21	amod	_	_
19	tyrosine	_	NN	NN	_	21	nn	_	_
20	kinase	_	NN	NN	_	21	nn	_	_
21	Syk	_	NN	NN	_	10	conj	_	_
22	.	_	.	.	_	9	punct	_	_

1	In	_	IN	IN	_	8	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	8	punct	_	_
4	integrin	_	NN	NN	_	5	nn	_	_
5	ligation	_	NN	NN	_	8	nsubj	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	antibodies	_	NNS	NNS	_	6	pobj	_	_
8	induces	_	VBZ	VBZ	_	0	root	_	_
9	tyrosine	_	NN	NN	_	10	nn	_	_
10	phosphorylation	_	NN	NN	_	8	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	Syk	_	NN	NN	_	11	pobj	_	_
13	but	_	CC	CC	_	11	cc	_	_
14	not	_	RB	RB	_	15	neg	_	_
15	of	_	IN	IN	_	11	conj	_	_
16	FAK	_	NN	NN	_	15	pobj	_	_
17	or	_	CC	CC	_	16	cc	_	_
18	paxillin	_	NN	NN	_	16	conj	_	_
19	.	_	.	.	_	8	punct	_	_

1	In	_	IN	IN	_	9	prep	_	_
2	adhering	_	JJ	JJ	_	3	amod	_	_
3	cells	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	9	punct	_	_
5	pre-treatment	_	NN	NN	_	9	nsubj	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	cytochalasin	_	NN	NN	_	8	nn	_	_
8	D	_	NN	NN	_	6	pobj	_	_
9	suppresses	_	VBZ	VBZ	_	0	root	_	_
10	tyrosine	_	NN	NN	_	11	nn	_	_
11	phosphorylation	_	NN	NN	_	9	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	FAK	_	NN	NN	_	12	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	paxillin	_	NN	NN	_	13	conj	_	_
16	but	_	CC	CC	_	12	cc	_	_
17	not	_	RB	RB	_	18	neg	_	_
18	of	_	IN	IN	_	12	conj	_	_
19	Syk	_	NN	NN	_	18	pobj	_	_
20	,	_	,	,	_	9	punct	_	_
21	while	_	IN	IN	_	27	mark	_	_
22	IL-1	_	NN	NN	_	23	nn	_	_
23	beta	_	NN	NN	_	25	nn	_	_
24	message	_	NN	NN	_	25	nn	_	_
25	induction	_	NN	NN	_	27	nsubj	_	_
26	is	_	VBZ	VBZ	_	27	cop	_	_
27	unaffected	_	JJ	JJ	_	9	advcl	_	_
28	.	_	.	.	_	9	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	observations	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	13	mark	_	_
5	the	_	DT	DT	_	8	det	_	_
6	Syk	_	NN	NN	_	8	nn	_	_
7	tyrosine	_	NN	NN	_	8	nn	_	_
8	kinase	_	NN	NN	_	13	nsubj	_	_
9	may	_	MD	MD	_	13	aux	_	_
10	be	_	VB	VB	_	13	cop	_	_
11	an	_	DT	DT	_	13	det	_	_
12	important	_	JJ	JJ	_	13	amod	_	_
13	component	_	NN	NN	_	3	ccomp	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	an	_	DT	DT	_	18	det	_	_
16	integrin	_	NN	NN	_	18	nn	_	_
17	signaling	_	NN	NN	_	18	nn	_	_
18	pathway	_	NN	NN	_	14	pobj	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	monocytic	_	JJ	JJ	_	21	amod	_	_
21	cells	_	NNS	NNS	_	19	pobj	_	_
22	,	_	,	,	_	18	punct	_	_
23	leading	_	VBG	VBG	_	18	vmod	_	_
24	to	_	TO	TO	_	23	prep	_	_
25	activation	_	NN	NN	_	24	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	NF-kappa	_	NN	NN	_	28	nn	_	_
28	B	_	NN	NN	_	26	pobj	_	_
29	and	_	CC	CC	_	24	cc	_	_
30	to	_	TO	TO	_	24	conj	_	_
31	increased	_	VBN	VBN	_	32	amod	_	_
32	levels	_	NNS	NNS	_	30	pobj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	cytokine	_	NN	NN	_	35	nn	_	_
35	messages	_	NNS	NNS	_	33	pobj	_	_
36	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	Ah	_	NN	NN	_	3	nn	_	_
3	receptor	_	NN	NN	_	4	nsubj	_	_
4	recognizes	_	VBZ	VBZ	_	0	root	_	_
5	DNA	_	NN	NN	_	7	nn	_	_
6	binding	_	NN	NN	_	7	nn	_	_
7	sites	_	NNS	NNS	_	4	dobj	_	_
8	for	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	13	det	_	_
10	B	_	NN	NN	_	13	nn	_	_
11	cell	_	NN	NN	_	13	nn	_	_
12	transcription	_	NN	NN	_	13	nn	_	_
13	factor	_	NN	NN	_	8	pobj	_	_
14	,	_	,	,	_	13	punct	_	_
15	BSAP	_	NN	NN	_	13	appos	_	_
16	:	_	:	:	_	4	punct	_	_
17	a	_	DT	DT	_	19	det	_	_
18	possible	_	JJ	JJ	_	19	amod	_	_
19	mechanism	_	NN	NN	_	4	dep	_	_
20	for	_	IN	IN	_	19	prep	_	_
21	dioxin-mediated	_	JJ	JJ	_	22	amod	_	_
22	alteration	_	NN	NN	_	20	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	CD19	_	NN	NN	_	25	nn	_	_
25	gene	_	NN	NN	_	26	nn	_	_
26	expression	_	NN	NN	_	23	pobj	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	human	_	JJ	JJ	_	30	amod	_	_
29	B	_	NN	NN	_	30	nn	_	_
30	lymphocytes	_	NNS	NNS	_	27	pobj	_	_
31	.	_	.	.	_	4	punct	_	_

1	2,3,7,8-tetrachlorodibenzo-p-dioxin	_	NN	NN	_	5	nsubj	_	_
2	-LRB-	_	-LRB-	-LRB-	_	3	punct	_	_
3	TCDD	_	NN	NN	_	1	appos	_	_
4	-RRB-	_	-RRB-	-RRB-	_	3	punct	_	_
5	inhibits	_	VBZ	VBZ	_	0	root	_	_
6	murine	_	JJ	JJ	_	5	dobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	human	_	JJ	JJ	_	6	conj	_	_
9	B	_	NN	NN	_	12	nn	_	_
10	lymphocyte	_	NN	NN	_	12	nn	_	_
11	immunoglobulin	_	NN	NN	_	12	nn	_	_
12	production	_	NN	NN	_	6	dep	_	_
13	through	_	IN	IN	_	5	prep	_	_
14	an	_	DT	DT	_	16	det	_	_
15	unknown	_	JJ	JJ	_	16	amod	_	_
16	mechanism	_	NN	NN	_	13	pobj	_	_
17	.	_	.	.	_	5	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	study	_	NN	NN	_	3	nsubj	_	_
3	investigated	_	VBD	VBD	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	effect	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	TCDD	_	NN	NN	_	6	pobj	_	_
8	on	_	IN	IN	_	5	prep	_	_
9	expression	_	NN	NN	_	8	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	CD19	_	NN	NN	_	13	nn	_	_
13	gene	_	NN	NN	_	10	pobj	_	_
14	in	_	IN	IN	_	9	prep	_	_
15	a	_	DT	DT	_	20	det	_	_
16	human	_	JJ	JJ	_	20	amod	_	_
17	B	_	NN	NN	_	20	nn	_	_
18	lymphocyte	_	NN	NN	_	20	nn	_	_
19	cell	_	NN	NN	_	20	nn	_	_
20	line	_	NN	NN	_	14	pobj	_	_
21	.	_	.	.	_	3	punct	_	_

1	Northern	_	NN	NN	_	3	nn	_	_
2	blot	_	NN	NN	_	3	nn	_	_
3	analysis	_	NN	NN	_	4	nsubj	_	_
4	showed	_	VBD	VBD	_	0	root	_	_
5	that	_	IN	IN	_	8	mark	_	_
6	TCDD	_	NN	NN	_	7	nn	_	_
7	treatment	_	NN	NN	_	8	nsubj	_	_
8	decreased	_	VBD	VBD	_	4	ccomp	_	_
9	steady	_	JJ	JJ	_	11	amod	_	_
10	state	_	NN	NN	_	11	nn	_	_
11	levels	_	NNS	NNS	_	8	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	CD19	_	NN	NN	_	14	nn	_	_
14	mRNA	_	NN	NN	_	12	pobj	_	_
15	by	_	IN	IN	_	8	prep	_	_
16	67	_	CD	CD	_	17	num	_	_
17	%	_	NN	NN	_	15	pobj	_	_
18	in	_	IN	IN	_	8	prep	_	_
19	the	_	DT	DT	_	22	det	_	_
20	IM-9	_	NN	NN	_	22	nn	_	_
21	cell	_	NN	NN	_	22	nn	_	_
22	line	_	NN	NN	_	18	pobj	_	_
23	.	_	.	.	_	4	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	a	_	DT	DT	_	6	det	_	_
3	gel	_	NN	NN	_	6	nn	_	_
4	mobility	_	NN	NN	_	6	nn	_	_
5	shift	_	NN	NN	_	6	nn	_	_
6	assay	_	NN	NN	_	1	dobj	_	_
7	,	_	,	,	_	1	punct	_	_
8	we	_	PRP	PRP	_	9	nsubj	_	_
9	identified	_	VBD	VBD	_	1	parataxis	_	_
10	a	_	DT	DT	_	12	det	_	_
11	DNA-binding	_	NN	NN	_	12	nn	_	_
12	complex	_	NN	NN	_	9	dobj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	IM-9	_	NN	NN	_	16	nn	_	_
15	nuclear	_	JJ	JJ	_	16	amod	_	_
16	extracts	_	NNS	NNS	_	13	pobj	_	_
17	that	_	WDT	WDT	_	21	nsubj	_	_
18	by	_	IN	IN	_	21	prep	_	_
19	several	_	JJ	JJ	_	20	amod	_	_
20	criteria	_	NNS	NNS	_	18	pobj	_	_
21	appears	_	VBZ	VBZ	_	12	rcmod	_	_
22	to	_	TO	TO	_	26	aux	_	_
23	be	_	VB	VB	_	26	cop	_	_
24	the	_	DT	DT	_	26	det	_	_
25	Ah	_	NN	NN	_	26	nn	_	_
26	receptor	_	NN	NN	_	21	xcomp	_	_
27	.	_	.	.	_	1	punct	_	_

1	In	_	IN	IN	_	8	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	8	punct	_	_
4	the	_	DT	DT	_	7	det	_	_
5	Ah	_	NN	NN	_	7	nn	_	_
6	receptor	_	NN	NN	_	7	nn	_	_
7	complex	_	NN	NN	_	8	nsubj	_	_
8	recognized	_	VBD	VBD	_	0	root	_	_
9	a	_	DT	DT	_	12	det	_	_
10	DNA	_	NN	NN	_	12	nn	_	_
11	binding	_	NN	NN	_	12	nn	_	_
12	site	_	NN	NN	_	8	dobj	_	_
13	for	_	IN	IN	_	12	prep	_	_
14	B	_	NN	NN	_	18	nn	_	_
15	cell	_	NN	NN	_	18	nn	_	_
16	lineage-specific	_	JJ	JJ	_	18	amod	_	_
17	activator	_	NN	NN	_	18	nn	_	_
18	protein	_	NN	NN	_	13	pobj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	BSAP	_	NN	NN	_	18	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	in	_	IN	IN	_	18	prep	_	_
23	the	_	DT	DT	_	25	det	_	_
24	promoter	_	NN	NN	_	25	nn	_	_
25	region	_	NN	NN	_	22	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	30	det	_	_
28	human	_	JJ	JJ	_	30	amod	_	_
29	CD19	_	NN	NN	_	30	nn	_	_
30	gene	_	NN	NN	_	26	pobj	_	_
31	which	_	WDT	WDT	_	33	nsubj	_	_
32	is	_	VBZ	VBZ	_	33	cop	_	_
33	similar	_	JJ	JJ	_	12	rcmod	_	_
34	to	_	TO	TO	_	33	prep	_	_
35	the	_	DT	DT	_	41	det	_	_
36	consensus	_	NN	NN	_	41	nn	_	_
37	Ah	_	NN	NN	_	41	nn	_	_
38	receptor	_	NN	NN	_	41	nn	_	_
39	DNA	_	NN	NN	_	41	nn	_	_
40	binding	_	NN	NN	_	41	nn	_	_
41	site	_	NN	NN	_	34	pobj	_	_
42	.	_	.	.	_	8	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	8	mark	_	_
5	the	_	DT	DT	_	6	det	_	_
6	AhR	_	NN	NN	_	8	nsubj	_	_
7	could	_	MD	MD	_	8	aux	_	_
8	interfere	_	VB	VB	_	3	ccomp	_	_
9	with	_	IN	IN	_	8	prep	_	_
10	BSAP-stimulated	_	JJ	JJ	_	13	amod	_	_
11	CD19	_	NN	NN	_	12	nn	_	_
12	gene	_	NN	NN	_	13	nn	_	_
13	transcription	_	NN	NN	_	9	pobj	_	_
14	by	_	IN	IN	_	8	prep	_	_
15	competition	_	NN	NN	_	14	pobj	_	_
16	for	_	IN	IN	_	15	prep	_	_
17	a	_	DT	DT	_	21	det	_	_
18	common	_	JJ	JJ	_	21	amod	_	_
19	DNA	_	NN	NN	_	21	nn	_	_
20	binding	_	NN	NN	_	21	nn	_	_
21	site	_	NN	NN	_	16	pobj	_	_
22	.	_	.	.	_	3	punct	_	_

1	Nitric	_	JJ	JJ	_	2	amod	_	_
2	oxide	_	NN	NN	_	3	nsubj	_	_
3	decreases	_	VBZ	VBZ	_	0	root	_	_
4	cytokine-induced	_	JJ	JJ	_	6	amod	_	_
5	endothelial	_	JJ	JJ	_	6	amod	_	_
6	activation	_	NN	NN	_	3	dobj	_	_
7	.	_	.	.	_	3	punct	_	_

1	Nitric	_	JJ	JJ	_	2	amod	_	_
2	oxide	_	NN	NN	_	4	nsubj	_	_
3	selectively	_	RB	RB	_	4	advmod	_	_
4	reduces	_	VBZ	VBZ	_	0	root	_	_
5	endothelial	_	JJ	JJ	_	6	amod	_	_
6	expression	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	adhesion	_	NN	NN	_	9	nn	_	_
9	molecules	_	NNS	NNS	_	7	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	proinflammatory	_	JJ	JJ	_	12	amod	_	_
12	cytokines	_	NNS	NNS	_	9	conj	_	_
13	.	_	.	.	_	4	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	test	_	VB	VB	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	hypothesis	_	NN	NN	_	2	dobj	_	_
5	that	_	IN	IN	_	11	mark	_	_
6	nitric	_	JJ	JJ	_	7	amod	_	_
7	oxide	_	NN	NN	_	11	nsubj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	NO	_	NN	NN	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	limits	_	VBZ	VBZ	_	4	ccomp	_	_
12	endothelial	_	JJ	JJ	_	13	amod	_	_
13	activation	_	NN	NN	_	11	dobj	_	_
14	,	_	,	,	_	2	punct	_	_
15	we	_	PRP	PRP	_	16	nsubj	_	_
16	treated	_	VBD	VBD	_	2	parataxis	_	_
17	cytokine-stimulated	_	JJ	JJ	_	22	amod	_	_
18	human	_	JJ	JJ	_	22	amod	_	_
19	saphenous	_	JJ	JJ	_	22	amod	_	_
20	vein	_	NN	NN	_	22	nn	_	_
21	endothelial	_	JJ	JJ	_	22	amod	_	_
22	cells	_	NNS	NNS	_	16	dobj	_	_
23	with	_	IN	IN	_	16	prep	_	_
24	several	_	JJ	JJ	_	26	amod	_	_
25	NO	_	NN	NN	_	26	nn	_	_
26	donors	_	NNS	NNS	_	23	pobj	_	_
27	and	_	CC	CC	_	16	cc	_	_
28	assessed	_	VBD	VBD	_	16	conj	_	_
29	their	_	PRP$	PRP$	_	30	poss	_	_
30	effects	_	NNS	NNS	_	28	dobj	_	_
31	on	_	IN	IN	_	30	prep	_	_
32	the	_	DT	DT	_	34	det	_	_
33	inducible	_	JJ	JJ	_	34	amod	_	_
34	expression	_	NN	NN	_	31	pobj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	vascular	_	JJ	JJ	_	39	amod	_	_
37	cell	_	NN	NN	_	39	nn	_	_
38	adhesion	_	NN	NN	_	39	nn	_	_
39	molecule-1	_	NN	NN	_	35	pobj	_	_
40	-LRB-	_	-LRB-	-LRB-	_	41	punct	_	_
41	VCAM-1	_	NN	NN	_	39	appos	_	_
42	-RRB-	_	-RRB-	-RRB-	_	41	punct	_	_
43	.	_	.	.	_	2	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	a	_	DT	DT	_	4	det	_	_
3	concentration-dependent	_	JJ	JJ	_	4	amod	_	_
4	manner	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	7	punct	_	_
6	NO	_	NN	NN	_	7	nsubj	_	_
7	inhibited	_	VBD	VBD	_	0	root	_	_
8	interleukin	_	NN	NN	_	10	nn	_	_
9	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	IL	_	NN	NN	_	15	nn	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	-1	_	CD	CD	_	10	num	_	_
13	alpha-stimulated	_	JJ	JJ	_	15	amod	_	_
14	VCAM-1	_	NN	NN	_	15	nn	_	_
15	expression	_	NN	NN	_	7	dobj	_	_
16	by	_	IN	IN	_	7	prep	_	_
17	35-55	_	CD	CD	_	18	num	_	_
18	%	_	NN	NN	_	16	pobj	_	_
19	as	_	IN	IN	_	20	mark	_	_
20	determined	_	VBN	VBN	_	7	advcl	_	_
21	by	_	IN	IN	_	20	prep	_	_
22	cell	_	NN	NN	_	25	nn	_	_
23	surface	_	NN	NN	_	25	nn	_	_
24	enzyme	_	NN	NN	_	25	nn	_	_
25	immunoassays	_	NNS	NNS	_	21	pobj	_	_
26	and	_	CC	CC	_	25	cc	_	_
27	flow	_	NN	NN	_	28	nn	_	_
28	cytometry	_	NN	NN	_	25	conj	_	_
29	.	_	.	.	_	7	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	inhibition	_	NN	NN	_	4	nsubjpass	_	_
3	was	_	VBD	VBD	_	4	auxpass	_	_
4	paralleled	_	VBN	VBN	_	0	root	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	reduced	_	VBN	VBN	_	8	amod	_	_
7	monocyte	_	NN	NN	_	8	nn	_	_
8	adhesion	_	NN	NN	_	5	pobj	_	_
9	to	_	TO	TO	_	8	prep	_	_
10	endothelial	_	JJ	JJ	_	11	amod	_	_
11	monolayers	_	NNS	NNS	_	9	pobj	_	_
12	in	_	IN	IN	_	8	prep	_	_
13	nonstatic	_	JJ	JJ	_	14	amod	_	_
14	assays	_	NNS	NNS	_	12	pobj	_	_
15	,	_	,	,	_	4	punct	_	_
16	was	_	VBD	VBD	_	17	cop	_	_
17	unaffected	_	JJ	JJ	_	4	conj	_	_
18	by	_	IN	IN	_	17	prep	_	_
19	cGMP	_	NN	NN	_	20	nn	_	_
20	analogues	_	NNS	NNS	_	18	pobj	_	_
21	,	_	,	,	_	4	punct	_	_
22	and	_	CC	CC	_	4	cc	_	_
23	was	_	VBD	VBD	_	25	cop	_	_
24	quantitatively	_	RB	RB	_	25	advmod	_	_
25	similar	_	JJ	JJ	_	4	conj	_	_
26	after	_	IN	IN	_	25	prep	_	_
27	stimulation	_	NN	NN	_	26	pobj	_	_
28	by	_	IN	IN	_	27	prep	_	_
29	either	_	CC	CC	_	31	preconj	_	_
30	IL-1	_	NN	NN	_	31	nn	_	_
31	alpha	_	NN	NN	_	28	pobj	_	_
32	,	_	,	,	_	31	punct	_	_
33	IL-1	_	NN	NN	_	34	nn	_	_
34	beta	_	NN	NN	_	31	conj	_	_
35	,	_	,	,	_	31	punct	_	_
36	IL-4	_	NN	NN	_	31	conj	_	_
37	,	_	,	,	_	31	punct	_	_
38	tumor	_	NN	NN	_	40	nn	_	_
39	necrosis	_	NN	NN	_	40	nn	_	_
40	factor	_	NN	NN	_	31	conj	_	_
41	-LRB-	_	-LRB-	-LRB-	_	43	punct	_	_
42	TNF	_	NN	NN	_	43	nn	_	_
43	alpha	_	NN	NN	_	40	appos	_	_
44	-RRB-	_	-RRB-	-RRB-	_	43	punct	_	_
45	,	_	,	,	_	31	punct	_	_
46	or	_	CC	CC	_	31	cc	_	_
47	bacterial	_	JJ	JJ	_	48	amod	_	_
48	lipopolysaccharide	_	NN	NN	_	31	conj	_	_
49	.	_	.	.	_	4	punct	_	_

1	NO	_	NN	NN	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	decreased	_	VBD	VBD	_	0	root	_	_
4	the	_	DT	DT	_	6	det	_	_
5	endothelial	_	JJ	JJ	_	6	amod	_	_
6	expression	_	NN	NN	_	3	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	other	_	JJ	JJ	_	11	amod	_	_
9	leukocyte	_	NN	NN	_	11	nn	_	_
10	adhesion	_	NN	NN	_	11	nn	_	_
11	molecules	_	NNS	NNS	_	7	pobj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	E-selectin	_	NN	NN	_	11	dep	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	to	_	TO	TO	_	13	conj	_	_
16	a	_	DT	DT	_	18	det	_	_
17	lesser	_	JJR	JJR	_	18	amod	_	_
18	extent	_	NN	NN	_	15	pobj	_	_
19	,	_	,	,	_	13	punct	_	_
20	intercellular	_	JJ	JJ	_	22	amod	_	_
21	adhesion	_	NN	NN	_	22	nn	_	_
22	molecule-1	_	NN	NN	_	13	conj	_	_
23	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
24	and	_	CC	CC	_	11	cc	_	_
25	secretable	_	JJ	JJ	_	26	amod	_	_
26	cytokines	_	NNS	NNS	_	11	conj	_	_
27	-LRB-	_	-LRB-	-LRB-	_	28	punct	_	_
28	IL-6	_	NN	NN	_	26	dep	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	IL-8	_	NN	NN	_	28	conj	_	_
31	-RRB-	_	-RRB-	-RRB-	_	28	punct	_	_
32	.	_	.	.	_	3	punct	_	_

1	Inhibition	_	NN	NN	_	9	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	endogenous	_	JJ	JJ	_	5	amod	_	_
4	NO	_	NN	NN	_	5	nn	_	_
5	production	_	NN	NN	_	2	pobj	_	_
6	by	_	IN	IN	_	1	prep	_	_
7	L-N-monomethyl-arginine	_	NN	NN	_	6	pobj	_	_
8	also	_	RB	RB	_	9	advmod	_	_
9	induced	_	VBD	VBD	_	0	root	_	_
10	the	_	DT	DT	_	11	det	_	_
11	expression	_	NN	NN	_	9	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	VCAM-1	_	NN	NN	_	12	pobj	_	_
14	,	_	,	,	_	9	punct	_	_
15	but	_	CC	CC	_	9	cc	_	_
16	did	_	VBD	VBD	_	18	aux	_	_
17	not	_	RB	RB	_	18	neg	_	_
18	augment	_	VB	VB	_	9	conj	_	_
19	cytokine-induced	_	JJ	JJ	_	21	amod	_	_
20	VCAM-1	_	NN	NN	_	21	nn	_	_
21	expression	_	NN	NN	_	18	dobj	_	_
22	.	_	.	.	_	9	punct	_	_

1	Nuclear	_	JJ	JJ	_	3	amod	_	_
2	run-on	_	JJ	JJ	_	3	amod	_	_
3	assays	_	NNS	NNS	_	20	nsubj	_	_
4	,	_	,	,	_	3	punct	_	_
5	transfection	_	NN	NN	_	6	nn	_	_
6	studies	_	NNS	NNS	_	3	conj	_	_
7	using	_	VBG	VBG	_	6	vmod	_	_
8	various	_	JJ	JJ	_	13	amod	_	_
9	VCAM-1	_	NN	NN	_	13	nn	_	_
10	promoter	_	NN	NN	_	13	nn	_	_
11	reporter	_	NN	NN	_	13	nn	_	_
12	gene	_	NN	NN	_	13	nn	_	_
13	constructs	_	NNS	NNS	_	7	dobj	_	_
14	,	_	,	,	_	3	punct	_	_
15	and	_	CC	CC	_	3	cc	_	_
16	electrophoretic	_	JJ	JJ	_	19	amod	_	_
17	mobility	_	NN	NN	_	19	nn	_	_
18	shift	_	NN	NN	_	19	nn	_	_
19	assays	_	NNS	NNS	_	3	conj	_	_
20	indicated	_	VBD	VBD	_	0	root	_	_
21	that	_	IN	IN	_	23	mark	_	_
22	NO	_	NN	NN	_	23	nsubj	_	_
23	represses	_	VBZ	VBZ	_	20	ccomp	_	_
24	VCAM-1	_	NN	NN	_	26	nn	_	_
25	gene	_	NN	NN	_	26	nn	_	_
26	transcription	_	NN	NN	_	23	dobj	_	_
27	,	_	,	,	_	23	punct	_	_
28	in	_	IN	IN	_	23	prep	_	_
29	part	_	NN	NN	_	28	pobj	_	_
30	,	_	,	,	_	23	punct	_	_
31	by	_	IN	IN	_	23	prep	_	_
32	inhibiting	_	VBG	VBG	_	31	pcomp	_	_
33	NF-kappa	_	NN	NN	_	34	nn	_	_
34	B	_	NN	NN	_	32	dobj	_	_
35	.	_	.	.	_	20	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	propose	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	16	mark	_	_
4	NO	_	NN	NN	_	6	poss	_	_
5	's	_	POS	POS	_	6	possessive	_	_
6	ability	_	NN	NN	_	16	nsubj	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	limit	_	VB	VB	_	6	vmod	_	_
9	endothelial	_	JJ	JJ	_	10	amod	_	_
10	activation	_	NN	NN	_	8	dobj	_	_
11	and	_	CC	CC	_	8	cc	_	_
12	inhibit	_	VB	VB	_	8	conj	_	_
13	monocyte	_	NN	NN	_	14	nn	_	_
14	adhesion	_	NN	NN	_	12	dobj	_	_
15	may	_	MD	MD	_	16	aux	_	_
16	contribute	_	VB	VB	_	2	ccomp	_	_
17	to	_	TO	TO	_	16	prep	_	_
18	some	_	DT	DT	_	17	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	its	_	PRP$	PRP$	_	21	poss	_	_
21	antiatherogenic	_	JJ	JJ	_	19	pobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	antiinflammatory	_	JJ	JJ	_	21	conj	_	_
24	properties	_	NNS	NNS	_	21	dep	_	_
25	within	_	IN	IN	_	21	prep	_	_
26	the	_	DT	DT	_	28	det	_	_
27	vessel	_	NN	NN	_	28	nn	_	_
28	wall	_	NN	NN	_	25	pobj	_	_
29	.	_	.	.	_	2	punct	_	_

1	Signalling	_	NN	NN	_	0	root	_	_
2	via	_	IN	IN	_	1	prep	_	_
3	CD28	_	NN	NN	_	2	pobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	human	_	JJ	JJ	_	9	amod	_	_
6	naive	_	JJ	JJ	_	9	amod	_	_
7	neonatal	_	JJ	JJ	_	9	amod	_	_
8	T	_	NN	NN	_	9	nn	_	_
9	lymphocytes	_	NNS	NNS	_	4	pobj	_	_
10	.	_	.	.	_	1	punct	_	_

1	Accessory	_	JJ	JJ	_	2	amod	_	_
2	molecules	_	NNS	NNS	_	3	nsubj	_	_
3	play	_	VBP	VBP	_	0	root	_	_
4	a	_	DT	DT	_	6	det	_	_
5	crucial	_	JJ	JJ	_	6	amod	_	_
6	role	_	NN	NN	_	3	dobj	_	_
7	in	_	IN	IN	_	3	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	development	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	14	det	_	_
12	T	_	NN	NN	_	14	nn	_	_
13	cell	_	NN	NN	_	14	nn	_	_
14	response	_	NN	NN	_	10	pobj	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	antigenic	_	JJ	JJ	_	17	amod	_	_
17	challenge	_	NN	NN	_	15	pobj	_	_
18	.	_	.	.	_	3	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	examined	_	VBN	VBN	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	role	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	CD28	_	NN	NN	_	6	pobj	_	_
8	in	_	IN	IN	_	5	prep	_	_
9	modulating	_	VBG	VBG	_	8	pcomp	_	_
10	the	_	DT	DT	_	17	det	_	_
11	'	_	``	``	_	14	punct	_	_
12	naive	_	JJ	JJ	_	14	amod	_	_
13	'	_	''	''	_	14	punct	_	_
14	neonatal	_	JJ	JJ	_	17	amod	_	_
15	T	_	NN	NN	_	17	nn	_	_
16	cell	_	NN	NN	_	17	nn	_	_
17	response	_	NN	NN	_	9	dobj	_	_
18	to	_	TO	TO	_	17	prep	_	_
19	anti-CD2-mediated	_	JJ	JJ	_	20	amod	_	_
20	activation	_	NN	NN	_	18	pobj	_	_
21	.	_	.	.	_	3	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	compare	_	VB	VB	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	role	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	CD28	_	NN	NN	_	5	pobj	_	_
7	,	_	,	,	_	2	punct	_	_
8	neonatal	_	JJ	JJ	_	14	nsubjpass	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	adult	_	JJ	JJ	_	12	amod	_	_
11	T	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	8	conj	_	_
13	were	_	VBD	VBD	_	14	auxpass	_	_
14	stimulated	_	VBN	VBN	_	2	parataxis	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	a	_	DT	DT	_	17	det	_	_
17	pair	_	NN	NN	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	mitogenic	_	JJ	JJ	_	21	amod	_	_
20	anti-CD2	_	JJ	JJ	_	21	amod	_	_
21	antibodies	_	NNS	NNS	_	18	pobj	_	_
22	in	_	IN	IN	_	14	prep	_	_
23	the	_	DT	DT	_	24	dep	_	_
24	presence	_	NN	NN	_	22	pobj	_	_
25	or	_	CC	CC	_	24	cc	_	_
26	absence	_	NN	NN	_	24	conj	_	_
27	of	_	IN	IN	_	24	prep	_	_
28	anti-CD28	_	JJ	JJ	_	29	amod	_	_
29	MoAb	_	NN	NN	_	27	pobj	_	_
30	.	_	.	.	_	2	punct	_	_

1	With	_	IN	IN	_	8	prep	_	_
2	anti-CD2	_	NN	NN	_	1	pobj	_	_
3	alone	_	RB	RB	_	2	advmod	_	_
4	,	_	,	,	_	8	punct	_	_
5	neonatal	_	JJ	JJ	_	7	amod	_	_
6	T	_	NN	NN	_	7	nn	_	_
7	cells	_	NNS	NNS	_	8	nsubj	_	_
8	proliferated	_	VBD	VBD	_	0	root	_	_
9	slightly	_	RB	RB	_	8	advmod	_	_
10	but	_	CC	CC	_	8	cc	_	_
11	produced	_	VBD	VBD	_	8	conj	_	_
12	no	_	DT	DT	_	14	neg	_	_
13	detectable	_	JJ	JJ	_	14	amod	_	_
14	IL-2	_	NN	NN	_	11	dobj	_	_
15	,	_	,	,	_	8	punct	_	_
16	whereas	_	IN	IN	_	20	mark	_	_
17	adult	_	JJ	JJ	_	19	amod	_	_
18	T	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	20	nsubj	_	_
20	proliferated	_	VBD	VBD	_	8	advcl	_	_
21	vigorously	_	RB	RB	_	20	advmod	_	_
22	,	_	,	,	_	20	punct	_	_
23	with	_	IN	IN	_	20	prep	_	_
24	significant	_	JJ	JJ	_	26	amod	_	_
25	IL-2	_	NN	NN	_	26	nn	_	_
26	production	_	NN	NN	_	23	pobj	_	_
27	.	_	.	.	_	8	punct	_	_

1	Costimulation	_	NN	NN	_	6	nsubj	_	_
2	with	_	IN	IN	_	1	prep	_	_
3	anti-CD28	_	JJ	JJ	_	4	amod	_	_
4	MoAb	_	NN	NN	_	2	pobj	_	_
5	greatly	_	RB	RB	_	6	advmod	_	_
6	enhanced	_	VBD	VBD	_	0	root	_	_
7	the	_	DT	DT	_	9	det	_	_
8	proliferative	_	JJ	JJ	_	9	amod	_	_
9	response	_	NN	NN	_	6	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	neonatal	_	JJ	JJ	_	13	amod	_	_
12	T	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	10	pobj	_	_
14	to	_	TO	TO	_	6	prep	_	_
15	levels	_	NNS	NNS	_	14	pobj	_	_
16	equivalent	_	JJ	JJ	_	15	amod	_	_
17	to	_	TO	TO	_	16	prep	_	_
18	those	_	DT	DT	_	17	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	adult	_	JJ	JJ	_	22	amod	_	_
21	T	_	NN	NN	_	22	nn	_	_
22	cells	_	NNS	NNS	_	19	pobj	_	_
23	,	_	,	,	_	6	punct	_	_
24	whereas	_	IN	IN	_	28	mark	_	_
25	adult	_	JJ	JJ	_	27	amod	_	_
26	T	_	NN	NN	_	27	nn	_	_
27	cells	_	NNS	NNS	_	28	nsubj	_	_
28	showed	_	VBD	VBD	_	6	advcl	_	_
29	only	_	RB	RB	_	30	advmod	_	_
30	slight	_	JJ	JJ	_	31	amod	_	_
31	increases	_	NNS	NNS	_	28	dobj	_	_
32	.	_	.	.	_	6	punct	_	_

1	Although	_	IN	IN	_	5	mark	_	_
2	IL-2	_	NN	NN	_	3	nn	_	_
3	secretion	_	NN	NN	_	5	nsubjpass	_	_
4	was	_	VBD	VBD	_	5	auxpass	_	_
5	increased	_	VBN	VBN	_	18	advcl	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	presence	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	anti-CD28	_	JJ	JJ	_	11	amod	_	_
11	MoAb	_	NN	NN	_	9	pobj	_	_
12	,	_	,	,	_	18	punct	_	_
13	neonatal	_	JJ	JJ	_	15	amod	_	_
14	T	_	NN	NN	_	15	nn	_	_
15	cell	_	NN	NN	_	17	nn	_	_
16	IL-2	_	NN	NN	_	17	nn	_	_
17	production	_	NN	NN	_	18	nsubj	_	_
18	remained	_	VBD	VBD	_	0	root	_	_
19	lower	_	JJR	JJR	_	18	acomp	_	_
20	than	_	IN	IN	_	19	prep	_	_
21	in	_	IN	IN	_	20	pobj	_	_
22	adults	_	NNS	NNS	_	21	pobj	_	_
23	.	_	.	.	_	18	punct	_	_

1	In	_	IN	IN	_	12	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	12	punct	_	_
4	enhancement	_	NN	NN	_	12	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	IL-2	_	NN	NN	_	7	nn	_	_
7	mRNA	_	NN	NN	_	8	nn	_	_
8	expression	_	NN	NN	_	5	pobj	_	_
9	in	_	IN	IN	_	4	prep	_	_
10	neonates	_	NNS	NNS	_	9	pobj	_	_
11	was	_	VBD	VBD	_	12	cop	_	_
12	similar	_	JJ	JJ	_	0	root	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	adult	_	JJ	JJ	_	15	amod	_	_
15	levels	_	NNS	NNS	_	13	pobj	_	_
16	.	_	.	.	_	12	punct	_	_

1	Anti-CD28	_	JJ	JJ	_	3	amod	_	_
2	MoAb	_	NN	NN	_	3	nn	_	_
3	costimulation	_	NN	NN	_	4	nsubj	_	_
4	increased	_	VBD	VBD	_	0	root	_	_
5	NF	_	NN	NN	_	7	nn	_	_
6	kappa	_	NN	NN	_	7	nn	_	_
7	B	_	NN	NN	_	8	nn	_	_
8	levels	_	NNS	NNS	_	4	dobj	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	neonates	_	NNS	NNS	_	9	pobj	_	_
11	,	_	,	,	_	4	punct	_	_
12	albeit	_	IN	IN	_	4	prep	_	_
13	to	_	TO	TO	_	12	pcomp	_	_
14	levels	_	NNS	NNS	_	13	pobj	_	_
15	lower	_	JJR	JJR	_	14	amod	_	_
16	than	_	IN	IN	_	15	prep	_	_
17	that	_	DT	DT	_	16	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	adults	_	NNS	NNS	_	18	pobj	_	_
20	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	cellular	_	JJ	JJ	_	3	amod	_	_
3	mechanism	_	NN	NN	_	18	nsubj	_	_
4	governing	_	VBG	VBG	_	3	vmod	_	_
5	the	_	DT	DT	_	8	det	_	_
6	diminished	_	VBN	VBN	_	8	amod	_	_
7	proliferative	_	JJ	JJ	_	8	amod	_	_
8	response	_	NN	NN	_	4	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	neonatal	_	JJ	JJ	_	12	amod	_	_
11	T	_	NN	NN	_	12	nn	_	_
12	lymphocytes	_	NNS	NNS	_	9	pobj	_	_
13	to	_	TO	TO	_	8	prep	_	_
14	anti-CD2	_	NN	NN	_	13	pobj	_	_
15	may	_	MD	MD	_	18	aux	_	_
16	therefore	_	RB	RB	_	18	advmod	_	_
17	be	_	VB	VB	_	18	cop	_	_
18	due	_	JJ	JJ	_	0	root	_	_
19	to	_	TO	TO	_	18	prep	_	_
20	decreased	_	VBN	VBN	_	24	amod	_	_
21	NF	_	NN	NN	_	23	nn	_	_
22	kappa	_	NN	NN	_	23	nn	_	_
23	B	_	NN	NN	_	24	nn	_	_
24	induction	_	NN	NN	_	19	pobj	_	_
25	,	_	,	,	_	24	punct	_	_
26	reduced	_	VBN	VBN	_	29	amod	_	_
27	IL-2	_	NN	NN	_	28	nn	_	_
28	mRNA	_	NN	NN	_	29	nn	_	_
29	expression	_	NN	NN	_	24	conj	_	_
30	and	_	CC	CC	_	24	cc	_	_
31	deficient	_	JJ	JJ	_	33	amod	_	_
32	IL-2	_	NN	NN	_	33	nn	_	_
33	production	_	NN	NN	_	24	conj	_	_
34	.	_	.	.	_	18	punct	_	_

1	Although	_	IN	IN	_	5	mark	_	_
2	anti-CD28	_	JJ	JJ	_	3	amod	_	_
3	MoAb	_	NN	NN	_	4	nn	_	_
4	costimulation	_	NN	NN	_	5	nsubj	_	_
5	enhances	_	VBZ	VBZ	_	18	advcl	_	_
6	all	_	DT	DT	_	5	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	above	_	JJ	JJ	_	10	amod	_	_
10	signals	_	NNS	NNS	_	7	pobj	_	_
11	,	_	,	,	_	18	punct	_	_
12	NF	_	NN	NN	_	14	nn	_	_
13	kappa	_	NN	NN	_	14	nn	_	_
14	B	_	NN	NN	_	18	nsubj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	IL-2	_	NN	NN	_	14	conj	_	_
17	levels	_	NNS	NNS	_	14	dep	_	_
18	remain	_	VBP	VBP	_	0	root	_	_
19	lower	_	JJR	JJR	_	18	acomp	_	_
20	than	_	IN	IN	_	19	prep	_	_
21	in	_	IN	IN	_	20	pobj	_	_
22	adults	_	NNS	NNS	_	21	pobj	_	_
23	,	_	,	,	_	18	punct	_	_
24	suggesting	_	VBG	VBG	_	18	xcomp	_	_
25	the	_	DT	DT	_	26	det	_	_
26	need	_	NN	NN	_	24	dobj	_	_
27	for	_	IN	IN	_	26	prep	_	_
28	further	_	JJ	JJ	_	30	amod	_	_
29	activation	_	NN	NN	_	30	nn	_	_
30	requirements	_	NNS	NNS	_	27	pobj	_	_
31	in	_	IN	IN	_	30	prep	_	_
32	the	_	DT	DT	_	33	det	_	_
33	neonate	_	NN	NN	_	31	pobj	_	_
34	.	_	.	.	_	18	punct	_	_

1	Regulation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	human	_	JJ	JJ	_	6	amod	_	_
4	immunodeficiency	_	NN	NN	_	6	nn	_	_
5	virus	_	NN	NN	_	6	nn	_	_
6	type	_	NN	NN	_	11	nn	_	_
7	1	_	CD	CD	_	6	num	_	_
8	and	_	CC	CC	_	6	cc	_	_
9	cytokine	_	NN	NN	_	10	nn	_	_
10	gene	_	NN	NN	_	6	conj	_	_
11	expression	_	NN	NN	_	2	pobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	myeloid	_	JJ	JJ	_	14	amod	_	_
14	cells	_	NNS	NNS	_	12	pobj	_	_
15	by	_	IN	IN	_	1	prep	_	_
16	NF-kappa	_	NN	NN	_	18	nn	_	_
17	B	_	NN	NN	_	18	nn	_	_
18	/Rel	_	NN	NN	_	15	pobj	_	_
19	transcription	_	NN	NN	_	20	nn	_	_
20	factors	_	NNS	NNS	_	18	dep	_	_
21	.	_	.	.	_	1	punct	_	_

1	CD4+	_	JJ	JJ	_	2	amod	_	_
2	macrophages	_	NNS	NNS	_	25	nsubj	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	tissues	_	NNS	NNS	_	3	pobj	_	_
5	such	_	JJ	JJ	_	6	mwe	_	_
6	as	_	IN	IN	_	4	prep	_	_
7	lung	_	NN	NN	_	6	pobj	_	_
8	,	_	,	,	_	7	punct	_	_
9	skin	_	NN	NN	_	7	conj	_	_
10	,	_	,	,	_	7	punct	_	_
11	and	_	CC	CC	_	7	cc	_	_
12	lymph	_	NN	NN	_	13	nn	_	_
13	nodes	_	NNS	NNS	_	7	conj	_	_
14	,	_	,	,	_	4	punct	_	_
15	promyelocytic	_	JJ	JJ	_	16	amod	_	_
16	cells	_	NNS	NNS	_	4	appos	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	bone	_	NN	NN	_	19	nn	_	_
19	marrow	_	NN	NN	_	17	pobj	_	_
20	,	_	,	,	_	16	punct	_	_
21	and	_	CC	CC	_	16	cc	_	_
22	peripheral	_	JJ	JJ	_	24	amod	_	_
23	blood	_	NN	NN	_	24	nn	_	_
24	monocytes	_	NNS	NNS	_	16	conj	_	_
25	serve	_	VBP	VBP	_	0	root	_	_
26	as	_	IN	IN	_	25	prep	_	_
27	important	_	JJ	JJ	_	28	amod	_	_
28	targets	_	NNS	NNS	_	26	pobj	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	reservoirs	_	NNS	NNS	_	28	conj	_	_
31	for	_	IN	IN	_	28	prep	_	_
32	human	_	JJ	JJ	_	35	amod	_	_
33	immunodeficiency	_	NN	NN	_	35	nn	_	_
34	virus	_	NN	NN	_	35	nn	_	_
35	type	_	NN	NN	_	40	nn	_	_
36	1	_	CD	CD	_	35	num	_	_
37	-LRB-	_	-LRB-	-LRB-	_	38	punct	_	_
38	HIV-1	_	NN	NN	_	35	appos	_	_
39	-RRB-	_	-RRB-	-RRB-	_	38	punct	_	_
40	replication	_	NN	NN	_	31	pobj	_	_
41	.	_	.	.	_	25	punct	_	_

1	HIV-1-infected	_	JJ	JJ	_	3	amod	_	_
2	myeloid	_	JJ	JJ	_	3	amod	_	_
3	cells	_	NNS	NNS	_	6	nsubjpass	_	_
4	are	_	VBP	VBP	_	6	auxpass	_	_
5	often	_	RB	RB	_	6	advmod	_	_
6	diminished	_	VBN	VBN	_	0	root	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	their	_	PRP$	PRP$	_	9	poss	_	_
9	ability	_	NN	NN	_	7	pobj	_	_
10	to	_	TO	TO	_	11	aux	_	_
11	participate	_	VB	VB	_	9	vmod	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	chemotaxis	_	NN	NN	_	12	pobj	_	_
14	,	_	,	,	_	13	punct	_	_
15	phagocytosis	_	NN	NN	_	13	conj	_	_
16	,	_	,	,	_	13	punct	_	_
17	and	_	CC	CC	_	13	cc	_	_
18	intracellular	_	JJ	JJ	_	19	amod	_	_
19	killing	_	NN	NN	_	13	conj	_	_
20	.	_	.	.	_	6	punct	_	_

1	HIV-1	_	NN	NN	_	2	nn	_	_
2	infection	_	NN	NN	_	7	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	myeloid	_	JJ	JJ	_	5	amod	_	_
5	cells	_	NNS	NNS	_	3	pobj	_	_
6	can	_	MD	MD	_	7	aux	_	_
7	lead	_	VB	VB	_	0	root	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	expression	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	surface	_	NN	NN	_	13	nn	_	_
13	receptors	_	NNS	NNS	_	11	pobj	_	_
14	associated	_	VBN	VBN	_	13	vmod	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	cellular	_	JJ	JJ	_	17	amod	_	_
17	activation	_	NN	NN	_	15	pobj	_	_
18	and/or	_	CC	CC	_	17	cc	_	_
19	differentiation	_	NN	NN	_	17	conj	_	_
20	that	_	WDT	WDT	_	21	nsubj	_	_
21	increase	_	VBP	VBP	_	10	rcmod	_	_
22	the	_	DT	DT	_	23	det	_	_
23	responsiveness	_	NN	NN	_	21	dobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	these	_	DT	DT	_	26	det	_	_
26	cells	_	NNS	NNS	_	24	pobj	_	_
27	to	_	TO	TO	_	23	prep	_	_
28	cytokines	_	NNS	NNS	_	27	pobj	_	_
29	secreted	_	VBN	VBN	_	28	vmod	_	_
30	by	_	IN	IN	_	29	prep	_	_
31	neighboring	_	VBG	VBG	_	32	amod	_	_
32	cells	_	NNS	NNS	_	30	pobj	_	_
33	as	_	RB	RB	_	34	advmod	_	_
34	well	_	RB	RB	_	27	cc	_	_
35	as	_	IN	IN	_	34	mwe	_	_
36	to	_	TO	TO	_	27	conj	_	_
37	bacteria	_	NNS	NNS	_	36	pobj	_	_
38	or	_	CC	CC	_	37	cc	_	_
39	other	_	JJ	JJ	_	40	amod	_	_
40	pathogens	_	NNS	NNS	_	37	conj	_	_
41	.	_	.	.	_	7	punct	_	_

1	Enhancement	_	NN	NN	_	6	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	HIV-1	_	NN	NN	_	4	nn	_	_
4	replication	_	NN	NN	_	2	pobj	_	_
5	is	_	VBZ	VBZ	_	6	cop	_	_
6	related	_	JJ	JJ	_	0	root	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	part	_	NN	NN	_	7	pobj	_	_
9	to	_	TO	TO	_	6	prep	_	_
10	increased	_	VBN	VBN	_	12	amod	_	_
11	DNA-binding	_	JJ	JJ	_	12	amod	_	_
12	activity	_	NN	NN	_	9	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	cellular	_	JJ	JJ	_	16	amod	_	_
15	transcription	_	NN	NN	_	16	nn	_	_
16	factors	_	NNS	NNS	_	13	pobj	_	_
17	such	_	JJ	JJ	_	18	mwe	_	_
18	as	_	IN	IN	_	16	prep	_	_
19	NF-kappa	_	NN	NN	_	20	nn	_	_
20	B	_	NN	NN	_	18	pobj	_	_
21	.	_	.	.	_	6	punct	_	_

1	NF-kappa	_	NN	NN	_	2	nn	_	_
2	B	_	NN	NN	_	3	nsubj	_	_
3	binds	_	VBZ	VBZ	_	0	root	_	_
4	to	_	TO	TO	_	3	prep	_	_
5	the	_	DT	DT	_	8	det	_	_
6	HIV-1	_	NN	NN	_	7	nn	_	_
7	enhancer	_	NN	NN	_	8	nn	_	_
8	region	_	NN	NN	_	4	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	13	det	_	_
11	long	_	JJ	JJ	_	13	amod	_	_
12	terminal	_	JJ	JJ	_	13	amod	_	_
13	repeat	_	NN	NN	_	9	pobj	_	_
14	and	_	CC	CC	_	3	cc	_	_
15	contributes	_	VBZ	VBZ	_	3	conj	_	_
16	to	_	TO	TO	_	15	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	inducibility	_	NN	NN	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	HIV-1	_	NN	NN	_	22	nn	_	_
21	gene	_	NN	NN	_	22	nn	_	_
22	expression	_	NN	NN	_	19	pobj	_	_
23	in	_	IN	IN	_	18	prep	_	_
24	response	_	NN	NN	_	23	pobj	_	_
25	to	_	TO	TO	_	24	prep	_	_
26	multiple	_	JJ	JJ	_	28	amod	_	_
27	activating	_	VBG	VBG	_	28	amod	_	_
28	agents	_	NNS	NNS	_	25	pobj	_	_
29	.	_	.	.	_	3	punct	_	_

1	Phosphorylation	_	NN	NN	_	15	nsubj	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	degradation	_	NN	NN	_	1	conj	_	_
4	of	_	IN	IN	_	1	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	cytoplasmic	_	JJ	JJ	_	7	amod	_	_
7	inhibitor	_	NN	NN	_	4	pobj	_	_
8	I	_	NN	NN	_	10	nn	_	_
9	kappa	_	NN	NN	_	10	nn	_	_
10	B	_	NN	NN	_	11	nn	_	_
11	alpha	_	NN	NN	_	7	dep	_	_
12	are	_	VBP	VBP	_	15	cop	_	_
13	crucial	_	JJ	JJ	_	15	amod	_	_
14	regulatory	_	JJ	JJ	_	15	amod	_	_
15	events	_	NNS	NNS	_	0	root	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	activation	_	NN	NN	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	NF-kappa	_	NN	NN	_	21	nn	_	_
21	B	_	NN	NN	_	23	nn	_	_
22	DNA-binding	_	JJ	JJ	_	23	amod	_	_
23	activity	_	NN	NN	_	19	pobj	_	_
24	.	_	.	.	_	15	punct	_	_

1	Both	_	CC	CC	_	2	preconj	_	_
2	N-	_	NN	NN	_	12	nsubjpass	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	C-terminal	_	JJ	JJ	_	2	conj	_	_
5	residues	_	NNS	NNS	_	2	dep	_	_
6	of	_	IN	IN	_	2	prep	_	_
7	I	_	NN	NN	_	9	nn	_	_
8	kappa	_	NN	NN	_	9	nn	_	_
9	B	_	NN	NN	_	10	nn	_	_
10	alpha	_	NN	NN	_	6	pobj	_	_
11	are	_	VBP	VBP	_	12	auxpass	_	_
12	required	_	VBN	VBN	_	0	root	_	_
13	for	_	IN	IN	_	12	prep	_	_
14	inducer-mediated	_	JJ	JJ	_	15	amod	_	_
15	degradation	_	NN	NN	_	13	pobj	_	_
16	.	_	.	.	_	12	punct	_	_

1	Chronic	_	JJ	JJ	_	3	amod	_	_
2	HIV-1	_	NN	NN	_	3	nn	_	_
3	infection	_	NN	NN	_	7	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	myeloid	_	JJ	JJ	_	6	amod	_	_
6	cells	_	NNS	NNS	_	4	pobj	_	_
7	leads	_	VBZ	VBZ	_	0	root	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	constitutive	_	JJ	JJ	_	13	amod	_	_
10	NF-kappa	_	NN	NN	_	11	nn	_	_
11	B	_	NN	NN	_	13	nn	_	_
12	DNA-binding	_	JJ	JJ	_	13	amod	_	_
13	activity	_	NN	NN	_	8	pobj	_	_
14	and	_	CC	CC	_	7	cc	_	_
15	provides	_	VBZ	VBZ	_	7	conj	_	_
16	an	_	DT	DT	_	18	det	_	_
17	intranuclear	_	JJ	JJ	_	18	amod	_	_
18	environment	_	NN	NN	_	15	dobj	_	_
19	capable	_	JJ	JJ	_	18	amod	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	perpetuating	_	VBG	VBG	_	20	pcomp	_	_
22	HIV-1	_	NN	NN	_	23	nn	_	_
23	replication	_	NN	NN	_	21	dobj	_	_
24	.	_	.	.	_	7	punct	_	_

1	Increased	_	VBN	VBN	_	3	amod	_	_
2	intracellular	_	JJ	JJ	_	3	amod	_	_
3	stores	_	NNS	NNS	_	10	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	latent	_	JJ	JJ	_	7	amod	_	_
6	NF-kappa	_	NN	NN	_	7	nn	_	_
7	B	_	NN	NN	_	4	pobj	_	_
8	may	_	MD	MD	_	10	aux	_	_
9	also	_	RB	RB	_	10	advmod	_	_
10	result	_	VB	VB	_	0	root	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	rapid	_	JJ	JJ	_	13	amod	_	_
13	inducibility	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	NF-kappa	_	NN	NN	_	19	nn	_	_
16	B-dependent	_	JJ	JJ	_	19	amod	_	_
17	cytokine	_	NN	NN	_	19	nn	_	_
18	gene	_	NN	NN	_	19	nn	_	_
19	expression	_	NN	NN	_	14	pobj	_	_
20	.	_	.	.	_	10	punct	_	_

1	In	_	IN	IN	_	14	prep	_	_
2	response	_	NN	NN	_	1	pobj	_	_
3	to	_	TO	TO	_	2	prep	_	_
4	secondary	_	JJ	JJ	_	6	amod	_	_
5	pathogenic	_	JJ	JJ	_	6	amod	_	_
6	infections	_	NNS	NNS	_	3	pobj	_	_
7	or	_	CC	CC	_	6	cc	_	_
8	antigenic	_	JJ	JJ	_	9	amod	_	_
9	challenge	_	NN	NN	_	6	conj	_	_
10	,	_	,	,	_	14	punct	_	_
11	cytokine	_	NN	NN	_	13	nn	_	_
12	gene	_	NN	NN	_	13	nn	_	_
13	expression	_	NN	NN	_	14	nsubj	_	_
14	is	_	VBZ	VBZ	_	0	root	_	_
15	rapidly	_	RB	RB	_	16	advmod	_	_
16	induced	_	VBN	VBN	_	14	dep	_	_
17	,	_	,	,	_	16	punct	_	_
18	enhanced	_	VBN	VBN	_	16	conj	_	_
19	,	_	,	,	_	16	punct	_	_
20	and	_	CC	CC	_	16	cc	_	_
21	sustained	_	JJ	JJ	_	16	conj	_	_
22	over	_	RP	RP	_	21	prep	_	_
23	prolonged	_	JJ	JJ	_	24	amod	_	_
24	periods	_	NNS	NNS	_	22	dep	_	_
25	in	_	IN	IN	_	16	dep	_	_
26	HIV-1-infected	_	JJ	JJ	_	28	amod	_	_
27	myeloid	_	JJ	JJ	_	28	amod	_	_
28	cells	_	NNS	NNS	_	25	pobj	_	_
29	compared	_	VBN	VBN	_	16	dep	_	_
30	with	_	IN	IN	_	29	pcomp	_	_
31	uninfected	_	JJ	JJ	_	32	amod	_	_
32	cells	_	NNS	NNS	_	30	pobj	_	_
33	.	_	.	.	_	14	punct	_	_

1	Elevated	_	JJ	JJ	_	2	amod	_	_
2	levels	_	NNS	NNS	_	9	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	several	_	JJ	JJ	_	6	amod	_	_
5	inflammatory	_	JJ	JJ	_	6	amod	_	_
6	cytokines	_	NNS	NNS	_	3	pobj	_	_
7	have	_	VBP	VBP	_	9	aux	_	_
8	been	_	VBN	VBN	_	9	auxpass	_	_
9	detected	_	VBN	VBN	_	0	root	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	sera	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	HIV-1-infected	_	JJ	JJ	_	15	amod	_	_
15	individuals	_	NNS	NNS	_	13	pobj	_	_
16	.	_	.	.	_	9	punct	_	_

1	Secretion	_	NN	NN	_	8	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	myeloid	_	JJ	JJ	_	5	amod	_	_
4	cell-derived	_	JJ	JJ	_	5	amod	_	_
5	cytokines	_	NNS	NNS	_	2	pobj	_	_
6	may	_	MD	MD	_	8	aux	_	_
7	both	_	CC	CC	_	8	preconj	_	_
8	increase	_	VB	VB	_	0	root	_	_
9	virus	_	NN	NN	_	10	nn	_	_
10	production	_	NN	NN	_	8	dobj	_	_
11	and	_	CC	CC	_	8	cc	_	_
12	contribute	_	VB	VB	_	8	conj	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	AIDS-associated	_	JJ	JJ	_	15	amod	_	_
15	disorders	_	NNS	NNS	_	13	pobj	_	_
16	.	_	.	.	_	8	punct	_	_

1	A	_	DT	DT	_	3	det	_	_
2	central	_	JJ	JJ	_	3	amod	_	_
3	role	_	NN	NN	_	0	root	_	_
4	for	_	IN	IN	_	3	prep	_	_
5	a	_	DT	DT	_	9	det	_	_
6	single	_	JJ	JJ	_	9	amod	_	_
7	c-Myb	_	NN	NN	_	9	nn	_	_
8	binding	_	NN	NN	_	9	nn	_	_
9	site	_	NN	NN	_	4	pobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	a	_	DT	DT	_	15	det	_	_
12	thymic	_	JJ	JJ	_	15	amod	_	_
13	locus	_	NN	NN	_	15	nn	_	_
14	control	_	NN	NN	_	15	nn	_	_
15	region	_	NN	NN	_	10	pobj	_	_
16	.	_	.	.	_	3	punct	_	_

1	Locus	_	NN	NN	_	3	nn	_	_
2	control	_	NN	NN	_	3	nn	_	_
3	regions	_	NNS	NNS	_	9	nsubj	_	_
4	-LRB-	_	-LRB-	-LRB-	_	5	punct	_	_
5	LCRs	_	NNS	NNS	_	3	appos	_	_
6	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
7	are	_	VBP	VBP	_	9	cop	_	_
8	powerful	_	JJ	JJ	_	9	amod	_	_
9	assemblies	_	NNS	NNS	_	0	root	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	cis	_	JJ	JJ	_	12	amod	_	_
12	elements	_	NNS	NNS	_	10	pobj	_	_
13	that	_	WDT	WDT	_	14	nsubj	_	_
14	organize	_	VBP	VBP	_	12	rcmod	_	_
15	the	_	DT	DT	_	16	det	_	_
16	actions	_	NNS	NNS	_	14	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	cell-type-specific	_	JJ	JJ	_	20	amod	_	_
19	trans-acting	_	JJ	JJ	_	20	amod	_	_
20	factors	_	NNS	NNS	_	17	pobj	_	_
21	.	_	.	.	_	9	punct	_	_

1	A	_	DT	DT	_	3	det	_	_
2	2.3-kb	_	JJ	JJ	_	3	amod	_	_
3	LCR	_	NN	NN	_	23	nsubjpass	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	14	det	_	_
6	human	_	JJ	JJ	_	14	amod	_	_
7	adenosine	_	NN	NN	_	14	nn	_	_
8	deaminase	_	NN	NN	_	14	nn	_	_
9	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
10	ADA	_	NN	NN	_	14	nn	_	_
11	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
12	gene	_	NN	NN	_	14	nn	_	_
13	first	_	JJ	JJ	_	14	amod	_	_
14	intron	_	NN	NN	_	4	pobj	_	_
15	,	_	,	,	_	3	punct	_	_
16	which	_	WDT	WDT	_	17	nsubj	_	_
17	controls	_	VBZ	VBZ	_	3	rcmod	_	_
18	expression	_	NN	NN	_	17	dobj	_	_
19	in	_	IN	IN	_	17	prep	_	_
20	thymocytes	_	NNS	NNS	_	19	pobj	_	_
21	,	_	,	,	_	3	punct	_	_
22	is	_	VBZ	VBZ	_	23	auxpass	_	_
23	composed	_	VBN	VBN	_	0	root	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	a	_	DT	DT	_	28	det	_	_
26	200-bp	_	JJ	JJ	_	28	amod	_	_
27	enhancer	_	NN	NN	_	28	nn	_	_
28	domain	_	NN	NN	_	24	pobj	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	extended	_	JJ	JJ	_	32	amod	_	_
31	flanking	_	NN	NN	_	32	nn	_	_
32	sequences	_	NNS	NNS	_	28	conj	_	_
33	that	_	WDT	WDT	_	34	nsubj	_	_
34	facilitate	_	VBP	VBP	_	28	rcmod	_	_
35	activation	_	NN	NN	_	34	dobj	_	_
36	from	_	IN	IN	_	34	prep	_	_
37	within	_	IN	IN	_	36	pcomp	_	_
38	chromatin	_	NN	NN	_	37	pobj	_	_
39	.	_	.	.	_	23	punct	_	_

1	Prior	_	RB	RB	_	2	advmod	_	_
2	analyses	_	NNS	NNS	_	4	nsubj	_	_
3	have	_	VBP	VBP	_	4	aux	_	_
4	demonstrated	_	VBN	VBN	_	0	root	_	_
5	that	_	IN	IN	_	8	mark	_	_
6	the	_	DT	DT	_	7	det	_	_
7	enhancer	_	NN	NN	_	8	nsubj	_	_
8	contains	_	VBZ	VBZ	_	4	ccomp	_	_
9	a	_	DT	DT	_	12	det	_	_
10	28-bp	_	JJ	JJ	_	12	amod	_	_
11	core	_	NN	NN	_	12	nn	_	_
12	region	_	NN	NN	_	8	dobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	local	_	JJ	JJ	_	16	amod	_	_
15	adjacent	_	JJ	JJ	_	16	amod	_	_
16	augmentative	_	JJ	JJ	_	18	amod	_	_
17	cis	_	JJ	JJ	_	18	amod	_	_
18	elements	_	NNS	NNS	_	12	conj	_	_
19	.	_	.	.	_	4	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	now	_	RB	RB	_	3	advmod	_	_
3	show	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	7	mark	_	_
5	the	_	DT	DT	_	6	det	_	_
6	core	_	NN	NN	_	7	nsubj	_	_
7	contains	_	VBZ	VBZ	_	3	ccomp	_	_
8	a	_	DT	DT	_	13	det	_	_
9	single	_	JJ	JJ	_	13	amod	_	_
10	critical	_	JJ	JJ	_	13	amod	_	_
11	c-Myb	_	NN	NN	_	13	nn	_	_
12	binding	_	NN	NN	_	13	nn	_	_
13	site	_	NN	NN	_	7	dobj	_	_
14	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	15	prep	_	_
2	both	_	CC	CC	_	6	preconj	_	_
3	transiently	_	RB	RB	_	6	advmod	_	_
4	cotransfected	_	VBN	VBN	_	6	amod	_	_
5	human	_	JJ	JJ	_	6	amod	_	_
6	cells	_	NNS	NNS	_	1	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	stable	_	JJ	JJ	_	11	amod	_	_
9	chromatin-integrated	_	JJ	JJ	_	11	amod	_	_
10	yeast	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	6	conj	_	_
12	,	_	,	,	_	15	punct	_	_
13	c-Myb	_	NN	NN	_	15	nsubj	_	_
14	strongly	_	RB	RB	_	15	advmod	_	_
15	transactivated	_	VBD	VBD	_	0	root	_	_
16	reporter	_	NN	NN	_	17	nn	_	_
17	constructs	_	NNS	NNS	_	15	dobj	_	_
18	that	_	WDT	WDT	_	19	nsubj	_	_
19	contained	_	VBD	VBD	_	17	rcmod	_	_
20	polymerized	_	JJ	JJ	_	22	amod	_	_
21	core	_	NN	NN	_	22	nn	_	_
22	sequences	_	NNS	NNS	_	19	dobj	_	_
23	.	_	.	.	_	15	punct	_	_

1	c-Myb	_	NN	NN	_	2	nn	_	_
2	protein	_	NN	NN	_	5	nsubj	_	_
3	was	_	VBD	VBD	_	5	cop	_	_
4	strongly	_	RB	RB	_	5	advmod	_	_
5	evident	_	JJ	JJ	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	T	_	NN	NN	_	8	nn	_	_
8	lymphoblasts	_	NNS	NNS	_	6	pobj	_	_
9	in	_	IN	IN	_	14	prep	_	_
10	which	_	WDT	WDT	_	9	pobj	_	_
11	the	_	DT	DT	_	12	det	_	_
12	enhancer	_	NN	NN	_	14	nsubj	_	_
13	was	_	VBD	VBD	_	14	cop	_	_
14	active	_	JJ	JJ	_	8	rcmod	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	was	_	VBD	VBD	_	17	cop	_	_
17	localized	_	JJ	JJ	_	14	conj	_	_
18	within	_	IN	IN	_	17	prep	_	_
19	discrete	_	JJ	JJ	_	21	amod	_	_
20	nuclear	_	JJ	JJ	_	21	amod	_	_
21	structures	_	NNS	NNS	_	18	pobj	_	_
22	.	_	.	.	_	5	punct	_	_

1	Fetal	_	JJ	JJ	_	3	amod	_	_
2	murine	_	NN	NN	_	3	nn	_	_
3	thymus	_	NN	NN	_	4	nsubj	_	_
4	exhibited	_	VBD	VBD	_	0	root	_	_
5	a	_	DT	DT	_	7	det	_	_
6	striking	_	JJ	JJ	_	7	amod	_	_
7	concordance	_	NN	NN	_	4	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	endogenous	_	JJ	JJ	_	11	amod	_	_
10	c-myb	_	NN	NN	_	11	nn	_	_
11	expression	_	NN	NN	_	8	pobj	_	_
12	with	_	IN	IN	_	7	prep	_	_
13	that	_	DT	DT	_	12	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	mouse	_	NN	NN	_	16	nn	_	_
16	ADA	_	NN	NN	_	14	pobj	_	_
17	and	_	CC	CC	_	13	cc	_	_
18	human	_	JJ	JJ	_	22	amod	_	_
19	ADA	_	NN	NN	_	22	nn	_	_
20	LCR-directed	_	JJ	JJ	_	22	amod	_	_
21	transgene	_	NN	NN	_	22	nn	_	_
22	expression	_	NN	NN	_	13	conj	_	_
23	.	_	.	.	_	4	punct	_	_

1	Point	_	NN	NN	_	2	nn	_	_
2	mutation	_	NN	NN	_	13	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	c-Myb	_	NN	NN	_	6	nn	_	_
6	site	_	NN	NN	_	3	pobj	_	_
7	within	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	11	det	_	_
9	intact	_	JJ	JJ	_	11	amod	_	_
10	2.3-kb	_	JJ	JJ	_	11	amod	_	_
11	LCR	_	NN	NN	_	7	pobj	_	_
12	severely	_	RB	RB	_	13	advmod	_	_
13	attenuated	_	VBD	VBD	_	0	root	_	_
14	enhancer	_	NN	NN	_	15	nn	_	_
15	activity	_	NN	NN	_	13	dobj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	transfections	_	NNS	NNS	_	16	pobj	_	_
18	and	_	CC	CC	_	15	cc	_	_
19	LCR	_	NN	NN	_	20	nn	_	_
20	activity	_	NN	NN	_	15	conj	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	transgenic	_	JJ	JJ	_	23	amod	_	_
23	thymocytes	_	NNS	NNS	_	21	pobj	_	_
24	.	_	.	.	_	13	punct	_	_

1	Within	_	IN	IN	_	13	prep	_	_
2	the	_	DT	DT	_	3	det	_	_
3	context	_	NN	NN	_	1	pobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	a	_	DT	DT	_	7	det	_	_
6	complex	_	NN	NN	_	7	nn	_	_
7	enhancer	_	NN	NN	_	4	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	LCR	_	NN	NN	_	7	conj	_	_
10	,	_	,	,	_	13	punct	_	_
11	c-Myb	_	NN	NN	_	13	nsubj	_	_
12	can	_	MD	MD	_	13	aux	_	_
13	act	_	VB	VB	_	0	root	_	_
14	as	_	IN	IN	_	13	prep	_	_
15	an	_	DT	DT	_	16	det	_	_
16	organizer	_	NN	NN	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	thymocyte-specific	_	JJ	JJ	_	19	amod	_	_
19	gene	_	NN	NN	_	20	nn	_	_
20	expression	_	NN	NN	_	17	pobj	_	_
21	via	_	IN	IN	_	13	prep	_	_
22	a	_	DT	DT	_	25	det	_	_
23	single	_	JJ	JJ	_	25	amod	_	_
24	binding	_	VBG	VBG	_	25	amod	_	_
25	site	_	NN	NN	_	21	pobj	_	_
26	.	_	.	.	_	13	punct	_	_

1	Immunosuppression	_	NN	NN	_	0	root	_	_
2	by	_	IN	IN	_	1	prep	_	_
3	glucocorticoids	_	NNS	NNS	_	2	pobj	_	_
4	:	_	:	:	_	1	punct	_	_
5	inhibition	_	NN	NN	_	1	dep	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	NF-kappa	_	NN	NN	_	8	nn	_	_
8	B	_	NN	NN	_	9	nn	_	_
9	activity	_	NN	NN	_	6	pobj	_	_
10	through	_	IN	IN	_	5	prep	_	_
11	induction	_	NN	NN	_	10	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	I	_	NN	NN	_	15	nn	_	_
14	kappa	_	NN	NN	_	15	nn	_	_
15	B	_	NN	NN	_	16	nn	_	_
16	synthesis	_	NN	NN	_	12	pobj	_	_
17	-LSB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	see	_	VB	VB	_	1	dep	_	_
19	comments	_	NNS	NNS	_	18	dobj	_	_
20	-RSB-	_	-RRB-	-RRB-	_	18	punct	_	_

1	Glucocorticoids	_	NNS	NNS	_	2	nsubj	_	_
2	are	_	VBP	VBP	_	0	root	_	_
3	among	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	10	det	_	_
5	most	_	RBS	RBS	_	6	advmod	_	_
6	potent	_	JJ	JJ	_	10	amod	_	_
7	anti-inflammatory	_	JJ	JJ	_	10	amod	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	immunosuppressive	_	JJ	JJ	_	7	conj	_	_
10	agents	_	NNS	NNS	_	3	pobj	_	_
11	.	_	.	.	_	2	punct	_	_

1	They	_	PRP	PRP	_	2	nsubj	_	_
2	inhibit	_	VBP	VBP	_	0	root	_	_
3	synthesis	_	NN	NN	_	2	dobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	almost	_	RB	RB	_	7	advmod	_	_
6	all	_	DT	DT	_	7	det	_	_
7	known	_	JJ	JJ	_	8	amod	_	_
8	cytokines	_	NNS	NNS	_	4	pobj	_	_
9	and	_	CC	CC	_	4	cc	_	_
10	of	_	IN	IN	_	4	conj	_	_
11	several	_	JJ	JJ	_	14	amod	_	_
12	cell	_	NN	NN	_	14	nn	_	_
13	surface	_	NN	NN	_	14	nn	_	_
14	molecules	_	NNS	NNS	_	10	pobj	_	_
15	required	_	VBN	VBN	_	14	vmod	_	_
16	for	_	IN	IN	_	15	prep	_	_
17	immune	_	JJ	JJ	_	18	amod	_	_
18	function	_	NN	NN	_	16	pobj	_	_
19	,	_	,	,	_	2	punct	_	_
20	but	_	CC	CC	_	2	cc	_	_
21	the	_	DT	DT	_	22	det	_	_
22	mechanism	_	NN	NN	_	28	nsubj	_	_
23	underlying	_	VBG	VBG	_	22	vmod	_	_
24	this	_	DT	DT	_	25	det	_	_
25	activity	_	NN	NN	_	23	dobj	_	_
26	has	_	VBZ	VBZ	_	28	aux	_	_
27	been	_	VBN	VBN	_	28	cop	_	_
28	unclear	_	JJ	JJ	_	2	conj	_	_
29	.	_	.	.	_	2	punct	_	_

1	Here	_	RB	RB	_	4	advmod	_	_
2	it	_	PRP	PRP	_	4	nsubjpass	_	_
3	is	_	VBZ	VBZ	_	4	auxpass	_	_
4	shown	_	VBN	VBN	_	0	root	_	_
5	that	_	IN	IN	_	9	mark	_	_
6	glucocorticoids	_	NNS	NNS	_	9	nsubj	_	_
7	are	_	VBP	VBP	_	9	cop	_	_
8	potent	_	JJ	JJ	_	9	amod	_	_
9	inhibitors	_	NNS	NNS	_	4	ccomp	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	nuclear	_	JJ	JJ	_	14	amod	_	_
12	factor	_	NN	NN	_	14	nn	_	_
13	kappa	_	NN	NN	_	14	nn	_	_
14	B	_	NN	NN	_	19	nn	_	_
15	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
16	NF-kappa	_	NN	NN	_	17	nn	_	_
17	B	_	NN	NN	_	14	appos	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	activation	_	NN	NN	_	10	pobj	_	_
20	in	_	IN	IN	_	9	prep	_	_
21	mice	_	NNS	NNS	_	20	pobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	cultured	_	VBN	VBN	_	24	amod	_	_
24	cells	_	NNS	NNS	_	21	conj	_	_
25	.	_	.	.	_	4	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	inhibition	_	NN	NN	_	4	nsubjpass	_	_
3	is	_	VBZ	VBZ	_	4	auxpass	_	_
4	mediated	_	VBN	VBN	_	0	root	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	induction	_	NN	NN	_	5	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	14	det	_	_
9	I	_	NN	NN	_	11	nn	_	_
10	kappa	_	NN	NN	_	11	nn	_	_
11	B	_	NN	NN	_	14	nn	_	_
12	alpha	_	NN	NN	_	14	nn	_	_
13	inhibitory	_	JJ	JJ	_	14	amod	_	_
14	protein	_	NN	NN	_	7	pobj	_	_
15	,	_	,	,	_	14	punct	_	_
16	which	_	WDT	WDT	_	17	nsubj	_	_
17	traps	_	VBZ	VBZ	_	14	rcmod	_	_
18	activated	_	VBN	VBN	_	20	amod	_	_
19	NF-kappa	_	NN	NN	_	20	nn	_	_
20	B	_	NN	NN	_	17	dobj	_	_
21	in	_	IN	IN	_	17	prep	_	_
22	inactive	_	JJ	JJ	_	24	amod	_	_
23	cytoplasmic	_	JJ	JJ	_	24	amod	_	_
24	complexes	_	NNS	NNS	_	21	pobj	_	_
25	.	_	.	.	_	4	punct	_	_

1	Because	_	IN	IN	_	4	mark	_	_
2	NF-kappa	_	NN	NN	_	3	nn	_	_
3	B	_	NN	NN	_	4	nsubj	_	_
4	activates	_	VBZ	VBZ	_	23	advcl	_	_
5	many	_	JJ	JJ	_	7	amod	_	_
6	immunoregulatory	_	JJ	JJ	_	7	amod	_	_
7	genes	_	NNS	NNS	_	4	dobj	_	_
8	in	_	IN	IN	_	4	prep	_	_
9	response	_	NN	NN	_	8	pobj	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	pro-inflammatory	_	JJ	JJ	_	12	amod	_	_
12	stimuli	_	NNS	NNS	_	10	pobj	_	_
13	,	_	,	,	_	23	punct	_	_
14	the	_	DT	DT	_	15	det	_	_
15	inhibition	_	NN	NN	_	23	nsubj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	its	_	PRP$	PRP$	_	18	poss	_	_
18	activity	_	NN	NN	_	16	pobj	_	_
19	can	_	MD	MD	_	23	aux	_	_
20	be	_	VB	VB	_	23	cop	_	_
21	a	_	DT	DT	_	23	det	_	_
22	major	_	JJ	JJ	_	23	amod	_	_
23	component	_	NN	NN	_	0	root	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	27	det	_	_
26	anti-inflammatory	_	JJ	JJ	_	27	amod	_	_
27	activity	_	NN	NN	_	24	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	glucocorticoids	_	NNS	NNS	_	28	pobj	_	_
30	.	_	.	.	_	23	punct	_	_

1	Pathogenesis	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	atherosclerosis	_	NN	NN	_	2	pobj	_	_
4	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	earliest	_	JJS	JJS	_	3	amod	_	_
3	lesion	_	NN	NN	_	14	nsubj	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	6	det	_	_
6	development	_	NN	NN	_	4	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	an	_	DT	DT	_	10	det	_	_
9	atherosclerotic	_	JJ	JJ	_	10	amod	_	_
10	plaque	_	NN	NN	_	7	pobj	_	_
11	is	_	VBZ	VBZ	_	14	cop	_	_
12	the	_	DT	DT	_	14	det	_	_
13	fatty	_	JJ	JJ	_	14	amod	_	_
14	streak	_	NN	NN	_	0	root	_	_
15	.	_	.	.	_	14	punct	_	_

1	This	_	DT	DT	_	4	det	_	_
2	chronic	_	JJ	JJ	_	4	amod	_	_
3	inflammatory	_	JJ	JJ	_	2	dep	_	_
4	reaction	_	NN	NN	_	5	nsubj	_	_
5	results	_	VBZ	VBZ	_	0	root	_	_
6	from	_	IN	IN	_	5	prep	_	_
7	a	_	DT	DT	_	8	det	_	_
8	sequence	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	events	_	NNS	NNS	_	9	pobj	_	_
11	that	_	WDT	WDT	_	12	nsubj	_	_
12	begins	_	VBZ	VBZ	_	8	rcmod	_	_
13	with	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	trapping	_	NN	NN	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	low	_	JJ	JJ	_	19	amod	_	_
18	density	_	NN	NN	_	19	nn	_	_
19	lipoprotein	_	NN	NN	_	16	pobj	_	_
20	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	LDL	_	NN	NN	_	19	appos	_	_
22	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
23	in	_	IN	IN	_	15	prep	_	_
24	the	_	DT	DT	_	26	det	_	_
25	subendothelial	_	JJ	JJ	_	26	amod	_	_
26	space	_	NN	NN	_	23	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	30	det	_	_
29	artery	_	NN	NN	_	30	nn	_	_
30	wall	_	NN	NN	_	27	pobj	_	_
31	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	trapped	_	VBN	VBN	_	3	amod	_	_
3	LDL	_	NN	NN	_	5	nsubjpass	_	_
4	is	_	VBZ	VBZ	_	5	auxpass	_	_
5	seeded	_	VBN	VBN	_	0	root	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	oxidative	_	JJ	JJ	_	8	amod	_	_
8	species	_	NNS	NNS	_	6	pobj	_	_
9	released	_	VBN	VBN	_	8	vmod	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	overlying	_	VBG	VBG	_	13	amod	_	_
13	endothelium	_	NN	NN	_	10	pobj	_	_
14	,	_	,	,	_	5	punct	_	_
15	and	_	CC	CC	_	5	cc	_	_
16	lipid	_	NN	NN	_	17	nn	_	_
17	oxidation	_	NN	NN	_	19	nsubjpass	_	_
18	is	_	VBZ	VBZ	_	19	auxpass	_	_
19	initiated	_	VBN	VBN	_	5	conj	_	_
20	within	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	LDL	_	NN	NN	_	23	nn	_	_
23	particle	_	NN	NN	_	20	pobj	_	_
24	.	_	.	.	_	5	punct	_	_

1	Some	_	DT	DT	_	7	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	4	det	_	_
4	lipids	_	NNS	NNS	_	2	pobj	_	_
5	that	_	WDT	WDT	_	6	nsubj	_	_
6	result	_	VBP	VBP	_	1	rcmod	_	_
7	lead	_	VBP	VBP	_	0	root	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	activation	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	NFkB-like	_	JJ	JJ	_	14	amod	_	_
13	transcription	_	NN	NN	_	14	nn	_	_
14	factors	_	NNS	NNS	_	11	pobj	_	_
15	that	_	WDT	WDT	_	16	nsubj	_	_
16	cause	_	VBP	VBP	_	14	rcmod	_	_
17	the	_	DT	DT	_	18	det	_	_
18	expression	_	NN	NN	_	16	dobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	genes	_	NNS	NNS	_	19	pobj	_	_
21	whose	_	WP$	WP$	_	23	poss	_	_
22	protein	_	NN	NN	_	23	nn	_	_
23	products	_	NNS	NNS	_	24	nsubj	_	_
24	mediate	_	VBP	VBP	_	20	rcmod	_	_
25	monocyte	_	NN	NN	_	26	nn	_	_
26	binding	_	NN	NN	_	24	dobj	_	_
27	,	_	,	,	_	26	punct	_	_
28	monocyte	_	NN	NN	_	29	nn	_	_
29	chemotaxis	_	NN	NN	_	26	conj	_	_
30	into	_	IN	IN	_	29	prep	_	_
31	the	_	DT	DT	_	33	det	_	_
32	subendothelial	_	JJ	JJ	_	33	amod	_	_
33	space	_	NN	NN	_	30	pobj	_	_
34	,	_	,	,	_	26	punct	_	_
35	and	_	CC	CC	_	26	cc	_	_
36	conversion	_	NN	NN	_	26	conj	_	_
37	into	_	IN	IN	_	36	prep	_	_
38	macrophages	_	NNS	NNS	_	37	pobj	_	_
39	.	_	.	.	_	7	punct	_	_

1	At	_	IN	IN	_	3	quantmod	_	_
2	least	_	JJS	JJS	_	1	mwe	_	_
3	1	_	CD	CD	_	5	num	_	_
4	major	_	JJ	JJ	_	5	amod	_	_
5	gene	_	NN	NN	_	6	nsubj	_	_
6	modulates	_	VBZ	VBZ	_	0	root	_	_
7	the	_	DT	DT	_	8	det	_	_
8	oxidation	_	NN	NN	_	6	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	LDL	_	NN	NN	_	11	nn	_	_
11	lipids	_	NNS	NNS	_	9	pobj	_	_
12	and/or	_	CC	CC	_	8	cc	_	_
13	the	_	DT	DT	_	15	det	_	_
14	biologic	_	JJ	JJ	_	15	amod	_	_
15	response	_	NN	NN	_	8	conj	_	_
16	to	_	TO	TO	_	15	prep	_	_
17	these	_	DT	DT	_	18	det	_	_
18	lipids	_	NNS	NNS	_	16	pobj	_	_
19	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	inverse	_	JJ	JJ	_	3	amod	_	_
3	relation	_	NN	NN	_	18	nsubj	_	_
4	between	_	IN	IN	_	3	prep	_	_
5	high	_	JJ	JJ	_	7	amod	_	_
6	density	_	NN	NN	_	7	nn	_	_
7	lipoprotein	_	NN	NN	_	4	pobj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	HDL	_	NN	NN	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	and	_	CC	CC	_	7	cc	_	_
12	atherosclerotic	_	JJ	JJ	_	13	amod	_	_
13	events	_	NNS	NNS	_	7	conj	_	_
14	may	_	MD	MD	_	18	aux	_	_
15	in	_	IN	IN	_	18	prep	_	_
16	part	_	NN	NN	_	15	pobj	_	_
17	be	_	VB	VB	_	18	cop	_	_
18	due	_	JJ	JJ	_	0	root	_	_
19	to	_	TO	TO	_	18	prep	_	_
20	enzymes	_	NNS	NNS	_	19	pobj	_	_
21	associated	_	VBN	VBN	_	20	vmod	_	_
22	with	_	IN	IN	_	21	prep	_	_
23	HDL	_	NN	NN	_	22	pobj	_	_
24	that	_	WDT	WDT	_	25	nsubj	_	_
25	destroy	_	VBP	VBP	_	20	rcmod	_	_
26	the	_	DT	DT	_	29	det	_	_
27	biologically	_	RB	RB	_	28	advmod	_	_
28	active	_	JJ	JJ	_	29	amod	_	_
29	lipids	_	NNS	NNS	_	25	dobj	_	_
30	generated	_	VBN	VBN	_	29	vmod	_	_
31	in	_	IN	IN	_	30	prep	_	_
32	LDL	_	NN	NN	_	31	pobj	_	_
33	.	_	.	.	_	18	punct	_	_

1	IFN-gamma	_	NN	NN	_	2	nn	_	_
2	priming	_	NN	NN	_	5	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	monocytes	_	NNS	NNS	_	3	pobj	_	_
5	enhances	_	VBZ	VBZ	_	0	root	_	_
6	LPS-induced	_	JJ	JJ	_	8	amod	_	_
7	TNF	_	NN	NN	_	8	nn	_	_
8	production	_	NN	NN	_	5	dobj	_	_
9	by	_	IN	IN	_	5	prep	_	_
10	augmenting	_	VBG	VBG	_	9	pcomp	_	_
11	both	_	CC	CC	_	12	preconj	_	_
12	transcription	_	NN	NN	_	10	dobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	MRNA	_	NN	NN	_	15	nn	_	_
15	stability	_	NN	NN	_	12	conj	_	_
16	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	induction	_	NN	NN	_	21	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	cytokine	_	NN	NN	_	5	nn	_	_
5	expression	_	NN	NN	_	3	pobj	_	_
6	in	_	IN	IN	_	2	prep	_	_
7	monocytes/macrophages	_	NNS	NNS	_	6	pobj	_	_
8	by	_	IN	IN	_	2	prep	_	_
9	bacterial	_	JJ	JJ	_	10	amod	_	_
10	endotoxin	_	NN	NN	_	8	pobj	_	_
11	or	_	CC	CC	_	10	cc	_	_
12	lipopolysaccharide	_	NN	NN	_	10	conj	_	_
13	is	_	VBZ	VBZ	_	21	cop	_	_
14	a	_	DT	DT	_	21	det	_	_
15	critical	_	JJ	JJ	_	21	amod	_	_
16	,	_	,	,	_	15	punct	_	_
17	highly	_	RB	RB	_	18	advmod	_	_
18	regulated	_	VBN	VBN	_	15	dep	_	_
19	host	_	NN	NN	_	21	nn	_	_
20	defence	_	NN	NN	_	21	nn	_	_
21	response	_	NN	NN	_	0	root	_	_
22	.	_	.	.	_	21	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	augmentation	_	NN	NN	_	20	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	LPS	_	NN	NN	_	5	nn	_	_
5	responses	_	NNS	NNS	_	3	pobj	_	_
6	by	_	IN	IN	_	2	prep	_	_
7	interferon	_	NN	NN	_	8	nn	_	_
8	gamma	_	NN	NN	_	6	pobj	_	_
9	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	IFN-gamma	_	NN	NN	_	8	appos	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	,	_	,	,	_	2	punct	_	_
13	referred	_	VBN	VBN	_	2	vmod	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	as	_	IN	IN	_	13	prep	_	_
16	priming	_	NN	NN	_	15	pobj	_	_
17	,	_	,	,	_	2	punct	_	_
18	is	_	VBZ	VBZ	_	20	auxpass	_	_
19	well	_	RB	RB	_	20	advmod	_	_
20	established	_	VBN	VBN	_	0	root	_	_
21	.	_	.	.	_	20	punct	_	_

1	However	_	RB	RB	_	14	advmod	_	_
2	,	_	,	,	_	14	punct	_	_
3	the	_	DT	DT	_	6	det	_	_
4	mechanism	_	NN	NN	_	6	nn	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	s	_	NNS	NNS	_	14	nsubjpass	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	by	_	IN	IN	_	11	prep	_	_
9	which	_	WDT	WDT	_	8	pobj	_	_
10	priming	_	NN	NN	_	11	nsubj	_	_
11	occurs	_	VBZ	VBZ	_	6	rcmod	_	_
12	is	_	VBZ	VBZ	_	14	auxpass	_	_
13	poorly	_	RB	RB	_	14	advmod	_	_
14	defined	_	VBN	VBN	_	0	root	_	_
15	.	_	.	.	_	14	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	tumour	_	NN	NN	_	4	nn	_	_
3	necrosis	_	NN	NN	_	4	nn	_	_
4	factor	_	NN	NN	_	8	nn	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	TNF	_	NN	NN	_	4	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	induction	_	NN	NN	_	1	dobj	_	_
9	as	_	IN	IN	_	1	prep	_	_
10	a	_	DT	DT	_	11	det	_	_
11	model	_	NN	NN	_	9	pobj	_	_
12	,	_	,	,	_	1	punct	_	_
13	experiments	_	NNS	NNS	_	15	nsubjpass	_	_
14	were	_	VBD	VBD	_	15	auxpass	_	_
15	designed	_	VBN	VBN	_	1	parataxis	_	_
16	to	_	TO	TO	_	17	aux	_	_
17	analyse	_	VB	VB	_	15	xcomp	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	detail	_	NN	NN	_	18	pobj	_	_
20	the	_	DT	DT	_	22	det	_	_
21	priming	_	NN	NN	_	22	nn	_	_
22	effect	_	NN	NN	_	17	dobj	_	_
23	on	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	26	det	_	_
25	LPS	_	NN	NN	_	26	nn	_	_
26	response	_	NN	NN	_	23	pobj	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	human	_	JJ	JJ	_	29	amod	_	_
29	monocytes	_	NNS	NNS	_	27	pobj	_	_
30	.	_	.	.	_	1	punct	_	_

1	Priming	_	NN	NN	_	6	nsubjpass	_	_
2	by	_	IN	IN	_	1	prep	_	_
3	IFN-gamma	_	NN	NN	_	2	pobj	_	_
4	was	_	VBD	VBD	_	6	auxpass	_	_
5	primarily	_	RB	RB	_	6	advmod	_	_
6	manifested	_	VBN	VBN	_	0	root	_	_
7	at	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	level	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	TNF	_	NN	NN	_	12	nn	_	_
12	mRNA	_	NN	NN	_	13	nn	_	_
13	accumulation	_	NN	NN	_	10	pobj	_	_
14	.	_	.	.	_	6	punct	_	_

1	IFN-gamma	_	NN	NN	_	2	nn	_	_
2	pre-treatment	_	NN	NN	_	3	nsubj	_	_
3	affected	_	VBD	VBD	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	magnitude	_	NN	NN	_	3	dobj	_	_
6	rather	_	RB	RB	_	5	cc	_	_
7	than	_	IN	IN	_	6	mwe	_	_
8	the	_	DT	DT	_	9	det	_	_
9	sensitivity	_	NN	NN	_	5	conj	_	_
10	of	_	IN	IN	_	5	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	LPS	_	NN	NN	_	13	nn	_	_
13	response	_	NN	NN	_	10	pobj	_	_
14	.	_	.	.	_	3	punct	_	_

1	Priming	_	NN	NN	_	2	nsubj	_	_
2	occurred	_	VBD	VBD	_	0	root	_	_
3	after	_	IN	IN	_	2	prep	_	_
4	several	_	JJ	JJ	_	5	amod	_	_
5	hours	_	NNS	NNS	_	3	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	treatment	_	NN	NN	_	6	pobj	_	_
8	,	_	,	,	_	2	punct	_	_
9	and	_	CC	CC	_	2	cc	_	_
10	the	_	DT	DT	_	12	det	_	_
11	primed	_	JJ	JJ	_	12	amod	_	_
12	state	_	NN	NN	_	14	nsubjpass	_	_
13	was	_	VBD	VBD	_	14	auxpass	_	_
14	induced	_	VBN	VBN	_	2	conj	_	_
15	by	_	IN	IN	_	14	prep	_	_
16	either	_	CC	CC	_	17	preconj	_	_
17	IFN-gamma	_	NN	NN	_	15	pobj	_	_
18	or	_	CC	CC	_	17	cc	_	_
19	GM-CSF	_	NN	NN	_	17	conj	_	_
20	,	_	,	,	_	17	punct	_	_
21	but	_	CC	CC	_	22	cc	_	_
22	not	_	RB	RB	_	17	cc	_	_
23	M-CSF	_	NN	NN	_	17	conj	_	_
24	.	_	.	.	_	2	punct	_	_

1	Primed	_	VBN	VBN	_	2	amod	_	_
2	monocytes	_	NNS	NNS	_	3	nsubj	_	_
3	transcribed	_	VBD	VBD	_	0	root	_	_
4	TNF	_	NN	NN	_	5	nn	_	_
5	mRNA	_	NN	NN	_	3	dobj	_	_
6	at	_	IN	IN	_	3	prep	_	_
7	a	_	DT	DT	_	9	det	_	_
8	higher	_	JJR	JJR	_	9	amod	_	_
9	rate	_	NN	NN	_	6	pobj	_	_
10	than	_	IN	IN	_	9	prep	_	_
11	freshly	_	RB	RB	_	12	advmod	_	_
12	isolated	_	VBN	VBN	_	13	amod	_	_
13	monocytes	_	NNS	NNS	_	10	pobj	_	_
14	upon	_	IN	IN	_	3	prep	_	_
15	activation	_	NN	NN	_	14	pobj	_	_
16	with	_	IN	IN	_	15	prep	_	_
17	LPS	_	NN	NN	_	16	pobj	_	_
18	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	increased	_	VBN	VBN	_	4	amod	_	_
3	transcriptional	_	JJ	JJ	_	4	amod	_	_
4	rate	_	NN	NN	_	5	nsubj	_	_
5	correlated	_	VBD	VBD	_	0	root	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	a	_	DT	DT	_	9	det	_	_
8	marked	_	JJ	JJ	_	9	amod	_	_
9	increase	_	NN	NN	_	6	pobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	nuclear	_	JJ	JJ	_	13	amod	_	_
12	factor-kappa	_	NN	NN	_	13	nn	_	_
13	B	_	NN	NN	_	14	nn	_	_
14	activity	_	NN	NN	_	10	pobj	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	these	_	DT	DT	_	17	det	_	_
17	cells	_	NNS	NNS	_	15	pobj	_	_
18	as	_	IN	IN	_	19	mark	_	_
19	determined	_	VBN	VBN	_	5	advcl	_	_
20	by	_	IN	IN	_	19	prep	_	_
21	electrophoretic	_	JJ	JJ	_	24	amod	_	_
22	mobility	_	NN	NN	_	24	nn	_	_
23	shift	_	NN	NN	_	24	nn	_	_
24	assay	_	NN	NN	_	20	pobj	_	_
25	using	_	VBG	VBG	_	24	vmod	_	_
26	a	_	DT	DT	_	30	det	_	_
27	consensus	_	NN	NN	_	30	nn	_	_
28	NF-kappa	_	NN	NN	_	30	nn	_	_
29	B	_	NN	NN	_	30	nn	_	_
30	oligonucleotide	_	NN	NN	_	25	dobj	_	_
31	.	_	.	.	_	5	punct	_	_

1	An	_	DT	DT	_	4	det	_	_
2	additional	_	JJ	JJ	_	4	amod	_	_
3	significant	_	JJ	JJ	_	2	dep	_	_
4	finding	_	NN	NN	_	5	nsubj	_	_
5	was	_	VBD	VBD	_	0	root	_	_
6	than	_	IN	IN	_	16	mark	_	_
7	TNF	_	NN	NN	_	8	nn	_	_
8	mRNA	_	NN	NN	_	16	nsubj	_	_
9	induced	_	VBN	VBN	_	8	vmod	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	primed	_	VBN	VBN	_	12	amod	_	_
12	cells	_	NNS	NNS	_	10	pobj	_	_
13	was	_	VBD	VBD	_	16	cop	_	_
14	much	_	RB	RB	_	15	advmod	_	_
15	more	_	RBR	RBR	_	16	advmod	_	_
16	stable	_	JJ	JJ	_	5	advcl	_	_
17	than	_	IN	IN	_	16	prep	_	_
18	in	_	IN	IN	_	17	pcomp	_	_
19	unprimed	_	JJ	JJ	_	20	amod	_	_
20	cells	_	NNS	NNS	_	18	pobj	_	_
21	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
22	T1/2	_	NN	NN	_	23	nsubj	_	_
23	increased	_	VBN	VBN	_	16	dep	_	_
24	6-8-fold	_	RB	RB	_	23	dobj	_	_
25	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
26	.	_	.	.	_	5	punct	_	_

1	Consistent	_	JJ	JJ	_	14	advmod	_	_
2	with	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	6	det	_	_
4	increased	_	VBN	VBN	_	6	amod	_	_
5	mRNA	_	NN	NN	_	6	nn	_	_
6	stability	_	NN	NN	_	2	pobj	_	_
7	,	_	,	,	_	14	punct	_	_
8	the	_	DT	DT	_	9	det	_	_
9	duration	_	NN	NN	_	14	nsubj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	mRNA	_	NN	NN	_	12	nn	_	_
12	accumulation	_	NN	NN	_	10	pobj	_	_
13	was	_	VBD	VBD	_	14	cop	_	_
14	longer	_	RBR	RBR	_	0	root	_	_
15	following	_	VBG	VBG	_	14	prep	_	_
16	LPS	_	NN	NN	_	17	nn	_	_
17	stimulation	_	NN	NN	_	15	pobj	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	primed	_	VBN	VBN	_	20	amod	_	_
20	monocytes	_	NNS	NNS	_	18	pobj	_	_
21	,	_	,	,	_	14	punct	_	_
22	in	_	IN	IN	_	14	prep	_	_
23	addition	_	NN	NN	_	22	pobj	_	_
24	to	_	TO	TO	_	23	prep	_	_
25	being	_	VBG	VBG	_	24	pcomp	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	greater	_	JJR	JJR	_	28	amod	_	_
28	magnitude	_	NN	NN	_	26	pobj	_	_
29	.	_	.	.	_	14	punct	_	_

1	Finally	_	RB	RB	_	7	advmod	_	_
2	,	_	,	,	_	7	punct	_	_
3	primed	_	VBN	VBN	_	7	nsubj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	unprimed	_	JJ	JJ	_	3	conj	_	_
6	cells	_	NNS	NNS	_	3	dep	_	_
7	possessed	_	VBD	VBD	_	0	root	_	_
8	a	_	DT	DT	_	10	det	_	_
9	differential	_	JJ	JJ	_	10	amod	_	_
10	sensitivity	_	NN	NN	_	7	dobj	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	the	_	DT	DT	_	15	det	_	_
13	kinase	_	NN	NN	_	15	nn	_	_
14	inhibitor	_	NN	NN	_	15	nn	_	_
15	H-89	_	NN	NN	_	11	pobj	_	_
16	.	_	.	.	_	7	punct	_	_

1	H-89	_	NN	NN	_	3	nsubj	_	_
2	substantially	_	RB	RB	_	3	advmod	_	_
3	suppressed	_	VBD	VBD	_	0	root	_	_
4	LPS-induced	_	JJ	JJ	_	7	amod	_	_
5	TNF	_	NN	NN	_	6	nn	_	_
6	mRNA	_	NN	NN	_	7	nn	_	_
7	accumulation	_	NN	NN	_	3	dobj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	unprimed	_	JJ	JJ	_	10	amod	_	_
10	cells	_	NNS	NNS	_	8	pobj	_	_
11	,	_	,	,	_	3	punct	_	_
12	but	_	CC	CC	_	3	cc	_	_
13	had	_	VBD	VBD	_	3	conj	_	_
14	no	_	DT	DT	_	15	neg	_	_
15	effect	_	NN	NN	_	13	dobj	_	_
16	on	_	IN	IN	_	15	prep	_	_
17	primed	_	VBN	VBN	_	18	amod	_	_
18	monocytes	_	NNS	NNS	_	16	pobj	_	_
19	following	_	VBG	VBG	_	13	prep	_	_
20	LPS	_	NN	NN	_	21	nn	_	_
21	stimulation	_	NN	NN	_	19	pobj	_	_
22	.	_	.	.	_	3	punct	_	_

1	-LRB-	_	-LRB-	-LRB-	_	2	punct	_	_
2	ABSTRACT	_	NN	NN	_	0	root	_	_
3	TRUNCATED	_	VBN	VBN	_	2	vmod	_	_
4	AT	_	IN	IN	_	3	prep	_	_
5	250	_	CD	CD	_	6	num	_	_
6	WORDS	_	NNS	NNS	_	4	pobj	_	_
7	-RRB-	_	-RRB-	-RRB-	_	2	punct	_	_

1	Prolactin	_	NN	NN	_	8	nsubj	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	interleukin-2	_	NN	NN	_	4	nn	_	_
4	receptors	_	NNS	NNS	_	1	conj	_	_
5	in	_	IN	IN	_	1	prep	_	_
6	T	_	NN	NN	_	7	nn	_	_
7	lymphocytes	_	NNS	NNS	_	5	pobj	_	_
8	signal	_	VBP	VBP	_	0	root	_	_
9	through	_	IN	IN	_	8	prep	_	_
10	a	_	DT	DT	_	13	det	_	_
11	MGF-STAT5-like	_	JJ	JJ	_	13	amod	_	_
12	transcription	_	NN	NN	_	13	nn	_	_
13	factor	_	NN	NN	_	9	pobj	_	_
14	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	cell	_	NN	NN	_	4	nn	_	_
3	surface	_	NN	NN	_	4	nn	_	_
4	receptors	_	NNS	NNS	_	14	nsubj	_	_
5	for	_	IN	IN	_	4	prep	_	_
6	PRL	_	NN	NN	_	5	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	interleukin-2	_	NN	NN	_	6	conj	_	_
9	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	IL-2	_	NN	NN	_	8	appos	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	are	_	VBP	VBP	_	14	cop	_	_
13	structurally	_	RB	RB	_	14	advmod	_	_
14	distinct	_	JJ	JJ	_	0	root	_	_
15	,	_	,	,	_	14	punct	_	_
16	but	_	CC	CC	_	14	cc	_	_
17	share	_	VBP	VBP	_	14	conj	_	_
18	regulatory	_	JJ	JJ	_	19	amod	_	_
19	tasks	_	NNS	NNS	_	17	dobj	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	T	_	NN	NN	_	22	nn	_	_
22	lymphocytes	_	NNS	NNS	_	20	pobj	_	_
23	.	_	.	.	_	14	punct	_	_

1	They	_	PRP	PRP	_	3	nsubj	_	_
2	can	_	MD	MD	_	3	aux	_	_
3	stimulate	_	VB	VB	_	0	root	_	_
4	proliferation	_	NN	NN	_	3	dobj	_	_
5	and	_	CC	CC	_	3	cc	_	_
6	activate	_	VB	VB	_	3	conj	_	_
7	transcription	_	NN	NN	_	6	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	over-lapping	_	JJ	JJ	_	10	amod	_	_
10	sets	_	NNS	NNS	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	genes	_	NNS	NNS	_	11	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	T	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	.	_	.	.	_	3	punct	_	_

1	PRL	_	NN	NN	_	8	nsubjpass	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	IL-2	_	NN	NN	_	1	conj	_	_
4	receptor	_	NN	NN	_	5	nn	_	_
5	activation	_	NN	NN	_	1	dep	_	_
6	are	_	VBP	VBP	_	8	auxpass	_	_
7	both	_	DT	DT	_	8	dep	_	_
8	linked	_	VBN	VBN	_	0	root	_	_
9	to	_	TO	TO	_	8	prep	_	_
10	the	_	DT	DT	_	20	det	_	_
11	Jak/Stat	_	NN	NN	_	20	nn	_	_
12	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
13	signal	_	NN	NN	_	14	nn	_	_
14	transducer	_	NN	NN	_	11	dep	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	activator	_	NN	NN	_	18	nn	_	_
17	of	_	IN	IN	_	18	amod	_	_
18	transcription	_	NN	NN	_	14	conj	_	_
19	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
20	pathway	_	NN	NN	_	9	pobj	_	_
21	.	_	.	.	_	8	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	investigated	_	VBD	VBD	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	ability	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	PRL	_	NN	NN	_	5	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	IL-2	_	NN	NN	_	6	conj	_	_
9	to	_	TO	TO	_	10	aux	_	_
10	activate	_	VB	VB	_	4	vmod	_	_
11	Stat	_	NN	NN	_	12	nn	_	_
12	proteins	_	NNS	NNS	_	10	dobj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	different	_	JJ	JJ	_	17	amod	_	_
15	T	_	NN	NN	_	17	nn	_	_
16	cell	_	NN	NN	_	17	nn	_	_
17	lines	_	NNS	NNS	_	13	pobj	_	_
18	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	DNA	_	NN	NN	_	4	nn	_	_
3	binding	_	NN	NN	_	4	nn	_	_
4	specificities	_	NNS	NNS	_	30	nsubjpass	_	_
5	,	_	,	,	_	4	punct	_	_
6	the	_	DT	DT	_	7	det	_	_
7	reactivities	_	NNS	NNS	_	4	conj	_	_
8	toward	_	IN	IN	_	7	prep	_	_
9	Stat-specific	_	JJ	JJ	_	10	amod	_	_
10	antisera	_	NNS	NNS	_	8	pobj	_	_
11	,	_	,	,	_	4	punct	_	_
12	and	_	CC	CC	_	4	cc	_	_
13	the	_	DT	DT	_	15	det	_	_
14	mol	_	NN	NN	_	15	nn	_	_
15	wt	_	NN	NN	_	4	conj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	IL-2-	_	NN	NN	_	16	pobj	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	PRL-induced	_	JJ	JJ	_	21	amod	_	_
20	DNA-binding	_	JJ	JJ	_	21	amod	_	_
21	proteins	_	NNS	NNS	_	17	conj	_	_
22	in	_	IN	IN	_	17	prep	_	_
23	Nb2	_	NN	NN	_	22	pobj	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	C196	_	NN	NN	_	23	conj	_	_
26	T	_	NN	NN	_	28	nn	_	_
27	cell	_	NN	NN	_	28	nn	_	_
28	lines	_	NNS	NNS	_	23	dep	_	_
29	were	_	VBD	VBD	_	30	auxpass	_	_
30	investigated	_	VBN	VBN	_	0	root	_	_
31	.	_	.	.	_	30	punct	_	_

1	A	_	DT	DT	_	2	det	_	_
2	comparison	_	NN	NN	_	21	nsubjpass	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	Stat	_	NN	NN	_	6	nn	_	_
6	proteins	_	NNS	NNS	_	3	pobj	_	_
7	induced	_	VBN	VBN	_	6	vmod	_	_
8	by	_	IN	IN	_	7	prep	_	_
9	interferon-gamma	_	NN	NN	_	8	pobj	_	_
10	,	_	,	,	_	9	punct	_	_
11	PRL	_	NN	NN	_	9	conj	_	_
12	,	_	,	,	_	9	punct	_	_
13	and	_	CC	CC	_	9	cc	_	_
14	IL-6	_	NN	NN	_	9	conj	_	_
15	in	_	IN	IN	_	9	prep	_	_
16	T47D	_	NN	NN	_	19	nn	_	_
17	mammary	_	JJ	JJ	_	19	amod	_	_
18	tumor	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	15	pobj	_	_
20	was	_	VBD	VBD	_	21	auxpass	_	_
21	made	_	VBN	VBN	_	0	root	_	_
22	.	_	.	.	_	21	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	found	_	VBD	VBD	_	0	root	_	_
3	that	_	IN	IN	_	7	mark	_	_
4	these	_	DT	DT	_	5	det	_	_
5	parameters	_	NNS	NNS	_	7	nsubj	_	_
6	were	_	VBD	VBD	_	7	cop	_	_
7	indistinguishable	_	JJ	JJ	_	2	ccomp	_	_
8	for	_	IN	IN	_	7	prep	_	_
9	one	_	CD	CD	_	8	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	12	dep	_	_
12	PRL-	_	NN	NN	_	10	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	IL-2-induced	_	JJ	JJ	_	12	conj	_	_
15	factors	_	NNS	NNS	_	12	dep	_	_
16	.	_	.	.	_	2	punct	_	_

1	A	_	DT	DT	_	3	det	_	_
2	transcription	_	NN	NN	_	3	nn	_	_
3	factor	_	NN	NN	_	12	nsubjpass	_	_
4	closely	_	RB	RB	_	5	advmod	_	_
5	related	_	JJ	JJ	_	3	amod	_	_
6	to	_	TO	TO	_	5	prep	_	_
7	mammary	_	JJ	JJ	_	9	amod	_	_
8	gland	_	NN	NN	_	9	nn	_	_
9	factor-Stat5	_	NN	NN	_	6	pobj	_	_
10	is	_	VBZ	VBZ	_	12	auxpass	_	_
11	rapidly	_	RB	RB	_	12	advmod	_	_
12	activated	_	VBN	VBN	_	0	root	_	_
13	upon	_	IN	IN	_	12	prep	_	_
14	interaction	_	NN	NN	_	13	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	IL-2	_	NN	NN	_	15	pobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	PRL	_	NN	NN	_	16	conj	_	_
19	with	_	IN	IN	_	14	prep	_	_
20	their	_	PRP$	PRP$	_	22	poss	_	_
21	respective	_	JJ	JJ	_	22	amod	_	_
22	receptors	_	NNS	NNS	_	19	pobj	_	_
23	.	_	.	.	_	12	punct	_	_

1	Activation	_	NN	NN	_	11	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	a	_	DT	DT	_	5	det	_	_
4	second	_	JJ	JJ	_	5	amod	_	_
5	protein	_	NN	NN	_	2	pobj	_	_
6	related	_	JJ	JJ	_	5	amod	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	Stat1	_	NN	NN	_	7	pobj	_	_
9	was	_	VBD	VBD	_	11	auxpass	_	_
10	also	_	RB	RB	_	11	advmod	_	_
11	observed	_	VBN	VBN	_	0	root	_	_
12	.	_	.	.	_	11	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	emphasize	_	VBP	VBP	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	role	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	PRL	_	NN	NN	_	6	pobj	_	_
8	as	_	IN	IN	_	5	prep	_	_
9	a	_	DT	DT	_	10	det	_	_
10	regulator	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	immune	_	JJ	JJ	_	14	amod	_	_
14	response	_	NN	NN	_	11	pobj	_	_
15	and	_	CC	CC	_	3	cc	_	_
16	indicate	_	VBP	VBP	_	3	conj	_	_
17	that	_	IN	IN	_	26	mark	_	_
18	the	_	DT	DT	_	20	det	_	_
19	Stat	_	NN	NN	_	20	nn	_	_
20	factors	_	NNS	NNS	_	26	nsubj	_	_
21	mammary	_	JJ	JJ	_	23	amod	_	_
22	gland	_	NN	NN	_	23	nn	_	_
23	factor-Stat5	_	NN	NN	_	20	dep	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	Stat1	_	NN	NN	_	23	conj	_	_
26	play	_	VBP	VBP	_	16	ccomp	_	_
27	a	_	DT	DT	_	28	det	_	_
28	role	_	NN	NN	_	26	dobj	_	_
29	in	_	IN	IN	_	26	prep	_	_
30	the	_	DT	DT	_	31	det	_	_
31	regulation	_	NN	NN	_	29	pobj	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	gene	_	NN	NN	_	34	nn	_	_
34	expression	_	NN	NN	_	32	pobj	_	_
35	during	_	IN	IN	_	31	prep	_	_
36	T	_	NN	NN	_	38	nn	_	_
37	cell	_	NN	NN	_	38	nn	_	_
38	development	_	NN	NN	_	35	pobj	_	_
39	.	_	.	.	_	3	punct	_	_

1	CD30	_	NN	NN	_	2	nn	_	_
2	ligation	_	NN	NN	_	3	nsubj	_	_
3	induces	_	VBZ	VBZ	_	0	root	_	_
4	nuclear	_	JJ	JJ	_	6	amod	_	_
5	factor-kappa	_	NN	NN	_	6	nn	_	_
6	B	_	NN	NN	_	7	nn	_	_
7	activation	_	NN	NN	_	3	dobj	_	_
8	in	_	IN	IN	_	3	prep	_	_
9	human	_	JJ	JJ	_	12	amod	_	_
10	T	_	NN	NN	_	12	nn	_	_
11	cell	_	NN	NN	_	12	nn	_	_
12	lines	_	NNS	NNS	_	8	pobj	_	_
13	.	_	.	.	_	3	punct	_	_

1	CD30	_	NN	NN	_	6	nsubj	_	_
2	is	_	VBZ	VBZ	_	6	cop	_	_
3	a	_	DT	DT	_	6	det	_	_
4	recently	_	RB	RB	_	5	advmod	_	_
5	described	_	VBN	VBN	_	6	amod	_	_
6	member	_	NN	NN	_	0	root	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	15	det	_	_
9	tumor	_	NN	NN	_	15	nn	_	_
10	necrosis	_	NN	NN	_	15	nn	_	_
11	factor/nerve	_	NN	NN	_	15	nn	_	_
12	growth	_	NN	NN	_	15	nn	_	_
13	factor	_	NN	NN	_	15	nn	_	_
14	receptor	_	NN	NN	_	15	nn	_	_
15	superfamily	_	NN	NN	_	7	pobj	_	_
16	.	_	.	.	_	6	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	report	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	show	_	VBP	VBP	_	0	root	_	_
7	that	_	IN	IN	_	49	mark	_	_
8	following	_	VBG	VBG	_	49	prep	_	_
9	incubation	_	NN	NN	_	8	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	L540	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	10	pobj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
14	Hodgkin	_	NN	NN	_	22	poss	_	_
15	's	_	POS	POS	_	22	possessive	_	_
16	disease-derived	_	JJ	JJ	_	22	amod	_	_
17	,	_	,	,	_	22	punct	_	_
18	T	_	NN	NN	_	22	nn	_	_
19	cell-like	_	JJ	JJ	_	22	amod	_	_
20	,	_	,	,	_	22	punct	_	_
21	CD30+	_	JJ	JJ	_	22	amod	_	_
22	cells	_	NNS	NNS	_	12	appos	_	_
23	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
24	with	_	IN	IN	_	9	prep	_	_
25	the	_	DT	DT	_	29	det	_	_
26	agonistic	_	JJ	JJ	_	29	amod	_	_
27	anti-CD30	_	JJ	JJ	_	29	amod	_	_
28	monoclonal	_	JJ	JJ	_	29	amod	_	_
29	antibodies	_	NNS	NNS	_	24	pobj	_	_
30	-LRB-	_	-LRB-	-LRB-	_	31	punct	_	_
31	mAb	_	NN	NN	_	29	appos	_	_
32	-RRB-	_	-RRB-	-RRB-	_	31	punct	_	_
33	M44	_	NN	NN	_	29	dep	_	_
34	and	_	CC	CC	_	33	cc	_	_
35	M67	_	NN	NN	_	33	conj	_	_
36	,	_	,	,	_	49	punct	_	_
37	two	_	CD	CD	_	47	num	_	_
38	nuclear	_	JJ	JJ	_	44	amod	_	_
39	factor	_	NN	NN	_	44	nn	_	_
40	-LRB-	_	-LRB-	-LRB-	_	44	punct	_	_
41	NF	_	NN	NN	_	44	nn	_	_
42	-RRB-	_	-RRB-	-RRB-	_	44	punct	_	_
43	-kappa	_	NN	NN	_	44	nn	_	_
44	B	_	NN	NN	_	47	nn	_	_
45	DNA	_	NN	NN	_	47	nn	_	_
46	binding	_	NN	NN	_	47	nn	_	_
47	activities	_	NNS	NNS	_	49	nsubjpass	_	_
48	were	_	VBD	VBD	_	49	auxpass	_	_
49	induced	_	VBN	VBN	_	6	ccomp	_	_
50	in	_	IN	IN	_	49	prep	_	_
51	nuclear	_	JJ	JJ	_	52	amod	_	_
52	extracts	_	NNS	NNS	_	50	pobj	_	_
53	,	_	,	,	_	49	punct	_	_
54	as	_	IN	IN	_	55	mark	_	_
55	determined	_	VBN	VBN	_	49	advcl	_	_
56	in	_	IN	IN	_	55	prep	_	_
57	gel	_	NN	NN	_	59	nn	_	_
58	retardation	_	NN	NN	_	59	nn	_	_
59	assays	_	NNS	NNS	_	56	pobj	_	_
60	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	effect	_	NN	NN	_	11	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	5	det	_	_
5	mAb	_	NN	NN	_	3	pobj	_	_
6	towards	_	IN	IN	_	2	prep	_	_
7	NF-kappa	_	NN	NN	_	8	nn	_	_
8	B	_	NN	NN	_	9	nn	_	_
9	activation	_	NN	NN	_	6	pobj	_	_
10	was	_	VBD	VBD	_	11	cop	_	_
11	rapid	_	JJ	JJ	_	0	root	_	_
12	,	_	,	,	_	11	punct	_	_
13	as	_	IN	IN	_	15	mark	_	_
14	it	_	PRP	PRP	_	15	nsubj	_	_
15	occurred	_	VBD	VBD	_	11	advcl	_	_
16	within	_	IN	IN	_	15	prep	_	_
17	20	_	CD	CD	_	18	num	_	_
18	min	_	NN	NN	_	16	pobj	_	_
19	,	_	,	,	_	15	punct	_	_
20	and	_	CC	CC	_	15	cc	_	_
21	was	_	VBD	VBD	_	22	cop	_	_
22	sustained	_	JJ	JJ	_	15	conj	_	_
23	for	_	IN	IN	_	22	prep	_	_
24	up	_	RB	RB	_	26	quantmod	_	_
25	to	_	TO	TO	_	26	dep	_	_
26	6	_	CD	CD	_	27	num	_	_
27	h	_	NN	NN	_	23	pobj	_	_
28	.	_	.	.	_	11	punct	_	_

1	By	_	IN	IN	_	7	prep	_	_
2	comparison	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	7	punct	_	_
4	an	_	DT	DT	_	6	det	_	_
5	isotype-matched	_	JJ	JJ	_	6	amod	_	_
6	antibody	_	NN	NN	_	7	nsubj	_	_
7	had	_	VBD	VBD	_	0	root	_	_
8	no	_	DT	DT	_	9	neg	_	_
9	effect	_	NN	NN	_	7	dobj	_	_
10	on	_	IN	IN	_	7	prep	_	_
11	NF-kappa	_	NN	NN	_	12	nn	_	_
12	B	_	NN	NN	_	13	nn	_	_
13	activation	_	NN	NN	_	10	pobj	_	_
14	.	_	.	.	_	7	punct	_	_

1	Moreover	_	RB	RB	_	47	advmod	_	_
2	,	_	,	,	_	47	punct	_	_
3	in	_	IN	IN	_	47	prep	_	_
4	human	_	JJ	JJ	_	10	amod	_	_
5	T	_	NN	NN	_	10	nn	_	_
6	helper	_	NN	NN	_	10	nn	_	_
7	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
8	Th	_	NN	NN	_	10	nn	_	_
9	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
10	clones	_	NNS	NNS	_	3	pobj	_	_
11	functionally	_	RB	RB	_	12	advmod	_	_
12	characterized	_	VBN	VBN	_	10	vmod	_	_
13	as	_	IN	IN	_	12	prep	_	_
14	being	_	VBG	VBG	_	13	pcomp	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	17	dep	_	_
17	type	_	NN	NN	_	15	pobj	_	_
18	0	_	CD	CD	_	17	num	_	_
19	,	_	,	,	_	17	punct	_	_
20	type	_	NN	NN	_	17	conj	_	_
21	1	_	CD	CD	_	20	num	_	_
22	and	_	CC	CC	_	17	cc	_	_
23	type	_	NN	NN	_	17	conj	_	_
24	2	_	CD	CD	_	23	num	_	_
25	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
26	28	_	CD	CD	_	27	num	_	_
27	%	_	NN	NN	_	17	dep	_	_
28	,	_	,	,	_	27	punct	_	_
29	&lt;	_	JJR	JJR	_	30	quantmod	_	_
30	1	_	CD	CD	_	31	dep	_	_
31	%	_	NN	NN	_	27	conj	_	_
32	und	_	CC	CC	_	27	cc	_	_
33	93	_	CD	CD	_	34	num	_	_
34	%	_	NN	NN	_	27	conj	_	_
35	CD30+	_	JJ	JJ	_	27	dep	_	_
36	,	_	,	,	_	27	punct	_	_
37	respectively	_	RB	RB	_	27	advmod	_	_
38	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
39	,	_	,	,	_	47	punct	_	_
40	the	_	DT	DT	_	41	det	_	_
41	extent	_	NN	NN	_	47	nsubj	_	_
42	of	_	IN	IN	_	41	prep	_	_
43	CD30-mediated	_	JJ	JJ	_	46	amod	_	_
44	NF-kappa	_	NN	NN	_	45	nn	_	_
45	B	_	NN	NN	_	46	nn	_	_
46	activation	_	NN	NN	_	42	pobj	_	_
47	correlated	_	VBD	VBD	_	0	root	_	_
48	with	_	IN	IN	_	47	prep	_	_
49	the	_	DT	DT	_	50	det	_	_
50	proportion	_	NN	NN	_	48	pobj	_	_
51	of	_	IN	IN	_	50	prep	_	_
52	CD30+	_	JJ	JJ	_	53	amod	_	_
53	cells	_	NNS	NNS	_	51	pobj	_	_
54	.	_	.	.	_	47	punct	_	_

1	In	_	IN	IN	_	16	prep	_	_
2	all	_	DT	DT	_	4	det	_	_
3	cell	_	NN	NN	_	4	nn	_	_
4	lines	_	NNS	NNS	_	1	pobj	_	_
5	investigated	_	VBN	VBN	_	4	vmod	_	_
6	,	_	,	,	_	16	punct	_	_
7	the	_	DT	DT	_	10	det	_	_
8	NF-kappa	_	NN	NN	_	10	nn	_	_
9	B	_	NN	NN	_	10	nn	_	_
10	complexes	_	NNS	NNS	_	16	nsubjpass	_	_
11	induced	_	VBN	VBN	_	10	vmod	_	_
12	following	_	VBG	VBG	_	11	prep	_	_
13	CD30	_	NN	NN	_	14	nn	_	_
14	engagement	_	NN	NN	_	12	pobj	_	_
15	were	_	VBD	VBD	_	16	auxpass	_	_
16	shown	_	VBN	VBN	_	0	root	_	_
17	to	_	TO	TO	_	18	aux	_	_
18	contain	_	VB	VB	_	16	xcomp	_	_
19	p50	_	NN	NN	_	21	nn	_	_
20	NF-kappa	_	NN	NN	_	21	nn	_	_
21	B1	_	NN	NN	_	18	dobj	_	_
22	,	_	,	,	_	21	punct	_	_
23	p65	_	NN	NN	_	24	nn	_	_
24	RelA	_	NN	NN	_	21	conj	_	_
25	,	_	,	,	_	21	punct	_	_
26	and	_	CC	CC	_	21	cc	_	_
27	possibly	_	RB	RB	_	30	advmod	_	_
28	other	_	JJ	JJ	_	30	amod	_	_
29	transcription	_	NN	NN	_	30	nn	_	_
30	factors	_	NNS	NNS	_	21	conj	_	_
31	.	_	.	.	_	16	punct	_	_

1	Collectively	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	our	_	PRP$	PRP$	_	4	poss	_	_
4	results	_	NNS	NNS	_	5	nsubj	_	_
5	demonstrate	_	VBP	VBP	_	0	root	_	_
6	that	_	IN	IN	_	14	mark	_	_
7	nuclear	_	JJ	JJ	_	8	amod	_	_
8	translocation	_	NN	NN	_	14	nsubj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	activation	_	NN	NN	_	8	conj	_	_
11	of	_	IN	IN	_	8	prep	_	_
12	NF-kappa	_	NN	NN	_	13	nn	_	_
13	B	_	NN	NN	_	11	pobj	_	_
14	rank	_	NN	NN	_	5	ccomp	_	_
15	among	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	19	det	_	_
17	short-term	_	JJ	JJ	_	19	amod	_	_
18	cellular	_	JJ	JJ	_	19	amod	_	_
19	responses	_	NNS	NNS	_	15	pobj	_	_
20	elicited	_	VBD	VBD	_	19	vmod	_	_
21	following	_	VBG	VBG	_	20	prep	_	_
22	CD30	_	NN	NN	_	23	nn	_	_
23	ligation	_	NN	NN	_	21	pobj	_	_
24	.	_	.	.	_	5	punct	_	_

1	Constitutive	_	JJ	JJ	_	4	amod	_	_
2	NF-kappa	_	NN	NN	_	3	nn	_	_
3	B	_	NN	NN	_	4	nn	_	_
4	activation	_	NN	NN	_	0	root	_	_
5	,	_	,	,	_	4	punct	_	_
6	enhanced	_	VBN	VBN	_	7	amod	_	_
7	granulopoiesis	_	NN	NN	_	4	conj	_	_
8	,	_	,	,	_	4	punct	_	_
9	and	_	CC	CC	_	4	cc	_	_
10	neonatal	_	JJ	JJ	_	11	amod	_	_
11	lethality	_	NN	NN	_	4	conj	_	_
12	in	_	IN	IN	_	4	prep	_	_
13	I	_	NN	NN	_	17	nn	_	_
14	kappa	_	NN	NN	_	17	nn	_	_
15	B	_	NN	NN	_	17	nn	_	_
16	alpha-deficient	_	JJ	JJ	_	17	amod	_	_
17	mice	_	NNS	NNS	_	12	pobj	_	_
18	.	_	.	.	_	4	punct	_	_

1	Transcription	_	NN	NN	_	2	nn	_	_
2	factors	_	NNS	NNS	_	10	nsubjpass	_	_
3	belonging	_	VBG	VBG	_	2	vmod	_	_
4	to	_	TO	TO	_	3	prep	_	_
5	the	_	DT	DT	_	8	det	_	_
6	NF-kappa	_	NN	NN	_	8	nn	_	_
7	B	_	NN	NN	_	8	nn	_	_
8	family	_	NN	NN	_	4	pobj	_	_
9	are	_	VBP	VBP	_	10	auxpass	_	_
10	controlled	_	VBN	VBN	_	0	root	_	_
11	by	_	IN	IN	_	10	prep	_	_
12	inhibitory	_	JJ	JJ	_	16	amod	_	_
13	I	_	NN	NN	_	16	nn	_	_
14	kappa	_	NN	NN	_	16	nn	_	_
15	B	_	NN	NN	_	16	nn	_	_
16	proteins	_	NNS	NNS	_	11	pobj	_	_
17	,	_	,	,	_	16	punct	_	_
18	mainly	_	RB	RB	_	22	advmod	_	_
19	I	_	NN	NN	_	22	nn	_	_
20	kappa	_	NN	NN	_	22	nn	_	_
21	B	_	NN	NN	_	22	nn	_	_
22	alpha	_	NN	NN	_	16	appos	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	I	_	NN	NN	_	27	nn	_	_
25	kappa	_	NN	NN	_	27	nn	_	_
26	B	_	NN	NN	_	27	nn	_	_
27	beta	_	NN	NN	_	22	conj	_	_
28	.	_	.	.	_	10	punct	_	_

1	Apparently	_	RB	RB	_	2	advmod	_	_
2	normal	_	JJ	JJ	_	11	advmod	_	_
3	at	_	IN	IN	_	2	prep	_	_
4	birth	_	NN	NN	_	3	pobj	_	_
5	,	_	,	,	_	11	punct	_	_
6	I	_	NN	NN	_	10	nn	_	_
7	kappa	_	NN	NN	_	10	nn	_	_
8	B	_	NN	NN	_	10	nn	_	_
9	alpha-/-	_	JJ	JJ	_	10	amod	_	_
10	mice	_	NNS	NNS	_	11	nsubj	_	_
11	exhibit	_	VBP	VBP	_	0	root	_	_
12	severe	_	JJ	JJ	_	13	amod	_	_
13	runting	_	NN	NN	_	11	dobj	_	_
14	,	_	,	,	_	13	punct	_	_
15	skin	_	NN	NN	_	16	nn	_	_
16	defects	_	NNS	NNS	_	13	conj	_	_
17	,	_	,	,	_	13	punct	_	_
18	and	_	CC	CC	_	13	cc	_	_
19	extensive	_	JJ	JJ	_	20	amod	_	_
20	granulopoiesis	_	NN	NN	_	13	conj	_	_
21	postnatally	_	RB	RB	_	11	advmod	_	_
22	,	_	,	,	_	11	punct	_	_
23	typically	_	RB	RB	_	24	advmod	_	_
24	dying	_	VBG	VBG	_	11	vmod	_	_
25	by	_	IN	IN	_	24	prep	_	_
26	8	_	CD	CD	_	27	num	_	_
27	days	_	NNS	NNS	_	25	pobj	_	_
28	.	_	.	.	_	11	punct	_	_

1	Hematopoietic	_	JJ	JJ	_	2	amod	_	_
2	tissues	_	NNS	NNS	_	6	nsubj	_	_
3	from	_	IN	IN	_	2	prep	_	_
4	these	_	DT	DT	_	5	det	_	_
5	mice	_	NNS	NNS	_	3	pobj	_	_
6	display	_	VBP	VBP	_	0	root	_	_
7	elevated	_	JJ	JJ	_	8	amod	_	_
8	levels	_	NNS	NNS	_	6	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	both	_	CC	CC	_	13	preconj	_	_
11	nuclear	_	JJ	JJ	_	13	amod	_	_
12	NF-kappa	_	NN	NN	_	13	nn	_	_
13	B	_	NN	NN	_	9	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	mRNAs	_	NNS	NNS	_	13	conj	_	_
16	of	_	IN	IN	_	13	prep	_	_
17	some	_	DT	DT	_	16	pobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	but	_	CC	CC	_	17	cc	_	_
20	not	_	RB	RB	_	21	neg	_	_
21	all	_	DT	DT	_	17	conj	_	_
22	,	_	,	,	_	17	punct	_	_
23	genes	_	NNS	NNS	_	17	conj	_	_
24	thought	_	VBN	VBN	_	23	vmod	_	_
25	to	_	TO	TO	_	27	aux	_	_
26	be	_	VB	VB	_	27	auxpass	_	_
27	regulated	_	VBN	VBN	_	24	xcomp	_	_
28	by	_	IN	IN	_	27	prep	_	_
29	NF-kappa	_	NN	NN	_	30	nn	_	_
30	B	_	NN	NN	_	28	pobj	_	_
31	.	_	.	.	_	6	punct	_	_

1	NF-kappa	_	NN	NN	_	2	nn	_	_
2	B	_	NN	NN	_	3	nn	_	_
3	elevation	_	NN	NN	_	4	nsubj	_	_
4	results	_	VBZ	VBZ	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	these	_	DT	DT	_	8	det	_	_
7	phenotypic	_	JJ	JJ	_	8	amod	_	_
8	abnormalities	_	NNS	NNS	_	5	pobj	_	_
9	because	_	IN	IN	_	24	mark	_	_
10	mice	_	NNS	NNS	_	24	nsubj	_	_
11	lacking	_	VBG	VBG	_	10	vmod	_	_
12	both	_	CC	CC	_	16	preconj	_	_
13	I	_	NN	NN	_	16	nn	_	_
14	kappa	_	NN	NN	_	16	nn	_	_
15	B	_	NN	NN	_	16	nn	_	_
16	alpha	_	NN	NN	_	11	dobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	the	_	DT	DT	_	20	det	_	_
19	p50	_	NN	NN	_	20	nn	_	_
20	subunit	_	NN	NN	_	16	conj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	NF-kappa	_	NN	NN	_	23	nn	_	_
23	B	_	NN	NN	_	21	pobj	_	_
24	show	_	VBP	VBP	_	4	advcl	_	_
25	a	_	DT	DT	_	28	det	_	_
26	dramatically	_	RB	RB	_	27	advmod	_	_
27	delayed	_	VBN	VBN	_	28	amod	_	_
28	onset	_	NN	NN	_	24	dobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	abnormalities	_	NNS	NNS	_	29	pobj	_	_
31	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	13	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	to	_	TO	TO	_	2	prep	_	_
4	hematopoietic	_	JJ	JJ	_	5	amod	_	_
5	cells	_	NNS	NNS	_	3	pobj	_	_
6	,	_	,	,	_	13	punct	_	_
7	I	_	NN	NN	_	12	nn	_	_
8	kappa	_	NN	NN	_	12	nn	_	_
9	B	_	NN	NN	_	12	nn	_	_
10	alpha-/-	_	JJ	JJ	_	12	amod	_	_
11	embryonic	_	JJ	JJ	_	12	amod	_	_
12	fibroblasts	_	NNS	NNS	_	13	nsubj	_	_
13	show	_	VBP	VBP	_	0	root	_	_
14	minimal	_	JJ	JJ	_	17	amod	_	_
15	constitutive	_	JJ	JJ	_	17	amod	_	_
16	NF-kappa	_	NN	NN	_	17	nn	_	_
17	B	_	NN	NN	_	13	dobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	as	_	RB	RB	_	20	advmod	_	_
20	well	_	RB	RB	_	17	cc	_	_
21	as	_	IN	IN	_	20	mwe	_	_
22	normal	_	JJ	JJ	_	26	amod	_	_
23	signal-dependent	_	JJ	JJ	_	22	dep	_	_
24	NF-kappa	_	NN	NN	_	25	nn	_	_
25	B	_	NN	NN	_	26	nn	_	_
26	activation	_	NN	NN	_	17	conj	_	_
27	that	_	WDT	WDT	_	29	nsubj	_	_
28	is	_	VBZ	VBZ	_	29	cop	_	_
29	concomitant	_	JJ	JJ	_	26	rcmod	_	_
30	with	_	IN	IN	_	29	prep	_	_
31	I	_	NN	NN	_	34	nn	_	_
32	kappa	_	NN	NN	_	34	nn	_	_
33	B	_	NN	NN	_	34	nn	_	_
34	beta	_	NN	NN	_	35	nn	_	_
35	degradation	_	NN	NN	_	30	pobj	_	_
36	.	_	.	.	_	13	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	18	mark	_	_
5	I	_	NN	NN	_	8	nn	_	_
6	kappa	_	NN	NN	_	8	nn	_	_
7	b	_	NN	NN	_	8	nn	_	_
8	beta	_	NN	NN	_	18	nsubjpass	_	_
9	,	_	,	,	_	8	punct	_	_
10	but	_	CC	CC	_	11	cc	_	_
11	not	_	RB	RB	_	8	cc	_	_
12	I	_	NN	NN	_	15	nn	_	_
13	kappa	_	NN	NN	_	15	nn	_	_
14	B	_	NN	NN	_	15	nn	_	_
15	alpha	_	NN	NN	_	8	conj	_	_
16	,	_	,	,	_	8	punct	_	_
17	is	_	VBZ	VBZ	_	18	auxpass	_	_
18	required	_	VBN	VBN	_	3	ccomp	_	_
19	for	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	22	det	_	_
21	signal-dependent	_	JJ	JJ	_	22	amod	_	_
22	activation	_	NN	NN	_	19	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	NF-kappa	_	NN	NN	_	25	nn	_	_
25	B	_	NN	NN	_	23	pobj	_	_
26	in	_	IN	IN	_	22	prep	_	_
27	fibroblasts	_	NNS	NNS	_	26	pobj	_	_
28	.	_	.	.	_	3	punct	_	_

1	However	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	I	_	NN	NN	_	6	nn	_	_
4	kappa	_	NN	NN	_	6	nn	_	_
5	B	_	NN	NN	_	6	nn	_	_
6	alpha	_	NN	NN	_	8	nsubjpass	_	_
7	is	_	VBZ	VBZ	_	8	auxpass	_	_
8	required	_	VBN	VBN	_	0	root	_	_
9	for	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	postinduction	_	JJ	JJ	_	12	amod	_	_
12	repression	_	NN	NN	_	9	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	NF-kappa	_	NN	NN	_	15	nn	_	_
15	B	_	NN	NN	_	13	pobj	_	_
16	in	_	IN	IN	_	12	prep	_	_
17	fibroblasts	_	NNS	NNS	_	16	pobj	_	_
18	.	_	.	.	_	8	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	define	_	VBP	VBP	_	0	root	_	_
4	distinct	_	JJ	JJ	_	5	amod	_	_
5	roles	_	NNS	NNS	_	3	dobj	_	_
6	for	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	two	_	CD	CD	_	9	num	_	_
9	forms	_	NNS	NNS	_	6	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	I	_	NN	NN	_	13	nn	_	_
12	kappa	_	NN	NN	_	13	nn	_	_
13	B	_	NN	NN	_	10	pobj	_	_
14	and	_	CC	CC	_	3	cc	_	_
15	demonstrate	_	VBP	VBP	_	3	conj	_	_
16	the	_	DT	DT	_	17	det	_	_
17	necessity	_	NN	NN	_	15	dobj	_	_
18	for	_	IN	IN	_	17	prep	_	_
19	stringent	_	JJ	JJ	_	20	amod	_	_
20	control	_	NN	NN	_	18	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	NF-kappa	_	NN	NN	_	23	nn	_	_
23	B	_	NN	NN	_	21	pobj	_	_
24	.	_	.	.	_	3	punct	_	_

1	Attenuation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	gamma	_	NN	NN	_	6	nn	_	_
4	interferon-induced	_	JJ	JJ	_	6	amod	_	_
5	tyrosine	_	NN	NN	_	6	nn	_	_
6	phosphorylation	_	NN	NN	_	2	pobj	_	_
7	in	_	IN	IN	_	1	prep	_	_
8	mononuclear	_	JJ	JJ	_	9	amod	_	_
9	phagocytes	_	NNS	NNS	_	7	pobj	_	_
10	infected	_	VBN	VBN	_	9	vmod	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	Leishmania	_	FW	FW	_	13	nn	_	_
13	donovani	_	FW	FW	_	11	pobj	_	_
14	:	_	:	:	_	1	punct	_	_
15	selective	_	JJ	JJ	_	16	amod	_	_
16	inhibition	_	NN	NN	_	1	dep	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	signaling	_	NN	NN	_	17	pobj	_	_
19	through	_	IN	IN	_	18	prep	_	_
20	Janus	_	NN	NN	_	21	nn	_	_
21	kinases	_	NNS	NNS	_	19	pobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	Stat1	_	NN	NN	_	21	conj	_	_
24	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	induction	_	NN	NN	_	12	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	gene	_	NN	NN	_	5	nn	_	_
5	transcription	_	NN	NN	_	3	pobj	_	_
6	in	_	IN	IN	_	2	prep	_	_
7	response	_	NN	NN	_	6	pobj	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	gamma	_	NN	NN	_	10	nn	_	_
10	interferon	_	NN	NN	_	8	pobj	_	_
11	is	_	VBZ	VBZ	_	12	cop	_	_
12	impaired	_	JJ	JJ	_	0	root	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	mononuclear	_	JJ	JJ	_	15	amod	_	_
15	phagocytes	_	NNS	NNS	_	13	pobj	_	_
16	infected	_	VBN	VBN	_	15	vmod	_	_
17	with	_	IN	IN	_	16	prep	_	_
18	Leishmania	_	FW	FW	_	19	nn	_	_
19	donovani	_	FW	FW	_	17	pobj	_	_
20	,	_	,	,	_	12	punct	_	_
21	and	_	CC	CC	_	12	cc	_	_
22	the	_	DT	DT	_	23	det	_	_
23	mechanisms	_	NNS	NNS	_	28	nsubjpass	_	_
24	involved	_	VBN	VBN	_	23	vmod	_	_
25	are	_	VBP	VBP	_	28	auxpass	_	_
26	not	_	RB	RB	_	28	neg	_	_
27	fully	_	RB	RB	_	28	advmod	_	_
28	understood	_	VBN	VBN	_	12	conj	_	_
29	.	_	.	.	_	12	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	changes	_	NNS	NNS	_	12	nsubjpass	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	gene	_	NN	NN	_	5	nn	_	_
5	expression	_	NN	NN	_	3	pobj	_	_
6	brought	_	VBN	VBN	_	2	vmod	_	_
7	about	_	RP	RP	_	6	prt	_	_
8	by	_	IN	IN	_	6	prep	_	_
9	gamma	_	NN	NN	_	10	nn	_	_
10	interferon	_	NN	NN	_	8	pobj	_	_
11	are	_	VBP	VBP	_	12	auxpass	_	_
12	thought	_	VBN	VBN	_	0	root	_	_
13	to	_	TO	TO	_	14	aux	_	_
14	involve	_	VB	VB	_	12	xcomp	_	_
15	transient	_	JJ	JJ	_	16	amod	_	_
16	increases	_	NNS	NNS	_	14	dobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	19	det	_	_
19	activities	_	NNS	NNS	_	17	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	cellular	_	JJ	JJ	_	24	amod	_	_
22	protein	_	NN	NN	_	24	nn	_	_
23	tyrosine	_	NN	NN	_	24	nn	_	_
24	kinases	_	NNS	NNS	_	20	pobj	_	_
25	,	_	,	,	_	24	punct	_	_
26	including	_	VBG	VBG	_	24	prep	_	_
27	the	_	DT	DT	_	29	det	_	_
28	Janus	_	NN	NN	_	29	nn	_	_
29	kinases	_	NNS	NNS	_	26	pobj	_	_
30	Jak1	_	NN	NN	_	29	dep	_	_
31	and	_	CC	CC	_	30	cc	_	_
32	Jak2	_	NN	NN	_	30	conj	_	_
33	,	_	,	,	_	12	punct	_	_
34	leading	_	VBG	VBG	_	12	vmod	_	_
35	to	_	TO	TO	_	34	prep	_	_
36	tyrosine	_	NN	NN	_	37	nn	_	_
37	phosphorylation	_	NN	NN	_	35	pobj	_	_
38	of	_	IN	IN	_	37	prep	_	_
39	the	_	DT	DT	_	42	det	_	_
40	transcription	_	NN	NN	_	42	nn	_	_
41	factor	_	NN	NN	_	42	nn	_	_
42	Stat1	_	NN	NN	_	38	pobj	_	_
43	.	_	.	.	_	12	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	investigate	_	VB	VB	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	mechanisms	_	NNS	NNS	_	2	dobj	_	_
5	accounting	_	VBG	VBG	_	4	vmod	_	_
6	for	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	impaired	_	JJ	JJ	_	9	amod	_	_
9	responses	_	NNS	NNS	_	6	pobj	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	gamma	_	NN	NN	_	12	nn	_	_
12	interferon	_	NN	NN	_	10	pobj	_	_
13	,	_	,	,	_	2	punct	_	_
14	a	_	DT	DT	_	16	det	_	_
15	model	_	JJ	JJ	_	16	amod	_	_
16	system	_	NN	NN	_	36	nsubjpass	_	_
17	for	_	IN	IN	_	16	prep	_	_
18	examining	_	VBG	VBG	_	17	pcomp	_	_
19	overall	_	JJ	JJ	_	20	amod	_	_
20	changes	_	NNS	NNS	_	18	dobj	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	protein	_	NN	NN	_	24	nn	_	_
23	tyrosine	_	NN	NN	_	24	nn	_	_
24	phosphorylation	_	NN	NN	_	21	pobj	_	_
25	,	_	,	,	_	20	punct	_	_
26	activation	_	NN	NN	_	20	conj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	Jak1	_	NN	NN	_	27	pobj	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	Jak2	_	NN	NN	_	28	conj	_	_
31	and	_	CC	CC	_	20	cc	_	_
32	phosphorylation	_	NN	NN	_	20	conj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	Stat1	_	NN	NN	_	33	pobj	_	_
35	was	_	VBD	VBD	_	36	auxpass	_	_
36	developed	_	VBN	VBN	_	2	parataxis	_	_
37	in	_	IN	IN	_	36	prep	_	_
38	phorbol	_	NN	NN	_	42	nn	_	_
39	12-myristate	_	NN	NN	_	42	nn	_	_
40	13-acetate-differentiated	_	JJ	JJ	_	42	amod	_	_
41	U-937	_	NN	NN	_	42	nn	_	_
42	cells	_	NNS	NNS	_	37	pobj	_	_
43	.	_	.	.	_	2	punct	_	_

1	Analysis	_	NN	NN	_	8	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	whole-cell	_	JJ	JJ	_	4	amod	_	_
4	lysates	_	NNS	NNS	_	2	pobj	_	_
5	by	_	IN	IN	_	1	prep	_	_
6	antiphosphotyrosine	_	NN	NN	_	7	nn	_	_
7	immunoblotting	_	NN	NN	_	5	pobj	_	_
8	showed	_	VBD	VBD	_	0	root	_	_
9	that	_	IN	IN	_	14	mark	_	_
10	incubation	_	NN	NN	_	14	nsubj	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	gamma	_	NN	NN	_	13	nn	_	_
13	interferon	_	NN	NN	_	11	pobj	_	_
14	brought	_	VBD	VBD	_	8	ccomp	_	_
15	about	_	RP	RP	_	14	advmod	_	_
16	specific	_	JJ	JJ	_	17	amod	_	_
17	increases	_	NNS	NNS	_	14	dobj	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	phosphotyrosine	_	NN	NN	_	20	nn	_	_
20	labeling	_	NN	NN	_	18	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	several	_	JJ	JJ	_	23	amod	_	_
23	proteins	_	NNS	NNS	_	21	pobj	_	_
24	.	_	.	.	_	8	punct	_	_

1	Increased	_	VBN	VBN	_	2	amod	_	_
2	labeling	_	NN	NN	_	6	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	these	_	DT	DT	_	5	det	_	_
5	proteins	_	NNS	NNS	_	3	pobj	_	_
6	occurred	_	VBD	VBD	_	0	root	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	similar	_	JJ	JJ	_	9	amod	_	_
9	extents	_	NNS	NNS	_	7	pobj	_	_
10	in	_	IN	IN	_	6	prep	_	_
11	control	_	JJ	JJ	_	12	amod	_	_
12	cells	_	NNS	NNS	_	10	pobj	_	_
13	and	_	CC	CC	_	10	cc	_	_
14	in	_	IN	IN	_	10	conj	_	_
15	cells	_	NNS	NNS	_	14	pobj	_	_
16	that	_	WDT	WDT	_	19	nsubjpass	_	_
17	had	_	VBD	VBD	_	19	aux	_	_
18	been	_	VBN	VBN	_	19	auxpass	_	_
19	infected	_	VBN	VBN	_	15	rcmod	_	_
20	with	_	IN	IN	_	19	prep	_	_
21	L.	_	FW	FW	_	22	nn	_	_
22	donovani	_	FW	FW	_	20	pobj	_	_
23	for	_	IN	IN	_	19	prep	_	_
24	16	_	CD	CD	_	25	num	_	_
25	h	_	NN	NN	_	23	pobj	_	_
26	.	_	.	.	_	6	punct	_	_

1	Jak1	_	NN	NN	_	8	nsubjpass	_	_
2	,	_	,	,	_	1	punct	_	_
3	Jak2	_	NN	NN	_	1	conj	_	_
4	,	_	,	,	_	1	punct	_	_
5	and	_	CC	CC	_	1	cc	_	_
6	Stat1	_	NN	NN	_	1	conj	_	_
7	were	_	VBD	VBD	_	8	auxpass	_	_
8	immunoprecipitated	_	VBN	VBN	_	0	root	_	_
9	from	_	IN	IN	_	8	prep	_	_
10	control	_	JJ	JJ	_	9	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	interferon-treated	_	JJ	JJ	_	13	amod	_	_
13	cells	_	NNS	NNS	_	10	conj	_	_
14	,	_	,	,	_	8	punct	_	_
15	and	_	CC	CC	_	8	cc	_	_
16	tyrosine	_	NN	NN	_	17	nn	_	_
17	phosphorylation	_	NN	NN	_	27	nsubjpass	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	these	_	DT	DT	_	20	det	_	_
20	proteins	_	NNS	NNS	_	18	pobj	_	_
21	,	_	,	,	_	17	punct	_	_
22	detected	_	VBN	VBN	_	17	vmod	_	_
23	by	_	IN	IN	_	22	prep	_	_
24	antiphosphotyrosine	_	NN	NN	_	25	nn	_	_
25	immunoblotting	_	NN	NN	_	23	pobj	_	_
26	was	_	VBD	VBD	_	27	auxpass	_	_
27	used	_	VBN	VBN	_	8	conj	_	_
28	to	_	TO	TO	_	29	aux	_	_
29	measured	_	VBN	VBN	_	27	xcomp	_	_
30	their	_	PRP$	PRP$	_	31	poss	_	_
31	activation	_	NN	NN	_	29	dobj	_	_
32	.	_	.	.	_	8	punct	_	_

1	Tyrosine	_	NN	NN	_	2	nn	_	_
2	phosphorylation	_	NN	NN	_	10	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	Jak1	_	NN	NN	_	3	pobj	_	_
5	,	_	,	,	_	4	punct	_	_
6	Jak2	_	NN	NN	_	4	conj	_	_
7	,	_	,	,	_	4	punct	_	_
8	and	_	CC	CC	_	4	cc	_	_
9	Stat1	_	NN	NN	_	4	conj	_	_
10	increased	_	VBD	VBD	_	0	root	_	_
11	markedly	_	RB	RB	_	10	advmod	_	_
12	,	_	,	,	_	10	punct	_	_
13	in	_	IN	IN	_	10	prep	_	_
14	a	_	DT	DT	_	16	det	_	_
15	dose-dependent	_	JJ	JJ	_	16	amod	_	_
16	manner	_	NN	NN	_	13	pobj	_	_
17	,	_	,	,	_	10	punct	_	_
18	in	_	IN	IN	_	10	prep	_	_
19	U-937	_	NN	NN	_	20	nn	_	_
20	cells	_	NNS	NNS	_	18	pobj	_	_
21	incubated	_	VBN	VBN	_	20	vmod	_	_
22	with	_	IN	IN	_	21	prep	_	_
23	gamma	_	NN	NN	_	24	nn	_	_
24	interferon	_	NN	NN	_	22	pobj	_	_
25	.	_	.	.	_	10	punct	_	_

1	In	_	IN	IN	_	22	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	22	punct	_	_
4	in	_	IN	IN	_	22	prep	_	_
5	cells	_	NNS	NNS	_	4	pobj	_	_
6	infected	_	VBN	VBN	_	5	vmod	_	_
7	with	_	IN	IN	_	6	prep	_	_
8	L.	_	FW	FW	_	9	nn	_	_
9	donovani	_	FW	FW	_	7	pobj	_	_
10	,	_	,	,	_	22	punct	_	_
11	tyrosine	_	NN	NN	_	12	nn	_	_
12	phosphorylation	_	NN	NN	_	22	nsubj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	Jak1	_	NN	NN	_	13	pobj	_	_
15	,	_	,	,	_	14	punct	_	_
16	Jak2	_	NN	NN	_	14	conj	_	_
17	,	_	,	,	_	14	punct	_	_
18	and	_	CC	CC	_	14	cc	_	_
19	Stat1	_	NN	NN	_	14	conj	_	_
20	was	_	VBD	VBD	_	22	cop	_	_
21	markedly	_	RB	RB	_	22	advmod	_	_
22	impaired	_	JJ	JJ	_	0	root	_	_
23	.	_	.	.	_	22	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	effect	_	NN	NN	_	4	nsubj	_	_
3	was	_	VBD	VBD	_	4	cop	_	_
4	dependent	_	JJ	JJ	_	0	root	_	_
5	upon	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	duration	_	NN	NN	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	exposure	_	NN	NN	_	8	pobj	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	L.	_	FW	FW	_	12	nn	_	_
12	donovani	_	FW	FW	_	10	pobj	_	_
13	and	_	CC	CC	_	4	cc	_	_
14	was	_	VBD	VBD	_	15	cop	_	_
15	maximal	_	JJ	JJ	_	4	conj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	complete	_	JJ	JJ	_	15	conj	_	_
18	at	_	IN	IN	_	15	prep	_	_
19	16	_	CD	CD	_	20	num	_	_
20	h	_	NN	NN	_	18	pobj	_	_
21	.	_	.	.	_	4	punct	_	_

1	Results	_	NNS	NNS	_	11	nsubjpass	_	_
2	similar	_	JJ	JJ	_	1	amod	_	_
3	to	_	TO	TO	_	2	prep	_	_
4	those	_	DT	DT	_	3	pobj	_	_
5	observed	_	VBN	VBN	_	4	vmod	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	U-937	_	NN	NN	_	8	nn	_	_
8	cells	_	NNS	NNS	_	6	pobj	_	_
9	were	_	VBD	VBD	_	11	auxpass	_	_
10	also	_	RB	RB	_	11	advmod	_	_
11	obtained	_	VBN	VBN	_	0	root	_	_
12	with	_	IN	IN	_	11	prep	_	_
13	human	_	JJ	JJ	_	16	amod	_	_
14	peripheral	_	JJ	JJ	_	16	amod	_	_
15	blood	_	NN	NN	_	16	nn	_	_
16	monocytes	_	NNS	NNS	_	12	pobj	_	_
17	.	_	.	.	_	11	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	findings	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	13	mark	_	_
5	infection	_	NN	NN	_	13	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	human	_	JJ	JJ	_	9	amod	_	_
8	mononuclear	_	JJ	JJ	_	9	amod	_	_
9	phagocytes	_	NNS	NNS	_	6	pobj	_	_
10	with	_	IN	IN	_	5	prep	_	_
11	L.	_	FW	FW	_	12	nn	_	_
12	donovani	_	FW	FW	_	10	pobj	_	_
13	leads	_	VBZ	VBZ	_	3	ccomp	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	impaired	_	JJ	JJ	_	19	amod	_	_
16	gamma	_	NN	NN	_	19	nn	_	_
17	interferon-mediated	_	JJ	JJ	_	19	amod	_	_
18	tyrosine	_	NN	NN	_	19	nn	_	_
19	phosphorylation	_	NN	NN	_	14	pobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	selective	_	JJ	JJ	_	22	amod	_	_
22	effects	_	NNS	NNS	_	19	conj	_	_
23	on	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	26	det	_	_
25	Jak-Stat1	_	NN	NN	_	26	nn	_	_
26	pathway	_	NN	NN	_	23	pobj	_	_
27	.	_	.	.	_	3	punct	_	_

1	Unresponsiveness	_	NN	NN	_	11	nsubj	_	_
2	to	_	TO	TO	_	1	prep	_	_
3	gamma	_	NN	NN	_	4	nn	_	_
4	interferon	_	NN	NN	_	2	pobj	_	_
5	for	_	IN	IN	_	1	prep	_	_
6	activation	_	NN	NN	_	5	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	this	_	DT	DT	_	9	det	_	_
9	pathway	_	NN	NN	_	7	pobj	_	_
10	may	_	MD	MD	_	11	aux	_	_
11	explain	_	VB	VB	_	0	root	_	_
12	impaired	_	JJ	JJ	_	14	amod	_	_
13	transcriptional	_	JJ	JJ	_	14	amod	_	_
14	responses	_	NNS	NNS	_	11	dobj	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	leishmania-infected	_	JJ	JJ	_	17	amod	_	_
17	cells	_	NNS	NNS	_	15	pobj	_	_
18	.	_	.	.	_	11	punct	_	_

1	Mutually	_	RB	RB	_	2	advmod	_	_
2	exclusive	_	JJ	JJ	_	3	amod	_	_
3	interaction	_	NN	NN	_	0	root	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	a	_	DT	DT	_	11	det	_	_
6	novel	_	JJ	JJ	_	11	amod	_	_
7	matrix	_	NN	NN	_	11	nn	_	_
8	attachment	_	NN	NN	_	11	nn	_	_
9	region	_	NN	NN	_	11	nn	_	_
10	binding	_	NN	NN	_	11	nn	_	_
11	protein	_	NN	NN	_	4	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	the	_	DT	DT	_	16	det	_	_
14	NF-muNR	_	NN	NN	_	16	nn	_	_
15	enhancer	_	NN	NN	_	16	nn	_	_
16	repressor	_	NN	NN	_	11	conj	_	_
17	.	_	.	.	_	3	punct	_	_

1	Implications	_	NNS	NNS	_	0	root	_	_
2	for	_	IN	IN	_	1	prep	_	_
3	regulation	_	NN	NN	_	2	pobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	immunoglobulin	_	NN	NN	_	7	nn	_	_
6	heavy	_	JJ	JJ	_	7	amod	_	_
7	chain	_	NN	NN	_	8	nn	_	_
8	expression	_	NN	NN	_	4	pobj	_	_
9	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	9	det	_	_
2	immunoglobulin	_	NN	NN	_	4	nn	_	_
3	heavy	_	NN	NN	_	4	nn	_	_
4	chain	_	NN	NN	_	9	nn	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	IgH	_	NN	NN	_	4	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	intronic	_	JJ	JJ	_	9	amod	_	_
9	enhancer	_	NN	NN	_	10	nsubj	_	_
10	stimulates	_	VBZ	VBZ	_	0	root	_	_
11	transcription	_	NN	NN	_	10	dobj	_	_
12	from	_	IN	IN	_	11	prep	_	_
13	functional	_	JJ	JJ	_	14	amod	_	_
14	promoters	_	NNS	NNS	_	12	pobj	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	B	_	NN	NN	_	17	nn	_	_
17	lymphocytes	_	NNS	NNS	_	15	pobj	_	_
18	but	_	CC	CC	_	19	cc	_	_
19	not	_	RB	RB	_	17	cc	_	_
20	other	_	JJ	JJ	_	22	amod	_	_
21	cell	_	NN	NN	_	22	nn	_	_
22	types	_	NNS	NNS	_	17	conj	_	_
23	.	_	.	.	_	10	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	observation	_	NN	NN	_	29	nsubj	_	_
3	that	_	IN	IN	_	17	mark	_	_
4	binding	_	VBG	VBG	_	5	amod	_	_
5	sites	_	NNS	NNS	_	17	nsubj	_	_
6	for	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	16	det	_	_
8	nuclear	_	JJ	JJ	_	16	amod	_	_
9	factor-mu	_	NN	NN	_	16	nn	_	_
10	negative	_	JJ	JJ	_	16	amod	_	_
11	regulator	_	NN	NN	_	16	nn	_	_
12	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
13	NF-muNR	_	NN	NN	_	16	nn	_	_
14	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
15	enhancer	_	NN	NN	_	16	nn	_	_
16	repressor	_	NN	NN	_	6	pobj	_	_
17	overlap	_	VBP	VBP	_	2	ccomp	_	_
18	nuclear	_	JJ	JJ	_	21	amod	_	_
19	matrix	_	NN	NN	_	21	nn	_	_
20	attachment	_	NN	NN	_	21	nn	_	_
21	regions	_	NNS	NNS	_	17	dobj	_	_
22	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
23	MARs	_	NNS	NNS	_	21	appos	_	_
24	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
25	in	_	IN	IN	_	21	prep	_	_
26	this	_	DT	DT	_	27	det	_	_
27	enhancer	_	NN	NN	_	25	pobj	_	_
28	has	_	VBZ	VBZ	_	29	aux	_	_
29	lead	_	VBN	VBN	_	0	root	_	_
30	to	_	TO	TO	_	29	prep	_	_
31	the	_	DT	DT	_	32	det	_	_
32	hypothesis	_	NN	NN	_	30	pobj	_	_
33	that	_	IN	IN	_	43	mark	_	_
34	the	_	DT	DT	_	37	det	_	_
35	cell	_	NN	NN	_	37	nn	_	_
36	type	_	NN	NN	_	37	nn	_	_
37	specificity	_	NN	NN	_	43	nsubjpass	_	_
38	of	_	IN	IN	_	37	prep	_	_
39	the	_	DT	DT	_	40	det	_	_
40	enhancer	_	NN	NN	_	38	pobj	_	_
41	might	_	MD	MD	_	43	aux	_	_
42	be	_	VB	VB	_	43	auxpass	_	_
43	controlled	_	VBN	VBN	_	32	ccomp	_	_
44	by	_	IN	IN	_	43	prep	_	_
45	regulating	_	VBG	VBG	_	44	pcomp	_	_
46	nuclear	_	JJ	JJ	_	48	amod	_	_
47	matrix	_	NN	NN	_	48	nn	_	_
48	attachment	_	NN	NN	_	45	dobj	_	_
49	-LRB-	_	-LRB-	-LRB-	_	50	punct	_	_
50	Scheuermann	_	NNP	NNP	_	29	dep	_	_
51	,	_	,	,	_	50	punct	_	_
52	R.	_	NNP	NNP	_	53	nn	_	_
53	H.	_	NNP	NNP	_	50	conj	_	_
54	,	_	,	,	_	50	punct	_	_
55	and	_	CC	CC	_	50	cc	_	_
56	Chen	_	NNP	NNP	_	58	nn	_	_
57	,	_	,	,	_	58	punct	_	_
58	U.	_	NNP	NNP	_	50	conj	_	_
59	-LRB-	_	-LRB-	-LRB-	_	60	punct	_	_
60	1989	_	CD	CD	_	50	appos	_	_
61	-RRB-	_	-RRB-	-RRB-	_	60	punct	_	_
62	Genes	_	NNP	NNP	_	50	dep	_	_
63	&amp;	_	CC	CC	_	62	cc	_	_
64	Dev.	_	NNP	NNP	_	62	conj	_	_
65	3	_	CD	CD	_	62	num	_	_
66	,	_	,	,	_	50	punct	_	_
67	1255-1266	_	CD	CD	_	50	amod	_	_
68	-RRB-	_	-RRB-	-RRB-	_	50	punct	_	_
69	.	_	.	.	_	29	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	understand	_	VB	VB	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	role	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	MARs	_	NNS	NNS	_	5	pobj	_	_
7	in	_	IN	IN	_	4	prep	_	_
8	IgH	_	NN	NN	_	9	nn	_	_
9	enhancer	_	NN	NN	_	10	nn	_	_
10	regulation	_	NN	NN	_	7	pobj	_	_
11	,	_	,	,	_	2	punct	_	_
12	we	_	PRP	PRP	_	14	nsubj	_	_
13	have	_	VBP	VBP	_	14	aux	_	_
14	identified	_	VBN	VBN	_	2	parataxis	_	_
15	a	_	DT	DT	_	18	det	_	_
16	novel	_	JJ	JJ	_	18	amod	_	_
17	MAR-binding	_	JJ	JJ	_	18	amod	_	_
18	protein	_	NN	NN	_	14	dobj	_	_
19	,	_	,	,	_	18	punct	_	_
20	MAR-BP1	_	NN	NN	_	18	appos	_	_
21	,	_	,	,	_	14	punct	_	_
22	from	_	IN	IN	_	14	prep	_	_
23	soluble	_	JJ	JJ	_	24	amod	_	_
24	nuclear	_	JJ	JJ	_	26	amod	_	_
25	matrix	_	NN	NN	_	26	nn	_	_
26	preparations	_	NNS	NNS	_	22	pobj	_	_
27	based	_	VBN	VBN	_	14	prep	_	_
28	on	_	IN	IN	_	27	pcomp	_	_
29	its	_	PRP$	PRP$	_	30	poss	_	_
30	ability	_	NN	NN	_	28	pobj	_	_
31	to	_	TO	TO	_	32	aux	_	_
32	bind	_	VB	VB	_	30	vmod	_	_
33	to	_	TO	TO	_	32	prep	_	_
34	the	_	DT	DT	_	35	det	_	_
35	MARs	_	NNS	NNS	_	33	pobj	_	_
36	associated	_	VBN	VBN	_	35	vmod	_	_
37	with	_	IN	IN	_	36	prep	_	_
38	the	_	DT	DT	_	40	det	_	_
39	IgH	_	NN	NN	_	40	nn	_	_
40	enhancer	_	NN	NN	_	37	pobj	_	_
41	.	_	.	.	_	2	punct	_	_

1	Purified	_	VBN	VBN	_	2	amod	_	_
2	MAR-BP1	_	NN	NN	_	3	nsubj	_	_
3	migrates	_	VBZ	VBZ	_	0	root	_	_
4	as	_	IN	IN	_	3	prep	_	_
5	a	_	DT	DT	_	7	det	_	_
6	33-kDa	_	JJ	JJ	_	7	amod	_	_
7	protein	_	NN	NN	_	4	pobj	_	_
8	,	_	,	,	_	3	punct	_	_
9	and	_	CC	CC	_	3	cc	_	_
10	it	_	PRP	PRP	_	13	nsubjpass	_	_
11	can	_	MD	MD	_	13	aux	_	_
12	be	_	VB	VB	_	13	auxpass	_	_
13	found	_	VBN	VBN	_	3	conj	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	nuclear	_	JJ	JJ	_	17	amod	_	_
16	matrix	_	NN	NN	_	17	nn	_	_
17	preparations	_	NNS	NNS	_	14	pobj	_	_
18	from	_	IN	IN	_	17	prep	_	_
19	a	_	DT	DT	_	20	det	_	_
20	number	_	NN	NN	_	18	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	different	_	JJ	JJ	_	23	amod	_	_
23	types	_	NNS	NNS	_	21	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	lymphoid	_	JJ	JJ	_	27	amod	_	_
26	cell	_	NN	NN	_	27	nn	_	_
27	lines	_	NNS	NNS	_	24	pobj	_	_
28	.	_	.	.	_	3	punct	_	_

1	Although	_	IN	IN	_	7	mark	_	_
2	specific	_	JJ	JJ	_	4	amod	_	_
3	binding	_	VBG	VBG	_	4	amod	_	_
4	sites	_	NNS	NNS	_	7	nsubj	_	_
5	have	_	VBP	VBP	_	7	aux	_	_
6	been	_	VBN	VBN	_	7	cop	_	_
7	difficult	_	JJ	JJ	_	21	advcl	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	localize	_	VB	VB	_	7	ccomp	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	chemical	_	JJ	JJ	_	10	pobj	_	_
12	or	_	CC	CC	_	11	cc	_	_
13	enzymatic	_	JJ	JJ	_	11	conj	_	_
14	footprinting	_	NN	NN	_	15	nn	_	_
15	procedures	_	NNS	NNS	_	11	dep	_	_
16	,	_	,	,	_	21	punct	_	_
17	NF-muNR	_	NN	NN	_	19	nn	_	_
18	binding	_	NN	NN	_	19	nn	_	_
19	sites	_	NNS	NNS	_	21	nsubj	_	_
20	are	_	VBP	VBP	_	21	cop	_	_
21	critical	_	JJ	JJ	_	0	root	_	_
22	for	_	IN	IN	_	21	prep	_	_
23	efficient	_	JJ	JJ	_	25	amod	_	_
24	MAR-BP1	_	NN	NN	_	25	nn	_	_
25	binding	_	NN	NN	_	22	pobj	_	_
26	.	_	.	.	_	21	punct	_	_

1	Indeed	_	RB	RB	_	19	advmod	_	_
2	,	_	,	,	_	19	punct	_	_
3	binding	_	NN	NN	_	19	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	IgH	_	NN	NN	_	7	nn	_	_
7	enhancer	_	NN	NN	_	4	pobj	_	_
8	to	_	TO	TO	_	3	prep	_	_
9	either	_	CC	CC	_	8	dep	_	_
10	intact	_	JJ	JJ	_	11	amod	_	_
11	nuclear	_	JJ	JJ	_	13	amod	_	_
12	matrix	_	NN	NN	_	13	nn	_	_
13	preparations	_	NNS	NNS	_	8	conj	_	_
14	or	_	CC	CC	_	8	cc	_	_
15	to	_	TO	TO	_	8	conj	_	_
16	MAR-BP1	_	NN	NN	_	15	pobj	_	_
17	is	_	VBZ	VBZ	_	19	cop	_	_
18	mutually	_	RB	RB	_	19	advmod	_	_
19	exclusive	_	JJ	JJ	_	0	root	_	_
20	to	_	TO	TO	_	19	prep	_	_
21	NF-muNR	_	NN	NN	_	22	nn	_	_
22	binding	_	NN	NN	_	20	pobj	_	_
23	.	_	.	.	_	19	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	4	nsubj	_	_
3	are	_	VBP	VBP	_	4	cop	_	_
4	consistent	_	JJ	JJ	_	0	root	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	a	_	DT	DT	_	7	det	_	_
7	model	_	NN	NN	_	5	pobj	_	_
8	for	_	IN	IN	_	7	prep	_	_
9	cell-type	_	JJ	JJ	_	10	amod	_	_
10	specific	_	JJ	JJ	_	11	amod	_	_
11	regulation	_	NN	NN	_	8	pobj	_	_
12	in	_	IN	IN	_	23	prep	_	_
13	which	_	WDT	WDT	_	12	pobj	_	_
14	binding	_	NN	NN	_	23	nsubj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	NF-muNR	_	NN	NN	_	18	nn	_	_
18	repressor	_	NN	NN	_	15	pobj	_	_
19	to	_	TO	TO	_	14	prep	_	_
20	the	_	DT	DT	_	22	det	_	_
21	IgH	_	NN	NN	_	22	nn	_	_
22	enhancer	_	NN	NN	_	19	pobj	_	_
23	prevents	_	VBZ	VBZ	_	11	rcmod	_	_
24	nuclear	_	JJ	JJ	_	26	amod	_	_
25	matrix	_	NN	NN	_	26	nn	_	_
26	attachment	_	NN	NN	_	23	dobj	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	inappropriate	_	JJ	JJ	_	29	amod	_	_
29	cells	_	NNS	NNS	_	27	pobj	_	_
30	by	_	IN	IN	_	23	prep	_	_
31	interfering	_	VBG	VBG	_	30	pcomp	_	_
32	with	_	IN	IN	_	31	prep	_	_
33	MAR-BP1/enhancer	_	NN	NN	_	34	nn	_	_
34	interaction	_	NN	NN	_	32	pobj	_	_
35	.	_	.	.	_	4	punct	_	_

1	Multiple	_	JJ	JJ	_	2	amod	_	_
2	proteins	_	NNS	NNS	_	3	nsubj	_	_
3	interact	_	VBP	VBP	_	0	root	_	_
4	with	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	10	det	_	_
6	nuclear	_	JJ	JJ	_	10	amod	_	_
7	inhibitory	_	JJ	JJ	_	10	amod	_	_
8	protein	_	NN	NN	_	10	nn	_	_
9	repressor	_	NN	NN	_	10	nn	_	_
10	element	_	NN	NN	_	4	pobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	15	det	_	_
13	human	_	JJ	JJ	_	15	amod	_	_
14	interleukin-3	_	NN	NN	_	15	nn	_	_
15	promoter	_	NN	NN	_	11	pobj	_	_
16	.	_	.	.	_	3	punct	_	_

1	T	_	NN	NN	_	3	nn	_	_
2	cell	_	NN	NN	_	3	nn	_	_
3	expression	_	NN	NN	_	11	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	interleukin	_	NN	NN	_	4	pobj	_	_
6	3	_	CD	CD	_	5	num	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	IL-3	_	NN	NN	_	5	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	is	_	VBZ	VBZ	_	11	auxpass	_	_
11	directed	_	VBN	VBN	_	0	root	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	positive	_	JJ	JJ	_	12	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	negative	_	JJ	JJ	_	13	conj	_	_
16	cis-acting	_	JJ	JJ	_	18	amod	_	_
17	DNA	_	NN	NN	_	18	nn	_	_
18	elements	_	NNS	NNS	_	13	dep	_	_
19	clustered	_	JJ	JJ	_	13	amod	_	_
20	within	_	IN	IN	_	19	prep	_	_
21	300	_	CD	CD	_	23	num	_	_
22	base	_	NN	NN	_	23	nn	_	_
23	pairs	_	NNS	NNS	_	20	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	28	det	_	_
26	transcriptional	_	JJ	JJ	_	28	amod	_	_
27	start	_	NN	NN	_	28	nn	_	_
28	site	_	NN	NN	_	24	pobj	_	_
29	.	_	.	.	_	11	punct	_	_

1	A	_	DT	DT	_	4	det	_	_
2	strong	_	JJ	JJ	_	4	amod	_	_
3	repressor	_	NN	NN	_	4	nn	_	_
4	element	_	NN	NN	_	16	nsubjpass	_	_
5	,	_	,	,	_	4	punct	_	_
6	termed	_	VBN	VBN	_	4	vmod	_	_
7	nuclear	_	JJ	JJ	_	9	amod	_	_
8	inhibitory	_	JJ	JJ	_	9	amod	_	_
9	protein	_	NN	NN	_	6	dep	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	NIP	_	NN	NN	_	9	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	,	_	,	,	_	4	punct	_	_
14	was	_	VBD	VBD	_	16	auxpass	_	_
15	previously	_	RB	RB	_	16	advmod	_	_
16	mapped	_	VBN	VBN	_	0	root	_	_
17	to	_	TO	TO	_	16	prep	_	_
18	a	_	DT	DT	_	19	det	_	_
19	segment	_	NN	NN	_	17	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	IL-3	_	NN	NN	_	23	nn	_	_
23	promoter	_	NN	NN	_	20	pobj	_	_
24	between	_	IN	IN	_	23	prep	_	_
25	nucleotides	_	NNS	NNS	_	24	pobj	_	_
26	-271	_	CD	CD	_	25	num	_	_
27	and	_	CC	CC	_	25	cc	_	_
28	-250	_	CD	CD	_	25	conj	_	_
29	.	_	.	.	_	16	punct	_	_

1	Functional	_	JJ	JJ	_	2	amod	_	_
2	characterization	_	NN	NN	_	6	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	this	_	DT	DT	_	5	det	_	_
5	element	_	NN	NN	_	3	pobj	_	_
6	demonstrates	_	VBZ	VBZ	_	0	root	_	_
7	that	_	IN	IN	_	10	mark	_	_
8	it	_	PRP	PRP	_	10	nsubj	_	_
9	can	_	MD	MD	_	10	aux	_	_
10	mediate	_	VB	VB	_	6	ccomp	_	_
11	repression	_	NN	NN	_	10	dobj	_	_
12	when	_	WRB	WRB	_	13	advmod	_	_
13	linked	_	VBN	VBN	_	10	advcl	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	cis	_	NN	NN	_	14	pobj	_	_
16	to	_	TO	TO	_	13	prep	_	_
17	a	_	DT	DT	_	19	det	_	_
18	heterologous	_	JJ	JJ	_	19	amod	_	_
19	promoter	_	NN	NN	_	16	pobj	_	_
20	.	_	.	.	_	6	punct	_	_

1	DNA	_	NN	NN	_	3	nn	_	_
2	binding	_	NN	NN	_	3	nn	_	_
3	experiments	_	NNS	NNS	_	5	nsubjpass	_	_
4	were	_	VBD	VBD	_	5	auxpass	_	_
5	carried	_	VBN	VBN	_	0	root	_	_
6	out	_	RP	RP	_	5	prt	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	characterize	_	VB	VB	_	5	xcomp	_	_
9	the	_	DT	DT	_	11	det	_	_
10	repressor	_	NN	NN	_	11	nn	_	_
11	activity	_	NN	NN	_	8	dobj	_	_
12	.	_	.	.	_	5	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	varying	_	JJ	JJ	_	3	amod	_	_
3	conditions	_	NNS	NNS	_	1	dobj	_	_
4	,	_	,	,	_	1	punct	_	_
5	three	_	CD	CD	_	7	num	_	_
6	distinct	_	JJ	JJ	_	7	amod	_	_
7	complexes	_	NNS	NNS	_	9	nsubjpass	_	_
8	were	_	VBD	VBD	_	9	auxpass	_	_
9	shown	_	VBN	VBN	_	1	parataxis	_	_
10	to	_	TO	TO	_	11	aux	_	_
11	interact	_	VB	VB	_	9	xcomp	_	_
12	specifically	_	RB	RB	_	13	advmod	_	_
13	with	_	IN	IN	_	11	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	NIP	_	NN	NN	_	16	nn	_	_
16	region	_	NN	NN	_	13	pobj	_	_
17	,	_	,	,	_	9	punct	_	_
18	although	_	IN	IN	_	9	prep	_	_
19	only	_	RB	RB	_	20	quantmod	_	_
20	one	_	CD	CD	_	18	pobj	_	_
21	correlates	_	VBZ	VBZ	_	18	dep	_	_
22	with	_	IN	IN	_	21	prep	_	_
23	repressor	_	NN	NN	_	24	nn	_	_
24	activity	_	NN	NN	_	22	pobj	_	_
25	.	_	.	.	_	1	punct	_	_

1	Complex	_	NN	NN	_	3	nsubj	_	_
2	1	_	CD	CD	_	1	num	_	_
3	results	_	VBZ	VBZ	_	0	root	_	_
4	from	_	IN	IN	_	3	prep	_	_
5	binding	_	NN	NN	_	4	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	a	_	DT	DT	_	9	det	_	_
8	ubiquitous	_	JJ	JJ	_	9	amod	_	_
9	polypeptide	_	NN	NN	_	6	pobj	_	_
10	that	_	WDT	WDT	_	11	nsubj	_	_
11	recognizes	_	VBZ	VBZ	_	9	rcmod	_	_
12	the	_	DT	DT	_	14	det	_	_
13	3'	_	JJ	JJ	_	14	amod	_	_
14	portion	_	NN	NN	_	11	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	this	_	DT	DT	_	17	det	_	_
17	sequence	_	NN	NN	_	15	pobj	_	_
18	and	_	CC	CC	_	11	cc	_	_
19	is	_	VBZ	VBZ	_	21	auxpass	_	_
20	not	_	RB	RB	_	21	neg	_	_
21	required	_	VBN	VBN	_	11	conj	_	_
22	for	_	IN	IN	_	21	prep	_	_
23	repression	_	NN	NN	_	22	pobj	_	_
24	.	_	.	.	_	3	punct	_	_

1	Complex	_	NN	NN	_	3	nsubj	_	_
2	2	_	CD	CD	_	1	num	_	_
3	corresponds	_	VBZ	VBZ	_	0	root	_	_
4	to	_	TO	TO	_	3	prep	_	_
5	binding	_	NN	NN	_	4	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	transcription	_	NN	NN	_	8	nn	_	_
8	factor	_	NN	NN	_	6	pobj	_	_
9	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
10	upstream	_	JJ	JJ	_	12	amod	_	_
11	stimulatory	_	JJ	JJ	_	12	amod	_	_
12	factor	_	NN	NN	_	8	appos	_	_
13	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	to	_	TO	TO	_	5	prep	_	_
15	an	_	DT	DT	_	17	det	_	_
16	E-box	_	NN	NN	_	17	nn	_	_
17	motif	_	NN	NN	_	14	pobj	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	5'	_	JJ	JJ	_	21	amod	_	_
21	portion	_	NN	NN	_	18	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	25	det	_	_
24	NIP	_	NN	NN	_	25	nn	_	_
25	region	_	NN	NN	_	22	pobj	_	_
26	.	_	.	.	_	3	punct	_	_

1	DNA	_	NN	NN	_	3	nn	_	_
2	binding	_	NN	NN	_	3	nn	_	_
3	specificity	_	NN	NN	_	7	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	complex	_	NN	NN	_	4	pobj	_	_
6	3	_	CD	CD	_	5	num	_	_
7	overlaps	_	VBZ	VBZ	_	0	root	_	_
8	with	_	IN	IN	_	7	prep	_	_
9	that	_	DT	DT	_	8	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	upstream	_	JJ	JJ	_	13	amod	_	_
12	stimulatory	_	JJ	JJ	_	13	amod	_	_
13	factor	_	NN	NN	_	10	pobj	_	_
14	but	_	CC	CC	_	7	cc	_	_
15	is	_	VBZ	VBZ	_	17	cop	_	_
16	clearly	_	RB	RB	_	17	advmod	_	_
17	distinct	_	JJ	JJ	_	7	conj	_	_
18	.	_	.	.	_	7	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	determine	_	VB	VB	_	0	root	_	_
3	which	_	WDT	WDT	_	9	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	8	det	_	_
6	latter	_	JJ	JJ	_	8	amod	_	_
7	two	_	CD	CD	_	8	num	_	_
8	complexes	_	NNS	NNS	_	4	pobj	_	_
9	represents	_	VBZ	VBZ	_	2	ccomp	_	_
10	NIP	_	NN	NN	_	11	nn	_	_
11	activity	_	NN	NN	_	9	dobj	_	_
12	,	_	,	,	_	2	punct	_	_
13	we	_	PRP	PRP	_	14	nsubj	_	_
14	incorporated	_	VBD	VBD	_	2	parataxis	_	_
15	small	_	JJ	JJ	_	16	amod	_	_
16	alterations	_	NNS	NNS	_	14	dobj	_	_
17	into	_	IN	IN	_	14	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	NIP	_	NN	NN	_	20	nn	_	_
20	site	_	NN	NN	_	17	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	an	_	DT	DT	_	26	det	_	_
23	IL-3	_	NN	NN	_	26	nn	_	_
24	promoter-linked	_	JJ	JJ	_	26	amod	_	_
25	reporter	_	NN	NN	_	26	nn	_	_
26	construct	_	NN	NN	_	21	pobj	_	_
27	and	_	CC	CC	_	14	cc	_	_
28	examined	_	VBD	VBD	_	14	conj	_	_
29	their	_	PRP$	PRP$	_	30	poss	_	_
30	effects	_	NNS	NNS	_	28	dobj	_	_
31	on	_	IN	IN	_	30	prep	_	_
32	NIP-mediated	_	JJ	JJ	_	33	amod	_	_
33	repression	_	NN	NN	_	31	pobj	_	_
34	.	_	.	.	_	2	punct	_	_

1	Functional	_	JJ	JJ	_	2	amod	_	_
2	specificity	_	NN	NN	_	5	nsubj	_	_
3	for	_	IN	IN	_	2	prep	_	_
4	repression	_	NN	NN	_	3	pobj	_	_
5	matches	_	VBZ	VBZ	_	0	root	_	_
6	the	_	DT	DT	_	9	det	_	_
7	DNA	_	NN	NN	_	9	nn	_	_
8	binding	_	NN	NN	_	9	nn	_	_
9	specificity	_	NN	NN	_	5	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	complex	_	NN	NN	_	10	pobj	_	_
12	3	_	CD	CD	_	11	num	_	_
13	;	_	:	:	_	5	punct	_	_
14	both	_	DT	DT	_	16	preconj	_	_
15	repressor	_	NN	NN	_	16	nn	_	_
16	activity	_	NN	NN	_	21	nsubj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	complex	_	NN	NN	_	20	nn	_	_
19	3	_	CD	CD	_	18	num	_	_
20	binding	_	NN	NN	_	16	conj	_	_
21	require	_	VBP	VBP	_	5	parataxis	_	_
22	the	_	DT	DT	_	25	det	_	_
23	consensus	_	NN	NN	_	24	nn	_	_
24	sequence	_	NN	NN	_	25	nn	_	_
25	CTCACNTNC	_	NN	NN	_	21	dobj	_	_
26	.	_	.	.	_	5	punct	_	_

1	Activation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	signal	_	NN	NN	_	5	nn	_	_
5	transducer	_	NN	NN	_	12	nn	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	transcription	_	NN	NN	_	5	conj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	STAT	_	NN	NN	_	5	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	signaling	_	NN	NN	_	12	nn	_	_
12	pathway	_	NN	NN	_	2	pobj	_	_
13	in	_	IN	IN	_	1	prep	_	_
14	a	_	DT	DT	_	18	det	_	_
15	primary	_	JJ	JJ	_	18	amod	_	_
16	T	_	NN	NN	_	18	nn	_	_
17	cell	_	NN	NN	_	18	nn	_	_
18	response	_	NN	NN	_	13	pobj	_	_
19	.	_	.	.	_	1	punct	_	_

1	Critical	_	JJ	JJ	_	2	amod	_	_
2	role	_	NN	NN	_	0	root	_	_
3	for	_	IN	IN	_	2	prep	_	_
4	IL-6	_	NN	NN	_	3	pobj	_	_
5	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	T	_	NN	NN	_	4	nn	_	_
3	cell	_	NN	NN	_	4	nn	_	_
4	activation	_	NN	NN	_	6	nsubjpass	_	_
5	is	_	VBZ	VBZ	_	6	auxpass	_	_
6	initiated	_	VBN	VBN	_	0	root	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	interaction	_	NN	NN	_	7	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	specific	_	JJ	JJ	_	11	amod	_	_
11	Ags	_	NNS	NNS	_	9	pobj	_	_
12	with	_	IN	IN	_	8	prep	_	_
13	TCR	_	NN	NN	_	12	pobj	_	_
14	,	_	,	,	_	6	punct	_	_
15	followed	_	VBN	VBN	_	6	vmod	_	_
16	by	_	IN	IN	_	15	prep	_	_
17	activation	_	NN	NN	_	16	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	intracellular	_	JJ	JJ	_	21	amod	_	_
20	biochemical	_	JJ	JJ	_	21	amod	_	_
21	events	_	NNS	NNS	_	18	pobj	_	_
22	leading	_	VBG	VBG	_	21	vmod	_	_
23	to	_	TO	TO	_	22	prep	_	_
24	activation	_	NN	NN	_	23	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	several	_	JJ	JJ	_	27	amod	_	_
27	genes	_	NNS	NNS	_	25	pobj	_	_
28	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	activation	_	NN	NN	_	24	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	signal	_	JJ	JJ	_	5	amod	_	_
5	transducer	_	NN	NN	_	3	pobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	activator	_	NN	NN	_	5	conj	_	_
8	of	_	IN	IN	_	5	prep	_	_
9	transcription	_	NN	NN	_	13	nn	_	_
10	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
11	STAT	_	NN	NN	_	13	nn	_	_
12	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
13	proteins	_	NNS	NNS	_	8	pobj	_	_
14	in	_	IN	IN	_	2	prep	_	_
15	a	_	DT	DT	_	18	det	_	_
16	primary	_	JJ	JJ	_	18	amod	_	_
17	TCR-mediated	_	JJ	JJ	_	18	amod	_	_
18	activation	_	NN	NN	_	14	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	T	_	NN	NN	_	21	nn	_	_
21	cells	_	NNS	NNS	_	19	pobj	_	_
22	have	_	VBP	VBP	_	24	aux	_	_
23	been	_	VBN	VBN	_	24	auxpass	_	_
24	explored	_	VBN	VBN	_	0	root	_	_
25	.	_	.	.	_	24	punct	_	_

1	In	_	IN	IN	_	13	prep	_	_
2	purified	_	VBN	VBN	_	7	amod	_	_
3	human	_	JJ	JJ	_	7	amod	_	_
4	peripheral	_	JJ	JJ	_	7	amod	_	_
5	blood	_	NN	NN	_	7	nn	_	_
6	T	_	NN	NN	_	7	nn	_	_
7	cells	_	NNS	NNS	_	1	pobj	_	_
8	,	_	,	,	_	13	punct	_	_
9	nuclear	_	JJ	JJ	_	11	amod	_	_
10	STAT	_	NN	NN	_	11	nn	_	_
11	proteins	_	NNS	NNS	_	13	nsubjpass	_	_
12	were	_	VBD	VBD	_	13	auxpass	_	_
13	activated	_	VBN	VBN	_	0	root	_	_
14	approximately	_	RB	RB	_	15	quantmod	_	_
15	3	_	CD	CD	_	16	num	_	_
16	h	_	NN	NN	_	17	npadvmod	_	_
17	after	_	IN	IN	_	13	prep	_	_
18	activation	_	NN	NN	_	17	pobj	_	_
19	by	_	IN	IN	_	18	prep	_	_
20	cross-linked	_	JJ	JJ	_	22	amod	_	_
21	anti-CD3	_	JJ	JJ	_	22	amod	_	_
22	Abs	_	NNS	NNS	_	19	pobj	_	_
23	.	_	.	.	_	13	punct	_	_

1	These	_	DT	DT	_	3	det	_	_
2	STAT	_	NN	NN	_	3	nn	_	_
3	proteins	_	NNS	NNS	_	5	nsubjpass	_	_
4	were	_	VBD	VBD	_	5	auxpass	_	_
5	detected	_	VBN	VBN	_	0	root	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	using	_	VBG	VBG	_	6	pcomp	_	_
8	the	_	DT	DT	_	10	det	_	_
9	IFN-gamma-activated	_	JJ	JJ	_	10	amod	_	_
10	sequence	_	NN	NN	_	7	dobj	_	_
11	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
12	GAS	_	NN	NN	_	10	appos	_	_
13	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	and	_	CC	CC	_	10	cc	_	_
15	related	_	JJ	JJ	_	16	amod	_	_
16	oligonucleotides	_	NNS	NNS	_	10	conj	_	_
17	as	_	IN	IN	_	7	prep	_	_
18	probes	_	NNS	NNS	_	17	pobj	_	_
19	in	_	IN	IN	_	7	prep	_	_
20	electrophoretic	_	JJ	JJ	_	23	amod	_	_
21	mobility	_	NN	NN	_	23	nn	_	_
22	shift	_	NN	NN	_	23	nn	_	_
23	assay	_	NN	NN	_	19	pobj	_	_
24	.	_	.	.	_	5	punct	_	_

1	Analysis	_	NN	NN	_	9	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	nuclear	_	JJ	JJ	_	5	amod	_	_
5	extracts	_	NNS	NNS	_	2	pobj	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	anti-STAT	_	JJ	JJ	_	8	amod	_	_
8	Abs	_	NNS	NNS	_	6	pobj	_	_
9	indicated	_	VBD	VBD	_	0	root	_	_
10	that	_	IN	IN	_	12	mark	_	_
11	they	_	PRP	PRP	_	12	nsubj	_	_
12	contained	_	VBD	VBD	_	9	ccomp	_	_
13	STAT-3	_	NN	NN	_	12	dobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	additional	_	JJ	JJ	_	16	amod	_	_
16	proteins	_	NNS	NNS	_	13	conj	_	_
17	crossreactive	_	JJ	JJ	_	16	amod	_	_
18	with	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	STAT	_	NN	NN	_	21	nn	_	_
21	family	_	NN	NN	_	18	pobj	_	_
22	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	induction	_	NN	NN	_	7	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	STAT	_	NN	NN	_	5	nn	_	_
5	activity	_	NN	NN	_	3	pobj	_	_
6	was	_	VBD	VBD	_	7	auxpass	_	_
7	inhibited	_	VBN	VBN	_	0	root	_	_
8	completely	_	RB	RB	_	9	advmod	_	_
9	by	_	IN	IN	_	7	prep	_	_
10	pretreatment	_	NN	NN	_	9	pobj	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	either	_	CC	CC	_	13	preconj	_	_
13	cycloheximide	_	NN	NN	_	11	pobj	_	_
14	or	_	CC	CC	_	13	cc	_	_
15	cyclosporin	_	NN	NN	_	16	nn	_	_
16	A	_	NN	NN	_	13	conj	_	_
17	,	_	,	,	_	7	punct	_	_
18	thus	_	RB	RB	_	19	advmod	_	_
19	indicating	_	VBG	VBG	_	7	vmod	_	_
20	that	_	IN	IN	_	24	mark	_	_
21	the	_	DT	DT	_	22	det	_	_
22	induction	_	NN	NN	_	24	nsubj	_	_
23	was	_	VBD	VBD	_	24	cop	_	_
24	due	_	JJ	JJ	_	19	ccomp	_	_
25	to	_	TO	TO	_	24	prep	_	_
26	a	_	DT	DT	_	28	det	_	_
27	secondary	_	JJ	JJ	_	28	amod	_	_
28	factor	_	NN	NN	_	25	pobj	_	_
29	produced	_	VBN	VBN	_	28	vmod	_	_
30	by	_	IN	IN	_	29	prep	_	_
31	the	_	DT	DT	_	34	det	_	_
32	activated	_	VBN	VBN	_	34	amod	_	_
33	T	_	NN	NN	_	34	nn	_	_
34	cells	_	NNS	NNS	_	30	pobj	_	_
35	.	_	.	.	_	7	punct	_	_

1	As	_	IN	IN	_	6	mark	_	_
2	neutralizing	_	NN	NN	_	4	nn	_	_
3	anti-IL-6	_	JJ	JJ	_	4	amod	_	_
4	Abs	_	NNS	NNS	_	6	nsubj	_	_
5	effectively	_	RB	RB	_	6	advmod	_	_
6	down-regulated	_	VBD	VBD	_	30	dep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	early	_	JJ	JJ	_	9	amod	_	_
9	induction	_	NN	NN	_	6	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	STAT	_	NN	NN	_	12	nn	_	_
12	proteins	_	NNS	NNS	_	10	pobj	_	_
13	and	_	CC	CC	_	6	cc	_	_
14	as	_	IN	IN	_	19	mark	_	_
15	exogenously	_	RB	RB	_	16	advmod	_	_
16	added	_	VBN	VBN	_	17	amod	_	_
17	IL-6	_	NN	NN	_	19	nsubj	_	_
18	rapidly	_	RB	RB	_	19	advmod	_	_
19	activated	_	VBD	VBD	_	6	conj	_	_
20	DNA	_	NN	NN	_	21	nn	_	_
21	binding	_	NN	NN	_	19	dobj	_	_
22	similar	_	JJ	JJ	_	21	amod	_	_
23	to	_	TO	TO	_	22	prep	_	_
24	TCR-mediated	_	JJ	JJ	_	23	dep	_	_
25	bindings	_	NNS	NNS	_	23	dep	_	_
26	,	_	,	,	_	30	punct	_	_
27	it	_	PRP	PRP	_	30	nsubjpass	_	_
28	can	_	MD	MD	_	30	aux	_	_
29	be	_	VB	VB	_	30	auxpass	_	_
30	concluded	_	VBN	VBN	_	0	root	_	_
31	that	_	IN	IN	_	35	mark	_	_
32	IL-6	_	NN	NN	_	35	nsubj	_	_
33	is	_	VBZ	VBZ	_	35	cop	_	_
34	the	_	DT	DT	_	35	det	_	_
35	factor	_	NN	NN	_	30	ccomp	_	_
36	responsible	_	JJ	JJ	_	35	amod	_	_
37	for	_	IN	IN	_	36	prep	_	_
38	the	_	DT	DT	_	39	det	_	_
39	activation	_	NN	NN	_	37	pobj	_	_
40	of	_	IN	IN	_	39	prep	_	_
41	STAT	_	NN	NN	_	42	nn	_	_
42	proteins	_	NNS	NNS	_	40	pobj	_	_
43	in	_	IN	IN	_	39	prep	_	_
44	a	_	DT	DT	_	48	det	_	_
45	primary	_	JJ	JJ	_	48	amod	_	_
46	T	_	NN	NN	_	48	nn	_	_
47	cell	_	NN	NN	_	48	nn	_	_
48	response	_	NN	NN	_	43	pobj	_	_
49	.	_	.	.	_	30	punct	_	_

1	Regulation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	IkB	_	NN	NN	_	4	nn	_	_
4	alpha	_	NN	NN	_	5	nn	_	_
5	phosphorylation	_	NN	NN	_	2	pobj	_	_
6	by	_	IN	IN	_	1	prep	_	_
7	PKC-	_	NN	NN	_	6	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	Ca-LRB-2+-RRB--dependent	_	JJ	JJ	_	7	conj	_	_
10	signal	_	NN	NN	_	12	nn	_	_
11	transduction	_	NN	NN	_	12	nn	_	_
12	pathways	_	NNS	NNS	_	7	dep	_	_
13	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	Ca-LRB-2+-RRB--dependent	_	JJ	JJ	_	3	amod	_	_
3	phosphatase	_	NN	NN	_	13	nsubj	_	_
4	calcineurin	_	NN	NN	_	3	dep	_	_
5	,	_	,	,	_	3	punct	_	_
6	a	_	DT	DT	_	7	det	_	_
7	target	_	NN	NN	_	3	appos	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	FK506	_	NN	NN	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	CsA	_	NN	NN	_	9	conj	_	_
12	,	_	,	,	_	3	punct	_	_
13	synergizes	_	VBZ	VBZ	_	0	root	_	_
14	with	_	IN	IN	_	13	prep	_	_
15	PKC-induced	_	JJ	JJ	_	16	amod	_	_
16	activation	_	NN	NN	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	nuclear	_	JJ	JJ	_	24	amod	_	_
19	factor	_	NN	NN	_	24	nn	_	_
20	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
21	NF	_	NN	NN	_	24	nn	_	_
22	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
23	-kappa	_	NN	NN	_	24	nn	_	_
24	B	_	NN	NN	_	17	pobj	_	_
25	in	_	IN	IN	_	16	prep	_	_
26	T	_	NN	NN	_	28	nn	_	_
27	cell	_	NN	NN	_	28	nn	_	_
28	lines	_	NNS	NNS	_	25	pobj	_	_
29	.	_	.	.	_	13	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	investigated	_	VBN	VBN	_	0	root	_	_
4	whether	_	IN	IN	_	8	mark	_	_
5	this	_	DT	DT	_	6	det	_	_
6	synergy	_	NN	NN	_	8	nsubj	_	_
7	is	_	VBZ	VBZ	_	8	cop	_	_
8	present	_	JJ	JJ	_	3	dep	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	other	_	JJ	JJ	_	12	amod	_	_
11	cell	_	NN	NN	_	12	nn	_	_
12	types	_	NNS	NNS	_	9	pobj	_	_
13	and	_	CC	CC	_	8	cc	_	_
14	the	_	DT	DT	_	17	det	_	_
15	mechanism	_	NN	NN	_	17	nn	_	_
16	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
17	s	_	NNS	NNS	_	8	conj	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	by	_	IN	IN	_	24	prep	_	_
20	which	_	WDT	WDT	_	19	pobj	_	_
21	these	_	DT	DT	_	23	det	_	_
22	two	_	CD	CD	_	23	num	_	_
23	pathways	_	NNS	NNS	_	24	nsubj	_	_
24	lead	_	VBP	VBP	_	17	rcmod	_	_
25	to	_	TO	TO	_	24	prep	_	_
26	NF-kappa	_	NN	NN	_	27	nn	_	_
27	B	_	NN	NN	_	28	nn	_	_
28	activation	_	NN	NN	_	25	pobj	_	_
29	.	_	.	.	_	3	punct	_	_

1	While	_	IN	IN	_	5	mark	_	_
2	this	_	DT	DT	_	3	det	_	_
3	synergy	_	NN	NN	_	5	nsubj	_	_
4	is	_	VBZ	VBZ	_	5	cop	_	_
5	present	_	JJ	JJ	_	20	advcl	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	other	_	JJ	JJ	_	9	amod	_	_
8	cell	_	NN	NN	_	9	nn	_	_
9	types	_	NNS	NNS	_	6	pobj	_	_
10	,	_	,	,	_	20	punct	_	_
11	in	_	IN	IN	_	20	prep	_	_
12	the	_	DT	DT	_	16	det	_	_
13	monocytic	_	JJ	JJ	_	16	amod	_	_
14	cell	_	NN	NN	_	16	nn	_	_
15	line	_	NN	NN	_	16	nn	_	_
16	U937	_	NN	NN	_	11	pobj	_	_
17	calcineurin	_	NN	NN	_	20	nsubj	_	_
18	is	_	VBZ	VBZ	_	20	cop	_	_
19	also	_	RB	RB	_	20	advmod	_	_
20	sufficient	_	JJ	JJ	_	0	root	_	_
21	to	_	TO	TO	_	22	aux	_	_
22	activate	_	VB	VB	_	20	xcomp	_	_
23	NF-kappa	_	NN	NN	_	24	nn	_	_
24	B	_	NN	NN	_	22	dobj	_	_
25	.	_	.	.	_	20	punct	_	_

1	Having	_	VBG	VBG	_	3	aux	_	_
2	previously	_	RB	RB	_	3	advmod	_	_
3	shown	_	VBN	VBN	_	0	root	_	_
4	that	_	IN	IN	_	10	mark	_	_
5	Ca-LRB-2+-RRB--	_	NN	NN	_	10	nsubj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	PKC-	_	NN	NN	_	5	conj	_	_
8	dependent	_	JJ	JJ	_	9	amod	_	_
9	pathways	_	NNS	NNS	_	5	dep	_	_
10	synergize	_	VBP	VBP	_	3	ccomp	_	_
11	by	_	IN	IN	_	10	prep	_	_
12	accelerating	_	VBG	VBG	_	11	pcomp	_	_
13	the	_	DT	DT	_	14	det	_	_
14	degradation	_	NN	NN	_	12	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	IkB	_	NN	NN	_	17	nn	_	_
17	alpha	_	NN	NN	_	15	pobj	_	_
18	,	_	,	,	_	3	punct	_	_
19	we	_	PRP	PRP	_	20	nsubj	_	_
20	focused	_	VBD	VBD	_	3	parataxis	_	_
21	on	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	23	det	_	_
23	regulation	_	NN	NN	_	21	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	IkB	_	NN	NN	_	26	nn	_	_
26	alpha	_	NN	NN	_	27	nn	_	_
27	phosphorylation	_	NN	NN	_	24	pobj	_	_
28	.	_	.	.	_	3	punct	_	_

1	While	_	IN	IN	_	5	mark	_	_
2	PKC-dependent	_	JJ	JJ	_	3	amod	_	_
3	pathways	_	NNS	NNS	_	5	nsubj	_	_
4	sequentially	_	RB	RB	_	5	advmod	_	_
5	result	_	VBP	VBP	_	26	advcl	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	phosphorylation	_	NN	NN	_	6	pobj	_	_
9	and	_	CC	CC	_	6	cc	_	_
10	in	_	IN	IN	_	6	conj	_	_
11	an	_	DT	DT	_	13	det	_	_
12	incomplete	_	JJ	JJ	_	13	amod	_	_
13	degradation	_	NN	NN	_	10	pobj	_	_
14	of	_	IN	IN	_	6	dep	_	_
15	IkB	_	NN	NN	_	16	nn	_	_
16	alpha	_	NN	NN	_	14	pobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	T	_	NN	NN	_	20	nn	_	_
19	cell	_	NN	NN	_	20	nn	_	_
20	lines	_	NNS	NNS	_	17	pobj	_	_
21	,	_	,	,	_	26	punct	_	_
22	co-activation	_	NN	NN	_	26	nsubj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	Ca-LRB-2+-RRB--dependent	_	JJ	JJ	_	25	amod	_	_
25	pathways	_	NNS	NNS	_	23	pobj	_	_
26	accelerates	_	VBZ	VBZ	_	0	root	_	_
27	the	_	DT	DT	_	28	det	_	_
28	rate	_	NN	NN	_	26	dobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	IkB	_	NN	NN	_	31	nn	_	_
31	alpha	_	NN	NN	_	32	nn	_	_
32	phosphorylation	_	NN	NN	_	29	pobj	_	_
33	and	_	CC	CC	_	26	cc	_	_
34	results	_	VBZ	VBZ	_	26	conj	_	_
35	in	_	IN	IN	_	34	prep	_	_
36	its	_	PRP$	PRP$	_	38	poss	_	_
37	complete	_	JJ	JJ	_	38	amod	_	_
38	degradation	_	NN	NN	_	35	pobj	_	_
39	.	_	.	.	_	26	punct	_	_

1	Activation	_	NN	NN	_	8	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	Ca-LRB-2+-RRB--dependent	_	JJ	JJ	_	4	amod	_	_
4	pathways	_	NNS	NNS	_	2	pobj	_	_
5	alone	_	RB	RB	_	4	advmod	_	_
6	do	_	VBP	VBP	_	8	aux	_	_
7	not	_	RB	RB	_	8	neg	_	_
8	result	_	VB	VB	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	dep	_	_
11	phosphorylation	_	NN	NN	_	9	pobj	_	_
12	and/or	_	CC	CC	_	11	cc	_	_
13	degradation	_	NN	NN	_	11	conj	_	_
14	of	_	IN	IN	_	11	prep	_	_
15	IkB	_	NN	NN	_	16	nn	_	_
16	alpha	_	NN	NN	_	14	pobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	Jurkat	_	NN	NN	_	19	nn	_	_
19	T	_	NN	NN	_	17	pobj	_	_
20	or	_	CC	CC	_	17	cc	_	_
21	in	_	IN	IN	_	17	conj	_	_
22	U937	_	NN	NN	_	23	nn	_	_
23	cells	_	NNS	NNS	_	21	pobj	_	_
24	.	_	.	.	_	8	punct	_	_

1	Treatment	_	NN	NN	_	11	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	T	_	NN	NN	_	4	nn	_	_
4	cells	_	NNS	NNS	_	2	pobj	_	_
5	with	_	IN	IN	_	1	prep	_	_
6	the	_	DT	DT	_	10	det	_	_
7	selective	_	JJ	JJ	_	10	amod	_	_
8	PKC	_	NN	NN	_	10	nn	_	_
9	inhibitor	_	NN	NN	_	10	nn	_	_
10	GF109203X	_	NN	NN	_	5	pobj	_	_
11	abrogates	_	VBZ	VBZ	_	0	root	_	_
12	the	_	DT	DT	_	16	det	_	_
13	PMA-induced	_	JJ	JJ	_	16	amod	_	_
14	IkB	_	NN	NN	_	15	nn	_	_
15	alpha	_	NN	NN	_	16	nn	_	_
16	phosphorylation/degradation	_	NN	NN	_	11	dobj	_	_
17	irrespective	_	JJ	JJ	_	16	amod	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	activation	_	NN	NN	_	18	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	Ca-LRB-2+-RRB--dependent	_	JJ	JJ	_	22	amod	_	_
22	pathways	_	NNS	NNS	_	20	pobj	_	_
23	,	_	,	,	_	16	punct	_	_
24	but	_	CC	CC	_	25	cc	_	_
25	not	_	RB	RB	_	16	cc	_	_
26	the	_	DT	DT	_	27	dep	_	_
27	phosphorylation	_	NN	NN	_	16	conj	_	_
28	and	_	CC	CC	_	27	cc	_	_
29	degradation	_	NN	NN	_	27	conj	_	_
30	of	_	IN	IN	_	27	prep	_	_
31	IkB	_	NN	NN	_	32	nn	_	_
32	alpha	_	NN	NN	_	30	pobj	_	_
33	induced	_	VBN	VBN	_	32	vmod	_	_
34	by	_	IN	IN	_	33	prep	_	_
35	TNF-alpha	_	NN	NN	_	34	pobj	_	_
36	,	_	,	,	_	35	punct	_	_
37	a	_	DT	DT	_	39	det	_	_
38	PKC-independent	_	JJ	JJ	_	39	amod	_	_
39	stimulus	_	NN	NN	_	35	appos	_	_
40	.	_	.	.	_	11	punct	_	_

1	Contrary	_	JJ	JJ	_	10	advmod	_	_
2	to	_	TO	TO	_	1	prep	_	_
3	the	_	DT	DT	_	4	det	_	_
4	interaction	_	NN	NN	_	2	pobj	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	PKC	_	NN	NN	_	5	pobj	_	_
7	,	_	,	,	_	10	punct	_	_
8	Ca-LRB-2+-RRB--dependent	_	JJ	JJ	_	9	amod	_	_
9	pathways	_	NNS	NNS	_	10	nsubj	_	_
10	synergize	_	VBP	VBP	_	0	root	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	TNF-alpha	_	NN	NN	_	11	pobj	_	_
13	not	_	RB	RB	_	14	neg	_	_
14	at	_	IN	IN	_	10	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	level	_	NN	NN	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	IkB	_	NN	NN	_	19	nn	_	_
19	alpha	_	NN	NN	_	20	nn	_	_
20	phosphorylation	_	NN	NN	_	17	pobj	_	_
21	,	_	,	,	_	14	punct	_	_
22	but	_	CC	CC	_	14	cc	_	_
23	at	_	IN	IN	_	14	conj	_	_
24	the	_	DT	DT	_	25	det	_	_
25	level	_	NN	NN	_	23	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	its	_	PRP$	PRP$	_	28	poss	_	_
28	degradation	_	NN	NN	_	26	pobj	_	_
29	.	_	.	.	_	10	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	13	mark	_	_
5	Ca-LRB-2+-RRB--dependent	_	JJ	JJ	_	6	amod	_	_
6	pathways	_	NNS	NNS	_	13	nsubj	_	_
7	,	_	,	,	_	6	punct	_	_
8	including	_	VBG	VBG	_	6	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	phosphatase	_	NN	NN	_	8	pobj	_	_
11	calcineurin	_	NN	NN	_	10	dep	_	_
12	,	_	,	,	_	6	punct	_	_
13	participate	_	VBP	VBP	_	3	ccomp	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	regulation	_	NN	NN	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	NF-kappa	_	NN	NN	_	19	nn	_	_
19	B	_	NN	NN	_	17	pobj	_	_
20	in	_	IN	IN	_	13	prep	_	_
21	a	_	DT	DT	_	24	det	_	_
22	cell	_	NN	NN	_	24	nn	_	_
23	specific	_	JJ	JJ	_	24	amod	_	_
24	fashion	_	NN	NN	_	20	pobj	_	_
25	and	_	CC	CC	_	13	cc	_	_
26	synergize	_	VBP	VBP	_	13	conj	_	_
27	with	_	IN	IN	_	26	prep	_	_
28	PKC-dependent	_	JJ	JJ	_	27	pobj	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	-independent	_	JJ	JJ	_	28	conj	_	_
31	pathways	_	NNS	NNS	_	28	dep	_	_
32	at	_	IN	IN	_	26	prep	_	_
33	the	_	DT	DT	_	34	det	_	_
34	level	_	NN	NN	_	32	pobj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	IkB	_	NN	NN	_	37	nn	_	_
37	alpha	_	NN	NN	_	35	pobj	_	_
38	phosphorylation	_	NN	NN	_	37	dep	_	_
39	and	_	CC	CC	_	37	cc	_	_
40	degradation	_	NN	NN	_	37	conj	_	_
41	.	_	.	.	_	3	punct	_	_

1	Triggering	_	NN	NN	_	14	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	complement	_	NN	NN	_	4	nn	_	_
4	receptors	_	NNS	NNS	_	2	pobj	_	_
5	CR1	_	NN	NN	_	4	dep	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	CD35	_	NN	NN	_	5	appos	_	_
8	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
9	and	_	CC	CC	_	5	cc	_	_
10	CR3	_	NN	NN	_	5	conj	_	_
11	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
12	CD11b/CD18	_	NN	NN	_	10	appos	_	_
13	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	induces	_	VBZ	VBZ	_	0	root	_	_
15	nuclear	_	JJ	JJ	_	16	amod	_	_
16	translocation	_	NN	NN	_	14	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	NF-kappa	_	NN	NN	_	19	nn	_	_
19	B	_	NN	NN	_	17	pobj	_	_
20	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
21	p50	_	NN	NN	_	22	nn	_	_
22	/p65	_	NN	NN	_	19	appos	_	_
23	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
24	in	_	IN	IN	_	16	prep	_	_
25	human	_	JJ	JJ	_	26	amod	_	_
26	monocytes	_	NNS	NNS	_	24	pobj	_	_
27	and	_	CC	CC	_	14	cc	_	_
28	enhances	_	VBZ	VBZ	_	14	conj	_	_
29	viral	_	JJ	JJ	_	30	amod	_	_
30	replication	_	NN	NN	_	28	dobj	_	_
31	in	_	IN	IN	_	30	prep	_	_
32	HIV-infected	_	JJ	JJ	_	34	amod	_	_
33	monocytic	_	JJ	JJ	_	34	amod	_	_
34	cells	_	NNS	NNS	_	31	pobj	_	_
35	.	_	.	.	_	14	punct	_	_

1	Monocyte/macrophages	_	NNS	NNS	_	3	nsubj	_	_
2	may	_	MD	MD	_	3	aux	_	_
3	harbor	_	VB	VB	_	0	root	_	_
4	HIV	_	NN	NN	_	3	dobj	_	_
5	in	_	IN	IN	_	3	prep	_	_
6	a	_	DT	DT	_	8	det	_	_
7	nonproductive	_	JJ	JJ	_	8	amod	_	_
8	fashion	_	NN	NN	_	5	pobj	_	_
9	for	_	IN	IN	_	3	prep	_	_
10	prolonged	_	JJ	JJ	_	11	amod	_	_
11	periods	_	NNS	NNS	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	time	_	NN	NN	_	12	pobj	_	_
14	.	_	.	.	_	3	punct	_	_

1	Viral	_	JJ	JJ	_	3	amod	_	_
2	gene	_	NN	NN	_	3	nn	_	_
3	expression	_	NN	NN	_	6	nsubjpass	_	_
4	may	_	MD	MD	_	6	aux	_	_
5	be	_	VB	VB	_	6	auxpass	_	_
6	reactivated	_	VBN	VBN	_	0	root	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	stimulation	_	NN	NN	_	7	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	cells	_	NNS	NNS	_	9	pobj	_	_
12	with	_	IN	IN	_	8	prep	_	_
13	LPS	_	NN	NN	_	12	pobj	_	_
14	or	_	CC	CC	_	13	cc	_	_
15	cytokines	_	NNS	NNS	_	13	conj	_	_
16	such	_	JJ	JJ	_	17	mwe	_	_
17	as	_	IN	IN	_	15	prep	_	_
18	TNF-alpha	_	NN	NN	_	17	pobj	_	_
19	in	_	FW	FW	_	20	nn	_	_
20	vitro	_	FW	FW	_	6	advmod	_	_
21	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	effect	_	NN	NN	_	8	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	LPS	_	NN	NN	_	3	pobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	TNF-alpha	_	NN	NN	_	4	conj	_	_
7	is	_	VBZ	VBZ	_	8	auxpass	_	_
8	mediated	_	VBN	VBN	_	0	root	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	their	_	PRP$	PRP$	_	11	poss	_	_
11	ability	_	NN	NN	_	9	pobj	_	_
12	to	_	TO	TO	_	13	aux	_	_
13	induce	_	VB	VB	_	11	vmod	_	_
14	nuclear	_	JJ	JJ	_	15	amod	_	_
15	translocation	_	NN	NN	_	13	dobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	DNA-binding	_	JJ	JJ	_	19	amod	_	_
19	heterodimer	_	NN	NN	_	16	pobj	_	_
20	NF-kappa	_	NN	NN	_	21	nn	_	_
21	B	_	NN	NN	_	19	dep	_	_
22	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
23	p50	_	NN	NN	_	24	nn	_	_
24	/p65	_	NN	NN	_	21	appos	_	_
25	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
26	,	_	,	,	_	19	punct	_	_
27	which	_	WDT	WDT	_	28	nsubj	_	_
28	binds	_	VBZ	VBZ	_	19	rcmod	_	_
29	to	_	TO	TO	_	28	prep	_	_
30	a	_	DT	DT	_	32	det	_	_
31	specific	_	JJ	JJ	_	32	amod	_	_
32	sequence	_	NN	NN	_	29	pobj	_	_
33	in	_	IN	IN	_	32	prep	_	_
34	the	_	DT	DT	_	37	det	_	_
35	HIV-long	_	JJ	JJ	_	37	amod	_	_
36	terminal	_	JJ	JJ	_	37	amod	_	_
37	repeat	_	NN	NN	_	33	pobj	_	_
38	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	present	_	JJ	JJ	_	3	amod	_	_
3	study	_	NN	NN	_	4	nsubj	_	_
4	demonstrates	_	VBZ	VBZ	_	0	root	_	_
5	that	_	IN	IN	_	19	mark	_	_
6	triggering	_	NN	NN	_	19	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	complement	_	NN	NN	_	9	nn	_	_
9	receptors	_	NNS	NNS	_	7	pobj	_	_
10	CR1	_	NN	NN	_	9	dep	_	_
11	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
12	CD35	_	NN	NN	_	10	appos	_	_
13	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	and	_	CC	CC	_	10	cc	_	_
15	CR3	_	NN	NN	_	10	conj	_	_
16	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
17	CD11b/CD18	_	NN	NN	_	15	appos	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	enhances	_	VBZ	VBZ	_	4	ccomp	_	_
20	viral	_	JJ	JJ	_	21	amod	_	_
21	replication	_	NN	NN	_	19	dobj	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	HIV-infected	_	JJ	JJ	_	26	amod	_	_
24	human	_	JJ	JJ	_	26	amod	_	_
25	monocytic	_	JJ	JJ	_	26	amod	_	_
26	cells	_	NNS	NNS	_	22	pobj	_	_
27	.	_	.	.	_	4	punct	_	_

1	Monocytic	_	JJ	JJ	_	3	amod	_	_
2	cell	_	NN	NN	_	3	nn	_	_
3	lines	_	NNS	NNS	_	10	nsubjpass	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	normal	_	JJ	JJ	_	8	amod	_	_
6	peripheral	_	JJ	JJ	_	8	amod	_	_
7	blood	_	NN	NN	_	8	nn	_	_
8	monocytes	_	NNS	NNS	_	3	conj	_	_
9	were	_	VBD	VBD	_	10	auxpass	_	_
10	infected	_	VBN	VBN	_	0	root	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	HIV-1	_	NN	NN	_	11	pobj	_	_
13	in	_	FW	FW	_	14	nn	_	_
14	vitro	_	FW	FW	_	10	advmod	_	_
15	and	_	CC	CC	_	10	cc	_	_
16	cultured	_	VBN	VBN	_	10	conj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	19	dep	_	_
19	presence	_	NN	NN	_	17	pobj	_	_
20	or	_	CC	CC	_	19	cc	_	_
21	absence	_	NN	NN	_	19	conj	_	_
22	of	_	IN	IN	_	19	prep	_	_
23	F-LRB-ab'-RRB-2	_	NN	NN	_	24	nn	_	_
24	fragments	_	NNS	NNS	_	22	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	monoclonal	_	JJ	JJ	_	27	amod	_	_
27	anti-CR1	_	JJ	JJ	_	25	pobj	_	_
28	or	_	CC	CC	_	27	cc	_	_
29	anti-CR3	_	JJ	JJ	_	30	amod	_	_
30	Abs	_	NNS	NNS	_	27	conj	_	_
31	or	_	CC	CC	_	17	cc	_	_
32	with	_	IN	IN	_	17	conj	_	_
33	C3	_	NN	NN	_	34	nn	_	_
34	fragments	_	NNS	NNS	_	32	pobj	_	_
35	.	_	.	.	_	10	punct	_	_

1	Stimulation	_	NN	NN	_	6	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	CR1	_	NN	NN	_	2	pobj	_	_
4	or	_	CC	CC	_	3	cc	_	_
5	CR3	_	NN	NN	_	3	conj	_	_
6	induces	_	VBZ	VBZ	_	0	root	_	_
7	a	_	DT	DT	_	11	det	_	_
8	two-	_	CD	CD	_	10	number	_	_
9	to	_	TO	TO	_	10	dep	_	_
10	fourfold	_	JJ	JJ	_	11	amod	_	_
11	increase	_	NN	NN	_	6	dobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	amount	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	cell-associated	_	JJ	JJ	_	20	amod	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	released	_	VBN	VBN	_	16	conj	_	_
19	p24	_	NN	NN	_	20	nn	_	_
20	Ag	_	NN	NN	_	15	pobj	_	_
21	in	_	IN	IN	_	14	prep	_	_
22	cell	_	NN	NN	_	23	nn	_	_
23	cultures	_	NNS	NNS	_	21	pobj	_	_
24	that	_	WDT	WDT	_	26	nsubj	_	_
25	was	_	VBD	VBD	_	26	cop	_	_
26	equivalent	_	JJ	JJ	_	11	rcmod	_	_
27	to	_	TO	TO	_	26	prep	_	_
28	that	_	DT	DT	_	27	pobj	_	_
29	observed	_	VBN	VBN	_	28	vmod	_	_
30	in	_	IN	IN	_	29	prep	_	_
31	control	_	JJ	JJ	_	32	amod	_	_
32	cultures	_	NNS	NNS	_	30	pobj	_	_
33	triggered	_	VBN	VBN	_	32	vmod	_	_
34	with	_	IN	IN	_	33	prep	_	_
35	LPS	_	NN	NN	_	34	pobj	_	_
36	.	_	.	.	_	6	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	further	_	RB	RB	_	3	advmod	_	_
3	observed	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	10	mark	_	_
5	stimulation	_	NN	NN	_	10	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	CR1	_	NN	NN	_	6	pobj	_	_
8	or	_	CC	CC	_	7	cc	_	_
9	CR3	_	NN	NN	_	7	conj	_	_
10	induces	_	VBZ	VBZ	_	3	ccomp	_	_
11	the	_	DT	DT	_	13	det	_	_
12	nuclear	_	JJ	JJ	_	13	amod	_	_
13	translocation	_	NN	NN	_	10	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	NF-kappa	_	NN	NN	_	16	nn	_	_
16	B	_	NN	NN	_	14	pobj	_	_
17	p50	_	NN	NN	_	18	nn	_	_
18	/p65	_	NN	NN	_	16	dep	_	_
19	in	_	IN	IN	_	13	prep	_	_
20	infected	_	JJ	JJ	_	21	amod	_	_
21	cells	_	NNS	NNS	_	19	pobj	_	_
22	.	_	.	.	_	3	punct	_	_

1	Translocation	_	NN	NN	_	9	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	NF-kappa	_	NN	NN	_	4	nn	_	_
4	B	_	NN	NN	_	2	pobj	_	_
5	p50	_	NN	NN	_	6	nn	_	_
6	/p65	_	NN	NN	_	4	dep	_	_
7	was	_	VBD	VBD	_	9	auxpass	_	_
8	also	_	RB	RB	_	9	advmod	_	_
9	observed	_	VBN	VBN	_	0	root	_	_
10	following	_	VBG	VBG	_	9	prep	_	_
11	stimulation	_	NN	NN	_	10	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	CR1	_	NN	NN	_	12	pobj	_	_
14	or	_	CC	CC	_	13	cc	_	_
15	CR3	_	NN	NN	_	13	conj	_	_
16	of	_	IN	IN	_	13	prep	_	_
17	uninfected	_	JJ	JJ	_	20	amod	_	_
18	peripheral	_	JJ	JJ	_	20	amod	_	_
19	blood	_	NN	NN	_	20	nn	_	_
20	monocytes	_	NNS	NNS	_	16	pobj	_	_
21	from	_	IN	IN	_	20	prep	_	_
22	HIV-seronegative	_	JJ	JJ	_	23	amod	_	_
23	donors	_	NNS	NNS	_	21	pobj	_	_
24	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	amount	_	NN	NN	_	7	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	protein	_	NN	NN	_	3	pobj	_	_
5	translocated	_	VBN	VBN	_	4	vmod	_	_
6	was	_	VBD	VBD	_	7	cop	_	_
7	similar	_	JJ	JJ	_	0	root	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	that	_	DT	DT	_	8	pobj	_	_
10	observed	_	VBN	VBN	_	9	vmod	_	_
11	when	_	WRB	WRB	_	14	advmod	_	_
12	cells	_	NNS	NNS	_	14	nsubjpass	_	_
13	were	_	VBD	VBD	_	14	auxpass	_	_
14	stimulated	_	VBN	VBN	_	10	advcl	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	rhTNF-alpha	_	NN	NN	_	15	pobj	_	_
17	.	_	.	.	_	7	punct	_	_

1	TNF-alpha	_	NN	NN	_	4	nsubj	_	_
2	did	_	VBD	VBD	_	4	aux	_	_
3	not	_	RB	RB	_	4	neg	_	_
4	mediate	_	VB	VB	_	0	root	_	_
5	the	_	DT	DT	_	6	det	_	_
6	translocation	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	NF-kappa	_	NN	NN	_	9	nn	_	_
9	B	_	NN	NN	_	7	pobj	_	_
10	p50	_	NN	NN	_	11	nn	_	_
11	/p65	_	NN	NN	_	9	dep	_	_
12	induced	_	VBN	VBN	_	9	vmod	_	_
13	by	_	IN	IN	_	12	prep	_	_
14	triggering	_	NN	NN	_	13	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	complement	_	NN	NN	_	17	nn	_	_
17	receptors	_	NNS	NNS	_	15	pobj	_	_
18	.	_	.	.	_	4	punct	_	_

1	Taken	_	VBN	VBN	_	0	root	_	_
2	together	_	RB	RB	_	1	advmod	_	_
3	,	_	,	,	_	1	punct	_	_
4	these	_	DT	DT	_	5	det	_	_
5	observations	_	NNS	NNS	_	6	nsubj	_	_
6	suggest	_	VBP	VBP	_	1	parataxis	_	_
7	that	_	IN	IN	_	13	mark	_	_
8	HIV	_	NN	NN	_	10	nn	_	_
9	gene	_	NN	NN	_	10	nn	_	_
10	expression	_	NN	NN	_	13	nsubjpass	_	_
11	may	_	MD	MD	_	13	aux	_	_
12	be	_	VB	VB	_	13	auxpass	_	_
13	activated	_	VBN	VBN	_	6	ccomp	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	infected	_	JJ	JJ	_	16	amod	_	_
16	monocytes	_	NNS	NNS	_	14	pobj	_	_
17	through	_	IN	IN	_	13	prep	_	_
18	interaction	_	NN	NN	_	17	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	21	det	_	_
21	cells	_	NNS	NNS	_	19	pobj	_	_
22	with	_	IN	IN	_	18	prep	_	_
23	complement-opsonized	_	JJ	JJ	_	24	amod	_	_
24	particles	_	NNS	NNS	_	22	pobj	_	_
25	and	_	CC	CC	_	13	cc	_	_
26	that	_	IN	IN	_	31	mark	_	_
27	enhanced	_	VBN	VBN	_	29	amod	_	_
28	viral	_	JJ	JJ	_	29	amod	_	_
29	replication	_	NN	NN	_	31	nsubjpass	_	_
30	is	_	VBZ	VBZ	_	31	auxpass	_	_
31	associated	_	VBN	VBN	_	13	conj	_	_
32	with	_	IN	IN	_	31	prep	_	_
33	C3	_	NN	NN	_	36	nn	_	_
34	receptor-mediated	_	JJ	JJ	_	36	amod	_	_
35	nuclear	_	JJ	JJ	_	36	amod	_	_
36	translocation	_	NN	NN	_	32	pobj	_	_
37	of	_	IN	IN	_	36	prep	_	_
38	the	_	DT	DT	_	41	det	_	_
39	NF-kappa	_	NN	NN	_	41	nn	_	_
40	B	_	NN	NN	_	41	nn	_	_
41	complex	_	NN	NN	_	37	pobj	_	_
42	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	activation	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	8	det	_	_
5	Jak-STAT	_	JJ	JJ	_	8	amod	_	_
6	1	_	CD	CD	_	8	num	_	_
7	signaling	_	NN	NN	_	8	nn	_	_
8	pathway	_	NN	NN	_	3	pobj	_	_
9	by	_	IN	IN	_	2	prep	_	_
10	IL-5	_	NN	NN	_	9	pobj	_	_
11	in	_	IN	IN	_	2	prep	_	_
12	eosinophils	_	NNS	NNS	_	11	pobj	_	_
13	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	intracellular	_	JJ	JJ	_	4	amod	_	_
3	signal	_	NN	NN	_	4	nn	_	_
4	transduction	_	NN	NN	_	10	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	IL-5	_	NN	NN	_	5	pobj	_	_
7	in	_	IN	IN	_	4	prep	_	_
8	eosinophils	_	NNS	NNS	_	7	pobj	_	_
9	is	_	VBZ	VBZ	_	10	cop	_	_
10	unknown	_	JJ	JJ	_	0	root	_	_
11	.	_	.	.	_	10	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	objective	_	NN	NN	_	6	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	this	_	DT	DT	_	5	det	_	_
5	study	_	NN	NN	_	3	pobj	_	_
6	was	_	VBD	VBD	_	0	root	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	investigate	_	VB	VB	_	6	xcomp	_	_
9	the	_	DT	DT	_	10	det	_	_
10	involvement	_	NN	NN	_	8	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	16	det	_	_
13	newly	_	RB	RB	_	14	advmod	_	_
14	discovered	_	VBN	VBN	_	16	amod	_	_
15	Jak-STAT	_	JJ	JJ	_	16	amod	_	_
16	pathway	_	NN	NN	_	11	pobj	_	_
17	in	_	IN	IN	_	8	prep	_	_
18	the	_	DT	DT	_	22	det	_	_
19	IL-5	_	NN	NN	_	22	nn	_	_
20	signal	_	NN	NN	_	22	nn	_	_
21	transduction	_	NN	NN	_	22	nn	_	_
22	mechanism	_	NN	NN	_	17	pobj	_	_
23	.	_	.	.	_	6	punct	_	_

1	Eosinophils	_	NNS	NNS	_	3	nsubjpass	_	_
2	were	_	VBD	VBD	_	3	auxpass	_	_
3	purified	_	VBN	VBN	_	0	root	_	_
4	from	_	IN	IN	_	3	prep	_	_
5	peripheral	_	JJ	JJ	_	6	amod	_	_
6	blood	_	NN	NN	_	4	pobj	_	_
7	by	_	IN	IN	_	3	prep	_	_
8	discontinuous	_	JJ	JJ	_	10	amod	_	_
9	Percoll	_	NN	NN	_	10	nn	_	_
10	gradients	_	NNS	NNS	_	7	pobj	_	_
11	and	_	CC	CC	_	3	cc	_	_
12	stimulated	_	VBN	VBN	_	3	conj	_	_
13	with	_	IN	IN	_	12	prep	_	_
14	IL-5	_	NN	NN	_	13	pobj	_	_
15	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	involvement	_	NN	NN	_	7	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	Jak	_	NN	NN	_	3	pobj	_	_
5	2	_	CD	CD	_	4	num	_	_
6	was	_	VBD	VBD	_	7	auxpass	_	_
7	investigated	_	VBN	VBN	_	0	root	_	_
8	by	_	IN	IN	_	7	prep	_	_
9	immunoprecipitation	_	NN	NN	_	8	pobj	_	_
10	followed	_	VBN	VBN	_	7	dep	_	_
11	by	_	IN	IN	_	10	prep	_	_
12	immunoblotting	_	VBG	VBG	_	11	pobj	_	_
13	for	_	IN	IN	_	12	prep	_	_
14	tyrosine	_	NN	NN	_	15	nn	_	_
15	phosphorylation	_	NN	NN	_	13	pobj	_	_
16	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	activation	_	NN	NN	_	7	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	Jak	_	NN	NN	_	3	pobj	_	_
5	2	_	CD	CD	_	4	num	_	_
6	was	_	VBD	VBD	_	7	auxpass	_	_
7	studied	_	VBN	VBN	_	0	root	_	_
8	by	_	IN	IN	_	7	prep	_	_
9	autophosphorylation	_	NN	NN	_	8	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	immunoprecipitated	_	VBN	VBN	_	13	amod	_	_
13	kinase	_	NN	NN	_	10	pobj	_	_
14	.	_	.	.	_	7	punct	_	_

1	Jak	_	NN	NN	_	5	nsubj	_	_
2	2	_	CD	CD	_	1	num	_	_
3	was	_	VBD	VBD	_	5	cop	_	_
4	tyrosine	_	NN	NN	_	5	npadvmod	_	_
5	phosphorylated	_	JJ	JJ	_	0	root	_	_
6	within	_	IN	IN	_	5	prep	_	_
7	1	_	CD	CD	_	9	number	_	_
8	to	_	TO	TO	_	9	dep	_	_
9	3	_	CD	CD	_	10	num	_	_
10	min	_	NN	NN	_	6	pobj	_	_
11	after	_	IN	IN	_	10	prep	_	_
12	stimulation	_	NN	NN	_	11	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	eosinophils	_	NNS	NNS	_	13	pobj	_	_
15	with	_	IN	IN	_	12	prep	_	_
16	IL-5	_	NN	NN	_	15	pobj	_	_
17	.	_	.	.	_	5	punct	_	_

1	Further	_	RB	RB	_	11	advmod	_	_
2	,	_	,	,	_	11	punct	_	_
3	the	_	DT	DT	_	5	det	_	_
4	immunoprecipitated	_	VBN	VBN	_	5	amod	_	_
5	Jak	_	NN	NN	_	11	nsubj	_	_
6	2	_	CD	CD	_	5	num	_	_
7	obtained	_	VBN	VBN	_	5	vmod	_	_
8	from	_	IN	IN	_	7	prep	_	_
9	IL-5-stimulated	_	JJ	JJ	_	10	amod	_	_
10	cells	_	NNS	NNS	_	8	pobj	_	_
11	underwent	_	VBD	VBD	_	0	root	_	_
12	autophosphorylation	_	NN	NN	_	11	dobj	_	_
13	.	_	.	.	_	11	punct	_	_

1	Jak	_	NN	NN	_	3	nsubj	_	_
2	2	_	CD	CD	_	1	num	_	_
3	coprecipitated	_	VBD	VBD	_	0	root	_	_
4	with	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	6	det	_	_
6	beta-subunit	_	NN	NN	_	4	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	IL-5	_	NN	NN	_	10	nn	_	_
10	receptor	_	NN	NN	_	7	pobj	_	_
11	,	_	,	,	_	3	punct	_	_
12	suggesting	_	VBG	VBG	_	3	xcomp	_	_
13	a	_	DT	DT	_	15	det	_	_
14	physical	_	JJ	JJ	_	15	amod	_	_
15	association	_	NN	NN	_	12	dobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	kinase	_	NN	NN	_	16	pobj	_	_
19	with	_	IN	IN	_	15	prep	_	_
20	the	_	DT	DT	_	21	det	_	_
21	receptor	_	NN	NN	_	19	pobj	_	_
22	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	nuclear	_	JJ	JJ	_	4	amod	_	_
3	factor	_	NN	NN	_	4	nn	_	_
4	STAT-1	_	NN	NN	_	9	nsubjpass	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	p91	_	NN	NN	_	4	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	was	_	VBD	VBD	_	9	auxpass	_	_
9	investigated	_	VBN	VBN	_	0	root	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	immunoprecipitation	_	NN	NN	_	10	pobj	_	_
12	followed	_	VBN	VBN	_	9	dep	_	_
13	by	_	IN	IN	_	12	prep	_	_
14	immunoblotting	_	VBG	VBG	_	13	pobj	_	_
15	for	_	IN	IN	_	14	prep	_	_
16	tyrosine	_	NN	NN	_	17	nn	_	_
17	phosphorylation	_	NN	NN	_	15	pobj	_	_
18	.	_	.	.	_	9	punct	_	_

1	STAT-1	_	NN	NN	_	4	nsubj	_	_
2	was	_	VBD	VBD	_	4	cop	_	_
3	tyrosine	_	NN	NN	_	4	npadvmod	_	_
4	phosphorylated	_	JJ	JJ	_	0	root	_	_
5	within	_	IN	IN	_	4	prep	_	_
6	15	_	CD	CD	_	7	num	_	_
7	min	_	NN	NN	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	IL-5	_	NN	NN	_	10	nn	_	_
10	stimulation	_	NN	NN	_	8	pobj	_	_
11	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	presence	_	NN	NN	_	10	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	STAT-1	_	NN	NN	_	3	pobj	_	_
5	in	_	IN	IN	_	2	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	nuclear	_	JJ	JJ	_	8	amod	_	_
8	extract	_	NN	NN	_	5	pobj	_	_
9	was	_	VBD	VBD	_	10	auxpass	_	_
10	studied	_	VBN	VBN	_	0	root	_	_
11	by	_	IN	IN	_	10	prep	_	_
12	electrophoretic	_	JJ	JJ	_	15	amod	_	_
13	mobility	_	NN	NN	_	15	nn	_	_
14	shift	_	NN	NN	_	15	nn	_	_
15	assay	_	NN	NN	_	11	pobj	_	_
16	.	_	.	.	_	10	punct	_	_

1	IL-5	_	NN	NN	_	2	nsubj	_	_
2	induced	_	VBD	VBD	_	0	root	_	_
3	two	_	CD	CD	_	4	num	_	_
4	proteins	_	NNS	NNS	_	2	dobj	_	_
5	that	_	WDT	WDT	_	6	nsubj	_	_
6	bound	_	VBD	VBD	_	4	rcmod	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	gamma-activating	_	JJ	JJ	_	10	amod	_	_
10	sequence	_	NN	NN	_	7	pobj	_	_
11	.	_	.	.	_	2	punct	_	_

1	In	_	IN	IN	_	12	prep	_	_
2	the	_	DT	DT	_	3	det	_	_
3	presence	_	NN	NN	_	1	pobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	an	_	DT	DT	_	7	det	_	_
6	anti-STAT-1	_	JJ	JJ	_	7	amod	_	_
7	Ab	_	NN	NN	_	4	pobj	_	_
8	,	_	,	,	_	12	punct	_	_
9	the	_	DT	DT	_	10	det	_	_
10	band	_	NN	NN	_	12	nsubjpass	_	_
11	was	_	VBD	VBD	_	12	auxpass	_	_
12	supershifted	_	VBN	VBN	_	0	root	_	_
13	.	_	.	.	_	12	punct	_	_

1	Thus	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	demonstrated	_	VBD	VBD	_	0	root	_	_
5	that	_	IN	IN	_	7	mark	_	_
6	IL-5	_	NN	NN	_	7	nsubj	_	_
7	activated	_	VBD	VBD	_	4	ccomp	_	_
8	the	_	DT	DT	_	13	det	_	_
9	Jak	_	NN	NN	_	13	nn	_	_
10	2-STAT	_	NN	NN	_	13	nn	_	_
11	1	_	CD	CD	_	13	num	_	_
12	signaling	_	NN	NN	_	13	nn	_	_
13	pathway	_	NN	NN	_	7	dobj	_	_
14	in	_	IN	IN	_	7	prep	_	_
15	eosinophils	_	NNS	NNS	_	14	pobj	_	_
16	.	_	.	.	_	4	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	speculate	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	11	mark	_	_
4	the	_	DT	DT	_	8	det	_	_
5	Jak	_	NN	NN	_	8	nn	_	_
6	2-STAT	_	NN	NN	_	8	nn	_	_
7	1	_	CD	CD	_	8	num	_	_
8	pathway	_	NN	NN	_	11	nsubjpass	_	_
9	may	_	MD	MD	_	11	aux	_	_
10	be	_	VB	VB	_	11	auxpass	_	_
11	involved	_	VBN	VBN	_	2	ccomp	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	activation	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	IL-5-inducible	_	JJ	JJ	_	17	amod	_	_
17	genes	_	NNS	NNS	_	15	pobj	_	_
18	in	_	IN	IN	_	14	prep	_	_
19	eosinophils	_	NNS	NNS	_	18	pobj	_	_
20	.	_	.	.	_	2	punct	_	_

1	Constitutively	_	RB	RB	_	2	advmod	_	_
2	activated	_	VBN	VBN	_	4	amod	_	_
3	Jak-STAT	_	JJ	JJ	_	4	amod	_	_
4	pathway	_	NN	NN	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	T	_	NN	NN	_	7	nn	_	_
7	cells	_	NNS	NNS	_	5	pobj	_	_
8	transformed	_	VBN	VBN	_	7	vmod	_	_
9	with	_	IN	IN	_	8	prep	_	_
10	HTLV-I	_	NN	NN	_	9	pobj	_	_
11	.	_	.	.	_	4	punct	_	_

1	Human	_	JJ	JJ	_	6	amod	_	_
2	T	_	NN	NN	_	6	nn	_	_
3	cell	_	NN	NN	_	6	nn	_	_
4	lymphotropic	_	JJ	JJ	_	6	amod	_	_
5	virus	_	NN	NN	_	6	nn	_	_
6	I	_	NN	NN	_	13	nsubj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	HTLV-I	_	NN	NN	_	6	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	is	_	VBZ	VBZ	_	13	cop	_	_
11	the	_	DT	DT	_	13	det	_	_
12	etiological	_	JJ	JJ	_	13	amod	_	_
13	agent	_	NN	NN	_	0	root	_	_
14	for	_	IN	IN	_	13	prep	_	_
15	adult	_	JJ	JJ	_	18	amod	_	_
16	T	_	NN	NN	_	18	nn	_	_
17	cell	_	NN	NN	_	18	nn	_	_
18	leukemia	_	NN	NN	_	14	pobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	tropical	_	JJ	JJ	_	21	amod	_	_
21	spastic	_	JJ	JJ	_	22	amod	_	_
22	paraparesis	_	NN	NN	_	18	conj	_	_
23	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
24	also	_	RB	RB	_	25	dep	_	_
25	termed	_	VBN	VBN	_	22	dep	_	_
26	HTLV-I-associated	_	JJ	JJ	_	27	amod	_	_
27	myelopathy	_	NN	NN	_	25	dep	_	_
28	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
29	.	_	.	.	_	13	punct	_	_

1	HTLV-I-infected	_	JJ	JJ	_	5	amod	_	_
2	peripheral	_	JJ	JJ	_	5	amod	_	_
3	blood	_	NN	NN	_	5	nn	_	_
4	T	_	NN	NN	_	5	nn	_	_
5	cells	_	NNS	NNS	_	6	nsubj	_	_
6	exhibit	_	VBP	VBP	_	0	root	_	_
7	an	_	DT	DT	_	9	det	_	_
8	initial	_	JJ	JJ	_	9	amod	_	_
9	phase	_	NN	NN	_	6	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	interleukin-2	_	NN	NN	_	16	nn	_	_
12	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
13	IL-2	_	NN	NN	_	16	nn	_	_
14	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
15	-dependent	_	JJ	JJ	_	16	amod	_	_
16	growth	_	NN	NN	_	10	pobj	_	_
17	;	_	:	:	_	6	punct	_	_
18	over	_	IN	IN	_	28	prep	_	_
19	time	_	NN	NN	_	18	pobj	_	_
20	,	_	,	,	_	28	punct	_	_
21	by	_	IN	IN	_	28	prep	_	_
22	an	_	DT	DT	_	24	det	_	_
23	unknown	_	JJ	JJ	_	24	amod	_	_
24	mechanism	_	NN	NN	_	21	pobj	_	_
25	,	_	,	,	_	28	punct	_	_
26	the	_	DT	DT	_	27	det	_	_
27	cells	_	NNS	NNS	_	28	nsubj	_	_
28	become	_	VBP	VBP	_	6	parataxis	_	_
29	IL-2-independent	_	JJ	JJ	_	28	acomp	_	_
30	.	_	.	.	_	6	punct	_	_

1	Whereas	_	IN	IN	_	21	mark	_	_
2	the	_	DT	DT	_	4	det	_	_
3	Jak	_	NN	NN	_	4	nn	_	_
4	kinases	_	NNS	NNS	_	21	nsubjpass	_	_
5	Jak1	_	NN	NN	_	4	dep	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	Jak3	_	NN	NN	_	5	conj	_	_
8	and	_	CC	CC	_	4	cc	_	_
9	the	_	DT	DT	_	10	det	_	_
10	signal	_	NN	NN	_	4	conj	_	_
11	transducer	_	NN	NN	_	10	dep	_	_
12	and	_	CC	CC	_	10	cc	_	_
13	activator	_	NN	NN	_	10	conj	_	_
14	of	_	IN	IN	_	10	prep	_	_
15	transcription	_	NN	NN	_	16	nn	_	_
16	proteins	_	NNS	NNS	_	14	pobj	_	_
17	Stat3	_	NN	NN	_	10	dep	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	Stat5	_	NN	NN	_	17	conj	_	_
20	are	_	VBP	VBP	_	21	auxpass	_	_
21	activated	_	VBN	VBN	_	36	advcl	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	normal	_	JJ	JJ	_	25	amod	_	_
24	T	_	NN	NN	_	25	nn	_	_
25	cells	_	NNS	NNS	_	22	pobj	_	_
26	in	_	IN	IN	_	21	prep	_	_
27	response	_	NN	NN	_	26	pobj	_	_
28	to	_	TO	TO	_	27	prep	_	_
29	IL-2	_	NN	NN	_	28	pobj	_	_
30	,	_	,	,	_	36	punct	_	_
31	this	_	DT	DT	_	33	det	_	_
32	signaling	_	NN	NN	_	33	nn	_	_
33	pathway	_	NN	NN	_	36	nsubjpass	_	_
34	was	_	VBD	VBD	_	36	auxpass	_	_
35	constitutively	_	RB	RB	_	36	advmod	_	_
36	activated	_	VBN	VBN	_	0	root	_	_
37	in	_	IN	IN	_	36	prep	_	_
38	HTLV-I-transformed	_	JJ	JJ	_	39	amod	_	_
39	cells	_	NNS	NNS	_	37	pobj	_	_
40	.	_	.	.	_	36	punct	_	_

1	In	_	IN	IN	_	14	prep	_	_
2	HTLV-I-infected	_	JJ	JJ	_	5	amod	_	_
3	cord	_	NN	NN	_	5	nn	_	_
4	blood	_	NN	NN	_	5	nn	_	_
5	lymphocytes	_	NNS	NNS	_	1	pobj	_	_
6	,	_	,	,	_	14	punct	_	_
7	the	_	DT	DT	_	8	det	_	_
8	transition	_	NN	NN	_	14	nsubj	_	_
9	from	_	IN	IN	_	8	prep	_	_
10	IL-2-dependent	_	JJ	JJ	_	9	pobj	_	_
11	to	_	TO	TO	_	8	prep	_	_
12	IL-2-independent	_	JJ	JJ	_	13	amod	_	_
13	growth	_	NN	NN	_	11	pobj	_	_
14	correlated	_	VBD	VBD	_	0	root	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	17	det	_	_
17	acquisition	_	NN	NN	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	a	_	DT	DT	_	23	det	_	_
20	constitutively	_	RB	RB	_	21	advmod	_	_
21	activated	_	JJ	JJ	_	23	amod	_	_
22	Jak-STAT	_	JJ	JJ	_	23	amod	_	_
23	pathway	_	NN	NN	_	18	pobj	_	_
24	,	_	,	,	_	14	punct	_	_
25	which	_	WDT	WDT	_	26	nsubj	_	_
26	suggests	_	VBZ	VBZ	_	14	ccomp	_	_
27	that	_	IN	IN	_	30	mark	_	_
28	this	_	DT	DT	_	29	det	_	_
29	pathway	_	NN	NN	_	30	nsubj	_	_
30	participates	_	VBZ	VBZ	_	26	ccomp	_	_
31	in	_	IN	IN	_	30	prep	_	_
32	HTLV-I-mediated	_	JJ	JJ	_	35	amod	_	_
33	T	_	NN	NN	_	35	nn	_	_
34	cell	_	NN	NN	_	35	nn	_	_
35	transformation	_	NN	NN	_	31	pobj	_	_
36	.	_	.	.	_	14	punct	_	_

1	Positive	_	JJ	JJ	_	0	root	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	negative	_	JJ	JJ	_	1	conj	_	_
4	regulation	_	NN	NN	_	1	dep	_	_
5	of	_	IN	IN	_	1	prep	_	_
6	granulocyte-macrophage	_	JJ	JJ	_	8	amod	_	_
7	colony-stimulating	_	JJ	JJ	_	8	amod	_	_
8	factor	_	NN	NN	_	10	nn	_	_
9	promoter	_	NN	NN	_	10	nn	_	_
10	activity	_	NN	NN	_	5	pobj	_	_
11	by	_	IN	IN	_	1	prep	_	_
12	AML1-related	_	JJ	JJ	_	14	amod	_	_
13	transcription	_	NN	NN	_	14	nn	_	_
14	factor	_	NN	NN	_	11	pobj	_	_
15	,	_	,	,	_	14	punct	_	_
16	PEBP2	_	NN	NN	_	14	appos	_	_
17	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	9	det	_	_
2	granulocyte-macrophage	_	JJ	JJ	_	9	amod	_	_
3	colony-stimulating	_	JJ	JJ	_	9	amod	_	_
4	factor	_	NN	NN	_	9	nn	_	_
5	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
6	GM-CSF	_	NN	NN	_	9	nn	_	_
7	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
8	gene	_	NN	NN	_	9	nn	_	_
9	promoter	_	NN	NN	_	10	nsubj	_	_
10	contains	_	VBZ	VBZ	_	0	root	_	_
11	a	_	DT	DT	_	13	det	_	_
12	consensus	_	NN	NN	_	13	nn	_	_
13	sequence	_	NN	NN	_	10	dobj	_	_
14	for	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	24	det	_	_
16	polyomavirus	_	NN	NN	_	24	nn	_	_
17	enhancer	_	NN	NN	_	24	nn	_	_
18	binding-protein	_	NN	NN	_	24	nn	_	_
19	2	_	CD	CD	_	24	num	_	_
20	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
21	PEBP2	_	NN	NN	_	24	nn	_	_
22	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
23	transcription	_	NN	NN	_	24	nn	_	_
24	factor	_	NN	NN	_	14	pobj	_	_
25	,	_	,	,	_	24	punct	_	_
26	which	_	WDT	WDT	_	27	nsubj	_	_
27	consists	_	VBZ	VBZ	_	24	rcmod	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	alpha	_	NN	NN	_	28	pobj	_	_
30	and	_	CC	CC	_	29	cc	_	_
31	beta	_	NN	NN	_	29	conj	_	_
32	subunits	_	NNS	NNS	_	29	dep	_	_
33	.	_	.	.	_	10	punct	_	_

1	There	_	EX	EX	_	2	expl	_	_
2	are	_	VBP	VBP	_	0	root	_	_
3	at	_	IN	IN	_	5	quantmod	_	_
4	least	_	JJS	JJS	_	3	mwe	_	_
5	two	_	CD	CD	_	6	num	_	_
6	genes	_	NNS	NNS	_	2	nsubj	_	_
7	,	_	,	,	_	6	punct	_	_
8	alpha	_	NN	NN	_	9	nn	_	_
9	A	_	NN	NN	_	6	appos	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	alpha	_	NN	NN	_	12	nn	_	_
12	B	_	NN	NN	_	9	conj	_	_
13	,	_	,	,	_	6	punct	_	_
14	encoding	_	VBG	VBG	_	6	vmod	_	_
15	the	_	DT	DT	_	17	det	_	_
16	alpha	_	NN	NN	_	17	nn	_	_
17	subunit	_	NN	NN	_	14	dobj	_	_
18	.	_	.	.	_	2	punct	_	_

1	alpha	_	NN	NN	_	2	nn	_	_
2	B	_	NN	NN	_	6	nsubj	_	_
3	is	_	VBZ	VBZ	_	6	cop	_	_
4	the	_	DT	DT	_	6	det	_	_
5	mouse	_	NN	NN	_	6	nn	_	_
6	homologue	_	NN	NN	_	0	root	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	human	_	JJ	JJ	_	10	amod	_	_
9	AML1	_	NN	NN	_	10	nn	_	_
10	gene	_	NN	NN	_	7	pobj	_	_
11	detected	_	VBN	VBN	_	10	vmod	_	_
12	at	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	breakpoints	_	NNS	NNS	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	t	_	NN	NN	_	15	pobj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
18	8	_	CD	CD	_	16	num	_	_
19	;	_	:	:	_	16	punct	_	_
20	21	_	CD	CD	_	16	num	_	_
21	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
22	and	_	CC	CC	_	16	cc	_	_
23	t	_	NN	NN	_	16	conj	_	_
24	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
25	3	_	CD	CD	_	23	num	_	_
26	;	_	:	:	_	23	punct	_	_
27	21	_	CD	CD	_	23	num	_	_
28	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
29	myeloid	_	JJ	JJ	_	30	amod	_	_
30	leukemias	_	NNS	NNS	_	16	dep	_	_
31	.	_	.	.	_	6	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	examined	_	VBD	VBD	_	0	root	_	_
3	alpha	_	NN	NN	_	4	nn	_	_
4	A1	_	NN	NN	_	2	dobj	_	_
5	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
6	an	_	DT	DT	_	9	det	_	_
7	alpha	_	NN	NN	_	9	nn	_	_
8	A-gene	_	JJ	JJ	_	9	amod	_	_
9	product	_	NN	NN	_	4	dep	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	and	_	CC	CC	_	4	cc	_	_
12	alpha	_	NN	NN	_	13	nn	_	_
13	B1	_	NN	NN	_	4	conj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	alpha	_	NN	NN	_	16	nn	_	_
16	B2	_	NN	NN	_	13	conj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
18	two	_	CD	CD	_	21	num	_	_
19	alpha	_	NN	NN	_	21	nn	_	_
20	B-encoded	_	JJ	JJ	_	21	amod	_	_
21	isomers	_	NNS	NNS	_	13	appos	_	_
22	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
23	for	_	IN	IN	_	2	prep	_	_
24	their	_	PRP$	PRP$	_	25	poss	_	_
25	effects	_	NNS	NNS	_	23	pobj	_	_
26	on	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	29	det	_	_
28	GM-CSF	_	NN	NN	_	29	nn	_	_
29	promoter	_	NN	NN	_	26	pobj	_	_
30	.	_	.	.	_	2	punct	_	_

1	PEBP2	_	NN	NN	_	3	nn	_	_
2	alpha	_	NN	NN	_	3	nn	_	_
3	A1	_	NN	NN	_	12	nsubj	_	_
4	,	_	,	,	_	3	punct	_	_
5	alpha	_	NN	NN	_	6	nn	_	_
6	B1	_	NN	NN	_	3	conj	_	_
7	,	_	,	,	_	3	punct	_	_
8	and	_	CC	CC	_	3	cc	_	_
9	alpha	_	NN	NN	_	11	nn	_	_
10	B2	_	NN	NN	_	11	nn	_	_
11	proteins	_	NNS	NNS	_	3	conj	_	_
12	bound	_	VBD	VBD	_	0	root	_	_
13	the	_	DT	DT	_	15	det	_	_
14	PEBP2	_	NN	NN	_	15	nn	_	_
15	site	_	NN	NN	_	12	dobj	_	_
16	within	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	20	det	_	_
18	mouse	_	NN	NN	_	20	nn	_	_
19	GM-CSF	_	NN	NN	_	20	nn	_	_
20	promoter	_	NN	NN	_	16	pobj	_	_
21	.	_	.	.	_	12	punct	_	_

1	PEBP2	_	NN	NN	_	3	nn	_	_
2	alpha	_	NN	NN	_	3	nn	_	_
3	A1	_	NN	NN	_	7	nsubj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	alpha	_	NN	NN	_	6	nn	_	_
6	B1	_	NN	NN	_	3	conj	_	_
7	enhanced	_	VBD	VBD	_	0	root	_	_
8	the	_	DT	DT	_	9	det	_	_
9	expression	_	NN	NN	_	7	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	15	det	_	_
12	GM-CSF	_	NN	NN	_	15	nn	_	_
13	promoter-driven	_	JJ	JJ	_	15	amod	_	_
14	reporter	_	NN	NN	_	15	nn	_	_
15	plasmid	_	NN	NN	_	10	pobj	_	_
16	in	_	IN	IN	_	9	prep	_	_
17	unstimulated	_	JJ	JJ	_	16	pobj	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	12-O-tetradecanoylphorbol	_	NN	NN	_	17	conj	_	_
20	13-acetate/phytohemagglutinin-stimulated	_	JJ	JJ	_	19	amod	_	_
21	human	_	JJ	JJ	_	24	amod	_	_
22	Jurkat	_	NN	NN	_	24	nn	_	_
23	T	_	NN	NN	_	24	nn	_	_
24	cells	_	NNS	NNS	_	17	dep	_	_
25	.	_	.	.	_	7	punct	_	_

1	In	_	IN	IN	_	8	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	8	punct	_	_
4	the	_	DT	DT	_	6	det	_	_
5	promoter	_	NN	NN	_	6	nn	_	_
6	activity	_	NN	NN	_	8	nsubjpass	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	suppressed	_	VBN	VBN	_	0	root	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	alpha	_	NN	NN	_	11	nn	_	_
11	B2	_	NN	NN	_	9	pobj	_	_
12	.	_	.	.	_	8	punct	_	_

1	Coexpression	_	NN	NN	_	8	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	alpha	_	NN	NN	_	4	nn	_	_
4	B1	_	NN	NN	_	2	pobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	alpha	_	NN	NN	_	7	nn	_	_
7	B2	_	NN	NN	_	4	conj	_	_
8	showed	_	VBD	VBD	_	0	root	_	_
9	that	_	IN	IN	_	15	mark	_	_
10	the	_	DT	DT	_	12	det	_	_
11	promoter	_	NN	NN	_	12	nn	_	_
12	activity	_	NN	NN	_	15	nsubjpass	_	_
13	could	_	MD	MD	_	15	aux	_	_
14	be	_	VB	VB	_	15	auxpass	_	_
15	determined	_	VBN	VBN	_	8	ccomp	_	_
16	by	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	21	det	_	_
18	alpha	_	NN	NN	_	21	nn	_	_
19	B1/alpha	_	NN	NN	_	21	nn	_	_
20	B2	_	NN	NN	_	21	nn	_	_
21	ratio	_	NN	NN	_	16	pobj	_	_
22	.	_	.	.	_	8	punct	_	_

1	Jurkat	_	NN	NN	_	3	nn	_	_
2	cell	_	NN	NN	_	3	nn	_	_
3	extract	_	NN	NN	_	4	nsubj	_	_
4	contained	_	VBD	VBD	_	0	root	_	_
5	PEBP2	_	NN	NN	_	7	nn	_	_
6	site-binding	_	JJ	JJ	_	7	amod	_	_
7	protein	_	NN	NN	_	9	nn	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	s	_	NNS	NNS	_	4	dobj	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	that	_	WDT	WDT	_	12	nsubj	_	_
12	cross-reacted	_	VBD	VBD	_	9	rcmod	_	_
13	with	_	IN	IN	_	12	prep	_	_
14	antimouse	_	JJ	JJ	_	17	amod	_	_
15	alpha	_	NN	NN	_	17	nn	_	_
16	A1	_	NN	NN	_	17	nn	_	_
17	antibodies	_	NNS	NNS	_	13	pobj	_	_
18	.	_	.	.	_	4	punct	_	_

1	Northern	_	NN	NN	_	3	nn	_	_
2	blot	_	NN	NN	_	3	nn	_	_
3	analysis	_	NN	NN	_	4	nsubj	_	_
4	indicated	_	VBD	VBD	_	0	root	_	_
5	the	_	DT	DT	_	6	det	_	_
6	expression	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	human	_	JJ	JJ	_	11	amod	_	_
9	PEBP2	_	NN	NN	_	11	nn	_	_
10	alpha	_	NN	NN	_	11	nn	_	_
11	A	_	NN	NN	_	7	pobj	_	_
12	,	_	,	,	_	11	punct	_	_
13	alpha	_	NN	NN	_	14	nn	_	_
14	B	_	NN	NN	_	11	conj	_	_
15	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
16	AML1	_	NN	NN	_	14	appos	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	,	_	,	,	_	11	punct	_	_
19	and	_	CC	CC	_	11	cc	_	_
20	beta	_	NN	NN	_	21	nn	_	_
21	genes	_	NNS	NNS	_	11	conj	_	_
22	in	_	IN	IN	_	6	prep	_	_
23	Jurkat	_	NN	NN	_	24	nn	_	_
24	cells	_	NNS	NNS	_	22	pobj	_	_
25	.	_	.	.	_	4	punct	_	_

1	Although	_	IN	IN	_	5	mark	_	_
2	further	_	JJ	JJ	_	3	amod	_	_
3	studies	_	NNS	NNS	_	5	nsubjpass	_	_
4	are	_	VBP	VBP	_	5	auxpass	_	_
5	required	_	VBN	VBN	_	22	advcl	_	_
6	to	_	TO	TO	_	7	aux	_	_
7	determine	_	VB	VB	_	5	xcomp	_	_
8	the	_	DT	DT	_	10	det	_	_
9	precise	_	JJ	JJ	_	10	amod	_	_
10	role	_	NN	NN	_	7	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	PEBP2	_	NN	NN	_	11	pobj	_	_
13	in	_	IN	IN	_	10	prep	_	_
14	the	_	DT	DT	_	17	det	_	_
15	GM-CSF	_	NN	NN	_	17	nn	_	_
16	promoter	_	NN	NN	_	17	nn	_	_
17	activity	_	NN	NN	_	13	pobj	_	_
18	,	_	,	,	_	22	punct	_	_
19	the	_	DT	DT	_	21	det	_	_
20	present	_	JJ	JJ	_	21	amod	_	_
21	findings	_	NNS	NNS	_	22	nsubj	_	_
22	suggested	_	VBD	VBD	_	0	root	_	_
23	the	_	DT	DT	_	24	det	_	_
24	importance	_	NN	NN	_	22	dobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	28	det	_	_
27	relative	_	JJ	JJ	_	28	amod	_	_
28	ratio	_	NN	NN	_	25	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	different	_	JJ	JJ	_	32	amod	_	_
31	PEBP2	_	NN	NN	_	32	nn	_	_
32	isoforms	_	NNS	NNS	_	29	pobj	_	_
33	in	_	IN	IN	_	24	prep	_	_
34	regulating	_	VBG	VBG	_	33	pcomp	_	_
35	the	_	DT	DT	_	36	det	_	_
36	levels	_	NNS	NNS	_	34	dobj	_	_
37	of	_	IN	IN	_	36	prep	_	_
38	the	_	DT	DT	_	40	det	_	_
39	promoter	_	NN	NN	_	40	nn	_	_
40	activity	_	NN	NN	_	37	pobj	_	_
41	.	_	.	.	_	22	punct	_	_

1	Does	_	VBZ	VBZ	_	7	aux	_	_
2	activation	_	NN	NN	_	7	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	TAL1	_	NN	NN	_	6	nn	_	_
6	gene	_	NN	NN	_	3	pobj	_	_
7	occur	_	VB	VB	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	a	_	DT	DT	_	10	det	_	_
10	majority	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	patients	_	NNS	NNS	_	11	pobj	_	_
13	with	_	IN	IN	_	12	prep	_	_
14	T-cell	_	NN	NN	_	17	nn	_	_
15	acute	_	JJ	JJ	_	17	amod	_	_
16	lymphoblastic	_	JJ	JJ	_	17	amod	_	_
17	leukemia	_	NN	NN	_	13	pobj	_	_
18	?	_	.	.	_	7	punct	_	_

1	A	_	DT	DT	_	5	det	_	_
2	pediatric	_	JJ	JJ	_	5	amod	_	_
3	oncology	_	NN	NN	_	5	nn	_	_
4	group	_	NN	NN	_	5	nn	_	_
5	study	_	NN	NN	_	0	root	_	_
6	.	_	.	.	_	5	punct	_	_

1	Almost	_	RB	RB	_	2	quantmod	_	_
2	25	_	CD	CD	_	3	num	_	_
3	%	_	NN	NN	_	14	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	patients	_	NNS	NNS	_	4	pobj	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	T-cell	_	NN	NN	_	10	nn	_	_
8	acute	_	JJ	JJ	_	10	amod	_	_
9	lymphoblastic	_	JJ	JJ	_	10	amod	_	_
10	leukemia	_	NN	NN	_	6	pobj	_	_
11	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
12	T-ALL	_	NN	NN	_	10	appos	_	_
13	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	have	_	VBP	VBP	_	0	root	_	_
15	tumor-specific	_	JJ	JJ	_	16	amod	_	_
16	rearrangements	_	NNS	NNS	_	14	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	TAL1	_	NN	NN	_	20	nn	_	_
20	gene	_	NN	NN	_	17	pobj	_	_
21	.	_	.	.	_	14	punct	_	_

1	Although	_	IN	IN	_	7	mark	_	_
2	TAL1	_	NN	NN	_	3	nn	_	_
3	expression	_	NN	NN	_	7	nsubjpass	_	_
4	has	_	VBZ	VBZ	_	7	aux	_	_
5	not	_	RB	RB	_	7	neg	_	_
6	been	_	VBN	VBN	_	7	auxpass	_	_
7	observed	_	VBN	VBN	_	17	advcl	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	normal	_	JJ	JJ	_	10	amod	_	_
10	lymphocytes	_	NNS	NNS	_	8	pobj	_	_
11	,	_	,	,	_	17	punct	_	_
12	TAL1	_	NN	NN	_	14	nn	_	_
13	gene	_	NN	NN	_	14	nn	_	_
14	products	_	NNS	NNS	_	17	nsubjpass	_	_
15	are	_	VBP	VBP	_	17	auxpass	_	_
16	readily	_	RB	RB	_	17	advmod	_	_
17	detected	_	VBN	VBN	_	0	root	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	leukemic	_	JJ	JJ	_	20	amod	_	_
20	cells	_	NNS	NNS	_	18	pobj	_	_
21	that	_	WDT	WDT	_	22	nsubj	_	_
22	harbor	_	VBP	VBP	_	20	rcmod	_	_
23	a	_	DT	DT	_	26	det	_	_
24	rearranged	_	VBN	VBN	_	26	amod	_	_
25	TAL1	_	NN	NN	_	26	nn	_	_
26	allele	_	NN	NN	_	22	dobj	_	_
27	.	_	.	.	_	17	punct	_	_

1	Hence	_	RB	RB	_	6	advmod	_	_
2	,	_	,	,	_	6	punct	_	_
3	it	_	PRP	PRP	_	6	nsubjpass	_	_
4	has	_	VBZ	VBZ	_	6	aux	_	_
5	been	_	VBN	VBN	_	6	auxpass	_	_
6	proposed	_	VBN	VBN	_	0	root	_	_
7	that	_	IN	IN	_	12	mark	_	_
8	ectopic	_	JJ	JJ	_	9	amod	_	_
9	expression	_	NN	NN	_	12	nsubj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	TAL1	_	NN	NN	_	10	pobj	_	_
12	promotes	_	VBZ	VBZ	_	6	ccomp	_	_
13	the	_	DT	DT	_	14	det	_	_
14	development	_	NN	NN	_	12	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	T-ALL	_	NN	NN	_	15	pobj	_	_
17	.	_	.	.	_	6	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	report	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	show	_	VBP	VBP	_	0	root	_	_
7	that	_	IN	IN	_	10	mark	_	_
8	TAL1	_	NN	NN	_	10	nsubjpass	_	_
9	is	_	VBZ	VBZ	_	10	auxpass	_	_
10	expressed	_	VBN	VBN	_	6	ccomp	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	leukemic	_	JJ	JJ	_	14	amod	_	_
14	cells	_	NNS	NNS	_	11	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	most	_	JJS	JJS	_	17	amod	_	_
17	patients	_	NNS	NNS	_	15	pobj	_	_
18	with	_	IN	IN	_	17	prep	_	_
19	T-ALL	_	NN	NN	_	18	pobj	_	_
20	,	_	,	,	_	14	punct	_	_
21	including	_	VBG	VBG	_	14	prep	_	_
22	many	_	JJ	JJ	_	21	pobj	_	_
23	that	_	WDT	WDT	_	26	nsubj	_	_
24	do	_	VBP	VBP	_	26	aux	_	_
25	not	_	RB	RB	_	26	neg	_	_
26	display	_	VB	VB	_	22	rcmod	_	_
27	an	_	DT	DT	_	31	det	_	_
28	apparent	_	JJ	JJ	_	31	amod	_	_
29	TAL1	_	NN	NN	_	30	nn	_	_
30	gene	_	NN	NN	_	31	nn	_	_
31	alteration	_	NN	NN	_	26	dobj	_	_
32	.	_	.	.	_	6	punct	_	_

1	A	_	DT	DT	_	4	det	_	_
2	polymorphic	_	JJ	JJ	_	4	amod	_	_
3	dinucleotide	_	NN	NN	_	4	nn	_	_
4	repeat	_	NN	NN	_	12	nsubjpass	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	transcribed	_	VBN	VBN	_	8	amod	_	_
8	sequences	_	NNS	NNS	_	5	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	TAL1	_	NN	NN	_	9	pobj	_	_
11	was	_	VBD	VBD	_	12	auxpass	_	_
12	used	_	VBN	VBN	_	0	root	_	_
13	to	_	TO	TO	_	14	aux	_	_
14	determine	_	VB	VB	_	12	xcomp	_	_
15	the	_	DT	DT	_	17	det	_	_
16	allele	_	NN	NN	_	17	nn	_	_
17	specificity	_	NN	NN	_	14	dobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	TAL1	_	NN	NN	_	20	nn	_	_
20	transcription	_	NN	NN	_	18	pobj	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	primary	_	JJ	JJ	_	24	amod	_	_
23	T-ALL	_	NN	NN	_	24	nn	_	_
24	cells	_	NNS	NNS	_	21	pobj	_	_
25	.	_	.	.	_	12	punct	_	_

1	Monoallelic	_	JJ	JJ	_	2	amod	_	_
2	expression	_	NN	NN	_	6	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	TAL1	_	NN	NN	_	3	pobj	_	_
5	was	_	VBD	VBD	_	6	auxpass	_	_
6	observed	_	VBN	VBN	_	0	root	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	leukemic	_	JJ	JJ	_	10	amod	_	_
10	cells	_	NNS	NNS	_	7	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	all	_	DT	DT	_	13	det	_	_
13	patients	_	NNS	NNS	_	11	pobj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
15	8	_	CD	CD	_	17	number	_	_
16	of	_	IN	IN	_	17	quantmod	_	_
17	8	_	CD	CD	_	13	dep	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	bearing	_	VBG	VBG	_	10	vmod	_	_
20	a	_	DT	DT	_	23	det	_	_
21	TAL1	_	NN	NN	_	22	nn	_	_
22	gene	_	NN	NN	_	23	nn	_	_
23	rearrangement	_	NN	NN	_	19	dobj	_	_
24	.	_	.	.	_	6	punct	_	_

1	In	_	IN	IN	_	14	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	leukemic	_	JJ	JJ	_	4	amod	_	_
4	cells	_	NNS	NNS	_	1	pobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	patients	_	NNS	NNS	_	5	pobj	_	_
7	without	_	IN	IN	_	4	prep	_	_
8	detectable	_	JJ	JJ	_	10	amod	_	_
9	TAL1	_	NN	NN	_	10	nn	_	_
10	rearrangements	_	NNS	NNS	_	7	pobj	_	_
11	,	_	,	,	_	14	punct	_	_
12	TAL1	_	NN	NN	_	13	nn	_	_
13	transcription	_	NN	NN	_	14	nsubj	_	_
14	occurred	_	VBD	VBD	_	0	root	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	either	_	CC	CC	_	18	preconj	_	_
17	a	_	DT	DT	_	18	det	_	_
18	monoallelic	_	JJ	JJ	_	15	pobj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
20	3	_	CD	CD	_	22	number	_	_
21	of	_	IN	IN	_	22	quantmod	_	_
22	7	_	CD	CD	_	23	num	_	_
23	patients	_	NNS	NNS	_	18	appos	_	_
24	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
25	or	_	CC	CC	_	18	cc	_	_
26	a	_	DT	DT	_	27	det	_	_
27	biallelic	_	JJ	JJ	_	18	conj	_	_
28	-LRB-	_	-LRB-	-LRB-	_	32	punct	_	_
29	4	_	CD	CD	_	32	number	_	_
30	of	_	IN	IN	_	32	quantmod	_	_
31	7	_	CD	CD	_	32	number	_	_
32	patients	_	NNS	NNS	_	27	dep	_	_
33	-RRB-	_	-RRB-	-RRB-	_	32	punct	_	_
34	fashion	_	NN	NN	_	18	dep	_	_
35	.	_	.	.	_	14	punct	_	_

1	Thus	_	RB	RB	_	9	advmod	_	_
2	,	_	,	,	_	9	punct	_	_
3	TAL1	_	NN	NN	_	4	nn	_	_
4	activation	_	NN	NN	_	9	nsubj	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	these	_	DT	DT	_	7	det	_	_
7	patients	_	NNS	NNS	_	5	pobj	_	_
8	may	_	MD	MD	_	9	aux	_	_
9	result	_	VB	VB	_	0	root	_	_
10	from	_	IN	IN	_	9	prep	_	_
11	subtle	_	JJ	JJ	_	12	amod	_	_
12	alterations	_	NNS	NNS	_	10	pobj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	cis-acting	_	JJ	JJ	_	16	amod	_	_
15	regulatory	_	JJ	JJ	_	16	amod	_	_
16	sequences	_	NNS	NNS	_	13	pobj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	affecting	_	VBG	VBG	_	16	dep	_	_
19	expression	_	NN	NN	_	18	dobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	a	_	DT	DT	_	24	det	_	_
22	single	_	JJ	JJ	_	24	amod	_	_
23	TAL1	_	NN	NN	_	24	nn	_	_
24	allele	_	NN	NN	_	20	pobj	_	_
25	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
26	or	_	CC	CC	_	12	cc	_	_
27	changes	_	NNS	NNS	_	12	conj	_	_
28	in	_	IN	IN	_	27	prep	_	_
29	trans-acting	_	JJ	JJ	_	30	amod	_	_
30	factors	_	NNS	NNS	_	28	pobj	_	_
31	that	_	WDT	WDT	_	32	nsubj	_	_
32	control	_	VBP	VBP	_	30	rcmod	_	_
33	TAL1	_	NN	NN	_	34	nn	_	_
34	transcription	_	NN	NN	_	32	dobj	_	_
35	-LRB-	_	-LRB-	-LRB-	_	36	punct	_	_
36	affecting	_	VBG	VBG	_	30	dep	_	_
37	expression	_	NN	NN	_	36	dobj	_	_
38	of	_	IN	IN	_	37	prep	_	_
39	both	_	DT	DT	_	41	dep	_	_
40	TAL1	_	NN	NN	_	41	nn	_	_
41	alleles	_	NNS	NNS	_	38	pobj	_	_
42	-RRB-	_	-RRB-	-RRB-	_	36	punct	_	_
43	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	interleukin-5/receptor	_	NN	NN	_	3	nn	_	_
3	interaction	_	NN	NN	_	4	nsubj	_	_
4	activates	_	VBZ	VBZ	_	0	root	_	_
5	Lyn	_	NN	NN	_	4	dobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	Jak2	_	NN	NN	_	5	conj	_	_
8	tyrosine	_	NN	NN	_	9	nn	_	_
9	kinases	_	NNS	NNS	_	5	dep	_	_
10	and	_	CC	CC	_	4	cc	_	_
11	propagates	_	VBZ	VBZ	_	4	conj	_	_
12	signals	_	NNS	NNS	_	11	dobj	_	_
13	via	_	IN	IN	_	11	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	Ras-Raf-1-MAP	_	NN	NN	_	16	nn	_	_
16	kinase	_	NN	NN	_	13	pobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	the	_	DT	DT	_	20	det	_	_
19	Jak-STAT	_	JJ	JJ	_	20	amod	_	_
20	pathways	_	NNS	NNS	_	16	conj	_	_
21	in	_	IN	IN	_	16	prep	_	_
22	eosinophils	_	NNS	NNS	_	21	pobj	_	_
23	.	_	.	.	_	4	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	shown	_	VBN	VBN	_	0	root	_	_
4	that	_	IN	IN	_	16	mark	_	_
5	the	_	DT	DT	_	6	det	_	_
6	interaction	_	NN	NN	_	16	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	interleukin	_	NN	NN	_	10	nn	_	_
9	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	IL	_	NN	NN	_	7	pobj	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	-5	_	CD	CD	_	10	num	_	_
13	with	_	IN	IN	_	6	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	receptor	_	NN	NN	_	13	pobj	_	_
16	activates	_	VBZ	VBZ	_	3	ccomp	_	_
17	Lyn	_	NN	NN	_	19	nn	_	_
18	tyrosine	_	NN	NN	_	19	nn	_	_
19	kinase	_	NN	NN	_	16	dobj	_	_
20	within	_	IN	IN	_	16	prep	_	_
21	1	_	CD	CD	_	22	num	_	_
22	min	_	NN	NN	_	20	pobj	_	_
23	and	_	CC	CC	_	16	cc	_	_
24	Jak2	_	NN	NN	_	26	nn	_	_
25	tyrosine	_	NN	NN	_	26	nn	_	_
26	kinase	_	NN	NN	_	16	conj	_	_
27	within	_	IN	IN	_	16	prep	_	_
28	1-3	_	CD	CD	_	29	num	_	_
29	min	_	NN	NN	_	27	pobj	_	_
30	.	_	.	.	_	3	punct	_	_

1	IL-5	_	NN	NN	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	stimulates	_	VBZ	VBZ	_	0	root	_	_
4	GTP	_	NN	NN	_	3	dobj	_	_
5	binding	_	VBG	VBG	_	4	vmod	_	_
6	to	_	TO	TO	_	5	prep	_	_
7	p21ras	_	NN	NN	_	6	pobj	_	_
8	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	signal	_	NN	NN	_	5	nsubjpass	_	_
3	is	_	VBZ	VBZ	_	5	auxpass	_	_
4	subsequently	_	RB	RB	_	5	advmod	_	_
5	propagated	_	VBN	VBN	_	0	root	_	_
6	through	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	activation	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	Raf-1	_	NN	NN	_	9	pobj	_	_
11	,	_	,	,	_	10	punct	_	_
12	MEK	_	NN	NN	_	10	conj	_	_
13	,	_	,	,	_	10	punct	_	_
14	and	_	CC	CC	_	10	cc	_	_
15	MAP	_	NN	NN	_	16	nn	_	_
16	kinases	_	NNS	NNS	_	10	conj	_	_
17	as	_	IN	IN	_	18	mark	_	_
18	shown	_	VBN	VBN	_	5	advcl	_	_
19	by	_	IN	IN	_	18	prep	_	_
20	their	_	PRP$	PRP$	_	22	poss	_	_
21	increased	_	VBN	VBN	_	22	amod	_	_
22	autophosphorylation	_	NN	NN	_	19	pobj	_	_
23	in	_	FW	FW	_	24	nn	_	_
24	vitro	_	FW	FW	_	22	advmod	_	_
25	and	_	CC	CC	_	22	cc	_	_
26	phosphorylation	_	NN	NN	_	22	conj	_	_
27	in	_	FW	FW	_	28	nn	_	_
28	situ	_	FW	FW	_	26	advmod	_	_
29	.	_	.	.	_	5	punct	_	_

1	Jak2	_	NN	NN	_	2	nn	_	_
2	kinase	_	NN	NN	_	5	nsubjpass	_	_
3	has	_	VBZ	VBZ	_	5	aux	_	_
4	been	_	VBN	VBN	_	5	auxpass	_	_
5	shown	_	VBN	VBN	_	0	root	_	_
6	to	_	TO	TO	_	7	aux	_	_
7	phosphorylate	_	VB	VB	_	5	xcomp	_	_
8	STAT	_	NN	NN	_	10	nn	_	_
9	nuclear	_	JJ	JJ	_	10	amod	_	_
10	proteins	_	NNS	NNS	_	7	dobj	_	_
11	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	activation	_	NN	NN	_	8	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	STAT	_	NN	NN	_	6	nn	_	_
5	nuclear	_	JJ	JJ	_	6	amod	_	_
6	factors	_	NNS	NNS	_	3	pobj	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	studied	_	VBN	VBN	_	0	root	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	electrophoretic	_	JJ	JJ	_	13	amod	_	_
11	mobility	_	NN	NN	_	13	nn	_	_
12	shift	_	NN	NN	_	13	nn	_	_
13	assay	_	NN	NN	_	9	pobj	_	_
14	using	_	VBG	VBG	_	13	vmod	_	_
15	a	_	DT	DT	_	22	det	_	_
16	gamma	_	NN	NN	_	18	nn	_	_
17	activation	_	NN	NN	_	18	nn	_	_
18	site	_	NN	NN	_	22	nn	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	GAS	_	NN	NN	_	18	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	probe	_	NN	NN	_	14	dobj	_	_
23	.	_	.	.	_	8	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	found	_	VBD	VBD	_	0	root	_	_
3	that	_	IN	IN	_	5	mark	_	_
4	IL-5	_	NN	NN	_	5	nsubj	_	_
5	induces	_	VBZ	VBZ	_	2	ccomp	_	_
6	two	_	CD	CD	_	8	num	_	_
7	GAS-binding	_	JJ	JJ	_	8	amod	_	_
8	proteins	_	NNS	NNS	_	5	dobj	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	eosinophils	_	NNS	NNS	_	9	pobj	_	_
11	,	_	,	,	_	8	punct	_	_
12	one	_	CD	CD	_	16	nsubj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	which	_	WDT	WDT	_	13	pobj	_	_
15	is	_	VBZ	VBZ	_	16	cop	_	_
16	STAT1	_	NN	NN	_	8	rcmod	_	_
17	.	_	.	.	_	2	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	conclude	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	8	mark	_	_
4	IL-5	_	NN	NN	_	6	nn	_	_
5	induced	_	JJ	JJ	_	6	amod	_	_
6	signals	_	NNS	NNS	_	8	nsubjpass	_	_
7	are	_	VBP	VBP	_	8	auxpass	_	_
8	propagated	_	VBN	VBN	_	2	ccomp	_	_
9	through	_	IN	IN	_	8	prep	_	_
10	two	_	CD	CD	_	12	num	_	_
11	distinct	_	JJ	JJ	_	12	amod	_	_
12	pathways	_	NNS	NNS	_	9	pobj	_	_
13	:	_	:	:	_	2	punct	_	_
14	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	1	_	LS	LS	_	17	dep	_	_
16	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
17	Lyn	_	NN	NN	_	2	dep	_	_
18	--&gt;	_	TO	TO	_	19	dep	_	_
19	Ras	_	NN	NN	_	17	amod	_	_
20	--&gt;	_	TO	TO	_	21	dep	_	_
21	Raf-1	_	NN	NN	_	19	amod	_	_
22	--&gt;	_	TO	TO	_	23	dep	_	_
23	MEK	_	NN	NN	_	21	amod	_	_
24	--&gt;	_	TO	TO	_	26	dep	_	_
25	MAP	_	NN	NN	_	26	nn	_	_
26	kinase	_	NN	NN	_	23	amod	_	_
27	and	_	CC	CC	_	17	cc	_	_
28	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
29	2	_	LS	LS	_	31	dep	_	_
30	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
31	Jak2	_	NN	NN	_	17	conj	_	_
32	--&gt;	_	TO	TO	_	33	dep	_	_
33	STAT1	_	NN	NN	_	31	amod	_	_
34	.	_	.	.	_	2	punct	_	_

1	Thapsigargin	_	NN	NN	_	2	nsubj	_	_
2	induces	_	VBZ	VBZ	_	0	root	_	_
3	IL-2	_	NN	NN	_	5	nn	_	_
4	receptor	_	NN	NN	_	5	nn	_	_
5	alpha-chain	_	NN	NN	_	2	dobj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	human	_	JJ	JJ	_	8	amod	_	_
8	peripheral	_	JJ	JJ	_	6	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	Jurkat	_	NN	NN	_	12	nn	_	_
11	T	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	8	conj	_	_
13	via	_	IN	IN	_	2	prep	_	_
14	a	_	DT	DT	_	18	det	_	_
15	protein	_	NN	NN	_	18	nn	_	_
16	kinase	_	NN	NN	_	18	nn	_	_
17	C-independent	_	JJ	JJ	_	18	amod	_	_
18	mechanism	_	NN	NN	_	13	pobj	_	_
19	.	_	.	.	_	2	punct	_	_

1	Thapsigargin	_	NN	NN	_	11	nsubj	_	_
2	-LRB-	_	-LRB-	-LRB-	_	3	punct	_	_
3	TG	_	NN	NN	_	1	appos	_	_
4	-RRB-	_	-RRB-	-RRB-	_	3	punct	_	_
5	,	_	,	,	_	1	punct	_	_
6	an	_	DT	DT	_	7	det	_	_
7	inhibitor	_	NN	NN	_	1	appos	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	Ca-LRB-2+-RRB--ATPase	_	NN	NN	_	8	pobj	_	_
10	,	_	,	,	_	1	punct	_	_
11	depletes	_	VBZ	VBZ	_	0	root	_	_
12	intracellular	_	JJ	JJ	_	14	amod	_	_
13	Ca2+	_	NN	NN	_	14	nn	_	_
14	stores	_	NNS	NNS	_	11	dobj	_	_
15	and	_	CC	CC	_	11	cc	_	_
16	induces	_	VBZ	VBZ	_	11	conj	_	_
17	a	_	DT	DT	_	20	det	_	_
18	sustained	_	JJ	JJ	_	20	amod	_	_
19	Ca2+	_	NN	NN	_	20	nn	_	_
20	influx	_	NN	NN	_	16	dobj	_	_
21	without	_	IN	IN	_	11	prep	_	_
22	altering	_	VBG	VBG	_	21	pcomp	_	_
23	phosphatidyl	_	JJ	JJ	_	25	amod	_	_
24	inositol	_	NN	NN	_	25	nn	_	_
25	levels	_	NNS	NNS	_	22	dobj	_	_
26	.	_	.	.	_	11	punct	_	_

1	TG	_	NN	NN	_	13	nsubj	_	_
2	plus	_	CC	CC	_	1	cc	_	_
3	phorbol	_	NN	NN	_	5	nn	_	_
4	myristate	_	NN	NN	_	5	nn	_	_
5	acetate	_	NN	NN	_	1	conj	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	PMA	_	NN	NN	_	5	appos	_	_
8	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
9	but	_	CC	CC	_	10	cc	_	_
10	not	_	RB	RB	_	1	cc	_	_
11	TG	_	NN	NN	_	1	conj	_	_
12	alone	_	RB	RB	_	11	advmod	_	_
13	induced	_	VBD	VBD	_	0	root	_	_
14	IL-2	_	NN	NN	_	13	dobj	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	Jurkat	_	NN	NN	_	18	nn	_	_
17	T	_	NN	NN	_	18	nn	_	_
18	cells	_	NNS	NNS	_	15	pobj	_	_
19	,	_	,	,	_	13	punct	_	_
20	suggesting	_	VBG	VBG	_	13	vmod	_	_
21	that	_	IN	IN	_	23	mark	_	_
22	TG	_	NN	NN	_	23	nsubj	_	_
23	had	_	VBD	VBD	_	20	ccomp	_	_
24	no	_	DT	DT	_	25	neg	_	_
25	effect	_	NN	NN	_	23	dobj	_	_
26	on	_	IN	IN	_	23	prep	_	_
27	protein	_	NN	NN	_	29	nn	_	_
28	kinase	_	NN	NN	_	29	nn	_	_
29	C	_	NN	NN	_	26	pobj	_	_
30	-LRB-	_	-LRB-	-LRB-	_	31	punct	_	_
31	PKC	_	NN	NN	_	29	appos	_	_
32	-RRB-	_	-RRB-	-RRB-	_	31	punct	_	_
33	.	_	.	.	_	13	punct	_	_

1	However	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	TG	_	NN	NN	_	4	nsubj	_	_
4	induced	_	VBD	VBD	_	0	root	_	_
5	increases	_	NNS	NNS	_	4	dobj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	IL-2R	_	NN	NN	_	9	nn	_	_
8	alpha	_	NN	NN	_	9	nn	_	_
9	protein	_	NN	NN	_	6	pobj	_	_
10	as	_	RB	RB	_	11	advmod	_	_
11	well	_	RB	RB	_	9	cc	_	_
12	as	_	IN	IN	_	11	mwe	_	_
13	IL-2R	_	NN	NN	_	15	nn	_	_
14	alpha	_	NN	NN	_	15	nn	_	_
15	mRNA	_	NN	NN	_	9	conj	_	_
16	in	_	IN	IN	_	9	prep	_	_
17	Jurkat	_	NN	NN	_	19	nn	_	_
18	T	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	16	pobj	_	_
20	in	_	IN	IN	_	4	prep	_	_
21	a	_	DT	DT	_	23	det	_	_
22	dose-dependent	_	JJ	JJ	_	23	amod	_	_
23	manner	_	NN	NN	_	20	pobj	_	_
24	.	_	.	.	_	4	punct	_	_

1	A	_	DT	DT	_	3	det	_	_
2	similar	_	JJ	JJ	_	3	amod	_	_
3	increase	_	NN	NN	_	11	nsubjpass	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	IL-2R	_	NN	NN	_	6	nn	_	_
6	alpha	_	NN	NN	_	4	pobj	_	_
7	by	_	IN	IN	_	3	prep	_	_
8	TG	_	NN	NN	_	7	pobj	_	_
9	was	_	VBD	VBD	_	11	auxpass	_	_
10	also	_	RB	RB	_	11	advmod	_	_
11	observed	_	VBN	VBN	_	0	root	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	human	_	JJ	JJ	_	16	amod	_	_
14	peripheral	_	JJ	JJ	_	16	amod	_	_
15	T	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	12	pobj	_	_
17	.	_	.	.	_	11	punct	_	_

1	Further	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	like	_	IN	IN	_	8	prep	_	_
4	PMA	_	NN	NN	_	3	pobj	_	_
5	,	_	,	,	_	8	punct	_	_
6	TG	_	NN	NN	_	8	nsubj	_	_
7	markedly	_	RB	RB	_	8	advmod	_	_
8	induced	_	VBD	VBD	_	0	root	_	_
9	NF	_	NN	NN	_	11	nn	_	_
10	kappa	_	NN	NN	_	11	nn	_	_
11	B	_	NN	NN	_	8	dobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	Jurkat	_	NN	NN	_	15	nn	_	_
14	T	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	12	pobj	_	_
16	.	_	.	.	_	8	punct	_	_

1	However	_	RB	RB	_	6	advmod	_	_
2	,	_	,	,	_	6	punct	_	_
3	TG	_	NN	NN	_	6	nsubj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	PMA	_	NN	NN	_	3	conj	_	_
6	exhibited	_	VBD	VBD	_	0	root	_	_
7	a	_	DT	DT	_	9	det	_	_
8	synergistic	_	JJ	JJ	_	9	amod	_	_
9	action	_	NN	NN	_	6	dobj	_	_
10	on	_	IN	IN	_	6	prep	_	_
11	IL-2R	_	NN	NN	_	12	nn	_	_
12	alpha	_	NN	NN	_	13	nn	_	_
13	expression	_	NN	NN	_	10	pobj	_	_
14	,	_	,	,	_	6	punct	_	_
15	suggesting	_	VBG	VBG	_	6	vmod	_	_
16	that	_	IN	IN	_	20	mark	_	_
17	TG	_	NN	NN	_	20	nsubj	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	PMA	_	NN	NN	_	17	conj	_	_
20	induce	_	VBP	VBP	_	15	ccomp	_	_
21	IL-2R	_	NN	NN	_	22	nn	_	_
22	alpha	_	NN	NN	_	20	dobj	_	_
23	through	_	IN	IN	_	20	prep	_	_
24	distinct	_	JJ	JJ	_	25	amod	_	_
25	pathways	_	NNS	NNS	_	23	pobj	_	_
26	.	_	.	.	_	6	punct	_	_

1	PMA-	_	NN	NN	_	8	nsubjpass	_	_
2	but	_	CC	CC	_	3	cc	_	_
3	not	_	RB	RB	_	1	cc	_	_
4	TG-induced	_	JJ	JJ	_	1	conj	_	_
5	IL-2R	_	NN	NN	_	6	nn	_	_
6	alpha	_	NN	NN	_	1	dep	_	_
7	is	_	VBZ	VBZ	_	8	auxpass	_	_
8	inhibited	_	VBN	VBN	_	0	root	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	13	det	_	_
11	PKC	_	NN	NN	_	13	nn	_	_
12	inhibitor	_	NN	NN	_	13	nn	_	_
13	H7	_	NN	NN	_	9	pobj	_	_
14	,	_	,	,	_	8	punct	_	_
15	whereas	_	IN	IN	_	23	mark	_	_
16	TG-	_	NN	NN	_	23	nsubjpass	_	_
17	but	_	CC	CC	_	18	cc	_	_
18	not	_	RB	RB	_	16	cc	_	_
19	PMA-induced	_	JJ	JJ	_	16	conj	_	_
20	IL-2R	_	NN	NN	_	21	nn	_	_
21	alpha	_	NN	NN	_	16	dep	_	_
22	was	_	VBD	VBD	_	23	auxpass	_	_
23	inhibited	_	VBN	VBN	_	8	advcl	_	_
24	by	_	IN	IN	_	23	prep	_	_
25	cholera	_	NN	NN	_	26	nn	_	_
26	toxin	_	NN	NN	_	24	pobj	_	_
27	,	_	,	,	_	26	punct	_	_
28	forskolin	_	NN	NN	_	26	conj	_	_
29	and	_	CC	CC	_	26	cc	_	_
30	1,9-dideoxy	_	JJ	JJ	_	31	amod	_	_
31	forskolin	_	NN	NN	_	26	conj	_	_
32	.	_	.	.	_	8	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	toto	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	6	punct	_	_
4	these	_	DT	DT	_	5	det	_	_
5	results	_	NNS	NNS	_	6	nsubj	_	_
6	suggest	_	VBP	VBP	_	0	root	_	_
7	that	_	IN	IN	_	9	mark	_	_
8	TG	_	NN	NN	_	9	nsubj	_	_
9	induces	_	VBZ	VBZ	_	6	ccomp	_	_
10	IL-2R	_	NN	NN	_	11	nn	_	_
11	alpha	_	NN	NN	_	9	dobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	human	_	JJ	JJ	_	15	amod	_	_
14	T	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	12	pobj	_	_
16	through	_	IN	IN	_	9	prep	_	_
17	a	_	DT	DT	_	19	det	_	_
18	PKC-independent	_	JJ	JJ	_	19	amod	_	_
19	pathway	_	NN	NN	_	16	pobj	_	_
20	.	_	.	.	_	6	punct	_	_

1	A	_	DT	DT	_	6	det	_	_
2	functional	_	JJ	JJ	_	6	amod	_	_
3	T-cell	_	NN	NN	_	4	nn	_	_
4	receptor	_	NN	NN	_	6	nn	_	_
5	signaling	_	NN	NN	_	6	nn	_	_
6	pathway	_	NN	NN	_	8	nsubjpass	_	_
7	is	_	VBZ	VBZ	_	8	auxpass	_	_
8	required	_	VBN	VBN	_	0	root	_	_
9	for	_	IN	IN	_	8	prep	_	_
10	p95vav	_	NN	NN	_	11	nn	_	_
11	activity	_	NN	NN	_	9	pobj	_	_
12	.	_	.	.	_	8	punct	_	_

1	Stimulation	_	NN	NN	_	10	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	6	det	_	_
4	T-cell	_	NN	NN	_	6	nn	_	_
5	antigen	_	NN	NN	_	6	nn	_	_
6	receptor	_	NN	NN	_	2	pobj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	TCR	_	NN	NN	_	6	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	induces	_	VBZ	VBZ	_	0	root	_	_
11	activation	_	NN	NN	_	10	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	multiple	_	JJ	JJ	_	15	amod	_	_
14	tyrosine	_	NN	NN	_	15	nn	_	_
15	kinases	_	NNS	NNS	_	12	pobj	_	_
16	,	_	,	,	_	10	punct	_	_
17	resulting	_	VBG	VBG	_	10	vmod	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	phosphorylation	_	NN	NN	_	18	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	numerous	_	JJ	JJ	_	23	amod	_	_
22	intracellular	_	JJ	JJ	_	23	amod	_	_
23	substrates	_	NNS	NNS	_	20	pobj	_	_
24	.	_	.	.	_	10	punct	_	_

1	One	_	CD	CD	_	2	num	_	_
2	substrate	_	NN	NN	_	4	nsubj	_	_
3	is	_	VBZ	VBZ	_	4	cop	_	_
4	p95vav	_	NN	NN	_	0	root	_	_
5	,	_	,	,	_	4	punct	_	_
6	which	_	WDT	WDT	_	8	nsubjpass	_	_
7	is	_	VBZ	VBZ	_	8	auxpass	_	_
8	expressed	_	VBN	VBN	_	4	rcmod	_	_
9	exclusively	_	RB	RB	_	8	advmod	_	_
10	in	_	IN	IN	_	8	prep	_	_
11	hematopoietic	_	JJ	JJ	_	10	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	trophoblast	_	NN	NN	_	11	conj	_	_
14	cells	_	NNS	NNS	_	11	dep	_	_
15	.	_	.	.	_	4	punct	_	_

1	It	_	PRP	PRP	_	2	nsubj	_	_
2	contains	_	VBZ	VBZ	_	0	root	_	_
3	a	_	DT	DT	_	4	det	_	_
4	number	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	structural	_	JJ	JJ	_	7	amod	_	_
7	motifs	_	NNS	NNS	_	5	pobj	_	_
8	,	_	,	,	_	7	punct	_	_
9	including	_	VBG	VBG	_	7	prep	_	_
10	Src	_	NN	NN	_	15	nn	_	_
11	homology	_	NN	NN	_	15	nn	_	_
12	2	_	CD	CD	_	15	num	_	_
13	,	_	,	,	_	15	punct	_	_
14	Src	_	NN	NN	_	15	dep	_	_
15	homology	_	NN	NN	_	9	pobj	_	_
16	3	_	CD	CD	_	15	num	_	_
17	,	_	,	,	_	15	punct	_	_
18	and	_	CC	CC	_	15	cc	_	_
19	pleckstrin	_	NN	NN	_	21	nn	_	_
20	homology	_	NN	NN	_	21	nn	_	_
21	domains	_	NNS	NNS	_	15	conj	_	_
22	and	_	CC	CC	_	15	cc	_	_
23	a	_	DT	DT	_	28	det	_	_
24	putative	_	JJ	JJ	_	28	amod	_	_
25	guanine	_	NN	NN	_	28	nn	_	_
26	nucleotide	_	NN	NN	_	28	nn	_	_
27	exchange	_	NN	NN	_	28	nn	_	_
28	domain	_	NN	NN	_	15	conj	_	_
29	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	role	_	NN	NN	_	10	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	p95vav	_	NN	NN	_	3	pobj	_	_
5	in	_	IN	IN	_	2	prep	_	_
6	TCR-mediated	_	JJ	JJ	_	8	amod	_	_
7	signaling	_	NN	NN	_	8	nn	_	_
8	processes	_	NNS	NNS	_	5	pobj	_	_
9	is	_	VBZ	VBZ	_	10	cop	_	_
10	unclear	_	JJ	JJ	_	0	root	_	_
11	.	_	.	.	_	10	punct	_	_

1	Here	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	show	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	14	mark	_	_
6	overexpression	_	NN	NN	_	14	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	p95vav	_	NN	NN	_	7	pobj	_	_
9	alone	_	RB	RB	_	8	advmod	_	_
10	in	_	IN	IN	_	6	prep	_	_
11	Jurkat	_	NN	NN	_	10	pobj	_	_
12	T	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	11	dep	_	_
14	leads	_	VBZ	VBZ	_	4	ccomp	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	activation	_	NN	NN	_	15	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	nuclear	_	JJ	JJ	_	20	amod	_	_
20	factors	_	NNS	NNS	_	17	pobj	_	_
21	,	_	,	,	_	20	punct	_	_
22	including	_	VBG	VBG	_	20	prep	_	_
23	NFAT	_	NN	NN	_	22	pobj	_	_
24	,	_	,	,	_	23	punct	_	_
25	involved	_	VBN	VBN	_	23	vmod	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	interleukin-2	_	NN	NN	_	28	nn	_	_
28	expression	_	NN	NN	_	26	pobj	_	_
29	.	_	.	.	_	4	punct	_	_

1	Furthermore	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	p95vav	_	NN	NN	_	4	nsubj	_	_
4	synergizes	_	VBZ	VBZ	_	0	root	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	TCR	_	NN	NN	_	7	nn	_	_
7	stimulation	_	NN	NN	_	5	pobj	_	_
8	in	_	IN	IN	_	4	prep	_	_
9	inducing	_	VBG	VBG	_	8	pcomp	_	_
10	NFAT-	_	NN	NN	_	9	dobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	interleukin-2-dependent	_	JJ	JJ	_	10	conj	_	_
13	transcription	_	NN	NN	_	10	dep	_	_
14	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	12	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	12	punct	_	_
4	NFAT	_	NN	NN	_	5	nn	_	_
5	activation	_	NN	NN	_	12	nsubjpass	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	a	_	DT	DT	_	9	det	_	_
8	G-protein-coupled	_	JJ	JJ	_	9	amod	_	_
9	receptor	_	NN	NN	_	6	pobj	_	_
10	is	_	VBZ	VBZ	_	12	auxpass	_	_
11	not	_	RB	RB	_	12	neg	_	_
12	modulated	_	VBN	VBN	_	0	root	_	_
13	by	_	IN	IN	_	12	prep	_	_
14	p95vav	_	NN	NN	_	15	nn	_	_
15	overexpression	_	NN	NN	_	13	pobj	_	_
16	,	_	,	,	_	12	punct	_	_
17	suggesting	_	VBG	VBG	_	12	vmod	_	_
18	that	_	IN	IN	_	22	mark	_	_
19	the	_	DT	DT	_	20	det	_	_
20	effect	_	NN	NN	_	22	nsubj	_	_
21	is	_	VBZ	VBZ	_	22	cop	_	_
22	specific	_	JJ	JJ	_	17	ccomp	_	_
23	to	_	TO	TO	_	22	prep	_	_
24	the	_	DT	DT	_	27	det	_	_
25	TCR	_	NN	NN	_	27	nn	_	_
26	signaling	_	NN	NN	_	27	nn	_	_
27	pathways	_	NNS	NNS	_	23	pobj	_	_
28	.	_	.	.	_	12	punct	_	_

1	Although	_	IN	IN	_	11	mark	_	_
2	removal	_	NN	NN	_	11	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	8	det	_	_
5	first	_	JJ	JJ	_	8	amod	_	_
6	67	_	CD	CD	_	8	num	_	_
7	amino	_	NN	NN	_	8	nn	_	_
8	acids	_	NNS	NNS	_	3	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	p95vav	_	NN	NN	_	9	pobj	_	_
11	activates	_	VBZ	VBZ	_	22	advcl	_	_
12	its	_	PRP$	PRP$	_	14	poss	_	_
13	transforming	_	NN	NN	_	14	nn	_	_
14	potential	_	NN	NN	_	11	dobj	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	NIH	_	NN	NN	_	18	nn	_	_
17	3T3	_	NN	NN	_	18	nn	_	_
18	cells	_	NNS	NNS	_	15	pobj	_	_
19	,	_	,	,	_	22	punct	_	_
20	this	_	DT	DT	_	21	det	_	_
21	region	_	NN	NN	_	22	nsubj	_	_
22	appears	_	VBZ	VBZ	_	0	root	_	_
23	to	_	TO	TO	_	25	aux	_	_
24	be	_	VB	VB	_	25	auxpass	_	_
25	required	_	VBN	VBN	_	22	xcomp	_	_
26	for	_	IN	IN	_	25	prep	_	_
27	its	_	PRP$	PRP$	_	28	poss	_	_
28	function	_	NN	NN	_	26	pobj	_	_
29	in	_	IN	IN	_	28	prep	_	_
30	T	_	NN	NN	_	31	nn	_	_
31	cells	_	NNS	NNS	_	29	pobj	_	_
32	.	_	.	.	_	22	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	further	_	RB	RB	_	3	advmod	_	_
3	demonstrate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	11	mark	_	_
5	the	_	DT	DT	_	8	det	_	_
6	p95vav-induced	_	JJ	JJ	_	8	amod	_	_
7	NFAT	_	NN	NN	_	8	nn	_	_
8	activation	_	NN	NN	_	11	nsubjpass	_	_
9	is	_	VBZ	VBZ	_	11	auxpass	_	_
10	not	_	RB	RB	_	11	neg	_	_
11	mimicked	_	VBN	VBN	_	3	ccomp	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	Ras	_	NN	NN	_	14	nn	_	_
14	activation	_	NN	NN	_	12	pobj	_	_
15	,	_	,	,	_	11	punct	_	_
16	though	_	IN	IN	_	20	mark	_	_
17	its	_	PRP$	PRP$	_	18	poss	_	_
18	function	_	NN	NN	_	20	nsubj	_	_
19	is	_	VBZ	VBZ	_	20	cop	_	_
20	dependent	_	JJ	JJ	_	11	advcl	_	_
21	upon	_	IN	IN	_	20	prep	_	_
22	Ras	_	NN	NN	_	21	pobj	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	Raf	_	NN	NN	_	22	conj	_	_
25	.	_	.	.	_	3	punct	_	_

1	Furthermore	_	RB	RB	_	9	advmod	_	_
2	,	_	,	,	_	9	punct	_	_
3	the	_	DT	DT	_	5	det	_	_
4	activating	_	NN	NN	_	5	nn	_	_
5	function	_	NN	NN	_	9	nsubjpass	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	p95vav	_	NN	NN	_	6	pobj	_	_
8	is	_	VBZ	VBZ	_	9	auxpass	_	_
9	blocked	_	VBN	VBN	_	0	root	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	FK506	_	NN	NN	_	10	pobj	_	_
12	,	_	,	,	_	9	punct	_	_
13	suggesting	_	VBG	VBG	_	9	vmod	_	_
14	that	_	IN	IN	_	18	mark	_	_
15	its	_	PRP$	PRP$	_	16	poss	_	_
16	activity	_	NN	NN	_	18	nsubj	_	_
17	also	_	RB	RB	_	18	advmod	_	_
18	depends	_	VBZ	VBZ	_	13	ccomp	_	_
19	on	_	IN	IN	_	18	prep	_	_
20	calcineurin	_	NN	NN	_	19	pobj	_	_
21	.	_	.	.	_	9	punct	_	_

1	To	_	TO	TO	_	3	aux	_	_
2	further	_	RB	RB	_	3	advmod	_	_
3	dissect	_	VB	VB	_	0	root	_	_
4	p95vav	_	NN	NN	_	5	nn	_	_
5	involvement	_	NN	NN	_	3	dobj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	TCR	_	NN	NN	_	8	nn	_	_
8	signaling	_	NN	NN	_	6	pobj	_	_
9	,	_	,	,	_	3	punct	_	_
10	we	_	PRP	PRP	_	11	nsubj	_	_
11	analyzed	_	VBD	VBD	_	3	parataxis	_	_
12	various	_	JJ	JJ	_	14	amod	_	_
13	Jurkat	_	NN	NN	_	14	nn	_	_
14	mutants	_	NNS	NNS	_	11	dobj	_	_
15	deficient	_	JJ	JJ	_	14	amod	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	TCR	_	NN	NN	_	19	nn	_	_
18	signaling	_	NN	NN	_	19	nn	_	_
19	function	_	NN	NN	_	16	pobj	_	_
20	or	_	CC	CC	_	19	cc	_	_
21	TCR	_	NN	NN	_	22	nn	_	_
22	expression	_	NN	NN	_	19	conj	_	_
23	and	_	CC	CC	_	11	cc	_	_
24	showed	_	VBD	VBD	_	11	conj	_	_
25	that	_	IN	IN	_	32	mark	_	_
26	an	_	DT	DT	_	30	det	_	_
27	intact	_	JJ	JJ	_	30	amod	_	_
28	TCR	_	NN	NN	_	30	nn	_	_
29	signaling	_	NN	NN	_	30	nn	_	_
30	pathway	_	NN	NN	_	32	nsubjpass	_	_
31	is	_	VBZ	VBZ	_	32	auxpass	_	_
32	required	_	VBN	VBN	_	24	ccomp	_	_
33	for	_	IN	IN	_	36	mark	_	_
34	p95vav	_	NN	NN	_	36	nsubj	_	_
35	to	_	TO	TO	_	36	aux	_	_
36	function	_	VB	VB	_	32	advcl	_	_
37	.	_	.	.	_	3	punct	_	_

1	However	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	overexpression	_	NN	NN	_	8	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	p95vav	_	NN	NN	_	4	pobj	_	_
6	does	_	VBZ	VBZ	_	8	aux	_	_
7	not	_	RB	RB	_	8	neg	_	_
8	appear	_	VB	VB	_	0	root	_	_
9	to	_	TO	TO	_	10	aux	_	_
10	influence	_	VB	VB	_	8	xcomp	_	_
11	TCR-induced	_	JJ	JJ	_	14	amod	_	_
12	protein	_	NN	NN	_	14	nn	_	_
13	tyrosine	_	NN	NN	_	14	nn	_	_
14	phosphorylation	_	NN	NN	_	10	dobj	_	_
15	or	_	CC	CC	_	14	cc	_	_
16	increases	_	NNS	NNS	_	14	conj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	cytoplasmic	_	JJ	JJ	_	20	amod	_	_
19	free	_	JJ	JJ	_	20	amod	_	_
20	calcium	_	NN	NN	_	17	pobj	_	_
21	.	_	.	.	_	8	punct	_	_

1	Taken	_	VBN	VBN	_	0	root	_	_
2	together	_	RB	RB	_	1	advmod	_	_
3	,	_	,	,	_	1	punct	_	_
4	our	_	PRP$	PRP$	_	5	poss	_	_
5	data	_	NNS	NNS	_	6	nsubj	_	_
6	suggest	_	VBP	VBP	_	1	parataxis	_	_
7	that	_	IN	IN	_	9	mark	_	_
8	p95vav	_	NN	NN	_	9	nsubj	_	_
9	plays	_	VBZ	VBZ	_	6	ccomp	_	_
10	an	_	DT	DT	_	12	det	_	_
11	important	_	JJ	JJ	_	12	amod	_	_
12	role	_	NN	NN	_	9	dobj	_	_
13	at	_	IN	IN	_	9	prep	_	_
14	an	_	DT	DT	_	18	det	_	_
15	yet	_	RB	RB	_	16	advmod	_	_
16	unidentified	_	JJ	JJ	_	18	amod	_	_
17	proximal	_	JJ	JJ	_	18	amod	_	_
18	position	_	NN	NN	_	13	pobj	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	23	det	_	_
21	TCR	_	NN	NN	_	23	nn	_	_
22	signaling	_	NN	NN	_	23	nn	_	_
23	cascade	_	NN	NN	_	19	pobj	_	_
24	.	_	.	.	_	1	punct	_	_

1	Activation	_	NN	NN	_	8	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	NF-kappa	_	NN	NN	_	4	nn	_	_
4	B	_	NN	NN	_	2	pobj	_	_
5	by	_	IN	IN	_	1	prep	_	_
6	phosphatase	_	NN	NN	_	7	nn	_	_
7	inhibitors	_	NNS	NNS	_	5	pobj	_	_
8	involves	_	VBZ	VBZ	_	0	root	_	_
9	the	_	DT	DT	_	10	det	_	_
10	phosphorylation	_	NN	NN	_	8	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	I	_	NN	NN	_	15	nn	_	_
13	kappa	_	NN	NN	_	15	nn	_	_
14	B	_	NN	NN	_	15	nn	_	_
15	alpha	_	NN	NN	_	11	pobj	_	_
16	at	_	IN	IN	_	10	prep	_	_
17	phosphatase	_	NN	NN	_	19	nn	_	_
18	2A-sensitive	_	JJ	JJ	_	19	amod	_	_
19	sites	_	NNS	NNS	_	16	pobj	_	_
20	.	_	.	.	_	8	punct	_	_

1	Activation	_	NN	NN	_	9	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	NF-kappa	_	NN	NN	_	4	nn	_	_
4	B	_	NN	NN	_	2	pobj	_	_
5	by	_	IN	IN	_	1	prep	_	_
6	various	_	JJ	JJ	_	8	amod	_	_
7	cellular	_	JJ	JJ	_	8	amod	_	_
8	stimuli	_	NNS	NNS	_	5	pobj	_	_
9	involves	_	VBZ	VBZ	_	0	root	_	_
10	the	_	DT	DT	_	11	dep	_	_
11	phosphorylation	_	NN	NN	_	9	dobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	subsequent	_	JJ	JJ	_	14	amod	_	_
14	degradation	_	NN	NN	_	11	conj	_	_
15	of	_	IN	IN	_	11	prep	_	_
16	its	_	PRP$	PRP$	_	17	poss	_	_
17	inhibitor	_	NN	NN	_	15	pobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	I	_	NN	NN	_	22	nn	_	_
20	kappa	_	NN	NN	_	22	nn	_	_
21	B	_	NN	NN	_	22	nn	_	_
22	alpha	_	NN	NN	_	17	appos	_	_
23	,	_	,	,	_	9	punct	_	_
24	although	_	IN	IN	_	28	mark	_	_
25	the	_	DT	DT	_	27	det	_	_
26	underlying	_	VBG	VBG	_	27	amod	_	_
27	mechanism	_	NN	NN	_	28	nsubj	_	_
28	remains	_	VBZ	VBZ	_	9	advcl	_	_
29	unclear	_	JJ	JJ	_	28	acomp	_	_
30	.	_	.	.	_	9	punct	_	_

1	In	_	IN	IN	_	21	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	present	_	JJ	JJ	_	4	amod	_	_
4	study	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	21	punct	_	_
6	the	_	DT	DT	_	7	det	_	_
7	role	_	NN	NN	_	21	nsubjpass	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	serine/threonine	_	NN	NN	_	10	nn	_	_
10	phosphatases	_	NNS	NNS	_	8	pobj	_	_
11	in	_	IN	IN	_	7	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	regulation	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	I	_	NN	NN	_	18	nn	_	_
16	kappa	_	NN	NN	_	18	nn	_	_
17	B	_	NN	NN	_	18	nn	_	_
18	alpha	_	NN	NN	_	19	nn	_	_
19	phosphorylation	_	NN	NN	_	14	pobj	_	_
20	was	_	VBD	VBD	_	21	auxpass	_	_
21	investigated	_	VBN	VBN	_	0	root	_	_
22	.	_	.	.	_	21	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	studies	_	NNS	NNS	_	3	nsubj	_	_
3	demonstrate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	42	mark	_	_
5	incubation	_	NN	NN	_	42	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	human	_	JJ	JJ	_	9	amod	_	_
8	T	_	NN	NN	_	9	nn	_	_
9	cells	_	NNS	NNS	_	6	pobj	_	_
10	with	_	IN	IN	_	5	prep	_	_
11	low	_	JJ	JJ	_	12	amod	_	_
12	concentrations	_	NNS	NNS	_	10	pobj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
14	approximately	_	RB	RB	_	15	quantmod	_	_
15	1-5	_	CD	CD	_	16	num	_	_
16	nM	_	NN	NN	_	12	appos	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	of	_	IN	IN	_	12	prep	_	_
19	calyculin	_	NN	NN	_	20	nn	_	_
20	A	_	NN	NN	_	18	pobj	_	_
21	or	_	CC	CC	_	20	cc	_	_
22	okadaic	_	JJ	JJ	_	23	amod	_	_
23	acid	_	NN	NN	_	20	conj	_	_
24	,	_	,	,	_	20	punct	_	_
25	potent	_	JJ	JJ	_	26	amod	_	_
26	inhibitors	_	NNS	NNS	_	20	appos	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	protein	_	NN	NN	_	29	nn	_	_
29	phosphatase	_	NN	NN	_	30	nn	_	_
30	type	_	NN	NN	_	27	pobj	_	_
31	1	_	CD	CD	_	30	num	_	_
32	-LRB-	_	-LRB-	-LRB-	_	33	punct	_	_
33	PP-1	_	NN	NN	_	30	appos	_	_
34	-RRB-	_	-RRB-	-RRB-	_	33	punct	_	_
35	and	_	CC	CC	_	30	cc	_	_
36	type	_	NN	NN	_	37	nn	_	_
37	2A	_	NN	NN	_	30	conj	_	_
38	-LRB-	_	-LRB-	-LRB-	_	39	punct	_	_
39	PP-2A	_	NN	NN	_	37	appos	_	_
40	-RRB-	_	-RRB-	-RRB-	_	39	punct	_	_
41	,	_	,	,	_	5	punct	_	_
42	induces	_	VBZ	VBZ	_	3	ccomp	_	_
43	the	_	DT	DT	_	44	det	_	_
44	phosphorylation	_	NN	NN	_	42	dobj	_	_
45	of	_	IN	IN	_	44	prep	_	_
46	I	_	NN	NN	_	49	nn	_	_
47	kappa	_	NN	NN	_	49	nn	_	_
48	B	_	NN	NN	_	49	nn	_	_
49	alpha	_	NN	NN	_	45	pobj	_	_
50	even	_	RB	RB	_	42	advmod	_	_
51	in	_	IN	IN	_	42	prep	_	_
52	the	_	DT	DT	_	53	det	_	_
53	absence	_	NN	NN	_	51	pobj	_	_
54	of	_	IN	IN	_	53	prep	_	_
55	any	_	DT	DT	_	57	det	_	_
56	cellular	_	JJ	JJ	_	57	amod	_	_
57	stimulus	_	NN	NN	_	54	pobj	_	_
58	.	_	.	.	_	3	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	action	_	NN	NN	_	23	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	phosphatase	_	NN	NN	_	6	nn	_	_
6	inhibitors	_	NNS	NNS	_	3	pobj	_	_
7	,	_	,	,	_	2	punct	_	_
8	which	_	WDT	WDT	_	10	nsubjpass	_	_
9	is	_	VBZ	VBZ	_	10	auxpass	_	_
10	associated	_	VBN	VBN	_	2	rcmod	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	activation	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	19	det	_	_
16	RelA.p50	_	NN	NN	_	19	nn	_	_
17	NF-kappa	_	NN	NN	_	19	nn	_	_
18	B	_	NN	NN	_	19	nn	_	_
19	heterodimer	_	NN	NN	_	14	pobj	_	_
20	,	_	,	,	_	2	punct	_	_
21	is	_	VBZ	VBZ	_	23	auxpass	_	_
22	not	_	RB	RB	_	23	neg	_	_
23	affected	_	VBN	VBN	_	0	root	_	_
24	by	_	IN	IN	_	23	prep	_	_
25	agents	_	NNS	NNS	_	24	pobj	_	_
26	that	_	WDT	WDT	_	27	nsubj	_	_
27	block	_	VBP	VBP	_	25	rcmod	_	_
28	the	_	DT	DT	_	29	det	_	_
29	induction	_	NN	NN	_	27	dobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	I	_	NN	NN	_	34	nn	_	_
32	kappa	_	NN	NN	_	34	nn	_	_
33	B	_	NN	NN	_	34	nn	_	_
34	alpha	_	NN	NN	_	35	nn	_	_
35	phosphorylation	_	NN	NN	_	30	pobj	_	_
36	by	_	IN	IN	_	29	prep	_	_
37	tumor	_	NN	NN	_	40	nn	_	_
38	necrosis	_	NN	NN	_	40	nn	_	_
39	factor	_	NN	NN	_	40	nn	_	_
40	alpha	_	NN	NN	_	36	pobj	_	_
41	-LRB-	_	-LRB-	-LRB-	_	42	punct	_	_
42	TNF-alpha	_	NN	NN	_	40	appos	_	_
43	-RRB-	_	-RRB-	-RRB-	_	42	punct	_	_
44	.	_	.	.	_	23	punct	_	_

1	Furthermore	_	RB	RB	_	22	advmod	_	_
2	,	_	,	,	_	22	punct	_	_
3	the	_	DT	DT	_	8	det	_	_
4	phosphorylated	_	VBN	VBN	_	8	amod	_	_
5	I	_	NN	NN	_	8	nn	_	_
6	kappa	_	NN	NN	_	8	nn	_	_
7	B	_	NN	NN	_	8	nn	_	_
8	alpha	_	NN	NN	_	22	nsubj	_	_
9	from	_	IN	IN	_	8	prep	_	_
10	calyculin	_	NN	NN	_	12	nn	_	_
11	A-treated	_	JJ	JJ	_	12	amod	_	_
12	cells	_	NNS	NNS	_	9	pobj	_	_
13	,	_	,	,	_	8	punct	_	_
14	but	_	CC	CC	_	15	cc	_	_
15	not	_	RB	RB	_	8	cc	_	_
16	that	_	DT	DT	_	8	conj	_	_
17	from	_	IN	IN	_	16	prep	_	_
18	TNF-alpha-stimulated	_	JJ	JJ	_	19	amod	_	_
19	cells	_	NNS	NNS	_	17	pobj	_	_
20	,	_	,	,	_	8	punct	_	_
21	is	_	VBZ	VBZ	_	22	cop	_	_
22	sensitive	_	JJ	JJ	_	0	root	_	_
23	to	_	TO	TO	_	22	prep	_	_
24	PP-2A	_	NN	NN	_	23	pobj	_	_
25	in	_	FW	FW	_	26	nn	_	_
26	vitro	_	FW	FW	_	22	advmod	_	_
27	,	_	,	,	_	22	punct	_	_
28	suggesting	_	VBG	VBG	_	22	xcomp	_	_
29	the	_	DT	DT	_	30	det	_	_
30	existence	_	NN	NN	_	28	dobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	fundamental	_	JJ	JJ	_	33	amod	_	_
33	differences	_	NNS	NNS	_	31	pobj	_	_
34	in	_	IN	IN	_	33	prep	_	_
35	the	_	DT	DT	_	36	det	_	_
36	phosphorylation	_	NN	NN	_	34	pobj	_	_
37	of	_	IN	IN	_	36	prep	_	_
38	I	_	NN	NN	_	41	nn	_	_
39	kappa	_	NN	NN	_	41	nn	_	_
40	B	_	NN	NN	_	41	nn	_	_
41	alpha	_	NN	NN	_	37	pobj	_	_
42	induced	_	VBN	VBN	_	36	vmod	_	_
43	by	_	IN	IN	_	42	prep	_	_
44	the	_	DT	DT	_	49	det	_	_
45	two	_	CD	CD	_	49	num	_	_
46	different	_	JJ	JJ	_	49	amod	_	_
47	NF-kappa	_	NN	NN	_	48	nn	_	_
48	B	_	NN	NN	_	49	nn	_	_
49	inducers	_	NNS	NNS	_	43	pobj	_	_
50	.	_	.	.	_	22	punct	_	_

1	However	_	RB	RB	_	18	advmod	_	_
2	,	_	,	,	_	18	punct	_	_
3	induction	_	NN	NN	_	18	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	I	_	NN	NN	_	8	nn	_	_
6	kappa	_	NN	NN	_	8	nn	_	_
7	B	_	NN	NN	_	8	nn	_	_
8	alpha	_	NN	NN	_	9	nn	_	_
9	phosphorylation	_	NN	NN	_	4	pobj	_	_
10	by	_	IN	IN	_	3	prep	_	_
11	both	_	CC	CC	_	12	preconj	_	_
12	TNF-alpha	_	NN	NN	_	10	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	the	_	DT	DT	_	16	det	_	_
15	phosphatase	_	NN	NN	_	16	nn	_	_
16	inhibitors	_	NNS	NNS	_	12	conj	_	_
17	is	_	VBZ	VBZ	_	18	auxpass	_	_
18	associated	_	VBN	VBN	_	0	root	_	_
19	with	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	22	det	_	_
21	subsequent	_	JJ	JJ	_	22	amod	_	_
22	degradation	_	NN	NN	_	19	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	I	_	NN	NN	_	27	nn	_	_
25	kappa	_	NN	NN	_	27	nn	_	_
26	B	_	NN	NN	_	27	nn	_	_
27	alpha	_	NN	NN	_	23	pobj	_	_
28	.	_	.	.	_	18	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	further	_	RB	RB	_	3	advmod	_	_
3	demonstrate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	14	mark	_	_
5	TNF-alpha-	_	NN	NN	_	14	nsubj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	calyculin	_	NN	NN	_	5	conj	_	_
8	A-induced	_	JJ	JJ	_	7	amod	_	_
9	I	_	NN	NN	_	13	nn	_	_
10	kappa	_	NN	NN	_	13	nn	_	_
11	B	_	NN	NN	_	13	nn	_	_
12	alpha	_	NN	NN	_	13	nn	_	_
13	degradation	_	NN	NN	_	5	dep	_	_
14	exhibits	_	VBZ	VBZ	_	3	ccomp	_	_
15	similar	_	JJ	JJ	_	19	amod	_	_
16	but	_	CC	CC	_	17	cc	_	_
17	not	_	RB	RB	_	15	cc	_	_
18	identical	_	JJ	JJ	_	15	conj	_	_
19	sensitivities	_	NNS	NNS	_	14	dobj	_	_
20	to	_	TO	TO	_	19	prep	_	_
21	a	_	DT	DT	_	23	det	_	_
22	proteasome	_	JJ	JJ	_	23	amod	_	_
23	inhibitor	_	NN	NN	_	20	pobj	_	_
24	.	_	.	.	_	3	punct	_	_

1	Together	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	these	_	DT	DT	_	4	det	_	_
4	results	_	NNS	NNS	_	5	nsubj	_	_
5	suggest	_	VBP	VBP	_	0	root	_	_
6	that	_	IN	IN	_	25	mark	_	_
7	phosphorylation	_	NN	NN	_	25	nsubj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	I	_	NN	NN	_	12	nn	_	_
10	kappa	_	NN	NN	_	12	nn	_	_
11	B	_	NN	NN	_	12	nn	_	_
12	alpha	_	NN	NN	_	8	pobj	_	_
13	,	_	,	,	_	7	punct	_	_
14	mediated	_	VBN	VBN	_	7	vmod	_	_
15	through	_	IN	IN	_	14	prep	_	_
16	both	_	CC	CC	_	18	dep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	TNF-alpha-inducible	_	JJ	JJ	_	15	pobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	the	_	DT	DT	_	22	det	_	_
21	PP-2A-opposing	_	JJ	JJ	_	22	amod	_	_
22	kinases	_	NNS	NNS	_	18	conj	_	_
23	,	_	,	,	_	7	punct	_	_
24	may	_	MD	MD	_	25	aux	_	_
25	serve	_	VB	VB	_	5	ccomp	_	_
26	to	_	TO	TO	_	27	aux	_	_
27	target	_	NN	NN	_	25	xcomp	_	_
28	I	_	NN	NN	_	31	nn	_	_
29	kappa	_	NN	NN	_	31	nn	_	_
30	B	_	NN	NN	_	31	nn	_	_
31	alpha	_	NN	NN	_	27	dobj	_	_
32	for	_	IN	IN	_	27	prep	_	_
33	proteasome-mediated	_	JJ	JJ	_	34	amod	_	_
34	degradation	_	NN	NN	_	32	pobj	_	_
35	.	_	.	.	_	5	punct	_	_

1	RB	_	NN	NN	_	0	root	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	a	_	DT	DT	_	7	det	_	_
4	novel	_	JJ	JJ	_	7	amod	_	_
5	E2F-1	_	NN	NN	_	7	nn	_	_
6	binding	_	NN	NN	_	7	nn	_	_
7	protein	_	NN	NN	_	1	conj	_	_
8	in	_	IN	IN	_	1	prep	_	_
9	MHC	_	NN	NN	_	14	nn	_	_
10	class	_	NN	NN	_	14	nn	_	_
11	II	_	CD	CD	_	14	num	_	_
12	deficient	_	JJ	JJ	_	14	amod	_	_
13	B-cell	_	NN	NN	_	14	nn	_	_
14	lines	_	NNS	NNS	_	8	pobj	_	_
15	and	_	CC	CC	_	1	cc	_	_
16	normal	_	JJ	JJ	_	18	amod	_	_
17	IFN-gamma	_	NN	NN	_	18	nn	_	_
18	induction	_	NN	NN	_	1	conj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	23	det	_	_
21	class	_	NN	NN	_	23	nn	_	_
22	IL	_	NN	NN	_	23	nn	_	_
23	transactivator	_	NN	NN	_	19	pobj	_	_
24	CIITA	_	NN	NN	_	23	dep	_	_
25	in	_	IN	IN	_	18	prep	_	_
26	class	_	NN	NN	_	31	nn	_	_
27	II	_	CD	CD	_	31	num	_	_
28	non-inducible	_	JJ	JJ	_	31	amod	_	_
29	RB-defective	_	JJ	JJ	_	31	amod	_	_
30	tumor	_	NN	NN	_	31	nn	_	_
31	lines	_	NNS	NNS	_	25	pobj	_	_
32	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	9	det	_	_
2	major	_	JJ	JJ	_	9	amod	_	_
3	histocompatibility	_	NN	NN	_	9	nn	_	_
4	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
5	MHC	_	NN	NN	_	9	nn	_	_
6	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
7	class	_	NN	NN	_	9	nn	_	_
8	II	_	CD	CD	_	9	num	_	_
9	genes	_	NNS	NNS	_	10	nsubj	_	_
10	encode	_	VBP	VBP	_	0	root	_	_
11	cell	_	NN	NN	_	13	nn	_	_
12	surface	_	NN	NN	_	13	nn	_	_
13	proteins	_	NNS	NNS	_	10	dobj	_	_
14	that	_	WDT	WDT	_	15	nsubj	_	_
15	bind	_	VBP	VBP	_	13	rcmod	_	_
16	antigenic	_	JJ	JJ	_	17	amod	_	_
17	peptide	_	NN	NN	_	15	dobj	_	_
18	for	_	IN	IN	_	15	prep	_	_
19	presentation	_	NN	NN	_	18	pobj	_	_
20	to	_	TO	TO	_	19	prep	_	_
21	T-cells	_	NNS	NNS	_	20	pobj	_	_
22	.	_	.	.	_	10	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	class	_	NN	NN	_	4	nn	_	_
3	II	_	CD	CD	_	4	num	_	_
4	proteins	_	NNS	NNS	_	6	nsubjpass	_	_
5	are	_	VBP	VBP	_	6	auxpass	_	_
6	expressed	_	VBN	VBN	_	0	root	_	_
7	constitutively	_	RB	RB	_	6	advmod	_	_
8	on	_	IN	IN	_	6	prep	_	_
9	B-cells	_	NNS	NNS	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	EBV-transformed	_	JJ	JJ	_	12	amod	_	_
12	B-cells	_	NNS	NNS	_	9	conj	_	_
13	,	_	,	,	_	12	punct	_	_
14	and	_	CC	CC	_	6	cc	_	_
15	are	_	VBP	VBP	_	16	cop	_	_
16	inducible	_	JJ	JJ	_	6	conj	_	_
17	by	_	IN	IN	_	16	prep	_	_
18	IFN-gamma	_	NN	NN	_	17	pobj	_	_
19	on	_	IN	IN	_	18	prep	_	_
20	a	_	DT	DT	_	22	det	_	_
21	wide	_	JJ	JJ	_	22	amod	_	_
22	variety	_	NN	NN	_	19	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	cell	_	NN	NN	_	25	nn	_	_
25	types	_	NNS	NNS	_	23	pobj	_	_
26	.	_	.	.	_	6	punct	_	_

1	Retinoblastoma	_	NN	NN	_	2	nn	_	_
2	protein	_	NN	NN	_	9	nsubj	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	RB	_	NN	NN	_	2	appos	_	_
5	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
6	is	_	VBZ	VBZ	_	9	cop	_	_
7	a	_	DT	DT	_	9	det	_	_
8	tumor	_	NN	NN	_	9	nn	_	_
9	suppressor	_	NN	NN	_	0	root	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	functions	_	VBZ	VBZ	_	9	conj	_	_
12	as	_	IN	IN	_	11	prep	_	_
13	a	_	DT	DT	_	15	det	_	_
14	transcriptional	_	JJ	JJ	_	15	amod	_	_
15	repressor	_	NN	NN	_	12	pobj	_	_
16	by	_	IN	IN	_	11	prep	_	_
17	binding	_	VBG	VBG	_	16	pcomp	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	inactivating	_	VBG	VBG	_	17	conj	_	_
20	the	_	DT	DT	_	22	det	_	_
21	transactivator	_	NN	NN	_	22	nn	_	_
22	E2F-I	_	NN	NN	_	17	dobj	_	_
23	.	_	.	.	_	9	punct	_	_

1	RB-defective	_	JJ	JJ	_	3	amod	_	_
2	tumor	_	NN	NN	_	3	nn	_	_
3	lines	_	NNS	NNS	_	5	nsubj	_	_
4	are	_	VBP	VBP	_	5	cop	_	_
5	non-inducible	_	JJ	JJ	_	0	root	_	_
6	for	_	IN	IN	_	5	prep	_	_
7	MHC	_	NN	NN	_	8	nn	_	_
8	class	_	NN	NN	_	6	pobj	_	_
9	II	_	CD	CD	_	8	num	_	_
10	by	_	IN	IN	_	5	prep	_	_
11	IFN-gamma	_	NN	NN	_	10	pobj	_	_
12	,	_	,	,	_	5	punct	_	_
13	or	_	CC	CC	_	5	cc	_	_
14	very	_	RB	RB	_	16	advmod	_	_
15	weakly	_	RB	RB	_	16	advmod	_	_
16	inducible	_	JJ	JJ	_	5	conj	_	_
17	,	_	,	,	_	5	punct	_	_
18	but	_	CC	CC	_	5	cc	_	_
19	transfection	_	NN	NN	_	28	nsubj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	2	_	CD	CD	_	23	num	_	_
22	different	_	JJ	JJ	_	23	amod	_	_
23	lines	_	NNS	NNS	_	20	pobj	_	_
24	with	_	IN	IN	_	19	prep	_	_
25	RB	_	NN	NN	_	27	nn	_	_
26	expression	_	NN	NN	_	27	nn	_	_
27	vectors	_	NNS	NNS	_	24	pobj	_	_
28	re-establishes	_	VBZ	VBZ	_	5	conj	_	_
29	or	_	CC	CC	_	28	cc	_	_
30	substantially	_	RB	RB	_	31	advmod	_	_
31	enhances	_	VBZ	VBZ	_	28	conj	_	_
32	class	_	NN	NN	_	34	nn	_	_
33	II	_	CD	CD	_	34	num	_	_
34	inducibility	_	NN	NN	_	28	dobj	_	_
35	.	_	.	.	_	5	punct	_	_

1	Therefore	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	examined	_	VBD	VBD	_	0	root	_	_
5	the	_	DT	DT	_	7	det	_	_
6	RB	_	NN	NN	_	7	nn	_	_
7	status	_	NN	NN	_	4	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	a	_	DT	DT	_	10	det	_	_
10	series	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	B-cell	_	NN	NN	_	13	nn	_	_
13	mutants	_	NNS	NNS	_	11	pobj	_	_
14	that	_	WDT	WDT	_	16	nsubj	_	_
15	are	_	VBP	VBP	_	16	cop	_	_
16	defective	_	JJ	JJ	_	13	rcmod	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	class	_	NN	NN	_	20	nn	_	_
19	II	_	CD	CD	_	20	num	_	_
20	expression	_	NN	NN	_	17	pobj	_	_
21	,	_	,	,	_	16	punct	_	_
22	generated	_	VBN	VBN	_	16	ccomp	_	_
23	either	_	CC	CC	_	22	dep	_	_
24	in	_	FW	FW	_	25	nn	_	_
25	vitro	_	FW	FW	_	22	advmod	_	_
26	or	_	CC	CC	_	22	cc	_	_
27	derived	_	VBN	VBN	_	22	conj	_	_
28	from	_	IN	IN	_	27	prep	_	_
29	Bare	_	NN	NN	_	31	nn	_	_
30	Lymphocyte	_	NN	NN	_	31	nn	_	_
31	Syndrome	_	NN	NN	_	35	nn	_	_
32	-LRB-	_	-LRB-	-LRB-	_	33	punct	_	_
33	BLS	_	NN	NN	_	31	appos	_	_
34	-RRB-	_	-RRB-	-RRB-	_	33	punct	_	_
35	patients	_	NNS	NNS	_	28	pobj	_	_
36	.	_	.	.	_	4	punct	_	_

1	Nuclear	_	JJ	JJ	_	2	amod	_	_
2	matrix-bound	_	JJ	JJ	_	3	amod	_	_
3	RB	_	NN	NN	_	5	nsubj	_	_
4	was	_	VBD	VBD	_	5	cop	_	_
5	detectable	_	JJ	JJ	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	all	_	DT	DT	_	8	det	_	_
8	cases	_	NNS	NNS	_	6	pobj	_	_
9	,	_	,	,	_	5	punct	_	_
10	indicating	_	VBG	VBG	_	5	xcomp	_	_
11	that	_	IN	IN	_	17	mark	_	_
12	loss	_	NN	NN	_	17	nsubj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	RB	_	NN	NN	_	13	pobj	_	_
15	is	_	VBZ	VBZ	_	17	cop	_	_
16	not	_	RB	RB	_	17	neg	_	_
17	responsible	_	JJ	JJ	_	10	ccomp	_	_
18	for	_	IN	IN	_	17	prep	_	_
19	decreased	_	VBN	VBN	_	22	amod	_	_
20	class	_	NN	NN	_	22	nn	_	_
21	II	_	CD	CD	_	22	num	_	_
22	expression	_	NN	NN	_	18	pobj	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	these	_	DT	DT	_	25	det	_	_
25	lines	_	NNS	NNS	_	23	pobj	_	_
26	.	_	.	.	_	5	punct	_	_

1	A	_	DT	DT	_	5	det	_	_
2	second	_	JJ	JJ	_	5	amod	_	_
3	E2F-I	_	NN	NN	_	5	nn	_	_
4	binding	_	NN	NN	_	5	nn	_	_
5	protein	_	NN	NN	_	14	nsubj	_	_
6	,	_	,	,	_	5	punct	_	_
7	most	_	RBS	RBS	_	8	advmod	_	_
8	likely	_	RB	RB	_	9	advmod	_	_
9	DP-I	_	NN	NN	_	5	appos	_	_
10	,	_	,	,	_	5	punct	_	_
11	was	_	VBD	VBD	_	14	cop	_	_
12	also	_	RB	RB	_	14	advmod	_	_
13	apparently	_	RB	RB	_	14	advmod	_	_
14	normal	_	JJ	JJ	_	0	root	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	both	_	CC	CC	_	17	preconj	_	_
17	class	_	NN	NN	_	15	pobj	_	_
18	II-positive	_	JJ	JJ	_	17	dep	_	_
19	and	_	CC	CC	_	17	cc	_	_
20	-negative	_	JJ	JJ	_	17	conj	_	_
21	B-cell	_	NN	NN	_	22	nn	_	_
22	lines	_	NNS	NNS	_	17	dep	_	_
23	.	_	.	.	_	14	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	examined	_	VBD	VBD	_	0	root	_	_
4	the	_	DT	DT	_	6	det	_	_
5	IFN-gamma	_	NN	NN	_	6	nn	_	_
6	induction	_	NN	NN	_	3	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	CIITA	_	NN	NN	_	7	pobj	_	_
9	in	_	IN	IN	_	6	prep	_	_
10	RB-defective	_	JJ	JJ	_	9	dep	_	_
11	lines	_	NNS	NNS	_	9	dep	_	_
12	.	_	.	.	_	3	punct	_	_

1	CIITA	_	NN	NN	_	7	nsubj	_	_
2	is	_	VBZ	VBZ	_	7	cop	_	_
3	a	_	DT	DT	_	7	det	_	_
4	class	_	NN	NN	_	7	nn	_	_
5	II	_	CD	CD	_	7	num	_	_
6	gene	_	NN	NN	_	7	nn	_	_
7	transactivator	_	NN	NN	_	0	root	_	_
8	known	_	VBN	VBN	_	7	vmod	_	_
9	to	_	TO	TO	_	11	aux	_	_
10	be	_	VB	VB	_	11	cop	_	_
11	defective	_	JJ	JJ	_	8	ccomp	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	one	_	CD	CD	_	14	num	_	_
14	form	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	BLS	_	NN	NN	_	15	pobj	_	_
17	and	_	CC	CC	_	11	cc	_	_
18	to	_	TO	TO	_	20	aux	_	_
19	be	_	VB	VB	_	20	auxpass	_	_
20	required	_	VBN	VBN	_	11	conj	_	_
21	for	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	23	det	_	_
23	induction	_	NN	NN	_	21	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	MHC	_	NN	NN	_	26	nn	_	_
26	class	_	NN	NN	_	24	pobj	_	_
27	II	_	CD	CD	_	26	num	_	_
28	by	_	IN	IN	_	23	prep	_	_
29	IFN-gamma	_	NN	NN	_	28	pobj	_	_
30	.	_	.	.	_	7	punct	_	_

1	CIITA	_	NN	NN	_	2	nn	_	_
2	mRNA	_	NN	NN	_	5	nsubj	_	_
3	is	_	VBZ	VBZ	_	5	cop	_	_
4	normally	_	RB	RB	_	5	advmod	_	_
5	inducible	_	JJ	JJ	_	0	root	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	IFN-gamma	_	NN	NN	_	6	pobj	_	_
8	in	_	IN	IN	_	5	prep	_	_
9	class	_	NN	NN	_	14	nn	_	_
10	II	_	CD	CD	_	14	num	_	_
11	non-inducible	_	JJ	JJ	_	14	amod	_	_
12	,	_	,	,	_	14	punct	_	_
13	RB-defective	_	JJ	JJ	_	14	amod	_	_
14	lines	_	NNS	NNS	_	8	pobj	_	_
15	,	_	,	,	_	5	punct	_	_
16	and	_	CC	CC	_	5	cc	_	_
17	in	_	IN	IN	_	24	prep	_	_
18	one	_	CD	CD	_	19	num	_	_
19	line	_	NN	NN	_	17	pobj	_	_
20	,	_	,	,	_	24	punct	_	_
21	re-expression	_	NN	NN	_	24	nsubj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	RB	_	NN	NN	_	22	pobj	_	_
24	has	_	VBZ	VBZ	_	5	conj	_	_
25	no	_	DT	DT	_	26	neg	_	_
26	effect	_	NN	NN	_	24	dobj	_	_
27	on	_	IN	IN	_	24	prep	_	_
28	CIITA	_	NN	NN	_	29	nn	_	_
29	mRNA	_	NN	NN	_	31	nn	_	_
30	induction	_	NN	NN	_	31	nn	_	_
31	levels	_	NNS	NNS	_	27	pobj	_	_
32	.	_	.	.	_	5	punct	_	_

1	Thus	_	RB	RB	_	15	advmod	_	_
2	,	_	,	,	_	15	punct	_	_
3	the	_	DT	DT	_	4	det	_	_
4	block	_	NN	NN	_	15	nsubj	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	MHC	_	NN	NN	_	9	nn	_	_
7	class	_	NN	NN	_	9	nn	_	_
8	II	_	CD	CD	_	9	num	_	_
9	inducibility	_	NN	NN	_	5	pobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	RB-defective	_	JJ	JJ	_	12	amod	_	_
12	cells	_	NNS	NNS	_	10	pobj	_	_
13	is	_	VBZ	VBZ	_	15	cop	_	_
14	not	_	RB	RB	_	15	neg	_	_
15	due	_	JJ	JJ	_	0	root	_	_
16	to	_	TO	TO	_	15	prep	_	_
17	a	_	DT	DT	_	18	det	_	_
18	block	_	NN	NN	_	16	pobj	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	CIITA	_	NN	NN	_	21	nn	_	_
21	inducibility	_	NN	NN	_	19	pobj	_	_
22	.	_	.	.	_	15	punct	_	_

1	Latent	_	JJ	JJ	_	3	amod	_	_
2	membrane	_	NN	NN	_	3	nn	_	_
3	protein-1	_	NN	NN	_	4	nsubj	_	_
4	induces	_	VBZ	VBZ	_	0	root	_	_
5	cyclin	_	NN	NN	_	6	nn	_	_
6	D2	_	NN	NN	_	7	nn	_	_
7	expression	_	NN	NN	_	4	dobj	_	_
8	,	_	,	,	_	7	punct	_	_
9	pRb	_	NN	NN	_	10	nn	_	_
10	hyperphosphorylation	_	NN	NN	_	7	conj	_	_
11	,	_	,	,	_	7	punct	_	_
12	and	_	CC	CC	_	7	cc	_	_
13	loss	_	NN	NN	_	7	conj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	TGF-beta	_	NN	NN	_	18	nn	_	_
16	1-mediated	_	JJ	JJ	_	18	amod	_	_
17	growth	_	NN	NN	_	18	nn	_	_
18	inhibition	_	NN	NN	_	14	pobj	_	_
19	in	_	IN	IN	_	7	prep	_	_
20	EBV-positive	_	JJ	JJ	_	22	amod	_	_
21	B	_	NN	NN	_	22	nn	_	_
22	cells	_	NNS	NNS	_	19	pobj	_	_
23	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	normal	_	JJ	JJ	_	4	amod	_	_
3	cell	_	NN	NN	_	4	nn	_	_
4	cycle	_	NN	NN	_	6	nsubjpass	_	_
5	is	_	VBZ	VBZ	_	6	auxpass	_	_
6	regulated	_	VBN	VBN	_	0	root	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	several	_	JJ	JJ	_	9	amod	_	_
9	molecules	_	NNS	NNS	_	7	pobj	_	_
10	,	_	,	,	_	9	punct	_	_
11	such	_	JJ	JJ	_	12	mwe	_	_
12	as	_	IN	IN	_	9	prep	_	_
13	the	_	DT	DT	_	16	det	_	_
14	tumor-suppressor	_	JJ	JJ	_	16	amod	_	_
15	protein	_	NN	NN	_	16	nn	_	_
16	pRb	_	NN	NN	_	12	pobj	_	_
17	,	_	,	,	_	16	punct	_	_
18	the	_	DT	DT	_	20	det	_	_
19	G1	_	NN	NN	_	20	nn	_	_
20	cyclins	_	NNS	NNS	_	16	conj	_	_
21	,	_	,	,	_	16	punct	_	_
22	the	_	DT	DT	_	24	det	_	_
23	cyclin-dependent	_	JJ	JJ	_	24	amod	_	_
24	kinases	_	NNS	NNS	_	16	conj	_	_
25	,	_	,	,	_	16	punct	_	_
26	and	_	CC	CC	_	16	cc	_	_
27	their	_	PRP$	PRP$	_	28	poss	_	_
28	inhibitors	_	NNS	NNS	_	16	conj	_	_
29	.	_	.	.	_	6	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	regulators	_	NNS	NNS	_	4	nsubjpass	_	_
3	are	_	VBP	VBP	_	4	auxpass	_	_
4	targeted	_	VBN	VBN	_	0	root	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	negative	_	JJ	JJ	_	9	amod	_	_
7	growth	_	NN	NN	_	9	nn	_	_
8	regulatory	_	JJ	JJ	_	9	amod	_	_
9	signals	_	NNS	NNS	_	5	pobj	_	_
10	,	_	,	,	_	9	punct	_	_
11	such	_	JJ	JJ	_	12	mwe	_	_
12	as	_	IN	IN	_	9	prep	_	_
13	that	_	DT	DT	_	12	pobj	_	_
14	provided	_	VBN	VBN	_	13	vmod	_	_
15	by	_	IN	IN	_	14	prep	_	_
16	TGF-beta	_	NN	NN	_	15	pobj	_	_
17	.	_	.	.	_	4	punct	_	_

1	Here	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	show	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	21	mark	_	_
6	the	_	DT	DT	_	7	det	_	_
7	presence	_	NN	NN	_	21	nsubj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	either	_	CC	CC	_	11	preconj	_	_
10	wild-type	_	JJ	JJ	_	11	amod	_	_
11	EBV	_	NN	NN	_	8	pobj	_	_
12	or	_	CC	CC	_	11	cc	_	_
13	its	_	PRP$	PRP$	_	17	poss	_	_
14	transforming	_	VBG	VBG	_	17	amod	_	_
15	latent	_	JJ	JJ	_	17	amod	_	_
16	membrane	_	NN	NN	_	17	nn	_	_
17	protein-1	_	NN	NN	_	11	conj	_	_
18	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
19	LMP-1	_	NN	NN	_	17	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	results	_	VBZ	VBZ	_	4	ccomp	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	24	det	_	_
24	loss	_	NN	NN	_	22	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	TGF-beta	_	NN	NN	_	29	nn	_	_
27	1-mediated	_	JJ	JJ	_	29	amod	_	_
28	growth	_	NN	NN	_	29	nn	_	_
29	inhibition	_	NN	NN	_	25	pobj	_	_
30	in	_	IN	IN	_	24	prep	_	_
31	human	_	JJ	JJ	_	33	amod	_	_
32	B	_	NN	NN	_	33	nn	_	_
33	cells	_	NNS	NNS	_	30	pobj	_	_
34	.	_	.	.	_	4	punct	_	_

1	Chemical	_	JJ	JJ	_	2	amod	_	_
2	cross-linking	_	NN	NN	_	7	nsubj	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	125I-labeled	_	JJ	JJ	_	5	amod	_	_
5	TGF-beta	_	NN	NN	_	3	pobj	_	_
6	1	_	CD	CD	_	5	num	_	_
7	showed	_	VBD	VBD	_	0	root	_	_
8	an	_	DT	DT	_	13	det	_	_
9	essentially	_	RB	RB	_	10	advmod	_	_
10	normal	_	JJ	JJ	_	13	amod	_	_
11	TGF-beta	_	NN	NN	_	12	nn	_	_
12	receptor	_	NN	NN	_	13	nn	_	_
13	profile	_	NN	NN	_	7	dobj	_	_
14	in	_	IN	IN	_	7	prep	_	_
15	EBV-positive	_	JJ	JJ	_	14	pobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	EBV-negative	_	JJ	JJ	_	15	conj	_	_
18	Burkitt	_	NN	NN	_	22	poss	_	_
19	's	_	POS	POS	_	22	possessive	_	_
20	lymphoma	_	NN	NN	_	22	nn	_	_
21	cell	_	NN	NN	_	22	nn	_	_
22	lines	_	NNS	NNS	_	15	dep	_	_
23	,	_	,	,	_	7	punct	_	_
24	and	_	CC	CC	_	7	cc	_	_
25	these	_	DT	DT	_	26	det	_	_
26	receptors	_	NNS	NNS	_	28	nsubjpass	_	_
27	were	_	VBD	VBD	_	28	auxpass	_	_
28	shown	_	VBN	VBN	_	7	conj	_	_
29	to	_	TO	TO	_	31	aux	_	_
30	be	_	VB	VB	_	31	cop	_	_
31	functional	_	JJ	JJ	_	28	xcomp	_	_
32	in	_	IN	IN	_	31	prep	_	_
33	transducing	_	VBG	VBG	_	32	pcomp	_	_
34	signals	_	NNS	NNS	_	33	dobj	_	_
35	,	_	,	,	_	28	punct	_	_
36	as	_	IN	IN	_	37	mark	_	_
37	evidenced	_	VBN	VBN	_	28	advcl	_	_
38	by	_	IN	IN	_	37	prep	_	_
39	the	_	DT	DT	_	42	det	_	_
40	TGF-beta	_	NN	NN	_	42	nn	_	_
41	1-mediated	_	JJ	JJ	_	42	amod	_	_
42	modulation	_	NN	NN	_	38	pobj	_	_
43	of	_	IN	IN	_	42	prep	_	_
44	junB	_	NN	NN	_	45	nn	_	_
45	gene	_	NN	NN	_	46	nn	_	_
46	expression	_	NN	NN	_	43	pobj	_	_
47	.	_	.	.	_	7	punct	_	_

1	However	_	RB	RB	_	7	advmod	_	_
2	,	_	,	,	_	7	punct	_	_
3	TGF-beta	_	NN	NN	_	7	nsubj	_	_
4	1	_	CD	CD	_	3	num	_	_
5	did	_	VBD	VBD	_	7	aux	_	_
6	not	_	RB	RB	_	7	neg	_	_
7	induce	_	VB	VB	_	0	root	_	_
8	dephosphorylation	_	NN	NN	_	7	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	pRb	_	NN	NN	_	9	pobj	_	_
11	in	_	IN	IN	_	7	prep	_	_
12	EBV	_	NN	NN	_	11	pobj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
14	or	_	CC	CC	_	12	cc	_	_
15	LMP-1	_	NN	NN	_	18	nn	_	_
16	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
17	-positive	_	JJ	JJ	_	18	amod	_	_
18	cells	_	NNS	NNS	_	12	conj	_	_
19	as	_	IN	IN	_	20	mark	_	_
20	opposed	_	VBN	VBN	_	7	advcl	_	_
21	to	_	TO	TO	_	20	prep	_	_
22	EBV	_	JJ	JJ	_	24	amod	_	_
23	-negative	_	JJ	JJ	_	24	amod	_	_
24	cells	_	NNS	NNS	_	21	pobj	_	_
25	,	_	,	,	_	20	punct	_	_
26	suggesting	_	VBG	VBG	_	20	dep	_	_
27	a	_	DT	DT	_	28	det	_	_
28	dichotomy	_	NN	NN	_	26	dobj	_	_
29	in	_	IN	IN	_	28	prep	_	_
30	the	_	DT	DT	_	34	det	_	_
31	TGF-beta	_	NN	NN	_	34	nn	_	_
32	1	_	CD	CD	_	31	num	_	_
33	signaling	_	NN	NN	_	34	nn	_	_
34	pathway	_	NN	NN	_	29	pobj	_	_
35	leading	_	VBG	VBG	_	28	vmod	_	_
36	to	_	TO	TO	_	35	prep	_	_
37	separable	_	JJ	JJ	_	38	amod	_	_
38	gene	_	NN	NN	_	36	pobj	_	_
39	regulatory	_	JJ	JJ	_	38	dep	_	_
40	and	_	CC	CC	_	38	cc	_	_
41	growth	_	NN	NN	_	38	conj	_	_
42	inhibitory	_	JJ	JJ	_	41	amod	_	_
43	responses	_	NNS	NNS	_	38	dep	_	_
44	.	_	.	.	_	7	punct	_	_

1	Furthermore	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	LMP-1	_	NN	NN	_	5	nsubjpass	_	_
4	was	_	VBD	VBD	_	5	auxpass	_	_
5	found	_	VBN	VBN	_	0	root	_	_
6	to	_	TO	TO	_	7	aux	_	_
7	induce	_	VB	VB	_	5	xcomp	_	_
8	the	_	DT	DT	_	9	det	_	_
9	expression	_	NN	NN	_	7	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	cyclin	_	NN	NN	_	12	nn	_	_
12	D2	_	NN	NN	_	10	pobj	_	_
13	;	_	:	:	_	5	punct	_	_
14	normal	_	JJ	JJ	_	16	amod	_	_
15	B	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	25	nsubj	_	_
17	or	_	CC	CC	_	16	cc	_	_
18	EBV-negative	_	JJ	JJ	_	22	amod	_	_
19	Burkitt	_	NN	NN	_	22	poss	_	_
20	's	_	POS	POS	_	22	possessive	_	_
21	lymphoma	_	NN	NN	_	22	nn	_	_
22	cells	_	NNS	NNS	_	16	conj	_	_
23	do	_	VBP	VBP	_	25	aux	_	_
24	not	_	RB	RB	_	25	neg	_	_
25	express	_	VB	VB	_	5	parataxis	_	_
26	D-type	_	JJ	JJ	_	27	amod	_	_
27	cyclins	_	NNS	NNS	_	25	dobj	_	_
28	.	_	.	.	_	5	punct	_	_

1	Taken	_	VBN	VBN	_	0	root	_	_
2	together	_	RB	RB	_	1	advmod	_	_
3	,	_	,	,	_	1	punct	_	_
4	these	_	DT	DT	_	5	det	_	_
5	data	_	NNS	NNS	_	6	nsubj	_	_
6	point	_	VBP	VBP	_	1	parataxis	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	a	_	DT	DT	_	10	det	_	_
9	potential	_	JJ	JJ	_	10	amod	_	_
10	mechanism	_	NN	NN	_	7	pobj	_	_
11	underlying	_	VBG	VBG	_	10	vmod	_	_
12	EBV-mediated	_	JJ	JJ	_	15	amod	_	_
13	B	_	NN	NN	_	15	nn	_	_
14	cell	_	NN	NN	_	15	nn	_	_
15	transformation	_	NN	NN	_	11	dobj	_	_
16	whereby	_	WRB	WRB	_	27	advmod	_	_
17	constitutive	_	JJ	JJ	_	18	amod	_	_
18	induction	_	NN	NN	_	27	nsubj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	key	_	JJ	JJ	_	23	amod	_	_
21	cell	_	NN	NN	_	23	nn	_	_
22	cycle	_	NN	NN	_	23	nn	_	_
23	regulators	_	NNS	NNS	_	19	pobj	_	_
24	by	_	IN	IN	_	18	prep	_	_
25	LMP-1	_	NN	NN	_	24	pobj	_	_
26	can	_	MD	MD	_	27	aux	_	_
27	lead	_	VB	VB	_	15	rcmod	_	_
28	to	_	TO	TO	_	27	prep	_	_
29	pRb	_	NN	NN	_	30	nn	_	_
30	hyperphosphorylation	_	NN	NN	_	28	pobj	_	_
31	and	_	CC	CC	_	30	cc	_	_
32	uncontrolled	_	JJ	JJ	_	34	amod	_	_
33	cell	_	NN	NN	_	34	nn	_	_
34	proliferation	_	NN	NN	_	30	conj	_	_
35	.	_	.	.	_	1	punct	_	_

1	C/EBP	_	NN	NN	_	2	nn	_	_
2	proteins	_	NNS	NNS	_	3	nsubj	_	_
3	activate	_	VBP	VBP	_	0	root	_	_
4	transcription	_	NN	NN	_	3	dobj	_	_
5	from	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	14	det	_	_
7	human	_	JJ	JJ	_	14	amod	_	_
8	immunodeficiency	_	NN	NN	_	14	nn	_	_
9	virus	_	NN	NN	_	14	nn	_	_
10	type	_	NN	NN	_	14	nn	_	_
11	1	_	CD	CD	_	14	num	_	_
12	long	_	JJ	JJ	_	14	amod	_	_
13	terminal	_	JJ	JJ	_	14	amod	_	_
14	repeat	_	NN	NN	_	5	pobj	_	_
15	in	_	IN	IN	_	4	prep	_	_
16	macrophages/monocytes	_	NNS	NNS	_	15	pobj	_	_
17	.	_	.	.	_	3	punct	_	_

1	Three	_	CD	CD	_	3	num	_	_
2	binding	_	VBG	VBG	_	3	amod	_	_
3	sites	_	NNS	NNS	_	8	nsubjpass	_	_
4	for	_	IN	IN	_	3	prep	_	_
5	C/EBP	_	NN	NN	_	6	nn	_	_
6	proteins	_	NNS	NNS	_	4	pobj	_	_
7	are	_	VBP	VBP	_	8	auxpass	_	_
8	found	_	VBN	VBN	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	21	det	_	_
11	human	_	JJ	JJ	_	21	amod	_	_
12	immunodeficiency	_	NN	NN	_	21	nn	_	_
13	virus	_	NN	NN	_	21	nn	_	_
14	type	_	NN	NN	_	21	nn	_	_
15	1	_	CD	CD	_	21	num	_	_
16	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
17	HIV-1	_	NN	NN	_	21	nn	_	_
18	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
19	long	_	JJ	JJ	_	21	amod	_	_
20	terminal	_	JJ	JJ	_	21	amod	_	_
21	repeat	_	NN	NN	_	9	pobj	_	_
22	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
23	LTR	_	NN	NN	_	21	appos	_	_
24	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
25	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
26	V.M.	_	NNP	NNP	_	27	nn	_	_
27	Tesmer	_	NNP	NNP	_	8	dep	_	_
28	,	_	,	,	_	27	punct	_	_
29	A.Rajadhyaksha	_	NNP	NNP	_	27	conj	_	_
30	,	_	,	,	_	27	punct	_	_
31	J.Babin	_	NNP	NNP	_	27	conj	_	_
32	,	_	,	,	_	27	punct	_	_
33	and	_	CC	CC	_	27	cc	_	_
34	M.Bina	_	NNP	NNP	_	27	conj	_	_
35	,	_	,	,	_	27	punct	_	_
36	Proc.Natl.Acad.Sci.	_	NNP	NNP	_	37	nn	_	_
37	USA	_	NNP	NNP	_	27	appos	_	_
38	90	_	CD	CD	_	37	num	_	_
39	:	_	:	:	_	27	punct	_	_
40	7298-7302	_	CD	CD	_	27	dep	_	_
41	,	_	,	,	_	27	punct	_	_
42	1993	_	CD	CD	_	27	amod	_	_
43	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
44	.	_	.	.	_	8	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	determined	_	VBN	VBN	_	0	root	_	_
4	the	_	DT	DT	_	6	det	_	_
5	functional	_	JJ	JJ	_	6	amod	_	_
6	role	_	NN	NN	_	3	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	C/EBP	_	NN	NN	_	9	nn	_	_
9	proteins	_	NNS	NNS	_	7	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	C/EBP	_	NN	NN	_	12	nn	_	_
12	sites	_	NNS	NNS	_	9	conj	_	_
13	in	_	IN	IN	_	6	prep	_	_
14	regulating	_	VBG	VBG	_	13	pcomp	_	_
15	transcription	_	NN	NN	_	14	dobj	_	_
16	from	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	HIV-1	_	NN	NN	_	19	nn	_	_
19	LTR	_	NN	NN	_	16	pobj	_	_
20	in	_	IN	IN	_	15	prep	_	_
21	monocytes/macrophages	_	NNS	NNS	_	20	pobj	_	_
22	.	_	.	.	_	3	punct	_	_

1	Inhibition	_	NN	NN	_	21	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	endogenous	_	JJ	JJ	_	5	amod	_	_
4	C/EBP	_	NN	NN	_	5	nn	_	_
5	proteins	_	NNS	NNS	_	2	pobj	_	_
6	,	_	,	,	_	1	punct	_	_
7	using	_	VBG	VBG	_	1	vmod	_	_
8	either	_	CC	CC	_	10	preconj	_	_
9	an	_	DT	DT	_	10	det	_	_
10	excess	_	NN	NN	_	7	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	C/EBP	_	NN	NN	_	14	nn	_	_
13	binding	_	NN	NN	_	14	nn	_	_
14	sites	_	NNS	NNS	_	11	pobj	_	_
15	or	_	CC	CC	_	10	cc	_	_
16	a	_	DT	DT	_	19	det	_	_
17	trans-dominant	_	JJ	JJ	_	19	amod	_	_
18	negative	_	JJ	JJ	_	19	amod	_	_
19	inhibitor	_	NN	NN	_	10	conj	_	_
20	,	_	,	,	_	1	punct	_	_
21	demonstrated	_	VBD	VBD	_	0	root	_	_
22	that	_	IN	IN	_	26	mark	_	_
23	C/EBP	_	NN	NN	_	24	nn	_	_
24	proteins	_	NNS	NNS	_	26	nsubjpass	_	_
25	are	_	VBP	VBP	_	26	auxpass	_	_
26	required	_	VBN	VBN	_	21	ccomp	_	_
27	for	_	IN	IN	_	26	prep	_	_
28	basal	_	JJ	JJ	_	27	pobj	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	activated	_	VBN	VBN	_	28	conj	_	_
31	levels	_	NNS	NNS	_	28	dep	_	_
32	of	_	IN	IN	_	28	prep	_	_
33	HIV-1	_	NN	NN	_	34	nn	_	_
34	LTR	_	NN	NN	_	35	nn	_	_
35	transcription	_	NN	NN	_	32	pobj	_	_
36	in	_	IN	IN	_	35	prep	_	_
37	the	_	DT	DT	_	41	det	_	_
38	promonocytic	_	JJ	JJ	_	41	amod	_	_
39	cell	_	NN	NN	_	41	nn	_	_
40	line	_	NN	NN	_	41	nn	_	_
41	U937	_	NN	NN	_	36	pobj	_	_
42	.	_	.	.	_	21	punct	_	_

1	Northern	_	NN	NN	_	9	nsubj	_	_
2	-LRB-	_	-LRB-	-LRB-	_	3	punct	_	_
3	RNA	_	NN	NN	_	1	appos	_	_
4	-RRB-	_	-RRB-	-RRB-	_	3	punct	_	_
5	blots	_	NNS	NNS	_	1	dep	_	_
6	and	_	CC	CC	_	1	cc	_	_
7	binding	_	NN	NN	_	1	conj	_	_
8	assays	_	NNS	NNS	_	1	dep	_	_
9	showed	_	VBD	VBD	_	0	root	_	_
10	that	_	IN	IN	_	18	mark	_	_
11	NF-IL6	_	NN	NN	_	18	nsubj	_	_
12	is	_	VBZ	VBZ	_	18	cop	_	_
13	the	_	DT	DT	_	18	det	_	_
14	only	_	RB	RB	_	18	advmod	_	_
15	known	_	JJ	JJ	_	18	amod	_	_
16	C/EBP	_	NN	NN	_	18	nn	_	_
17	family	_	NN	NN	_	18	nn	_	_
18	member	_	NN	NN	_	9	ccomp	_	_
19	which	_	WDT	WDT	_	21	nsubjpass	_	_
20	is	_	VBZ	VBZ	_	21	auxpass	_	_
21	increased	_	VBN	VBN	_	18	rcmod	_	_
22	when	_	WRB	WRB	_	26	advmod	_	_
23	U937	_	NN	NN	_	24	nn	_	_
24	cells	_	NNS	NNS	_	26	nsubjpass	_	_
25	are	_	VBP	VBP	_	26	auxpass	_	_
26	activated	_	VBN	VBN	_	21	advcl	_	_
27	.	_	.	.	_	9	punct	_	_

1	Mutational	_	JJ	JJ	_	2	amod	_	_
2	analyses	_	NNS	NNS	_	7	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	HIV-1	_	NN	NN	_	6	nn	_	_
6	LTR	_	NN	NN	_	3	pobj	_	_
7	showed	_	VBD	VBD	_	0	root	_	_
8	that	_	IN	IN	_	13	mark	_	_
9	one	_	CD	CD	_	11	num	_	_
10	C/EBP	_	NN	NN	_	11	nn	_	_
11	site	_	NN	NN	_	13	nsubjpass	_	_
12	is	_	VBZ	VBZ	_	13	auxpass	_	_
13	required	_	VBN	VBN	_	7	ccomp	_	_
14	for	_	IN	IN	_	13	prep	_	_
15	normal	_	JJ	JJ	_	17	amod	_	_
16	LTR	_	NN	NN	_	17	nn	_	_
17	transcription	_	NN	NN	_	14	pobj	_	_
18	both	_	CC	CC	_	19	preconj	_	_
19	before	_	IN	IN	_	17	prep	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	after	_	IN	IN	_	19	conj	_	_
22	cellular	_	JJ	JJ	_	23	amod	_	_
23	activation	_	NN	NN	_	19	pobj	_	_
24	and	_	CC	CC	_	13	cc	_	_
25	that	_	IN	IN	_	33	mark	_	_
26	the	_	DT	DT	_	30	det	_	_
27	two	_	CD	CD	_	30	num	_	_
28	3'	_	JJ	JJ	_	30	amod	_	_
29	C/EBP	_	NN	NN	_	30	nn	_	_
30	sites	_	NNS	NNS	_	33	nsubj	_	_
31	are	_	VBP	VBP	_	33	cop	_	_
32	functionally	_	RB	RB	_	33	advmod	_	_
33	equivalent	_	JJ	JJ	_	13	conj	_	_
34	.	_	.	.	_	7	punct	_	_

1	However	_	RB	RB	_	14	advmod	_	_
2	,	_	,	,	_	14	punct	_	_
3	transcription	_	NN	NN	_	14	nsubjpass	_	_
4	from	_	IN	IN	_	3	prep	_	_
5	crippled	_	VBN	VBN	_	7	amod	_	_
6	HIV-1	_	NN	NN	_	7	nn	_	_
7	LTRs	_	NNS	NNS	_	4	pobj	_	_
8	lacking	_	VBG	VBG	_	7	vmod	_	_
9	C/EBP	_	NN	NN	_	10	nn	_	_
10	sites	_	NNS	NNS	_	8	dobj	_	_
11	can	_	MD	MD	_	14	aux	_	_
12	still	_	RB	RB	_	14	advmod	_	_
13	be	_	VB	VB	_	14	auxpass	_	_
14	induced	_	VBN	VBN	_	0	root	_	_
15	following	_	VBG	VBG	_	14	prep	_	_
16	activation	_	NN	NN	_	15	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	U937	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	17	pobj	_	_
20	.	_	.	.	_	14	punct	_	_

1	Several	_	JJ	JJ	_	2	amod	_	_
2	models	_	NNS	NNS	_	4	nsubjpass	_	_
3	are	_	VBP	VBP	_	4	auxpass	_	_
4	suggested	_	VBN	VBN	_	0	root	_	_
5	for	_	IN	IN	_	4	prep	_	_
6	how	_	WRB	WRB	_	10	advmod	_	_
7	elevated	_	JJ	JJ	_	8	amod	_	_
8	NF-IL6	_	NN	NN	_	10	nsubj	_	_
9	may	_	MD	MD	_	10	aux	_	_
10	participate	_	VB	VB	_	5	pcomp	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	an	_	DT	DT	_	14	det	_	_
13	autostimulatory	_	JJ	JJ	_	14	amod	_	_
14	loop	_	NN	NN	_	11	pobj	_	_
15	involving	_	VBG	VBG	_	14	vmod	_	_
16	HIV	_	NN	NN	_	17	nn	_	_
17	infection	_	NN	NN	_	15	dobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	macrophage	_	NN	NN	_	20	nn	_	_
20	activation	_	NN	NN	_	17	conj	_	_
21	,	_	,	,	_	17	punct	_	_
22	cytokine	_	NN	NN	_	23	nn	_	_
23	expression	_	NN	NN	_	17	conj	_	_
24	,	_	,	,	_	17	punct	_	_
25	and	_	CC	CC	_	17	cc	_	_
26	HIV	_	NN	NN	_	27	nn	_	_
27	replication	_	NN	NN	_	17	conj	_	_
28	.	_	.	.	_	4	punct	_	_

1	An	_	DT	DT	_	3	det	_	_
2	IRF-1-dependent	_	JJ	JJ	_	3	amod	_	_
3	pathway	_	NN	NN	_	0	root	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	DNA	_	NN	NN	_	7	nn	_	_
6	damage-induced	_	JJ	JJ	_	7	amod	_	_
7	apoptosis	_	NN	NN	_	4	pobj	_	_
8	in	_	IN	IN	_	3	prep	_	_
9	mitogen-activated	_	JJ	JJ	_	11	amod	_	_
10	T	_	NN	NN	_	11	nn	_	_
11	lymphocytes	_	NNS	NNS	_	8	pobj	_	_
12	.	_	.	.	_	3	punct	_	_

1	Lymphocytes	_	NNS	NNS	_	4	nsubj	_	_
2	are	_	VBP	VBP	_	4	cop	_	_
3	particularly	_	RB	RB	_	4	advmod	_	_
4	susceptible	_	JJ	JJ	_	0	root	_	_
5	to	_	TO	TO	_	4	prep	_	_
6	DNA	_	NN	NN	_	8	nn	_	_
7	damage-induced	_	JJ	JJ	_	8	amod	_	_
8	apoptosis	_	NN	NN	_	5	pobj	_	_
9	,	_	,	,	_	8	punct	_	_
10	a	_	DT	DT	_	11	det	_	_
11	response	_	NN	NN	_	8	appos	_	_
12	which	_	WDT	WDT	_	14	nsubj	_	_
13	may	_	MD	MD	_	14	aux	_	_
14	serve	_	VB	VB	_	11	rcmod	_	_
15	as	_	IN	IN	_	14	prep	_	_
16	a	_	DT	DT	_	17	det	_	_
17	form	_	NN	NN	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	'	_	``	``	_	21	punct	_	_
20	altruistic	_	JJ	JJ	_	21	amod	_	_
21	suicide	_	NN	NN	_	18	pobj	_	_
22	'	_	''	''	_	21	punct	_	_
23	to	_	TO	TO	_	24	aux	_	_
24	counter	_	VB	VB	_	14	xcomp	_	_
25	their	_	PRP$	PRP$	_	28	poss	_	_
26	intrinsic	_	JJ	JJ	_	27	amod	_	_
27	high	_	JJ	JJ	_	28	amod	_	_
28	potential	_	NN	NN	_	24	dobj	_	_
29	for	_	IN	IN	_	28	prep	_	_
30	mutation	_	NN	NN	_	29	pobj	_	_
31	and	_	CC	CC	_	30	cc	_	_
32	clonal	_	JJ	JJ	_	33	amod	_	_
33	expansion	_	NN	NN	_	30	conj	_	_
34	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	tumour	_	NN	NN	_	4	nn	_	_
3	suppressor	_	NN	NN	_	4	nn	_	_
4	p53	_	NN	NN	_	7	nsubjpass	_	_
5	has	_	VBZ	VBZ	_	7	aux	_	_
6	been	_	VBN	VBN	_	7	auxpass	_	_
7	shown	_	VBN	VBN	_	0	root	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	regulate	_	VB	VB	_	7	xcomp	_	_
10	this	_	DT	DT	_	11	det	_	_
11	type	_	NN	NN	_	9	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	apoptosis	_	NN	NN	_	12	pobj	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	thymocytes	_	NNS	NNS	_	14	pobj	_	_
16	,	_	,	,	_	7	punct	_	_
17	but	_	CC	CC	_	7	cc	_	_
18	an	_	DT	DT	_	26	det	_	_
19	as	_	RB	RB	_	21	advmod	_	_
20	yet	_	RB	RB	_	21	advmod	_	_
21	unknown	_	JJ	JJ	_	26	amod	_	_
22	,	_	,	,	_	26	punct	_	_
23	p53-independent	_	JJ	JJ	_	26	amod	_	_
24	pathway	_	NN	NN	_	26	nn	_	_
25	-LRB-	_	-LRB-	-LRB-	_	26	punct	_	_
26	s	_	NNS	NNS	_	28	nsubj	_	_
27	-RRB-	_	-RRB-	-RRB-	_	26	punct	_	_
28	appears	_	VBZ	VBZ	_	7	conj	_	_
29	to	_	TO	TO	_	30	aux	_	_
30	mediate	_	VB	VB	_	28	xcomp	_	_
31	the	_	DT	DT	_	33	det	_	_
32	same	_	JJ	JJ	_	33	amod	_	_
33	event	_	NN	NN	_	30	dobj	_	_
34	in	_	IN	IN	_	30	prep	_	_
35	mitogen-activated	_	JJ	JJ	_	38	amod	_	_
36	mature	_	JJ	JJ	_	38	amod	_	_
37	T	_	NN	NN	_	38	nn	_	_
38	lymphocytes	_	NNS	NNS	_	34	pobj	_	_
39	.	_	.	.	_	7	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	show	_	VBP	VBP	_	0	root	_	_
4	DNA	_	NN	NN	_	6	nn	_	_
5	damage-induced	_	JJ	JJ	_	6	amod	_	_
6	apoptosis	_	NN	NN	_	3	dobj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	these	_	DT	DT	_	10	det	_	_
9	T	_	NN	NN	_	10	nn	_	_
10	lymphocytes	_	NNS	NNS	_	7	pobj	_	_
11	is	_	VBZ	VBZ	_	12	cop	_	_
12	dependent	_	JJ	JJ	_	3	dep	_	_
13	on	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	20	det	_	_
15	antioncogenic	_	JJ	JJ	_	20	amod	_	_
16	transcription	_	NN	NN	_	20	nn	_	_
17	factor	_	NN	NN	_	20	nn	_	_
18	interferon	_	NN	NN	_	20	nn	_	_
19	regulatory	_	JJ	JJ	_	20	amod	_	_
20	factor	_	NN	NN	_	13	pobj	_	_
21	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
22	IRF	_	NN	NN	_	20	dep	_	_
23	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
24	-1	_	CD	CD	_	22	num	_	_
25	.	_	.	.	_	3	punct	_	_

1	Thus	_	RB	RB	_	13	advmod	_	_
2	two	_	CD	CD	_	6	num	_	_
3	different	_	JJ	JJ	_	6	amod	_	_
4	anti-onco-genic	_	JJ	JJ	_	6	amod	_	_
5	transcription	_	NN	NN	_	6	nn	_	_
6	factors	_	NNS	NNS	_	13	nsubjpass	_	_
7	,	_	,	,	_	6	punct	_	_
8	p53	_	NN	NN	_	6	appos	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	IRF-1	_	NN	NN	_	8	conj	_	_
11	,	_	,	,	_	6	punct	_	_
12	are	_	VBP	VBP	_	13	auxpass	_	_
13	required	_	VBN	VBN	_	0	root	_	_
14	for	_	IN	IN	_	13	prep	_	_
15	distinct	_	JJ	JJ	_	17	amod	_	_
16	apoptotic	_	JJ	JJ	_	17	amod	_	_
17	pathways	_	NNS	NNS	_	14	pobj	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	T	_	NN	NN	_	20	nn	_	_
20	lymphocytes	_	NNS	NNS	_	18	pobj	_	_
21	.	_	.	.	_	13	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	show	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	31	mark	_	_
5	mitogen	_	NN	NN	_	6	nn	_	_
6	induction	_	NN	NN	_	31	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	16	det	_	_
9	interleukin-1	_	NN	NN	_	16	nn	_	_
10	beta	_	NN	NN	_	16	nn	_	_
11	converting	_	NN	NN	_	16	nn	_	_
12	enzyme	_	NN	NN	_	16	nn	_	_
13	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
14	ICE	_	NN	NN	_	16	nn	_	_
15	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
16	gene	_	NN	NN	_	7	pobj	_	_
17	,	_	,	,	_	16	punct	_	_
18	a	_	DT	DT	_	20	det	_	_
19	mammalian	_	JJ	JJ	_	20	amod	_	_
20	homologue	_	NN	NN	_	16	appos	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	27	det	_	_
23	Caenorhabditis	_	FW	FW	_	27	nn	_	_
24	elegans	_	FW	FW	_	27	nn	_	_
25	cell	_	NN	NN	_	27	nn	_	_
26	death	_	NN	NN	_	27	nn	_	_
27	gene	_	NN	NN	_	21	pobj	_	_
28	ced-3	_	NN	NN	_	27	dep	_	_
29	,	_	,	,	_	6	punct	_	_
30	is	_	VBZ	VBZ	_	31	cop	_	_
31	IRF-1-dependent	_	JJ	JJ	_	3	ccomp	_	_
32	.	_	.	.	_	3	punct	_	_

1	Ectopic	_	JJ	JJ	_	2	amod	_	_
2	overexpression	_	NN	NN	_	5	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	IRF-1	_	NN	NN	_	3	pobj	_	_
5	results	_	VBZ	VBZ	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	activation	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	endogenous	_	JJ	JJ	_	12	amod	_	_
12	gene	_	NN	NN	_	9	pobj	_	_
13	for	_	IN	IN	_	8	prep	_	_
14	ICE	_	NN	NN	_	13	pobj	_	_
15	and	_	CC	CC	_	5	cc	_	_
16	enhances	_	VBZ	VBZ	_	5	conj	_	_
17	the	_	DT	DT	_	18	det	_	_
18	sensitivity	_	NN	NN	_	16	dobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	cells	_	NNS	NNS	_	19	pobj	_	_
21	to	_	TO	TO	_	18	prep	_	_
22	radiation-induced	_	JJ	JJ	_	23	amod	_	_
23	apoptosis	_	NN	NN	_	21	pobj	_	_
24	.	_	.	.	_	5	punct	_	_

1	Sp1	_	NN	NN	_	2	nsubj	_	_
2	functions	_	VBZ	VBZ	_	0	root	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	a	_	DT	DT	_	6	det	_	_
5	chromatin-dependent	_	JJ	JJ	_	6	amod	_	_
6	manner	_	NN	NN	_	3	pobj	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	augment	_	VB	VB	_	2	xcomp	_	_
9	human	_	JJ	JJ	_	11	amod	_	_
10	alpha-globin	_	NN	NN	_	11	nn	_	_
11	promoter	_	NN	NN	_	12	nn	_	_
12	activity	_	NN	NN	_	8	dobj	_	_
13	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	5'	_	JJ	JJ	_	4	amod	_	_
3	flanking	_	JJ	JJ	_	4	amod	_	_
4	region	_	NN	NN	_	13	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	9	det	_	_
7	human	_	JJ	JJ	_	9	amod	_	_
8	alpha-globin	_	NN	NN	_	9	nn	_	_
9	gene	_	NN	NN	_	5	pobj	_	_
10	is	_	VBZ	VBZ	_	13	cop	_	_
11	highly	_	RB	RB	_	13	advmod	_	_
12	G+C	_	NN	NN	_	13	npadvmod	_	_
13	rich	_	JJ	JJ	_	0	root	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	contains	_	VBZ	VBZ	_	13	conj	_	_
16	multiple	_	JJ	JJ	_	17	amod	_	_
17	copies	_	NNS	NNS	_	15	dobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	consensus	_	NN	NN	_	21	nn	_	_
21	sequence	_	NN	NN	_	18	pobj	_	_
22	for	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	26	det	_	_
24	Sp1	_	NN	NN	_	26	nn	_	_
25	binding	_	NN	NN	_	26	nn	_	_
26	site	_	NN	NN	_	22	pobj	_	_
27	.	_	.	.	_	13	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	investigated	_	VBD	VBD	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	role	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	this	_	DT	DT	_	8	det	_	_
7	G+C-rich	_	JJ	JJ	_	8	amod	_	_
8	region	_	NN	NN	_	5	pobj	_	_
9	in	_	IN	IN	_	2	prep	_	_
10	augmenting	_	VBG	VBG	_	9	pcomp	_	_
11	alpha-globin	_	NN	NN	_	12	nn	_	_
12	promoter	_	NN	NN	_	13	nn	_	_
13	activity	_	NN	NN	_	10	dobj	_	_
14	in	_	IN	IN	_	10	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	presence	_	NN	NN	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	21	det	_	_
19	far-upstream	_	JJ	JJ	_	21	amod	_	_
20	alpha-globin	_	NN	NN	_	21	nn	_	_
21	enhancer	_	NN	NN	_	17	pobj	_	_
22	,	_	,	,	_	21	punct	_	_
23	HS-40	_	NN	NN	_	21	appos	_	_
24	.	_	.	.	_	2	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	show	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	18	mark	_	_
4	in	_	IN	IN	_	18	prep	_	_
5	transiently	_	RB	RB	_	8	advmod	_	_
6	transfected	_	VBN	VBN	_	8	amod	_	_
7	erythroid	_	JJ	JJ	_	8	amod	_	_
8	cells	_	NNS	NNS	_	4	pobj	_	_
9	,	_	,	,	_	18	punct	_	_
10	deletion	_	NN	NN	_	18	nsubj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	17	det	_	_
13	alpha-globin	_	NN	NN	_	17	nn	_	_
14	G+C-rich	_	JJ	JJ	_	17	amod	_	_
15	5'	_	JJ	JJ	_	17	amod	_	_
16	flanking	_	JJ	JJ	_	17	amod	_	_
17	region	_	NN	NN	_	11	pobj	_	_
18	has	_	VBZ	VBZ	_	2	ccomp	_	_
19	no	_	DT	DT	_	20	neg	_	_
20	effect	_	NN	NN	_	18	dobj	_	_
21	on	_	IN	IN	_	18	prep	_	_
22	alpha-globin	_	NN	NN	_	23	nn	_	_
23	promoter	_	NN	NN	_	24	nn	_	_
24	activity	_	NN	NN	_	21	pobj	_	_
25	.	_	.	.	_	2	punct	_	_

1	However	_	RB	RB	_	13	advmod	_	_
2	,	_	,	,	_	13	punct	_	_
3	upon	_	IN	IN	_	13	prep	_	_
4	stable	_	JJ	JJ	_	5	amod	_	_
5	integration	_	NN	NN	_	3	pobj	_	_
6	into	_	IN	IN	_	5	prep	_	_
7	chromatin	_	NN	NN	_	6	pobj	_	_
8	,	_	,	,	_	13	punct	_	_
9	deletion	_	NN	NN	_	13	nsubj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	this	_	DT	DT	_	12	det	_	_
12	region	_	NN	NN	_	10	pobj	_	_
13	causes	_	VBZ	VBZ	_	0	root	_	_
14	a	_	DT	DT	_	18	det	_	_
15	nearly	_	RB	RB	_	16	quantmod	_	_
16	90	_	CD	CD	_	17	dep	_	_
17	%	_	NN	NN	_	18	dep	_	_
18	decrease	_	NN	NN	_	13	dobj	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	promoter	_	NN	NN	_	21	nn	_	_
21	activity	_	NN	NN	_	19	pobj	_	_
22	compared	_	VBN	VBN	_	13	prep	_	_
23	with	_	IN	IN	_	22	pcomp	_	_
24	expression	_	NN	NN	_	23	pobj	_	_
25	from	_	IN	IN	_	24	prep	_	_
26	an	_	DT	DT	_	28	det	_	_
27	alpha-globin	_	NN	NN	_	28	nn	_	_
28	promoter	_	NN	NN	_	25	pobj	_	_
29	retaining	_	VBG	VBG	_	28	vmod	_	_
30	this	_	DT	DT	_	31	det	_	_
31	region	_	NN	NN	_	29	dobj	_	_
32	.	_	.	.	_	13	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	11	mark	_	_
5	the	_	DT	DT	_	10	det	_	_
6	alpha-globin	_	NN	NN	_	10	nn	_	_
7	G+C-rich	_	JJ	JJ	_	10	amod	_	_
8	5'	_	JJ	JJ	_	10	amod	_	_
9	flanking	_	JJ	JJ	_	10	amod	_	_
10	region	_	NN	NN	_	11	nsubj	_	_
11	augments	_	VBZ	VBZ	_	3	ccomp	_	_
12	alpha-globin	_	NN	NN	_	13	nn	_	_
13	promoter	_	NN	NN	_	14	nn	_	_
14	activity	_	NN	NN	_	11	dobj	_	_
15	in	_	IN	IN	_	11	prep	_	_
16	a	_	DT	DT	_	18	det	_	_
17	chromatin-dependent	_	JJ	JJ	_	18	amod	_	_
18	manner	_	NN	NN	_	15	pobj	_	_
19	.	_	.	.	_	3	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	further	_	RB	RB	_	3	advmod	_	_
3	show	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	9	mark	_	_
5	this	_	DT	DT	_	7	det	_	_
6	G+C-rich	_	JJ	JJ	_	7	amod	_	_
7	region	_	NN	NN	_	9	nsubjpass	_	_
8	is	_	VBZ	VBZ	_	9	auxpass	_	_
9	required	_	VBN	VBN	_	3	ccomp	_	_
10	for	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	activation	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	alpha-globin	_	NN	NN	_	15	nn	_	_
15	gene	_	NN	NN	_	16	nn	_	_
16	expression	_	NN	NN	_	13	pobj	_	_
17	during	_	IN	IN	_	9	prep	_	_
18	erythroid	_	JJ	JJ	_	19	amod	_	_
19	differentiation	_	NN	NN	_	17	pobj	_	_
20	.	_	.	.	_	3	punct	_	_

1	Finally	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	show	_	VBP	VBP	_	0	root	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	both	_	CC	CC	_	8	preconj	_	_
7	footprint	_	NN	NN	_	8	nn	_	_
8	analysis	_	NN	NN	_	5	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	functional	_	JJ	JJ	_	11	amod	_	_
11	assays	_	NNS	NNS	_	8	conj	_	_
12	that	_	IN	IN	_	31	mark	_	_
13	the	_	DT	DT	_	14	det	_	_
14	ability	_	NN	NN	_	31	nsubjpass	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	G+C-rich	_	JJ	JJ	_	18	amod	_	_
18	region	_	NN	NN	_	15	pobj	_	_
19	to	_	TO	TO	_	20	aux	_	_
20	increase	_	VB	VB	_	14	vmod	_	_
21	alpha-globin	_	NN	NN	_	22	nn	_	_
22	promoter	_	NN	NN	_	23	nn	_	_
23	activity	_	NN	NN	_	20	dobj	_	_
24	from	_	IN	IN	_	23	prep	_	_
25	a	_	DT	DT	_	29	det	_	_
26	stably	_	RB	RB	_	27	advmod	_	_
27	integrated	_	VBN	VBN	_	29	amod	_	_
28	alpha-globin	_	NN	NN	_	29	nn	_	_
29	gene	_	NN	NN	_	24	pobj	_	_
30	is	_	VBZ	VBZ	_	31	auxpass	_	_
31	mediated	_	VBN	VBN	_	4	ccomp	_	_
32	by	_	IN	IN	_	31	prep	_	_
33	its	_	PRP$	PRP$	_	36	poss	_	_
34	multiple	_	JJ	JJ	_	36	amod	_	_
35	binding	_	VBG	VBG	_	36	amod	_	_
36	sites	_	NNS	NNS	_	32	pobj	_	_
37	for	_	IN	IN	_	36	prep	_	_
38	the	_	DT	DT	_	40	det	_	_
39	transcription	_	NN	NN	_	40	nn	_	_
40	factor	_	NN	NN	_	37	pobj	_	_
41	Sp1	_	NN	NN	_	40	dep	_	_
42	.	_	.	.	_	4	punct	_	_

1	Interleukin	_	NN	NN	_	3	nsubj	_	_
2	12	_	CD	CD	_	1	num	_	_
3	induces	_	VBZ	VBZ	_	0	root	_	_
4	tyrosine	_	NN	NN	_	5	nn	_	_
5	phosphorylation	_	NN	NN	_	3	dobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	activation	_	NN	NN	_	5	conj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	STAT4	_	NN	NN	_	8	pobj	_	_
10	in	_	IN	IN	_	3	prep	_	_
11	human	_	JJ	JJ	_	12	amod	_	_
12	lymphocytes	_	NNS	NNS	_	10	pobj	_	_
13	.	_	.	.	_	3	punct	_	_

1	Interleukin	_	NN	NN	_	10	nsubj	_	_
2	12	_	CD	CD	_	1	num	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	IL-12	_	NN	NN	_	1	appos	_	_
5	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
6	is	_	VBZ	VBZ	_	10	cop	_	_
7	an	_	DT	DT	_	10	det	_	_
8	important	_	JJ	JJ	_	10	amod	_	_
9	immunoregulatory	_	JJ	JJ	_	10	amod	_	_
10	cytokine	_	NN	NN	_	0	root	_	_
11	whose	_	WP$	WP$	_	12	poss	_	_
12	receptor	_	NN	NN	_	15	nsubj	_	_
13	is	_	VBZ	VBZ	_	15	cop	_	_
14	a	_	DT	DT	_	15	det	_	_
15	member	_	NN	NN	_	10	rcmod	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	20	det	_	_
18	hematopoietin	_	NN	NN	_	20	nn	_	_
19	receptor	_	NN	NN	_	20	nn	_	_
20	superfamily	_	NN	NN	_	16	pobj	_	_
21	.	_	.	.	_	10	punct	_	_

1	We	_	PRP	PRP	_	4	nsubj	_	_
2	have	_	VBP	VBP	_	4	aux	_	_
3	recently	_	RB	RB	_	4	advmod	_	_
4	demonstrated	_	VBN	VBN	_	0	root	_	_
5	that	_	IN	IN	_	16	mark	_	_
6	stimulation	_	NN	NN	_	16	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	human	_	JJ	JJ	_	9	amod	_	_
9	T	_	NN	NN	_	7	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	natural	_	JJ	JJ	_	12	amod	_	_
12	killer	_	NN	NN	_	9	conj	_	_
13	cells	_	NNS	NNS	_	9	dep	_	_
14	with	_	IN	IN	_	6	prep	_	_
15	IL-12	_	NN	NN	_	14	pobj	_	_
16	induces	_	VBZ	VBZ	_	4	ccomp	_	_
17	tyrosine	_	NN	NN	_	18	nn	_	_
18	phosphorylation	_	NN	NN	_	16	dobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	24	det	_	_
21	Janus	_	NN	NN	_	24	nn	_	_
22	family	_	NN	NN	_	24	nn	_	_
23	tyrosine	_	NN	NN	_	24	nn	_	_
24	kinase	_	NN	NN	_	19	pobj	_	_
25	JAK2	_	NN	NN	_	24	dep	_	_
26	and	_	CC	CC	_	25	cc	_	_
27	Tyk2	_	NN	NN	_	25	conj	_	_
28	,	_	,	,	_	16	punct	_	_
29	implicating	_	VBG	VBG	_	16	vmod	_	_
30	these	_	DT	DT	_	31	det	_	_
31	kinases	_	NNS	NNS	_	29	dobj	_	_
32	in	_	IN	IN	_	29	prep	_	_
33	the	_	DT	DT	_	36	det	_	_
34	immediate	_	JJ	JJ	_	36	amod	_	_
35	biochemical	_	JJ	JJ	_	36	amod	_	_
36	response	_	NN	NN	_	32	pobj	_	_
37	to	_	TO	TO	_	36	prep	_	_
38	IL-12	_	NN	NN	_	37	pobj	_	_
39	.	_	.	.	_	4	punct	_	_

1	Recently	_	RB	RB	_	18	advmod	_	_
2	,	_	,	,	_	18	punct	_	_
3	transcription	_	NN	NN	_	4	nn	_	_
4	factors	_	NNS	NNS	_	18	nsubjpass	_	_
5	known	_	VBN	VBN	_	4	vmod	_	_
6	as	_	IN	IN	_	5	prep	_	_
7	STATs	_	NNS	NNS	_	6	pobj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
9	signal	_	NN	NN	_	10	nn	_	_
10	transducers	_	NNS	NNS	_	7	dep	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	activators	_	NNS	NNS	_	14	nn	_	_
13	of	_	IN	IN	_	14	amod	_	_
14	transcription	_	NN	NN	_	10	conj	_	_
15	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
16	have	_	VBP	VBP	_	18	aux	_	_
17	been	_	VBN	VBN	_	18	auxpass	_	_
18	shown	_	VBN	VBN	_	0	root	_	_
19	to	_	TO	TO	_	22	aux	_	_
20	be	_	VB	VB	_	22	auxpass	_	_
21	tyrosine	_	NN	NN	_	22	npadvmod	_	_
22	phosphorylated	_	JJ	JJ	_	18	xcomp	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	activated	_	VBN	VBN	_	22	conj	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	response	_	NN	NN	_	25	pobj	_	_
27	to	_	TO	TO	_	26	prep	_	_
28	a	_	DT	DT	_	29	det	_	_
29	number	_	NN	NN	_	27	pobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	cytokines	_	NNS	NNS	_	30	pobj	_	_
32	that	_	WDT	WDT	_	33	nsubj	_	_
33	bind	_	VBP	VBP	_	31	rcmod	_	_
34	hematopoietin	_	NN	NN	_	35	nn	_	_
35	receptors	_	NNS	NNS	_	33	dobj	_	_
36	and	_	CC	CC	_	33	cc	_	_
37	activate	_	VBP	VBP	_	33	conj	_	_
38	JAK	_	NN	NN	_	39	nn	_	_
39	kinases	_	NNS	NNS	_	37	dobj	_	_
40	.	_	.	.	_	18	punct	_	_

1	In	_	IN	IN	_	5	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	report	_	NN	NN	_	1	pobj	_	_
4	we	_	PRP	PRP	_	5	nsubj	_	_
5	demonstrate	_	VBP	VBP	_	0	root	_	_
6	that	_	IN	IN	_	8	mark	_	_
7	IL-12	_	NN	NN	_	8	nsubj	_	_
8	induces	_	VBZ	VBZ	_	5	ccomp	_	_
9	tyrosine	_	NN	NN	_	10	nn	_	_
10	phosphorylation	_	NN	NN	_	8	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	a	_	DT	DT	_	17	det	_	_
13	recently	_	RB	RB	_	14	advmod	_	_
14	identified	_	VBN	VBN	_	17	amod	_	_
15	STAT	_	NN	NN	_	17	nn	_	_
16	family	_	NN	NN	_	17	nn	_	_
17	member	_	NN	NN	_	11	pobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	STAT4	_	NN	NN	_	17	appos	_	_
20	,	_	,	,	_	5	punct	_	_
21	and	_	CC	CC	_	5	cc	_	_
22	show	_	VBP	VBP	_	5	conj	_	_
23	that	_	IN	IN	_	27	mark	_	_
24	STAT4	_	NN	NN	_	25	nn	_	_
25	expression	_	NN	NN	_	27	nsubjpass	_	_
26	is	_	VBZ	VBZ	_	27	auxpass	_	_
27	regulated	_	VBN	VBN	_	22	ccomp	_	_
28	by	_	IN	IN	_	27	prep	_	_
29	T-cell	_	NN	NN	_	30	nn	_	_
30	activation	_	NN	NN	_	28	pobj	_	_
31	.	_	.	.	_	5	punct	_	_

1	Furthermore	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	show	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	7	mark	_	_
6	IL-12	_	NN	NN	_	7	nsubj	_	_
7	stimulates	_	VBZ	VBZ	_	4	ccomp	_	_
8	formation	_	NN	NN	_	7	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	a	_	DT	DT	_	12	det	_	_
11	DNA-binding	_	JJ	JJ	_	12	amod	_	_
12	complex	_	NN	NN	_	9	pobj	_	_
13	that	_	WDT	WDT	_	14	nsubj	_	_
14	recognizes	_	VBZ	VBZ	_	12	rcmod	_	_
15	a	_	DT	DT	_	17	det	_	_
16	DNA	_	NN	NN	_	17	nn	_	_
17	sequence	_	NN	NN	_	14	dobj	_	_
18	previously	_	RB	RB	_	17	advmod	_	_
19	shown	_	VBN	VBN	_	17	vmod	_	_
20	to	_	TO	TO	_	21	aux	_	_
21	bind	_	VB	VB	_	19	xcomp	_	_
22	STAT	_	NN	NN	_	23	nn	_	_
23	proteins	_	NNS	NNS	_	21	dobj	_	_
24	and	_	CC	CC	_	7	cc	_	_
25	that	_	IN	IN	_	28	mark	_	_
26	this	_	DT	DT	_	27	det	_	_
27	complex	_	NN	NN	_	28	nsubj	_	_
28	contains	_	VBZ	VBZ	_	7	conj	_	_
29	STAT4	_	NN	NN	_	28	dobj	_	_
30	.	_	.	.	_	4	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	14	nsubj	_	_
3	,	_	,	,	_	2	punct	_	_
4	and	_	CC	CC	_	2	cc	_	_
5	the	_	DT	DT	_	7	det	_	_
6	recent	_	JJ	JJ	_	7	amod	_	_
7	demonstration	_	NN	NN	_	2	conj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	JAK	_	NN	NN	_	10	nn	_	_
10	phosphorylation	_	NN	NN	_	8	pobj	_	_
11	by	_	IN	IN	_	10	prep	_	_
12	IL-12	_	NN	NN	_	11	pobj	_	_
13	,	_	,	,	_	2	punct	_	_
14	identify	_	VBP	VBP	_	0	root	_	_
15	a	_	DT	DT	_	18	det	_	_
16	rapid	_	JJ	JJ	_	18	amod	_	_
17	signal-transduction	_	JJ	JJ	_	18	amod	_	_
18	pathway	_	NN	NN	_	14	dobj	_	_
19	likely	_	JJ	JJ	_	18	amod	_	_
20	to	_	TO	TO	_	21	aux	_	_
21	mediate	_	VB	VB	_	19	xcomp	_	_
22	IL-12-induced	_	JJ	JJ	_	24	amod	_	_
23	gene	_	NN	NN	_	24	nn	_	_
24	expression	_	NN	NN	_	21	dobj	_	_
25	.	_	.	.	_	14	punct	_	_

1	Regulation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	c-jun	_	NN	NN	_	4	nn	_	_
4	mRNA	_	NN	NN	_	5	nn	_	_
5	expression	_	NN	NN	_	2	pobj	_	_
6	by	_	IN	IN	_	1	prep	_	_
7	hydroxyurea	_	NN	NN	_	6	pobj	_	_
8	in	_	IN	IN	_	1	prep	_	_
9	human	_	JJ	JJ	_	11	amod	_	_
10	K562	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	8	pobj	_	_
12	during	_	IN	IN	_	1	prep	_	_
13	erythroid	_	JJ	JJ	_	14	amod	_	_
14	differentiation	_	NN	NN	_	12	pobj	_	_
15	-LSB-	_	-LRB-	-LRB-	_	18	punct	_	_
16	published	_	VBN	VBN	_	17	amod	_	_
17	erratum	_	NN	NN	_	18	nsubj	_	_
18	appears	_	VBZ	VBZ	_	1	dep	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	Biochim	_	NNP	NNP	_	24	nn	_	_
21	Biophys	_	NNP	NNP	_	24	nn	_	_
22	Acta	_	NNP	NNP	_	24	nn	_	_
23	1995	_	CD	CD	_	24	num	_	_
24	Dec	_	NNP	NNP	_	19	pobj	_	_
25	27	_	CD	CD	_	24	num	_	_
26	;	_	:	:	_	24	punct	_	_
27	1264	_	CD	CD	_	29	num	_	_
28	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
29	3	_	CD	CD	_	24	dep	_	_
30	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
31	:	_	:	:	_	24	punct	_	_
32	409	_	CD	CD	_	24	dep	_	_
33	-RSB-	_	-RRB-	-RRB-	_	18	punct	_	_

1	Hydroxyurea	_	NN	NN	_	8	nsubj	_	_
2	-LRB-	_	-LRB-	-LRB-	_	3	punct	_	_
3	HU	_	NN	NN	_	1	appos	_	_
4	-RRB-	_	-RRB-	-RRB-	_	3	punct	_	_
5	is	_	VBZ	VBZ	_	8	cop	_	_
6	an	_	DT	DT	_	8	det	_	_
7	antitumor	_	JJ	JJ	_	8	amod	_	_
8	agent	_	NN	NN	_	0	root	_	_
9	which	_	WDT	WDT	_	11	nsubj	_	_
10	also	_	RB	RB	_	11	advmod	_	_
11	induces	_	VBZ	VBZ	_	8	rcmod	_	_
12	hemoglobinization	_	NN	NN	_	11	dobj	_	_
13	during	_	IN	IN	_	11	prep	_	_
14	erythroid	_	JJ	JJ	_	15	amod	_	_
15	differentiation	_	NN	NN	_	13	pobj	_	_
16	.	_	.	.	_	8	punct	_	_

1	In	_	IN	IN	_	5	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	5	punct	_	_
4	HU	_	NN	NN	_	5	nsubj	_	_
5	stimulates	_	VBZ	VBZ	_	0	root	_	_
6	the	_	DT	DT	_	7	det	_	_
7	synthesis	_	NN	NN	_	5	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	fetal	_	JJ	JJ	_	10	amod	_	_
10	hemoglobin	_	NN	NN	_	8	pobj	_	_
11	in	_	IN	IN	_	7	prep	_	_
12	sickle	_	NN	NN	_	15	nn	_	_
13	cell	_	NN	NN	_	15	nn	_	_
14	anemia	_	NN	NN	_	15	nn	_	_
15	patients	_	NNS	NNS	_	11	pobj	_	_
16	.	_	.	.	_	5	punct	_	_

1	To	_	TO	TO	_	3	aux	_	_
2	further	_	RB	RB	_	3	advmod	_	_
3	understand	_	VB	VB	_	0	root	_	_
4	its	_	PRP$	PRP$	_	5	poss	_	_
5	mechanism	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	action	_	NN	NN	_	6	pobj	_	_
8	,	_	,	,	_	3	punct	_	_
9	we	_	PRP	PRP	_	10	nsubj	_	_
10	investigated	_	VBD	VBD	_	3	parataxis	_	_
11	the	_	DT	DT	_	12	det	_	_
12	effects	_	NNS	NNS	_	10	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	HU	_	NN	NN	_	13	pobj	_	_
15	on	_	IN	IN	_	12	prep	_	_
16	regulation	_	NN	NN	_	15	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	c-jun	_	NN	NN	_	19	nn	_	_
19	expression	_	NN	NN	_	17	pobj	_	_
20	prior	_	RB	RB	_	12	advmod	_	_
21	to	_	TO	TO	_	20	prep	_	_
22	the	_	DT	DT	_	23	det	_	_
23	onset	_	NN	NN	_	21	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	erythroid	_	JJ	JJ	_	26	amod	_	_
26	differentiation	_	NN	NN	_	24	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	K562	_	NN	NN	_	29	nn	_	_
29	cells	_	NNS	NNS	_	27	pobj	_	_
30	.	_	.	.	_	3	punct	_	_

1	HU	_	NN	NN	_	2	nsubj	_	_
2	induced	_	VBD	VBD	_	0	root	_	_
3	a	_	DT	DT	_	5	det	_	_
4	dose-dependent	_	JJ	JJ	_	5	amod	_	_
5	stimulation	_	NN	NN	_	2	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	c-jun	_	NN	NN	_	8	nn	_	_
8	synthesis	_	NN	NN	_	6	pobj	_	_
9	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	levels	_	NNS	NNS	_	7	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	c-jun	_	NN	NN	_	5	nn	_	_
5	mRNA	_	NN	NN	_	3	pobj	_	_
6	was	_	VBD	VBD	_	7	auxpass	_	_
7	elevated	_	VBN	VBN	_	0	root	_	_
8	4	_	CD	CD	_	7	dobj	_	_
9	to	_	TO	TO	_	8	dep	_	_
10	7.5-fold	_	RB	RB	_	8	advmod	_	_
11	by	_	IN	IN	_	7	prep	_	_
12	HU	_	NN	NN	_	11	pobj	_	_
13	within	_	IN	IN	_	7	prep	_	_
14	2	_	CD	CD	_	15	num	_	_
15	h	_	NN	NN	_	13	pobj	_	_
16	.	_	.	.	_	7	punct	_	_

1	This	_	DT	DT	_	3	nsubjpass	_	_
2	was	_	VBD	VBD	_	3	auxpass	_	_
3	followed	_	VBN	VBN	_	0	root	_	_
4	by	_	IN	IN	_	3	prep	_	_
5	a	_	DT	DT	_	7	det	_	_
6	gradual	_	JJ	JJ	_	7	amod	_	_
7	decline	_	NN	NN	_	4	pobj	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	basal	_	JJ	JJ	_	11	amod	_	_
11	level	_	NN	NN	_	8	pobj	_	_
12	by	_	IN	IN	_	3	prep	_	_
13	24	_	CD	CD	_	14	num	_	_
14	h	_	NN	NN	_	12	pobj	_	_
15	.	_	.	.	_	3	punct	_	_

1	Both	_	CC	CC	_	3	preconj	_	_
2	nuclear	_	JJ	JJ	_	3	amod	_	_
3	run-on	_	JJ	JJ	_	10	nsubj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	actinomycin	_	NN	NN	_	7	nn	_	_
6	D	_	NN	NN	_	7	nn	_	_
7	pulse	_	NN	NN	_	3	conj	_	_
8	experiments	_	NNS	NNS	_	3	dep	_	_
9	strongly	_	RB	RB	_	10	advmod	_	_
10	indicate	_	VBP	VBP	_	0	root	_	_
11	that	_	IN	IN	_	13	mark	_	_
12	HU	_	NN	NN	_	13	nsubj	_	_
13	regulates	_	VBZ	VBZ	_	10	ccomp	_	_
14	c-jun	_	NN	NN	_	15	nn	_	_
15	mRNA	_	NN	NN	_	16	nn	_	_
16	expression	_	NN	NN	_	13	dobj	_	_
17	by	_	IN	IN	_	13	prep	_	_
18	increasing	_	VBG	VBG	_	17	pcomp	_	_
19	the	_	DT	DT	_	20	det	_	_
20	rate	_	NN	NN	_	18	dobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	synthesis	_	NN	NN	_	21	pobj	_	_
23	as	_	RB	RB	_	24	advmod	_	_
24	well	_	RB	RB	_	18	cc	_	_
25	as	_	IN	IN	_	24	mwe	_	_
26	stabilizing	_	VBG	VBG	_	18	conj	_	_
27	the	_	DT	DT	_	29	det	_	_
28	c-jun	_	NN	NN	_	29	nn	_	_
29	mRNA	_	NN	NN	_	26	dobj	_	_
30	.	_	.	.	_	10	punct	_	_

1	In	_	IN	IN	_	10	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	10	punct	_	_
4	the	_	DT	DT	_	5	det	_	_
5	level	_	NN	NN	_	10	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	jun	_	NN	NN	_	8	nn	_	_
8	protein	_	NN	NN	_	6	pobj	_	_
9	was	_	VBD	VBD	_	10	cop	_	_
10	elevated	_	JJ	JJ	_	0	root	_	_
11	by	_	IN	IN	_	10	prep	_	_
12	2	_	CD	CD	_	14	num	_	_
13	to	_	TO	TO	_	14	dep	_	_
14	5-fold	_	NN	NN	_	11	pobj	_	_
15	within	_	IN	IN	_	10	prep	_	_
16	4	_	CD	CD	_	17	num	_	_
17	h	_	NN	NN	_	15	pobj	_	_
18	in	_	IN	IN	_	10	prep	_	_
19	HU	_	NN	NN	_	21	nn	_	_
20	treated	_	JJ	JJ	_	21	amod	_	_
21	cells	_	NNS	NNS	_	18	pobj	_	_
22	.	_	.	.	_	10	punct	_	_

1	Furthermore	_	RB	RB	_	10	advmod	_	_
2	,	_	,	,	_	10	punct	_	_
3	concentrations	_	NNS	NNS	_	10	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	HU	_	NN	NN	_	4	pobj	_	_
6	below	_	IN	IN	_	3	prep	_	_
7	250	_	CD	CD	_	8	num	_	_
8	microM	_	NN	NN	_	6	pobj	_	_
9	slightly	_	RB	RB	_	10	advmod	_	_
10	increased	_	VBD	VBD	_	0	root	_	_
11	the	_	DT	DT	_	14	det	_	_
12	5X	_	NN	NN	_	14	nn	_	_
13	AP-1/CAT	_	NN	NN	_	14	nn	_	_
14	activity	_	NN	NN	_	10	dobj	_	_
15	.	_	.	.	_	10	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	4	nsubj	_	_
3	strongly	_	RB	RB	_	4	advmod	_	_
4	suggest	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	7	mark	_	_
6	HU	_	NN	NN	_	7	nsubj	_	_
7	induces	_	VBZ	VBZ	_	4	ccomp	_	_
8	both	_	CC	CC	_	9	preconj	_	_
9	transcriptional	_	JJ	JJ	_	7	dobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	post-transcription	_	JJ	JJ	_	9	conj	_	_
12	regulation	_	NN	NN	_	9	dep	_	_
13	of	_	IN	IN	_	9	prep	_	_
14	c-jun	_	NN	NN	_	13	pobj	_	_
15	during	_	IN	IN	_	9	prep	_	_
16	erythroid	_	JJ	JJ	_	17	amod	_	_
17	differentiation	_	NN	NN	_	15	pobj	_	_
18	.	_	.	.	_	4	punct	_	_

1	IL-2	_	NN	NN	_	2	nn	_	_
2	gene	_	NN	NN	_	3	nn	_	_
3	expression	_	NN	NN	_	10	nsubj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	NF-kappa	_	NN	NN	_	6	nn	_	_
6	B	_	NN	NN	_	7	nn	_	_
7	activation	_	NN	NN	_	3	conj	_	_
8	through	_	IN	IN	_	3	prep	_	_
9	CD28	_	NN	NN	_	8	pobj	_	_
10	requires	_	VBZ	VBZ	_	0	root	_	_
11	reactive	_	JJ	JJ	_	13	amod	_	_
12	oxygen	_	NN	NN	_	13	nn	_	_
13	production	_	NN	NN	_	10	dobj	_	_
14	by	_	IN	IN	_	13	prep	_	_
15	5-lipoxygenase	_	NN	NN	_	14	pobj	_	_
16	.	_	.	.	_	10	punct	_	_

1	Activation	_	NN	NN	_	7	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	6	det	_	_
4	CD28	_	NN	NN	_	6	nn	_	_
5	surface	_	NN	NN	_	6	nn	_	_
6	receptor	_	NN	NN	_	2	pobj	_	_
7	provides	_	VBZ	VBZ	_	0	root	_	_
8	a	_	DT	DT	_	11	det	_	_
9	major	_	JJ	JJ	_	11	amod	_	_
10	costimulatory	_	JJ	JJ	_	11	amod	_	_
11	signal	_	NN	NN	_	7	dobj	_	_
12	for	_	IN	IN	_	11	prep	_	_
13	T	_	NN	NN	_	15	nn	_	_
14	cell	_	NN	NN	_	15	nn	_	_
15	activation	_	NN	NN	_	12	pobj	_	_
16	resulting	_	VBG	VBG	_	11	vmod	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	enhanced	_	VBN	VBN	_	19	amod	_	_
19	production	_	NN	NN	_	17	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	interleukin-2	_	NN	NN	_	20	pobj	_	_
22	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
23	IL-2	_	NN	NN	_	21	appos	_	_
24	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
25	and	_	CC	CC	_	19	cc	_	_
26	cell	_	NN	NN	_	27	nn	_	_
27	proliferation	_	NN	NN	_	19	conj	_	_
28	.	_	.	.	_	7	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	primary	_	JJ	JJ	_	4	amod	_	_
3	T	_	NN	NN	_	4	nn	_	_
4	lymphocytes	_	NNS	NNS	_	1	pobj	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	show	_	VBP	VBP	_	0	root	_	_
7	that	_	IN	IN	_	10	mark	_	_
8	CD28	_	NN	NN	_	9	nn	_	_
9	ligation	_	NN	NN	_	10	nsubj	_	_
10	leads	_	VBZ	VBZ	_	6	ccomp	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	the	_	DT	DT	_	15	det	_	_
13	rapid	_	JJ	JJ	_	15	amod	_	_
14	intracellular	_	JJ	JJ	_	15	amod	_	_
15	formation	_	NN	NN	_	11	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	reactive	_	JJ	JJ	_	19	amod	_	_
18	oxygen	_	NN	NN	_	19	nn	_	_
19	intermediates	_	NNS	NNS	_	16	pobj	_	_
20	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	ROIs	_	NNS	NNS	_	19	appos	_	_
22	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
23	which	_	WDT	WDT	_	25	nsubjpass	_	_
24	are	_	VBP	VBP	_	25	auxpass	_	_
25	required	_	VBN	VBN	_	19	rcmod	_	_
26	for	_	IN	IN	_	25	prep	_	_
27	CD28-mediated	_	JJ	JJ	_	28	amod	_	_
28	activation	_	NN	NN	_	26	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	the	_	DT	DT	_	33	det	_	_
31	NF-kappa	_	NN	NN	_	33	nn	_	_
32	B/CD28-responsive	_	JJ	JJ	_	33	amod	_	_
33	complex	_	NN	NN	_	29	pobj	_	_
34	and	_	CC	CC	_	28	cc	_	_
35	IL-2	_	NN	NN	_	36	nn	_	_
36	expression	_	NN	NN	_	28	conj	_	_
37	.	_	.	.	_	6	punct	_	_

1	Delineation	_	NN	NN	_	8	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	6	det	_	_
4	CD28	_	NN	NN	_	6	nn	_	_
5	signaling	_	NN	NN	_	6	nn	_	_
6	cascade	_	NN	NN	_	2	pobj	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	found	_	VBN	VBN	_	0	root	_	_
9	to	_	TO	TO	_	8	dep	_	_
10	involve	_	VB	VB	_	9	ccomp	_	_
11	protein	_	NN	NN	_	13	nn	_	_
12	tyrosine	_	NN	NN	_	13	nn	_	_
13	kinase	_	NN	NN	_	14	nn	_	_
14	activity	_	NN	NN	_	10	dobj	_	_
15	,	_	,	,	_	10	punct	_	_
16	followed	_	VBN	VBN	_	10	vmod	_	_
17	by	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	19	det	_	_
19	activation	_	NN	NN	_	17	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	phospholipase	_	NN	NN	_	22	nn	_	_
22	A2	_	NN	NN	_	20	pobj	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	5-lipoxygenase	_	NN	NN	_	22	conj	_	_
25	.	_	.	.	_	8	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	7	mark	_	_
5	lipoxygenase	_	NN	NN	_	6	nn	_	_
6	metabolites	_	NNS	NNS	_	7	nsubj	_	_
7	activate	_	VBP	VBP	_	3	ccomp	_	_
8	ROI	_	NN	NN	_	9	nn	_	_
9	formation	_	NN	NN	_	7	dobj	_	_
10	which	_	WDT	WDT	_	12	nsubj	_	_
11	then	_	RB	RB	_	12	advmod	_	_
12	induce	_	VBP	VBP	_	9	rcmod	_	_
13	IL-2	_	NN	NN	_	14	nn	_	_
14	expression	_	NN	NN	_	12	dobj	_	_
15	via	_	IN	IN	_	12	prep	_	_
16	NF-kappa	_	NN	NN	_	17	nn	_	_
17	B	_	NN	NN	_	18	nn	_	_
18	activation	_	NN	NN	_	15	pobj	_	_
19	.	_	.	.	_	3	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	findings	_	NNS	NNS	_	5	nsubj	_	_
3	should	_	MD	MD	_	5	aux	_	_
4	be	_	VB	VB	_	5	cop	_	_
5	useful	_	JJ	JJ	_	0	root	_	_
6	for	_	IN	IN	_	5	prep	_	_
7	therapeutic	_	JJ	JJ	_	8	amod	_	_
8	strategies	_	NNS	NNS	_	6	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	the	_	DT	DT	_	11	det	_	_
11	development	_	NN	NN	_	8	conj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	immunosuppressants	_	NNS	NNS	_	12	pobj	_	_
14	targeting	_	VBG	VBG	_	13	vmod	_	_
15	the	_	DT	DT	_	18	det	_	_
16	CD28	_	NN	NN	_	18	nn	_	_
17	costimulatory	_	NN	NN	_	18	nn	_	_
18	pathway	_	NN	NN	_	14	dobj	_	_
19	.	_	.	.	_	5	punct	_	_

1	HIV-1	_	NN	NN	_	3	nn	_	_
2	envelope	_	NN	NN	_	3	nn	_	_
3	glycoproteins	_	NNS	NNS	_	4	nsubj	_	_
4	induce	_	VBP	VBP	_	0	root	_	_
5	activation	_	NN	NN	_	4	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	activated	_	VBN	VBN	_	8	amod	_	_
8	protein-1	_	NN	NN	_	6	pobj	_	_
9	in	_	IN	IN	_	5	prep	_	_
10	CD4+	_	JJ	JJ	_	12	amod	_	_
11	T	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	9	pobj	_	_
13	-LSB-	_	-LRB-	-LRB-	_	16	punct	_	_
14	published	_	VBN	VBN	_	15	amod	_	_
15	erratum	_	NN	NN	_	16	nsubj	_	_
16	appears	_	VBZ	VBZ	_	4	parataxis	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	J	_	NNP	NNP	_	22	nn	_	_
19	Biol	_	NNP	NNP	_	22	nn	_	_
20	Chem	_	NNP	NNP	_	22	nn	_	_
21	1995	_	CD	CD	_	22	num	_	_
22	Dec	_	NNP	NNP	_	17	pobj	_	_
23	1	_	CD	CD	_	22	num	_	_
24	;	_	:	:	_	22	punct	_	_
25	270	_	CD	CD	_	30	num	_	_
26	-LRB-	_	-LRB-	-LRB-	_	30	punct	_	_
27	48	_	CD	CD	_	30	num	_	_
28	-RRB-	_	-RRB-	-RRB-	_	30	punct	_	_
29	:	_	:	:	_	30	punct	_	_
30	29038	_	CD	CD	_	22	dep	_	_
31	-RSB-	_	-RRB-	-RRB-	_	16	punct	_	_

1	Activation	_	NN	NN	_	10	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	CD4	_	NN	NN	_	6	nn	_	_
4	positive	_	JJ	JJ	_	6	amod	_	_
5	T	_	NN	NN	_	6	nn	_	_
6	cells	_	NNS	NNS	_	2	pobj	_	_
7	is	_	VBZ	VBZ	_	10	cop	_	_
8	a	_	DT	DT	_	10	det	_	_
9	primary	_	JJ	JJ	_	10	amod	_	_
10	requirement	_	NN	NN	_	0	root	_	_
11	for	_	IN	IN	_	10	prep	_	_
12	human	_	JJ	JJ	_	14	amod	_	_
13	immunodeficiency	_	NN	NN	_	14	nn	_	_
14	virus	_	NN	NN	_	11	pobj	_	_
15	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
16	HIV	_	NN	NN	_	14	appos	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	entry	_	NN	NN	_	14	dep	_	_
19	,	_	,	,	_	14	punct	_	_
20	efficient	_	JJ	JJ	_	22	amod	_	_
21	HIV	_	NN	NN	_	22	nn	_	_
22	replication	_	NN	NN	_	14	conj	_	_
23	,	_	,	,	_	14	punct	_	_
24	and	_	CC	CC	_	14	cc	_	_
25	progression	_	NN	NN	_	14	conj	_	_
26	to	_	TO	TO	_	25	prep	_	_
27	AIDS	_	NN	NN	_	26	pobj	_	_
28	,	_	,	,	_	10	punct	_	_

1	Utilizing	_	VBG	VBG	_	0	root	_	_
2	CD4	_	NN	NN	_	6	nn	_	_
3	positive	_	JJ	JJ	_	6	amod	_	_
4	T	_	NN	NN	_	6	nn	_	_
5	cell	_	NN	NN	_	6	nn	_	_
6	lines	_	NNS	NNS	_	1	dobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	purified	_	VBN	VBN	_	10	amod	_	_
9	T	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	6	conj	_	_
11	from	_	IN	IN	_	6	prep	_	_
12	normal	_	JJ	JJ	_	13	amod	_	_
13	individuals	_	NNS	NNS	_	11	pobj	_	_
14	,	_	,	,	_	1	punct	_	_
15	we	_	PRP	PRP	_	17	nsubj	_	_
16	have	_	VBP	VBP	_	17	aux	_	_
17	demonstrated	_	VBN	VBN	_	1	parataxis	_	_
18	that	_	IN	IN	_	29	mark	_	_
19	native	_	JJ	JJ	_	21	amod	_	_
20	envelope	_	NN	NN	_	21	nn	_	_
21	glycoproteins	_	NNS	NNS	_	29	nsubj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	HIV	_	NN	NN	_	22	pobj	_	_
24	,	_	,	,	_	23	punct	_	_
25	gp	_	NN	NN	_	23	appos	_	_
26	160	_	CD	CD	_	25	num	_	_
27	,	_	,	,	_	23	punct	_	_
28	can	_	MD	MD	_	29	aux	_	_
29	induce	_	VB	VB	_	17	ccomp	_	_
30	activation	_	NN	NN	_	29	dobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	transcription	_	NN	NN	_	36	nn	_	_
33	factor	_	NN	NN	_	36	nn	_	_
34	,	_	,	,	_	36	punct	_	_
35	activated	_	VBN	VBN	_	36	amod	_	_
36	protein-1	_	NN	NN	_	31	pobj	_	_
37	-LRB-	_	-LRB-	-LRB-	_	38	punct	_	_
38	AP-1	_	NN	NN	_	36	appos	_	_
39	-RRB-	_	-RRB-	-RRB-	_	38	punct	_	_
40	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	stimulatory	_	JJ	JJ	_	3	amod	_	_
3	effects	_	NNS	NNS	_	7	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	gp160	_	NN	NN	_	4	pobj	_	_
6	are	_	VBP	VBP	_	7	auxpass	_	_
7	mediated	_	VBN	VBN	_	0	root	_	_
8	through	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	CD4	_	NN	NN	_	11	nn	_	_
11	molecule	_	NN	NN	_	8	pobj	_	_
12	,	_	,	,	_	7	punct	_	_
13	since	_	IN	IN	_	20	mark	_	_
14	treatment	_	NN	NN	_	20	nsubj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	gp160	_	NN	NN	_	15	pobj	_	_
17	with	_	IN	IN	_	14	prep	_	_
18	soluble	_	JJ	JJ	_	19	amod	_	_
19	CD4-IgG	_	NN	NN	_	17	pobj	_	_
20	abrogates	_	VBZ	VBZ	_	7	advcl	_	_
21	its	_	PRP$	PRP$	_	22	poss	_	_
22	activity	_	NN	NN	_	20	dobj	_	_
23	,	_	,	,	_	20	punct	_	_
24	and	_	CC	CC	_	20	cc	_	_
25	CD4	_	NN	NN	_	29	nn	_	_
26	negative	_	JJ	JJ	_	29	amod	_	_
27	T	_	NN	NN	_	29	nn	_	_
28	cell	_	NN	NN	_	29	nn	_	_
29	lines	_	NNS	NNS	_	30	nsubj	_	_
30	fail	_	VBP	VBP	_	20	conj	_	_
31	to	_	TO	TO	_	33	aux	_	_
32	be	_	VB	VB	_	33	auxpass	_	_
33	stimulated	_	VBN	VBN	_	30	xcomp	_	_
34	with	_	IN	IN	_	33	prep	_	_
35	gp160	_	NN	NN	_	34	pobj	_	_
36	.	_	.	.	_	7	punct	_	_

1	Immunoprecipitation	_	NN	NN	_	16	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	7	det	_	_
4	gp	_	NN	NN	_	7	nn	_	_
5	160-induced	_	JJ	JJ	_	7	amod	_	_
6	nuclear	_	JJ	JJ	_	7	amod	_	_
7	extracts	_	NNS	NNS	_	2	pobj	_	_
8	with	_	IN	IN	_	1	prep	_	_
9	polyclonal	_	JJ	JJ	_	10	amod	_	_
10	antibodies	_	NNS	NNS	_	8	pobj	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	Fos	_	NN	NN	_	11	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	Jun	_	NN	NN	_	15	nn	_	_
15	proteins	_	NNS	NNS	_	12	conj	_	_
16	indicates	_	VBZ	VBZ	_	0	root	_	_
17	that	_	IN	IN	_	21	mark	_	_
18	AP-1	_	NN	NN	_	19	nn	_	_
19	complex	_	NN	NN	_	21	nsubjpass	_	_
20	is	_	VBZ	VBZ	_	21	auxpass	_	_
21	comprised	_	VBN	VBN	_	16	ccomp	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	members	_	NNS	NNS	_	22	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	these	_	DT	DT	_	26	det	_	_
26	family	_	NN	NN	_	24	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	proteins	_	NNS	NNS	_	27	pobj	_	_
29	.	_	.	.	_	16	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	gp160-induced	_	JJ	JJ	_	4	amod	_	_
3	AP-1	_	NN	NN	_	4	nn	_	_
4	complex	_	NN	NN	_	6	nsubj	_	_
5	is	_	VBZ	VBZ	_	6	cop	_	_
6	dependent	_	JJ	JJ	_	0	root	_	_
7	upon	_	IN	IN	_	6	prep	_	_
8	protein	_	NN	NN	_	10	nn	_	_
9	tyrosine	_	NN	NN	_	10	nn	_	_
10	phosphorylation	_	NN	NN	_	7	pobj	_	_
11	and	_	CC	CC	_	6	cc	_	_
12	is	_	VBZ	VBZ	_	14	cop	_	_
13	protein	_	NN	NN	_	14	npadvmod	_	_
14	synthesis-independent	_	JJ	JJ	_	6	conj	_	_
15	.	_	.	.	_	6	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	stimulation	_	NN	NN	_	6	nsubjpass	_	_
3	can	_	MD	MD	_	6	aux	_	_
4	also	_	RB	RB	_	6	advmod	_	_
5	be	_	VB	VB	_	6	auxpass	_	_
6	abolished	_	VBN	VBN	_	0	root	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	inhibitors	_	NNS	NNS	_	7	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	protein	_	NN	NN	_	12	nn	_	_
11	kinase	_	NN	NN	_	12	nn	_	_
12	C	_	NN	NN	_	9	pobj	_	_
13	,	_	,	,	_	6	punct	_	_
14	but	_	CC	CC	_	6	cc	_	_
15	it	_	PRP	PRP	_	17	nsubj	_	_
16	is	_	VBZ	VBZ	_	17	cop	_	_
17	unaffected	_	JJ	JJ	_	6	conj	_	_
18	by	_	IN	IN	_	17	prep	_	_
19	calcium	_	NN	NN	_	21	nn	_	_
20	channel	_	NN	NN	_	21	nn	_	_
21	blocker	_	NN	NN	_	18	pobj	_	_
22	or	_	CC	CC	_	21	cc	_	_
23	cyclosporine	_	NN	NN	_	24	nn	_	_
24	A	_	NN	NN	_	21	conj	_	_
25	.	_	.	.	_	6	punct	_	_

1	This	_	DT	DT	_	3	det	_	_
2	gp160	_	NN	NN	_	3	nn	_	_
3	treatment	_	NN	NN	_	5	nsubj	_	_
4	adversely	_	RB	RB	_	5	advmod	_	_
5	affects	_	VBZ	VBZ	_	0	root	_	_
6	the	_	DT	DT	_	8	det	_	_
7	functional	_	JJ	JJ	_	8	amod	_	_
8	capabilities	_	NNS	NNS	_	5	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	T	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	9	pobj	_	_
12	:	_	:	:	_	5	punct	_	_
13	pre-treatment	_	NN	NN	_	27	nsubj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	CD4+	_	JJ	JJ	_	17	amod	_	_
16	T	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	14	pobj	_	_
18	with	_	IN	IN	_	13	prep	_	_
19	gp160	_	NN	NN	_	18	pobj	_	_
20	for	_	IN	IN	_	13	prep	_	_
21	4	_	CD	CD	_	22	num	_	_
22	h	_	NN	NN	_	20	pobj	_	_
23	at	_	IN	IN	_	13	prep	_	_
24	37	_	CD	CD	_	26	num	_	_
25	degrees	_	NNS	NNS	_	26	nn	_	_
26	C	_	NN	NN	_	23	pobj	_	_
27	inhibited	_	VBD	VBD	_	5	parataxis	_	_
28	anti-CD3-induced	_	JJ	JJ	_	30	amod	_	_
29	interleukin-2	_	NN	NN	_	30	nn	_	_
30	secretion	_	NN	NN	_	27	dobj	_	_
31	.	_	.	.	_	5	punct	_	_

1	Effects	_	NNS	NNS	_	6	nsubjpass	_	_
2	similar	_	JJ	JJ	_	1	amod	_	_
3	to	_	TO	TO	_	2	prep	_	_
4	gp160	_	NN	NN	_	3	pobj	_	_
5	were	_	VBD	VBD	_	6	auxpass	_	_
6	seen	_	VBN	VBN	_	0	root	_	_
7	with	_	IN	IN	_	6	prep	_	_
8	anti-CD4	_	JJ	JJ	_	9	amod	_	_
9	mAb	_	NN	NN	_	7	pobj	_	_
10	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	aberrant	_	JJ	JJ	_	3	amod	_	_
3	activation	_	NN	NN	_	14	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	AP-1	_	NN	NN	_	4	pobj	_	_
6	by	_	IN	IN	_	3	prep	_	_
7	gp160	_	NN	NN	_	6	pobj	_	_
8	in	_	IN	IN	_	3	prep	_	_
9	CD4	_	NN	NN	_	12	nn	_	_
10	positive	_	JJ	JJ	_	12	amod	_	_
11	T	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	8	pobj	_	_
13	could	_	MD	MD	_	14	aux	_	_
14	result	_	VB	VB	_	0	root	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	up-regulation	_	NN	NN	_	15	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	cytokines	_	NNS	NNS	_	17	pobj	_	_
19	containing	_	VBG	VBG	_	18	vmod	_	_
20	AP-1	_	NN	NN	_	21	nn	_	_
21	sites	_	NNS	NNS	_	19	dobj	_	_
22	,	_	,	,	_	21	punct	_	_
23	e.g.	_	FW	FW	_	21	prep	_	_
24	interleukin-3	_	NN	NN	_	21	dep	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	granulocyte	_	NN	NN	_	29	nn	_	_
27	macrophage	_	NN	NN	_	29	nn	_	_
28	colony-stimulating	_	JJ	JJ	_	29	amod	_	_
29	factor	_	NN	NN	_	24	conj	_	_
30	,	_	,	,	_	14	punct	_	_
31	and	_	CC	CC	_	14	cc	_	_
32	concurrently	_	RB	RB	_	33	advmod	_	_
33	lead	_	VBP	VBP	_	14	conj	_	_
34	to	_	TO	TO	_	33	prep	_	_
35	T	_	NN	NN	_	36	nn	_	_
36	cell	_	NN	NN	_	37	nn	_	_
37	unresponsiveness	_	NN	NN	_	34	pobj	_	_
38	by	_	IN	IN	_	33	prep	_	_
39	inhibiting	_	VBG	VBG	_	38	pcomp	_	_
40	interleukin-2	_	NN	NN	_	41	nn	_	_
41	secretion	_	NN	NN	_	39	dobj	_	_
42	.	_	.	.	_	14	punct	_	_

1	Infection	_	NN	NN	_	0	root	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	replication	_	NN	NN	_	1	conj	_	_
4	of	_	IN	IN	_	1	prep	_	_
5	Tat-	_	JJ	JJ	_	8	amod	_	_
6	human	_	JJ	JJ	_	8	amod	_	_
7	immunodeficiency	_	NN	NN	_	8	nn	_	_
8	viruses	_	NNS	NNS	_	4	pobj	_	_
9	:	_	:	:	_	1	punct	_	_
10	genetic	_	JJ	JJ	_	11	amod	_	_
11	analyses	_	NNS	NNS	_	1	dep	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	LTR	_	NN	NN	_	12	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	tat	_	NN	NN	_	13	conj	_	_
16	mutations	_	NNS	NNS	_	13	dep	_	_
17	in	_	IN	IN	_	13	prep	_	_
18	primary	_	JJ	JJ	_	17	pobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	long-term	_	JJ	JJ	_	18	conj	_	_
21	human	_	JJ	JJ	_	23	amod	_	_
22	lymphoid	_	JJ	JJ	_	23	amod	_	_
23	cells	_	NNS	NNS	_	18	dep	_	_
24	.	_	.	.	_	1	punct	_	_

1	Tat	_	NN	NN	_	6	nsubj	_	_
2	is	_	VBZ	VBZ	_	6	cop	_	_
3	an	_	DT	DT	_	6	det	_	_
4	essential	_	JJ	JJ	_	6	amod	_	_
5	regulatory	_	JJ	JJ	_	6	amod	_	_
6	protein	_	NN	NN	_	0	root	_	_
7	for	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	replication	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	human	_	JJ	JJ	_	13	amod	_	_
12	immunodeficiency	_	NN	NN	_	13	nn	_	_
13	virus	_	NN	NN	_	10	pobj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	HIV	_	NN	NN	_	13	appos	_	_
16	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
17	.	_	.	.	_	6	punct	_	_

1	Mutations	_	NNS	NNS	_	8	nsubjpass	_	_
2	in	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	tat	_	NN	NN	_	5	nn	_	_
5	gene	_	NN	NN	_	2	pobj	_	_
6	have	_	VBP	VBP	_	8	aux	_	_
7	been	_	VBN	VBN	_	8	auxpass	_	_
8	shown	_	VBN	VBN	_	0	root	_	_
9	to	_	TO	TO	_	10	aux	_	_
10	block	_	VB	VB	_	8	xcomp	_	_
11	HIV	_	NN	NN	_	12	nn	_	_
12	replication	_	NN	NN	_	10	dobj	_	_
13	in	_	IN	IN	_	10	prep	_	_
14	human	_	JJ	JJ	_	16	amod	_	_
15	T	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	13	pobj	_	_
17	.	_	.	.	_	8	punct	_	_

1	Several	_	JJ	JJ	_	2	amod	_	_
2	studies	_	NNS	NNS	_	4	nsubj	_	_
3	have	_	VBP	VBP	_	4	aux	_	_
4	established	_	VBN	VBN	_	0	root	_	_
5	that	_	IN	IN	_	7	mark	_	_
6	Tat	_	NN	NN	_	7	nsubj	_	_
7	releases	_	VBZ	VBZ	_	4	ccomp	_	_
8	an	_	DT	DT	_	10	det	_	_
9	elongation	_	NN	NN	_	10	nn	_	_
10	block	_	NN	NN	_	7	dobj	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	transcription	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	HIV	_	NN	NN	_	18	nn	_	_
16	long	_	JJ	JJ	_	18	amod	_	_
17	terminal	_	JJ	JJ	_	18	amod	_	_
18	repeat	_	NN	NN	_	14	pobj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	LTR	_	NN	NN	_	18	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	;	_	:	:	_	4	punct	_	_
23	however	_	RB	RB	_	4	advmod	_	_
24	,	_	,	,	_	4	punct	_	_
25	it	_	PRP	PRP	_	28	nsubjpass	_	_
26	is	_	VBZ	VBZ	_	28	auxpass	_	_
27	not	_	RB	RB	_	28	neg	_	_
28	known	_	VBN	VBN	_	4	parataxis	_	_
29	whether	_	IN	IN	_	34	mark	_	_
30	this	_	DT	DT	_	31	det	_	_
31	mechanism	_	NN	NN	_	34	nsubj	_	_
32	alone	_	RB	RB	_	31	advmod	_	_
33	is	_	VBZ	VBZ	_	34	cop	_	_
34	sufficient	_	JJ	JJ	_	28	ccomp	_	_
35	to	_	TO	TO	_	36	aux	_	_
36	explain	_	VB	VB	_	34	xcomp	_	_
37	the	_	DT	DT	_	38	det	_	_
38	block	_	NN	NN	_	36	dobj	_	_
39	to	_	TO	TO	_	38	prep	_	_
40	HIV	_	NN	NN	_	41	nn	_	_
41	replication	_	NN	NN	_	39	pobj	_	_
42	in	_	IN	IN	_	41	prep	_	_
43	human	_	JJ	JJ	_	45	amod	_	_
44	T	_	NN	NN	_	45	nn	_	_
45	cells	_	NNS	NNS	_	42	pobj	_	_
46	when	_	WRB	WRB	_	49	advmod	_	_
47	Tat	_	NN	NN	_	49	nsubj	_	_
48	is	_	VBZ	VBZ	_	49	cop	_	_
49	absent	_	JJ	JJ	_	36	advcl	_	_
50	.	_	.	.	_	4	punct	_	_

1	It	_	PRP	PRP	_	3	nsubj	_	_
2	is	_	VBZ	VBZ	_	3	cop	_	_
3	possible	_	JJ	JJ	_	0	root	_	_
4	that	_	IN	IN	_	8	mark	_	_
5	Tat	_	NN	NN	_	8	nsubjpass	_	_
6	is	_	VBZ	VBZ	_	8	auxpass	_	_
7	also	_	RB	RB	_	8	advmod	_	_
8	needed	_	VBN	VBN	_	3	ccomp	_	_
9	for	_	IN	IN	_	8	prep	_	_
10	other	_	JJ	JJ	_	11	amod	_	_
11	functions	_	NNS	NNS	_	9	pobj	_	_
12	during	_	IN	IN	_	8	prep	_	_
13	HIV	_	NN	NN	_	14	nn	_	_
14	replication	_	NN	NN	_	12	pobj	_	_
15	.	_	.	.	_	3	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	test	_	VB	VB	_	0	root	_	_
3	these	_	DT	DT	_	4	det	_	_
4	hypotheses	_	NNS	NNS	_	2	dobj	_	_
5	,	_	,	,	_	2	punct	_	_
6	we	_	PRP	PRP	_	7	nsubj	_	_
7	studied	_	VBD	VBD	_	2	parataxis	_	_
8	several	_	JJ	JJ	_	10	amod	_	_
9	tat	_	NN	NN	_	10	nn	_	_
10	mutants	_	NNS	NNS	_	7	dobj	_	_
11	,	_	,	,	_	10	punct	_	_
12	including	_	VBG	VBG	_	10	prep	_	_
13	two	_	CD	CD	_	16	num	_	_
14	stop	_	NN	NN	_	16	nn	_	_
15	codon	_	NN	NN	_	16	nn	_	_
16	mutants	_	NNS	NNS	_	12	pobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	one	_	CD	CD	_	20	num	_	_
19	deletion	_	NN	NN	_	20	nn	_	_
20	mutant	_	NN	NN	_	16	conj	_	_
21	using	_	VBG	VBG	_	7	xcomp	_	_
22	replication-competent	_	JJ	JJ	_	24	amod	_	_
23	HIV-1	_	NN	NN	_	24	nn	_	_
24	constructs	_	NNS	NNS	_	21	dobj	_	_
25	carrying	_	VBG	VBG	_	24	vmod	_	_
26	wild-type	_	JJ	JJ	_	25	dobj	_	_
27	or	_	CC	CC	_	26	cc	_	_
28	mutant	_	JJ	JJ	_	26	conj	_	_
29	LTRs	_	NNS	NNS	_	26	dep	_	_
30	with	_	IN	IN	_	26	prep	_	_
31	modifications	_	NNS	NNS	_	30	pobj	_	_
32	in	_	IN	IN	_	31	prep	_	_
33	the	_	DT	DT	_	35	dep	_	_
34	NF-kappa	_	NN	NN	_	35	nn	_	_
35	B	_	NN	NN	_	32	pobj	_	_
36	and/or	_	CC	CC	_	35	cc	_	_
37	Sp1	_	NN	NN	_	35	conj	_	_
38	binding	_	NN	NN	_	39	nn	_	_
39	sites	_	NNS	NNS	_	35	dep	_	_
40	.	_	.	.	_	2	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	study	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	show	_	VBP	VBP	_	0	root	_	_
7	that	_	IN	IN	_	14	mark	_	_
8	Tat-	_	JJ	JJ	_	9	amod	_	_
9	HIV-1	_	NN	NN	_	14	nsubj	_	_
10	with	_	IN	IN	_	9	prep	_	_
11	wild-type	_	JJ	JJ	_	12	amod	_	_
12	LTRs	_	NNS	NNS	_	10	pobj	_	_
13	can	_	MD	MD	_	14	aux	_	_
14	replicate	_	VB	VB	_	6	ccomp	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	HeLa	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	15	pobj	_	_
18	,	_	,	,	_	14	punct	_	_
19	and	_	CC	CC	_	14	cc	_	_
20	the	_	DT	DT	_	21	det	_	_
21	virus	_	NN	NN	_	27	nsubj	_	_
22	produced	_	VBN	VBN	_	21	vmod	_	_
23	from	_	IN	IN	_	22	prep	_	_
24	HeLa	_	NN	NN	_	25	nn	_	_
25	cells	_	NNS	NNS	_	23	pobj	_	_
26	can	_	MD	MD	_	27	aux	_	_
27	infect	_	VB	VB	_	14	conj	_	_
28	primary	_	JJ	JJ	_	31	amod	_	_
29	peripheral	_	JJ	JJ	_	31	amod	_	_
30	blood	_	NN	NN	_	31	nn	_	_
31	lymphocytes	_	NNS	NNS	_	27	dobj	_	_
32	and	_	CC	CC	_	31	cc	_	_
33	macrophages	_	NNS	NNS	_	31	conj	_	_
34	.	_	.	.	_	6	punct	_	_

1	It	_	PRP	PRP	_	3	nsubjpass	_	_
2	was	_	VBD	VBD	_	3	auxpass	_	_
3	found	_	VBN	VBN	_	0	root	_	_
4	that	_	IN	IN	_	16	mark	_	_
5	the	_	DT	DT	_	6	det	_	_
6	propagation	_	NN	NN	_	16	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	Tat	_	NN	NN	_	10	nn	_	_
10	mutants	_	NNS	NNS	_	7	pobj	_	_
11	containing	_	VBG	VBG	_	10	vmod	_	_
12	wild-type	_	JJ	JJ	_	13	amod	_	_
13	LTRs	_	NNS	NNS	_	11	dobj	_	_
14	was	_	VBD	VBD	_	16	cop	_	_
15	less	_	RBR	RBR	_	16	advmod	_	_
16	efficient	_	JJ	JJ	_	3	ccomp	_	_
17	than	_	IN	IN	_	16	prep	_	_
18	that	_	DT	DT	_	17	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	23	det	_	_
21	LTR-modified	_	JJ	JJ	_	23	amod	_	_
22	Tat	_	NN	NN	_	23	nn	_	_
23	mutants	_	NNS	NNS	_	19	pobj	_	_
24	.	_	.	.	_	3	punct	_	_

1	Large	_	JJ	JJ	_	2	amod	_	_
2	amounts	_	NNS	NNS	_	9	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	viral	_	JJ	JJ	_	5	amod	_	_
5	RNA	_	NN	NN	_	3	pobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	particles	_	NNS	NNS	_	5	conj	_	_
8	were	_	VBD	VBD	_	9	auxpass	_	_
9	synthesized	_	VBN	VBN	_	0	root	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	infections	_	NNS	NNS	_	10	pobj	_	_
12	established	_	VBN	VBN	_	11	vmod	_	_
13	using	_	VBG	VBG	_	9	xcomp	_	_
14	the	_	DT	DT	_	16	det	_	_
15	tat	_	NN	NN	_	16	nn	_	_
16	mutants	_	NNS	NNS	_	13	dobj	_	_
17	that	_	WDT	WDT	_	18	nsubj	_	_
18	contain	_	VBP	VBP	_	16	rcmod	_	_
19	modified	_	VBN	VBN	_	20	amod	_	_
20	LTRs	_	NNS	NNS	_	18	dobj	_	_
21	.	_	.	.	_	9	punct	_	_

1	However	_	RB	RB	_	12	advmod	_	_
2	,	_	,	,	_	12	punct	_	_
3	this	_	DT	DT	_	5	det	_	_
4	efficient	_	JJ	JJ	_	5	amod	_	_
5	propagation	_	NN	NN	_	12	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	10	det	_	_
8	LTR-modified	_	JJ	JJ	_	10	amod	_	_
9	tat	_	NN	NN	_	10	nn	_	_
10	mutants	_	NNS	NNS	_	6	pobj	_	_
11	was	_	VBD	VBD	_	12	cop	_	_
12	restricted	_	JJ	JJ	_	0	root	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	some	_	DT	DT	_	17	det	_	_
15	lymphoid	_	JJ	JJ	_	17	amod	_	_
16	cell	_	NN	NN	_	17	nn	_	_
17	lines	_	NNS	NNS	_	13	pobj	_	_
18	that	_	WDT	WDT	_	21	nsubjpass	_	_
19	have	_	VBP	VBP	_	21	aux	_	_
20	been	_	VBN	VBN	_	21	auxpass	_	_
21	transformed	_	VBN	VBN	_	17	rcmod	_	_
22	with	_	IN	IN	_	21	prep	_	_
23	other	_	JJ	JJ	_	24	amod	_	_
24	viruses	_	NNS	NNS	_	22	pobj	_	_
25	.	_	.	.	_	12	punct	_	_

1	Thus	_	RB	RB	_	18	advmod	_	_
2	,	_	,	,	_	18	punct	_	_
3	despite	_	IN	IN	_	18	prep	_	_
4	its	_	PRP$	PRP$	_	6	poss	_	_
5	essential	_	JJ	JJ	_	6	amod	_	_
6	role	_	NN	NN	_	3	pobj	_	_
7	for	_	IN	IN	_	6	prep	_	_
8	releasing	_	VBG	VBG	_	7	pcomp	_	_
9	an	_	DT	DT	_	11	det	_	_
10	elongation	_	NN	NN	_	11	nn	_	_
11	block	_	NN	NN	_	8	dobj	_	_
12	,	_	,	,	_	18	punct	_	_
13	Tat	_	NN	NN	_	18	nsubjpass	_	_
14	is	_	VBZ	VBZ	_	18	auxpass	_	_
15	not	_	RB	RB	_	18	neg	_	_
16	otherwise	_	RB	RB	_	18	advmod	_	_
17	absolutely	_	RB	RB	_	18	advmod	_	_
18	required	_	VBN	VBN	_	0	root	_	_
19	for	_	IN	IN	_	18	prep	_	_
20	synthesis	_	NN	NN	_	19	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	full-length	_	JJ	JJ	_	24	amod	_	_
23	HIV	_	NN	NN	_	24	nn	_	_
24	transcripts	_	NNS	NNS	_	21	pobj	_	_
25	and	_	CC	CC	_	20	cc	_	_
26	assembly	_	NN	NN	_	20	conj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	virus	_	NN	NN	_	29	nn	_	_
29	particles	_	NNS	NNS	_	27	pobj	_	_
30	.	_	.	.	_	18	punct	_	_

1	Direct	_	JJ	JJ	_	2	amod	_	_
2	sequencing	_	NN	NN	_	10	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	viral	_	JJ	JJ	_	6	amod	_	_
6	genomes	_	NNS	NNS	_	3	pobj	_	_
7	and	_	CC	CC	_	2	cc	_	_
8	reinfection	_	NN	NN	_	9	nn	_	_
9	kinetics	_	NNS	NNS	_	2	conj	_	_
10	showed	_	VBD	VBD	_	0	root	_	_
11	no	_	DT	DT	_	12	neg	_	_
12	evidence	_	NN	NN	_	10	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	wild-type	_	JJ	JJ	_	15	amod	_	_
15	reversion	_	NN	NN	_	13	pobj	_	_
16	even	_	RB	RB	_	10	advmod	_	_
17	after	_	IN	IN	_	10	prep	_	_
18	prolonged	_	JJ	JJ	_	19	amod	_	_
19	infection	_	NN	NN	_	17	pobj	_	_
20	with	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	Tat-	_	JJ	JJ	_	23	amod	_	_
23	virus	_	NN	NN	_	20	pobj	_	_
24	.	_	.	.	_	10	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	implications	_	NNS	NNS	_	22	nsubjpass	_	_
3	for	_	IN	IN	_	2	prep	_	_
4	in	_	FW	FW	_	7	amod	_	_
5	vivo	_	FW	FW	_	4	dep	_	_
6	HIV-1	_	NN	NN	_	7	nn	_	_
7	replication	_	NN	NN	_	3	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	potential	_	JJ	JJ	_	10	amod	_	_
10	application	_	NN	NN	_	7	conj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	this	_	DT	DT	_	13	det	_	_
13	system	_	NN	NN	_	11	pobj	_	_
14	to	_	TO	TO	_	10	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	study	_	NN	NN	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	alternative	_	JJ	JJ	_	20	amod	_	_
19	Tat	_	NN	NN	_	20	nn	_	_
20	function	_	NN	NN	_	17	pobj	_	_
21	are	_	VBP	VBP	_	22	auxpass	_	_
22	discussed	_	VBN	VBN	_	0	root	_	_
23	.	_	.	.	_	22	punct	_	_

1	Restoration	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	9	det	_	_
4	Epstein-Barr	_	JJ	JJ	_	7	amod	_	_
5	virus	_	NN	NN	_	7	nn	_	_
6	ZEBRA	_	NN	NN	_	7	nn	_	_
7	protein	_	NN	NN	_	9	poss	_	_
8	's	_	POS	POS	_	9	possessive	_	_
9	capacity	_	NN	NN	_	2	pobj	_	_
10	to	_	TO	TO	_	11	aux	_	_
11	disrupt	_	VB	VB	_	9	vmod	_	_
12	latency	_	NN	NN	_	11	dobj	_	_
13	by	_	IN	IN	_	1	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	addition	_	NN	NN	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	heterologous	_	JJ	JJ	_	19	amod	_	_
18	activation	_	NN	NN	_	19	nn	_	_
19	regions	_	NNS	NNS	_	16	pobj	_	_
20	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	ZEBRA	_	NN	NN	_	3	nn	_	_
3	protein	_	NN	NN	_	4	nsubj	_	_
4	has	_	VBZ	VBZ	_	0	root	_	_
5	a	_	DT	DT	_	8	det	_	_
6	unique	_	JJ	JJ	_	8	amod	_	_
7	biological	_	JJ	JJ	_	8	amod	_	_
8	function	_	NN	NN	_	4	dobj	_	_
9	among	_	IN	IN	_	4	prep	_	_
10	herpesviral	_	JJ	JJ	_	11	amod	_	_
11	proteins	_	NNS	NNS	_	9	pobj	_	_
12	.	_	.	.	_	4	punct	_	_

1	It	_	PRP	PRP	_	3	nsubj	_	_
2	is	_	VBZ	VBZ	_	3	cop	_	_
3	responsible	_	JJ	JJ	_	0	root	_	_
4	for	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	6	det	_	_
6	disruption	_	NN	NN	_	4	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	Epstein-Barr	_	JJ	JJ	_	9	amod	_	_
9	virus	_	NN	NN	_	13	nn	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	EBV	_	NN	NN	_	9	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	latency	_	NN	NN	_	7	pobj	_	_
14	and	_	CC	CC	_	6	cc	_	_
15	the	_	DT	DT	_	16	det	_	_
16	induction	_	NN	NN	_	6	conj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	lytic	_	JJ	JJ	_	20	amod	_	_
20	cycle	_	NN	NN	_	17	pobj	_	_
21	.	_	.	.	_	3	punct	_	_

1	ZEBRA	_	NN	NN	_	6	nsubj	_	_
2	is	_	VBZ	VBZ	_	6	cop	_	_
3	a	_	DT	DT	_	6	det	_	_
4	bZIP	_	NN	NN	_	6	nn	_	_
5	transcriptional	_	JJ	JJ	_	6	amod	_	_
6	activator	_	NN	NN	_	0	root	_	_
7	which	_	WDT	WDT	_	8	nsubj	_	_
8	binds	_	VBZ	VBZ	_	6	rcmod	_	_
9	as	_	IN	IN	_	8	prep	_	_
10	a	_	DT	DT	_	11	det	_	_
11	dimer	_	NN	NN	_	9	pobj	_	_
12	to	_	TO	TO	_	8	prep	_	_
13	7-bp	_	JJ	JJ	_	15	amod	_	_
14	response	_	NN	NN	_	15	nn	_	_
15	elements	_	NNS	NNS	_	12	pobj	_	_
16	within	_	IN	IN	_	15	prep	_	_
17	EBV	_	NN	NN	_	18	nn	_	_
18	promoters	_	NNS	NNS	_	16	pobj	_	_
19	and	_	CC	CC	_	8	cc	_	_
20	is	_	VBZ	VBZ	_	22	auxpass	_	_
21	directly	_	RB	RB	_	22	advmod	_	_
22	involved	_	VBN	VBN	_	8	conj	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	25	det	_	_
25	stimulation	_	NN	NN	_	23	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	virus	_	NN	NN	_	28	nn	_	_
28	replication	_	NN	NN	_	26	pobj	_	_
29	at	_	IN	IN	_	25	prep	_	_
30	the	_	DT	DT	_	33	det	_	_
31	EBV	_	NN	NN	_	33	nn	_	_
32	lytic	_	JJ	JJ	_	33	amod	_	_
33	origin	_	NN	NN	_	29	pobj	_	_
34	.	_	.	.	_	6	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	employed	_	VBN	VBN	_	0	root	_	_
4	the	_	DT	DT	_	7	det	_	_
5	ZEBRA/EBV	_	NN	NN	_	7	nn	_	_
6	biological	_	JJ	JJ	_	7	amod	_	_
7	system	_	NN	NN	_	3	dobj	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	test	_	VB	VB	_	3	xcomp	_	_
10	whether	_	IN	IN	_	16	mark	_	_
11	a	_	DT	DT	_	14	det	_	_
12	heterologous	_	JJ	JJ	_	14	amod	_	_
13	activation	_	NN	NN	_	14	nn	_	_
14	domain	_	NN	NN	_	16	nsubj	_	_
15	can	_	MD	MD	_	16	aux	_	_
16	substitute	_	VB	VB	_	9	ccomp	_	_
17	for	_	IN	IN	_	16	prep	_	_
18	another	_	DT	DT	_	20	det	_	_
19	activation	_	NN	NN	_	20	nn	_	_
20	domain	_	NN	NN	_	17	pobj	_	_
21	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
22	the	_	DT	DT	_	24	det	_	_
23	ZEBRA	_	NN	NN	_	24	nn	_	_
24	domain	_	NN	NN	_	20	appos	_	_
25	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
26	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	ZEBRA	_	NN	NN	_	4	nn	_	_
3	activation	_	NN	NN	_	4	nn	_	_
4	region	_	NN	NN	_	6	nsubjpass	_	_
5	was	_	VBD	VBD	_	6	auxpass	_	_
6	replaced	_	VBN	VBN	_	0	root	_	_
7	with	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	12	det	_	_
9	potent	_	JJ	JJ	_	12	amod	_	_
10	acid	_	NN	NN	_	12	nn	_	_
11	activation	_	NN	NN	_	12	nn	_	_
12	region	_	NN	NN	_	7	pobj	_	_
13	from	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	19	det	_	_
15	herpes	_	NN	NN	_	19	nn	_	_
16	simplex	_	JJ	JJ	_	19	amod	_	_
17	virus	_	NN	NN	_	19	nn	_	_
18	VP16	_	NN	NN	_	19	nn	_	_
19	protein	_	NN	NN	_	13	pobj	_	_
20	or	_	CC	CC	_	7	cc	_	_
21	with	_	IN	IN	_	7	conj	_	_
22	the	_	DT	DT	_	24	det	_	_
23	activation	_	NN	NN	_	24	nn	_	_
24	region	_	NN	NN	_	21	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	29	det	_	_
27	EBV	_	NN	NN	_	29	nn	_	_
28	R	_	NN	NN	_	29	nn	_	_
29	protein	_	NN	NN	_	25	pobj	_	_
30	.	_	.	.	_	6	punct	_	_

1	Both	_	DT	DT	_	2	det	_	_
2	chimeras	_	NNS	NNS	_	4	nsubjpass	_	_
3	were	_	VBD	VBD	_	4	auxpass	_	_
4	found	_	VBN	VBN	_	0	root	_	_
5	to	_	TO	TO	_	6	aux	_	_
6	transactivate	_	VB	VB	_	4	xcomp	_	_
7	model	_	NN	NN	_	6	dobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	native	_	JJ	JJ	_	7	conj	_	_
10	promoters	_	NNS	NNS	_	7	dep	_	_
11	at	_	IN	IN	_	6	prep	_	_
12	equivalent	_	JJ	JJ	_	11	pobj	_	_
13	or	_	CC	CC	_	12	cc	_	_
14	better	_	JJR	JJR	_	12	conj	_	_
15	levels	_	NNS	NNS	_	12	dep	_	_
16	than	_	IN	IN	_	4	prep	_	_
17	ZEBRA	_	NN	NN	_	16	pobj	_	_
18	itself	_	PRP	PRP	_	17	npadvmod	_	_
19	.	_	.	.	_	4	punct	_	_

1	Activation	_	NN	NN	_	4	nsubj	_	_
2	was	_	VBD	VBD	_	4	cop	_	_
3	not	_	RB	RB	_	4	neg	_	_
4	target-	_	NN	NN	_	0	root	_	_
5	or	_	CC	CC	_	4	cc	_	_
6	cell-type	_	NN	NN	_	4	conj	_	_
7	dependent	_	JJ	JJ	_	4	dep	_	_
8	,	_	,	,	_	4	punct	_	_
9	nor	_	CC	CC	_	4	cc	_	_
10	was	_	VBD	VBD	_	12	cop	_	_
11	it	_	PRP	PRP	_	12	nsubj	_	_
12	dependent	_	JJ	JJ	_	4	conj	_	_
13	on	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	presence	_	NN	NN	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	virus	_	NN	NN	_	16	pobj	_	_
18	.	_	.	.	_	4	punct	_	_

1	These	_	DT	DT	_	3	det	_	_
2	activation	_	NN	NN	_	3	nn	_	_
3	domains	_	NNS	NNS	_	4	nsubj	_	_
4	restored	_	VBD	VBD	_	0	root	_	_
5	ZEBRA	_	NN	NN	_	7	poss	_	_
6	's	_	POS	POS	_	7	possessive	_	_
7	ability	_	NN	NN	_	4	dobj	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	induce	_	VB	VB	_	7	dep	_	_
10	early	_	JJ	JJ	_	11	amod	_	_
11	antigen	_	NN	NN	_	9	dobj	_	_
12	and	_	CC	CC	_	9	cc	_	_
13	to	_	TO	TO	_	14	aux	_	_
14	stimulate	_	VB	VB	_	9	conj	_	_
15	origin	_	NN	NN	_	16	nn	_	_
16	replication	_	NN	NN	_	14	dobj	_	_
17	to	_	TO	TO	_	14	prep	_	_
18	levels	_	NNS	NNS	_	17	pobj	_	_
19	that	_	WDT	WDT	_	21	nsubj	_	_
20	were	_	VBD	VBD	_	21	cop	_	_
21	equal	_	JJ	JJ	_	18	rcmod	_	_
22	to	_	TO	TO	_	21	prep	_	_
23	or	_	CC	CC	_	21	cc	_	_
24	greater	_	JJR	JJR	_	21	conj	_	_
25	than	_	IN	IN	_	24	prep	_	_
26	those	_	DT	DT	_	21	dep	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	wild	_	JJ	JJ	_	29	amod	_	_
29	type	_	NN	NN	_	27	pobj	_	_
30	.	_	.	.	_	4	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	studies	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	18	mark	_	_
5	the	_	DT	DT	_	6	det	_	_
6	specificities	_	NNS	NNS	_	18	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	some	_	DT	DT	_	7	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	13	det	_	_
11	known	_	JJ	JJ	_	13	amod	_	_
12	biological	_	JJ	JJ	_	13	amod	_	_
13	functions	_	NNS	NNS	_	9	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	ZEBRA	_	NN	NN	_	14	pobj	_	_
16	are	_	VBP	VBP	_	18	cop	_	_
17	not	_	RB	RB	_	18	neg	_	_
18	dependent	_	JJ	JJ	_	3	ccomp	_	_
19	upon	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	21	det	_	_
21	nature	_	NN	NN	_	19	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	25	det	_	_
24	activation	_	NN	NN	_	25	nn	_	_
25	domain	_	NN	NN	_	22	pobj	_	_
26	present	_	JJ	JJ	_	25	amod	_	_
27	within	_	IN	IN	_	26	prep	_	_
28	ZEBRA	_	NN	NN	_	27	pobj	_	_
29	.	_	.	.	_	3	punct	_	_

1	Activation	_	NN	NN	_	0	root	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	expression	_	NN	NN	_	1	conj	_	_
4	of	_	IN	IN	_	1	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	nuclear	_	JJ	JJ	_	7	amod	_	_
7	factors	_	NNS	NNS	_	4	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	activated	_	VBN	VBN	_	11	amod	_	_
10	T	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	8	pobj	_	_
12	,	_	,	,	_	7	punct	_	_
13	NFATp	_	NN	NN	_	7	appos	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	NFATc	_	NN	NN	_	13	conj	_	_
16	,	_	,	,	_	1	punct	_	_
17	in	_	IN	IN	_	1	prep	_	_
18	human	_	JJ	JJ	_	21	amod	_	_
19	natural	_	JJ	JJ	_	21	amod	_	_
20	killer	_	NN	NN	_	21	nn	_	_
21	cells	_	NNS	NNS	_	17	pobj	_	_
22	:	_	:	:	_	1	punct	_	_
23	regulation	_	NN	NN	_	1	dep	_	_
24	upon	_	IN	IN	_	23	prep	_	_
25	CD16	_	NN	NN	_	27	nn	_	_
26	ligand	_	NN	NN	_	27	nn	_	_
27	binding	_	NN	NN	_	24	pobj	_	_
28	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	putative	_	JJ	JJ	_	3	amod	_	_
3	factors	_	NNS	NNS	_	28	nsubjpass	_	_
4	that	_	WDT	WDT	_	5	nsubj	_	_
5	couple	_	VBP	VBP	_	3	rcmod	_	_
6	the	_	DT	DT	_	8	det	_	_
7	signal	_	NN	NN	_	8	nn	_	_
8	transduction	_	NN	NN	_	5	dobj	_	_
9	from	_	IN	IN	_	8	prep	_	_
10	surface	_	NN	NN	_	11	nn	_	_
11	receptors	_	NNS	NNS	_	9	pobj	_	_
12	to	_	TO	TO	_	8	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	activation	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	cytokine	_	NN	NN	_	17	nn	_	_
17	synthesis	_	NN	NN	_	15	pobj	_	_
18	in	_	IN	IN	_	5	prep	_	_
19	natural	_	JJ	JJ	_	24	amod	_	_
20	killer	_	NN	NN	_	24	nn	_	_
21	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
22	NK	_	NN	NN	_	24	nn	_	_
23	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
24	cells	_	NNS	NNS	_	18	pobj	_	_
25	have	_	VBP	VBP	_	28	aux	_	_
26	not	_	RB	RB	_	28	neg	_	_
27	been	_	VBN	VBN	_	28	auxpass	_	_
28	elucidated	_	VBN	VBN	_	0	root	_	_
29	.	_	.	.	_	28	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	report	_	VBP	VBP	_	0	root	_	_
3	here	_	RB	RB	_	2	advmod	_	_
4	that	_	IN	IN	_	32	mark	_	_
5	the	_	DT	DT	_	7	det	_	_
6	nuclear	_	JJ	JJ	_	7	amod	_	_
7	factor	_	NN	NN	_	32	nsubj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	activated	_	VBN	VBN	_	11	amod	_	_
10	T	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	8	pobj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	NFATp	_	NN	NN	_	7	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	,	_	,	,	_	7	punct	_	_
16	a	_	DT	DT	_	23	det	_	_
17	cyclosporin	_	NN	NN	_	23	nn	_	_
18	A	_	NN	NN	_	23	nn	_	_
19	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
20	CsA	_	NN	NN	_	23	nn	_	_
21	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
22	-sensitive	_	JJ	JJ	_	23	amod	_	_
23	factor	_	NN	NN	_	7	appos	_	_
24	that	_	WDT	WDT	_	25	nsubj	_	_
25	regulates	_	VBZ	VBZ	_	23	rcmod	_	_
26	the	_	DT	DT	_	27	det	_	_
27	transcription	_	NN	NN	_	25	dobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	several	_	JJ	JJ	_	30	amod	_	_
30	cytokines	_	NNS	NNS	_	28	pobj	_	_
31	,	_	,	,	_	7	punct	_	_
32	mediates	_	VBZ	VBZ	_	2	ccomp	_	_
33	CD16-induced	_	JJ	JJ	_	34	amod	_	_
34	activation	_	NN	NN	_	32	dobj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	cytokine	_	NN	NN	_	37	nn	_	_
37	genes	_	NNS	NNS	_	35	pobj	_	_
38	in	_	IN	IN	_	34	prep	_	_
39	human	_	JJ	JJ	_	41	amod	_	_
40	NK	_	NN	NN	_	41	nn	_	_
41	cells	_	NNS	NNS	_	38	pobj	_	_
42	.	_	.	.	_	2	punct	_	_

1	CD16	_	NN	NN	_	8	nn	_	_
2	-LRB-	_	-LRB-	-LRB-	_	5	punct	_	_
3	Fc	_	NN	NN	_	5	nn	_	_
4	gamma	_	NN	NN	_	5	nn	_	_
5	RIIIA	_	NN	NN	_	1	appos	_	_
6	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
7	-induced	_	JJ	JJ	_	8	amod	_	_
8	expression	_	NN	NN	_	15	nsubj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	cytokine	_	NN	NN	_	11	nn	_	_
11	mRNA	_	NN	NN	_	9	pobj	_	_
12	in	_	IN	IN	_	8	prep	_	_
13	NK	_	NN	NN	_	14	nn	_	_
14	cells	_	NNS	NNS	_	12	pobj	_	_
15	occurs	_	VBZ	VBZ	_	0	root	_	_
16	via	_	IN	IN	_	15	prep	_	_
17	a	_	DT	DT	_	21	det	_	_
18	CsA-sensitive	_	JJ	JJ	_	21	amod	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	Ca-LRB-2+-RRB--dependent	_	JJ	JJ	_	18	conj	_	_
21	mechanism	_	NN	NN	_	16	pobj	_	_
22	.	_	.	.	_	15	punct	_	_

1	Stimulation	_	NN	NN	_	8	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	NK	_	NN	NN	_	4	nn	_	_
4	cells	_	NNS	NNS	_	2	pobj	_	_
5	with	_	IN	IN	_	1	prep	_	_
6	CD16	_	NN	NN	_	7	nn	_	_
7	ligands	_	NNS	NNS	_	5	pobj	_	_
8	induces	_	VBZ	VBZ	_	0	root	_	_
9	NFAT-like	_	JJ	JJ	_	12	amod	_	_
10	DNA	_	NN	NN	_	12	nn	_	_
11	binding	_	NN	NN	_	12	nn	_	_
12	activity	_	NN	NN	_	8	dobj	_	_
13	in	_	IN	IN	_	8	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	nuclear	_	JJ	JJ	_	16	amod	_	_
16	extracts	_	NNS	NNS	_	13	pobj	_	_
17	from	_	IN	IN	_	16	prep	_	_
18	these	_	DT	DT	_	19	det	_	_
19	cells	_	NNS	NNS	_	17	pobj	_	_
20	,	_	,	,	_	8	punct	_	_
21	as	_	IN	IN	_	22	mark	_	_
22	detected	_	VBN	VBN	_	8	advcl	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	electrophoretic	_	JJ	JJ	_	27	amod	_	_
25	mobility	_	NN	NN	_	27	nn	_	_
26	shift	_	NN	NN	_	27	nn	_	_
27	assays	_	NNS	NNS	_	23	pobj	_	_
28	.	_	.	.	_	8	punct	_	_

1	This	_	DT	DT	_	2	nsubj	_	_
2	occurs	_	VBZ	VBZ	_	0	root	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	fast	_	JJ	JJ	_	5	amod	_	_
5	kinetics	_	NNS	NNS	_	3	pobj	_	_
6	after	_	IN	IN	_	2	prep	_	_
7	stimulation	_	NN	NN	_	6	pobj	_	_
8	,	_	,	,	_	2	punct	_	_
9	via	_	IN	IN	_	2	prep	_	_
10	a	_	DT	DT	_	14	det	_	_
11	CsA-sensitive	_	JJ	JJ	_	14	amod	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	Ca-LRB-2+-RRB--dependent	_	JJ	JJ	_	11	conj	_	_
14	mechanism	_	NN	NN	_	9	pobj	_	_
15	that	_	WDT	WDT	_	18	nsubj	_	_
16	does	_	VBZ	VBZ	_	18	aux	_	_
17	not	_	RB	RB	_	18	neg	_	_
18	require	_	VB	VB	_	14	rcmod	_	_
19	de	_	FW	FW	_	22	amod	_	_
20	novo	_	FW	FW	_	19	dep	_	_
21	protein	_	NN	NN	_	22	nn	_	_
22	synthesis	_	NN	NN	_	18	dobj	_	_
23	.	_	.	.	_	2	punct	_	_

1	NK	_	NN	NN	_	3	nn	_	_
2	cell	_	NN	NN	_	3	nn	_	_
3	NFAT	_	NN	NN	_	5	nsubj	_	_
4	is	_	VBZ	VBZ	_	5	cop	_	_
5	present	_	JJ	JJ	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	cytosol	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	nonstimulated	_	JJ	JJ	_	11	amod	_	_
11	cells	_	NNS	NNS	_	9	pobj	_	_
12	,	_	,	,	_	5	punct	_	_
13	migrates	_	VBZ	VBZ	_	5	conj	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	nucleus	_	NN	NN	_	14	pobj	_	_
17	upon	_	IN	IN	_	13	prep	_	_
18	stimulation	_	NN	NN	_	17	pobj	_	_
19	,	_	,	,	_	5	punct	_	_
20	and	_	CC	CC	_	5	cc	_	_
21	can	_	MD	MD	_	22	aux	_	_
22	associate	_	VB	VB	_	5	conj	_	_
23	with	_	IN	IN	_	22	prep	_	_
24	AP-1	_	NN	NN	_	23	pobj	_	_
25	.	_	.	.	_	5	punct	_	_

1	Two	_	CD	CD	_	3	num	_	_
2	distinct	_	JJ	JJ	_	3	amod	_	_
3	molecules	_	NNS	NNS	_	11	nsubjpass	_	_
4	,	_	,	,	_	3	punct	_	_
5	NFATp	_	NN	NN	_	3	appos	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	NFATc	_	NN	NN	_	5	conj	_	_
8	,	_	,	,	_	3	punct	_	_
9	have	_	VBP	VBP	_	11	aux	_	_
10	been	_	VBN	VBN	_	11	auxpass	_	_
11	reported	_	VBN	VBN	_	0	root	_	_
12	to	_	TO	TO	_	13	aux	_	_
13	mediate	_	VB	VB	_	11	xcomp	_	_
14	NFAT	_	NN	NN	_	15	nn	_	_
15	activity	_	NN	NN	_	13	dobj	_	_
16	.	_	.	.	_	11	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	11	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	supershift	_	NN	NN	_	5	nn	_	_
5	assays	_	NNS	NNS	_	3	pobj	_	_
6	using	_	VBG	VBG	_	5	vmod	_	_
7	NFATp-	_	NN	NN	_	6	dobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	NFATc-specific	_	JJ	JJ	_	7	conj	_	_
10	antibodies	_	NNS	NNS	_	7	dep	_	_
11	indicate	_	VBP	VBP	_	0	root	_	_
12	that	_	IN	IN	_	21	mark	_	_
13	NK	_	NN	NN	_	15	nn	_	_
14	cell	_	NN	NN	_	15	nn	_	_
15	activation	_	NN	NN	_	21	nsubj	_	_
16	early	_	RB	RB	_	15	advmod	_	_
17	after	_	IN	IN	_	15	prep	_	_
18	CD16	_	NN	NN	_	20	nn	_	_
19	ligand	_	NN	NN	_	20	nn	_	_
20	binding	_	NN	NN	_	17	pobj	_	_
21	involves	_	VBZ	VBZ	_	11	ccomp	_	_
22	primarily	_	RB	RB	_	21	advmod	_	_
23	,	_	,	,	_	22	punct	_	_
24	if	_	IN	IN	_	25	dep	_	_
25	not	_	RB	RB	_	22	cc	_	_
26	exclusively	_	RB	RB	_	22	conj	_	_
27	,	_	,	,	_	21	punct	_	_
28	NFATp	_	NN	NN	_	21	dobj	_	_
29	,	_	,	,	_	11	punct	_	_
30	and	_	CC	CC	_	11	cc	_	_
31	Western	_	NN	NN	_	33	nn	_	_
32	blot	_	NN	NN	_	33	nn	_	_
33	analysis	_	NN	NN	_	34	nsubj	_	_
34	shows	_	VBZ	VBZ	_	11	conj	_	_
35	that	_	IN	IN	_	37	mark	_	_
36	this	_	DT	DT	_	37	nsubj	_	_
37	has	_	VBZ	VBZ	_	34	ccomp	_	_
38	the	_	DT	DT	_	41	det	_	_
39	same	_	JJ	JJ	_	41	amod	_	_
40	electrophoretic	_	JJ	JJ	_	41	amod	_	_
41	mobility	_	NN	NN	_	37	dobj	_	_
42	-LRB-	_	-LRB-	-LRB-	_	45	punct	_	_
43	approximately	_	RB	RB	_	44	quantmod	_	_
44	120	_	CD	CD	_	45	num	_	_
45	kD	_	NN	NN	_	41	appos	_	_
46	-RRB-	_	-RRB-	-RRB-	_	45	punct	_	_
47	as	_	IN	IN	_	41	prep	_	_
48	that	_	DT	DT	_	47	pobj	_	_
49	of	_	IN	IN	_	48	prep	_	_
50	T	_	NN	NN	_	51	nn	_	_
51	lymphocytes	_	NNS	NNS	_	49	pobj	_	_
52	.	_	.	.	_	11	punct	_	_

1	NK	_	NN	NN	_	2	nn	_	_
2	cells	_	NNS	NNS	_	5	nsubj	_	_
3	do	_	VBP	VBP	_	5	aux	_	_
4	not	_	RB	RB	_	5	neg	_	_
5	express	_	VB	VB	_	0	root	_	_
6	NFATc	_	NN	NN	_	5	dobj	_	_
7	constitutively	_	RB	RB	_	5	advmod	_	_
8	,	_	,	,	_	5	punct	_	_
9	but	_	CC	CC	_	5	cc	_	_
10	NFATc	_	NN	NN	_	11	nn	_	_
11	mRNA	_	NN	NN	_	12	nn	_	_
12	accumulation	_	NN	NN	_	14	nsubjpass	_	_
13	is	_	VBZ	VBZ	_	14	auxpass	_	_
14	induced	_	VBN	VBN	_	5	conj	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	these	_	DT	DT	_	17	det	_	_
17	cells	_	NNS	NNS	_	15	pobj	_	_
18	within	_	IN	IN	_	14	prep	_	_
19	2	_	CD	CD	_	20	num	_	_
20	h	_	NN	NN	_	18	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	stimulation	_	NN	NN	_	21	pobj	_	_
23	with	_	IN	IN	_	22	prep	_	_
24	CD16	_	NN	NN	_	25	nn	_	_
25	ligands	_	NNS	NNS	_	23	pobj	_	_
26	.	_	.	.	_	5	punct	_	_

1	However	_	RB	RB	_	14	advmod	_	_
2	,	_	,	,	_	14	punct	_	_
3	supershift	_	NN	NN	_	4	nn	_	_
4	assays	_	NNS	NNS	_	14	nsubj	_	_
5	using	_	VBG	VBG	_	4	vmod	_	_
6	the	_	DT	DT	_	8	det	_	_
7	available	_	JJ	JJ	_	8	amod	_	_
8	mAb	_	NN	NN	_	5	dobj	_	_
9	recognizing	_	VBG	VBG	_	8	vmod	_	_
10	the	_	DT	DT	_	13	det	_	_
11	T	_	NN	NN	_	13	nn	_	_
12	cell	_	NN	NN	_	13	nn	_	_
13	NFATc	_	NN	NN	_	9	dobj	_	_
14	revealed	_	VBD	VBD	_	0	root	_	_
15	no	_	DT	DT	_	18	neg	_	_
16	detectable	_	JJ	JJ	_	18	amod	_	_
17	NFATc	_	NN	NN	_	18	nn	_	_
18	protein	_	NN	NN	_	14	dobj	_	_
19	in	_	IN	IN	_	14	prep	_	_
20	nuclear	_	JJ	JJ	_	19	pobj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	cytoplasmic	_	JJ	JJ	_	20	conj	_	_
23	extracts	_	NNS	NNS	_	20	dep	_	_
24	from	_	IN	IN	_	20	prep	_	_
25	CD16-	_	NN	NN	_	24	pobj	_	_
26	or	_	CC	CC	_	25	cc	_	_
27	phorbol	_	NN	NN	_	29	nn	_	_
28	ester-stimulated	_	JJ	JJ	_	29	amod	_	_
29	cells	_	NNS	NNS	_	25	conj	_	_
30	at	_	IN	IN	_	14	prep	_	_
31	any	_	DT	DT	_	32	det	_	_
32	time	_	NN	NN	_	30	pobj	_	_
33	tested	_	VBN	VBN	_	32	vmod	_	_
34	,	_	,	,	_	32	punct	_	_
35	up	_	RB	RB	_	37	quantmod	_	_
36	to	_	TO	TO	_	37	dep	_	_
37	4	_	CD	CD	_	38	num	_	_
38	h	_	NN	NN	_	32	appos	_	_
39	.	_	.	.	_	14	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	provide	_	VBP	VBP	_	0	root	_	_
4	the	_	DT	DT	_	7	det	_	_
5	first	_	JJ	JJ	_	7	amod	_	_
6	direct	_	JJ	JJ	_	7	amod	_	_
7	evidence	_	NN	NN	_	3	dobj	_	_
8	that	_	IN	IN	_	19	mark	_	_
9	both	_	DT	DT	_	12	dep	_	_
10	CsA-sensitive	_	JJ	JJ	_	12	amod	_	_
11	transcription	_	NN	NN	_	12	nn	_	_
12	factors	_	NNS	NNS	_	19	nsubjpass	_	_
13	,	_	,	,	_	12	punct	_	_
14	NFATp	_	NN	NN	_	12	appos	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	NFATc	_	NN	NN	_	14	conj	_	_
17	,	_	,	,	_	12	punct	_	_
18	are	_	VBP	VBP	_	19	auxpass	_	_
19	expressed	_	VBN	VBN	_	7	ccomp	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	human	_	JJ	JJ	_	23	amod	_	_
22	NK	_	NN	NN	_	23	nn	_	_
23	cells	_	NNS	NNS	_	20	pobj	_	_
24	,	_	,	,	_	19	punct	_	_
25	and	_	CC	CC	_	19	cc	_	_
26	that	_	IN	IN	_	33	mark	_	_
27	their	_	PRP$	PRP$	_	28	poss	_	_
28	activation	_	NN	NN	_	33	nsubjpass	_	_
29	and/or	_	CC	CC	_	28	cc	_	_
30	expression	_	NN	NN	_	28	conj	_	_
31	can	_	MD	MD	_	33	aux	_	_
32	be	_	VB	VB	_	33	auxpass	_	_
33	regulated	_	VBN	VBN	_	19	conj	_	_
34	in	_	IN	IN	_	33	prep	_	_
35	primary	_	JJ	JJ	_	36	amod	_	_
36	cells	_	NNS	NNS	_	34	pobj	_	_
37	by	_	IN	IN	_	33	prep	_	_
38	a	_	DT	DT	_	40	det	_	_
39	single	_	JJ	JJ	_	40	amod	_	_
40	stimulus	_	NN	NN	_	37	pobj	_	_
41	,	_	,	,	_	40	punct	_	_
42	that	_	WDT	WDT	_	53	nsubj	_	_
43	,	_	,	,	_	53	punct	_	_
44	in	_	IN	IN	_	53	prep	_	_
45	the	_	DT	DT	_	46	det	_	_
46	case	_	NN	NN	_	44	pobj	_	_
47	of	_	IN	IN	_	46	prep	_	_
48	CD16	_	NN	NN	_	47	pobj	_	_
49	in	_	IN	IN	_	48	prep	_	_
50	NK	_	NN	NN	_	51	nn	_	_
51	cells	_	NNS	NNS	_	49	pobj	_	_
52	,	_	,	,	_	53	punct	_	_
53	results	_	VBZ	VBZ	_	40	rcmod	_	_
54	in	_	IN	IN	_	53	prep	_	_
55	early	_	JJ	JJ	_	56	amod	_	_
56	activation	_	NN	NN	_	54	pobj	_	_
57	of	_	IN	IN	_	56	prep	_	_
58	NFATp	_	NN	NN	_	57	pobj	_	_
59	and	_	CC	CC	_	56	cc	_	_
60	subsequently	_	RB	RB	_	61	advmod	_	_
61	induced	_	VBN	VBN	_	62	amod	_	_
62	expression	_	NN	NN	_	56	conj	_	_
63	of	_	IN	IN	_	62	prep	_	_
64	NFATc	_	NN	NN	_	65	nn	_	_
65	mRNA	_	NN	NN	_	63	pobj	_	_
66	.	_	.	.	_	3	punct	_	_

1	Activation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	HIV-1	_	NN	NN	_	5	nn	_	_
5	enhancer	_	NN	NN	_	2	pobj	_	_
6	by	_	IN	IN	_	1	prep	_	_
7	the	_	DT	DT	_	10	det	_	_
8	LEF-1	_	NN	NN	_	10	nn	_	_
9	HMG	_	NN	NN	_	10	nn	_	_
10	protein	_	NN	NN	_	6	pobj	_	_
11	on	_	IN	IN	_	10	prep	_	_
12	nucleosome-assembled	_	JJ	JJ	_	13	amod	_	_
13	DNA	_	NN	NN	_	11	pobj	_	_
14	in	_	FW	FW	_	15	nn	_	_
15	vitro	_	FW	FW	_	13	advmod	_	_
16	.	_	.	.	_	1	punct	_	_

1	Lymphoid	_	NN	NN	_	3	nn	_	_
2	enhancer-binding	_	JJ	JJ	_	3	amod	_	_
3	factor	_	NN	NN	_	17	nsubj	_	_
4	1	_	CD	CD	_	3	num	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	LEF-1	_	NN	NN	_	3	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	is	_	VBZ	VBZ	_	17	cop	_	_
9	a	_	DT	DT	_	17	det	_	_
10	regulatory	_	JJ	JJ	_	17	amod	_	_
11	high	_	JJ	JJ	_	17	amod	_	_
12	mobility	_	NN	NN	_	17	nn	_	_
13	group	_	NN	NN	_	17	nn	_	_
14	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
15	HMG	_	NN	NN	_	17	nn	_	_
16	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
17	protein	_	NN	NN	_	0	root	_	_
18	that	_	WDT	WDT	_	19	nsubj	_	_
19	activates	_	VBZ	VBZ	_	17	rcmod	_	_
20	the	_	DT	DT	_	29	det	_	_
21	T	_	NN	NN	_	29	nn	_	_
22	cell	_	NN	NN	_	29	nn	_	_
23	receptor	_	NN	NN	_	29	nn	_	_
24	alpha	_	NN	NN	_	29	nn	_	_
25	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
26	TCR	_	NN	NN	_	29	nn	_	_
27	alpha	_	NN	NN	_	29	nn	_	_
28	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
29	enhancer	_	NN	NN	_	19	dobj	_	_
30	in	_	IN	IN	_	19	prep	_	_
31	a	_	DT	DT	_	33	det	_	_
32	context-restricted	_	JJ	JJ	_	33	amod	_	_
33	manner	_	NN	NN	_	30	pobj	_	_
34	in	_	IN	IN	_	19	prep	_	_
35	T	_	NN	NN	_	36	nn	_	_
36	cells	_	NNS	NNS	_	34	pobj	_	_
37	.	_	.	.	_	17	punct	_	_

1	In	_	IN	IN	_	5	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	paper	_	NN	NN	_	1	pobj	_	_
4	we	_	PRP	PRP	_	5	nsubj	_	_
5	demonstrate	_	VBP	VBP	_	0	root	_	_
6	that	_	IN	IN	_	30	mark	_	_
7	the	_	DT	DT	_	9	det	_	_
8	distal	_	JJ	JJ	_	9	amod	_	_
9	region	_	NN	NN	_	30	nsubj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	18	det	_	_
12	human	_	JJ	JJ	_	18	amod	_	_
13	immunodeficiency	_	NN	NN	_	18	nn	_	_
14	virus-1	_	NN	NN	_	18	nn	_	_
15	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
16	HIV-1	_	NN	NN	_	18	nn	_	_
17	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
18	enhancer	_	NN	NN	_	10	pobj	_	_
19	,	_	,	,	_	9	punct	_	_
20	which	_	WDT	WDT	_	21	nsubj	_	_
21	contains	_	VBZ	VBZ	_	9	rcmod	_	_
22	DNA-binding	_	JJ	JJ	_	23	amod	_	_
23	sites	_	NNS	NNS	_	21	dobj	_	_
24	for	_	IN	IN	_	23	prep	_	_
25	LEF-1	_	NN	NN	_	24	pobj	_	_
26	and	_	CC	CC	_	25	cc	_	_
27	Ets-1	_	NN	NN	_	25	conj	_	_
28	,	_	,	,	_	9	punct	_	_
29	also	_	RB	RB	_	30	advmod	_	_
30	provides	_	VBZ	VBZ	_	5	ccomp	_	_
31	a	_	DT	DT	_	33	det	_	_
32	functional	_	JJ	JJ	_	33	amod	_	_
33	context	_	NN	NN	_	30	dobj	_	_
34	for	_	IN	IN	_	33	prep	_	_
35	activation	_	NN	NN	_	34	pobj	_	_
36	by	_	IN	IN	_	35	prep	_	_
37	LEF-1	_	NN	NN	_	36	pobj	_	_
38	.	_	.	.	_	5	punct	_	_

1	First	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	show	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	11	mark	_	_
6	mutations	_	NNS	NNS	_	11	nsubj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	LEF-1-binding	_	JJ	JJ	_	10	amod	_	_
10	site	_	NN	NN	_	7	pobj	_	_
11	inhibit	_	VBP	VBP	_	4	ccomp	_	_
12	the	_	DT	DT	_	13	det	_	_
13	activity	_	NN	NN	_	11	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	multimerized	_	JJ	JJ	_	16	amod	_	_
16	copies	_	NNS	NNS	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	HIV-1	_	NN	NN	_	20	nn	_	_
20	enhancer	_	NN	NN	_	17	pobj	_	_
21	in	_	IN	IN	_	11	prep	_	_
22	Jurkat	_	NN	NN	_	24	nn	_	_
23	T	_	NN	NN	_	24	nn	_	_
24	cells	_	NNS	NNS	_	21	pobj	_	_
25	,	_	,	,	_	11	punct	_	_
26	and	_	CC	CC	_	11	cc	_	_
27	that	_	IN	IN	_	30	mark	_	_
28	LEF-1/GAL4	_	NN	NN	_	30	nsubj	_	_
29	can	_	MD	MD	_	30	aux	_	_
30	activate	_	VB	VB	_	11	conj	_	_
31	a	_	DT	DT	_	34	det	_	_
32	GAL4-substituted	_	JJ	JJ	_	34	amod	_	_
33	HIV-1	_	NN	NN	_	34	nn	_	_
34	enhancer	_	NN	NN	_	30	iobj	_	_
35	80-	_	CD	CD	_	30	dobj	_	_
36	to	_	TO	TO	_	35	prep	_	_
37	100-fold	_	RB	RB	_	36	pobj	_	_
38	in	_	FW	FW	_	39	nn	_	_
39	vivo	_	FW	FW	_	30	advmod	_	_
40	.	_	.	.	_	4	punct	_	_

1	Second	_	RB	RB	_	6	advmod	_	_
2	,	_	,	,	_	6	punct	_	_
3	recombinant	_	JJ	JJ	_	4	amod	_	_
4	LEF-1	_	NN	NN	_	6	nsubjpass	_	_
5	is	_	VBZ	VBZ	_	6	auxpass	_	_
6	shown	_	VBN	VBN	_	0	root	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	activate	_	VB	VB	_	6	xcomp	_	_
9	HIV-1	_	NN	NN	_	10	nn	_	_
10	transcription	_	NN	NN	_	8	dobj	_	_
11	on	_	IN	IN	_	10	prep	_	_
12	chromatin-assembled	_	JJ	JJ	_	13	amod	_	_
13	DNA	_	NN	NN	_	11	pobj	_	_
14	in	_	FW	FW	_	15	nn	_	_
15	vitro	_	FW	FW	_	8	advmod	_	_
16	.	_	.	.	_	6	punct	_	_

1	By	_	IN	IN	_	12	prep	_	_
2	using	_	VBG	VBG	_	1	pcomp	_	_
3	a	_	DT	DT	_	5	det	_	_
4	nucleosome-assembly	_	JJ	JJ	_	5	amod	_	_
5	system	_	NN	NN	_	2	dobj	_	_
6	derived	_	VBN	VBN	_	5	vmod	_	_
7	from	_	IN	IN	_	6	prep	_	_
8	Drosophila	_	FW	FW	_	9	nn	_	_
9	embryos	_	NNS	NNS	_	7	pobj	_	_
10	,	_	,	,	_	12	punct	_	_
11	we	_	PRP	PRP	_	12	nsubj	_	_
12	find	_	VBP	VBP	_	0	root	_	_
13	that	_	IN	IN	_	23	mark	_	_
14	the	_	DT	DT	_	15	det	_	_
15	packaging	_	NN	NN	_	23	nsubj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	DNA	_	NN	NN	_	16	pobj	_	_
18	into	_	IN	IN	_	15	prep	_	_
19	chromatin	_	NN	NN	_	18	pobj	_	_
20	in	_	FW	FW	_	21	nn	_	_
21	vitro	_	FW	FW	_	15	advmod	_	_
22	strongly	_	RB	RB	_	23	advmod	_	_
23	represses	_	VBZ	VBZ	_	12	ccomp	_	_
24	HIV-1	_	NN	NN	_	25	nn	_	_
25	transcription	_	NN	NN	_	23	dobj	_	_
26	and	_	CC	CC	_	23	cc	_	_
27	that	_	IN	IN	_	31	mark	_	_
28	repression	_	NN	NN	_	31	nsubjpass	_	_
29	can	_	MD	MD	_	31	aux	_	_
30	be	_	VB	VB	_	31	auxpass	_	_
31	counteracted	_	VBN	VBN	_	23	conj	_	_
32	efficiently	_	RB	RB	_	31	advmod	_	_
33	by	_	IN	IN	_	31	prep	_	_
34	preincubation	_	NN	NN	_	33	pobj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	the	_	DT	DT	_	37	det	_	_
37	DNA	_	NN	NN	_	35	pobj	_	_
38	with	_	IN	IN	_	34	prep	_	_
39	LEF-1	_	NN	NN	_	38	pobj	_	_
40	-LRB-	_	-LRB-	-LRB-	_	42	punct	_	_
41	or	_	CC	CC	_	42	cc	_	_
42	LEF-1	_	NN	NN	_	39	dep	_	_
43	and	_	CC	CC	_	42	cc	_	_
44	Ets-1	_	NN	NN	_	42	conj	_	_
45	-RRB-	_	-RRB-	-RRB-	_	42	punct	_	_
46	supplemented	_	VBN	VBN	_	39	vmod	_	_
47	with	_	IN	IN	_	46	prep	_	_
48	fractions	_	NNS	NNS	_	47	pobj	_	_
49	containing	_	VBG	VBG	_	48	vmod	_	_
50	the	_	DT	DT	_	52	det	_	_
51	promoter-binding	_	JJ	JJ	_	52	amod	_	_
52	protein	_	NN	NN	_	49	dobj	_	_
53	,	_	,	,	_	52	punct	_	_
54	Sp1	_	NN	NN	_	52	appos	_	_
55	.	_	.	.	_	12	punct	_	_

1	Addition	_	NN	NN	_	20	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	TFE-3	_	NN	NN	_	2	pobj	_	_
4	,	_	,	,	_	3	punct	_	_
5	which	_	WDT	WDT	_	6	nsubj	_	_
6	binds	_	VBZ	VBZ	_	3	rcmod	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	an	_	DT	DT	_	10	det	_	_
9	E-box	_	NN	NN	_	10	nn	_	_
10	motif	_	NN	NN	_	7	pobj	_	_
11	upstream	_	JJ	JJ	_	10	advmod	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	14	dep	_	_
14	LEF-1	_	NN	NN	_	12	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	Ets-1	_	NN	NN	_	14	conj	_	_
17	sites	_	NNS	NNS	_	14	dep	_	_
18	,	_	,	,	_	1	punct	_	_
19	further	_	RB	RB	_	20	advmod	_	_
20	augments	_	VBZ	VBZ	_	0	root	_	_
21	transcription	_	NN	NN	_	20	dobj	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	this	_	DT	DT	_	24	det	_	_
24	system	_	NN	NN	_	22	pobj	_	_
25	.	_	.	.	_	20	punct	_	_

1	Individually	_	RB	RB	_	20	advmod	_	_
2	or	_	CC	CC	_	1	cc	_	_
3	collectively	_	RB	RB	_	1	conj	_	_
4	,	_	,	,	_	20	punct	_	_
5	none	_	NN	NN	_	20	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	10	det	_	_
8	three	_	CD	CD	_	10	num	_	_
9	enhancer-binding	_	JJ	JJ	_	10	amod	_	_
10	proteins	_	NNS	NNS	_	6	pobj	_	_
11	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
12	LEF-1	_	NN	NN	_	10	dep	_	_
13	,	_	,	,	_	12	punct	_	_
14	Ets-1	_	NN	NN	_	12	conj	_	_
15	,	_	,	,	_	12	punct	_	_
16	and	_	CC	CC	_	12	cc	_	_
17	TFE-3	_	NN	NN	_	12	conj	_	_
18	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
19	could	_	MD	MD	_	20	aux	_	_
20	activate	_	VB	VB	_	0	root	_	_
21	transcription	_	NN	NN	_	20	dobj	_	_
22	in	_	IN	IN	_	20	prep	_	_
23	the	_	DT	DT	_	24	det	_	_
24	absence	_	NN	NN	_	22	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	Sp1	_	NN	NN	_	25	pobj	_	_
27	.	_	.	.	_	20	punct	_	_

1	A	_	DT	DT	_	3	det	_	_
2	truncation	_	NN	NN	_	3	nn	_	_
3	mutant	_	NN	NN	_	23	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	LEF-1	_	NN	NN	_	4	pobj	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	HMG-88	_	CD	CD	_	3	appos	_	_
8	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
9	,	_	,	,	_	3	punct	_	_
10	which	_	WDT	WDT	_	11	nsubj	_	_
11	contains	_	VBZ	VBZ	_	3	rcmod	_	_
12	the	_	DT	DT	_	14	det	_	_
13	HMG	_	NN	NN	_	14	nn	_	_
14	box	_	NN	NN	_	11	dobj	_	_
15	but	_	CC	CC	_	11	cc	_	_
16	lacks	_	VBZ	VBZ	_	11	conj	_	_
17	the	_	DT	DT	_	19	det	_	_
18	trans-activation	_	JJ	JJ	_	19	amod	_	_
19	domain	_	NN	NN	_	16	dobj	_	_
20	,	_	,	,	_	3	punct	_	_
21	did	_	VBD	VBD	_	23	aux	_	_
22	not	_	RB	RB	_	23	neg	_	_
23	activate	_	VB	VB	_	0	root	_	_
24	transcription	_	NN	NN	_	23	dobj	_	_
25	from	_	IN	IN	_	24	prep	_	_
26	nucleosomal	_	JJ	JJ	_	27	amod	_	_
27	DNA	_	NN	NN	_	25	pobj	_	_
28	,	_	,	,	_	23	punct	_	_
29	indicating	_	VBG	VBG	_	23	vmod	_	_
30	that	_	IN	IN	_	40	mark	_	_
31	bending	_	NN	NN	_	40	nsubj	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	DNA	_	NN	NN	_	32	pobj	_	_
34	by	_	IN	IN	_	31	prep	_	_
35	the	_	DT	DT	_	37	det	_	_
36	HMG	_	NN	NN	_	37	nn	_	_
37	domain	_	NN	NN	_	34	pobj	_	_
38	is	_	VBZ	VBZ	_	40	cop	_	_
39	not	_	RB	RB	_	40	neg	_	_
40	sufficient	_	JJ	JJ	_	29	ccomp	_	_
41	to	_	TO	TO	_	42	aux	_	_
42	activate	_	VB	VB	_	40	xcomp	_	_
43	transcription	_	NN	NN	_	42	dobj	_	_
44	in	_	FW	FW	_	45	nn	_	_
45	vitro	_	FW	FW	_	42	advmod	_	_
46	.	_	.	.	_	23	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	conclude	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	13	mark	_	_
4	transcription	_	NN	NN	_	5	nn	_	_
5	activation	_	NN	NN	_	13	nsubj	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	LEF-1	_	NN	NN	_	6	pobj	_	_
8	in	_	FW	FW	_	9	nn	_	_
9	vitro	_	FW	FW	_	5	advmod	_	_
10	is	_	VBZ	VBZ	_	13	cop	_	_
11	a	_	DT	DT	_	13	det	_	_
12	chromatin-dependent	_	JJ	JJ	_	13	amod	_	_
13	process	_	NN	NN	_	2	ccomp	_	_
14	that	_	WDT	WDT	_	15	nsubj	_	_
15	requires	_	VBZ	VBZ	_	13	rcmod	_	_
16	a	_	DT	DT	_	19	det	_	_
17	functional	_	JJ	JJ	_	19	amod	_	_
18	trans-activation	_	NN	NN	_	19	nn	_	_
19	domain	_	NN	NN	_	15	dobj	_	_
20	in	_	IN	IN	_	15	prep	_	_
21	addition	_	NN	NN	_	20	pobj	_	_
22	to	_	TO	TO	_	21	prep	_	_
23	the	_	DT	DT	_	25	det	_	_
24	HMG	_	NN	NN	_	25	nn	_	_
25	domain	_	NN	NN	_	22	pobj	_	_
26	.	_	.	.	_	2	punct	_	_

1	TCL1	_	NN	NN	_	3	nn	_	_
2	oncogene	_	NN	NN	_	3	nn	_	_
3	activation	_	NN	NN	_	0	root	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	preleukemic	_	JJ	JJ	_	7	amod	_	_
6	T	_	NN	NN	_	7	nn	_	_
7	cells	_	NNS	NNS	_	4	pobj	_	_
8	from	_	IN	IN	_	7	prep	_	_
9	a	_	DT	DT	_	10	det	_	_
10	case	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	ataxia-telangiectasia	_	NN	NN	_	11	pobj	_	_
13	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	TCL1	_	NN	NN	_	3	nn	_	_
3	oncogene	_	NN	NN	_	9	nsubjpass	_	_
4	on	_	IN	IN	_	3	prep	_	_
5	human	_	JJ	JJ	_	6	amod	_	_
6	chromosome	_	NN	NN	_	4	pobj	_	_
7	14q32.1	_	NN	NN	_	6	dep	_	_
8	is	_	VBZ	VBZ	_	9	auxpass	_	_
9	involved	_	VBN	VBN	_	0	root	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	chromosome	_	NN	NN	_	10	pobj	_	_
12	translocations	_	NNS	NNS	_	11	dep	_	_
13	-LSB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	t-LRB-14;14-RRB--LRB-q11;q32.1-RRB-	_	NN	NN	_	12	dep	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	t-LRB-7;14-RRB--LRB-q35;q32.1-RRB-	_	NN	NN	_	14	conj	_	_
17	-RSB-	_	-RRB-	-RRB-	_	14	punct	_	_
18	and	_	CC	CC	_	11	cc	_	_
19	inversions	_	NNS	NNS	_	11	conj	_	_
20	-LSB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	inv14-LRB-q11;q32.1-RRB-	_	NN	NN	_	19	appos	_	_
22	-RSB-	_	-RRB-	-RRB-	_	21	punct	_	_
23	with	_	IN	IN	_	19	prep	_	_
24	TCR	_	NN	NN	_	26	nn	_	_
25	alpha/beta	_	NN	NN	_	26	nn	_	_
26	loci	_	NNS	NNS	_	23	pobj	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	T-cell	_	NN	NN	_	29	nn	_	_
29	leukemias	_	NNS	NNS	_	27	pobj	_	_
30	,	_	,	,	_	29	punct	_	_
31	such	_	JJ	JJ	_	32	mwe	_	_
32	as	_	IN	IN	_	29	prep	_	_
33	T-prolymphocytic	_	JJ	JJ	_	32	pobj	_	_
34	-LRB-	_	-LRB-	-LRB-	_	35	punct	_	_
35	T-PLL	_	NN	NN	_	33	appos	_	_
36	-RRB-	_	-RRB-	-RRB-	_	35	punct	_	_
37	.	_	.	.	_	9	punct	_	_

1	It	_	PRP	PRP	_	4	nsubjpass	_	_
2	is	_	VBZ	VBZ	_	4	auxpass	_	_
3	also	_	RB	RB	_	4	advmod	_	_
4	involved	_	VBN	VBN	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	T-acute	_	JJ	JJ	_	5	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	-chronic	_	JJ	JJ	_	6	conj	_	_
9	leukemias	_	NNS	NNS	_	6	dep	_	_
10	arising	_	VBG	VBG	_	6	vmod	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	cases	_	NNS	NNS	_	11	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	ataxia-telangiectasia	_	NN	NN	_	13	pobj	_	_
15	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
16	AT	_	NN	NN	_	14	appos	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	,	_	,	,	_	14	punct	_	_
19	an	_	DT	DT	_	21	det	_	_
20	immunodeficiency	_	NN	NN	_	21	nn	_	_
21	syndrome	_	NN	NN	_	14	appos	_	_
22	.	_	.	.	_	4	punct	_	_

1	Similar	_	JJ	JJ	_	3	amod	_	_
2	chromosomal	_	JJ	JJ	_	3	amod	_	_
3	rearrangements	_	NNS	NNS	_	4	nsubj	_	_
4	occur	_	VBP	VBP	_	0	root	_	_
5	also	_	RB	RB	_	4	advmod	_	_
6	in	_	IN	IN	_	4	prep	_	_
7	the	_	DT	DT	_	11	det	_	_
8	clonally	_	RB	RB	_	9	advmod	_	_
9	expanded	_	VBN	VBN	_	11	amod	_	_
10	T	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	6	pobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	AT	_	NN	NN	_	14	nn	_	_
14	patients	_	NNS	NNS	_	12	pobj	_	_
15	before	_	IN	IN	_	4	prep	_	_
16	the	_	DT	DT	_	17	det	_	_
17	appearance	_	NN	NN	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	overt	_	JJ	JJ	_	21	amod	_	_
21	leukemia	_	NN	NN	_	18	pobj	_	_
22	.	_	.	.	_	4	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	analyzed	_	VBN	VBN	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	expression	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	TCL1	_	NN	NN	_	8	nn	_	_
8	mRNA	_	NN	NN	_	6	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	protein	_	NN	NN	_	8	conj	_	_
11	in	_	IN	IN	_	3	prep	_	_
12	peripheral	_	JJ	JJ	_	14	amod	_	_
13	blood	_	NN	NN	_	14	nn	_	_
14	lymphocytes	_	NNS	NNS	_	11	pobj	_	_
15	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
16	PBLs	_	NNS	NNS	_	14	appos	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	from	_	IN	IN	_	14	prep	_	_
19	four	_	CD	CD	_	21	num	_	_
20	AT	_	NN	NN	_	21	nn	_	_
21	cases	_	NNS	NNS	_	18	pobj	_	_
22	and	_	CC	CC	_	18	cc	_	_
23	from	_	IN	IN	_	18	conj	_	_
24	healthy	_	JJ	JJ	_	25	amod	_	_
25	controls	_	NNS	NNS	_	23	pobj	_	_
26	.	_	.	.	_	3	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	found	_	VBD	VBD	_	0	root	_	_
3	that	_	IN	IN	_	8	mark	_	_
4	the	_	DT	DT	_	6	det	_	_
5	TCL1	_	NN	NN	_	6	nn	_	_
6	gene	_	NN	NN	_	8	nsubjpass	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	overexpressed	_	VBN	VBN	_	2	ccomp	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	PBLs	_	NNS	NNS	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	an	_	DT	DT	_	15	det	_	_
14	AT	_	NN	NN	_	15	nn	_	_
15	patient	_	NN	NN	_	12	pobj	_	_
16	with	_	IN	IN	_	15	prep	_	_
17	a	_	DT	DT	_	21	det	_	_
18	large	_	JJ	JJ	_	21	amod	_	_
19	clonal	_	JJ	JJ	_	21	amod	_	_
20	T-cell	_	NN	NN	_	21	nn	_	_
21	population	_	NN	NN	_	16	pobj	_	_
22	exhibiting	_	VBG	VBG	_	21	vmod	_	_
23	the	_	DT	DT	_	25	det	_	_
24	t-LRB-14;14-RRB-	_	NN	NN	_	25	nn	_	_
25	translocation	_	NN	NN	_	22	dobj	_	_
26	but	_	CC	CC	_	9	cc	_	_
27	not	_	RB	RB	_	28	neg	_	_
28	in	_	IN	IN	_	9	conj	_	_
29	the	_	DT	DT	_	30	det	_	_
30	lymphocytes	_	NNS	NNS	_	28	pobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	the	_	DT	DT	_	34	det	_	_
33	other	_	JJ	JJ	_	34	amod	_	_
34	cases	_	NNS	NNS	_	31	pobj	_	_
35	.	_	.	.	_	2	punct	_	_

1	Fluorescence	_	NN	NN	_	4	nn	_	_
2	in	_	FW	FW	_	4	amod	_	_
3	situ	_	FW	FW	_	2	dep	_	_
4	hybridization	_	NN	NN	_	22	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	9	det	_	_
7	TCL1	_	NN	NN	_	9	nn	_	_
8	genomic	_	JJ	JJ	_	9	amod	_	_
9	locus	_	NN	NN	_	5	pobj	_	_
10	to	_	TO	TO	_	4	prep	_	_
11	lymphocyte	_	NN	NN	_	12	nn	_	_
12	metaphases	_	NNS	NNS	_	10	pobj	_	_
13	from	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	AT	_	NN	NN	_	16	nn	_	_
16	patient	_	NN	NN	_	13	pobj	_	_
17	with	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	21	det	_	_
19	T-cell	_	NN	NN	_	21	nn	_	_
20	clonal	_	JJ	JJ	_	21	amod	_	_
21	expansion	_	NN	NN	_	17	pobj	_	_
22	showed	_	VBD	VBD	_	0	root	_	_
23	that	_	IN	IN	_	30	mark	_	_
24	the	_	DT	DT	_	25	det	_	_
25	breakpoint	_	NN	NN	_	30	nsubj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	29	det	_	_
28	t-LRB-14;14-RRB-	_	NN	NN	_	29	nn	_	_
29	translocation	_	NN	NN	_	26	pobj	_	_
30	lies	_	VBZ	VBZ	_	22	ccomp	_	_
31	within	_	IN	IN	_	30	prep	_	_
32	the	_	DT	DT	_	34	det	_	_
33	TCL1	_	NN	NN	_	34	nn	_	_
34	locus	_	NN	NN	_	31	pobj	_	_
35	and	_	CC	CC	_	30	cc	_	_
36	is	_	VBZ	VBZ	_	37	auxpass	_	_
37	accompanied	_	VBN	VBN	_	30	conj	_	_
38	by	_	IN	IN	_	37	prep	_	_
39	an	_	DT	DT	_	41	det	_	_
40	inverted	_	VBN	VBN	_	41	amod	_	_
41	duplication	_	NN	NN	_	38	pobj	_	_
42	of	_	IN	IN	_	41	prep	_	_
43	the	_	DT	DT	_	45	det	_	_
44	distal	_	JJ	JJ	_	45	amod	_	_
45	part	_	NN	NN	_	42	pobj	_	_
46	of	_	IN	IN	_	45	prep	_	_
47	chromosome	_	NN	NN	_	46	pobj	_	_
48	14	_	CD	CD	_	47	num	_	_
49	.	_	.	.	_	22	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	7	mark	_	_
5	TCL1	_	NN	NN	_	7	nsubjpass	_	_
6	is	_	VBZ	VBZ	_	7	auxpass	_	_
7	activated	_	VBN	VBN	_	3	ccomp	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	preleukemic	_	JJ	JJ	_	11	amod	_	_
10	clonal	_	JJ	JJ	_	11	amod	_	_
11	cells	_	NNS	NNS	_	8	pobj	_	_
12	as	_	IN	IN	_	7	prep	_	_
13	a	_	DT	DT	_	14	det	_	_
14	consequence	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	chromosome	_	NN	NN	_	17	nn	_	_
17	translocation	_	NN	NN	_	15	pobj	_	_
18	involving	_	NN	NN	_	17	dep	_	_
19	sequences	_	NNS	NNS	_	18	dobj	_	_
20	from	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	TCR	_	NN	NN	_	23	nn	_	_
23	locus	_	NN	NN	_	20	pobj	_	_
24	at	_	IN	IN	_	23	prep	_	_
25	14q11	_	NN	NN	_	24	pobj	_	_
26	.	_	.	.	_	3	punct	_	_

1	Deregulation	_	NN	NN	_	7	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	TCL1	_	NN	NN	_	2	pobj	_	_
4	is	_	VBZ	VBZ	_	7	cop	_	_
5	the	_	DT	DT	_	7	det	_	_
6	first	_	JJ	JJ	_	7	amod	_	_
7	event	_	NN	NN	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	initiation	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	malignancy	_	NN	NN	_	11	pobj	_	_
13	in	_	IN	IN	_	7	prep	_	_
14	these	_	DT	DT	_	15	det	_	_
15	types	_	NNS	NNS	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	leukemias	_	NNS	NNS	_	16	pobj	_	_
18	and	_	CC	CC	_	7	cc	_	_
19	represents	_	VBZ	VBZ	_	7	conj	_	_
20	a	_	DT	DT	_	22	det	_	_
21	potential	_	JJ	JJ	_	22	amod	_	_
22	tool	_	NN	NN	_	19	dobj	_	_
23	for	_	IN	IN	_	22	prep	_	_
24	clinical	_	JJ	JJ	_	25	amod	_	_
25	evaluation	_	NN	NN	_	23	pobj	_	_
26	.	_	.	.	_	7	punct	_	_

1	Ubiquitin-mediated	_	JJ	JJ	_	2	amod	_	_
2	processing	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	NF-kappa	_	NN	NN	_	5	nn	_	_
5	B	_	NN	NN	_	3	pobj	_	_
6	transcriptional	_	JJ	JJ	_	8	amod	_	_
7	activator	_	NN	NN	_	8	nn	_	_
8	precursor	_	NN	NN	_	5	dep	_	_
9	p105	_	NN	NN	_	5	dep	_	_
10	.	_	.	.	_	2	punct	_	_

1	Reconstitution	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	a	_	DT	DT	_	5	det	_	_
4	cell-free	_	JJ	JJ	_	5	amod	_	_
5	system	_	NN	NN	_	2	pobj	_	_
6	and	_	CC	CC	_	1	cc	_	_
7	identification	_	NN	NN	_	1	conj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	ubiquitin-carrier	_	JJ	JJ	_	11	amod	_	_
11	protein	_	NN	NN	_	8	pobj	_	_
12	,	_	,	,	_	11	punct	_	_
13	E2	_	NN	NN	_	11	appos	_	_
14	,	_	,	,	_	11	punct	_	_
15	and	_	CC	CC	_	11	cc	_	_
16	a	_	DT	DT	_	19	det	_	_
17	novel	_	JJ	JJ	_	19	amod	_	_
18	ubiquitin-protein	_	JJ	JJ	_	19	amod	_	_
19	ligase	_	NN	NN	_	11	conj	_	_
20	,	_	,	,	_	11	punct	_	_
21	E3	_	NN	NN	_	11	conj	_	_
22	,	_	,	,	_	11	punct	_	_
23	involved	_	VBN	VBN	_	11	vmod	_	_
24	in	_	IN	IN	_	23	prep	_	_
25	conjugation	_	NN	NN	_	24	pobj	_	_
26	.	_	.	.	_	1	punct	_	_

1	In	_	IN	IN	_	12	prep	_	_
2	most	_	JJS	JJS	_	3	amod	_	_
3	cases	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	12	punct	_	_
5	the	_	DT	DT	_	7	det	_	_
6	transcriptional	_	JJ	JJ	_	7	amod	_	_
7	factor	_	NN	NN	_	12	nsubj	_	_
8	NF-kappa	_	NN	NN	_	9	nn	_	_
9	B	_	NN	NN	_	7	dep	_	_
10	is	_	VBZ	VBZ	_	12	cop	_	_
11	a	_	DT	DT	_	12	det	_	_
12	heterodimer	_	NN	NN	_	0	root	_	_
13	consisting	_	VBG	VBG	_	12	vmod	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	two	_	CD	CD	_	16	num	_	_
16	subunits	_	NNS	NNS	_	14	pobj	_	_
17	,	_	,	,	_	16	punct	_	_
18	p50	_	NN	NN	_	16	appos	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	p65	_	NN	NN	_	18	conj	_	_
21	,	_	,	,	_	16	punct	_	_
22	which	_	WDT	WDT	_	24	nsubjpass	_	_
23	are	_	VBP	VBP	_	24	auxpass	_	_
24	encoded	_	VBN	VBN	_	16	rcmod	_	_
25	by	_	IN	IN	_	24	prep	_	_
26	two	_	CD	CD	_	28	num	_	_
27	distinct	_	JJ	JJ	_	28	amod	_	_
28	genes	_	NNS	NNS	_	25	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	the	_	DT	DT	_	32	det	_	_
31	Rel	_	NN	NN	_	32	nn	_	_
32	family	_	NN	NN	_	29	pobj	_	_
33	.	_	.	.	_	12	punct	_	_

1	p50	_	NN	NN	_	3	nsubjpass	_	_
2	is	_	VBZ	VBZ	_	3	auxpass	_	_
3	translated	_	VBN	VBN	_	0	root	_	_
4	as	_	IN	IN	_	3	prep	_	_
5	a	_	DT	DT	_	6	det	_	_
6	precursor	_	NN	NN	_	4	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	105	_	CD	CD	_	9	num	_	_
9	kDa	_	NN	NN	_	7	pobj	_	_
10	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	C-terminal	_	JJ	JJ	_	3	amod	_	_
3	domain	_	NN	NN	_	9	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	6	det	_	_
6	precursor	_	NN	NN	_	4	pobj	_	_
7	is	_	VBZ	VBZ	_	9	auxpass	_	_
8	rapidly	_	RB	RB	_	9	advmod	_	_
9	degraded	_	VBN	VBN	_	0	root	_	_
10	,	_	,	,	_	9	punct	_	_
11	forming	_	VBG	VBG	_	9	vmod	_	_
12	the	_	DT	DT	_	15	det	_	_
13	mature	_	JJ	JJ	_	15	amod	_	_
14	p50	_	NN	NN	_	15	nn	_	_
15	subunit	_	NN	NN	_	11	dobj	_	_
16	consisted	_	VBN	VBN	_	15	vmod	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	N-terminal	_	JJ	JJ	_	20	amod	_	_
20	region	_	NN	NN	_	17	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	23	det	_	_
23	molecule	_	NN	NN	_	21	pobj	_	_
24	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	mechanism	_	NN	NN	_	9	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	generation	_	NN	NN	_	3	pobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	p50	_	NN	NN	_	5	pobj	_	_
7	is	_	VBZ	VBZ	_	9	auxpass	_	_
8	not	_	RB	RB	_	9	neg	_	_
9	known	_	VBN	VBN	_	0	root	_	_
10	.	_	.	.	_	9	punct	_	_

1	It	_	PRP	PRP	_	4	nsubjpass	_	_
2	has	_	VBZ	VBZ	_	4	aux	_	_
3	been	_	VBN	VBN	_	4	auxpass	_	_
4	suggested	_	VBN	VBN	_	0	root	_	_
5	that	_	IN	IN	_	10	mark	_	_
6	the	_	DT	DT	_	8	det	_	_
7	ubiquitin-proteasome	_	JJ	JJ	_	8	amod	_	_
8	system	_	NN	NN	_	10	nsubjpass	_	_
9	is	_	VBZ	VBZ	_	10	auxpass	_	_
10	involved	_	VBN	VBN	_	4	ccomp	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	process	_	NN	NN	_	11	pobj	_	_
14	;	_	:	:	_	4	punct	_	_
15	however	_	RB	RB	_	39	advmod	_	_
16	,	_	,	,	_	39	punct	_	_
17	the	_	DT	DT	_	19	det	_	_
18	specific	_	JJ	JJ	_	19	amod	_	_
19	enzymes	_	NNS	NNS	_	39	nsubj	_	_
20	involved	_	VBN	VBN	_	19	vmod	_	_
21	and	_	CC	CC	_	19	cc	_	_
22	the	_	DT	DT	_	23	det	_	_
23	mechanism	_	NN	NN	_	19	conj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	limited	_	JJ	JJ	_	26	amod	_	_
26	proteolysis	_	NN	NN	_	24	pobj	_	_
27	,	_	,	,	_	26	punct	_	_
28	in	_	IN	IN	_	35	prep	_	_
29	which	_	WDT	WDT	_	28	pobj	_	_
30	half	_	NN	NN	_	35	nsubjpass	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	the	_	DT	DT	_	33	det	_	_
33	molecule	_	NN	NN	_	31	pobj	_	_
34	is	_	VBZ	VBZ	_	35	auxpass	_	_
35	spared	_	VBN	VBN	_	26	rcmod	_	_
36	,	_	,	,	_	19	punct	_	_
37	have	_	VBP	VBP	_	39	aux	_	_
38	been	_	VBN	VBN	_	39	cop	_	_
39	obscure	_	JJ	JJ	_	4	parataxis	_	_
40	.	_	.	.	_	4	punct	_	_

1	Palombella	_	NNP	NNP	_	30	nsubj	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	colleagues	_	NNS	NNS	_	1	conj	_	_
4	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
5	Palombella	_	NNP	NNP	_	7	nn	_	_
6	,	_	,	,	_	7	punct	_	_
7	V.J.	_	NNP	NNP	_	1	dep	_	_
8	,	_	,	,	_	7	punct	_	_
9	Rando	_	NNP	NNP	_	11	nn	_	_
10	,	_	,	,	_	11	punct	_	_
11	O.J.	_	NNP	NNP	_	7	conj	_	_
12	,	_	,	,	_	7	punct	_	_
13	Goldberg	_	NNP	NNP	_	15	nn	_	_
14	,	_	,	,	_	15	punct	_	_
15	A.L.	_	NNP	NNP	_	7	conj	_	_
16	,	_	,	,	_	7	punct	_	_
17	and	_	CC	CC	_	7	cc	_	_
18	Maniatis	_	NNP	NNP	_	20	nn	_	_
19	,	_	,	,	_	20	punct	_	_
20	T.	_	NNP	NNP	_	7	conj	_	_
21	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
22	1994	_	CD	CD	_	7	appos	_	_
23	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
24	Cell	_	NNP	NNP	_	7	dep	_	_
25	78	_	CD	CD	_	24	num	_	_
26	,	_	,	,	_	7	punct	_	_
27	773-785	_	CD	CD	_	7	amod	_	_
28	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
29	have	_	VBP	VBP	_	30	aux	_	_
30	shown	_	VBN	VBN	_	0	root	_	_
31	that	_	IN	IN	_	34	mark	_	_
32	ubiquitin	_	NN	NN	_	34	nsubjpass	_	_
33	is	_	VBZ	VBZ	_	34	auxpass	_	_
34	required	_	VBN	VBN	_	30	ccomp	_	_
35	for	_	IN	IN	_	34	prep	_	_
36	the	_	DT	DT	_	37	det	_	_
37	processing	_	NN	NN	_	35	pobj	_	_
38	in	_	IN	IN	_	37	prep	_	_
39	a	_	DT	DT	_	41	det	_	_
40	cell-free	_	JJ	JJ	_	41	amod	_	_
41	system	_	NN	NN	_	38	pobj	_	_
42	of	_	IN	IN	_	41	prep	_	_
43	a	_	DT	DT	_	50	det	_	_
44	truncated	_	VBN	VBN	_	50	amod	_	_
45	,	_	,	,	_	44	punct	_	_
46	artificially	_	RB	RB	_	47	advmod	_	_
47	constructed	_	VBN	VBN	_	44	dep	_	_
48	,	_	,	,	_	50	punct	_	_
49	60-kDa	_	JJ	JJ	_	50	amod	_	_
50	precursor	_	NN	NN	_	42	pobj	_	_
51	.	_	.	.	_	30	punct	_	_

1	They	_	PRP	PRP	_	4	nsubj	_	_
2	have	_	VBP	VBP	_	4	aux	_	_
3	also	_	RB	RB	_	4	advmod	_	_
4	shown	_	VBN	VBN	_	0	root	_	_
5	that	_	IN	IN	_	8	mark	_	_
6	proteasome	_	NN	NN	_	7	nn	_	_
7	inhibitors	_	NNS	NNS	_	8	nsubj	_	_
8	block	_	VBP	VBP	_	4	ccomp	_	_
9	the	_	DT	DT	_	10	det	_	_
10	processing	_	NN	NN	_	8	dobj	_	_
11	both	_	CC	CC	_	13	preconj	_	_
12	in	_	FW	FW	_	13	nn	_	_
13	vitro	_	FW	FW	_	8	advmod	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	in	_	FW	FW	_	13	conj	_	_
16	vivo	_	FW	FW	_	15	dep	_	_
17	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	study	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	demonstrate	_	VBP	VBP	_	0	root	_	_
7	reconstitution	_	NN	NN	_	6	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	a	_	DT	DT	_	12	det	_	_
10	cell-free	_	JJ	JJ	_	12	amod	_	_
11	processing	_	NN	NN	_	12	nn	_	_
12	system	_	NN	NN	_	8	pobj	_	_
13	and	_	CC	CC	_	6	cc	_	_
14	demonstrate	_	VBP	VBP	_	6	conj	_	_
15	directly	_	RB	RB	_	14	advmod	_	_
16	that	_	IN	IN	_	25	mark	_	_
17	:	_	:	:	_	25	punct	_	_
18	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
19	a	_	LS	LS	_	25	dep	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	the	_	DT	DT	_	23	det	_	_
22	ubiquitin-proteasome	_	JJ	JJ	_	23	amod	_	_
23	system	_	NN	NN	_	25	nsubjpass	_	_
24	is	_	VBZ	VBZ	_	25	auxpass	_	_
25	involved	_	VBN	VBN	_	14	ccomp	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	processing	_	NN	NN	_	26	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	the	_	DT	DT	_	32	det	_	_
30	intact	_	JJ	JJ	_	32	amod	_	_
31	p105	_	NN	NN	_	32	nn	_	_
32	precursor	_	NN	NN	_	28	pobj	_	_
33	,	_	,	,	_	25	punct	_	_
34	-LRB-	_	-LRB-	-LRB-	_	35	punct	_	_
35	b	_	LS	LS	_	47	dep	_	_
36	-RRB-	_	-RRB-	-RRB-	_	35	punct	_	_
37	conjugation	_	NN	NN	_	47	nsubj	_	_
38	of	_	IN	IN	_	37	prep	_	_
39	ubiquitin	_	NN	NN	_	38	pobj	_	_
40	to	_	TO	TO	_	37	prep	_	_
41	the	_	DT	DT	_	42	det	_	_
42	precursor	_	NN	NN	_	40	pobj	_	_
43	is	_	VBZ	VBZ	_	47	cop	_	_
44	an	_	DT	DT	_	47	det	_	_
45	essential	_	JJ	JJ	_	47	amod	_	_
46	intermediate	_	JJ	JJ	_	47	amod	_	_
47	step	_	NN	NN	_	25	ccomp	_	_
48	in	_	IN	IN	_	47	prep	_	_
49	the	_	DT	DT	_	50	det	_	_
50	processing	_	NN	NN	_	48	pobj	_	_
51	,	_	,	,	_	25	punct	_	_
52	-LRB-	_	-LRB-	-LRB-	_	53	punct	_	_
53	c	_	LS	LS	_	80	dep	_	_
54	-RRB-	_	-RRB-	-RRB-	_	53	punct	_	_
55	the	_	DT	DT	_	59	det	_	_
56	recently	_	RB	RB	_	58	advmod	_	_
57	discovered	_	VBN	VBN	_	58	dep	_	_
58	novel	_	JJ	JJ	_	59	amod	_	_
59	species	_	NNS	NNS	_	80	nsubjpass	_	_
60	of	_	IN	IN	_	59	prep	_	_
61	the	_	DT	DT	_	63	det	_	_
62	ubiquitin-carrier	_	JJ	JJ	_	63	amod	_	_
63	protein	_	NN	NN	_	60	pobj	_	_
64	,	_	,	,	_	59	punct	_	_
65	E2-F1	_	NN	NN	_	59	appos	_	_
66	,	_	,	,	_	59	punct	_	_
67	that	_	WDT	WDT	_	69	nsubjpass	_	_
68	is	_	VBZ	VBZ	_	69	auxpass	_	_
69	involved	_	VBN	VBN	_	59	rcmod	_	_
70	in	_	IN	IN	_	69	prep	_	_
71	the	_	DT	DT	_	72	dep	_	_
72	conjugation	_	NN	NN	_	70	pobj	_	_
73	and	_	CC	CC	_	72	cc	_	_
74	degradation	_	NN	NN	_	72	conj	_	_
75	of	_	IN	IN	_	72	prep	_	_
76	p53	_	NN	NN	_	75	pobj	_	_
77	,	_	,	,	_	59	punct	_	_
78	is	_	VBZ	VBZ	_	80	auxpass	_	_
79	also	_	RB	RB	_	80	advmod	_	_
80	required	_	VBN	VBN	_	25	ccomp	_	_
81	for	_	IN	IN	_	80	prep	_	_
82	the	_	DT	DT	_	84	det	_	_
83	limited	_	JJ	JJ	_	84	amod	_	_
84	processing	_	NN	NN	_	81	pobj	_	_
85	of	_	IN	IN	_	84	prep	_	_
86	the	_	DT	DT	_	88	det	_	_
87	p105	_	NN	NN	_	88	nn	_	_
88	precursor	_	NN	NN	_	85	pobj	_	_
89	,	_	,	,	_	25	punct	_	_
90	and	_	CC	CC	_	25	cc	_	_
91	-LRB-	_	-LRB-	-LRB-	_	92	punct	_	_
92	d	_	LS	LS	_	105	dep	_	_
93	-RRB-	_	-RRB-	-RRB-	_	92	punct	_	_
94	a	_	DT	DT	_	99	det	_	_
95	novel	_	JJ	JJ	_	99	amod	_	_
96	,	_	,	,	_	99	punct	_	_
97	approximately	_	RB	RB	_	99	advmod	_	_
98	320-kDa	_	CD	CD	_	99	num	_	_
99	species	_	NNS	NNS	_	105	nsubjpass	_	_
100	of	_	IN	IN	_	99	prep	_	_
101	ubiquitin-protein	_	JJ	JJ	_	102	amod	_	_
102	ligase	_	NN	NN	_	100	pobj	_	_
103	,	_	,	,	_	99	punct	_	_
104	is	_	VBZ	VBZ	_	105	auxpass	_	_
105	involved	_	VBN	VBN	_	25	conj	_	_
106	in	_	IN	IN	_	105	prep	_	_
107	the	_	DT	DT	_	108	det	_	_
108	process	_	NN	NN	_	106	pobj	_	_
109	.	_	.	.	_	6	punct	_	_

1	This	_	DT	DT	_	3	det	_	_
2	novel	_	JJ	JJ	_	3	amod	_	_
3	enzyme	_	NN	NN	_	5	nsubj	_	_
4	is	_	VBZ	VBZ	_	5	cop	_	_
5	distinct	_	JJ	JJ	_	0	root	_	_
6	from	_	IN	IN	_	5	prep	_	_
7	E6-AP	_	NN	NN	_	6	pobj	_	_
8	,	_	,	,	_	7	punct	_	_
9	the	_	DT	DT	_	11	det	_	_
10	p53-conjugating	_	NN	NN	_	11	nn	_	_
11	ligase	_	NN	NN	_	7	appos	_	_
12	,	_	,	,	_	6	punct	_	_
13	and	_	CC	CC	_	6	cc	_	_
14	from	_	IN	IN	_	6	conj	_	_
15	E3	_	NN	NN	_	16	nn	_	_
16	alpha	_	NN	NN	_	14	pobj	_	_
17	,	_	,	,	_	16	punct	_	_
18	the	_	DT	DT	_	22	det	_	_
19	``	_	``	``	_	22	punct	_	_
20	N-end	_	JJ	JJ	_	22	amod	_	_
21	rule	_	NN	NN	_	22	nn	_	_
22	ligase	_	NN	NN	_	16	appos	_	_
23	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	hematopoietic	_	JJ	JJ	_	4	amod	_	_
3	transcription	_	NN	NN	_	4	nn	_	_
4	factor	_	NN	NN	_	7	nsubjpass	_	_
5	PU.1	_	NN	NN	_	4	dep	_	_
6	is	_	VBZ	VBZ	_	7	auxpass	_	_
7	downregulated	_	VBN	VBN	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	human	_	JJ	JJ	_	13	amod	_	_
10	multiple	_	JJ	JJ	_	13	amod	_	_
11	myeloma	_	NN	NN	_	13	nn	_	_
12	cell	_	NN	NN	_	13	nn	_	_
13	lines	_	NNS	NNS	_	8	pobj	_	_
14	.	_	.	.	_	7	punct	_	_

1	PU.1	_	NN	NN	_	6	nsubj	_	_
2	is	_	VBZ	VBZ	_	6	cop	_	_
3	a	_	DT	DT	_	6	det	_	_
4	hematopoietic	_	JJ	JJ	_	6	amod	_	_
5	transcription	_	NN	NN	_	6	nn	_	_
6	factor	_	NN	NN	_	0	root	_	_
7	belonging	_	VBG	VBG	_	6	vmod	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	Ets-family	_	NN	NN	_	8	pobj	_	_
11	.	_	.	.	_	6	punct	_	_

1	It	_	PRP	PRP	_	3	nsubj	_	_
2	is	_	VBZ	VBZ	_	3	cop	_	_
3	identical	_	JJ	JJ	_	0	root	_	_
4	to	_	TO	TO	_	3	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	Spi-1	_	NN	NN	_	7	nn	_	_
7	oncogene	_	NN	NN	_	4	pobj	_	_
8	,	_	,	,	_	7	punct	_	_
9	which	_	WDT	WDT	_	11	nsubjpass	_	_
10	is	_	VBZ	VBZ	_	11	auxpass	_	_
11	implicated	_	VBN	VBN	_	7	rcmod	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	spleen	_	NN	NN	_	14	npadvmod	_	_
14	focus-forming	_	JJ	JJ	_	17	amod	_	_
15	virus-induced	_	JJ	JJ	_	14	dep	_	_
16	murine	_	JJ	JJ	_	14	dep	_	_
17	erythroleukemias	_	NNS	NNS	_	12	pobj	_	_
18	.	_	.	.	_	3	punct	_	_

1	PU.1	_	NN	NN	_	2	nsubj	_	_
2	seems	_	VBZ	VBZ	_	0	root	_	_
3	to	_	TO	TO	_	5	aux	_	_
4	be	_	VB	VB	_	5	auxpass	_	_
5	required	_	VBN	VBN	_	2	xcomp	_	_
6	for	_	IN	IN	_	5	prep	_	_
7	early	_	JJ	JJ	_	8	amod	_	_
8	development	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	multiple	_	JJ	JJ	_	12	amod	_	_
11	hematopoietic	_	JJ	JJ	_	12	amod	_	_
12	lineages	_	NNS	NNS	_	9	pobj	_	_
13	,	_	,	,	_	2	punct	_	_
14	but	_	CC	CC	_	2	cc	_	_
15	its	_	PRP$	PRP$	_	16	poss	_	_
16	expression	_	NN	NN	_	22	nsubjpass	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	mature	_	JJ	JJ	_	19	amod	_	_
19	cells	_	NNS	NNS	_	17	pobj	_	_
20	is	_	VBZ	VBZ	_	22	auxpass	_	_
21	preferentially	_	RB	RB	_	22	advmod	_	_
22	observed	_	VBN	VBN	_	2	conj	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	cells	_	NNS	NNS	_	23	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	29	det	_	_
27	B-cell-and	_	NN	NN	_	29	nn	_	_
28	monocyte/macrophage-differentiation	_	NN	NN	_	29	nn	_	_
29	lineage	_	NN	NN	_	25	pobj	_	_
30	.	_	.	.	_	2	punct	_	_

1	It	_	PRP	PRP	_	2	nsubj	_	_
2	binds	_	VBZ	VBZ	_	0	root	_	_
3	the	_	DT	DT	_	6	det	_	_
4	so-called	_	JJ	JJ	_	6	amod	_	_
5	Pu	_	NN	NN	_	6	nn	_	_
6	box	_	NN	NN	_	2	dobj	_	_
7	,	_	,	,	_	6	punct	_	_
8	an	_	DT	DT	_	13	det	_	_
9	important	_	JJ	JJ	_	13	amod	_	_
10	tissue-specific	_	JJ	JJ	_	13	amod	_	_
11	regulatory	_	JJ	JJ	_	13	amod	_	_
12	DNA	_	NN	NN	_	13	nn	_	_
13	element	_	NN	NN	_	6	appos	_	_
14	present	_	JJ	JJ	_	13	amod	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	a	_	DT	DT	_	17	det	_	_
17	number	_	NN	NN	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	genes	_	NNS	NNS	_	18	pobj	_	_
20	expressed	_	VBN	VBN	_	17	vmod	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	these	_	DT	DT	_	24	det	_	_
23	cell	_	NN	NN	_	24	nn	_	_
24	lineages	_	NNS	NNS	_	21	pobj	_	_
25	.	_	.	.	_	2	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	analyzed	_	VBN	VBN	_	0	root	_	_
4	the	_	DT	DT	_	5	dep	_	_
5	expression	_	NN	NN	_	3	dobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	activity	_	NN	NN	_	5	conj	_	_
8	of	_	IN	IN	_	5	prep	_	_
9	PU.1	_	NN	NN	_	8	pobj	_	_
10	during	_	IN	IN	_	5	prep	_	_
11	human	_	JJ	JJ	_	13	amod	_	_
12	B-cell	_	NN	NN	_	13	nn	_	_
13	development	_	NN	NN	_	10	pobj	_	_
14	using	_	VBG	VBG	_	3	xcomp	_	_
15	a	_	DT	DT	_	16	det	_	_
16	panel	_	NN	NN	_	14	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	B-cell	_	NN	NN	_	19	nn	_	_
19	lines	_	NNS	NNS	_	17	pobj	_	_
20	representing	_	VBG	VBG	_	16	vmod	_	_
21	different	_	JJ	JJ	_	22	amod	_	_
22	stages	_	NNS	NNS	_	20	dobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	maturation	_	NN	NN	_	23	pobj	_	_
25	,	_	,	,	_	22	punct	_	_
26	from	_	IN	IN	_	22	prep	_	_
27	early	_	JJ	JJ	_	28	amod	_	_
28	precursors	_	NNS	NNS	_	26	pobj	_	_
29	to	_	TO	TO	_	22	prep	_	_
30	differentiated	_	VBN	VBN	_	32	amod	_	_
31	plasma	_	NN	NN	_	32	nn	_	_
32	cells	_	NNS	NNS	_	29	pobj	_	_
33	.	_	.	.	_	3	punct	_	_

1	PU.1	_	NN	NN	_	2	nn	_	_
2	mRNA	_	NN	NN	_	3	nn	_	_
3	expression	_	NN	NN	_	25	nsubj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	PU.1	_	NN	NN	_	8	nn	_	_
6	DNA	_	NN	NN	_	8	nn	_	_
7	binding	_	NN	NN	_	8	nn	_	_
8	activity	_	NN	NN	_	3	conj	_	_
9	,	_	,	,	_	3	punct	_	_
10	as	_	IN	IN	_	11	mark	_	_
11	measured	_	VBN	VBN	_	25	dep	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	Northern	_	NN	NN	_	15	nn	_	_
14	blot	_	NN	NN	_	15	nn	_	_
15	analysis	_	NN	NN	_	12	pobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	electrophoretic	_	JJ	JJ	_	20	amod	_	_
18	mobility	_	NN	NN	_	20	nn	_	_
19	shift	_	NN	NN	_	20	nn	_	_
20	assay	_	NN	NN	_	15	conj	_	_
21	,	_	,	,	_	11	punct	_	_
22	respectively	_	RB	RB	_	11	advmod	_	_
23	,	_	,	,	_	25	punct	_	_
24	were	_	VBD	VBD	_	25	cop	_	_
25	evident	_	JJ	JJ	_	0	root	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	cell	_	NN	NN	_	28	nn	_	_
28	lines	_	NNS	NNS	_	26	pobj	_	_
29	representing	_	VBG	VBG	_	28	vmod	_	_
30	pro-B	_	JJ	JJ	_	29	dobj	_	_
31	,	_	,	,	_	30	punct	_	_
32	pre-B	_	JJ	JJ	_	30	conj	_	_
33	,	_	,	,	_	30	punct	_	_
34	and	_	CC	CC	_	30	cc	_	_
35	mature	_	JJ	JJ	_	36	amod	_	_
36	B	_	NN	NN	_	30	conj	_	_
37	cells	_	NNS	NNS	_	30	dep	_	_
38	.	_	.	.	_	25	punct	_	_

1	We	_	PRP	PRP	_	4	nsubj	_	_
2	could	_	MD	MD	_	4	aux	_	_
3	also	_	RB	RB	_	4	advmod	_	_
4	show	_	VB	VB	_	0	root	_	_
5	Pu	_	NN	NN	_	7	nn	_	_
6	box-dependent	_	JJ	JJ	_	7	amod	_	_
7	transactivation	_	NN	NN	_	4	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	a	_	DT	DT	_	11	det	_	_
10	reporter	_	NN	NN	_	11	nn	_	_
11	gene	_	NN	NN	_	8	pobj	_	_
12	in	_	IN	IN	_	7	prep	_	_
13	transient	_	JJ	JJ	_	14	amod	_	_
14	transfections	_	NNS	NNS	_	12	pobj	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	these	_	DT	DT	_	18	det	_	_
17	cell	_	NN	NN	_	18	nn	_	_
18	lines	_	NNS	NNS	_	15	pobj	_	_
19	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	34	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	34	punct	_	_
4	in	_	IN	IN	_	34	prep	_	_
5	a	_	DT	DT	_	6	det	_	_
6	number	_	NN	NN	_	4	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	multiple	_	JJ	JJ	_	11	amod	_	_
9	myeloma	_	NN	NN	_	11	nn	_	_
10	cell	_	NN	NN	_	11	nn	_	_
11	lines	_	NNS	NNS	_	7	pobj	_	_
12	,	_	,	,	_	6	punct	_	_
13	representing	_	VBG	VBG	_	6	vmod	_	_
14	differentiated	_	VBN	VBN	_	19	amod	_	_
15	,	_	,	,	_	19	punct	_	_
16	plasma	_	NN	NN	_	19	nn	_	_
17	cell-like	_	JJ	JJ	_	19	amod	_	_
18	B	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	13	dobj	_	_
20	,	_	,	,	_	34	punct	_	_
21	PU.1	_	NN	NN	_	24	nn	_	_
22	DNA	_	NN	NN	_	24	nn	_	_
23	binding	_	NN	NN	_	24	nn	_	_
24	activity	_	NN	NN	_	34	nsubj	_	_
25	,	_	,	,	_	24	punct	_	_
26	mRNA	_	NN	NN	_	27	nn	_	_
27	expression	_	NN	NN	_	24	conj	_	_
28	,	_	,	,	_	24	punct	_	_
29	and	_	CC	CC	_	24	cc	_	_
30	Pu	_	NN	NN	_	32	nn	_	_
31	box-dependent	_	JJ	JJ	_	32	amod	_	_
32	transactivation	_	NN	NN	_	24	conj	_	_
33	were	_	VBD	VBD	_	34	cop	_	_
34	absent	_	JJ	JJ	_	0	root	_	_
35	or	_	CC	CC	_	34	cc	_	_
36	detectable	_	JJ	JJ	_	34	conj	_	_
37	at	_	IN	IN	_	36	prep	_	_
38	a	_	DT	DT	_	41	det	_	_
39	very	_	RB	RB	_	40	advmod	_	_
40	low	_	JJ	JJ	_	41	amod	_	_
41	level	_	NN	NN	_	37	pobj	_	_
42	.	_	.	.	_	34	punct	_	_

1	In	_	IN	IN	_	21	prep	_	_
2	lymphoblastoid	_	JJ	JJ	_	4	amod	_	_
3	cell	_	NN	NN	_	4	nn	_	_
4	lines	_	NNS	NNS	_	1	pobj	_	_
5	,	_	,	,	_	4	punct	_	_
6	which	_	WDT	WDT	_	7	nsubj	_	_
7	exemplify	_	VBP	VBP	_	4	rcmod	_	_
8	an	_	DT	DT	_	10	det	_	_
9	intermediate	_	JJ	JJ	_	10	amod	_	_
10	stage	_	NN	NN	_	7	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	B-cell	_	NN	NN	_	13	nn	_	_
13	differentiation	_	NN	NN	_	11	pobj	_	_
14	,	_	,	,	_	21	punct	_	_
15	a	_	DT	DT	_	17	det	_	_
16	reduced	_	VBN	VBN	_	17	amod	_	_
17	expression	_	NN	NN	_	21	nsubjpass	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	activity	_	NN	NN	_	17	conj	_	_
20	were	_	VBD	VBD	_	21	auxpass	_	_
21	observed	_	VBN	VBN	_	0	root	_	_
22	.	_	.	.	_	21	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	findings	_	NNS	NNS	_	10	nsubj	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	9	det	_	_
5	human	_	JJ	JJ	_	9	amod	_	_
6	multiple	_	JJ	JJ	_	9	amod	_	_
7	myeloma	_	NN	NN	_	9	nn	_	_
8	cell	_	NN	NN	_	9	nn	_	_
9	lines	_	NNS	NNS	_	3	pobj	_	_
10	represent	_	VBP	VBP	_	0	root	_	_
11	the	_	DT	DT	_	13	det	_	_
12	first	_	JJ	JJ	_	13	amod	_	_
13	examples	_	NNS	NNS	_	10	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	B	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	14	pobj	_	_
17	with	_	IN	IN	_	16	prep	_	_
18	downregulated	_	VBN	VBN	_	20	amod	_	_
19	PU.1	_	NN	NN	_	20	nn	_	_
20	expression	_	NN	NN	_	17	pobj	_	_
21	and	_	CC	CC	_	10	cc	_	_
22	apparently	_	RB	RB	_	23	advmod	_	_
23	contradict	_	VBP	VBP	_	10	conj	_	_
24	observations	_	NNS	NNS	_	23	dobj	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	28	det	_	_
27	murine	_	JJ	JJ	_	28	amod	_	_
28	system	_	NN	NN	_	25	pobj	_	_
29	in	_	IN	IN	_	32	prep	_	_
30	which	_	WDT	WDT	_	29	pobj	_	_
31	PU.1	_	NN	NN	_	32	nsubj	_	_
32	is	_	VBZ	VBZ	_	24	rcmod	_	_
33	expressed	_	VBN	VBN	_	32	dep	_	_
34	and	_	CC	CC	_	33	cc	_	_
35	active	_	JJ	JJ	_	33	conj	_	_
36	in	_	IN	IN	_	32	prep	_	_
37	plasmacytoma	_	NN	NN	_	39	nn	_	_
38	cell	_	NN	NN	_	39	nn	_	_
39	lines	_	NNS	NNS	_	36	pobj	_	_
40	.	_	.	.	_	10	punct	_	_

1	At	_	IN	IN	_	6	prep	_	_
2	present	_	JJ	JJ	_	1	pobj	_	_
3	,	_	,	,	_	6	punct	_	_
4	it	_	PRP	PRP	_	6	nsubj	_	_
5	is	_	VBZ	VBZ	_	6	cop	_	_
6	unclear	_	JJ	JJ	_	0	root	_	_
7	whether	_	IN	IN	_	21	mark	_	_
8	the	_	DT	DT	_	9	det	_	_
9	lack	_	NN	NN	_	21	nsubj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	PU.1	_	NN	NN	_	10	pobj	_	_
12	expression	_	NN	NN	_	11	dep	_	_
13	and	_	CC	CC	_	11	cc	_	_
14	activity	_	NN	NN	_	11	conj	_	_
15	in	_	IN	IN	_	9	prep	_	_
16	human	_	JJ	JJ	_	20	amod	_	_
17	multiple	_	JJ	JJ	_	20	amod	_	_
18	myeloma	_	NN	NN	_	20	nn	_	_
19	cell	_	NN	NN	_	20	nn	_	_
20	lines	_	NNS	NNS	_	15	pobj	_	_
21	represents	_	VBZ	VBZ	_	6	ccomp	_	_
22	a	_	DT	DT	_	24	det	_	_
23	malignancy-associated	_	JJ	JJ	_	24	amod	_	_
24	defect	_	NN	NN	_	21	dobj	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	these	_	DT	DT	_	27	det	_	_
27	cells	_	NNS	NNS	_	25	pobj	_	_
28	or	_	CC	CC	_	21	cc	_	_
29	exemplifies	_	VBZ	VBZ	_	21	conj	_	_
30	a	_	DT	DT	_	33	det	_	_
31	normal	_	JJ	JJ	_	33	amod	_	_
32	developmental	_	JJ	JJ	_	33	amod	_	_
33	regulation	_	NN	NN	_	29	dobj	_	_
34	in	_	IN	IN	_	33	prep	_	_
35	terminally	_	RB	RB	_	38	advmod	_	_
36	differentiated	_	VBN	VBN	_	38	amod	_	_
37	B	_	NN	NN	_	38	nn	_	_
38	cells	_	NNS	NNS	_	34	pobj	_	_
39	.	_	.	.	_	6	punct	_	_

1	Microtubules	_	NNS	NNS	_	2	nsubj	_	_
2	mediate	_	VBP	VBP	_	0	root	_	_
3	cellular	_	JJ	JJ	_	6	amod	_	_
4	25-hydroxyvitamin	_	NN	NN	_	6	nn	_	_
5	D3	_	NN	NN	_	6	nn	_	_
6	trafficking	_	NN	NN	_	2	dobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	the	_	DT	DT	_	10	det	_	_
9	genomic	_	JJ	JJ	_	10	amod	_	_
10	response	_	NN	NN	_	6	conj	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	1,25-dihydroxyvitamin	_	NN	NN	_	13	nn	_	_
13	D3	_	NN	NN	_	11	pobj	_	_
14	in	_	IN	IN	_	2	prep	_	_
15	normal	_	JJ	JJ	_	17	amod	_	_
16	human	_	JJ	JJ	_	17	amod	_	_
17	monocytes	_	NNS	NNS	_	14	pobj	_	_
18	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	genomic	_	JJ	JJ	_	3	amod	_	_
3	actions	_	NNS	NNS	_	11	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	1,25-dihydroxyvitamin	_	NN	NN	_	6	nn	_	_
6	D3	_	NN	NN	_	4	pobj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	1,25-LRB-OH-RRB-2D3	_	NN	NN	_	6	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	are	_	VBP	VBP	_	11	auxpass	_	_
11	mediated	_	VBN	VBN	_	0	root	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	17	det	_	_
14	intracellular	_	JJ	JJ	_	17	amod	_	_
15	vitamin	_	NN	NN	_	17	nn	_	_
16	D	_	NN	NN	_	17	nn	_	_
17	receptor	_	NN	NN	_	12	pobj	_	_
18	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
19	VDR	_	NN	NN	_	17	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	.	_	.	.	_	11	punct	_	_

1	Although	_	IN	IN	_	4	mark	_	_
2	immunocytochemistry	_	NN	NN	_	4	nsubj	_	_
3	has	_	VBZ	VBZ	_	4	aux	_	_
4	shown	_	VBN	VBN	_	30	advcl	_	_
5	that	_	IN	IN	_	10	mark	_	_
6	disruption	_	NN	NN	_	10	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	microtubular	_	JJ	JJ	_	9	amod	_	_
9	assembly	_	NN	NN	_	7	pobj	_	_
10	prevents	_	VBZ	VBZ	_	4	ccomp	_	_
11	nuclear	_	JJ	JJ	_	12	amod	_	_
12	access	_	NN	NN	_	10	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	sterol-VDR	_	NN	NN	_	16	nn	_	_
16	complex	_	NN	NN	_	13	pobj	_	_
17	,	_	,	,	_	30	punct	_	_
18	the	_	DT	DT	_	19	det	_	_
19	role	_	NN	NN	_	30	nsubjpass	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	microtubules	_	NNS	NNS	_	20	pobj	_	_
22	in	_	IN	IN	_	19	prep	_	_
23	the	_	DT	DT	_	24	det	_	_
24	response	_	NN	NN	_	22	pobj	_	_
25	to	_	TO	TO	_	24	prep	_	_
26	1,25-LRB-OH-RRB-2D3	_	NN	NN	_	25	pobj	_	_
27	has	_	VBZ	VBZ	_	30	aux	_	_
28	not	_	RB	RB	_	30	neg	_	_
29	been	_	VBN	VBN	_	30	auxpass	_	_
30	studied	_	VBN	VBN	_	0	root	_	_
31	in	_	IN	IN	_	30	prep	_	_
32	viable	_	JJ	JJ	_	33	amod	_	_
33	cells	_	NNS	NNS	_	31	pobj	_	_
34	.	_	.	.	_	30	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	studies	_	NNS	NNS	_	3	nsubj	_	_
3	examined	_	VBD	VBD	_	0	root	_	_
4	this	_	DT	DT	_	5	det	_	_
5	interaction	_	NN	NN	_	3	dobj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	normal	_	JJ	JJ	_	9	amod	_	_
8	human	_	JJ	JJ	_	9	amod	_	_
9	monocytes	_	NNS	NNS	_	6	pobj	_	_
10	.	_	.	.	_	3	punct	_	_

1	Monocytes	_	NNS	NNS	_	2	nsubj	_	_
2	convert	_	VBP	VBP	_	0	root	_	_
3	25-LRB-OH-RRB-D3	_	NN	NN	_	2	dobj	_	_
4	to	_	TO	TO	_	2	prep	_	_
5	1,25-LRB-OH-RRB-2D3	_	NN	NN	_	4	pobj	_	_
6	and	_	CC	CC	_	4	cc	_	_
7	to	_	TO	TO	_	4	conj	_	_
8	24-hydroxylated	_	JJ	JJ	_	9	amod	_	_
9	metabolites	_	NNS	NNS	_	7	pobj	_	_
10	more	_	RBR	RBR	_	11	advmod	_	_
11	polar	_	JJ	JJ	_	9	amod	_	_
12	than	_	IN	IN	_	11	prep	_	_
13	1,25-LRB-OH-RRB-2D3	_	NN	NN	_	12	pobj	_	_
14	.	_	.	.	_	2	punct	_	_

1	Microtubule	_	NN	NN	_	2	nn	_	_
2	disruption	_	NN	NN	_	4	nsubj	_	_
3	totally	_	RB	RB	_	4	advmod	_	_
4	abolished	_	VBD	VBD	_	0	root	_	_
5	the	_	DT	DT	_	6	det	_	_
6	ability	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	exogenous	_	JJ	JJ	_	9	amod	_	_
9	1,25-LRB-OH-RRB-2D3	_	NN	NN	_	7	pobj	_	_
10	to	_	TO	TO	_	11	aux	_	_
11	suppress	_	VB	VB	_	6	dep	_	_
12	its	_	PRP$	PRP$	_	14	poss	_	_
13	own	_	JJ	JJ	_	14	amod	_	_
14	synthesis	_	NN	NN	_	11	dobj	_	_
15	and	_	CC	CC	_	11	cc	_	_
16	to	_	TO	TO	_	17	aux	_	_
17	induce	_	VB	VB	_	11	conj	_	_
18	24-hydroxylase	_	NN	NN	_	19	nn	_	_
19	mRNA	_	NN	NN	_	17	dobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	activity	_	NN	NN	_	19	conj	_	_
22	,	_	,	,	_	4	punct	_	_
23	without	_	IN	IN	_	4	prep	_	_
24	affecting	_	VBG	VBG	_	23	pcomp	_	_
25	either	_	CC	CC	_	28	preconj	_	_
26	total	_	JJ	JJ	_	28	amod	_	_
27	1,25-LRB-OH-RRB-2D3	_	NN	NN	_	28	nn	_	_
28	uptake	_	NN	NN	_	24	dobj	_	_
29	or	_	CC	CC	_	28	cc	_	_
30	maximal	_	JJ	JJ	_	32	amod	_	_
31	1,25-LRB-OH-RRB-2D3-VDR	_	JJ	JJ	_	32	amod	_	_
32	binding	_	NN	NN	_	28	conj	_	_
33	.	_	.	.	_	4	punct	_	_

1	Thus	_	RB	RB	_	6	advmod	_	_
2	,	_	,	,	_	6	punct	_	_
3	intact	_	JJ	JJ	_	4	amod	_	_
4	microtubules	_	NNS	NNS	_	6	nsubj	_	_
5	are	_	VBP	VBP	_	6	cop	_	_
6	essential	_	JJ	JJ	_	0	root	_	_
7	for	_	IN	IN	_	6	prep	_	_
8	1,25-LRB-OH-RRB-2D3-dependent	_	JJ	JJ	_	9	amod	_	_
9	modulation	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	gene	_	NN	NN	_	12	nn	_	_
12	transcription	_	NN	NN	_	10	pobj	_	_
13	.	_	.	.	_	6	punct	_	_

1	Interestingly	_	RB	RB	_	6	advmod	_	_
2	,	_	,	,	_	6	punct	_	_
3	microtubule	_	NN	NN	_	4	nn	_	_
4	disruption	_	NN	NN	_	6	nsubj	_	_
5	also	_	RB	RB	_	6	advmod	_	_
6	decreased	_	VBD	VBD	_	0	root	_	_
7	monocyte	_	NN	NN	_	9	nn	_	_
8	1,25-LRB-OH-RRB-2D3	_	NN	NN	_	9	nn	_	_
9	synthesis	_	NN	NN	_	6	dobj	_	_
10	,	_	,	,	_	6	punct	_	_
11	not	_	RB	RB	_	12	neg	_	_
12	by	_	IN	IN	_	6	prep	_	_
13	decreasing	_	VBG	VBG	_	12	pcomp	_	_
14	the	_	DT	DT	_	15	det	_	_
15	Vmax	_	NN	NN	_	13	dobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	monocyte	_	NN	NN	_	20	nn	_	_
18	mitochondrial	_	JJ	JJ	_	20	amod	_	_
19	1	_	CD	CD	_	20	num	_	_
20	alpha-hydroxylase	_	NN	NN	_	16	pobj	_	_
21	but	_	CC	CC	_	12	cc	_	_
22	through	_	IN	IN	_	12	conj	_	_
23	an	_	DT	DT	_	24	det	_	_
24	increase	_	NN	NN	_	22	pobj	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	27	det	_	_
27	Km	_	NN	NN	_	25	pobj	_	_
28	for	_	IN	IN	_	27	prep	_	_
29	25-LRB-OH-RRB-2D3	_	NN	NN	_	28	pobj	_	_
30	.	_	.	.	_	6	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	examined	_	VBD	VBD	_	0	root	_	_
3	25-LRB-OH-RRB-D3	_	NN	NN	_	4	nn	_	_
4	transport	_	NN	NN	_	2	dobj	_	_
5	.	_	.	.	_	2	punct	_	_

1	Microtubule	_	NN	NN	_	2	nn	_	_
2	disruption	_	NN	NN	_	5	nsubj	_	_
3	did	_	VBD	VBD	_	5	aux	_	_
4	not	_	RB	RB	_	5	neg	_	_
5	affect	_	VB	VB	_	0	root	_	_
6	total	_	JJ	JJ	_	9	amod	_	_
7	cellular	_	JJ	JJ	_	9	amod	_	_
8	25-LRB-OH-RRB-D3	_	NN	NN	_	9	nn	_	_
9	uptake	_	NN	NN	_	5	dobj	_	_
10	but	_	CC	CC	_	5	cc	_	_
11	reduced	_	VBD	VBD	_	5	conj	_	_
12	its	_	PRP$	PRP$	_	14	poss	_	_
13	intracellular	_	JJ	JJ	_	14	amod	_	_
14	trafficking	_	NN	NN	_	11	dobj	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	the	_	DT	DT	_	17	det	_	_
17	mitochondria	_	NN	NN	_	15	pobj	_	_
18	.	_	.	.	_	5	punct	_	_

1	Thus	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	microtubules	_	NNS	NNS	_	4	nsubj	_	_
4	participate	_	VBP	VBP	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	intracellular	_	JJ	JJ	_	8	amod	_	_
7	25-LRB-OH-RRB-D3	_	NN	NN	_	8	nn	_	_
8	transport	_	NN	NN	_	5	pobj	_	_
9	,	_	,	,	_	4	punct	_	_
10	and	_	CC	CC	_	4	cc	_	_
11	their	_	PRP$	PRP$	_	12	poss	_	_
12	integrity	_	NN	NN	_	13	nsubj	_	_
13	determines	_	VBZ	VBZ	_	4	conj	_	_
14	normal	_	JJ	JJ	_	16	amod	_	_
15	1,25-LRB-OH-RRB-2D3	_	NN	NN	_	16	nn	_	_
16	synthesis	_	NN	NN	_	13	dobj	_	_
17	.	_	.	.	_	4	punct	_	_

1	Functional	_	JJ	JJ	_	2	amod	_	_
2	characterization	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	novel	_	JJ	JJ	_	7	amod	_	_
5	IL-2	_	NN	NN	_	7	nn	_	_
6	transcriptional	_	JJ	JJ	_	7	amod	_	_
7	inhibitors	_	NNS	NNS	_	3	pobj	_	_
8	.	_	.	.	_	2	punct	_	_

1	IL-2-mediated	_	JJ	JJ	_	4	amod	_	_
2	T	_	NN	NN	_	3	nn	_	_
3	cell	_	NN	NN	_	4	nn	_	_
4	proliferation	_	NN	NN	_	9	nsubj	_	_
5	is	_	VBZ	VBZ	_	9	cop	_	_
6	a	_	DT	DT	_	9	det	_	_
7	critical	_	JJ	JJ	_	9	amod	_	_
8	early	_	JJ	JJ	_	7	dep	_	_
9	event	_	NN	NN	_	0	root	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	inflammatory	_	JJ	JJ	_	13	amod	_	_
13	process	_	NN	NN	_	10	pobj	_	_
14	.	_	.	.	_	9	punct	_	_

1	Formation	_	NN	NN	_	12	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	6	det	_	_
4	NFAT-1	_	NN	NN	_	6	nn	_	_
5	transcriptional	_	JJ	JJ	_	6	amod	_	_
6	complex	_	NN	NN	_	2	pobj	_	_
7	on	_	IN	IN	_	1	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	IL-2	_	NN	NN	_	10	nn	_	_
10	promoter	_	NN	NN	_	7	pobj	_	_
11	is	_	VBZ	VBZ	_	12	cop	_	_
12	essential	_	JJ	JJ	_	0	root	_	_
13	for	_	IN	IN	_	12	prep	_	_
14	IL-2	_	NN	NN	_	15	nn	_	_
15	transcription	_	NN	NN	_	13	pobj	_	_
16	.	_	.	.	_	12	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	a	_	DT	DT	_	4	det	_	_
3	cell	_	NN	NN	_	4	nn	_	_
4	line	_	NN	NN	_	1	dobj	_	_
5	that	_	WDT	WDT	_	8	nsubjpass	_	_
6	is	_	VBZ	VBZ	_	8	auxpass	_	_
7	stably	_	RB	RB	_	8	advmod	_	_
8	transfected	_	VBN	VBN	_	4	rcmod	_	_
9	with	_	IN	IN	_	8	prep	_	_
10	a	_	DT	DT	_	11	det	_	_
11	trimer	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	16	det	_	_
14	NFAT-1	_	NN	NN	_	16	nn	_	_
15	regulatory	_	JJ	JJ	_	16	amod	_	_
16	element	_	NN	NN	_	12	pobj	_	_
17	linked	_	VBN	VBN	_	16	vmod	_	_
18	to	_	TO	TO	_	17	prep	_	_
19	a	_	DT	DT	_	22	det	_	_
20	lac-Z	_	NN	NN	_	22	nn	_	_
21	reporter	_	NN	NN	_	22	nn	_	_
22	gene	_	NN	NN	_	18	pobj	_	_
23	,	_	,	,	_	1	punct	_	_
24	we	_	PRP	PRP	_	25	nsubj	_	_
25	screened	_	VBD	VBD	_	1	parataxis	_	_
26	for	_	IN	IN	_	25	prep	_	_
27	inhibitors	_	NNS	NNS	_	26	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	NFAT-1-mediated	_	JJ	JJ	_	31	amod	_	_
30	beta-galactosidase	_	NN	NN	_	31	nn	_	_
31	activity	_	NN	NN	_	28	pobj	_	_
32	.	_	.	.	_	1	punct	_	_

1	WIN	_	NN	NN	_	7	nsubjpass	_	_
2	61058	_	CD	CD	_	1	num	_	_
3	and	_	CC	CC	_	1	cc	_	_
4	WIN	_	NN	NN	_	1	conj	_	_
5	53071	_	CD	CD	_	4	num	_	_
6	were	_	VBD	VBD	_	7	auxpass	_	_
7	identified	_	VBN	VBN	_	0	root	_	_
8	as	_	IN	IN	_	7	prep	_	_
9	microM	_	NN	NN	_	10	nn	_	_
10	inhibitors	_	NNS	NNS	_	8	pobj	_	_
11	.	_	.	.	_	7	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	compounds	_	NNS	NNS	_	4	nsubj	_	_
3	also	_	RB	RB	_	4	advmod	_	_
4	inhibited	_	VBD	VBD	_	0	root	_	_
5	beta-galactosidase	_	NN	NN	_	6	nn	_	_
6	mRNA	_	NN	NN	_	7	nn	_	_
7	levels	_	NNS	NNS	_	4	dobj	_	_
8	.	_	.	.	_	4	punct	_	_

1	Similar	_	JJ	JJ	_	2	amod	_	_
2	inhibition	_	NN	NN	_	8	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	NFAT-1-mediated	_	JJ	JJ	_	6	amod	_	_
5	gene	_	NN	NN	_	6	nn	_	_
6	expression	_	NN	NN	_	3	pobj	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	observed	_	VBN	VBN	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	a	_	DT	DT	_	13	det	_	_
11	second	_	JJ	JJ	_	13	amod	_	_
12	cell	_	NN	NN	_	13	nn	_	_
13	line	_	NN	NN	_	9	pobj	_	_
14	,	_	,	,	_	13	punct	_	_
15	which	_	WDT	WDT	_	18	nsubjpass	_	_
16	is	_	VBZ	VBZ	_	18	auxpass	_	_
17	stably	_	RB	RB	_	18	advmod	_	_
18	transfected	_	VBN	VBN	_	13	rcmod	_	_
19	with	_	IN	IN	_	18	prep	_	_
20	NFAT-1	_	NN	NN	_	22	nn	_	_
21	regulatory	_	JJ	JJ	_	22	amod	_	_
22	elements	_	NNS	NNS	_	19	pobj	_	_
23	linked	_	VBN	VBN	_	22	vmod	_	_
24	to	_	TO	TO	_	23	prep	_	_
25	the	_	DT	DT	_	29	det	_	_
26	reporter	_	NN	NN	_	29	nn	_	_
27	gene	_	NN	NN	_	29	nn	_	_
28	for	_	IN	IN	_	29	amod	_	_
29	sCD8	_	NN	NN	_	24	pobj	_	_
30	.	_	.	.	_	8	punct	_	_

1	At	_	IN	IN	_	7	prep	_	_
2	10	_	CD	CD	_	3	num	_	_
3	microM	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	7	punct	_	_
5	both	_	DT	DT	_	6	det	_	_
6	compounds	_	NNS	NNS	_	7	nsubj	_	_
7	inhibited	_	VBD	VBD	_	0	root	_	_
8	IL-2	_	NN	NN	_	9	nn	_	_
9	mRNA	_	NN	NN	_	7	dobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	protein	_	NN	NN	_	9	conj	_	_
12	levels	_	NNS	NNS	_	9	dep	_	_
13	in	_	IN	IN	_	7	prep	_	_
14	the	_	DT	DT	_	17	det	_	_
15	NFAT-1-linked	_	JJ	JJ	_	17	amod	_	_
16	lac-Z	_	NN	NN	_	17	nn	_	_
17	transfectants	_	NNS	NNS	_	13	pobj	_	_
18	,	_	,	,	_	13	punct	_	_
19	and	_	CC	CC	_	13	cc	_	_
20	in	_	IN	IN	_	13	conj	_	_
21	human	_	JJ	JJ	_	22	amod	_	_
22	lymphocytes	_	NNS	NNS	_	20	pobj	_	_
23	.	_	.	.	_	7	punct	_	_

1	Both	_	DT	DT	_	2	det	_	_
2	compounds	_	NNS	NNS	_	3	nsubj	_	_
3	inhibited	_	VBD	VBD	_	0	root	_	_
4	the	_	DT	DT	_	7	det	_	_
5	mixed	_	JJ	JJ	_	7	amod	_	_
6	lymphocyte	_	NN	NN	_	7	nn	_	_
7	reaction	_	NN	NN	_	3	dobj	_	_
8	,	_	,	,	_	3	punct	_	_
9	and	_	CC	CC	_	3	cc	_	_
10	this	_	DT	DT	_	11	det	_	_
11	inhibition	_	NN	NN	_	13	nsubjpass	_	_
12	was	_	VBD	VBD	_	13	auxpass	_	_
13	reversed	_	VBN	VBN	_	3	conj	_	_
14	by	_	IN	IN	_	13	prep	_	_
15	exogenous	_	JJ	JJ	_	16	amod	_	_
16	IL-2	_	NN	NN	_	14	pobj	_	_
17	.	_	.	.	_	3	punct	_	_

1	WIN	_	NN	NN	_	3	nsubj	_	_
2	53071	_	CD	CD	_	1	num	_	_
3	inhibited	_	VBD	VBD	_	0	root	_	_
4	IL-2	_	NN	NN	_	5	nn	_	_
5	production	_	NN	NN	_	3	dobj	_	_
6	induced	_	VBN	VBN	_	5	vmod	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	dep	_	_
9	calcium-dependent	_	JJ	JJ	_	10	amod	_	_
10	PMA	_	NN	NN	_	7	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	ionomycin	_	NN	NN	_	10	conj	_	_
13	pathway	_	NN	NN	_	10	dep	_	_
14	.	_	.	.	_	3	punct	_	_

1	Conversely	_	RB	RB	_	11	advmod	_	_
2	,	_	,	,	_	11	punct	_	_
3	calcium-independent	_	JJ	JJ	_	5	amod	_	_
4	anti-CD28	_	JJ	JJ	_	5	amod	_	_
5	Ab	_	NN	NN	_	9	nn	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	PMA-induced	_	JJ	JJ	_	8	amod	_	_
8	IL-2	_	NN	NN	_	5	conj	_	_
9	production	_	NN	NN	_	11	nsubj	_	_
10	was	_	VBD	VBD	_	11	cop	_	_
11	resistant	_	JJ	JJ	_	0	root	_	_
12	.	_	.	.	_	11	punct	_	_

1	Both	_	DT	DT	_	2	det	_	_
2	compounds	_	NNS	NNS	_	3	nsubj	_	_
3	altered	_	VBD	VBD	_	0	root	_	_
4	the	_	DT	DT	_	7	det	_	_
5	NFAT-1	_	NN	NN	_	7	nn	_	_
6	transcriptional	_	JJ	JJ	_	7	amod	_	_
7	complex	_	NN	NN	_	3	dobj	_	_
8	,	_	,	,	_	3	punct	_	_
9	causing	_	VBG	VBG	_	3	vmod	_	_
10	its	_	PRP$	PRP$	_	12	poss	_	_
11	retarded	_	VBN	VBN	_	12	amod	_	_
12	mobility	_	NN	NN	_	9	dobj	_	_
13	on	_	IN	IN	_	12	prep	_	_
14	gels	_	NNS	NNS	_	13	pobj	_	_
15	.	_	.	.	_	3	punct	_	_

1	By	_	IN	IN	_	7	prep	_	_
2	these	_	DT	DT	_	4	det	_	_
3	functional	_	JJ	JJ	_	4	amod	_	_
4	criteria	_	NNS	NNS	_	1	pobj	_	_
5	,	_	,	,	_	7	punct	_	_
6	we	_	PRP	PRP	_	7	nsubj	_	_
7	believe	_	VBP	VBP	_	0	root	_	_
8	we	_	PRP	PRP	_	7	dobj	_	_
9	have	_	VBP	VBP	_	10	aux	_	_
10	identified	_	VBN	VBN	_	7	dep	_	_
11	two	_	CD	CD	_	16	num	_	_
12	structurally	_	RB	RB	_	13	advmod	_	_
13	distinct	_	JJ	JJ	_	16	amod	_	_
14	,	_	,	,	_	13	punct	_	_
15	novel	_	JJ	JJ	_	13	dep	_	_
16	inhibitors	_	NNS	NNS	_	10	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	NFAT-1-mediated	_	JJ	JJ	_	19	amod	_	_
19	transcription	_	NN	NN	_	17	pobj	_	_
20	.	_	.	.	_	7	punct	_	_

1	Platelet-activating	_	JJ	JJ	_	2	amod	_	_
2	factor	_	NN	NN	_	3	nsubj	_	_
3	stimulates	_	VBZ	VBZ	_	0	root	_	_
4	transcription	_	NN	NN	_	3	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	12	det	_	_
7	heparin-binding	_	JJ	JJ	_	12	amod	_	_
8	epidermal	_	JJ	JJ	_	12	amod	_	_
9	growth	_	NN	NN	_	12	nn	_	_
10	factor-like	_	JJ	JJ	_	12	amod	_	_
11	growth	_	NN	NN	_	12	nn	_	_
12	factor	_	NN	NN	_	5	pobj	_	_
13	in	_	IN	IN	_	4	prep	_	_
14	monocytes	_	NNS	NNS	_	13	pobj	_	_
15	.	_	.	.	_	3	punct	_	_

1	Correlation	_	NN	NN	_	0	root	_	_
2	with	_	IN	IN	_	1	prep	_	_
3	an	_	DT	DT	_	8	det	_	_
4	increased	_	VBN	VBN	_	8	amod	_	_
5	kappa	_	NN	NN	_	8	nn	_	_
6	B	_	NN	NN	_	8	nn	_	_
7	binding	_	NN	NN	_	8	nn	_	_
8	activity	_	NN	NN	_	2	pobj	_	_
9	.	_	.	.	_	1	punct	_	_

1	Human	_	JJ	JJ	_	3	amod	_	_
2	peripheral	_	JJ	JJ	_	3	amod	_	_
3	blood	_	NN	NN	_	5	nsubj	_	_
4	monocytes	_	NNS	NNS	_	3	dep	_	_
5	responded	_	VBD	VBD	_	0	root	_	_
6	to	_	TO	TO	_	5	prep	_	_
7	stimulation	_	NN	NN	_	6	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	platelet-activating	_	JJ	JJ	_	10	amod	_	_
10	factor	_	NN	NN	_	8	pobj	_	_
11	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
12	PAF	_	NN	NN	_	10	appos	_	_
13	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	with	_	IN	IN	_	7	prep	_	_
15	up-regulation	_	NN	NN	_	14	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	transcript	_	NN	NN	_	16	pobj	_	_
19	for	_	IN	IN	_	18	prep	_	_
20	heparin-binding	_	JJ	JJ	_	25	amod	_	_
21	epidermal	_	JJ	JJ	_	25	amod	_	_
22	growth	_	NN	NN	_	25	nn	_	_
23	factor-like	_	JJ	JJ	_	25	amod	_	_
24	growth	_	NN	NN	_	25	nn	_	_
25	factor	_	NN	NN	_	19	pobj	_	_
26	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
27	HB-EGF	_	NN	NN	_	25	appos	_	_
28	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
29	,	_	,	,	_	25	punct	_	_
30	a	_	DT	DT	_	32	det	_	_
31	potent	_	JJ	JJ	_	32	amod	_	_
32	mitogen	_	NN	NN	_	25	appos	_	_
33	for	_	IN	IN	_	32	prep	_	_
34	vascular	_	JJ	JJ	_	37	amod	_	_
35	smooth	_	JJ	JJ	_	37	amod	_	_
36	muscle	_	NN	NN	_	37	nn	_	_
37	cells	_	NNS	NNS	_	33	pobj	_	_
38	.	_	.	.	_	5	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	function	_	NN	NN	_	6	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	PAF	_	NN	NN	_	3	pobj	_	_
5	was	_	VBD	VBD	_	6	auxpass	_	_
6	observed	_	VBN	VBN	_	0	root	_	_
7	at	_	IN	IN	_	6	prep	_	_
8	nanomolar	_	JJ	JJ	_	9	amod	_	_
9	concentrations	_	NNS	NNS	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	ligand	_	NN	NN	_	10	pobj	_	_
13	,	_	,	,	_	6	punct	_	_
14	starting	_	VBG	VBG	_	6	vmod	_	_
15	at	_	IN	IN	_	14	prep	_	_
16	30	_	CD	CD	_	17	num	_	_
17	min	_	NN	NN	_	15	pobj	_	_
18	after	_	IN	IN	_	17	prep	_	_
19	stimulation	_	NN	NN	_	18	pobj	_	_
20	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	PAF-induced	_	JJ	JJ	_	3	amod	_	_
3	up-regulation	_	NN	NN	_	8	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	HB-EGF	_	NN	NN	_	6	nn	_	_
6	mRNA	_	NN	NN	_	4	pobj	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	accompanied	_	VBN	VBN	_	0	root	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	an	_	DT	DT	_	11	det	_	_
11	increase	_	NN	NN	_	9	pobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	kappa	_	NN	NN	_	16	nn	_	_
14	B	_	NN	NN	_	16	nn	_	_
15	binding	_	NN	NN	_	16	nn	_	_
16	activity	_	NN	NN	_	12	pobj	_	_
17	.	_	.	.	_	8	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	functions	_	NNS	NNS	_	5	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	PAF	_	NN	NN	_	3	pobj	_	_
5	appeared	_	VBD	VBD	_	0	root	_	_
6	to	_	TO	TO	_	8	aux	_	_
7	be	_	VB	VB	_	8	auxpass	_	_
8	mediated	_	VBN	VBN	_	5	xcomp	_	_
9	through	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	14	det	_	_
11	cell	_	NN	NN	_	14	nn	_	_
12	surface	_	NN	NN	_	14	nn	_	_
13	PAF	_	NN	NN	_	14	nn	_	_
14	receptors	_	NNS	NNS	_	9	pobj	_	_
15	,	_	,	,	_	5	punct	_	_
16	as	_	IN	IN	_	29	mark	_	_
17	two	_	CD	CD	_	20	num	_	_
18	PAF	_	NN	NN	_	20	nn	_	_
19	receptor	_	NN	NN	_	20	nn	_	_
20	antagonists	_	NNS	NNS	_	29	nsubj	_	_
21	,	_	,	,	_	20	punct	_	_
22	WEB	_	NN	NN	_	20	appos	_	_
23	2086	_	CD	CD	_	22	num	_	_
24	and	_	CC	CC	_	22	cc	_	_
25	L-659	_	NN	NN	_	22	conj	_	_
26	,	_	,	,	_	25	punct	_	_
27	989	_	CD	CD	_	25	num	_	_
28	,	_	,	,	_	20	punct	_	_
29	blocked	_	VBD	VBD	_	5	advcl	_	_
30	both	_	CC	CC	_	32	preconj	_	_
31	the	_	DT	DT	_	32	det	_	_
32	up-regulation	_	NN	NN	_	29	dobj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	HB-EGF	_	NN	NN	_	35	nn	_	_
35	mRNA	_	NN	NN	_	33	pobj	_	_
36	and	_	CC	CC	_	32	cc	_	_
37	kappa	_	NN	NN	_	40	nn	_	_
38	B	_	NN	NN	_	40	nn	_	_
39	binding	_	NN	NN	_	40	nn	_	_
40	activity	_	NN	NN	_	32	conj	_	_
41	induced	_	VBN	VBN	_	32	vmod	_	_
42	by	_	IN	IN	_	41	prep	_	_
43	PAF	_	NN	NN	_	42	pobj	_	_
44	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	antagonists	_	NNS	NNS	_	6	nsubj	_	_
3	,	_	,	,	_	2	punct	_	_
4	however	_	RB	RB	_	6	advmod	_	_
5	,	_	,	,	_	6	punct	_	_
6	had	_	VBD	VBD	_	0	root	_	_
7	no	_	DT	DT	_	8	neg	_	_
8	effect	_	NN	NN	_	6	dobj	_	_
9	on	_	IN	IN	_	6	prep	_	_
10	phorbol	_	NN	NN	_	12	nn	_	_
11	ester-induced	_	JJ	JJ	_	12	amod	_	_
12	up-regulation	_	NN	NN	_	9	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	HB-EGF	_	NN	NN	_	15	nn	_	_
15	mRNA	_	NN	NN	_	13	pobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	kappa	_	NN	NN	_	20	nn	_	_
18	B	_	NN	NN	_	20	nn	_	_
19	binding	_	NN	NN	_	20	nn	_	_
20	activity	_	NN	NN	_	15	conj	_	_
21	.	_	.	.	_	6	punct	_	_

1	Pretreatment	_	NN	NN	_	7	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	monocytes	_	NNS	NNS	_	2	pobj	_	_
4	with	_	IN	IN	_	1	prep	_	_
5	pertussis	_	NN	NN	_	6	nn	_	_
6	toxin	_	NN	NN	_	4	pobj	_	_
7	inhibited	_	VBD	VBD	_	0	root	_	_
8	these	_	DT	DT	_	9	det	_	_
9	functions	_	NNS	NNS	_	7	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	PAF	_	NN	NN	_	10	pobj	_	_
12	,	_	,	,	_	7	punct	_	_
13	whereas	_	IN	IN	_	16	mark	_	_
14	cholera	_	NN	NN	_	15	nn	_	_
15	toxin	_	NN	NN	_	16	nsubj	_	_
16	had	_	VBD	VBD	_	7	advcl	_	_
17	no	_	DT	DT	_	19	neg	_	_
18	inhibitory	_	JJ	JJ	_	19	amod	_	_
19	effect	_	NN	NN	_	16	dobj	_	_
20	.	_	.	.	_	7	punct	_	_

1	Pyrrolidine	_	NN	NN	_	2	nn	_	_
2	dithiocarbamate	_	NN	NN	_	12	nsubj	_	_
3	,	_	,	,	_	2	punct	_	_
4	an	_	DT	DT	_	5	det	_	_
5	inhibitor	_	NN	NN	_	2	appos	_	_
6	for	_	IN	IN	_	5	prep	_	_
7	NF-kappa	_	NN	NN	_	8	nn	_	_
8	B	_	NN	NN	_	9	nn	_	_
9	activation	_	NN	NN	_	6	pobj	_	_
10	,	_	,	,	_	2	punct	_	_
11	markedly	_	RB	RB	_	12	advmod	_	_
12	reduced	_	VBD	VBD	_	0	root	_	_
13	PAF-stimulated	_	JJ	JJ	_	17	amod	_	_
14	kappa	_	NN	NN	_	17	nn	_	_
15	B	_	NN	NN	_	17	nn	_	_
16	binding	_	NN	NN	_	17	nn	_	_
17	activity	_	NN	NN	_	12	dobj	_	_
18	as	_	RB	RB	_	19	advmod	_	_
19	well	_	RB	RB	_	17	cc	_	_
20	as	_	IN	IN	_	19	mwe	_	_
21	up-regulation	_	NN	NN	_	17	conj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	HB-EGF	_	NN	NN	_	24	nn	_	_
24	mRNA	_	NN	NN	_	22	pobj	_	_
25	.	_	.	.	_	12	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	a	_	DT	DT	_	6	det	_	_
5	potential	_	JJ	JJ	_	6	amod	_	_
6	role	_	NN	NN	_	3	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	PAF	_	NN	NN	_	7	pobj	_	_
9	in	_	IN	IN	_	6	prep	_	_
10	HB-EGF	_	NN	NN	_	11	nn	_	_
11	expression	_	NN	NN	_	9	pobj	_	_
12	and	_	CC	CC	_	3	cc	_	_
13	provide	_	VBP	VBP	_	3	conj	_	_
14	evidence	_	NN	NN	_	13	dobj	_	_
15	that	_	IN	IN	_	19	mark	_	_
16	this	_	DT	DT	_	17	det	_	_
17	stimulation	_	NN	NN	_	19	nsubj	_	_
18	may	_	MD	MD	_	19	aux	_	_
19	occur	_	VB	VB	_	14	ccomp	_	_
20	through	_	IN	IN	_	19	prep	_	_
21	increased	_	VBN	VBN	_	25	amod	_	_
22	kappa	_	NN	NN	_	25	nn	_	_
23	B	_	NN	NN	_	25	nn	_	_
24	binding	_	NN	NN	_	25	nn	_	_
25	activity	_	NN	NN	_	20	pobj	_	_
26	.	_	.	.	_	3	punct	_	_

1	IL-1	_	NN	NN	_	2	nn	_	_
2	receptor	_	NN	NN	_	6	nsubj	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	TCR	_	NN	NN	_	2	conj	_	_
5	signals	_	NNS	NNS	_	2	dep	_	_
6	synergize	_	VBP	VBP	_	0	root	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	activate	_	VB	VB	_	6	xcomp	_	_
9	NF-kappa	_	NN	NN	_	12	nn	_	_
10	B-mediated	_	JJ	JJ	_	12	amod	_	_
11	gene	_	NN	NN	_	12	nn	_	_
12	transcription	_	NN	NN	_	8	dobj	_	_
13	.	_	.	.	_	6	punct	_	_

1	Previous	_	JJ	JJ	_	2	amod	_	_
2	studies	_	NNS	NNS	_	4	nsubj	_	_
3	have	_	VBP	VBP	_	4	aux	_	_
4	demonstrated	_	VBN	VBN	_	0	root	_	_
5	that	_	IN	IN	_	16	mark	_	_
6	IL-1	_	NN	NN	_	7	nn	_	_
7	receptor	_	NN	NN	_	16	nsubj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	IL-1R	_	NN	NN	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	-	_	:	:	_	7	punct	_	_
12	and	_	CC	CC	_	7	cc	_	_
13	TCR-initiated	_	JJ	JJ	_	14	amod	_	_
14	signals	_	NNS	NNS	_	7	conj	_	_
15	can	_	MD	MD	_	16	aux	_	_
16	interact	_	VB	VB	_	4	ccomp	_	_
17	synergistically	_	RB	RB	_	16	advmod	_	_
18	to	_	TO	TO	_	19	aux	_	_
19	increase	_	VB	VB	_	16	xcomp	_	_
20	the	_	DT	DT	_	21	det	_	_
21	rate	_	NN	NN	_	19	dobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	transcription	_	NN	NN	_	22	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	several	_	JJ	JJ	_	26	amod	_	_
26	lymphokine	_	NN	NN	_	24	pobj	_	_
27	and	_	CC	CC	_	26	cc	_	_
28	lymphokine	_	NN	NN	_	29	nn	_	_
29	receptor	_	NN	NN	_	26	conj	_	_
30	genes	_	NNS	NNS	_	26	dep	_	_
31	during	_	IN	IN	_	19	prep	_	_
32	the	_	DT	DT	_	34	det	_	_
33	competence	_	NN	NN	_	34	nn	_	_
34	phase	_	NN	NN	_	31	pobj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	the	_	DT	DT	_	38	det	_	_
37	activation	_	NN	NN	_	38	nn	_	_
38	program	_	NN	NN	_	35	pobj	_	_
39	in	_	IN	IN	_	34	prep	_	_
40	T	_	NN	NN	_	42	nn	_	_
41	helper	_	NN	NN	_	42	nn	_	_
42	lymphocytes	_	NNS	NNS	_	39	pobj	_	_
43	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	5	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	report	_	NN	NN	_	1	pobj	_	_
4	we	_	PRP	PRP	_	5	nsubj	_	_
5	describe	_	VBP	VBP	_	0	root	_	_
6	how	_	WRB	WRB	_	14	advmod	_	_
7	signals	_	NNS	NNS	_	14	nsubj	_	_
8	initiated	_	VBN	VBN	_	7	vmod	_	_
9	through	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	13	det	_	_
11	type	_	NN	NN	_	13	nn	_	_
12	I	_	CD	CD	_	13	num	_	_
13	IL-1R	_	NN	NN	_	9	pobj	_	_
14	interact	_	VBP	VBP	_	5	ccomp	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	signals	_	NNS	NNS	_	15	pobj	_	_
17	from	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	antigen	_	NN	NN	_	20	nn	_	_
20	receptor	_	NN	NN	_	17	pobj	_	_
21	to	_	TO	TO	_	23	aux	_	_
22	synergistically	_	RB	RB	_	23	advmod	_	_
23	augment	_	VB	VB	_	14	xcomp	_	_
24	the	_	DT	DT	_	26	det	_	_
25	transactivating	_	NN	NN	_	26	nn	_	_
26	properties	_	NNS	NNS	_	23	dobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	NF-kappa	_	NN	NN	_	29	nn	_	_
29	B	_	NN	NN	_	27	pobj	_	_
30	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	6	det	_	_
2	synergistic	_	JJ	JJ	_	6	amod	_	_
3	antigen	_	NN	NN	_	4	nn	_	_
4	receptor	_	NN	NN	_	6	nn	_	_
5	initiated	_	JJ	JJ	_	6	amod	_	_
6	signals	_	NNS	NNS	_	8	nsubjpass	_	_
7	are	_	VBP	VBP	_	8	auxpass	_	_
8	mediated	_	VBN	VBN	_	0	root	_	_
9	through	_	IN	IN	_	8	prep	_	_
10	protein	_	NN	NN	_	12	nn	_	_
11	kinase	_	NN	NN	_	12	nn	_	_
12	C	_	NN	NN	_	9	pobj	_	_
13	because	_	IN	IN	_	17	mark	_	_
14	they	_	PRP	PRP	_	17	nsubjpass	_	_
15	can	_	MD	MD	_	17	aux	_	_
16	be	_	VB	VB	_	17	auxpass	_	_
17	mimicked	_	VBN	VBN	_	8	advcl	_	_
18	by	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	phorbol	_	NN	NN	_	21	nn	_	_
21	ester	_	NN	NN	_	18	pobj	_	_
22	,	_	,	,	_	21	punct	_	_
23	12-O-tetradecanoylphorbol-13-acetate	_	NN	NN	_	21	appos	_	_
24	,	_	,	,	_	18	punct	_	_
25	but	_	CC	CC	_	18	cc	_	_
26	not	_	RB	RB	_	27	neg	_	_
27	with	_	IN	IN	_	18	conj	_	_
28	calcium	_	NN	NN	_	29	nn	_	_
29	ionophores	_	NNS	NNS	_	27	pobj	_	_
30	;	_	:	:	_	8	punct	_	_
31	and	_	CC	CC	_	8	cc	_	_
32	are	_	VBP	VBP	_	34	cop	_	_
33	staurosporine	_	NN	NN	_	34	npadvmod	_	_
34	sensitive	_	JJ	JJ	_	8	conj	_	_
35	but	_	CC	CC	_	34	cc	_	_
36	cyclosporine	_	NN	NN	_	37	npadvmod	_	_
37	resistant	_	JJ	JJ	_	34	conj	_	_
38	.	_	.	.	_	8	punct	_	_

1	Gel	_	NN	NN	_	3	nn	_	_
2	shift	_	NN	NN	_	3	nn	_	_
3	analyses	_	NNS	NNS	_	4	nsubj	_	_
4	demonstrate	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	11	mark	_	_
6	NF-kappa	_	NN	NN	_	7	nn	_	_
7	B	_	NN	NN	_	9	nn	_	_
8	nuclear	_	JJ	JJ	_	9	amod	_	_
9	translocation	_	NN	NN	_	11	nsubjpass	_	_
10	is	_	VBZ	VBZ	_	11	auxpass	_	_
11	stimulated	_	VBN	VBN	_	4	ccomp	_	_
12	primarily	_	RB	RB	_	11	advmod	_	_
13	by	_	IN	IN	_	11	prep	_	_
14	IL-1	_	NN	NN	_	13	pobj	_	_
15	rather	_	RB	RB	_	13	cc	_	_
16	than	_	IN	IN	_	15	mwe	_	_
17	by	_	IN	IN	_	13	conj	_	_
18	antigen	_	NN	NN	_	19	nn	_	_
19	receptor	_	NN	NN	_	20	nn	_	_
20	signals	_	NNS	NNS	_	17	pobj	_	_
21	.	_	.	.	_	4	punct	_	_

1	Western	_	NN	NN	_	2	nn	_	_
2	blot	_	NN	NN	_	6	nsubj	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	phosphorylation	_	NN	NN	_	2	conj	_	_
5	analyses	_	NNS	NNS	_	2	dep	_	_
6	demonstrate	_	VBP	VBP	_	0	root	_	_
7	that	_	IN	IN	_	17	mark	_	_
8	the	_	DT	DT	_	10	det	_	_
9	synergistic	_	JJ	JJ	_	10	amod	_	_
10	effect	_	NN	NN	_	17	nsubj	_	_
11	on	_	IN	IN	_	10	prep	_	_
12	NF-kappa	_	NN	NN	_	13	nn	_	_
13	B	_	NN	NN	_	15	nn	_	_
14	functional	_	JJ	JJ	_	15	amod	_	_
15	activity	_	NN	NN	_	11	pobj	_	_
16	is	_	VBZ	VBZ	_	17	cop	_	_
17	independent	_	JJ	JJ	_	6	ccomp	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	I	_	NN	NN	_	22	nn	_	_
20	kappa	_	NN	NN	_	22	nn	_	_
21	B	_	NN	NN	_	22	nn	_	_
22	alpha	_	NN	NN	_	28	nn	_	_
23	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
24	MAD3	_	NN	NN	_	22	appos	_	_
25	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
26	-NF-kappa	_	NN	NN	_	28	nn	_	_
27	B	_	NN	NN	_	28	nn	_	_
28	dissociation	_	NN	NN	_	18	pobj	_	_
29	in	_	IN	IN	_	28	prep	_	_
30	the	_	DT	DT	_	31	det	_	_
31	cytosol	_	NN	NN	_	29	pobj	_	_
32	and	_	CC	CC	_	17	cc	_	_
33	is	_	VBZ	VBZ	_	35	auxpass	_	_
34	not	_	RB	RB	_	35	neg	_	_
35	associated	_	VBN	VBN	_	17	conj	_	_
36	with	_	IN	IN	_	35	prep	_	_
37	I	_	NN	NN	_	39	nn	_	_
38	kappa	_	NN	NN	_	39	nn	_	_
39	B	_	NN	NN	_	41	nn	_	_
40	nuclear	_	JJ	JJ	_	41	amod	_	_
41	translocation	_	NN	NN	_	36	pobj	_	_
42	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	7	det	_	_
2	IL-1-induced	_	JJ	JJ	_	7	amod	_	_
3	NF-kappa	_	NN	NN	_	4	nn	_	_
4	B	_	NN	NN	_	7	nn	_	_
5	DNA	_	NN	NN	_	7	nn	_	_
6	nuclear	_	JJ	JJ	_	7	amod	_	_
7	localization	_	NN	NN	_	9	nsubj	_	_
8	is	_	VBZ	VBZ	_	9	cop	_	_
9	transient	_	JJ	JJ	_	0	root	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	can	_	MD	MD	_	13	aux	_	_
12	be	_	VB	VB	_	13	cop	_	_
13	prolonged	_	JJ	JJ	_	9	conj	_	_
14	either	_	CC	CC	_	15	preconj	_	_
15	by	_	IN	IN	_	13	prep	_	_
16	an	_	DT	DT	_	19	det	_	_
17	antigen	_	NN	NN	_	19	nn	_	_
18	receptor-initiated	_	JJ	JJ	_	19	amod	_	_
19	signal	_	NN	NN	_	15	pobj	_	_
20	or	_	CC	CC	_	15	cc	_	_
21	by	_	IN	IN	_	15	conj	_	_
22	inhibiting	_	VBG	VBG	_	21	pcomp	_	_
23	protein	_	NN	NN	_	24	nn	_	_
24	synthesis	_	NN	NN	_	22	dobj	_	_
25	.	_	.	.	_	9	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	6	mark	_	_
5	IL-1	_	NN	NN	_	6	nsubj	_	_
6	induces	_	VBZ	VBZ	_	3	ccomp	_	_
7	both	_	CC	CC	_	11	preconj	_	_
8	NF-kappa	_	NN	NN	_	9	nn	_	_
9	B	_	NN	NN	_	11	nn	_	_
10	nuclear	_	JJ	JJ	_	11	amod	_	_
11	translocation	_	NN	NN	_	6	dobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	the	_	DT	DT	_	14	det	_	_
14	synthesis	_	NN	NN	_	11	conj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	a	_	DT	DT	_	19	det	_	_
17	protein	_	NN	NN	_	19	nn	_	_
18	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
19	s	_	NNS	NNS	_	15	pobj	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	responsible	_	JJ	JJ	_	19	amod	_	_
22	for	_	IN	IN	_	21	prep	_	_
23	terminating	_	VBG	VBG	_	22	pcomp	_	_
24	NF-kappa	_	NN	NN	_	26	nn	_	_
25	B-DNA	_	NN	NN	_	26	nn	_	_
26	interaction	_	NN	NN	_	23	dobj	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	29	det	_	_
29	nucleus	_	NN	NN	_	27	pobj	_	_
30	.	_	.	.	_	3	punct	_	_

1	Antigen	_	NN	NN	_	3	nn	_	_
2	receptor	_	NN	NN	_	3	nn	_	_
3	signals	_	NNS	NNS	_	4	nsubj	_	_
4	prolong	_	VBP	VBP	_	0	root	_	_
5	NF-kappa	_	NN	NN	_	7	nn	_	_
6	B-DNA	_	NN	NN	_	7	nn	_	_
7	interaction	_	NN	NN	_	4	dobj	_	_
8	,	_	,	,	_	4	punct	_	_
9	probably	_	RB	RB	_	10	advmod	_	_
10	by	_	IN	IN	_	4	prep	_	_
11	functionally	_	RB	RB	_	12	advmod	_	_
12	antagonizing	_	VBG	VBG	_	10	pcomp	_	_
13	the	_	DT	DT	_	15	det	_	_
14	IL-1-induced	_	JJ	JJ	_	15	amod	_	_
15	synthesis	_	NN	NN	_	12	dobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	a	_	DT	DT	_	20	det	_	_
18	protein	_	NN	NN	_	20	nn	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	s	_	NNS	NNS	_	16	pobj	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	responsible	_	JJ	JJ	_	20	amod	_	_
23	for	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	28	det	_	_
25	transient	_	JJ	JJ	_	28	amod	_	_
26	NF-kappa	_	NN	NN	_	28	nn	_	_
27	B-DNA	_	NN	NN	_	28	nn	_	_
28	interaction	_	NN	NN	_	23	pobj	_	_
29	and	_	CC	CC	_	4	cc	_	_
30	consequently	_	RB	RB	_	4	advmod	_	_
31	synergistically	_	RB	RB	_	4	advmod	_	_
32	enhance	_	VBP	VBP	_	4	dep	_	_
33	IL-1-induced	_	JJ	JJ	_	37	amod	_	_
34	NF-kappa	_	NN	NN	_	37	nn	_	_
35	B-dependent	_	JJ	JJ	_	37	amod	_	_
36	gene	_	NN	NN	_	37	nn	_	_
37	transcription	_	NN	NN	_	32	dobj	_	_
38	.	_	.	.	_	4	punct	_	_

1	Identification	_	NN	NN	_	0	root	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	purification	_	NN	NN	_	1	conj	_	_
4	of	_	IN	IN	_	1	prep	_	_
5	human	_	JJ	JJ	_	7	amod	_	_
6	Stat	_	NN	NN	_	7	nn	_	_
7	proteins	_	NNS	NNS	_	4	pobj	_	_
8	activated	_	VBN	VBN	_	7	vmod	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	response	_	NN	NN	_	9	pobj	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	interleukin-2	_	NN	NN	_	11	pobj	_	_
13	.	_	.	.	_	1	punct	_	_

1	A	_	DT	DT	_	3	det	_	_
2	key	_	JJ	JJ	_	3	amod	_	_
3	cytokine	_	NN	NN	_	10	nsubj	_	_
4	induced	_	VBN	VBN	_	3	vmod	_	_
5	during	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	immune	_	JJ	JJ	_	8	amod	_	_
8	response	_	NN	NN	_	5	pobj	_	_
9	is	_	VBZ	VBZ	_	10	cop	_	_
10	IL-2	_	NN	NN	_	0	root	_	_
11	.	_	.	.	_	10	punct	_	_

1	Following	_	VBG	VBG	_	19	prep	_	_
2	T	_	NN	NN	_	4	nn	_	_
3	cell	_	NN	NN	_	4	nn	_	_
4	activation	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	19	punct	_	_
6	the	_	DT	DT	_	7	det	_	_
7	genes	_	NNS	NNS	_	19	nsubjpass	_	_
8	encoding	_	VBG	VBG	_	7	vmod	_	_
9	IL-2	_	NN	NN	_	8	dobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	the	_	DT	DT	_	13	det	_	_
12	various	_	JJ	JJ	_	13	amod	_	_
13	chains	_	NNS	NNS	_	9	conj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	its	_	PRP$	PRP$	_	16	poss	_	_
16	receptor	_	NN	NN	_	14	pobj	_	_
17	are	_	VBP	VBP	_	19	auxpass	_	_
18	transcriptionally	_	RB	RB	_	19	advmod	_	_
19	induced	_	VBN	VBN	_	0	root	_	_
20	.	_	.	.	_	19	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	turn	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	6	punct	_	_
4	secreted	_	VBN	VBN	_	5	amod	_	_
5	IL-2	_	NN	NN	_	6	nsubj	_	_
6	serves	_	VBZ	VBZ	_	0	root	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	stimulate	_	VB	VB	_	6	xcomp	_	_
9	the	_	DT	DT	_	10	dep	_	_
10	proliferation	_	NN	NN	_	8	dobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	differentiation	_	NN	NN	_	10	conj	_	_
13	of	_	IN	IN	_	10	prep	_	_
14	T	_	NN	NN	_	15	nn	_	_
15	lymphocytes	_	NNS	NNS	_	13	pobj	_	_
16	.	_	.	.	_	6	punct	_	_

1	Several	_	JJ	JJ	_	3	amod	_	_
2	recent	_	JJ	JJ	_	3	amod	_	_
3	studies	_	NNS	NNS	_	5	nsubj	_	_
4	have	_	VBP	VBP	_	5	aux	_	_
5	implicated	_	VBN	VBN	_	0	root	_	_
6	Jak	_	NN	NN	_	7	nn	_	_
7	kinases	_	NNS	NNS	_	5	dobj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	signaling	_	NN	NN	_	11	nn	_	_
11	pathway	_	NN	NN	_	8	pobj	_	_
12	induced	_	VBN	VBN	_	11	vmod	_	_
13	by	_	IN	IN	_	12	prep	_	_
14	IL-2	_	NN	NN	_	13	pobj	_	_
15	.	_	.	.	_	5	punct	_	_

1	Following	_	VBG	VBG	_	0	root	_	_
2	this	_	DT	DT	_	3	det	_	_
3	lead	_	NN	NN	_	1	dobj	_	_
4	,	_	,	,	_	1	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	set	_	VBD	VBD	_	1	parataxis	_	_
7	out	_	RP	RP	_	6	prt	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	identify	_	VB	VB	_	6	xcomp	_	_
10	transcription	_	NN	NN	_	11	nn	_	_
11	factors	_	NNS	NNS	_	9	dobj	_	_
12	induced	_	VBN	VBN	_	11	vmod	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	response	_	NN	NN	_	13	pobj	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	IL-2	_	NN	NN	_	15	pobj	_	_
17	.	_	.	.	_	1	punct	_	_

1	Human	_	JJ	JJ	_	4	amod	_	_
2	peripheral	_	JJ	JJ	_	4	amod	_	_
3	blood	_	NN	NN	_	4	nn	_	_
4	lymphocytes	_	NNS	NNS	_	6	nsubjpass	_	_
5	were	_	VBD	VBD	_	6	auxpass	_	_
6	observed	_	VBN	VBN	_	0	root	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	contain	_	VB	VB	_	6	xcomp	_	_
9	several	_	JJ	JJ	_	13	amod	_	_
10	IL-2-inducible	_	JJ	JJ	_	13	amod	_	_
11	DNA	_	NN	NN	_	13	nn	_	_
12	binding	_	NN	NN	_	13	nn	_	_
13	activities	_	NNS	NNS	_	8	dobj	_	_
14	.	_	.	.	_	6	punct	_	_

1	Similar	_	JJ	JJ	_	2	amod	_	_
2	activities	_	NNS	NNS	_	5	nsubjpass	_	_
3	were	_	VBD	VBD	_	5	auxpass	_	_
4	also	_	RB	RB	_	5	advmod	_	_
5	observed	_	VBN	VBN	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	a	_	DT	DT	_	11	det	_	_
8	transformed	_	VBN	VBN	_	11	amod	_	_
9	human	_	JJ	JJ	_	11	amod	_	_
10	lymphocyte	_	NN	NN	_	11	nn	_	_
11	line	_	NN	NN	_	6	pobj	_	_
12	,	_	,	,	_	11	punct	_	_
13	termed	_	VBN	VBN	_	11	vmod	_	_
14	YT	_	NN	NN	_	13	dep	_	_
15	.	_	.	.	_	5	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	purified	_	VBN	VBN	_	0	root	_	_
4	these	_	DT	DT	_	5	det	_	_
5	activities	_	NNS	NNS	_	3	dobj	_	_
6	and	_	CC	CC	_	3	cc	_	_
7	found	_	VBD	VBD	_	3	conj	_	_
8	that	_	IN	IN	_	13	mark	_	_
9	the	_	DT	DT	_	12	det	_	_
10	principal	_	JJ	JJ	_	12	amod	_	_
11	IL-2-inducible	_	JJ	JJ	_	12	amod	_	_
12	component	_	NN	NN	_	13	nsubj	_	_
13	bears	_	VBZ	VBZ	_	7	ccomp	_	_
14	significant	_	JJ	JJ	_	15	amod	_	_
15	relatedness	_	NN	NN	_	13	dobj	_	_
16	to	_	TO	TO	_	15	prep	_	_
17	a	_	DT	DT	_	20	det	_	_
18	prolactin-induced	_	JJ	JJ	_	20	amod	_	_
19	transcription	_	NN	NN	_	20	nn	_	_
20	factor	_	NN	NN	_	16	pobj	_	_
21	first	_	RB	RB	_	22	advmod	_	_
22	identified	_	VBN	VBN	_	20	vmod	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	sheep	_	NN	NN	_	27	nn	_	_
25	mammary	_	JJ	JJ	_	27	amod	_	_
26	gland	_	NN	NN	_	27	nn	_	_
27	tissue	_	NN	NN	_	23	pobj	_	_
28	.	_	.	.	_	3	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	hypothesize	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	12	mark	_	_
4	activation	_	NN	NN	_	12	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	this	_	DT	DT	_	7	det	_	_
7	protein	_	NN	NN	_	5	pobj	_	_
8	,	_	,	,	_	7	punct	_	_
9	designated	_	VBN	VBN	_	7	vmod	_	_
10	hStat5	_	NN	NN	_	9	dep	_	_
11	,	_	,	,	_	4	punct	_	_
12	helps	_	VBZ	VBZ	_	2	ccomp	_	_
13	govern	_	VB	VB	_	12	ccomp	_	_
14	the	_	DT	DT	_	16	det	_	_
15	biological	_	JJ	JJ	_	16	amod	_	_
16	effects	_	NNS	NNS	_	13	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	IL-2	_	NN	NN	_	17	pobj	_	_
19	during	_	IN	IN	_	13	prep	_	_
20	the	_	DT	DT	_	22	det	_	_
21	immune	_	JJ	JJ	_	22	amod	_	_
22	response	_	NN	NN	_	19	pobj	_	_
23	.	_	.	.	_	2	punct	_	_

1	Induction	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	transcription	_	NN	NN	_	4	nn	_	_
4	factors	_	NNS	NNS	_	2	pobj	_	_
5	in	_	IN	IN	_	1	prep	_	_
6	human	_	JJ	JJ	_	8	amod	_	_
7	T	_	NN	NN	_	8	nn	_	_
8	lymphocytes	_	NNS	NNS	_	5	pobj	_	_
9	by	_	IN	IN	_	1	prep	_	_
10	aspirin-like	_	JJ	JJ	_	11	amod	_	_
11	drugs	_	NNS	NNS	_	9	pobj	_	_
12	.	_	.	.	_	1	punct	_	_

1	Aspirin-like	_	JJ	JJ	_	2	amod	_	_
2	drugs	_	NNS	NNS	_	6	nsubj	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	ALD	_	NN	NN	_	2	appos	_	_
5	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
6	induce	_	VBP	VBP	_	0	root	_	_
7	calcium	_	NN	NN	_	8	nn	_	_
8	mobilization	_	NN	NN	_	6	dobj	_	_
9	,	_	,	,	_	8	punct	_	_
10	an	_	DT	DT	_	12	det	_	_
11	essential	_	JJ	JJ	_	12	amod	_	_
12	component	_	NN	NN	_	8	appos	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	T	_	NN	NN	_	16	nn	_	_
15	cell	_	NN	NN	_	16	nn	_	_
16	activation	_	NN	NN	_	13	pobj	_	_
17	,	_	,	,	_	6	punct	_	_
18	but	_	CC	CC	_	6	cc	_	_
19	do	_	VBP	VBP	_	21	aux	_	_
20	not	_	RB	RB	_	21	neg	_	_
21	induce	_	VB	VB	_	6	conj	_	_
22	the	_	DT	DT	_	23	det	_	_
23	biosynthesis	_	NN	NN	_	21	dobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	IL-2	_	NN	NN	_	24	pobj	_	_
26	.	_	.	.	_	6	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	understand	_	VB	VB	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	extent	_	NN	NN	_	2	dobj	_	_
5	to	_	TO	TO	_	9	prep	_	_
6	which	_	WDT	WDT	_	5	pobj	_	_
7	ALD	_	NN	NN	_	9	nsubj	_	_
8	may	_	MD	MD	_	9	aux	_	_
9	mimic	_	VB	VB	_	4	rcmod	_	_
10	mitogenic	_	JJ	JJ	_	11	amod	_	_
11	stimulation	_	NN	NN	_	9	dobj	_	_
12	,	_	,	,	_	2	punct	_	_
13	we	_	PRP	PRP	_	14	nsubj	_	_
14	studied	_	VBD	VBD	_	2	parataxis	_	_
15	cytoplasmic	_	JJ	JJ	_	14	dobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	nuclear	_	JJ	JJ	_	15	conj	_	_
18	signaling	_	NN	NN	_	19	nn	_	_
19	steps	_	NNS	NNS	_	15	dep	_	_
20	in	_	IN	IN	_	15	prep	_	_
21	ALD-treated	_	JJ	JJ	_	23	amod	_	_
22	T	_	NN	NN	_	23	nn	_	_
23	cells	_	NNS	NNS	_	20	pobj	_	_
24	.	_	.	.	_	2	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	found	_	VBD	VBD	_	0	root	_	_
3	that	_	IN	IN	_	5	mark	_	_
4	ALD	_	NN	NN	_	5	nsubj	_	_
5	induce	_	VBP	VBP	_	2	ccomp	_	_
6	a	_	DT	DT	_	8	det	_	_
7	transient	_	JJ	JJ	_	8	amod	_	_
8	activation	_	NN	NN	_	5	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	protein	_	NN	NN	_	11	nn	_	_
11	kinase	_	NN	NN	_	9	pobj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	PKC	_	NN	NN	_	11	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	but	_	CC	CC	_	5	cc	_	_
16	have	_	VBP	VBP	_	5	conj	_	_
17	no	_	DT	DT	_	18	neg	_	_
18	effect	_	NN	NN	_	16	dobj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	in	_	IN	IN	_	16	dep	_	_
21	comparison	_	NN	NN	_	20	pobj	_	_
22	to	_	TO	TO	_	21	prep	_	_
23	anti-CD3	_	JJ	JJ	_	24	amod	_	_
24	antibodies	_	NNS	NNS	_	22	pobj	_	_
25	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
26	on	_	IN	IN	_	16	prep	_	_
27	protein	_	NN	NN	_	29	nn	_	_
28	tyrosine	_	NN	NN	_	29	nn	_	_
29	phosphorylation	_	NN	NN	_	26	pobj	_	_
30	nor	_	CC	CC	_	26	cc	_	_
31	on	_	IN	IN	_	26	conj	_	_
32	PCL	_	NN	NN	_	36	nn	_	_
33	gamma	_	NN	NN	_	36	nn	_	_
34	1	_	CD	CD	_	36	num	_	_
35	tyrosine	_	NN	NN	_	36	nn	_	_
36	phosphorylation	_	NN	NN	_	31	pobj	_	_
37	.	_	.	.	_	2	punct	_	_

1	ALD-induced	_	JJ	JJ	_	3	amod	_	_
2	calcium	_	NN	NN	_	3	nn	_	_
3	mobilization	_	NN	NN	_	8	nsubj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	PKC	_	NN	NN	_	6	nn	_	_
6	activation	_	NN	NN	_	3	conj	_	_
7	are	_	VBP	VBP	_	8	cop	_	_
8	independent	_	JJ	JJ	_	0	root	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	tyrosine	_	NN	NN	_	12	nn	_	_
11	protein	_	NN	NN	_	12	nn	_	_
12	kinase	_	NN	NN	_	13	nn	_	_
13	activity	_	NN	NN	_	9	pobj	_	_
14	as	_	IN	IN	_	15	mark	_	_
15	shown	_	VBN	VBN	_	8	advcl	_	_
16	by	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	lack	_	NN	NN	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	effect	_	NN	NN	_	19	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	herbimycin	_	NN	NN	_	21	pobj	_	_
23	,	_	,	,	_	22	punct	_	_
24	a	_	DT	DT	_	27	det	_	_
25	tyrosine-protein	_	JJ	JJ	_	27	amod	_	_
26	kinase-specific	_	JJ	JJ	_	27	amod	_	_
27	inhibitor	_	NN	NN	_	22	appos	_	_
28	.	_	.	.	_	8	punct	_	_

1	Although	_	IN	IN	_	3	mark	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	detected	_	VBD	VBD	_	16	advcl	_	_
4	no	_	DT	DT	_	6	neg	_	_
5	IL-2	_	NN	NN	_	6	nn	_	_
6	mRNA	_	NN	NN	_	3	dobj	_	_
7	in	_	IN	IN	_	3	prep	_	_
8	ALD-treated	_	JJ	JJ	_	9	amod	_	_
9	cells	_	NNS	NNS	_	7	pobj	_	_
10	,	_	,	,	_	16	punct	_	_
11	the	_	DT	DT	_	12	det	_	_
12	nuclei	_	NNS	NNS	_	16	nsubj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	these	_	DT	DT	_	15	det	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	contain	_	VBP	VBP	_	0	root	_	_
17	proteins	_	NNS	NNS	_	16	dobj	_	_
18	capable	_	JJ	JJ	_	17	amod	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	binding	_	VBG	VBG	_	19	pcomp	_	_
21	to	_	TO	TO	_	20	prep	_	_
22	three	_	CD	CD	_	24	num	_	_
23	regulatory	_	JJ	JJ	_	24	amod	_	_
24	sequences	_	NNS	NNS	_	21	pobj	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	29	det	_	_
27	IL-2	_	NN	NN	_	29	nn	_	_
28	promoter	_	NN	NN	_	29	nn	_	_
29	region	_	NN	NN	_	25	pobj	_	_
30	:	_	:	:	_	16	punct	_	_
31	NFAT	_	NN	NN	_	16	dep	_	_
32	,	_	,	,	_	31	punct	_	_
33	NF	_	NN	NN	_	35	nn	_	_
34	kappa	_	NN	NN	_	35	nn	_	_
35	B	_	NN	NN	_	31	conj	_	_
36	,	_	,	,	_	31	punct	_	_
37	and	_	CC	CC	_	31	cc	_	_
38	AP-1	_	NN	NN	_	31	conj	_	_
39	.	_	.	.	_	16	punct	_	_

1	These	_	DT	DT	_	3	det	_	_
2	binding	_	NN	NN	_	3	nn	_	_
3	activities	_	NNS	NNS	_	5	nsubjpass	_	_
4	are	_	VBP	VBP	_	5	auxpass	_	_
5	expressed	_	VBN	VBN	_	0	root	_	_
6	only	_	RB	RB	_	5	advmod	_	_
7	in	_	IN	IN	_	5	prep	_	_
8	activated	_	VBN	VBN	_	10	amod	_	_
9	T	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	7	pobj	_	_
11	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	expression	_	NN	NN	_	5	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	AP-1	_	NN	NN	_	3	pobj	_	_
5	depended	_	VBD	VBD	_	0	root	_	_
6	on	_	IN	IN	_	5	prep	_	_
7	calcium	_	NN	NN	_	8	nn	_	_
8	mobilization	_	NN	NN	_	6	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	PKC	_	NN	NN	_	11	nn	_	_
11	activation	_	NN	NN	_	8	conj	_	_
12	.	_	.	.	_	5	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	6	mark	_	_
5	ALD	_	NN	NN	_	6	nsubj	_	_
6	cause	_	VBP	VBP	_	3	ccomp	_	_
7	transient	_	JJ	JJ	_	10	amod	_	_
8	but	_	CC	CC	_	7	cc	_	_
9	significant	_	JJ	JJ	_	7	conj	_	_
10	changes	_	NNS	NNS	_	6	dobj	_	_
11	in	_	IN	IN	_	6	prep	_	_
12	T	_	NN	NN	_	15	nn	_	_
13	cell	_	NN	NN	_	15	nn	_	_
14	transmembrane	_	NN	NN	_	15	nn	_	_
15	signaling	_	NN	NN	_	11	pobj	_	_
16	,	_	,	,	_	6	punct	_	_
17	although	_	IN	IN	_	28	mark	_	_
18	some	_	DT	DT	_	19	det	_	_
19	events	_	NNS	NNS	_	28	nsubjpass	_	_
20	induced	_	VBN	VBN	_	19	vmod	_	_
21	by	_	IN	IN	_	20	prep	_	_
22	stimulation	_	NN	NN	_	21	pobj	_	_
23	with	_	IN	IN	_	22	prep	_	_
24	anti-CD3	_	JJ	JJ	_	25	amod	_	_
25	antibodies	_	NNS	NNS	_	23	pobj	_	_
26	are	_	VBP	VBP	_	28	auxpass	_	_
27	not	_	RB	RB	_	28	neg	_	_
28	induced	_	VBN	VBN	_	6	advcl	_	_
29	by	_	IN	IN	_	28	prep	_	_
30	ALD	_	NN	NN	_	29	pobj	_	_
31	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	signal	_	NN	NN	_	4	nsubjpass	_	_
3	is	_	VBZ	VBZ	_	4	auxpass	_	_
4	transmitted	_	VBN	VBN	_	0	root	_	_
5	to	_	TO	TO	_	4	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	nucleus	_	NN	NN	_	5	pobj	_	_
8	and	_	CC	CC	_	4	cc	_	_
9	induces	_	VBZ	VBZ	_	4	conj	_	_
10	DNA-binding	_	JJ	JJ	_	11	amod	_	_
11	activity	_	NN	NN	_	9	dobj	_	_
12	by	_	IN	IN	_	9	prep	_	_
13	several	_	JJ	JJ	_	15	amod	_	_
14	transcription	_	NN	NN	_	15	nn	_	_
15	factors	_	NNS	NNS	_	12	pobj	_	_
16	.	_	.	.	_	4	punct	_	_

1	However	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	the	_	DT	DT	_	5	det	_	_
4	ALD	_	NN	NN	_	5	nn	_	_
5	stimulus	_	NN	NN	_	8	nsubj	_	_
6	is	_	VBZ	VBZ	_	8	cop	_	_
7	not	_	RB	RB	_	8	neg	_	_
8	capable	_	JJ	JJ	_	0	root	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	causing	_	VBG	VBG	_	9	pcomp	_	_
11	complete	_	JJ	JJ	_	14	amod	_	_
12	T	_	NN	NN	_	14	nn	_	_
13	cell	_	NN	NN	_	14	nn	_	_
14	activation	_	NN	NN	_	10	dobj	_	_
15	.	_	.	.	_	8	punct	_	_

1	Interleukin	_	NN	NN	_	3	nn	_	_
2	-LRB-	_	-LRB-	-LRB-	_	3	punct	_	_
3	IL	_	NN	NN	_	6	nsubj	_	_
4	-RRB-	_	-RRB-	-RRB-	_	3	punct	_	_
5	-10	_	CD	CD	_	3	num	_	_
6	inhibits	_	VBZ	VBZ	_	0	root	_	_
7	nuclear	_	JJ	JJ	_	10	amod	_	_
8	factor	_	NN	NN	_	10	nn	_	_
9	kappa	_	NN	NN	_	10	nn	_	_
10	B	_	NN	NN	_	16	nn	_	_
11	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
12	NF	_	NN	NN	_	14	nn	_	_
13	kappa	_	NN	NN	_	14	nn	_	_
14	B	_	NN	NN	_	10	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	activation	_	NN	NN	_	6	dobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	human	_	JJ	JJ	_	19	amod	_	_
19	monocytes	_	NNS	NNS	_	17	pobj	_	_
20	.	_	.	.	_	6	punct	_	_

1	IL-10	_	NN	NN	_	4	nsubj	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	IL-4	_	NN	NN	_	1	conj	_	_
4	suppress	_	VBP	VBP	_	0	root	_	_
5	cytokine	_	NN	NN	_	6	nn	_	_
6	synthesis	_	NN	NN	_	4	dobj	_	_
7	by	_	IN	IN	_	4	prep	_	_
8	different	_	JJ	JJ	_	9	amod	_	_
9	mechanisms	_	NNS	NNS	_	7	pobj	_	_
10	.	_	.	.	_	4	punct	_	_

1	Our	_	PRP$	PRP$	_	3	poss	_	_
2	previous	_	JJ	JJ	_	3	amod	_	_
3	studies	_	NNS	NNS	_	8	nsubj	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	human	_	JJ	JJ	_	6	amod	_	_
6	monocytes	_	NNS	NNS	_	4	pobj	_	_
7	have	_	VBP	VBP	_	8	aux	_	_
8	demonstrated	_	VBN	VBN	_	0	root	_	_
9	that	_	IN	IN	_	15	mark	_	_
10	interleukin	_	NN	NN	_	12	nn	_	_
11	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
12	IL	_	NN	NN	_	15	nsubj	_	_
13	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	-10	_	CD	CD	_	12	num	_	_
15	inhibits	_	VBZ	VBZ	_	8	ccomp	_	_
16	lipopolysaccharide	_	NN	NN	_	21	nn	_	_
17	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
18	LPS	_	NN	NN	_	21	nn	_	_
19	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
20	-stimulated	_	JJ	JJ	_	21	amod	_	_
21	production	_	NN	NN	_	15	dobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	inflammatory	_	JJ	JJ	_	24	amod	_	_
24	cytokines	_	NNS	NNS	_	22	pobj	_	_
25	,	_	,	,	_	24	punct	_	_
26	IL-1	_	NN	NN	_	27	nn	_	_
27	beta	_	NN	NN	_	24	appos	_	_
28	,	_	,	,	_	27	punct	_	_
29	IL-6	_	NN	NN	_	27	conj	_	_
30	,	_	,	,	_	27	punct	_	_
31	IL-8	_	NN	NN	_	27	conj	_	_
32	,	_	,	,	_	27	punct	_	_
33	and	_	CC	CC	_	27	cc	_	_
34	tumor	_	NN	NN	_	40	nn	_	_
35	necrosis	_	NN	NN	_	40	nn	_	_
36	factor	_	NN	NN	_	40	nn	_	_
37	-LRB-	_	-LRB-	-LRB-	_	40	punct	_	_
38	TNF	_	NN	NN	_	40	nn	_	_
39	-RRB-	_	-RRB-	-RRB-	_	40	punct	_	_
40	-alpha	_	NN	NN	_	27	conj	_	_
41	by	_	IN	IN	_	15	prep	_	_
42	blocking	_	VBG	VBG	_	41	pcomp	_	_
43	gene	_	NN	NN	_	44	nn	_	_
44	transcription	_	NN	NN	_	42	dobj	_	_
45	.	_	.	.	_	8	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	electrophoretic	_	JJ	JJ	_	5	amod	_	_
3	mobility	_	NN	NN	_	5	nn	_	_
4	shift	_	NN	NN	_	5	nn	_	_
5	assays	_	NNS	NNS	_	1	dobj	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	EMSA	_	NN	NN	_	5	appos	_	_
8	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
9	,	_	,	,	_	1	punct	_	_
10	we	_	PRP	PRP	_	12	nsubj	_	_
11	now	_	RB	RB	_	12	advmod	_	_
12	show	_	VBP	VBP	_	1	parataxis	_	_
13	that	_	IN	IN	_	25	mark	_	_
14	,	_	,	,	_	25	punct	_	_
15	in	_	IN	IN	_	25	prep	_	_
16	monocytes	_	NNS	NNS	_	15	pobj	_	_
17	stimulated	_	VBN	VBN	_	16	vmod	_	_
18	with	_	IN	IN	_	17	prep	_	_
19	LPS	_	NN	NN	_	18	pobj	_	_
20	or	_	CC	CC	_	19	cc	_	_
21	TNF	_	NN	NN	_	22	nn	_	_
22	alpha	_	NN	NN	_	19	conj	_	_
23	,	_	,	,	_	25	punct	_	_
24	IL-10	_	NN	NN	_	25	nsubj	_	_
25	inhibits	_	VBZ	VBZ	_	12	ccomp	_	_
26	nuclear	_	JJ	JJ	_	27	amod	_	_
27	stimulation	_	NN	NN	_	25	dobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	nuclear	_	JJ	JJ	_	32	amod	_	_
30	factor	_	NN	NN	_	32	nn	_	_
31	kappa	_	NN	NN	_	32	nn	_	_
32	B	_	NN	NN	_	28	pobj	_	_
33	-LRB-	_	-LRB-	-LRB-	_	36	punct	_	_
34	NF	_	NN	NN	_	36	nn	_	_
35	kappa	_	NN	NN	_	36	nn	_	_
36	B	_	NN	NN	_	32	appos	_	_
37	-RRB-	_	-RRB-	-RRB-	_	36	punct	_	_
38	,	_	,	,	_	32	punct	_	_
39	a	_	DT	DT	_	41	det	_	_
40	transcription	_	NN	NN	_	41	nn	_	_
41	factor	_	NN	NN	_	32	appos	_	_
42	involved	_	VBN	VBN	_	41	vmod	_	_
43	in	_	IN	IN	_	42	prep	_	_
44	the	_	DT	DT	_	45	det	_	_
45	expression	_	NN	NN	_	43	pobj	_	_
46	of	_	IN	IN	_	45	prep	_	_
47	inflammatory	_	JJ	JJ	_	49	amod	_	_
48	cytokine	_	NN	NN	_	49	nn	_	_
49	genes	_	NNS	NNS	_	46	pobj	_	_
50	.	_	.	.	_	1	punct	_	_

1	Several	_	JJ	JJ	_	2	amod	_	_
2	other	_	JJ	JJ	_	4	amod	_	_
3	transcription	_	NN	NN	_	4	nn	_	_
4	factors	_	NNS	NNS	_	22	nsubjpass	_	_
5	including	_	VBG	VBG	_	4	prep	_	_
6	NF-IL-6	_	NN	NN	_	5	pobj	_	_
7	,	_	,	,	_	6	punct	_	_
8	AP-1	_	NN	NN	_	6	conj	_	_
9	,	_	,	,	_	6	punct	_	_
10	AP-2	_	NN	NN	_	6	conj	_	_
11	,	_	,	,	_	6	punct	_	_
12	GR	_	NN	NN	_	6	conj	_	_
13	,	_	,	,	_	6	punct	_	_
14	CREB	_	NN	NN	_	6	conj	_	_
15	,	_	,	,	_	6	punct	_	_
16	Oct-1	_	NN	NN	_	6	conj	_	_
17	,	_	,	,	_	6	punct	_	_
18	and	_	CC	CC	_	6	cc	_	_
19	Sp-1	_	NN	NN	_	6	conj	_	_
20	are	_	VBP	VBP	_	22	auxpass	_	_
21	not	_	RB	RB	_	22	neg	_	_
22	affected	_	VBN	VBN	_	0	root	_	_
23	by	_	IN	IN	_	22	prep	_	_
24	IL-10	_	NN	NN	_	23	pobj	_	_
25	.	_	.	.	_	22	punct	_	_

1	This	_	DT	DT	_	3	det	_	_
2	selective	_	JJ	JJ	_	3	amod	_	_
3	inhibition	_	NN	NN	_	11	nsubj	_	_
4	by	_	IN	IN	_	3	prep	_	_
5	IL-10	_	NN	NN	_	4	pobj	_	_
6	of	_	IN	IN	_	3	prep	_	_
7	NF	_	NN	NN	_	9	nn	_	_
8	kappa	_	NN	NN	_	9	nn	_	_
9	B	_	NN	NN	_	10	nn	_	_
10	activation	_	NN	NN	_	6	pobj	_	_
11	occurs	_	VBZ	VBZ	_	0	root	_	_
12	rapidly	_	RB	RB	_	11	advmod	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	in	_	IN	IN	_	12	conj	_	_
15	a	_	DT	DT	_	17	det	_	_
16	dose-dependent	_	JJ	JJ	_	17	amod	_	_
17	manner	_	NN	NN	_	14	pobj	_	_
18	and	_	CC	CC	_	11	cc	_	_
19	correlates	_	VBZ	VBZ	_	11	conj	_	_
20	well	_	RB	RB	_	19	advmod	_	_
21	with	_	IN	IN	_	19	prep	_	_
22	IL-10	_	NN	NN	_	27	poss	_	_
23	's	_	POS	POS	_	27	possessive	_	_
24	cytokine	_	NN	NN	_	27	nn	_	_
25	synthesis	_	NN	NN	_	27	nn	_	_
26	inhibitory	_	JJ	JJ	_	27	amod	_	_
27	activity	_	NN	NN	_	21	pobj	_	_
28	in	_	IN	IN	_	19	prep	_	_
29	terms	_	NNS	NNS	_	28	pobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	both	_	CC	CC	_	32	preconj	_	_
32	kinetics	_	NNS	NNS	_	30	pobj	_	_
33	and	_	CC	CC	_	32	cc	_	_
34	dose	_	NN	NN	_	35	nn	_	_
35	responsiveness	_	NN	NN	_	32	conj	_	_
36	.	_	.	.	_	11	punct	_	_

1	Furthermore	_	RB	RB	_	21	advmod	_	_
2	,	_	,	,	_	21	punct	_	_
3	compounds	_	NNS	NNS	_	21	nsubj	_	_
4	such	_	JJ	JJ	_	5	mwe	_	_
5	as	_	IN	IN	_	3	prep	_	_
6	tosylphenylalanyl	_	NN	NN	_	8	nn	_	_
7	chloromethyl	_	NN	NN	_	8	nn	_	_
8	ketone	_	NN	NN	_	5	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	pyrrolidinedithiocarbamate	_	NN	NN	_	8	conj	_	_
11	that	_	WDT	WDT	_	13	nsubjpass	_	_
12	are	_	VBP	VBP	_	13	auxpass	_	_
13	known	_	VBN	VBN	_	8	rcmod	_	_
14	to	_	TO	TO	_	16	aux	_	_
15	selectively	_	RB	RB	_	16	advmod	_	_
16	inhibit	_	VB	VB	_	13	xcomp	_	_
17	NF	_	NN	NN	_	19	nn	_	_
18	kappa	_	NN	NN	_	19	nn	_	_
19	B	_	NN	NN	_	20	nn	_	_
20	activation	_	NN	NN	_	16	dobj	_	_
21	block	_	VBP	VBP	_	0	root	_	_
22	cytokine	_	NN	NN	_	24	nn	_	_
23	gene	_	NN	NN	_	24	nn	_	_
24	transcription	_	NN	NN	_	21	dobj	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	LPS-stimulated	_	JJ	JJ	_	27	amod	_	_
27	monocytes	_	NNS	NNS	_	25	pobj	_	_
28	.	_	.	.	_	21	punct	_	_

1	Taken	_	VBN	VBN	_	0	root	_	_
2	together	_	RB	RB	_	1	advmod	_	_
3	,	_	,	,	_	1	punct	_	_
4	these	_	DT	DT	_	5	det	_	_
5	results	_	NNS	NNS	_	6	nsubj	_	_
6	suggest	_	VBP	VBP	_	1	parataxis	_	_
7	that	_	IN	IN	_	18	mark	_	_
8	inhibition	_	NN	NN	_	18	nsubj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	NF	_	NN	NN	_	12	nn	_	_
11	kappa	_	NN	NN	_	12	nn	_	_
12	B	_	NN	NN	_	13	nn	_	_
13	activation	_	NN	NN	_	9	pobj	_	_
14	may	_	MD	MD	_	18	aux	_	_
15	be	_	VB	VB	_	18	cop	_	_
16	an	_	DT	DT	_	18	det	_	_
17	important	_	JJ	JJ	_	18	amod	_	_
18	mechanism	_	NN	NN	_	6	ccomp	_	_
19	for	_	IN	IN	_	18	prep	_	_
20	IL-10	_	NN	NN	_	21	nn	_	_
21	suppression	_	NN	NN	_	19	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	cytokine	_	NN	NN	_	25	nn	_	_
24	gene	_	NN	NN	_	25	nn	_	_
25	transcription	_	NN	NN	_	22	pobj	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	human	_	JJ	JJ	_	28	amod	_	_
28	monocytes	_	NNS	NNS	_	26	pobj	_	_
29	.	_	.	.	_	1	punct	_	_

1	IL-4	_	NN	NN	_	13	nsubj	_	_
2	,	_	,	,	_	1	punct	_	_
3	another	_	DT	DT	_	4	det	_	_
4	cytokine	_	NN	NN	_	1	appos	_	_
5	that	_	WDT	WDT	_	6	nsubj	_	_
6	inhibits	_	VBZ	VBZ	_	4	rcmod	_	_
7	cytokine	_	NN	NN	_	8	nn	_	_
8	mRNA	_	NN	NN	_	9	nn	_	_
9	accumulation	_	NN	NN	_	6	dobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	monocytes	_	NNS	NNS	_	10	pobj	_	_
12	,	_	,	,	_	1	punct	_	_
13	shows	_	VBZ	VBZ	_	0	root	_	_
14	little	_	JJ	JJ	_	16	amod	_	_
15	inhibitory	_	JJ	JJ	_	16	amod	_	_
16	effect	_	NN	NN	_	13	dobj	_	_
17	on	_	IN	IN	_	13	prep	_	_
18	LPS-induced	_	JJ	JJ	_	22	amod	_	_
19	NF	_	NN	NN	_	21	nn	_	_
20	kappa	_	NN	NN	_	21	nn	_	_
21	B	_	NN	NN	_	22	nn	_	_
22	activation	_	NN	NN	_	17	pobj	_	_
23	.	_	.	.	_	13	punct	_	_

1	Further	_	RB	RB	_	2	advmod	_	_
2	examination	_	NN	NN	_	3	nsubj	_	_
3	reveals	_	VBZ	VBZ	_	0	root	_	_
4	that	_	IN	IN	_	10	mark	_	_
5	,	_	,	,	_	10	punct	_	_
6	unlike	_	IN	IN	_	10	prep	_	_
7	IL-10	_	NN	NN	_	6	pobj	_	_
8	,	_	,	,	_	10	punct	_	_
9	IL-4	_	NN	NN	_	10	nsubj	_	_
10	enhances	_	VBZ	VBZ	_	3	ccomp	_	_
11	mRNA	_	NN	NN	_	12	nn	_	_
12	degradation	_	NN	NN	_	10	dobj	_	_
13	and	_	CC	CC	_	10	cc	_	_
14	does	_	VBZ	VBZ	_	16	aux	_	_
15	not	_	RB	RB	_	16	neg	_	_
16	suppress	_	VB	VB	_	10	conj	_	_
17	cytokine	_	NN	NN	_	19	nn	_	_
18	gene	_	NN	NN	_	19	nn	_	_
19	transcription	_	NN	NN	_	16	dobj	_	_
20	.	_	.	.	_	3	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	8	mark	_	_
5	IL-10	_	NN	NN	_	8	nsubj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	IL-4	_	NN	NN	_	5	conj	_	_
8	inhibit	_	VBP	VBP	_	3	ccomp	_	_
9	cytokine	_	NN	NN	_	10	nn	_	_
10	production	_	NN	NN	_	8	dobj	_	_
11	by	_	IN	IN	_	10	prep	_	_
12	different	_	JJ	JJ	_	13	amod	_	_
13	mechanisms	_	NNS	NNS	_	11	pobj	_	_
14	.	_	.	.	_	3	punct	_	_

1	Coupling	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	a	_	DT	DT	_	6	det	_	_
4	signal	_	NN	NN	_	6	nn	_	_
5	response	_	NN	NN	_	6	nn	_	_
6	domain	_	NN	NN	_	2	pobj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	I	_	NN	NN	_	11	nn	_	_
9	kappa	_	NN	NN	_	11	nn	_	_
10	B	_	NN	NN	_	11	nn	_	_
11	alpha	_	NN	NN	_	7	pobj	_	_
12	to	_	TO	TO	_	1	prep	_	_
13	multiple	_	JJ	JJ	_	14	amod	_	_
14	pathways	_	NNS	NNS	_	12	pobj	_	_
15	for	_	IN	IN	_	14	prep	_	_
16	NF-kappa	_	NN	NN	_	17	nn	_	_
17	B	_	NN	NN	_	18	nn	_	_
18	activation	_	NN	NN	_	15	pobj	_	_
19	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	eukaryotic	_	JJ	JJ	_	4	amod	_	_
3	transcription	_	NN	NN	_	4	nn	_	_
4	factor	_	NN	NN	_	7	nsubj	_	_
5	NF-kappa	_	NN	NN	_	6	nn	_	_
6	B	_	NN	NN	_	4	dep	_	_
7	plays	_	VBZ	VBZ	_	0	root	_	_
8	a	_	DT	DT	_	10	det	_	_
9	central	_	JJ	JJ	_	10	amod	_	_
10	role	_	NN	NN	_	7	dobj	_	_
11	in	_	IN	IN	_	7	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	induced	_	VBN	VBN	_	14	amod	_	_
14	expression	_	NN	NN	_	11	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	human	_	JJ	JJ	_	19	amod	_	_
17	immunodeficiency	_	NN	NN	_	19	nn	_	_
18	virus	_	NN	NN	_	19	nn	_	_
19	type	_	NN	NN	_	15	pobj	_	_
20	1	_	CD	CD	_	19	num	_	_
21	and	_	CC	CC	_	11	cc	_	_
22	in	_	IN	IN	_	11	conj	_	_
23	many	_	JJ	JJ	_	24	amod	_	_
24	aspects	_	NNS	NNS	_	22	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	28	det	_	_
27	genetic	_	JJ	JJ	_	28	amod	_	_
28	program	_	NN	NN	_	25	pobj	_	_
29	mediating	_	VBG	VBG	_	28	vmod	_	_
30	normal	_	JJ	JJ	_	31	amod	_	_
31	T-cell	_	NN	NN	_	29	dobj	_	_
32	activation	_	NN	NN	_	31	dep	_	_
33	and	_	CC	CC	_	31	cc	_	_
34	growth	_	NN	NN	_	31	conj	_	_
35	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	nuclear	_	JJ	JJ	_	3	amod	_	_
3	activity	_	NN	NN	_	9	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	NF-kappa	_	NN	NN	_	6	nn	_	_
6	B	_	NN	NN	_	4	pobj	_	_
7	is	_	VBZ	VBZ	_	9	auxpass	_	_
8	tightly	_	RB	RB	_	9	advmod	_	_
9	regulated	_	VBN	VBN	_	0	root	_	_
10	from	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	cytoplasmic	_	JJ	JJ	_	13	amod	_	_
13	compartment	_	NN	NN	_	10	pobj	_	_
14	by	_	IN	IN	_	9	prep	_	_
15	an	_	DT	DT	_	17	det	_	_
16	inhibitory	_	JJ	JJ	_	17	amod	_	_
17	subunit	_	NN	NN	_	14	pobj	_	_
18	called	_	VBN	VBN	_	17	vmod	_	_
19	I	_	NN	NN	_	22	nn	_	_
20	kappa	_	NN	NN	_	22	nn	_	_
21	B	_	NN	NN	_	22	nn	_	_
22	alpha	_	NN	NN	_	18	dep	_	_
23	.	_	.	.	_	9	punct	_	_

1	This	_	DT	DT	_	3	det	_	_
2	cytoplasmic	_	JJ	JJ	_	3	amod	_	_
3	inhibitor	_	NN	NN	_	6	nsubjpass	_	_
4	is	_	VBZ	VBZ	_	6	auxpass	_	_
5	rapidly	_	RB	RB	_	6	advmod	_	_
6	phosphorylated	_	VBN	VBN	_	0	root	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	degraded	_	VBN	VBN	_	6	conj	_	_
9	in	_	IN	IN	_	6	prep	_	_
10	response	_	NN	NN	_	9	pobj	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	a	_	DT	DT	_	14	det	_	_
13	diverse	_	JJ	JJ	_	14	amod	_	_
14	set	_	NN	NN	_	11	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	NF-kappa	_	NN	NN	_	18	nn	_	_
17	B-inducing	_	JJ	JJ	_	18	amod	_	_
18	agents	_	NNS	NNS	_	15	pobj	_	_
19	,	_	,	,	_	14	punct	_	_
20	including	_	VBG	VBG	_	14	prep	_	_
21	T-cell	_	NN	NN	_	22	nn	_	_
22	mitogens	_	NNS	NNS	_	20	pobj	_	_
23	,	_	,	,	_	22	punct	_	_
24	proinflammatory	_	JJ	JJ	_	25	amod	_	_
25	cytokines	_	NNS	NNS	_	22	dep	_	_
26	,	_	,	,	_	22	punct	_	_
27	and	_	CC	CC	_	22	cc	_	_
28	viral	_	JJ	JJ	_	29	amod	_	_
29	transactivators	_	NNS	NNS	_	22	conj	_	_
30	such	_	JJ	JJ	_	31	mwe	_	_
31	as	_	IN	IN	_	29	prep	_	_
32	the	_	DT	DT	_	34	det	_	_
33	Tax	_	NN	NN	_	34	nn	_	_
34	protein	_	NN	NN	_	31	pobj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	human	_	JJ	JJ	_	40	amod	_	_
37	T-cell	_	NN	NN	_	40	nn	_	_
38	leukemia	_	NN	NN	_	40	nn	_	_
39	virus	_	NN	NN	_	40	nn	_	_
40	type	_	NN	NN	_	35	pobj	_	_
41	1	_	CD	CD	_	40	num	_	_
42	.	_	.	.	_	6	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	explore	_	VB	VB	_	0	root	_	_
3	these	_	DT	DT	_	8	det	_	_
4	I	_	NN	NN	_	8	nn	_	_
5	kappa	_	NN	NN	_	8	nn	_	_
6	B	_	NN	NN	_	8	nn	_	_
7	alpha-dependent	_	JJ	JJ	_	8	amod	_	_
8	mechanisms	_	NNS	NNS	_	2	dobj	_	_
9	for	_	IN	IN	_	8	prep	_	_
10	NF-kappa	_	NN	NN	_	11	nn	_	_
11	B	_	NN	NN	_	12	nn	_	_
12	induction	_	NN	NN	_	9	pobj	_	_
13	,	_	,	,	_	2	punct	_	_
14	we	_	PRP	PRP	_	15	nsubj	_	_
15	identified	_	VBD	VBD	_	2	parataxis	_	_
16	novel	_	JJ	JJ	_	17	amod	_	_
17	mutants	_	NNS	NNS	_	15	dobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	I	_	NN	NN	_	22	nn	_	_
20	kappa	_	NN	NN	_	22	nn	_	_
21	B	_	NN	NN	_	22	nn	_	_
22	alpha	_	NN	NN	_	18	pobj	_	_
23	that	_	WDT	WDT	_	24	nsubj	_	_
24	uncouple	_	VBP	VBP	_	17	rcmod	_	_
25	its	_	PRP$	PRP$	_	29	poss	_	_
26	inhibitory	_	JJ	JJ	_	29	amod	_	_
27	and	_	CC	CC	_	26	cc	_	_
28	signal-transducing	_	JJ	JJ	_	26	conj	_	_
29	functions	_	NNS	NNS	_	24	dobj	_	_
30	in	_	IN	IN	_	24	prep	_	_
31	human	_	JJ	JJ	_	33	amod	_	_
32	T	_	NN	NN	_	33	nn	_	_
33	lymphocytes	_	NNS	NNS	_	30	pobj	_	_
34	.	_	.	.	_	2	punct	_	_

1	Specifically	_	RB	RB	_	15	advmod	_	_
2	,	_	,	,	_	15	punct	_	_
3	removal	_	NN	NN	_	15	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	9	det	_	_
6	N-terminal	_	JJ	JJ	_	9	amod	_	_
7	36	_	CD	CD	_	9	num	_	_
8	amino	_	NN	NN	_	9	nn	_	_
9	acids	_	NNS	NNS	_	4	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	I	_	NN	NN	_	14	nn	_	_
12	kappa	_	NN	NN	_	14	nn	_	_
13	B	_	NN	NN	_	14	nn	_	_
14	alpha	_	NN	NN	_	10	pobj	_	_
15	failed	_	VBD	VBD	_	0	root	_	_
16	to	_	TO	TO	_	17	aux	_	_
17	disrupt	_	VB	VB	_	15	xcomp	_	_
18	its	_	PRP$	PRP$	_	19	poss	_	_
19	ability	_	NN	NN	_	17	dobj	_	_
20	to	_	TO	TO	_	21	aux	_	_
21	form	_	VB	VB	_	19	vmod	_	_
22	latent	_	JJ	JJ	_	23	amod	_	_
23	complexes	_	NNS	NNS	_	21	dobj	_	_
24	with	_	IN	IN	_	23	prep	_	_
25	NF-kappa	_	NN	NN	_	26	nn	_	_
26	B	_	NN	NN	_	24	pobj	_	_
27	in	_	IN	IN	_	23	prep	_	_
28	the	_	DT	DT	_	29	det	_	_
29	cytoplasm	_	NN	NN	_	27	pobj	_	_
30	.	_	.	.	_	15	punct	_	_

1	However	_	RB	RB	_	6	advmod	_	_
2	,	_	,	,	_	6	punct	_	_
3	this	_	DT	DT	_	5	det	_	_
4	deletion	_	NN	NN	_	5	nn	_	_
5	mutation	_	NN	NN	_	6	nsubj	_	_
6	prevented	_	VBD	VBD	_	0	root	_	_
7	the	_	DT	DT	_	9	det	_	_
8	induced	_	VBN	VBN	_	9	amod	_	_
9	phosphorylation	_	NN	NN	_	6	dobj	_	_
10	,	_	,	,	_	9	punct	_	_
11	degradative	_	JJ	JJ	_	12	amod	_	_
12	loss	_	NN	NN	_	9	conj	_	_
13	,	_	,	,	_	9	punct	_	_
14	and	_	CC	CC	_	9	cc	_	_
15	functional	_	JJ	JJ	_	16	amod	_	_
16	release	_	NN	NN	_	9	conj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	I	_	NN	NN	_	21	nn	_	_
19	kappa	_	NN	NN	_	21	nn	_	_
20	B	_	NN	NN	_	21	nn	_	_
21	alpha	_	NN	NN	_	17	pobj	_	_
22	from	_	IN	IN	_	16	prep	_	_
23	NF-kappa	_	NN	NN	_	24	nn	_	_
24	B	_	NN	NN	_	22	pobj	_	_
25	in	_	IN	IN	_	9	prep	_	_
26	Tax-expressing	_	JJ	JJ	_	27	amod	_	_
27	cells	_	NNS	NNS	_	25	pobj	_	_
28	.	_	.	.	_	6	punct	_	_

1	Alanine	_	NN	NN	_	2	nn	_	_
2	substitutions	_	NNS	NNS	_	20	nsubj	_	_
3	introduced	_	VBN	VBN	_	2	vmod	_	_
4	at	_	IN	IN	_	3	prep	_	_
5	two	_	CD	CD	_	7	num	_	_
6	serine	_	NN	NN	_	7	nn	_	_
7	residues	_	NNS	NNS	_	4	pobj	_	_
8	positioned	_	JJ	JJ	_	7	amod	_	_
9	within	_	IN	IN	_	8	prep	_	_
10	this	_	DT	DT	_	13	det	_	_
11	N-terminal	_	JJ	JJ	_	13	amod	_	_
12	regulatory	_	JJ	JJ	_	13	amod	_	_
13	region	_	NN	NN	_	9	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	I	_	NN	NN	_	18	nn	_	_
16	kappa	_	NN	NN	_	18	nn	_	_
17	B	_	NN	NN	_	18	nn	_	_
18	alpha	_	NN	NN	_	14	pobj	_	_
19	also	_	RB	RB	_	20	advmod	_	_
20	yielded	_	VBD	VBD	_	0	root	_	_
21	constitutive	_	JJ	JJ	_	22	amod	_	_
22	repressors	_	NNS	NNS	_	20	dobj	_	_
23	that	_	WDT	WDT	_	24	nsubj	_	_
24	escaped	_	VBD	VBD	_	22	rcmod	_	_
25	from	_	IN	IN	_	24	prep	_	_
26	Tax-induced	_	JJ	JJ	_	27	amod	_	_
27	turnover	_	NN	NN	_	25	pobj	_	_
28	and	_	CC	CC	_	24	cc	_	_
29	that	_	WDT	WDT	_	31	nsubj	_	_
30	potently	_	RB	RB	_	31	advmod	_	_
31	inhibited	_	VBD	VBD	_	24	conj	_	_
32	immune	_	JJ	JJ	_	34	amod	_	_
33	activation	_	NN	NN	_	34	nn	_	_
34	pathways	_	NNS	NNS	_	31	dobj	_	_
35	for	_	IN	IN	_	34	prep	_	_
36	NF-kappa	_	NN	NN	_	37	nn	_	_
37	B	_	NN	NN	_	38	nn	_	_
38	induction	_	NN	NN	_	35	pobj	_	_
39	,	_	,	,	_	34	punct	_	_
40	including	_	VBG	VBG	_	34	prep	_	_
41	those	_	DT	DT	_	40	pobj	_	_
42	initiated	_	VBN	VBN	_	41	vmod	_	_
43	from	_	IN	IN	_	42	prep	_	_
44	antigen	_	NN	NN	_	43	pobj	_	_
45	and	_	CC	CC	_	44	cc	_	_
46	cytokine	_	NN	NN	_	44	conj	_	_
47	receptors	_	NNS	NNS	_	44	dep	_	_
48	.	_	.	.	_	20	punct	_	_

1	In	_	IN	IN	_	12	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	12	punct	_	_
4	introduction	_	NN	NN	_	12	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	a	_	DT	DT	_	7	det	_	_
7	phosphoserine	_	NN	NN	_	5	pobj	_	_
8	mimetic	_	JJ	JJ	_	7	amod	_	_
9	at	_	IN	IN	_	8	prep	_	_
10	these	_	DT	DT	_	11	det	_	_
11	sites	_	NNS	NNS	_	9	pobj	_	_
12	rectified	_	VBD	VBD	_	0	root	_	_
13	this	_	DT	DT	_	15	det	_	_
14	functional	_	JJ	JJ	_	15	amod	_	_
15	defect	_	NN	NN	_	12	dobj	_	_
16	,	_	,	,	_	12	punct	_	_
17	a	_	DT	DT	_	18	det	_	_
18	finding	_	NN	NN	_	12	dep	_	_
19	consistent	_	JJ	JJ	_	18	amod	_	_
20	with	_	IN	IN	_	19	prep	_	_
21	a	_	DT	DT	_	23	det	_	_
22	causal	_	JJ	JJ	_	23	amod	_	_
23	linkage	_	NN	NN	_	20	pobj	_	_
24	between	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	27	det	_	_
26	phosphorylation	_	NN	NN	_	27	nn	_	_
27	status	_	NN	NN	_	24	pobj	_	_
28	and	_	CC	CC	_	27	cc	_	_
29	proteolytic	_	JJ	JJ	_	30	amod	_	_
30	stability	_	NN	NN	_	27	conj	_	_
31	of	_	IN	IN	_	27	prep	_	_
32	this	_	DT	DT	_	34	det	_	_
33	cytoplasmic	_	JJ	JJ	_	34	amod	_	_
34	inhibitor	_	NN	NN	_	31	pobj	_	_
35	.	_	.	.	_	12	punct	_	_

1	Together	_	RB	RB	_	7	advmod	_	_
2	,	_	,	,	_	7	punct	_	_
3	these	_	DT	DT	_	6	det	_	_
4	in	_	FW	FW	_	6	amod	_	_
5	vivo	_	FW	FW	_	4	dep	_	_
6	studies	_	NNS	NNS	_	7	nsubj	_	_
7	define	_	VBP	VBP	_	0	root	_	_
8	a	_	DT	DT	_	12	det	_	_
9	critical	_	JJ	JJ	_	12	amod	_	_
10	signal	_	NN	NN	_	12	nn	_	_
11	response	_	NN	NN	_	12	nn	_	_
12	domain	_	NN	NN	_	7	dobj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	I	_	NN	NN	_	17	nn	_	_
15	kappa	_	NN	NN	_	17	nn	_	_
16	B	_	NN	NN	_	17	nn	_	_
17	alpha	_	NN	NN	_	13	pobj	_	_
18	that	_	WDT	WDT	_	20	nsubj	_	_
19	coordinately	_	RB	RB	_	20	advmod	_	_
20	controls	_	VBZ	VBZ	_	12	rcmod	_	_
21	the	_	DT	DT	_	23	det	_	_
22	biologic	_	JJ	JJ	_	23	amod	_	_
23	activities	_	NNS	NNS	_	20	dobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	I	_	NN	NN	_	28	nn	_	_
26	kappa	_	NN	NN	_	28	nn	_	_
27	B	_	NN	NN	_	28	nn	_	_
28	alpha	_	NN	NN	_	24	pobj	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	NF-kappa	_	NN	NN	_	31	nn	_	_
31	B	_	NN	NN	_	28	conj	_	_
32	in	_	IN	IN	_	20	prep	_	_
33	response	_	NN	NN	_	32	pobj	_	_
34	to	_	TO	TO	_	33	prep	_	_
35	viral	_	JJ	JJ	_	34	pobj	_	_
36	and	_	CC	CC	_	35	cc	_	_
37	immune	_	JJ	JJ	_	35	conj	_	_
38	stimuli	_	NNS	NNS	_	35	dep	_	_
39	.	_	.	.	_	7	punct	_	_

1	HIV	_	NN	NN	_	5	nn	_	_
2	type	_	NN	NN	_	5	nn	_	_
3	1	_	CD	CD	_	5	num	_	_
4	protease	_	NN	NN	_	5	nn	_	_
5	activation	_	NN	NN	_	0	root	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	NF-kappa	_	NN	NN	_	8	nn	_	_
8	B	_	NN	NN	_	6	pobj	_	_
9	within	_	IN	IN	_	5	prep	_	_
10	T	_	NN	NN	_	12	nn	_	_
11	lymphoid	_	JJ	JJ	_	12	amod	_	_
12	cells	_	NNS	NNS	_	9	pobj	_	_
13	.	_	.	.	_	5	punct	_	_

1	NF-kappa	_	NN	NN	_	2	nn	_	_
2	B	_	NN	NN	_	6	nsubj	_	_
3	is	_	VBZ	VBZ	_	6	cop	_	_
4	a	_	DT	DT	_	6	det	_	_
5	nuclear	_	JJ	JJ	_	6	amod	_	_
6	protein	_	NN	NN	_	0	root	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	11	det	_	_
9	rel	_	NN	NN	_	11	nn	_	_
10	oncogene	_	NN	NN	_	11	nn	_	_
11	family	_	NN	NN	_	7	pobj	_	_
12	capable	_	JJ	JJ	_	11	amod	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	enhancing	_	VBG	VBG	_	13	pcomp	_	_
15	transcription	_	NN	NN	_	14	dobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	several	_	JJ	JJ	_	19	amod	_	_
18	cellular	_	JJ	JJ	_	19	amod	_	_
19	genes	_	NNS	NNS	_	16	pobj	_	_
20	,	_	,	,	_	19	punct	_	_
21	including	_	VBG	VBG	_	19	prep	_	_
22	IL-2	_	NN	NN	_	21	pobj	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	the	_	DT	DT	_	26	det	_	_
25	IL-2	_	NN	NN	_	26	nn	_	_
26	receptor	_	NN	NN	_	22	conj	_	_
27	,	_	,	,	_	22	punct	_	_
28	and	_	CC	CC	_	22	cc	_	_
29	viral	_	JJ	JJ	_	30	amod	_	_
30	genes	_	NNS	NNS	_	22	conj	_	_
31	transcribed	_	VBN	VBN	_	30	vmod	_	_
32	from	_	IN	IN	_	31	prep	_	_
33	the	_	DT	DT	_	35	det	_	_
34	HIV-1	_	NN	NN	_	35	nn	_	_
35	LTR	_	NN	NN	_	32	pobj	_	_
36	.	_	.	.	_	6	punct	_	_

1	It	_	PRP	PRP	_	4	nsubjpass	_	_
2	has	_	VBZ	VBZ	_	4	aux	_	_
3	been	_	VBN	VBN	_	4	auxpass	_	_
4	reported	_	VBN	VBN	_	0	root	_	_
5	that	_	IN	IN	_	9	mark	_	_
6	HIV-1	_	NN	NN	_	7	nn	_	_
7	protease	_	NN	NN	_	9	nsubj	_	_
8	may	_	MD	MD	_	9	aux	_	_
9	cleave	_	VB	VB	_	4	ccomp	_	_
10	the	_	DT	DT	_	13	det	_	_
11	NF-kappa	_	NN	NN	_	12	nn	_	_
12	B	_	NN	NN	_	13	nn	_	_
13	precursor	_	NN	NN	_	9	dobj	_	_
14	to	_	TO	TO	_	9	prep	_	_
15	its	_	PRP$	PRP$	_	17	poss	_	_
16	active	_	JJ	JJ	_	17	amod	_	_
17	form	_	NN	NN	_	14	pobj	_	_
18	in	_	FW	FW	_	19	nn	_	_
19	vitro	_	FW	FW	_	9	advmod	_	_
20	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	15	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	study	_	NN	NN	_	1	pobj	_	_
4	the	_	DT	DT	_	5	det	_	_
5	effects	_	NNS	NNS	_	15	nsubjpass	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	HIV	_	NN	NN	_	8	nn	_	_
8	protease	_	NN	NN	_	6	pobj	_	_
9	on	_	IN	IN	_	5	prep	_	_
10	NF-kappa	_	NN	NN	_	11	nn	_	_
11	B	_	NN	NN	_	13	nn	_	_
12	precursor	_	NN	NN	_	13	nn	_	_
13	activation	_	NN	NN	_	9	pobj	_	_
14	were	_	VBD	VBD	_	15	auxpass	_	_
15	examined	_	VBN	VBN	_	0	root	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	Jurkat	_	NN	NN	_	16	pobj	_	_
18	T	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	17	dep	_	_
20	by	_	IN	IN	_	15	prep	_	_
21	introducing	_	VBG	VBG	_	20	pcomp	_	_
22	a	_	DT	DT	_	25	det	_	_
23	protease	_	NN	NN	_	25	nn	_	_
24	expression	_	NN	NN	_	25	nn	_	_
25	vector	_	NN	NN	_	21	dobj	_	_
26	into	_	IN	IN	_	21	prep	_	_
27	the	_	DT	DT	_	28	det	_	_
28	cells	_	NNS	NNS	_	26	pobj	_	_
29	.	_	.	.	_	15	punct	_	_

1	Increased	_	VBN	VBN	_	4	amod	_	_
2	NF-kappa	_	NN	NN	_	3	nn	_	_
3	B	_	NN	NN	_	4	nn	_	_
4	activity	_	NN	NN	_	6	nsubjpass	_	_
5	was	_	VBD	VBD	_	6	auxpass	_	_
6	observed	_	VBN	VBN	_	0	root	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	this	_	DT	DT	_	10	det	_	_
9	increased	_	VBN	VBN	_	10	amod	_	_
10	activity	_	NN	NN	_	12	nsubjpass	_	_
11	was	_	VBD	VBD	_	12	auxpass	_	_
12	blocked	_	VBN	VBN	_	6	conj	_	_
13	by	_	IN	IN	_	12	prep	_	_
14	a	_	DT	DT	_	16	det	_	_
15	specific	_	JJ	JJ	_	16	amod	_	_
16	inhibitor	_	NN	NN	_	13	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	viral	_	JJ	JJ	_	20	amod	_	_
20	protease	_	NN	NN	_	17	pobj	_	_
21	.	_	.	.	_	6	punct	_	_

1	Viral	_	JJ	JJ	_	2	amod	_	_
2	transcription	_	NN	NN	_	13	nsubjpass	_	_
3	,	_	,	,	_	2	punct	_	_
4	as	_	IN	IN	_	5	mark	_	_
5	measured	_	VBN	VBN	_	13	dep	_	_
6	using	_	VBG	VBG	_	5	xcomp	_	_
7	LTR-CAT	_	JJ	JJ	_	8	amod	_	_
8	assays	_	NNS	NNS	_	6	dobj	_	_
9	,	_	,	,	_	13	punct	_	_
10	was	_	VBD	VBD	_	13	auxpass	_	_
11	only	_	RB	RB	_	12	advmod	_	_
12	slightly	_	RB	RB	_	13	advmod	_	_
13	enhanced	_	VBN	VBN	_	0	root	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	18	det	_	_
16	HIV-protease	_	NN	NN	_	18	nn	_	_
17	expressing	_	JJ	JJ	_	18	amod	_	_
18	cells	_	NNS	NNS	_	14	pobj	_	_
19	,	_	,	,	_	13	punct	_	_
20	while	_	IN	IN	_	32	mark	_	_
21	secretion	_	NN	NN	_	32	nsubjpass	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	IL-2	_	NN	NN	_	22	pobj	_	_
24	and	_	CC	CC	_	21	cc	_	_
25	expression	_	NN	NN	_	21	conj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	29	det	_	_
28	IL-2	_	NN	NN	_	29	nn	_	_
29	receptor	_	NN	NN	_	26	pobj	_	_
30	were	_	VBD	VBD	_	32	auxpass	_	_
31	not	_	RB	RB	_	32	neg	_	_
32	affected	_	VBN	VBN	_	13	advcl	_	_
33	.	_	.	.	_	13	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	limited	_	JJ	JJ	_	3	amod	_	_
3	activation	_	NN	NN	_	10	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	NF-kappa	_	NN	NN	_	6	nn	_	_
6	B	_	NN	NN	_	4	pobj	_	_
7	by	_	IN	IN	_	3	prep	_	_
8	HIV	_	NN	NN	_	9	nn	_	_
9	protease	_	NN	NN	_	7	pobj	_	_
10	appears	_	VBZ	VBZ	_	0	root	_	_
11	unlikely	_	JJ	JJ	_	10	acomp	_	_
12	to	_	TO	TO	_	13	aux	_	_
13	have	_	VB	VB	_	11	xcomp	_	_
14	a	_	DT	DT	_	16	det	_	_
15	significant	_	JJ	JJ	_	16	amod	_	_
16	effect	_	NN	NN	_	13	dobj	_	_
17	on	_	IN	IN	_	13	prep	_	_
18	virus	_	NN	NN	_	19	nn	_	_
19	expression	_	NN	NN	_	17	pobj	_	_
20	or	_	CC	CC	_	19	cc	_	_
21	T	_	NN	NN	_	23	nn	_	_
22	cell	_	NN	NN	_	23	nn	_	_
23	function	_	NN	NN	_	19	conj	_	_
24	.	_	.	.	_	10	punct	_	_

1	Erythropoietin	_	NN	NN	_	2	nsubj	_	_
2	stimulates	_	VBZ	VBZ	_	0	root	_	_
3	transcription	_	NN	NN	_	2	dobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	TAL1/SCL	_	NN	NN	_	7	nn	_	_
7	gene	_	NN	NN	_	4	pobj	_	_
8	and	_	CC	CC	_	3	cc	_	_
9	phosphorylation	_	NN	NN	_	3	conj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	its	_	PRP$	PRP$	_	13	poss	_	_
12	protein	_	NN	NN	_	13	nn	_	_
13	products	_	NNS	NNS	_	10	pobj	_	_
14	.	_	.	.	_	2	punct	_	_

1	Activation	_	NN	NN	_	27	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	4	det	_	_
4	TAL1	_	NN	NN	_	2	pobj	_	_
5	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
6	or	_	CC	CC	_	4	cc	_	_
7	SCL	_	NN	NN	_	9	nn	_	_
8	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
9	gene	_	NN	NN	_	4	conj	_	_
10	,	_	,	,	_	4	punct	_	_
11	originally	_	RB	RB	_	12	advmod	_	_
12	identified	_	VBN	VBN	_	4	vmod	_	_
13	through	_	IN	IN	_	12	prep	_	_
14	its	_	PRP$	PRP$	_	15	poss	_	_
15	involvement	_	NN	NN	_	13	pobj	_	_
16	by	_	IN	IN	_	15	prep	_	_
17	a	_	DT	DT	_	20	det	_	_
18	recurrent	_	JJ	JJ	_	20	amod	_	_
19	chromosomal	_	JJ	JJ	_	20	amod	_	_
20	translocation	_	NN	NN	_	16	pobj	_	_
21	,	_	,	,	_	1	punct	_	_
22	is	_	VBZ	VBZ	_	27	cop	_	_
23	the	_	DT	DT	_	27	det	_	_
24	most	_	RBS	RBS	_	26	advmod	_	_
25	frequent	_	JJ	JJ	_	26	amod	_	_
26	molecular	_	JJ	JJ	_	27	amod	_	_
27	lesion	_	NN	NN	_	0	root	_	_
28	recognized	_	VBN	VBN	_	27	vmod	_	_
29	in	_	IN	IN	_	28	prep	_	_
30	T-cell	_	NN	NN	_	33	nn	_	_
31	acute	_	JJ	JJ	_	33	amod	_	_
32	lymphoblastic	_	JJ	JJ	_	33	amod	_	_
33	leukemia	_	NN	NN	_	29	pobj	_	_
34	.	_	.	.	_	27	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	protein	_	NN	NN	_	3	nn	_	_
3	products	_	NNS	NNS	_	7	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	this	_	DT	DT	_	6	det	_	_
6	gene	_	NN	NN	_	4	pobj	_	_
7	contain	_	VBP	VBP	_	0	root	_	_
8	the	_	DT	DT	_	10	det	_	_
9	basic-helix-loop-helix	_	JJ	JJ	_	10	amod	_	_
10	motif	_	NN	NN	_	7	dobj	_	_
11	characteristic	_	JJ	JJ	_	10	amod	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	a	_	DT	DT	_	15	det	_	_
14	large	_	JJ	JJ	_	15	amod	_	_
15	family	_	NN	NN	_	12	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	transcription	_	NN	NN	_	18	nn	_	_
18	factors	_	NNS	NNS	_	16	pobj	_	_
19	that	_	WDT	WDT	_	20	nsubj	_	_
20	bind	_	VBP	VBP	_	18	rcmod	_	_
21	to	_	TO	TO	_	20	prep	_	_
22	the	_	DT	DT	_	26	det	_	_
23	canonical	_	JJ	JJ	_	26	amod	_	_
24	DNA	_	NN	NN	_	26	nn	_	_
25	sequence	_	NN	NN	_	26	nn	_	_
26	CANNTG	_	NN	NN	_	21	pobj	_	_
27	as	_	IN	IN	_	20	prep	_	_
28	protein	_	NN	NN	_	29	nn	_	_
29	heterodimers	_	NNS	NNS	_	27	pobj	_	_
30	.	_	.	.	_	7	punct	_	_

1	TAL1	_	NN	NN	_	2	nn	_	_
2	expression	_	NN	NN	_	16	nsubj	_	_
3	by	_	IN	IN	_	2	prep	_	_
4	erythroid	_	JJ	JJ	_	5	amod	_	_
5	cells	_	NNS	NNS	_	3	pobj	_	_
6	in	_	FW	FW	_	5	amod	_	_
7	vivo	_	FW	FW	_	6	dep	_	_
8	and	_	CC	CC	_	3	cc	_	_
9	in	_	IN	IN	_	3	conj	_	_
10	chemical-induced	_	JJ	JJ	_	13	amod	_	_
11	erythroleukemia	_	NN	NN	_	13	nn	_	_
12	cell	_	NN	NN	_	13	nn	_	_
13	lines	_	NNS	NNS	_	9	pobj	_	_
14	in	_	FW	FW	_	13	amod	_	_
15	vivo	_	FW	FW	_	14	dep	_	_
16	suggested	_	VBD	VBD	_	0	root	_	_
17	the	_	DT	DT	_	18	det	_	_
18	gene	_	NN	NN	_	16	dobj	_	_
19	might	_	MD	MD	_	20	aux	_	_
20	regulate	_	VB	VB	_	16	dep	_	_
21	aspects	_	NNS	NNS	_	20	dobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	erythroid	_	JJ	JJ	_	24	amod	_	_
24	differentiation	_	NN	NN	_	22	pobj	_	_
25	.	_	.	.	_	16	punct	_	_

1	Since	_	IN	IN	_	8	mark	_	_
2	the	_	DT	DT	_	4	det	_	_
3	terminal	_	JJ	JJ	_	4	amod	_	_
4	events	_	NNS	NNS	_	8	nsubjpass	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	erythropoiesis	_	NN	NN	_	5	pobj	_	_
7	are	_	VBP	VBP	_	8	auxpass	_	_
8	controlled	_	VBN	VBN	_	19	advcl	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	13	det	_	_
11	glycoprotein	_	NN	NN	_	13	nn	_	_
12	hormone	_	NN	NN	_	13	nn	_	_
13	erythropoietin	_	NN	NN	_	9	pobj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	Epo	_	NN	NN	_	13	appos	_	_
16	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
17	,	_	,	,	_	19	punct	_	_
18	we	_	PRP	PRP	_	19	nsubj	_	_
19	investigated	_	VBD	VBD	_	0	root	_	_
20	whether	_	IN	IN	_	34	mark	_	_
21	the	_	DT	DT	_	22	dep	_	_
22	expression	_	NN	NN	_	34	nsubjpass	_	_
23	or	_	CC	CC	_	22	cc	_	_
24	activity	_	NN	NN	_	22	conj	_	_
25	of	_	IN	IN	_	22	prep	_	_
26	the	_	DT	DT	_	28	det	_	_
27	TAL1	_	NN	NN	_	28	nn	_	_
28	gene	_	NN	NN	_	25	pobj	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	its	_	PRP$	PRP$	_	32	poss	_	_
31	protein	_	NN	NN	_	32	nn	_	_
32	products	_	NNS	NNS	_	28	conj	_	_
33	were	_	VBD	VBD	_	34	auxpass	_	_
34	affected	_	VBN	VBN	_	19	ccomp	_	_
35	by	_	IN	IN	_	34	prep	_	_
36	Epo	_	NN	NN	_	35	pobj	_	_
37	in	_	IN	IN	_	36	prep	_	_
38	splenic	_	JJ	JJ	_	39	amod	_	_
39	erythroblasts	_	NNS	NNS	_	37	pobj	_	_
40	from	_	IN	IN	_	39	prep	_	_
41	mice	_	NNS	NNS	_	40	pobj	_	_
42	infected	_	VBN	VBN	_	41	vmod	_	_
43	with	_	IN	IN	_	42	prep	_	_
44	an	_	DT	DT	_	46	det	_	_
45	anemia-inducing	_	JJ	JJ	_	46	amod	_	_
46	strain	_	NN	NN	_	43	pobj	_	_
47	of	_	IN	IN	_	46	prep	_	_
48	Friend	_	NN	NN	_	49	nn	_	_
49	virus	_	NN	NN	_	47	pobj	_	_
50	-LRB-	_	-LRB-	-LRB-	_	52	punct	_	_
51	FVA	_	NN	NN	_	52	nn	_	_
52	cells	_	NNS	NNS	_	49	appos	_	_
53	-RRB-	_	-RRB-	-RRB-	_	52	punct	_	_
54	.	_	.	.	_	19	punct	_	_

1	Epo	_	NN	NN	_	2	nsubj	_	_
2	elicited	_	VBD	VBD	_	0	root	_	_
3	a	_	DT	DT	_	7	det	_	_
4	rapid	_	JJ	JJ	_	7	amod	_	_
5	,	_	,	,	_	4	punct	_	_
6	dose-related	_	JJ	JJ	_	4	dep	_	_
7	increase	_	NN	NN	_	2	dobj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	TAL1	_	NN	NN	_	10	nn	_	_
10	mRNA	_	NN	NN	_	8	pobj	_	_
11	by	_	IN	IN	_	2	prep	_	_
12	increasing	_	VBG	VBG	_	11	pcomp	_	_
13	transcription	_	NN	NN	_	12	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	gene	_	NN	NN	_	14	pobj	_	_
17	and	_	CC	CC	_	12	cc	_	_
18	stabilizing	_	VBG	VBG	_	12	conj	_	_
19	one	_	CD	CD	_	18	dobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	its	_	PRP$	PRP$	_	22	poss	_	_
22	mRNAs	_	NNS	NNS	_	20	pobj	_	_
23	.	_	.	.	_	2	punct	_	_

1	An	_	DT	DT	_	6	det	_	_
2	Epo-inducible	_	JJ	JJ	_	6	amod	_	_
3	TAL1	_	NN	NN	_	6	nn	_	_
4	DNA	_	NN	NN	_	6	nn	_	_
5	binding	_	NN	NN	_	6	nn	_	_
6	activity	_	NN	NN	_	8	nsubjpass	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	identified	_	VBN	VBN	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	FVA	_	NN	NN	_	13	nn	_	_
11	cell	_	NN	NN	_	13	nn	_	_
12	nuclear	_	JJ	JJ	_	13	amod	_	_
13	extracts	_	NNS	NNS	_	9	pobj	_	_
14	that	_	WDT	WDT	_	16	nsubj	_	_
15	subsequently	_	RB	RB	_	16	advmod	_	_
16	decayed	_	VBD	VBD	_	13	rcmod	_	_
17	despite	_	IN	IN	_	16	prep	_	_
18	accumulating	_	VBG	VBG	_	17	pcomp	_	_
19	mRNA	_	NN	NN	_	18	dobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	protein	_	NN	NN	_	19	conj	_	_
22	.	_	.	.	_	8	punct	_	_

1	Induction	_	NN	NN	_	7	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	DNA	_	NN	NN	_	5	nn	_	_
4	binding	_	NN	NN	_	5	nn	_	_
5	activity	_	NN	NN	_	2	pobj	_	_
6	was	_	VBD	VBD	_	7	auxpass	_	_
7	associated	_	VBN	VBN	_	0	root	_	_
8	temporally	_	RB	RB	_	7	advmod	_	_
9	with	_	IN	IN	_	7	prep	_	_
10	Epo-induced	_	JJ	JJ	_	11	amod	_	_
11	phosphorylation	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	nuclear	_	JJ	JJ	_	15	amod	_	_
14	TAL1	_	NN	NN	_	15	nn	_	_
15	protein	_	NN	NN	_	12	pobj	_	_
16	.	_	.	.	_	7	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	6	mark	_	_
5	Epo	_	NN	NN	_	6	nsubj	_	_
6	acts	_	VBZ	VBZ	_	3	ccomp	_	_
7	at	_	IN	IN	_	6	prep	_	_
8	both	_	CC	CC	_	9	preconj	_	_
9	transcriptional	_	JJ	JJ	_	7	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	posttranscriptional	_	JJ	JJ	_	9	conj	_	_
12	levels	_	NNS	NNS	_	9	dep	_	_
13	on	_	IN	IN	_	9	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	TAL1	_	NN	NN	_	16	nn	_	_
16	locus	_	NN	NN	_	13	pobj	_	_
17	in	_	IN	IN	_	6	prep	_	_
18	Friend	_	NN	NN	_	20	nn	_	_
19	virus-induced	_	JJ	JJ	_	20	amod	_	_
20	erythroblasts	_	NNS	NNS	_	17	pobj	_	_
21	and	_	CC	CC	_	3	cc	_	_
22	establish	_	VBP	VBP	_	3	conj	_	_
23	a	_	DT	DT	_	24	det	_	_
24	link	_	NN	NN	_	22	dobj	_	_
25	between	_	IN	IN	_	24	prep	_	_
26	Epo	_	NN	NN	_	28	nn	_	_
27	signaling	_	NN	NN	_	28	nn	_	_
28	mechanisms	_	NNS	NNS	_	25	pobj	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	a	_	DT	DT	_	31	det	_	_
31	member	_	NN	NN	_	28	conj	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	a	_	DT	DT	_	34	det	_	_
34	family	_	NN	NN	_	32	pobj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	transcription	_	NN	NN	_	37	nn	_	_
37	factors	_	NNS	NNS	_	35	pobj	_	_
38	involved	_	VBN	VBN	_	37	vmod	_	_
39	in	_	IN	IN	_	38	prep	_	_
40	the	_	DT	DT	_	41	det	_	_
41	differentiation	_	NN	NN	_	39	pobj	_	_
42	of	_	IN	IN	_	41	prep	_	_
43	diverse	_	JJ	JJ	_	45	amod	_	_
44	cell	_	NN	NN	_	45	nn	_	_
45	lineages	_	NNS	NNS	_	42	pobj	_	_
46	.	_	.	.	_	3	punct	_	_

1	Abnormal	_	JJ	JJ	_	2	amod	_	_
2	regulation	_	NN	NN	_	12	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	IL-2	_	NN	NN	_	6	nn	_	_
6	promoter	_	NN	NN	_	3	pobj	_	_
7	in	_	IN	IN	_	2	prep	_	_
8	lpr	_	NN	NN	_	7	pobj	_	_
9	CD4-CD8-	_	JJ	JJ	_	11	amod	_	_
10	T	_	NN	NN	_	11	nn	_	_
11	lymphocytes	_	NNS	NNS	_	8	dep	_	_
12	results	_	VBZ	VBZ	_	0	root	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	constitutive	_	JJ	JJ	_	15	amod	_	_
15	expression	_	NN	NN	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	a	_	DT	DT	_	25	det	_	_
18	novel	_	JJ	JJ	_	25	amod	_	_
19	nuclear	_	JJ	JJ	_	25	amod	_	_
20	factor	_	NN	NN	_	25	nn	_	_
21	of	_	IN	IN	_	25	amod	_	_
22	activated	_	VBN	VBN	_	25	amod	_	_
23	T	_	NN	NN	_	25	nn	_	_
24	cells-binding	_	JJ	JJ	_	25	amod	_	_
25	factor	_	NN	NN	_	16	pobj	_	_
26	.	_	.	.	_	12	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	inert	_	JJ	JJ	_	3	amod	_	_
3	quality	_	NN	NN	_	16	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	MRL-Ipr/Ipr	_	NN	NN	_	15	nn	_	_
6	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
7	Ipr	_	NN	NN	_	15	nn	_	_
8	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
9	peripheral	_	JJ	JJ	_	15	amod	_	_
10	CD4-CD8-	_	JJ	JJ	_	15	amod	_	_
11	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
12	CD4-8-	_	JJ	JJ	_	15	amod	_	_
13	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
14	T	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	4	pobj	_	_
16	manifests	_	VBZ	VBZ	_	0	root	_	_
17	primarily	_	RB	RB	_	16	advmod	_	_
18	as	_	IN	IN	_	16	prep	_	_
19	an	_	DT	DT	_	20	det	_	_
20	inability	_	NN	NN	_	18	pobj	_	_
21	to	_	TO	TO	_	22	aux	_	_
22	proliferate	_	VB	VB	_	20	vmod	_	_
23	or	_	CC	CC	_	22	cc	_	_
24	produce	_	VB	VB	_	22	conj	_	_
25	IL-2	_	NN	NN	_	22	dobj	_	_
26	in	_	IN	IN	_	22	prep	_	_
27	response	_	NN	NN	_	26	pobj	_	_
28	to	_	TO	TO	_	27	prep	_	_
29	TCR	_	NN	NN	_	28	pobj	_	_
30	or	_	CC	CC	_	29	cc	_	_
31	mitogenic	_	JJ	JJ	_	29	conj	_	_
32	stimulation	_	NN	NN	_	29	dep	_	_
33	.	_	.	.	_	16	punct	_	_

1	Yet	_	RB	RB	_	6	advmod	_	_
2	these	_	DT	DT	_	4	det	_	_
3	same	_	JJ	JJ	_	4	amod	_	_
4	cells	_	NNS	NNS	_	6	nsubj	_	_
5	do	_	VBP	VBP	_	6	aux	_	_
6	initiate	_	VB	VB	_	0	root	_	_
7	early	_	JJ	JJ	_	10	amod	_	_
8	TCR-mediated	_	JJ	JJ	_	10	amod	_	_
9	signaling	_	NN	NN	_	10	nn	_	_
10	events	_	NNS	NNS	_	6	dobj	_	_
11	,	_	,	,	_	10	punct	_	_
12	such	_	JJ	JJ	_	13	mwe	_	_
13	as	_	IN	IN	_	10	prep	_	_
14	generation	_	NN	NN	_	13	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	inositol	_	JJ	JJ	_	17	amod	_	_
17	phosphates	_	NNS	NNS	_	15	pobj	_	_
18	and	_	CC	CC	_	14	cc	_	_
19	increased	_	VBN	VBN	_	21	amod	_	_
20	intracellular	_	JJ	JJ	_	21	amod	_	_
21	calcium	_	NN	NN	_	14	conj	_	_
22	.	_	.	.	_	6	punct	_	_

1	They	_	PRP	PRP	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	display	_	VBP	VBP	_	0	root	_	_
4	constitutively	_	RB	RB	_	3	advmod	_	_
5	high	_	JJ	JJ	_	6	amod	_	_
6	levels	_	NNS	NNS	_	3	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	p59fyn	_	NN	NN	_	7	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	CD3	_	NN	NN	_	11	nn	_	_
11	zeta	_	NN	NN	_	12	nn	_	_
12	tyrosine	_	NN	NN	_	8	conj	_	_
13	phosphorylation	_	NN	NN	_	8	dep	_	_
14	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	generation	_	NN	NN	_	10	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	second	_	JJ	JJ	_	5	amod	_	_
5	messengers	_	NNS	NNS	_	3	pobj	_	_
6	in	_	IN	IN	_	2	prep	_	_
7	T	_	NN	NN	_	8	nn	_	_
8	cells	_	NNS	NNS	_	6	pobj	_	_
9	normally	_	RB	RB	_	10	advmod	_	_
10	leads	_	VBZ	VBZ	_	0	root	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	downstream	_	JJ	JJ	_	13	amod	_	_
13	signaling	_	NN	NN	_	11	pobj	_	_
14	that	_	WDT	WDT	_	15	nsubj	_	_
15	results	_	VBZ	VBZ	_	13	rcmod	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	transcriptional	_	JJ	JJ	_	18	amod	_	_
18	activation	_	NN	NN	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	22	det	_	_
21	IL-2	_	NN	NN	_	22	nn	_	_
22	gene	_	NN	NN	_	19	pobj	_	_
23	.	_	.	.	_	10	punct	_	_

1	We	_	PRP	PRP	_	5	nsubj	_	_
2	,	_	,	,	_	1	punct	_	_
3	therefore	_	RB	RB	_	5	advmod	_	_
4	,	_	,	,	_	5	punct	_	_
5	compared	_	VBD	VBD	_	0	root	_	_
6	the	_	DT	DT	_	8	det	_	_
7	activation	_	NN	NN	_	8	nn	_	_
8	state	_	NN	NN	_	5	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	14	det	_	_
11	IL-2	_	NN	NN	_	14	nn	_	_
12	gene	_	NN	NN	_	14	nn	_	_
13	promoter	_	NN	NN	_	14	nn	_	_
14	region	_	NN	NN	_	9	pobj	_	_
15	in	_	IN	IN	_	8	prep	_	_
16	freshly	_	RB	RB	_	17	advmod	_	_
17	isolated	_	VBN	VBN	_	15	pobj	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	stimulated	_	VBN	VBN	_	17	conj	_	_
20	Ipr	_	NN	NN	_	23	nn	_	_
21	CD4-8-	_	JJ	JJ	_	23	amod	_	_
22	T	_	NN	NN	_	23	nn	_	_
23	cells	_	NNS	NNS	_	17	dep	_	_
24	with	_	IN	IN	_	5	prep	_	_
25	that	_	DT	DT	_	24	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	normal	_	JJ	JJ	_	29	amod	_	_
28	T	_	NN	NN	_	29	nn	_	_
29	lymphocytes	_	NNS	NNS	_	26	pobj	_	_
30	.	_	.	.	_	5	punct	_	_

1	Levels	_	NNS	NNS	_	19	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	4	det	_	_
4	octamer	_	NN	NN	_	2	pobj	_	_
5	,	_	,	,	_	4	punct	_	_
6	NF-kappa	_	NN	NN	_	7	nn	_	_
7	B	_	NN	NN	_	4	conj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
9	p50-p65	_	NN	NN	_	10	nn	_	_
10	heterodimer	_	NN	NN	_	4	appos	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	,	_	,	,	_	4	punct	_	_
13	and	_	CC	CC	_	4	cc	_	_
14	AP-1	_	NN	NN	_	16	nn	_	_
15	transcriptional	_	JJ	JJ	_	16	amod	_	_
16	factors	_	NNS	NNS	_	4	conj	_	_
17	are	_	VBP	VBP	_	19	auxpass	_	_
18	constitutively	_	RB	RB	_	19	advmod	_	_
19	elevated	_	VBN	VBN	_	0	root	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	freshly	_	RB	RB	_	22	advmod	_	_
22	isolated	_	VBN	VBN	_	26	amod	_	_
23	Ipr	_	NN	NN	_	26	nn	_	_
24	CD4-8-	_	JJ	JJ	_	26	amod	_	_
25	T	_	NN	NN	_	26	nn	_	_
26	cells	_	NNS	NNS	_	20	pobj	_	_
27	,	_	,	,	_	19	punct	_	_
28	consistent	_	JJ	JJ	_	19	acomp	_	_
29	with	_	IN	IN	_	28	prep	_	_
30	the	_	DT	DT	_	32	det	_	_
31	activated	_	VBN	VBN	_	32	amod	_	_
32	phenotype	_	NN	NN	_	29	pobj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	these	_	DT	DT	_	35	det	_	_
35	cells	_	NNS	NNS	_	33	pobj	_	_
36	.	_	.	.	_	19	punct	_	_

1	Upon	_	IN	IN	_	22	prep	_	_
2	stimulation	_	NN	NN	_	1	pobj	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	mitogens	_	NNS	NNS	_	3	pobj	_	_
5	,	_	,	,	_	22	punct	_	_
6	formation	_	NN	NN	_	22	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	transactivating	_	VBG	VBG	_	10	amod	_	_
10	complex	_	NN	NN	_	7	pobj	_	_
11	,	_	,	,	_	10	punct	_	_
12	nuclear	_	JJ	JJ	_	17	amod	_	_
13	factor	_	NN	NN	_	17	nn	_	_
14	of	_	IN	IN	_	17	amod	_	_
15	activated	_	VBN	VBN	_	17	amod	_	_
16	T	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	10	appos	_	_
18	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
19	NF-AT	_	NN	NN	_	17	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	,	_	,	,	_	6	punct	_	_
22	occurs	_	VBZ	VBZ	_	0	root	_	_
23	with	_	IN	IN	_	22	prep	_	_
24	normal	_	JJ	JJ	_	25	amod	_	_
25	kinetics	_	NNS	NNS	_	23	pobj	_	_
26	in	_	IN	IN	_	22	prep	_	_
27	Ipr	_	NN	NN	_	30	nn	_	_
28	CD4-8-	_	JJ	JJ	_	30	amod	_	_
29	T	_	NN	NN	_	30	nn	_	_
30	cells	_	NNS	NNS	_	26	pobj	_	_
31	.	_	.	.	_	22	punct	_	_

1	Yet	_	RB	RB	_	11	advmod	_	_
2	,	_	,	,	_	11	punct	_	_
3	the	_	DT	DT	_	4	det	_	_
4	levels	_	NNS	NNS	_	11	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	9	det	_	_
7	activating	_	VBG	VBG	_	9	amod	_	_
8	NF-AT	_	NN	NN	_	9	nn	_	_
9	complex	_	NN	NN	_	5	pobj	_	_
10	never	_	RB	RB	_	11	neg	_	_
11	reach	_	VBP	VBP	_	0	root	_	_
12	those	_	DT	DT	_	11	dobj	_	_
13	observed	_	VBN	VBN	_	12	vmod	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	similarly	_	RB	RB	_	16	advmod	_	_
16	stimulated	_	VBN	VBN	_	19	amod	_	_
17	normal	_	JJ	JJ	_	19	amod	_	_
18	T	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	14	pobj	_	_
20	.	_	.	.	_	11	punct	_	_

1	Furthermore	_	RB	RB	_	10	advmod	_	_
2	,	_	,	,	_	10	punct	_	_
3	nuclear	_	JJ	JJ	_	4	amod	_	_
4	extracts	_	NNS	NNS	_	10	nsubj	_	_
5	from	_	IN	IN	_	4	prep	_	_
6	Ipr	_	NN	NN	_	9	nn	_	_
7	CD4-8-	_	JJ	JJ	_	9	amod	_	_
8	T	_	NN	NN	_	9	nn	_	_
9	cells	_	NNS	NNS	_	5	pobj	_	_
10	display	_	VBP	VBP	_	0	root	_	_
11	high	_	JJ	JJ	_	12	amod	_	_
12	levels	_	NNS	NNS	_	10	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	a	_	DT	DT	_	18	det	_	_
15	novel	_	JJ	JJ	_	18	amod	_	_
16	specific	_	JJ	JJ	_	15	dep	_	_
17	binding	_	NN	NN	_	18	nn	_	_
18	activity	_	NN	NN	_	13	pobj	_	_
19	at	_	IN	IN	_	10	prep	_	_
20	the	_	DT	DT	_	22	det	_	_
21	NF-AT	_	NN	NN	_	22	nn	_	_
22	site	_	NN	NN	_	19	pobj	_	_
23	,	_	,	,	_	22	punct	_	_
24	which	_	WDT	WDT	_	26	nsubj	_	_
25	is	_	VBZ	VBZ	_	26	cop	_	_
26	present	_	JJ	JJ	_	22	rcmod	_	_
27	at	_	IN	IN	_	26	prep	_	_
28	much	_	JJ	JJ	_	30	amod	_	_
29	lower	_	JJR	JJR	_	28	dep	_	_
30	levels	_	NNS	NNS	_	27	pobj	_	_
31	in	_	IN	IN	_	30	prep	_	_
32	freshly	_	RB	RB	_	33	advmod	_	_
33	isolated	_	VBN	VBN	_	36	amod	_	_
34	normal	_	JJ	JJ	_	36	amod	_	_
35	T	_	NN	NN	_	36	nn	_	_
36	lymphocytes	_	NNS	NNS	_	31	pobj	_	_
37	.	_	.	.	_	10	punct	_	_

1	Upon	_	IN	IN	_	15	prep	_	_
2	mitogenic	_	JJ	JJ	_	3	amod	_	_
3	stimulation	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	15	punct	_	_
5	the	_	DT	DT	_	7	det	_	_
6	binding	_	NN	NN	_	7	nn	_	_
7	activity	_	NN	NN	_	15	nsubjpass	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	12	det	_	_
10	novel	_	JJ	JJ	_	12	amod	_	_
11	NF-AT-binding	_	JJ	JJ	_	12	amod	_	_
12	factor	_	NN	NN	_	8	pobj	_	_
13	is	_	VBZ	VBZ	_	15	auxpass	_	_
14	rapidly	_	RB	RB	_	15	advmod	_	_
15	down-regulated	_	VBN	VBN	_	0	root	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	normal	_	JJ	JJ	_	19	amod	_	_
18	T	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	16	pobj	_	_
20	,	_	,	,	_	15	punct	_	_
21	but	_	CC	CC	_	15	cc	_	_
22	persists	_	VBZ	VBZ	_	15	conj	_	_
23	at	_	IN	IN	_	22	prep	_	_
24	high	_	JJ	JJ	_	25	amod	_	_
25	levels	_	NNS	NNS	_	23	pobj	_	_
26	in	_	IN	IN	_	22	prep	_	_
27	Ipr	_	NN	NN	_	30	nn	_	_
28	CD4-8-	_	JJ	JJ	_	30	amod	_	_
29	T	_	NN	NN	_	30	nn	_	_
30	cells	_	NNS	NNS	_	26	pobj	_	_
31	.	_	.	.	_	15	punct	_	_

1	These	_	DT	DT	_	3	det	_	_
2	two	_	CD	CD	_	3	num	_	_
3	abnormalities	_	NNS	NNS	_	8	nsubj	_	_
4	at	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	NF-AT	_	NN	NN	_	7	nn	_	_
7	site	_	NN	NN	_	4	pobj	_	_
8	provide	_	VBP	VBP	_	0	root	_	_
9	a	_	DT	DT	_	11	det	_	_
10	potential	_	JJ	JJ	_	11	amod	_	_
11	mechanism	_	NN	NN	_	8	dobj	_	_
12	to	_	TO	TO	_	13	aux	_	_
13	account	_	VB	VB	_	11	vmod	_	_
14	for	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	defect	_	NN	NN	_	14	pobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	IL-2	_	NN	NN	_	19	nn	_	_
19	production	_	NN	NN	_	17	pobj	_	_
20	from	_	IN	IN	_	19	prep	_	_
21	Ipr	_	NN	NN	_	24	nn	_	_
22	CD4-8-	_	JJ	JJ	_	24	amod	_	_
23	T	_	NN	NN	_	24	nn	_	_
24	cells	_	NNS	NNS	_	20	pobj	_	_
25	.	_	.	.	_	8	punct	_	_

1	GM-CSF	_	NN	NN	_	4	nsubj	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	IL-2	_	NN	NN	_	1	conj	_	_
4	share	_	VBP	VBP	_	0	root	_	_
5	common	_	JJ	JJ	_	7	amod	_	_
6	control	_	NN	NN	_	7	nn	_	_
7	mechanisms	_	NNS	NNS	_	4	dobj	_	_
8	in	_	IN	IN	_	4	prep	_	_
9	response	_	NN	NN	_	8	pobj	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	costimulatory	_	JJ	JJ	_	12	amod	_	_
12	signals	_	NNS	NNS	_	10	pobj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	T	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	.	_	.	.	_	4	punct	_	_

1	Antigen	_	NN	NN	_	19	nsubj	_	_
2	complexed	_	VBN	VBN	_	1	vmod	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	major	_	JJ	JJ	_	7	amod	_	_
5	histocompatibility	_	NN	NN	_	7	nn	_	_
6	complex	_	NN	NN	_	7	nn	_	_
7	class	_	NN	NN	_	3	pobj	_	_
8	I	_	CD	CD	_	7	dep	_	_
9	or	_	CC	CC	_	7	cc	_	_
10	II	_	CD	CD	_	7	conj	_	_
11	molecules	_	NNS	NNS	_	7	dep	_	_
12	on	_	IN	IN	_	2	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	surface	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	antigen	_	NN	NN	_	18	nn	_	_
17	presenting	_	NN	NN	_	18	nn	_	_
18	cells	_	NNS	NNS	_	15	pobj	_	_
19	interacts	_	VBZ	VBZ	_	0	root	_	_
20	with	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	24	det	_	_
22	T	_	NN	NN	_	24	nn	_	_
23	cell	_	NN	NN	_	24	nn	_	_
24	receptor	_	NN	NN	_	20	pobj	_	_
25	-LRB-	_	-LRB-	-LRB-	_	26	punct	_	_
26	TCR	_	NN	NN	_	24	appos	_	_
27	-RRB-	_	-RRB-	-RRB-	_	26	punct	_	_
28	on	_	IN	IN	_	19	prep	_	_
29	the	_	DT	DT	_	30	det	_	_
30	surface	_	NN	NN	_	28	pobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	T	_	NN	NN	_	33	nn	_	_
33	cells	_	NNS	NNS	_	31	pobj	_	_
34	and	_	CC	CC	_	19	cc	_	_
35	initiates	_	VBZ	VBZ	_	19	conj	_	_
36	an	_	DT	DT	_	38	det	_	_
37	activation	_	NN	NN	_	38	nn	_	_
38	cascade	_	NN	NN	_	35	dobj	_	_
39	.	_	.	.	_	19	punct	_	_

1	So	_	RB	RB	_	2	advmod	_	_
2	called	_	VBN	VBN	_	4	amod	_	_
3	costimulatory	_	JJ	JJ	_	4	amod	_	_
4	signals	_	NNS	NNS	_	23	nsubjpass	_	_
5	,	_	,	,	_	4	punct	_	_
6	mediated	_	VBN	VBN	_	4	vmod	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	other	_	JJ	JJ	_	11	amod	_	_
9	cell	_	NN	NN	_	11	nn	_	_
10	surface	_	NN	NN	_	11	nn	_	_
11	interactions	_	NNS	NNS	_	7	pobj	_	_
12	or	_	CC	CC	_	11	cc	_	_
13	soluble	_	JJ	JJ	_	14	amod	_	_
14	cytokines	_	NNS	NNS	_	11	conj	_	_
15	produced	_	VBN	VBN	_	14	vmod	_	_
16	by	_	IN	IN	_	15	prep	_	_
17	antigen	_	NN	NN	_	19	nn	_	_
18	presenting	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	16	pobj	_	_
20	,	_	,	,	_	4	punct	_	_
21	are	_	VBP	VBP	_	23	auxpass	_	_
22	also	_	RB	RB	_	23	advmod	_	_
23	required	_	VBN	VBN	_	0	root	_	_
24	for	_	IN	IN	_	23	prep	_	_
25	complete	_	JJ	JJ	_	28	amod	_	_
26	T	_	NN	NN	_	28	nn	_	_
27	cell	_	NN	NN	_	28	nn	_	_
28	activation	_	NN	NN	_	24	pobj	_	_
29	.	_	.	.	_	23	punct	_	_

1	High	_	JJ	JJ	_	2	amod	_	_
2	levels	_	NNS	NNS	_	11	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	cytokine	_	NN	NN	_	6	nn	_	_
5	gene	_	NN	NN	_	6	nn	_	_
6	expression	_	NN	NN	_	3	pobj	_	_
7	in	_	IN	IN	_	2	prep	_	_
8	T	_	NN	NN	_	9	nn	_	_
9	cells	_	NNS	NNS	_	7	pobj	_	_
10	also	_	RB	RB	_	11	advmod	_	_
11	required	_	VBD	VBD	_	0	root	_	_
12	both	_	CC	CC	_	13	preconj	_	_
13	TCR	_	NN	NN	_	11	dobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	costimulatory	_	JJ	JJ	_	13	conj	_	_
16	signals	_	NNS	NNS	_	13	dep	_	_
17	.	_	.	.	_	11	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	granulocyte-macrophage	_	JJ	JJ	_	4	amod	_	_
3	colony-stimulating	_	JJ	JJ	_	4	amod	_	_
4	factor	_	NN	NN	_	5	nsubj	_	_
5	requires	_	VBZ	VBZ	_	0	root	_	_
6	sequences	_	NNS	NNS	_	5	dobj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	promoter	_	NN	NN	_	7	pobj	_	_
10	as	_	RB	RB	_	11	advmod	_	_
11	well	_	RB	RB	_	6	cc	_	_
12	as	_	IN	IN	_	11	mwe	_	_
13	a	_	DT	DT	_	15	det	_	_
14	powerful	_	JJ	JJ	_	15	amod	_	_
15	enhancer	_	NN	NN	_	6	conj	_	_
16	located	_	JJ	JJ	_	15	amod	_	_
17	3kb	_	RB	RB	_	18	npadvmod	_	_
18	upstream	_	RB	RB	_	16	advmod	_	_
19	to	_	TO	TO	_	20	aux	_	_
20	respond	_	VB	VB	_	5	xcomp	_	_
21	to	_	TO	TO	_	20	prep	_	_
22	TCR-like	_	JJ	JJ	_	21	dep	_	_
23	signals	_	NNS	NNS	_	21	dep	_	_
24	.	_	.	.	_	5	punct	_	_

1	These	_	DT	DT	_	5	det	_	_
2	promoter	_	NN	NN	_	5	nn	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	enhancer	_	NN	NN	_	2	conj	_	_
5	regions	_	NNS	NNS	_	8	nsubjpass	_	_
6	are	_	VBP	VBP	_	8	auxpass	_	_
7	mainly	_	RB	RB	_	8	advmod	_	_
8	activated	_	VBN	VBN	_	0	root	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	18	det	_	_
11	transcription	_	NN	NN	_	18	nn	_	_
12	factor	_	NN	NN	_	18	nn	_	_
13	nuclear	_	JJ	JJ	_	18	amod	_	_
14	factor	_	NN	NN	_	18	nn	_	_
15	of	_	IN	IN	_	18	amod	_	_
16	activated	_	VBN	VBN	_	18	amod	_	_
17	T	_	NN	NN	_	18	nn	_	_
18	cells	_	NNS	NNS	_	9	pobj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	NFAT	_	NN	NN	_	18	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	activation	_	NN	NN	_	11	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	NFAT	_	NN	NN	_	3	pobj	_	_
5	by	_	IN	IN	_	2	prep	_	_
6	TCR	_	NN	NN	_	7	nn	_	_
7	signals	_	NNS	NNS	_	5	pobj	_	_
8	has	_	VBZ	VBZ	_	11	aux	_	_
9	been	_	VBN	VBN	_	11	auxpass	_	_
10	well	_	RB	RB	_	11	advmod	_	_
11	described	_	VBN	VBN	_	0	root	_	_
12	for	_	IN	IN	_	11	prep	_	_
13	interleukin-2	_	NN	NN	_	12	pobj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	IL-2	_	NN	NN	_	13	appos	_	_
16	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
17	and	_	CC	CC	_	13	cc	_	_
18	IL-4	_	NN	NN	_	13	conj	_	_
19	gene	_	NN	NN	_	20	nn	_	_
20	transcription	_	NN	NN	_	13	dep	_	_
21	in	_	IN	IN	_	13	prep	_	_
22	T	_	NN	NN	_	23	nn	_	_
23	cells	_	NNS	NNS	_	21	pobj	_	_
24	.	_	.	.	_	11	punct	_	_

1	Costimulatory	_	JJ	JJ	_	2	amod	_	_
2	signals	_	NNS	NNS	_	17	nsubj	_	_
3	,	_	,	,	_	2	punct	_	_
4	such	_	JJ	JJ	_	5	mwe	_	_
5	as	_	IN	IN	_	2	prep	_	_
6	activation	_	NN	NN	_	5	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	12	det	_	_
9	CD28	_	NN	NN	_	12	nn	_	_
10	cell	_	NN	NN	_	12	nn	_	_
11	surface	_	NN	NN	_	12	nn	_	_
12	molecule	_	NN	NN	_	7	pobj	_	_
13	on	_	IN	IN	_	6	prep	_	_
14	T	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	,	_	,	,	_	2	punct	_	_
17	lead	_	VBP	VBP	_	0	root	_	_
18	to	_	TO	TO	_	17	prep	_	_
19	activation	_	NN	NN	_	18	pobj	_	_
20	through	_	IN	IN	_	17	prep	_	_
21	a	_	DT	DT	_	23	det	_	_
22	distinct	_	JJ	JJ	_	23	amod	_	_
23	region	_	NN	NN	_	20	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	32	det	_	_
26	granulocyte-macrophage	_	JJ	JJ	_	32	amod	_	_
27	colony-stimulating	_	JJ	JJ	_	32	amod	_	_
28	factor	_	NN	NN	_	32	nn	_	_
29	-LRB-	_	-LRB-	-LRB-	_	32	punct	_	_
30	GM-CSF	_	NN	NN	_	32	nn	_	_
31	-RRB-	_	-RRB-	-RRB-	_	32	punct	_	_
32	promoter	_	NN	NN	_	24	pobj	_	_
33	.	_	.	.	_	17	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	region	_	NN	NN	_	4	nsubjpass	_	_
3	is	_	VBZ	VBZ	_	4	auxpass	_	_
4	termed	_	VBN	VBN	_	0	root	_	_
5	the	_	DT	DT	_	6	dep	_	_
6	CK-1	_	NN	NN	_	4	xcomp	_	_
7	or	_	CC	CC	_	6	cc	_	_
8	CD28RE	_	NN	NN	_	6	conj	_	_
9	and	_	CC	CC	_	4	cc	_	_
10	appears	_	VBZ	VBZ	_	4	conj	_	_
11	to	_	TO	TO	_	12	aux	_	_
12	bind	_	VB	VB	_	10	xcomp	_	_
13	specific	_	JJ	JJ	_	14	amod	_	_
14	members	_	NNS	NNS	_	12	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	19	det	_	_
17	NF-kappa	_	NN	NN	_	19	nn	_	_
18	B	_	NN	NN	_	19	nn	_	_
19	family	_	NN	NN	_	15	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	transcription	_	NN	NN	_	22	nn	_	_
22	factors	_	NNS	NNS	_	20	pobj	_	_
23	.	_	.	.	_	4	punct	_	_

1	Human	_	JJ	JJ	_	5	amod	_	_
2	T	_	NN	NN	_	5	nn	_	_
3	leukemia	_	NN	NN	_	5	nn	_	_
4	virus	_	NN	NN	_	5	nn	_	_
5	type	_	NN	NN	_	10	nsubj	_	_
6	1	_	CD	CD	_	5	num	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	HTLV-1	_	NN	NN	_	5	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	infects	_	VBZ	VBZ	_	0	root	_	_
11	T	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	10	dobj	_	_
13	and	_	CC	CC	_	10	cc	_	_
14	can	_	MD	MD	_	15	aux	_	_
15	lead	_	VB	VB	_	10	conj	_	_
16	to	_	TO	TO	_	17	aux	_	_
17	increase	_	VB	VB	_	15	xcomp	_	_
18	GM-CSF	_	NN	NN	_	19	nn	_	_
19	expression	_	NN	NN	_	17	dobj	_	_
20	.	_	.	.	_	10	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	found	_	VBN	VBN	_	0	root	_	_
4	that	_	IN	IN	_	12	mark	_	_
5	the	_	DT	DT	_	8	det	_	_
6	HTLV-1	_	NN	NN	_	8	nn	_	_
7	transactivator	_	NN	NN	_	8	nn	_	_
8	protein	_	NN	NN	_	12	nsubj	_	_
9	,	_	,	,	_	8	punct	_	_
10	tax	_	NN	NN	_	8	appos	_	_
11	,	_	,	,	_	8	punct	_	_
12	acts	_	VBZ	VBZ	_	3	ccomp	_	_
13	as	_	IN	IN	_	12	prep	_	_
14	a	_	DT	DT	_	16	det	_	_
15	costimulatory	_	JJ	JJ	_	16	amod	_	_
16	signal	_	NN	NN	_	13	pobj	_	_
17	for	_	IN	IN	_	16	prep	_	_
18	GM-CSF	_	NN	NN	_	17	pobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	IL-2	_	NN	NN	_	18	conj	_	_
21	gene	_	NN	NN	_	22	nn	_	_
22	transcription	_	NN	NN	_	18	dep	_	_
23	,	_	,	,	_	12	punct	_	_
24	in	_	IN	IN	_	12	prep	_	_
25	that	_	IN	IN	_	28	mark	_	_
26	it	_	PRP	PRP	_	28	nsubj	_	_
27	can	_	MD	MD	_	28	aux	_	_
28	cooperate	_	VB	VB	_	24	pcomp	_	_
29	with	_	IN	IN	_	28	prep	_	_
30	TCR	_	NN	NN	_	31	nn	_	_
31	signals	_	NNS	NNS	_	29	pobj	_	_
32	to	_	TO	TO	_	33	aux	_	_
33	mediate	_	VB	VB	_	28	xcomp	_	_
34	high	_	JJ	JJ	_	37	amod	_	_
35	level	_	NN	NN	_	37	nn	_	_
36	gene	_	NN	NN	_	37	nn	_	_
37	expression	_	NN	NN	_	33	dobj	_	_
38	.	_	.	.	_	3	punct	_	_

1	Tax	_	NN	NN	_	2	nsubj	_	_
2	activates	_	VBZ	VBZ	_	0	root	_	_
3	the	_	DT	DT	_	5	det	_	_
4	GM-CSF	_	NN	NN	_	5	nn	_	_
5	promoter	_	NN	NN	_	2	dobj	_	_
6	through	_	IN	IN	_	2	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	CK-1/CD28RE	_	NN	NN	_	9	nn	_	_
9	region	_	NN	NN	_	6	pobj	_	_
10	and	_	CC	CC	_	2	cc	_	_
11	also	_	RB	RB	_	12	advmod	_	_
12	activates	_	VBZ	VBZ	_	2	conj	_	_
13	nuclear	_	JJ	JJ	_	15	amod	_	_
14	factor-kappa	_	NN	NN	_	15	nn	_	_
15	B	_	NN	NN	_	12	dobj	_	_
16	binding	_	VBG	VBG	_	15	vmod	_	_
17	to	_	TO	TO	_	16	prep	_	_
18	this	_	DT	DT	_	19	det	_	_
19	region	_	NN	NN	_	17	pobj	_	_
20	.	_	.	.	_	2	punct	_	_

1	However	_	RB	RB	_	12	advmod	_	_
2	,	_	,	,	_	12	punct	_	_
3	other	_	JJ	JJ	_	5	amod	_	_
4	transcription	_	NN	NN	_	5	nn	_	_
5	factors	_	NNS	NNS	_	12	nsubjpass	_	_
6	or	_	CC	CC	_	5	cc	_	_
7	coactivators	_	NNS	NNS	_	5	conj	_	_
8	of	_	IN	IN	_	5	prep	_	_
9	NF-kappa	_	NN	NN	_	10	nn	_	_
10	B	_	NN	NN	_	8	pobj	_	_
11	are	_	VBP	VBP	_	12	auxpass	_	_
12	required	_	VBN	VBN	_	0	root	_	_
13	for	_	IN	IN	_	12	prep	_	_
14	tax	_	NN	NN	_	15	nn	_	_
15	activation	_	NN	NN	_	13	pobj	_	_
16	but	_	CC	CC	_	12	cc	_	_
17	these	_	DT	DT	_	18	nsubj	_	_
18	remain	_	VBP	VBP	_	12	conj	_	_
19	to	_	TO	TO	_	21	aux	_	_
20	be	_	VB	VB	_	21	auxpass	_	_
21	identified	_	VBN	VBN	_	18	xcomp	_	_
22	.	_	.	.	_	12	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	CK-1/CD28RE	_	NN	NN	_	5	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	GM-CSF	_	NN	NN	_	3	pobj	_	_
5	shows	_	VBZ	VBZ	_	0	root	_	_
6	a	_	DT	DT	_	8	det	_	_
7	high	_	JJ	JJ	_	8	amod	_	_
8	degree	_	NN	NN	_	5	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	similarity	_	NN	NN	_	9	pobj	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	IL-2	_	NN	NN	_	11	pobj	_	_
14	CD28RE	_	NN	NN	_	13	dep	_	_
15	and	_	CC	CC	_	5	cc	_	_
16	the	_	DT	DT	_	18	det	_	_
17	IL-3	_	NN	NN	_	18	nn	_	_
18	gene	_	NN	NN	_	20	nsubj	_	_
19	also	_	RB	RB	_	20	advmod	_	_
20	contains	_	VBZ	VBZ	_	5	conj	_	_
21	a	_	DT	DT	_	23	det	_	_
22	related	_	JJ	JJ	_	23	amod	_	_
23	region	_	NN	NN	_	20	dobj	_	_
24	.	_	.	.	_	5	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	observation	_	NN	NN	_	20	nsubj	_	_
3	,	_	,	,	_	2	punct	_	_
4	together	_	RB	RB	_	20	advmod	_	_
5	with	_	IN	IN	_	20	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	fact	_	NN	NN	_	5	pobj	_	_
8	that	_	IN	IN	_	13	mark	_	_
9	both	_	CC	CC	_	10	preconj	_	_
10	GM-CSF	_	NN	NN	_	13	nsubj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	IL-2	_	NN	NN	_	10	conj	_	_
13	respond	_	VBP	VBP	_	7	ccomp	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	TCR	_	NN	NN	_	16	nn	_	_
16	signals	_	NNS	NNS	_	14	pobj	_	_
17	via	_	IN	IN	_	13	prep	_	_
18	NFAT	_	NN	NN	_	17	pobj	_	_
19	,	_	,	,	_	20	punct	_	_
20	implies	_	VBZ	VBZ	_	0	root	_	_
21	a	_	DT	DT	_	23	det	_	_
22	high	_	JJ	JJ	_	23	amod	_	_
23	degree	_	NN	NN	_	20	dobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	conservation	_	NN	NN	_	24	pobj	_	_
26	in	_	IN	IN	_	20	prep	_	_
27	the	_	DT	DT	_	28	det	_	_
28	regulation	_	NN	NN	_	26	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	cytokine	_	NN	NN	_	32	nn	_	_
31	gene	_	NN	NN	_	32	nn	_	_
32	expression	_	NN	NN	_	29	pobj	_	_
33	in	_	IN	IN	_	28	prep	_	_
34	T	_	NN	NN	_	35	nn	_	_
35	cells	_	NNS	NNS	_	33	pobj	_	_
36	.	_	.	.	_	20	punct	_	_

1	MIP1	_	NN	NN	_	4	nn	_	_
2	alpha	_	NN	NN	_	4	nn	_	_
3	nuclear	_	JJ	JJ	_	4	amod	_	_
4	protein	_	NN	NN	_	0	root	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	MNP	_	NN	NN	_	4	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	,	_	,	,	_	4	punct	_	_
9	a	_	DT	DT	_	12	det	_	_
10	novel	_	JJ	JJ	_	12	amod	_	_
11	transcription	_	NN	NN	_	12	nn	_	_
12	factor	_	NN	NN	_	4	appos	_	_
13	expressed	_	VBN	VBN	_	12	vmod	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	hematopoietic	_	JJ	JJ	_	16	amod	_	_
16	cells	_	NNS	NNS	_	14	pobj	_	_
17	that	_	WDT	WDT	_	19	nsubj	_	_
18	is	_	VBZ	VBZ	_	19	cop	_	_
19	crucial	_	JJ	JJ	_	12	rcmod	_	_
20	for	_	IN	IN	_	19	prep	_	_
21	transcription	_	NN	NN	_	20	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	27	det	_	_
24	human	_	JJ	JJ	_	27	amod	_	_
25	MIP-1	_	NN	NN	_	27	nn	_	_
26	alpha	_	NN	NN	_	27	nn	_	_
27	gene	_	NN	NN	_	22	pobj	_	_
28	.	_	.	.	_	4	punct	_	_

1	Murine	_	JJ	JJ	_	6	amod	_	_
2	macrophage	_	NN	NN	_	6	nn	_	_
3	inflammatory	_	JJ	JJ	_	6	amod	_	_
4	protein	_	NN	NN	_	6	nn	_	_
5	1	_	CD	CD	_	6	num	_	_
6	alpha	_	NN	NN	_	24	nsubj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
8	MIP-1	_	NN	NN	_	9	nn	_	_
9	alpha	_	NN	NN	_	6	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	and	_	CC	CC	_	6	cc	_	_
12	its	_	PRP$	PRP$	_	14	poss	_	_
13	human	_	JJ	JJ	_	14	amod	_	_
14	equivalent	_	NN	NN	_	6	conj	_	_
15	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
16	GOS19	_	NN	NN	_	14	dep	_	_
17	,	_	,	,	_	16	punct	_	_
18	LD78	_	NN	NN	_	16	conj	_	_
19	,	_	,	,	_	16	punct	_	_
20	or	_	CC	CC	_	16	cc	_	_
21	AT464	_	NN	NN	_	16	conj	_	_
22	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
23	are	_	VBP	VBP	_	24	cop	_	_
24	members	_	NNS	NNS	_	0	root	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	28	det	_	_
27	-C-C	_	NN	NN	_	28	nn	_	_
28	family	_	NN	NN	_	25	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	low-molecular-weight	_	JJ	JJ	_	31	amod	_	_
31	chemokines	_	NNS	NNS	_	29	pobj	_	_
32	.	_	.	.	_	24	punct	_	_

1	Secreted	_	VBN	VBN	_	0	root	_	_
2	from	_	IN	IN	_	1	prep	_	_
3	activated	_	VBN	VBN	_	5	amod	_	_
4	T	_	NN	NN	_	5	nn	_	_
5	cells	_	NNS	NNS	_	2	pobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	macrophages	_	NNS	NNS	_	5	conj	_	_
8	,	_	,	,	_	1	punct	_	_
9	bone	_	NN	NN	_	13	nsubj	_	_
10	marrow-derived	_	JJ	JJ	_	12	amod	_	_
11	MIP-1	_	NN	NN	_	12	nn	_	_
12	alpha/GOS19	_	NN	NN	_	9	dep	_	_
13	inhibits	_	VBZ	VBZ	_	1	parataxis	_	_
14	primitive	_	JJ	JJ	_	17	amod	_	_
15	hematopoietic	_	JJ	JJ	_	17	amod	_	_
16	stem	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	13	dobj	_	_
18	and	_	CC	CC	_	13	cc	_	_
19	appears	_	VBZ	VBZ	_	13	conj	_	_
20	to	_	TO	TO	_	22	aux	_	_
21	be	_	VB	VB	_	22	auxpass	_	_
22	involved	_	VBN	VBN	_	19	xcomp	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	26	det	_	_
25	homeostatic	_	JJ	JJ	_	26	amod	_	_
26	control	_	NN	NN	_	23	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	stem	_	NN	NN	_	29	nn	_	_
29	cell	_	NN	NN	_	30	nn	_	_
30	proliferation	_	NN	NN	_	27	pobj	_	_
31	.	_	.	.	_	1	punct	_	_

1	It	_	PRP	PRP	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	induces	_	VBZ	VBZ	_	0	root	_	_
4	chemotaxis	_	NN	NN	_	3	dobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	inflammatory	_	JJ	JJ	_	7	amod	_	_
7	responses	_	NNS	NNS	_	4	conj	_	_
8	in	_	IN	IN	_	3	prep	_	_
9	mature	_	JJ	JJ	_	11	amod	_	_
10	cell	_	NN	NN	_	11	nn	_	_
11	types	_	NNS	NNS	_	8	pobj	_	_
12	.	_	.	.	_	3	punct	_	_

1	Therefore	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	it	_	PRP	PRP	_	5	nsubj	_	_
4	is	_	VBZ	VBZ	_	5	cop	_	_
5	important	_	JJ	JJ	_	0	root	_	_
6	to	_	TO	TO	_	7	aux	_	_
7	understand	_	VB	VB	_	5	xcomp	_	_
8	the	_	DT	DT	_	9	det	_	_
9	mechanisms	_	NNS	NNS	_	7	dobj	_	_
10	which	_	WDT	WDT	_	11	nsubj	_	_
11	control	_	VBP	VBP	_	9	rcmod	_	_
12	the	_	DT	DT	_	13	det	_	_
13	expression	_	NN	NN	_	11	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	MIP-1	_	NN	NN	_	16	nn	_	_
16	alpha/GOS19	_	NN	NN	_	14	pobj	_	_
17	.	_	.	.	_	5	punct	_	_

1	Previous	_	JJ	JJ	_	2	amod	_	_
2	work	_	NN	NN	_	4	nsubj	_	_
3	has	_	VBZ	VBZ	_	4	aux	_	_
4	shown	_	VBN	VBN	_	0	root	_	_
5	that	_	IN	IN	_	23	mark	_	_
6	in	_	IN	IN	_	23	prep	_	_
7	Jurkat	_	NN	NN	_	9	nn	_	_
8	T	_	NN	NN	_	9	nn	_	_
9	cells	_	NNS	NNS	_	6	pobj	_	_
10	,	_	,	,	_	23	punct	_	_
11	a	_	DT	DT	_	12	det	_	_
12	set	_	NN	NN	_	23	nsubj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	widely	_	RB	RB	_	15	advmod	_	_
15	expressed	_	VBN	VBN	_	17	amod	_	_
16	transcription	_	NN	NN	_	17	nn	_	_
17	factors	_	NNS	NNS	_	13	pobj	_	_
18	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
19	the	_	DT	DT	_	21	det	_	_
20	ICK-1	_	NN	NN	_	21	nn	_	_
21	family	_	NN	NN	_	12	appos	_	_
22	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
23	affect	_	VBP	VBP	_	4	ccomp	_	_
24	the	_	DT	DT	_	26	det	_	_
25	GOS19	_	NN	NN	_	26	nn	_	_
26	promoter	_	NN	NN	_	23	dobj	_	_
27	.	_	.	.	_	4	punct	_	_

1	One	_	CD	CD	_	2	num	_	_
2	member	_	NN	NN	_	6	nsubj	_	_
3	,	_	,	,	_	2	punct	_	_
4	ICK-1A	_	NN	NN	_	2	appos	_	_
5	,	_	,	,	_	2	punct	_	_
6	behaves	_	VBZ	VBZ	_	0	root	_	_
7	as	_	IN	IN	_	6	prep	_	_
8	a	_	DT	DT	_	11	det	_	_
9	strong	_	JJ	JJ	_	11	amod	_	_
10	negative	_	JJ	JJ	_	11	amod	_	_
11	regulator	_	NN	NN	_	7	pobj	_	_
12	.	_	.	.	_	6	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	communication	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	provide	_	VBP	VBP	_	0	root	_	_
7	evidence	_	NN	NN	_	6	dobj	_	_
8	that	_	IN	IN	_	20	mark	_	_
9	the	_	DT	DT	_	10	det	_	_
10	pathway	_	NN	NN	_	20	nsubj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	induction	_	NN	NN	_	11	pobj	_	_
13	in	_	IN	IN	_	10	prep	_	_
14	the	_	DT	DT	_	17	det	_	_
15	macrophage	_	NN	NN	_	17	nn	_	_
16	cell	_	NN	NN	_	17	nn	_	_
17	line	_	NN	NN	_	13	pobj	_	_
18	U937	_	NN	NN	_	17	dep	_	_
19	is	_	VBZ	VBZ	_	20	cop	_	_
20	different	_	JJ	JJ	_	7	ccomp	_	_
21	from	_	IN	IN	_	20	prep	_	_
22	that	_	DT	DT	_	21	pobj	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	Jurkat	_	NN	NN	_	25	nn	_	_
25	cells	_	NNS	NNS	_	23	pobj	_	_
26	.	_	.	.	_	6	punct	_	_

1	Furthermore	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	show	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	12	mark	_	_
6	the	_	DT	DT	_	9	det	_	_
7	ICK-1	_	NN	NN	_	9	nn	_	_
8	binding	_	NN	NN	_	9	nn	_	_
9	site	_	NN	NN	_	12	nsubj	_	_
10	does	_	VBZ	VBZ	_	12	aux	_	_
11	not	_	RB	RB	_	12	neg	_	_
12	confer	_	VB	VB	_	4	ccomp	_	_
13	negative	_	JJ	JJ	_	14	amod	_	_
14	regulation	_	NN	NN	_	12	dobj	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	U937	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	15	pobj	_	_
18	.	_	.	.	_	4	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	provide	_	VBP	VBP	_	0	root	_	_
3	evidence	_	NN	NN	_	2	dobj	_	_
4	for	_	IN	IN	_	3	prep	_	_
5	an	_	DT	DT	_	8	det	_	_
6	additional	_	JJ	JJ	_	8	amod	_	_
7	binding	_	VBG	VBG	_	8	amod	_	_
8	site	_	NN	NN	_	4	pobj	_	_
9	,	_	,	,	_	8	punct	_	_
10	the	_	DT	DT	_	18	det	_	_
11	MIP-1	_	NN	NN	_	18	nn	_	_
12	alpha	_	NN	NN	_	18	nn	_	_
13	nuclear	_	JJ	JJ	_	18	amod	_	_
14	protein	_	NN	NN	_	18	nn	_	_
15	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
16	MNP	_	NN	NN	_	18	nn	_	_
17	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
18	site	_	NN	NN	_	8	appos	_	_
19	,	_	,	,	_	18	punct	_	_
20	which	_	WDT	WDT	_	21	nsubj	_	_
21	overlaps	_	VBZ	VBZ	_	18	rcmod	_	_
22	the	_	DT	DT	_	24	det	_	_
23	ICK-1	_	NN	NN	_	24	nn	_	_
24	site	_	NN	NN	_	21	dobj	_	_
25	.	_	.	.	_	2	punct	_	_

1	Interaction	_	NN	NN	_	15	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	nuclear	_	JJ	JJ	_	4	amod	_	_
4	extracts	_	NNS	NNS	_	2	pobj	_	_
5	from	_	IN	IN	_	4	prep	_	_
6	various	_	JJ	JJ	_	8	amod	_	_
7	cell	_	NN	NN	_	8	nn	_	_
8	lines	_	NNS	NNS	_	5	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	tissue	_	NN	NN	_	8	conj	_	_
11	with	_	IN	IN	_	1	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	MNP	_	NN	NN	_	14	nn	_	_
14	site	_	NN	NN	_	11	pobj	_	_
15	leads	_	VBZ	VBZ	_	0	root	_	_
16	to	_	TO	TO	_	15	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	formation	_	NN	NN	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	fast-migrating	_	JJ	JJ	_	22	amod	_	_
21	protein-DNA	_	JJ	JJ	_	22	amod	_	_
22	complexes	_	NNS	NNS	_	19	pobj	_	_
23	with	_	IN	IN	_	18	prep	_	_
24	similar	_	JJ	JJ	_	28	amod	_	_
25	but	_	CC	CC	_	24	cc	_	_
26	distinct	_	JJ	JJ	_	24	conj	_	_
27	electrophoretic	_	JJ	JJ	_	28	amod	_	_
28	mobilities	_	NNS	NNS	_	23	pobj	_	_
29	.	_	.	.	_	15	punct	_	_

1	A	_	DT	DT	_	2	det	_	_
2	mutation	_	NN	NN	_	13	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	MNP	_	NN	NN	_	6	nn	_	_
6	site	_	NN	NN	_	3	pobj	_	_
7	which	_	WDT	WDT	_	10	nsubj	_	_
8	does	_	VBZ	VBZ	_	10	aux	_	_
9	not	_	RB	RB	_	10	neg	_	_
10	abrogate	_	VB	VB	_	6	rcmod	_	_
11	ICK-1	_	NN	NN	_	12	nn	_	_
12	binding	_	NN	NN	_	10	dobj	_	_
13	inactivates	_	VBZ	VBZ	_	0	root	_	_
14	the	_	DT	DT	_	16	det	_	_
15	GOS19.1	_	NN	NN	_	16	nn	_	_
16	promoter	_	NN	NN	_	13	dobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	U937	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	17	pobj	_	_
20	and	_	CC	CC	_	13	cc	_	_
21	reduces	_	VBZ	VBZ	_	13	conj	_	_
22	its	_	PRP$	PRP$	_	23	poss	_	_
23	activity	_	NN	NN	_	21	dobj	_	_
24	by	_	IN	IN	_	21	prep	_	_
25	fourfold	_	RB	RB	_	24	pobj	_	_
26	in	_	IN	IN	_	21	prep	_	_
27	Jurkat	_	NN	NN	_	28	nn	_	_
28	cells	_	NNS	NNS	_	26	pobj	_	_
29	.	_	.	.	_	13	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	propose	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	15	mark	_	_
4	the	_	DT	DT	_	8	det	_	_
5	MNP	_	NN	NN	_	6	nn	_	_
6	protein	_	NN	NN	_	8	nn	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	s	_	NNS	NNS	_	15	nsubj	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	binding	_	VBG	VBG	_	8	vmod	_	_
11	at	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	MNP	_	NN	NN	_	14	nn	_	_
14	site	_	NN	NN	_	11	pobj	_	_
15	constitutes	_	VBZ	VBZ	_	2	ccomp	_	_
16	a	_	DT	DT	_	21	det	_	_
17	novel	_	JJ	JJ	_	21	amod	_	_
18	transcription	_	NN	NN	_	19	nn	_	_
19	factor	_	NN	NN	_	21	nn	_	_
20	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	s	_	NNS	NNS	_	15	dobj	_	_
22	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
23	expressed	_	VBN	VBN	_	21	vmod	_	_
24	in	_	IN	IN	_	23	prep	_	_
25	hematopoietic	_	JJ	JJ	_	26	amod	_	_
26	cells	_	NNS	NNS	_	24	pobj	_	_
27	.	_	.	.	_	2	punct	_	_

1	Ligand-dependent	_	JJ	JJ	_	2	amod	_	_
2	repression	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	7	det	_	_
5	erythroid	_	JJ	JJ	_	7	amod	_	_
6	transcription	_	NN	NN	_	7	nn	_	_
7	factor	_	NN	NN	_	3	pobj	_	_
8	GATA-1	_	NN	NN	_	7	dep	_	_
9	by	_	IN	IN	_	2	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	estrogen	_	NN	NN	_	12	nn	_	_
12	receptor	_	NN	NN	_	9	pobj	_	_
13	.	_	.	.	_	2	punct	_	_

1	High-dose	_	JJ	JJ	_	3	amod	_	_
2	estrogen	_	NN	NN	_	3	nn	_	_
3	administration	_	NN	NN	_	4	nsubj	_	_
4	induces	_	VBZ	VBZ	_	0	root	_	_
5	anemia	_	NN	NN	_	4	dobj	_	_
6	in	_	IN	IN	_	4	prep	_	_
7	mammals	_	NNS	NNS	_	6	pobj	_	_
8	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	5	prep	_	_
2	chickens	_	NNS	NNS	_	1	pobj	_	_
3	,	_	,	,	_	5	punct	_	_
4	estrogens	_	NNS	NNS	_	5	nsubj	_	_
5	stimulate	_	VBP	VBP	_	0	root	_	_
6	outgrowth	_	NN	NN	_	5	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	bone	_	NN	NN	_	12	nn	_	_
9	marrow-derived	_	JJ	JJ	_	12	amod	_	_
10	erythroid	_	JJ	JJ	_	12	amod	_	_
11	progenitor	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	7	pobj	_	_
13	and	_	CC	CC	_	5	cc	_	_
14	delay	_	VBP	VBP	_	5	conj	_	_
15	their	_	PRP$	PRP$	_	16	poss	_	_
16	maturation	_	NN	NN	_	14	dobj	_	_
17	.	_	.	.	_	5	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	delay	_	NN	NN	_	4	nsubjpass	_	_
3	is	_	VBZ	VBZ	_	4	auxpass	_	_
4	associated	_	VBN	VBN	_	0	root	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	down-regulation	_	NN	NN	_	5	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	many	_	JJ	JJ	_	11	amod	_	_
9	erythroid	_	JJ	JJ	_	11	amod	_	_
10	cell-specific	_	JJ	JJ	_	11	amod	_	_
11	genes	_	NNS	NNS	_	7	pobj	_	_
12	,	_	,	,	_	11	punct	_	_
13	including	_	VBG	VBG	_	11	prep	_	_
14	alpha-	_	NN	NN	_	13	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	beta-globin	_	NN	NN	_	14	conj	_	_
17	,	_	,	,	_	14	punct	_	_
18	band	_	NN	NN	_	14	conj	_	_
19	3	_	CD	CD	_	18	num	_	_
20	,	_	,	,	_	14	punct	_	_
21	band	_	NN	NN	_	14	conj	_	_
22	4.1	_	CD	CD	_	21	num	_	_
23	,	_	,	,	_	14	punct	_	_
24	and	_	CC	CC	_	14	cc	_	_
25	the	_	DT	DT	_	28	det	_	_
26	erythroid	_	JJ	JJ	_	28	amod	_	_
27	cell-specific	_	JJ	JJ	_	28	amod	_	_
28	histone	_	NN	NN	_	14	conj	_	_
29	H5	_	NN	NN	_	28	dep	_	_
30	.	_	.	.	_	4	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	show	_	VBP	VBP	_	0	root	_	_
3	here	_	RB	RB	_	2	advmod	_	_
4	that	_	IN	IN	_	7	mark	_	_
5	estrogens	_	NNS	NNS	_	7	nsubj	_	_
6	also	_	RB	RB	_	7	advmod	_	_
7	reduce	_	VBP	VBP	_	2	ccomp	_	_
8	the	_	DT	DT	_	9	det	_	_
9	number	_	NN	NN	_	7	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	erythroid	_	JJ	JJ	_	13	amod	_	_
12	progenitor	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	10	pobj	_	_
14	in	_	IN	IN	_	7	prep	_	_
15	primary	_	JJ	JJ	_	19	amod	_	_
16	human	_	JJ	JJ	_	19	amod	_	_
17	bone	_	NN	NN	_	19	nn	_	_
18	marrow	_	NN	NN	_	19	nn	_	_
19	cultures	_	NNS	NNS	_	14	pobj	_	_
20	.	_	.	.	_	2	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	address	_	VB	VB	_	0	root	_	_
3	potential	_	JJ	JJ	_	4	amod	_	_
4	mechanisms	_	NNS	NNS	_	2	dobj	_	_
5	by	_	IN	IN	_	8	prep	_	_
6	which	_	WDT	WDT	_	5	pobj	_	_
7	estrogens	_	NNS	NNS	_	8	nsubj	_	_
8	suppress	_	VBP	VBP	_	4	rcmod	_	_
9	erythropoiesis	_	NN	NN	_	8	dobj	_	_
10	,	_	,	,	_	2	punct	_	_
11	we	_	PRP	PRP	_	13	nsubj	_	_
12	have	_	VBP	VBP	_	13	aux	_	_
13	examined	_	VBN	VBN	_	2	parataxis	_	_
14	their	_	PRP$	PRP$	_	15	poss	_	_
15	effects	_	NNS	NNS	_	13	dobj	_	_
16	on	_	IN	IN	_	15	prep	_	_
17	GATA-1	_	NN	NN	_	16	pobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	an	_	DT	DT	_	22	det	_	_
20	erythroid	_	JJ	JJ	_	22	amod	_	_
21	transcription	_	NN	NN	_	22	nn	_	_
22	factor	_	NN	NN	_	17	appos	_	_
23	that	_	WDT	WDT	_	24	nsubj	_	_
24	participates	_	VBZ	VBZ	_	22	rcmod	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	27	det	_	_
27	regulation	_	NN	NN	_	25	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	the	_	DT	DT	_	30	det	_	_
30	majority	_	NN	NN	_	28	pobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	erythroid	_	JJ	JJ	_	34	amod	_	_
33	cell-specific	_	JJ	JJ	_	34	amod	_	_
34	genes	_	NNS	NNS	_	31	pobj	_	_
35	and	_	CC	CC	_	24	cc	_	_
36	is	_	VBZ	VBZ	_	37	cop	_	_
37	necessary	_	JJ	JJ	_	24	conj	_	_
38	for	_	IN	IN	_	37	prep	_	_
39	full	_	JJ	JJ	_	40	amod	_	_
40	maturation	_	NN	NN	_	38	pobj	_	_
41	of	_	IN	IN	_	40	prep	_	_
42	erythrocytes	_	NNS	NNS	_	41	pobj	_	_
43	.	_	.	.	_	2	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	demonstrate	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	11	mark	_	_
4	the	_	DT	DT	_	6	det	_	_
5	transcriptional	_	JJ	JJ	_	6	amod	_	_
6	activity	_	NN	NN	_	11	nsubjpass	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	GATA-1	_	NN	NN	_	7	pobj	_	_
9	is	_	VBZ	VBZ	_	11	auxpass	_	_
10	strongly	_	RB	RB	_	11	advmod	_	_
11	repressed	_	VBN	VBN	_	2	ccomp	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	estrogen	_	NN	NN	_	15	nn	_	_
15	receptor	_	NN	NN	_	12	pobj	_	_
16	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
17	ER	_	NN	NN	_	15	appos	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	in	_	IN	IN	_	11	prep	_	_
20	a	_	DT	DT	_	22	det	_	_
21	ligand-dependent	_	JJ	JJ	_	22	amod	_	_
22	manner	_	NN	NN	_	19	pobj	_	_
23	and	_	CC	CC	_	11	cc	_	_
24	that	_	IN	IN	_	28	mark	_	_
25	this	_	DT	DT	_	26	det	_	_
26	repression	_	NN	NN	_	28	nsubj	_	_
27	is	_	VBZ	VBZ	_	28	cop	_	_
28	reversible	_	JJ	JJ	_	11	conj	_	_
29	in	_	IN	IN	_	28	prep	_	_
30	the	_	DT	DT	_	31	det	_	_
31	presence	_	NN	NN	_	29	pobj	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	4-hydroxytamoxifen	_	NN	NN	_	32	pobj	_	_
34	.	_	.	.	_	2	punct	_	_

1	ER-mediated	_	JJ	JJ	_	2	amod	_	_
2	repression	_	NN	NN	_	6	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	GATA-1	_	NN	NN	_	5	nn	_	_
5	activity	_	NN	NN	_	3	pobj	_	_
6	occurs	_	VBZ	VBZ	_	0	root	_	_
7	on	_	IN	IN	_	6	prep	_	_
8	an	_	DT	DT	_	10	det	_	_
9	artificial	_	JJ	JJ	_	10	amod	_	_
10	promoter	_	NN	NN	_	7	pobj	_	_
11	containing	_	VBG	VBG	_	10	vmod	_	_
12	a	_	DT	DT	_	15	det	_	_
13	single	_	JJ	JJ	_	15	amod	_	_
14	GATA-binding	_	JJ	JJ	_	15	amod	_	_
15	site	_	NN	NN	_	11	dobj	_	_
16	,	_	,	,	_	7	punct	_	_
17	as	_	RB	RB	_	18	advmod	_	_
18	well	_	RB	RB	_	7	cc	_	_
19	as	_	IN	IN	_	18	mwe	_	_
20	in	_	IN	IN	_	7	conj	_	_
21	the	_	DT	DT	_	22	det	_	_
22	context	_	NN	NN	_	20	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	an	_	DT	DT	_	26	det	_	_
25	intact	_	JJ	JJ	_	26	amod	_	_
26	promoter	_	NN	NN	_	23	pobj	_	_
27	which	_	WDT	WDT	_	30	nsubjpass	_	_
28	is	_	VBZ	VBZ	_	30	auxpass	_	_
29	normally	_	RB	RB	_	30	advmod	_	_
30	regulated	_	VBN	VBN	_	26	rcmod	_	_
31	by	_	IN	IN	_	30	prep	_	_
32	GATA-1	_	NN	NN	_	31	pobj	_	_
33	.	_	.	.	_	6	punct	_	_

1	GATA-1	_	NN	NN	_	4	nsubj	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	ER	_	NN	NN	_	1	conj	_	_
4	bind	_	VBP	VBP	_	0	root	_	_
5	to	_	TO	TO	_	4	prep	_	_
6	each	_	DT	DT	_	7	det	_	_
7	other	_	JJ	JJ	_	5	pobj	_	_
8	in	_	FW	FW	_	9	nn	_	_
9	vitro	_	FW	FW	_	4	advmod	_	_
10	in	_	IN	IN	_	4	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	absence	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	DNA	_	NN	NN	_	13	pobj	_	_
15	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	12	prep	_	_
2	coimmunoprecipitation	_	NN	NN	_	3	nn	_	_
3	experiments	_	NNS	NNS	_	1	pobj	_	_
4	using	_	VBG	VBG	_	3	vmod	_	_
5	transfected	_	VBN	VBN	_	7	amod	_	_
6	COS	_	NN	NN	_	7	nn	_	_
7	cells	_	NNS	NNS	_	4	dobj	_	_
8	,	_	,	,	_	12	punct	_	_
9	GATA-1	_	NN	NN	_	12	nsubj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	ER	_	NN	NN	_	9	conj	_	_
12	associate	_	VBP	VBP	_	0	root	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	a	_	DT	DT	_	16	det	_	_
15	ligand-dependent	_	JJ	JJ	_	16	amod	_	_
16	manner	_	NN	NN	_	13	pobj	_	_
17	.	_	.	.	_	12	punct	_	_

1	Mapping	_	NN	NN	_	2	nn	_	_
2	experiments	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	9	mark	_	_
5	GATA-1	_	NN	NN	_	9	nsubj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	the	_	DT	DT	_	8	det	_	_
8	ER	_	NN	NN	_	5	conj	_	_
9	form	_	VBP	VBP	_	3	ccomp	_	_
10	at	_	IN	IN	_	12	quantmod	_	_
11	least	_	JJS	JJS	_	10	mwe	_	_
12	two	_	CD	CD	_	13	num	_	_
13	contacts	_	NNS	NNS	_	9	dobj	_	_
14	,	_	,	,	_	13	punct	_	_
15	which	_	WDT	WDT	_	16	nsubj	_	_
16	involve	_	VBP	VBP	_	13	rcmod	_	_
17	the	_	DT	DT	_	19	det	_	_
18	finger	_	NN	NN	_	19	nn	_	_
19	region	_	NN	NN	_	16	dobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	the	_	DT	DT	_	24	det	_	_
22	N-terminal	_	JJ	JJ	_	24	amod	_	_
23	activation	_	NN	NN	_	24	nn	_	_
24	domain	_	NN	NN	_	19	conj	_	_
25	of	_	IN	IN	_	19	prep	_	_
26	GATA-1	_	NN	NN	_	25	pobj	_	_
27	.	_	.	.	_	3	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	speculate	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	5	mark	_	_
4	estrogens	_	NNS	NNS	_	5	nsubj	_	_
5	exert	_	VBP	VBP	_	2	ccomp	_	_
6	effects	_	NNS	NNS	_	5	dobj	_	_
7	on	_	IN	IN	_	5	prep	_	_
8	erythropoiesis	_	NN	NN	_	7	pobj	_	_
9	by	_	IN	IN	_	5	prep	_	_
10	modulating	_	VBG	VBG	_	9	pcomp	_	_
11	GATA-1	_	NN	NN	_	12	nn	_	_
12	activity	_	NN	NN	_	10	dobj	_	_
13	through	_	IN	IN	_	10	prep	_	_
14	protein-protein	_	JJ	JJ	_	15	amod	_	_
15	interaction	_	NN	NN	_	13	pobj	_	_
16	with	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	ER	_	NN	NN	_	16	pobj	_	_
19	.	_	.	.	_	2	punct	_	_

1	-LRB-	_	-LRB-	-LRB-	_	2	punct	_	_
2	ABSTRACT	_	NN	NN	_	0	root	_	_
3	TRUNCATED	_	VBN	VBN	_	2	vmod	_	_
4	AT	_	IN	IN	_	3	prep	_	_
5	250	_	CD	CD	_	6	num	_	_
6	WORDS	_	NNS	NNS	_	4	pobj	_	_
7	-RRB-	_	-RRB-	-RRB-	_	2	punct	_	_

1	Reduced	_	VBN	VBN	_	3	amod	_	_
2	mitogenic	_	JJ	JJ	_	3	amod	_	_
3	stimulation	_	NN	NN	_	0	root	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	peripheral	_	JJ	JJ	_	8	amod	_	_
6	blood	_	NN	NN	_	8	nn	_	_
7	mononuclear	_	JJ	JJ	_	8	amod	_	_
8	cells	_	NNS	NNS	_	4	pobj	_	_
9	as	_	IN	IN	_	3	prep	_	_
10	a	_	DT	DT	_	12	det	_	_
11	prognostic	_	JJ	JJ	_	12	amod	_	_
12	parameter	_	NN	NN	_	9	pobj	_	_
13	for	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	course	_	NN	NN	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	breast	_	NN	NN	_	18	nn	_	_
18	cancer	_	NN	NN	_	16	pobj	_	_
19	:	_	:	:	_	3	punct	_	_
20	a	_	DT	DT	_	23	det	_	_
21	prospective	_	JJ	JJ	_	23	amod	_	_
22	longitudinal	_	JJ	JJ	_	21	dep	_	_
23	study	_	NN	NN	_	3	dep	_	_
24	.	_	.	.	_	3	punct	_	_

1	Immunosuppression	_	NN	NN	_	5	nsubjpass	_	_
2	has	_	VBZ	VBZ	_	5	aux	_	_
3	been	_	VBN	VBN	_	5	auxpass	_	_
4	often	_	RB	RB	_	5	advmod	_	_
5	associated	_	VBN	VBN	_	0	root	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	course	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	malignant	_	JJ	JJ	_	11	amod	_	_
11	diseases	_	NNS	NNS	_	9	pobj	_	_
12	.	_	.	.	_	5	punct	_	_

1	In	_	IN	IN	_	27	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	present	_	JJ	JJ	_	4	amod	_	_
4	study	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	27	punct	_	_
6	the	_	DT	DT	_	7	det	_	_
7	proliferation	_	NN	NN	_	27	nsubjpass	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	peripheral	_	JJ	JJ	_	12	amod	_	_
10	blood	_	NN	NN	_	12	nn	_	_
11	mononuclear	_	JJ	JJ	_	12	amod	_	_
12	cells	_	NNS	NNS	_	8	pobj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	PBMCs	_	NNS	NNS	_	12	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	in	_	IN	IN	_	7	prep	_	_
17	response	_	NN	NN	_	16	pobj	_	_
18	to	_	TO	TO	_	17	prep	_	_
19	mitogenic	_	JJ	JJ	_	20	amod	_	_
20	stimulation	_	NN	NN	_	18	pobj	_	_
21	with	_	IN	IN	_	20	prep	_	_
22	phytohaemagglutinin	_	NN	NN	_	21	pobj	_	_
23	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
24	PHA	_	NN	NN	_	22	appos	_	_
25	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
26	was	_	VBD	VBD	_	27	auxpass	_	_
27	assessed	_	VBN	VBN	_	0	root	_	_
28	prospectively	_	RB	RB	_	27	advmod	_	_
29	in	_	IN	IN	_	27	prep	_	_
30	90	_	CD	CD	_	31	num	_	_
31	patients	_	NNS	NNS	_	29	pobj	_	_
32	with	_	IN	IN	_	31	prep	_	_
33	stage	_	NN	NN	_	36	nn	_	_
34	I-III	_	CD	CD	_	36	num	_	_
35	breast	_	NN	NN	_	36	nn	_	_
36	cancer	_	NN	NN	_	32	pobj	_	_
37	.	_	.	.	_	27	punct	_	_

1	Whereas	_	IN	IN	_	15	mark	_	_
2	PHA-induced	_	JJ	JJ	_	3	amod	_	_
3	proliferation	_	NN	NN	_	15	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	PBMCs	_	NNS	NNS	_	4	pobj	_	_
6	derived	_	VBN	VBN	_	5	vmod	_	_
7	from	_	IN	IN	_	6	prep	_	_
8	patients	_	NNS	NNS	_	7	pobj	_	_
9	with	_	IN	IN	_	8	prep	_	_
10	breast	_	NN	NN	_	11	nn	_	_
11	cancer	_	NN	NN	_	9	pobj	_	_
12	preoperatively	_	RB	RB	_	6	advmod	_	_
13	was	_	VBD	VBD	_	15	auxpass	_	_
14	significantly	_	RB	RB	_	15	advmod	_	_
15	decreased	_	VBN	VBN	_	41	advcl	_	_
16	when	_	WRB	WRB	_	17	advmod	_	_
17	compared	_	VBN	VBN	_	15	advcl	_	_
18	with	_	IN	IN	_	17	prep	_	_
19	data	_	NNS	NNS	_	18	pobj	_	_
20	obtained	_	VBN	VBN	_	19	vmod	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	healthy	_	JJ	JJ	_	24	amod	_	_
23	control	_	JJ	JJ	_	24	amod	_	_
24	individuals	_	NNS	NNS	_	21	pobj	_	_
25	-LRB-	_	-LRB-	-LRB-	_	26	punct	_	_
26	P	_	NN	NN	_	24	dep	_	_
27	&lt;	_	JJR	JJR	_	26	amod	_	_
28	0.001	_	CD	CD	_	27	dep	_	_
29	-RRB-	_	-RRB-	-RRB-	_	26	punct	_	_
30	,	_	,	,	_	41	punct	_	_
31	the	_	DT	DT	_	32	det	_	_
32	degree	_	NN	NN	_	41	nsubj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	the	_	DT	DT	_	35	det	_	_
35	defect	_	NN	NN	_	33	pobj	_	_
36	in	_	IN	IN	_	35	prep	_	_
37	PHA-induced	_	JJ	JJ	_	38	amod	_	_
38	proliferation	_	NN	NN	_	36	pobj	_	_
39	of	_	IN	IN	_	38	prep	_	_
40	PBMCs	_	NNS	NNS	_	39	pobj	_	_
41	depended	_	VBD	VBD	_	0	root	_	_
42	upon	_	IN	IN	_	41	prep	_	_
43	the	_	DT	DT	_	45	det	_	_
44	tumour	_	NN	NN	_	45	nn	_	_
45	burden	_	NN	NN	_	42	pobj	_	_
46	as	_	IN	IN	_	47	mark	_	_
47	manifested	_	VBN	VBN	_	41	advcl	_	_
48	by	_	IN	IN	_	47	prep	_	_
49	tumour	_	NN	NN	_	50	nn	_	_
50	size	_	NN	NN	_	48	pobj	_	_
51	and	_	CC	CC	_	50	cc	_	_
52	axillary	_	NN	NN	_	55	nn	_	_
53	lymph	_	NN	NN	_	55	nn	_	_
54	node	_	NN	NN	_	55	nn	_	_
55	involvement	_	NN	NN	_	50	conj	_	_
56	-LRB-	_	-LRB-	-LRB-	_	57	punct	_	_
57	P	_	NN	NN	_	50	dep	_	_
58	&lt;	_	JJR	JJR	_	57	amod	_	_
59	0.003	_	CD	CD	_	58	dep	_	_
60	in	_	IN	IN	_	57	prep	_	_
61	each	_	DT	DT	_	62	det	_	_
62	case	_	NN	NN	_	60	pobj	_	_
63	-RRB-	_	-RRB-	-RRB-	_	57	punct	_	_
64	.	_	.	.	_	41	punct	_	_

1	PHA-induced	_	JJ	JJ	_	2	amod	_	_
2	proliferation	_	NN	NN	_	5	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	PBMCs	_	NNS	NNS	_	3	pobj	_	_
5	dropped	_	VBD	VBD	_	0	root	_	_
6	significantly	_	RB	RB	_	5	advmod	_	_
7	in	_	IN	IN	_	5	prep	_	_
8	patients	_	NNS	NNS	_	7	pobj	_	_
9	who	_	WP	WP	_	10	nsubj	_	_
10	received	_	VBD	VBD	_	8	rcmod	_	_
11	adjuvant	_	JJ	JJ	_	12	amod	_	_
12	chemotherapy	_	NN	NN	_	10	dobj	_	_
13	consisting	_	VBG	VBG	_	12	vmod	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	cyclophosphamide	_	NN	NN	_	14	pobj	_	_
16	,	_	,	,	_	15	punct	_	_
17	methotrexate	_	NN	NN	_	15	conj	_	_
18	and	_	CC	CC	_	15	cc	_	_
19	fluorouracil	_	NN	NN	_	15	conj	_	_
20	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	CMF	_	NN	NN	_	15	appos	_	_
22	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
23	after	_	IN	IN	_	10	prep	_	_
24	an	_	DT	DT	_	26	det	_	_
25	observation	_	NN	NN	_	26	nn	_	_
26	period	_	NN	NN	_	23	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	6	_	CD	CD	_	29	num	_	_
29	months	_	NNS	NNS	_	27	pobj	_	_
30	-LRB-	_	-LRB-	-LRB-	_	31	punct	_	_
31	P	_	NN	NN	_	8	dep	_	_
32	&lt;	_	JJR	JJR	_	31	amod	_	_
33	0.01	_	CD	CD	_	32	dep	_	_
34	-RRB-	_	-RRB-	-RRB-	_	31	punct	_	_
35	,	_	,	,	_	7	punct	_	_
36	but	_	CC	CC	_	7	cc	_	_
37	not	_	RB	RB	_	38	neg	_	_
38	in	_	IN	IN	_	7	conj	_	_
39	patients	_	NNS	NNS	_	38	pobj	_	_
40	under	_	IN	IN	_	39	prep	_	_
41	adjuvant	_	JJ	JJ	_	42	amod	_	_
42	treatment	_	NN	NN	_	40	pobj	_	_
43	with	_	IN	IN	_	42	prep	_	_
44	tamoxifen	_	NN	NN	_	43	pobj	_	_
45	only	_	RB	RB	_	44	advmod	_	_
46	.	_	.	.	_	5	punct	_	_

1	After	_	IN	IN	_	19	prep	_	_
2	an	_	DT	DT	_	5	det	_	_
3	additional	_	JJ	JJ	_	5	amod	_	_
4	6	_	CD	CD	_	5	num	_	_
5	months	_	NNS	NNS	_	1	pobj	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	i.e.	_	FW	FW	_	1	dep	_	_
8	12	_	CD	CD	_	9	num	_	_
9	months	_	NNS	NNS	_	10	npadvmod	_	_
10	after	_	IN	IN	_	7	prep	_	_
11	surgery	_	NN	NN	_	10	pobj	_	_
12	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
13	,	_	,	,	_	19	punct	_	_
14	PHA-induced	_	JJ	JJ	_	15	amod	_	_
15	proliferation	_	NN	NN	_	19	nsubj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	PBMCs	_	NNS	NNS	_	16	pobj	_	_
18	was	_	VBD	VBD	_	19	cop	_	_
19	similar	_	JJ	JJ	_	0	root	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	patients	_	NNS	NNS	_	20	pobj	_	_
22	after	_	IN	IN	_	21	prep	_	_
23	adjuvant	_	JJ	JJ	_	24	amod	_	_
24	chemotherapy	_	NN	NN	_	22	pobj	_	_
25	with	_	IN	IN	_	24	prep	_	_
26	CMF	_	NN	NN	_	25	pobj	_	_
27	and	_	CC	CC	_	20	cc	_	_
28	in	_	IN	IN	_	20	conj	_	_
29	those	_	DT	DT	_	28	pobj	_	_
30	receiving	_	VBG	VBG	_	29	vmod	_	_
31	continued	_	JJ	JJ	_	34	amod	_	_
32	adjuvant	_	JJ	JJ	_	34	amod	_	_
33	tamoxifen	_	NN	NN	_	34	nn	_	_
34	treatment	_	NN	NN	_	30	dobj	_	_
35	-LRB-	_	-LRB-	-LRB-	_	36	punct	_	_
36	P	_	NN	NN	_	29	dep	_	_
37	&gt;	_	JJR	JJR	_	36	amod	_	_
38	0.1	_	CD	CD	_	37	dep	_	_
39	-RRB-	_	-RRB-	-RRB-	_	36	punct	_	_
40	,	_	,	,	_	19	punct	_	_
41	but	_	CC	CC	_	19	cc	_	_
42	in	_	IN	IN	_	19	conj	_	_
43	all	_	DT	DT	_	44	det	_	_
44	patients	_	NNS	NNS	_	42	pobj	_	_
45	still	_	RB	RB	_	46	advmod	_	_
46	significantly	_	RB	RB	_	19	advmod	_	_
47	decreased	_	VBD	VBD	_	19	dep	_	_
48	as	_	IN	IN	_	49	mark	_	_
49	compared	_	VBN	VBN	_	47	advcl	_	_
50	with	_	IN	IN	_	49	prep	_	_
51	healthy	_	JJ	JJ	_	52	amod	_	_
52	controls	_	NNS	NNS	_	50	pobj	_	_
53	-LRB-	_	-LRB-	-LRB-	_	54	punct	_	_
54	P	_	NN	NN	_	52	dep	_	_
55	&lt;	_	JJR	JJR	_	54	amod	_	_
56	0.001	_	CD	CD	_	55	dep	_	_
57	-RRB-	_	-RRB-	-RRB-	_	54	punct	_	_
58	.	_	.	.	_	19	punct	_	_

1	When	_	WRB	WRB	_	10	advmod	_	_
2	data	_	NNS	NNS	_	10	nsubjpass	_	_
3	obtained	_	VBN	VBN	_	2	vmod	_	_
4	preoperatively	_	RB	RB	_	3	advmod	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	after	_	IN	IN	_	4	conj	_	_
7	12	_	CD	CD	_	8	num	_	_
8	months	_	NNS	NNS	_	6	pobj	_	_
9	were	_	VBD	VBD	_	10	auxpass	_	_
10	compared	_	VBN	VBN	_	14	advcl	_	_
11	,	_	,	,	_	14	punct	_	_
12	it	_	PRP	PRP	_	14	nsubjpass	_	_
13	was	_	VBD	VBD	_	14	auxpass	_	_
14	found	_	VBN	VBN	_	0	root	_	_
15	that	_	IN	IN	_	37	mark	_	_
16	out	_	RB	RB	_	17	advmod	_	_
17	of	_	IN	IN	_	37	prep	_	_
18	23	_	CD	CD	_	19	num	_	_
19	patients	_	NNS	NNS	_	17	pobj	_	_
20	whose	_	WP$	WP$	_	21	poss	_	_
21	PBMCs	_	NNS	NNS	_	23	nsubj	_	_
22	had	_	VBD	VBD	_	23	aux	_	_
23	experienced	_	VBN	VBN	_	19	rcmod	_	_
24	a	_	DT	DT	_	25	det	_	_
25	drop	_	NN	NN	_	23	dobj	_	_
26	in	_	IN	IN	_	23	prep	_	_
27	their	_	PRP$	PRP$	_	29	poss	_	_
28	PHA-induced	_	JJ	JJ	_	29	amod	_	_
29	proliferation	_	NN	NN	_	26	pobj	_	_
30	,	_	,	,	_	37	punct	_	_
31	14	_	CD	CD	_	37	nsubj	_	_
32	-LRB-	_	-LRB-	-LRB-	_	34	punct	_	_
33	61	_	CD	CD	_	34	num	_	_
34	%	_	NN	NN	_	31	appos	_	_
35	-RRB-	_	-RRB-	-RRB-	_	34	punct	_	_
36	had	_	VBD	VBD	_	37	aux	_	_
37	developed	_	VBN	VBN	_	14	ccomp	_	_
38	metastatic	_	JJ	JJ	_	39	amod	_	_
39	disease	_	NN	NN	_	37	dobj	_	_
40	within	_	IN	IN	_	37	prep	_	_
41	the	_	DT	DT	_	44	det	_	_
42	subsequent	_	JJ	JJ	_	44	amod	_	_
43	24	_	CD	CD	_	44	num	_	_
44	months	_	NNS	NNS	_	40	pobj	_	_
45	-LRB-	_	-LRB-	-LRB-	_	48	punct	_	_
46	i.e.	_	FW	FW	_	48	prep	_	_
47	36	_	CD	CD	_	48	num	_	_
48	months	_	NNS	NNS	_	40	dep	_	_
49	after	_	IN	IN	_	48	prep	_	_
50	surgery	_	NN	NN	_	49	pobj	_	_
51	-RRB-	_	-RRB-	-RRB-	_	48	punct	_	_
52	.	_	.	.	_	14	punct	_	_

1	In	_	IN	IN	_	31	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	31	punct	_	_
4	out	_	RB	RB	_	5	advmod	_	_
5	of	_	IN	IN	_	31	prep	_	_
6	59	_	CD	CD	_	7	num	_	_
7	patients	_	NNS	NNS	_	5	pobj	_	_
8	whose	_	WP$	WP$	_	9	poss	_	_
9	PBMCs	_	NNS	NNS	_	10	nsubj	_	_
10	showed	_	VBD	VBD	_	7	rcmod	_	_
11	an	_	DT	DT	_	12	det	_	_
12	increase	_	NN	NN	_	10	dobj	_	_
13	in	_	IN	IN	_	10	prep	_	_
14	their	_	PRP$	PRP$	_	16	poss	_	_
15	PHA-induced	_	JJ	JJ	_	16	amod	_	_
16	proliferation	_	NN	NN	_	13	pobj	_	_
17	within	_	IN	IN	_	10	prep	_	_
18	the	_	DT	DT	_	21	det	_	_
19	first	_	JJ	JJ	_	21	amod	_	_
20	12	_	CD	CD	_	21	num	_	_
21	months	_	NNS	NNS	_	17	pobj	_	_
22	after	_	IN	IN	_	21	prep	_	_
23	surgery	_	NN	NN	_	22	pobj	_	_
24	,	_	,	,	_	31	punct	_	_
25	only	_	RB	RB	_	26	quantmod	_	_
26	one	_	CD	CD	_	31	nsubj	_	_
27	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
28	2	_	CD	CD	_	29	num	_	_
29	%	_	NN	NN	_	26	appos	_	_
30	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
31	presented	_	VBD	VBD	_	0	root	_	_
32	with	_	IN	IN	_	31	prep	_	_
33	disease	_	NN	NN	_	34	nn	_	_
34	progression	_	NN	NN	_	32	pobj	_	_
35	.	_	.	.	_	31	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	thus	_	RB	RB	_	3	advmod	_	_
3	conclude	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	15	mark	_	_
5	PHA-induced	_	JJ	JJ	_	6	amod	_	_
6	proliferation	_	NN	NN	_	15	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	PBMCs	_	NNS	NNS	_	7	pobj	_	_
9	derived	_	VBN	VBN	_	8	vmod	_	_
10	from	_	IN	IN	_	9	prep	_	_
11	patients	_	NNS	NNS	_	10	pobj	_	_
12	with	_	IN	IN	_	11	prep	_	_
13	breast	_	NN	NN	_	14	nn	_	_
14	cancer	_	NN	NN	_	12	pobj	_	_
15	depends	_	VBZ	VBZ	_	3	ccomp	_	_
16	upon	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	tumour	_	NN	NN	_	19	nn	_	_
19	load	_	NN	NN	_	16	pobj	_	_
20	and	_	CC	CC	_	15	cc	_	_
21	is	_	VBZ	VBZ	_	25	cop	_	_
22	a	_	DT	DT	_	25	det	_	_
23	good	_	JJ	JJ	_	25	amod	_	_
24	clinical	_	JJ	JJ	_	23	dep	_	_
25	predictor	_	NN	NN	_	15	conj	_	_
26	for	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	29	det	_	_
28	further	_	JJ	JJ	_	29	amod	_	_
29	course	_	NN	NN	_	26	pobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	the	_	DT	DT	_	32	det	_	_
32	disease	_	NN	NN	_	30	pobj	_	_
33	.	_	.	.	_	3	punct	_	_

1	Characterization	_	NN	NN	_	6	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	CD48	_	NN	NN	_	5	nn	_	_
5	gene	_	NN	NN	_	2	pobj	_	_
6	demonstrates	_	VBZ	VBZ	_	0	root	_	_
7	a	_	DT	DT	_	9	det	_	_
8	positive	_	JJ	JJ	_	9	amod	_	_
9	element	_	NN	NN	_	6	dobj	_	_
10	that	_	WDT	WDT	_	12	nsubj	_	_
11	is	_	VBZ	VBZ	_	12	cop	_	_
12	specific	_	JJ	JJ	_	9	rcmod	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	Epstein-Barr	_	JJ	JJ	_	17	amod	_	_
15	virus-immortalized	_	JJ	JJ	_	17	amod	_	_
16	B-cell	_	NN	NN	_	17	nn	_	_
17	lines	_	NNS	NNS	_	13	pobj	_	_
18	and	_	CC	CC	_	12	cc	_	_
19	contains	_	VBZ	VBZ	_	12	conj	_	_
20	an	_	DT	DT	_	24	det	_	_
21	essential	_	JJ	JJ	_	24	amod	_	_
22	NF-kappa	_	NN	NN	_	24	nn	_	_
23	B	_	NN	NN	_	24	nn	_	_
24	site	_	NN	NN	_	19	dobj	_	_
25	.	_	.	.	_	6	punct	_	_

1	Epstein-Barr	_	JJ	JJ	_	2	amod	_	_
2	virus	_	NN	NN	_	6	nn	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	EBV	_	NN	NN	_	2	appos	_	_
5	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
6	infection	_	NN	NN	_	13	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	mature	_	JJ	JJ	_	12	amod	_	_
9	,	_	,	,	_	12	punct	_	_
10	resting	_	VBG	VBG	_	12	amod	_	_
11	B	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	7	pobj	_	_
13	drives	_	VBZ	VBZ	_	0	root	_	_
14	them	_	PRP	PRP	_	13	dobj	_	_
15	to	_	TO	TO	_	16	aux	_	_
16	become	_	VB	VB	_	13	vmod	_	_
17	lymphoblasts	_	NNS	NNS	_	16	xcomp	_	_
18	expressing	_	VBG	VBG	_	17	vmod	_	_
19	high	_	JJ	JJ	_	20	amod	_	_
20	levels	_	NNS	NNS	_	18	dobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	cell	_	NN	NN	_	24	nn	_	_
23	surface	_	NN	NN	_	24	nn	_	_
24	molecules	_	NNS	NNS	_	21	pobj	_	_
25	,	_	,	,	_	24	punct	_	_
26	such	_	JJ	JJ	_	27	mwe	_	_
27	as	_	IN	IN	_	24	prep	_	_
28	CD48	_	NN	NN	_	27	pobj	_	_
29	,	_	,	,	_	28	punct	_	_
30	characteristically	_	RB	RB	_	31	advmod	_	_
31	expressed	_	VBN	VBN	_	28	vmod	_	_
32	on	_	IN	IN	_	31	prep	_	_
33	normal	_	JJ	JJ	_	36	amod	_	_
34	activated	_	VBN	VBN	_	36	amod	_	_
35	B	_	NN	NN	_	36	nn	_	_
36	cells	_	NNS	NNS	_	32	pobj	_	_
37	.	_	.	.	_	13	punct	_	_

1	Here	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	report	_	VBP	VBP	_	0	root	_	_
5	on	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	identification	_	NN	NN	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	an	_	DT	DT	_	11	det	_	_
10	enhancer	_	NN	NN	_	11	nn	_	_
11	element	_	NN	NN	_	8	pobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	CD48	_	NN	NN	_	15	nn	_	_
15	gene	_	NN	NN	_	12	pobj	_	_
16	which	_	WDT	WDT	_	18	nsubj	_	_
17	reproducibly	_	RB	RB	_	18	advmod	_	_
18	confers	_	VBZ	VBZ	_	11	rcmod	_	_
19	strong	_	JJ	JJ	_	21	amod	_	_
20	transcriptional	_	JJ	JJ	_	21	amod	_	_
21	activity	_	NN	NN	_	18	dobj	_	_
22	only	_	RB	RB	_	23	advmod	_	_
23	in	_	IN	IN	_	18	prep	_	_
24	EBV-positive	_	JJ	JJ	_	27	amod	_	_
25	B-lymphoblastoid	_	JJ	JJ	_	27	amod	_	_
26	cell	_	NN	NN	_	27	nn	_	_
27	lines	_	NNS	NNS	_	23	pobj	_	_
28	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	element	_	NN	NN	_	5	nsubjpass	_	_
3	is	_	VBZ	VBZ	_	5	auxpass	_	_
4	not	_	RB	RB	_	5	neg	_	_
5	activated	_	VBN	VBN	_	0	root	_	_
6	upon	_	IN	IN	_	5	prep	_	_
7	infection	_	NN	NN	_	6	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	established	_	JJ	JJ	_	12	amod	_	_
10	EBV-negative	_	JJ	JJ	_	12	amod	_	_
11	B-cell	_	NN	NN	_	12	nn	_	_
12	lines	_	NNS	NNS	_	8	pobj	_	_
13	,	_	,	,	_	5	punct	_	_
14	indicating	_	VBG	VBG	_	5	vmod	_	_
15	that	_	IN	IN	_	17	mark	_	_
16	EBV	_	NN	NN	_	17	nsubj	_	_
17	fails	_	VBZ	VBZ	_	14	ccomp	_	_
18	to	_	TO	TO	_	19	aux	_	_
19	drive	_	VB	VB	_	17	xcomp	_	_
20	these	_	DT	DT	_	21	det	_	_
21	cells	_	NNS	NNS	_	19	dobj	_	_
22	to	_	TO	TO	_	19	prep	_	_
23	a	_	DT	DT	_	26	det	_	_
24	fully	_	RB	RB	_	26	advmod	_	_
25	lymphoblastoid	_	JJ	JJ	_	26	amod	_	_
26	phenotype	_	NN	NN	_	22	pobj	_	_
27	.	_	.	.	_	5	punct	_	_

1	An	_	DT	DT	_	5	det	_	_
2	NF-kappa	_	NN	NN	_	3	nn	_	_
3	B	_	NN	NN	_	5	nn	_	_
4	binding	_	NN	NN	_	5	nn	_	_
5	site	_	NN	NN	_	9	nsubj	_	_
6	is	_	VBZ	VBZ	_	9	cop	_	_
7	an	_	DT	DT	_	9	det	_	_
8	essential	_	JJ	JJ	_	9	amod	_	_
9	component	_	NN	NN	_	0	root	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	element	_	NN	NN	_	10	pobj	_	_
13	but	_	CC	CC	_	9	cc	_	_
14	alone	_	RB	RB	_	17	advmod	_	_
15	is	_	VBZ	VBZ	_	17	cop	_	_
16	not	_	RB	RB	_	17	neg	_	_
17	sufficient	_	JJ	JJ	_	9	conj	_	_
18	to	_	TO	TO	_	19	aux	_	_
19	account	_	VB	VB	_	17	xcomp	_	_
20	for	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	22	det	_	_
22	activity	_	NN	NN	_	20	pobj	_	_
23	or	_	CC	CC	_	22	cc	_	_
24	the	_	DT	DT	_	25	det	_	_
25	specificity	_	NN	NN	_	22	conj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	28	det	_	_
28	element	_	NN	NN	_	26	pobj	_	_
29	.	_	.	.	_	9	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	detected	_	VBN	VBN	_	0	root	_	_
4	a	_	DT	DT	_	8	det	_	_
5	specific	_	JJ	JJ	_	8	amod	_	_
6	nuclear	_	JJ	JJ	_	8	amod	_	_
7	protein	_	NN	NN	_	8	nn	_	_
8	complex	_	NN	NN	_	3	dobj	_	_
9	that	_	WDT	WDT	_	10	nsubj	_	_
10	binds	_	VBZ	VBZ	_	8	rcmod	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	element	_	NN	NN	_	11	pobj	_	_
14	and	_	CC	CC	_	3	cc	_	_
15	show	_	VBP	VBP	_	3	conj	_	_
16	that	_	IN	IN	_	24	mark	_	_
17	NF-kappa	_	NN	NN	_	18	nn	_	_
18	B1	_	NN	NN	_	24	nsubj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	p50	_	NN	NN	_	18	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	is	_	VBZ	VBZ	_	24	cop	_	_
23	a	_	DT	DT	_	24	det	_	_
24	part	_	NN	NN	_	15	ccomp	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	this	_	DT	DT	_	27	det	_	_
27	complex	_	NN	NN	_	25	pobj	_	_
28	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	EBV-encoded	_	JJ	JJ	_	5	amod	_	_
3	latent	_	JJ	JJ	_	5	amod	_	_
4	membrane	_	NN	NN	_	5	nn	_	_
5	protein	_	NN	NN	_	8	nsubj	_	_
6	1	_	CD	CD	_	5	num	_	_
7	is	_	VBZ	VBZ	_	8	cop	_	_
8	capable	_	JJ	JJ	_	0	root	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	transactivating	_	VBG	VBG	_	9	pcomp	_	_
11	the	_	DT	DT	_	13	det	_	_
12	isolated	_	VBN	VBN	_	13	amod	_	_
13	CD48	_	NN	NN	_	10	dobj	_	_
14	NF-kappa	_	NN	NN	_	16	nn	_	_
15	B	_	NN	NN	_	16	nn	_	_
16	site	_	NN	NN	_	13	dep	_	_
17	but	_	CC	CC	_	18	cc	_	_
18	not	_	RB	RB	_	13	cc	_	_
19	the	_	DT	DT	_	21	det	_	_
20	intact	_	JJ	JJ	_	21	amod	_	_
21	element	_	NN	NN	_	13	conj	_	_
22	,	_	,	,	_	8	punct	_	_
23	suggesting	_	VBG	VBG	_	8	xcomp	_	_
24	that	_	IN	IN	_	35	mark	_	_
25	the	_	DT	DT	_	30	det	_	_
26	latent	_	JJ	JJ	_	30	amod	_	_
27	membrane	_	NN	NN	_	30	nn	_	_
28	protein	_	NN	NN	_	30	nn	_	_
29	1-driven	_	JJ	JJ	_	30	amod	_	_
30	activation	_	NN	NN	_	35	nsubj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	NF-kappa	_	NN	NN	_	33	nn	_	_
33	B/Rel	_	NN	NN	_	31	pobj	_	_
34	must	_	MD	MD	_	35	aux	_	_
35	interact	_	VB	VB	_	23	ccomp	_	_
36	with	_	IN	IN	_	35	prep	_	_
37	other	_	JJ	JJ	_	39	amod	_	_
38	regulatory	_	JJ	JJ	_	39	amod	_	_
39	pathways	_	NNS	NNS	_	36	pobj	_	_
40	to	_	TO	TO	_	41	aux	_	_
41	control	_	VB	VB	_	35	xcomp	_	_
42	expression	_	NN	NN	_	41	dobj	_	_
43	of	_	IN	IN	_	42	prep	_	_
44	cellular	_	JJ	JJ	_	45	amod	_	_
45	genes	_	NNS	NNS	_	43	pobj	_	_
46	as	_	IN	IN	_	48	mark	_	_
47	EBV	_	NN	NN	_	48	nsubj	_	_
48	drives	_	VBZ	VBZ	_	35	advcl	_	_
49	resting	_	VBG	VBG	_	51	amod	_	_
50	B	_	NN	NN	_	51	nn	_	_
51	cells	_	NNS	NNS	_	48	dobj	_	_
52	into	_	IN	IN	_	48	prep	_	_
53	the	_	DT	DT	_	55	det	_	_
54	cell	_	NN	NN	_	55	nn	_	_
55	cycle	_	NN	NN	_	52	pobj	_	_
56	.	_	.	.	_	8	punct	_	_

1	Distinct	_	JJ	JJ	_	2	amod	_	_
2	roles	_	NNS	NNS	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	7	det	_	_
5	molecular	_	JJ	JJ	_	7	amod	_	_
6	chaperone	_	NN	NN	_	7	nn	_	_
7	hsp90	_	NN	NN	_	3	pobj	_	_
8	in	_	IN	IN	_	2	prep	_	_
9	modulating	_	VBG	VBG	_	8	pcomp	_	_
10	dioxin	_	NN	NN	_	12	nn	_	_
11	receptor	_	NN	NN	_	12	nn	_	_
12	function	_	NN	NN	_	9	dobj	_	_
13	via	_	IN	IN	_	9	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	basic	_	JJ	JJ	_	16	amod	_	_
16	helix-loop-helix	_	JJ	JJ	_	13	pobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	PAS	_	NN	NN	_	19	nn	_	_
19	domains	_	NNS	NNS	_	16	conj	_	_
20	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	intracellular	_	JJ	JJ	_	4	amod	_	_
3	dioxin	_	NN	NN	_	4	nn	_	_
4	receptor	_	NN	NN	_	5	nsubj	_	_
5	mediates	_	VBZ	VBZ	_	0	root	_	_
6	signal	_	NN	NN	_	7	nn	_	_
7	transduction	_	NN	NN	_	5	dobj	_	_
8	by	_	IN	IN	_	5	prep	_	_
9	dioxin	_	NN	NN	_	8	pobj	_	_
10	and	_	CC	CC	_	5	cc	_	_
11	functions	_	VBZ	VBZ	_	5	conj	_	_
12	as	_	IN	IN	_	11	prep	_	_
13	a	_	DT	DT	_	16	det	_	_
14	ligand-activated	_	JJ	JJ	_	16	amod	_	_
15	transcription	_	NN	NN	_	16	nn	_	_
16	factor	_	NN	NN	_	12	pobj	_	_
17	.	_	.	.	_	5	punct	_	_

1	It	_	PRP	PRP	_	2	nsubj	_	_
2	contains	_	VBZ	VBZ	_	0	root	_	_
3	a	_	DT	DT	_	9	det	_	_
4	basic	_	JJ	JJ	_	9	amod	_	_
5	helix-loop-helix	_	JJ	JJ	_	9	amod	_	_
6	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
7	bHLH	_	JJ	JJ	_	9	amod	_	_
8	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
9	motif	_	NN	NN	_	2	dobj	_	_
10	contiguous	_	JJ	JJ	_	9	amod	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	a	_	DT	DT	_	18	det	_	_
13	Per-Arnt-Sim	_	NN	NN	_	18	nn	_	_
14	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
15	PAS	_	NN	NN	_	18	nn	_	_
16	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
17	homology	_	NN	NN	_	18	nn	_	_
18	region	_	NN	NN	_	11	pobj	_	_
19	.	_	.	.	_	2	punct	_	_

1	In	_	IN	IN	_	9	prep	_	_
2	extracts	_	NNS	NNS	_	1	pobj	_	_
3	from	_	IN	IN	_	2	prep	_	_
4	nonstimulated	_	JJ	JJ	_	5	amod	_	_
5	cells	_	NNS	NNS	_	3	pobj	_	_
6	the	_	DT	DT	_	7	det	_	_
7	receptor	_	NN	NN	_	9	nsubjpass	_	_
8	is	_	VBZ	VBZ	_	9	auxpass	_	_
9	recovered	_	VBN	VBN	_	0	root	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	an	_	DT	DT	_	14	det	_	_
12	inducible	_	JJ	JJ	_	14	amod	_	_
13	cytoplasmic	_	JJ	JJ	_	12	dep	_	_
14	form	_	NN	NN	_	10	pobj	_	_
15	associated	_	VBN	VBN	_	14	vmod	_	_
16	with	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	21	det	_	_
18	90-kDa	_	JJ	JJ	_	21	amod	_	_
19	heat	_	NN	NN	_	21	nn	_	_
20	shock	_	NN	NN	_	21	nn	_	_
21	protein	_	NN	NN	_	16	pobj	_	_
22	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
23	hsp90	_	NN	NN	_	21	appos	_	_
24	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
25	,	_	,	,	_	21	punct	_	_
26	a	_	DT	DT	_	28	det	_	_
27	molecular	_	JJ	JJ	_	28	amod	_	_
28	chaperone	_	NN	NN	_	21	appos	_	_
29	.	_	.	.	_	9	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	reconstituted	_	VBN	VBN	_	0	root	_	_
4	ligand-dependent	_	JJ	JJ	_	5	amod	_	_
5	activation	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	receptor	_	NN	NN	_	6	pobj	_	_
9	to	_	TO	TO	_	3	prep	_	_
10	a	_	DT	DT	_	12	det	_	_
11	DNA-binding	_	JJ	JJ	_	12	amod	_	_
12	form	_	NN	NN	_	9	pobj	_	_
13	by	_	IN	IN	_	3	prep	_	_
14	using	_	VBG	VBG	_	13	pcomp	_	_
15	the	_	DT	DT	_	17	det	_	_
16	dioxin	_	NN	NN	_	17	nn	_	_
17	receptor	_	NN	NN	_	14	dobj	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	its	_	PRP$	PRP$	_	22	poss	_	_
20	bHLH-PAS	_	JJ	JJ	_	22	amod	_	_
21	partner	_	NN	NN	_	22	nn	_	_
22	factor	_	NN	NN	_	17	conj	_	_
23	Arnt	_	NN	NN	_	22	dep	_	_
24	expressed	_	VBN	VBN	_	22	vmod	_	_
25	by	_	IN	IN	_	24	prep	_	_
26	in	_	FW	FW	_	28	amod	_	_
27	vitro	_	FW	FW	_	26	dep	_	_
28	translation	_	NN	NN	_	25	pobj	_	_
29	in	_	IN	IN	_	28	prep	_	_
30	reticulocyte	_	JJ	JJ	_	31	amod	_	_
31	lysate	_	NN	NN	_	29	pobj	_	_
32	.	_	.	.	_	3	punct	_	_

1	Deletion	_	NN	NN	_	9	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	PAS	_	NN	NN	_	5	nn	_	_
5	domain	_	NN	NN	_	2	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	receptor	_	NN	NN	_	6	pobj	_	_
9	resulted	_	VBD	VBD	_	0	root	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	constitutive	_	JJ	JJ	_	12	amod	_	_
12	dimerization	_	NN	NN	_	10	pobj	_	_
13	with	_	IN	IN	_	12	prep	_	_
14	Arnt	_	NN	NN	_	13	pobj	_	_
15	.	_	.	.	_	9	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	7	punct	_	_
4	this	_	DT	DT	_	6	det	_	_
5	receptor	_	NN	NN	_	6	nn	_	_
6	mutant	_	NN	NN	_	7	nsubj	_	_
7	showed	_	VBD	VBD	_	0	root	_	_
8	low	_	JJ	JJ	_	9	amod	_	_
9	levels	_	NNS	NNS	_	7	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	xenobiotic	_	JJ	JJ	_	14	amod	_	_
12	response	_	NN	NN	_	14	nn	_	_
13	element-binding	_	JJ	JJ	_	14	amod	_	_
14	activity	_	NN	NN	_	10	pobj	_	_
15	,	_	,	,	_	7	punct	_	_
16	indicating	_	VBG	VBG	_	7	vmod	_	_
17	that	_	IN	IN	_	23	mark	_	_
18	the	_	DT	DT	_	20	det	_	_
19	PAS	_	NN	NN	_	20	nn	_	_
20	domain	_	NN	NN	_	23	nsubj	_	_
21	may	_	MD	MD	_	23	aux	_	_
22	be	_	VB	VB	_	23	cop	_	_
23	important	_	JJ	JJ	_	16	ccomp	_	_
24	for	_	IN	IN	_	23	prep	_	_
25	DNA-binding	_	JJ	JJ	_	26	amod	_	_
26	affinity	_	NN	NN	_	24	pobj	_	_
27	and/or	_	CC	CC	_	26	cc	_	_
28	specificity	_	NN	NN	_	26	conj	_	_
29	of	_	IN	IN	_	26	prep	_	_
30	the	_	DT	DT	_	31	det	_	_
31	receptor	_	NN	NN	_	29	pobj	_	_
32	.	_	.	.	_	7	punct	_	_

1	It	_	PRP	PRP	_	4	nsubj	_	_
2	was	_	VBD	VBD	_	4	cop	_	_
3	not	_	RB	RB	_	4	neg	_	_
4	possible	_	JJ	JJ	_	0	root	_	_
5	to	_	TO	TO	_	6	aux	_	_
6	reconstitute	_	VB	VB	_	4	xcomp	_	_
7	dioxin	_	NN	NN	_	8	nn	_	_
8	receptor	_	NN	NN	_	9	nn	_	_
9	function	_	NN	NN	_	6	dobj	_	_
10	with	_	IN	IN	_	6	prep	_	_
11	proteins	_	NNS	NNS	_	10	pobj	_	_
12	expressed	_	VBN	VBN	_	11	vmod	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	wheat	_	NN	NN	_	16	nn	_	_
15	germ	_	NN	NN	_	16	nn	_	_
16	lysate	_	NN	NN	_	13	pobj	_	_
17	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	14	prep	_	_
2	line	_	NN	NN	_	1	pobj	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	these	_	DT	DT	_	5	det	_	_
5	observations	_	NNS	NNS	_	3	pobj	_	_
6	,	_	,	,	_	14	punct	_	_
7	reticulocyte	_	NN	NN	_	8	nn	_	_
8	lysate	_	NN	NN	_	14	nsubj	_	_
9	but	_	CC	CC	_	10	cc	_	_
10	not	_	RB	RB	_	8	cc	_	_
11	wheat	_	NN	NN	_	13	nn	_	_
12	germ	_	NN	NN	_	13	nn	_	_
13	lysate	_	NN	NN	_	8	conj	_	_
14	promoted	_	VBD	VBD	_	0	root	_	_
15	the	_	DT	DT	_	16	det	_	_
16	association	_	NN	NN	_	14	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	de	_	FW	FW	_	22	amod	_	_
19	novo	_	FW	FW	_	18	dep	_	_
20	synthesized	_	VBN	VBN	_	22	amod	_	_
21	dioxin	_	NN	NN	_	22	nn	_	_
22	receptor	_	NN	NN	_	17	pobj	_	_
23	with	_	IN	IN	_	16	prep	_	_
24	hsp90	_	NN	NN	_	23	pobj	_	_
25	.	_	.	.	_	14	punct	_	_

1	At	_	IN	IN	_	3	quantmod	_	_
2	least	_	JJS	JJS	_	1	mwe	_	_
3	two	_	CD	CD	_	5	num	_	_
4	distinct	_	JJ	JJ	_	5	amod	_	_
5	domains	_	NNS	NNS	_	9	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	receptor	_	NN	NN	_	6	pobj	_	_
9	mediated	_	VBD	VBD	_	0	root	_	_
10	interaction	_	NN	NN	_	9	dobj	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	hsp90	_	NN	NN	_	11	pobj	_	_
13	:	_	:	:	_	9	punct	_	_
14	the	_	DT	DT	_	16	det	_	_
15	ligand-binding	_	JJ	JJ	_	16	amod	_	_
16	domain	_	NN	NN	_	9	dep	_	_
17	located	_	JJ	JJ	_	16	amod	_	_
18	within	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	PAS	_	NN	NN	_	21	nn	_	_
21	region	_	NN	NN	_	18	pobj	_	_
22	and	_	CC	CC	_	16	cc	_	_
23	,	_	,	,	_	16	punct	_	_
24	surprisingly	_	RB	RB	_	16	advmod	_	_
25	,	_	,	,	_	16	punct	_	_
26	the	_	DT	DT	_	28	det	_	_
27	bHLH	_	JJ	JJ	_	28	amod	_	_
28	domain	_	NN	NN	_	16	conj	_	_
29	.	_	.	.	_	9	punct	_	_

1	Whereas	_	IN	IN	_	4	mark	_	_
2	ligand-binding	_	JJ	JJ	_	3	amod	_	_
3	activity	_	NN	NN	_	4	nsubj	_	_
4	correlated	_	VBD	VBD	_	12	advcl	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	association	_	NN	NN	_	5	pobj	_	_
7	with	_	IN	IN	_	6	prep	_	_
8	hsp90	_	NN	NN	_	7	pobj	_	_
9	,	_	,	,	_	12	punct	_	_
10	bHLH-hsp90	_	JJ	JJ	_	11	amod	_	_
11	interaction	_	NN	NN	_	12	nsubj	_	_
12	appeared	_	VBD	VBD	_	0	root	_	_
13	to	_	TO	TO	_	15	aux	_	_
14	be	_	VB	VB	_	15	cop	_	_
15	important	_	JJ	JJ	_	12	xcomp	_	_
16	for	_	IN	IN	_	15	prep	_	_
17	DNA-binding	_	JJ	JJ	_	18	amod	_	_
18	activity	_	NN	NN	_	16	pobj	_	_
19	but	_	CC	CC	_	16	cc	_	_
20	not	_	RB	RB	_	21	neg	_	_
21	for	_	IN	IN	_	16	conj	_	_
22	dimerization	_	NN	NN	_	21	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	25	det	_	_
25	receptor	_	NN	NN	_	23	pobj	_	_
26	.	_	.	.	_	12	punct	_	_

1	Several	_	JJ	JJ	_	2	amod	_	_
2	distinct	_	JJ	JJ	_	3	amod	_	_
3	roles	_	NNS	NNS	_	13	nsubj	_	_
4	for	_	IN	IN	_	3	prep	_	_
5	hsp90	_	NN	NN	_	4	pobj	_	_
6	in	_	IN	IN	_	3	prep	_	_
7	modulating	_	VBG	VBG	_	6	pcomp	_	_
8	dioxin	_	NN	NN	_	9	nn	_	_
9	receptor	_	NN	NN	_	10	nn	_	_
10	function	_	NN	NN	_	7	dobj	_	_
11	are	_	VBP	VBP	_	13	cop	_	_
12	therefore	_	RB	RB	_	13	advmod	_	_
13	likely	_	JJ	JJ	_	0	root	_	_
14	:	_	:	:	_	13	punct	_	_
15	correct	_	JJ	JJ	_	16	amod	_	_
16	folding	_	NN	NN	_	13	dep	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	ligand-binding	_	JJ	JJ	_	20	amod	_	_
20	domain	_	NN	NN	_	17	pobj	_	_
21	,	_	,	,	_	16	punct	_	_
22	interference	_	NN	NN	_	16	conj	_	_
23	with	_	IN	IN	_	22	prep	_	_
24	Arnt	_	NN	NN	_	25	nn	_	_
25	heterodimerization	_	NN	NN	_	23	pobj	_	_
26	,	_	,	,	_	16	punct	_	_
27	and	_	CC	CC	_	16	cc	_	_
28	folding	_	NN	NN	_	16	conj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	a	_	DT	DT	_	32	det	_	_
31	DNA-binding	_	JJ	JJ	_	32	amod	_	_
32	conformation	_	NN	NN	_	29	pobj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	the	_	DT	DT	_	36	det	_	_
35	bHLH	_	JJ	JJ	_	36	amod	_	_
36	domain	_	NN	NN	_	33	pobj	_	_
37	.	_	.	.	_	13	punct	_	_

1	Thus	_	RB	RB	_	7	advmod	_	_
2	,	_	,	,	_	7	punct	_	_
3	the	_	DT	DT	_	6	det	_	_
4	dioxin	_	NN	NN	_	5	nn	_	_
5	receptor	_	NN	NN	_	6	nn	_	_
6	system	_	NN	NN	_	7	nsubj	_	_
7	provides	_	VBZ	VBZ	_	0	root	_	_
8	a	_	DT	DT	_	12	det	_	_
9	complex	_	JJ	JJ	_	12	amod	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	interesting	_	JJ	JJ	_	9	conj	_	_
12	model	_	NN	NN	_	7	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	regulation	_	NN	NN	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	transcription	_	NN	NN	_	18	nn	_	_
18	factors	_	NNS	NNS	_	16	pobj	_	_
19	by	_	IN	IN	_	15	prep	_	_
20	hsp90	_	NN	NN	_	19	pobj	_	_
21	.	_	.	.	_	7	punct	_	_

1	T-cell	_	NN	NN	_	3	nn	_	_
2	functional	_	JJ	JJ	_	3	amod	_	_
3	regions	_	NNS	NNS	_	0	root	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	9	det	_	_
6	human	_	JJ	JJ	_	9	amod	_	_
7	IL-3	_	NN	NN	_	9	nn	_	_
8	proximal	_	JJ	JJ	_	9	amod	_	_
9	promoter	_	NN	NN	_	4	pobj	_	_
10	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	7	det	_	_
2	human	_	JJ	JJ	_	7	amod	_	_
3	interleukin-3	_	NN	NN	_	7	nn	_	_
4	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
5	IL-3	_	NN	NN	_	7	nn	_	_
6	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
7	gene	_	NN	NN	_	9	nsubjpass	_	_
8	is	_	VBZ	VBZ	_	9	auxpass	_	_
9	expressed	_	VBN	VBN	_	0	root	_	_
10	almost	_	RB	RB	_	11	advmod	_	_
11	exclusively	_	RB	RB	_	9	advmod	_	_
12	in	_	IN	IN	_	9	prep	_	_
13	activated	_	VBN	VBN	_	15	amod	_	_
14	T	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	12	pobj	_	_
16	.	_	.	.	_	9	punct	_	_

1	Its	_	PRP$	PRP$	_	2	poss	_	_
2	expression	_	NN	NN	_	4	nsubjpass	_	_
3	is	_	VBZ	VBZ	_	4	auxpass	_	_
4	regulated	_	VBN	VBN	_	0	root	_	_
5	at	_	IN	IN	_	4	prep	_	_
6	both	_	CC	CC	_	8	preconj	_	_
7	the	_	DT	DT	_	8	dep	_	_
8	transcriptional	_	JJ	JJ	_	5	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	post-transcriptional	_	JJ	JJ	_	8	conj	_	_
11	level	_	NN	NN	_	8	dep	_	_
12	.	_	.	.	_	4	punct	_	_

1	We	_	PRP	PRP	_	4	nsubj	_	_
2	have	_	VBP	VBP	_	4	aux	_	_
3	previously	_	RB	RB	_	4	advmod	_	_
4	shown	_	VBN	VBN	_	0	root	_	_
5	that	_	IN	IN	_	23	mark	_	_
6	treatment	_	NN	NN	_	23	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	Jurkat	_	NN	NN	_	10	nn	_	_
9	T	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	7	pobj	_	_
11	with	_	IN	IN	_	6	prep	_	_
12	phytohemaglutinin	_	NN	NN	_	11	pobj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	PHA	_	NN	NN	_	12	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	and	_	CC	CC	_	12	cc	_	_
17	the	_	DT	DT	_	19	det	_	_
18	phorbol	_	NN	NN	_	19	nn	_	_
19	ester	_	NN	NN	_	12	conj	_	_
20	,	_	,	,	_	19	punct	_	_
21	PMA	_	NN	NN	_	19	appos	_	_
22	,	_	,	,	_	19	punct	_	_
23	activated	_	VBD	VBD	_	4	ccomp	_	_
24	transcription	_	NN	NN	_	25	nn	_	_
25	initiation	_	NN	NN	_	23	dobj	_	_
26	from	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	29	det	_	_
28	IL-3	_	NN	NN	_	29	nn	_	_
29	gene	_	NN	NN	_	26	pobj	_	_
30	.	_	.	.	_	4	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	define	_	VB	VB	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	regions	_	NNS	NNS	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	gene	_	NN	NN	_	5	pobj	_	_
8	required	_	VBN	VBN	_	7	vmod	_	_
9	for	_	IN	IN	_	8	prep	_	_
10	transcription	_	NN	NN	_	11	nn	_	_
11	activation	_	NN	NN	_	9	pobj	_	_
12	,	_	,	,	_	2	punct	_	_
13	we	_	PRP	PRP	_	14	nsubj	_	_
14	generated	_	VBD	VBD	_	2	parataxis	_	_
15	a	_	DT	DT	_	16	det	_	_
16	series	_	NN	NN	_	14	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	reporter	_	NN	NN	_	19	nn	_	_
19	constructs	_	NNS	NNS	_	17	pobj	_	_
20	containing	_	VBG	VBG	_	19	vmod	_	_
21	different	_	JJ	JJ	_	22	amod	_	_
22	regions	_	NNS	NNS	_	20	dobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	27	det	_	_
25	IL-3	_	NN	NN	_	27	npadvmod	_	_
26	gene	_	NN	NN	_	27	npadvmod	_	_
27	5'	_	JJ	JJ	_	23	pobj	_	_
28	and	_	CC	CC	_	27	cc	_	_
29	3'	_	JJ	JJ	_	31	amod	_	_
30	flanking	_	JJ	JJ	_	31	amod	_	_
31	sequences	_	NNS	NNS	_	27	conj	_	_
32	.	_	.	.	_	2	punct	_	_

1	Both	_	CC	CC	_	2	preconj	_	_
2	positive	_	JJ	JJ	_	8	nsubjpass	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	negative	_	JJ	JJ	_	2	conj	_	_
5	regulatory	_	JJ	JJ	_	6	amod	_	_
6	elements	_	NNS	NNS	_	2	dep	_	_
7	were	_	VBD	VBD	_	8	auxpass	_	_
8	identified	_	VBN	VBN	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	14	det	_	_
11	proximal	_	JJ	JJ	_	14	amod	_	_
12	5'	_	JJ	JJ	_	14	amod	_	_
13	flanking	_	JJ	JJ	_	14	amod	_	_
14	region	_	NN	NN	_	9	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	IL-3	_	NN	NN	_	18	nn	_	_
18	gene	_	NN	NN	_	15	pobj	_	_
19	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	promoter	_	NN	NN	_	3	nn	_	_
3	region	_	NN	NN	_	8	nsubj	_	_
4	between	_	IN	IN	_	3	prep	_	_
5	-173	_	CD	CD	_	4	pobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	-60	_	CD	CD	_	5	conj	_	_
8	contained	_	VBD	VBD	_	0	root	_	_
9	the	_	DT	DT	_	12	det	_	_
10	strongest	_	JJS	JJS	_	12	amod	_	_
11	activating	_	VBG	VBG	_	12	amod	_	_
12	elements	_	NNS	NNS	_	8	dobj	_	_
13	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	transcription	_	NN	NN	_	3	nn	_	_
3	factor	_	NN	NN	_	6	nsubj	_	_
4	AP-1	_	NN	NN	_	3	dep	_	_
5	could	_	MD	MD	_	6	aux	_	_
6	bind	_	VB	VB	_	0	root	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	this	_	DT	DT	_	11	det	_	_
9	positive	_	JJ	JJ	_	11	amod	_	_
10	activator	_	NN	NN	_	11	nn	_	_
11	region	_	NN	NN	_	7	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	promoter	_	NN	NN	_	12	pobj	_	_
15	.	_	.	.	_	6	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	examined	_	VBD	VBD	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	function	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	10	det	_	_
8	IL-3	_	NN	NN	_	10	nn	_	_
9	CK-1/CK-2	_	NN	NN	_	10	nn	_	_
10	elements	_	NNS	NNS	_	6	pobj	_	_
11	that	_	WDT	WDT	_	13	nsubj	_	_
12	are	_	VBP	VBP	_	13	cop	_	_
13	present	_	JJ	JJ	_	10	rcmod	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	many	_	JJ	JJ	_	17	amod	_	_
16	cytokine	_	NN	NN	_	17	nn	_	_
17	genes	_	NNS	NNS	_	14	pobj	_	_
18	and	_	CC	CC	_	3	cc	_	_
19	found	_	VBD	VBD	_	3	conj	_	_
20	that	_	IN	IN	_	22	mark	_	_
21	they	_	PRP	PRP	_	22	nsubj	_	_
22	acted	_	VBD	VBD	_	19	ccomp	_	_
23	as	_	IN	IN	_	22	prep	_	_
24	a	_	DT	DT	_	25	det	_	_
25	repressor	_	NN	NN	_	23	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	basal	_	JJ	JJ	_	29	amod	_	_
28	level	_	NN	NN	_	29	nn	_	_
29	expression	_	NN	NN	_	26	pobj	_	_
30	when	_	WRB	WRB	_	31	advmod	_	_
31	cloned	_	VBN	VBN	_	22	advcl	_	_
32	upstream	_	RB	RB	_	31	advmod	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	a	_	DT	DT	_	36	det	_	_
35	heterologous	_	JJ	JJ	_	36	amod	_	_
36	promoter	_	NN	NN	_	33	pobj	_	_
37	but	_	CC	CC	_	22	cc	_	_
38	were	_	VBD	VBD	_	40	cop	_	_
39	also	_	RB	RB	_	40	advmod	_	_
40	inducible	_	JJ	JJ	_	22	conj	_	_
41	by	_	IN	IN	_	40	prep	_	_
42	PMA/PHA	_	NN	NN	_	41	pobj	_	_
43	.	_	.	.	_	3	punct	_	_

1	Two	_	CD	CD	_	4	num	_	_
2	distinct	_	JJ	JJ	_	4	amod	_	_
3	signalling	_	NN	NN	_	4	nn	_	_
4	pathways	_	NNS	NNS	_	6	nsubjpass	_	_
5	are	_	VBP	VBP	_	6	auxpass	_	_
6	involved	_	VBN	VBN	_	0	root	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	control	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	14	det	_	_
12	biphasic	_	JJ	JJ	_	14	amod	_	_
13	junB	_	NN	NN	_	14	nn	_	_
14	transcription	_	NN	NN	_	10	pobj	_	_
15	induced	_	VBN	VBN	_	14	vmod	_	_
16	by	_	IN	IN	_	15	prep	_	_
17	interleukin-6	_	NN	NN	_	16	pobj	_	_
18	in	_	IN	IN	_	15	prep	_	_
19	the	_	DT	DT	_	23	det	_	_
20	B	_	NN	NN	_	23	nn	_	_
21	cell	_	NN	NN	_	23	nn	_	_
22	hybridoma	_	NN	NN	_	23	nn	_	_
23	7TD1	_	NN	NN	_	18	pobj	_	_
24	.	_	.	.	_	6	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	measured	_	VBN	VBN	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	level	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	junB	_	NN	NN	_	8	nn	_	_
8	mRNA	_	NN	NN	_	6	pobj	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	15	det	_	_
11	B	_	NN	NN	_	15	nn	_	_
12	hybridoma	_	NN	NN	_	15	nn	_	_
13	cell	_	NN	NN	_	15	nn	_	_
14	line	_	NN	NN	_	15	nn	_	_
15	7TD1	_	NN	NN	_	9	pobj	_	_
16	,	_	,	,	_	3	punct	_	_
17	under	_	IN	IN	_	3	prep	_	_
18	interleukin-6	_	NN	NN	_	22	nn	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	IL-6	_	NN	NN	_	18	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	stimulation	_	NN	NN	_	17	pobj	_	_
23	.	_	.	.	_	3	punct	_	_

1	IL-6	_	NN	NN	_	2	nsubj	_	_
2	increases	_	VBZ	VBZ	_	0	root	_	_
3	junB	_	NN	NN	_	4	nn	_	_
4	mRNA	_	NN	NN	_	2	dobj	_	_
5	in	_	IN	IN	_	2	prep	_	_
6	a	_	DT	DT	_	8	det	_	_
7	biphasic	_	JJ	JJ	_	8	amod	_	_
8	fashion	_	NN	NN	_	5	pobj	_	_
9	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	first	_	JJ	JJ	_	4	amod	_	_
3	early-induced	_	JJ	JJ	_	2	dep	_	_
4	peak	_	NN	NN	_	6	nsubj	_	_
5	was	_	VBD	VBD	_	6	cop	_	_
6	transient	_	JJ	JJ	_	0	root	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	likely	_	RB	RB	_	9	advmod	_	_
9	corresponds	_	VBZ	VBZ	_	6	conj	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	the	_	DT	DT	_	16	det	_	_
12	well	_	RB	RB	_	13	advmod	_	_
13	documented	_	VBN	VBN	_	16	amod	_	_
14	typical	_	JJ	JJ	_	13	dep	_	_
15	junB	_	NN	NN	_	16	nn	_	_
16	mRNA	_	NN	NN	_	10	pobj	_	_
17	,	_	,	,	_	16	punct	_	_
18	stimulated	_	VBN	VBN	_	16	vmod	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	response	_	NN	NN	_	19	pobj	_	_
21	to	_	TO	TO	_	20	prep	_	_
22	numerous	_	JJ	JJ	_	24	amod	_	_
23	growth	_	NN	NN	_	24	nn	_	_
24	factors	_	NNS	NNS	_	21	pobj	_	_
25	,	_	,	,	_	24	punct	_	_
26	including	_	VBG	VBG	_	24	prep	_	_
27	IL-6	_	NN	NN	_	26	pobj	_	_
28	.	_	.	.	_	6	punct	_	_

1	At	_	IN	IN	_	14	prep	_	_
2	variance	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	14	punct	_	_
4	the	_	DT	DT	_	6	det	_	_
5	second	_	JJ	JJ	_	6	amod	_	_
6	peak	_	NN	NN	_	14	nsubj	_	_
7	which	_	WDT	WDT	_	11	nsubjpass	_	_
8	has	_	VBZ	VBZ	_	11	aux	_	_
9	never	_	RB	RB	_	11	neg	_	_
10	been	_	VBN	VBN	_	11	auxpass	_	_
11	reported	_	VBN	VBN	_	6	rcmod	_	_
12	previously	_	RB	RB	_	11	advmod	_	_
13	,	_	,	,	_	6	punct	_	_
14	lasted	_	VBD	VBD	_	0	root	_	_
15	several	_	JJ	JJ	_	16	amod	_	_
16	hours	_	NNS	NNS	_	14	dobj	_	_
17	.	_	.	.	_	14	punct	_	_

1	As	_	IN	IN	_	12	prep	_	_
2	a	_	DT	DT	_	3	det	_	_
3	consequence	_	NN	NN	_	1	pobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	its	_	PRP$	PRP$	_	6	poss	_	_
6	effect	_	NN	NN	_	4	pobj	_	_
7	on	_	IN	IN	_	6	prep	_	_
8	junB	_	NN	NN	_	9	nn	_	_
9	mRNA	_	NN	NN	_	7	pobj	_	_
10	,	_	,	,	_	12	punct	_	_
11	IL-6	_	NN	NN	_	12	nsubj	_	_
12	stimulated	_	VBD	VBD	_	0	root	_	_
13	,	_	,	,	_	12	punct	_	_
14	in	_	IN	IN	_	12	prep	_	_
15	a	_	DT	DT	_	17	det	_	_
16	biphasic	_	JJ	JJ	_	17	amod	_	_
17	fashion	_	NN	NN	_	14	pobj	_	_
18	,	_	,	,	_	12	punct	_	_
19	the	_	DT	DT	_	21	det	_	_
20	nuclear	_	JJ	JJ	_	21	amod	_	_
21	accumulation	_	NN	NN	_	12	dobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	25	det	_	_
24	JunB	_	NN	NN	_	25	nn	_	_
25	protein	_	NN	NN	_	22	pobj	_	_
26	.	_	.	.	_	12	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	study	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	demonstrated	_	VBD	VBD	_	0	root	_	_
7	that	_	IN	IN	_	10	mark	_	_
8	IL-6	_	NN	NN	_	9	nn	_	_
9	regulation	_	NN	NN	_	10	nsubj	_	_
10	occurred	_	VBD	VBD	_	6	ccomp	_	_
11	exclusively	_	RB	RB	_	10	advmod	_	_
12	at	_	IN	IN	_	10	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	transcriptional	_	JJ	JJ	_	15	amod	_	_
15	level	_	NN	NN	_	12	pobj	_	_
16	and	_	CC	CC	_	10	cc	_	_
17	that	_	IN	IN	_	29	mark	_	_
18	the	_	DT	DT	_	20	det	_	_
19	bimodal	_	JJ	JJ	_	20	amod	_	_
20	increase	_	NN	NN	_	29	nsubjpass	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	junB	_	NN	NN	_	23	nn	_	_
23	mRNA	_	NN	NN	_	21	pobj	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	JunB	_	NN	NN	_	26	nn	_	_
26	protein	_	NN	NN	_	23	conj	_	_
27	can	_	MD	MD	_	29	aux	_	_
28	be	_	VB	VB	_	29	auxpass	_	_
29	accounted	_	VBN	VBN	_	10	conj	_	_
30	for	_	IN	IN	_	29	prep	_	_
31	by	_	IN	IN	_	30	pcomp	_	_
32	a	_	DT	DT	_	34	det	_	_
33	biphasic	_	JJ	JJ	_	34	amod	_	_
34	stimulation	_	NN	NN	_	31	pobj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	junB	_	NN	NN	_	37	nn	_	_
37	transcription	_	NN	NN	_	35	pobj	_	_
38	.	_	.	.	_	6	punct	_	_

1	Furthermore	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	our	_	PRP$	PRP$	_	4	poss	_	_
4	data	_	NNS	NNS	_	5	nsubj	_	_
5	point	_	VBP	VBP	_	0	root	_	_
6	to	_	TO	TO	_	5	prep	_	_
7	two	_	CD	CD	_	9	num	_	_
8	major	_	JJ	JJ	_	9	amod	_	_
9	differences	_	NNS	NNS	_	6	pobj	_	_
10	between	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	mechanism	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	control	_	NN	NN	_	13	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	17	det	_	_
17	early	_	JJ	JJ	_	15	pobj	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	the	_	DT	DT	_	20	det	_	_
20	late	_	JJ	JJ	_	17	conj	_	_
21	IL-6-induced	_	JJ	JJ	_	24	amod	_	_
22	junB	_	NN	NN	_	24	nn	_	_
23	transcription	_	NN	NN	_	24	nn	_	_
24	waves	_	NNS	NNS	_	17	dep	_	_
25	.	_	.	.	_	5	punct	_	_

1	First	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	cycloheximide	_	NN	NN	_	5	nsubj	_	_
4	strongly	_	RB	RB	_	5	advmod	_	_
5	potentiated	_	VBD	VBD	_	0	root	_	_
6	the	_	DT	DT	_	7	det	_	_
7	transcription	_	NN	NN	_	5	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	second	_	JJ	JJ	_	11	amod	_	_
11	wave	_	NN	NN	_	8	pobj	_	_
12	,	_	,	,	_	5	punct	_	_
13	whereas	_	IN	IN	_	15	mark	_	_
14	it	_	PRP	PRP	_	15	nsubj	_	_
15	failed	_	VBD	VBD	_	5	advcl	_	_
16	to	_	TO	TO	_	17	aux	_	_
17	affect	_	VB	VB	_	15	xcomp	_	_
18	the	_	DT	DT	_	20	det	_	_
19	early-induced	_	JJ	JJ	_	20	amod	_	_
20	burst	_	NN	NN	_	17	dobj	_	_
21	.	_	.	.	_	5	punct	_	_

1	Second	_	RB	RB	_	10	advmod	_	_
2	,	_	,	,	_	10	punct	_	_
3	tyrphostin	_	NN	NN	_	10	nsubj	_	_
4	,	_	,	,	_	3	punct	_	_
5	a	_	DT	DT	_	8	det	_	_
6	tyrosine	_	NN	NN	_	8	nn	_	_
7	kinase	_	NN	NN	_	8	nn	_	_
8	inhibitor	_	NN	NN	_	3	appos	_	_
9	,	_	,	,	_	3	punct	_	_
10	impaired	_	VBD	VBD	_	0	root	_	_
11	the	_	DT	DT	_	12	det	_	_
12	expression	_	NN	NN	_	10	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	first	_	JJ	JJ	_	13	pobj	_	_
16	but	_	CC	CC	_	17	cc	_	_
17	not	_	RB	RB	_	15	cc	_	_
18	the	_	DT	DT	_	19	det	_	_
19	second	_	JJ	JJ	_	15	conj	_	_
20	junB	_	NN	NN	_	21	nn	_	_
21	mRNA	_	NN	NN	_	22	nn	_	_
22	peak	_	NN	NN	_	15	dep	_	_
23	.	_	.	.	_	10	punct	_	_

1	Conversely	_	RB	RB	_	11	advmod	_	_
2	,	_	,	,	_	11	punct	_	_
3	genistein	_	NN	NN	_	11	nsubj	_	_
4	,	_	,	,	_	3	punct	_	_
5	another	_	DT	DT	_	8	det	_	_
6	tyrosine	_	NN	NN	_	8	nn	_	_
7	kinase	_	NN	NN	_	8	nn	_	_
8	inhibitor	_	NN	NN	_	3	appos	_	_
9	,	_	,	,	_	3	punct	_	_
10	totally	_	RB	RB	_	11	advmod	_	_
11	abolished	_	VBD	VBD	_	0	root	_	_
12	the	_	DT	DT	_	13	det	_	_
13	expression	_	NN	NN	_	11	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	17	det	_	_
16	second	_	JJ	JJ	_	17	amod	_	_
17	peak	_	NN	NN	_	14	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	junB	_	NN	NN	_	20	nn	_	_
20	mRNA	_	NN	NN	_	18	pobj	_	_
21	whereas	_	IN	IN	_	25	mark	_	_
22	it	_	PRP	PRP	_	25	nsubj	_	_
23	did	_	VBD	VBD	_	25	aux	_	_
24	not	_	RB	RB	_	25	neg	_	_
25	affect	_	VB	VB	_	11	advcl	_	_
26	the	_	DT	DT	_	27	det	_	_
27	expression	_	NN	NN	_	25	dobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	the	_	DT	DT	_	31	det	_	_
30	first	_	JJ	JJ	_	31	amod	_	_
31	peak	_	NN	NN	_	28	pobj	_	_
32	.	_	.	.	_	11	punct	_	_

1	Altogether	_	RB	RB	_	4	advmod	_	_
2	these	_	DT	DT	_	3	det	_	_
3	data	_	NNS	NNS	_	4	nsubj	_	_
4	indicate	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	12	mark	_	_
6	,	_	,	,	_	12	punct	_	_
7	in	_	IN	IN	_	12	prep	_	_
8	7TD1	_	NN	NN	_	9	nn	_	_
9	cells	_	NNS	NNS	_	7	pobj	_	_
10	,	_	,	,	_	12	punct	_	_
11	IL-6	_	NN	NN	_	12	nsubj	_	_
12	controls	_	VBZ	VBZ	_	4	ccomp	_	_
13	junB	_	NN	NN	_	14	nn	_	_
14	transcription	_	NN	NN	_	12	dobj	_	_
15	in	_	IN	IN	_	12	prep	_	_
16	a	_	DT	DT	_	18	det	_	_
17	biphasic	_	JJ	JJ	_	18	amod	_	_
18	fashion	_	NN	NN	_	15	pobj	_	_
19	by	_	IN	IN	_	12	prep	_	_
20	means	_	NNS	NNS	_	19	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	two	_	CD	CD	_	25	num	_	_
23	separate	_	JJ	JJ	_	25	amod	_	_
24	transduction	_	NN	NN	_	25	nn	_	_
25	pathways	_	NNS	NNS	_	21	pobj	_	_
26	.	_	.	.	_	4	punct	_	_

1	Posttranscriptional	_	JJ	JJ	_	2	amod	_	_
2	regulation	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	macrophage	_	NN	NN	_	7	nn	_	_
5	tissue	_	NN	NN	_	6	nn	_	_
6	factor	_	NN	NN	_	7	nn	_	_
7	expression	_	NN	NN	_	3	pobj	_	_
8	by	_	IN	IN	_	2	prep	_	_
9	antioxidants	_	NNS	NNS	_	8	pobj	_	_
10	.	_	.	.	_	2	punct	_	_

1	Tissue	_	NN	NN	_	2	nn	_	_
2	factor	_	NN	NN	_	6	nn	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	TF	_	NN	NN	_	2	appos	_	_
5	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
6	expression	_	NN	NN	_	12	nsubj	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	cells	_	NNS	NNS	_	7	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	monocyte/macrophage	_	NN	NN	_	11	nn	_	_
11	lineage	_	NN	NN	_	9	pobj	_	_
12	represents	_	VBZ	VBZ	_	0	root	_	_
13	an	_	DT	DT	_	15	det	_	_
14	important	_	JJ	JJ	_	15	amod	_	_
15	mechanism	_	NN	NN	_	12	dobj	_	_
16	underlying	_	VBG	VBG	_	15	vmod	_	_
17	the	_	DT	DT	_	18	det	_	_
18	initiation	_	NN	NN	_	16	dobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	fibrin	_	NN	NN	_	21	nn	_	_
21	deposition	_	NN	NN	_	19	pobj	_	_
22	at	_	IN	IN	_	18	prep	_	_
23	sites	_	NNS	NNS	_	22	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	extravascular	_	JJ	JJ	_	26	amod	_	_
26	inflammation	_	NN	NN	_	24	pobj	_	_
27	.	_	.	.	_	12	punct	_	_

1	Recent	_	JJ	JJ	_	2	amod	_	_
2	evidence	_	NN	NN	_	3	nsubj	_	_
3	suggests	_	VBZ	VBZ	_	0	root	_	_
4	a	_	DT	DT	_	5	det	_	_
5	role	_	NN	NN	_	3	dobj	_	_
6	for	_	IN	IN	_	5	prep	_	_
7	oxidant	_	JJ	JJ	_	8	amod	_	_
8	stress	_	NN	NN	_	6	pobj	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	signalling	_	NN	NN	_	12	nn	_	_
12	pathway	_	NN	NN	_	9	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	various	_	JJ	JJ	_	16	amod	_	_
15	cell	_	NN	NN	_	16	nn	_	_
16	types	_	NNS	NNS	_	13	pobj	_	_
17	by	_	IN	IN	_	3	prep	_	_
18	virtue	_	NN	NN	_	17	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	its	_	PRP$	PRP$	_	21	poss	_	_
21	ability	_	NN	NN	_	19	pobj	_	_
22	to	_	TO	TO	_	23	aux	_	_
23	induce	_	VB	VB	_	21	vmod	_	_
24	DNA	_	NN	NN	_	25	nn	_	_
25	binding	_	NN	NN	_	23	dobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	various	_	JJ	JJ	_	29	amod	_	_
28	transcription	_	NN	NN	_	29	nn	_	_
29	factors	_	NNS	NNS	_	26	pobj	_	_
30	,	_	,	,	_	29	punct	_	_
31	including	_	VBG	VBG	_	29	prep	_	_
32	nuclear	_	JJ	JJ	_	35	amod	_	_
33	factor	_	NN	NN	_	35	nn	_	_
34	kappa	_	NN	NN	_	35	nn	_	_
35	B	_	NN	NN	_	31	pobj	_	_
36	and	_	CC	CC	_	35	cc	_	_
37	AP-1	_	NN	NN	_	35	conj	_	_
38	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	effect	_	NN	NN	_	15	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	antioxidant	_	JJ	JJ	_	5	amod	_	_
5	treatment	_	NN	NN	_	3	pobj	_	_
6	on	_	IN	IN	_	2	prep	_	_
7	lipopolysaccharide	_	NN	NN	_	13	nn	_	_
8	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
9	LPS	_	NN	NN	_	13	nn	_	_
10	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
11	-induced	_	JJ	JJ	_	13	amod	_	_
12	TF	_	NN	NN	_	13	nn	_	_
13	expression	_	NN	NN	_	6	pobj	_	_
14	was	_	VBD	VBD	_	15	auxpass	_	_
15	examined	_	VBN	VBN	_	0	root	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	murine	_	NN	NN	_	19	nn	_	_
18	peritoneal	_	JJ	JJ	_	19	amod	_	_
19	macrophages	_	NNS	NNS	_	16	pobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	human	_	JJ	JJ	_	22	amod	_	_
22	monocytes	_	NNS	NNS	_	19	conj	_	_
23	.	_	.	.	_	15	punct	_	_

1	Both	_	CC	CC	_	3	preconj	_	_
2	pyrrolidine	_	NN	NN	_	3	nn	_	_
3	dithiocarbamate	_	NN	NN	_	20	nsubj	_	_
4	,	_	,	,	_	3	punct	_	_
5	an	_	DT	DT	_	7	det	_	_
6	oxidant	_	JJ	JJ	_	7	amod	_	_
7	scavenger	_	NN	NN	_	3	appos	_	_
8	,	_	,	,	_	3	punct	_	_
9	and	_	CC	CC	_	3	cc	_	_
10	N-acetyl-cysteine	_	NN	NN	_	3	conj	_	_
11	,	_	,	,	_	10	punct	_	_
12	a	_	DT	DT	_	13	det	_	_
13	precursor	_	NN	NN	_	10	appos	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	17	det	_	_
16	endogenous	_	JJ	JJ	_	17	amod	_	_
17	antioxidant	_	JJ	JJ	_	14	pobj	_	_
18	glutathione	_	NN	NN	_	17	dep	_	_
19	,	_	,	,	_	3	punct	_	_
20	inhibited	_	VBD	VBD	_	0	root	_	_
21	stimulation	_	NN	NN	_	20	dobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	macrophage	_	NN	NN	_	25	nn	_	_
24	procoagulant	_	NN	NN	_	25	nn	_	_
25	activity	_	NN	NN	_	22	pobj	_	_
26	by	_	IN	IN	_	21	prep	_	_
27	LPS	_	NN	NN	_	26	pobj	_	_
28	.	_	.	.	_	20	punct	_	_

1	Northern	_	NN	NN	_	3	nn	_	_
2	blot	_	NN	NN	_	3	nn	_	_
3	analysis	_	NN	NN	_	4	nsubj	_	_
4	showed	_	VBD	VBD	_	0	root	_	_
5	that	_	IN	IN	_	10	mark	_	_
6	neither	_	DT	DT	_	10	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	these	_	DT	DT	_	9	det	_	_
9	agents	_	NNS	NNS	_	7	pobj	_	_
10	reduced	_	VBD	VBD	_	4	ccomp	_	_
11	LPS-stimulated	_	JJ	JJ	_	14	amod	_	_
12	TF	_	NN	NN	_	14	nn	_	_
13	mRNA	_	NN	NN	_	14	nn	_	_
14	accumulation	_	NN	NN	_	10	dobj	_	_
15	,	_	,	,	_	4	punct	_	_
16	thereby	_	RB	RB	_	17	advmod	_	_
17	suggesting	_	VBG	VBG	_	4	xcomp	_	_
18	a	_	DT	DT	_	20	det	_	_
19	posttranscriptional	_	JJ	JJ	_	20	amod	_	_
20	mechanism	_	NN	NN	_	17	dobj	_	_
21	for	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	23	det	_	_
23	effect	_	NN	NN	_	21	pobj	_	_
24	.	_	.	.	_	4	punct	_	_

1	Immunofluorescence	_	NN	NN	_	2	nn	_	_
2	studies	_	NNS	NNS	_	10	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	human	_	JJ	JJ	_	5	amod	_	_
5	monocytes	_	NNS	NNS	_	3	pobj	_	_
6	using	_	VBG	VBG	_	2	vmod	_	_
7	polyclonal	_	JJ	JJ	_	9	amod	_	_
8	anti-TF	_	JJ	JJ	_	9	amod	_	_
9	antibody	_	NN	NN	_	6	dobj	_	_
10	showed	_	VBD	VBD	_	0	root	_	_
11	that	_	IN	IN	_	14	mark	_	_
12	N-acetyl-cysteine	_	NN	NN	_	13	nn	_	_
13	treatment	_	NN	NN	_	14	nsubj	_	_
14	prevented	_	VBD	VBD	_	10	ccomp	_	_
15	the	_	DT	DT	_	18	det	_	_
16	characteristic	_	JJ	JJ	_	18	amod	_	_
17	plasmalemmal	_	JJ	JJ	_	18	amod	_	_
18	localization	_	NN	NN	_	14	dobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	TF	_	NN	NN	_	21	nn	_	_
21	antigen	_	NN	NN	_	19	pobj	_	_
22	that	_	WDT	WDT	_	23	nsubj	_	_
23	occurs	_	VBZ	VBZ	_	18	rcmod	_	_
24	in	_	IN	IN	_	23	prep	_	_
25	response	_	NN	NN	_	24	pobj	_	_
26	to	_	TO	TO	_	25	prep	_	_
27	LPS	_	NN	NN	_	26	pobj	_	_
28	.	_	.	.	_	10	punct	_	_

1	Western	_	NN	NN	_	3	nn	_	_
2	blot	_	NN	NN	_	3	nn	_	_
3	analysis	_	NN	NN	_	4	nsubj	_	_
4	showed	_	VBD	VBD	_	0	root	_	_
5	that	_	IN	IN	_	7	mark	_	_
6	N-acetyl-cysteine	_	NN	NN	_	7	nsubj	_	_
7	reduced	_	VBD	VBD	_	4	ccomp	_	_
8	the	_	DT	DT	_	9	det	_	_
9	accumulation	_	NN	NN	_	7	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	14	det	_	_
12	47-kD	_	JJ	JJ	_	14	amod	_	_
13	mature	_	JJ	JJ	_	14	amod	_	_
14	glycoprotein	_	NN	NN	_	10	pobj	_	_
15	in	_	IN	IN	_	9	prep	_	_
16	LPS-treated	_	JJ	JJ	_	17	amod	_	_
17	cells	_	NNS	NNS	_	15	pobj	_	_
18	,	_	,	,	_	4	punct	_	_
19	a	_	DT	DT	_	20	det	_	_
20	finding	_	NN	NN	_	4	dep	_	_
21	consistent	_	JJ	JJ	_	20	amod	_	_
22	with	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	24	det	_	_
24	results	_	NNS	NNS	_	22	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	28	det	_	_
27	immunofluorescence	_	NN	NN	_	28	nn	_	_
28	studies	_	NNS	NNS	_	25	pobj	_	_
29	.	_	.	.	_	4	punct	_	_

1	Furthermore	_	RB	RB	_	7	advmod	_	_
2	,	_	,	,	_	7	punct	_	_
3	these	_	DT	DT	_	4	det	_	_
4	conditions	_	NNS	NNS	_	7	nsubj	_	_
5	did	_	VBD	VBD	_	7	aux	_	_
6	not	_	RB	RB	_	7	neg	_	_
7	result	_	VB	VB	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	an	_	DT	DT	_	10	det	_	_
10	accumulation	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	15	det	_	_
13	less	_	RBR	RBR	_	14	advmod	_	_
14	mature	_	JJ	JJ	_	15	amod	_	_
15	forms	_	NNS	NNS	_	11	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	TF	_	NN	NN	_	16	pobj	_	_
18	.	_	.	.	_	7	punct	_	_

1	When	_	WRB	WRB	_	2	advmod	_	_
2	considered	_	VBN	VBN	_	7	advcl	_	_
3	together	_	RB	RB	_	2	advmod	_	_
4	,	_	,	,	_	7	punct	_	_
5	these	_	DT	DT	_	6	det	_	_
6	data	_	NNS	NNS	_	7	nsubj	_	_
7	suggest	_	VBP	VBP	_	0	root	_	_
8	that	_	IN	IN	_	10	mark	_	_
9	antioxidants	_	NNS	NNS	_	10	nsubj	_	_
10	exert	_	VBP	VBP	_	7	ccomp	_	_
11	their	_	PRP$	PRP$	_	12	poss	_	_
12	effects	_	NNS	NNS	_	10	dobj	_	_
13	by	_	IN	IN	_	10	prep	_	_
14	impairing	_	VBG	VBG	_	13	pcomp	_	_
15	translation	_	NN	NN	_	14	dobj	_	_
16	and/or	_	CC	CC	_	13	cc	_	_
17	by	_	IN	IN	_	13	conj	_	_
18	causing	_	VBG	VBG	_	17	pcomp	_	_
19	degradation	_	NN	NN	_	18	dobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	newly	_	RB	RB	_	23	advmod	_	_
22	translated	_	VBN	VBN	_	23	amod	_	_
23	protein	_	NN	NN	_	20	pobj	_	_
24	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	effect	_	NN	NN	_	9	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	antioxidants	_	NNS	NNS	_	3	pobj	_	_
5	on	_	IN	IN	_	2	prep	_	_
6	tumor	_	NN	NN	_	8	nn	_	_
7	necrosis	_	NN	NN	_	8	nn	_	_
8	factor	_	NN	NN	_	5	pobj	_	_
9	appeared	_	VBD	VBD	_	0	root	_	_
10	to	_	TO	TO	_	13	aux	_	_
11	be	_	VB	VB	_	13	cop	_	_
12	species	_	NNS	NNS	_	13	dep	_	_
13	specific	_	JJ	JJ	_	9	xcomp	_	_
14	,	_	,	,	_	13	punct	_	_
15	with	_	IN	IN	_	13	prep	_	_
16	no	_	DT	DT	_	17	neg	_	_
17	effect	_	NN	NN	_	15	pobj	_	_
18	on	_	IN	IN	_	17	prep	_	_
19	LPS-induced	_	JJ	JJ	_	22	amod	_	_
20	tumor	_	NN	NN	_	22	nn	_	_
21	necrosis	_	NN	NN	_	22	nn	_	_
22	factor	_	NN	NN	_	18	pobj	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	murine	_	NN	NN	_	25	nn	_	_
25	cells	_	NNS	NNS	_	23	pobj	_	_
26	,	_	,	,	_	15	punct	_	_
27	but	_	CC	CC	_	15	cc	_	_
28	with	_	IN	IN	_	15	conj	_	_
29	inhibition	_	NN	NN	_	28	pobj	_	_
30	in	_	IN	IN	_	29	prep	_	_
31	human	_	JJ	JJ	_	32	amod	_	_
32	monocytes	_	NNS	NNS	_	30	pobj	_	_
33	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	posttranscriptional	_	JJ	JJ	_	3	amod	_	_
3	effect	_	NN	NN	_	10	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	antioxidants	_	NNS	NNS	_	4	pobj	_	_
6	on	_	IN	IN	_	3	prep	_	_
7	TF	_	NN	NN	_	9	nn	_	_
8	expression	_	NN	NN	_	9	nn	_	_
9	data	_	NNS	NNS	_	6	pobj	_	_
10	suggests	_	VBZ	VBZ	_	0	root	_	_
11	a	_	DT	DT	_	13	det	_	_
12	novel	_	JJ	JJ	_	13	amod	_	_
13	mechanism	_	NN	NN	_	10	dobj	_	_
14	whereby	_	WRB	WRB	_	18	advmod	_	_
15	these	_	DT	DT	_	16	det	_	_
16	agents	_	NNS	NNS	_	18	nsubj	_	_
17	might	_	MD	MD	_	18	aux	_	_
18	modulate	_	VB	VB	_	13	rcmod	_	_
19	monocyte/macrophage	_	NN	NN	_	20	nn	_	_
20	activation	_	NN	NN	_	18	dobj	_	_
21	.	_	.	.	_	10	punct	_	_

1	1,25-Dihydroxyvitamin	_	NN	NN	_	3	nn	_	_
2	D3	_	NN	NN	_	3	nn	_	_
3	receptors	_	NNS	NNS	_	0	root	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	peripheral	_	JJ	JJ	_	8	amod	_	_
6	blood	_	NN	NN	_	8	nn	_	_
7	mononuclear	_	JJ	JJ	_	8	amod	_	_
8	cells	_	NNS	NNS	_	4	pobj	_	_
9	from	_	IN	IN	_	8	prep	_	_
10	patients	_	NNS	NNS	_	9	pobj	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	primary	_	JJ	JJ	_	11	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	secondary	_	JJ	JJ	_	12	conj	_	_
15	hyperparathyroidism	_	NN	NN	_	12	dep	_	_
16	.	_	.	.	_	3	punct	_	_

1	A	_	DT	DT	_	3	det	_	_
2	decreased	_	VBN	VBN	_	3	amod	_	_
3	number	_	NN	NN	_	12	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	calcitriol	_	NN	NN	_	9	nn	_	_
6	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
7	1,25-LRB-OH-RRB-2D3	_	NN	NN	_	9	nn	_	_
8	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
9	receptors	_	NNS	NNS	_	4	pobj	_	_
10	has	_	VBZ	VBZ	_	12	aux	_	_
11	been	_	VBN	VBN	_	12	auxpass	_	_
12	observed	_	VBN	VBN	_	0	root	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	parathyroid	_	JJ	JJ	_	15	amod	_	_
15	glands	_	NNS	NNS	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	uremic	_	JJ	JJ	_	18	amod	_	_
18	animals	_	NNS	NNS	_	16	pobj	_	_
19	.	_	.	.	_	12	punct	_	_

1	In	_	IN	IN	_	13	prep	_	_
2	humans	_	NNS	NNS	_	1	pobj	_	_
3	,	_	,	,	_	13	punct	_	_
4	studies	_	NNS	NNS	_	13	nsubj	_	_
5	carried	_	VBN	VBN	_	4	vmod	_	_
6	out	_	RP	RP	_	5	prt	_	_
7	in	_	IN	IN	_	5	prep	_	_
8	surgically	_	RB	RB	_	9	advmod	_	_
9	removed	_	VBN	VBN	_	11	amod	_	_
10	parathyroid	_	JJ	JJ	_	11	amod	_	_
11	glands	_	NNS	NNS	_	7	pobj	_	_
12	have	_	VBP	VBP	_	13	aux	_	_
13	shown	_	VBN	VBN	_	0	root	_	_
14	that	_	IN	IN	_	18	mark	_	_
15	calcitriol	_	NN	NN	_	16	nn	_	_
16	binding	_	NN	NN	_	18	nsubj	_	_
17	is	_	VBZ	VBZ	_	18	cop	_	_
18	higher	_	JJR	JJR	_	13	ccomp	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	primary	_	JJ	JJ	_	19	pobj	_	_
21	than	_	IN	IN	_	18	prep	_	_
22	in	_	IN	IN	_	21	pcomp	_	_
23	secondary	_	JJ	JJ	_	24	amod	_	_
24	hyperparathyroidism	_	NN	NN	_	22	pobj	_	_
25	.	_	.	.	_	13	punct	_	_

1	Since	_	IN	IN	_	8	mark	_	_
2	specific	_	JJ	JJ	_	3	amod	_	_
3	receptors	_	NNS	NNS	_	8	nsubjpass	_	_
4	for	_	IN	IN	_	3	prep	_	_
5	calcitriol	_	NN	NN	_	4	pobj	_	_
6	have	_	VBP	VBP	_	8	aux	_	_
7	been	_	VBN	VBN	_	8	auxpass	_	_
8	described	_	VBN	VBN	_	20	advcl	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	peripheral	_	JJ	JJ	_	13	amod	_	_
11	blood	_	NN	NN	_	13	nn	_	_
12	mononuclear	_	JJ	JJ	_	13	amod	_	_
13	cells	_	NNS	NNS	_	9	pobj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	PBMC	_	NN	NN	_	13	appos	_	_
16	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
17	,	_	,	,	_	20	punct	_	_
18	we	_	PRP	PRP	_	20	nsubj	_	_
19	have	_	VBP	VBP	_	20	aux	_	_
20	investigated	_	VBN	VBN	_	0	root	_	_
21	the	_	DT	DT	_	23	det	_	_
22	specific	_	JJ	JJ	_	23	amod	_	_
23	uptake	_	NN	NN	_	20	dobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	3H-labelled	_	JJ	JJ	_	26	amod	_	_
26	1,25-LRB-OH-RRB-2D3	_	NN	NN	_	24	pobj	_	_
27	in	_	IN	IN	_	23	prep	_	_
28	PBMC	_	NN	NN	_	27	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	12	_	CD	CD	_	31	num	_	_
31	women	_	NNS	NNS	_	29	pobj	_	_
32	with	_	IN	IN	_	31	prep	_	_
33	primary	_	JJ	JJ	_	34	amod	_	_
34	hyperparathyroidism	_	NN	NN	_	32	pobj	_	_
35	-LRB-	_	-LRB-	-LRB-	_	36	punct	_	_
36	PHP	_	NN	NN	_	34	appos	_	_
37	-RRB-	_	-RRB-	-RRB-	_	36	punct	_	_
38	,	_	,	,	_	31	punct	_	_
39	8	_	CD	CD	_	40	num	_	_
40	women	_	NNS	NNS	_	31	conj	_	_
41	with	_	IN	IN	_	40	prep	_	_
42	hyperparathyroidism	_	NN	NN	_	41	pobj	_	_
43	secondary	_	JJ	JJ	_	42	amod	_	_
44	to	_	TO	TO	_	43	prep	_	_
45	chronic	_	JJ	JJ	_	46	amod	_	_
46	renal	_	JJ	JJ	_	47	amod	_	_
47	failure	_	NN	NN	_	44	pobj	_	_
48	-LRB-	_	-LRB-	-LRB-	_	49	punct	_	_
49	SH	_	NN	NN	_	42	appos	_	_
50	-RRB-	_	-RRB-	-RRB-	_	49	punct	_	_
51	,	_	,	,	_	31	punct	_	_
52	9	_	CD	CD	_	53	num	_	_
53	women	_	NNS	NNS	_	31	conj	_	_
54	with	_	IN	IN	_	53	prep	_	_
55	renal	_	JJ	JJ	_	56	amod	_	_
56	transplant	_	NN	NN	_	54	pobj	_	_
57	-LRB-	_	-LRB-	-LRB-	_	58	punct	_	_
58	RT	_	NN	NN	_	56	appos	_	_
59	-RRB-	_	-RRB-	-RRB-	_	58	punct	_	_
60	,	_	,	,	_	31	punct	_	_
61	and	_	CC	CC	_	31	cc	_	_
62	23	_	CD	CD	_	64	num	_	_
63	healthy	_	JJ	JJ	_	64	amod	_	_
64	women	_	NNS	NNS	_	31	conj	_	_
65	.	_	.	.	_	20	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	median	_	JJ	JJ	_	4	amod	_	_
3	dissociation	_	NN	NN	_	4	nn	_	_
4	constant	_	NN	NN	_	9	nsubj	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	Kd	_	NN	NN	_	4	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	was	_	VBD	VBD	_	9	cop	_	_
9	similar	_	JJ	JJ	_	0	root	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	all	_	DT	DT	_	13	det	_	_
12	three	_	CD	CD	_	13	num	_	_
13	groups	_	NNS	NNS	_	10	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	patients	_	NNS	NNS	_	14	pobj	_	_
16	and	_	CC	CC	_	10	cc	_	_
17	in	_	IN	IN	_	10	conj	_	_
18	healthy	_	JJ	JJ	_	19	amod	_	_
19	women	_	NNS	NNS	_	17	pobj	_	_
20	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	mean	_	NN	NN	_	9	dep	_	_
22	+/-	_	CC	CC	_	21	cc	_	_
23	S.D.	_	NN	NN	_	21	conj	_	_
24	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
25	range	_	NN	NN	_	21	appos	_	_
26	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
27	:	_	:	:	_	21	punct	_	_
28	PHP	_	NN	NN	_	21	dep	_	_
29	,	_	,	,	_	28	punct	_	_
30	1.2	_	CD	CD	_	28	appos	_	_
31	+/-	_	CC	CC	_	30	cc	_	_
32	1.0	_	CD	CD	_	30	conj	_	_
33	-LRB-	_	-LRB-	-LRB-	_	34	punct	_	_
34	0.2-4	_	CD	CD	_	30	appos	_	_
35	-RRB-	_	-RRB-	-RRB-	_	34	punct	_	_
36	x	_	CC	CC	_	30	cc	_	_
37	10-LRB--10-RRB-	_	CD	CD	_	38	num	_	_
38	M	_	NN	NN	_	30	conj	_	_
39	;	_	:	:	_	28	punct	_	_
40	SH	_	NN	NN	_	28	dep	_	_
41	,	_	,	,	_	40	punct	_	_
42	0.6	_	CD	CD	_	40	appos	_	_
43	+/-	_	CC	CC	_	42	cc	_	_
44	0.4	_	CD	CD	_	42	conj	_	_
45	-LRB-	_	-LRB-	-LRB-	_	46	punct	_	_
46	0.2-1.2	_	CD	CD	_	42	appos	_	_
47	-RRB-	_	-RRB-	-RRB-	_	46	punct	_	_
48	x	_	CC	CC	_	42	cc	_	_
49	10-LRB--10-RRB-	_	CD	CD	_	50	num	_	_
50	M	_	NN	NN	_	42	conj	_	_
51	;	_	:	:	_	28	punct	_	_
52	RT	_	NN	NN	_	28	dep	_	_
53	,	_	,	,	_	52	punct	_	_
54	1.1	_	CD	CD	_	52	appos	_	_
55	+/-	_	CC	CC	_	54	cc	_	_
56	0.5	_	CD	CD	_	54	conj	_	_
57	-LRB-	_	-LRB-	-LRB-	_	58	punct	_	_
58	0.4-1.9	_	CD	CD	_	54	appos	_	_
59	-RRB-	_	-RRB-	-RRB-	_	58	punct	_	_
60	x	_	CC	CC	_	54	cc	_	_
61	10-LRB--10-RRB-	_	CD	CD	_	62	num	_	_
62	M	_	NN	NN	_	54	conj	_	_
63	;	_	:	:	_	21	punct	_	_
64	controls	_	NNS	NNS	_	21	dep	_	_
65	,	_	,	,	_	64	punct	_	_
66	1.0	_	CD	CD	_	64	appos	_	_
67	+/-	_	CC	CC	_	66	cc	_	_
68	0.6	_	CD	CD	_	66	conj	_	_
69	-LRB-	_	-LRB-	-LRB-	_	70	punct	_	_
70	0.3-2.6	_	CD	CD	_	66	appos	_	_
71	-RRB-	_	-RRB-	-RRB-	_	70	punct	_	_
72	x	_	CC	CC	_	66	cc	_	_
73	10-LRB--10-RRB-	_	CD	CD	_	74	num	_	_
74	M	_	NN	NN	_	66	conj	_	_
75	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
76	.	_	.	.	_	9	punct	_	_

1	However	_	RB	RB	_	12	advmod	_	_
2	,	_	,	,	_	12	punct	_	_
3	the	_	DT	DT	_	6	det	_	_
4	maximal	_	JJ	JJ	_	6	amod	_	_
5	binding	_	NN	NN	_	6	nn	_	_
6	capacity	_	NN	NN	_	12	nsubjpass	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	Nmax	_	NN	NN	_	6	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	was	_	VBD	VBD	_	12	auxpass	_	_
11	significantly	_	RB	RB	_	12	advmod	_	_
12	enhanced	_	VBN	VBN	_	0	root	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	PHP	_	NN	NN	_	13	pobj	_	_
15	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
16	3.9	_	CD	CD	_	23	nn	_	_
17	+/-	_	CC	CC	_	16	cc	_	_
18	1.9	_	CD	CD	_	16	conj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	1.3-7.6	_	CD	CD	_	16	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	fmol/10-LRB-7-RRB-	_	NN	NN	_	23	nn	_	_
23	cells	_	NNS	NNS	_	12	dep	_	_
24	vs.	_	CC	CC	_	23	cc	_	_
25	2.3	_	CD	CD	_	32	nn	_	_
26	+/-	_	CC	CC	_	25	cc	_	_
27	0.9	_	CD	CD	_	25	conj	_	_
28	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
29	1.1-4.4	_	CD	CD	_	25	appos	_	_
30	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
31	fmol/10-LRB-7-RRB-	_	NN	NN	_	32	nn	_	_
32	cells	_	NNS	NNS	_	23	conj	_	_
33	in	_	IN	IN	_	23	prep	_	_
34	controls	_	NNS	NNS	_	33	pobj	_	_
35	;	_	:	:	_	23	punct	_	_
36	P	_	NN	NN	_	23	dep	_	_
37	=	_	JJ	JJ	_	36	amod	_	_
38	0.0006	_	CD	CD	_	37	dep	_	_
39	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
40	and	_	CC	CC	_	12	cc	_	_
41	decreased	_	VBN	VBN	_	12	conj	_	_
42	in	_	IN	IN	_	41	prep	_	_
43	SH	_	NN	NN	_	42	pobj	_	_
44	-LRB-	_	-LRB-	-LRB-	_	52	punct	_	_
45	0.8	_	CD	CD	_	52	nn	_	_
46	+/-	_	CC	CC	_	45	cc	_	_
47	0.5	_	CD	CD	_	45	conj	_	_
48	-LRB-	_	-LRB-	-LRB-	_	49	punct	_	_
49	0.2-1.6	_	CD	CD	_	45	appos	_	_
50	-RRB-	_	-RRB-	-RRB-	_	49	punct	_	_
51	fmol/10-LRB-7-RRB-	_	NN	NN	_	52	nn	_	_
52	cells	_	NNS	NNS	_	41	dep	_	_
53	vs.	_	CC	CC	_	52	cc	_	_
54	2.3	_	CD	CD	_	61	nn	_	_
55	+/-	_	CC	CC	_	54	cc	_	_
56	0.9	_	CD	CD	_	54	conj	_	_
57	-LRB-	_	-LRB-	-LRB-	_	58	punct	_	_
58	1.1-4.4	_	CD	CD	_	54	appos	_	_
59	-RRB-	_	-RRB-	-RRB-	_	58	punct	_	_
60	fmol/10-LRB-7-RRB-	_	NN	NN	_	61	nn	_	_
61	cells	_	NNS	NNS	_	52	conj	_	_
62	in	_	IN	IN	_	52	prep	_	_
63	controls	_	NNS	NNS	_	62	pobj	_	_
64	;	_	:	:	_	52	punct	_	_
65	P	_	NN	NN	_	52	dep	_	_
66	=	_	JJ	JJ	_	65	amod	_	_
67	0.0001	_	CD	CD	_	66	dep	_	_
68	-RRB-	_	-RRB-	-RRB-	_	52	punct	_	_
69	,	_	,	,	_	12	punct	_	_
70	whereas	_	IN	IN	_	74	mark	_	_
71	no	_	DT	DT	_	72	neg	_	_
72	changes	_	NNS	NNS	_	74	nsubjpass	_	_
73	were	_	VBD	VBD	_	74	auxpass	_	_
74	seen	_	VBN	VBN	_	12	advcl	_	_
75	in	_	IN	IN	_	74	prep	_	_
76	RT	_	NN	NN	_	75	pobj	_	_
77	-LRB-	_	-LRB-	-LRB-	_	85	punct	_	_
78	2.3	_	CD	CD	_	85	nn	_	_
79	+/-	_	CC	CC	_	78	cc	_	_
80	0.7	_	CD	CD	_	78	conj	_	_
81	-LRB-	_	-LRB-	-LRB-	_	82	punct	_	_
82	1.2-3.3	_	CD	CD	_	78	appos	_	_
83	-RRB-	_	-RRB-	-RRB-	_	82	punct	_	_
84	fmol/10-LRB-7-RRB-	_	NN	NN	_	85	nn	_	_
85	cells	_	NNS	NNS	_	76	dep	_	_
86	vs.	_	CC	CC	_	85	cc	_	_
87	2.3	_	CD	CD	_	94	nn	_	_
88	+/-	_	CC	CC	_	87	cc	_	_
89	0.9	_	CD	CD	_	87	conj	_	_
90	-LRB-	_	-LRB-	-LRB-	_	91	punct	_	_
91	1.1-4.4	_	CD	CD	_	87	appos	_	_
92	-RRB-	_	-RRB-	-RRB-	_	91	punct	_	_
93	fmol/10-LRB-7-RRB-	_	NN	NN	_	94	nn	_	_
94	cells	_	NNS	NNS	_	85	conj	_	_
95	in	_	IN	IN	_	85	prep	_	_
96	controls	_	NNS	NNS	_	95	pobj	_	_
97	-RRB-	_	-RRB-	-RRB-	_	85	punct	_	_
98	.	_	.	.	_	12	punct	_	_

1	In	_	IN	IN	_	15	prep	_	_
2	three	_	CD	CD	_	3	num	_	_
3	patients	_	NNS	NNS	_	1	pobj	_	_
4	with	_	IN	IN	_	3	prep	_	_
5	PHP	_	NN	NN	_	4	pobj	_	_
6	who	_	WP	WP	_	8	nsubjpass	_	_
7	were	_	VBD	VBD	_	8	auxpass	_	_
8	subjected	_	VBN	VBN	_	3	rcmod	_	_
9	to	_	TO	TO	_	8	prep	_	_
10	parathyroidectomy	_	NN	NN	_	9	pobj	_	_
11	,	_	,	,	_	15	punct	_	_
12	the	_	DT	DT	_	14	det	_	_
13	calcitriol	_	NN	NN	_	14	nn	_	_
14	number	_	NN	NN	_	15	nsubj	_	_
15	came	_	VBD	VBD	_	0	root	_	_
16	down	_	RB	RB	_	15	prt	_	_
17	to	_	TO	TO	_	15	prep	_	_
18	normal	_	JJ	JJ	_	17	pobj	_	_
19	.	_	.	.	_	15	punct	_	_

1	Changes	_	NNS	NNS	_	11	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	calcitriol	_	NN	NN	_	4	nn	_	_
4	receptors	_	NNS	NNS	_	2	pobj	_	_
5	in	_	IN	IN	_	1	prep	_	_
6	primary	_	JJ	JJ	_	5	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	secondary	_	JJ	JJ	_	6	conj	_	_
9	hyperparathyroidism	_	NN	NN	_	6	dep	_	_
10	could	_	MD	MD	_	11	aux	_	_
11	magnify	_	VB	VB	_	0	root	_	_
12	the	_	DT	DT	_	13	det	_	_
13	consequences	_	NNS	NNS	_	11	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	disturbances	_	NNS	NNS	_	14	pobj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	serum	_	NN	NN	_	18	nn	_	_
18	concentration	_	NN	NN	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	calcitriol	_	NN	NN	_	19	pobj	_	_
21	itself	_	PRP	PRP	_	20	npadvmod	_	_
22	and	_	CC	CC	_	11	cc	_	_
23	might	_	MD	MD	_	24	aux	_	_
24	play	_	VB	VB	_	11	conj	_	_
25	an	_	DT	DT	_	27	det	_	_
26	important	_	JJ	JJ	_	27	amod	_	_
27	role	_	NN	NN	_	24	dobj	_	_
28	in	_	IN	IN	_	24	prep	_	_
29	the	_	DT	DT	_	30	det	_	_
30	development	_	NN	NN	_	28	pobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	secondary	_	JJ	JJ	_	33	amod	_	_
33	hyperparathyroidism	_	NN	NN	_	31	pobj	_	_
34	in	_	IN	IN	_	33	prep	_	_
35	uremia	_	NN	NN	_	34	pobj	_	_
36	.	_	.	.	_	11	punct	_	_

1	Effects	_	NNS	NNS	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	6	det	_	_
4	antisense	_	JJ	JJ	_	6	amod	_	_
5	myb	_	NN	NN	_	6	nn	_	_
6	expression	_	NN	NN	_	2	pobj	_	_
7	on	_	IN	IN	_	1	prep	_	_
8	hemin-	_	NN	NN	_	7	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	erythropoietin-induced	_	JJ	JJ	_	12	amod	_	_
11	erythroid	_	JJ	JJ	_	12	amod	_	_
12	differentiation	_	NN	NN	_	8	conj	_	_
13	of	_	IN	IN	_	8	prep	_	_
14	K562	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	.	_	.	.	_	1	punct	_	_

1	In	_	IN	IN	_	4	mark	_	_
2	order	_	NN	NN	_	4	dep	_	_
3	to	_	TO	TO	_	4	aux	_	_
4	elucidate	_	VB	VB	_	29	dep	_	_
5	the	_	DT	DT	_	6	det	_	_
6	role	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	c-myb	_	NN	NN	_	9	nn	_	_
9	gene	_	NN	NN	_	7	pobj	_	_
10	in	_	IN	IN	_	6	prep	_	_
11	erythroid	_	JJ	JJ	_	12	amod	_	_
12	differentiation	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	K562	_	NN	NN	_	15	nn	_	_
15	cell	_	NN	NN	_	13	pobj	_	_
16	induced	_	VBN	VBN	_	12	vmod	_	_
17	by	_	IN	IN	_	16	prep	_	_
18	hemin	_	NN	NN	_	17	pobj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	Hm	_	NN	NN	_	18	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	and	_	CC	CC	_	18	cc	_	_
23	erythropoietin	_	NN	NN	_	18	conj	_	_
24	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
25	Epo	_	NN	NN	_	23	appos	_	_
26	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
27	,	_	,	,	_	29	punct	_	_
28	we	_	PRP	PRP	_	29	nsubj	_	_
29	constructed	_	VBD	VBD	_	0	root	_	_
30	recombinant	_	JJ	JJ	_	31	amod	_	_
31	plasmid	_	NN	NN	_	29	dobj	_	_
32	that	_	WDT	WDT	_	34	nsubj	_	_
33	could	_	MD	MD	_	34	aux	_	_
34	produce	_	VB	VB	_	31	rcmod	_	_
35	antisense	_	JJ	JJ	_	37	amod	_	_
36	myb	_	NN	NN	_	37	nn	_	_
37	RNA	_	NN	NN	_	34	dobj	_	_
38	after	_	IN	IN	_	34	prep	_	_
39	induction	_	NN	NN	_	38	pobj	_	_
40	with	_	IN	IN	_	39	prep	_	_
41	dexamethasone	_	NN	NN	_	40	pobj	_	_
42	.	_	.	.	_	29	punct	_	_

1	During	_	IN	IN	_	9	prep	_	_
2	treatment	_	NN	NN	_	1	pobj	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	Hm	_	NN	NN	_	3	pobj	_	_
5	,	_	,	,	_	9	punct	_	_
6	K562	_	NN	NN	_	7	nn	_	_
7	cells	_	NNS	NNS	_	9	nsubj	_	_
8	constitutively	_	RB	RB	_	9	advmod	_	_
9	expressed	_	VBD	VBD	_	0	root	_	_
10	c-myb	_	NN	NN	_	11	nn	_	_
11	mRNA	_	NN	NN	_	9	dobj	_	_
12	,	_	,	,	_	9	punct	_	_
13	and	_	CC	CC	_	9	cc	_	_
14	50	_	CD	CD	_	15	num	_	_
15	%	_	NN	NN	_	18	nsubj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	them	_	PRP	PRP	_	16	pobj	_	_
18	began	_	VBD	VBD	_	9	conj	_	_
19	to	_	TO	TO	_	20	aux	_	_
20	synthesize	_	VB	VB	_	18	xcomp	_	_
21	hemoglobin	_	NN	NN	_	20	dobj	_	_
22	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
23	Hb	_	NN	NN	_	21	appos	_	_
24	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
25	.	_	.	.	_	9	punct	_	_

1	Expression	_	NN	NN	_	6	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	antisense	_	JJ	JJ	_	5	amod	_	_
4	myb	_	NN	NN	_	5	nn	_	_
5	RNA	_	NN	NN	_	2	pobj	_	_
6	reduced	_	VBD	VBD	_	0	root	_	_
7	the	_	DT	DT	_	8	det	_	_
8	amount	_	NN	NN	_	6	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	c-myb	_	NN	NN	_	11	nn	_	_
11	mRNA	_	NN	NN	_	9	pobj	_	_
12	,	_	,	,	_	6	punct	_	_
13	and	_	CC	CC	_	6	cc	_	_
14	the	_	DT	DT	_	15	det	_	_
15	percentage	_	NN	NN	_	20	nsubjpass	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	Hb-synthesizing	_	JJ	JJ	_	18	amod	_	_
18	cells	_	NNS	NNS	_	16	pobj	_	_
19	was	_	VBD	VBD	_	20	auxpass	_	_
20	decreased	_	VBN	VBN	_	6	conj	_	_
21	to	_	TO	TO	_	20	prep	_	_
22	20	_	CD	CD	_	23	num	_	_
23	%	_	NN	NN	_	21	pobj	_	_
24	.	_	.	.	_	6	punct	_	_

1	In	_	IN	IN	_	9	prep	_	_
2	the	_	DT	DT	_	3	det	_	_
3	presence	_	NN	NN	_	1	pobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	Epo	_	NN	NN	_	4	pobj	_	_
6	,	_	,	,	_	9	punct	_	_
7	c-myb	_	NN	NN	_	8	nn	_	_
8	mRNA	_	NN	NN	_	9	nsubj	_	_
9	declined	_	VBD	VBD	_	0	root	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	20	_	CD	CD	_	12	num	_	_
12	%	_	NN	NN	_	16	nsubj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	K562	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	synthesized	_	VBD	VBD	_	9	conj	_	_
17	Hb	_	NN	NN	_	16	dobj	_	_
18	regardless	_	JJ	JJ	_	16	advmod	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	antisense	_	JJ	JJ	_	22	amod	_	_
21	myb	_	NN	NN	_	22	nn	_	_
22	RNA	_	NN	NN	_	23	nn	_	_
23	expression	_	NN	NN	_	19	pobj	_	_
24	.	_	.	.	_	9	punct	_	_

1	It	_	PRP	PRP	_	3	nsubjpass	_	_
2	is	_	VBZ	VBZ	_	3	auxpass	_	_
3	suggested	_	VBN	VBN	_	0	root	_	_
4	that	_	IN	IN	_	11	mark	_	_
5	constitutive	_	JJ	JJ	_	6	amod	_	_
6	expression	_	NN	NN	_	11	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	c-myb	_	NN	NN	_	9	nn	_	_
9	mRNA	_	NN	NN	_	7	pobj	_	_
10	is	_	VBZ	VBZ	_	11	cop	_	_
11	necessary	_	JJ	JJ	_	3	ccomp	_	_
12	for	_	IN	IN	_	11	prep	_	_
13	Hm-induced	_	JJ	JJ	_	12	dep	_	_
14	differentiation	_	NN	NN	_	12	dep	_	_
15	,	_	,	,	_	11	punct	_	_
16	and	_	CC	CC	_	11	cc	_	_
17	that	_	IN	IN	_	32	mark	_	_
18	a	_	DT	DT	_	19	det	_	_
19	decrease	_	NN	NN	_	32	nsubj	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	22	det	_	_
22	amount	_	NN	NN	_	20	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	c-myb	_	NN	NN	_	25	nn	_	_
25	mRNA	_	NN	NN	_	23	pobj	_	_
26	induced	_	VBN	VBN	_	25	vmod	_	_
27	by	_	IN	IN	_	26	prep	_	_
28	antisense	_	JJ	JJ	_	30	amod	_	_
29	myb	_	NN	NN	_	30	nn	_	_
30	RNA	_	NN	NN	_	31	nn	_	_
31	expression	_	NN	NN	_	27	pobj	_	_
32	suppresses	_	VBZ	VBZ	_	11	conj	_	_
33	Hm-induced	_	JJ	JJ	_	34	amod	_	_
34	differentiation	_	NN	NN	_	32	dobj	_	_
35	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	amount	_	NN	NN	_	10	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	c-myb	_	NN	NN	_	5	nn	_	_
5	mRNA	_	NN	NN	_	3	pobj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	K562	_	NN	NN	_	8	nn	_	_
8	cells	_	NNS	NNS	_	6	pobj	_	_
9	was	_	VBD	VBD	_	10	auxpass	_	_
10	reduced	_	VBN	VBN	_	0	root	_	_
11	during	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	differentiation	_	NN	NN	_	11	pobj	_	_
14	induced	_	VBN	VBN	_	13	vmod	_	_
15	by	_	IN	IN	_	14	prep	_	_
16	Epo	_	NN	NN	_	15	pobj	_	_
17	.	_	.	.	_	10	punct	_	_

1	Expression	_	NN	NN	_	7	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	GATA-1	_	NN	NN	_	4	nn	_	_
4	mRNA	_	NN	NN	_	2	pobj	_	_
5	was	_	VBD	VBD	_	7	cop	_	_
6	almost	_	RB	RB	_	7	advmod	_	_
7	constant	_	JJ	JJ	_	0	root	_	_
8	during	_	IN	IN	_	7	prep	_	_
9	Hm-induced	_	JJ	JJ	_	10	amod	_	_
10	differentiation	_	NN	NN	_	8	pobj	_	_
11	,	_	,	,	_	7	punct	_	_
12	but	_	CC	CC	_	7	cc	_	_
13	increased	_	VBD	VBD	_	7	conj	_	_
14	during	_	IN	IN	_	13	prep	_	_
15	Epo	_	NN	NN	_	16	nn	_	_
16	treatment	_	NN	NN	_	14	pobj	_	_
17	.	_	.	.	_	7	punct	_	_

1	It	_	PRP	PRP	_	3	nsubjpass	_	_
2	is	_	VBZ	VBZ	_	3	auxpass	_	_
3	supposed	_	VBN	VBN	_	0	root	_	_
4	that	_	IN	IN	_	11	mark	_	_
5	the	_	DT	DT	_	6	det	_	_
6	mechanism	_	NN	NN	_	11	nsubjpass	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	Hm-induced	_	JJ	JJ	_	9	amod	_	_
9	differentiation	_	NN	NN	_	7	pobj	_	_
10	is	_	VBZ	VBZ	_	11	auxpass	_	_
11	distinguished	_	VBN	VBN	_	3	ccomp	_	_
12	from	_	IN	IN	_	11	prep	_	_
13	that	_	DT	DT	_	12	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	Epo-induced	_	JJ	JJ	_	16	amod	_	_
16	differentiation	_	NN	NN	_	14	pobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	K562	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	17	pobj	_	_
20	.	_	.	.	_	3	punct	_	_

1	Regulation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	I	_	NN	NN	_	6	nn	_	_
4	kappa	_	NN	NN	_	6	nn	_	_
5	B	_	NN	NN	_	6	nn	_	_
6	alpha	_	NN	NN	_	2	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	p105	_	NN	NN	_	6	conj	_	_
9	in	_	IN	IN	_	6	prep	_	_
10	monocytes	_	NNS	NNS	_	9	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	macrophages	_	NNS	NNS	_	10	conj	_	_
13	persistently	_	RB	RB	_	14	advmod	_	_
14	infected	_	VBN	VBN	_	10	vmod	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	human	_	JJ	JJ	_	18	amod	_	_
17	immunodeficiency	_	NN	NN	_	18	nn	_	_
18	virus	_	NN	NN	_	15	pobj	_	_
19	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	mechanisms	_	NNS	NNS	_	16	nsubjpass	_	_
3	regulating	_	VBG	VBG	_	2	vmod	_	_
4	human	_	JJ	JJ	_	6	amod	_	_
5	immunodeficiency	_	NN	NN	_	6	nn	_	_
6	virus	_	NN	NN	_	10	nn	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	HIV	_	NN	NN	_	6	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	persistence	_	NN	NN	_	3	dobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	human	_	JJ	JJ	_	13	amod	_	_
13	monocytes/macrophages	_	NNS	NNS	_	11	pobj	_	_
14	are	_	VBP	VBP	_	16	auxpass	_	_
15	partially	_	RB	RB	_	16	advmod	_	_
16	understood	_	VBN	VBN	_	0	root	_	_
17	.	_	.	.	_	16	punct	_	_

1	Persistent	_	JJ	JJ	_	3	amod	_	_
2	HIV	_	NN	NN	_	3	nn	_	_
3	infection	_	NN	NN	_	8	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	U937	_	NN	NN	_	7	nn	_	_
6	monocytic	_	JJ	JJ	_	7	amod	_	_
7	cells	_	NNS	NNS	_	4	pobj	_	_
8	results	_	VBZ	VBZ	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	NF-kappa	_	NN	NN	_	11	nn	_	_
11	B	_	NN	NN	_	12	nn	_	_
12	activation	_	NN	NN	_	9	pobj	_	_
13	.	_	.	.	_	8	punct	_	_

1	Whether	_	IN	IN	_	8	mark	_	_
2	virus-induced	_	JJ	JJ	_	5	amod	_	_
3	NF-kappa	_	NN	NN	_	4	nn	_	_
4	B	_	NN	NN	_	5	nn	_	_
5	activation	_	NN	NN	_	8	nsubj	_	_
6	is	_	VBZ	VBZ	_	8	cop	_	_
7	a	_	DT	DT	_	8	det	_	_
8	mechanism	_	NN	NN	_	16	csubj	_	_
9	that	_	WDT	WDT	_	10	nsubj	_	_
10	favors	_	VBZ	VBZ	_	8	rcmod	_	_
11	continuous	_	JJ	JJ	_	13	amod	_	_
12	viral	_	JJ	JJ	_	13	amod	_	_
13	replication	_	NN	NN	_	10	dobj	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	macrophages	_	NNS	NNS	_	14	pobj	_	_
16	remains	_	VBZ	VBZ	_	0	root	_	_
17	unknown	_	JJ	JJ	_	16	acomp	_	_
18	.	_	.	.	_	16	punct	_	_

1	To	_	TO	TO	_	3	aux	_	_
2	further	_	RB	RB	_	3	advmod	_	_
3	delineate	_	VB	VB	_	0	root	_	_
4	the	_	DT	DT	_	6	det	_	_
5	molecular	_	JJ	JJ	_	6	amod	_	_
6	mechanisms	_	NNS	NNS	_	3	dobj	_	_
7	involved	_	VBN	VBN	_	6	vmod	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	activation	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	NF-kappa	_	NN	NN	_	13	nn	_	_
13	B	_	NN	NN	_	11	pobj	_	_
14	in	_	IN	IN	_	10	prep	_	_
15	HIV-infected	_	JJ	JJ	_	16	amod	_	_
16	monocytes	_	NNS	NNS	_	14	pobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	macrophages	_	NNS	NNS	_	16	conj	_	_
19	,	_	,	,	_	3	punct	_	_
20	we	_	PRP	PRP	_	22	nsubj	_	_
21	have	_	VBP	VBP	_	22	aux	_	_
22	focused	_	VBN	VBN	_	3	parataxis	_	_
23	on	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	25	det	_	_
25	regulation	_	NN	NN	_	23	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	31	det	_	_
28	I	_	NN	NN	_	31	nn	_	_
29	kappa	_	NN	NN	_	31	nn	_	_
30	B	_	NN	NN	_	31	nn	_	_
31	molecules	_	NNS	NNS	_	26	pobj	_	_
32	.	_	.	.	_	3	punct	_	_

1	First	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	show	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	9	mark	_	_
6	persistent	_	JJ	JJ	_	8	amod	_	_
7	HIV	_	NN	NN	_	8	nn	_	_
8	infection	_	NN	NN	_	9	nsubj	_	_
9	results	_	VBZ	VBZ	_	4	ccomp	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	activation	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	NF-kappa	_	NN	NN	_	15	nn	_	_
15	B	_	NN	NN	_	13	pobj	_	_
16	not	_	RB	RB	_	17	neg	_	_
17	only	_	RB	RB	_	18	preconj	_	_
18	in	_	IN	IN	_	12	prep	_	_
19	monocytic	_	JJ	JJ	_	20	amod	_	_
20	cells	_	NNS	NNS	_	18	pobj	_	_
21	but	_	CC	CC	_	22	cc	_	_
22	also	_	RB	RB	_	18	cc	_	_
23	in	_	IN	IN	_	18	conj	_	_
24	macrophages	_	NNS	NNS	_	23	pobj	_	_
25	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	12	prep	_	_
2	HIV-infected	_	JJ	JJ	_	3	amod	_	_
3	cells	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	12	punct	_	_
5	I	_	NN	NN	_	8	nn	_	_
6	kappa	_	NN	NN	_	8	nn	_	_
7	B	_	NN	NN	_	8	nn	_	_
8	alpha	_	NN	NN	_	10	nn	_	_
9	protein	_	NN	NN	_	10	nn	_	_
10	levels	_	NNS	NNS	_	12	nsubjpass	_	_
11	are	_	VBP	VBP	_	12	auxpass	_	_
12	decreased	_	VBN	VBN	_	0	root	_	_
13	secondary	_	JJ	JJ	_	12	acomp	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	enhanced	_	VBN	VBN	_	17	amod	_	_
16	protein	_	NN	NN	_	17	nn	_	_
17	degradation	_	NN	NN	_	14	pobj	_	_
18	.	_	.	.	_	12	punct	_	_

1	This	_	DT	DT	_	2	nsubj	_	_
2	parallels	_	VBZ	VBZ	_	0	root	_	_
3	the	_	DT	DT	_	9	det	_	_
4	increased	_	VBN	VBN	_	9	amod	_	_
5	I	_	NN	NN	_	8	nn	_	_
6	kappa	_	NN	NN	_	8	nn	_	_
7	B	_	NN	NN	_	8	nn	_	_
8	alpha	_	NN	NN	_	9	nn	_	_
9	synthesis	_	NN	NN	_	2	dobj	_	_
10	secondary	_	JJ	JJ	_	9	amod	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	increased	_	VBN	VBN	_	18	amod	_	_
13	I	_	NN	NN	_	16	nn	_	_
14	kappa	_	NN	NN	_	16	nn	_	_
15	B	_	NN	NN	_	16	nn	_	_
16	alpha	_	NN	NN	_	18	nn	_	_
17	gene	_	NN	NN	_	18	nn	_	_
18	transcription	_	NN	NN	_	11	pobj	_	_
19	,	_	,	,	_	18	punct	_	_
20	i.e.	_	FW	FW	_	18	prep	_	_
21	,	_	,	,	_	18	punct	_	_
22	increased	_	VBN	VBN	_	23	amod	_	_
23	RNA	_	NN	NN	_	18	appos	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	transcriptional	_	JJ	JJ	_	23	conj	_	_
26	activity	_	NN	NN	_	23	dep	_	_
27	of	_	IN	IN	_	23	prep	_	_
28	its	_	PRP$	PRP$	_	29	poss	_	_
29	promoter-enhancer	_	NN	NN	_	27	pobj	_	_
30	.	_	.	.	_	2	punct	_	_

1	Another	_	DT	DT	_	2	det	_	_
2	protein	_	NN	NN	_	13	nsubjpass	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	I	_	NN	NN	_	7	nn	_	_
5	kappa	_	NN	NN	_	7	nn	_	_
6	B	_	NN	NN	_	7	nn	_	_
7	function	_	NN	NN	_	3	pobj	_	_
8	,	_	,	,	_	2	punct	_	_
9	p105	_	NN	NN	_	2	appos	_	_
10	,	_	,	,	_	2	punct	_	_
11	is	_	VBZ	VBZ	_	13	auxpass	_	_
12	also	_	RB	RB	_	13	advmod	_	_
13	modified	_	VBN	VBN	_	0	root	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	HIV-infected	_	JJ	JJ	_	16	amod	_	_
16	cells	_	NNS	NNS	_	14	pobj	_	_
17	:	_	:	:	_	13	punct	_	_
18	p105	_	NN	NN	_	25	nsubjpass	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	p50	_	NN	NN	_	18	conj	_	_
21	steady-state	_	JJ	JJ	_	23	amod	_	_
22	protein	_	NN	NN	_	23	nn	_	_
23	levels	_	NNS	NNS	_	18	dep	_	_
24	are	_	VBP	VBP	_	25	auxpass	_	_
25	increased	_	VBN	VBN	_	13	parataxis	_	_
26	as	_	IN	IN	_	25	prep	_	_
27	a	_	DT	DT	_	28	det	_	_
28	result	_	NN	NN	_	26	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	increased	_	VBN	VBN	_	31	amod	_	_
31	synthesis	_	NN	NN	_	29	pobj	_	_
32	and	_	CC	CC	_	31	cc	_	_
33	proteolytic	_	JJ	JJ	_	34	amod	_	_
34	processing	_	NN	NN	_	31	conj	_	_
35	of	_	IN	IN	_	31	prep	_	_
36	p105	_	NN	NN	_	35	pobj	_	_
37	.	_	.	.	_	13	punct	_	_

1	Transcriptional	_	JJ	JJ	_	2	amod	_	_
2	activity	_	NN	NN	_	7	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	p105	_	NN	NN	_	3	pobj	_	_
5	is	_	VBZ	VBZ	_	7	auxpass	_	_
6	also	_	RB	RB	_	7	advmod	_	_
7	increased	_	VBN	VBN	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	infected	_	JJ	JJ	_	10	amod	_	_
10	cells	_	NNS	NNS	_	8	pobj	_	_
11	and	_	CC	CC	_	7	cc	_	_
12	is	_	VBZ	VBZ	_	14	auxpass	_	_
13	also	_	RB	RB	_	14	advmod	_	_
14	mediated	_	VBN	VBN	_	7	conj	_	_
15	by	_	IN	IN	_	14	prep	_	_
16	NF-kappa	_	NN	NN	_	17	nn	_	_
17	B	_	NN	NN	_	15	pobj	_	_
18	through	_	IN	IN	_	14	prep	_	_
19	a	_	DT	DT	_	23	det	_	_
20	specific	_	JJ	JJ	_	23	amod	_	_
21	kappa	_	NN	NN	_	23	nn	_	_
22	B	_	NN	NN	_	23	nn	_	_
23	motif	_	NN	NN	_	18	pobj	_	_
24	.	_	.	.	_	7	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	demonstrate	_	VBP	VBP	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	existence	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	a	_	DT	DT	_	10	det	_	_
8	triple	_	JJ	JJ	_	10	amod	_	_
9	autoregulatory	_	JJ	JJ	_	10	amod	_	_
10	loop	_	NN	NN	_	6	pobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	monocytes	_	NNS	NNS	_	11	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	macrophages	_	NNS	NNS	_	12	conj	_	_
15	involving	_	VBG	VBG	_	10	vmod	_	_
16	HIV	_	NN	NN	_	15	dobj	_	_
17	,	_	,	,	_	16	punct	_	_
18	p105	_	NN	NN	_	16	conj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	p50	_	NN	NN	_	18	conj	_	_
21	,	_	,	,	_	16	punct	_	_
22	and	_	CC	CC	_	16	cc	_	_
23	MAD3	_	NN	NN	_	16	conj	_	_
24	,	_	,	,	_	5	punct	_	_
25	with	_	IN	IN	_	5	prep	_	_
26	the	_	DT	DT	_	28	det	_	_
27	end	_	NN	NN	_	28	nn	_	_
28	result	_	NN	NN	_	25	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	persistent	_	JJ	JJ	_	33	amod	_	_
31	NF-kappa	_	NN	NN	_	33	nn	_	_
32	B	_	NN	NN	_	33	nn	_	_
33	activation	_	NN	NN	_	29	pobj	_	_
34	and	_	CC	CC	_	33	cc	_	_
35	viral	_	JJ	JJ	_	36	amod	_	_
36	persistence	_	NN	NN	_	33	conj	_	_
37	.	_	.	.	_	3	punct	_	_

1	Furthermore	_	RB	RB	_	10	advmod	_	_
2	,	_	,	,	_	10	punct	_	_
3	persistent	_	JJ	JJ	_	5	amod	_	_
4	HIV	_	NN	NN	_	5	nn	_	_
5	infection	_	NN	NN	_	10	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	monocytes	_	NNS	NNS	_	6	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	macrophages	_	NNS	NNS	_	7	conj	_	_
10	provides	_	VBZ	VBZ	_	0	root	_	_
11	a	_	DT	DT	_	13	det	_	_
12	useful	_	JJ	JJ	_	13	amod	_	_
13	model	_	NN	NN	_	10	dobj	_	_
14	with	_	IN	IN	_	17	prep	_	_
15	which	_	WDT	WDT	_	14	pobj	_	_
16	to	_	TO	TO	_	17	aux	_	_
17	study	_	VB	VB	_	13	rcmod	_	_
18	concomitant	_	JJ	JJ	_	19	amod	_	_
19	modifications	_	NNS	NNS	_	17	dobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	different	_	JJ	JJ	_	25	amod	_	_
22	I	_	NN	NN	_	25	nn	_	_
23	kappa	_	NN	NN	_	25	nn	_	_
24	B	_	NN	NN	_	25	nn	_	_
25	molecules	_	NNS	NNS	_	20	pobj	_	_
26	.	_	.	.	_	10	punct	_	_

1	Detection	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	9	det	_	_
4	chromosome	_	NN	NN	_	9	nn	_	_
5	16	_	CD	CD	_	9	num	_	_
6	CBF	_	NN	NN	_	9	nn	_	_
7	beta-MYH11	_	NN	NN	_	9	nn	_	_
8	fusion	_	NN	NN	_	9	nn	_	_
9	transcript	_	NN	NN	_	2	pobj	_	_
10	in	_	IN	IN	_	1	prep	_	_
11	myelomonocytic	_	JJ	JJ	_	12	amod	_	_
12	leukemias	_	NNS	NNS	_	10	pobj	_	_
13	.	_	.	.	_	1	punct	_	_

1	Karyotypic	_	JJ	JJ	_	2	amod	_	_
2	detection	_	NN	NN	_	14	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	chromosomal	_	JJ	JJ	_	6	amod	_	_
5	16	_	CD	CD	_	6	num	_	_
6	abnormalities	_	NNS	NNS	_	3	pobj	_	_
7	classically	_	RB	RB	_	8	advmod	_	_
8	associated	_	VBN	VBN	_	6	vmod	_	_
9	with	_	IN	IN	_	8	prep	_	_
10	AML	_	NN	NN	_	11	nn	_	_
11	M4Eo	_	NN	NN	_	9	pobj	_	_
12	can	_	MD	MD	_	14	aux	_	_
13	be	_	VB	VB	_	14	cop	_	_
14	difficult	_	JJ	JJ	_	0	root	_	_
15	.	_	.	.	_	14	punct	_	_

1	Characterization	_	NN	NN	_	17	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	two	_	CD	CD	_	5	num	_	_
5	genes	_	NNS	NNS	_	2	pobj	_	_
6	involved	_	VBN	VBN	_	5	vmod	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	inv-LRB-16-RRB--LRB-p13q22-RRB-	_	NN	NN	_	7	pobj	_	_
10	,	_	,	,	_	5	punct	_	_
11	CBF	_	NN	NN	_	12	nn	_	_
12	beta	_	NN	NN	_	5	appos	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	MYH11	_	NN	NN	_	12	conj	_	_
15	,	_	,	,	_	1	punct	_	_
16	has	_	VBZ	VBZ	_	17	aux	_	_
17	allowed	_	VBN	VBN	_	0	root	_	_
18	the	_	DT	DT	_	19	det	_	_
19	detection	_	NN	NN	_	17	dobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	fusion	_	NN	NN	_	22	nn	_	_
22	transcripts	_	NNS	NNS	_	20	pobj	_	_
23	by	_	IN	IN	_	19	prep	_	_
24	reverse-transcriptase	_	NN	NN	_	27	nn	_	_
25	polymerase	_	NN	NN	_	27	nn	_	_
26	chain	_	NN	NN	_	27	nn	_	_
27	reaction	_	NN	NN	_	23	pobj	_	_
28	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
29	RT-PCR	_	NN	NN	_	27	appos	_	_
30	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
31	.	_	.	.	_	17	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	analyzed	_	VBN	VBN	_	0	root	_	_
4	CBF	_	NN	NN	_	7	nn	_	_
5	beta-MYH11	_	NN	NN	_	7	nn	_	_
6	fusion	_	NN	NN	_	7	nn	_	_
7	transcripts	_	NNS	NNS	_	3	dobj	_	_
8	by	_	IN	IN	_	3	prep	_	_
9	RT-PCR	_	NN	NN	_	8	pobj	_	_
10	in	_	IN	IN	_	3	prep	_	_
11	myelomonocytic	_	JJ	JJ	_	12	amod	_	_
12	leukemias	_	NNS	NNS	_	10	pobj	_	_
13	,	_	,	,	_	3	punct	_	_
14	with	_	IN	IN	_	3	prep	_	_
15	or	_	CC	CC	_	14	cc	_	_
16	without	_	IN	IN	_	14	conj	_	_
17	eosinophilia	_	NN	NN	_	14	pobj	_	_
18	,	_	,	,	_	3	punct	_	_
19	to	_	TO	TO	_	20	aux	_	_
20	determine	_	VB	VB	_	3	xcomp	_	_
21	whether	_	IN	IN	_	24	mark	_	_
22	their	_	PRP$	PRP$	_	23	poss	_	_
23	presence	_	NN	NN	_	24	nsubj	_	_
24	correlates	_	VBZ	VBZ	_	20	ccomp	_	_
25	with	_	IN	IN	_	24	prep	_	_
26	morphology	_	NN	NN	_	25	pobj	_	_
27	.	_	.	.	_	3	punct	_	_

1	Fifty-three	_	CD	CD	_	2	num	_	_
2	cases	_	NNS	NNS	_	41	nsubjpass	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	11	_	CD	CD	_	2	dep	_	_
5	AML	_	NN	NN	_	6	nn	_	_
6	M4Eo	_	NN	NN	_	4	dep	_	_
7	;	_	:	:	_	4	punct	_	_
8	1	_	CD	CD	_	10	num	_	_
9	AML	_	NN	NN	_	10	nn	_	_
10	M4	_	NN	NN	_	4	conj	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	atypical	_	JJ	JJ	_	14	amod	_	_
13	abnormal	_	JJ	JJ	_	14	amod	_	_
14	eosinophils	_	NNS	NNS	_	11	pobj	_	_
15	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
16	AML	_	NN	NN	_	19	nn	_	_
17	M4	_	NN	NN	_	19	nn	_	_
18	``	_	``	``	_	19	punct	_	_
19	Eo	_	NN	NN	_	10	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	;	_	:	:	_	4	punct	_	_
22	29	_	CD	CD	_	4	conj	_	_
23	AML	_	NN	NN	_	24	nn	_	_
24	M4	_	NN	NN	_	22	dep	_	_
25	;	_	:	:	_	4	punct	_	_
26	8	_	CD	CD	_	4	conj	_	_
27	AML	_	NN	NN	_	28	nn	_	_
28	M5	_	NN	NN	_	26	dep	_	_
29	;	_	:	:	_	4	punct	_	_
30	3	_	CD	CD	_	4	conj	_	_
31	CMML	_	NN	NN	_	30	dep	_	_
32	;	_	:	:	_	4	punct	_	_
33	and	_	CC	CC	_	4	cc	_	_
34	1	_	CD	CD	_	4	conj	_	_
35	AML	_	NN	NN	_	36	nn	_	_
36	M2	_	NN	NN	_	34	dep	_	_
37	with	_	IN	IN	_	36	prep	_	_
38	eosinophilia	_	NN	NN	_	37	pobj	_	_
39	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
40	were	_	VBD	VBD	_	41	auxpass	_	_
41	analyzed	_	VBN	VBN	_	0	root	_	_
42	.	_	.	.	_	41	punct	_	_

1	All	_	DT	DT	_	5	det	_	_
2	11	_	CD	CD	_	5	num	_	_
3	typical	_	JJ	JJ	_	5	amod	_	_
4	AML	_	NN	NN	_	5	nn	_	_
5	M4Eo	_	NN	NN	_	9	nsubj	_	_
6	were	_	VBD	VBD	_	9	cop	_	_
7	CBF	_	NN	NN	_	9	npadvmod	_	_
8	beta-MYH11	_	NN	NN	_	9	npadvmod	_	_
9	positive	_	JJ	JJ	_	0	root	_	_
10	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	single	_	JJ	JJ	_	3	amod	_	_
3	case	_	NN	NN	_	12	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	AML	_	NN	NN	_	6	nn	_	_
6	M4	_	NN	NN	_	4	pobj	_	_
7	with	_	IN	IN	_	6	prep	_	_
8	distinctive	_	JJ	JJ	_	10	amod	_	_
9	eosinophil	_	NN	NN	_	10	nn	_	_
10	abnormalities	_	NNS	NNS	_	7	pobj	_	_
11	was	_	VBD	VBD	_	12	cop	_	_
12	negative	_	JJ	JJ	_	0	root	_	_
13	by	_	IN	IN	_	12	prep	_	_
14	karyotype	_	NN	NN	_	13	pobj	_	_
15	,	_	,	,	_	14	punct	_	_
16	RT-PCR	_	NN	NN	_	14	conj	_	_
17	and	_	CC	CC	_	14	cc	_	_
18	fluorescent	_	JJ	JJ	_	21	amod	_	_
19	in	_	FW	FW	_	21	amod	_	_
20	situ	_	FW	FW	_	19	dep	_	_
21	hybridization	_	NN	NN	_	14	conj	_	_
22	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
23	FISH	_	NN	NN	_	21	appos	_	_
24	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
25	.	_	.	.	_	12	punct	_	_

1	Three	_	CD	CD	_	16	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	29	_	CD	CD	_	2	pobj	_	_
4	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
5	10	_	CD	CD	_	6	num	_	_
6	%	_	NN	NN	_	3	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	AML	_	NN	NN	_	9	nn	_	_
9	M4	_	NN	NN	_	3	dep	_	_
10	without	_	IN	IN	_	9	prep	_	_
11	abnormal	_	JJ	JJ	_	12	amod	_	_
12	eosinophils	_	NNS	NNS	_	10	pobj	_	_
13	were	_	VBD	VBD	_	16	cop	_	_
14	CBF	_	NN	NN	_	16	npadvmod	_	_
15	beta-MYH11	_	NN	NN	_	16	npadvmod	_	_
16	positive	_	JJ	JJ	_	0	root	_	_
17	,	_	,	,	_	16	punct	_	_
18	1	_	CD	CD	_	23	nsubj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	which	_	WDT	WDT	_	18	dep	_	_
21	did	_	VBD	VBD	_	23	aux	_	_
22	not	_	RB	RB	_	23	neg	_	_
23	show	_	VB	VB	_	16	dep	_	_
24	any	_	DT	DT	_	28	det	_	_
25	apparent	_	JJ	JJ	_	28	amod	_	_
26	chromosome	_	NN	NN	_	28	nn	_	_
27	16	_	CD	CD	_	26	num	_	_
28	abnormalities	_	NNS	NNS	_	23	dobj	_	_
29	by	_	IN	IN	_	23	prep	_	_
30	classical	_	JJ	JJ	_	32	amod	_	_
31	metaphase	_	NN	NN	_	32	nn	_	_
32	analysis	_	NN	NN	_	29	pobj	_	_
33	-LRB-	_	-LRB-	-LRB-	_	34	punct	_	_
34	2	_	CD	CD	_	16	dep	_	_
35	not	_	RB	RB	_	36	neg	_	_
36	tested	_	VBN	VBN	_	34	vmod	_	_
37	-RRB-	_	-RRB-	-RRB-	_	34	punct	_	_
38	.	_	.	.	_	16	punct	_	_

1	Both	_	DT	DT	_	2	det	_	_
2	cases	_	NNS	NNS	_	5	nsubj	_	_
3	tested	_	VBN	VBN	_	2	vmod	_	_
4	also	_	RB	RB	_	5	advmod	_	_
5	showed	_	VBD	VBD	_	0	root	_	_
6	MYH11	_	NN	NN	_	8	nn	_	_
7	genomic	_	JJ	JJ	_	8	amod	_	_
8	rearrangement	_	NN	NN	_	5	dobj	_	_
9	.	_	.	.	_	5	punct	_	_

1	None	_	NN	NN	_	8	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	other	_	JJ	JJ	_	5	amod	_	_
5	leukemias	_	NNS	NNS	_	2	pobj	_	_
6	were	_	VBD	VBD	_	8	cop	_	_
7	RT-PCR	_	NN	NN	_	8	npadvmod	_	_
8	positive	_	JJ	JJ	_	0	root	_	_
9	.	_	.	.	_	8	punct	_	_

1	Follow-up	_	NN	NN	_	5	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	three	_	CD	CD	_	4	num	_	_
4	patient	_	NN	NN	_	2	pobj	_	_
5	showed	_	VBD	VBD	_	0	root	_	_
6	residual	_	JJ	JJ	_	7	amod	_	_
7	positivity	_	NN	NN	_	5	dobj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	apparent	_	JJ	JJ	_	11	amod	_	_
10	complete	_	JJ	JJ	_	9	dep	_	_
11	remission	_	NN	NN	_	8	pobj	_	_
12	.	_	.	.	_	5	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	show	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	9	mark	_	_
5	CBF	_	NN	NN	_	8	nn	_	_
6	beta-MYH11	_	NN	NN	_	8	nn	_	_
7	fusion	_	NN	NN	_	8	nn	_	_
8	transcripts	_	NNS	NNS	_	9	nsubj	_	_
9	occur	_	VBP	VBP	_	3	ccomp	_	_
10	not	_	RB	RB	_	11	neg	_	_
11	only	_	RB	RB	_	12	preconj	_	_
12	in	_	IN	IN	_	9	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	vast	_	JJ	JJ	_	15	amod	_	_
15	majority	_	NN	NN	_	12	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	typical	_	JJ	JJ	_	19	amod	_	_
18	AML	_	NN	NN	_	19	nn	_	_
19	M4Eo	_	NN	NN	_	16	pobj	_	_
20	,	_	,	,	_	12	punct	_	_
21	but	_	CC	CC	_	22	cc	_	_
22	also	_	RB	RB	_	12	cc	_	_
23	in	_	IN	IN	_	12	conj	_	_
24	approximately	_	RB	RB	_	25	quantmod	_	_
25	10	_	CD	CD	_	26	num	_	_
26	%	_	NN	NN	_	23	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	AML	_	NN	NN	_	29	nn	_	_
29	M4	_	NN	NN	_	27	pobj	_	_
30	without	_	IN	IN	_	29	prep	_	_
31	eosinophilic	_	JJ	JJ	_	32	amod	_	_
32	abnormalities	_	NNS	NNS	_	30	pobj	_	_
33	,	_	,	,	_	26	punct	_	_
34	a	_	DT	DT	_	37	det	_	_
35	much	_	RB	RB	_	36	advmod	_	_
36	higher	_	JJR	JJR	_	37	amod	_	_
37	incidence	_	NN	NN	_	26	appos	_	_
38	than	_	IN	IN	_	50	mark	_	_
39	the	_	DT	DT	_	41	det	_	_
40	sporadic	_	JJ	JJ	_	41	amod	_	_
41	reports	_	NNS	NNS	_	50	nsubj	_	_
42	of	_	IN	IN	_	41	prep	_	_
43	chromosome	_	NN	NN	_	45	nn	_	_
44	16	_	CD	CD	_	43	num	_	_
45	abnormalities	_	NNS	NNS	_	42	pobj	_	_
46	in	_	IN	IN	_	45	prep	_	_
47	AML	_	NN	NN	_	48	nn	_	_
48	M4	_	NN	NN	_	46	pobj	_	_
49	would	_	MD	MD	_	50	aux	_	_
50	suggest	_	VB	VB	_	37	advcl	_	_
51	.	_	.	.	_	3	punct	_	_

1	Taken	_	VBN	VBN	_	0	root	_	_
2	together	_	RB	RB	_	1	advmod	_	_
3	with	_	IN	IN	_	1	prep	_	_
4	the	_	DT	DT	_	5	det	_	_
5	detection	_	NN	NN	_	3	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	CBF	_	NN	NN	_	9	nn	_	_
8	beta-MYH11	_	NN	NN	_	9	nn	_	_
9	transcripts	_	NNS	NNS	_	6	pobj	_	_
10	in	_	IN	IN	_	5	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	absence	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	apparent	_	JJ	JJ	_	17	amod	_	_
15	chromosome	_	NN	NN	_	17	nn	_	_
16	16	_	CD	CD	_	15	num	_	_
17	abnormalities	_	NNS	NNS	_	13	pobj	_	_
18	by	_	IN	IN	_	5	prep	_	_
19	classical	_	JJ	JJ	_	21	amod	_	_
20	banding	_	NN	NN	_	21	nn	_	_
21	techniques	_	NNS	NNS	_	18	pobj	_	_
22	,	_	,	,	_	1	punct	_	_
23	these	_	DT	DT	_	24	det	_	_
24	data	_	NNS	NNS	_	25	nsubj	_	_
25	show	_	VBP	VBP	_	1	parataxis	_	_
26	that	_	IN	IN	_	36	mark	_	_
27	additional	_	JJ	JJ	_	28	amod	_	_
28	screening	_	NN	NN	_	36	nsubjpass	_	_
29	by	_	IN	IN	_	28	prep	_	_
30	either	_	CC	CC	_	31	preconj	_	_
31	RT-PCR	_	NN	NN	_	29	pobj	_	_
32	or	_	CC	CC	_	31	cc	_	_
33	FISH	_	NN	NN	_	31	conj	_	_
34	should	_	MD	MD	_	36	aux	_	_
35	be	_	VB	VB	_	36	auxpass	_	_
36	performed	_	VBN	VBN	_	25	ccomp	_	_
37	in	_	IN	IN	_	36	prep	_	_
38	all	_	DT	DT	_	40	det	_	_
39	AML	_	NN	NN	_	40	nn	_	_
40	M4	_	NN	NN	_	37	pobj	_	_
41	,	_	,	,	_	36	punct	_	_
42	regardless	_	RB	RB	_	36	advmod	_	_
43	of	_	IN	IN	_	42	prep	_	_
44	morphologic	_	JJ	JJ	_	45	amod	_	_
45	features	_	NNS	NNS	_	43	pobj	_	_
46	,	_	,	,	_	36	punct	_	_
47	to	_	TO	TO	_	48	aux	_	_
48	allow	_	VB	VB	_	36	xcomp	_	_
49	accurate	_	JJ	JJ	_	50	amod	_	_
50	evaluation	_	NN	NN	_	48	dobj	_	_
51	of	_	IN	IN	_	50	prep	_	_
52	the	_	DT	DT	_	54	det	_	_
53	prognostic	_	JJ	JJ	_	54	amod	_	_
54	importance	_	NN	NN	_	51	pobj	_	_
55	of	_	IN	IN	_	54	prep	_	_
56	this	_	DT	DT	_	58	det	_	_
57	fusion	_	NN	NN	_	58	nn	_	_
58	transcript	_	NN	NN	_	55	pobj	_	_
59	.	_	.	.	_	1	punct	_	_

1	OBF-1	_	NN	NN	_	0	root	_	_
2	,	_	,	,	_	1	punct	_	_
3	a	_	DT	DT	_	7	det	_	_
4	novel	_	JJ	JJ	_	7	amod	_	_
5	B	_	NN	NN	_	7	nn	_	_
6	cell-specific	_	JJ	JJ	_	7	amod	_	_
7	coactivator	_	NN	NN	_	1	appos	_	_
8	that	_	WDT	WDT	_	9	nsubj	_	_
9	stimulates	_	VBZ	VBZ	_	7	rcmod	_	_
10	immunoglobulin	_	NN	NN	_	11	nn	_	_
11	promoter	_	NN	NN	_	12	nn	_	_
12	activity	_	NN	NN	_	9	dobj	_	_
13	through	_	IN	IN	_	9	prep	_	_
14	association	_	NN	NN	_	13	pobj	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	octamer-binding	_	JJ	JJ	_	17	amod	_	_
17	proteins	_	NNS	NNS	_	15	pobj	_	_
18	.	_	.	.	_	1	punct	_	_

1	Recent	_	JJ	JJ	_	2	amod	_	_
2	biochemical	_	JJ	JJ	_	6	nsubj	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	genetic	_	JJ	JJ	_	2	conj	_	_
5	studies	_	NNS	NNS	_	2	dep	_	_
6	indicate	_	VBP	VBP	_	0	root	_	_
7	that	_	IN	IN	_	23	mark	_	_
8	in	_	IN	IN	_	23	prep	_	_
9	addition	_	NN	NN	_	8	pobj	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	octamer-binding	_	JJ	JJ	_	13	amod	_	_
13	proteins	_	NNS	NNS	_	10	pobj	_	_
14	Oct-1	_	NN	NN	_	13	dep	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	Oct-2	_	NN	NN	_	14	conj	_	_
17	,	_	,	,	_	23	punct	_	_
18	other	_	JJ	JJ	_	21	amod	_	_
19	B	_	NN	NN	_	21	nn	_	_
20	cell	_	NN	NN	_	21	nn	_	_
21	components	_	NNS	NNS	_	23	nsubjpass	_	_
22	are	_	VBP	VBP	_	23	auxpass	_	_
23	required	_	VBN	VBN	_	6	ccomp	_	_
24	for	_	IN	IN	_	23	prep	_	_
25	lymphoid-restricted	_	JJ	JJ	_	32	amod	_	_
26	,	_	,	,	_	25	punct	_	_
27	octamer	_	NN	NN	_	28	npadvmod	_	_
28	site-mediated	_	JJ	JJ	_	25	dep	_	_
29	immunoglobulin	_	NN	NN	_	31	nn	_	_
30	gene	_	NN	NN	_	31	nn	_	_
31	promoter	_	NN	NN	_	32	nn	_	_
32	activity	_	NN	NN	_	24	pobj	_	_
33	.	_	.	.	_	6	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	a	_	DT	DT	_	4	det	_	_
3	genetic	_	JJ	JJ	_	4	amod	_	_
4	screen	_	NN	NN	_	1	dobj	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	yeast	_	NN	NN	_	5	pobj	_	_
7	,	_	,	,	_	1	punct	_	_
8	we	_	PRP	PRP	_	10	nsubj	_	_
9	have	_	VBP	VBP	_	10	aux	_	_
10	isolated	_	VBN	VBN	_	1	parataxis	_	_
11	B	_	NN	NN	_	13	nn	_	_
12	cell-derived	_	JJ	JJ	_	13	amod	_	_
13	cDNAs	_	NNS	NNS	_	10	dobj	_	_
14	encoding	_	JJ	JJ	_	13	dep	_	_
15	Oct-binding	_	JJ	JJ	_	16	amod	_	_
16	factor	_	NN	NN	_	14	dobj	_	_
17	1	_	CD	CD	_	16	num	_	_
18	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
19	OBF-1	_	NN	NN	_	16	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	,	_	,	,	_	16	punct	_	_
22	a	_	DT	DT	_	24	det	_	_
23	novel	_	JJ	JJ	_	24	amod	_	_
24	protein	_	NN	NN	_	16	appos	_	_
25	that	_	WDT	WDT	_	27	nsubj	_	_
26	specifically	_	RB	RB	_	27	advmod	_	_
27	associates	_	VBZ	VBZ	_	24	rcmod	_	_
28	with	_	IN	IN	_	27	prep	_	_
29	Oct-1	_	NN	NN	_	28	pobj	_	_
30	and	_	CC	CC	_	29	cc	_	_
31	Oct-2	_	NN	NN	_	29	conj	_	_
32	.	_	.	.	_	1	punct	_	_

1	Biochemical	_	JJ	JJ	_	2	amod	_	_
2	studies	_	NNS	NNS	_	3	nsubj	_	_
3	demonstrate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	6	mark	_	_
5	OBF-1	_	NN	NN	_	6	nsubj	_	_
6	has	_	VBZ	VBZ	_	3	ccomp	_	_
7	no	_	DT	DT	_	10	neg	_	_
8	intrinsic	_	JJ	JJ	_	10	amod	_	_
9	DNA-binding	_	JJ	JJ	_	10	amod	_	_
10	activity	_	NN	NN	_	6	dobj	_	_
11	and	_	CC	CC	_	6	cc	_	_
12	recognizes	_	VBZ	VBZ	_	6	conj	_	_
13	the	_	DT	DT	_	15	det	_	_
14	POU	_	NN	NN	_	15	nn	_	_
15	domains	_	NNS	NNS	_	12	dobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	Oct-1	_	NN	NN	_	16	pobj	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	Oct-2	_	NN	NN	_	17	conj	_	_
20	,	_	,	,	_	15	punct	_	_
21	but	_	CC	CC	_	22	cc	_	_
22	not	_	RB	RB	_	15	cc	_	_
23	those	_	DT	DT	_	15	conj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	Oct-4	_	NN	NN	_	24	pobj	_	_
26	and	_	CC	CC	_	25	cc	_	_
27	Oct-6	_	NN	NN	_	25	conj	_	_
28	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	OBF-1	_	NN	NN	_	3	nn	_	_
3	mRNA	_	NN	NN	_	5	nsubjpass	_	_
4	is	_	VBZ	VBZ	_	5	auxpass	_	_
5	expressed	_	VBN	VBN	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	a	_	DT	DT	_	10	det	_	_
8	highly	_	RB	RB	_	9	advmod	_	_
9	cell-specific	_	JJ	JJ	_	10	amod	_	_
10	manner	_	NN	NN	_	6	pobj	_	_
11	,	_	,	,	_	5	punct	_	_
12	being	_	VBG	VBG	_	14	cop	_	_
13	most	_	RBS	RBS	_	14	advmod	_	_
14	abundant	_	JJ	JJ	_	5	vmod	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	B	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	15	pobj	_	_
18	and	_	CC	CC	_	14	cc	_	_
19	essentially	_	RB	RB	_	14	advmod	_	_
20	absent	_	JJ	JJ	_	14	conj	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	most	_	JJS	JJS	_	21	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	26	dep	_	_
25	other	_	JJ	JJ	_	26	amod	_	_
26	cells	_	NNS	NNS	_	23	pobj	_	_
27	or	_	CC	CC	_	26	cc	_	_
28	tissues	_	NNS	NNS	_	26	conj	_	_
29	tested	_	VBN	VBN	_	26	vmod	_	_
30	.	_	.	.	_	5	punct	_	_

1	Furthermore	_	RB	RB	_	10	advmod	_	_
2	,	_	,	,	_	10	punct	_	_
3	expression	_	NN	NN	_	10	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	OBF-1	_	NN	NN	_	4	pobj	_	_
6	in	_	IN	IN	_	3	prep	_	_
7	HeLa	_	NN	NN	_	8	nn	_	_
8	cells	_	NNS	NNS	_	6	pobj	_	_
9	selectively	_	RB	RB	_	10	advmod	_	_
10	stimulates	_	VBZ	VBZ	_	0	root	_	_
11	the	_	DT	DT	_	12	det	_	_
12	activity	_	NN	NN	_	10	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	a	_	DT	DT	_	17	det	_	_
15	natural	_	JJ	JJ	_	17	amod	_	_
16	immunoglobulin	_	NN	NN	_	17	nn	_	_
17	promoter	_	NN	NN	_	13	pobj	_	_
18	in	_	IN	IN	_	10	prep	_	_
19	an	_	DT	DT	_	22	det	_	_
20	octamer	_	NN	NN	_	22	nn	_	_
21	site-dependent	_	JJ	JJ	_	22	amod	_	_
22	manner	_	NN	NN	_	18	pobj	_	_
23	.	_	.	.	_	10	punct	_	_

1	Thus	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	OBF-1	_	NN	NN	_	4	nsubj	_	_
4	has	_	VBZ	VBZ	_	0	root	_	_
5	all	_	PDT	PDT	_	7	predet	_	_
6	the	_	DT	DT	_	7	det	_	_
7	properties	_	NNS	NNS	_	4	dobj	_	_
8	expected	_	VBN	VBN	_	7	vmod	_	_
9	for	_	IN	IN	_	8	prep	_	_
10	a	_	DT	DT	_	15	det	_	_
11	B	_	NN	NN	_	15	nn	_	_
12	cell-specific	_	JJ	JJ	_	15	amod	_	_
13	transcriptional	_	JJ	JJ	_	15	amod	_	_
14	coactivator	_	NN	NN	_	15	nn	_	_
15	protein	_	NN	NN	_	9	pobj	_	_
16	.	_	.	.	_	4	punct	_	_

1	HIV-1	_	NN	NN	_	2	nn	_	_
2	Tat	_	NN	NN	_	3	nsubj	_	_
3	potentiates	_	VBZ	VBZ	_	0	root	_	_
4	TNF-induced	_	JJ	JJ	_	7	amod	_	_
5	NF-kappa	_	NN	NN	_	6	nn	_	_
6	B	_	NN	NN	_	7	nn	_	_
7	activation	_	NN	NN	_	3	dobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	cytotoxicity	_	NN	NN	_	7	conj	_	_
10	by	_	IN	IN	_	3	prep	_	_
11	altering	_	VBG	VBG	_	10	pcomp	_	_
12	the	_	DT	DT	_	15	det	_	_
13	cellular	_	JJ	JJ	_	15	amod	_	_
14	redox	_	NN	NN	_	15	nn	_	_
15	state	_	NN	NN	_	11	dobj	_	_
16	.	_	.	.	_	3	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	study	_	NN	NN	_	3	nsubj	_	_
3	demonstrates	_	VBZ	VBZ	_	0	root	_	_
4	that	_	IN	IN	_	15	mark	_	_
5	human	_	JJ	JJ	_	14	amod	_	_
6	immunodeficiency	_	NN	NN	_	14	nn	_	_
7	virus	_	NN	NN	_	14	nn	_	_
8	type	_	NN	NN	_	14	nn	_	_
9	1	_	CD	CD	_	14	num	_	_
10	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
11	HIV-1	_	NN	NN	_	14	nn	_	_
12	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
13	Tat	_	NN	NN	_	14	nn	_	_
14	protein	_	NN	NN	_	15	nsubj	_	_
15	amplifies	_	VBZ	VBZ	_	3	ccomp	_	_
16	the	_	DT	DT	_	17	det	_	_
17	activity	_	NN	NN	_	15	dobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	tumor	_	NN	NN	_	21	nn	_	_
20	necrosis	_	NN	NN	_	21	nn	_	_
21	factor	_	NN	NN	_	18	pobj	_	_
22	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
23	TNF	_	NN	NN	_	21	appos	_	_
24	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
25	,	_	,	,	_	21	punct	_	_
26	a	_	DT	DT	_	27	det	_	_
27	cytokine	_	NN	NN	_	21	appos	_	_
28	that	_	WDT	WDT	_	29	nsubj	_	_
29	stimulates	_	VBZ	VBZ	_	27	rcmod	_	_
30	HIV-1	_	NN	NN	_	31	nn	_	_
31	replication	_	NN	NN	_	29	dobj	_	_
32	through	_	IN	IN	_	29	prep	_	_
33	activation	_	NN	NN	_	32	pobj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	NF-kappa	_	NN	NN	_	36	nn	_	_
36	B	_	NN	NN	_	34	pobj	_	_
37	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	21	prep	_	_
2	HeLa	_	NN	NN	_	3	nn	_	_
3	cells	_	NNS	NNS	_	1	pobj	_	_
4	stably	_	RB	RB	_	5	advmod	_	_
5	transfected	_	VBN	VBN	_	3	vmod	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	10	det	_	_
8	HIV-1	_	NN	NN	_	10	nn	_	_
9	tat	_	NN	NN	_	10	nn	_	_
10	gene	_	NN	NN	_	6	pobj	_	_
11	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
12	HeLa-tat	_	JJ	JJ	_	13	amod	_	_
13	cells	_	NNS	NNS	_	3	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	,	_	,	,	_	21	punct	_	_
16	expression	_	NN	NN	_	21	nsubj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	Tat	_	NN	NN	_	20	nn	_	_
20	protein	_	NN	NN	_	17	pobj	_	_
21	enhanced	_	VBD	VBD	_	0	root	_	_
22	both	_	CC	CC	_	24	preconj	_	_
23	TNF-induced	_	JJ	JJ	_	24	amod	_	_
24	activation	_	NN	NN	_	21	dobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	NF-kappa	_	NN	NN	_	27	nn	_	_
27	B	_	NN	NN	_	25	pobj	_	_
28	and	_	CC	CC	_	24	cc	_	_
29	TNF-mediated	_	JJ	JJ	_	30	amod	_	_
30	cytotoxicity	_	NN	NN	_	24	conj	_	_
31	.	_	.	.	_	21	punct	_	_

1	A	_	DT	DT	_	3	det	_	_
2	similar	_	JJ	JJ	_	3	amod	_	_
3	potentiation	_	NN	NN	_	8	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	TNF	_	NN	NN	_	6	nn	_	_
6	effects	_	NNS	NNS	_	4	pobj	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	observed	_	VBN	VBN	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	Jurkat	_	NN	NN	_	12	nn	_	_
11	T	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	9	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	HeLa	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	12	conj	_	_
16	treated	_	VBN	VBN	_	12	vmod	_	_
17	with	_	IN	IN	_	16	prep	_	_
18	soluble	_	JJ	JJ	_	20	amod	_	_
19	Tat	_	NN	NN	_	20	nn	_	_
20	protein	_	NN	NN	_	17	pobj	_	_
21	.	_	.	.	_	8	punct	_	_

1	TNF-mediated	_	JJ	JJ	_	2	amod	_	_
2	activation	_	NN	NN	_	8	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	NF-kappa	_	NN	NN	_	5	nn	_	_
5	B	_	NN	NN	_	3	pobj	_	_
6	and	_	CC	CC	_	2	cc	_	_
7	cytotoxicity	_	NN	NN	_	2	conj	_	_
8	involves	_	VBZ	VBZ	_	0	root	_	_
9	the	_	DT	DT	_	11	det	_	_
10	intracellular	_	JJ	JJ	_	11	amod	_	_
11	formation	_	NN	NN	_	8	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	reactive	_	JJ	JJ	_	15	amod	_	_
14	oxygen	_	NN	NN	_	15	nn	_	_
15	intermediates	_	NNS	NNS	_	12	pobj	_	_
16	.	_	.	.	_	8	punct	_	_

1	Therefore	_	RB	RB	_	11	advmod	_	_
2	,	_	,	,	_	11	punct	_	_
3	Tat-mediated	_	JJ	JJ	_	4	amod	_	_
4	effects	_	NNS	NNS	_	11	nsubjpass	_	_
5	on	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	9	det	_	_
7	cellular	_	JJ	JJ	_	9	amod	_	_
8	redox	_	NN	NN	_	9	nn	_	_
9	state	_	NN	NN	_	5	pobj	_	_
10	were	_	VBD	VBD	_	11	auxpass	_	_
11	analyzed	_	VBN	VBN	_	0	root	_	_
12	.	_	.	.	_	11	punct	_	_

1	In	_	IN	IN	_	10	prep	_	_
2	both	_	CC	CC	_	4	preconj	_	_
3	T	_	NN	NN	_	4	nn	_	_
4	cells	_	NNS	NNS	_	1	pobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	HeLa	_	NN	NN	_	7	nn	_	_
7	cells	_	NNS	NNS	_	4	conj	_	_
8	HIV-1	_	NN	NN	_	9	nn	_	_
9	Tat	_	NN	NN	_	10	nsubj	_	_
10	suppressed	_	VBD	VBD	_	0	root	_	_
11	the	_	DT	DT	_	12	det	_	_
12	expression	_	NN	NN	_	10	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	Mn-dependent	_	JJ	JJ	_	16	amod	_	_
15	superoxide	_	NN	NN	_	16	nn	_	_
16	dismutase	_	NN	NN	_	13	pobj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	Mn-SOD	_	NN	NN	_	16	appos	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	,	_	,	,	_	16	punct	_	_
21	a	_	DT	DT	_	23	det	_	_
22	mitochondrial	_	JJ	JJ	_	23	amod	_	_
23	enzyme	_	NN	NN	_	16	appos	_	_
24	that	_	WDT	WDT	_	26	nsubj	_	_
25	is	_	VBZ	VBZ	_	26	cop	_	_
26	part	_	NN	NN	_	23	rcmod	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	31	det	_	_
29	cellular	_	JJ	JJ	_	31	amod	_	_
30	defense	_	NN	NN	_	31	nn	_	_
31	system	_	NN	NN	_	27	pobj	_	_
32	against	_	IN	IN	_	31	prep	_	_
33	oxidative	_	JJ	JJ	_	34	amod	_	_
34	stress	_	NN	NN	_	32	pobj	_	_
35	.	_	.	.	_	10	punct	_	_

1	Thus	_	RB	RB	_	11	advmod	_	_
2	,	_	,	,	_	11	punct	_	_
3	Mn-SOD	_	NN	NN	_	5	nn	_	_
4	RNA	_	NN	NN	_	5	nn	_	_
5	protein	_	NN	NN	_	11	nsubjpass	_	_
6	levels	_	NNS	NNS	_	5	dep	_	_
7	and	_	CC	CC	_	5	cc	_	_
8	activity	_	NN	NN	_	5	conj	_	_
9	were	_	VBD	VBD	_	11	auxpass	_	_
10	markedly	_	RB	RB	_	11	advmod	_	_
11	reduced	_	VBN	VBN	_	0	root	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	presence	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	Tat	_	NN	NN	_	15	pobj	_	_
17	.	_	.	.	_	11	punct	_	_

1	Decreased	_	VBN	VBN	_	3	amod	_	_
2	Mn-SOD	_	NN	NN	_	3	nn	_	_
3	expression	_	NN	NN	_	5	nsubjpass	_	_
4	was	_	VBD	VBD	_	5	auxpass	_	_
5	associated	_	VBN	VBN	_	0	root	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	decreased	_	VBN	VBN	_	8	amod	_	_
8	levels	_	NNS	NNS	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	glutathione	_	NN	NN	_	9	pobj	_	_
11	and	_	CC	CC	_	8	cc	_	_
12	a	_	DT	DT	_	14	det	_	_
13	lower	_	JJR	JJR	_	14	amod	_	_
14	ratio	_	NN	NN	_	8	conj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	reduced	_	VBN	VBN	_	19	amod	_	_
17	:	_	:	:	_	16	punct	_	_
18	oxidized	_	VBN	VBN	_	16	dep	_	_
19	glutathione	_	NN	NN	_	15	pobj	_	_
20	.	_	.	.	_	5	punct	_	_

1	A	_	DT	DT	_	4	det	_	_
2	truncated	_	VBN	VBN	_	4	amod	_	_
3	Tat	_	NN	NN	_	4	nn	_	_
4	protein	_	NN	NN	_	23	nsubj	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	Tat1-72	_	CD	CD	_	4	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	,	_	,	,	_	4	punct	_	_
9	known	_	VBN	VBN	_	4	vmod	_	_
10	to	_	TO	TO	_	11	aux	_	_
11	transactivate	_	VB	VB	_	9	xcomp	_	_
12	the	_	DT	DT	_	16	det	_	_
13	HIV-1	_	NN	NN	_	16	nn	_	_
14	long	_	JJ	JJ	_	16	amod	_	_
15	terminal	_	JJ	JJ	_	16	amod	_	_
16	repeat	_	NN	NN	_	11	dobj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	LTR	_	NN	NN	_	16	appos	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	,	_	,	,	_	4	punct	_	_
21	no	_	RB	RB	_	22	neg	_	_
22	longer	_	RBR	RBR	_	23	advmod	_	_
23	affected	_	VBD	VBD	_	0	root	_	_
24	Mn-SOD	_	NN	NN	_	25	nn	_	_
25	expression	_	NN	NN	_	23	dobj	_	_
26	,	_	,	,	_	25	punct	_	_
27	the	_	DT	DT	_	30	det	_	_
28	cellular	_	JJ	JJ	_	30	amod	_	_
29	redox	_	NN	NN	_	30	nn	_	_
30	state	_	NN	NN	_	25	conj	_	_
31	or	_	CC	CC	_	25	cc	_	_
32	TNF-mediated	_	JJ	JJ	_	33	amod	_	_
33	cytotoxicity	_	NN	NN	_	25	conj	_	_
34	.	_	.	.	_	23	punct	_	_

1	Thus	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	our	_	PRP$	PRP$	_	4	poss	_	_
4	experiments	_	NNS	NNS	_	5	nsubj	_	_
5	demonstrate	_	VBP	VBP	_	0	root	_	_
6	that	_	IN	IN	_	14	mark	_	_
7	the	_	DT	DT	_	9	det	_	_
8	C-terminal	_	JJ	JJ	_	9	amod	_	_
9	region	_	NN	NN	_	14	nsubjpass	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	HIV-1	_	NN	NN	_	12	nn	_	_
12	Tat	_	NN	NN	_	10	pobj	_	_
13	is	_	VBZ	VBZ	_	14	auxpass	_	_
14	required	_	VBN	VBN	_	5	ccomp	_	_
15	to	_	TO	TO	_	16	aux	_	_
16	suppress	_	VB	VB	_	14	ccomp	_	_
17	Mn-SOD	_	NN	NN	_	18	nn	_	_
18	expression	_	NN	NN	_	16	dobj	_	_
19	and	_	CC	CC	_	16	cc	_	_
20	to	_	TO	TO	_	21	aux	_	_
21	induce	_	VB	VB	_	16	conj	_	_
22	pro-oxidative	_	JJ	JJ	_	23	amod	_	_
23	conditions	_	NNS	NNS	_	21	dobj	_	_
24	reflected	_	VBN	VBN	_	23	vmod	_	_
25	by	_	IN	IN	_	24	prep	_	_
26	a	_	DT	DT	_	27	det	_	_
27	drop	_	NN	NN	_	25	pobj	_	_
28	in	_	IN	IN	_	27	prep	_	_
29	reduced	_	VBN	VBN	_	30	amod	_	_
30	glutathione	_	NN	NN	_	28	pobj	_	_
31	-LRB-	_	-LRB-	-LRB-	_	32	punct	_	_
32	GSH	_	NN	NN	_	30	appos	_	_
33	-RRB-	_	-RRB-	-RRB-	_	32	punct	_	_
34	and	_	CC	CC	_	30	cc	_	_
35	the	_	DT	DT	_	43	det	_	_
36	GSH	_	NN	NN	_	43	nn	_	_
37	:	_	:	:	_	36	punct	_	_
38	oxidized	_	VBN	VBN	_	39	amod	_	_
39	GSH	_	NN	NN	_	36	dep	_	_
40	-LRB-	_	-LRB-	-LRB-	_	41	punct	_	_
41	GSSG	_	NN	NN	_	39	appos	_	_
42	-RRB-	_	-RRB-	-RRB-	_	41	punct	_	_
43	ratio	_	NN	NN	_	30	conj	_	_
44	.	_	.	.	_	5	punct	_	_

1	-LRB-	_	-LRB-	-LRB-	_	2	punct	_	_
2	ABSTRACT	_	NN	NN	_	0	root	_	_
3	TRUNCATED	_	VBN	VBN	_	2	vmod	_	_
4	AT	_	IN	IN	_	3	prep	_	_
5	250	_	CD	CD	_	6	num	_	_
6	WORDS	_	NNS	NNS	_	4	pobj	_	_
7	-RRB-	_	-RRB-	-RRB-	_	2	punct	_	_

1	Calcium/calmodulin-dependent	_	JJ	JJ	_	3	amod	_	_
2	protein	_	NN	NN	_	3	nn	_	_
3	kinase	_	NN	NN	_	5	nsubj	_	_
4	II	_	CD	CD	_	3	num	_	_
5	downregulates	_	VBZ	VBZ	_	0	root	_	_
6	both	_	CC	CC	_	7	preconj	_	_
7	calcineurin	_	NN	NN	_	5	dobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	protein	_	NN	NN	_	10	nn	_	_
10	kinase	_	NN	NN	_	7	conj	_	_
11	C-mediated	_	JJ	JJ	_	10	amod	_	_
12	pathways	_	NNS	NNS	_	7	dep	_	_
13	for	_	IN	IN	_	7	prep	_	_
14	cytokine	_	NN	NN	_	15	nn	_	_
15	gene	_	NN	NN	_	16	nn	_	_
16	transcription	_	NN	NN	_	13	pobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	human	_	JJ	JJ	_	20	amod	_	_
19	T	_	NN	NN	_	20	nn	_	_
20	cells	_	NNS	NNS	_	17	pobj	_	_
21	.	_	.	.	_	5	punct	_	_

1	Engagement	_	NN	NN	_	9	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	6	det	_	_
4	T	_	NN	NN	_	6	nn	_	_
5	cell	_	NN	NN	_	6	nn	_	_
6	receptor	_	NN	NN	_	2	pobj	_	_
7	for	_	IN	IN	_	6	prep	_	_
8	antigen	_	NN	NN	_	7	pobj	_	_
9	activates	_	VBZ	VBZ	_	0	root	_	_
10	phospholipase	_	NN	NN	_	11	nn	_	_
11	C	_	NN	NN	_	9	dobj	_	_
12	resulting	_	VBG	VBG	_	9	xcomp	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	an	_	DT	DT	_	15	det	_	_
15	increase	_	NN	NN	_	13	pobj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	intracellular	_	JJ	JJ	_	20	amod	_	_
18	free	_	JJ	JJ	_	20	amod	_	_
19	calcium	_	NN	NN	_	20	nn	_	_
20	concentration	_	NN	NN	_	16	pobj	_	_
21	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
22	-LSB-Ca2+-RSB-i	_	NN	NN	_	20	appos	_	_
23	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
24	and	_	CC	CC	_	15	cc	_	_
25	activation	_	NN	NN	_	15	conj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	protein	_	NN	NN	_	29	nn	_	_
28	kinase	_	NN	NN	_	29	nn	_	_
29	C	_	NN	NN	_	26	pobj	_	_
30	-LRB-	_	-LRB-	-LRB-	_	31	punct	_	_
31	PKC	_	NN	NN	_	29	appos	_	_
32	-RRB-	_	-RRB-	-RRB-	_	31	punct	_	_
33	.	_	.	.	_	9	punct	_	_

1	Increased	_	VBN	VBN	_	2	amod	_	_
2	-LSB-Ca2+-RSB-i	_	NN	NN	_	3	nsubj	_	_
3	activates	_	VBZ	VBZ	_	0	root	_	_
4	Ca2+/calmodulin-dependent	_	JJ	JJ	_	5	amod	_	_
5	kinases	_	NNS	NNS	_	3	dobj	_	_
6	including	_	VBG	VBG	_	5	prep	_	_
7	the	_	DT	DT	_	11	det	_	_
8	multifunctional	_	JJ	JJ	_	11	amod	_	_
9	Ca2+/calmodulin-dependent	_	JJ	JJ	_	11	amod	_	_
10	protein	_	NN	NN	_	11	nn	_	_
11	kinase	_	NN	NN	_	6	pobj	_	_
12	II	_	CD	CD	_	11	num	_	_
13	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	CaM-K	_	NN	NN	_	11	appos	_	_
15	II	_	CD	CD	_	14	num	_	_
16	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
17	,	_	,	,	_	11	punct	_	_
18	as	_	RB	RB	_	19	advmod	_	_
19	well	_	RB	RB	_	11	cc	_	_
20	as	_	IN	IN	_	19	mwe	_	_
21	calcineurin	_	NN	NN	_	11	conj	_	_
22	,	_	,	,	_	21	punct	_	_
23	a	_	DT	DT	_	27	det	_	_
24	type	_	NN	NN	_	27	nn	_	_
25	2B	_	NN	NN	_	27	nn	_	_
26	protein	_	NN	NN	_	27	nn	_	_
27	phosphatase	_	NN	NN	_	21	appos	_	_
28	.	_	.	.	_	3	punct	_	_

1	Recent	_	JJ	JJ	_	2	amod	_	_
2	studies	_	NNS	NNS	_	4	nsubj	_	_
3	have	_	VBP	VBP	_	4	aux	_	_
4	identified	_	VBN	VBN	_	0	root	_	_
5	calcineurin	_	NN	NN	_	4	dobj	_	_
6	as	_	IN	IN	_	4	prep	_	_
7	a	_	DT	DT	_	9	det	_	_
8	key	_	JJ	JJ	_	9	amod	_	_
9	enzyme	_	NN	NN	_	6	pobj	_	_
10	for	_	IN	IN	_	9	prep	_	_
11	interleukin	_	NN	NN	_	10	pobj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	IL	_	NN	NN	_	11	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	-2	_	CD	CD	_	11	num	_	_
16	and	_	CC	CC	_	11	cc	_	_
17	IL-4	_	NN	NN	_	11	conj	_	_
18	promoter	_	NN	NN	_	19	nn	_	_
19	activation	_	NN	NN	_	11	dep	_	_
20	.	_	.	.	_	4	punct	_	_

1	However	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	the	_	DT	DT	_	4	det	_	_
4	role	_	NN	NN	_	8	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	CaM-K	_	NN	NN	_	5	pobj	_	_
7	II	_	CD	CD	_	6	num	_	_
8	remains	_	VBZ	VBZ	_	0	root	_	_
9	unknown	_	JJ	JJ	_	8	acomp	_	_
10	.	_	.	.	_	8	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	used	_	VBN	VBN	_	0	root	_	_
4	mutants	_	NNS	NNS	_	3	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	these	_	DT	DT	_	7	dep	_	_
7	kinases	_	NNS	NNS	_	5	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	phosphatases	_	NNS	NNS	_	7	conj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
11	gamma	_	NN	NN	_	12	nn	_	_
12	B*CaM-K	_	NN	NN	_	7	dep	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	delta	_	NN	NN	_	15	nn	_	_
15	CaM-AI	_	NN	NN	_	12	conj	_	_
16	,	_	,	,	_	12	punct	_	_
17	respectively	_	RB	RB	_	12	advmod	_	_
18	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
19	to	_	TO	TO	_	20	aux	_	_
20	explore	_	VB	VB	_	3	xcomp	_	_
21	their	_	PRP$	PRP$	_	23	poss	_	_
22	relative	_	JJ	JJ	_	23	amod	_	_
23	role	_	NN	NN	_	20	dobj	_	_
24	in	_	IN	IN	_	23	prep	_	_
25	cytokine	_	NN	NN	_	26	nn	_	_
26	gene	_	NN	NN	_	27	nn	_	_
27	transcription	_	NN	NN	_	24	pobj	_	_
28	and	_	CC	CC	_	27	cc	_	_
29	their	_	PRP$	PRP$	_	30	poss	_	_
30	interactions	_	NNS	NNS	_	27	conj	_	_
31	with	_	IN	IN	_	30	prep	_	_
32	PKC-dependent	_	JJ	JJ	_	34	amod	_	_
33	signaling	_	NN	NN	_	34	nn	_	_
34	systems	_	NNS	NNS	_	31	pobj	_	_
35	.	_	.	.	_	3	punct	_	_

1	gamma	_	NN	NN	_	2	nn	_	_
2	B*CaM-K	_	NN	NN	_	15	nsubjpass	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	delta	_	NN	NN	_	5	nn	_	_
5	CaM-AI	_	NN	NN	_	2	conj	_	_
6	,	_	,	,	_	2	punct	_	_
7	known	_	VBN	VBN	_	2	vmod	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	exhibit	_	VB	VB	_	7	xcomp	_	_
10	constitutive	_	JJ	JJ	_	11	amod	_	_
11	Ca-LRB-2+-RRB--independent	_	JJ	JJ	_	12	amod	_	_
12	activity	_	NN	NN	_	9	dobj	_	_
13	,	_	,	,	_	2	punct	_	_
14	were	_	VBD	VBD	_	15	auxpass	_	_
15	cotransfected	_	VBN	VBN	_	0	root	_	_
16	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
17	alone	_	RB	RB	_	15	dep	_	_
18	or	_	CC	CC	_	17	cc	_	_
19	in	_	IN	IN	_	17	conj	_	_
20	combination	_	NN	NN	_	19	pobj	_	_
21	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
22	in	_	IN	IN	_	15	prep	_	_
23	Jurkat	_	NN	NN	_	25	nn	_	_
24	T	_	NN	NN	_	25	nn	_	_
25	cells	_	NNS	NNS	_	22	pobj	_	_
26	with	_	IN	IN	_	15	prep	_	_
27	a	_	DT	DT	_	28	det	_	_
28	plasmid	_	NN	NN	_	26	pobj	_	_
29	containing	_	VBG	VBG	_	28	vmod	_	_
30	the	_	DT	DT	_	33	det	_	_
31	intact	_	JJ	JJ	_	33	amod	_	_
32	IL-2	_	NN	NN	_	33	nn	_	_
33	promoter	_	NN	NN	_	29	dobj	_	_
34	driving	_	VBG	VBG	_	33	vmod	_	_
35	the	_	DT	DT	_	36	det	_	_
36	expression	_	NN	NN	_	34	dobj	_	_
37	of	_	IN	IN	_	36	prep	_	_
38	the	_	DT	DT	_	42	det	_	_
39	chloramphenicol	_	NN	NN	_	42	nn	_	_
40	acetyltransferase	_	NN	NN	_	42	nn	_	_
41	reporter	_	NN	NN	_	42	nn	_	_
42	gene	_	NN	NN	_	37	pobj	_	_
43	.	_	.	.	_	15	punct	_	_

1	Cotransfection	_	NN	NN	_	10	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	gamma	_	NN	NN	_	4	nn	_	_
4	B*CaM-K	_	NN	NN	_	2	pobj	_	_
5	with	_	IN	IN	_	1	prep	_	_
6	the	_	DT	DT	_	9	det	_	_
7	IL-2	_	NN	NN	_	9	nn	_	_
8	promoter	_	NN	NN	_	9	nn	_	_
9	construct	_	NN	NN	_	5	pobj	_	_
10	downregulated	_	VBD	VBD	_	0	root	_	_
11	its	_	PRP$	PRP$	_	12	poss	_	_
12	transcription	_	NN	NN	_	10	dobj	_	_
13	in	_	IN	IN	_	10	prep	_	_
14	response	_	NN	NN	_	13	pobj	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	stimulation	_	NN	NN	_	15	pobj	_	_
17	with	_	IN	IN	_	16	prep	_	_
18	ionomycin	_	NN	NN	_	17	pobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	phorbol	_	NN	NN	_	22	nn	_	_
21	myristate	_	NN	NN	_	22	nn	_	_
22	acetate	_	NN	NN	_	18	conj	_	_
23	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
24	PMA	_	NN	NN	_	22	appos	_	_
25	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
26	.	_	.	.	_	10	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	inhibitory	_	JJ	JJ	_	3	amod	_	_
3	effect	_	NN	NN	_	11	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	CaM-K	_	NN	NN	_	4	pobj	_	_
6	II	_	CD	CD	_	5	num	_	_
7	on	_	IN	IN	_	3	prep	_	_
8	IL-2	_	NN	NN	_	9	nn	_	_
9	promoter	_	NN	NN	_	7	pobj	_	_
10	was	_	VBD	VBD	_	11	auxpass	_	_
11	associated	_	VBN	VBN	_	0	root	_	_
12	with	_	IN	IN	_	11	prep	_	_
13	decreased	_	VBN	VBN	_	14	amod	_	_
14	transcription	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	its	_	PRP$	PRP$	_	17	poss	_	_
17	AP-1	_	NN	NN	_	15	pobj	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	NF-AT	_	NN	NN	_	17	conj	_	_
20	transactivating	_	NN	NN	_	21	nn	_	_
21	pathways	_	NNS	NNS	_	17	dep	_	_
22	.	_	.	.	_	11	punct	_	_

1	Under	_	IN	IN	_	8	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	same	_	JJ	JJ	_	4	amod	_	_
4	conditions	_	NNS	NNS	_	1	pobj	_	_
5	,	_	,	,	_	8	punct	_	_
6	delta	_	NN	NN	_	7	nn	_	_
7	CaM-AI	_	NN	NN	_	8	nsubj	_	_
8	superinduced	_	VBD	VBD	_	0	root	_	_
9	IL-2	_	NN	NN	_	10	nn	_	_
10	promoter	_	NN	NN	_	11	nn	_	_
11	activity	_	NN	NN	_	8	dobj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
13	approximately	_	RB	RB	_	14	advmod	_	_
14	twofold	_	JJ	JJ	_	15	amod	_	_
15	increase	_	NN	NN	_	11	appos	_	_
16	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
17	.	_	.	.	_	8	punct	_	_

1	When	_	WRB	WRB	_	5	advmod	_	_
2	both	_	DT	DT	_	3	det	_	_
3	mutants	_	NNS	NNS	_	5	nsubjpass	_	_
4	were	_	VBD	VBD	_	5	auxpass	_	_
5	used	_	VBN	VBN	_	11	advcl	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	combination	_	NN	NN	_	6	pobj	_	_
8	,	_	,	,	_	11	punct	_	_
9	gamma	_	NN	NN	_	10	nn	_	_
10	B*CaM-K	_	NN	NN	_	11	nsubj	_	_
11	inhibited	_	VBD	VBD	_	0	root	_	_
12	the	_	DT	DT	_	13	det	_	_
13	induction	_	NN	NN	_	11	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	17	det	_	_
16	IL-2	_	NN	NN	_	17	nn	_	_
17	promoter	_	NN	NN	_	14	pobj	_	_
18	by	_	IN	IN	_	13	prep	_	_
19	delta	_	NN	NN	_	20	nn	_	_
20	CaM-AI	_	NN	NN	_	18	pobj	_	_
21	.	_	.	.	_	11	punct	_	_

1	Similar	_	JJ	JJ	_	2	amod	_	_
2	results	_	NNS	NNS	_	4	nsubjpass	_	_
3	were	_	VBD	VBD	_	4	auxpass	_	_
4	obtained	_	VBN	VBN	_	0	root	_	_
5	when	_	WRB	WRB	_	14	advmod	_	_
6	a	_	DT	DT	_	7	det	_	_
7	construct	_	NN	NN	_	14	nsubjpass	_	_
8	containing	_	VBG	VBG	_	7	vmod	_	_
9	the	_	DT	DT	_	11	det	_	_
10	IL-4	_	NN	NN	_	11	nn	_	_
11	promoter	_	NN	NN	_	8	dobj	_	_
12	also	_	RB	RB	_	14	advmod	_	_
13	was	_	VBD	VBD	_	14	auxpass	_	_
14	used	_	VBN	VBN	_	4	advcl	_	_
15	.	_	.	.	_	4	punct	_	_

1	gamma	_	NN	NN	_	2	nn	_	_
2	B*CaM-K	_	NN	NN	_	4	nsubj	_	_
3	also	_	RB	RB	_	4	advmod	_	_
4	downregulated	_	VBD	VBD	_	0	root	_	_
5	the	_	DT	DT	_	6	det	_	_
6	activation	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	AP-1	_	NN	NN	_	7	pobj	_	_
9	in	_	IN	IN	_	4	prep	_	_
10	response	_	NN	NN	_	9	pobj	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	transfection	_	NN	NN	_	11	pobj	_	_
13	with	_	IN	IN	_	12	prep	_	_
14	a	_	DT	DT	_	17	det	_	_
15	constitutively	_	RB	RB	_	16	advmod	_	_
16	active	_	JJ	JJ	_	17	amod	_	_
17	mutant	_	NN	NN	_	13	pobj	_	_
18	of	_	IN	IN	_	13	prep	_	_
19	PKC	_	NN	NN	_	18	pobj	_	_
20	or	_	CC	CC	_	12	cc	_	_
21	stimulation	_	NN	NN	_	12	conj	_	_
22	with	_	IN	IN	_	21	prep	_	_
23	PMA	_	NN	NN	_	22	pobj	_	_
24	.	_	.	.	_	4	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	8	mark	_	_
5	CaM-K	_	NN	NN	_	8	nsubj	_	_
6	II	_	CD	CD	_	5	num	_	_
7	may	_	MD	MD	_	8	aux	_	_
8	exert	_	VB	VB	_	3	ccomp	_	_
9	negative	_	JJ	JJ	_	10	amod	_	_
10	influences	_	NNS	NNS	_	8	dobj	_	_
11	on	_	IN	IN	_	8	prep	_	_
12	cytokine	_	NN	NN	_	13	nn	_	_
13	gene	_	NN	NN	_	14	nn	_	_
14	transcription	_	NN	NN	_	11	pobj	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	human	_	JJ	JJ	_	18	amod	_	_
17	T	_	NN	NN	_	18	nn	_	_
18	cells	_	NNS	NNS	_	15	pobj	_	_
19	,	_	,	,	_	3	punct	_	_
20	and	_	CC	CC	_	3	cc	_	_
21	provide	_	VBP	VBP	_	3	conj	_	_
22	preliminary	_	JJ	JJ	_	23	amod	_	_
23	evidence	_	NN	NN	_	21	dobj	_	_
24	for	_	IN	IN	_	23	prep	_	_
25	negative	_	JJ	JJ	_	26	amod	_	_
26	cross-talk	_	NN	NN	_	24	pobj	_	_
27	with	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	29	dep	_	_
29	calcineurin-	_	NN	NN	_	27	pobj	_	_
30	and	_	CC	CC	_	29	cc	_	_
31	PKC-	_	NN	NN	_	29	conj	_	_
32	dependent	_	JJ	JJ	_	34	amod	_	_
33	signaling	_	NN	NN	_	34	nn	_	_
34	systems	_	NNS	NNS	_	29	dep	_	_
35	.	_	.	.	_	3	punct	_	_

1	Regulation	_	NN	NN	_	0	root	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	specificity	_	NN	NN	_	1	conj	_	_
4	of	_	IN	IN	_	1	prep	_	_
5	MNDA	_	NN	NN	_	6	nn	_	_
6	expression	_	NN	NN	_	4	pobj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	monocytes	_	NNS	NNS	_	7	pobj	_	_
9	,	_	,	,	_	8	punct	_	_
10	macrophages	_	NNS	NNS	_	8	conj	_	_
11	,	_	,	,	_	8	punct	_	_
12	and	_	CC	CC	_	8	cc	_	_
13	leukemia/B	_	NN	NN	_	16	nn	_	_
14	lymphoma	_	NN	NN	_	16	nn	_	_
15	cell	_	NN	NN	_	16	nn	_	_
16	lines	_	NNS	NNS	_	8	conj	_	_
17	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	expression	_	NN	NN	_	15	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	10	det	_	_
5	human	_	JJ	JJ	_	10	amod	_	_
6	myeloid	_	JJ	JJ	_	10	amod	_	_
7	cell	_	NN	NN	_	10	nn	_	_
8	nuclear	_	JJ	JJ	_	10	amod	_	_
9	differentiation	_	NN	NN	_	10	nn	_	_
10	antigen	_	NN	NN	_	3	pobj	_	_
11	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
12	MNDA	_	NN	NN	_	10	appos	_	_
13	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	was	_	VBD	VBD	_	15	auxpass	_	_
15	observed	_	VBN	VBN	_	0	root	_	_
16	specifically	_	RB	RB	_	15	advmod	_	_
17	in	_	IN	IN	_	15	prep	_	_
18	cells	_	NNS	NNS	_	17	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	22	det	_	_
21	granulocyte-macrophage	_	JJ	JJ	_	22	amod	_	_
22	lineage	_	NN	NN	_	19	pobj	_	_
23	in	_	IN	IN	_	15	prep	_	_
24	our	_	PRP$	PRP$	_	26	poss	_	_
25	earlier	_	JJR	JJR	_	26	amod	_	_
26	reports	_	NNS	NNS	_	23	pobj	_	_
27	.	_	.	.	_	15	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	specificity	_	NN	NN	_	13	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	MNDA	_	NN	NN	_	5	nn	_	_
5	expression	_	NN	NN	_	3	pobj	_	_
6	for	_	IN	IN	_	5	prep	_	_
7	cells	_	NNS	NNS	_	6	pobj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	granulocyte-macrophage	_	NN	NN	_	11	nn	_	_
11	lineage	_	NN	NN	_	8	pobj	_	_
12	was	_	VBD	VBD	_	13	auxpass	_	_
13	reexamined	_	VBN	VBN	_	0	root	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	cell	_	NN	NN	_	16	nn	_	_
16	lines	_	NNS	NNS	_	14	pobj	_	_
17	established	_	VBN	VBN	_	16	vmod	_	_
18	from	_	IN	IN	_	17	prep	_	_
19	patients	_	NNS	NNS	_	18	pobj	_	_
20	with	_	IN	IN	_	19	prep	_	_
21	Philadelphia	_	NN	NN	_	25	nn	_	_
22	chromosome-positive	_	JJ	JJ	_	25	amod	_	_
23	chronic	_	JJ	JJ	_	25	amod	_	_
24	myeloid	_	JJ	JJ	_	25	amod	_	_
25	leukemia	_	NN	NN	_	20	pobj	_	_
26	.	_	.	.	_	13	punct	_	_

1	Cell	_	NN	NN	_	2	nn	_	_
2	lines	_	NNS	NNS	_	6	nsubj	_	_
3	that	_	WDT	WDT	_	4	nsubj	_	_
4	expressed	_	VBD	VBD	_	2	rcmod	_	_
5	MNDA	_	NN	NN	_	4	dobj	_	_
6	exhibited	_	VBD	VBD	_	0	root	_	_
7	myeloid	_	JJ	JJ	_	9	amod	_	_
8	cell	_	NN	NN	_	9	nn	_	_
9	features	_	NNS	NNS	_	6	dobj	_	_
10	and	_	CC	CC	_	6	cc	_	_
11	granulocyte	_	NN	NN	_	17	nsubjpass	_	_
12	or	_	CC	CC	_	11	cc	_	_
13	monocyte	_	NN	NN	_	11	conj	_	_
14	differentiation	_	NN	NN	_	11	dep	_	_
15	could	_	MD	MD	_	17	aux	_	_
16	be	_	VB	VB	_	17	auxpass	_	_
17	induced	_	VBN	VBN	_	6	conj	_	_
18	in	_	FW	FW	_	19	nn	_	_
19	vitro	_	FW	FW	_	17	advmod	_	_
20	,	_	,	,	_	6	punct	_	_
21	while	_	IN	IN	_	36	mark	_	_
22	cell	_	NN	NN	_	23	nn	_	_
23	lines	_	NNS	NNS	_	36	nsubj	_	_
24	exhibiting	_	VBG	VBG	_	23	vmod	_	_
25	properties	_	NNS	NNS	_	24	dobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	very	_	RB	RB	_	30	advmod	_	_
28	early	_	JJ	JJ	_	30	amod	_	_
29	stage	_	NN	NN	_	30	nn	_	_
30	cells	_	NNS	NNS	_	26	pobj	_	_
31	or	_	CC	CC	_	30	cc	_	_
32	multipotential	_	JJ	JJ	_	33	amod	_	_
33	cells	_	NNS	NNS	_	30	conj	_	_
34	did	_	VBD	VBD	_	36	aux	_	_
35	not	_	RB	RB	_	36	neg	_	_
36	express	_	VB	VB	_	6	dep	_	_
37	MNDA	_	NN	NN	_	36	dobj	_	_
38	.	_	.	.	_	6	punct	_	_

1	Cells	_	NNS	NNS	_	10	nsubj	_	_
2	originating	_	VBG	VBG	_	1	vmod	_	_
3	from	_	IN	IN	_	2	prep	_	_
4	cases	_	NNS	NNS	_	3	pobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	Burkitt	_	NN	NN	_	8	poss	_	_
7	's	_	POS	POS	_	8	possessive	_	_
8	lymphoma	_	NN	NN	_	5	pobj	_	_
9	were	_	VBD	VBD	_	10	cop	_	_
10	negative	_	JJ	JJ	_	0	root	_	_
11	.	_	.	.	_	10	punct	_	_

1	By	_	IN	IN	_	18	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	18	punct	_	_
4	three	_	CD	CD	_	7	num	_	_
5	lymphoblastoid	_	JJ	JJ	_	7	amod	_	_
6	cell	_	NN	NN	_	7	nn	_	_
7	lines	_	NNS	NNS	_	18	nsubj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	immortalized	_	VBN	VBN	_	7	dep	_	_
10	in	_	FW	FW	_	11	nn	_	_
11	vitro	_	FW	FW	_	9	advmod	_	_
12	with	_	IN	IN	_	9	prep	_	_
13	Epstein-Barr	_	JJ	JJ	_	14	amod	_	_
14	virus	_	NN	NN	_	12	pobj	_	_
15	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
16	were	_	VBD	VBD	_	18	cop	_	_
17	weakly	_	RB	RB	_	18	advmod	_	_
18	positive	_	JJ	JJ	_	0	root	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	MNDA	_	NN	NN	_	22	nsubjpass	_	_
21	was	_	VBD	VBD	_	22	auxpass	_	_
22	up-regulated	_	VBN	VBN	_	18	conj	_	_
23	by	_	IN	IN	_	22	prep	_	_
24	interferon-alpha	_	NN	NN	_	28	nn	_	_
25	-LRB-	_	-LRB-	-LRB-	_	26	punct	_	_
26	IFN-alpha	_	NN	NN	_	24	appos	_	_
27	-RRB-	_	-RRB-	-RRB-	_	26	punct	_	_
28	treatment	_	NN	NN	_	23	pobj	_	_
29	.	_	.	.	_	18	punct	_	_

1	As	_	IN	IN	_	3	mark	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	reported	_	VBD	VBD	_	13	advcl	_	_
4	previously	_	RB	RB	_	3	advmod	_	_
5	,	_	,	,	_	13	punct	_	_
6	MNDA	_	NN	NN	_	7	nn	_	_
7	mRNA	_	NN	NN	_	8	nn	_	_
8	level	_	NN	NN	_	13	nsubjpass	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	adherent	_	JJ	JJ	_	11	amod	_	_
11	monocytes	_	NNS	NNS	_	9	pobj	_	_
12	is	_	VBZ	VBZ	_	13	auxpass	_	_
13	elevated	_	VBN	VBN	_	0	root	_	_
14	by	_	IN	IN	_	13	prep	_	_
15	IFN-alpha	_	NN	NN	_	14	pobj	_	_
16	;	_	:	:	_	13	punct	_	_
17	in	_	IN	IN	_	23	prep	_	_
18	this	_	DT	DT	_	19	det	_	_
19	study	_	NN	NN	_	17	pobj	_	_
20	,	_	,	,	_	23	punct	_	_
21	we	_	PRP	PRP	_	23	nsubj	_	_
22	further	_	RB	RB	_	23	advmod	_	_
23	assessed	_	VBD	VBD	_	13	parataxis	_	_
24	MNDA	_	NN	NN	_	25	nn	_	_
25	expression	_	NN	NN	_	23	dobj	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	in	_	FW	FW	_	30	amod	_	_
28	vitro	_	FW	FW	_	27	dep	_	_
29	monocyte-derived	_	JJ	JJ	_	30	amod	_	_
30	macrophages	_	NNS	NNS	_	26	pobj	_	_
31	.	_	.	.	_	13	punct	_	_

1	Three	_	CD	CD	_	3	num	_	_
2	additional	_	JJ	JJ	_	3	amod	_	_
3	agents	_	NNS	NNS	_	30	nsubjpass	_	_
4	-LRB-	_	-LRB-	-LRB-	_	5	punct	_	_
5	endotoxin	_	NN	NN	_	3	dep	_	_
6	,	_	,	,	_	5	punct	_	_
7	phytohemagglutinin	_	NN	NN	_	5	conj	_	_
8	,	_	,	,	_	5	punct	_	_
9	and	_	CC	CC	_	5	cc	_	_
10	phorbol	_	NN	NN	_	11	nn	_	_
11	ester	_	NN	NN	_	5	conj	_	_
12	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
13	and	_	CC	CC	_	3	cc	_	_
14	other	_	JJ	JJ	_	15	amod	_	_
15	conditions	_	NNS	NNS	_	3	conj	_	_
16	that	_	WDT	WDT	_	17	nsubj	_	_
17	affect	_	VBP	VBP	_	15	rcmod	_	_
18	function	_	NN	NN	_	17	dobj	_	_
19	,	_	,	,	_	18	punct	_	_
20	cytokine	_	NN	NN	_	18	appos	_	_
21	production	_	NN	NN	_	20	dep	_	_
22	,	_	,	,	_	20	punct	_	_
23	differentiation	_	NN	NN	_	20	appos	_	_
24	,	_	,	,	_	20	punct	_	_
25	and/or	_	CC	CC	_	20	cc	_	_
26	growth	_	NN	NN	_	20	conj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	monocytes	_	NNS	NNS	_	27	pobj	_	_
29	were	_	VBD	VBD	_	30	auxpass	_	_
30	examined	_	VBN	VBN	_	0	root	_	_
31	for	_	IN	IN	_	30	prep	_	_
32	their	_	PRP$	PRP$	_	33	poss	_	_
33	ability	_	NN	NN	_	31	pobj	_	_
34	to	_	TO	TO	_	35	aux	_	_
35	alter	_	VB	VB	_	33	vmod	_	_
36	MNDA	_	NN	NN	_	37	nn	_	_
37	expression	_	NN	NN	_	35	dobj	_	_
38	.	_	.	.	_	30	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	varied	_	VBD	VBD	_	0	root	_	_
4	with	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	6	det	_	_
6	agent	_	NN	NN	_	4	pobj	_	_
7	,	_	,	,	_	6	punct	_	_
8	cell	_	NN	NN	_	9	nn	_	_
9	type	_	NN	NN	_	6	conj	_	_
10	,	_	,	,	_	6	punct	_	_
11	and	_	CC	CC	_	6	cc	_	_
12	stage	_	NN	NN	_	6	conj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	differentiation	_	NN	NN	_	13	pobj	_	_
15	.	_	.	.	_	3	punct	_	_

1	Changes	_	NNS	NNS	_	5	nsubj	_	_
2	in	_	IN	IN	_	1	prep	_	_
3	MNDA	_	NN	NN	_	4	nn	_	_
4	expression	_	NN	NN	_	2	pobj	_	_
5	occurred	_	VBD	VBD	_	0	root	_	_
6	slowly	_	RB	RB	_	5	advmod	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	hours	_	NNS	NNS	_	6	dep	_	_
9	to	_	TO	TO	_	8	prep	_	_
10	days	_	NNS	NNS	_	9	pobj	_	_
11	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
12	,	_	,	,	_	5	punct	_	_
13	suggesting	_	VBG	VBG	_	5	xcomp	_	_
14	that	_	IN	IN	_	17	mark	_	_
15	MNDA	_	NN	NN	_	17	nsubj	_	_
16	could	_	MD	MD	_	17	aux	_	_
17	mediate	_	VB	VB	_	13	ccomp	_	_
18	changes	_	NNS	NNS	_	17	dobj	_	_
19	realized	_	VBN	VBN	_	18	vmod	_	_
20	over	_	IN	IN	_	19	prep	_	_
21	a	_	DT	DT	_	23	det	_	_
22	long	_	JJ	JJ	_	23	amod	_	_
23	period	_	NN	NN	_	20	pobj	_	_
24	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	4	nsubj	_	_
3	also	_	RB	RB	_	4	advmod	_	_
4	reveal	_	VBP	VBP	_	0	root	_	_
5	a	_	DT	DT	_	6	det	_	_
6	discordance	_	NN	NN	_	4	dobj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	certain	_	JJ	JJ	_	11	amod	_	_
9	MNDA	_	NN	NN	_	11	nn	_	_
10	positive	_	JJ	JJ	_	11	amod	_	_
11	cells	_	NNS	NNS	_	7	pobj	_	_
12	between	_	IN	IN	_	6	prep	_	_
13	steady-state	_	JJ	JJ	_	14	amod	_	_
14	levels	_	NNS	NNS	_	12	pobj	_	_
15	or	_	CC	CC	_	14	cc	_	_
16	changes	_	NNS	NNS	_	14	conj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	levels	_	NNS	NNS	_	17	pobj	_	_
19	of	_	IN	IN	_	16	prep	_	_
20	protein	_	NN	NN	_	19	pobj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	mRNA	_	NN	NN	_	20	conj	_	_
23	indicating	_	VBG	VBG	_	16	vmod	_	_
24	that	_	IN	IN	_	30	mark	_	_
25	the	_	DT	DT	_	26	det	_	_
26	regulation	_	NN	NN	_	30	nsubj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	MNDA	_	NN	NN	_	29	nn	_	_
29	expression	_	NN	NN	_	27	pobj	_	_
30	occurs	_	VBZ	VBZ	_	23	ccomp	_	_
31	at	_	IN	IN	_	30	prep	_	_
32	more	_	JJR	JJR	_	33	mwe	_	_
33	than	_	IN	IN	_	34	quantmod	_	_
34	one	_	CD	CD	_	35	num	_	_
35	point	_	NN	NN	_	31	pobj	_	_
36	.	_	.	.	_	4	punct	_	_

1	Changes	_	NNS	NNS	_	6	nsubj	_	_
2	in	_	IN	IN	_	1	prep	_	_
3	MNDA	_	NN	NN	_	4	nn	_	_
4	expression	_	NN	NN	_	2	pobj	_	_
5	are	_	VBP	VBP	_	6	cop	_	_
6	consistent	_	JJ	JJ	_	0	root	_	_
7	with	_	IN	IN	_	6	prep	_	_
8	a	_	DT	DT	_	9	det	_	_
9	role	_	NN	NN	_	7	pobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	opposing	_	VBG	VBG	_	10	pcomp	_	_
12	macrophage	_	NN	NN	_	13	nn	_	_
13	differentiation	_	NN	NN	_	11	dobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	activation	_	NN	NN	_	13	conj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	monocytes/macrophages	_	NNS	NNS	_	16	pobj	_	_
18	.	_	.	.	_	6	punct	_	_

1	Differences	_	NNS	NNS	_	0	root	_	_
2	in	_	IN	IN	_	1	prep	_	_
3	binding	_	NN	NN	_	2	pobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	glucocorticoid	_	NN	NN	_	6	nn	_	_
6	receptor	_	NN	NN	_	4	pobj	_	_
7	to	_	TO	TO	_	3	prep	_	_
8	DNA	_	NN	NN	_	7	pobj	_	_
9	in	_	IN	IN	_	1	prep	_	_
10	steroid-resistant	_	JJ	JJ	_	11	amod	_	_
11	asthma	_	NN	NN	_	9	pobj	_	_
12	.	_	.	.	_	1	punct	_	_

1	Although	_	IN	IN	_	7	mark	_	_
2	glucocorticosteroids	_	NNS	NNS	_	7	nsubj	_	_
3	are	_	VBP	VBP	_	7	cop	_	_
4	a	_	DT	DT	_	7	det	_	_
5	very	_	RB	RB	_	6	advmod	_	_
6	effective	_	JJ	JJ	_	7	amod	_	_
7	treatment	_	NN	NN	_	22	advcl	_	_
8	for	_	IN	IN	_	7	prep	_	_
9	asthma	_	NN	NN	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	other	_	JJ	JJ	_	14	amod	_	_
12	chronic	_	JJ	JJ	_	14	amod	_	_
13	inflammatory	_	JJ	JJ	_	12	dep	_	_
14	diseases	_	NNS	NNS	_	9	conj	_	_
15	,	_	,	,	_	22	punct	_	_
16	a	_	DT	DT	_	18	det	_	_
17	small	_	JJ	JJ	_	18	amod	_	_
18	proportion	_	NN	NN	_	22	nsubj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	patients	_	NNS	NNS	_	19	pobj	_	_
21	are	_	VBP	VBP	_	22	cop	_	_
22	resistant	_	JJ	JJ	_	0	root	_	_
23	to	_	TO	TO	_	22	prep	_	_
24	their	_	PRP$	PRP$	_	26	poss	_	_
25	therapeutic	_	JJ	JJ	_	26	amod	_	_
26	effects	_	NNS	NNS	_	23	pobj	_	_
27	.	_	.	.	_	22	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	molecular	_	JJ	JJ	_	3	amod	_	_
3	mechanism	_	NN	NN	_	9	nsubj	_	_
4	for	_	IN	IN	_	3	prep	_	_
5	this	_	DT	DT	_	7	det	_	_
6	steroid	_	NN	NN	_	7	nn	_	_
7	resistance	_	NN	NN	_	4	pobj	_	_
8	is	_	VBZ	VBZ	_	9	cop	_	_
9	unclear	_	JJ	JJ	_	0	root	_	_
10	.	_	.	.	_	9	punct	_	_

1	Steroid	_	NN	NN	_	2	nn	_	_
2	resistance	_	NN	NN	_	6	nsubjpass	_	_
3	can	_	MD	MD	_	6	aux	_	_
4	not	_	RB	RB	_	6	neg	_	_
5	be	_	VB	VB	_	6	auxpass	_	_
6	explained	_	VBN	VBN	_	0	root	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	pharmacokinetic	_	JJ	JJ	_	9	amod	_	_
9	mechanisms	_	NNS	NNS	_	7	pobj	_	_
10	,	_	,	,	_	7	punct	_	_
11	by	_	IN	IN	_	7	conj	_	_
12	a	_	DT	DT	_	13	det	_	_
13	defect	_	NN	NN	_	11	pobj	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	binding	_	NN	NN	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	steroids	_	NNS	NNS	_	17	pobj	_	_
19	to	_	TO	TO	_	16	prep	_	_
20	glucocorticoid	_	NN	NN	_	21	nn	_	_
21	receptors	_	NNS	NNS	_	19	pobj	_	_
22	,	_	,	,	_	7	punct	_	_
23	nor	_	CC	CC	_	7	cc	_	_
24	by	_	IN	IN	_	7	conj	_	_
25	defective	_	JJ	JJ	_	27	amod	_	_
26	nuclear	_	JJ	JJ	_	27	amod	_	_
27	translocation	_	NN	NN	_	24	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	this	_	DT	DT	_	30	det	_	_
30	receptor	_	NN	NN	_	28	pobj	_	_
31	,	_	,	,	_	6	punct	_	_
32	thereby	_	RB	RB	_	33	advmod	_	_
33	suggesting	_	VBG	VBG	_	6	vmod	_	_
34	that	_	IN	IN	_	38	mark	_	_
35	the	_	DT	DT	_	37	det	_	_
36	molecular	_	JJ	JJ	_	37	amod	_	_
37	abnormality	_	NN	NN	_	38	nsubj	_	_
38	lies	_	VBZ	VBZ	_	33	ccomp	_	_
39	distal	_	JJ	JJ	_	38	acomp	_	_
40	to	_	TO	TO	_	39	prep	_	_
41	nuclear	_	JJ	JJ	_	42	amod	_	_
42	translocation	_	NN	NN	_	40	pobj	_	_
43	.	_	.	.	_	6	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	examined	_	VBD	VBD	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	ability	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	nuclear	_	JJ	JJ	_	9	amod	_	_
7	translocated	_	VBN	VBN	_	9	amod	_	_
8	glucocorticoid	_	NN	NN	_	9	nn	_	_
9	receptors	_	NNS	NNS	_	5	pobj	_	_
10	to	_	TO	TO	_	11	aux	_	_
11	bind	_	VB	VB	_	4	vmod	_	_
12	to	_	TO	TO	_	11	prep	_	_
13	their	_	PRP$	PRP$	_	16	poss	_	_
14	DNA	_	NN	NN	_	16	nn	_	_
15	binding	_	NN	NN	_	16	nn	_	_
16	sites	_	NNS	NNS	_	12	pobj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	GRE	_	NN	NN	_	16	appos	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	using	_	VBG	VBG	_	2	xcomp	_	_
21	electrophoretic	_	JJ	JJ	_	24	amod	_	_
22	mobility	_	NN	NN	_	24	nn	_	_
23	shift	_	NN	NN	_	24	nn	_	_
24	assays	_	NNS	NNS	_	20	dobj	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	PBMC	_	NN	NN	_	25	pobj	_	_
27	from	_	IN	IN	_	26	prep	_	_
28	patients	_	NNS	NNS	_	27	pobj	_	_
29	with	_	IN	IN	_	28	prep	_	_
30	steroid-sensitive	_	JJ	JJ	_	29	pobj	_	_
31	and	_	CC	CC	_	30	cc	_	_
32	steroid-resistant	_	JJ	JJ	_	30	conj	_	_
33	asthma	_	NN	NN	_	30	dep	_	_
34	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	binding	_	NN	NN	_	14	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	glucocorticoid	_	NN	NN	_	6	nn	_	_
6	receptor	_	NN	NN	_	3	pobj	_	_
7	to	_	TO	TO	_	2	prep	_	_
8	DNA	_	NN	NN	_	7	pobj	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	these	_	DT	DT	_	11	det	_	_
11	patients	_	NNS	NNS	_	9	pobj	_	_
12	was	_	VBD	VBD	_	14	auxpass	_	_
13	also	_	RB	RB	_	14	advmod	_	_
14	studied	_	VBN	VBN	_	0	root	_	_
15	using	_	VBG	VBG	_	14	xcomp	_	_
16	Scatchard	_	NN	NN	_	17	nn	_	_
17	analysis	_	NN	NN	_	15	dobj	_	_
18	.	_	.	.	_	14	punct	_	_

1	Dexamethasone	_	NN	NN	_	2	nsubj	_	_
2	induced	_	VBD	VBD	_	0	root	_	_
3	a	_	DT	DT	_	9	det	_	_
4	significant	_	JJ	JJ	_	8	dep	_	_
5	rapid	_	JJ	JJ	_	8	dep	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	sustained	_	JJ	JJ	_	5	conj	_	_
8	twofold	_	JJ	JJ	_	9	amod	_	_
9	increase	_	NN	NN	_	2	dobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	GRE	_	NN	NN	_	12	nn	_	_
12	binding	_	NN	NN	_	10	pobj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	PBMCs	_	NNS	NNS	_	13	pobj	_	_
15	from	_	IN	IN	_	14	prep	_	_
16	steroid-sensitive	_	JJ	JJ	_	18	amod	_	_
17	asthmatic	_	JJ	JJ	_	18	amod	_	_
18	patients	_	NNS	NNS	_	15	pobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	nonasthmatic	_	JJ	JJ	_	21	amod	_	_
21	individuals	_	NNS	NNS	_	18	conj	_	_
22	,	_	,	,	_	2	punct	_	_
23	but	_	CC	CC	_	2	cc	_	_
24	this	_	DT	DT	_	27	nsubjpass	_	_
25	was	_	VBD	VBD	_	27	auxpass	_	_
26	markedly	_	RB	RB	_	27	advmod	_	_
27	reduced	_	VBN	VBN	_	2	conj	_	_
28	in	_	IN	IN	_	27	prep	_	_
29	steroid-resistant	_	JJ	JJ	_	31	amod	_	_
30	asthmatic	_	JJ	JJ	_	31	amod	_	_
31	patients	_	NNS	NNS	_	28	pobj	_	_
32	.	_	.	.	_	2	punct	_	_

1	Scatchard	_	NN	NN	_	2	nn	_	_
2	analysis	_	NN	NN	_	7	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	glucocorticoid	_	NN	NN	_	6	nn	_	_
5	receptor-GRE	_	NN	NN	_	6	nn	_	_
6	binding	_	NN	NN	_	3	pobj	_	_
7	showed	_	VBD	VBD	_	0	root	_	_
8	no	_	DT	DT	_	9	neg	_	_
9	change	_	NN	NN	_	7	dobj	_	_
10	in	_	IN	IN	_	7	prep	_	_
11	binding	_	NN	NN	_	12	nn	_	_
12	affinity	_	NN	NN	_	10	pobj	_	_
13	but	_	CC	CC	_	7	cc	_	_
14	did	_	VBD	VBD	_	15	aux	_	_
15	show	_	VB	VB	_	7	conj	_	_
16	a	_	DT	DT	_	18	det	_	_
17	reduced	_	VBN	VBN	_	18	amod	_	_
18	number	_	NN	NN	_	15	dobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	receptors	_	NNS	NNS	_	19	pobj	_	_
21	available	_	JJ	JJ	_	20	amod	_	_
22	for	_	IN	IN	_	21	prep	_	_
23	DNA	_	NN	NN	_	24	nn	_	_
24	binding	_	NN	NN	_	22	pobj	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	28	det	_	_
27	steroid-resistant	_	JJ	JJ	_	28	amod	_	_
28	patients	_	NNS	NNS	_	25	pobj	_	_
29	.	_	.	.	_	7	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	16	mark	_	_
5	the	_	DT	DT	_	6	det	_	_
6	ability	_	NN	NN	_	16	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	glucocorticoid	_	NN	NN	_	10	nn	_	_
10	receptor	_	NN	NN	_	7	pobj	_	_
11	to	_	TO	TO	_	12	aux	_	_
12	bind	_	VB	VB	_	6	vmod	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	GRE	_	NN	NN	_	13	pobj	_	_
15	is	_	VBZ	VBZ	_	16	cop	_	_
16	impaired	_	JJ	JJ	_	3	ccomp	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	steroid-resistant	_	JJ	JJ	_	19	amod	_	_
19	patients	_	NNS	NNS	_	17	pobj	_	_
20	because	_	IN	IN	_	16	prep	_	_
21	of	_	IN	IN	_	20	pcomp	_	_
22	a	_	DT	DT	_	24	det	_	_
23	reduced	_	VBN	VBN	_	24	amod	_	_
24	number	_	NN	NN	_	21	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	receptors	_	NNS	NNS	_	25	pobj	_	_
27	available	_	JJ	JJ	_	26	amod	_	_
28	for	_	IN	IN	_	27	prep	_	_
29	binding	_	VBG	VBG	_	28	pcomp	_	_
30	to	_	TO	TO	_	29	prep	_	_
31	DNA	_	NN	NN	_	30	pobj	_	_
32	.	_	.	.	_	3	punct	_	_

1	A	_	DT	DT	_	2	det	_	_
2	family	_	NN	NN	_	12	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	serine	_	NN	NN	_	5	nn	_	_
5	proteases	_	NNS	NNS	_	3	pobj	_	_
6	expressed	_	VBN	VBN	_	5	vmod	_	_
7	exclusively	_	RB	RB	_	6	advmod	_	_
8	in	_	IN	IN	_	6	prep	_	_
9	myelo-monocytic	_	JJ	JJ	_	10	amod	_	_
10	cells	_	NNS	NNS	_	8	pobj	_	_
11	specifically	_	RB	RB	_	12	advmod	_	_
12	processes	_	VBZ	VBZ	_	0	root	_	_
13	the	_	DT	DT	_	18	det	_	_
14	nuclear	_	JJ	JJ	_	18	amod	_	_
15	factor-kappa	_	NN	NN	_	18	nn	_	_
16	B	_	NN	NN	_	18	nn	_	_
17	subunit	_	NN	NN	_	18	nn	_	_
18	p65	_	NN	NN	_	12	dobj	_	_
19	in	_	FW	FW	_	20	nn	_	_
20	vitro	_	FW	FW	_	12	advmod	_	_
21	and	_	CC	CC	_	12	cc	_	_
22	may	_	MD	MD	_	23	aux	_	_
23	impair	_	VB	VB	_	12	conj	_	_
24	human	_	JJ	JJ	_	27	amod	_	_
25	immunodeficiency	_	NN	NN	_	27	nn	_	_
26	virus	_	NN	NN	_	27	nn	_	_
27	replication	_	NN	NN	_	23	dobj	_	_
28	in	_	IN	IN	_	27	prep	_	_
29	these	_	DT	DT	_	30	det	_	_
30	cells	_	NNS	NNS	_	28	pobj	_	_
31	.	_	.	.	_	12	punct	_	_

1	Two	_	CD	CD	_	2	num	_	_
2	groups	_	NNS	NNS	_	8	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	U937	_	NN	NN	_	6	nn	_	_
5	promonocytic	_	JJ	JJ	_	6	amod	_	_
6	cells	_	NNS	NNS	_	3	pobj	_	_
7	were	_	VBD	VBD	_	8	auxpass	_	_
8	obtained	_	VBN	VBN	_	0	root	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	limiting	_	VBG	VBG	_	9	pcomp	_	_
11	dilution	_	NN	NN	_	12	nn	_	_
12	cloning	_	NN	NN	_	10	dobj	_	_
13	which	_	WDT	WDT	_	14	nsubj	_	_
14	differed	_	VBD	VBD	_	12	rcmod	_	_
15	strikingly	_	RB	RB	_	14	advmod	_	_
16	in	_	IN	IN	_	14	prep	_	_
17	their	_	PRP$	PRP$	_	18	poss	_	_
18	ability	_	NN	NN	_	16	pobj	_	_
19	to	_	TO	TO	_	20	aux	_	_
20	support	_	VB	VB	_	18	vmod	_	_
21	human	_	JJ	JJ	_	23	amod	_	_
22	immunodeficiency	_	NN	NN	_	23	nn	_	_
23	virus	_	NN	NN	_	28	nn	_	_
24	1	_	CD	CD	_	23	num	_	_
25	-LRB-	_	-LRB-	-LRB-	_	26	punct	_	_
26	HIV-1	_	NN	NN	_	23	appos	_	_
27	-RRB-	_	-RRB-	-RRB-	_	26	punct	_	_
28	replication	_	NN	NN	_	20	dobj	_	_
29	.	_	.	.	_	8	punct	_	_

1	``	_	``	``	_	3	punct	_	_
2	Plus	_	JJ	JJ	_	3	amod	_	_
3	clones	_	NNS	NNS	_	4	nsubj	_	_
4	replicated	_	VBD	VBD	_	0	root	_	_
5	the	_	DT	DT	_	6	det	_	_
6	virus	_	NN	NN	_	4	dobj	_	_
7	efficiently	_	RB	RB	_	4	advmod	_	_
8	,	_	,	,	_	4	punct	_	_
9	whereas	_	IN	IN	_	13	mark	_	_
10	``	_	``	``	_	12	punct	_	_
11	minus	_	JJ	JJ	_	12	amod	_	_
12	clones	_	NNS	NNS	_	13	nsubj	_	_
13	did	_	VBD	VBD	_	4	advcl	_	_
14	not	_	RB	RB	_	13	neg	_	_
15	.	_	.	.	_	4	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	examined	_	VBD	VBD	_	0	root	_	_
3	these	_	DT	DT	_	4	det	_	_
4	clones	_	NNS	NNS	_	2	dobj	_	_
5	for	_	IN	IN	_	2	prep	_	_
6	differences	_	NNS	NNS	_	5	pobj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	nuclear	_	JJ	JJ	_	14	amod	_	_
9	factor	_	NN	NN	_	14	nn	_	_
10	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
11	NF	_	NN	NN	_	14	nn	_	_
12	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
13	-kappa	_	NN	NN	_	14	nn	_	_
14	B	_	NN	NN	_	15	nn	_	_
15	activity	_	NN	NN	_	7	pobj	_	_
16	which	_	WDT	WDT	_	18	nsubj	_	_
17	might	_	MD	MD	_	18	aux	_	_
18	account	_	VB	VB	_	15	rcmod	_	_
19	for	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	22	det	_	_
21	observed	_	VBN	VBN	_	22	amod	_	_
22	phenomenon	_	NN	NN	_	19	pobj	_	_
23	.	_	.	.	_	2	punct	_	_

1	Stimulation	_	NN	NN	_	5	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	plus	_	CC	CC	_	4	cc	_	_
4	clones	_	NNS	NNS	_	2	pobj	_	_
5	liberated	_	VBD	VBD	_	0	root	_	_
6	the	_	DT	DT	_	9	det	_	_
7	classical	_	JJ	JJ	_	9	amod	_	_
8	p50-p65	_	NN	NN	_	9	nn	_	_
9	complex	_	NN	NN	_	5	dobj	_	_
10	from	_	IN	IN	_	5	prep	_	_
11	cytoplasmic	_	JJ	JJ	_	12	amod	_	_
12	pools	_	NNS	NNS	_	10	pobj	_	_
13	,	_	,	,	_	5	punct	_	_
14	whereas	_	IN	IN	_	17	mark	_	_
15	minus	_	JJ	JJ	_	16	amod	_	_
16	clones	_	NNS	NNS	_	17	nsubj	_	_
17	produced	_	VBD	VBD	_	5	advcl	_	_
18	an	_	DT	DT	_	23	det	_	_
19	apparently	_	RB	RB	_	20	advmod	_	_
20	novel	_	JJ	JJ	_	23	amod	_	_
21	,	_	,	,	_	23	punct	_	_
22	faster-migrating	_	JJ	JJ	_	23	amod	_	_
23	complex	_	NN	NN	_	17	dobj	_	_
24	,	_	,	,	_	5	punct	_	_
25	as	_	IN	IN	_	26	mark	_	_
26	judged	_	VBN	VBN	_	5	advcl	_	_
27	by	_	IN	IN	_	26	prep	_	_
28	electrophoretic	_	JJ	JJ	_	31	amod	_	_
29	mobility	_	NN	NN	_	31	nn	_	_
30	shift	_	NN	NN	_	31	nn	_	_
31	assays	_	NNS	NNS	_	27	pobj	_	_
32	.	_	.	.	_	5	punct	_	_

1	It	_	PRP	PRP	_	3	nsubj	_	_
2	is	_	VBZ	VBZ	_	3	cop	_	_
3	surprising	_	JJ	JJ	_	0	root	_	_
4	that	_	IN	IN	_	9	mark	_	_
5	the	_	DT	DT	_	7	det	_	_
6	faster-migrating	_	JJ	JJ	_	7	amod	_	_
7	complex	_	NN	NN	_	9	nsubjpass	_	_
8	was	_	VBD	VBD	_	9	auxpass	_	_
9	composed	_	VBN	VBN	_	3	ccomp	_	_
10	also	_	RB	RB	_	9	advmod	_	_
11	of	_	IN	IN	_	9	prep	_	_
12	p50	_	NN	NN	_	11	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	p65	_	NN	NN	_	12	conj	_	_
15	.	_	.	.	_	3	punct	_	_

1	However	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	the	_	DT	DT	_	5	det	_	_
4	p65	_	NN	NN	_	5	nn	_	_
5	subunit	_	NN	NN	_	8	nsubjpass	_	_
6	was	_	VBD	VBD	_	8	auxpass	_	_
7	COOH-terminally	_	RB	RB	_	8	advmod	_	_
8	truncated	_	VBN	VBN	_	0	root	_	_
9	,	_	,	,	_	8	punct	_	_
10	as	_	IN	IN	_	11	mark	_	_
11	shown	_	VBN	VBN	_	8	advcl	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	immunoprecipitation	_	NN	NN	_	12	pobj	_	_
14	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	truncation	_	NN	NN	_	3	nsubj	_	_
3	resulted	_	VBD	VBD	_	0	root	_	_
4	from	_	IN	IN	_	3	prep	_	_
5	limited	_	JJ	JJ	_	6	amod	_	_
6	proteolysis	_	NN	NN	_	4	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	p65	_	NN	NN	_	7	pobj	_	_
9	during	_	IN	IN	_	3	prep	_	_
10	cellular	_	JJ	JJ	_	11	amod	_	_
11	extraction	_	NN	NN	_	9	pobj	_	_
12	which	_	WDT	WDT	_	13	nsubj	_	_
13	released	_	VBD	VBD	_	11	rcmod	_	_
14	particular	_	JJ	JJ	_	17	amod	_	_
15	lysosomal	_	JJ	JJ	_	17	amod	_	_
16	serine	_	NN	NN	_	17	nn	_	_
17	proteases	_	NNS	NNS	_	13	dobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	such	_	JJ	JJ	_	20	mwe	_	_
20	as	_	IN	IN	_	17	prep	_	_
21	elastase	_	NN	NN	_	20	pobj	_	_
22	,	_	,	,	_	21	punct	_	_
23	cathepsin	_	NN	NN	_	24	nn	_	_
24	G	_	NN	NN	_	21	conj	_	_
25	,	_	,	,	_	21	punct	_	_
26	and	_	CC	CC	_	21	cc	_	_
27	proteinase	_	NN	NN	_	21	conj	_	_
28	3	_	CD	CD	_	27	num	_	_
29	.	_	.	.	_	3	punct	_	_

1	These	_	DT	DT	_	3	det	_	_
2	specific	_	JJ	JJ	_	3	amod	_	_
3	proteases	_	NNS	NNS	_	6	nsubjpass	_	_
4	are	_	VBP	VBP	_	6	auxpass	_	_
5	coordinately	_	RB	RB	_	6	advmod	_	_
6	expressed	_	VBN	VBN	_	0	root	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	were	_	VBD	VBD	_	9	cop	_	_
9	present	_	JJ	JJ	_	6	conj	_	_
10	exclusively	_	RB	RB	_	11	advmod	_	_
11	in	_	IN	IN	_	9	prep	_	_
12	the	_	DT	DT	_	15	det	_	_
13	minus	_	JJ	JJ	_	15	amod	_	_
14	U937	_	NN	NN	_	15	nn	_	_
15	clones	_	NNS	NNS	_	11	pobj	_	_
16	,	_	,	,	_	11	punct	_	_
17	but	_	CC	CC	_	11	cc	_	_
18	not	_	RB	RB	_	19	neg	_	_
19	in	_	IN	IN	_	11	conj	_	_
20	the	_	DT	DT	_	22	det	_	_
21	plus	_	JJ	JJ	_	22	amod	_	_
22	clones	_	NNS	NNS	_	19	pobj	_	_
23	,	_	,	,	_	9	punct	_	_
24	as	_	IN	IN	_	25	mark	_	_
25	demonstrated	_	VBN	VBN	_	9	advcl	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	28	det	_	_
28	case	_	NN	NN	_	26	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	cathepsin	_	NN	NN	_	31	nn	_	_
31	G	_	NN	NN	_	29	pobj	_	_
32	.	_	.	.	_	6	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	7	punct	_	_
4	these	_	DT	DT	_	5	det	_	_
5	proteases	_	NNS	NNS	_	7	nsubjpass	_	_
6	were	_	VBD	VBD	_	7	auxpass	_	_
7	detected	_	VBN	VBN	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	certain	_	JJ	JJ	_	10	amod	_	_
10	subclones	_	NNS	NNS	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	THP-1	_	NN	NN	_	11	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	HL-60	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	12	conj	_	_
16	and	_	CC	CC	_	8	cc	_	_
17	in	_	IN	IN	_	8	conj	_	_
18	primary	_	JJ	JJ	_	19	amod	_	_
19	monocytes	_	NNS	NNS	_	17	pobj	_	_
20	,	_	,	,	_	7	punct	_	_
21	in	_	IN	IN	_	24	prep	_	_
22	each	_	DT	DT	_	23	det	_	_
23	case	_	NN	NN	_	21	pobj	_	_
24	correlating	_	VBG	VBG	_	7	vmod	_	_
25	with	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	25	pobj	_	_
27	truncated	_	VBN	VBN	_	26	amod	_	_
28	from	_	IN	IN	_	26	amod	_	_
29	of	_	IN	IN	_	26	prep	_	_
30	p65	_	NN	NN	_	29	pobj	_	_
31	.	_	.	.	_	7	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	demonstrate	_	VBP	VBP	_	0	root	_	_
3	in	_	FW	FW	_	5	amod	_	_
4	vitro	_	FW	FW	_	3	dep	_	_
5	cleavage	_	NN	NN	_	2	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	p65	_	NN	NN	_	6	pobj	_	_
8	by	_	IN	IN	_	2	prep	_	_
9	purified	_	VBN	VBN	_	10	amod	_	_
10	elastase	_	NN	NN	_	8	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	cathepsin	_	NN	NN	_	13	nn	_	_
13	G	_	NN	NN	_	10	conj	_	_
14	.	_	.	.	_	2	punct	_	_

1	It	_	PRP	PRP	_	3	nsubj	_	_
2	is	_	VBZ	VBZ	_	3	cop	_	_
3	possible	_	JJ	JJ	_	0	root	_	_
4	that	_	IN	IN	_	9	mark	_	_
5	particular	_	JJ	JJ	_	7	amod	_	_
6	serine	_	NN	NN	_	7	nn	_	_
7	proteases	_	NNS	NNS	_	9	nsubj	_	_
8	may	_	MD	MD	_	9	aux	_	_
9	have	_	VB	VB	_	3	ccomp	_	_
10	inhibiting	_	NN	NN	_	11	nn	_	_
11	effects	_	NNS	NNS	_	9	dobj	_	_
12	on	_	IN	IN	_	9	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	replication	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	HIV-1	_	NN	NN	_	15	pobj	_	_
17	in	_	IN	IN	_	14	prep	_	_
18	myelo-monocytic	_	JJ	JJ	_	19	amod	_	_
19	cells	_	NNS	NNS	_	17	pobj	_	_
20	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	4	nsubj	_	_
3	also	_	RB	RB	_	4	advmod	_	_
4	demonstrate	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	10	mark	_	_
6	special	_	JJ	JJ	_	7	amod	_	_
7	precautions	_	NNS	NNS	_	10	nsubjpass	_	_
8	must	_	MD	MD	_	10	aux	_	_
9	be	_	VB	VB	_	10	auxpass	_	_
10	taken	_	VBN	VBN	_	4	ccomp	_	_
11	when	_	WRB	WRB	_	12	advmod	_	_
12	making	_	VBG	VBG	_	10	advcl	_	_
13	extracts	_	NNS	NNS	_	12	dobj	_	_
14	from	_	IN	IN	_	12	prep	_	_
15	myelo-monocytic	_	JJ	JJ	_	16	amod	_	_
16	cells	_	NNS	NNS	_	14	pobj	_	_
17	.	_	.	.	_	4	punct	_	_

1	Positive	_	JJ	JJ	_	0	root	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	negative	_	JJ	JJ	_	1	conj	_	_
4	regulation	_	NN	NN	_	1	dep	_	_
5	of	_	IN	IN	_	1	prep	_	_
6	the	_	DT	DT	_	9	det	_	_
7	composite	_	JJ	JJ	_	9	amod	_	_
8	octamer	_	NN	NN	_	9	nn	_	_
9	motif	_	NN	NN	_	5	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	14	det	_	_
12	interleukin	_	NN	NN	_	14	nn	_	_
13	2	_	CD	CD	_	14	num	_	_
14	enhancer	_	NN	NN	_	10	pobj	_	_
15	by	_	IN	IN	_	1	prep	_	_
16	AP-1	_	NN	NN	_	15	pobj	_	_
17	,	_	,	,	_	16	punct	_	_
18	Oct-2	_	NN	NN	_	16	conj	_	_
19	,	_	,	,	_	16	punct	_	_
20	and	_	CC	CC	_	16	cc	_	_
21	retinoic	_	JJ	JJ	_	23	amod	_	_
22	acid	_	NN	NN	_	23	nn	_	_
23	receptor	_	NN	NN	_	16	conj	_	_
24	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	differentiating	_	VBG	VBG	_	5	amod	_	_
3	agent	_	NN	NN	_	5	nn	_	_
4	retinoic	_	JJ	JJ	_	5	amod	_	_
5	acid	_	NN	NN	_	12	nsubjpass	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	RA	_	NN	NN	_	5	appos	_	_
8	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
9	has	_	VBZ	VBZ	_	12	aux	_	_
10	been	_	VBN	VBN	_	12	auxpass	_	_
11	previously	_	RB	RB	_	12	advmod	_	_
12	reported	_	VBN	VBN	_	0	root	_	_
13	to	_	TO	TO	_	14	aux	_	_
14	interfere	_	VB	VB	_	12	xcomp	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	12-O-tetradecanoyl-phorbol-13-acetate	_	NN	NN	_	21	nn	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	TPA	_	NN	NN	_	16	appos	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	/Ca-LRB-2+-RRB--induced	_	JJ	JJ	_	21	amod	_	_
21	signals	_	NNS	NNS	_	15	pobj	_	_
22	for	_	IN	IN	_	14	prep	_	_
23	the	_	DT	DT	_	24	det	_	_
24	regulation	_	NN	NN	_	22	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	31	det	_	_
27	-96	_	CD	CD	_	31	num	_	_
28	to	_	TO	TO	_	31	dep	_	_
29	-66-bp	_	JJ	JJ	_	31	amod	_	_
30	octamer	_	NN	NN	_	31	nn	_	_
31	motif	_	NN	NN	_	25	pobj	_	_
32	found	_	VBN	VBN	_	31	vmod	_	_
33	in	_	IN	IN	_	32	prep	_	_
34	the	_	DT	DT	_	35	det	_	_
35	enhancer	_	NN	NN	_	33	pobj	_	_
36	for	_	IN	IN	_	35	prep	_	_
37	the	_	DT	DT	_	43	det	_	_
38	interleukin	_	NN	NN	_	43	nn	_	_
39	-LRB-	_	-LRB-	-LRB-	_	43	punct	_	_
40	IL	_	NN	NN	_	43	nn	_	_
41	-RRB-	_	-RRB-	-RRB-	_	43	punct	_	_
42	-2	_	CD	CD	_	43	num	_	_
43	gene	_	NN	NN	_	36	pobj	_	_
44	,	_	,	,	_	43	punct	_	_
45	which	_	WDT	WDT	_	46	nsubj	_	_
46	encodes	_	VBZ	VBZ	_	43	rcmod	_	_
47	a	_	DT	DT	_	52	det	_	_
48	major	_	JJ	JJ	_	52	amod	_	_
49	T	_	NN	NN	_	52	nn	_	_
50	lymphocyte	_	NN	NN	_	52	nn	_	_
51	growth	_	NN	NN	_	52	nn	_	_
52	factor	_	NN	NN	_	46	dobj	_	_
53	.	_	.	.	_	12	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	IL-2	_	NN	NN	_	4	nn	_	_
3	octamer	_	NN	NN	_	4	nn	_	_
4	motif	_	NN	NN	_	8	nsubj	_	_
5	is	_	VBZ	VBZ	_	8	cop	_	_
6	a	_	DT	DT	_	8	det	_	_
7	composite	_	JJ	JJ	_	8	amod	_	_
8	cis-element	_	NN	NN	_	0	root	_	_
9	which	_	WDT	WDT	_	10	nsubj	_	_
10	binds	_	VBZ	VBZ	_	8	rcmod	_	_
11	Oct-1	_	NN	NN	_	10	dobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	Oct-2	_	NN	NN	_	11	conj	_	_
14	as	_	RB	RB	_	15	advmod	_	_
15	well	_	RB	RB	_	11	cc	_	_
16	as	_	IN	IN	_	15	mwe	_	_
17	a	_	DT	DT	_	20	det	_	_
18	TPA/Ca-LRB-2+-RRB--inducible	_	JJ	JJ	_	20	amod	_	_
19	nuclear	_	JJ	JJ	_	20	amod	_	_
20	factor	_	NN	NN	_	11	conj	_	_
21	,	_	,	,	_	20	punct	_	_
22	previously	_	RB	RB	_	23	advmod	_	_
23	termed	_	VBN	VBN	_	20	vmod	_	_
24	octamer-associated	_	JJ	JJ	_	25	amod	_	_
25	protein	_	NN	NN	_	23	dep	_	_
26	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
27	OAP40	_	CD	CD	_	25	appos	_	_
28	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
29	.	_	.	.	_	8	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	show	_	VBP	VBP	_	0	root	_	_
3	here	_	RB	RB	_	2	advmod	_	_
4	that	_	IN	IN	_	17	mark	_	_
5	Oct-2	_	NN	NN	_	17	nsubj	_	_
6	,	_	,	,	_	5	punct	_	_
7	despite	_	IN	IN	_	17	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	presence	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	an	_	DT	DT	_	15	det	_	_
12	active	_	JJ	JJ	_	15	amod	_	_
13	transcriptional	_	JJ	JJ	_	12	dep	_	_
14	activation	_	NN	NN	_	15	nn	_	_
15	domain	_	NN	NN	_	10	pobj	_	_
16	,	_	,	,	_	17	punct	_	_
17	requires	_	VBZ	VBZ	_	2	ccomp	_	_
18	TPA/Ca-LRB-2+-RRB--induced	_	JJ	JJ	_	19	amod	_	_
19	signals	_	NNS	NNS	_	17	dobj	_	_
20	to	_	TO	TO	_	22	aux	_	_
21	strongly	_	RB	RB	_	22	advmod	_	_
22	transactivate	_	VB	VB	_	17	xcomp	_	_
23	the	_	DT	DT	_	26	det	_	_
24	IL-2	_	NN	NN	_	26	nn	_	_
25	octamer	_	NN	NN	_	26	nn	_	_
26	motif	_	NN	NN	_	22	dobj	_	_
27	in	_	IN	IN	_	22	prep	_	_
28	Jurkat	_	NN	NN	_	30	nn	_	_
29	T	_	NN	NN	_	30	nn	_	_
30	cells	_	NNS	NNS	_	27	pobj	_	_
31	.	_	.	.	_	2	punct	_	_

1	This	_	DT	DT	_	3	det	_	_
2	Oct-2-dependent	_	JJ	JJ	_	3	amod	_	_
3	transactivation	_	NN	NN	_	5	nsubjpass	_	_
4	is	_	VBZ	VBZ	_	5	auxpass	_	_
5	inhibited	_	VBN	VBN	_	0	root	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	RA	_	NN	NN	_	6	pobj	_	_
8	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	presence	_	NN	NN	_	10	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	an	_	DT	DT	_	7	det	_	_
5	intact	_	JJ	JJ	_	7	amod	_	_
6	COOH-terminal	_	JJ	JJ	_	7	amod	_	_
7	domain	_	NN	NN	_	3	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	Oct-2	_	NN	NN	_	8	pobj	_	_
10	contributes	_	VBZ	VBZ	_	0	root	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	both	_	CC	CC	_	14	preconj	_	_
13	TPA/Ca-LRB-2+-RRB--induced	_	JJ	JJ	_	14	amod	_	_
14	transactivation	_	NN	NN	_	11	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	the	_	DT	DT	_	18	det	_	_
17	RA-mediated	_	JJ	JJ	_	18	amod	_	_
18	repression	_	NN	NN	_	14	conj	_	_
19	.	_	.	.	_	10	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	show	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	14	mark	_	_
5	both	_	CC	CC	_	6	preconj	_	_
6	Fos	_	NN	NN	_	14	nsubj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	Jun	_	NN	NN	_	6	conj	_	_
9	components	_	NNS	NNS	_	6	dep	_	_
10	of	_	IN	IN	_	6	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	AP-1	_	NN	NN	_	13	nn	_	_
13	factors	_	NNS	NNS	_	10	pobj	_	_
14	participate	_	VBP	VBP	_	3	ccomp	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	OAP40	_	NN	NN	_	18	nn	_	_
18	complex	_	NN	NN	_	15	pobj	_	_
19	.	_	.	.	_	3	punct	_	_

1	Furthermore	_	RB	RB	_	17	advmod	_	_
2	,	_	,	,	_	17	punct	_	_
3	transfected	_	VBN	VBN	_	4	amod	_	_
4	c-jun	_	NN	NN	_	17	nsubj	_	_
5	,	_	,	,	_	4	punct	_	_
6	jun-B	_	NN	NN	_	4	conj	_	_
7	,	_	,	,	_	4	punct	_	_
8	jun-D	_	NN	NN	_	4	conj	_	_
9	,	_	,	,	_	4	punct	_	_
10	c-fos	_	NN	NN	_	4	conj	_	_
11	,	_	,	,	_	4	punct	_	_
12	or	_	CC	CC	_	4	cc	_	_
13	Fos-B	_	NN	NN	_	4	conj	_	_
14	expression	_	NN	NN	_	15	nn	_	_
15	vectors	_	NNS	NNS	_	4	dep	_	_
16	partially	_	RB	RB	_	17	advmod	_	_
17	substitute	_	VBP	VBP	_	0	root	_	_
18	for	_	IN	IN	_	17	prep	_	_
19	TPA	_	NN	NN	_	18	pobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	Ca2+	_	NN	NN	_	19	conj	_	_
22	and	_	CC	CC	_	17	cc	_	_
23	cooperate	_	VBP	VBP	_	17	conj	_	_
24	with	_	IN	IN	_	23	prep	_	_
25	Oct-2	_	NN	NN	_	24	pobj	_	_
26	for	_	IN	IN	_	23	prep	_	_
27	the	_	DT	DT	_	28	det	_	_
28	transactivation	_	NN	NN	_	26	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	the	_	DT	DT	_	33	det	_	_
31	combined	_	JJ	JJ	_	33	amod	_	_
32	OAP/octamer	_	NN	NN	_	33	nn	_	_
33	cis-element	_	NN	NN	_	29	pobj	_	_
34	.	_	.	.	_	17	punct	_	_

1	Mutations	_	NNS	NNS	_	7	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	6	det	_	_
4	genuine	_	JJ	JJ	_	6	amod	_	_
5	octamer-binding	_	JJ	JJ	_	6	amod	_	_
6	site	_	NN	NN	_	2	pobj	_	_
7	abrogate	_	VBP	VBP	_	0	root	_	_
8	both	_	CC	CC	_	10	preconj	_	_
9	the	_	DT	DT	_	10	det	_	_
10	binding	_	NN	NN	_	7	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	Oct-1	_	NN	NN	_	11	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	Oct-2	_	NN	NN	_	12	conj	_	_
15	and	_	CC	CC	_	10	cc	_	_
16	the	_	DT	DT	_	18	det	_	_
17	TPA/Ca-LRB-2+-RRB--induced	_	JJ	JJ	_	18	amod	_	_
18	transactivation	_	NN	NN	_	10	conj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	22	det	_	_
21	OAP/octamer	_	NN	NN	_	22	nn	_	_
22	motif	_	NN	NN	_	19	pobj	_	_
23	.	_	.	.	_	7	punct	_	_

1	OAP	_	NN	NN	_	2	nsubj	_	_
2	confers	_	VBZ	VBZ	_	0	root	_	_
3	to	_	TO	TO	_	2	prep	_	_
4	Oct-2	_	NN	NN	_	5	nn	_	_
5	responsivity	_	NN	NN	_	3	pobj	_	_
6	to	_	TO	TO	_	5	prep	_	_
7	both	_	CC	CC	_	8	preconj	_	_
8	TPA/Ca2+	_	NN	NN	_	6	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	RA	_	NN	NN	_	8	conj	_	_
11	,	_	,	,	_	2	punct	_	_
12	since	_	IN	IN	_	20	mark	_	_
13	specific	_	JJ	JJ	_	14	amod	_	_
14	mutations	_	NNS	NNS	_	20	nsubj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	AP-1/OAP-binding	_	JJ	JJ	_	18	amod	_	_
18	site	_	NN	NN	_	15	pobj	_	_
19	significantly	_	RB	RB	_	20	advmod	_	_
20	reduce	_	VBP	VBP	_	2	advcl	_	_
21	the	_	DT	DT	_	22	det	_	_
22	transactivation	_	NN	NN	_	20	dobj	_	_
23	by	_	IN	IN	_	22	prep	_	_
24	Oct-2	_	NN	NN	_	23	pobj	_	_
25	in	_	IN	IN	_	20	prep	_	_
26	response	_	NN	NN	_	25	pobj	_	_
27	to	_	TO	TO	_	26	prep	_	_
28	TPA	_	NN	NN	_	27	pobj	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	Ca2+	_	NN	NN	_	28	conj	_	_
31	and	_	CC	CC	_	20	cc	_	_
32	abolish	_	VBP	VBP	_	20	conj	_	_
33	the	_	DT	DT	_	34	det	_	_
34	inhibition	_	NN	NN	_	32	dobj	_	_
35	by	_	IN	IN	_	34	prep	_	_
36	RA	_	NN	NN	_	35	pobj	_	_
37	.	_	.	.	_	2	punct	_	_

1	Furthermore	_	RB	RB	_	11	advmod	_	_
2	,	_	,	,	_	11	punct	_	_
3	retinoic	_	JJ	JJ	_	5	amod	_	_
4	acid	_	NN	NN	_	5	nn	_	_
5	receptor	_	NN	NN	_	9	nn	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	RAR	_	NN	NN	_	5	appos	_	_
8	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
9	alpha	_	NN	NN	_	11	nsubj	_	_
10	is	_	VBZ	VBZ	_	11	cop	_	_
11	able	_	JJ	JJ	_	0	root	_	_
12	to	_	TO	TO	_	13	aux	_	_
13	inhibit	_	VB	VB	_	11	xcomp	_	_
14	in	_	FW	FW	_	15	nn	_	_
15	vitro	_	FW	FW	_	13	advmod	_	_
16	the	_	DT	DT	_	17	det	_	_
17	formation	_	NN	NN	_	13	dobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	20	det	_	_
20	complex	_	NN	NN	_	18	pobj	_	_
21	between	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	24	det	_	_
23	nuclear	_	JJ	JJ	_	24	amod	_	_
24	AP-1/OAP	_	NN	NN	_	21	pobj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	its	_	PRP$	PRP$	_	29	poss	_	_
27	specific	_	JJ	JJ	_	29	amod	_	_
28	binding	_	VBG	VBG	_	29	amod	_	_
29	site	_	NN	NN	_	24	conj	_	_
30	,	_	,	,	_	11	punct	_	_
31	resulting	_	VBG	VBG	_	11	xcomp	_	_
32	in	_	IN	IN	_	31	prep	_	_
33	the	_	DT	DT	_	34	det	_	_
34	interference	_	NN	NN	_	32	pobj	_	_
35	with	_	IN	IN	_	34	prep	_	_
36	Oct-2-dependent	_	JJ	JJ	_	38	amod	_	_
37	cis-regulatory	_	JJ	JJ	_	38	amod	_	_
38	function	_	NN	NN	_	35	pobj	_	_
39	of	_	IN	IN	_	38	prep	_	_
40	this	_	DT	DT	_	42	det	_	_
41	AP-1	_	NN	NN	_	42	nn	_	_
42	element	_	NN	NN	_	39	pobj	_	_
43	.	_	.	.	_	11	punct	_	_

1	Therefore	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	propose	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	13	mark	_	_
6	the	_	DT	DT	_	9	det	_	_
7	TPA/calcium-activated	_	JJ	JJ	_	9	amod	_	_
8	AP-1/OAP	_	NN	NN	_	9	nn	_	_
9	element	_	NN	NN	_	13	nsubj	_	_
10	is	_	VBZ	VBZ	_	13	cop	_	_
11	the	_	DT	DT	_	13	det	_	_
12	main	_	JJ	JJ	_	13	amod	_	_
13	target	_	NN	NN	_	4	ccomp	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	positive	_	JJ	JJ	_	14	pobj	_	_
16	or	_	CC	CC	_	15	cc	_	_
17	negative	_	JJ	JJ	_	15	conj	_	_
18	regulatory	_	JJ	JJ	_	19	amod	_	_
19	signals	_	NNS	NNS	_	15	dep	_	_
20	influencing	_	VBG	VBG	_	15	vmod	_	_
21	the	_	DT	DT	_	24	det	_	_
22	IL-2	_	NN	NN	_	24	nn	_	_
23	octamer	_	NN	NN	_	24	nn	_	_
24	motif	_	NN	NN	_	20	dobj	_	_
25	,	_	,	,	_	20	punct	_	_
26	through	_	IN	IN	_	20	prep	_	_
27	synergism	_	NN	NN	_	26	pobj	_	_
28	with	_	IN	IN	_	27	prep	_	_
29	Oct-2	_	NN	NN	_	28	pobj	_	_
30	and	_	CC	CC	_	27	cc	_	_
31	antagonism	_	NN	NN	_	27	conj	_	_
32	by	_	IN	IN	_	31	prep	_	_
33	RAR	_	NN	NN	_	32	pobj	_	_
34	.	_	.	.	_	4	punct	_	_

1	Human	_	JJ	JJ	_	8	amod	_	_
2	T-cell	_	NN	NN	_	8	nn	_	_
3	leukemia	_	NN	NN	_	8	nn	_	_
4	virus	_	NN	NN	_	8	nn	_	_
5	type	_	NN	NN	_	8	nn	_	_
6	I	_	CD	CD	_	8	num	_	_
7	Tax	_	NN	NN	_	8	nn	_	_
8	activation	_	NN	NN	_	12	nsubj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	NF-kappa	_	NN	NN	_	11	nn	_	_
11	B/Rel	_	NN	NN	_	9	pobj	_	_
12	involves	_	VBZ	VBZ	_	0	root	_	_
13	phosphorylation	_	NN	NN	_	12	dobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	degradation	_	NN	NN	_	13	conj	_	_
16	of	_	IN	IN	_	13	prep	_	_
17	I	_	NN	NN	_	20	nn	_	_
18	kappa	_	NN	NN	_	20	nn	_	_
19	B	_	NN	NN	_	20	nn	_	_
20	alpha	_	NN	NN	_	16	pobj	_	_
21	and	_	CC	CC	_	13	cc	_	_
22	RelA	_	NN	NN	_	27	nn	_	_
23	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
24	p65	_	NN	NN	_	22	appos	_	_
25	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
26	-mediated	_	JJ	JJ	_	27	amod	_	_
27	induction	_	NN	NN	_	13	conj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	the	_	DT	DT	_	31	det	_	_
30	c-rel	_	JJ	JJ	_	31	amod	_	_
31	gene	_	NN	NN	_	28	pobj	_	_
32	.	_	.	.	_	12	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	tax	_	NN	NN	_	4	nn	_	_
3	gene	_	NN	NN	_	4	nn	_	_
4	product	_	NN	NN	_	19	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	human	_	JJ	JJ	_	10	amod	_	_
7	T-cell	_	NN	NN	_	10	nn	_	_
8	leukemia	_	NN	NN	_	10	nn	_	_
9	virus	_	NN	NN	_	10	nn	_	_
10	type	_	NN	NN	_	5	pobj	_	_
11	I	_	CD	CD	_	10	num	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	HTLV-I	_	NN	NN	_	10	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	is	_	VBZ	VBZ	_	19	cop	_	_
16	a	_	DT	DT	_	19	det	_	_
17	potent	_	JJ	JJ	_	19	amod	_	_
18	transcriptional	_	JJ	JJ	_	19	amod	_	_
19	activator	_	NN	NN	_	0	root	_	_
20	that	_	WDT	WDT	_	22	nsubj	_	_
21	both	_	CC	CC	_	22	preconj	_	_
22	stimulates	_	VBZ	VBZ	_	19	rcmod	_	_
23	viral	_	JJ	JJ	_	25	amod	_	_
24	gene	_	NN	NN	_	25	nn	_	_
25	expression	_	NN	NN	_	22	dobj	_	_
26	and	_	CC	CC	_	22	cc	_	_
27	activates	_	VBZ	VBZ	_	22	conj	_	_
28	an	_	DT	DT	_	29	det	_	_
29	array	_	NN	NN	_	27	dobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	cellular	_	JJ	JJ	_	32	amod	_	_
32	genes	_	NNS	NNS	_	30	pobj	_	_
33	involved	_	VBN	VBN	_	32	vmod	_	_
34	in	_	IN	IN	_	33	prep	_	_
35	T-cell	_	NN	NN	_	36	nn	_	_
36	growth	_	NN	NN	_	34	pobj	_	_
37	.	_	.	.	_	19	punct	_	_

1	Tax	_	NN	NN	_	2	nsubj	_	_
2	acts	_	VBZ	VBZ	_	0	root	_	_
3	indirectly	_	RB	RB	_	2	advmod	_	_
4	by	_	IN	IN	_	2	prep	_	_
5	inducing	_	VBG	VBG	_	4	pcomp	_	_
6	or	_	CC	CC	_	5	cc	_	_
7	modifying	_	VBG	VBG	_	5	conj	_	_
8	the	_	DT	DT	_	9	det	_	_
9	action	_	NN	NN	_	5	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	various	_	JJ	JJ	_	12	amod	_	_
12	host	_	NN	NN	_	10	pobj	_	_
13	transcription	_	NN	NN	_	14	nn	_	_
14	factors	_	NNS	NNS	_	12	dep	_	_
15	,	_	,	,	_	12	punct	_	_
16	including	_	VBG	VBG	_	12	prep	_	_
17	members	_	NNS	NNS	_	16	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	22	det	_	_
20	NF-kappa	_	NN	NN	_	22	nn	_	_
21	B/Rel	_	NN	NN	_	22	nn	_	_
22	family	_	NN	NN	_	18	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	enhancer-binding	_	JJ	JJ	_	25	amod	_	_
25	proteins	_	NNS	NNS	_	23	pobj	_	_
26	.	_	.	.	_	2	punct	_	_

1	In	_	IN	IN	_	13	prep	_	_
2	resting	_	VBG	VBG	_	4	amod	_	_
3	T	_	NN	NN	_	4	nn	_	_
4	cells	_	NNS	NNS	_	1	pobj	_	_
5	,	_	,	,	_	13	punct	_	_
6	many	_	JJ	JJ	_	13	nsubjpass	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	these	_	DT	DT	_	11	det	_	_
9	NF-kappa	_	NN	NN	_	11	nn	_	_
10	B/Rel	_	NN	NN	_	11	nn	_	_
11	factors	_	NNS	NNS	_	7	pobj	_	_
12	are	_	VBP	VBP	_	13	auxpass	_	_
13	sequestered	_	VBN	VBN	_	0	root	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	cytoplasm	_	NN	NN	_	14	pobj	_	_
17	by	_	IN	IN	_	13	prep	_	_
18	various	_	JJ	JJ	_	21	amod	_	_
19	ankyrin-rich	_	JJ	JJ	_	21	amod	_	_
20	inhibitory	_	JJ	JJ	_	21	amod	_	_
21	proteins	_	NNS	NNS	_	17	pobj	_	_
22	,	_	,	,	_	21	punct	_	_
23	including	_	VBG	VBG	_	21	prep	_	_
24	I	_	NN	NN	_	27	nn	_	_
25	kappa	_	NN	NN	_	27	nn	_	_
26	B	_	NN	NN	_	27	nn	_	_
27	alpha	_	NN	NN	_	23	pobj	_	_
28	.	_	.	.	_	13	punct	_	_

1	HTLV-I	_	NN	NN	_	2	nn	_	_
2	Tax	_	NN	NN	_	3	nn	_	_
3	expression	_	NN	NN	_	4	nsubj	_	_
4	leads	_	VBZ	VBZ	_	0	root	_	_
5	to	_	TO	TO	_	4	prep	_	_
6	the	_	DT	DT	_	9	det	_	_
7	constitutive	_	JJ	JJ	_	9	amod	_	_
8	nuclear	_	JJ	JJ	_	9	amod	_	_
9	expression	_	NN	NN	_	5	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	biologically	_	RB	RB	_	12	advmod	_	_
12	active	_	JJ	JJ	_	14	amod	_	_
13	NF-kappa	_	NN	NN	_	14	nn	_	_
14	B	_	NN	NN	_	10	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	c-Rel	_	NN	NN	_	17	nn	_	_
17	complexes	_	NNS	NNS	_	14	conj	_	_
18	;	_	:	:	_	4	punct	_	_
19	however	_	RB	RB	_	30	advmod	_	_
20	,	_	,	,	_	30	punct	_	_
21	the	_	DT	DT	_	25	det	_	_
22	biochemical	_	JJ	JJ	_	25	amod	_	_
23	mechanism	_	NN	NN	_	25	nn	_	_
24	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
25	s	_	NNS	NNS	_	30	nsubj	_	_
26	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
27	underlying	_	VBG	VBG	_	25	vmod	_	_
28	this	_	DT	DT	_	29	det	_	_
29	response	_	NN	NN	_	27	dobj	_	_
30	remains	_	VBZ	VBZ	_	4	parataxis	_	_
31	poorly	_	RB	RB	_	32	advmod	_	_
32	understood	_	VBN	VBN	_	30	acomp	_	_
33	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	study	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	demonstrate	_	VBP	VBP	_	0	root	_	_
7	that	_	IN	IN	_	23	mark	_	_
8	Tax-stimulated	_	JJ	JJ	_	10	amod	_	_
9	nuclear	_	JJ	JJ	_	10	amod	_	_
10	expression	_	NN	NN	_	23	nsubjpass	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	NF-kappa	_	NN	NN	_	13	nn	_	_
13	B	_	NN	NN	_	11	pobj	_	_
14	in	_	IN	IN	_	10	prep	_	_
15	both	_	CC	CC	_	21	dep	_	_
16	HTLV-I-infected	_	JJ	JJ	_	21	amod	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	Tax-transfected	_	JJ	JJ	_	16	conj	_	_
19	human	_	JJ	JJ	_	21	amod	_	_
20	T	_	NN	NN	_	21	nn	_	_
21	cells	_	NNS	NNS	_	14	pobj	_	_
22	is	_	VBZ	VBZ	_	23	auxpass	_	_
23	associated	_	VBN	VBN	_	6	ccomp	_	_
24	with	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	26	dep	_	_
26	phosphorylation	_	NN	NN	_	24	pobj	_	_
27	and	_	CC	CC	_	26	cc	_	_
28	rapid	_	JJ	JJ	_	30	amod	_	_
29	proteolytic	_	JJ	JJ	_	28	dep	_	_
30	degradation	_	NN	NN	_	26	conj	_	_
31	of	_	IN	IN	_	26	prep	_	_
32	I	_	NN	NN	_	35	nn	_	_
33	kappa	_	NN	NN	_	35	nn	_	_
34	B	_	NN	NN	_	35	nn	_	_
35	alpha	_	NN	NN	_	31	pobj	_	_
36	.	_	.	.	_	6	punct	_	_

1	In	_	IN	IN	_	22	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	to	_	TO	TO	_	2	prep	_	_
4	prior	_	JJ	JJ	_	7	amod	_	_
5	in	_	FW	FW	_	4	dep	_	_
6	vitro	_	FW	FW	_	5	dep	_	_
7	studies	_	NNS	NNS	_	3	pobj	_	_
8	,	_	,	,	_	22	punct	_	_
9	at	_	IN	IN	_	12	advmod	_	_
10	least	_	JJS	JJS	_	9	pobj	_	_
11	a	_	DT	DT	_	12	det	_	_
12	fraction	_	NN	NN	_	22	nsubj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	phosphorylated	_	JJ	JJ	_	16	amod	_	_
16	form	_	NN	NN	_	13	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	I	_	NN	NN	_	21	nn	_	_
19	kappa	_	NN	NN	_	21	nn	_	_
20	B	_	NN	NN	_	21	nn	_	_
21	alpha	_	NN	NN	_	17	pobj	_	_
22	remains	_	VBZ	VBZ	_	0	root	_	_
23	physically	_	RB	RB	_	22	advmod	_	_
24	associated	_	VBN	VBN	_	22	acomp	_	_
25	with	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	29	det	_	_
27	NF-kappa	_	NN	NN	_	29	nn	_	_
28	B	_	NN	NN	_	29	nn	_	_
29	complex	_	NN	NN	_	25	pobj	_	_
30	in	_	FW	FW	_	31	nn	_	_
31	vivo	_	FW	FW	_	24	advmod	_	_
32	but	_	CC	CC	_	22	cc	_	_
33	is	_	VBZ	VBZ	_	34	cop	_	_
34	subject	_	JJ	JJ	_	22	conj	_	_
35	to	_	TO	TO	_	34	prep	_	_
36	rapid	_	JJ	JJ	_	37	amod	_	_
37	degradation	_	NN	NN	_	35	pobj	_	_
38	,	_	,	,	_	34	punct	_	_
39	thereby	_	RB	RB	_	40	advmod	_	_
40	promoting	_	VBG	VBG	_	34	xcomp	_	_
41	the	_	DT	DT	_	43	det	_	_
42	nuclear	_	JJ	JJ	_	43	amod	_	_
43	translocation	_	NN	NN	_	40	dobj	_	_
44	of	_	IN	IN	_	43	prep	_	_
45	the	_	DT	DT	_	49	det	_	_
46	active	_	JJ	JJ	_	49	amod	_	_
47	NF-kappa	_	NN	NN	_	49	nn	_	_
48	B	_	NN	NN	_	49	nn	_	_
49	complex	_	NN	NN	_	44	pobj	_	_
50	.	_	.	.	_	22	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	further	_	RB	RB	_	3	advmod	_	_
3	demonstrate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	12	mark	_	_
5	Tax	_	NN	NN	_	6	nn	_	_
6	induction	_	NN	NN	_	12	nsubjpass	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	nuclear	_	JJ	JJ	_	10	amod	_	_
9	c-Rel	_	NN	NN	_	10	nn	_	_
10	expression	_	NN	NN	_	7	pobj	_	_
11	is	_	VBZ	VBZ	_	12	auxpass	_	_
12	activated	_	VBN	VBN	_	3	ccomp	_	_
13	by	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	RelA	_	NN	NN	_	19	nn	_	_
16	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
17	p65	_	NN	NN	_	15	appos	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	subunit	_	NN	NN	_	13	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	NF-kappa	_	NN	NN	_	22	nn	_	_
22	B	_	NN	NN	_	20	pobj	_	_
23	,	_	,	,	_	19	punct	_	_
24	which	_	WDT	WDT	_	25	nsubj	_	_
25	activates	_	VBZ	VBZ	_	19	rcmod	_	_
26	transcription	_	NN	NN	_	25	dobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	30	det	_	_
29	c-rel	_	JJ	JJ	_	30	amod	_	_
30	gene	_	NN	NN	_	27	pobj	_	_
31	through	_	IN	IN	_	25	prep	_	_
32	an	_	DT	DT	_	37	det	_	_
33	intrinsic	_	JJ	JJ	_	37	amod	_	_
34	kappa	_	NN	NN	_	37	nn	_	_
35	B	_	NN	NN	_	37	nn	_	_
36	enhancer	_	NN	NN	_	37	nn	_	_
37	element	_	NN	NN	_	31	pobj	_	_
38	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	11	prep	_	_
2	normal	_	JJ	JJ	_	3	amod	_	_
3	cells	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	11	punct	_	_
5	the	_	DT	DT	_	7	det	_	_
6	subsequent	_	JJ	JJ	_	7	amod	_	_
7	accumulation	_	NN	NN	_	11	nsubj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	nuclear	_	JJ	JJ	_	10	amod	_	_
10	c-Rel	_	NN	NN	_	8	pobj	_	_
11	acts	_	VBZ	VBZ	_	0	root	_	_
12	to	_	TO	TO	_	13	aux	_	_
13	inhibit	_	VB	VB	_	11	xcomp	_	_
14	its	_	PRP$	PRP$	_	17	poss	_	_
15	own	_	JJ	JJ	_	17	amod	_	_
16	continued	_	JJ	JJ	_	17	amod	_	_
17	production	_	NN	NN	_	13	dobj	_	_
18	,	_	,	,	_	11	punct	_	_
19	indicating	_	VBG	VBG	_	11	xcomp	_	_
20	the	_	DT	DT	_	21	det	_	_
21	presence	_	NN	NN	_	19	dobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	an	_	DT	DT	_	25	det	_	_
24	autoregulatory	_	JJ	JJ	_	25	amod	_	_
25	loop	_	NN	NN	_	22	pobj	_	_
26	.	_	.	.	_	11	punct	_	_

1	-LRB-	_	-LRB-	-LRB-	_	2	punct	_	_
2	ABSTRACT	_	NN	NN	_	0	root	_	_
3	TRUNCATED	_	VBN	VBN	_	2	vmod	_	_
4	AT	_	IN	IN	_	3	prep	_	_
5	250	_	CD	CD	_	6	num	_	_
6	WORDS	_	NNS	NNS	_	4	pobj	_	_
7	-RRB-	_	-RRB-	-RRB-	_	2	punct	_	_

1	Distinct	_	JJ	JJ	_	4	amod	_	_
2	DNase-I	_	NN	NN	_	4	nn	_	_
3	hypersensitive	_	JJ	JJ	_	4	amod	_	_
4	sites	_	NNS	NNS	_	6	nsubjpass	_	_
5	are	_	VBP	VBP	_	6	auxpass	_	_
6	associated	_	VBN	VBN	_	0	root	_	_
7	with	_	IN	IN	_	6	prep	_	_
8	TAL-1	_	NN	NN	_	9	nn	_	_
9	transcription	_	NN	NN	_	7	pobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	erythroid	_	JJ	JJ	_	10	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	T-cell	_	NN	NN	_	11	conj	_	_
14	lines	_	NNS	NNS	_	11	dep	_	_
15	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	tal-1	_	NN	NN	_	3	nn	_	_
3	gene	_	NN	NN	_	18	nsubjpass	_	_
4	,	_	,	,	_	3	punct	_	_
5	frequently	_	RB	RB	_	6	advmod	_	_
6	activated	_	VBN	VBN	_	3	vmod	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	human	_	JJ	JJ	_	12	amod	_	_
9	T-cell	_	NN	NN	_	12	nn	_	_
10	acute	_	JJ	JJ	_	12	amod	_	_
11	lymphoblastic	_	JJ	JJ	_	12	amod	_	_
12	leukemia	_	NN	NN	_	7	pobj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	T-ALL	_	NN	NN	_	12	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	,	_	,	,	_	3	punct	_	_
17	is	_	VBZ	VBZ	_	18	auxpass	_	_
18	expressed	_	VBN	VBN	_	0	root	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	21	dep	_	_
21	erythroid	_	JJ	JJ	_	19	pobj	_	_
22	,	_	,	,	_	21	punct	_	_
23	megakaryocytic	_	JJ	JJ	_	21	conj	_	_
24	,	_	,	,	_	21	punct	_	_
25	and	_	CC	CC	_	21	cc	_	_
26	mast	_	NN	NN	_	21	conj	_	_
27	cell	_	NN	NN	_	28	nn	_	_
28	lineages	_	NNS	NNS	_	21	dep	_	_
29	during	_	IN	IN	_	18	prep	_	_
30	normal	_	JJ	JJ	_	31	amod	_	_
31	hematopoiesis	_	NN	NN	_	29	pobj	_	_
32	.	_	.	.	_	18	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	gain	_	VB	VB	_	0	root	_	_
3	further	_	JJ	JJ	_	4	amod	_	_
4	insight	_	NN	NN	_	2	dobj	_	_
5	into	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	molecular	_	JJ	JJ	_	8	amod	_	_
8	mechanisms	_	NNS	NNS	_	5	pobj	_	_
9	that	_	WDT	WDT	_	10	nsubj	_	_
10	control	_	VBP	VBP	_	8	rcmod	_	_
11	tal-1	_	NN	NN	_	12	nn	_	_
12	expression	_	NN	NN	_	10	dobj	_	_
13	,	_	,	,	_	2	punct	_	_
14	we	_	PRP	PRP	_	15	nsubj	_	_
15	investigated	_	VBD	VBD	_	2	parataxis	_	_
16	tal-1	_	NN	NN	_	18	nn	_	_
17	chromatin	_	NN	NN	_	18	nn	_	_
18	structure	_	NN	NN	_	15	dobj	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	erythroid/megakaryocytic	_	JJ	JJ	_	22	amod	_	_
21	cell	_	NN	NN	_	22	nn	_	_
22	lines	_	NNS	NNS	_	19	pobj	_	_
23	and	_	CC	CC	_	19	cc	_	_
24	in	_	IN	IN	_	19	conj	_	_
25	T-cell	_	NN	NN	_	26	nn	_	_
26	lines	_	NNS	NNS	_	24	pobj	_	_
27	either	_	CC	CC	_	28	preconj	_	_
28	with	_	IN	IN	_	26	prep	_	_
29	or	_	CC	CC	_	28	cc	_	_
30	without	_	IN	IN	_	28	conj	_	_
31	tal-1	_	NN	NN	_	32	nn	_	_
32	rearrangements	_	NNS	NNS	_	28	pobj	_	_
33	.	_	.	.	_	2	punct	_	_

1	Tal-1	_	NN	NN	_	2	nn	_	_
2	transcription	_	NN	NN	_	4	nsubjpass	_	_
3	was	_	VBD	VBD	_	4	auxpass	_	_
4	shown	_	VBN	VBN	_	0	root	_	_
5	to	_	TO	TO	_	7	aux	_	_
6	be	_	VB	VB	_	7	cop	_	_
7	monoallelic	_	JJ	JJ	_	4	xcomp	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	Jurkat	_	NN	NN	_	8	pobj	_	_
10	,	_	,	,	_	9	punct	_	_
11	a	_	DT	DT	_	13	det	_	_
12	T-cell	_	NN	NN	_	13	nn	_	_
13	line	_	NN	NN	_	9	appos	_	_
14	that	_	WDT	WDT	_	15	nsubj	_	_
15	expresses	_	VBZ	VBZ	_	13	rcmod	_	_
16	tal-1	_	NN	NN	_	15	dobj	_	_
17	in	_	IN	IN	_	15	prep	_	_
18	the	_	DT	DT	_	19	det	_	_
19	absence	_	NN	NN	_	17	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	apparent	_	JJ	JJ	_	23	dep	_	_
22	genomic	_	JJ	JJ	_	23	dep	_	_
23	alteration	_	NN	NN	_	20	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	26	det	_	_
26	locus	_	NN	NN	_	24	pobj	_	_
27	.	_	.	.	_	4	punct	_	_

1	Methylation	_	NN	NN	_	2	nn	_	_
2	studies	_	NNS	NNS	_	3	nsubj	_	_
3	indicated	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	10	mark	_	_
5	the	_	DT	DT	_	9	det	_	_
6	tal-15	_	NN	NN	_	9	poss	_	_
7	'	_	POS	POS	_	9	possessive	_	_
8	GC-rich	_	JJ	JJ	_	9	amod	_	_
9	region	_	NN	NN	_	10	nsubj	_	_
10	behaves	_	VBZ	VBZ	_	3	ccomp	_	_
11	like	_	IN	IN	_	10	prep	_	_
12	a	_	DT	DT	_	14	det	_	_
13	CpG	_	NN	NN	_	14	nn	_	_
14	island	_	NN	NN	_	11	pobj	_	_
15	,	_	,	,	_	14	punct	_	_
16	hypomethylated	_	VBN	VBN	_	14	dep	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	normal	_	JJ	JJ	_	19	amod	_	_
19	cells	_	NNS	NNS	_	17	pobj	_	_
20	,	_	,	,	_	16	punct	_	_
21	and	_	CC	CC	_	16	cc	_	_
22	methylated	_	VBN	VBN	_	16	conj	_	_
23	de	_	FW	FW	_	24	nn	_	_
24	novo	_	FW	FW	_	22	advmod	_	_
25	on	_	IN	IN	_	22	prep	_	_
26	transcriptionally	_	RB	RB	_	28	advmod	_	_
27	inactive	_	JJ	JJ	_	28	amod	_	_
28	alleles	_	NNS	NNS	_	25	pobj	_	_
29	in	_	IN	IN	_	28	prep	_	_
30	established	_	JJ	JJ	_	32	amod	_	_
31	cell	_	NN	NN	_	32	nn	_	_
32	lines	_	NNS	NNS	_	29	pobj	_	_
33	.	_	.	.	_	3	punct	_	_

1	Five	_	CD	CD	_	5	num	_	_
2	major	_	JJ	JJ	_	5	amod	_	_
3	DNase-I	_	NN	NN	_	5	nn	_	_
4	hypersensitive	_	JJ	JJ	_	5	amod	_	_
5	sites	_	NNS	NNS	_	10	nsubjpass	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	HS	_	NN	NN	_	5	appos	_	_
8	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
9	were	_	VBD	VBD	_	10	auxpass	_	_
10	mapped	_	VBN	VBN	_	0	root	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	tal-1	_	NN	NN	_	14	nn	_	_
14	locus	_	NN	NN	_	11	pobj	_	_
15	.	_	.	.	_	10	punct	_	_

1	HS	_	NN	NN	_	10	nsubjpass	_	_
2	I	_	CD	CD	_	1	dep	_	_
3	,	_	,	,	_	1	punct	_	_
4	IV	_	CD	CD	_	1	conj	_	_
5	,	_	,	,	_	1	punct	_	_
6	and	_	CC	CC	_	1	cc	_	_
7	V	_	CD	CD	_	1	conj	_	_
8	were	_	VBD	VBD	_	10	auxpass	_	_
9	exclusively	_	RB	RB	_	10	advmod	_	_
10	observed	_	VBN	VBN	_	0	root	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	15	det	_	_
13	erythroid/megakaryocytic	_	JJ	JJ	_	15	amod	_	_
14	cell	_	NN	NN	_	15	nn	_	_
15	lines	_	NNS	NNS	_	11	pobj	_	_
16	that	_	WDT	WDT	_	17	nsubj	_	_
17	express	_	VBP	VBP	_	15	rcmod	_	_
18	tal-1	_	NN	NN	_	17	dobj	_	_
19	from	_	IN	IN	_	17	prep	_	_
20	the	_	DT	DT	_	21	det	_	_
21	promoters	_	NNS	NNS	_	19	pobj	_	_
22	1a	_	NN	NN	_	21	dep	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	1b	_	NN	NN	_	22	conj	_	_
25	.	_	.	.	_	10	punct	_	_

1	HS	_	NN	NN	_	4	nsubjpass	_	_
2	II	_	CD	CD	_	1	num	_	_
3	was	_	VBD	VBD	_	4	auxpass	_	_
4	weak	_	JJ	JJ	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	hematopoietic	_	JJ	JJ	_	8	amod	_	_
7	cell	_	NN	NN	_	8	nn	_	_
8	lines	_	NNS	NNS	_	5	pobj	_	_
9	,	_	,	,	_	4	punct	_	_
10	absent	_	JJ	JJ	_	4	conj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	Hela	_	NN	NN	_	11	pobj	_	_
13	,	_	,	,	_	4	punct	_	_
14	and	_	CC	CC	_	4	cc	_	_
15	greatly	_	RB	RB	_	4	advmod	_	_
16	enhanced	_	VBN	VBN	_	4	conj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	Jurkat	_	NN	NN	_	17	pobj	_	_
19	,	_	,	,	_	4	punct	_	_
20	suggesting	_	VBG	VBG	_	4	xcomp	_	_
21	that	_	IN	IN	_	26	mark	_	_
22	this	_	DT	DT	_	23	det	_	_
23	region	_	NN	NN	_	26	nsubjpass	_	_
24	might	_	MD	MD	_	26	aux	_	_
25	be	_	VB	VB	_	26	auxpass	_	_
26	implicated	_	VBN	VBN	_	20	ccomp	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	29	det	_	_
29	cis-activation	_	NN	NN	_	27	pobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	tal-1	_	NN	NN	_	33	nn	_	_
32	promoter	_	NN	NN	_	33	nn	_	_
33	1b	_	NN	NN	_	30	pobj	_	_
34	in	_	IN	IN	_	33	prep	_	_
35	this	_	DT	DT	_	37	det	_	_
36	cell	_	NN	NN	_	37	nn	_	_
37	line	_	NN	NN	_	34	pobj	_	_
38	.	_	.	.	_	4	punct	_	_

1	HS	_	NN	NN	_	4	nsubjpass	_	_
2	III	_	CD	CD	_	1	num	_	_
3	was	_	VBD	VBD	_	4	auxpass	_	_
4	weak	_	JJ	JJ	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	HEL	_	NN	NN	_	5	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	Jurkat	_	NN	NN	_	6	conj	_	_
9	,	_	,	,	_	4	punct	_	_
10	and	_	CC	CC	_	4	cc	_	_
11	greatly	_	RB	RB	_	4	advmod	_	_
12	enhanced	_	VBN	VBN	_	4	conj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	DU528	_	NN	NN	_	13	pobj	_	_
15	,	_	,	,	_	14	punct	_	_
16	a	_	DT	DT	_	18	det	_	_
17	T-cell	_	NN	NN	_	18	nn	_	_
18	line	_	NN	NN	_	14	appos	_	_
19	that	_	WDT	WDT	_	20	nsubj	_	_
20	bears	_	VBZ	VBZ	_	18	rcmod	_	_
21	a	_	DT	DT	_	22	det	_	_
22	t-LRB-1;14-RRB-	_	NN	NN	_	20	dobj	_	_
23	and	_	CC	CC	_	20	cc	_	_
24	initiates	_	VBZ	VBZ	_	20	conj	_	_
25	tal-1	_	NN	NN	_	26	nn	_	_
26	transcription	_	NN	NN	_	24	dobj	_	_
27	within	_	IN	IN	_	24	prep	_	_
28	exon	_	NN	NN	_	27	pobj	_	_
29	4	_	CD	CD	_	28	num	_	_
30	.	_	.	.	_	4	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	9	mark	_	_
5	distinct	_	JJ	JJ	_	7	amod	_	_
6	regulatory	_	JJ	JJ	_	7	amod	_	_
7	elements	_	NNS	NNS	_	9	nsubjpass	_	_
8	are	_	VBP	VBP	_	9	auxpass	_	_
9	associated	_	VBN	VBN	_	3	ccomp	_	_
10	with	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	use	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	17	det	_	_
15	different	_	JJ	JJ	_	17	amod	_	_
16	tal-1	_	NN	NN	_	17	nn	_	_
17	promoters	_	NNS	NNS	_	13	pobj	_	_
18	.	_	.	.	_	3	punct	_	_

1	Functions	_	NNS	NNS	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	glutathione	_	NN	NN	_	2	pobj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	glutathione	_	NN	NN	_	6	nn	_	_
6	disulfide	_	NN	NN	_	3	conj	_	_
7	in	_	IN	IN	_	1	prep	_	_
8	immunology	_	NN	NN	_	7	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	immunopathology	_	NN	NN	_	8	conj	_	_
11	.	_	.	.	_	1	punct	_	_

1	Even	_	RB	RB	_	4	advmod	_	_
2	a	_	DT	DT	_	4	det	_	_
3	moderate	_	JJ	JJ	_	4	amod	_	_
4	increase	_	NN	NN	_	10	nsubj	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	9	det	_	_
7	cellular	_	JJ	JJ	_	9	amod	_	_
8	cysteine	_	NN	NN	_	9	nn	_	_
9	supply	_	NN	NN	_	5	pobj	_	_
10	elevates	_	VBZ	VBZ	_	0	root	_	_
11	the	_	DT	DT	_	13	dep	_	_
12	intracellular	_	JJ	JJ	_	13	amod	_	_
13	glutathione	_	NN	NN	_	10	dobj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	GSH	_	NN	NN	_	13	appos	_	_
16	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
17	and	_	CC	CC	_	13	cc	_	_
18	glutathione	_	NN	NN	_	19	nn	_	_
19	disulfide	_	NN	NN	_	13	conj	_	_
20	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	GSSG	_	NN	NN	_	19	appos	_	_
22	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
23	levels	_	NNS	NNS	_	13	dep	_	_
24	and	_	CC	CC	_	10	cc	_	_
25	potentiates	_	VBZ	VBZ	_	10	conj	_	_
26	immunological	_	JJ	JJ	_	27	amod	_	_
27	functions	_	NNS	NNS	_	25	dobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	lymphocytes	_	NNS	NNS	_	28	pobj	_	_
30	in	_	FW	FW	_	31	nn	_	_
31	vitro	_	FW	FW	_	25	advmod	_	_
32	.	_	.	.	_	10	punct	_	_

1	At	_	IN	IN	_	11	prep	_	_
2	low	_	JJ	JJ	_	4	amod	_	_
3	GSSG	_	NN	NN	_	4	nn	_	_
4	levels	_	NNS	NNS	_	1	pobj	_	_
5	,	_	,	,	_	11	punct	_	_
6	T	_	NN	NN	_	7	nn	_	_
7	cells	_	NNS	NNS	_	11	nsubj	_	_
8	can	_	MD	MD	_	11	aux	_	_
9	not	_	RB	RB	_	11	neg	_	_
10	optimally	_	RB	RB	_	11	advmod	_	_
11	activate	_	VB	VB	_	0	root	_	_
12	the	_	DT	DT	_	16	det	_	_
13	immunologically	_	RB	RB	_	14	advmod	_	_
14	important	_	JJ	JJ	_	16	amod	_	_
15	transcription	_	NN	NN	_	16	nn	_	_
16	factor	_	NN	NN	_	11	dobj	_	_
17	NF	_	NN	NN	_	19	nn	_	_
18	kappa	_	NN	NN	_	19	nn	_	_
19	B	_	NN	NN	_	16	dep	_	_
20	,	_	,	,	_	11	punct	_	_
21	whereas	_	IN	IN	_	25	mark	_	_
22	high	_	JJ	JJ	_	24	amod	_	_
23	GSSG	_	NN	NN	_	24	nn	_	_
24	levels	_	NNS	NNS	_	25	nsubj	_	_
25	inhibit	_	VBP	VBP	_	11	advcl	_	_
26	the	_	DT	DT	_	29	det	_	_
27	DNA	_	NN	NN	_	29	nn	_	_
28	binding	_	NN	NN	_	29	nn	_	_
29	activity	_	NN	NN	_	25	dobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	NF	_	NN	NN	_	33	nn	_	_
32	kappa	_	NN	NN	_	33	nn	_	_
33	B	_	NN	NN	_	30	pobj	_	_
34	.	_	.	.	_	11	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	effects	_	NNS	NNS	_	6	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	GSSG	_	NN	NN	_	3	pobj	_	_
5	are	_	VBP	VBP	_	6	auxpass	_	_
6	antagonized	_	VBN	VBN	_	0	root	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	reduced	_	VBN	VBN	_	9	amod	_	_
9	thioredoxin	_	NN	NN	_	7	pobj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	TRX	_	NN	NN	_	9	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	.	_	.	.	_	6	punct	_	_

1	As	_	IN	IN	_	11	mark	_	_
2	the	_	DT	DT	_	6	det	_	_
3	protein	_	NN	NN	_	5	nn	_	_
4	tyrosine	_	NN	NN	_	5	nn	_	_
5	kinase	_	NN	NN	_	6	nn	_	_
6	activities	_	NNS	NNS	_	11	nsubjpass	_	_
7	p56lck	_	NN	NN	_	6	dep	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	p59fyn	_	NN	NN	_	7	conj	_	_
10	are	_	VBP	VBP	_	11	auxpass	_	_
11	activated	_	VBN	VBN	_	22	advcl	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	intact	_	JJ	JJ	_	14	amod	_	_
14	cells	_	NNS	NNS	_	12	pobj	_	_
15	by	_	IN	IN	_	11	prep	_	_
16	hydrogen	_	NN	NN	_	17	nn	_	_
17	peroxide	_	NN	NN	_	15	pobj	_	_
18	,	_	,	,	_	22	punct	_	_
19	they	_	PRP	PRP	_	22	nsubj	_	_
20	are	_	VBP	VBP	_	22	cop	_	_
21	likely	_	JJ	JJ	_	22	amod	_	_
22	targets	_	NNS	NNS	_	0	root	_	_
23	for	_	IN	IN	_	22	prep	_	_
24	GSSG	_	NN	NN	_	25	nn	_	_
25	action	_	NN	NN	_	23	pobj	_	_
26	.	_	.	.	_	22	punct	_	_

1	These	_	DT	DT	_	3	det	_	_
2	redox-regulated	_	JJ	JJ	_	3	amod	_	_
3	enzymes	_	NNS	NNS	_	4	nsubj	_	_
4	trigger	_	VBP	VBP	_	0	root	_	_
5	signal	_	NN	NN	_	6	nn	_	_
6	cascades	_	NNS	NNS	_	4	dobj	_	_
7	for	_	IN	IN	_	4	prep	_	_
8	NF	_	NN	NN	_	10	nn	_	_
9	kappa	_	NN	NN	_	10	nn	_	_
10	B	_	NN	NN	_	11	nn	_	_
11	activation	_	NN	NN	_	7	pobj	_	_
12	and	_	CC	CC	_	4	cc	_	_
13	transduce	_	VBP	VBP	_	4	conj	_	_
14	signals	_	NNS	NNS	_	13	dobj	_	_
15	from	_	IN	IN	_	13	prep	_	_
16	the	_	DT	DT	_	20	det	_	_
17	T	_	NN	NN	_	20	nn	_	_
18	cell	_	NN	NN	_	20	nn	_	_
19	antigen	_	NN	NN	_	20	nn	_	_
20	receptor	_	NN	NN	_	15	pobj	_	_
21	,	_	,	,	_	15	punct	_	_
22	from	_	IN	IN	_	15	conj	_	_
23	CD4	_	NN	NN	_	22	pobj	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	CD8	_	NN	NN	_	26	nn	_	_
26	molecules	_	NNS	NNS	_	23	conj	_	_
27	,	_	,	,	_	15	punct	_	_
28	and	_	CC	CC	_	15	cc	_	_
29	from	_	IN	IN	_	15	conj	_	_
30	the	_	DT	DT	_	33	det	_	_
31	IL-2	_	NN	NN	_	33	nn	_	_
32	receptor	_	NN	NN	_	33	nn	_	_
33	beta-chain	_	NN	NN	_	29	pobj	_	_
34	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	effector	_	NN	NN	_	3	nn	_	_
3	phase	_	NN	NN	_	13	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	cytotoxic	_	JJ	JJ	_	7	amod	_	_
6	T	_	NN	NN	_	7	nn	_	_
7	cell	_	NN	NN	_	8	nn	_	_
8	responses	_	NNS	NNS	_	4	pobj	_	_
9	and	_	CC	CC	_	3	cc	_	_
10	IL-2-dependent	_	JJ	JJ	_	11	amod	_	_
11	functions	_	NNS	NNS	_	3	conj	_	_
12	are	_	VBP	VBP	_	13	auxpass	_	_
13	inhibited	_	VBN	VBN	_	0	root	_	_
14	even	_	RB	RB	_	15	advmod	_	_
15	by	_	IN	IN	_	13	prep	_	_
16	a	_	DT	DT	_	18	det	_	_
17	partial	_	JJ	JJ	_	18	amod	_	_
18	depletion	_	NN	NN	_	15	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	23	det	_	_
21	intracellular	_	JJ	JJ	_	23	amod	_	_
22	GSH	_	NN	NN	_	23	nn	_	_
23	pool	_	NN	NN	_	19	pobj	_	_
24	.	_	.	.	_	13	punct	_	_

1	As	_	IN	IN	_	5	mark	_	_
2	signal	_	NN	NN	_	3	nn	_	_
3	transduction	_	NN	NN	_	5	nsubjpass	_	_
4	is	_	VBZ	VBZ	_	5	auxpass	_	_
5	facilitated	_	VBN	VBN	_	11	advcl	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	prooxidant	_	JJ	JJ	_	8	amod	_	_
8	conditions	_	NNS	NNS	_	6	pobj	_	_
9	,	_	,	,	_	11	punct	_	_
10	we	_	PRP	PRP	_	11	nsubj	_	_
11	propose	_	VBP	VBP	_	0	root	_	_
12	that	_	IN	IN	_	23	mark	_	_
13	the	_	DT	DT	_	16	det	_	_
14	well-known	_	JJ	JJ	_	16	amod	_	_
15	immunological	_	JJ	JJ	_	14	dep	_	_
16	consequences	_	NNS	NNS	_	23	nsubj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	GSH	_	NN	NN	_	19	nn	_	_
19	depletion	_	NN	NN	_	17	pobj	_	_
20	ultimately	_	RB	RB	_	23	advmod	_	_
21	may	_	MD	MD	_	23	aux	_	_
22	be	_	VB	VB	_	23	cop	_	_
23	results	_	NNS	NNS	_	11	ccomp	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	28	det	_	_
26	accompanying	_	VBG	VBG	_	28	amod	_	_
27	GSSG	_	NN	NN	_	28	nn	_	_
28	deficiency	_	NN	NN	_	24	pobj	_	_
29	.	_	.	.	_	11	punct	_	_

1	As	_	IN	IN	_	8	mark	_	_
2	HIV-infected	_	JJ	JJ	_	3	amod	_	_
3	patients	_	NNS	NNS	_	8	nsubj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	SIV-infected	_	JJ	JJ	_	7	amod	_	_
6	rhesus	_	NN	NN	_	7	nn	_	_
7	macaques	_	NNS	NNS	_	3	conj	_	_
8	have	_	VBP	VBP	_	29	advcl	_	_
9	,	_	,	,	_	8	punct	_	_
10	on	_	IN	IN	_	8	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	average	_	NN	NN	_	10	pobj	_	_
13	,	_	,	,	_	8	punct	_	_
14	significantly	_	RB	RB	_	21	advmod	_	_
15	decreased	_	VBN	VBN	_	21	amod	_	_
16	plasma	_	NN	NN	_	21	nn	_	_
17	cyst	_	NN	NN	_	21	nn	_	_
18	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
19	e	_	NN	NN	_	21	nn	_	_
20	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
21	ine	_	NN	NN	_	8	dobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	intracellular	_	JJ	JJ	_	24	amod	_	_
24	GSH	_	NN	NN	_	21	conj	_	_
25	levels	_	NNS	NNS	_	21	dep	_	_
26	,	_	,	,	_	29	punct	_	_
27	we	_	PRP	PRP	_	29	nsubj	_	_
28	also	_	RB	RB	_	29	advmod	_	_
29	hypothesize	_	VBP	VBP	_	0	root	_	_
30	that	_	IN	IN	_	35	mark	_	_
31	AIDS	_	NN	NN	_	35	nsubj	_	_
32	may	_	MD	MD	_	35	aux	_	_
33	be	_	VB	VB	_	35	cop	_	_
34	the	_	DT	DT	_	35	det	_	_
35	consequence	_	NN	NN	_	29	ccomp	_	_
36	of	_	IN	IN	_	35	prep	_	_
37	a	_	DT	DT	_	39	det	_	_
38	GSSG	_	NN	NN	_	39	nn	_	_
39	deficiency	_	NN	NN	_	36	pobj	_	_
40	as	_	RB	RB	_	41	advmod	_	_
41	well	_	RB	RB	_	35	advmod	_	_
42	.	_	.	.	_	29	punct	_	_

1	Erythropoietin-dependent	_	JJ	JJ	_	2	amod	_	_
2	induction	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	hemoglobin	_	NN	NN	_	5	nn	_	_
5	synthesis	_	NN	NN	_	3	pobj	_	_
6	in	_	IN	IN	_	2	prep	_	_
7	a	_	DT	DT	_	10	det	_	_
8	cytokine-dependent	_	JJ	JJ	_	10	amod	_	_
9	cell	_	NN	NN	_	10	nn	_	_
10	line	_	NN	NN	_	6	pobj	_	_
11	M-TAT	_	NN	NN	_	10	dep	_	_
12	.	_	.	.	_	2	punct	_	_

1	M-TAT	_	NN	NN	_	6	nsubj	_	_
2	is	_	VBZ	VBZ	_	6	cop	_	_
3	a	_	DT	DT	_	6	det	_	_
4	cytokine-dependent	_	JJ	JJ	_	6	amod	_	_
5	cell	_	NN	NN	_	6	nn	_	_
6	line	_	NN	NN	_	0	root	_	_
7	with	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	potential	_	NN	NN	_	7	pobj	_	_
10	to	_	TO	TO	_	11	aux	_	_
11	differentiate	_	VB	VB	_	9	vmod	_	_
12	along	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	14	dep	_	_
14	erythroid	_	JJ	JJ	_	12	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	megakaryocytic	_	JJ	JJ	_	14	conj	_	_
17	lineages	_	NNS	NNS	_	14	dep	_	_
18	.	_	.	.	_	6	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	cultured	_	VBD	VBD	_	0	root	_	_
3	M-TAT	_	NN	NN	_	4	nn	_	_
4	cells	_	NNS	NNS	_	2	iobj	_	_
5	long	_	JJ	JJ	_	6	amod	_	_
6	term	_	NN	NN	_	2	dobj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	&gt;	_	JJR	JJR	_	6	dep	_	_
9	1	_	CD	CD	_	10	num	_	_
10	year	_	NN	NN	_	8	tmod	_	_
11	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
12	in	_	IN	IN	_	2	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	continuous	_	JJ	JJ	_	15	amod	_	_
15	presence	_	NN	NN	_	12	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	erythropoietin	_	NN	NN	_	16	pobj	_	_
18	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
19	EPO	_	NN	NN	_	17	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	,	_	,	,	_	17	punct	_	_
22	granulocyte-macrophage	_	JJ	JJ	_	24	amod	_	_
23	colony-stimulating	_	JJ	JJ	_	24	amod	_	_
24	factor	_	NN	NN	_	17	conj	_	_
25	-LRB-	_	-LRB-	-LRB-	_	26	punct	_	_
26	GM-CSF	_	NN	NN	_	24	appos	_	_
27	-RRB-	_	-RRB-	-RRB-	_	26	punct	_	_
28	,	_	,	,	_	17	punct	_	_
29	or	_	CC	CC	_	17	cc	_	_
30	stem	_	NN	NN	_	32	nn	_	_
31	cell	_	NN	NN	_	32	nn	_	_
32	factor	_	NN	NN	_	17	conj	_	_
33	-LRB-	_	-LRB-	-LRB-	_	34	punct	_	_
34	SCF	_	NN	NN	_	32	appos	_	_
35	-RRB-	_	-RRB-	-RRB-	_	34	punct	_	_
36	.	_	.	.	_	2	punct	_	_

1	These	_	DT	DT	_	4	det	_	_
2	long	_	JJ	JJ	_	4	amod	_	_
3	term	_	NN	NN	_	4	nn	_	_
4	cultures	_	NNS	NNS	_	6	nsubjpass	_	_
5	are	_	VBP	VBP	_	6	auxpass	_	_
6	referred	_	VBN	VBN	_	0	root	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	as	_	IN	IN	_	6	prep	_	_
9	M-TAT/EPO	_	NN	NN	_	8	pobj	_	_
10	,	_	,	,	_	9	punct	_	_
11	M-TAT/GM-CSF	_	NN	NN	_	9	conj	_	_
12	,	_	,	,	_	9	punct	_	_
13	and	_	CC	CC	_	9	cc	_	_
14	M-TAT/SCF	_	NN	NN	_	9	conj	_	_
15	cells	_	NNS	NNS	_	9	dep	_	_
16	,	_	,	,	_	6	punct	_	_
17	respectively	_	RB	RB	_	6	advmod	_	_
18	.	_	.	.	_	6	punct	_	_

1	Hemoglobin	_	NN	NN	_	2	nn	_	_
2	concentration	_	NN	NN	_	13	nsubj	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	gamma-globin	_	NN	NN	_	2	conj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	erythroid	_	JJ	JJ	_	9	amod	_	_
7	delta-aminolevulinate	_	JJ	JJ	_	9	amod	_	_
8	synthase	_	NN	NN	_	9	nn	_	_
9	mRNA	_	NN	NN	_	4	conj	_	_
10	levels	_	NNS	NNS	_	4	dep	_	_
11	were	_	VBD	VBD	_	13	cop	_	_
12	significantly	_	RB	RB	_	13	advmod	_	_
13	higher	_	JJR	JJR	_	0	root	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	M-TAT/EPO	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	14	pobj	_	_
17	than	_	IN	IN	_	13	prep	_	_
18	in	_	IN	IN	_	17	pcomp	_	_
19	M-TAT/GM-CSF	_	NN	NN	_	20	nn	_	_
20	cells	_	NNS	NNS	_	18	pobj	_	_
21	.	_	.	.	_	13	punct	_	_

1	When	_	WRB	WRB	_	6	advmod	_	_
2	the	_	DT	DT	_	4	det	_	_
3	supplemented	_	VBN	VBN	_	4	amod	_	_
4	cytokine	_	NN	NN	_	6	nsubjpass	_	_
5	was	_	VBD	VBD	_	6	auxpass	_	_
6	switched	_	VBN	VBN	_	17	advcl	_	_
7	from	_	IN	IN	_	6	prep	_	_
8	GM-CSF	_	NN	NN	_	7	pobj	_	_
9	to	_	TO	TO	_	6	prep	_	_
10	EPO	_	NN	NN	_	9	pobj	_	_
11	,	_	,	,	_	17	punct	_	_
12	hemoglobin	_	NN	NN	_	13	nn	_	_
13	synthesis	_	NN	NN	_	17	nsubj	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	M-TAT/GM-CSF	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	14	pobj	_	_
17	increased	_	VBD	VBD	_	0	root	_	_
18	rapidly	_	RB	RB	_	17	advmod	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	within	_	IN	IN	_	18	dep	_	_
21	5	_	CD	CD	_	22	num	_	_
22	h	_	NN	NN	_	20	pobj	_	_
23	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
24	,	_	,	,	_	17	punct	_	_
25	and	_	CC	CC	_	17	cc	_	_
26	the	_	DT	DT	_	27	det	_	_
27	level	_	NN	NN	_	31	nsubj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	GATA-1	_	NN	NN	_	30	nn	_	_
30	mRNA	_	NN	NN	_	28	pobj	_	_
31	increased	_	VBD	VBD	_	17	conj	_	_
32	.	_	.	.	_	17	punct	_	_

1	In	_	IN	IN	_	13	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	13	punct	_	_
4	the	_	DT	DT	_	5	det	_	_
5	addition	_	NN	NN	_	13	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	GM-CSF	_	NN	NN	_	6	pobj	_	_
8	to	_	TO	TO	_	5	prep	_	_
9	the	_	DT	DT	_	12	det	_	_
10	M-TAT/EPO	_	NN	NN	_	12	nn	_	_
11	cell	_	NN	NN	_	12	nn	_	_
12	culture	_	NN	NN	_	8	pobj	_	_
13	decreased	_	VBD	VBD	_	0	root	_	_
14	the	_	DT	DT	_	15	det	_	_
15	amount	_	NN	NN	_	13	dobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	hemoglobin	_	NN	NN	_	16	pobj	_	_
18	,	_	,	,	_	13	punct	_	_
19	even	_	RB	RB	_	20	advmod	_	_
20	in	_	IN	IN	_	13	prep	_	_
21	the	_	DT	DT	_	22	det	_	_
22	presence	_	NN	NN	_	20	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	EPO	_	NN	NN	_	23	pobj	_	_
25	,	_	,	,	_	13	punct	_	_
26	indicating	_	VBG	VBG	_	13	vmod	_	_
27	that	_	IN	IN	_	35	mark	_	_
28	the	_	DT	DT	_	30	det	_	_
29	EPO	_	NN	NN	_	30	nn	_	_
30	signal	_	NN	NN	_	35	nsubjpass	_	_
31	for	_	IN	IN	_	30	prep	_	_
32	erythroid	_	JJ	JJ	_	33	amod	_	_
33	differentiation	_	NN	NN	_	31	pobj	_	_
34	is	_	VBZ	VBZ	_	35	auxpass	_	_
35	suppressed	_	VBN	VBN	_	26	ccomp	_	_
36	by	_	IN	IN	_	35	prep	_	_
37	GM-CSF	_	NN	NN	_	36	pobj	_	_
38	.	_	.	.	_	13	punct	_	_

1	Thus	_	RB	RB	_	9	advmod	_	_
2	,	_	,	,	_	9	punct	_	_
3	erythroid	_	JJ	JJ	_	4	amod	_	_
4	development	_	NN	NN	_	9	nsubjpass	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	M-TAT	_	NN	NN	_	7	nn	_	_
7	cells	_	NNS	NNS	_	5	pobj	_	_
8	is	_	VBZ	VBZ	_	9	auxpass	_	_
9	promoted	_	VBN	VBN	_	0	root	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	EPO	_	NN	NN	_	10	pobj	_	_
12	and	_	CC	CC	_	9	cc	_	_
13	suppressed	_	VBN	VBN	_	9	conj	_	_
14	by	_	IN	IN	_	13	prep	_	_
15	GM-CSF	_	NN	NN	_	14	pobj	_	_
16	.	_	.	.	_	9	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	support	_	VBP	VBP	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	hypothesis	_	NN	NN	_	3	dobj	_	_
6	that	_	IN	IN	_	9	mark	_	_
7	EPO	_	NN	NN	_	9	nsubj	_	_
8	actively	_	RB	RB	_	9	advmod	_	_
9	influences	_	VBZ	VBZ	_	5	ccomp	_	_
10	the	_	DT	DT	_	11	det	_	_
11	programming	_	NN	NN	_	9	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	gene	_	NN	NN	_	14	nn	_	_
14	expression	_	NN	NN	_	12	pobj	_	_
15	required	_	VBN	VBN	_	14	vmod	_	_
16	for	_	IN	IN	_	15	prep	_	_
17	erythroid	_	JJ	JJ	_	19	amod	_	_
18	progenitor	_	NN	NN	_	19	nn	_	_
19	cell	_	NN	NN	_	20	nn	_	_
20	differentiation	_	NN	NN	_	16	pobj	_	_
21	.	_	.	.	_	3	punct	_	_

1	DNA-binding	_	JJ	JJ	_	2	amod	_	_
2	studies	_	NNS	NNS	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	8	det	_	_
5	Epstein-Barr	_	JJ	JJ	_	8	amod	_	_
6	virus	_	NN	NN	_	8	nn	_	_
7	nuclear	_	JJ	JJ	_	8	amod	_	_
8	antigen	_	NN	NN	_	3	pobj	_	_
9	2	_	CD	CD	_	8	num	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	EBNA-2	_	NN	NN	_	8	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	:	_	:	:	_	2	punct	_	_
14	evidence	_	NN	NN	_	2	dep	_	_
15	for	_	IN	IN	_	14	prep	_	_
16	complex	_	JJ	JJ	_	17	amod	_	_
17	formation	_	NN	NN	_	15	pobj	_	_
18	by	_	IN	IN	_	17	prep	_	_
19	latent	_	JJ	JJ	_	24	amod	_	_
20	membrane	_	NN	NN	_	24	nn	_	_
21	protein	_	NN	NN	_	24	nn	_	_
22	gene	_	NN	NN	_	24	nn	_	_
23	promoter-binding	_	JJ	JJ	_	24	amod	_	_
24	proteins	_	NNS	NNS	_	18	pobj	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	EBNA-2-positive	_	JJ	JJ	_	28	amod	_	_
27	cell	_	NN	NN	_	28	nn	_	_
28	lines	_	NNS	NNS	_	25	pobj	_	_
29	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	13	det	_	_
2	Epstein-Barr	_	JJ	JJ	_	8	amod	_	_
3	virus	_	NN	NN	_	8	nn	_	_
4	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
5	EBV	_	NN	NN	_	8	nn	_	_
6	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
7	nuclear	_	JJ	JJ	_	8	amod	_	_
8	antigen	_	NN	NN	_	13	nn	_	_
9	2	_	CD	CD	_	8	num	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	EBNA-2	_	NN	NN	_	8	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	protein	_	NN	NN	_	15	nsubj	_	_
14	is	_	VBZ	VBZ	_	15	cop	_	_
15	essential	_	JJ	JJ	_	0	root	_	_
16	for	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	immortalization	_	NN	NN	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	human	_	JJ	JJ	_	23	amod	_	_
21	primary	_	JJ	JJ	_	23	amod	_	_
22	B	_	NN	NN	_	23	nn	_	_
23	cells	_	NNS	NNS	_	19	pobj	_	_
24	by	_	IN	IN	_	18	prep	_	_
25	EBV	_	NN	NN	_	24	pobj	_	_
26	.	_	.	.	_	15	punct	_	_

1	EBNA-2	_	NN	NN	_	2	nsubj	_	_
2	trans-activates	_	VBZ	VBZ	_	0	root	_	_
3	cellular	_	JJ	JJ	_	2	dobj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	viral	_	JJ	JJ	_	3	conj	_	_
6	genes	_	NNS	NNS	_	3	dep	_	_
7	like	_	IN	IN	_	3	prep	_	_
8	CD23	_	NN	NN	_	7	pobj	_	_
9	,	_	,	,	_	8	punct	_	_
10	c-fgr	_	NN	NN	_	8	conj	_	_
11	,	_	,	,	_	8	punct	_	_
12	latent	_	JJ	JJ	_	14	amod	_	_
13	membrane	_	NN	NN	_	14	nn	_	_
14	protein	_	NN	NN	_	8	conj	_	_
15	1	_	CD	CD	_	14	num	_	_
16	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
17	LMP1	_	NN	NN	_	14	appos	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	and	_	CC	CC	_	8	cc	_	_
20	terminal	_	JJ	JJ	_	21	amod	_	_
21	protein	_	NN	NN	_	8	conj	_	_
22	1	_	CD	CD	_	21	num	_	_
23	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
24	TP1	_	NN	NN	_	21	appos	_	_
25	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
26	.	_	.	.	_	2	punct	_	_

1	Trans-activation	_	NN	NN	_	15	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	TP1	_	NN	NN	_	5	nn	_	_
5	promoter	_	NN	NN	_	2	pobj	_	_
6	and	_	CC	CC	_	2	cc	_	_
7	of	_	IN	IN	_	2	conj	_	_
8	the	_	DT	DT	_	11	det	_	_
9	BamHI	_	NN	NN	_	11	nn	_	_
10	C	_	NN	NN	_	11	nn	_	_
11	promoter	_	NN	NN	_	7	pobj	_	_
12	has	_	VBZ	VBZ	_	15	aux	_	_
13	already	_	RB	RB	_	15	advmod	_	_
14	been	_	VBN	VBN	_	15	auxpass	_	_
15	investigated	_	VBN	VBN	_	0	root	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	detail	_	NN	NN	_	16	pobj	_	_
18	and	_	CC	CC	_	15	cc	_	_
19	appears	_	VBZ	VBZ	_	15	conj	_	_
20	to	_	TO	TO	_	22	aux	_	_
21	be	_	VB	VB	_	22	auxpass	_	_
22	mediated	_	VBN	VBN	_	19	xcomp	_	_
23	via	_	IN	IN	_	22	prep	_	_
24	protein-protein	_	JJ	JJ	_	25	amod	_	_
25	interactions	_	NNS	NNS	_	23	pobj	_	_
26	and	_	CC	CC	_	23	cc	_	_
27	not	_	RB	RB	_	28	neg	_	_
28	by	_	IN	IN	_	23	conj	_	_
29	direct	_	JJ	JJ	_	30	amod	_	_
30	binding	_	NN	NN	_	28	pobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	EBNA-2	_	NN	NN	_	34	nn	_	_
33	type	_	NN	NN	_	34	nn	_	_
34	A	_	NN	NN	_	31	pobj	_	_
35	-LRB-	_	-LRB-	-LRB-	_	36	punct	_	_
36	of	_	IN	IN	_	34	prep	_	_
37	EBV	_	NN	NN	_	38	nn	_	_
38	type	_	NN	NN	_	36	pobj	_	_
39	1	_	CD	CD	_	38	num	_	_
40	-RRB-	_	-RRB-	-RRB-	_	36	punct	_	_
41	to	_	TO	TO	_	30	prep	_	_
42	the	_	DT	DT	_	43	det	_	_
43	DNA	_	NN	NN	_	41	pobj	_	_
44	.	_	.	.	_	15	punct	_	_

1	EBNA-2	_	NN	NN	_	3	nsubj	_	_
2	is	_	VBZ	VBZ	_	3	cop	_	_
3	able	_	JJ	JJ	_	0	root	_	_
4	to	_	TO	TO	_	5	aux	_	_
5	trans-activate	_	VB	VB	_	3	xcomp	_	_
6	the	_	DT	DT	_	7	det	_	_
7	expression	_	NN	NN	_	5	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	LMP	_	NN	NN	_	11	nn	_	_
11	gene	_	NN	NN	_	8	pobj	_	_
12	in	_	IN	IN	_	7	prep	_	_
13	several	_	JJ	JJ	_	15	amod	_	_
14	cell	_	NN	NN	_	15	nn	_	_
15	lines	_	NNS	NNS	_	12	pobj	_	_
16	.	_	.	.	_	3	punct	_	_

1	Various	_	JJ	JJ	_	2	amod	_	_
2	reports	_	NNS	NNS	_	4	nsubj	_	_
3	have	_	VBP	VBP	_	4	aux	_	_
4	delineated	_	VBN	VBN	_	0	root	_	_
5	the	_	DT	DT	_	7	det	_	_
6	cis-acting	_	JJ	JJ	_	7	amod	_	_
7	elements	_	NNS	NNS	_	4	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	LMP	_	NN	NN	_	11	nn	_	_
11	promoter	_	NN	NN	_	8	pobj	_	_
12	through	_	IN	IN	_	15	prep	_	_
13	which	_	WDT	WDT	_	12	pobj	_	_
14	EBNA-2	_	NN	NN	_	15	nsubj	_	_
15	mediates	_	VBZ	VBZ	_	7	rcmod	_	_
16	trans-activation	_	NN	NN	_	15	dobj	_	_
17	.	_	.	.	_	4	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	determine	_	VB	VB	_	0	root	_	_
3	whether	_	IN	IN	_	6	mark	_	_
4	EBNA-2	_	NN	NN	_	6	nsubj	_	_
5	also	_	RB	RB	_	6	advmod	_	_
6	trans-activates	_	VBZ	VBZ	_	2	ccomp	_	_
7	the	_	DT	DT	_	9	det	_	_
8	LMP	_	NN	NN	_	9	nn	_	_
9	promoter	_	NN	NN	_	6	dobj	_	_
10	by	_	IN	IN	_	6	prep	_	_
11	protein-protein	_	JJ	JJ	_	12	amod	_	_
12	interactions	_	NNS	NNS	_	10	pobj	_	_
13	,	_	,	,	_	2	punct	_	_
14	we	_	PRP	PRP	_	15	nsubj	_	_
15	performed	_	VBD	VBD	_	2	parataxis	_	_
16	a	_	DT	DT	_	17	det	_	_
17	series	_	NN	NN	_	15	dobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	gel	_	NN	NN	_	21	nn	_	_
20	retardation	_	NN	NN	_	21	nn	_	_
21	assays	_	NNS	NNS	_	18	pobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	competition	_	NN	NN	_	24	nn	_	_
24	experiments	_	NNS	NNS	_	21	conj	_	_
25	with	_	IN	IN	_	21	prep	_	_
26	LMP	_	NN	NN	_	28	nn	_	_
27	promoter	_	NN	NN	_	28	nn	_	_
28	fragments	_	NNS	NNS	_	25	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	different	_	JJ	JJ	_	31	amod	_	_
31	sizes	_	NNS	NNS	_	29	pobj	_	_
32	.	_	.	.	_	2	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	determined	_	VBD	VBD	_	0	root	_	_
3	that	_	IN	IN	_	11	mark	_	_
4	the	_	DT	DT	_	6	det	_	_
5	protein-binding	_	JJ	JJ	_	6	amod	_	_
6	region	_	NN	NN	_	11	nsubj	_	_
7	on	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	LMP	_	NN	NN	_	10	nn	_	_
10	promoter	_	NN	NN	_	7	pobj	_	_
11	was	_	VBD	VBD	_	2	ccomp	_	_
12	within	_	IN	IN	_	11	prep	_	_
13	a	_	DT	DT	_	16	det	_	_
14	42	_	CD	CD	_	16	num	_	_
15	bp	_	NN	NN	_	16	nn	_	_
16	fragment	_	NN	NN	_	12	pobj	_	_
17	encompassing	_	VBG	VBG	_	16	vmod	_	_
18	nucleotides	_	NNS	NNS	_	17	dobj	_	_
19	-135	_	CD	CD	_	18	num	_	_
20	to	_	TO	TO	_	18	dep	_	_
21	-176	_	CD	CD	_	18	num	_	_
22	relative	_	JJ	JJ	_	18	amod	_	_
23	to	_	TO	TO	_	22	prep	_	_
24	the	_	DT	DT	_	28	det	_	_
25	LMP	_	NN	NN	_	28	nn	_	_
26	transcriptional	_	JJ	JJ	_	28	amod	_	_
27	start	_	NN	NN	_	28	nn	_	_
28	site	_	NN	NN	_	23	pobj	_	_
29	.	_	.	.	_	2	punct	_	_

1	None	_	NN	NN	_	7	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	DNA	_	NN	NN	_	5	nn	_	_
5	fragments	_	NNS	NNS	_	2	pobj	_	_
6	investigated	_	VBN	VBN	_	5	vmod	_	_
7	indicated	_	VBD	VBD	_	0	root	_	_
8	interaction	_	NN	NN	_	7	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	EBNA-2	_	NN	NN	_	9	pobj	_	_
11	with	_	IN	IN	_	8	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	DNA	_	NN	NN	_	11	pobj	_	_
14	via	_	IN	IN	_	8	prep	_	_
15	protein-protein	_	JJ	JJ	_	16	amod	_	_
16	interactions	_	NNS	NNS	_	14	pobj	_	_
17	.	_	.	.	_	7	punct	_	_

1	No	_	DT	DT	_	3	neg	_	_
2	significant	_	JJ	JJ	_	3	amod	_	_
3	differences	_	NNS	NNS	_	12	nsubjpass	_	_
4	between	_	IN	IN	_	3	prep	_	_
5	EBNA-2-positive	_	JJ	JJ	_	4	pobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	EBNA-2-negative	_	JJ	JJ	_	5	conj	_	_
8	nuclear	_	JJ	JJ	_	9	amod	_	_
9	extracts	_	NNS	NNS	_	5	dep	_	_
10	could	_	MD	MD	_	12	aux	_	_
11	be	_	VB	VB	_	12	auxpass	_	_
12	seen	_	VBN	VBN	_	0	root	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	17	det	_	_
15	gel	_	NN	NN	_	17	nn	_	_
16	retardation	_	NN	NN	_	17	nn	_	_
17	assay	_	NN	NN	_	13	pobj	_	_
18	under	_	IN	IN	_	12	prep	_	_
19	conditions	_	NNS	NNS	_	18	pobj	_	_
20	that	_	WDT	WDT	_	22	nsubj	_	_
21	clearly	_	RB	RB	_	22	advmod	_	_
22	showed	_	VBD	VBD	_	19	rcmod	_	_
23	binding	_	NN	NN	_	22	dobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	EBNA-2A	_	NN	NN	_	24	pobj	_	_
26	to	_	TO	TO	_	23	prep	_	_
27	the	_	DT	DT	_	29	det	_	_
28	TP1	_	NN	NN	_	29	nn	_	_
29	promoter	_	NN	NN	_	26	pobj	_	_
30	.	_	.	.	_	12	punct	_	_

1	However	_	RB	RB	_	13	advmod	_	_
2	,	_	,	,	_	13	punct	_	_
3	analysis	_	NN	NN	_	13	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	sucrose	_	NN	NN	_	7	nn	_	_
6	gradient	_	NN	NN	_	7	nn	_	_
7	fractions	_	NNS	NNS	_	4	pobj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	12	det	_	_
10	gel	_	NN	NN	_	12	nn	_	_
11	retardation	_	NN	NN	_	12	nn	_	_
12	assay	_	NN	NN	_	8	pobj	_	_
13	provided	_	VBD	VBD	_	0	root	_	_
14	evidence	_	NN	NN	_	13	dobj	_	_
15	that	_	IN	IN	_	20	mark	_	_
16	the	_	DT	DT	_	19	det	_	_
17	LMP	_	NN	NN	_	19	nn	_	_
18	promoter-binding	_	JJ	JJ	_	19	amod	_	_
19	proteins	_	NNS	NNS	_	20	nsubj	_	_
20	form	_	VBP	VBP	_	14	ccomp	_	_
21	a	_	DT	DT	_	22	det	_	_
22	complex	_	NN	NN	_	20	dobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	higher	_	JJR	JJR	_	25	amod	_	_
25	M-LRB-r-RRB-	_	NN	NN	_	23	pobj	_	_
26	in	_	IN	IN	_	20	prep	_	_
27	EBNA-2-positive	_	JJ	JJ	_	28	amod	_	_
28	cell	_	NN	NN	_	29	nn	_	_
29	extracts	_	NNS	NNS	_	26	pobj	_	_
30	.	_	.	.	_	13	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	complexes	_	NNS	NNS	_	4	nsubjpass	_	_
3	were	_	VBD	VBD	_	4	auxpass	_	_
4	destroyed	_	VBN	VBN	_	0	root	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	detergent	_	NN	NN	_	5	pobj	_	_
7	.	_	.	.	_	4	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	deduce	_	VBP	VBP	_	0	root	_	_
3	from	_	IN	IN	_	2	prep	_	_
4	these	_	DT	DT	_	5	det	_	_
5	results	_	NNS	NNS	_	3	pobj	_	_
6	that	_	IN	IN	_	11	mark	_	_
7	EBNA-2-positive	_	JJ	JJ	_	8	amod	_	_
8	cells	_	NNS	NNS	_	11	nsubj	_	_
9	might	_	MD	MD	_	11	aux	_	_
10	indeed	_	RB	RB	_	11	advmod	_	_
11	contain	_	VB	VB	_	2	ccomp	_	_
12	specific	_	JJ	JJ	_	13	amod	_	_
13	complexes	_	NNS	NNS	_	11	dobj	_	_
14	bound	_	VBN	VBN	_	13	vmod	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	LMP	_	NN	NN	_	18	nn	_	_
18	promoter	_	NN	NN	_	15	pobj	_	_
19	which	_	WDT	WDT	_	25	nsubj	_	_
20	are	_	VBP	VBP	_	25	cop	_	_
21	,	_	,	,	_	25	punct	_	_
22	however	_	RB	RB	_	25	advmod	_	_
23	,	_	,	,	_	25	punct	_	_
24	too	_	RB	RB	_	25	advmod	_	_
25	labile	_	JJ	JJ	_	13	rcmod	_	_
26	to	_	TO	TO	_	28	aux	_	_
27	be	_	VB	VB	_	28	auxpass	_	_
28	detected	_	VBN	VBN	_	25	ccomp	_	_
29	in	_	IN	IN	_	28	prep	_	_
30	a	_	DT	DT	_	34	det	_	_
31	standard	_	JJ	JJ	_	34	amod	_	_
32	gel	_	NN	NN	_	34	nn	_	_
33	retardation	_	NN	NN	_	34	nn	_	_
34	assay	_	NN	NN	_	29	pobj	_	_
35	.	_	.	.	_	2	punct	_	_

1	Enhanced	_	VBN	VBN	_	2	amod	_	_
2	responsiveness	_	NN	NN	_	8	nsubj	_	_
3	to	_	TO	TO	_	2	prep	_	_
4	nuclear	_	JJ	JJ	_	7	amod	_	_
5	factor	_	NN	NN	_	7	nn	_	_
6	kappa	_	NN	NN	_	7	nn	_	_
7	B	_	NN	NN	_	3	pobj	_	_
8	contributes	_	VBZ	VBZ	_	0	root	_	_
9	to	_	TO	TO	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	unique	_	JJ	JJ	_	12	amod	_	_
12	phenotype	_	NN	NN	_	9	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	simian	_	JJ	JJ	_	17	amod	_	_
15	immunodeficiency	_	NN	NN	_	17	nn	_	_
16	virus	_	NN	NN	_	17	nn	_	_
17	variant	_	NN	NN	_	13	pobj	_	_
18	SIVsmmPBj14	_	NN	NN	_	17	dep	_	_
19	.	_	.	.	_	8	punct	_	_

1	Infection	_	NN	NN	_	12	nsubj	_	_
2	with	_	IN	IN	_	1	prep	_	_
3	a	_	DT	DT	_	4	det	_	_
4	variant	_	NN	NN	_	2	pobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	simian	_	JJ	JJ	_	8	amod	_	_
7	immunodeficiency	_	NN	NN	_	8	nn	_	_
8	virus	_	NN	NN	_	5	pobj	_	_
9	,	_	,	,	_	4	punct	_	_
10	SIVsmmPBj14	_	NN	NN	_	4	appos	_	_
11	,	_	,	,	_	1	punct	_	_
12	leads	_	VBZ	VBZ	_	0	root	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	severe	_	JJ	JJ	_	16	amod	_	_
15	acute	_	JJ	JJ	_	14	dep	_	_
16	disease	_	NN	NN	_	13	pobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	macaques	_	NNS	NNS	_	17	pobj	_	_
19	.	_	.	.	_	12	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	study	_	NN	NN	_	4	nsubjpass	_	_
3	was	_	VBD	VBD	_	4	auxpass	_	_
4	designed	_	VBN	VBN	_	0	root	_	_
5	to	_	TO	TO	_	6	aux	_	_
6	investigate	_	VB	VB	_	4	ccomp	_	_
7	the	_	DT	DT	_	9	det	_	_
8	functional	_	JJ	JJ	_	9	amod	_	_
9	significance	_	NN	NN	_	6	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	previously	_	RB	RB	_	12	advmod	_	_
12	described	_	VBN	VBN	_	13	amod	_	_
13	mutations	_	NNS	NNS	_	10	pobj	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	19	det	_	_
16	viral	_	JJ	JJ	_	19	amod	_	_
17	long	_	JJ	JJ	_	19	amod	_	_
18	terminal	_	JJ	JJ	_	19	amod	_	_
19	repeat	_	NN	NN	_	14	pobj	_	_
20	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	LTR	_	NN	NN	_	19	appos	_	_
22	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
23	and	_	CC	CC	_	6	cc	_	_
24	to	_	TO	TO	_	25	aux	_	_
25	elucidate	_	VB	VB	_	6	conj	_	_
26	their	_	PRP$	PRP$	_	27	poss	_	_
27	contribution	_	NN	NN	_	25	dobj	_	_
28	to	_	TO	TO	_	27	prep	_	_
29	the	_	DT	DT	_	31	det	_	_
30	unique	_	JJ	JJ	_	31	amod	_	_
31	phenotype	_	NN	NN	_	28	pobj	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	SIVsmmPBj14	_	NN	NN	_	32	pobj	_	_
34	.	_	.	.	_	4	punct	_	_

1	LTR-directed	_	JJ	JJ	_	2	amod	_	_
2	transcription	_	NN	NN	_	4	nsubjpass	_	_
3	was	_	VBD	VBD	_	4	auxpass	_	_
4	measured	_	VBN	VBN	_	0	root	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	using	_	VBG	VBG	_	5	pcomp	_	_
7	luciferase	_	NN	NN	_	9	nn	_	_
8	reporter	_	NN	NN	_	9	nn	_	_
9	constructs	_	NNS	NNS	_	6	dobj	_	_
10	that	_	WDT	WDT	_	13	nsubjpass	_	_
11	were	_	VBD	VBD	_	13	auxpass	_	_
12	transiently	_	RB	RB	_	13	advmod	_	_
13	transfected	_	VBN	VBN	_	9	rcmod	_	_
14	into	_	IN	IN	_	13	prep	_	_
15	cultured	_	VBN	VBN	_	16	amod	_	_
16	cells	_	NNS	NNS	_	14	pobj	_	_
17	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	19	prep	_	_
2	a	_	DT	DT	_	4	det	_	_
3	wide	_	JJ	JJ	_	4	amod	_	_
4	range	_	NN	NN	_	1	pobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	cell	_	NN	NN	_	7	nn	_	_
7	types	_	NNS	NNS	_	5	pobj	_	_
8	,	_	,	,	_	19	punct	_	_
9	the	_	DT	DT	_	12	det	_	_
10	basal	_	JJ	JJ	_	12	amod	_	_
11	transcriptional	_	JJ	JJ	_	10	dep	_	_
12	activity	_	NN	NN	_	19	nsubjpass	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	LTR	_	NN	NN	_	13	pobj	_	_
16	from	_	IN	IN	_	15	prep	_	_
17	SIVsmmPBj14	_	NN	NN	_	16	pobj	_	_
18	was	_	VBD	VBD	_	19	auxpass	_	_
19	found	_	VBN	VBN	_	0	root	_	_
20	to	_	TO	TO	_	25	aux	_	_
21	be	_	VB	VB	_	25	cop	_	_
22	2-	_	CD	CD	_	25	npadvmod	_	_
23	to	_	TO	TO	_	22	dep	_	_
24	4.5-fold	_	RB	RB	_	22	advmod	_	_
25	higher	_	JJR	JJR	_	19	xcomp	_	_
26	than	_	IN	IN	_	25	prep	_	_
27	that	_	DT	DT	_	26	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	an	_	DT	DT	_	30	det	_	_
30	LTR	_	NN	NN	_	28	pobj	_	_
31	from	_	IN	IN	_	30	prep	_	_
32	a	_	DT	DT	_	35	det	_	_
33	non-acutely	_	RB	RB	_	34	advmod	_	_
34	pathogenic	_	JJ	JJ	_	35	amod	_	_
35	strain	_	NN	NN	_	31	pobj	_	_
36	.	_	.	.	_	19	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	LTRs	_	NNS	NNS	_	3	nsubj	_	_
3	differ	_	VBP	VBP	_	0	root	_	_
4	by	_	IN	IN	_	3	prep	_	_
5	five	_	CD	CD	_	7	num	_	_
6	point	_	NN	NN	_	7	nn	_	_
7	mutations	_	NNS	NNS	_	4	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	a	_	DT	DT	_	11	det	_	_
10	22-bp	_	JJ	JJ	_	11	amod	_	_
11	duplication	_	NN	NN	_	7	conj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	SIVsmmPBj14	_	NN	NN	_	12	pobj	_	_
14	,	_	,	,	_	11	punct	_	_
15	which	_	WDT	WDT	_	16	nsubj	_	_
16	includes	_	VBZ	VBZ	_	11	rcmod	_	_
17	a	_	DT	DT	_	27	det	_	_
18	nuclear	_	JJ	JJ	_	27	amod	_	_
19	factor	_	NN	NN	_	27	nn	_	_
20	kappa	_	NN	NN	_	27	nn	_	_
21	B	_	NN	NN	_	27	nn	_	_
22	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
23	NF	_	NN	NN	_	27	nn	_	_
24	kappa	_	NN	NN	_	27	nn	_	_
25	B	_	NN	NN	_	27	nn	_	_
26	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
27	site	_	NN	NN	_	16	dobj	_	_
28	.	_	.	.	_	3	punct	_	_

1	Transcriptional	_	JJ	JJ	_	2	amod	_	_
2	differences	_	NNS	NNS	_	8	nsubjpass	_	_
3	between	_	IN	IN	_	2	prep	_	_
4	these	_	DT	DT	_	5	det	_	_
5	LTRs	_	NNS	NNS	_	3	pobj	_	_
6	were	_	VBD	VBD	_	8	auxpass	_	_
7	further	_	RB	RB	_	8	advmod	_	_
8	enhanced	_	VBN	VBN	_	0	root	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	two-	_	CD	CD	_	9	pobj	_	_
11	to	_	TO	TO	_	10	dep	_	_
12	threefold	_	RB	RB	_	10	advmod	_	_
13	upon	_	IN	IN	_	8	prep	_	_
14	treatment	_	NN	NN	_	13	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	cells	_	NNS	NNS	_	15	pobj	_	_
17	with	_	IN	IN	_	14	prep	_	_
18	phorbol	_	NN	NN	_	19	nn	_	_
19	ester	_	NN	NN	_	17	pobj	_	_
20	or	_	CC	CC	_	19	cc	_	_
21	tumor	_	NN	NN	_	24	nn	_	_
22	necrosis	_	NN	NN	_	24	nn	_	_
23	factor	_	NN	NN	_	24	nn	_	_
24	alpha	_	NN	NN	_	19	conj	_	_
25	or	_	CC	CC	_	13	cc	_	_
26	by	_	IN	IN	_	13	conj	_	_
27	cotransfection	_	NN	NN	_	26	pobj	_	_
28	with	_	IN	IN	_	27	prep	_	_
29	plasmids	_	NNS	NNS	_	28	pobj	_	_
30	expressing	_	VBG	VBG	_	29	vmod	_	_
31	NF	_	NN	NN	_	33	nn	_	_
32	kappa	_	NN	NN	_	33	nn	_	_
33	B	_	NN	NN	_	34	nn	_	_
34	subunits	_	NNS	NNS	_	30	dobj	_	_
35	.	_	.	.	_	8	punct	_	_

1	Mutagenesis	_	NN	NN	_	2	nn	_	_
2	studies	_	NNS	NNS	_	16	nsubj	_	_
3	,	_	,	,	_	2	punct	_	_
4	and	_	CC	CC	_	2	cc	_	_
5	the	_	DT	DT	_	6	det	_	_
6	use	_	NN	NN	_	2	conj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	a	_	DT	DT	_	10	det	_	_
9	reporter	_	NN	NN	_	10	nn	_	_
10	construct	_	NN	NN	_	7	pobj	_	_
11	containing	_	VBG	VBG	_	10	vmod	_	_
12	an	_	DT	DT	_	14	det	_	_
13	enhancerless	_	JJ	JJ	_	14	amod	_	_
14	promoter	_	NN	NN	_	11	dobj	_	_
15	,	_	,	,	_	2	punct	_	_
16	indicate	_	VBP	VBP	_	0	root	_	_
17	that	_	IN	IN	_	22	mark	_	_
18	these	_	DT	DT	_	20	det	_	_
19	transcriptional	_	JJ	JJ	_	20	amod	_	_
20	effects	_	NNS	NNS	_	22	nsubj	_	_
21	are	_	VBP	VBP	_	22	cop	_	_
22	due	_	JJ	JJ	_	16	ccomp	_	_
23	principally	_	RB	RB	_	24	advmod	_	_
24	to	_	TO	TO	_	22	prep	_	_
25	the	_	DT	DT	_	28	det	_	_
26	22-bp	_	JJ	JJ	_	28	amod	_	_
27	sequence	_	NN	NN	_	28	nn	_	_
28	duplication	_	NN	NN	_	24	pobj	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	the	_	DT	DT	_	34	det	_	_
31	NF	_	NN	NN	_	34	nn	_	_
32	kappa	_	NN	NN	_	34	nn	_	_
33	B	_	NN	NN	_	34	nn	_	_
34	site	_	NN	NN	_	28	conj	_	_
35	contained	_	VBN	VBN	_	34	vmod	_	_
36	within	_	IN	IN	_	35	prep	_	_
37	it	_	PRP	PRP	_	36	pobj	_	_
38	.	_	.	.	_	16	punct	_	_

1	Finally	_	RB	RB	_	14	advmod	_	_
2	,	_	,	,	_	14	punct	_	_
3	infectious	_	JJ	JJ	_	5	amod	_	_
4	virus	_	NN	NN	_	5	nn	_	_
5	stocks	_	NNS	NNS	_	14	nsubjpass	_	_
6	that	_	WDT	WDT	_	8	nsubj	_	_
7	were	_	VBD	VBD	_	8	cop	_	_
8	isogenic	_	JJ	JJ	_	5	rcmod	_	_
9	except	_	IN	IN	_	8	prep	_	_
10	for	_	IN	IN	_	9	pcomp	_	_
11	the	_	DT	DT	_	12	det	_	_
12	LTR	_	NN	NN	_	10	pobj	_	_
13	were	_	VBD	VBD	_	14	auxpass	_	_
14	generated	_	VBN	VBN	_	0	root	_	_
15	.	_	.	.	_	14	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	LTR	_	NN	NN	_	6	nsubjpass	_	_
3	from	_	IN	IN	_	2	prep	_	_
4	SIVsmmPBj14	_	NN	NN	_	3	pobj	_	_
5	was	_	VBD	VBD	_	6	auxpass	_	_
6	found	_	VBN	VBN	_	0	root	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	confer	_	VB	VB	_	6	xcomp	_	_
9	an	_	DT	DT	_	10	det	_	_
10	increase	_	NN	NN	_	8	dobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	kinetics	_	NNS	NNS	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	virus	_	NN	NN	_	16	nn	_	_
16	replication	_	NN	NN	_	14	pobj	_	_
17	in	_	IN	IN	_	8	prep	_	_
18	cultured	_	VBN	VBN	_	19	amod	_	_
19	cells	_	NNS	NNS	_	17	pobj	_	_
20	.	_	.	.	_	6	punct	_	_

1	Inclusion	_	NN	NN	_	9	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	this	_	DT	DT	_	4	det	_	_
4	LTR	_	NN	NN	_	2	pobj	_	_
5	in	_	IN	IN	_	1	prep	_	_
6	recombinant	_	JJ	JJ	_	7	amod	_	_
7	SIVs	_	NNS	NNS	_	5	pobj	_	_
8	also	_	RB	RB	_	9	advmod	_	_
9	resulted	_	VBD	VBD	_	0	root	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	a	_	DT	DT	_	15	det	_	_
12	two-	_	CD	CD	_	14	number	_	_
13	to	_	TO	TO	_	14	dep	_	_
14	threefold	_	JJ	JJ	_	15	amod	_	_
15	rise	_	NN	NN	_	10	pobj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	extent	_	NN	NN	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	cellular	_	JJ	JJ	_	21	amod	_	_
21	proliferation	_	NN	NN	_	19	pobj	_	_
22	that	_	WDT	WDT	_	24	nsubjpass	_	_
23	was	_	VBD	VBD	_	24	auxpass	_	_
24	induced	_	VBN	VBN	_	21	rcmod	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	quiescent	_	JJ	JJ	_	31	amod	_	_
27	simian	_	JJ	JJ	_	31	amod	_	_
28	peripheral	_	JJ	JJ	_	31	amod	_	_
29	blood	_	NN	NN	_	31	nn	_	_
30	mononuclear	_	JJ	JJ	_	31	amod	_	_
31	cells	_	NNS	NNS	_	25	pobj	_	_
32	.	_	.	.	_	9	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	studies	_	NNS	NNS	_	4	nsubj	_	_
3	are	_	VBP	VBP	_	4	cop	_	_
4	consistent	_	JJ	JJ	_	0	root	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	hypothesis	_	NN	NN	_	5	pobj	_	_
8	that	_	IN	IN	_	11	mark	_	_
9	LTR	_	NN	NN	_	10	nn	_	_
10	mutations	_	NNS	NNS	_	11	nsubj	_	_
11	assist	_	VBP	VBP	_	7	ccomp	_	_
12	SIVsmmPBj14	_	NN	NN	_	11	dobj	_	_
13	in	_	IN	IN	_	11	prep	_	_
14	responding	_	VBG	VBG	_	13	pcomp	_	_
15	efficiently	_	RB	RB	_	14	advmod	_	_
16	to	_	TO	TO	_	14	prep	_	_
17	cellular	_	JJ	JJ	_	18	amod	_	_
18	stimulation	_	NN	NN	_	16	pobj	_	_
19	and	_	CC	CC	_	11	cc	_	_
20	allow	_	VBP	VBP	_	11	conj	_	_
21	it	_	PRP	PRP	_	20	dobj	_	_
22	to	_	TO	TO	_	23	aux	_	_
23	replicate	_	VB	VB	_	20	xcomp	_	_
24	to	_	TO	TO	_	23	prep	_	_
25	high	_	JJ	JJ	_	26	amod	_	_
26	titers	_	NNS	NNS	_	24	pobj	_	_
27	during	_	IN	IN	_	23	prep	_	_
28	the	_	DT	DT	_	30	det	_	_
29	acute	_	JJ	JJ	_	30	amod	_	_
30	phase	_	NN	NN	_	27	pobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	viral	_	JJ	JJ	_	33	amod	_	_
33	infection	_	NN	NN	_	31	pobj	_	_
34	.	_	.	.	_	4	punct	_	_

1	Identification	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	a	_	DT	DT	_	4	det	_	_
4	region	_	NN	NN	_	2	pobj	_	_
5	which	_	WDT	WDT	_	6	nsubj	_	_
6	directs	_	VBZ	VBZ	_	4	rcmod	_	_
7	the	_	DT	DT	_	9	det	_	_
8	monocytic	_	JJ	JJ	_	9	amod	_	_
9	activity	_	NN	NN	_	6	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	21	det	_	_
12	colony-stimulating	_	JJ	JJ	_	21	amod	_	_
13	factor	_	NN	NN	_	21	nn	_	_
14	1	_	CD	CD	_	21	num	_	_
15	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
16	macrophage	_	NN	NN	_	21	nn	_	_
17	colony-stimulating	_	JJ	JJ	_	21	amod	_	_
18	factor	_	NN	NN	_	21	nn	_	_
19	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
20	receptor	_	NN	NN	_	21	nn	_	_
21	promoter	_	NN	NN	_	10	pobj	_	_
22	and	_	CC	CC	_	6	cc	_	_
23	binds	_	VBZ	VBZ	_	6	conj	_	_
24	PEBP2/CBF	_	NN	NN	_	23	dobj	_	_
25	-LRB-	_	-LRB-	-LRB-	_	26	punct	_	_
26	AML1	_	NN	NN	_	24	appos	_	_
27	-RRB-	_	-RRB-	-RRB-	_	26	punct	_	_
28	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	receptor	_	NN	NN	_	18	nsubjpass	_	_
3	for	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	7	det	_	_
5	macrophage	_	NN	NN	_	7	nn	_	_
6	colony-stimulating	_	JJ	JJ	_	7	amod	_	_
7	factor	_	NN	NN	_	3	pobj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
9	or	_	CC	CC	_	11	cc	_	_
10	colony-stimulating	_	JJ	JJ	_	11	amod	_	_
11	factor	_	NN	NN	_	7	dep	_	_
12	1	_	CD	CD	_	11	num	_	_
13	-LSB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	CSF-1	_	NN	NN	_	11	appos	_	_
15	-RSB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
17	is	_	VBZ	VBZ	_	18	auxpass	_	_
18	expressed	_	VBN	VBN	_	0	root	_	_
19	from	_	IN	IN	_	18	prep	_	_
20	different	_	JJ	JJ	_	21	amod	_	_
21	promoters	_	NNS	NNS	_	19	pobj	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	monocytic	_	JJ	JJ	_	24	amod	_	_
24	cells	_	NNS	NNS	_	22	pobj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	placental	_	JJ	JJ	_	27	amod	_	_
27	trophoblasts	_	NNS	NNS	_	24	conj	_	_
28	.	_	.	.	_	18	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	demonstrated	_	VBN	VBN	_	0	root	_	_
4	that	_	IN	IN	_	13	mark	_	_
5	the	_	DT	DT	_	7	det	_	_
6	monocyte-specific	_	JJ	JJ	_	7	amod	_	_
7	expression	_	NN	NN	_	13	nsubjpass	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	CSF-1	_	NN	NN	_	11	nn	_	_
11	receptor	_	NN	NN	_	8	pobj	_	_
12	is	_	VBZ	VBZ	_	13	auxpass	_	_
13	regulated	_	VBN	VBN	_	3	ccomp	_	_
14	at	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	level	_	NN	NN	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	transcription	_	NN	NN	_	17	pobj	_	_
19	by	_	IN	IN	_	13	prep	_	_
20	a	_	DT	DT	_	22	det	_	_
21	tissue-specific	_	JJ	JJ	_	22	amod	_	_
22	promoter	_	NN	NN	_	19	pobj	_	_
23	whose	_	WP$	WP$	_	24	poss	_	_
24	activity	_	NN	NN	_	26	nsubjpass	_	_
25	is	_	VBZ	VBZ	_	26	auxpass	_	_
26	stimulated	_	VBN	VBN	_	22	rcmod	_	_
27	by	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	31	det	_	_
29	monocyte/B-cell-specific	_	JJ	JJ	_	31	amod	_	_
30	transcription	_	NN	NN	_	31	nn	_	_
31	factor	_	NN	NN	_	27	pobj	_	_
32	PU.1	_	NN	NN	_	31	dep	_	_
33	-LRB-	_	-LRB-	-LRB-	_	34	punct	_	_
34	D.-E.Zhang	_	NNP	NNP	_	3	dep	_	_
35	,	_	,	,	_	34	punct	_	_
36	C.J.Hetherington	_	NNP	NNP	_	34	conj	_	_
37	,	_	,	,	_	34	punct	_	_
38	H.-M.Chen	_	NNP	NNP	_	34	conj	_	_
39	,	_	,	,	_	34	punct	_	_
40	and	_	CC	CC	_	34	cc	_	_
41	D.G.Tenen	_	NNP	NNP	_	34	conj	_	_
42	,	_	,	,	_	34	punct	_	_
43	Mol	_	NNP	NNP	_	45	nn	_	_
44	.Cell.	_	NNP	NNP	_	45	nn	_	_
45	Biol.	_	NNP	NNP	_	34	appos	_	_
46	14	_	CD	CD	_	45	num	_	_
47	:	_	:	:	_	34	punct	_	_
48	373-381	_	CD	CD	_	34	dep	_	_
49	,	_	,	,	_	34	punct	_	_
50	1994	_	CD	CD	_	34	amod	_	_
51	-RRB-	_	-RRB-	-RRB-	_	34	punct	_	_
52	.	_	.	.	_	3	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	report	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	13	mark	_	_
5	the	_	DT	DT	_	7	det	_	_
6	tissue	_	NN	NN	_	7	nn	_	_
7	specificity	_	NN	NN	_	13	nsubjpass	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	this	_	DT	DT	_	10	det	_	_
10	promoter	_	NN	NN	_	8	pobj	_	_
11	is	_	VBZ	VBZ	_	13	auxpass	_	_
12	also	_	RB	RB	_	13	advmod	_	_
13	mediated	_	VBN	VBN	_	3	ccomp	_	_
14	by	_	IN	IN	_	13	prep	_	_
15	sequences	_	NNS	NNS	_	14	pobj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	a	_	DT	DT	_	18	det	_	_
18	region	_	NN	NN	_	16	pobj	_	_
19	II	_	CD	CD	_	18	num	_	_
20	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	bp	_	NN	NN	_	18	appos	_	_
22	-88	_	CD	CD	_	24	number	_	_
23	to	_	TO	TO	_	24	dep	_	_
24	-59	_	CD	CD	_	21	num	_	_
25	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
26	,	_	,	,	_	18	punct	_	_
27	which	_	WDT	WDT	_	28	nsubj	_	_
28	lies	_	VBZ	VBZ	_	18	rcmod	_	_
29	10	_	CD	CD	_	30	num	_	_
30	bp	_	NN	NN	_	28	dobj	_	_
31	upstream	_	RB	RB	_	30	advmod	_	_
32	from	_	IN	IN	_	30	prep	_	_
33	the	_	DT	DT	_	35	det	_	_
34	PU.1-binding	_	JJ	JJ	_	35	amod	_	_
35	site	_	NN	NN	_	32	pobj	_	_
36	.	_	.	.	_	3	punct	_	_

1	When	_	WRB	WRB	_	2	advmod	_	_
2	analyzed	_	VBN	VBN	_	10	advcl	_	_
3	by	_	IN	IN	_	2	prep	_	_
4	DNase	_	NN	NN	_	5	nn	_	_
5	footprinting	_	NN	NN	_	3	pobj	_	_
6	,	_	,	,	_	10	punct	_	_
7	region	_	NN	NN	_	10	nsubjpass	_	_
8	II	_	CD	CD	_	7	num	_	_
9	was	_	VBD	VBD	_	10	auxpass	_	_
10	protected	_	VBN	VBN	_	0	root	_	_
11	preferentially	_	RB	RB	_	10	advmod	_	_
12	in	_	IN	IN	_	10	prep	_	_
13	monocytic	_	JJ	JJ	_	14	amod	_	_
14	cells	_	NNS	NNS	_	12	pobj	_	_
15	.	_	.	.	_	10	punct	_	_

1	Electrophoretic	_	JJ	JJ	_	4	amod	_	_
2	mobility	_	NN	NN	_	4	nn	_	_
3	shift	_	NN	NN	_	4	nn	_	_
4	assays	_	NNS	NNS	_	5	nsubj	_	_
5	confirmed	_	VBD	VBD	_	0	root	_	_
6	that	_	IN	IN	_	9	mark	_	_
7	region	_	NN	NN	_	9	nsubj	_	_
8	II	_	CD	CD	_	7	num	_	_
9	interacts	_	VBZ	VBZ	_	5	ccomp	_	_
10	specifically	_	RB	RB	_	9	advmod	_	_
11	with	_	IN	IN	_	9	prep	_	_
12	nuclear	_	JJ	JJ	_	13	amod	_	_
13	proteins	_	NNS	NNS	_	11	pobj	_	_
14	from	_	IN	IN	_	13	prep	_	_
15	monocytic	_	JJ	JJ	_	16	amod	_	_
16	cells	_	NNS	NNS	_	14	pobj	_	_
17	.	_	.	.	_	5	punct	_	_

1	Two	_	CD	CD	_	4	num	_	_
2	gel	_	NN	NN	_	4	nn	_	_
3	shift	_	NN	NN	_	4	nn	_	_
4	complexes	_	NNS	NNS	_	13	nsubjpass	_	_
5	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
6	Mono	_	NN	NN	_	7	nn	_	_
7	A	_	NN	NN	_	4	dep	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	Mono	_	NN	NN	_	10	nn	_	_
10	B	_	NN	NN	_	7	conj	_	_
11	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
12	were	_	VBD	VBD	_	13	auxpass	_	_
13	formed	_	VBN	VBN	_	0	root	_	_
14	with	_	IN	IN	_	13	prep	_	_
15	separate	_	JJ	JJ	_	17	amod	_	_
16	sequence	_	NN	NN	_	17	nn	_	_
17	elements	_	NNS	NNS	_	14	pobj	_	_
18	within	_	IN	IN	_	17	prep	_	_
19	this	_	DT	DT	_	20	det	_	_
20	region	_	NN	NN	_	18	pobj	_	_
21	.	_	.	.	_	13	punct	_	_

1	Competition	_	NN	NN	_	5	nsubj	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	supershift	_	NN	NN	_	1	conj	_	_
4	experiments	_	NNS	NNS	_	1	dep	_	_
5	indicate	_	VBP	VBP	_	0	root	_	_
6	that	_	IN	IN	_	9	mark	_	_
7	Mono	_	NN	NN	_	8	nn	_	_
8	B	_	NN	NN	_	9	nsubj	_	_
9	contains	_	VBZ	VBZ	_	5	ccomp	_	_
10	a	_	DT	DT	_	11	det	_	_
11	member	_	NN	NN	_	9	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	22	det	_	_
14	polyomavirus	_	NN	NN	_	22	nn	_	_
15	enhancer-binding	_	JJ	JJ	_	22	amod	_	_
16	protein	_	NN	NN	_	22	nn	_	_
17	2/core-binding	_	JJ	JJ	_	22	amod	_	_
18	factor	_	NN	NN	_	22	nn	_	_
19	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
20	PEBP2/CBF	_	NN	NN	_	22	nn	_	_
21	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
22	family	_	NN	NN	_	12	pobj	_	_
23	,	_	,	,	_	22	punct	_	_
24	which	_	WDT	WDT	_	25	nsubj	_	_
25	includes	_	VBZ	VBZ	_	11	rcmod	_	_
26	the	_	DT	DT	_	29	det	_	_
27	AML1	_	NN	NN	_	29	nn	_	_
28	gene	_	NN	NN	_	29	nn	_	_
29	product	_	NN	NN	_	25	dobj	_	_
30	,	_	,	,	_	9	punct	_	_
31	while	_	IN	IN	_	37	mark	_	_
32	Mono	_	NN	NN	_	33	nn	_	_
33	A	_	NN	NN	_	37	nsubj	_	_
34	is	_	VBZ	VBZ	_	37	cop	_	_
35	a	_	DT	DT	_	37	det	_	_
36	distinct	_	JJ	JJ	_	37	amod	_	_
37	complex	_	NN	NN	_	9	advcl	_	_
38	preferentially	_	RB	RB	_	39	advmod	_	_
39	expressed	_	VBN	VBN	_	37	vmod	_	_
40	in	_	IN	IN	_	39	prep	_	_
41	monocytic	_	JJ	JJ	_	42	amod	_	_
42	cells	_	NNS	NNS	_	40	pobj	_	_
43	.	_	.	.	_	5	punct	_	_

1	Promoter	_	NN	NN	_	2	nn	_	_
2	constructs	_	NNS	NNS	_	12	nsubjpass	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	mutations	_	NNS	NNS	_	3	pobj	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	these	_	DT	DT	_	8	det	_	_
7	sequence	_	NN	NN	_	8	nn	_	_
8	elements	_	NNS	NNS	_	5	pobj	_	_
9	were	_	VBD	VBD	_	12	auxpass	_	_
10	no	_	RB	RB	_	11	neg	_	_
11	longer	_	RBR	RBR	_	12	advmod	_	_
12	expressed	_	VBN	VBN	_	0	root	_	_
13	specifically	_	RB	RB	_	12	advmod	_	_
14	in	_	IN	IN	_	12	prep	_	_
15	monocytes	_	NNS	NNS	_	14	pobj	_	_
16	.	_	.	.	_	12	punct	_	_

1	Furthermore	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	multimerized	_	JJ	JJ	_	7	amod	_	_
4	region	_	NN	NN	_	7	nn	_	_
5	II	_	CD	CD	_	7	num	_	_
6	sequence	_	NN	NN	_	7	nn	_	_
7	elements	_	NNS	NNS	_	8	nsubj	_	_
8	enhanced	_	VBD	VBD	_	0	root	_	_
9	the	_	DT	DT	_	10	det	_	_
10	activity	_	NN	NN	_	8	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	a	_	DT	DT	_	16	det	_	_
13	heterologous	_	JJ	JJ	_	16	amod	_	_
14	thymidine	_	NN	NN	_	16	nn	_	_
15	kinase	_	NN	NN	_	16	nn	_	_
16	promoter	_	NN	NN	_	11	pobj	_	_
17	in	_	IN	IN	_	10	prep	_	_
18	monocytic	_	JJ	JJ	_	19	amod	_	_
19	cells	_	NNS	NNS	_	17	pobj	_	_
20	but	_	CC	CC	_	21	cc	_	_
21	not	_	RB	RB	_	19	cc	_	_
22	other	_	JJ	JJ	_	24	amod	_	_
23	cell	_	NN	NN	_	24	nn	_	_
24	types	_	NNS	NNS	_	19	conj	_	_
25	tested	_	VBN	VBN	_	24	vmod	_	_
26	.	_	.	.	_	8	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	19	mark	_	_
5	the	_	DT	DT	_	8	det	_	_
6	monocyte/B-cell-specific	_	JJ	JJ	_	8	amod	_	_
7	transcription	_	NN	NN	_	8	nn	_	_
8	factor	_	NN	NN	_	19	nsubj	_	_
9	PU.1	_	NN	NN	_	8	dep	_	_
10	and	_	CC	CC	_	8	cc	_	_
11	the	_	DT	DT	_	13	dep	_	_
12	Mono	_	NN	NN	_	13	nn	_	_
13	A	_	NN	NN	_	8	conj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	Mono	_	NN	NN	_	16	nn	_	_
16	B	_	NN	NN	_	13	conj	_	_
17	protein	_	NN	NN	_	18	nn	_	_
18	complexes	_	NNS	NNS	_	13	dep	_	_
19	act	_	VBP	VBP	_	3	ccomp	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	concert	_	NN	NN	_	20	pobj	_	_
22	to	_	TO	TO	_	23	aux	_	_
23	regulate	_	VB	VB	_	19	xcomp	_	_
24	monocyte-specific	_	JJ	JJ	_	25	amod	_	_
25	transcription	_	NN	NN	_	23	dobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	29	det	_	_
28	CSF-1	_	NN	NN	_	29	nn	_	_
29	receptor	_	NN	NN	_	26	pobj	_	_
30	.	_	.	.	_	3	punct	_	_

1	Epstein-Barr	_	JJ	JJ	_	4	amod	_	_
2	virus	_	NN	NN	_	4	nn	_	_
3	SM	_	NN	NN	_	4	nn	_	_
4	protein	_	NN	NN	_	0	root	_	_
5	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	protein	_	NN	NN	_	3	nn	_	_
3	products	_	NNS	NNS	_	17	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	14	det	_	_
6	Epstein-Barr	_	JJ	JJ	_	7	amod	_	_
7	virus	_	NN	NN	_	14	nn	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	EBV	_	NN	NN	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	BMLF1	_	NN	NN	_	14	nn	_	_
12	open	_	JJ	JJ	_	14	amod	_	_
13	reading	_	NN	NN	_	14	nn	_	_
14	frame	_	NN	NN	_	4	pobj	_	_
15	have	_	VBP	VBP	_	17	aux	_	_
16	been	_	VBN	VBN	_	17	auxpass	_	_
17	characterized	_	VBN	VBN	_	0	root	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	22	det	_	_
20	early	_	JJ	JJ	_	22	amod	_	_
21	productive	_	JJ	JJ	_	20	dep	_	_
22	cycle	_	NN	NN	_	18	pobj	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	B95-8	_	NN	NN	_	23	pobj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	Akata	_	NN	NN	_	27	nn	_	_
27	cells	_	NNS	NNS	_	24	conj	_	_
28	.	_	.	.	_	17	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	SM	_	NN	NN	_	3	nn	_	_
3	protein	_	NN	NN	_	18	nsubj	_	_
4	derived	_	VBN	VBN	_	3	vmod	_	_
5	from	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	spliced	_	VBN	VBN	_	8	amod	_	_
8	RNA	_	NN	NN	_	5	pobj	_	_
9	joining	_	VBG	VBG	_	8	vmod	_	_
10	BSLF2	_	NN	NN	_	9	dobj	_	_
11	to	_	TO	TO	_	9	prep	_	_
12	BMLF1	_	NN	NN	_	11	pobj	_	_
13	is	_	VBZ	VBZ	_	18	cop	_	_
14	much	_	RB	RB	_	17	advmod	_	_
15	the	_	DT	DT	_	17	det	_	_
16	most	_	RBS	RBS	_	17	advmod	_	_
17	abundant	_	JJ	JJ	_	18	amod	_	_
18	protein	_	NN	NN	_	0	root	_	_
19	.	_	.	.	_	18	punct	_	_

1	SM	_	NN	NN	_	4	nsubj	_	_
2	is	_	VBZ	VBZ	_	4	cop	_	_
3	a	_	DT	DT	_	4	det	_	_
4	phosphoprotein	_	NN	NN	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	EBV-infected	_	JJ	JJ	_	7	amod	_	_
7	cells	_	NNS	NNS	_	5	pobj	_	_
8	and	_	CC	CC	_	4	cc	_	_
9	can	_	MD	MD	_	11	aux	_	_
10	be	_	VB	VB	_	11	auxpass	_	_
11	phosphorylated	_	VBN	VBN	_	4	conj	_	_
12	in	_	FW	FW	_	13	nn	_	_
13	vitro	_	FW	FW	_	11	advmod	_	_
14	with	_	IN	IN	_	11	prep	_	_
15	casein	_	NN	NN	_	16	nn	_	_
16	kinase	_	NN	NN	_	14	pobj	_	_
17	II	_	CD	CD	_	16	num	_	_
18	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
19	CKII	_	NN	NN	_	16	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	.	_	.	.	_	4	punct	_	_

1	Computer	_	NN	NN	_	2	nn	_	_
2	analysis	_	NN	NN	_	8	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	7	det	_	_
5	SM	_	NN	NN	_	6	nn	_	_
6	protein	_	NN	NN	_	7	nn	_	_
7	sequence	_	NN	NN	_	3	pobj	_	_
8	showed	_	VBD	VBD	_	0	root	_	_
9	a	_	DT	DT	_	12	det	_	_
10	C	_	NN	NN	_	12	nn	_	_
11	terminal	_	JJ	JJ	_	12	amod	_	_
12	section	_	NN	NN	_	8	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	SM	_	NN	NN	_	13	pobj	_	_
15	to	_	TO	TO	_	17	aux	_	_
16	be	_	VB	VB	_	17	cop	_	_
17	related	_	JJ	JJ	_	8	xcomp	_	_
18	to	_	TO	TO	_	17	prep	_	_
19	genome	_	NN	NN	_	21	nn	_	_
20	positional	_	JJ	JJ	_	21	amod	_	_
21	homologues	_	NNS	NNS	_	18	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	four	_	CD	CD	_	25	num	_	_
24	other	_	JJ	JJ	_	25	amod	_	_
25	herpesviruses	_	NNS	NNS	_	22	pobj	_	_
26	and	_	CC	CC	_	8	cc	_	_
27	revealed	_	VBD	VBD	_	8	conj	_	_
28	consensus	_	NN	NN	_	30	nn	_	_
29	CKII	_	NN	NN	_	30	nn	_	_
30	sites	_	NNS	NNS	_	27	dobj	_	_
31	near	_	JJ	JJ	_	30	prep	_	_
32	the	_	DT	DT	_	34	det	_	_
33	N	_	NN	NN	_	34	nn	_	_
34	termini	_	NNS	NNS	_	31	dep	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	the	_	DT	DT	_	39	det	_	_
37	EBV	_	NN	NN	_	39	nn	_	_
38	SM	_	NN	NN	_	39	nn	_	_
39	protein	_	NN	NN	_	35	pobj	_	_
40	,	_	,	,	_	39	punct	_	_
41	the	_	DT	DT	_	49	det	_	_
42	herpes	_	NN	NN	_	49	nn	_	_
43	simplex	_	JJ	JJ	_	49	amod	_	_
44	virus	_	NN	NN	_	49	nn	_	_
45	-LRB-	_	-LRB-	-LRB-	_	49	punct	_	_
46	HSV	_	NN	NN	_	49	nn	_	_
47	-RRB-	_	-RRB-	-RRB-	_	49	punct	_	_
48	ICP27	_	NN	NN	_	49	nn	_	_
49	protein	_	NN	NN	_	39	conj	_	_
50	and	_	CC	CC	_	39	cc	_	_
51	the	_	DT	DT	_	61	det	_	_
52	herpesvirus	_	NN	NN	_	61	nn	_	_
53	saimiri	_	NNS	NNS	_	61	nn	_	_
54	-LRB-	_	-LRB-	-LRB-	_	61	punct	_	_
55	HVS	_	NNS	NNS	_	61	nn	_	_
56	-RRB-	_	-RRB-	-RRB-	_	61	punct	_	_
57	open	_	JJ	JJ	_	61	amod	_	_
58	reading	_	NN	NN	_	61	nn	_	_
59	frame	_	NN	NN	_	61	nn	_	_
60	57	_	CD	CD	_	61	num	_	_
61	protein	_	NN	NN	_	39	conj	_	_
62	.	_	.	.	_	8	punct	_	_

1	Site-directed	_	JJ	JJ	_	2	amod	_	_
2	mutagenesis	_	NN	NN	_	12	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	7	det	_	_
5	consensus	_	NN	NN	_	7	nn	_	_
6	CKII	_	NN	NN	_	7	nn	_	_
7	site	_	NN	NN	_	3	pobj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	EBV	_	NN	NN	_	8	pobj	_	_
10	SM	_	NN	NN	_	9	dep	_	_
11	greatly	_	RB	RB	_	12	advmod	_	_
12	reduced	_	VBD	VBD	_	0	root	_	_
13	the	_	DT	DT	_	16	det	_	_
14	in	_	FW	FW	_	16	amod	_	_
15	vitro	_	FW	FW	_	14	dep	_	_
16	phosphorylation	_	NN	NN	_	12	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	SM	_	NN	NN	_	17	pobj	_	_
19	by	_	IN	IN	_	16	prep	_	_
20	CKII	_	NN	NN	_	19	pobj	_	_
21	.	_	.	.	_	12	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	mechanism	_	NN	NN	_	10	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	transactivation	_	NN	NN	_	3	pobj	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	BMLF1	_	NN	NN	_	7	nn	_	_
7	proteins	_	NNS	NNS	_	5	pobj	_	_
8	has	_	VBZ	VBZ	_	10	aux	_	_
9	been	_	VBN	VBN	_	10	cop	_	_
10	controversial	_	JJ	JJ	_	0	root	_	_
11	but	_	CC	CC	_	10	cc	_	_
12	SM	_	NN	NN	_	14	nsubjpass	_	_
13	was	_	VBD	VBD	_	14	auxpass	_	_
14	shown	_	VBN	VBN	_	10	conj	_	_
15	to	_	TO	TO	_	16	aux	_	_
16	transactivate	_	VB	VB	_	14	xcomp	_	_
17	gene	_	NN	NN	_	18	nn	_	_
18	expression	_	NN	NN	_	16	dobj	_	_
19	from	_	IN	IN	_	18	prep	_	_
20	a	_	DT	DT	_	23	det	_	_
21	CAT	_	NN	NN	_	23	nn	_	_
22	reporter	_	NN	NN	_	23	nn	_	_
23	construct	_	NN	NN	_	19	pobj	_	_
24	by	_	IN	IN	_	16	prep	_	_
25	increasing	_	VBG	VBG	_	24	pcomp	_	_
26	the	_	DT	DT	_	27	det	_	_
27	amount	_	NN	NN	_	25	dobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	cytoplasmic	_	JJ	JJ	_	31	amod	_	_
30	CAT	_	NN	NN	_	31	nn	_	_
31	mRNA	_	NN	NN	_	28	pobj	_	_
32	.	_	.	.	_	10	punct	_	_

1	Mutagenesis	_	NN	NN	_	8	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	CKII	_	NN	NN	_	5	nn	_	_
5	site	_	NN	NN	_	2	pobj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	SM	_	NN	NN	_	6	pobj	_	_
8	made	_	VBD	VBD	_	0	root	_	_
9	no	_	DT	DT	_	10	neg	_	_
10	difference	_	NN	NN	_	8	dobj	_	_
11	to	_	TO	TO	_	8	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	transactivation	_	NN	NN	_	11	pobj	_	_
14	in	_	IN	IN	_	8	prep	_	_
15	this	_	DT	DT	_	18	det	_	_
16	transient	_	JJ	JJ	_	18	amod	_	_
17	transfection	_	NN	NN	_	18	nn	_	_
18	assay	_	NN	NN	_	14	pobj	_	_
19	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	role	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	NFATp	_	NN	NN	_	3	pobj	_	_
5	in	_	IN	IN	_	2	prep	_	_
6	cyclosporin	_	NN	NN	_	11	nn	_	_
7	A-sensitive	_	JJ	JJ	_	11	amod	_	_
8	tumor	_	NN	NN	_	11	nn	_	_
9	necrosis	_	NN	NN	_	11	nn	_	_
10	factor-alpha	_	NN	NN	_	11	nn	_	_
11	gene	_	NN	NN	_	12	nn	_	_
12	transcription	_	NN	NN	_	5	pobj	_	_
13	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	9	det	_	_
2	tumor	_	NN	NN	_	9	nn	_	_
3	necrosis	_	NN	NN	_	9	nn	_	_
4	factor-alpha	_	NN	NN	_	9	nn	_	_
5	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
6	TNF	_	NN	NN	_	9	nn	_	_
7	alpha	_	NN	NN	_	9	nn	_	_
8	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
9	gene	_	NN	NN	_	14	nsubj	_	_
10	is	_	VBZ	VBZ	_	14	cop	_	_
11	an	_	DT	DT	_	14	det	_	_
12	immediate	_	JJ	JJ	_	14	amod	_	_
13	early	_	JJ	JJ	_	14	amod	_	_
14	gene	_	NN	NN	_	0	root	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	activated	_	VBN	VBN	_	18	amod	_	_
17	T	_	NN	NN	_	18	nn	_	_
18	cells	_	NNS	NNS	_	15	pobj	_	_
19	,	_	,	,	_	14	punct	_	_
20	in	_	IN	IN	_	14	prep	_	_
21	that	_	IN	IN	_	25	mark	_	_
22	it	_	PRP	PRP	_	25	nsubjpass	_	_
23	is	_	VBZ	VBZ	_	25	auxpass	_	_
24	rapidly	_	RB	RB	_	25	advmod	_	_
25	induced	_	VBN	VBN	_	20	pcomp	_	_
26	without	_	IN	IN	_	25	prep	_	_
27	a	_	DT	DT	_	28	det	_	_
28	requirement	_	NN	NN	_	26	pobj	_	_
29	for	_	IN	IN	_	28	prep	_	_
30	protein	_	NN	NN	_	31	nn	_	_
31	synthesis	_	NN	NN	_	29	pobj	_	_
32	.	_	.	.	_	14	punct	_	_

1	Maximal	_	JJ	JJ	_	2	amod	_	_
2	induction	_	NN	NN	_	9	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	TNF	_	NN	NN	_	6	nn	_	_
5	alpha	_	NN	NN	_	6	nn	_	_
6	mRNA	_	NN	NN	_	3	pobj	_	_
7	can	_	MD	MD	_	9	aux	_	_
8	be	_	VB	VB	_	9	auxpass	_	_
9	induced	_	VBN	VBN	_	0	root	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	treatment	_	NN	NN	_	10	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	T	_	NN	NN	_	14	nn	_	_
14	cells	_	NNS	NNS	_	12	pobj	_	_
15	with	_	IN	IN	_	11	prep	_	_
16	calcium	_	NN	NN	_	17	nn	_	_
17	ionophores	_	NNS	NNS	_	15	pobj	_	_
18	alone	_	RB	RB	_	17	advmod	_	_
19	,	_	,	,	_	9	punct	_	_
20	via	_	IN	IN	_	9	prep	_	_
21	a	_	DT	DT	_	23	det	_	_
22	calcineurin-dependent	_	JJ	JJ	_	23	amod	_	_
23	process	_	NN	NN	_	20	pobj	_	_
24	that	_	WDT	WDT	_	26	nsubjpass	_	_
25	is	_	VBZ	VBZ	_	26	auxpass	_	_
26	blocked	_	VBN	VBN	_	23	rcmod	_	_
27	by	_	IN	IN	_	26	prep	_	_
28	cyclosporin	_	NN	NN	_	29	nn	_	_
29	A	_	NN	NN	_	27	pobj	_	_
30	.	_	.	.	_	9	punct	_	_

1	We	_	PRP	PRP	_	4	nsubj	_	_
2	have	_	VBP	VBP	_	4	aux	_	_
3	previously	_	RB	RB	_	4	advmod	_	_
4	identified	_	VBN	VBN	_	0	root	_	_
5	a	_	DT	DT	_	7	det	_	_
6	promoter	_	NN	NN	_	7	nn	_	_
7	element	_	NN	NN	_	4	dobj	_	_
8	,	_	,	,	_	7	punct	_	_
9	kappa	_	NN	NN	_	7	appos	_	_
10	3	_	CD	CD	_	9	num	_	_
11	,	_	,	,	_	7	punct	_	_
12	that	_	WDT	WDT	_	14	nsubjpass	_	_
13	is	_	VBZ	VBZ	_	14	auxpass	_	_
14	required	_	VBN	VBN	_	7	rcmod	_	_
15	for	_	IN	IN	_	14	prep	_	_
16	calcium-stimulated	_	JJ	JJ	_	20	amod	_	_
17	,	_	,	,	_	16	punct	_	_
18	cyclosporin	_	NN	NN	_	19	npadvmod	_	_
19	A-sensitive	_	JJ	JJ	_	16	dep	_	_
20	induction	_	NN	NN	_	15	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	25	det	_	_
23	TNF	_	NN	NN	_	25	nn	_	_
24	alpha	_	NN	NN	_	25	nn	_	_
25	gene	_	NN	NN	_	21	pobj	_	_
26	in	_	IN	IN	_	20	prep	_	_
27	activated	_	VBN	VBN	_	29	amod	_	_
28	T	_	NN	NN	_	29	nn	_	_
29	cells	_	NNS	NNS	_	26	pobj	_	_
30	.	_	.	.	_	4	punct	_	_

1	Here	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	demonstrate	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	11	mark	_	_
6	the	_	DT	DT	_	10	det	_	_
7	kappa	_	NN	NN	_	10	nn	_	_
8	3	_	CD	CD	_	10	num	_	_
9	binding	_	NN	NN	_	10	nn	_	_
10	factor	_	NN	NN	_	11	nsubj	_	_
11	contains	_	VBZ	VBZ	_	4	ccomp	_	_
12	NFATp	_	NN	NN	_	11	dobj	_	_
13	,	_	,	,	_	12	punct	_	_
14	a	_	DT	DT	_	17	det	_	_
15	cyclosporin-sensitive	_	JJ	JJ	_	17	amod	_	_
16	DNA-binding	_	JJ	JJ	_	17	amod	_	_
17	protein	_	NN	NN	_	12	appos	_	_
18	required	_	VBN	VBN	_	17	vmod	_	_
19	for	_	IN	IN	_	18	prep	_	_
20	interleukin-2	_	NN	NN	_	21	nn	_	_
21	gene	_	NN	NN	_	22	nn	_	_
22	transcription	_	NN	NN	_	19	pobj	_	_
23	.	_	.	.	_	4	punct	_	_

1	NFATp	_	NN	NN	_	2	nsubj	_	_
2	binds	_	VBZ	VBZ	_	0	root	_	_
3	to	_	TO	TO	_	2	prep	_	_
4	two	_	CD	CD	_	5	num	_	_
5	sites	_	NNS	NNS	_	3	pobj	_	_
6	within	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	10	det	_	_
8	kappa	_	NN	NN	_	10	nn	_	_
9	3	_	CD	CD	_	10	num	_	_
10	element	_	NN	NN	_	6	pobj	_	_
11	,	_	,	,	_	2	punct	_	_
12	and	_	CC	CC	_	2	cc	_	_
13	occupancy	_	NN	NN	_	18	nsubjpass	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	both	_	DT	DT	_	16	det	_	_
16	sites	_	NNS	NNS	_	14	pobj	_	_
17	is	_	VBZ	VBZ	_	18	auxpass	_	_
18	required	_	VBN	VBN	_	2	conj	_	_
19	for	_	IN	IN	_	18	prep	_	_
20	TNF	_	NN	NN	_	23	nn	_	_
21	alpha	_	NN	NN	_	23	nn	_	_
22	gene	_	NN	NN	_	23	nn	_	_
23	induction	_	NN	NN	_	19	pobj	_	_
24	.	_	.	.	_	2	punct	_	_

1	Thus	_	RB	RB	_	18	advmod	_	_
2	,	_	,	,	_	18	punct	_	_
3	although	_	IN	IN	_	8	mark	_	_
4	the	_	DT	DT	_	7	det	_	_
5	kappa	_	NN	NN	_	7	nn	_	_
6	3	_	CD	CD	_	7	num	_	_
7	element	_	NN	NN	_	8	nsubj	_	_
8	has	_	VBZ	VBZ	_	18	dep	_	_
9	little	_	JJ	JJ	_	11	amod	_	_
10	sequence	_	NN	NN	_	11	nn	_	_
11	similarity	_	NN	NN	_	8	dobj	_	_
12	to	_	TO	TO	_	11	prep	_	_
13	other	_	JJ	JJ	_	15	amod	_	_
14	NFATp-binding	_	JJ	JJ	_	15	amod	_	_
15	sites	_	NNS	NNS	_	12	pobj	_	_
16	,	_	,	,	_	18	punct	_	_
17	it	_	PRP	PRP	_	18	nsubj	_	_
18	appears	_	VBZ	VBZ	_	0	root	_	_
19	to	_	TO	TO	_	20	aux	_	_
20	function	_	VB	VB	_	18	xcomp	_	_
21	as	_	IN	IN	_	20	prep	_	_
22	a	_	DT	DT	_	25	det	_	_
23	cyclosporin-sensitive	_	JJ	JJ	_	25	amod	_	_
24	promoter	_	NN	NN	_	25	nn	_	_
25	element	_	NN	NN	_	21	pobj	_	_
26	in	_	IN	IN	_	21	prep	_	_
27	T	_	NN	NN	_	28	nn	_	_
28	cells	_	NNS	NNS	_	26	pobj	_	_
29	by	_	IN	IN	_	21	prep	_	_
30	virtue	_	NN	NN	_	29	pobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	its	_	PRP$	PRP$	_	33	poss	_	_
33	ability	_	NN	NN	_	31	pobj	_	_
34	to	_	TO	TO	_	35	aux	_	_
35	bind	_	VB	VB	_	33	vmod	_	_
36	NFATp	_	NN	NN	_	35	dobj	_	_
37	.	_	.	.	_	18	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	involvement	_	NN	NN	_	16	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	NFATp	_	NN	NN	_	3	pobj	_	_
5	in	_	IN	IN	_	2	prep	_	_
6	transcriptional	_	JJ	JJ	_	7	amod	_	_
7	activation	_	NN	NN	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	both	_	DT	DT	_	11	dep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	interleukin-2	_	NN	NN	_	8	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	TNF	_	NN	NN	_	15	nn	_	_
14	alpha	_	NN	NN	_	15	nn	_	_
15	genes	_	NNS	NNS	_	11	conj	_	_
16	suggests	_	VBZ	VBZ	_	0	root	_	_
17	that	_	IN	IN	_	20	mark	_	_
18	this	_	DT	DT	_	19	det	_	_
19	factor	_	NN	NN	_	20	nsubj	_	_
20	plays	_	VBZ	VBZ	_	16	ccomp	_	_
21	an	_	DT	DT	_	23	det	_	_
22	important	_	JJ	JJ	_	23	amod	_	_
23	role	_	NN	NN	_	20	dobj	_	_
24	in	_	IN	IN	_	20	prep	_	_
25	the	_	DT	DT	_	27	det	_	_
26	coordinate	_	JJ	JJ	_	27	amod	_	_
27	induction	_	NN	NN	_	24	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	multiple	_	JJ	JJ	_	31	amod	_	_
30	cytokine	_	NN	NN	_	31	nn	_	_
31	genes	_	NNS	NNS	_	28	pobj	_	_
32	,	_	,	,	_	20	punct	_	_
33	starting	_	VBG	VBG	_	20	vmod	_	_
34	at	_	IN	IN	_	33	prep	_	_
35	the	_	DT	DT	_	37	det	_	_
36	earliest	_	JJS	JJS	_	37	amod	_	_
37	stages	_	NNS	NNS	_	34	pobj	_	_
38	of	_	IN	IN	_	37	prep	_	_
39	T	_	NN	NN	_	41	nn	_	_
40	cell	_	NN	NN	_	41	nn	_	_
41	activation	_	NN	NN	_	38	pobj	_	_
42	.	_	.	.	_	16	punct	_	_

1	Inhibition	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	human	_	JJ	JJ	_	8	amod	_	_
4	immunodeficiency	_	NN	NN	_	8	nn	_	_
5	virus	_	NN	NN	_	8	nn	_	_
6	type	_	NN	NN	_	8	nn	_	_
7	1	_	CD	CD	_	8	num	_	_
8	replication	_	NN	NN	_	2	pobj	_	_
9	by	_	IN	IN	_	1	prep	_	_
10	a	_	DT	DT	_	15	det	_	_
11	Tat-activated	_	JJ	JJ	_	15	amod	_	_
12	,	_	,	,	_	15	punct	_	_
13	transduced	_	VBN	VBN	_	15	amod	_	_
14	interferon	_	NN	NN	_	15	nn	_	_
15	gene	_	NN	NN	_	9	pobj	_	_
16	:	_	:	:	_	1	punct	_	_
17	targeted	_	VBN	VBN	_	18	amod	_	_
18	expression	_	NN	NN	_	1	dep	_	_
19	to	_	TO	TO	_	18	prep	_	_
20	human	_	JJ	JJ	_	25	amod	_	_
21	immunodeficiency	_	NN	NN	_	25	nn	_	_
22	virus	_	NN	NN	_	25	nn	_	_
23	type	_	NN	NN	_	25	nn	_	_
24	1-infected	_	JJ	JJ	_	25	amod	_	_
25	cells	_	NNS	NNS	_	19	pobj	_	_
26	.	_	.	.	_	1	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	examined	_	VBN	VBN	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	feasibility	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	using	_	VBG	VBG	_	6	pcomp	_	_
8	interferon	_	NN	NN	_	13	nn	_	_
9	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	IFN	_	NN	NN	_	8	appos	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	gene	_	NN	NN	_	13	nn	_	_
13	transfer	_	NN	NN	_	7	dobj	_	_
14	as	_	IN	IN	_	7	prep	_	_
15	a	_	DT	DT	_	17	det	_	_
16	novel	_	JJ	JJ	_	17	amod	_	_
17	approach	_	NN	NN	_	14	pobj	_	_
18	to	_	TO	TO	_	17	prep	_	_
19	anti-human	_	JJ	JJ	_	22	amod	_	_
20	immunodeficiency	_	NN	NN	_	22	nn	_	_
21	virus	_	NN	NN	_	22	nn	_	_
22	type	_	NN	NN	_	27	nn	_	_
23	1	_	CD	CD	_	22	num	_	_
24	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
25	HIV-1	_	NN	NN	_	22	appos	_	_
26	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
27	therapy	_	NN	NN	_	18	pobj	_	_
28	in	_	IN	IN	_	3	prep	_	_
29	this	_	DT	DT	_	30	det	_	_
30	study	_	NN	NN	_	28	pobj	_	_
31	.	_	.	.	_	3	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	limit	_	VB	VB	_	0	root	_	_
3	expression	_	NN	NN	_	2	dobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	a	_	DT	DT	_	14	det	_	_
6	transduced	_	VBN	VBN	_	14	amod	_	_
7	HIV-1	_	NN	NN	_	14	nn	_	_
8	long	_	JJ	JJ	_	14	amod	_	_
9	terminal	_	JJ	JJ	_	14	amod	_	_
10	repeat	_	NN	NN	_	14	nn	_	_
11	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
12	LTR	_	NN	NN	_	14	nn	_	_
13	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
14	-IFNA2	_	NN	NN	_	4	pobj	_	_
15	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
16	the	_	DT	DT	_	19	det	_	_
17	new	_	JJ	JJ	_	18	amod	_	_
18	approved	_	JJ	JJ	_	19	amod	_	_
19	nomenclature	_	NN	NN	_	24	nsubjpass	_	_
20	for	_	IN	IN	_	19	prep	_	_
21	IFN	_	NN	NN	_	22	nn	_	_
22	genes	_	NNS	NNS	_	20	pobj	_	_
23	is	_	VBZ	VBZ	_	24	auxpass	_	_
24	used	_	VBN	VBN	_	14	dep	_	_
25	throughout	_	IN	IN	_	24	prep	_	_
26	this	_	DT	DT	_	27	det	_	_
27	article	_	NN	NN	_	25	pobj	_	_
28	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
29	hybrid	_	NN	NN	_	30	nn	_	_
30	gene	_	NN	NN	_	39	nsubjpass	_	_
31	to	_	TO	TO	_	30	prep	_	_
32	the	_	DT	DT	_	34	det	_	_
33	HIV-1-infected	_	JJ	JJ	_	34	amod	_	_
34	cells	_	NNS	NNS	_	31	pobj	_	_
35	,	_	,	,	_	30	punct	_	_
36	HIV-1	_	NN	NN	_	37	nn	_	_
37	LTR	_	NN	NN	_	30	appos	_	_
38	was	_	VBD	VBD	_	39	auxpass	_	_
39	modified	_	VBN	VBN	_	2	parataxis	_	_
40	.	_	.	.	_	2	punct	_	_

1	Deletion	_	NN	NN	_	12	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	6	det	_	_
4	NF-kappa	_	NN	NN	_	6	nn	_	_
5	B	_	NN	NN	_	6	nn	_	_
6	elements	_	NNS	NNS	_	2	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	HIV-1	_	NN	NN	_	10	nn	_	_
10	LTR	_	NN	NN	_	7	pobj	_	_
11	significantly	_	RB	RB	_	12	advmod	_	_
12	inhibited	_	VBD	VBD	_	0	root	_	_
13	Tat-mediated	_	JJ	JJ	_	14	amod	_	_
14	transactivation	_	NN	NN	_	12	dobj	_	_
15	in	_	IN	IN	_	12	prep	_	_
16	T-cell	_	NN	NN	_	17	nn	_	_
17	lines	_	NNS	NNS	_	15	pobj	_	_
18	,	_	,	,	_	15	punct	_	_
19	as	_	RB	RB	_	20	advmod	_	_
20	well	_	RB	RB	_	15	cc	_	_
21	as	_	IN	IN	_	20	mwe	_	_
22	in	_	IN	IN	_	15	conj	_	_
23	a	_	DT	DT	_	25	det	_	_
24	monocyte	_	NN	NN	_	25	nn	_	_
25	line	_	NN	NN	_	22	pobj	_	_
26	,	_	,	,	_	25	punct	_	_
27	U937	_	NN	NN	_	25	appos	_	_
28	.	_	.	.	_	12	punct	_	_

1	Replacement	_	NN	NN	_	35	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	6	det	_	_
4	NF-kappa	_	NN	NN	_	6	nn	_	_
5	B	_	NN	NN	_	6	nn	_	_
6	elements	_	NNS	NNS	_	2	pobj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	HIV-1	_	NN	NN	_	10	nn	_	_
10	LTR	_	NN	NN	_	7	pobj	_	_
11	by	_	IN	IN	_	1	prep	_	_
12	a	_	DT	DT	_	14	det	_	_
13	DNA	_	NN	NN	_	14	nn	_	_
14	fragment	_	NN	NN	_	11	pobj	_	_
15	derived	_	VBN	VBN	_	14	vmod	_	_
16	from	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	5'-flanking	_	JJ	JJ	_	19	amod	_	_
19	region	_	NN	NN	_	16	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	IFN-stimulated	_	JJ	JJ	_	22	amod	_	_
22	gene	_	NN	NN	_	20	pobj	_	_
23	15	_	CD	CD	_	22	num	_	_
24	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
25	ISG15	_	NN	NN	_	22	appos	_	_
26	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
27	,	_	,	,	_	22	punct	_	_
28	containing	_	VBG	VBG	_	22	vmod	_	_
29	the	_	DT	DT	_	32	det	_	_
30	IFN-stimulated	_	JJ	JJ	_	32	amod	_	_
31	response	_	NN	NN	_	32	nn	_	_
32	element	_	NN	NN	_	28	dobj	_	_
33	,	_	,	,	_	1	punct	_	_
34	partially	_	RB	RB	_	35	advmod	_	_
35	restored	_	VBD	VBD	_	0	root	_	_
36	Tat-mediated	_	JJ	JJ	_	37	amod	_	_
37	activation	_	NN	NN	_	35	dobj	_	_
38	of	_	IN	IN	_	37	prep	_	_
39	LTR	_	NN	NN	_	38	pobj	_	_
40	in	_	IN	IN	_	37	prep	_	_
41	T	_	NN	NN	_	42	nn	_	_
42	cells	_	NNS	NNS	_	40	pobj	_	_
43	as	_	RB	RB	_	44	advmod	_	_
44	well	_	RB	RB	_	40	cc	_	_
45	as	_	IN	IN	_	44	mwe	_	_
46	in	_	IN	IN	_	40	conj	_	_
47	monocytes	_	NNS	NNS	_	46	pobj	_	_
48	.	_	.	.	_	35	punct	_	_

1	Insertion	_	NN	NN	_	16	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	this	_	DT	DT	_	5	det	_	_
4	chimeric	_	JJ	JJ	_	5	amod	_	_
5	promoter	_	NN	NN	_	2	pobj	_	_
6	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
7	ISG15	_	NN	NN	_	8	nn	_	_
8	LTR	_	NN	NN	_	5	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	upstream	_	JJ	JJ	_	1	advmod	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	15	det	_	_
13	human	_	JJ	JJ	_	15	amod	_	_
14	IFNA2	_	NN	NN	_	15	nn	_	_
15	gene	_	NN	NN	_	11	pobj	_	_
16	directed	_	VBD	VBD	_	0	root	_	_
17	high	_	JJ	JJ	_	18	amod	_	_
18	levels	_	NNS	NNS	_	16	dobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	IFN	_	NN	NN	_	21	nn	_	_
21	synthesis	_	NN	NN	_	19	pobj	_	_
22	in	_	IN	IN	_	16	prep	_	_
23	Tat-expressing	_	JJ	JJ	_	24	amod	_	_
24	cells	_	NNS	NNS	_	22	pobj	_	_
25	,	_	,	,	_	16	punct	_	_
26	while	_	IN	IN	_	31	mark	_	_
27	this	_	DT	DT	_	28	det	_	_
28	promoter	_	NN	NN	_	31	nsubj	_	_
29	was	_	VBD	VBD	_	31	cop	_	_
30	not	_	RB	RB	_	31	neg	_	_
31	responsive	_	JJ	JJ	_	16	advcl	_	_
32	to	_	TO	TO	_	31	prep	_	_
33	tumor	_	NN	NN	_	37	nn	_	_
34	necrosis	_	NN	NN	_	37	nn	_	_
35	factor	_	NN	NN	_	37	nn	_	_
36	alpha-mediated	_	JJ	JJ	_	37	amod	_	_
37	activation	_	NN	NN	_	32	pobj	_	_
38	.	_	.	.	_	16	punct	_	_

1	ISG15-LTR-IFN	_	JJ	JJ	_	3	amod	_	_
2	hybrid	_	NN	NN	_	3	nn	_	_
3	gene	_	NN	NN	_	10	nsubjpass	_	_
4	inserted	_	VBN	VBN	_	3	vmod	_	_
5	into	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	retrovirus	_	NN	NN	_	8	nn	_	_
8	vector	_	NN	NN	_	5	pobj	_	_
9	was	_	VBD	VBD	_	10	auxpass	_	_
10	transduced	_	VBN	VBN	_	0	root	_	_
11	into	_	IN	IN	_	10	prep	_	_
12	Jurkat	_	NN	NN	_	11	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	U937	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	12	conj	_	_
16	.	_	.	.	_	10	punct	_	_

1	Selected	_	VBN	VBN	_	3	amod	_	_
2	transfected	_	VBN	VBN	_	3	amod	_	_
3	clones	_	NNS	NNS	_	4	nsubj	_	_
4	produced	_	VBD	VBD	_	0	root	_	_
5	low	_	JJ	JJ	_	6	amod	_	_
6	levels	_	NNS	NNS	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	IFN	_	NN	NN	_	9	nn	_	_
9	A	_	NN	NN	_	7	pobj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	IFNA	_	NN	NN	_	9	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	constitutively	_	RB	RB	_	4	advmod	_	_
14	,	_	,	,	_	4	punct	_	_
15	and	_	CC	CC	_	4	cc	_	_
16	their	_	PRP$	PRP$	_	17	poss	_	_
17	abilities	_	NNS	NNS	_	33	nsubjpass	_	_
18	to	_	TO	TO	_	19	aux	_	_
19	express	_	VB	VB	_	17	vmod	_	_
20	interleukin-2	_	NN	NN	_	19	dobj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	interleukin-2	_	NN	NN	_	23	nn	_	_
23	receptor	_	NN	NN	_	20	conj	_	_
24	upon	_	IN	IN	_	19	prep	_	_
25	stimulation	_	NN	NN	_	24	pobj	_	_
26	with	_	IN	IN	_	25	prep	_	_
27	phytohemagglutinin	_	NN	NN	_	26	pobj	_	_
28	and	_	CC	CC	_	27	cc	_	_
29	phorbol	_	NN	NN	_	31	nn	_	_
30	myristate	_	NN	NN	_	31	nn	_	_
31	acetate	_	NN	NN	_	27	conj	_	_
32	were	_	VBD	VBD	_	33	auxpass	_	_
33	retained	_	VBN	VBN	_	4	conj	_	_
34	.	_	.	.	_	4	punct	_	_

1	Enhancement	_	NN	NN	_	9	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	IFNA	_	NN	NN	_	4	nn	_	_
4	synthesis	_	NN	NN	_	2	pobj	_	_
5	observed	_	VBN	VBN	_	1	vmod	_	_
6	upon	_	IN	IN	_	5	prep	_	_
7	HIV-1	_	NN	NN	_	8	nn	_	_
8	infection	_	NN	NN	_	6	pobj	_	_
9	resulted	_	VBD	VBD	_	0	root	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	significant	_	JJ	JJ	_	12	amod	_	_
12	inhibition	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	HIV-1	_	NN	NN	_	15	nn	_	_
15	replication	_	NN	NN	_	13	pobj	_	_
16	for	_	IN	IN	_	9	prep	_	_
17	a	_	DT	DT	_	18	det	_	_
18	period	_	NN	NN	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	at	_	IN	IN	_	22	quantmod	_	_
21	least	_	JJS	JJS	_	20	mwe	_	_
22	30	_	CD	CD	_	23	num	_	_
23	days	_	NNS	NNS	_	19	pobj	_	_
24	.	_	.	.	_	9	punct	_	_

1	Virus	_	NN	NN	_	7	nsubj	_	_
2	isolated	_	VBN	VBN	_	1	vmod	_	_
3	from	_	IN	IN	_	2	prep	_	_
4	IFNA-producing	_	JJ	JJ	_	5	amod	_	_
5	cells	_	NNS	NNS	_	3	pobj	_	_
6	was	_	VBD	VBD	_	7	cop	_	_
7	able	_	JJ	JJ	_	0	root	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	replicate	_	VB	VB	_	7	xcomp	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	U937	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	10	pobj	_	_
14	but	_	CC	CC	_	7	cc	_	_
15	did	_	VBD	VBD	_	17	aux	_	_
16	not	_	RB	RB	_	17	neg	_	_
17	replicate	_	VB	VB	_	7	conj	_	_
18	efficiently	_	RB	RB	_	17	advmod	_	_
19	in	_	IN	IN	_	17	prep	_	_
20	U937	_	NN	NN	_	21	nn	_	_
21	cells	_	NNS	NNS	_	19	pobj	_	_
22	transduced	_	VBN	VBN	_	21	vmod	_	_
23	with	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	26	det	_	_
25	IFNA	_	NN	NN	_	26	nn	_	_
26	gene	_	NN	NN	_	23	pobj	_	_
27	.	_	.	.	_	7	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	14	mark	_	_
5	targeting	_	VBG	VBG	_	14	csubj	_	_
6	IFN	_	NN	NN	_	7	nn	_	_
7	synthesis	_	NN	NN	_	5	dobj	_	_
8	to	_	TO	TO	_	5	prep	_	_
9	HIV-1-infected	_	JJ	JJ	_	10	amod	_	_
10	cells	_	NNS	NNS	_	8	pobj	_	_
11	is	_	VBZ	VBZ	_	14	cop	_	_
12	an	_	DT	DT	_	14	det	_	_
13	attainable	_	JJ	JJ	_	14	amod	_	_
14	goal	_	NN	NN	_	3	ccomp	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	that	_	IN	IN	_	20	mark	_	_
17	autocrine	_	NN	NN	_	19	nn	_	_
18	IFN	_	NN	NN	_	19	nn	_	_
19	synthesis	_	NN	NN	_	20	nsubj	_	_
20	results	_	VBZ	VBZ	_	14	conj	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	a	_	DT	DT	_	26	det	_	_
23	long-lasting	_	JJ	JJ	_	26	amod	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	permanent	_	JJ	JJ	_	23	conj	_	_
26	suppression	_	NN	NN	_	21	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	HIV-1	_	NN	NN	_	29	nn	_	_
29	replication	_	NN	NN	_	27	pobj	_	_
30	.	_	.	.	_	3	punct	_	_

1	Epstein-Barr	_	JJ	JJ	_	4	amod	_	_
2	virus	_	NN	NN	_	4	nn	_	_
3	nuclear	_	JJ	JJ	_	4	amod	_	_
4	protein	_	NN	NN	_	6	nn	_	_
5	2	_	CD	CD	_	4	num	_	_
6	transactivation	_	NN	NN	_	15	nsubjpass	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	13	det	_	_
9	latent	_	JJ	JJ	_	13	amod	_	_
10	membrane	_	NN	NN	_	13	nn	_	_
11	protein	_	NN	NN	_	13	nn	_	_
12	1	_	CD	CD	_	13	num	_	_
13	promoter	_	NN	NN	_	7	pobj	_	_
14	is	_	VBZ	VBZ	_	15	auxpass	_	_
15	mediated	_	VBN	VBN	_	0	root	_	_
16	by	_	IN	IN	_	15	prep	_	_
17	J	_	NN	NN	_	18	nn	_	_
18	kappa	_	NN	NN	_	16	pobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	PU.1	_	NN	NN	_	18	conj	_	_
21	.	_	.	.	_	15	punct	_	_

1	Expression	_	NN	NN	_	18	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	16	det	_	_
4	Epstein-Barr	_	JJ	JJ	_	16	amod	_	_
5	virus	_	NN	NN	_	16	nn	_	_
6	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
7	EBV	_	NN	NN	_	16	nn	_	_
8	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
9	latent	_	JJ	JJ	_	16	amod	_	_
10	membrane	_	NN	NN	_	16	nn	_	_
11	protein	_	NN	NN	_	16	nn	_	_
12	1	_	CD	CD	_	16	num	_	_
13	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
14	LMP-1	_	NN	NN	_	16	nn	_	_
15	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
16	oncogene	_	NN	NN	_	2	pobj	_	_
17	is	_	VBZ	VBZ	_	18	auxpass	_	_
18	regulated	_	VBN	VBN	_	0	root	_	_
19	by	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	28	det	_	_
21	EBV	_	NN	NN	_	28	nn	_	_
22	nuclear	_	JJ	JJ	_	28	amod	_	_
23	protein	_	NN	NN	_	28	nn	_	_
24	2	_	CD	CD	_	28	num	_	_
25	-LRB-	_	-LRB-	-LRB-	_	28	punct	_	_
26	EBNA-2	_	NN	NN	_	28	nn	_	_
27	-RRB-	_	-RRB-	-RRB-	_	28	punct	_	_
28	transactivator	_	NN	NN	_	19	pobj	_	_
29	.	_	.	.	_	18	punct	_	_

1	EBNA-2	_	NN	NN	_	3	nsubjpass	_	_
2	is	_	VBZ	VBZ	_	3	auxpass	_	_
3	known	_	VBN	VBN	_	0	root	_	_
4	to	_	TO	TO	_	5	aux	_	_
5	interact	_	VB	VB	_	3	xcomp	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	10	det	_	_
8	cellular	_	JJ	JJ	_	10	amod	_	_
9	DNA-binding	_	JJ	JJ	_	10	amod	_	_
10	protein	_	NN	NN	_	6	pobj	_	_
11	J	_	NN	NN	_	12	nn	_	_
12	kappa	_	NN	NN	_	10	dep	_	_
13	and	_	CC	CC	_	3	cc	_	_
14	is	_	VBZ	VBZ	_	15	auxpass	_	_
15	recruited	_	VBN	VBN	_	3	conj	_	_
16	to	_	TO	TO	_	15	prep	_	_
17	promoters	_	NNS	NNS	_	16	pobj	_	_
18	containing	_	VBG	VBG	_	17	vmod	_	_
19	the	_	DT	DT	_	20	det	_	_
20	GTGGGAA	_	NN	NN	_	18	dobj	_	_
21	J	_	NN	NN	_	24	nn	_	_
22	kappa	_	NN	NN	_	24	nn	_	_
23	recognition	_	NN	NN	_	24	nn	_	_
24	sequence	_	NN	NN	_	20	dep	_	_
25	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	minimal	_	JJ	JJ	_	5	amod	_	_
3	EBNA-2-responsive	_	JJ	JJ	_	5	amod	_	_
4	LMP-1	_	NN	NN	_	5	nn	_	_
5	promoter	_	NN	NN	_	6	nsubj	_	_
6	includes	_	VBZ	VBZ	_	0	root	_	_
7	one	_	CD	CD	_	10	num	_	_
8	J	_	NN	NN	_	10	nn	_	_
9	kappa-binding	_	JJ	JJ	_	10	amod	_	_
10	site	_	NN	NN	_	6	dobj	_	_
11	,	_	,	,	_	6	punct	_	_
12	and	_	CC	CC	_	6	cc	_	_
13	we	_	PRP	PRP	_	15	nsubj	_	_
14	now	_	RB	RB	_	15	advmod	_	_
15	show	_	VBP	VBP	_	6	conj	_	_
16	that	_	IN	IN	_	30	mark	_	_
17	mutation	_	NN	NN	_	30	nsubj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	that	_	DT	DT	_	20	det	_	_
20	site	_	NN	NN	_	18	pobj	_	_
21	,	_	,	,	_	17	punct	_	_
22	such	_	JJ	JJ	_	17	appos	_	_
23	that	_	IN	IN	_	28	dobj	_	_
24	J	_	NN	NN	_	25	nn	_	_
25	kappa	_	NN	NN	_	28	nsubj	_	_
26	can	_	MD	MD	_	28	aux	_	_
27	not	_	RB	RB	_	28	neg	_	_
28	bind	_	VB	VB	_	22	rcmod	_	_
29	,	_	,	,	_	17	punct	_	_
30	reduces	_	VBZ	VBZ	_	15	ccomp	_	_
31	EBNA-2	_	NN	NN	_	32	nn	_	_
32	responsiveness	_	NN	NN	_	30	dobj	_	_
33	by	_	IN	IN	_	30	prep	_	_
34	60	_	CD	CD	_	35	num	_	_
35	%	_	NN	NN	_	33	pobj	_	_
36	.	_	.	.	_	6	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	identify	_	VB	VB	_	0	root	_	_
3	other	_	JJ	JJ	_	4	amod	_	_
4	factors	_	NNS	NNS	_	2	dobj	_	_
5	which	_	WDT	WDT	_	6	nsubj	_	_
6	interact	_	VBP	VBP	_	4	rcmod	_	_
7	with	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	12	det	_	_
9	LMP-1	_	NN	NN	_	12	nn	_	_
10	EBNA-2	_	NN	NN	_	12	nn	_	_
11	response	_	NN	NN	_	12	nn	_	_
12	element	_	NN	NN	_	7	pobj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	E2RE	_	NN	NN	_	12	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	,	_	,	,	_	2	punct	_	_
17	a	_	DT	DT	_	20	det	_	_
18	-236/-145	_	JJ	JJ	_	20	amod	_	_
19	minimal	_	JJ	JJ	_	20	amod	_	_
20	E2RE	_	NN	NN	_	22	nsubjpass	_	_
21	was	_	VBD	VBD	_	22	auxpass	_	_
22	used	_	VBN	VBN	_	2	parataxis	_	_
23	as	_	IN	IN	_	22	prep	_	_
24	a	_	DT	DT	_	25	det	_	_
25	probe	_	NN	NN	_	23	pobj	_	_
26	in	_	IN	IN	_	22	prep	_	_
27	an	_	DT	DT	_	31	det	_	_
28	electrophoretic	_	JJ	JJ	_	31	amod	_	_
29	mobility	_	NN	NN	_	31	nn	_	_
30	shift	_	NN	NN	_	31	nn	_	_
31	assay	_	NN	NN	_	26	pobj	_	_
32	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	previously	_	RB	RB	_	3	advmod	_	_
3	characterized	_	VBN	VBN	_	4	amod	_	_
4	factors	_	NNS	NNS	_	12	nsubj	_	_
5	J	_	NN	NN	_	6	nn	_	_
6	kappa	_	NN	NN	_	4	dep	_	_
7	,	_	,	,	_	6	punct	_	_
8	PU.1	_	NN	NN	_	6	conj	_	_
9	,	_	,	,	_	6	punct	_	_
10	and	_	CC	CC	_	6	cc	_	_
11	AML1	_	NN	NN	_	6	conj	_	_
12	bind	_	VBP	VBP	_	0	root	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	LMP-1	_	NN	NN	_	16	nn	_	_
16	E2RE	_	NN	NN	_	13	pobj	_	_
17	,	_	,	,	_	12	punct	_	_
18	along	_	IN	IN	_	12	prep	_	_
19	with	_	IN	IN	_	18	pcomp	_	_
20	six	_	CD	CD	_	23	num	_	_
21	other	_	JJ	JJ	_	22	amod	_	_
22	unidentified	_	JJ	JJ	_	23	amod	_	_
23	factors	_	NNS	NNS	_	19	pobj	_	_
24	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
25	LBF2	_	NN	NN	_	23	appos	_	_
26	to	_	TO	TO	_	25	prep	_	_
27	LBF7	_	NN	NN	_	26	pobj	_	_
28	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
29	.	_	.	.	_	12	punct	_	_

1	Binding	_	VBG	VBG	_	2	amod	_	_
2	sites	_	NNS	NNS	_	4	nsubjpass	_	_
3	were	_	VBD	VBD	_	4	auxpass	_	_
4	mapped	_	VBN	VBN	_	0	root	_	_
5	for	_	IN	IN	_	4	prep	_	_
6	each	_	DT	DT	_	7	det	_	_
7	factor	_	NN	NN	_	5	pobj	_	_
8	.	_	.	.	_	4	punct	_	_

1	LBF4	_	NN	NN	_	6	nsubj	_	_
2	is	_	VBZ	VBZ	_	6	cop	_	_
3	B-	_	NN	NN	_	6	dep	_	_
4	and	_	CC	CC	_	6	cc	_	_
5	T-cell	_	NN	NN	_	6	conj	_	_
6	specific	_	JJ	JJ	_	0	root	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	recognizes	_	VBZ	VBZ	_	6	conj	_	_
9	the	_	DT	DT	_	13	det	_	_
10	PU.1	_	NN	NN	_	13	nn	_	_
11	GGAA	_	NN	NN	_	13	nn	_	_
12	core	_	NN	NN	_	13	nn	_	_
13	sequence	_	NN	NN	_	8	dobj	_	_
14	as	_	IN	IN	_	15	mark	_	_
15	shown	_	VBN	VBN	_	8	advcl	_	_
16	by	_	IN	IN	_	15	prep	_	_
17	methylation	_	NN	NN	_	18	nn	_	_
18	interference	_	NN	NN	_	16	pobj	_	_
19	.	_	.	.	_	6	punct	_	_

1	LBF4	_	NN	NN	_	2	nsubj	_	_
2	has	_	VBZ	VBZ	_	0	root	_	_
3	a	_	DT	DT	_	5	det	_	_
4	molecular	_	JJ	JJ	_	5	amod	_	_
5	mass	_	NN	NN	_	2	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	105	_	CD	CD	_	8	num	_	_
8	kDa	_	NN	NN	_	6	pobj	_	_
9	and	_	CC	CC	_	2	cc	_	_
10	is	_	VBZ	VBZ	_	12	cop	_	_
11	probably	_	RB	RB	_	12	advmod	_	_
12	unrelated	_	JJ	JJ	_	2	conj	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	PU.1	_	NN	NN	_	13	pobj	_	_
15	.	_	.	.	_	2	punct	_	_

1	LBF2	_	NN	NN	_	3	nsubjpass	_	_
2	was	_	VBD	VBD	_	3	auxpass	_	_
3	found	_	VBN	VBN	_	0	root	_	_
4	only	_	RB	RB	_	5	advmod	_	_
5	in	_	IN	IN	_	3	prep	_	_
6	epithelial	_	JJ	JJ	_	8	amod	_	_
7	cell	_	NN	NN	_	8	nn	_	_
8	lines	_	NNS	NNS	_	5	pobj	_	_
9	,	_	,	,	_	3	punct	_	_
10	whereas	_	IN	IN	_	23	mark	_	_
11	LBF3	_	NN	NN	_	23	nsubj	_	_
12	,	_	,	,	_	11	punct	_	_
13	LBF5	_	NN	NN	_	11	conj	_	_
14	,	_	,	,	_	11	punct	_	_
15	LBF6	_	NN	NN	_	11	conj	_	_
16	,	_	,	,	_	11	punct	_	_
17	and	_	CC	CC	_	11	cc	_	_
18	LBF7	_	NN	NN	_	11	conj	_	_
19	were	_	VBD	VBD	_	23	cop	_	_
20	not	_	RB	RB	_	23	neg	_	_
21	cell	_	NN	NN	_	23	npadvmod	_	_
22	type	_	NN	NN	_	23	npadvmod	_	_
23	specific	_	JJ	JJ	_	3	advcl	_	_
24	.	_	.	.	_	3	punct	_	_

1	Mutations	_	NNS	NNS	_	8	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	4	dep	_	_
4	AML1-	_	NN	NN	_	2	pobj	_	_
5	or	_	CC	CC	_	4	cc	_	_
6	LBF4-binding	_	JJ	JJ	_	4	conj	_	_
7	sites	_	NNS	NNS	_	4	dep	_	_
8	had	_	VBD	VBD	_	0	root	_	_
9	no	_	DT	DT	_	10	neg	_	_
10	effect	_	NN	NN	_	8	dobj	_	_
11	on	_	IN	IN	_	8	prep	_	_
12	EBNA-2	_	NN	NN	_	13	nn	_	_
13	transactivation	_	NN	NN	_	11	pobj	_	_
14	,	_	,	,	_	8	punct	_	_
15	whereas	_	IN	IN	_	22	mark	_	_
16	mutation	_	NN	NN	_	22	nsubj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	PU.1-binding	_	JJ	JJ	_	20	amod	_	_
20	site	_	NN	NN	_	17	pobj	_	_
21	completely	_	RB	RB	_	22	advmod	_	_
22	eliminated	_	VBD	VBD	_	8	advcl	_	_
23	EBNA-2	_	NN	NN	_	24	nn	_	_
24	responses	_	NNS	NNS	_	22	dobj	_	_
25	.	_	.	.	_	8	punct	_	_

1	A	_	DT	DT	_	4	det	_	_
2	gst-EBNA-2	_	NN	NN	_	4	nn	_	_
3	fusion	_	NN	NN	_	4	nn	_	_
4	protein	_	NN	NN	_	6	nsubj	_	_
5	specifically	_	RB	RB	_	6	advmod	_	_
6	depleted	_	VBD	VBD	_	0	root	_	_
7	PU.1	_	NN	NN	_	6	dobj	_	_
8	from	_	IN	IN	_	6	prep	_	_
9	nuclear	_	JJ	JJ	_	10	amod	_	_
10	extracts	_	NNS	NNS	_	8	pobj	_	_
11	and	_	CC	CC	_	6	cc	_	_
12	bound	_	VBD	VBD	_	6	conj	_	_
13	in	_	FW	FW	_	14	nn	_	_
14	vitro	_	FW	FW	_	12	advmod	_	_
15	translated	_	VBN	VBN	_	16	amod	_	_
16	PU.1	_	NN	NN	_	12	dobj	_	_
17	,	_	,	,	_	6	punct	_	_
18	providing	_	VBG	VBG	_	6	vmod	_	_
19	biochemical	_	JJ	JJ	_	20	amod	_	_
20	evidence	_	NN	NN	_	18	dobj	_	_
21	for	_	IN	IN	_	20	prep	_	_
22	a	_	DT	DT	_	25	det	_	_
23	direct	_	JJ	JJ	_	25	amod	_	_
24	EBNA-2-PU.1	_	JJ	JJ	_	25	amod	_	_
25	interaction	_	NN	NN	_	21	pobj	_	_
26	.	_	.	.	_	6	punct	_	_

1	Thus	_	RB	RB	_	10	advmod	_	_
2	,	_	,	,	_	10	punct	_	_
3	EBNA-2	_	NN	NN	_	4	nn	_	_
4	transactivation	_	NN	NN	_	10	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	LMP-1	_	NN	NN	_	8	nn	_	_
8	promoter	_	NN	NN	_	5	pobj	_	_
9	is	_	VBZ	VBZ	_	10	cop	_	_
10	dependent	_	JJ	JJ	_	0	root	_	_
11	on	_	IN	IN	_	10	prep	_	_
12	interaction	_	NN	NN	_	11	pobj	_	_
13	with	_	IN	IN	_	12	prep	_	_
14	at	_	IN	IN	_	16	quantmod	_	_
15	least	_	JJS	JJS	_	14	mwe	_	_
16	two	_	CD	CD	_	20	num	_	_
17	distinct	_	JJ	JJ	_	20	amod	_	_
18	sequence-specific	_	JJ	JJ	_	17	dep	_	_
19	DNA-binding	_	JJ	JJ	_	20	amod	_	_
20	proteins	_	NNS	NNS	_	13	pobj	_	_
21	,	_	,	,	_	20	punct	_	_
22	J	_	NN	NN	_	23	nn	_	_
23	kappa	_	NN	NN	_	20	appos	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	PU.1	_	NN	NN	_	23	conj	_	_
26	.	_	.	.	_	10	punct	_	_

1	LBF3	_	NN	NN	_	12	nsubjpass	_	_
2	,	_	,	,	_	1	punct	_	_
3	LBF5	_	NN	NN	_	1	conj	_	_
4	,	_	,	,	_	1	punct	_	_
5	LBF6	_	NN	NN	_	1	conj	_	_
6	,	_	,	,	_	1	punct	_	_
7	or	_	CC	CC	_	1	cc	_	_
8	LBF7	_	NN	NN	_	1	conj	_	_
9	may	_	MD	MD	_	12	aux	_	_
10	also	_	RB	RB	_	12	advmod	_	_
11	be	_	VB	VB	_	12	auxpass	_	_
12	involved	_	VBN	VBN	_	0	root	_	_
13	,	_	,	,	_	12	punct	_	_
14	since	_	IN	IN	_	19	mark	_	_
15	their	_	PRP$	PRP$	_	17	poss	_	_
16	binding	_	VBG	VBG	_	17	amod	_	_
17	sites	_	NNS	NNS	_	19	nsubj	_	_
18	also	_	RB	RB	_	19	advmod	_	_
19	contribute	_	VBP	VBP	_	12	advcl	_	_
20	to	_	TO	TO	_	19	prep	_	_
21	EBNA-2	_	NN	NN	_	22	nn	_	_
22	responsiveness	_	NN	NN	_	20	pobj	_	_
23	.	_	.	.	_	12	punct	_	_

1	Pyrrolidine	_	NN	NN	_	2	nn	_	_
2	dithiocarbamate	_	NN	NN	_	18	nsubj	_	_
3	,	_	,	,	_	2	punct	_	_
4	a	_	DT	DT	_	6	det	_	_
5	potent	_	JJ	JJ	_	6	amod	_	_
6	inhibitor	_	NN	NN	_	2	appos	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	nuclear	_	JJ	JJ	_	11	amod	_	_
9	factor	_	NN	NN	_	11	nn	_	_
10	kappa	_	NN	NN	_	11	nn	_	_
11	B	_	NN	NN	_	16	nn	_	_
12	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
13	NF-kappa	_	NN	NN	_	14	nn	_	_
14	B	_	NN	NN	_	11	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	activation	_	NN	NN	_	7	pobj	_	_
17	,	_	,	,	_	2	punct	_	_
18	prevents	_	VBZ	VBZ	_	0	root	_	_
19	apoptosis	_	NN	NN	_	18	dobj	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	human	_	JJ	JJ	_	25	amod	_	_
22	promyelocytic	_	JJ	JJ	_	25	amod	_	_
23	leukemia	_	NN	NN	_	25	nn	_	_
24	HL-60	_	NN	NN	_	25	nn	_	_
25	cells	_	NNS	NNS	_	20	pobj	_	_
26	and	_	CC	CC	_	25	cc	_	_
27	thymocytes	_	NNS	NNS	_	25	conj	_	_
28	.	_	.	.	_	18	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	examined	_	VBD	VBD	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	effect	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	pyrrolidine	_	NN	NN	_	7	nn	_	_
7	dithiocarbamate	_	NN	NN	_	5	pobj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	PDTC	_	NN	NN	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	,	_	,	,	_	7	punct	_	_
12	which	_	WDT	WDT	_	14	nsubj	_	_
13	potently	_	RB	RB	_	14	advmod	_	_
14	blocks	_	VBZ	VBZ	_	7	rcmod	_	_
15	the	_	DT	DT	_	16	det	_	_
16	activation	_	NN	NN	_	14	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	nuclear	_	JJ	JJ	_	21	amod	_	_
19	factor	_	NN	NN	_	21	nn	_	_
20	kappa	_	NN	NN	_	21	nn	_	_
21	B	_	NN	NN	_	17	pobj	_	_
22	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
23	NF-kappa	_	NN	NN	_	24	nn	_	_
24	B	_	NN	NN	_	21	appos	_	_
25	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
26	,	_	,	,	_	4	punct	_	_
27	on	_	IN	IN	_	4	prep	_	_
28	the	_	DT	DT	_	29	det	_	_
29	induction	_	NN	NN	_	27	pobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	apoptosis	_	NN	NN	_	30	pobj	_	_
32	by	_	IN	IN	_	31	prep	_	_
33	a	_	DT	DT	_	34	det	_	_
34	variety	_	NN	NN	_	32	pobj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	agents	_	NNS	NNS	_	35	pobj	_	_
37	.	_	.	.	_	2	punct	_	_

1	Treatment	_	NN	NN	_	20	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	a	_	DT	DT	_	8	det	_	_
4	human	_	JJ	JJ	_	8	amod	_	_
5	promyelocytic	_	JJ	JJ	_	8	amod	_	_
6	leukemia	_	NN	NN	_	8	nn	_	_
7	cell	_	NN	NN	_	8	nn	_	_
8	line	_	NN	NN	_	2	pobj	_	_
9	,	_	,	,	_	8	punct	_	_
10	HL-60	_	NN	NN	_	8	appos	_	_
11	,	_	,	,	_	1	punct	_	_
12	with	_	IN	IN	_	1	prep	_	_
13	10	_	CD	CD	_	15	num	_	_
14	micrograms/mL	_	NNS	NNS	_	15	nn	_	_
15	etoposide	_	NN	NN	_	12	pobj	_	_
16	or	_	CC	CC	_	15	cc	_	_
17	2	_	CD	CD	_	19	num	_	_
18	microM	_	NN	NN	_	19	nn	_	_
19	1-beta-D-arabinofuranosylcytosine	_	NN	NN	_	15	conj	_	_
20	induced	_	VBD	VBD	_	0	root	_	_
21	NF-kappa	_	NN	NN	_	22	nn	_	_
22	B	_	NN	NN	_	23	nn	_	_
23	activation	_	NN	NN	_	20	dobj	_	_
24	within	_	IN	IN	_	20	prep	_	_
25	1	_	CD	CD	_	26	num	_	_
26	hr	_	NN	NN	_	24	pobj	_	_
27	and	_	CC	CC	_	20	cc	_	_
28	subsequently	_	RB	RB	_	29	advmod	_	_
29	caused	_	VBD	VBD	_	20	conj	_	_
30	apoptosis	_	NN	NN	_	29	dobj	_	_
31	within	_	IN	IN	_	29	prep	_	_
32	3-4	_	JJ	JJ	_	33	num	_	_
33	hr	_	NN	NN	_	31	pobj	_	_
34	.	_	.	.	_	20	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	simultaneous	_	JJ	JJ	_	3	amod	_	_
3	addition	_	NN	NN	_	11	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	50-500	_	CD	CD	_	6	dep	_	_
6	microM	_	NN	NN	_	7	dep	_	_
7	PDTC	_	NN	NN	_	4	pobj	_	_
8	with	_	IN	IN	_	3	prep	_	_
9	these	_	DT	DT	_	10	det	_	_
10	agents	_	NNS	NNS	_	8	pobj	_	_
11	blocked	_	VBD	VBD	_	0	root	_	_
12	NF-kappa	_	NN	NN	_	13	nn	_	_
13	B	_	NN	NN	_	14	nn	_	_
14	activation	_	NN	NN	_	11	dobj	_	_
15	and	_	CC	CC	_	11	cc	_	_
16	completely	_	RB	RB	_	17	advmod	_	_
17	abrogated	_	VBD	VBD	_	11	conj	_	_
18	both	_	CC	CC	_	21	preconj	_	_
19	morphologically	_	RB	RB	_	21	advmod	_	_
20	apoptotic	_	JJ	JJ	_	21	amod	_	_
21	changes	_	NNS	NNS	_	17	dobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	internucleosomal	_	JJ	JJ	_	25	amod	_	_
24	DNA	_	NN	NN	_	25	nn	_	_
25	fragmentation	_	NN	NN	_	21	conj	_	_
26	for	_	IN	IN	_	17	prep	_	_
27	up	_	RB	RB	_	29	quantmod	_	_
28	to	_	TO	TO	_	29	dep	_	_
29	6	_	CD	CD	_	30	num	_	_
30	hr	_	NN	NN	_	26	pobj	_	_
31	.	_	.	.	_	11	punct	_	_

1	However	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	PDTC	_	NN	NN	_	4	nsubj	_	_
4	failed	_	VBD	VBD	_	0	root	_	_
5	to	_	TO	TO	_	6	aux	_	_
6	inhibit	_	VB	VB	_	4	xcomp	_	_
7	the	_	DT	DT	_	9	det	_	_
8	endonuclease	_	NN	NN	_	9	nn	_	_
9	activity	_	NN	NN	_	6	dobj	_	_
10	contained	_	VBN	VBN	_	9	vmod	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	15	det	_	_
13	whole	_	JJ	JJ	_	15	amod	_	_
14	cell	_	NN	NN	_	15	nn	_	_
15	lysates	_	NNS	NNS	_	11	pobj	_	_
16	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	inhibitory	_	JJ	JJ	_	3	amod	_	_
3	effect	_	NN	NN	_	8	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	PDTC	_	NN	NN	_	4	pobj	_	_
6	was	_	VBD	VBD	_	8	auxpass	_	_
7	also	_	RB	RB	_	8	advmod	_	_
8	observed	_	VBN	VBN	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	etoposide-	_	NN	NN	_	9	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	dexamethasone-induced	_	JJ	JJ	_	10	conj	_	_
13	apoptosis	_	NN	NN	_	10	dep	_	_
14	in	_	IN	IN	_	10	prep	_	_
15	human	_	JJ	JJ	_	16	amod	_	_
16	thymocytes	_	NNS	NNS	_	14	pobj	_	_
17	at	_	IN	IN	_	10	prep	_	_
18	a	_	DT	DT	_	19	det	_	_
19	concentration	_	NN	NN	_	17	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	1-10	_	CD	CD	_	22	num	_	_
22	microM	_	NN	NN	_	20	pobj	_	_
23	.	_	.	.	_	8	punct	_	_

1	Since	_	IN	IN	_	3	mark	_	_
2	PDTC	_	NN	NN	_	3	nsubj	_	_
3	has	_	VBZ	VBZ	_	12	advcl	_	_
4	both	_	CC	CC	_	5	preconj	_	_
5	antioxidant	_	NN	NN	_	3	dobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	metal-ion	_	JJ	JJ	_	5	conj	_	_
8	chelating	_	NN	NN	_	9	nn	_	_
9	activities	_	NNS	NNS	_	5	dep	_	_
10	,	_	,	,	_	12	punct	_	_
11	we	_	PRP	PRP	_	12	nsubj	_	_
12	tested	_	VBD	VBD	_	0	root	_	_
13	the	_	DT	DT	_	14	det	_	_
14	effects	_	NNS	NNS	_	12	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	N-acetyl-L-cysteine	_	NN	NN	_	15	pobj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	NAC	_	NN	NN	_	16	appos	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	antioxidant	_	JJ	JJ	_	16	dep	_	_
22	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
23	or	_	CC	CC	_	16	cc	_	_
24	o-phenanthroline	_	NN	NN	_	16	conj	_	_
25	-LRB-	_	-LRB-	-LRB-	_	26	punct	_	_
26	OP	_	NN	NN	_	24	appos	_	_
27	-RRB-	_	-RRB-	-RRB-	_	26	punct	_	_
28	-LRB-	_	-LRB-	-LRB-	_	30	punct	_	_
29	metal-ion	_	JJ	JJ	_	30	amod	_	_
30	chelator	_	NN	NN	_	24	appos	_	_
31	-RRB-	_	-RRB-	-RRB-	_	30	punct	_	_
32	on	_	IN	IN	_	14	prep	_	_
33	the	_	DT	DT	_	34	det	_	_
34	induction	_	NN	NN	_	32	pobj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	apoptosis	_	NN	NN	_	35	pobj	_	_
37	.	_	.	.	_	12	punct	_	_

1	Pretreatment	_	NN	NN	_	21	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	HL-60	_	NN	NN	_	4	nn	_	_
4	cells	_	NNS	NNS	_	2	pobj	_	_
5	or	_	CC	CC	_	4	cc	_	_
6	thymocytes	_	NNS	NNS	_	4	conj	_	_
7	with	_	IN	IN	_	1	prep	_	_
8	100-500	_	CD	CD	_	9	dep	_	_
9	microM	_	NN	NN	_	10	dep	_	_
10	OP	_	NN	NN	_	7	pobj	_	_
11	for	_	IN	IN	_	10	prep	_	_
12	2	_	CD	CD	_	13	num	_	_
13	hr	_	NN	NN	_	11	pobj	_	_
14	,	_	,	,	_	10	punct	_	_
15	but	_	CC	CC	_	16	cc	_	_
16	not	_	RB	RB	_	10	cc	_	_
17	10-60	_	CD	CD	_	18	dep	_	_
18	mM	_	NN	NN	_	19	dep	_	_
19	NAC	_	NN	NN	_	10	conj	_	_
20	,	_	,	,	_	1	punct	_	_
21	suppressed	_	VBD	VBD	_	0	root	_	_
22	subsequent	_	JJ	JJ	_	23	amod	_	_
23	occurrence	_	NN	NN	_	21	dobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	apoptosis	_	NN	NN	_	24	pobj	_	_
26	induced	_	VBN	VBN	_	25	vmod	_	_
27	by	_	IN	IN	_	26	prep	_	_
28	etoposide	_	NN	NN	_	27	pobj	_	_
29	.	_	.	.	_	21	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	10	mark	_	_
5	the	_	DT	DT	_	6	det	_	_
6	activation	_	NN	NN	_	10	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	NF-kappa	_	NN	NN	_	9	nn	_	_
9	B	_	NN	NN	_	7	pobj	_	_
10	plays	_	VBZ	VBZ	_	3	ccomp	_	_
11	an	_	DT	DT	_	13	det	_	_
12	important	_	JJ	JJ	_	13	amod	_	_
13	role	_	NN	NN	_	10	dobj	_	_
14	in	_	IN	IN	_	10	prep	_	_
15	the	_	DT	DT	_	17	det	_	_
16	apoptotic	_	JJ	JJ	_	17	amod	_	_
17	process	_	NN	NN	_	14	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	human	_	JJ	JJ	_	21	amod	_	_
20	hematopoietic	_	JJ	JJ	_	21	amod	_	_
21	cells	_	NNS	NNS	_	18	pobj	_	_
22	.	_	.	.	_	3	punct	_	_

1	Differential	_	JJ	JJ	_	2	amod	_	_
2	regulation	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	proto-oncogenes	_	NNS	NNS	_	3	pobj	_	_
5	c-jun	_	NN	NN	_	4	dep	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	c-fos	_	NN	NN	_	5	conj	_	_
8	in	_	IN	IN	_	2	prep	_	_
9	T	_	NN	NN	_	10	nn	_	_
10	lymphocytes	_	NNS	NNS	_	8	pobj	_	_
11	activated	_	VBN	VBN	_	10	vmod	_	_
12	through	_	IN	IN	_	11	prep	_	_
13	CD28	_	NN	NN	_	12	pobj	_	_
14	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	T	_	NN	NN	_	5	nn	_	_
3	cell	_	NN	NN	_	5	nn	_	_
4	surface	_	NN	NN	_	5	nn	_	_
5	molecule	_	NN	NN	_	7	nsubj	_	_
6	CD28	_	NN	NN	_	5	dep	_	_
7	binds	_	VBZ	VBZ	_	0	root	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	ligands	_	NNS	NNS	_	8	pobj	_	_
10	on	_	IN	IN	_	9	prep	_	_
11	accessory	_	JJ	JJ	_	12	amod	_	_
12	cells	_	NNS	NNS	_	10	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	APCs	_	NNS	NNS	_	12	conj	_	_
15	,	_	,	,	_	7	punct	_	_
16	playing	_	VBG	VBG	_	7	xcomp	_	_
17	an	_	DT	DT	_	20	det	_	_
18	important	_	JJ	JJ	_	20	amod	_	_
19	costimulatory	_	JJ	JJ	_	18	dep	_	_
20	role	_	NN	NN	_	16	dobj	_	_
21	in	_	IN	IN	_	16	prep	_	_
22	the	_	DT	DT	_	23	det	_	_
23	response	_	NN	NN	_	21	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	T	_	NN	NN	_	26	nn	_	_
26	cells	_	NNS	NNS	_	24	pobj	_	_
27	to	_	TO	TO	_	23	prep	_	_
28	Ags	_	NN	NN	_	27	pobj	_	_
29	.	_	.	.	_	7	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	knowledge	_	NN	NN	_	13	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	7	det	_	_
5	intracellular	_	JJ	JJ	_	7	amod	_	_
6	signaling	_	NN	NN	_	7	nn	_	_
7	pathways	_	NNS	NNS	_	3	pobj	_	_
8	coupled	_	VBN	VBN	_	7	vmod	_	_
9	to	_	TO	TO	_	8	prep	_	_
10	this	_	DT	DT	_	11	det	_	_
11	receptor	_	NN	NN	_	9	pobj	_	_
12	is	_	VBZ	VBZ	_	13	cop	_	_
13	incomplete	_	JJ	JJ	_	0	root	_	_
14	.	_	.	.	_	13	punct	_	_

1	In	_	IN	IN	_	16	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	to	_	TO	TO	_	2	prep	_	_
4	activation	_	NN	NN	_	3	pobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	phospholipase	_	NN	NN	_	8	nn	_	_
7	C	_	NN	NN	_	8	nn	_	_
8	gamma	_	NN	NN	_	5	pobj	_	_
9	1	_	CD	CD	_	8	num	_	_
10	,	_	,	,	_	16	punct	_	_
11	ligation	_	NN	NN	_	16	nsubj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	this	_	DT	DT	_	14	det	_	_
14	receptor	_	NN	NN	_	12	pobj	_	_
15	also	_	RB	RB	_	16	advmod	_	_
16	seems	_	VBZ	VBZ	_	0	root	_	_
17	to	_	TO	TO	_	18	aux	_	_
18	activate	_	VB	VB	_	16	xcomp	_	_
19	a	_	DT	DT	_	23	det	_	_
20	calcium-independent	_	JJ	JJ	_	23	amod	_	_
21	,	_	,	,	_	20	punct	_	_
22	CD28-specific	_	JJ	JJ	_	20	dep	_	_
23	pathway	_	NN	NN	_	18	dobj	_	_
24	.	_	.	.	_	16	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	paper	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	report	_	VBP	VBP	_	0	root	_	_
7	that	_	IN	IN	_	23	mark	_	_
8	cross-linking	_	NN	NN	_	23	nsubj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	CD28	_	NN	NN	_	9	pobj	_	_
11	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
12	but	_	CC	CC	_	13	cc	_	_
13	not	_	RB	RB	_	14	cc	_	_
14	CD2	_	NN	NN	_	10	dep	_	_
15	,	_	,	,	_	14	punct	_	_
16	CD5	_	NN	NN	_	14	conj	_	_
17	,	_	,	,	_	14	punct	_	_
18	LFA-1	_	NN	NN	_	14	conj	_	_
19	,	_	,	,	_	14	punct	_	_
20	or	_	CC	CC	_	14	cc	_	_
21	CD7	_	NN	NN	_	14	conj	_	_
22	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
23	leads	_	VBZ	VBZ	_	6	ccomp	_	_
24	to	_	TO	TO	_	23	prep	_	_
25	an	_	DT	DT	_	26	det	_	_
26	elevation	_	NN	NN	_	24	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	c-jun	_	NN	NN	_	29	nn	_	_
29	mRNA	_	NN	NN	_	27	pobj	_	_
30	,	_	,	,	_	23	punct	_	_
31	with	_	IN	IN	_	23	prep	_	_
32	only	_	RB	RB	_	34	advmod	_	_
33	minimal	_	JJ	JJ	_	34	amod	_	_
34	activation	_	NN	NN	_	31	pobj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	c-fos	_	NN	NN	_	37	nn	_	_
37	expression	_	NN	NN	_	35	pobj	_	_
38	.	_	.	.	_	6	punct	_	_

1	CD28-dependent	_	JJ	JJ	_	2	amod	_	_
2	induction	_	NN	NN	_	6	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	c-jun	_	NN	NN	_	5	nn	_	_
5	expression	_	NN	NN	_	3	pobj	_	_
6	requires	_	VBZ	VBZ	_	0	root	_	_
7	protein	_	NN	NN	_	9	nn	_	_
8	tyrosine	_	NN	NN	_	9	nn	_	_
9	kinase	_	NN	NN	_	10	nn	_	_
10	activity	_	NN	NN	_	6	dobj	_	_
11	,	_	,	,	_	6	punct	_	_
12	but	_	CC	CC	_	6	cc	_	_
13	does	_	VBZ	VBZ	_	15	aux	_	_
14	not	_	RB	RB	_	15	neg	_	_
15	depend	_	VB	VB	_	6	conj	_	_
16	on	_	IN	IN	_	15	prep	_	_
17	activation	_	NN	NN	_	16	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	a	_	DT	DT	_	24	det	_	_
20	phorbol	_	NN	NN	_	24	nn	_	_
21	ester-responsive	_	JJ	JJ	_	24	amod	_	_
22	protein	_	NN	NN	_	24	nn	_	_
23	kinase	_	NN	NN	_	24	nn	_	_
24	C	_	NN	NN	_	18	pobj	_	_
25	or	_	CC	CC	_	17	cc	_	_
26	elevation	_	NN	NN	_	17	conj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	cytosolic	_	JJ	JJ	_	29	amod	_	_
29	calcium	_	NN	NN	_	27	pobj	_	_
30	.	_	.	.	_	6	punct	_	_

1	Furthermore	_	RB	RB	_	10	advmod	_	_
2	,	_	,	,	_	10	punct	_	_
3	CD28-dependent	_	JJ	JJ	_	4	amod	_	_
4	elevation	_	NN	NN	_	10	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	c-jun	_	NN	NN	_	7	nn	_	_
7	mRNA	_	NN	NN	_	5	pobj	_	_
8	does	_	VBZ	VBZ	_	10	aux	_	_
9	not	_	RB	RB	_	10	neg	_	_
10	appear	_	VB	VB	_	0	root	_	_
11	to	_	TO	TO	_	13	aux	_	_
12	be	_	VB	VB	_	13	auxpass	_	_
13	mediated	_	VBN	VBN	_	10	xcomp	_	_
14	at	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	level	_	NN	NN	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	mRNA	_	NN	NN	_	19	nn	_	_
19	stability	_	NN	NN	_	17	pobj	_	_
20	.	_	.	.	_	10	punct	_	_

1	A	_	DT	DT	_	2	det	_	_
2	mechanism	_	NN	NN	_	4	nsubjpass	_	_
3	is	_	VBZ	VBZ	_	4	auxpass	_	_
4	suggested	_	VBN	VBN	_	0	root	_	_
5	whereby	_	WRB	WRB	_	4	advmod	_	_
6	expression	_	NN	NN	_	23	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	c-jun	_	NN	NN	_	7	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	junB	_	NN	NN	_	8	conj	_	_
11	,	_	,	,	_	6	punct	_	_
12	in	_	IN	IN	_	23	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	absence	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	members	_	NNS	NNS	_	15	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	fos	_	NN	NN	_	20	nn	_	_
20	family	_	NN	NN	_	17	pobj	_	_
21	,	_	,	,	_	23	punct	_	_
22	can	_	MD	MD	_	23	aux	_	_
23	prevent	_	VB	VB	_	4	ccomp	_	_
24	inappropriate	_	JJ	JJ	_	25	amod	_	_
25	activation	_	NN	NN	_	23	dobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	T	_	NN	NN	_	28	nn	_	_
28	cells	_	NNS	NNS	_	26	pobj	_	_
29	caused	_	VBN	VBN	_	25	vmod	_	_
30	by	_	IN	IN	_	29	prep	_	_
31	ligation	_	NN	NN	_	30	pobj	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	CD28	_	NN	NN	_	32	pobj	_	_
34	in	_	IN	IN	_	29	prep	_	_
35	the	_	DT	DT	_	36	det	_	_
36	absence	_	NN	NN	_	34	pobj	_	_
37	of	_	IN	IN	_	36	prep	_	_
38	a	_	DT	DT	_	41	det	_	_
39	specific	_	JJ	JJ	_	41	amod	_	_
40	antigenic	_	JJ	JJ	_	39	dep	_	_
41	stimulus	_	NN	NN	_	37	pobj	_	_
42	.	_	.	.	_	4	punct	_	_

1	Constitutive	_	JJ	JJ	_	4	amod	_	_
2	nuclear	_	JJ	JJ	_	4	amod	_	_
3	NF-kappa	_	NN	NN	_	4	nn	_	_
4	B	_	NN	NN	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	cells	_	NNS	NNS	_	5	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	monocyte	_	NN	NN	_	10	nn	_	_
10	lineage	_	NN	NN	_	7	pobj	_	_
11	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	11	prep	_	_
2	monocytes	_	NNS	NNS	_	1	pobj	_	_
3	,	_	,	,	_	11	punct	_	_
4	the	_	DT	DT	_	8	det	_	_
5	nuclear	_	JJ	JJ	_	8	amod	_	_
6	factor	_	NN	NN	_	8	nn	_	_
7	NF-kappa	_	NN	NN	_	8	nn	_	_
8	B	_	NN	NN	_	11	nsubjpass	_	_
9	has	_	VBZ	VBZ	_	11	aux	_	_
10	been	_	VBN	VBN	_	11	auxpass	_	_
11	invoked	_	VBN	VBN	_	0	root	_	_
12	as	_	IN	IN	_	11	prep	_	_
13	an	_	DT	DT	_	16	det	_	_
14	important	_	JJ	JJ	_	16	amod	_	_
15	transcription	_	NN	NN	_	16	nn	_	_
16	factor	_	NN	NN	_	12	pobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	19	det	_	_
19	expression	_	NN	NN	_	17	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	cytokine	_	NN	NN	_	22	nn	_	_
22	genes	_	NNS	NNS	_	20	pobj	_	_
23	,	_	,	,	_	20	punct	_	_
24	of	_	IN	IN	_	20	prep	_	_
25	cell-surface	_	JJ	JJ	_	26	amod	_	_
26	receptors	_	NNS	NNS	_	24	pobj	_	_
27	and	_	CC	CC	_	17	cc	_	_
28	in	_	IN	IN	_	17	conj	_	_
29	the	_	DT	DT	_	30	det	_	_
30	expression	_	NN	NN	_	28	pobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	human	_	JJ	JJ	_	34	amod	_	_
33	immunodeficiency	_	NN	NN	_	34	nn	_	_
34	virus	_	NN	NN	_	31	pobj	_	_
35	.	_	.	.	_	11	punct	_	_

1	In	_	IN	IN	_	13	prep	_	_
2	such	_	JJ	JJ	_	3	amod	_	_
3	cells	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	13	punct	_	_
5	DNA	_	NN	NN	_	7	nn	_	_
6	binding	_	NN	NN	_	7	nn	_	_
7	activity	_	NN	NN	_	13	nsubjpass	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	NF-kappa	_	NN	NN	_	10	nn	_	_
10	B	_	NN	NN	_	8	pobj	_	_
11	can	_	MD	MD	_	13	aux	_	_
12	be	_	VB	VB	_	13	auxpass	_	_
13	detected	_	VBN	VBN	_	0	root	_	_
14	without	_	IN	IN	_	13	prep	_	_
15	intentional	_	JJ	JJ	_	16	amod	_	_
16	stimulation	_	NN	NN	_	14	pobj	_	_
17	.	_	.	.	_	13	punct	_	_

1	In	_	IN	IN	_	31	prep	_	_
2	our	_	PRP$	PRP$	_	3	poss	_	_
3	studies	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	31	punct	_	_
5	cells	_	NNS	NNS	_	31	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	10	det	_	_
8	human	_	JJ	JJ	_	10	amod	_	_
9	monocytic	_	JJ	JJ	_	10	amod	_	_
10	line	_	NN	NN	_	6	pobj	_	_
11	Mono	_	NN	NN	_	12	nn	_	_
12	Mac	_	NN	NN	_	10	dep	_	_
13	6	_	CD	CD	_	12	num	_	_
14	,	_	,	,	_	5	punct	_	_
15	cultured	_	VBN	VBN	_	5	vmod	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	medium	_	NN	NN	_	16	pobj	_	_
18	containing	_	VBG	VBG	_	17	vmod	_	_
19	fetal-calf	_	JJ	JJ	_	20	amod	_	_
20	serum	_	NN	NN	_	18	dobj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	low	_	JJ	JJ	_	23	amod	_	_
23	levels	_	NNS	NNS	_	20	conj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	lipopolysaccharide	_	NN	NN	_	24	pobj	_	_
26	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
27	LPS	_	NN	NN	_	25	appos	_	_
28	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
29	,	_	,	,	_	5	punct	_	_
30	also	_	RB	RB	_	31	advmod	_	_
31	exhibit	_	VBP	VBP	_	0	root	_	_
32	such	_	JJ	JJ	_	34	amod	_	_
33	'	_	``	``	_	34	punct	_	_
34	constitutive	_	JJ	JJ	_	37	amod	_	_
35	'	_	''	''	_	34	punct	_	_
36	NF-kappa	_	NN	NN	_	37	nn	_	_
37	B	_	NN	NN	_	31	dobj	_	_
38	,	_	,	,	_	31	punct	_	_
39	as	_	IN	IN	_	40	mark	_	_
40	demonstrated	_	VBN	VBN	_	31	advcl	_	_
41	by	_	IN	IN	_	40	prep	_	_
42	mobility-shift	_	JJ	JJ	_	43	amod	_	_
43	analysis	_	NN	NN	_	41	pobj	_	_
44	of	_	IN	IN	_	43	prep	_	_
45	nuclear	_	JJ	JJ	_	46	amod	_	_
46	extracts	_	NNS	NNS	_	44	pobj	_	_
47	.	_	.	.	_	31	punct	_	_

1	This	_	DT	DT	_	4	det	_	_
2	nuclear	_	JJ	JJ	_	4	amod	_	_
3	NF-kappa	_	NN	NN	_	4	nn	_	_
4	B	_	NN	NN	_	7	nsubj	_	_
5	was	_	VBD	VBD	_	7	cop	_	_
6	still	_	RB	RB	_	7	advmod	_	_
7	present	_	JJ	JJ	_	0	root	_	_
8	when	_	WRB	WRB	_	12	advmod	_	_
9	contaminant	_	JJ	JJ	_	10	amod	_	_
10	LPS	_	NN	NN	_	12	nsubjpass	_	_
11	was	_	VBD	VBD	_	12	auxpass	_	_
12	removed	_	VBN	VBN	_	7	advcl	_	_
13	by	_	IN	IN	_	12	prep	_	_
14	ultrafiltration	_	NN	NN	_	13	pobj	_	_
15	and	_	CC	CC	_	12	cc	_	_
16	when	_	WRB	WRB	_	19	advmod	_	_
17	serum	_	NN	NN	_	19	nsubjpass	_	_
18	was	_	VBD	VBD	_	19	auxpass	_	_
19	omitted	_	VBN	VBN	_	12	conj	_	_
20	.	_	.	.	_	7	punct	_	_

1	Protein-DNA	_	JJ	JJ	_	2	amod	_	_
2	complexes	_	NNS	NNS	_	8	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	constitutive	_	JJ	JJ	_	6	amod	_	_
5	NF-kappa	_	NN	NN	_	6	nn	_	_
6	B	_	NN	NN	_	3	pobj	_	_
7	are	_	VBP	VBP	_	8	cop	_	_
8	similar	_	JJ	JJ	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	mobility	_	NN	NN	_	9	pobj	_	_
11	to	_	TO	TO	_	8	prep	_	_
12	the	_	DT	DT	_	15	det	_	_
13	LPS-induced	_	JJ	JJ	_	15	amod	_	_
14	NF-kappa	_	NN	NN	_	15	nn	_	_
15	B	_	NN	NN	_	11	pobj	_	_
16	and	_	CC	CC	_	8	cc	_	_
17	both	_	DT	DT	_	19	nsubjpass	_	_
18	are	_	VBP	VBP	_	19	auxpass	_	_
19	recognized	_	VBN	VBN	_	8	conj	_	_
20	by	_	IN	IN	_	19	prep	_	_
21	an	_	DT	DT	_	22	det	_	_
22	antibody	_	NN	NN	_	20	pobj	_	_
23	specific	_	JJ	JJ	_	22	amod	_	_
24	to	_	TO	TO	_	23	prep	_	_
25	the	_	DT	DT	_	27	det	_	_
26	p50	_	NN	NN	_	27	nn	_	_
27	subunit	_	NN	NN	_	24	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	NF-kappa	_	NN	NN	_	30	nn	_	_
30	B	_	NN	NN	_	28	pobj	_	_
31	.	_	.	.	_	8	punct	_	_

1	By	_	IN	IN	_	15	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	15	punct	_	_
4	treatment	_	NN	NN	_	15	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	cells	_	NNS	NNS	_	5	pobj	_	_
7	with	_	IN	IN	_	4	prep	_	_
8	pyrrolidine	_	NN	NN	_	9	nn	_	_
9	dithiocarbamate	_	NN	NN	_	7	pobj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	PDTC	_	NN	NN	_	9	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	will	_	MD	MD	_	15	aux	_	_
14	only	_	RB	RB	_	15	advmod	_	_
15	block	_	VB	VB	_	0	root	_	_
16	LPS-induced	_	JJ	JJ	_	18	amod	_	_
17	NF-kappa	_	NN	NN	_	18	nn	_	_
18	B	_	NN	NN	_	15	dobj	_	_
19	,	_	,	,	_	18	punct	_	_
20	but	_	CC	CC	_	21	cc	_	_
21	not	_	RB	RB	_	18	cc	_	_
22	the	_	DT	DT	_	25	det	_	_
23	constitutive	_	JJ	JJ	_	25	amod	_	_
24	binding	_	VBG	VBG	_	25	amod	_	_
25	protein	_	NN	NN	_	18	conj	_	_
26	.	_	.	.	_	15	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	LPS-free	_	JJ	JJ	_	1	dobj	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	serum-free	_	JJ	JJ	_	2	conj	_	_
5	conditions	_	NNS	NNS	_	2	dep	_	_
6	,	_	,	,	_	1	punct	_	_
7	constitutive	_	JJ	JJ	_	9	amod	_	_
8	NF-kappa	_	NN	NN	_	9	nn	_	_
9	B	_	NN	NN	_	12	nsubjpass	_	_
10	can	_	MD	MD	_	12	aux	_	_
11	be	_	VB	VB	_	12	auxpass	_	_
12	detected	_	VBN	VBN	_	1	parataxis	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	different	_	JJ	JJ	_	16	amod	_	_
15	cell	_	NN	NN	_	16	nn	_	_
16	lines	_	NNS	NNS	_	13	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	monocytic	_	JJ	JJ	_	20	amod	_	_
20	lineage	_	NN	NN	_	17	pobj	_	_
21	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
22	HL60	_	NN	NN	_	16	dep	_	_
23	,	_	,	,	_	22	punct	_	_
24	U937	_	NN	NN	_	22	conj	_	_
25	,	_	,	,	_	22	punct	_	_
26	THP-1	_	NN	NN	_	22	conj	_	_
27	,	_	,	,	_	22	punct	_	_
28	Mono	_	NN	NN	_	29	nn	_	_
29	Mac	_	NN	NN	_	22	conj	_	_
30	1	_	CD	CD	_	29	num	_	_
31	and	_	CC	CC	_	22	cc	_	_
32	Mono	_	NN	NN	_	33	nn	_	_
33	Mac	_	NN	NN	_	22	conj	_	_
34	6	_	CD	CD	_	33	num	_	_
35	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
36	,	_	,	,	_	13	punct	_	_
37	but	_	CC	CC	_	13	cc	_	_
38	not	_	RB	RB	_	39	neg	_	_
39	in	_	IN	IN	_	13	conj	_	_
40	Molt	_	NN	NN	_	43	nn	_	_
41	4	_	CD	CD	_	43	num	_	_
42	T	_	NN	NN	_	43	nn	_	_
43	cells	_	NNS	NNS	_	39	pobj	_	_
44	or	_	CC	CC	_	43	cc	_	_
45	K562	_	NN	NN	_	47	nn	_	_
46	stem	_	NN	NN	_	47	nn	_	_
47	cells	_	NNS	NNS	_	43	conj	_	_
48	.	_	.	.	_	1	punct	_	_

1	When	_	WRB	WRB	_	2	advmod	_	_
2	ordered	_	VBN	VBN	_	17	advcl	_	_
3	according	_	VBG	VBG	_	2	prep	_	_
4	to	_	TO	TO	_	3	pcomp	_	_
5	stage	_	NN	NN	_	4	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	maturation	_	NN	NN	_	6	pobj	_	_
8	,	_	,	,	_	17	punct	_	_
9	the	_	DT	DT	_	10	det	_	_
10	amount	_	NN	NN	_	17	nsubjpass	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	constitutive	_	JJ	JJ	_	14	amod	_	_
13	NF-kappa	_	NN	NN	_	14	nn	_	_
14	B	_	NN	NN	_	11	pobj	_	_
15	was	_	VBD	VBD	_	17	auxpass	_	_
16	not	_	RB	RB	_	17	neg	_	_
17	increased	_	VBN	VBN	_	0	root	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	more	_	RBR	RBR	_	22	advmod	_	_
20	mature	_	JJ	JJ	_	22	amod	_	_
21	cell	_	NN	NN	_	22	nn	_	_
22	lines	_	NNS	NNS	_	18	pobj	_	_
23	.	_	.	.	_	17	punct	_	_

1	Furthermore	_	RB	RB	_	26	advmod	_	_
2	,	_	,	,	_	26	punct	_	_
3	when	_	WRB	WRB	_	4	advmod	_	_
4	inducing	_	VBG	VBG	_	26	advcl	_	_
5	differentiation	_	NN	NN	_	4	dobj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	Mono	_	NN	NN	_	10	nn	_	_
8	Mac	_	NN	NN	_	10	nn	_	_
9	6	_	CD	CD	_	10	num	_	_
10	cells	_	NNS	NNS	_	6	pobj	_	_
11	,	_	,	,	_	4	punct	_	_
12	with	_	IN	IN	_	4	prep	_	_
13	vitamin	_	NN	NN	_	14	nn	_	_
14	D3	_	NN	NN	_	12	pobj	_	_
15	,	_	,	,	_	26	punct	_	_
16	no	_	DT	DT	_	17	neg	_	_
17	change	_	NN	NN	_	26	nsubjpass	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	constitutive	_	JJ	JJ	_	18	pobj	_	_
20	or	_	CC	CC	_	19	cc	_	_
21	inducible	_	JJ	JJ	_	19	conj	_	_
22	NF-kappa	_	NN	NN	_	23	nn	_	_
23	B	_	NN	NN	_	19	dep	_	_
24	can	_	MD	MD	_	26	aux	_	_
25	be	_	VB	VB	_	26	auxpass	_	_
26	detected	_	VBN	VBN	_	0	root	_	_
27	.	_	.	.	_	26	punct	_	_

1	Analysis	_	NN	NN	_	5	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	primary	_	JJ	JJ	_	4	amod	_	_
4	cells	_	NNS	NNS	_	2	pobj	_	_
5	revealed	_	VBD	VBD	_	0	root	_	_
6	substantial	_	JJ	JJ	_	10	amod	_	_
7	constitutive	_	JJ	JJ	_	6	dep	_	_
8	NF-kappa	_	NN	NN	_	10	nn	_	_
9	B-binding	_	JJ	JJ	_	10	amod	_	_
10	activity	_	NN	NN	_	5	dobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	blood	_	NN	NN	_	13	nn	_	_
13	monocytes	_	NNS	NNS	_	11	pobj	_	_
14	,	_	,	,	_	13	punct	_	_
15	pleural	_	JJ	JJ	_	16	amod	_	_
16	macrophages	_	NNS	NNS	_	13	conj	_	_
17	and	_	CC	CC	_	13	cc	_	_
18	alveolar	_	JJ	JJ	_	19	amod	_	_
19	macrophages	_	NNS	NNS	_	13	conj	_	_
20	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	constitutive	_	JJ	JJ	_	4	amod	_	_
3	NF-kappa	_	NN	NN	_	4	nn	_	_
4	B	_	NN	NN	_	5	nsubj	_	_
5	appears	_	VBZ	VBZ	_	0	root	_	_
6	to	_	TO	TO	_	9	aux	_	_
7	be	_	VB	VB	_	9	cop	_	_
8	functionally	_	RB	RB	_	9	advmod	_	_
9	active	_	JJ	JJ	_	5	xcomp	_	_
10	,	_	,	,	_	5	punct	_	_
11	since	_	IN	IN	_	24	mark	_	_
12	a	_	DT	DT	_	14	det	_	_
13	low	_	JJ	JJ	_	14	amod	_	_
14	level	_	NN	NN	_	24	nsubj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	tumour	_	NN	NN	_	22	nn	_	_
17	necrosis	_	NN	NN	_	22	nn	_	_
18	factor	_	NN	NN	_	22	nn	_	_
19	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
20	TNF	_	NN	NN	_	22	nn	_	_
21	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
22	transcript	_	NN	NN	_	15	pobj	_	_
23	is	_	VBZ	VBZ	_	24	cop	_	_
24	detectable	_	JJ	JJ	_	5	advcl	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	monocytes	_	NNS	NNS	_	25	pobj	_	_
27	,	_	,	,	_	5	punct	_	_
28	and	_	CC	CC	_	5	cc	_	_
29	this	_	DT	DT	_	30	det	_	_
30	level	_	NN	NN	_	33	nsubjpass	_	_
31	can	_	MD	MD	_	33	aux	_	_
32	be	_	VB	VB	_	33	auxpass	_	_
33	increased	_	VBN	VBN	_	5	conj	_	_
34	by	_	IN	IN	_	33	prep	_	_
35	blocking	_	VBG	VBG	_	34	pcomp	_	_
36	transcript	_	NN	NN	_	37	nn	_	_
37	degradation	_	NN	NN	_	35	dobj	_	_
38	using	_	VBG	VBG	_	35	vmod	_	_
39	cycloheximide	_	NN	NN	_	38	dobj	_	_
40	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	level	_	NN	NN	_	11	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	constitutive	_	JJ	JJ	_	6	amod	_	_
5	NF-kappa	_	NN	NN	_	6	nn	_	_
6	B	_	NN	NN	_	3	pobj	_	_
7	in	_	IN	IN	_	2	prep	_	_
8	these	_	DT	DT	_	9	det	_	_
9	cells	_	NNS	NNS	_	7	pobj	_	_
10	is	_	VBZ	VBZ	_	11	cop	_	_
11	variable	_	JJ	JJ	_	0	root	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	is	_	VBZ	VBZ	_	15	auxpass	_	_
14	frequently	_	RB	RB	_	15	advmod	_	_
15	found	_	VBN	VBN	_	11	conj	_	_
16	to	_	TO	TO	_	18	aux	_	_
17	be	_	VB	VB	_	18	cop	_	_
18	lower	_	JJR	JJR	_	15	xcomp	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	23	det	_	_
21	more	_	RBR	RBR	_	23	advmod	_	_
22	mature	_	JJ	JJ	_	23	amod	_	_
23	macrophages	_	NNS	NNS	_	19	pobj	_	_
24	.	_	.	.	_	11	punct	_	_

1	Constitutive	_	JJ	JJ	_	3	amod	_	_
2	NF-kappa	_	NN	NN	_	3	nn	_	_
3	B	_	NN	NN	_	6	nsubjpass	_	_
4	was	_	VBD	VBD	_	6	auxpass	_	_
5	not	_	RB	RB	_	6	neg	_	_
6	maintained	_	VBN	VBN	_	0	root	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	autocrine	_	JJ	JJ	_	9	amod	_	_
9	action	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	cytokines	_	NNS	NNS	_	10	pobj	_	_
12	TNF	_	NN	NN	_	11	dep	_	_
13	,	_	,	,	_	12	punct	_	_
14	interleukin	_	NN	NN	_	12	conj	_	_
15	6	_	CD	CD	_	14	num	_	_
16	,	_	,	,	_	12	punct	_	_
17	interleukin	_	NN	NN	_	12	conj	_	_
18	10	_	CD	CD	_	17	num	_	_
19	,	_	,	,	_	12	punct	_	_
20	granulocyte-macrophage	_	JJ	JJ	_	22	amod	_	_
21	colony-stimulating	_	JJ	JJ	_	22	amod	_	_
22	factor	_	NN	NN	_	12	conj	_	_
23	or	_	CC	CC	_	12	cc	_	_
24	macrophage	_	NN	NN	_	26	nn	_	_
25	colony-stimulating	_	JJ	JJ	_	26	amod	_	_
26	factor	_	NN	NN	_	12	conj	_	_
27	,	_	,	,	_	6	punct	_	_
28	since	_	IN	IN	_	33	mark	_	_
29	neutralizing	_	VBG	VBG	_	30	amod	_	_
30	antibodies	_	NNS	NNS	_	33	nsubj	_	_
31	did	_	VBD	VBD	_	33	aux	_	_
32	not	_	RB	RB	_	33	neg	_	_
33	reduce	_	VB	VB	_	6	advcl	_	_
34	constitutive	_	JJ	JJ	_	36	amod	_	_
35	DNA-binding	_	JJ	JJ	_	34	dep	_	_
36	activity	_	NN	NN	_	33	dobj	_	_
37	.	_	.	.	_	6	punct	_	_

1	Furthermore	_	RB	RB	_	11	advmod	_	_
2	,	_	,	,	_	11	punct	_	_
3	blockade	_	NN	NN	_	11	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	prostaglandin	_	NN	NN	_	4	pobj	_	_
6	or	_	CC	CC	_	3	cc	_	_
7	leukotriene	_	NN	NN	_	8	nn	_	_
8	biosynthesis	_	NN	NN	_	3	conj	_	_
9	did	_	VBD	VBD	_	11	aux	_	_
10	not	_	RB	RB	_	11	neg	_	_
11	affect	_	VB	VB	_	0	root	_	_
12	constitutive	_	JJ	JJ	_	14	amod	_	_
13	NF-kappa	_	NN	NN	_	14	nn	_	_
14	B	_	NN	NN	_	11	dobj	_	_
15	.	_	.	.	_	11	punct	_	_

1	-LRB-	_	-LRB-	-LRB-	_	2	punct	_	_
2	ABSTRACT	_	NN	NN	_	0	root	_	_
3	TRUNCATED	_	VBN	VBN	_	2	vmod	_	_
4	AT	_	IN	IN	_	3	prep	_	_
5	400	_	CD	CD	_	6	num	_	_
6	WORDS	_	NNS	NNS	_	4	pobj	_	_
7	-RRB-	_	-RRB-	-RRB-	_	2	punct	_	_

1	Protein	_	NN	NN	_	3	nn	_	_
2	kinase	_	NN	NN	_	3	nn	_	_
3	C-zeta	_	NN	NN	_	4	nsubj	_	_
4	mediates	_	VBZ	VBZ	_	0	root	_	_
5	NF-kappa	_	NN	NN	_	6	nn	_	_
6	B	_	NN	NN	_	7	nn	_	_
7	activation	_	NN	NN	_	4	dobj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	human	_	JJ	JJ	_	12	amod	_	_
10	immunodeficiency	_	NN	NN	_	12	nn	_	_
11	virus-infected	_	JJ	JJ	_	12	amod	_	_
12	monocytes	_	NNS	NNS	_	8	pobj	_	_
13	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	molecular	_	NN	NN	_	3	nn	_	_
3	mechanisms	_	NNS	NNS	_	21	nsubj	_	_
4	regulating	_	VBG	VBG	_	3	vmod	_	_
5	human	_	JJ	JJ	_	7	amod	_	_
6	immunodeficiency	_	NN	NN	_	7	nn	_	_
7	virus	_	NN	NN	_	11	nn	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	HIV	_	NN	NN	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	persistence	_	NN	NN	_	4	dobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	a	_	DT	DT	_	16	det	_	_
14	major	_	JJ	JJ	_	16	amod	_	_
15	cell	_	NN	NN	_	16	nn	_	_
16	reservoir	_	NN	NN	_	12	pobj	_	_
17	such	_	JJ	JJ	_	18	mwe	_	_
18	as	_	IN	IN	_	16	prep	_	_
19	the	_	DT	DT	_	20	det	_	_
20	macrophage	_	NN	NN	_	18	pobj	_	_
21	remain	_	VBP	VBP	_	0	root	_	_
22	unknown	_	JJ	JJ	_	21	acomp	_	_
23	.	_	.	.	_	21	punct	_	_

1	NF-kappa	_	NN	NN	_	2	nn	_	_
2	B	_	NN	NN	_	6	nsubj	_	_
3	is	_	VBZ	VBZ	_	6	cop	_	_
4	a	_	DT	DT	_	6	det	_	_
5	transcription	_	NN	NN	_	6	nn	_	_
6	factor	_	NN	NN	_	0	root	_	_
7	involved	_	VBN	VBN	_	6	vmod	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	regulation	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	16	det	_	_
13	HIV	_	NN	NN	_	16	nn	_	_
14	long	_	JJ	JJ	_	16	amod	_	_
15	terminal	_	JJ	JJ	_	16	amod	_	_
16	repeat	_	NN	NN	_	11	pobj	_	_
17	and	_	CC	CC	_	6	cc	_	_
18	is	_	VBZ	VBZ	_	20	auxpass	_	_
19	selectively	_	RB	RB	_	20	advmod	_	_
20	activated	_	VBN	VBN	_	6	conj	_	_
21	following	_	VBG	VBG	_	20	prep	_	_
22	HIV	_	NN	NN	_	23	nn	_	_
23	infection	_	NN	NN	_	21	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	human	_	JJ	JJ	_	26	amod	_	_
26	macrophages	_	NNS	NNS	_	24	pobj	_	_
27	.	_	.	.	_	6	punct	_	_

1	Although	_	IN	IN	_	17	mark	_	_
2	little	_	JJ	JJ	_	3	amod	_	_
3	information	_	NN	NN	_	17	nsubj	_	_
4	as	_	IN	IN	_	3	prep	_	_
5	to	_	TO	TO	_	4	pcomp	_	_
6	what	_	WP	WP	_	9	det	_	_
7	signal	_	NN	NN	_	9	nn	_	_
8	transduction	_	NN	NN	_	9	nn	_	_
9	pathways	_	NNS	NNS	_	10	nsubj	_	_
10	mediate	_	VBP	VBP	_	5	pcomp	_	_
11	NF-kappa	_	NN	NN	_	12	nn	_	_
12	B	_	NN	NN	_	13	nn	_	_
13	activation	_	NN	NN	_	10	dobj	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	monocytes-macrophages	_	NNS	NNS	_	14	pobj	_	_
16	is	_	VBZ	VBZ	_	17	cop	_	_
17	available	_	JJ	JJ	_	22	advcl	_	_
18	,	_	,	,	_	22	punct	_	_
19	our	_	PRP$	PRP$	_	21	poss	_	_
20	previous	_	JJ	JJ	_	21	amod	_	_
21	work	_	NN	NN	_	22	nsubj	_	_
22	indicated	_	VBD	VBD	_	0	root	_	_
23	that	_	IN	IN	_	34	mark	_	_
24	classical	_	JJ	JJ	_	31	amod	_	_
25	protein	_	NN	NN	_	31	nn	_	_
26	kinase	_	NN	NN	_	31	nn	_	_
27	C	_	NN	NN	_	31	nn	_	_
28	-LRB-	_	-LRB-	-LRB-	_	31	punct	_	_
29	PKC	_	NN	NN	_	31	nn	_	_
30	-RRB-	_	-RRB-	-RRB-	_	31	punct	_	_
31	isoenzymes	_	NNS	NNS	_	34	nsubjpass	_	_
32	were	_	VBD	VBD	_	34	auxpass	_	_
33	not	_	RB	RB	_	34	neg	_	_
34	involved	_	VBN	VBN	_	22	ccomp	_	_
35	in	_	IN	IN	_	34	prep	_	_
36	the	_	DT	DT	_	40	det	_	_
37	HIV-mediated	_	JJ	JJ	_	40	amod	_	_
38	NF-kappa	_	NN	NN	_	39	nn	_	_
39	B	_	NN	NN	_	40	nn	_	_
40	activation	_	NN	NN	_	35	pobj	_	_
41	.	_	.	.	_	22	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	study	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	7	punct	_	_
5	we	_	PRP	PRP	_	7	nsubj	_	_
6	have	_	VBP	VBP	_	7	aux	_	_
7	focused	_	VBN	VBN	_	0	root	_	_
8	on	_	IN	IN	_	7	prep	_	_
9	atypical	_	JJ	JJ	_	11	amod	_	_
10	PKC	_	NN	NN	_	11	nn	_	_
11	isoenzymes	_	NNS	NNS	_	8	pobj	_	_
12	.	_	.	.	_	7	punct	_	_

1	PKC-zeta	_	NN	NN	_	2	nsubj	_	_
2	belongs	_	VBZ	VBZ	_	0	root	_	_
3	to	_	TO	TO	_	2	prep	_	_
4	this	_	DT	DT	_	5	det	_	_
5	family	_	NN	NN	_	3	pobj	_	_
6	and	_	CC	CC	_	2	cc	_	_
7	is	_	VBZ	VBZ	_	8	auxpass	_	_
8	known	_	VBN	VBN	_	2	conj	_	_
9	to	_	TO	TO	_	13	aux	_	_
10	be	_	VB	VB	_	13	cop	_	_
11	an	_	DT	DT	_	13	det	_	_
12	important	_	JJ	JJ	_	13	amod	_	_
13	step	_	NN	NN	_	8	xcomp	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	NF-kappa	_	NN	NN	_	16	nn	_	_
16	B	_	NN	NN	_	17	nn	_	_
17	activation	_	NN	NN	_	14	pobj	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	other	_	JJ	JJ	_	21	amod	_	_
20	cell	_	NN	NN	_	21	nn	_	_
21	systems	_	NNS	NNS	_	18	pobj	_	_
22	.	_	.	.	_	2	punct	_	_

1	Immunoblotting	_	NN	NN	_	2	nn	_	_
2	experiments	_	NNS	NNS	_	6	nsubj	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	U937	_	NN	NN	_	5	nn	_	_
5	cells	_	NNS	NNS	_	3	pobj	_	_
6	demonstrate	_	VBP	VBP	_	0	root	_	_
7	that	_	IN	IN	_	10	mark	_	_
8	PKC-zeta	_	NN	NN	_	10	nsubj	_	_
9	is	_	VBZ	VBZ	_	10	cop	_	_
10	present	_	JJ	JJ	_	6	dep	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	these	_	DT	DT	_	13	det	_	_
13	cells	_	NNS	NNS	_	11	pobj	_	_
14	,	_	,	,	_	10	punct	_	_
15	and	_	CC	CC	_	10	cc	_	_
16	its	_	PRP$	PRP$	_	17	poss	_	_
17	expression	_	NN	NN	_	10	conj	_	_
18	can	_	MD	MD	_	20	aux	_	_
19	be	_	VB	VB	_	20	auxpass	_	_
20	downmodulated	_	VBN	VBN	_	10	dep	_	_
21	by	_	IN	IN	_	20	prep	_	_
22	antisense	_	JJ	JJ	_	23	amod	_	_
23	oligonucleotides	_	NNS	NNS	_	21	pobj	_	_
24	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
25	AO	_	NN	NN	_	23	appos	_	_
26	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
27	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	HIV-mediated	_	JJ	JJ	_	5	amod	_	_
3	NF-kappa	_	NN	NN	_	4	nn	_	_
4	B	_	NN	NN	_	5	nn	_	_
5	activation	_	NN	NN	_	8	nsubjpass	_	_
6	is	_	VBZ	VBZ	_	8	auxpass	_	_
7	selectively	_	RB	RB	_	8	advmod	_	_
8	reduced	_	VBN	VBN	_	0	root	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	AO	_	NN	NN	_	9	pobj	_	_
11	to	_	TO	TO	_	8	prep	_	_
12	PKC-zeta	_	NN	NN	_	11	pobj	_	_
13	.	_	.	.	_	8	punct	_	_

1	In	_	IN	IN	_	22	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	22	punct	_	_
4	cotransfection	_	NN	NN	_	22	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	a	_	DT	DT	_	9	det	_	_
7	negative	_	JJ	JJ	_	9	amod	_	_
8	dominant	_	JJ	JJ	_	9	amod	_	_
9	molecule	_	NN	NN	_	5	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	PKC-zeta	_	NN	NN	_	10	pobj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
13	PKC-zeta	_	NN	NN	_	14	nn	_	_
14	mut	_	NN	NN	_	9	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	with	_	IN	IN	_	4	prep	_	_
17	NF-kappa	_	NN	NN	_	20	nn	_	_
18	B-dependent	_	JJ	JJ	_	20	amod	_	_
19	reporter	_	NN	NN	_	20	nn	_	_
20	genes	_	NNS	NNS	_	16	pobj	_	_
21	selectively	_	RB	RB	_	22	advmod	_	_
22	inhibits	_	VBZ	VBZ	_	0	root	_	_
23	the	_	DT	DT	_	24	dep	_	_
24	HIV-	_	NN	NN	_	22	dobj	_	_
25	but	_	CC	CC	_	24	cc	_	_
26	not	_	RB	RB	_	29	neg	_	_
27	phorbol	_	NN	NN	_	29	nn	_	_
28	myristate	_	NN	NN	_	29	nn	_	_
29	acetate-	_	NN	NN	_	24	conj	_	_
30	or	_	CC	CC	_	29	cc	_	_
31	lipopolysaccharide-mediated	_	JJ	JJ	_	29	conj	_	_
32	activation	_	NN	NN	_	29	dep	_	_
33	of	_	IN	IN	_	24	prep	_	_
34	NF-kappa	_	NN	NN	_	35	nn	_	_
35	B	_	NN	NN	_	33	pobj	_	_
36	.	_	.	.	_	22	punct	_	_

1	That	_	IN	IN	_	4	mark	_	_
2	PKC-zeta	_	NN	NN	_	4	nsubj	_	_
3	is	_	VBZ	VBZ	_	4	cop	_	_
4	specific	_	JJ	JJ	_	10	csubjpass	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	regulating	_	VBG	VBG	_	5	pcomp	_	_
7	NF-kappa	_	NN	NN	_	8	nn	_	_
8	B	_	NN	NN	_	6	dobj	_	_
9	is	_	VBZ	VBZ	_	10	auxpass	_	_
10	concluded	_	VBN	VBN	_	0	root	_	_
11	from	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	inability	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	PKC-zeta	_	NN	NN	_	17	nn	_	_
16	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
17	mut	_	NN	NN	_	14	pobj	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	to	_	TO	TO	_	20	aux	_	_
20	interfere	_	VB	VB	_	13	vmod	_	_
21	with	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	23	dep	_	_
23	basal	_	JJ	JJ	_	21	pobj	_	_
24	or	_	CC	CC	_	23	cc	_	_
25	phorbol	_	NN	NN	_	26	nn	_	_
26	myristate	_	NN	NN	_	23	conj	_	_
27	acetate-inducible	_	JJ	JJ	_	26	amod	_	_
28	CREB-	_	NN	NN	_	23	dep	_	_
29	or	_	CC	CC	_	28	cc	_	_
30	AP1-dependent	_	JJ	JJ	_	28	conj	_	_
31	transcriptional	_	JJ	JJ	_	32	amod	_	_
32	activity	_	NN	NN	_	28	dep	_	_
33	.	_	.	.	_	10	punct	_	_

1	Lastly	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	demonstrate	_	VBP	VBP	_	0	root	_	_
5	a	_	DT	DT	_	7	det	_	_
6	selective	_	JJ	JJ	_	7	amod	_	_
7	inhibition	_	NN	NN	_	4	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	p24	_	NN	NN	_	10	nn	_	_
10	production	_	NN	NN	_	8	pobj	_	_
11	by	_	IN	IN	_	7	prep	_	_
12	HIV-infected	_	JJ	JJ	_	14	amod	_	_
13	human	_	JJ	JJ	_	14	amod	_	_
14	macrophages	_	NNS	NNS	_	11	pobj	_	_
15	when	_	WRB	WRB	_	16	advmod	_	_
16	treated	_	VBN	VBN	_	7	rcmod	_	_
17	with	_	IN	IN	_	16	prep	_	_
18	AO	_	NN	NN	_	17	pobj	_	_
19	to	_	TO	TO	_	16	prep	_	_
20	PKC-zeta	_	NN	NN	_	19	pobj	_	_
21	.	_	.	.	_	4	punct	_	_

1	Altogether	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	these	_	DT	DT	_	4	det	_	_
4	results	_	NNS	NNS	_	5	nsubj	_	_
5	suggest	_	VBP	VBP	_	0	root	_	_
6	that	_	IN	IN	_	14	mark	_	_
7	atypical	_	JJ	JJ	_	9	amod	_	_
8	PKC	_	NN	NN	_	9	nn	_	_
9	isoenzymes	_	NNS	NNS	_	14	nsubj	_	_
10	,	_	,	,	_	9	punct	_	_
11	including	_	VBG	VBG	_	9	prep	_	_
12	PKC-zeta	_	NN	NN	_	11	pobj	_	_
13	,	_	,	,	_	9	punct	_	_
14	participate	_	VBP	VBP	_	5	ccomp	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	19	det	_	_
17	signal	_	NN	NN	_	19	nn	_	_
18	transduction	_	NN	NN	_	19	nn	_	_
19	pathways	_	NNS	NNS	_	15	pobj	_	_
20	by	_	IN	IN	_	24	prep	_	_
21	which	_	WDT	WDT	_	20	pobj	_	_
22	HIV	_	NN	NN	_	23	nn	_	_
23	infection	_	NN	NN	_	24	nsubj	_	_
24	results	_	VBZ	VBZ	_	19	rcmod	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	27	det	_	_
27	activation	_	NN	NN	_	25	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	NF-kappa	_	NN	NN	_	30	nn	_	_
30	B	_	NN	NN	_	28	pobj	_	_
31	in	_	IN	IN	_	27	prep	_	_
32	human	_	JJ	JJ	_	34	amod	_	_
33	monocytic	_	JJ	JJ	_	34	amod	_	_
34	cells	_	NNS	NNS	_	31	pobj	_	_
35	and	_	CC	CC	_	34	cc	_	_
36	macrophages	_	NNS	NNS	_	34	conj	_	_
37	.	_	.	.	_	5	punct	_	_

1	Inhibition	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	NF-AT-dependent	_	JJ	JJ	_	4	amod	_	_
4	transcription	_	NN	NN	_	2	pobj	_	_
5	by	_	IN	IN	_	1	prep	_	_
6	NF-kappa	_	NN	NN	_	7	nn	_	_
7	B	_	NN	NN	_	5	pobj	_	_
8	:	_	:	:	_	1	punct	_	_
9	implications	_	NNS	NNS	_	1	dep	_	_
10	for	_	IN	IN	_	9	prep	_	_
11	differential	_	JJ	JJ	_	13	amod	_	_
12	gene	_	NN	NN	_	13	nn	_	_
13	expression	_	NN	NN	_	10	pobj	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	T	_	NN	NN	_	18	nn	_	_
16	helper	_	NN	NN	_	18	nn	_	_
17	cell	_	NN	NN	_	18	nn	_	_
18	subsets	_	NNS	NNS	_	14	pobj	_	_
19	.	_	.	.	_	1	punct	_	_

1	Activation	_	NN	NN	_	7	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	individual	_	JJ	JJ	_	6	amod	_	_
4	CD4+	_	JJ	JJ	_	6	amod	_	_
5	T	_	NN	NN	_	6	nn	_	_
6	cells	_	NNS	NNS	_	2	pobj	_	_
7	results	_	VBZ	VBZ	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	differential	_	JJ	JJ	_	11	amod	_	_
10	lymphokine	_	NN	NN	_	11	nn	_	_
11	expression	_	NN	NN	_	8	pobj	_	_
12	:	_	:	:	_	7	punct	_	_
13	interleukin	_	NN	NN	_	20	nsubjpass	_	_
14	2	_	CD	CD	_	13	num	_	_
15	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
16	IL-2	_	NN	NN	_	13	appos	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	is	_	VBZ	VBZ	_	20	auxpass	_	_
19	preferentially	_	RB	RB	_	20	advmod	_	_
20	produced	_	VBN	VBN	_	7	parataxis	_	_
21	by	_	IN	IN	_	20	prep	_	_
22	T	_	NN	NN	_	29	nn	_	_
23	helper	_	NN	NN	_	29	nn	_	_
24	type	_	NN	NN	_	29	nn	_	_
25	1	_	CD	CD	_	29	num	_	_
26	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
27	TH1	_	NN	NN	_	29	nn	_	_
28	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
29	cells	_	NNS	NNS	_	21	pobj	_	_
30	,	_	,	,	_	29	punct	_	_
31	which	_	WDT	WDT	_	33	nsubjpass	_	_
32	are	_	VBP	VBP	_	33	auxpass	_	_
33	involved	_	VBN	VBN	_	29	rcmod	_	_
34	in	_	IN	IN	_	33	prep	_	_
35	cell-mediated	_	JJ	JJ	_	37	amod	_	_
36	immune	_	JJ	JJ	_	37	amod	_	_
37	responses	_	NNS	NNS	_	34	pobj	_	_
38	,	_	,	,	_	20	punct	_	_
39	whereas	_	IN	IN	_	42	mark	_	_
40	IL-4	_	NN	NN	_	42	nsubjpass	_	_
41	is	_	VBZ	VBZ	_	42	auxpass	_	_
42	synthesized	_	VBN	VBN	_	20	advcl	_	_
43	by	_	IN	IN	_	42	prep	_	_
44	TH2	_	NN	NN	_	45	nn	_	_
45	cells	_	NNS	NNS	_	43	pobj	_	_
46	,	_	,	,	_	45	punct	_	_
47	which	_	WDT	WDT	_	49	nsubj	_	_
48	are	_	VBP	VBP	_	49	cop	_	_
49	essential	_	JJ	JJ	_	45	rcmod	_	_
50	for	_	IN	IN	_	49	prep	_	_
51	humoral	_	JJ	JJ	_	52	amod	_	_
52	immunity	_	NN	NN	_	50	pobj	_	_
53	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	Ca-LRB-2+-RRB--dependent	_	JJ	JJ	_	3	amod	_	_
3	factor	_	NN	NN	_	5	nsubj	_	_
4	NF-ATp	_	NN	NN	_	3	dep	_	_
5	plays	_	VBZ	VBZ	_	0	root	_	_
6	a	_	DT	DT	_	8	det	_	_
7	key	_	JJ	JJ	_	8	amod	_	_
8	role	_	NN	NN	_	5	dobj	_	_
9	in	_	IN	IN	_	5	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	inducible	_	JJ	JJ	_	12	amod	_	_
12	transcription	_	NN	NN	_	9	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	both	_	DT	DT	_	17	dep	_	_
15	these	_	DT	DT	_	17	det	_	_
16	lymphokine	_	NN	NN	_	17	nn	_	_
17	genes	_	NNS	NNS	_	13	pobj	_	_
18	.	_	.	.	_	5	punct	_	_

1	However	_	RB	RB	_	18	advmod	_	_
2	,	_	,	,	_	18	punct	_	_
3	while	_	IN	IN	_	6	mark	_	_
4	IL2	_	NN	NN	_	5	nn	_	_
5	expression	_	NN	NN	_	6	nsubj	_	_
6	requires	_	VBZ	VBZ	_	18	dep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	contribution	_	NN	NN	_	6	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	Ca-LRB-2+-RRB--	_	NN	NN	_	9	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	protein	_	NN	NN	_	15	nn	_	_
13	kinase	_	NN	NN	_	15	nn	_	_
14	C-dependent	_	JJ	JJ	_	15	amod	_	_
15	signals	_	NNS	NNS	_	10	conj	_	_
16	,	_	,	,	_	18	punct	_	_
17	we	_	PRP	PRP	_	18	nsubj	_	_
18	report	_	VBP	VBP	_	0	root	_	_
19	that	_	IN	IN	_	30	mark	_	_
20	activation	_	NN	NN	_	30	nsubjpass	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	human	_	JJ	JJ	_	23	amod	_	_
23	IL4	_	NN	NN	_	24	nn	_	_
24	transcription	_	NN	NN	_	21	pobj	_	_
25	through	_	IN	IN	_	20	prep	_	_
26	the	_	DT	DT	_	28	det	_	_
27	Ca-LRB-2+-RRB--dependent	_	JJ	JJ	_	28	amod	_	_
28	pathway	_	NN	NN	_	25	pobj	_	_
29	is	_	VBZ	VBZ	_	30	auxpass	_	_
30	diminished	_	VBN	VBN	_	18	ccomp	_	_
31	by	_	IN	IN	_	30	prep	_	_
32	protein	_	NN	NN	_	34	nn	_	_
33	kinase	_	NN	NN	_	34	nn	_	_
34	C	_	NN	NN	_	35	nn	_	_
35	stimulation	_	NN	NN	_	31	pobj	_	_
36	in	_	IN	IN	_	35	prep	_	_
37	Jurkat	_	NN	NN	_	39	nn	_	_
38	T	_	NN	NN	_	39	nn	_	_
39	cells	_	NNS	NNS	_	36	pobj	_	_
40	.	_	.	.	_	18	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	phenomenon	_	NN	NN	_	4	nsubj	_	_
3	is	_	VBZ	VBZ	_	4	cop	_	_
4	due	_	JJ	JJ	_	0	root	_	_
5	to	_	TO	TO	_	4	prep	_	_
6	mutually	_	RB	RB	_	7	advmod	_	_
7	exclusive	_	JJ	JJ	_	8	amod	_	_
8	binding	_	NN	NN	_	5	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	NF-ATp	_	NN	NN	_	9	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	NF-kappa	_	NN	NN	_	13	nn	_	_
13	B	_	NN	NN	_	10	conj	_	_
14	to	_	TO	TO	_	8	prep	_	_
15	the	_	DT	DT	_	17	det	_	_
16	P	_	NN	NN	_	17	nn	_	_
17	sequence	_	NN	NN	_	14	pobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	an	_	DT	DT	_	20	det	_	_
20	element	_	NN	NN	_	17	appos	_	_
21	located	_	JJ	JJ	_	20	amod	_	_
22	69	_	CD	CD	_	23	num	_	_
23	bp	_	NN	NN	_	25	npadvmod	_	_
24	upstream	_	RB	RB	_	23	advmod	_	_
25	of	_	IN	IN	_	21	prep	_	_
26	the	_	DT	DT	_	30	det	_	_
27	IL4	_	NN	NN	_	30	nn	_	_
28	transcription	_	NN	NN	_	30	nn	_	_
29	initiation	_	NN	NN	_	30	nn	_	_
30	site	_	NN	NN	_	25	pobj	_	_
31	.	_	.	.	_	4	punct	_	_

1	Human	_	JJ	JJ	_	4	amod	_	_
2	IL4	_	NN	NN	_	4	nn	_	_
3	promoter-mediated	_	JJ	JJ	_	4	amod	_	_
4	transcription	_	NN	NN	_	6	nsubjpass	_	_
5	is	_	VBZ	VBZ	_	6	auxpass	_	_
6	downregulated	_	VBN	VBN	_	0	root	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	Jurkat	_	NN	NN	_	9	nn	_	_
9	cells	_	NNS	NNS	_	7	pobj	_	_
10	stimulated	_	VBN	VBN	_	9	vmod	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	15	det	_	_
13	NF-kappa	_	NN	NN	_	15	nn	_	_
14	B-activating	_	JJ	JJ	_	15	amod	_	_
15	cytokine	_	NN	NN	_	11	pobj	_	_
16	tumor	_	NN	NN	_	19	nn	_	_
17	necrosis	_	NN	NN	_	19	nn	_	_
18	factor	_	NN	NN	_	19	nn	_	_
19	alpha	_	NN	NN	_	15	dep	_	_
20	and	_	CC	CC	_	6	cc	_	_
21	suppressed	_	VBN	VBN	_	6	conj	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	RelA-overexpressing	_	JJ	JJ	_	24	amod	_	_
24	cells	_	NNS	NNS	_	22	pobj	_	_
25	.	_	.	.	_	6	punct	_	_

1	In	_	IN	IN	_	13	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	13	punct	_	_
4	protein	_	NN	NN	_	6	nn	_	_
5	kinase	_	NN	NN	_	6	nn	_	_
6	C	_	NN	NN	_	7	nn	_	_
7	stimulation	_	NN	NN	_	13	nsubj	_	_
8	or	_	CC	CC	_	7	cc	_	_
9	RelA	_	NN	NN	_	10	nn	_	_
10	overexpression	_	NN	NN	_	7	conj	_	_
11	does	_	VBZ	VBZ	_	13	aux	_	_
12	not	_	RB	RB	_	13	neg	_	_
13	affect	_	VB	VB	_	0	root	_	_
14	the	_	DT	DT	_	15	det	_	_
15	activity	_	NN	NN	_	13	dobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	a	_	DT	DT	_	20	det	_	_
18	human	_	JJ	JJ	_	20	amod	_	_
19	IL4	_	NN	NN	_	20	nn	_	_
20	promoter	_	NN	NN	_	16	pobj	_	_
21	containing	_	VBG	VBG	_	20	vmod	_	_
22	a	_	DT	DT	_	25	det	_	_
23	mouse	_	NN	NN	_	25	nn	_	_
24	P	_	NN	NN	_	25	nn	_	_
25	sequence	_	NN	NN	_	21	dobj	_	_
26	,	_	,	,	_	25	punct	_	_
27	which	_	WDT	WDT	_	31	nsubj	_	_
28	is	_	VBZ	VBZ	_	31	cop	_	_
29	a	_	DT	DT	_	31	det	_	_
30	higher-affinity	_	JJ	JJ	_	31	amod	_	_
31	site	_	NN	NN	_	25	rcmod	_	_
32	for	_	IN	IN	_	31	prep	_	_
33	NF-ATp	_	NN	NN	_	32	pobj	_	_
34	and	_	CC	CC	_	31	cc	_	_
35	a	_	DT	DT	_	37	det	_	_
36	lower-affinity	_	JJ	JJ	_	37	amod	_	_
37	site	_	NN	NN	_	31	conj	_	_
38	for	_	IN	IN	_	37	prep	_	_
39	RelA	_	NN	NN	_	38	pobj	_	_
40	.	_	.	.	_	13	punct	_	_

1	Thus	_	RB	RB	_	14	advmod	_	_
2	,	_	,	,	_	14	punct	_	_
3	competition	_	NN	NN	_	14	nsubj	_	_
4	between	_	IN	IN	_	3	prep	_	_
5	two	_	CD	CD	_	8	num	_	_
6	general	_	JJ	JJ	_	8	amod	_	_
7	transcriptional	_	JJ	JJ	_	8	amod	_	_
8	activators	_	NNS	NNS	_	4	pobj	_	_
9	,	_	,	,	_	8	punct	_	_
10	RelA	_	NN	NN	_	8	appos	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	NF-ATp	_	NN	NN	_	10	conj	_	_
13	,	_	,	,	_	3	punct	_	_
14	mediates	_	VBZ	VBZ	_	0	root	_	_
15	the	_	DT	DT	_	17	det	_	_
16	inhibitory	_	JJ	JJ	_	17	amod	_	_
17	effect	_	NN	NN	_	14	dobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	protein	_	NN	NN	_	21	nn	_	_
20	kinase	_	NN	NN	_	21	nn	_	_
21	C	_	NN	NN	_	22	nn	_	_
22	stimulation	_	NN	NN	_	18	pobj	_	_
23	on	_	IN	IN	_	17	prep	_	_
24	IL4	_	NN	NN	_	25	nn	_	_
25	expression	_	NN	NN	_	23	pobj	_	_
26	and	_	CC	CC	_	14	cc	_	_
27	may	_	MD	MD	_	28	aux	_	_
28	contribute	_	VB	VB	_	14	conj	_	_
29	to	_	TO	TO	_	28	prep	_	_
30	differential	_	JJ	JJ	_	32	amod	_	_
31	gene	_	NN	NN	_	32	nn	_	_
32	expression	_	NN	NN	_	29	pobj	_	_
33	in	_	IN	IN	_	32	prep	_	_
34	TH	_	NN	NN	_	35	nn	_	_
35	cells	_	NNS	NNS	_	33	pobj	_	_
36	.	_	.	.	_	14	punct	_	_

1	Functional	_	JJ	JJ	_	2	amod	_	_
2	characterization	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	murine	_	JJ	JJ	_	6	amod	_	_
6	homolog	_	NN	NN	_	3	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	11	det	_	_
9	B	_	NN	NN	_	11	nn	_	_
10	cell-specific	_	JJ	JJ	_	11	amod	_	_
11	coactivator	_	NN	NN	_	7	pobj	_	_
12	BOB.1/OBF.1	_	NN	NN	_	11	dep	_	_
13	.	_	.	.	_	2	punct	_	_

1	B	_	NN	NN	_	5	nn	_	_
2	cell-specific	_	JJ	JJ	_	5	amod	_	_
3	transcriptional	_	JJ	JJ	_	5	amod	_	_
4	promoter	_	NN	NN	_	5	nn	_	_
5	activity	_	NN	NN	_	11	nsubj	_	_
6	mediated	_	VBN	VBN	_	5	vmod	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	octamer	_	NN	NN	_	10	nn	_	_
10	motif	_	NN	NN	_	7	pobj	_	_
11	requires	_	VBZ	VBZ	_	0	root	_	_
12	the	_	DT	DT	_	13	dep	_	_
13	Oct1	_	NN	NN	_	11	dobj	_	_
14	or	_	CC	CC	_	13	cc	_	_
15	Oct2	_	NN	NN	_	16	nn	_	_
16	protein	_	NN	NN	_	13	conj	_	_
17	and	_	CC	CC	_	13	cc	_	_
18	additional	_	JJ	JJ	_	21	amod	_	_
19	B	_	NN	NN	_	21	nn	_	_
20	cell-restricted	_	JJ	JJ	_	21	amod	_	_
21	cofactors	_	NNS	NNS	_	13	conj	_	_
22	.	_	.	.	_	11	punct	_	_

1	One	_	CD	CD	_	3	num	_	_
2	such	_	JJ	JJ	_	3	amod	_	_
3	cofactor	_	NN	NN	_	9	nsubjpass	_	_
4	,	_	,	,	_	3	punct	_	_
5	BOB.1/OBF.1	_	NN	NN	_	3	appos	_	_
6	,	_	,	,	_	3	punct	_	_
7	was	_	VBD	VBD	_	9	auxpass	_	_
8	recently	_	RB	RB	_	9	advmod	_	_
9	isolated	_	VBN	VBN	_	0	root	_	_
10	from	_	IN	IN	_	9	prep	_	_
11	human	_	JJ	JJ	_	13	amod	_	_
12	B	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	10	pobj	_	_
14	.	_	.	.	_	9	punct	_	_

1	Here	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	describe	_	VBP	VBP	_	0	root	_	_
5	the	_	DT	DT	_	6	det	_	_
6	isolation	_	NN	NN	_	4	dobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	detailed	_	JJ	JJ	_	9	amod	_	_
9	characterization	_	NN	NN	_	6	conj	_	_
10	of	_	IN	IN	_	6	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	murine	_	JJ	JJ	_	13	amod	_	_
13	homolog	_	NN	NN	_	10	pobj	_	_
14	.	_	.	.	_	4	punct	_	_

1	Full-length	_	JJ	JJ	_	2	amod	_	_
2	cDNAs	_	NNS	NNS	_	7	nsubjpass	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	genomic	_	JJ	JJ	_	5	amod	_	_
5	clones	_	NNS	NNS	_	2	conj	_	_
6	were	_	VBD	VBD	_	7	auxpass	_	_
7	isolated	_	VBN	VBN	_	0	root	_	_
8	,	_	,	,	_	7	punct	_	_
9	and	_	CC	CC	_	7	cc	_	_
10	the	_	DT	DT	_	12	det	_	_
11	gene	_	NN	NN	_	12	nn	_	_
12	structure	_	NN	NN	_	14	nsubjpass	_	_
13	was	_	VBD	VBD	_	14	auxpass	_	_
14	determined	_	VBN	VBN	_	7	conj	_	_
15	.	_	.	.	_	7	punct	_	_

1	Comparison	_	NN	NN	_	7	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	6	det	_	_
4	deduced	_	VBN	VBN	_	6	amod	_	_
5	amino	_	NN	NN	_	6	nn	_	_
6	acids	_	NNS	NNS	_	2	pobj	_	_
7	shows	_	VBZ	VBZ	_	0	root	_	_
8	88	_	CD	CD	_	9	number	_	_
9	%	_	NN	NN	_	11	amod	_	_
10	sequence	_	NN	NN	_	11	nn	_	_
11	identity	_	NN	NN	_	7	dobj	_	_
12	between	_	IN	IN	_	11	prep	_	_
13	mouse	_	NN	NN	_	12	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	human	_	JJ	JJ	_	13	conj	_	_
16	BOB.1/OBF.1	_	NN	NN	_	13	dep	_	_
17	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	NH2-terminal	_	JJ	JJ	_	5	amod	_	_
3	126	_	CD	CD	_	5	num	_	_
4	amino	_	NN	NN	_	5	nn	_	_
5	acids	_	NNS	NNS	_	10	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	BOB.1/OBF.1	_	NN	NN	_	6	pobj	_	_
8	are	_	VBP	VBP	_	10	cop	_	_
9	both	_	CC	CC	_	10	preconj	_	_
10	essential	_	JJ	JJ	_	0	root	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	sufficient	_	JJ	JJ	_	10	conj	_	_
13	for	_	IN	IN	_	10	prep	_	_
14	interaction	_	NN	NN	_	13	pobj	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	POU	_	NN	NN	_	18	nn	_	_
18	domains	_	NNS	NNS	_	15	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	either	_	CC	CC	_	21	preconj	_	_
21	Oct1	_	NN	NN	_	19	pobj	_	_
22	or	_	CC	CC	_	21	cc	_	_
23	Oct2	_	NN	NN	_	21	conj	_	_
24	.	_	.	.	_	10	punct	_	_

1	This	_	DT	DT	_	3	det	_	_
2	protein-protein	_	JJ	JJ	_	3	amod	_	_
3	interaction	_	NN	NN	_	6	nsubj	_	_
4	does	_	VBZ	VBZ	_	6	aux	_	_
5	not	_	RB	RB	_	6	neg	_	_
6	require	_	VB	VB	_	0	root	_	_
7	the	_	DT	DT	_	9	det	_	_
8	simultaneous	_	JJ	JJ	_	9	amod	_	_
9	binding	_	NN	NN	_	6	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	Oct	_	NN	NN	_	12	nn	_	_
12	proteins	_	NNS	NNS	_	10	pobj	_	_
13	to	_	TO	TO	_	9	prep	_	_
14	DNA	_	NN	NN	_	13	pobj	_	_
15	,	_	,	,	_	6	punct	_	_
16	and	_	CC	CC	_	6	cc	_	_
17	high	_	JJ	JJ	_	19	amod	_	_
18	resolution	_	NN	NN	_	19	nn	_	_
19	footprinting	_	NN	NN	_	24	nsubj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	Oct-DNA	_	NN	NN	_	23	nn	_	_
23	interaction	_	NN	NN	_	20	pobj	_	_
24	reveals	_	VBZ	VBZ	_	6	conj	_	_
25	that	_	IN	IN	_	35	mark	_	_
26	binding	_	NN	NN	_	35	nsubj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	BOB.1/OBF.1	_	NN	NN	_	27	pobj	_	_
29	to	_	TO	TO	_	26	prep	_	_
30	Oct1	_	NN	NN	_	29	pobj	_	_
31	or	_	CC	CC	_	30	cc	_	_
32	Oct2	_	NN	NN	_	30	conj	_	_
33	does	_	VBZ	VBZ	_	35	aux	_	_
34	not	_	RB	RB	_	35	neg	_	_
35	alter	_	VB	VB	_	24	ccomp	_	_
36	the	_	DT	DT	_	37	det	_	_
37	interaction	_	NN	NN	_	35	dobj	_	_
38	with	_	IN	IN	_	37	prep	_	_
39	DNA	_	NN	NN	_	38	pobj	_	_
40	.	_	.	.	_	6	punct	_	_

1	BOB.1/OBF.1	_	NN	NN	_	4	nsubj	_	_
2	can	_	MD	MD	_	4	aux	_	_
3	efficiently	_	RB	RB	_	4	advmod	_	_
4	activate	_	VB	VB	_	0	root	_	_
5	octamer-dependent	_	JJ	JJ	_	6	amod	_	_
6	promoters	_	NNS	NNS	_	4	dobj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	fibroblasts	_	NNS	NNS	_	7	pobj	_	_
9	;	_	:	:	_	4	punct	_	_
10	however	_	RB	RB	_	13	advmod	_	_
11	,	_	,	,	_	13	punct	_	_
12	it	_	PRP	PRP	_	13	nsubj	_	_
13	fails	_	VBZ	VBZ	_	4	parataxis	_	_
14	to	_	TO	TO	_	15	aux	_	_
15	stimulate	_	VB	VB	_	13	xcomp	_	_
16	octamer-dependent	_	JJ	JJ	_	17	amod	_	_
17	enhancer	_	NN	NN	_	18	nn	_	_
18	activity	_	NN	NN	_	15	dobj	_	_
19	.	_	.	.	_	4	punct	_	_

1	Fusion	_	NN	NN	_	12	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	subdomains	_	NNS	NNS	_	2	pobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	BOB.1/OBF.1	_	NN	NN	_	4	pobj	_	_
6	with	_	IN	IN	_	1	prep	_	_
7	the	_	DT	DT	_	11	det	_	_
8	GAL4	_	NN	NN	_	11	nn	_	_
9	DNA	_	NN	NN	_	11	nn	_	_
10	binding	_	NN	NN	_	11	nn	_	_
11	domain	_	NN	NN	_	6	pobj	_	_
12	reveals	_	VBZ	VBZ	_	0	root	_	_
13	that	_	IN	IN	_	21	mark	_	_
14	both	_	CC	CC	_	15	preconj	_	_
15	NH2-	_	NN	NN	_	21	nsubj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	COOH-terminal	_	JJ	JJ	_	18	amod	_	_
18	domains	_	NNS	NNS	_	15	conj	_	_
19	of	_	IN	IN	_	15	prep	_	_
20	BOB.1/OBF.1	_	NN	NN	_	19	pobj	_	_
21	contribute	_	VBP	VBP	_	12	dep	_	_
22	to	_	TO	TO	_	21	prep	_	_
23	full	_	JJ	JJ	_	25	amod	_	_
24	transactivation	_	NN	NN	_	25	nn	_	_
25	function	_	NN	NN	_	22	pobj	_	_
26	,	_	,	,	_	21	punct	_	_
27	the	_	DT	DT	_	29	det	_	_
28	COOH-terminal	_	JJ	JJ	_	29	amod	_	_
29	domain	_	NN	NN	_	21	dep	_	_
30	is	_	VBZ	VBZ	_	32	cop	_	_
31	more	_	RBR	RBR	_	32	advmod	_	_
32	efficient	_	JJ	JJ	_	21	dep	_	_
33	in	_	IN	IN	_	32	prep	_	_
34	this	_	DT	DT	_	36	det	_	_
35	transactivation	_	NN	NN	_	36	nn	_	_
36	assay	_	NN	NN	_	33	pobj	_	_
37	.	_	.	.	_	12	punct	_	_

1	Consistent	_	JJ	JJ	_	23	advmod	_	_
2	with	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	4	det	_	_
4	failure	_	NN	NN	_	2	pobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	full-length	_	JJ	JJ	_	7	amod	_	_
7	BOB.1/OBF.1	_	NN	NN	_	5	pobj	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	stimulate	_	VB	VB	_	4	vmod	_	_
10	octamer-dependent	_	JJ	JJ	_	12	amod	_	_
11	enhancer	_	NN	NN	_	12	nn	_	_
12	elements	_	NNS	NNS	_	9	dobj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	non	_	JJ	JJ	_	16	amod	_	_
15	B	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	13	pobj	_	_
17	,	_	,	,	_	23	punct	_	_
18	the	_	DT	DT	_	20	det	_	_
19	GAL4	_	NN	NN	_	20	nn	_	_
20	fusions	_	NNS	NNS	_	23	nsubj	_	_
21	likewise	_	RB	RB	_	23	advmod	_	_
22	only	_	RB	RB	_	23	advmod	_	_
23	stimulate	_	VBP	VBP	_	0	root	_	_
24	from	_	IN	IN	_	23	prep	_	_
25	a	_	DT	DT	_	27	det	_	_
26	promoter-proximal	_	JJ	JJ	_	27	amod	_	_
27	position	_	NN	NN	_	24	pobj	_	_
28	.	_	.	.	_	23	punct	_	_

1	IL-10	_	NN	NN	_	2	nsubj	_	_
2	cooperates	_	VBZ	VBZ	_	0	root	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	TNF-alpha	_	NN	NN	_	3	pobj	_	_
5	to	_	TO	TO	_	6	aux	_	_
6	activate	_	VB	VB	_	2	xcomp	_	_
7	HIV-1	_	NN	NN	_	6	dobj	_	_
8	from	_	IN	IN	_	6	prep	_	_
9	latently	_	RB	RB	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	acutely	_	RB	RB	_	9	conj	_	_
12	infected	_	JJ	JJ	_	13	amod	_	_
13	cells	_	NNS	NNS	_	9	dep	_	_
14	of	_	IN	IN	_	9	prep	_	_
15	monocyte/macrophage	_	NN	NN	_	16	nn	_	_
16	lineage	_	NN	NN	_	14	pobj	_	_
17	.	_	.	.	_	2	punct	_	_

1	IL-10	_	NN	NN	_	3	nsubj	_	_
2	is	_	VBZ	VBZ	_	3	cop	_	_
3	elevated	_	JJ	JJ	_	0	root	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	HIV-1-infected	_	JJ	JJ	_	6	amod	_	_
6	individuals	_	NNS	NNS	_	4	pobj	_	_
7	and	_	CC	CC	_	3	cc	_	_
8	has	_	VBZ	VBZ	_	10	aux	_	_
9	been	_	VBN	VBN	_	10	auxpass	_	_
10	implicated	_	VBN	VBN	_	3	conj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	disease	_	NN	NN	_	13	nn	_	_
13	progression	_	NN	NN	_	11	pobj	_	_
14	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	study	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	investigated	_	VBD	VBD	_	0	root	_	_
7	the	_	DT	DT	_	8	det	_	_
8	effects	_	NNS	NNS	_	6	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	IL-10	_	NN	NN	_	9	pobj	_	_
11	on	_	IN	IN	_	8	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	activation	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	HIV-1	_	NN	NN	_	14	pobj	_	_
16	from	_	IN	IN	_	15	prep	_	_
17	infected	_	JJ	JJ	_	18	amod	_	_
18	monocytes	_	NNS	NNS	_	16	pobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	macrophages	_	NNS	NNS	_	18	conj	_	_
21	.	_	.	.	_	6	punct	_	_

1	Although	_	IN	IN	_	6	mark	_	_
2	IL-10	_	NN	NN	_	6	nsubj	_	_
3	alone	_	RB	RB	_	2	advmod	_	_
4	did	_	VBD	VBD	_	6	aux	_	_
5	not	_	RB	RB	_	6	neg	_	_
6	induce	_	VB	VB	_	18	advcl	_	_
7	HIV-1	_	NN	NN	_	8	nn	_	_
8	replication	_	NN	NN	_	6	dobj	_	_
9	,	_	,	,	_	18	punct	_	_
10	in	_	IN	IN	_	18	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	presence	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	TNF-alpha	_	NN	NN	_	13	pobj	_	_
15	,	_	,	,	_	18	punct	_	_
16	IL-10	_	NN	NN	_	18	nsubj	_	_
17	markedly	_	RB	RB	_	18	advmod	_	_
18	enhanced	_	VBD	VBD	_	0	root	_	_
19	virion	_	NN	NN	_	20	nn	_	_
20	production	_	NN	NN	_	18	dobj	_	_
21	from	_	IN	IN	_	20	prep	_	_
22	a	_	DT	DT	_	27	det	_	_
23	chronically	_	RB	RB	_	24	advmod	_	_
24	infected	_	JJ	JJ	_	27	amod	_	_
25	promonocytic	_	JJ	JJ	_	27	amod	_	_
26	cell	_	NN	NN	_	27	nn	_	_
27	line	_	NN	NN	_	21	pobj	_	_
28	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
29	U1	_	NN	NN	_	27	appos	_	_
30	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
31	and	_	CC	CC	_	21	cc	_	_
32	in	_	IN	IN	_	21	conj	_	_
33	acutely	_	RB	RB	_	34	advmod	_	_
34	infected	_	JJ	JJ	_	36	amod	_	_
35	monocyte-derived	_	JJ	JJ	_	36	amod	_	_
36	macrophages	_	NNS	NNS	_	32	pobj	_	_
37	.	_	.	.	_	18	punct	_	_

1	Neutralizing	_	VBG	VBG	_	7	csubj	_	_
2	mAbs	_	NNS	NNS	_	1	dobj	_	_
3	to	_	TO	TO	_	1	prep	_	_
4	IL-10	_	NN	NN	_	3	pobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	TNF-alpha	_	NN	NN	_	4	conj	_	_
7	indicated	_	VBD	VBD	_	0	root	_	_
8	that	_	IN	IN	_	12	mark	_	_
9	both	_	DT	DT	_	10	dep	_	_
10	cytokines	_	NNS	NNS	_	12	nsubj	_	_
11	were	_	VBD	VBD	_	12	cop	_	_
12	essential	_	JJ	JJ	_	7	ccomp	_	_
13	for	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	induction	_	NN	NN	_	13	pobj	_	_
16	and	_	CC	CC	_	12	cc	_	_
17	were	_	VBD	VBD	_	18	auxpass	_	_
18	required	_	VBN	VBN	_	12	conj	_	_
19	to	_	TO	TO	_	20	aux	_	_
20	generate	_	VB	VB	_	18	xcomp	_	_
21	a	_	DT	DT	_	23	det	_	_
22	synergistic	_	JJ	JJ	_	23	amod	_	_
23	increase	_	NN	NN	_	20	dobj	_	_
24	in	_	IN	IN	_	23	prep	_	_
25	virus	_	NN	NN	_	26	nn	_	_
26	expression	_	NN	NN	_	24	pobj	_	_
27	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	effects	_	NNS	NNS	_	8	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	two	_	CD	CD	_	6	num	_	_
6	cytokines	_	NNS	NNS	_	3	pobj	_	_
7	were	_	VBD	VBD	_	8	cop	_	_
8	distinguishable	_	JJ	JJ	_	0	root	_	_
9	functionally	_	RB	RB	_	8	advmod	_	_
10	since	_	IN	IN	_	14	mark	_	_
11	pretreatment	_	NN	NN	_	14	nsubj	_	_
12	with	_	IN	IN	_	11	prep	_	_
13	TNF-alpha	_	NN	NN	_	12	pobj	_	_
14	attenuated	_	VBD	VBD	_	8	advcl	_	_
15	the	_	DT	DT	_	17	det	_	_
16	cytokine	_	NN	NN	_	17	nn	_	_
17	cooperativity	_	NN	NN	_	14	dobj	_	_
18	,	_	,	,	_	14	punct	_	_
19	while	_	IN	IN	_	23	mark	_	_
20	pretreatment	_	NN	NN	_	23	nsubj	_	_
21	with	_	IN	IN	_	20	prep	_	_
22	IL-10	_	NN	NN	_	21	pobj	_	_
23	potentiated	_	VBD	VBD	_	14	advcl	_	_
24	their	_	PRP$	PRP$	_	25	poss	_	_
25	cooperativity	_	NN	NN	_	23	dobj	_	_
26	,	_	,	,	_	14	punct	_	_
27	suggesting	_	VBG	VBG	_	14	xcomp	_	_
28	that	_	IN	IN	_	32	mark	_	_
29	IL-10	_	NN	NN	_	32	nsubj	_	_
30	and	_	CC	CC	_	29	cc	_	_
31	TNF-alpha	_	NN	NN	_	29	conj	_	_
32	play	_	VBP	VBP	_	27	ccomp	_	_
33	different	_	JJ	JJ	_	34	amod	_	_
34	roles	_	NNS	NNS	_	32	dobj	_	_
35	in	_	IN	IN	_	32	prep	_	_
36	the	_	DT	DT	_	37	det	_	_
37	activation	_	NN	NN	_	35	pobj	_	_
38	of	_	IN	IN	_	37	prep	_	_
39	virus	_	NN	NN	_	38	pobj	_	_
40	.	_	.	.	_	8	punct	_	_

1	Northern	_	JJ	JJ	_	3	amod	_	_
2	blot	_	NN	NN	_	3	nn	_	_
3	analysis	_	NN	NN	_	13	nsubj	_	_
4	as	_	RB	RB	_	5	advmod	_	_
5	well	_	RB	RB	_	3	cc	_	_
6	as	_	IN	IN	_	5	mwe	_	_
7	Ab	_	NN	NN	_	8	nn	_	_
8	blocking	_	NN	NN	_	3	conj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	cytokine	_	NN	NN	_	11	nn	_	_
11	secretion	_	NN	NN	_	8	conj	_	_
12	studies	_	NNS	NNS	_	8	dep	_	_
13	indicated	_	VBD	VBD	_	0	root	_	_
14	that	_	IN	IN	_	25	mark	_	_
15	the	_	DT	DT	_	16	det	_	_
16	induction	_	NN	NN	_	25	nsubjpass	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	either	_	CC	CC	_	20	preconj	_	_
19	endogenous	_	JJ	JJ	_	20	amod	_	_
20	TNF-alpha	_	NN	NN	_	17	pobj	_	_
21	or	_	CC	CC	_	20	cc	_	_
22	IL-10	_	NN	NN	_	20	conj	_	_
23	was	_	VBD	VBD	_	25	auxpass	_	_
24	not	_	RB	RB	_	25	neg	_	_
25	involved	_	VBN	VBN	_	13	ccomp	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	28	det	_	_
28	cooperativity	_	NN	NN	_	26	pobj	_	_
29	,	_	,	,	_	25	punct	_	_
30	nor	_	CC	CC	_	25	cc	_	_
31	was	_	VBD	VBD	_	33	dep	_	_
32	an	_	DT	DT	_	33	det	_	_
33	up-regulation	_	NN	NN	_	25	conj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	TNF-alpha	_	NN	NN	_	36	nn	_	_
36	receptors	_	NNS	NNS	_	34	pobj	_	_
37	.	_	.	.	_	13	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	combination	_	NN	NN	_	1	pobj	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	TNF-alpha	_	NN	NN	_	3	pobj	_	_
5	,	_	,	,	_	7	punct	_	_
6	IL-10	_	NN	NN	_	7	nsubj	_	_
7	stimulated	_	VBD	VBD	_	0	root	_	_
8	activating	_	VBG	VBG	_	9	amod	_	_
9	protein-1	_	NN	NN	_	7	dobj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	AP-1	_	NN	NN	_	9	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	and	_	CC	CC	_	9	cc	_	_
14	nuclear	_	JJ	JJ	_	20	amod	_	_
15	factor	_	NN	NN	_	20	nn	_	_
16	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
17	NF	_	NN	NN	_	20	nn	_	_
18	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
19	-kappa	_	NN	NN	_	20	nn	_	_
20	B	_	NN	NN	_	22	nn	_	_
21	binding	_	NN	NN	_	22	nn	_	_
22	activities	_	NNS	NNS	_	9	conj	_	_
23	and	_	CC	CC	_	7	cc	_	_
24	cooperated	_	VBD	VBD	_	7	conj	_	_
25	to	_	TO	TO	_	26	aux	_	_
26	increase	_	VB	VB	_	24	xcomp	_	_
27	HIV-1	_	NN	NN	_	30	nn	_	_
28	steady-state	_	JJ	JJ	_	30	amod	_	_
29	mRNA	_	NN	NN	_	30	nn	_	_
30	levels	_	NNS	NNS	_	26	dobj	_	_
31	and	_	CC	CC	_	26	cc	_	_
32	enhance	_	VB	VB	_	26	conj	_	_
33	long	_	JJ	JJ	_	36	amod	_	_
34	terminal	_	JJ	JJ	_	36	amod	_	_
35	repeat-directed	_	JJ	JJ	_	36	amod	_	_
36	transcription	_	NN	NN	_	32	dobj	_	_
37	through	_	IN	IN	_	32	prep	_	_
38	activation	_	NN	NN	_	37	pobj	_	_
39	of	_	IN	IN	_	38	prep	_	_
40	the	_	DT	DT	_	44	det	_	_
41	NF-kappa	_	NN	NN	_	44	nn	_	_
42	B	_	NN	NN	_	44	nn	_	_
43	binding	_	NN	NN	_	44	nn	_	_
44	sites	_	NNS	NNS	_	39	pobj	_	_
45	,	_	,	,	_	7	punct	_	_
46	suggesting	_	VBG	VBG	_	7	vmod	_	_
47	the	_	DT	DT	_	49	det	_	_
48	IL-10	_	NN	NN	_	49	nn	_	_
49	effect	_	NN	NN	_	46	dobj	_	_
50	occurs	_	VBZ	VBZ	_	46	dep	_	_
51	at	_	IN	IN	_	53	advmod	_	_
52	least	_	JJS	JJS	_	51	pobj	_	_
53	in	_	IN	IN	_	50	prep	_	_
54	part	_	NN	NN	_	53	pobj	_	_
55	at	_	IN	IN	_	50	prep	_	_
56	the	_	DT	DT	_	58	det	_	_
57	transcriptional	_	JJ	JJ	_	58	amod	_	_
58	level	_	NN	NN	_	55	pobj	_	_
59	.	_	.	.	_	7	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	20	mark	_	_
5	IL-10	_	NN	NN	_	20	nsubj	_	_
6	,	_	,	,	_	5	punct	_	_
7	in	_	IN	IN	_	20	prep	_	_
8	addition	_	NN	NN	_	7	pobj	_	_
9	to	_	TO	TO	_	8	prep	_	_
10	down-regulating	_	VBG	VBG	_	9	pcomp	_	_
11	the	_	DT	DT	_	14	det	_	_
12	cellular	_	JJ	JJ	_	14	amod	_	_
13	immune	_	JJ	JJ	_	14	amod	_	_
14	response	_	NN	NN	_	10	dobj	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	HIV-1	_	NN	NN	_	15	pobj	_	_
17	,	_	,	,	_	20	punct	_	_
18	may	_	MD	MD	_	20	aux	_	_
19	also	_	RB	RB	_	20	advmod	_	_
20	play	_	VB	VB	_	3	ccomp	_	_
21	a	_	DT	DT	_	22	det	_	_
22	role	_	NN	NN	_	20	dobj	_	_
23	in	_	IN	IN	_	20	prep	_	_
24	TNF-alpha-mediated	_	JJ	JJ	_	25	amod	_	_
25	activation	_	NN	NN	_	23	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	HIV-1	_	NN	NN	_	28	nn	_	_
28	replication	_	NN	NN	_	26	pobj	_	_
29	in	_	IN	IN	_	28	prep	_	_
30	the	_	DT	DT	_	32	det	_	_
31	monocyte/macrophage	_	JJ	JJ	_	32	amod	_	_
32	lineage	_	NN	NN	_	29	pobj	_	_
33	.	_	.	.	_	3	punct	_	_

1	Inhibition	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	lipopolysaccharide-induced	_	JJ	JJ	_	8	amod	_	_
4	monocyte	_	NN	NN	_	6	nn	_	_
5	interleukin-1	_	NN	NN	_	6	nn	_	_
6	receptor	_	NN	NN	_	8	nn	_	_
7	antagonist	_	NN	NN	_	8	nn	_	_
8	synthesis	_	NN	NN	_	2	pobj	_	_
9	by	_	IN	IN	_	1	prep	_	_
10	cortisol	_	NN	NN	_	9	pobj	_	_
11	:	_	:	:	_	1	punct	_	_
12	involvement	_	NN	NN	_	1	dep	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	mineralocorticoid	_	NN	NN	_	16	nn	_	_
16	receptor	_	NN	NN	_	13	pobj	_	_
17	.	_	.	.	_	1	punct	_	_

1	Glucocorticoids	_	NNS	NNS	_	19	nsubj	_	_
2	,	_	,	,	_	1	punct	_	_
3	as	_	IN	IN	_	19	prep	_	_
4	a	_	DT	DT	_	5	det	_	_
5	part	_	NN	NN	_	3	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	their	_	PRP$	PRP$	_	9	poss	_	_
8	physiological	_	JJ	JJ	_	9	amod	_	_
9	role	_	NN	NN	_	6	pobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	control	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	inflammatory	_	JJ	JJ	_	13	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	immune	_	JJ	JJ	_	14	conj	_	_
17	processes	_	NNS	NNS	_	14	dep	_	_
18	,	_	,	,	_	19	punct	_	_
19	suppress	_	VBP	VBP	_	0	root	_	_
20	the	_	DT	DT	_	21	det	_	_
21	expression	_	NN	NN	_	19	dobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	interleukin-1	_	NN	NN	_	22	pobj	_	_
24	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
25	IL-1	_	NN	NN	_	23	appos	_	_
26	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
27	and	_	CC	CC	_	23	cc	_	_
28	other	_	JJ	JJ	_	29	amod	_	_
29	cytokines	_	NNS	NNS	_	23	conj	_	_
30	.	_	.	.	_	19	punct	_	_

1	Human	_	JJ	JJ	_	11	amod	_	_
2	monocyte	_	NN	NN	_	11	nn	_	_
3	IL-1	_	NN	NN	_	11	nn	_	_
4	receptor	_	NN	NN	_	11	nn	_	_
5	antagonist	_	NN	NN	_	11	nn	_	_
6	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
7	IL-1ra	_	NN	NN	_	11	nn	_	_
8	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
9	messenger	_	NN	NN	_	11	nn	_	_
10	ribonucleic	_	NN	NN	_	11	nn	_	_
11	acid	_	NN	NN	_	15	nn	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	mRNA	_	NN	NN	_	11	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	expression	_	NN	NN	_	20	nsubjpass	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	protein	_	NN	NN	_	18	nn	_	_
18	secretion	_	NN	NN	_	15	conj	_	_
19	are	_	VBP	VBP	_	20	auxpass	_	_
20	inhibited	_	VBN	VBN	_	0	root	_	_
21	by	_	IN	IN	_	20	prep	_	_
22	dexamethasone	_	NN	NN	_	21	pobj	_	_
23	.	_	.	.	_	20	punct	_	_

1	We	_	PRP	PRP	_	5	nsubj	_	_
2	have	_	VBP	VBP	_	5	aux	_	_
3	now	_	RB	RB	_	5	advmod	_	_
4	further	_	RB	RB	_	5	advmod	_	_
5	studied	_	VBN	VBN	_	0	root	_	_
6	the	_	DT	DT	_	7	det	_	_
7	regulation	_	NN	NN	_	5	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	IL-1ra	_	NN	NN	_	8	pobj	_	_
10	by	_	IN	IN	_	7	prep	_	_
11	the	_	DT	DT	_	15	det	_	_
12	major	_	JJ	JJ	_	15	amod	_	_
13	physiological	_	JJ	JJ	_	12	dep	_	_
14	human	_	JJ	JJ	_	15	amod	_	_
15	glucocorticoid	_	NN	NN	_	10	pobj	_	_
16	,	_	,	,	_	15	punct	_	_
17	cortisol	_	NN	NN	_	15	appos	_	_
18	.	_	.	.	_	5	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	found	_	VBD	VBD	_	0	root	_	_
3	that	_	IN	IN	_	6	mark	_	_
4	cortisol	_	NN	NN	_	5	nn	_	_
5	incubation	_	NN	NN	_	6	nsubj	_	_
6	induced	_	VBD	VBD	_	2	ccomp	_	_
7	a	_	DT	DT	_	8	det	_	_
8	decrease	_	NN	NN	_	6	dobj	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	IL-1ra	_	NN	NN	_	11	nn	_	_
11	mRNA	_	NN	NN	_	12	nn	_	_
12	expression	_	NN	NN	_	9	pobj	_	_
13	and	_	CC	CC	_	8	cc	_	_
14	a	_	DT	DT	_	16	det	_	_
15	significant	_	JJ	JJ	_	16	amod	_	_
16	inhibition	_	NN	NN	_	8	conj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	IL-1ra	_	NN	NN	_	19	nn	_	_
19	protein	_	NN	NN	_	20	nn	_	_
20	secretion	_	NN	NN	_	17	pobj	_	_
21	in	_	IN	IN	_	6	prep	_	_
22	cell	_	NN	NN	_	23	nn	_	_
23	cultures	_	NNS	NNS	_	21	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	human	_	JJ	JJ	_	27	amod	_	_
26	peripheral	_	JJ	JJ	_	27	amod	_	_
27	monocytes	_	NNS	NNS	_	24	pobj	_	_
28	stimulated	_	VBN	VBN	_	27	vmod	_	_
29	with	_	IN	IN	_	28	prep	_	_
30	the	_	DT	DT	_	32	det	_	_
31	bacterial	_	JJ	JJ	_	32	amod	_	_
32	endotoxin	_	NN	NN	_	29	pobj	_	_
33	lipopolysaccharide	_	NN	NN	_	32	dep	_	_
34	-LRB-	_	-LRB-	-LRB-	_	35	punct	_	_
35	LPS	_	NN	NN	_	33	appos	_	_
36	-RRB-	_	-RRB-	-RRB-	_	35	punct	_	_
37	.	_	.	.	_	2	punct	_	_

1	Oral	_	JJ	JJ	_	2	amod	_	_
2	administration	_	NN	NN	_	11	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	276	_	CD	CD	_	5	number	_	_
5	mumol	_	NN	NN	_	6	amod	_	_
6	cortisol	_	NN	NN	_	3	pobj	_	_
7	to	_	TO	TO	_	2	prep	_	_
8	normal	_	JJ	JJ	_	9	amod	_	_
9	subjects	_	NNS	NNS	_	7	pobj	_	_
10	also	_	RB	RB	_	11	advmod	_	_
11	decreased	_	VBD	VBD	_	0	root	_	_
12	LPS-induced	_	JJ	JJ	_	14	amod	_	_
13	IL-1ra	_	NN	NN	_	14	nn	_	_
14	synthesis	_	NN	NN	_	11	dobj	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	cultured	_	VBN	VBN	_	17	amod	_	_
17	monocytes	_	NNS	NNS	_	15	pobj	_	_
18	.	_	.	.	_	11	punct	_	_

1	By	_	IN	IN	_	30	prep	_	_
2	coincubating	_	VBG	VBG	_	1	pcomp	_	_
3	the	_	DT	DT	_	4	det	_	_
4	monocytes	_	NNS	NNS	_	2	dobj	_	_
5	with	_	IN	IN	_	2	prep	_	_
6	either	_	CC	CC	_	10	preconj	_	_
7	the	_	DT	DT	_	10	det	_	_
8	mineralocorticoid	_	NN	NN	_	10	nn	_	_
9	antagonist	_	NN	NN	_	10	nn	_	_
10	spironolactone	_	NN	NN	_	5	pobj	_	_
11	or	_	CC	CC	_	10	cc	_	_
12	the	_	DT	DT	_	16	det	_	_
13	glucocorticoid	_	NN	NN	_	14	nn	_	_
14	receptor	_	NN	NN	_	16	nn	_	_
15	antagonist	_	NN	NN	_	16	nn	_	_
16	RU	_	NN	NN	_	10	conj	_	_
17	38486	_	CD	CD	_	16	num	_	_
18	,	_	,	,	_	30	punct	_	_
19	the	_	DT	DT	_	23	det	_	_
20	in	_	FW	FW	_	23	amod	_	_
21	vitro	_	FW	FW	_	20	dep	_	_
22	cortisol-induced	_	JJ	JJ	_	20	dep	_	_
23	inhibition	_	NN	NN	_	30	nsubjpass	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	LPS-stimulated	_	JJ	JJ	_	27	amod	_	_
26	IL-1ra	_	NN	NN	_	27	nn	_	_
27	secretion	_	NN	NN	_	24	pobj	_	_
28	was	_	VBD	VBD	_	30	auxpass	_	_
29	partially	_	RB	RB	_	30	advmod	_	_
30	reversed	_	VBN	VBN	_	0	root	_	_
31	.	_	.	.	_	30	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	mineralocorticoid	_	NN	NN	_	3	nn	_	_
3	aldosterone	_	NN	NN	_	4	nsubj	_	_
4	exerted	_	VBD	VBD	_	0	root	_	_
5	a	_	DT	DT	_	7	det	_	_
6	significant	_	JJ	JJ	_	7	amod	_	_
7	decrease	_	NN	NN	_	4	dobj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	LPS-induced	_	JJ	JJ	_	12	amod	_	_
10	monocyte	_	NN	NN	_	12	nn	_	_
11	IL-1ra	_	NN	NN	_	12	nn	_	_
12	secretion	_	NN	NN	_	8	pobj	_	_
13	in	_	FW	FW	_	14	nn	_	_
14	vitro	_	FW	FW	_	4	advmod	_	_
15	,	_	,	,	_	4	punct	_	_
16	which	_	WDT	WDT	_	18	nsubjpass	_	_
17	was	_	VBD	VBD	_	18	auxpass	_	_
18	blocked	_	VBN	VBN	_	4	dep	_	_
19	by	_	IN	IN	_	18	prep	_	_
20	coincubation	_	NN	NN	_	19	pobj	_	_
21	with	_	IN	IN	_	20	prep	_	_
22	spironolactone	_	NN	NN	_	21	pobj	_	_
23	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	14	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	14	punct	_	_
4	the	_	DT	DT	_	5	det	_	_
5	expression	_	NN	NN	_	14	nsubjpass	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	mineralocorticoid	_	NN	NN	_	9	nn	_	_
8	receptor	_	NN	NN	_	9	nn	_	_
9	mRNA	_	NN	NN	_	6	pobj	_	_
10	in	_	IN	IN	_	5	prep	_	_
11	human	_	JJ	JJ	_	12	amod	_	_
12	monocytes	_	NNS	NNS	_	10	pobj	_	_
13	was	_	VBD	VBD	_	14	auxpass	_	_
14	observed	_	VBN	VBN	_	0	root	_	_
15	by	_	IN	IN	_	14	prep	_	_
16	PCR	_	NN	NN	_	15	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	reversed	_	VBN	VBN	_	20	amod	_	_
19	transcribed	_	VBN	VBN	_	20	amod	_	_
20	RNA	_	NN	NN	_	17	pobj	_	_
21	.	_	.	.	_	14	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	results	_	NNS	NNS	_	4	nsubj	_	_
3	further	_	RB	RB	_	4	advmod	_	_
4	indicate	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	8	mark	_	_
6	corticosteroids	_	NNS	NNS	_	8	nsubj	_	_
7	physiologically	_	RB	RB	_	8	advmod	_	_
8	control	_	VBP	VBP	_	4	ccomp	_	_
9	the	_	DT	DT	_	11	det	_	_
10	IL-1/IL-1ra	_	JJ	JJ	_	11	amod	_	_
11	system	_	NN	NN	_	8	dobj	_	_
12	during	_	IN	IN	_	8	prep	_	_
13	inflammatory	_	JJ	JJ	_	12	pobj	_	_
14	or	_	CC	CC	_	13	cc	_	_
15	immune	_	JJ	JJ	_	13	conj	_	_
16	processes	_	NNS	NNS	_	13	dep	_	_
17	.	_	.	.	_	4	punct	_	_

1	Moreover	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	provide	_	VBP	VBP	_	0	root	_	_
5	evidence	_	NN	NN	_	4	dobj	_	_
6	that	_	IN	IN	_	20	mark	_	_
7	,	_	,	,	_	20	punct	_	_
8	in	_	IN	IN	_	20	prep	_	_
9	addition	_	NN	NN	_	8	pobj	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	a	_	DT	DT	_	14	det	_	_
12	glucocorticoid	_	NN	NN	_	14	nn	_	_
13	receptor-mediated	_	JJ	JJ	_	14	amod	_	_
14	effect	_	NN	NN	_	10	pobj	_	_
15	,	_	,	,	_	20	punct	_	_
16	the	_	DT	DT	_	18	det	_	_
17	mineralocorticoid	_	NN	NN	_	18	nn	_	_
18	receptor	_	NN	NN	_	20	nsubjpass	_	_
19	is	_	VBZ	VBZ	_	20	auxpass	_	_
20	involved	_	VBN	VBN	_	5	ccomp	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	23	det	_	_
23	inhibition	_	NN	NN	_	21	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	monocyte	_	NN	NN	_	27	nn	_	_
26	IL-1ra	_	NN	NN	_	27	nn	_	_
27	secretion	_	NN	NN	_	24	pobj	_	_
28	by	_	IN	IN	_	23	prep	_	_
29	cortisol	_	NN	NN	_	28	pobj	_	_
30	.	_	.	.	_	4	punct	_	_

1	Distinctive	_	JJ	JJ	_	3	amod	_	_
2	expression	_	NN	NN	_	3	nn	_	_
3	pattern	_	NN	NN	_	0	root	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	BCL-6	_	NN	NN	_	7	nn	_	_
7	protein	_	NN	NN	_	4	pobj	_	_
8	in	_	IN	IN	_	3	prep	_	_
9	nodular	_	JJ	JJ	_	14	amod	_	_
10	lymphocyte	_	NN	NN	_	14	nn	_	_
11	predominance	_	NN	NN	_	14	nn	_	_
12	Hodgkin	_	NN	NN	_	14	poss	_	_
13	's	_	POS	POS	_	14	possessive	_	_
14	disease	_	NN	NN	_	8	pobj	_	_
15	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	BCL-6	_	NN	NN	_	3	nn	_	_
3	gene	_	NN	NN	_	12	nsubjpass	_	_
4	encoding	_	VBG	VBG	_	3	vmod	_	_
5	a	_	DT	DT	_	10	det	_	_
6	nuclear-located	_	JJ	JJ	_	10	amod	_	_
7	Kruppel-type	_	JJ	JJ	_	10	amod	_	_
8	zinc	_	NN	NN	_	10	nn	_	_
9	finger	_	NN	NN	_	10	nn	_	_
10	protein	_	NN	NN	_	4	dobj	_	_
11	is	_	VBZ	VBZ	_	12	auxpass	_	_
12	rearranged	_	VBN	VBN	_	0	root	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	about	_	RB	RB	_	15	quantmod	_	_
15	30	_	CD	CD	_	16	dep	_	_
16	%	_	NN	NN	_	20	dep	_	_
17	diffuse	_	JJ	JJ	_	20	amod	_	_
18	large	_	JJ	JJ	_	20	amod	_	_
19	B-cell	_	NN	NN	_	20	nn	_	_
20	lymphomas	_	NNS	NNS	_	13	pobj	_	_
21	and	_	CC	CC	_	12	cc	_	_
22	is	_	VBZ	VBZ	_	23	auxpass	_	_
23	expressed	_	VBN	VBN	_	12	conj	_	_
24	predominantly	_	RB	RB	_	23	advmod	_	_
25	in	_	IN	IN	_	23	prep	_	_
26	normal	_	JJ	JJ	_	30	amod	_	_
27	germinal	_	JJ	JJ	_	30	amod	_	_
28	center	_	NN	NN	_	30	nn	_	_
29	B	_	NN	NN	_	30	nn	_	_
30	cells	_	NNS	NNS	_	25	pobj	_	_
31	and	_	CC	CC	_	30	cc	_	_
32	related	_	JJ	JJ	_	33	amod	_	_
33	lymphomas	_	NNS	NNS	_	30	conj	_	_
34	.	_	.	.	_	12	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	findings	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	7	mark	_	_
5	BCL-6	_	NN	NN	_	7	nsubj	_	_
6	may	_	MD	MD	_	7	aux	_	_
7	play	_	VB	VB	_	3	ccomp	_	_
8	a	_	DT	DT	_	9	det	_	_
9	role	_	NN	NN	_	7	dobj	_	_
10	in	_	IN	IN	_	7	prep	_	_
11	regulating	_	VBG	VBG	_	10	pcomp	_	_
12	differentiation	_	NN	NN	_	11	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	normal	_	JJ	JJ	_	18	amod	_	_
15	germinal	_	JJ	JJ	_	18	amod	_	_
16	center	_	NN	NN	_	18	nn	_	_
17	B	_	NN	NN	_	18	nn	_	_
18	cells	_	NNS	NNS	_	13	pobj	_	_
19	and	_	CC	CC	_	7	cc	_	_
20	that	_	IN	IN	_	28	mark	_	_
21	its	_	PRP$	PRP$	_	23	poss	_	_
22	deregulated	_	VBN	VBN	_	23	amod	_	_
23	expression	_	NN	NN	_	28	nsubj	_	_
24	caused	_	VBN	VBN	_	23	vmod	_	_
25	by	_	IN	IN	_	24	prep	_	_
26	rearrangements	_	NNS	NNS	_	25	pobj	_	_
27	may	_	MD	MD	_	28	aux	_	_
28	contribute	_	VB	VB	_	7	conj	_	_
29	to	_	TO	TO	_	28	prep	_	_
30	lymphomagenesis	_	NN	NN	_	29	pobj	_	_
31	.	_	.	.	_	3	punct	_	_

1	This	_	DT	DT	_	2	nsubj	_	_
2	prompted	_	VBD	VBD	_	0	root	_	_
3	us	_	PRP	PRP	_	2	dobj	_	_
4	to	_	TO	TO	_	5	aux	_	_
5	investigate	_	VB	VB	_	2	xcomp	_	_
6	the	_	DT	DT	_	7	det	_	_
7	expression	_	NN	NN	_	5	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	BCL-6	_	NN	NN	_	11	nn	_	_
11	protein	_	NN	NN	_	8	pobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	Hodgkin	_	NN	NN	_	15	poss	_	_
14	's	_	POS	POS	_	15	possessive	_	_
15	disease	_	NN	NN	_	12	pobj	_	_
16	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
17	HD	_	NN	NN	_	15	appos	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	,	_	,	,	_	5	punct	_	_
20	focusing	_	VBG	VBG	_	5	vmod	_	_
21	on	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	26	det	_	_
23	nodular	_	JJ	JJ	_	26	amod	_	_
24	lymphocyte	_	NN	NN	_	26	nn	_	_
25	predominance	_	NN	NN	_	26	nn	_	_
26	subtype	_	NN	NN	_	21	pobj	_	_
27	-LRB-	_	-LRB-	-LRB-	_	28	punct	_	_
28	NLPHD	_	NN	NN	_	26	appos	_	_
29	-RRB-	_	-RRB-	-RRB-	_	28	punct	_	_
30	,	_	,	,	_	26	punct	_	_
31	which	_	WDT	WDT	_	32	nsubj	_	_
32	differs	_	VBZ	VBZ	_	26	rcmod	_	_
33	from	_	IN	IN	_	32	prep	_	_
34	classical	_	JJ	JJ	_	35	amod	_	_
35	HD	_	NN	NN	_	33	pobj	_	_
36	by	_	IN	IN	_	32	prep	_	_
37	virtue	_	NN	NN	_	36	pobj	_	_
38	of	_	IN	IN	_	37	prep	_	_
39	the	_	DT	DT	_	41	det	_	_
40	B-cell	_	NN	NN	_	41	nn	_	_
41	nature	_	NN	NN	_	38	pobj	_	_
42	of	_	IN	IN	_	41	prep	_	_
43	the	_	DT	DT	_	46	det	_	_
44	malignant	_	JJ	JJ	_	46	amod	_	_
45	cell	_	NN	NN	_	46	nn	_	_
46	population	_	NN	NN	_	42	pobj	_	_
47	-LRB-	_	-LRB-	-LRB-	_	52	punct	_	_
48	so-called	_	JJ	JJ	_	52	amod	_	_
49	L	_	NN	NN	_	52	nn	_	_
50	&amp;	_	CC	CC	_	49	cc	_	_
51	H	_	NN	NN	_	49	conj	_	_
52	cells	_	NNS	NNS	_	46	dep	_	_
53	-RRB-	_	-RRB-	-RRB-	_	52	punct	_	_
54	and	_	CC	CC	_	41	cc	_	_
55	its	_	PRP$	PRP$	_	56	poss	_	_
56	relationship	_	NN	NN	_	41	conj	_	_
57	with	_	IN	IN	_	56	prep	_	_
58	germinal	_	JJ	JJ	_	59	amod	_	_
59	centers	_	NNS	NNS	_	57	pobj	_	_
60	.	_	.	.	_	2	punct	_	_

1	Forty-one	_	CD	CD	_	3	num	_	_
2	HD	_	NN	NN	_	3	nn	_	_
3	samples	_	NNS	NNS	_	18	nsubjpass	_	_
4	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
5	19	_	CD	CD	_	6	num	_	_
6	NLPHD	_	NN	NN	_	3	dep	_	_
7	,	_	,	,	_	6	punct	_	_
8	12	_	CD	CD	_	10	num	_	_
9	nodular	_	JJ	JJ	_	10	amod	_	_
10	sclerosis	_	NN	NN	_	6	conj	_	_
11	,	_	,	,	_	6	punct	_	_
12	and	_	CC	CC	_	6	cc	_	_
13	10	_	CD	CD	_	15	num	_	_
14	mixed	_	JJ	JJ	_	15	amod	_	_
15	cellularity	_	NN	NN	_	6	conj	_	_
16	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
17	were	_	VBD	VBD	_	18	auxpass	_	_
18	immunostained	_	VBN	VBN	_	0	root	_	_
19	with	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	22	det	_	_
21	monoclonal	_	JJ	JJ	_	22	amod	_	_
22	antibodies	_	NNS	NNS	_	19	pobj	_	_
23	PG-B6	_	NN	NN	_	22	dep	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	PG-B6p	_	NN	NN	_	23	conj	_	_
26	that	_	WDT	WDT	_	27	nsubj	_	_
27	react	_	VBP	VBP	_	22	rcmod	_	_
28	with	_	IN	IN	_	27	prep	_	_
29	a	_	DT	DT	_	30	det	_	_
30	fixative-sensitive	_	JJ	JJ	_	28	pobj	_	_
31	and	_	CC	CC	_	30	cc	_	_
32	a	_	DT	DT	_	34	det	_	_
33	formalin-resistant	_	JJ	JJ	_	34	amod	_	_
34	epitope	_	NN	NN	_	30	conj	_	_
35	on	_	IN	IN	_	30	prep	_	_
36	the	_	DT	DT	_	38	det	_	_
37	aminoterminal	_	JJ	JJ	_	38	amod	_	_
38	region	_	NN	NN	_	35	pobj	_	_
39	of	_	IN	IN	_	38	prep	_	_
40	the	_	DT	DT	_	43	det	_	_
41	BCL-6	_	NN	NN	_	43	nn	_	_
42	gene	_	NN	NN	_	43	nn	_	_
43	product	_	NN	NN	_	39	pobj	_	_
44	,	_	,	,	_	27	punct	_	_
45	respectively	_	RB	RB	_	27	advmod	_	_
46	.	_	.	.	_	18	punct	_	_

1	Strong	_	JJ	JJ	_	3	amod	_	_
2	nuclear	_	JJ	JJ	_	3	amod	_	_
3	positivity	_	NN	NN	_	9	nsubjpass	_	_
4	for	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	BCL-6	_	NN	NN	_	7	nn	_	_
7	protein	_	NN	NN	_	4	pobj	_	_
8	was	_	VBD	VBD	_	9	auxpass	_	_
9	detected	_	VBN	VBN	_	0	root	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	tumor	_	NN	NN	_	13	nn	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	L	_	NN	NN	_	10	pobj	_	_
14	&amp;	_	CC	CC	_	13	cc	_	_
15	H	_	NN	NN	_	17	nn	_	_
16	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
17	cells	_	NNS	NNS	_	13	conj	_	_
18	in	_	IN	IN	_	13	prep	_	_
19	all	_	DT	DT	_	20	det	_	_
20	cases	_	NNS	NNS	_	18	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	NLPHD	_	NN	NN	_	21	pobj	_	_
23	.	_	.	.	_	9	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	6	punct	_	_
4	BCL-6	_	NN	NN	_	6	nsubjpass	_	_
5	was	_	VBD	VBD	_	6	auxpass	_	_
6	expressed	_	VBN	VBN	_	0	root	_	_
7	only	_	RB	RB	_	8	advmod	_	_
8	in	_	IN	IN	_	6	prep	_	_
9	a	_	DT	DT	_	11	det	_	_
10	small	_	JJ	JJ	_	11	amod	_	_
11	percentage	_	NN	NN	_	8	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	Hodgkin	_	NN	NN	_	16	nn	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	Reed-Sternberg	_	NN	NN	_	13	conj	_	_
16	cells	_	NNS	NNS	_	12	pobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	about	_	RB	RB	_	19	quantmod	_	_
19	30	_	CD	CD	_	20	num	_	_
20	%	_	NN	NN	_	17	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	classical	_	JJ	JJ	_	24	amod	_	_
23	HD	_	NN	NN	_	24	nn	_	_
24	cases	_	NNS	NNS	_	21	pobj	_	_
25	.	_	.	.	_	6	punct	_	_

1	Notably	_	RB	RB	_	24	advmod	_	_
2	,	_	,	,	_	24	punct	_	_
3	the	_	DT	DT	_	4	det	_	_
4	nuclei	_	NNS	NNS	_	24	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	reactive	_	JJ	JJ	_	9	amod	_	_
7	CD3+/CD4+	_	JJ	JJ	_	9	amod	_	_
8	T	_	NN	NN	_	9	nn	_	_
9	cells	_	NNS	NNS	_	5	pobj	_	_
10	nearby	_	JJ	JJ	_	9	amod	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	and	_	CC	CC	_	10	cc	_	_
13	rosetting	_	VBG	VBG	_	10	conj	_	_
14	around	_	IN	IN	_	13	prep	_	_
15	L	_	NN	NN	_	18	nn	_	_
16	&amp;	_	CC	CC	_	15	cc	_	_
17	H	_	NN	NN	_	15	conj	_	_
18	cells	_	NNS	NNS	_	10	dep	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	NLPHD	_	NN	NN	_	19	pobj	_	_
21	were	_	VBD	VBD	_	24	cop	_	_
22	also	_	RB	RB	_	24	advmod	_	_
23	strongly	_	RB	RB	_	24	advmod	_	_
24	BCL-6+	_	JJ	JJ	_	0	root	_	_
25	,	_	,	,	_	24	punct	_	_
26	but	_	CC	CC	_	24	cc	_	_
27	lacked	_	VBD	VBD	_	24	conj	_	_
28	CD40	_	NN	NN	_	29	nn	_	_
29	ligand	_	NN	NN	_	33	nn	_	_
30	-LRB-	_	-LRB-	-LRB-	_	31	punct	_	_
31	CD40L	_	NN	NN	_	29	appos	_	_
32	-RRB-	_	-RRB-	-RRB-	_	31	punct	_	_
33	expression	_	NN	NN	_	27	dobj	_	_
34	.	_	.	.	_	24	punct	_	_

1	This	_	DT	DT	_	3	det	_	_
2	staining	_	NN	NN	_	3	nn	_	_
3	pattern	_	NN	NN	_	5	nsubj	_	_
4	clearly	_	RB	RB	_	5	advmod	_	_
5	differed	_	VBD	VBD	_	0	root	_	_
6	from	_	IN	IN	_	5	prep	_	_
7	that	_	DT	DT	_	6	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	classical	_	JJ	JJ	_	10	amod	_	_
10	HD	_	NN	NN	_	8	pobj	_	_
11	,	_	,	,	_	10	punct	_	_
12	whose	_	WP$	WP$	_	14	poss	_	_
13	cellular	_	JJ	JJ	_	14	amod	_	_
14	background	_	NN	NN	_	16	nsubjpass	_	_
15	was	_	VBD	VBD	_	16	auxpass	_	_
16	made	_	VBN	VBN	_	10	rcmod	_	_
17	up	_	IN	IN	_	16	prt	_	_
18	of	_	IN	IN	_	16	prep	_	_
19	CD3+/CD4+	_	JJ	JJ	_	21	amod	_	_
20	T	_	NN	NN	_	21	nn	_	_
21	cells	_	NNS	NNS	_	18	pobj	_	_
22	showing	_	VBG	VBG	_	21	vmod	_	_
23	the	_	DT	DT	_	25	det	_	_
24	BCL-6-/CD40L+	_	JJ	JJ	_	25	amod	_	_
25	phenotype	_	NN	NN	_	22	dobj	_	_
26	.	_	.	.	_	5	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	4	nsubj	_	_
3	further	_	RBR	RBR	_	4	advmod	_	_
4	support	_	VBP	VBP	_	0	root	_	_
5	the	_	DT	DT	_	6	det	_	_
6	concept	_	NN	NN	_	4	dobj	_	_
7	that	_	IN	IN	_	15	mark	_	_
8	NLPHD	_	NN	NN	_	15	nsubj	_	_
9	is	_	VBZ	VBZ	_	15	cop	_	_
10	an	_	DT	DT	_	15	det	_	_
11	histogenetically	_	RB	RB	_	12	advmod	_	_
12	distinct	_	JJ	JJ	_	15	amod	_	_
13	,	_	,	,	_	12	punct	_	_
14	B-cell-derived	_	JJ	JJ	_	12	dep	_	_
15	subtype	_	NN	NN	_	6	ccomp	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	HD	_	NN	NN	_	16	pobj	_	_
18	and	_	CC	CC	_	4	cc	_	_
19	suggest	_	VBP	VBP	_	4	conj	_	_
20	a	_	DT	DT	_	21	det	_	_
21	role	_	NN	NN	_	19	dobj	_	_
22	for	_	IN	IN	_	21	prep	_	_
23	BCL-6	_	NN	NN	_	22	pobj	_	_
24	in	_	IN	IN	_	21	prep	_	_
25	its	_	PRP$	PRP$	_	26	poss	_	_
26	development	_	NN	NN	_	24	pobj	_	_
27	.	_	.	.	_	4	punct	_	_

1	MEK1	_	NN	NN	_	8	nsubjpass	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	the	_	DT	DT	_	6	det	_	_
4	extracellular	_	JJ	JJ	_	6	amod	_	_
5	signal-regulated	_	JJ	JJ	_	6	amod	_	_
6	kinases	_	NNS	NNS	_	1	conj	_	_
7	are	_	VBP	VBP	_	8	auxpass	_	_
8	required	_	VBN	VBN	_	0	root	_	_
9	for	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	stimulation	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	IL-2	_	NN	NN	_	14	nn	_	_
14	gene	_	NN	NN	_	15	nn	_	_
15	transcription	_	NN	NN	_	12	pobj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	T	_	NN	NN	_	18	nn	_	_
18	cells	_	NNS	NNS	_	16	pobj	_	_
19	.	_	.	.	_	8	punct	_	_

1	TCR	_	NN	NN	_	2	nn	_	_
2	engagement	_	NN	NN	_	3	nsubj	_	_
3	stimulates	_	VBZ	VBZ	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	activation	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	protein	_	NN	NN	_	9	nn	_	_
9	kinase	_	NN	NN	_	6	pobj	_	_
10	Raf-1	_	NN	NN	_	9	dep	_	_
11	.	_	.	.	_	3	punct	_	_

1	Active	_	JJ	JJ	_	2	amod	_	_
2	Raf-1	_	NN	NN	_	3	nsubj	_	_
3	phosphorylates	_	VBZ	VBZ	_	0	root	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	activates	_	VBZ	VBZ	_	3	conj	_	_
6	the	_	DT	DT	_	15	det	_	_
7	mitogen-activated	_	JJ	JJ	_	15	amod	_	_
8	protein	_	NN	NN	_	15	nn	_	_
9	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
10	MAP	_	NN	NN	_	15	nn	_	_
11	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
12	kinase/extracellular	_	JJ	JJ	_	15	amod	_	_
13	signal-regulated	_	JJ	JJ	_	15	amod	_	_
14	kinase	_	NN	NN	_	15	nn	_	_
15	kinase	_	NN	NN	_	3	dobj	_	_
16	1	_	CD	CD	_	15	num	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	MEK1	_	NN	NN	_	15	appos	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	,	_	,	,	_	3	punct	_	_
21	which	_	WDT	WDT	_	24	nsubj	_	_
22	in	_	IN	IN	_	24	prep	_	_
23	turn	_	NN	NN	_	22	pobj	_	_
24	phosphorylates	_	VBZ	VBZ	_	3	dep	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	activates	_	VBZ	VBZ	_	24	conj	_	_
27	the	_	DT	DT	_	32	det	_	_
28	MAP	_	NN	NN	_	32	nn	_	_
29	kinases/extracellular	_	JJ	JJ	_	32	amod	_	_
30	signal	_	NN	NN	_	32	nn	_	_
31	regulated	_	JJ	JJ	_	32	amod	_	_
32	kinases	_	NNS	NNS	_	24	dobj	_	_
33	,	_	,	,	_	32	punct	_	_
34	ERK1	_	NN	NN	_	32	appos	_	_
35	and	_	CC	CC	_	34	cc	_	_
36	ERK2	_	NN	NN	_	34	conj	_	_
37	.	_	.	.	_	3	punct	_	_

1	Raf-1	_	NN	NN	_	2	nn	_	_
2	activity	_	NN	NN	_	3	nsubj	_	_
3	promotes	_	VBZ	VBZ	_	0	root	_	_
4	IL-2	_	NN	NN	_	5	nn	_	_
5	production	_	NN	NN	_	3	dobj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	activated	_	VBN	VBN	_	9	amod	_	_
8	T	_	NN	NN	_	9	nn	_	_
9	lymphocytes	_	NNS	NNS	_	6	pobj	_	_
10	.	_	.	.	_	3	punct	_	_

1	Therefore	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	sought	_	VBD	VBD	_	0	root	_	_
5	to	_	TO	TO	_	6	aux	_	_
6	determine	_	VB	VB	_	4	xcomp	_	_
7	whether	_	IN	IN	_	13	mark	_	_
8	MEK1	_	NN	NN	_	13	nsubj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	ERK	_	NN	NN	_	8	conj	_	_
11	activities	_	NNS	NNS	_	8	dep	_	_
12	also	_	RB	RB	_	13	advmod	_	_
13	stimulate	_	VBP	VBP	_	6	ccomp	_	_
14	IL-2	_	NN	NN	_	15	nn	_	_
15	gene	_	NN	NN	_	16	nn	_	_
16	transcription	_	NN	NN	_	13	dobj	_	_
17	.	_	.	.	_	4	punct	_	_

1	Expression	_	NN	NN	_	12	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	constitutively	_	RB	RB	_	4	advmod	_	_
4	active	_	JJ	JJ	_	5	amod	_	_
5	Raf-1	_	NN	NN	_	2	pobj	_	_
6	or	_	CC	CC	_	5	cc	_	_
7	MEK1	_	NN	NN	_	5	conj	_	_
8	in	_	IN	IN	_	1	prep	_	_
9	Jurkat	_	NN	NN	_	11	nn	_	_
10	T	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	8	pobj	_	_
12	enhanced	_	VBD	VBD	_	0	root	_	_
13	the	_	DT	DT	_	14	det	_	_
14	stimulation	_	NN	NN	_	12	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	IL-2	_	NN	NN	_	18	nn	_	_
17	promoter-driven	_	JJ	JJ	_	18	amod	_	_
18	transcription	_	NN	NN	_	15	pobj	_	_
19	stimulated	_	VBN	VBN	_	18	vmod	_	_
20	by	_	IN	IN	_	19	prep	_	_
21	a	_	DT	DT	_	23	det	_	_
22	calcium	_	NN	NN	_	23	nn	_	_
23	ionophore	_	NN	NN	_	20	pobj	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	PMA	_	NN	NN	_	23	conj	_	_
26	,	_	,	,	_	12	punct	_	_
27	and	_	CC	CC	_	12	cc	_	_
28	together	_	RB	RB	_	29	advmod	_	_
29	with	_	IN	IN	_	39	prep	_	_
30	a	_	DT	DT	_	32	det	_	_
31	calcium	_	NN	NN	_	32	nn	_	_
32	ionophore	_	NN	NN	_	29	pobj	_	_
33	the	_	DT	DT	_	34	det	_	_
34	expression	_	NN	NN	_	39	nsubj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	each	_	DT	DT	_	37	det	_	_
37	protein	_	NN	NN	_	35	pobj	_	_
38	was	_	VBD	VBD	_	39	cop	_	_
39	sufficient	_	JJ	JJ	_	12	conj	_	_
40	to	_	TO	TO	_	41	aux	_	_
41	stimulate	_	VB	VB	_	39	xcomp	_	_
42	NF-AT	_	NN	NN	_	43	nn	_	_
43	activity	_	NN	NN	_	41	dobj	_	_
44	.	_	.	.	_	12	punct	_	_

1	Expression	_	NN	NN	_	5	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	MEK1-interfering	_	JJ	JJ	_	4	amod	_	_
4	mutants	_	NNS	NNS	_	2	pobj	_	_
5	inhibited	_	VBD	VBD	_	0	root	_	_
6	the	_	DT	DT	_	7	det	_	_
7	stimulation	_	NN	NN	_	5	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	IL-2	_	NN	NN	_	11	nn	_	_
10	promoter-driven	_	JJ	JJ	_	11	amod	_	_
11	transcription	_	NN	NN	_	8	pobj	_	_
12	and	_	CC	CC	_	5	cc	_	_
13	blocked	_	VBD	VBD	_	5	conj	_	_
14	the	_	DT	DT	_	15	det	_	_
15	ability	_	NN	NN	_	13	dobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	constitutively	_	RB	RB	_	18	advmod	_	_
18	active	_	JJ	JJ	_	19	amod	_	_
19	Ras	_	NN	NN	_	16	pobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	Raf-1	_	NN	NN	_	19	conj	_	_
22	to	_	TO	TO	_	23	aux	_	_
23	costimulate	_	VB	VB	_	15	vmod	_	_
24	NF-AT	_	NN	NN	_	25	nn	_	_
25	activity	_	NN	NN	_	23	dobj	_	_
26	with	_	IN	IN	_	23	prep	_	_
27	a	_	DT	DT	_	29	det	_	_
28	calcium	_	NN	NN	_	29	nn	_	_
29	ionophore	_	NN	NN	_	26	pobj	_	_
30	.	_	.	.	_	5	punct	_	_

1	Expression	_	NN	NN	_	15	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	6	det	_	_
4	MAP	_	NN	NN	_	6	nn	_	_
5	kinase-specific	_	JJ	JJ	_	6	amod	_	_
6	phosphatase	_	NN	NN	_	2	pobj	_	_
7	,	_	,	,	_	6	punct	_	_
8	MKP-1	_	NN	NN	_	6	appos	_	_
9	,	_	,	,	_	6	punct	_	_
10	which	_	WDT	WDT	_	11	nsubj	_	_
11	blocks	_	VBZ	VBZ	_	6	rcmod	_	_
12	ERK	_	NN	NN	_	13	nn	_	_
13	activation	_	NN	NN	_	11	dobj	_	_
14	,	_	,	,	_	1	punct	_	_
15	inhibited	_	VBD	VBD	_	0	root	_	_
16	IL-2	_	NN	NN	_	17	nn	_	_
17	promoter	_	NN	NN	_	15	dobj	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	NF-AT-driven	_	JJ	JJ	_	20	amod	_	_
20	transcription	_	NN	NN	_	17	conj	_	_
21	stimulated	_	VBN	VBN	_	17	vmod	_	_
22	by	_	IN	IN	_	21	prep	_	_
23	a	_	DT	DT	_	25	det	_	_
24	calcium	_	NN	NN	_	25	nn	_	_
25	ionophore	_	NN	NN	_	22	pobj	_	_
26	and	_	CC	CC	_	25	cc	_	_
27	PMA	_	NN	NN	_	25	conj	_	_
28	,	_	,	,	_	15	punct	_	_
29	and	_	CC	CC	_	15	cc	_	_
30	in	_	IN	IN	_	34	prep	_	_
31	addition	_	NN	NN	_	30	pobj	_	_
32	,	_	,	,	_	34	punct	_	_
33	MKP-1	_	NN	NN	_	34	nsubj	_	_
34	neutralized	_	VBD	VBD	_	15	conj	_	_
35	the	_	DT	DT	_	37	det	_	_
36	transcriptional	_	JJ	JJ	_	37	amod	_	_
37	enhancement	_	NN	NN	_	34	dobj	_	_
38	caused	_	VBN	VBN	_	37	vmod	_	_
39	by	_	IN	IN	_	38	prep	_	_
40	active	_	JJ	JJ	_	41	amod	_	_
41	Raf-1	_	NN	NN	_	39	pobj	_	_
42	and	_	CC	CC	_	41	cc	_	_
43	MEK1	_	NN	NN	_	41	conj	_	_
44	expression	_	NN	NN	_	41	dep	_	_
45	.	_	.	.	_	15	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	conclude	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	20	mark	_	_
4	the	_	DT	DT	_	9	det	_	_
5	MAP	_	NN	NN	_	6	nn	_	_
6	kinase	_	NN	NN	_	9	nn	_	_
7	signal	_	NN	NN	_	9	nn	_	_
8	transduction	_	NN	NN	_	9	nn	_	_
9	pathway	_	NN	NN	_	20	nsubj	_	_
10	consisting	_	VBG	VBG	_	9	vmod	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	Raf-1	_	NN	NN	_	11	pobj	_	_
13	,	_	,	,	_	12	punct	_	_
14	MEK1	_	NN	NN	_	12	appos	_	_
15	,	_	,	,	_	12	punct	_	_
16	and	_	CC	CC	_	12	cc	_	_
17	ERK1	_	NN	NN	_	12	conj	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	ERK2	_	NN	NN	_	17	conj	_	_
20	functions	_	VBZ	VBZ	_	2	ccomp	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	26	det	_	_
23	stimulation	_	NN	NN	_	26	nn	_	_
24	IL-2	_	NN	NN	_	25	nn	_	_
25	gene	_	NN	NN	_	26	nn	_	_
26	transcription	_	NN	NN	_	21	pobj	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	activated	_	VBN	VBN	_	30	amod	_	_
29	T	_	NN	NN	_	30	nn	_	_
30	lymphocytes	_	NNS	NNS	_	27	pobj	_	_
31	.	_	.	.	_	2	punct	_	_

1	HIV	_	NN	NN	_	2	nn	_	_
2	glycoprotein	_	NN	NN	_	4	nsubj	_	_
3	120	_	CD	CD	_	2	num	_	_
4	enhances	_	VBZ	VBZ	_	0	root	_	_
5	intercellular	_	JJ	JJ	_	7	amod	_	_
6	adhesion	_	NN	NN	_	7	nn	_	_
7	molecule-1	_	NN	NN	_	9	nn	_	_
8	gene	_	NN	NN	_	9	nn	_	_
9	expression	_	NN	NN	_	4	dobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	glial	_	JJ	JJ	_	12	amod	_	_
12	cells	_	NNS	NNS	_	10	pobj	_	_
13	.	_	.	.	_	4	punct	_	_

1	Involvement	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	Janus	_	NN	NN	_	5	nn	_	_
4	kinase/signal	_	JJ	JJ	_	5	amod	_	_
5	transducer	_	NN	NN	_	2	pobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	activator	_	NN	NN	_	9	nn	_	_
8	of	_	IN	IN	_	9	amod	_	_
9	transcription	_	NN	NN	_	5	conj	_	_
10	and	_	CC	CC	_	1	cc	_	_
11	protein	_	NN	NN	_	13	nn	_	_
12	kinase	_	NN	NN	_	13	nn	_	_
13	C	_	NN	NN	_	15	nn	_	_
14	signaling	_	NN	NN	_	15	nn	_	_
15	pathways	_	NNS	NNS	_	1	conj	_	_
16	.	_	.	.	_	1	punct	_	_

1	It	_	PRP	PRP	_	4	nsubjpass	_	_
2	is	_	VBZ	VBZ	_	4	auxpass	_	_
3	well	_	RB	RB	_	4	advmod	_	_
4	established	_	VBN	VBN	_	0	root	_	_
5	that	_	IN	IN	_	26	mark	_	_
6	the	_	DT	DT	_	10	det	_	_
7	two	_	CD	CD	_	10	num	_	_
8	major	_	JJ	JJ	_	10	amod	_	_
9	glial	_	JJ	JJ	_	10	amod	_	_
10	cells	_	NNS	NNS	_	26	nsubj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	15	det	_	_
13	central	_	JJ	JJ	_	15	amod	_	_
14	nervous	_	JJ	JJ	_	15	amod	_	_
15	system	_	NN	NN	_	11	pobj	_	_
16	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
17	CNS	_	NN	NN	_	15	appos	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	,	_	,	,	_	10	punct	_	_
20	astrocytes	_	NNS	NNS	_	10	appos	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	microglia	_	NN	NN	_	20	conj	_	_
23	,	_	,	,	_	10	punct	_	_
24	are	_	VBP	VBP	_	26	cop	_	_
25	key	_	JJ	JJ	_	26	amod	_	_
26	participants	_	NNS	NNS	_	4	ccomp	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	mediating	_	VBG	VBG	_	27	pcomp	_	_
29	the	_	DT	DT	_	31	det	_	_
30	neurologic	_	JJ	JJ	_	31	amod	_	_
31	dysfunction	_	NN	NN	_	28	dobj	_	_
32	associated	_	VBN	VBN	_	31	vmod	_	_
33	with	_	IN	IN	_	32	prep	_	_
34	HIV	_	NN	NN	_	35	nn	_	_
35	infection	_	NN	NN	_	33	pobj	_	_
36	of	_	IN	IN	_	35	prep	_	_
37	the	_	DT	DT	_	38	det	_	_
38	CNS	_	NN	NN	_	36	pobj	_	_
39	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	study	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	investigated	_	VBD	VBD	_	0	root	_	_
7	the	_	DT	DT	_	8	det	_	_
8	ability	_	NN	NN	_	6	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	13	det	_	_
11	major	_	JJ	JJ	_	13	amod	_	_
12	envelope	_	NN	NN	_	13	nn	_	_
13	glycoprotein	_	NN	NN	_	9	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	HIV	_	NN	NN	_	14	pobj	_	_
16	,	_	,	,	_	9	punct	_	_
17	glycoprotein	_	NN	NN	_	9	pobj	_	_
18	120	_	CD	CD	_	17	num	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	gp120	_	NN	NN	_	17	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	,	_	,	,	_	8	punct	_	_
23	to	_	TO	TO	_	24	aux	_	_
24	regulate	_	VB	VB	_	8	vmod	_	_
25	intercellular	_	JJ	JJ	_	27	amod	_	_
26	adhesion	_	NN	NN	_	27	nn	_	_
27	molecule-1	_	NN	NN	_	31	nn	_	_
28	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
29	ICAM-1	_	NN	NN	_	27	appos	_	_
30	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
31	expression	_	NN	NN	_	24	dobj	_	_
32	in	_	IN	IN	_	31	prep	_	_
33	glial	_	JJ	JJ	_	34	amod	_	_
34	cells	_	NNS	NNS	_	32	pobj	_	_
35	,	_	,	,	_	6	punct	_	_
36	because	_	IN	IN	_	39	mark	_	_
37	ICAM-1	_	NN	NN	_	39	nsubj	_	_
38	is	_	VBZ	VBZ	_	39	cop	_	_
39	important	_	JJ	JJ	_	6	advcl	_	_
40	in	_	IN	IN	_	39	prep	_	_
41	mediating	_	VBG	VBG	_	40	pcomp	_	_
42	immune	_	JJ	JJ	_	43	amod	_	_
43	responsiveness	_	NN	NN	_	41	dobj	_	_
44	in	_	IN	IN	_	43	prep	_	_
45	the	_	DT	DT	_	46	det	_	_
46	CNS	_	NN	NN	_	44	pobj	_	_
47	,	_	,	,	_	41	punct	_	_
48	facilitating	_	VBG	VBG	_	41	conj	_	_
49	entry	_	NN	NN	_	48	dobj	_	_
50	of	_	IN	IN	_	49	prep	_	_
51	HIV-infected	_	JJ	JJ	_	52	amod	_	_
52	cells	_	NNS	NNS	_	50	pobj	_	_
53	into	_	IN	IN	_	49	prep	_	_
54	the	_	DT	DT	_	55	det	_	_
55	CNS	_	NN	NN	_	53	pobj	_	_
56	,	_	,	,	_	41	punct	_	_
57	and	_	CC	CC	_	41	cc	_	_
58	promoting	_	VBG	VBG	_	41	conj	_	_
59	syncytia	_	NN	NN	_	60	nn	_	_
60	formation	_	NN	NN	_	58	dobj	_	_
61	.	_	.	.	_	6	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	6	mark	_	_
5	gp120	_	NN	NN	_	6	nsubj	_	_
6	enhances	_	VBZ	VBZ	_	3	ccomp	_	_
7	ICAM-1	_	NN	NN	_	9	nn	_	_
8	gene	_	NN	NN	_	9	nn	_	_
9	expression	_	NN	NN	_	6	dobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	primary	_	JJ	JJ	_	13	amod	_	_
12	rat	_	NN	NN	_	13	nn	_	_
13	astrocytes	_	NNS	NNS	_	10	pobj	_	_
14	,	_	,	,	_	13	punct	_	_
15	primary	_	JJ	JJ	_	17	amod	_	_
16	human	_	JJ	JJ	_	17	amod	_	_
17	astrocytes	_	NNS	NNS	_	13	conj	_	_
18	,	_	,	,	_	13	punct	_	_
19	a	_	DT	DT	_	24	det	_	_
20	human	_	JJ	JJ	_	24	amod	_	_
21	astroglioma	_	NN	NN	_	24	nn	_	_
22	cell	_	NN	NN	_	24	nn	_	_
23	line	_	NN	NN	_	24	nn	_	_
24	CRT	_	NN	NN	_	13	conj	_	_
25	,	_	,	,	_	13	punct	_	_
26	and	_	CC	CC	_	13	cc	_	_
27	primary	_	JJ	JJ	_	29	amod	_	_
28	rat	_	NN	NN	_	29	nn	_	_
29	microglia	_	NNS	NNS	_	13	conj	_	_
30	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	signal	_	NN	NN	_	4	nn	_	_
3	transduction	_	NN	NN	_	4	nn	_	_
4	events	_	NNS	NNS	_	11	nsubj	_	_
5	involved	_	VBN	VBN	_	4	vmod	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	gp120-mediated	_	JJ	JJ	_	8	amod	_	_
8	enhancement	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	ICAM-1	_	NN	NN	_	9	pobj	_	_
11	appear	_	VBP	VBP	_	0	root	_	_
12	to	_	TO	TO	_	13	aux	_	_
13	involve	_	VB	VB	_	11	xcomp	_	_
14	activation	_	NN	NN	_	13	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	both	_	CC	CC	_	19	preconj	_	_
17	protein	_	NN	NN	_	19	nn	_	_
18	kinase	_	NN	NN	_	19	nn	_	_
19	C	_	NN	NN	_	15	pobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	tyrosine	_	NN	NN	_	22	nn	_	_
22	kinase	_	NN	NN	_	19	conj	_	_
23	,	_	,	,	_	11	punct	_	_
24	because	_	IN	IN	_	33	mark	_	_
25	inhibitors	_	NNS	NNS	_	33	nsubj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	protein	_	NN	NN	_	29	nn	_	_
28	kinase	_	NN	NN	_	29	nn	_	_
29	C	_	NN	NN	_	26	pobj	_	_
30	and	_	CC	CC	_	29	cc	_	_
31	tyrosine	_	NN	NN	_	32	nn	_	_
32	kinase	_	NN	NN	_	29	conj	_	_
33	abrogate	_	VBP	VBP	_	11	advcl	_	_
34	gp120-mediated	_	JJ	JJ	_	36	amod	_	_
35	ICAM-1	_	NN	NN	_	36	nn	_	_
36	expression	_	NN	NN	_	33	dobj	_	_
37	in	_	IN	IN	_	36	prep	_	_
38	both	_	CC	CC	_	39	preconj	_	_
39	astrocytes	_	NNS	NNS	_	37	pobj	_	_
40	and	_	CC	CC	_	39	cc	_	_
41	microglia	_	NNS	NNS	_	39	conj	_	_
42	.	_	.	.	_	11	punct	_	_

1	Moreover	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	gp120	_	NN	NN	_	4	nsubj	_	_
4	induces	_	VBZ	VBZ	_	0	root	_	_
5	tyrosine	_	NN	NN	_	6	nn	_	_
6	phosphorylation	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	signal	_	NN	NN	_	9	nn	_	_
9	transducer	_	NN	NN	_	7	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	activator	_	NN	NN	_	13	nn	_	_
12	of	_	IN	IN	_	13	amod	_	_
13	transcription	_	NN	NN	_	9	conj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
15	STAT-1	_	NN	NN	_	16	nn	_	_
16	alpha	_	NN	NN	_	9	appos	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	as	_	RB	RB	_	19	advmod	_	_
19	well	_	RB	RB	_	9	cc	_	_
20	as	_	IN	IN	_	19	mwe	_	_
21	the	_	DT	DT	_	23	det	_	_
22	Janus	_	NN	NN	_	23	nn	_	_
23	kinase	_	NN	NN	_	9	conj	_	_
24	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
25	JAK2	_	NN	NN	_	23	appos	_	_
26	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
27	in	_	IN	IN	_	23	prep	_	_
28	glial	_	JJ	JJ	_	29	amod	_	_
29	cells	_	NNS	NNS	_	27	pobj	_	_
30	.	_	.	.	_	4	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	demonstrate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	8	mark	_	_
5	gp120-mediated	_	JJ	JJ	_	7	amod	_	_
6	ICAM-1	_	NN	NN	_	7	nn	_	_
7	expression	_	NN	NN	_	8	nsubj	_	_
8	has	_	VBZ	VBZ	_	3	ccomp	_	_
9	functional	_	JJ	JJ	_	10	amod	_	_
10	significance	_	NN	NN	_	8	dobj	_	_
11	,	_	,	,	_	8	punct	_	_
12	as	_	IN	IN	_	14	dep	_	_
13	it	_	PRP	PRP	_	14	dep	_	_
14	enhances	_	VBZ	VBZ	_	8	advcl	_	_
15	the	_	DT	DT	_	16	det	_	_
16	ability	_	NN	NN	_	14	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	monocytic	_	JJ	JJ	_	19	amod	_	_
19	cells	_	NNS	NNS	_	17	pobj	_	_
20	to	_	TO	TO	_	21	aux	_	_
21	bind	_	VB	VB	_	16	vmod	_	_
22	to	_	TO	TO	_	21	prep	_	_
23	gp120-stimulated	_	JJ	JJ	_	25	amod	_	_
24	human	_	JJ	JJ	_	25	amod	_	_
25	astrocytes	_	NNS	NNS	_	22	pobj	_	_
26	in	_	IN	IN	_	21	prep	_	_
27	an	_	DT	DT	_	31	det	_	_
28	ICAM-1/beta	_	NN	NN	_	31	nn	_	_
29	2	_	CD	CD	_	31	num	_	_
30	integrin-dependent	_	JJ	JJ	_	31	amod	_	_
31	fashion	_	NN	NN	_	26	pobj	_	_
32	.	_	.	.	_	3	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	provide	_	VBP	VBP	_	0	root	_	_
4	new	_	JJ	JJ	_	5	amod	_	_
5	insights	_	NNS	NNS	_	3	dobj	_	_
6	into	_	IN	IN	_	5	prep	_	_
7	how	_	WRB	WRB	_	10	advmod	_	_
8	gp120	_	NN	NN	_	10	nsubj	_	_
9	can	_	MD	MD	_	10	aux	_	_
10	influence	_	VB	VB	_	6	pcomp	_	_
11	the	_	DT	DT	_	12	det	_	_
12	involvement	_	NN	NN	_	10	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	glial	_	JJ	JJ	_	15	amod	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	in	_	IN	IN	_	12	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	pathogenesis	_	NN	NN	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	AIDS	_	NN	NN	_	22	nn	_	_
21	dementia	_	JJ	JJ	_	22	amod	_	_
22	complex	_	NN	NN	_	19	pobj	_	_
23	.	_	.	.	_	3	punct	_	_

1	Inhibition	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	NF-AT	_	NN	NN	_	6	nn	_	_
4	signal	_	NN	NN	_	6	nn	_	_
5	transduction	_	NN	NN	_	6	nn	_	_
6	events	_	NNS	NNS	_	2	pobj	_	_
7	by	_	IN	IN	_	1	prep	_	_
8	a	_	DT	DT	_	10	det	_	_
9	dominant-negative	_	JJ	JJ	_	10	amod	_	_
10	form	_	NN	NN	_	7	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	calcineurin	_	NN	NN	_	11	pobj	_	_
13	.	_	.	.	_	1	punct	_	_

1	An	_	DT	DT	_	7	det	_	_
2	inhibitory	_	JJ	JJ	_	7	amod	_	_
3	,	_	,	,	_	2	punct	_	_
4	``	_	``	``	_	2	punct	_	_
5	dominant-negative	_	JJ	JJ	_	2	dep	_	_
6	,	_	,	,	_	2	punct	_	_
7	form	_	NN	NN	_	17	nsubjpass	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	15	det	_	_
10	calcineurin	_	NN	NN	_	15	nn	_	_
11	catalytic	_	JJ	JJ	_	15	amod	_	_
12	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
13	A	_	NN	NN	_	15	nn	_	_
14	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
15	subunit	_	NN	NN	_	8	pobj	_	_
16	was	_	VBD	VBD	_	17	auxpass	_	_
17	prepared	_	VBN	VBN	_	0	root	_	_
18	,	_	,	,	_	17	punct	_	_
19	which	_	WDT	WDT	_	20	nsubj	_	_
20	lacks	_	VBZ	VBZ	_	17	dep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	calmodulin-binding	_	JJ	JJ	_	23	amod	_	_
23	domain	_	NN	NN	_	20	dobj	_	_
24	,	_	,	,	_	23	punct	_	_
25	autoinhibitory	_	JJ	JJ	_	26	amod	_	_
26	domain	_	NN	NN	_	23	conj	_	_
27	and	_	CC	CC	_	23	cc	_	_
28	most	_	JJS	JJS	_	23	conj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	its	_	PRP$	PRP$	_	32	poss	_	_
31	catalytic	_	JJ	JJ	_	32	amod	_	_
32	core	_	NN	NN	_	29	pobj	_	_
33	but	_	CC	CC	_	20	cc	_	_
34	possesses	_	VBZ	VBZ	_	20	conj	_	_
35	the	_	DT	DT	_	42	det	_	_
36	regulatory	_	JJ	JJ	_	40	amod	_	_
37	-LRB-	_	-LRB-	-LRB-	_	40	punct	_	_
38	B	_	NN	NN	_	40	nn	_	_
39	-RRB-	_	-RRB-	-RRB-	_	40	punct	_	_
40	subunit	_	NN	NN	_	42	nn	_	_
41	binding	_	NN	NN	_	42	nn	_	_
42	domain	_	NN	NN	_	34	dobj	_	_
43	.	_	.	.	_	17	punct	_	_

1	When	_	WRB	WRB	_	2	advmod	_	_
2	tested	_	VBN	VBN	_	24	advcl	_	_
3	for	_	IN	IN	_	2	prep	_	_
4	its	_	PRP$	PRP$	_	5	poss	_	_
5	ability	_	NN	NN	_	3	pobj	_	_
6	to	_	TO	TO	_	7	aux	_	_
7	block	_	VB	VB	_	5	vmod	_	_
8	calcineurin-dependent	_	JJ	JJ	_	9	amod	_	_
9	signaling	_	NN	NN	_	7	dobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	Jurkat	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	10	pobj	_	_
13	,	_	,	,	_	24	punct	_	_
14	expression	_	NN	NN	_	24	nsubj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	this	_	DT	DT	_	23	det	_	_
17	``	_	``	``	_	23	punct	_	_
18	B-subunit	_	JJ	JJ	_	23	amod	_	_
19	knock-out	_	JJ	JJ	_	23	amod	_	_
20	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
21	BKO	_	NN	NN	_	23	nn	_	_
22	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
23	construct	_	NN	NN	_	15	pobj	_	_
24	suppressed	_	VBD	VBD	_	0	root	_	_
25	reporter	_	NN	NN	_	26	nn	_	_
26	gene	_	NN	NN	_	27	nn	_	_
27	activity	_	NN	NN	_	24	dobj	_	_
28	driven	_	VBN	VBN	_	27	vmod	_	_
29	by	_	IN	IN	_	28	prep	_	_
30	NF-AT	_	NN	NN	_	29	pobj	_	_
31	,	_	,	,	_	30	punct	_	_
32	the	_	DT	DT	_	35	det	_	_
33	pivotal	_	JJ	JJ	_	35	amod	_	_
34	promoter	_	NN	NN	_	35	nn	_	_
35	element	_	NN	NN	_	30	appos	_	_
36	for	_	IN	IN	_	35	prep	_	_
37	interleukin	_	NN	NN	_	42	nn	_	_
38	-LRB-	_	-LRB-	-LRB-	_	42	punct	_	_
39	IL	_	NN	NN	_	42	nn	_	_
40	-RRB-	_	-RRB-	-RRB-	_	42	punct	_	_
41	-2	_	CD	CD	_	42	num	_	_
42	gene	_	NN	NN	_	43	nn	_	_
43	induction	_	NN	NN	_	36	pobj	_	_
44	.	_	.	.	_	24	punct	_	_

1	Immunoprecipitation	_	NN	NN	_	5	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	epitope-labeled	_	JJ	JJ	_	4	amod	_	_
4	BKO	_	NN	NN	_	2	pobj	_	_
5	demonstrated	_	VBD	VBD	_	0	root	_	_
6	for	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	formation	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	a	_	DT	DT	_	12	det	_	_
11	tight	_	JJ	JJ	_	12	amod	_	_
12	complex	_	NN	NN	_	9	pobj	_	_
13	with	_	IN	IN	_	12	prep	_	_
14	endogenous	_	JJ	JJ	_	16	amod	_	_
15	B	_	NN	NN	_	16	nn	_	_
16	subunit	_	NN	NN	_	13	pobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	Jurkat	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	17	pobj	_	_
20	,	_	,	,	_	5	punct	_	_
21	consistent	_	JJ	JJ	_	5	advmod	_	_
22	with	_	IN	IN	_	21	prep	_	_
23	an	_	DT	DT	_	25	det	_	_
24	inhibitory	_	JJ	JJ	_	25	amod	_	_
25	mechanism	_	NN	NN	_	22	pobj	_	_
26	that	_	WDT	WDT	_	27	nsubj	_	_
27	involves	_	VBZ	VBZ	_	25	rcmod	_	_
28	the	_	DT	DT	_	29	det	_	_
29	sequestration	_	NN	NN	_	27	dobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	the	_	DT	DT	_	33	det	_	_
32	B	_	NN	NN	_	33	nn	_	_
33	subunit	_	NN	NN	_	30	pobj	_	_
34	.	_	.	.	_	5	punct	_	_

1	Furthermore	_	RB	RB	_	15	advmod	_	_
2	,	_	,	,	_	15	punct	_	_
3	the	_	DT	DT	_	7	det	_	_
4	sharply	_	RB	RB	_	5	advmod	_	_
5	reduced	_	VBN	VBN	_	7	amod	_	_
6	NF-AT	_	NN	NN	_	7	nn	_	_
7	activity	_	NN	NN	_	15	nsubjpass	_	_
8	produced	_	VBN	VBN	_	7	vmod	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	co-transfecting	_	VBG	VBG	_	11	amod	_	_
11	BKO	_	NN	NN	_	9	pobj	_	_
12	could	_	MD	MD	_	15	aux	_	_
13	be	_	VB	VB	_	15	auxpass	_	_
14	``	_	``	``	_	15	punct	_	_
15	rescued	_	VBN	VBN	_	0	root	_	_
16	by	_	IN	IN	_	15	prep	_	_
17	overexpression	_	NN	NN	_	16	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	transfected	_	VBN	VBN	_	21	amod	_	_
20	B	_	NN	NN	_	21	nn	_	_
21	subunit	_	NN	NN	_	18	pobj	_	_
22	,	_	,	,	_	15	punct	_	_
23	suggesting	_	VBG	VBG	_	15	vmod	_	_
24	that	_	IN	IN	_	30	mark	_	_
25	depletion	_	NN	NN	_	30	nsubj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	this	_	DT	DT	_	28	det	_	_
28	subunit	_	NN	NN	_	26	pobj	_	_
29	was	_	VBD	VBD	_	30	cop	_	_
30	responsible	_	JJ	JJ	_	23	ccomp	_	_
31	for	_	IN	IN	_	30	prep	_	_
32	the	_	DT	DT	_	33	det	_	_
33	inhibition	_	NN	NN	_	31	pobj	_	_
34	.	_	.	.	_	15	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	the	_	DT	DT	_	6	det	_	_
5	potential	_	JJ	JJ	_	6	amod	_	_
6	utility	_	NN	NN	_	3	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	agents	_	NNS	NNS	_	7	pobj	_	_
9	that	_	WDT	WDT	_	10	nsubj	_	_
10	disrupt	_	VBP	VBP	_	8	rcmod	_	_
11	calcineurin-mediated	_	JJ	JJ	_	14	amod	_	_
12	signal	_	NN	NN	_	14	nn	_	_
13	transduction	_	NN	NN	_	14	nn	_	_
14	pathways	_	NNS	NNS	_	10	dobj	_	_
15	by	_	IN	IN	_	10	prep	_	_
16	blocking	_	VBG	VBG	_	15	pcomp	_	_
17	formation	_	NN	NN	_	16	dobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	22	det	_	_
20	catalytically	_	RB	RB	_	22	advmod	_	_
21	active	_	JJ	JJ	_	22	amod	_	_
22	dimer	_	NN	NN	_	18	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	calcineurin	_	NN	NN	_	23	pobj	_	_
25	A	_	NN	NN	_	24	dep	_	_
26	and	_	CC	CC	_	24	cc	_	_
27	B	_	NN	NN	_	24	conj	_	_
28	subunits	_	NNS	NNS	_	24	dep	_	_
29	.	_	.	.	_	3	punct	_	_

1	Cross-linking	_	NN	NN	_	6	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	Fc	_	NN	NN	_	5	nn	_	_
4	gamma	_	NN	NN	_	5	nn	_	_
5	receptors	_	NNS	NNS	_	2	pobj	_	_
6	activates	_	VBZ	VBZ	_	0	root	_	_
7	HIV-1	_	NN	NN	_	11	nn	_	_
8	long	_	JJ	JJ	_	11	amod	_	_
9	terminal	_	JJ	JJ	_	11	amod	_	_
10	repeat-driven	_	JJ	JJ	_	11	amod	_	_
11	transcription	_	NN	NN	_	6	dobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	human	_	JJ	JJ	_	14	amod	_	_
14	monocytes	_	NNS	NNS	_	12	pobj	_	_
15	.	_	.	.	_	6	punct	_	_

1	Elevation	_	NN	NN	_	10	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	4	det	_	_
4	levels	_	NNS	NNS	_	2	pobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	circulating	_	VBG	VBG	_	8	amod	_	_
7	immune	_	JJ	JJ	_	8	amod	_	_
8	complexes	_	NNS	NNS	_	5	pobj	_	_
9	frequently	_	RB	RB	_	10	advmod	_	_
10	accompanies	_	VBZ	VBZ	_	0	root	_	_
11	HIV-1	_	NN	NN	_	12	nn	_	_
12	infection	_	NN	NN	_	10	dobj	_	_
13	and	_	CC	CC	_	10	cc	_	_
14	is	_	VBZ	VBZ	_	17	cop	_	_
15	a	_	DT	DT	_	17	det	_	_
16	prognostic	_	JJ	JJ	_	17	amod	_	_
17	indicator	_	NN	NN	_	10	conj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	clinical	_	JJ	JJ	_	20	amod	_	_
20	progression	_	NN	NN	_	18	pobj	_	_
21	from	_	IN	IN	_	20	prep	_	_
22	asymptomatic	_	JJ	JJ	_	23	amod	_	_
23	infection	_	NN	NN	_	21	pobj	_	_
24	to	_	TO	TO	_	20	prep	_	_
25	AIDS	_	NN	NN	_	24	pobj	_	_
26	.	_	.	.	_	10	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	report	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	25	mark	_	_
5	cross-linking	_	NN	NN	_	25	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	Fc	_	NN	NN	_	9	nn	_	_
8	gamma	_	NN	NN	_	9	nn	_	_
9	RI	_	NN	NN	_	6	pobj	_	_
10	or	_	CC	CC	_	9	cc	_	_
11	Fc	_	NN	NN	_	13	nn	_	_
12	gamma	_	NN	NN	_	13	nn	_	_
13	RII	_	NN	NN	_	9	conj	_	_
14	by	_	IN	IN	_	5	prep	_	_
15	adherent	_	JJ	JJ	_	17	amod	_	_
16	human	_	JJ	JJ	_	17	amod	_	_
17	IgG	_	NN	NN	_	14	pobj	_	_
18	or	_	CC	CC	_	14	cc	_	_
19	by	_	IN	IN	_	14	conj	_	_
20	specific	_	JJ	JJ	_	24	amod	_	_
21	anti-Fc	_	JJ	JJ	_	24	amod	_	_
22	gamma	_	NN	NN	_	24	nn	_	_
23	R	_	NN	NN	_	24	nn	_	_
24	mAb	_	NN	NN	_	19	pobj	_	_
25	activates	_	VBZ	VBZ	_	3	ccomp	_	_
26	HIV-1	_	NN	NN	_	28	nn	_	_
27	gene	_	NN	NN	_	28	nn	_	_
28	expression	_	NN	NN	_	25	dobj	_	_
29	in	_	IN	IN	_	28	prep	_	_
30	the	_	DT	DT	_	34	det	_	_
31	human	_	JJ	JJ	_	34	amod	_	_
32	monocytic	_	JJ	JJ	_	34	amod	_	_
33	cell	_	NN	NN	_	34	nn	_	_
34	line	_	NN	NN	_	29	pobj	_	_
35	BF24	_	NN	NN	_	34	dep	_	_
36	and	_	CC	CC	_	25	cc	_	_
37	increased	_	VBN	VBN	_	25	conj	_	_
38	HIV	_	NN	NN	_	39	nn	_	_
39	RNA	_	NN	NN	_	40	nn	_	_
40	expression	_	NN	NN	_	37	dobj	_	_
41	in	_	IN	IN	_	40	prep	_	_
42	monocytes	_	NNS	NNS	_	41	pobj	_	_
43	from	_	IN	IN	_	42	prep	_	_
44	HIV	_	NN	NN	_	46	nn	_	_
45	infected	_	JJ	JJ	_	46	amod	_	_
46	patients	_	NNS	NNS	_	43	pobj	_	_
47	as	_	IN	IN	_	48	mark	_	_
48	assayed	_	VBN	VBN	_	25	advcl	_	_
49	by	_	IN	IN	_	48	prep	_	_
50	reverse	_	JJ	JJ	_	51	amod	_	_
51	transcription-PCR	_	NN	NN	_	49	pobj	_	_
52	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	9	prep	_	_
2	THP-1	_	NN	NN	_	3	nn	_	_
3	cells	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	9	punct	_	_
5	Fc	_	NN	NN	_	7	nn	_	_
6	gamma	_	NN	NN	_	7	nn	_	_
7	R	_	NN	NN	_	8	nn	_	_
8	cross-linking	_	NN	NN	_	9	nsubj	_	_
9	induced	_	VBD	VBD	_	0	root	_	_
10	NF-kappa	_	NN	NN	_	11	nn	_	_
11	B	_	NN	NN	_	9	dobj	_	_
12	,	_	,	,	_	11	punct	_	_
13	which	_	WDT	WDT	_	15	nsubjpass	_	_
14	is	_	VBZ	VBZ	_	15	auxpass	_	_
15	known	_	VBN	VBN	_	11	rcmod	_	_
16	to	_	TO	TO	_	17	aux	_	_
17	bind	_	VB	VB	_	15	ccomp	_	_
18	to	_	TO	TO	_	17	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	regulatory	_	JJ	JJ	_	21	amod	_	_
21	region	_	NN	NN	_	18	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	26	det	_	_
24	long	_	JJ	JJ	_	26	amod	_	_
25	terminal	_	JJ	JJ	_	26	amod	_	_
26	repeat	_	NN	NN	_	22	pobj	_	_
27	-LRB-	_	-LRB-	-LRB-	_	28	punct	_	_
28	LTR	_	NN	NN	_	26	appos	_	_
29	-RRB-	_	-RRB-	-RRB-	_	28	punct	_	_
30	of	_	IN	IN	_	26	prep	_	_
31	HIV-1	_	NN	NN	_	30	pobj	_	_
32	and	_	CC	CC	_	17	cc	_	_
33	to	_	TO	TO	_	34	aux	_	_
34	activate	_	VB	VB	_	17	conj	_	_
35	HIV-1	_	NN	NN	_	36	nn	_	_
36	transcription	_	NN	NN	_	34	dobj	_	_
37	.	_	.	.	_	9	punct	_	_

1	Anti-TNF-alpha	_	JJ	JJ	_	2	amod	_	_
2	antibody	_	NN	NN	_	9	nsubj	_	_
3	but	_	CC	CC	_	4	cc	_	_
4	not	_	RB	RB	_	2	cc	_	_
5	anti-IL-1	_	JJ	JJ	_	7	amod	_	_
6	beta	_	NN	NN	_	7	nn	_	_
7	antibody	_	NN	NN	_	2	conj	_	_
8	strongly	_	RB	RB	_	9	advmod	_	_
9	inhibited	_	VBD	VBD	_	0	root	_	_
10	both	_	CC	CC	_	12	preconj	_	_
11	the	_	DT	DT	_	12	det	_	_
12	induction	_	NN	NN	_	9	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	HIV-1-LTR-driven	_	JJ	JJ	_	15	amod	_	_
15	transcription	_	NN	NN	_	13	pobj	_	_
16	and	_	CC	CC	_	12	cc	_	_
17	the	_	DT	DT	_	18	det	_	_
18	induction	_	NN	NN	_	12	conj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	NF-kappa	_	NN	NN	_	21	nn	_	_
21	B	_	NN	NN	_	19	pobj	_	_
22	by	_	IN	IN	_	12	prep	_	_
23	Fc	_	NN	NN	_	25	nn	_	_
24	gamma	_	NN	NN	_	25	nn	_	_
25	R	_	NN	NN	_	26	nn	_	_
26	cross-linking	_	NN	NN	_	22	pobj	_	_
27	.	_	.	.	_	9	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	9	mark	_	_
5	Fc	_	NN	NN	_	7	nn	_	_
6	gamma	_	NN	NN	_	7	nn	_	_
7	R	_	NN	NN	_	9	nsubj	_	_
8	can	_	MD	MD	_	9	aux	_	_
9	mediate	_	VB	VB	_	3	ccomp	_	_
10	a	_	DT	DT	_	12	det	_	_
11	TNF-alpha-dependent	_	JJ	JJ	_	12	amod	_	_
12	induction	_	NN	NN	_	9	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	HIV-1	_	NN	NN	_	15	nn	_	_
15	gene	_	NN	NN	_	16	nn	_	_
16	transcription	_	NN	NN	_	13	pobj	_	_
17	and	_	CC	CC	_	3	cc	_	_
18	suggest	_	VBP	VBP	_	3	conj	_	_
19	that	_	IN	IN	_	23	mark	_	_
20	immune	_	JJ	JJ	_	21	amod	_	_
21	complexes	_	NNS	NNS	_	23	nsubj	_	_
22	may	_	MD	MD	_	23	aux	_	_
23	contribute	_	VB	VB	_	18	ccomp	_	_
24	to	_	TO	TO	_	23	prep	_	_
25	the	_	DT	DT	_	26	det	_	_
26	pathophysiology	_	NN	NN	_	24	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	HIV-1	_	NN	NN	_	29	nn	_	_
29	infection	_	NN	NN	_	27	pobj	_	_
30	by	_	IN	IN	_	23	prep	_	_
31	augmenting	_	VBG	VBG	_	30	pcomp	_	_
32	viral	_	JJ	JJ	_	33	amod	_	_
33	replication	_	NN	NN	_	31	dobj	_	_
34	in	_	IN	IN	_	33	prep	_	_
35	monocytes	_	NNS	NNS	_	34	pobj	_	_
36	.	_	.	.	_	3	punct	_	_

1	Identification	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	an	_	DT	DT	_	6	det	_	_
4	ionomycin/cyclosporin	_	NN	NN	_	6	nn	_	_
5	A-responsive	_	JJ	JJ	_	6	amod	_	_
6	element	_	NN	NN	_	2	pobj	_	_
7	within	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	14	det	_	_
9	human	_	JJ	JJ	_	14	amod	_	_
10	T	_	NN	NN	_	14	nn	_	_
11	cell	_	NN	NN	_	14	nn	_	_
12	receptor	_	NN	NN	_	14	nn	_	_
13	gamma	_	NN	NN	_	14	nn	_	_
14	enhancer	_	NN	NN	_	7	pobj	_	_
15	.	_	.	.	_	1	punct	_	_

1	Activation	_	NN	NN	_	7	nsubj	_	_
2	through	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	Ca2+/calcineurin	_	NN	NN	_	5	nn	_	_
5	pathway	_	NN	NN	_	2	pobj	_	_
6	is	_	VBZ	VBZ	_	7	cop	_	_
7	essential	_	JJ	JJ	_	0	root	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	transcription	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	many	_	JJ	JJ	_	14	amod	_	_
13	cytokine	_	NN	NN	_	14	nn	_	_
14	genes	_	NNS	NNS	_	11	pobj	_	_
15	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	conserved	_	VBN	VBN	_	4	amod	_	_
3	cis-acting	_	NN	NN	_	4	nn	_	_
4	sequence	_	NN	NN	_	16	nsubjpass	_	_
5	,	_	,	,	_	4	punct	_	_
6	GGAAAA	_	NN	NN	_	4	appos	_	_
7	,	_	,	,	_	4	punct	_	_
8	and	_	CC	CC	_	4	cc	_	_
9	transcription	_	NN	NN	_	10	nn	_	_
10	factors	_	NNS	NNS	_	4	conj	_	_
11	binding	_	VBG	VBG	_	10	vmod	_	_
12	to	_	TO	TO	_	11	prep	_	_
13	this	_	DT	DT	_	14	det	_	_
14	sequence	_	NN	NN	_	12	pobj	_	_
15	are	_	VBP	VBP	_	16	auxpass	_	_
16	involved	_	VBN	VBN	_	0	root	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	19	det	_	_
19	response	_	NN	NN	_	17	pobj	_	_
20	to	_	TO	TO	_	19	prep	_	_
21	increased	_	VBN	VBN	_	24	amod	_	_
22	intracellular	_	JJ	JJ	_	24	amod	_	_
23	Ca2+	_	NN	NN	_	24	nn	_	_
24	concentrations	_	NNS	NNS	_	20	pobj	_	_
25	.	_	.	.	_	16	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	report	_	VBP	VBP	_	0	root	_	_
4	the	_	DT	DT	_	5	dep	_	_
5	identification	_	NN	NN	_	3	dobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	importance	_	NN	NN	_	5	conj	_	_
8	of	_	IN	IN	_	5	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	same	_	JJ	JJ	_	11	amod	_	_
11	sequence	_	NN	NN	_	8	pobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	a	_	DT	DT	_	15	det	_	_
14	non-cytokine	_	JJ	JJ	_	15	amod	_	_
15	gene	_	NN	NN	_	12	pobj	_	_
16	,	_	,	,	_	11	punct	_	_
17	the	_	DT	DT	_	26	det	_	_
18	human	_	JJ	JJ	_	26	amod	_	_
19	T	_	NN	NN	_	26	nn	_	_
20	cell	_	NN	NN	_	26	nn	_	_
21	receptor	_	NN	NN	_	26	nn	_	_
22	gamma	_	NN	NN	_	26	nn	_	_
23	-LRB-	_	-LRB-	-LRB-	_	26	punct	_	_
24	TCRG	_	NN	NN	_	26	nn	_	_
25	-RRB-	_	-RRB-	-RRB-	_	26	punct	_	_
26	enhancer	_	NN	NN	_	11	appos	_	_
27	.	_	.	.	_	3	punct	_	_

1	Results	_	NNS	NNS	_	11	nsubj	_	_
2	from	_	IN	IN	_	1	prep	_	_
3	site-directed	_	JJ	JJ	_	4	amod	_	_
4	mutations	_	NNS	NNS	_	2	pobj	_	_
5	and	_	CC	CC	_	1	cc	_	_
6	electrophoretic	_	JJ	JJ	_	9	amod	_	_
7	mobility	_	NN	NN	_	9	nn	_	_
8	shift	_	NN	NN	_	9	nn	_	_
9	assays	_	NNS	NNS	_	1	conj	_	_
10	strongly	_	RB	RB	_	11	advmod	_	_
11	suggest	_	VBP	VBP	_	0	root	_	_
12	that	_	IN	IN	_	15	mark	_	_
13	this	_	DT	DT	_	14	det	_	_
14	sequence	_	NN	NN	_	15	nsubj	_	_
15	mediates	_	VBZ	VBZ	_	11	ccomp	_	_
16	the	_	DT	DT	_	18	det	_	_
17	ionomycin-induced	_	JJ	JJ	_	18	amod	_	_
18	activation	_	NN	NN	_	15	dobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	22	det	_	_
21	TCRG	_	NN	NN	_	22	nn	_	_
22	enhancer	_	NN	NN	_	19	pobj	_	_
23	.	_	.	.	_	11	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	studies	_	NNS	NNS	_	3	nsubj	_	_
3	provide	_	VBP	VBP	_	0	root	_	_
4	an	_	DT	DT	_	5	det	_	_
5	explanation	_	NN	NN	_	3	dobj	_	_
6	for	_	IN	IN	_	5	prep	_	_
7	a	_	DT	DT	_	9	det	_	_
8	previous	_	JJ	JJ	_	9	amod	_	_
9	observation	_	NN	NN	_	6	pobj	_	_
10	that	_	IN	IN	_	28	mark	_	_
11	TCRG	_	NN	NN	_	12	nn	_	_
12	mRNA	_	NN	NN	_	13	nn	_	_
13	levels	_	NNS	NNS	_	28	nsubjpass	_	_
14	,	_	,	,	_	13	punct	_	_
15	but	_	CC	CC	_	16	cc	_	_
16	not	_	RB	RB	_	13	cc	_	_
17	mRNA	_	NN	NN	_	18	nn	_	_
18	levels	_	NNS	NNS	_	13	conj	_	_
19	for	_	IN	IN	_	13	prep	_	_
20	T	_	NN	NN	_	22	nn	_	_
21	cell	_	NN	NN	_	22	nn	_	_
22	receptor	_	NN	NN	_	19	pobj	_	_
23	alpha	_	NN	NN	_	22	dep	_	_
24	and	_	CC	CC	_	22	cc	_	_
25	-beta	_	NN	NN	_	22	conj	_	_
26	,	_	,	,	_	13	punct	_	_
27	are	_	VBP	VBP	_	28	auxpass	_	_
28	increased	_	VBN	VBN	_	9	ccomp	_	_
29	by	_	IN	IN	_	28	prep	_	_
30	ionomycin	_	NN	NN	_	31	nn	_	_
31	treatment	_	NN	NN	_	29	pobj	_	_
32	.	_	.	.	_	3	punct	_	_

1	Aspirin-like	_	JJ	JJ	_	2	amod	_	_
2	drugs	_	NNS	NNS	_	4	nsubj	_	_
3	can	_	MD	MD	_	4	aux	_	_
4	protect	_	VB	VB	_	0	root	_	_
5	human	_	JJ	JJ	_	7	amod	_	_
6	T	_	NN	NN	_	7	nn	_	_
7	lymphocytes	_	NNS	NNS	_	4	dobj	_	_
8	against	_	IN	IN	_	4	prep	_	_
9	benzoquinone	_	NN	NN	_	10	nn	_	_
10	cytotoxicity	_	NN	NN	_	8	pobj	_	_
11	:	_	:	:	_	4	punct	_	_
12	evidence	_	NN	NN	_	4	dep	_	_
13	for	_	IN	IN	_	12	prep	_	_
14	a	_	DT	DT	_	17	det	_	_
15	NAD-LRB-P-RRB-H:quinone	_	NN	NN	_	17	nn	_	_
16	reductase-dependent	_	JJ	JJ	_	17	amod	_	_
17	mechanism	_	NN	NN	_	13	pobj	_	_
18	.	_	.	.	_	4	punct	_	_

1	Benzene	_	NN	NN	_	2	nn	_	_
2	toxicity	_	NN	NN	_	6	nsubjpass	_	_
3	towards	_	IN	IN	_	2	prep	_	_
4	lymphocytes	_	NNS	NNS	_	3	pobj	_	_
5	is	_	VBZ	VBZ	_	6	auxpass	_	_
6	thought	_	VBN	VBN	_	0	root	_	_
7	to	_	TO	TO	_	9	aux	_	_
8	be	_	VB	VB	_	9	auxpass	_	_
9	mediated	_	VBN	VBN	_	6	xcomp	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	metabolites	_	NNS	NNS	_	10	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	benzene	_	NN	NN	_	12	pobj	_	_
14	including	_	VBG	VBG	_	11	prep	_	_
15	benzoquinone	_	NN	NN	_	14	pobj	_	_
16	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
17	BQ	_	NN	NN	_	15	appos	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	.	_	.	.	_	6	punct	_	_

1	NAD-LRB-P-RRB-H:quinone	_	NN	NN	_	2	nn	_	_
2	reductase	_	NN	NN	_	7	nsubjpass	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	QR	_	NN	NN	_	2	appos	_	_
5	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
6	is	_	VBZ	VBZ	_	7	auxpass	_	_
7	known	_	VBN	VBN	_	0	root	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	protect	_	VB	VB	_	7	xcomp	_	_
10	against	_	IN	IN	_	9	prep	_	_
11	BQ	_	NN	NN	_	12	nn	_	_
12	toxicity	_	NN	NN	_	10	pobj	_	_
13	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	expression	_	NN	NN	_	8	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	QR	_	NN	NN	_	6	nn	_	_
6	gene	_	NN	NN	_	3	pobj	_	_
7	is	_	VBZ	VBZ	_	8	auxpass	_	_
8	regulated	_	VBN	VBN	_	0	root	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	transcription	_	NN	NN	_	12	nn	_	_
12	factor	_	NN	NN	_	9	pobj	_	_
13	AP-1	_	NN	NN	_	12	dep	_	_
14	.	_	.	.	_	8	punct	_	_

1	We	_	PRP	PRP	_	4	nsubj	_	_
2	had	_	VBD	VBD	_	4	aux	_	_
3	previously	_	RB	RB	_	4	advmod	_	_
4	found	_	VBN	VBN	_	0	root	_	_
5	that	_	IN	IN	_	11	mark	_	_
6	aspirin-like	_	JJ	JJ	_	7	amod	_	_
7	drugs	_	NNS	NNS	_	11	nsubj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	ALD	_	NN	NN	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	induce	_	VBP	VBP	_	4	ccomp	_	_
12	AP-1	_	NN	NN	_	11	dobj	_	_
13	in	_	IN	IN	_	11	prep	_	_
14	human	_	JJ	JJ	_	16	amod	_	_
15	T	_	NN	NN	_	16	nn	_	_
16	lymphocytes	_	NNS	NNS	_	13	pobj	_	_
17	.	_	.	.	_	4	punct	_	_

1	It	_	PRP	PRP	_	4	nsubjpass	_	_
2	was	_	VBD	VBD	_	4	auxpass	_	_
3	therefore	_	RB	RB	_	4	advmod	_	_
4	hypothesized	_	VBN	VBN	_	0	root	_	_
5	that	_	IN	IN	_	8	mark	_	_
6	ALD	_	NN	NN	_	8	nsubj	_	_
7	would	_	MD	MD	_	8	aux	_	_
8	protect	_	VB	VB	_	4	ccomp	_	_
9	lymphocytes	_	NNS	NNS	_	8	dobj	_	_
10	against	_	IN	IN	_	8	prep	_	_
11	BQ	_	NN	NN	_	12	nn	_	_
12	toxicity	_	NN	NN	_	10	pobj	_	_
13	by	_	IN	IN	_	8	prep	_	_
14	inducing	_	VBG	VBG	_	13	pcomp	_	_
15	QR	_	NN	NN	_	14	dobj	_	_
16	.	_	.	.	_	4	punct	_	_

1	Molt-4	_	NN	NN	_	2	nn	_	_
2	cells	_	NNS	NNS	_	15	nsubjpass	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	M4	_	NN	NN	_	2	appos	_	_
5	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
6	,	_	,	,	_	2	punct	_	_
7	a	_	DT	DT	_	12	det	_	_
8	human	_	JJ	JJ	_	12	amod	_	_
9	T	_	NN	NN	_	12	nn	_	_
10	lymphocyte	_	NN	NN	_	12	nn	_	_
11	cell	_	NN	NN	_	12	nn	_	_
12	line	_	NN	NN	_	2	appos	_	_
13	,	_	,	,	_	2	punct	_	_
14	were	_	VBD	VBD	_	15	auxpass	_	_
15	incubated	_	VBN	VBN	_	0	root	_	_
16	with	_	IN	IN	_	15	prep	_	_
17	different	_	JJ	JJ	_	18	amod	_	_
18	concentrations	_	NNS	NNS	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	two	_	CD	CD	_	21	num	_	_
21	ALD	_	NN	NN	_	19	pobj	_	_
22	,	_	,	,	_	21	punct	_	_
23	flurbiprofen	_	NN	NN	_	21	appos	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	sodium	_	NN	NN	_	26	nn	_	_
26	diclofenac	_	NN	NN	_	23	conj	_	_
27	,	_	,	,	_	15	punct	_	_
28	and	_	CC	CC	_	15	cc	_	_
29	then	_	RB	RB	_	30	advmod	_	_
30	exposed	_	VBN	VBN	_	15	conj	_	_
31	to	_	TO	TO	_	30	prep	_	_
32	BQ	_	NN	NN	_	31	pobj	_	_
33	.	_	.	.	_	15	punct	_	_

1	Toxicity	_	NN	NN	_	3	nsubjpass	_	_
2	was	_	VBD	VBD	_	3	auxpass	_	_
3	measured	_	VBN	VBN	_	0	root	_	_
4	by	_	IN	IN	_	3	prep	_	_
5	viability	_	NN	NN	_	4	pobj	_	_
6	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
7	trypan	_	NN	NN	_	9	nn	_	_
8	blue	_	JJ	JJ	_	9	amod	_	_
9	exclusion	_	NN	NN	_	5	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	.	_	.	.	_	3	punct	_	_

1	Both	_	DT	DT	_	2	det	_	_
2	drugs	_	NNS	NNS	_	3	nsubj	_	_
3	protected	_	VBD	VBD	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	cells	_	NNS	NNS	_	3	dobj	_	_
6	against	_	IN	IN	_	3	prep	_	_
7	BQ	_	NN	NN	_	8	nn	_	_
8	cytotoxicity	_	NN	NN	_	6	pobj	_	_
9	in	_	IN	IN	_	3	prep	_	_
10	a	_	DT	DT	_	12	det	_	_
11	dose-dependent	_	JJ	JJ	_	12	amod	_	_
12	manner	_	NN	NN	_	9	pobj	_	_
13	,	_	,	,	_	3	punct	_	_
14	e.g.	_	FW	FW	_	3	prep	_	_
15	,	_	,	,	_	3	punct	_	_
16	sodium	_	NN	NN	_	17	nn	_	_
17	diclofenac	_	NN	NN	_	21	nsubj	_	_
18	at	_	IN	IN	_	17	prep	_	_
19	15	_	CD	CD	_	20	num	_	_
20	microM	_	NN	NN	_	18	pobj	_	_
21	reduced	_	VBD	VBD	_	3	parataxis	_	_
22	the	_	DT	DT	_	23	det	_	_
23	fraction	_	NN	NN	_	21	dobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	BQ-treated	_	JJ	JJ	_	27	amod	_	_
26	dead	_	JJ	JJ	_	27	amod	_	_
27	cells	_	NNS	NNS	_	24	pobj	_	_
28	by	_	IN	IN	_	21	prep	_	_
29	70	_	CD	CD	_	30	num	_	_
30	%	_	NN	NN	_	28	pobj	_	_
31	.	_	.	.	_	3	punct	_	_

1	ALDs	_	NNS	NNS	_	2	nsubj	_	_
2	induced	_	VBD	VBD	_	0	root	_	_
3	QR	_	NN	NN	_	4	nn	_	_
4	activity	_	NN	NN	_	2	dobj	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	M4	_	NN	NN	_	8	nn	_	_
8	cells	_	NNS	NNS	_	5	pobj	_	_
9	in	_	IN	IN	_	2	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	same	_	JJ	JJ	_	12	amod	_	_
12	range	_	NN	NN	_	9	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	concentrations	_	NNS	NNS	_	13	pobj	_	_
15	that	_	WDT	WDT	_	16	nsubj	_	_
16	protected	_	VBD	VBD	_	12	rcmod	_	_
17	the	_	DT	DT	_	18	det	_	_
18	cells	_	NNS	NNS	_	16	dobj	_	_
19	against	_	IN	IN	_	16	prep	_	_
20	BQ	_	NN	NN	_	21	nn	_	_
21	toxicity	_	NN	NN	_	19	pobj	_	_
22	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	protective	_	JJ	JJ	_	3	amod	_	_
3	effect	_	NN	NN	_	8	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	ALD	_	NN	NN	_	4	pobj	_	_
6	was	_	VBD	VBD	_	8	auxpass	_	_
7	significantly	_	RB	RB	_	8	advmod	_	_
8	reduced	_	VBN	VBN	_	0	root	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	dicoumarol	_	NN	NN	_	9	pobj	_	_
11	,	_	,	,	_	10	punct	_	_
12	a	_	DT	DT	_	14	det	_	_
13	QR-specific	_	JJ	JJ	_	14	amod	_	_
14	inhibitor	_	NN	NN	_	10	appos	_	_
15	.	_	.	.	_	8	punct	_	_

1	Since	_	IN	IN	_	11	mark	_	_
2	human	_	JJ	JJ	_	4	amod	_	_
3	T	_	NN	NN	_	4	nn	_	_
4	cells	_	NNS	NNS	_	11	nsubj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	T	_	NN	NN	_	8	nn	_	_
7	cell	_	NN	NN	_	8	nn	_	_
8	lines	_	NNS	NNS	_	4	conj	_	_
9	do	_	VBP	VBP	_	11	aux	_	_
10	not	_	RB	RB	_	11	neg	_	_
11	metabolize	_	VB	VB	_	17	advcl	_	_
12	arachidonic	_	JJ	JJ	_	13	amod	_	_
13	acid	_	NN	NN	_	11	dobj	_	_
14	,	_	,	,	_	17	punct	_	_
15	our	_	PRP$	PRP$	_	16	poss	_	_
16	data	_	NNS	NNS	_	17	nsubj	_	_
17	suggest	_	VBP	VBP	_	0	root	_	_
18	that	_	IN	IN	_	21	mark	_	_
19	ALD	_	NN	NN	_	21	nsubj	_	_
20	can	_	MD	MD	_	21	aux	_	_
21	protect	_	VB	VB	_	17	ccomp	_	_
22	human	_	JJ	JJ	_	24	amod	_	_
23	T	_	NN	NN	_	24	nn	_	_
24	lymphocytes	_	NNS	NNS	_	21	dobj	_	_
25	against	_	IN	IN	_	21	prep	_	_
26	a	_	DT	DT	_	27	det	_	_
27	metabolite	_	NN	NN	_	25	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	benzene	_	NN	NN	_	28	pobj	_	_
30	by	_	IN	IN	_	21	prep	_	_
31	induction	_	NN	NN	_	30	pobj	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	QR	_	NN	NN	_	34	nn	_	_
34	activity	_	NN	NN	_	32	pobj	_	_
35	.	_	.	.	_	17	punct	_	_

1	Human	_	JJ	JJ	_	2	amod	_	_
2	herpesvirus	_	NN	NN	_	12	nsubj	_	_
3	6	_	CD	CD	_	2	num	_	_
4	variant	_	NN	NN	_	5	nn	_	_
5	A	_	NN	NN	_	2	dep	_	_
6	,	_	,	,	_	2	punct	_	_
7	but	_	CC	CC	_	8	cc	_	_
8	not	_	RB	RB	_	2	cc	_	_
9	variant	_	NN	NN	_	10	nn	_	_
10	B	_	NN	NN	_	2	conj	_	_
11	,	_	,	,	_	2	punct	_	_
12	infects	_	VBZ	VBZ	_	0	root	_	_
13	EBV-positive	_	JJ	JJ	_	16	amod	_	_
14	B	_	NN	NN	_	16	nn	_	_
15	lymphoid	_	JJ	JJ	_	16	amod	_	_
16	cells	_	NNS	NNS	_	12	dobj	_	_
17	,	_	,	,	_	12	punct	_	_
18	activating	_	VBG	VBG	_	12	vmod	_	_
19	the	_	DT	DT	_	22	det	_	_
20	latent	_	JJ	JJ	_	22	amod	_	_
21	EBV	_	NN	NN	_	22	nn	_	_
22	genome	_	NN	NN	_	18	dobj	_	_
23	through	_	IN	IN	_	18	prep	_	_
24	a	_	DT	DT	_	26	det	_	_
25	BZLF-1-dependent	_	JJ	JJ	_	26	amod	_	_
26	mechanism	_	NN	NN	_	23	pobj	_	_
27	.	_	.	.	_	12	punct	_	_

1	Human	_	JJ	JJ	_	2	amod	_	_
2	herpesvirus	_	NN	NN	_	14	nsubjpass	_	_
3	6	_	CD	CD	_	2	num	_	_
4	,	_	,	,	_	2	punct	_	_
5	a	_	DT	DT	_	9	det	_	_
6	predominantly	_	RB	RB	_	8	advmod	_	_
7	T	_	NN	NN	_	8	npadvmod	_	_
8	lymphotropic	_	JJ	JJ	_	9	amod	_	_
9	virus	_	NN	NN	_	2	appos	_	_
10	,	_	,	,	_	2	punct	_	_
11	has	_	VBZ	VBZ	_	14	aux	_	_
12	been	_	VBN	VBN	_	14	auxpass	_	_
13	recently	_	RB	RB	_	14	advmod	_	_
14	shown	_	VBN	VBN	_	0	root	_	_
15	to	_	TO	TO	_	16	aux	_	_
16	infect	_	VB	VB	_	14	ccomp	_	_
17	some	_	DT	DT	_	22	det	_	_
18	EBV	_	JJ	JJ	_	22	amod	_	_
19	-positive	_	JJ	JJ	_	22	amod	_	_
20	B	_	NN	NN	_	22	nn	_	_
21	cell	_	NN	NN	_	22	nn	_	_
22	lines	_	NNS	NNS	_	16	dobj	_	_
23	,	_	,	,	_	16	punct	_	_
24	and	_	CC	CC	_	16	cc	_	_
25	to	_	TO	TO	_	26	aux	_	_
26	induce	_	VB	VB	_	16	conj	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	them	_	PRP	PRP	_	27	pobj	_	_
29	the	_	DT	DT	_	30	det	_	_
30	activation	_	NN	NN	_	26	dobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	the	_	DT	DT	_	35	det	_	_
33	EBV	_	NN	NN	_	35	nn	_	_
34	lytic	_	JJ	JJ	_	35	amod	_	_
35	cycle	_	NN	NN	_	31	pobj	_	_
36	.	_	.	.	_	14	punct	_	_

1	Here	_	RB	RB	_	4	advmod	_	_
2	we	_	PRP	PRP	_	4	nsubj	_	_
3	have	_	VBP	VBP	_	4	aux	_	_
4	confirmed	_	VBN	VBN	_	0	root	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	extended	_	VBN	VBN	_	4	conj	_	_
7	such	_	JJ	JJ	_	8	amod	_	_
8	observations	_	NNS	NNS	_	4	dobj	_	_
9	,	_	,	,	_	4	punct	_	_
10	showing	_	VBG	VBG	_	4	vmod	_	_
11	that	_	IN	IN	_	18	mark	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	1	_	LS	LS	_	18	dep	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	this	_	DT	DT	_	16	det	_	_
16	phenomenon	_	NN	NN	_	18	nsubj	_	_
17	is	_	VBZ	VBZ	_	18	cop	_	_
18	restricted	_	JJ	JJ	_	10	ccomp	_	_
19	to	_	TO	TO	_	18	prep	_	_
20	the	_	DT	DT	_	22	det	_	_
21	variant	_	NN	NN	_	22	nn	_	_
22	A	_	NN	NN	_	19	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	HHV-6	_	NN	NN	_	23	pobj	_	_
25	:	_	:	:	_	4	punct	_	_
26	in	_	IN	IN	_	41	prep	_	_
27	fact	_	NN	NN	_	26	pobj	_	_
28	two	_	CD	CD	_	29	num	_	_
29	isolates	_	NNS	NNS	_	41	nsubj	_	_
30	belonging	_	VBG	VBG	_	29	vmod	_	_
31	to	_	TO	TO	_	30	prep	_	_
32	the	_	DT	DT	_	35	det	_	_
33	HHV-6	_	NN	NN	_	35	nn	_	_
34	variant	_	NN	NN	_	35	nn	_	_
35	B	_	NN	NN	_	31	pobj	_	_
36	-LRB-	_	-LRB-	-LRB-	_	37	punct	_	_
37	BA92	_	NN	NN	_	35	dep	_	_
38	and	_	CC	CC	_	37	cc	_	_
39	Z29	_	NN	NN	_	37	conj	_	_
40	-RRB-	_	-RRB-	-RRB-	_	37	punct	_	_
41	were	_	VBD	VBD	_	4	parataxis	_	_
42	neither	_	CC	CC	_	41	dep	_	_
43	able	_	JJ	JJ	_	41	acomp	_	_
44	to	_	TO	TO	_	43	dep	_	_
45	infect	_	VB	VB	_	44	ccomp	_	_
46	any	_	DT	DT	_	49	det	_	_
47	B	_	NN	NN	_	49	nn	_	_
48	cell	_	NN	NN	_	49	nn	_	_
49	line	_	NN	NN	_	45	dobj	_	_
50	,	_	,	,	_	45	punct	_	_
51	independently	_	RB	RB	_	45	advmod	_	_
52	of	_	IN	IN	_	51	prep	_	_
53	the	_	DT	DT	_	55	det	_	_
54	EBV	_	NN	NN	_	55	nn	_	_
55	status	_	NN	NN	_	52	pobj	_	_
56	,	_	,	,	_	44	punct	_	_
57	nor	_	CC	CC	_	44	cc	_	_
58	to	_	TO	TO	_	44	conj	_	_
59	induce	_	VB	VB	_	58	ccomp	_	_
60	the	_	DT	DT	_	63	det	_	_
61	EBV	_	NN	NN	_	63	nn	_	_
62	genome	_	NN	NN	_	63	nn	_	_
63	expression	_	NN	NN	_	59	dobj	_	_
64	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	only	_	JJ	JJ	_	3	amod	_	_
3	exception	_	NN	NN	_	5	nsubjpass	_	_
4	is	_	VBZ	VBZ	_	5	auxpass	_	_
5	represented	_	VBN	VBN	_	0	root	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	P3HR1	_	NN	NN	_	9	nn	_	_
9	cells	_	NNS	NNS	_	6	pobj	_	_
10	,	_	,	,	_	9	punct	_	_
11	in	_	IN	IN	_	24	prep	_	_
12	which	_	WDT	WDT	_	11	pobj	_	_
13	,	_	,	,	_	24	punct	_	_
14	however	_	RB	RB	_	24	advmod	_	_
15	,	_	,	,	_	24	punct	_	_
16	the	_	DT	DT	_	17	det	_	_
17	infection	_	NN	NN	_	24	nsubj	_	_
18	by	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	variant	_	NN	NN	_	21	nn	_	_
21	B	_	NN	NN	_	18	pobj	_	_
22	does	_	VBZ	VBZ	_	24	aux	_	_
23	not	_	RB	RB	_	24	neg	_	_
24	determine	_	VB	VB	_	9	rcmod	_	_
25	induction	_	NN	NN	_	24	dobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	EBV	_	NN	NN	_	28	nn	_	_
28	antigens	_	NNS	NNS	_	26	pobj	_	_
29	;	_	:	:	_	5	punct	_	_
30	-LRB-	_	-LRB-	-LRB-	_	31	punct	_	_
31	2	_	LS	LS	_	39	dep	_	_
32	-RRB-	_	-RRB-	-RRB-	_	31	punct	_	_
33	the	_	DT	DT	_	34	det	_	_
34	presence	_	NN	NN	_	39	nsubj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	the	_	DT	DT	_	38	det	_	_
37	EBV	_	NN	NN	_	38	nn	_	_
38	genome	_	NN	NN	_	35	pobj	_	_
39	contributes	_	VBZ	VBZ	_	5	conj	_	_
40	to	_	TO	TO	_	39	prep	_	_
41	the	_	DT	DT	_	42	det	_	_
42	susceptibility	_	NN	NN	_	40	pobj	_	_
43	of	_	IN	IN	_	42	prep	_	_
44	the	_	DT	DT	_	47	det	_	_
45	B	_	NN	NN	_	47	nn	_	_
46	cell	_	NN	NN	_	47	nn	_	_
47	lines	_	NNS	NNS	_	43	pobj	_	_
48	to	_	TO	TO	_	42	prep	_	_
49	HHV-6	_	NN	NN	_	50	nn	_	_
50	infection	_	NN	NN	_	48	pobj	_	_
51	,	_	,	,	_	39	punct	_	_
52	increasing	_	VBG	VBG	_	39	xcomp	_	_
53	the	_	DT	DT	_	55	det	_	_
54	binding	_	VBG	VBG	_	55	amod	_	_
55	sites	_	NNS	NNS	_	52	dobj	_	_
56	and	_	CC	CC	_	55	cc	_	_
57	the	_	DT	DT	_	58	det	_	_
58	percentage	_	NN	NN	_	55	conj	_	_
59	of	_	IN	IN	_	58	prep	_	_
60	infectable	_	JJ	JJ	_	61	amod	_	_
61	cells	_	NNS	NNS	_	59	pobj	_	_
62	,	_	,	,	_	52	punct	_	_
63	as	_	IN	IN	_	64	dep	_	_
64	detected	_	VBN	VBN	_	52	advcl	_	_
65	by	_	IN	IN	_	64	prep	_	_
66	immunoelectron	_	NN	NN	_	67	nn	_	_
67	microscopy	_	NN	NN	_	65	pobj	_	_
68	;	_	:	:	_	5	punct	_	_
69	and	_	CC	CC	_	5	cc	_	_
70	-LRB-	_	-LRB-	-LRB-	_	71	punct	_	_
71	3	_	LS	LS	_	94	dep	_	_
72	-RRB-	_	-RRB-	-RRB-	_	71	punct	_	_
73	HHV-6	_	NN	NN	_	76	nn	_	_
74	infected	_	JJ	JJ	_	76	amod	_	_
75	T	_	NN	NN	_	76	nn	_	_
76	cells	_	NNS	NNS	_	94	nsubj	_	_
77	,	_	,	,	_	76	punct	_	_
78	transfected	_	VBN	VBN	_	76	vmod	_	_
79	with	_	IN	IN	_	78	prep	_	_
80	plasmids	_	NNS	NNS	_	79	pobj	_	_
81	bearing	_	VBG	VBG	_	80	vmod	_	_
82	the	_	DT	DT	_	84	det	_	_
83	promoter	_	NN	NN	_	84	nn	_	_
84	regions	_	NNS	NNS	_	81	dobj	_	_
85	of	_	IN	IN	_	84	prep	_	_
86	the	_	DT	DT	_	89	det	_	_
87	EBV	_	NN	NN	_	89	nn	_	_
88	early	_	RB	RB	_	89	advmod	_	_
89	genes	_	NNS	NNS	_	85	pobj	_	_
90	BZLF1	_	NN	NN	_	89	dep	_	_
91	and	_	CC	CC	_	90	cc	_	_
92	BMRF1	_	NN	NN	_	90	conj	_	_
93	,	_	,	,	_	76	punct	_	_
94	show	_	VBP	VBP	_	5	conj	_	_
95	a	_	DT	DT	_	97	det	_	_
96	strong	_	JJ	JJ	_	97	amod	_	_
97	transactivation	_	NN	NN	_	94	dobj	_	_
98	of	_	IN	IN	_	97	prep	_	_
99	these	_	DT	DT	_	100	det	_	_
100	promoters	_	NNS	NNS	_	98	pobj	_	_
101	.	_	.	.	_	5	punct	_	_

1	Activation	_	NN	NN	_	10	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	JAK3	_	NN	NN	_	2	pobj	_	_
4	,	_	,	,	_	3	punct	_	_
5	but	_	CC	CC	_	6	cc	_	_
6	not	_	RB	RB	_	3	cc	_	_
7	JAK1	_	NN	NN	_	3	conj	_	_
8	,	_	,	,	_	1	punct	_	_
9	is	_	VBZ	VBZ	_	10	cop	_	_
10	critical	_	JJ	JJ	_	0	root	_	_
11	for	_	IN	IN	_	10	prep	_	_
12	IL-2-induced	_	JJ	JJ	_	13	amod	_	_
13	proliferation	_	NN	NN	_	11	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	STAT5	_	NN	NN	_	16	nn	_	_
16	recruitment	_	NN	NN	_	13	conj	_	_
17	by	_	IN	IN	_	16	prep	_	_
18	a	_	DT	DT	_	20	det	_	_
19	COOH-terminal	_	JJ	JJ	_	20	amod	_	_
20	region	_	NN	NN	_	17	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	25	det	_	_
23	IL-2	_	NN	NN	_	25	nn	_	_
24	receptor	_	NN	NN	_	25	nn	_	_
25	beta-chain	_	NN	NN	_	21	pobj	_	_
26	.	_	.	.	_	10	punct	_	_

1	A	_	DT	DT	_	2	det	_	_
2	number	_	NN	NN	_	8	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	cytokines	_	NNS	NNS	_	3	pobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	growth	_	NN	NN	_	7	nn	_	_
7	factors	_	NNS	NNS	_	4	conj	_	_
8	use	_	VBP	VBP	_	0	root	_	_
9	the	_	DT	DT	_	11	det	_	_
10	JAK-STAT	_	NN	NN	_	11	nn	_	_
11	pathway	_	NN	NN	_	8	dobj	_	_
12	to	_	TO	TO	_	13	aux	_	_
13	signal	_	VB	VB	_	8	vmod	_	_
14	from	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	17	det	_	_
16	cell	_	NN	NN	_	17	nn	_	_
17	membrane	_	NN	NN	_	14	pobj	_	_
18	to	_	TO	TO	_	13	prep	_	_
19	the	_	DT	DT	_	20	det	_	_
20	nucleus	_	NN	NN	_	18	pobj	_	_
21	.	_	.	.	_	8	punct	_	_

1	While	_	IN	IN	_	6	mark	_	_
2	homodimerizing	_	VBG	VBG	_	4	amod	_	_
3	cytokine	_	NN	NN	_	4	nn	_	_
4	receptors	_	NNS	NNS	_	6	nsubj	_	_
5	may	_	MD	MD	_	6	aux	_	_
6	transmit	_	VB	VB	_	27	advcl	_	_
7	signal	_	NN	NN	_	6	dobj	_	_
8	via	_	IN	IN	_	6	prep	_	_
9	a	_	DT	DT	_	11	det	_	_
10	single	_	JJ	JJ	_	11	amod	_	_
11	form	_	NN	NN	_	8	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	JAK	_	NN	NN	_	12	pobj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
15	i.e.	_	FW	FW	_	18	prep	_	_
16	growth	_	NN	NN	_	18	nn	_	_
17	hormone	_	NN	NN	_	18	nn	_	_
18	receptors	_	NNS	NNS	_	13	appos	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	,	_	,	,	_	27	punct	_	_
21	several	_	JJ	JJ	_	24	amod	_	_
22	multicomponent	_	JJ	JJ	_	24	amod	_	_
23	cytokine	_	NN	NN	_	24	nn	_	_
24	receptors	_	NNS	NNS	_	27	nsubjpass	_	_
25	have	_	VBP	VBP	_	27	aux	_	_
26	been	_	VBN	VBN	_	27	auxpass	_	_
27	shown	_	VBN	VBN	_	0	root	_	_
28	to	_	TO	TO	_	29	aux	_	_
29	require	_	VB	VB	_	27	xcomp	_	_
30	simultaneous	_	JJ	JJ	_	31	amod	_	_
31	activation	_	NN	NN	_	29	dobj	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	pairs	_	NNS	NNS	_	32	pobj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	different	_	JJ	JJ	_	37	amod	_	_
36	JAK	_	NN	NN	_	37	nn	_	_
37	kinases	_	NNS	NNS	_	34	pobj	_	_
38	-LRB-	_	-LRB-	-LRB-	_	41	punct	_	_
39	i.e.	_	FW	FW	_	41	prep	_	_
40	interferon	_	NN	NN	_	41	nn	_	_
41	receptors	_	NNS	NNS	_	37	appos	_	_
42	-RRB-	_	-RRB-	-RRB-	_	41	punct	_	_
43	.	_	.	.	_	27	punct	_	_

1	Recent	_	JJ	JJ	_	2	amod	_	_
2	evidence	_	NN	NN	_	21	nsubj	_	_
3	for	_	IN	IN	_	2	prep	_	_
4	a	_	DT	DT	_	6	det	_	_
5	preferential	_	JJ	JJ	_	6	amod	_	_
6	coupling	_	NN	NN	_	3	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	JAK3	_	NN	NN	_	7	pobj	_	_
9	to	_	TO	TO	_	7	dep	_	_
10	interleukin-2	_	NN	NN	_	11	nn	_	_
11	receptor-gamma	_	NN	NN	_	9	pobj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
13	IL-2R	_	NN	NN	_	14	nn	_	_
14	gamma	_	NN	NN	_	11	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	and	_	CC	CC	_	7	cc	_	_
17	JAK1	_	NN	NN	_	18	dep	_	_
18	to	_	TO	TO	_	7	conj	_	_
19	IL-2R	_	NN	NN	_	20	nn	_	_
20	beta	_	NN	NN	_	18	pobj	_	_
21	supports	_	VBZ	VBZ	_	0	root	_	_
22	the	_	DT	DT	_	23	det	_	_
23	concept	_	NN	NN	_	21	dobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	heterotrans-activation	_	NN	NN	_	24	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	JAK1	_	NN	NN	_	26	pobj	_	_
28	and	_	CC	CC	_	27	cc	_	_
29	JAK3	_	NN	NN	_	27	conj	_	_
30	caused	_	VBN	VBN	_	25	vmod	_	_
31	by	_	IN	IN	_	30	prep	_	_
32	IL-2-induced	_	JJ	JJ	_	33	amod	_	_
33	heterodimerization	_	NN	NN	_	31	pobj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	their	_	PRP$	PRP$	_	37	poss	_	_
36	receptor	_	NN	NN	_	37	nn	_	_
37	partners	_	NNS	NNS	_	34	pobj	_	_
38	.	_	.	.	_	21	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	present	_	JJ	JJ	_	3	amod	_	_
3	study	_	NN	NN	_	4	nsubj	_	_
4	verified	_	VBD	VBD	_	0	root	_	_
5	the	_	DT	DT	_	6	det	_	_
6	ability	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	IL-2	_	NN	NN	_	7	pobj	_	_
9	to	_	TO	TO	_	10	aux	_	_
10	cause	_	VB	VB	_	6	vmod	_	_
11	tyrosine	_	NN	NN	_	12	nn	_	_
12	phosphorylation	_	NN	NN	_	10	dobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	activation	_	NN	NN	_	12	conj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	JAK1	_	NN	NN	_	15	pobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	JAK3	_	NN	NN	_	16	conj	_	_
19	,	_	,	,	_	4	punct	_	_
20	but	_	CC	CC	_	4	cc	_	_
21	demonstrated	_	VBD	VBD	_	4	conj	_	_
22	that	_	IN	IN	_	24	mark	_	_
23	IL-2	_	NN	NN	_	24	nsubj	_	_
24	stimulated	_	VBD	VBD	_	21	ccomp	_	_
25	JAK3	_	NN	NN	_	24	dobj	_	_
26	to	_	TO	TO	_	24	prep	_	_
27	a	_	DT	DT	_	30	det	_	_
28	significantly	_	RB	RB	_	29	advmod	_	_
29	larger	_	JJR	JJR	_	30	amod	_	_
30	extent	_	NN	NN	_	26	pobj	_	_
31	than	_	IN	IN	_	32	mark	_	_
32	JAK1	_	NN	NN	_	30	dep	_	_
33	in	_	IN	IN	_	32	prep	_	_
34	human	_	JJ	JJ	_	36	amod	_	_
35	T	_	NN	NN	_	36	nn	_	_
36	lymphocytes	_	NNS	NNS	_	33	pobj	_	_
37	and	_	CC	CC	_	36	cc	_	_
38	the	_	DT	DT	_	41	det	_	_
39	YT	_	NN	NN	_	41	nn	_	_
40	cell	_	NN	NN	_	41	nn	_	_
41	line	_	NN	NN	_	36	conj	_	_
42	.	_	.	.	_	4	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	conclusion	_	NN	NN	_	4	nsubjpass	_	_
3	was	_	VBD	VBD	_	4	auxpass	_	_
4	based	_	VBN	VBN	_	0	root	_	_
5	upon	_	IN	IN	_	4	prep	_	_
6	several	_	JJ	JJ	_	8	amod	_	_
7	independent	_	JJ	JJ	_	8	amod	_	_
8	criteria	_	NNS	NNS	_	5	pobj	_	_
9	,	_	,	,	_	8	punct	_	_
10	including	_	VBG	VBG	_	8	prep	_	_
11	more	_	RBR	RBR	_	12	advmod	_	_
12	vigorous	_	JJ	JJ	_	14	amod	_	_
13	tyrosine	_	NN	NN	_	14	nn	_	_
14	phosphorylation	_	NN	NN	_	10	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	JAK3	_	NN	NN	_	15	pobj	_	_
17	,	_	,	,	_	14	punct	_	_
18	more	_	RBR	RBR	_	20	advmod	_	_
19	marked	_	JJ	JJ	_	20	amod	_	_
20	enzymatic	_	JJ	JJ	_	21	amod	_	_
21	activation	_	NN	NN	_	14	conj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	JAK3	_	NN	NN	_	22	pobj	_	_
24	as	_	RB	RB	_	25	advmod	_	_
25	well	_	RB	RB	_	14	cc	_	_
26	as	_	IN	IN	_	25	mwe	_	_
27	higher	_	JJR	JJR	_	28	amod	_	_
28	abundance	_	NN	NN	_	14	conj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	JAK3	_	NN	NN	_	29	pobj	_	_
31	in	_	IN	IN	_	14	prep	_	_
32	activated	_	VBN	VBN	_	35	amod	_	_
33	IL-2	_	NN	NN	_	35	nn	_	_
34	receptor	_	NN	NN	_	35	nn	_	_
35	complexes	_	NNS	NNS	_	31	pobj	_	_
36	.	_	.	.	_	4	punct	_	_

1	Furthermore	_	RB	RB	_	21	advmod	_	_
2	,	_	,	,	_	21	punct	_	_
3	when	_	WRB	WRB	_	9	advmod	_	_
4	human	_	JJ	JJ	_	6	amod	_	_
5	IL-2R	_	NN	NN	_	6	nn	_	_
6	beta	_	NN	NN	_	9	nsubjpass	_	_
7	was	_	VBD	VBD	_	9	auxpass	_	_
8	stably	_	RB	RB	_	9	advmod	_	_
9	expressed	_	VBN	VBN	_	21	advcl	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	murine	_	JJ	JJ	_	13	amod	_	_
12	BA/F3	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	10	pobj	_	_
14	,	_	,	,	_	21	punct	_	_
15	robust	_	JJ	JJ	_	17	amod	_	_
16	IL-2-induced	_	JJ	JJ	_	17	amod	_	_
17	proliferation	_	NN	NN	_	21	nsubj	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	JAK3	_	NN	NN	_	20	nn	_	_
20	activation	_	NN	NN	_	17	conj	_	_
21	occurred	_	VBD	VBD	_	0	root	_	_
22	without	_	IN	IN	_	21	prep	_	_
23	detectable	_	JJ	JJ	_	24	amod	_	_
24	involvement	_	NN	NN	_	22	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	either	_	CC	CC	_	27	preconj	_	_
27	JAK1	_	NN	NN	_	25	pobj	_	_
28	,	_	,	,	_	27	punct	_	_
29	JAK2	_	NN	NN	_	27	conj	_	_
30	or	_	CC	CC	_	27	cc	_	_
31	TYK2	_	NN	NN	_	27	conj	_	_
32	.	_	.	.	_	21	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	therefore	_	RB	RB	_	3	advmod	_	_
3	propose	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	11	mark	_	_
5	IL-2	_	NN	NN	_	6	nn	_	_
6	receptor	_	NN	NN	_	8	nn	_	_
7	signal	_	NN	NN	_	8	nn	_	_
8	transduction	_	NN	NN	_	11	nsubj	_	_
9	does	_	VBZ	VBZ	_	11	aux	_	_
10	not	_	RB	RB	_	11	neg	_	_
11	depend	_	VB	VB	_	3	ccomp	_	_
12	on	_	IN	IN	_	11	prep	_	_
13	equimolar	_	JJ	JJ	_	14	amod	_	_
14	heterodimerization	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	JAK1	_	NN	NN	_	15	pobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	JAK3	_	NN	NN	_	16	conj	_	_
19	following	_	VBG	VBG	_	11	prep	_	_
20	IL-2-induced	_	JJ	JJ	_	21	amod	_	_
21	heterodimerization	_	NN	NN	_	19	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	IL-2R	_	NN	NN	_	24	nn	_	_
24	beta	_	NN	NN	_	22	pobj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	IL-2R	_	NN	NN	_	27	nn	_	_
27	gamma	_	NN	NN	_	24	conj	_	_
28	.	_	.	.	_	3	punct	_	_

1	Nonetheless	_	RB	RB	_	14	advmod	_	_
2	,	_	,	,	_	14	punct	_	_
3	a	_	DT	DT	_	5	det	_	_
4	membrane-proximal	_	JJ	JJ	_	5	amod	_	_
5	region	_	NN	NN	_	14	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	human	_	JJ	JJ	_	9	amod	_	_
8	IL-2R	_	NN	NN	_	9	nn	_	_
9	beta	_	NN	NN	_	6	pobj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	Asn240-Leu335	_	NN	NN	_	5	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	was	_	VBD	VBD	_	14	cop	_	_
14	critical	_	JJ	JJ	_	0	root	_	_
15	for	_	IN	IN	_	14	prep	_	_
16	JAK3	_	NN	NN	_	17	nn	_	_
17	activation	_	NN	NN	_	15	pobj	_	_
18	,	_	,	,	_	14	punct	_	_
19	and	_	CC	CC	_	14	cc	_	_
20	the	_	DT	DT	_	21	det	_	_
21	amount	_	NN	NN	_	30	nsubj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	JAK3	_	NN	NN	_	22	pobj	_	_
24	present	_	JJ	JJ	_	23	amod	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	activated	_	VBN	VBN	_	29	amod	_	_
27	IL-2	_	NN	NN	_	29	nn	_	_
28	receptor	_	NN	NN	_	29	nn	_	_
29	complexes	_	NNS	NNS	_	25	pobj	_	_
30	increased	_	VBD	VBD	_	14	conj	_	_
31	with	_	IN	IN	_	30	prep	_	_
32	time	_	NN	NN	_	31	pobj	_	_
33	,	_	,	,	_	14	punct	_	_
34	suggesting	_	VBG	VBG	_	14	conj	_	_
35	that	_	IN	IN	_	44	mark	_	_
36	stabilization	_	NN	NN	_	44	nsubj	_	_
37	of	_	IN	IN	_	36	prep	_	_
38	JAK3	_	NN	NN	_	39	nn	_	_
39	binding	_	NN	NN	_	37	pobj	_	_
40	to	_	TO	TO	_	39	prep	_	_
41	the	_	DT	DT	_	43	det	_	_
42	receptor	_	NN	NN	_	43	nn	_	_
43	complex	_	NN	NN	_	40	pobj	_	_
44	relies	_	VBZ	VBZ	_	34	ccomp	_	_
45	on	_	IN	IN	_	44	prep	_	_
46	both	_	CC	CC	_	48	preconj	_	_
47	IL-2R	_	NN	NN	_	48	nn	_	_
48	beta	_	NN	NN	_	45	pobj	_	_
49	and	_	CC	CC	_	48	cc	_	_
50	IL-2R	_	NN	NN	_	51	nn	_	_
51	gamma	_	NN	NN	_	48	conj	_	_
52	.	_	.	.	_	14	punct	_	_

1	Moreover	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	STAT5	_	NN	NN	_	5	nsubjpass	_	_
4	was	_	VBD	VBD	_	5	auxpass	_	_
5	found	_	VBN	VBN	_	0	root	_	_
6	to	_	TO	TO	_	12	aux	_	_
7	be	_	VB	VB	_	12	cop	_	_
8	the	_	DT	DT	_	12	det	_	_
9	predominant	_	JJ	JJ	_	12	amod	_	_
10	STAT	_	NN	NN	_	12	nn	_	_
11	transcription	_	NN	NN	_	12	nn	_	_
12	factor	_	NN	NN	_	5	xcomp	_	_
13	used	_	VBN	VBN	_	12	vmod	_	_
14	by	_	IN	IN	_	13	prep	_	_
15	IL-2	_	NN	NN	_	14	pobj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	human	_	JJ	JJ	_	19	amod	_	_
18	T	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	16	pobj	_	_
20	,	_	,	,	_	5	punct	_	_
21	and	_	CC	CC	_	5	cc	_	_
22	specifically	_	RB	RB	_	23	advmod	_	_
23	required	_	VBD	VBD	_	5	conj	_	_
24	a	_	DT	DT	_	26	det	_	_
25	COOH-terminal	_	JJ	JJ	_	26	amod	_	_
26	region	_	NN	NN	_	23	dobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	IL-2R	_	NN	NN	_	29	nn	_	_
29	beta	_	NN	NN	_	27	pobj	_	_
30	-LRB-	_	-LRB-	-LRB-	_	31	punct	_	_
31	Ser386-Val525	_	NN	NN	_	26	appos	_	_
32	-RRB-	_	-RRB-	-RRB-	_	31	punct	_	_
33	,	_	,	,	_	23	punct	_	_
34	while	_	IN	IN	_	39	mark	_	_
35	STAT5	_	NN	NN	_	36	nn	_	_
36	recruitment	_	NN	NN	_	39	nsubjpass	_	_
37	was	_	VBD	VBD	_	39	auxpass	_	_
38	not	_	RB	RB	_	39	neg	_	_
39	correlated	_	VBN	VBN	_	23	advcl	_	_
40	to	_	TO	TO	_	39	prep	_	_
41	activation	_	NN	NN	_	40	pobj	_	_
42	of	_	IN	IN	_	41	prep	_	_
43	IL-2R	_	NN	NN	_	44	nn	_	_
44	gamma	_	NN	NN	_	42	pobj	_	_
45	or	_	CC	CC	_	44	cc	_	_
46	JAK3	_	NN	NN	_	44	conj	_	_
47	.	_	.	.	_	5	punct	_	_

1	Transactivation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	interleukin-1alpha	_	NN	NN	_	5	nn	_	_
5	promoter	_	NN	NN	_	2	pobj	_	_
6	by	_	IN	IN	_	1	prep	_	_
7	human	_	JJ	JJ	_	10	amod	_	_
8	T-cell	_	NN	NN	_	10	nn	_	_
9	leukemia	_	NN	NN	_	10	nn	_	_
10	virus	_	NN	NN	_	6	pobj	_	_
11	type	_	NN	NN	_	10	dep	_	_
12	I	_	CD	CD	_	11	num	_	_
13	and	_	CC	CC	_	10	cc	_	_
14	type	_	NN	NN	_	10	conj	_	_
15	II	_	CD	CD	_	14	num	_	_
16	Tax	_	NN	NN	_	17	nn	_	_
17	proteins	_	NNS	NNS	_	10	dep	_	_
18	.	_	.	.	_	1	punct	_	_

1	Human	_	JJ	JJ	_	12	amod	_	_
2	T-cell	_	NN	NN	_	12	nn	_	_
3	leukemia	_	NN	NN	_	12	nn	_	_
4	virus	_	NN	NN	_	12	nn	_	_
5	type	_	NN	NN	_	12	nn	_	_
6	I	_	CD	CD	_	12	num	_	_
7	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
8	HTLV-I	_	NN	NN	_	12	nn	_	_
9	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
10	-infected	_	JJ	JJ	_	12	amod	_	_
11	T-cell	_	NN	NN	_	12	nn	_	_
12	lines	_	NNS	NNS	_	14	nsubj	_	_
13	constitutively	_	RB	RB	_	14	advmod	_	_
14	produce	_	VBP	VBP	_	0	root	_	_
15	high	_	JJ	JJ	_	16	amod	_	_
16	levels	_	NNS	NNS	_	14	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	interleukin-1alpha	_	NN	NN	_	17	pobj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	IL-1alpha	_	NN	NN	_	18	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	.	_	.	.	_	14	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	analyze	_	VB	VB	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	mechanisms	_	NNS	NNS	_	2	dobj	_	_
5	that	_	WDT	WDT	_	6	nsubj	_	_
6	lead	_	VBP	VBP	_	4	rcmod	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	expression	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	IL-1alpha	_	NN	NN	_	10	pobj	_	_
12	in	_	IN	IN	_	9	prep	_	_
13	HTLV-I-infected	_	JJ	JJ	_	15	amod	_	_
14	cell	_	NN	NN	_	15	nn	_	_
15	lines	_	NNS	NNS	_	12	pobj	_	_
16	,	_	,	,	_	2	punct	_	_
17	we	_	PRP	PRP	_	18	nsubj	_	_
18	studied	_	VBD	VBD	_	2	parataxis	_	_
19	regulatory	_	JJ	JJ	_	20	amod	_	_
20	regions	_	NNS	NNS	_	18	dobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	25	det	_	_
23	human	_	JJ	JJ	_	25	amod	_	_
24	IL-1alpha	_	NN	NN	_	25	nn	_	_
25	promoter	_	NN	NN	_	21	pobj	_	_
26	involved	_	VBN	VBN	_	25	vmod	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	activation	_	NN	NN	_	27	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	the	_	DT	DT	_	32	det	_	_
31	IL-1alpha	_	NN	NN	_	32	nn	_	_
32	gene	_	NN	NN	_	29	pobj	_	_
33	.	_	.	.	_	2	punct	_	_

1	IL-1alpha	_	NN	NN	_	3	nn	_	_
2	promoter	_	NN	NN	_	3	nn	_	_
3	constructs	_	NNS	NNS	_	4	nsubj	_	_
4	drive	_	VBP	VBP	_	0	root	_	_
5	transcription	_	NN	NN	_	4	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	14	det	_	_
8	chloramphenicol	_	NN	NN	_	14	nn	_	_
9	acetyltransferase	_	NN	NN	_	14	nn	_	_
10	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
11	CAT	_	NN	NN	_	14	nn	_	_
12	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
13	reporter	_	NN	NN	_	14	nn	_	_
14	gene	_	NN	NN	_	6	pobj	_	_
15	in	_	IN	IN	_	5	prep	_	_
16	HTLV-I-positive	_	JJ	JJ	_	18	amod	_	_
17	MT-2	_	NN	NN	_	18	nn	_	_
18	cells	_	NNS	NNS	_	15	pobj	_	_
19	,	_	,	,	_	18	punct	_	_
20	which	_	WDT	WDT	_	22	nsubj	_	_
21	constitutively	_	RB	RB	_	22	advmod	_	_
22	produce	_	VBP	VBP	_	18	rcmod	_	_
23	IL-1alpha	_	NN	NN	_	22	dobj	_	_
24	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	15	prep	_	_
2	a	_	DT	DT	_	4	det	_	_
3	cotransfection	_	NN	NN	_	4	nn	_	_
4	assay	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	15	punct	_	_
6	the	_	DT	DT	_	8	det	_	_
7	Tax	_	NN	NN	_	8	nn	_	_
8	protein	_	NN	NN	_	15	nsubj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	both	_	CC	CC	_	11	preconj	_	_
11	HTLV-I	_	NN	NN	_	9	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	HTLV-II	_	NN	NN	_	11	conj	_	_
14	specifically	_	RB	RB	_	15	advmod	_	_
15	activated	_	VBD	VBD	_	0	root	_	_
16	transcription	_	NN	NN	_	15	dobj	_	_
17	from	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	IL-1alpha	_	NN	NN	_	20	nn	_	_
20	promoter	_	NN	NN	_	17	pobj	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	an	_	DT	DT	_	26	det	_	_
23	uninfected	_	JJ	JJ	_	26	amod	_	_
24	Jurkat	_	NN	NN	_	26	nn	_	_
25	cell	_	NN	NN	_	26	nn	_	_
26	line	_	NN	NN	_	21	pobj	_	_
27	.	_	.	.	_	15	punct	_	_

1	A	_	DT	DT	_	4	det	_	_
2	mutant	_	JJ	JJ	_	4	amod	_	_
3	Tax	_	NN	NN	_	4	nn	_	_
4	protein	_	NN	NN	_	20	nsubj	_	_
5	deficient	_	JJ	JJ	_	4	amod	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	transactivation	_	NN	NN	_	6	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	genes	_	NNS	NNS	_	8	pobj	_	_
10	by	_	IN	IN	_	7	prep	_	_
11	the	_	DT	DT	_	18	det	_	_
12	nuclear	_	JJ	JJ	_	17	amod	_	_
13	factor	_	NN	NN	_	17	nn	_	_
14	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
15	NF	_	NN	NN	_	17	nn	_	_
16	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
17	-kappaB	_	NN	NN	_	18	nn	_	_
18	pathway	_	NN	NN	_	10	pobj	_	_
19	was	_	VBD	VBD	_	20	cop	_	_
20	unable	_	JJ	JJ	_	0	root	_	_
21	to	_	TO	TO	_	22	aux	_	_
22	induce	_	VB	VB	_	20	xcomp	_	_
23	transcriptional	_	JJ	JJ	_	24	amod	_	_
24	activity	_	NN	NN	_	22	dobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	IL-1alpha	_	NN	NN	_	28	nn	_	_
27	promoter-CAT	_	JJ	JJ	_	28	amod	_	_
28	constructs	_	NNS	NNS	_	25	pobj	_	_
29	,	_	,	,	_	20	punct	_	_
30	but	_	CC	CC	_	20	cc	_	_
31	was	_	VBD	VBD	_	32	auxpass	_	_
32	rescued	_	VBN	VBN	_	20	conj	_	_
33	by	_	IN	IN	_	32	prep	_	_
34	exogenous	_	JJ	JJ	_	35	amod	_	_
35	provision	_	NN	NN	_	33	pobj	_	_
36	of	_	IN	IN	_	35	prep	_	_
37	p65/p50	_	NN	NN	_	36	pobj	_	_
38	NF-kappaB	_	NN	NN	_	37	dep	_	_
39	.	_	.	.	_	20	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	found	_	VBD	VBD	_	0	root	_	_
3	that	_	IN	IN	_	19	mark	_	_
4	two	_	CD	CD	_	7	num	_	_
5	IL-1alpha	_	NN	NN	_	7	nn	_	_
6	kappaB-like	_	JJ	JJ	_	7	amod	_	_
7	sites	_	NNS	NNS	_	19	nsubj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	positions	_	NNS	NNS	_	7	appos	_	_
10	-1,065	_	CD	CD	_	12	num	_	_
11	to	_	TO	TO	_	12	dep	_	_
12	-1,056	_	CD	CD	_	9	dep	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	+646	_	CD	CD	_	16	num	_	_
15	to	_	TO	TO	_	16	dep	_	_
16	+655	_	CD	CD	_	12	conj	_	_
17	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
18	specifically	_	RB	RB	_	19	advmod	_	_
19	formed	_	VBD	VBD	_	2	ccomp	_	_
20	a	_	DT	DT	_	21	det	_	_
21	complex	_	JJ	JJ	_	19	dobj	_	_
22	with	_	IN	IN	_	19	prep	_	_
23	NF-kappaB-containing	_	JJ	JJ	_	25	amod	_	_
24	nuclear	_	JJ	JJ	_	25	amod	_	_
25	extract	_	NN	NN	_	22	pobj	_	_
26	from	_	IN	IN	_	25	prep	_	_
27	MT-2	_	NN	NN	_	28	nn	_	_
28	cells	_	NNS	NNS	_	26	pobj	_	_
29	and	_	CC	CC	_	19	cc	_	_
30	that	_	IN	IN	_	32	mark	_	_
31	NF-kappaB	_	NN	NN	_	32	nsubj	_	_
32	bound	_	VBD	VBD	_	19	conj	_	_
33	with	_	IN	IN	_	32	prep	_	_
34	higher	_	JJR	JJR	_	35	amod	_	_
35	affinity	_	NN	NN	_	33	pobj	_	_
36	to	_	TO	TO	_	35	prep	_	_
37	the	_	DT	DT	_	41	det	_	_
38	3'	_	JJ	JJ	_	41	amod	_	_
39	NF-kappaB	_	NN	NN	_	41	nn	_	_
40	binding	_	NN	NN	_	41	nn	_	_
41	site	_	NN	NN	_	36	pobj	_	_
42	than	_	IN	IN	_	35	prep	_	_
43	to	_	TO	TO	_	42	pcomp	_	_
44	the	_	DT	DT	_	47	det	_	_
45	5'	_	JJ	JJ	_	47	amod	_	_
46	NF-kappaB	_	NN	NN	_	47	nn	_	_
47	site	_	NN	NN	_	43	pobj	_	_
48	.	_	.	.	_	2	punct	_	_

1	Moreover	_	RB	RB	_	11	advmod	_	_
2	,	_	,	,	_	11	punct	_	_
3	deletion	_	NN	NN	_	11	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	either	_	CC	CC	_	6	preconj	_	_
6	5'	_	JJ	JJ	_	4	pobj	_	_
7	or	_	CC	CC	_	6	cc	_	_
8	3'	_	JJ	JJ	_	6	conj	_	_
9	NF-kappaB	_	NN	NN	_	10	nn	_	_
10	sites	_	NNS	NNS	_	6	dep	_	_
11	reduced	_	VBD	VBD	_	0	root	_	_
12	IL-1alpha	_	NN	NN	_	13	nn	_	_
13	promoter	_	NN	NN	_	14	nn	_	_
14	activity	_	NN	NN	_	11	dobj	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	MT-2	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	15	pobj	_	_
18	and	_	CC	CC	_	14	cc	_	_
19	transactivation	_	NN	NN	_	14	conj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	IL-1alpha	_	NN	NN	_	23	nn	_	_
23	promoter	_	NN	NN	_	20	pobj	_	_
24	by	_	IN	IN	_	19	prep	_	_
25	exogenous	_	JJ	JJ	_	26	amod	_	_
26	NF-kappaB	_	NN	NN	_	24	pobj	_	_
27	and	_	CC	CC	_	26	cc	_	_
28	Tax	_	NN	NN	_	26	conj	_	_
29	in	_	IN	IN	_	26	prep	_	_
30	Jurkat	_	NN	NN	_	31	nn	_	_
31	cells	_	NNS	NNS	_	29	pobj	_	_
32	.	_	.	.	_	11	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	a	_	DT	DT	_	6	det	_	_
5	general	_	JJ	JJ	_	6	amod	_	_
6	role	_	NN	NN	_	3	dobj	_	_
7	for	_	IN	IN	_	6	prep	_	_
8	Tax	_	NN	NN	_	9	nn	_	_
9	induction	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	IL-1alpha	_	NN	NN	_	12	nn	_	_
12	gene	_	NN	NN	_	13	nn	_	_
13	transcription	_	NN	NN	_	10	pobj	_	_
14	by	_	IN	IN	_	9	prep	_	_
15	the	_	DT	DT	_	17	det	_	_
16	NF-kappaB	_	NN	NN	_	17	nn	_	_
17	pathway	_	NN	NN	_	14	pobj	_	_
18	.	_	.	.	_	3	punct	_	_

1	Expression	_	NN	NN	_	11	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	IL-1alpha	_	NN	NN	_	2	pobj	_	_
4	by	_	IN	IN	_	1	prep	_	_
5	HTLV-I	_	NN	NN	_	4	pobj	_	_
6	productively	_	RB	RB	_	5	advmod	_	_
7	infected	_	JJ	JJ	_	8	amod	_	_
8	cells	_	NNS	NNS	_	5	dep	_	_
9	may	_	MD	MD	_	11	aux	_	_
10	be	_	VB	VB	_	11	cop	_	_
11	important	_	JJ	JJ	_	0	root	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	hypercalcemia	_	NN	NN	_	12	pobj	_	_
15	,	_	,	,	_	14	punct	_	_
16	osteolytic	_	JJ	JJ	_	18	amod	_	_
17	bone	_	NN	NN	_	18	nn	_	_
18	lesions	_	NNS	NNS	_	14	conj	_	_
19	,	_	,	,	_	14	punct	_	_
20	neutrophilia	_	NN	NN	_	14	conj	_	_
21	,	_	,	,	_	14	punct	_	_
22	elevation	_	NN	NN	_	14	conj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	C-reactive	_	JJ	JJ	_	25	amod	_	_
25	protein	_	NN	NN	_	23	pobj	_	_
26	,	_	,	,	_	14	punct	_	_
27	and	_	CC	CC	_	14	cc	_	_
28	fever	_	NN	NN	_	14	conj	_	_
29	frequently	_	RB	RB	_	30	advmod	_	_
30	seen	_	VBN	VBN	_	14	vmod	_	_
31	in	_	IN	IN	_	30	prep	_	_
32	patients	_	NNS	NNS	_	31	pobj	_	_
33	with	_	IN	IN	_	32	prep	_	_
34	HTLV-I-induced	_	JJ	JJ	_	37	amod	_	_
35	adult	_	JJ	JJ	_	37	amod	_	_
36	T-cell	_	NN	NN	_	37	nn	_	_
37	leukemia/lymphoma	_	NN	NN	_	33	pobj	_	_
38	.	_	.	.	_	11	punct	_	_

1	Activation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	c-Jun	_	NN	NN	_	5	nn	_	_
4	N-terminal	_	JJ	JJ	_	5	amod	_	_
5	kinase	_	NN	NN	_	2	pobj	_	_
6	in	_	IN	IN	_	1	prep	_	_
7	bacterial	_	JJ	JJ	_	9	amod	_	_
8	lipopolysaccharide-stimulated	_	JJ	JJ	_	9	amod	_	_
9	macrophages	_	NNS	NNS	_	6	pobj	_	_
10	.	_	.	.	_	1	punct	_	_

1	Activation	_	NN	NN	_	10	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	macrophages	_	NNS	NNS	_	2	pobj	_	_
4	by	_	IN	IN	_	1	prep	_	_
5	bacterial	_	JJ	JJ	_	6	amod	_	_
6	lipopolysaccharide	_	NN	NN	_	4	pobj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	LPS	_	NN	NN	_	6	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	induces	_	VBZ	VBZ	_	0	root	_	_
11	transcription	_	NN	NN	_	10	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	genes	_	NNS	NNS	_	12	pobj	_	_
14	that	_	WDT	WDT	_	15	nsubj	_	_
15	encode	_	VBP	VBP	_	13	rcmod	_	_
16	for	_	IN	IN	_	15	prep	_	_
17	proinflammatory	_	JJ	JJ	_	18	amod	_	_
18	regulators	_	NNS	NNS	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	22	det	_	_
21	immune	_	JJ	JJ	_	22	amod	_	_
22	response	_	NN	NN	_	19	pobj	_	_
23	.	_	.	.	_	10	punct	_	_

1	Previous	_	JJ	JJ	_	2	amod	_	_
2	work	_	NN	NN	_	4	nsubj	_	_
3	has	_	VBZ	VBZ	_	4	aux	_	_
4	suggested	_	VBN	VBN	_	0	root	_	_
5	that	_	IN	IN	_	20	mark	_	_
6	activation	_	NN	NN	_	20	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	12	det	_	_
9	transcription	_	NN	NN	_	12	nn	_	_
10	factor	_	NN	NN	_	12	nn	_	_
11	activator	_	NN	NN	_	12	nn	_	_
12	protein	_	NN	NN	_	7	pobj	_	_
13	1	_	CD	CD	_	12	num	_	_
14	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	AP-1	_	NN	NN	_	12	appos	_	_
16	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
17	is	_	VBZ	VBZ	_	20	cop	_	_
18	one	_	CD	CD	_	20	num	_	_
19	LPS-induced	_	JJ	JJ	_	20	amod	_	_
20	event	_	NN	NN	_	4	ccomp	_	_
21	that	_	WDT	WDT	_	22	nsubj	_	_
22	mediates	_	VBZ	VBZ	_	20	rcmod	_	_
23	this	_	DT	DT	_	24	det	_	_
24	response	_	NN	NN	_	22	dobj	_	_
25	.	_	.	.	_	4	punct	_	_

1	Consistent	_	JJ	JJ	_	7	advmod	_	_
2	with	_	IN	IN	_	1	prep	_	_
3	this	_	DT	DT	_	4	det	_	_
4	notion	_	NN	NN	_	2	pobj	_	_
5	,	_	,	,	_	7	punct	_	_
6	we	_	PRP	PRP	_	7	nsubj	_	_
7	found	_	VBD	VBD	_	0	root	_	_
8	that	_	IN	IN	_	10	mark	_	_
9	LPS	_	NN	NN	_	10	nsubj	_	_
10	stimulated	_	VBD	VBD	_	7	ccomp	_	_
11	AP-1-mediated	_	JJ	JJ	_	12	amod	_	_
12	transcription	_	NN	NN	_	10	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	a	_	DT	DT	_	17	det	_	_
15	transfected	_	VBN	VBN	_	17	amod	_	_
16	reporter	_	NN	NN	_	17	nn	_	_
17	gene	_	NN	NN	_	13	pobj	_	_
18	in	_	IN	IN	_	12	prep	_	_
19	the	_	DT	DT	_	24	det	_	_
20	murine	_	JJ	JJ	_	24	amod	_	_
21	macrophage	_	NN	NN	_	24	nn	_	_
22	cell	_	NN	NN	_	24	nn	_	_
23	line	_	NN	NN	_	24	nn	_	_
24	RAW	_	NN	NN	_	18	pobj	_	_
25	264.7	_	CD	CD	_	24	num	_	_
26	.	_	.	.	_	7	punct	_	_

1	As	_	IN	IN	_	5	mark	_	_
2	AP-1	_	NN	NN	_	3	nn	_	_
3	activity	_	NN	NN	_	5	nsubjpass	_	_
4	is	_	VBZ	VBZ	_	5	auxpass	_	_
5	regulated	_	VBN	VBN	_	31	advcl	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	part	_	NN	NN	_	6	pobj	_	_
8	by	_	IN	IN	_	5	prep	_	_
9	activation	_	NN	NN	_	8	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	14	det	_	_
12	c-Jun	_	NN	NN	_	14	nn	_	_
13	N-terminal	_	JJ	JJ	_	14	amod	_	_
14	kinase	_	NN	NN	_	10	pobj	_	_
15	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
16	JNK	_	NN	NN	_	14	appos	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	,	_	,	,	_	14	punct	_	_
19	which	_	WDT	WDT	_	20	nsubj	_	_
20	phosphorylates	_	VBZ	VBZ	_	14	rcmod	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	subsequently	_	RB	RB	_	23	advmod	_	_
23	increases	_	VBZ	VBZ	_	20	conj	_	_
24	the	_	DT	DT	_	26	det	_	_
25	transcriptional	_	JJ	JJ	_	26	amod	_	_
26	activity	_	NN	NN	_	23	dobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	c-Jun	_	NN	NN	_	27	pobj	_	_
29	,	_	,	,	_	31	punct	_	_
30	we	_	PRP	PRP	_	31	nsubj	_	_
31	examined	_	VBD	VBD	_	0	root	_	_
32	whether	_	IN	IN	_	37	mark	_	_
33	LPS	_	NN	NN	_	34	nn	_	_
34	treatment	_	NN	NN	_	37	nsubj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	macrophages	_	NNS	NNS	_	35	pobj	_	_
37	resulted	_	VBD	VBD	_	31	ccomp	_	_
38	in	_	IN	IN	_	37	prep	_	_
39	activation	_	NN	NN	_	38	pobj	_	_
40	of	_	IN	IN	_	39	prep	_	_
41	this	_	DT	DT	_	42	det	_	_
42	kinase	_	NN	NN	_	40	pobj	_	_
43	.	_	.	.	_	31	punct	_	_

1	LPS	_	NN	NN	_	2	nn	_	_
2	treatment	_	NN	NN	_	20	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	RAW	_	NN	NN	_	6	nn	_	_
5	264.7	_	CD	CD	_	6	num	_	_
6	cells	_	NNS	NNS	_	3	pobj	_	_
7	,	_	,	,	_	6	punct	_	_
8	murine	_	JJ	JJ	_	11	amod	_	_
9	bone	_	NN	NN	_	11	nn	_	_
10	marrow-derived	_	JJ	JJ	_	11	amod	_	_
11	macrophages	_	NNS	NNS	_	6	appos	_	_
12	,	_	,	,	_	6	punct	_	_
13	and	_	CC	CC	_	6	cc	_	_
14	the	_	DT	DT	_	19	det	_	_
15	human	_	JJ	JJ	_	19	amod	_	_
16	monocyte	_	NN	NN	_	19	nn	_	_
17	cell	_	NN	NN	_	19	nn	_	_
18	line	_	NN	NN	_	19	nn	_	_
19	THP-1	_	NN	NN	_	6	conj	_	_
20	resulted	_	VBD	VBD	_	0	root	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	rapid	_	JJ	JJ	_	23	amod	_	_
23	activation	_	NN	NN	_	21	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	26	dep	_	_
26	p46	_	NN	NN	_	24	pobj	_	_
27	and	_	CC	CC	_	26	cc	_	_
28	p54	_	NN	NN	_	26	conj	_	_
29	isoforms	_	NNS	NNS	_	26	dep	_	_
30	of	_	IN	IN	_	26	prep	_	_
31	JNK	_	NN	NN	_	30	pobj	_	_
32	.	_	.	.	_	20	punct	_	_

1	Treatment	_	NN	NN	_	14	nsubj	_	_
2	with	_	IN	IN	_	1	prep	_	_
3	wild-type	_	JJ	JJ	_	2	pobj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	rough	_	JJ	JJ	_	3	conj	_	_
6	mutant	_	JJ	JJ	_	7	amod	_	_
7	forms	_	NNS	NNS	_	3	dep	_	_
8	of	_	IN	IN	_	3	prep	_	_
9	LPS	_	NN	NN	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	synthetic	_	JJ	JJ	_	13	amod	_	_
12	lipid	_	NN	NN	_	13	nn	_	_
13	A	_	NN	NN	_	9	conj	_	_
14	resulted	_	VBD	VBD	_	0	root	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	JNK	_	NN	NN	_	17	nn	_	_
17	activation	_	NN	NN	_	15	pobj	_	_
18	,	_	,	,	_	14	punct	_	_
19	while	_	IN	IN	_	28	mark	_	_
20	pretreatment	_	NN	NN	_	28	nsubj	_	_
21	with	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	27	det	_	_
23	tyrosine	_	NN	NN	_	24	nn	_	_
24	kinase	_	NN	NN	_	27	nn	_	_
25	inhibitor	_	NN	NN	_	27	nn	_	_
26	herbimycin	_	NN	NN	_	27	nn	_	_
27	A	_	NN	NN	_	21	pobj	_	_
28	inhibited	_	VBD	VBD	_	14	advcl	_	_
29	this	_	DT	DT	_	30	det	_	_
30	response	_	NN	NN	_	28	dobj	_	_
31	.	_	.	.	_	14	punct	_	_

1	Binding	_	NN	NN	_	23	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	LPS-LPS	_	NN	NN	_	9	nn	_	_
4	binding	_	NN	NN	_	9	nn	_	_
5	protein	_	NN	NN	_	9	nn	_	_
6	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
7	LBP	_	NN	NN	_	9	nn	_	_
8	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
9	complexes	_	NNS	NNS	_	2	pobj	_	_
10	to	_	TO	TO	_	1	prep	_	_
11	CD14	_	NN	NN	_	10	pobj	_	_
12	,	_	,	,	_	11	punct	_	_
13	a	_	DT	DT	_	15	det	_	_
14	surface	_	NN	NN	_	15	nn	_	_
15	receptor	_	NN	NN	_	11	appos	_	_
16	that	_	WDT	WDT	_	17	nsubj	_	_
17	mediates	_	VBZ	VBZ	_	15	rcmod	_	_
18	many	_	JJ	JJ	_	20	amod	_	_
19	LPS	_	NN	NN	_	20	nn	_	_
20	responses	_	NNS	NNS	_	17	dobj	_	_
21	,	_	,	,	_	1	punct	_	_
22	was	_	VBD	VBD	_	23	auxpass	_	_
23	found	_	VBN	VBN	_	0	root	_	_
24	to	_	TO	TO	_	26	aux	_	_
25	be	_	VB	VB	_	26	cop	_	_
26	crucial	_	JJ	JJ	_	23	xcomp	_	_
27	,	_	,	,	_	23	punct	_	_
28	as	_	IN	IN	_	44	mark	_	_
29	pretreatment	_	NN	NN	_	44	nsubj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	THP-1	_	NN	NN	_	32	nn	_	_
32	cells	_	NNS	NNS	_	30	pobj	_	_
33	with	_	IN	IN	_	29	prep	_	_
34	the	_	DT	DT	_	37	det	_	_
35	monoclonal	_	JJ	JJ	_	37	amod	_	_
36	antibody	_	NN	NN	_	37	nn	_	_
37	60b	_	NN	NN	_	33	pobj	_	_
38	,	_	,	,	_	37	punct	_	_
39	which	_	WDT	WDT	_	40	nsubj	_	_
40	blocks	_	VBZ	VBZ	_	37	rcmod	_	_
41	this	_	DT	DT	_	42	det	_	_
42	binding	_	NN	NN	_	40	dobj	_	_
43	,	_	,	,	_	29	punct	_	_
44	inhibited	_	VBD	VBD	_	23	advcl	_	_
45	JNK	_	NN	NN	_	46	nn	_	_
46	activation	_	NN	NN	_	44	dobj	_	_
47	.	_	.	.	_	23	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	19	mark	_	_
5	LPS	_	NN	NN	_	6	nn	_	_
6	activation	_	NN	NN	_	19	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	JNK	_	NN	NN	_	7	pobj	_	_
9	in	_	IN	IN	_	6	prep	_	_
10	monocyte/macrophage	_	JJ	JJ	_	11	amod	_	_
11	cells	_	NNS	NNS	_	9	pobj	_	_
12	is	_	VBZ	VBZ	_	19	cop	_	_
13	a	_	DT	DT	_	19	det	_	_
14	CD14-	_	NN	NN	_	19	amod	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	protein	_	NN	NN	_	18	npadvmod	_	_
17	tyrosine	_	NN	NN	_	18	npadvmod	_	_
18	phosphorylation-dependent	_	JJ	JJ	_	14	conj	_	_
19	event	_	NN	NN	_	3	ccomp	_	_
20	that	_	WDT	WDT	_	22	nsubj	_	_
21	may	_	MD	MD	_	22	aux	_	_
22	mediate	_	VB	VB	_	19	rcmod	_	_
23	the	_	DT	DT	_	25	det	_	_
24	early	_	JJ	JJ	_	25	amod	_	_
25	activation	_	NN	NN	_	22	dobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	AP-1	_	NN	NN	_	26	pobj	_	_
28	in	_	IN	IN	_	22	prep	_	_
29	regulating	_	VBG	VBG	_	28	pcomp	_	_
30	LPS-triggered	_	JJ	JJ	_	32	amod	_	_
31	gene	_	NN	NN	_	32	nn	_	_
32	induction	_	NN	NN	_	29	dobj	_	_
33	.	_	.	.	_	3	punct	_	_

1	Transcriptional	_	JJ	JJ	_	2	amod	_	_
2	basis	_	NN	NN	_	0	root	_	_
3	for	_	IN	IN	_	2	prep	_	_
4	hyporesponsiveness	_	NN	NN	_	3	pobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	12	det	_	_
7	human	_	JJ	JJ	_	12	amod	_	_
8	inducible	_	JJ	JJ	_	12	amod	_	_
9	nitric	_	JJ	JJ	_	12	amod	_	_
10	oxide	_	NN	NN	_	12	nn	_	_
11	synthase	_	NN	NN	_	12	nn	_	_
12	gene	_	NN	NN	_	5	pobj	_	_
13	to	_	TO	TO	_	4	prep	_	_
14	lipopolysaccharide/interferon-gamma	_	NN	NN	_	13	pobj	_	_
15	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	work	_	NN	NN	_	5	nsubj	_	_
3	reported	_	VBN	VBN	_	2	vmod	_	_
4	here	_	RB	RB	_	3	advmod	_	_
5	resolves	_	VBZ	VBZ	_	0	root	_	_
6	,	_	,	,	_	5	punct	_	_
7	at	_	IN	IN	_	5	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	level	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	gene	_	NN	NN	_	12	nn	_	_
12	regulation	_	NN	NN	_	10	pobj	_	_
13	,	_	,	,	_	5	punct	_	_
14	the	_	DT	DT	_	15	det	_	_
15	controversy	_	NN	NN	_	5	dobj	_	_
16	as	_	IN	IN	_	15	prep	_	_
17	to	_	TO	TO	_	16	pcomp	_	_
18	whether	_	IN	IN	_	24	mark	_	_
19	or	_	CC	CC	_	24	cc	_	_
20	not	_	RB	RB	_	24	conj	_	_
21	human	_	JJ	JJ	_	22	amod	_	_
22	monocytes/macrophages	_	NNS	NNS	_	24	nsubj	_	_
23	can	_	MD	MD	_	24	aux	_	_
24	produce	_	VB	VB	_	17	pcomp	_	_
25	nitric	_	JJ	JJ	_	26	amod	_	_
26	oxide	_	NN	NN	_	24	dobj	_	_
27	-LRB-	_	-LRB-	-LRB-	_	28	punct	_	_
28	NO	_	NN	NN	_	26	appos	_	_
29	-RRB-	_	-RRB-	-RRB-	_	28	punct	_	_
30	when	_	WRB	WRB	_	31	advmod	_	_
31	stimulated	_	VBN	VBN	_	24	advcl	_	_
32	with	_	IN	IN	_	31	prep	_	_
33	lipopolysaccharide	_	NN	NN	_	32	pobj	_	_
34	-LRB-	_	-LRB-	-LRB-	_	35	punct	_	_
35	LPS	_	NN	NN	_	33	appos	_	_
36	-RRB-	_	-RRB-	-RRB-	_	35	punct	_	_
37	,	_	,	,	_	31	punct	_	_
38	with	_	IN	IN	_	31	prep	_	_
39	or	_	CC	CC	_	38	cc	_	_
40	without	_	IN	IN	_	38	conj	_	_
41	co-stimulation	_	NN	NN	_	38	pobj	_	_
42	by	_	IN	IN	_	41	prep	_	_
43	interferon-gamma	_	NN	NN	_	42	pobj	_	_
44	-LRB-	_	-LRB-	-LRB-	_	45	punct	_	_
45	IFN-gamma	_	NN	NN	_	43	appos	_	_
46	-RRB-	_	-RRB-	-RRB-	_	45	punct	_	_
47	.	_	.	.	_	5	punct	_	_

1	Studies	_	NNS	NNS	_	2	nsubj	_	_
2	included	_	VBD	VBD	_	0	root	_	_
3	structural	_	JJ	JJ	_	4	amod	_	_
4	comparison	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	promoters	_	NNS	NNS	_	5	pobj	_	_
8	for	_	IN	IN	_	7	prep	_	_
9	human	_	JJ	JJ	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	mouse	_	NN	NN	_	9	conj	_	_
12	inducible	_	JJ	JJ	_	18	amod	_	_
13	NO	_	NN	NN	_	18	nn	_	_
14	synthase	_	NN	NN	_	18	nn	_	_
15	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
16	iNOS	_	NN	NN	_	18	nn	_	_
17	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
18	genes	_	NNS	NNS	_	9	dep	_	_
19	,	_	,	,	_	4	punct	_	_
20	transfection	_	NN	NN	_	4	conj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	assay	_	NN	NN	_	20	conj	_	_
23	of	_	IN	IN	_	20	prep	_	_
24	human	_	JJ	JJ	_	23	pobj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	mouse	_	NN	NN	_	24	conj	_	_
27	iNOS	_	NN	NN	_	29	nn	_	_
28	promoter	_	NN	NN	_	29	nn	_	_
29	regions	_	NNS	NNS	_	24	dep	_	_
30	in	_	IN	IN	_	20	prep	_	_
31	response	_	NN	NN	_	30	pobj	_	_
32	to	_	TO	TO	_	31	prep	_	_
33	LPS	_	NN	NN	_	32	pobj	_	_
34	+/-	_	CC	CC	_	33	cc	_	_
35	IFN-gamma	_	NN	NN	_	33	conj	_	_
36	,	_	,	,	_	4	punct	_	_
37	and	_	CC	CC	_	4	cc	_	_
38	electrophoretic	_	JJ	JJ	_	41	amod	_	_
39	mobility	_	NN	NN	_	41	nn	_	_
40	shift	_	NN	NN	_	41	nn	_	_
41	assays	_	NNS	NNS	_	4	conj	_	_
42	of	_	IN	IN	_	41	prep	_	_
43	kappa	_	NN	NN	_	46	nn	_	_
44	B	_	NN	NN	_	46	nn	_	_
45	response	_	NN	NN	_	46	nn	_	_
46	elements	_	NNS	NNS	_	42	pobj	_	_
47	.	_	.	.	_	2	punct	_	_

1	Two	_	CD	CD	_	2	num	_	_
2	explanations	_	NNS	NNS	_	15	nsubjpass	_	_
3	for	_	IN	IN	_	2	prep	_	_
4	hyporesponsiveness	_	NN	NN	_	3	pobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	9	det	_	_
7	human	_	JJ	JJ	_	9	amod	_	_
8	iNOS	_	NN	NN	_	9	nn	_	_
9	promoter	_	NN	NN	_	5	pobj	_	_
10	to	_	TO	TO	_	4	prep	_	_
11	LPS	_	NN	NN	_	10	pobj	_	_
12	+/-	_	CC	CC	_	11	cc	_	_
13	IFN-gamma	_	NN	NN	_	11	conj	_	_
14	were	_	VBD	VBD	_	15	auxpass	_	_
15	found	_	VBN	VBN	_	0	root	_	_
16	:	_	:	:	_	15	punct	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	1	_	LS	LS	_	23	dep	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	multiple	_	JJ	JJ	_	23	amod	_	_
21	inactivating	_	VBG	VBG	_	20	dep	_	_
22	nucleotide	_	JJ	JJ	_	23	amod	_	_
23	substitutions	_	NNS	NNS	_	15	dep	_	_
24	in	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	27	det	_	_
26	human	_	JJ	JJ	_	27	amod	_	_
27	counterpart	_	NN	NN	_	24	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	the	_	DT	DT	_	31	det	_	_
30	enhancer	_	NN	NN	_	31	nn	_	_
31	element	_	NN	NN	_	28	pobj	_	_
32	that	_	WDT	WDT	_	35	nsubjpass	_	_
33	has	_	VBZ	VBZ	_	35	aux	_	_
34	been	_	VBN	VBN	_	35	auxpass	_	_
35	shown	_	VBN	VBN	_	27	rcmod	_	_
36	to	_	TO	TO	_	37	aux	_	_
37	regulate	_	VB	VB	_	35	xcomp	_	_
38	LPS/IFN-gamma	_	NN	NN	_	40	nn	_	_
39	induced	_	JJ	JJ	_	40	amod	_	_
40	expression	_	NN	NN	_	37	dobj	_	_
41	of	_	IN	IN	_	40	prep	_	_
42	the	_	DT	DT	_	45	det	_	_
43	mouse	_	NN	NN	_	45	nn	_	_
44	iNOS	_	NN	NN	_	45	nn	_	_
45	gene	_	NN	NN	_	41	pobj	_	_
46	;	_	:	:	_	23	punct	_	_
47	and	_	CC	CC	_	23	cc	_	_
48	-LRB-	_	-LRB-	-LRB-	_	49	punct	_	_
49	2	_	LS	LS	_	52	dep	_	_
50	-RRB-	_	-RRB-	-RRB-	_	49	punct	_	_
51	and	_	CC	CC	_	52	cc	_	_
52	absence	_	NN	NN	_	23	conj	_	_
53	of	_	IN	IN	_	52	prep	_	_
54	one	_	CD	CD	_	58	num	_	_
55	or	_	CC	CC	_	54	cc	_	_
56	more	_	JJR	JJR	_	54	conj	_	_
57	nuclear	_	JJ	JJ	_	58	amod	_	_
58	factors	_	NNS	NNS	_	53	pobj	_	_
59	in	_	IN	IN	_	58	prep	_	_
60	human	_	JJ	JJ	_	61	amod	_	_
61	macrophages	_	NNS	NNS	_	59	pobj	_	_
62	-LRB-	_	-LRB-	-LRB-	_	70	punct	_	_
63	e.g.	_	FW	FW	_	70	prep	_	_
64	,	_	,	,	_	70	punct	_	_
65	an	_	DT	DT	_	70	det	_	_
66	LPS-inducible	_	JJ	JJ	_	70	amod	_	_
67	nuclear	_	JJ	JJ	_	70	amod	_	_
68	factor-kappa	_	NN	NN	_	70	nn	_	_
69	B/Rel	_	NN	NN	_	70	nn	_	_
70	complex	_	NN	NN	_	58	dep	_	_
71	-RRB-	_	-RRB-	-RRB-	_	70	punct	_	_
72	,	_	,	,	_	58	punct	_	_
73	that	_	WDT	WDT	_	74	nsubj	_	_
74	is	_	VBZ	VBZ	_	58	rcmod	_	_
75	-LRB-	_	-LRB-	-LRB-	_	76	punct	_	_
76	are	_	VBP	VBP	_	74	dep	_	_
77	-RRB-	_	-RRB-	-RRB-	_	76	punct	_	_
78	required	_	VBN	VBN	_	74	dep	_	_
79	for	_	IN	IN	_	78	prep	_	_
80	maximal	_	JJ	JJ	_	81	amod	_	_
81	expression	_	NN	NN	_	79	pobj	_	_
82	of	_	IN	IN	_	81	prep	_	_
83	the	_	DT	DT	_	84	det	_	_
84	gene	_	NN	NN	_	82	pobj	_	_
85	.	_	.	.	_	15	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	importance	_	NN	NN	_	8	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	resolution	_	NN	NN	_	3	pobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	this	_	DT	DT	_	7	det	_	_
7	controversy	_	NN	NN	_	5	pobj	_	_
8	is	_	VBZ	VBZ	_	0	root	_	_
9	that	_	IN	IN	_	17	mark	_	_
10	future	_	JJ	JJ	_	11	amod	_	_
11	research	_	NN	NN	_	17	nsubjpass	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	this	_	DT	DT	_	14	det	_	_
14	area	_	NN	NN	_	12	pobj	_	_
15	should	_	MD	MD	_	17	aux	_	_
16	be	_	VB	VB	_	17	auxpass	_	_
17	directed	_	VBN	VBN	_	8	ccomp	_	_
18	toward	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	20	det	_	_
20	understanding	_	NN	NN	_	18	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	alternative	_	JJ	JJ	_	23	amod	_	_
23	mechanisms	_	NNS	NNS	_	21	pobj	_	_
24	that	_	WDT	WDT	_	26	nsubj	_	_
25	can	_	MD	MD	_	26	aux	_	_
26	result	_	VB	VB	_	23	rcmod	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	30	det	_	_
29	successful	_	JJ	JJ	_	30	amod	_	_
30	production	_	NN	NN	_	27	pobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	NO	_	NN	NN	_	31	pobj	_	_
33	.	_	.	.	_	8	punct	_	_

1	Ubiquitinylation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	transcription	_	NN	NN	_	4	nn	_	_
4	factors	_	NNS	NNS	_	2	pobj	_	_
5	c-Jun	_	NN	NN	_	4	dep	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	c-Fos	_	NN	NN	_	5	conj	_	_
8	using	_	VBG	VBG	_	1	dep	_	_
9	reconstituted	_	VBN	VBN	_	11	amod	_	_
10	ubiquitinylating	_	VBG	VBG	_	11	amod	_	_
11	enzymes	_	NNS	NNS	_	8	dobj	_	_
12	.	_	.	.	_	1	punct	_	_

1	Recombinant	_	JJ	JJ	_	2	amod	_	_
2	c-Jun	_	NN	NN	_	6	nsubjpass	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	c-Fos	_	NN	NN	_	2	conj	_	_
5	were	_	VBD	VBD	_	6	auxpass	_	_
6	ubiquitinylated	_	VBN	VBN	_	0	root	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	11	det	_	_
9	ubiquitin	_	NN	NN	_	11	nn	_	_
10	carrier	_	NN	NN	_	11	nn	_	_
11	enzymes	_	NNS	NNS	_	7	pobj	_	_
12	E214K	_	NN	NN	_	11	dep	_	_
13	,	_	,	,	_	12	punct	_	_
14	E220K	_	NN	NN	_	12	conj	_	_
15	,	_	,	,	_	12	punct	_	_
16	or	_	CC	CC	_	12	cc	_	_
17	E232K	_	NN	NN	_	12	conj	_	_
18	in	_	IN	IN	_	6	prep	_	_
19	the	_	DT	DT	_	20	det	_	_
20	presence	_	NN	NN	_	18	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	24	det	_	_
23	ubiquitin-activating	_	JJ	JJ	_	24	amod	_	_
24	enzyme	_	NN	NN	_	21	pobj	_	_
25	,	_	,	,	_	24	punct	_	_
26	E1	_	NN	NN	_	24	appos	_	_
27	.	_	.	.	_	6	punct	_	_

1	Addition	_	NN	NN	_	8	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	ubiquitin	_	NN	NN	_	6	nn	_	_
4	protein	_	NN	NN	_	6	nn	_	_
5	ligase	_	NN	NN	_	6	nn	_	_
6	E3	_	NN	NN	_	2	pobj	_	_
7	substantially	_	RB	RB	_	8	advmod	_	_
8	enhanced	_	VBD	VBD	_	0	root	_	_
9	the	_	DT	DT	_	11	det	_	_
10	E214K-mediated	_	JJ	JJ	_	11	amod	_	_
11	ubiquitinylation	_	NN	NN	_	8	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	c-Jun	_	NN	NN	_	12	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	c-Fos	_	NN	NN	_	13	conj	_	_
16	.	_	.	.	_	8	punct	_	_

1	Truncated	_	VBN	VBN	_	2	amod	_	_
2	c-Jun	_	NN	NN	_	13	nsubjpass	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	c-Fos	_	NN	NN	_	2	conj	_	_
5	mutant	_	JJ	JJ	_	6	amod	_	_
6	proteins	_	NNS	NNS	_	2	dep	_	_
7	including	_	VBG	VBG	_	2	prep	_	_
8	wbJun	_	NN	NN	_	7	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	wbFos	_	NN	NN	_	8	conj	_	_
11	were	_	VBD	VBD	_	13	auxpass	_	_
12	also	_	RB	RB	_	13	advmod	_	_
13	ubiquitinylated	_	VBN	VBN	_	0	root	_	_
14	under	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	17	det	_	_
16	same	_	JJ	JJ	_	17	amod	_	_
17	conditions	_	NNS	NNS	_	14	pobj	_	_
18	,	_	,	,	_	13	punct	_	_
19	suggesting	_	VBG	VBG	_	13	vmod	_	_
20	the	_	DT	DT	_	21	det	_	_
21	sites	_	NNS	NNS	_	25	nsubj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	ubiquitinylation	_	NN	NN	_	22	pobj	_	_
24	are	_	VBP	VBP	_	25	cop	_	_
25	located	_	JJ	JJ	_	19	ccomp	_	_
26	within	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	28	dep	_	_
28	dimerization	_	NN	NN	_	26	pobj	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	DNA	_	NN	NN	_	31	nn	_	_
31	binding	_	NN	NN	_	28	conj	_	_
32	domains	_	NNS	NNS	_	28	dep	_	_
33	of	_	IN	IN	_	28	prep	_	_
34	c-Jun	_	NN	NN	_	33	pobj	_	_
35	and	_	CC	CC	_	34	cc	_	_
36	c-Fos	_	NN	NN	_	34	conj	_	_
37	.	_	.	.	_	13	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	E3-dependent	_	JJ	JJ	_	3	amod	_	_
3	ubiquitinylation	_	NN	NN	_	7	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	c-Jun	_	NN	NN	_	4	pobj	_	_
6	was	_	VBD	VBD	_	7	auxpass	_	_
7	inhibited	_	VBN	VBN	_	0	root	_	_
8	upon	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	heterodimerization	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	c-Jun	_	NN	NN	_	11	pobj	_	_
13	with	_	IN	IN	_	10	prep	_	_
14	c-Fos	_	NN	NN	_	13	pobj	_	_
15	.	_	.	.	_	7	punct	_	_

1	Further	_	IN	IN	_	2	amod	_	_
2	addition	_	NN	NN	_	6	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	E220K	_	NN	NN	_	3	pobj	_	_
5	significantly	_	RB	RB	_	6	advmod	_	_
6	enhanced	_	VBD	VBD	_	0	root	_	_
7	ubiquitinylation	_	NN	NN	_	6	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	c-Jun	_	NN	NN	_	8	pobj	_	_
10	in	_	IN	IN	_	7	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	heterodimer	_	NN	NN	_	10	pobj	_	_
13	suggesting	_	VBG	VBG	_	6	xcomp	_	_
14	a	_	DT	DT	_	16	det	_	_
15	regulatory	_	JJ	JJ	_	16	amod	_	_
16	role	_	NN	NN	_	13	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	E220K	_	NN	NN	_	17	pobj	_	_
19	.	_	.	.	_	6	punct	_	_

1	Polyubiquitinylated	_	VBN	VBN	_	2	amod	_	_
2	c-Jun	_	NN	NN	_	16	nsubjpass	_	_
3	,	_	,	,	_	2	punct	_	_
4	wbFos	_	NN	NN	_	2	conj	_	_
5	,	_	,	,	_	2	punct	_	_
6	and	_	CC	CC	_	2	cc	_	_
7	wbJun	_	NN	NN	_	2	conj	_	_
8	,	_	,	,	_	2	punct	_	_
9	but	_	CC	CC	_	10	cc	_	_
10	not	_	RB	RB	_	2	cc	_	_
11	E220K-ubiquitinylated	_	JJ	JJ	_	12	amod	_	_
12	c-Jun	_	NN	NN	_	2	conj	_	_
13	,	_	,	,	_	2	punct	_	_
14	were	_	VBD	VBD	_	16	auxpass	_	_
15	readily	_	RB	RB	_	16	advmod	_	_
16	degraded	_	VBN	VBN	_	0	root	_	_
17	by	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	23	det	_	_
19	ATP-dependent	_	JJ	JJ	_	23	amod	_	_
20	26	_	CD	CD	_	23	num	_	_
21	S	_	NN	NN	_	23	nn	_	_
22	multicatalytic	_	JJ	JJ	_	23	amod	_	_
23	proteases	_	NNS	NNS	_	17	pobj	_	_
24	.	_	.	.	_	16	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	14	mark	_	_
5	the	_	DT	DT	_	7	det	_	_
6	temporal	_	JJ	JJ	_	7	amod	_	_
7	control	_	NN	NN	_	14	nsubjpass	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	c-Jun	_	NN	NN	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	c-Fos	_	NN	NN	_	9	conj	_	_
12	may	_	MD	MD	_	14	aux	_	_
13	be	_	VB	VB	_	14	auxpass	_	_
14	regulated	_	VBN	VBN	_	3	dep	_	_
15	through	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	ubiquitinylation	_	NN	NN	_	18	nn	_	_
18	pathways	_	NNS	NNS	_	15	pobj	_	_
19	,	_	,	,	_	14	punct	_	_
20	and	_	CC	CC	_	14	cc	_	_
21	the	_	DT	DT	_	22	det	_	_
22	ubiquitinylation	_	NN	NN	_	14	conj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	c-Jun	_	NN	NN	_	23	pobj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	c-Fos	_	NN	NN	_	24	conj	_	_
27	may	_	MD	MD	_	31	aux	_	_
28	in	_	IN	IN	_	31	prep	_	_
29	turn	_	NN	NN	_	28	pobj	_	_
30	be	_	VB	VB	_	31	auxpass	_	_
31	regulated	_	VBN	VBN	_	14	dep	_	_
32	in	_	IN	IN	_	31	prep	_	_
33	response	_	NN	NN	_	32	pobj	_	_
34	to	_	TO	TO	_	33	prep	_	_
35	the	_	DT	DT	_	36	det	_	_
36	heterodimerization	_	NN	NN	_	34	pobj	_	_
37	between	_	IN	IN	_	36	prep	_	_
38	them	_	PRP	PRP	_	37	pobj	_	_
39	and	_	CC	CC	_	36	cc	_	_
40	the	_	DT	DT	_	41	det	_	_
41	cooperation	_	NN	NN	_	36	conj	_	_
42	between	_	IN	IN	_	41	prep	_	_
43	E220K	_	NN	NN	_	42	pobj	_	_
44	and	_	CC	CC	_	43	cc	_	_
45	E3	_	NN	NN	_	43	conj	_	_
46	mediated	_	JJ	JJ	_	47	amod	_	_
47	polyubiquitinylation	_	NN	NN	_	43	dep	_	_
48	.	_	.	.	_	3	punct	_	_

1	Modulation	_	NN	NN	_	10	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	endogenous	_	JJ	JJ	_	5	amod	_	_
4	IL-1	_	NN	NN	_	5	nn	_	_
5	beta	_	NN	NN	_	2	pobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	IL-1	_	NN	NN	_	8	nn	_	_
8	receptor	_	NN	NN	_	9	nn	_	_
9	antagonist	_	NN	NN	_	5	conj	_	_
10	results	_	VBZ	VBZ	_	0	root	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	opposing	_	JJ	JJ	_	13	amod	_	_
13	effects	_	NNS	NNS	_	11	pobj	_	_
14	on	_	IN	IN	_	13	prep	_	_
15	HIV	_	NN	NN	_	16	nn	_	_
16	expression	_	NN	NN	_	14	pobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	chronically	_	RB	RB	_	21	advmod	_	_
19	infected	_	JJ	JJ	_	21	amod	_	_
20	monocytic	_	JJ	JJ	_	21	amod	_	_
21	cells	_	NNS	NNS	_	17	pobj	_	_
22	.	_	.	.	_	10	punct	_	_

1	A	_	DT	DT	_	2	det	_	_
2	proportion	_	NN	NN	_	6	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	HIV-infected	_	JJ	JJ	_	5	amod	_	_
5	individuals	_	NNS	NNS	_	3	pobj	_	_
6	experience	_	VBP	VBP	_	0	root	_	_
7	episodes	_	NNS	NNS	_	6	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	localized	_	JJ	JJ	_	8	pobj	_	_
10	or	_	CC	CC	_	9	cc	_	_
11	systemic	_	JJ	JJ	_	9	conj	_	_
12	bacterial	_	JJ	JJ	_	13	amod	_	_
13	infections	_	NNS	NNS	_	9	dep	_	_
14	caused	_	VBN	VBN	_	9	vmod	_	_
15	by	_	IN	IN	_	14	prep	_	_
16	Gram-negative	_	JJ	JJ	_	17	amod	_	_
17	bacteria	_	NNS	NNS	_	15	pobj	_	_
18	.	_	.	.	_	6	punct	_	_

1	Many	_	JJ	JJ	_	11	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	6	det	_	_
4	clinical	_	JJ	JJ	_	6	amod	_	_
5	side	_	JJ	JJ	_	6	amod	_	_
6	effects	_	NNS	NNS	_	2	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	these	_	DT	DT	_	9	det	_	_
9	infections	_	NNS	NNS	_	7	pobj	_	_
10	are	_	VBP	VBP	_	11	auxpass	_	_
11	associated	_	VBN	VBN	_	0	root	_	_
12	with	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	production	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	proinflammatory	_	JJ	JJ	_	17	amod	_	_
17	cytokines	_	NNS	NNS	_	15	pobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	which	_	WDT	WDT	_	21	nsubjpass	_	_
20	are	_	VBP	VBP	_	21	auxpass	_	_
21	induced	_	VBN	VBN	_	17	rcmod	_	_
22	primarily	_	RB	RB	_	23	advmod	_	_
23	by	_	IN	IN	_	21	prep	_	_
24	LPS	_	NN	NN	_	23	pobj	_	_
25	,	_	,	,	_	24	punct	_	_
26	a	_	DT	DT	_	27	det	_	_
27	constituent	_	NN	NN	_	24	appos	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	the	_	DT	DT	_	32	det	_	_
30	bacterial	_	JJ	JJ	_	32	amod	_	_
31	cell	_	NN	NN	_	32	nn	_	_
32	wall	_	NN	NN	_	28	pobj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	Gram-negative	_	JJ	JJ	_	35	amod	_	_
35	bacteria	_	NNS	NNS	_	33	pobj	_	_
36	.	_	.	.	_	11	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	present	_	JJ	JJ	_	3	amod	_	_
3	study	_	NN	NN	_	4	nsubj	_	_
4	examines	_	VBZ	VBZ	_	0	root	_	_
5	the	_	DT	DT	_	6	det	_	_
6	mechanisms	_	NNS	NNS	_	4	dobj	_	_
7	involved	_	VBN	VBN	_	6	vmod	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	LPS-mediated	_	JJ	JJ	_	10	amod	_	_
10	induction	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	HIV	_	NN	NN	_	13	nn	_	_
13	expression	_	NN	NN	_	11	pobj	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	U1	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	14	pobj	_	_
17	,	_	,	,	_	16	punct	_	_
18	a	_	DT	DT	_	21	det	_	_
19	promonocytic	_	JJ	JJ	_	21	amod	_	_
20	cell	_	NN	NN	_	21	nn	_	_
21	line	_	NN	NN	_	16	appos	_	_
22	chronically	_	RB	RB	_	23	advmod	_	_
23	infected	_	VBN	VBN	_	21	vmod	_	_
24	with	_	IN	IN	_	23	prep	_	_
25	HIV	_	NN	NN	_	24	pobj	_	_
26	.	_	.	.	_	4	punct	_	_

1	Stimulation	_	NN	NN	_	8	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	U1	_	NN	NN	_	4	nn	_	_
4	cells	_	NNS	NNS	_	2	pobj	_	_
5	by	_	IN	IN	_	1	prep	_	_
6	LPS	_	NN	NN	_	5	pobj	_	_
7	alone	_	RB	RB	_	6	advmod	_	_
8	induced	_	VBD	VBD	_	0	root	_	_
9	minimal	_	JJ	JJ	_	10	amod	_	_
10	levels	_	NNS	NNS	_	8	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	HIV	_	NN	NN	_	13	nn	_	_
13	expression	_	NN	NN	_	11	pobj	_	_
14	,	_	,	,	_	13	punct	_	_
15	which	_	WDT	WDT	_	18	nsubjpass	_	_
16	was	_	VBD	VBD	_	18	auxpass	_	_
17	significantly	_	RB	RB	_	18	advmod	_	_
18	enhanced	_	VBN	VBN	_	13	rcmod	_	_
19	by	_	IN	IN	_	18	prep	_	_
20	granulocyte-macrophage	_	JJ	JJ	_	22	amod	_	_
21	colony-stimulating	_	JJ	JJ	_	22	amod	_	_
22	factor	_	NN	NN	_	19	pobj	_	_
23	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
24	GM-CSF	_	NN	NN	_	22	appos	_	_
25	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
26	.	_	.	.	_	8	punct	_	_

1	Costimulation	_	NN	NN	_	9	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	U1	_	NN	NN	_	4	nn	_	_
4	cells	_	NNS	NNS	_	2	pobj	_	_
5	with	_	IN	IN	_	1	prep	_	_
6	LPS	_	NN	NN	_	5	pobj	_	_
7	plus	_	CC	CC	_	6	cc	_	_
8	GM-CSF	_	NN	NN	_	6	conj	_	_
9	resulted	_	VBD	VBD	_	0	root	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	accumulation	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	steady-state	_	JJ	JJ	_	15	amod	_	_
15	levels	_	NNS	NNS	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	HIV	_	NN	NN	_	18	nn	_	_
18	RNA	_	NN	NN	_	16	pobj	_	_
19	;	_	:	:	_	9	punct	_	_
20	however	_	RB	RB	_	50	advmod	_	_
21	,	_	,	,	_	50	punct	_	_
22	only	_	RB	RB	_	23	quantmod	_	_
23	a	_	DT	DT	_	24	dep	_	_
24	weak	_	JJ	JJ	_	25	dep	_	_
25	induction	_	NN	NN	_	50	nsubjpass	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	HIV	_	NN	NN	_	31	nn	_	_
28	long	_	JJ	JJ	_	31	amod	_	_
29	terminal	_	JJ	JJ	_	31	amod	_	_
30	repeat-driven	_	JJ	JJ	_	31	amod	_	_
31	transcription	_	NN	NN	_	26	pobj	_	_
32	,	_	,	,	_	31	punct	_	_
33	which	_	WDT	WDT	_	36	nsubjpass	_	_
34	was	_	VBD	VBD	_	36	auxpass	_	_
35	not	_	RB	RB	_	36	neg	_	_
36	associated	_	VBN	VBN	_	31	rcmod	_	_
37	with	_	IN	IN	_	36	prep	_	_
38	the	_	DT	DT	_	39	det	_	_
39	activation	_	NN	NN	_	37	pobj	_	_
40	of	_	IN	IN	_	39	prep	_	_
41	the	_	DT	DT	_	44	det	_	_
42	cellular	_	JJ	JJ	_	44	amod	_	_
43	transcription	_	NN	NN	_	44	nn	_	_
44	factor	_	NN	NN	_	40	pobj	_	_
45	nuclear	_	JJ	JJ	_	47	amod	_	_
46	factor-kappa	_	NN	NN	_	47	nn	_	_
47	B	_	NN	NN	_	44	dep	_	_
48	,	_	,	,	_	25	punct	_	_
49	was	_	VBD	VBD	_	50	auxpass	_	_
50	noted	_	VBN	VBN	_	9	parataxis	_	_
51	.	_	.	.	_	9	punct	_	_

1	Costimulation	_	NN	NN	_	8	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	cells	_	NNS	NNS	_	2	pobj	_	_
4	with	_	IN	IN	_	1	prep	_	_
5	LPS	_	NN	NN	_	4	pobj	_	_
6	plus	_	CC	CC	_	5	cc	_	_
7	GM-CSF	_	NN	NN	_	5	conj	_	_
8	induced	_	VBD	VBD	_	0	root	_	_
9	the	_	DT	DT	_	10	det	_	_
10	production	_	NN	NN	_	8	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	proinflammatory	_	JJ	JJ	_	13	amod	_	_
13	cytokines	_	NNS	NNS	_	11	pobj	_	_
14	,	_	,	,	_	13	punct	_	_
15	IL-8	_	NN	NN	_	13	conj	_	_
16	,	_	,	,	_	13	punct	_	_
17	IL-1	_	NN	NN	_	18	nn	_	_
18	beta	_	NN	NN	_	13	conj	_	_
19	and	_	CC	CC	_	13	cc	_	_
20	IL-6	_	NN	NN	_	13	conj	_	_
21	,	_	,	,	_	13	punct	_	_
22	but	_	CC	CC	_	23	cc	_	_
23	not	_	RB	RB	_	13	cc	_	_
24	TNF-alpha	_	NN	NN	_	13	conj	_	_
25	.	_	.	.	_	8	punct	_	_

1	IL-1	_	NN	NN	_	2	nn	_	_
2	receptor	_	NN	NN	_	3	nn	_	_
3	antagonist	_	NN	NN	_	7	nsubj	_	_
4	-LRB-	_	-LRB-	-LRB-	_	5	punct	_	_
5	ra	_	NN	NN	_	3	appos	_	_
6	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
7	inhibited	_	VBD	VBD	_	0	root	_	_
8	LPS	_	NN	NN	_	9	nn	_	_
9	enhancement	_	NN	NN	_	7	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	HIV	_	NN	NN	_	12	nn	_	_
12	expression	_	NN	NN	_	10	pobj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	GM-CSF-stimulated	_	JJ	JJ	_	15	amod	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	,	_	,	,	_	7	punct	_	_
17	suggesting	_	VBG	VBG	_	7	vmod	_	_
18	that	_	IN	IN	_	22	mark	_	_
19	endogenous	_	JJ	JJ	_	20	amod	_	_
20	IL-1	_	NN	NN	_	22	nsubjpass	_	_
21	was	_	VBD	VBD	_	22	auxpass	_	_
22	involved	_	VBN	VBN	_	17	ccomp	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	LPS-mediated	_	JJ	JJ	_	26	amod	_	_
25	viral	_	JJ	JJ	_	26	amod	_	_
26	production	_	NN	NN	_	23	pobj	_	_
27	.	_	.	.	_	7	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	regard	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	7	punct	_	_
5	anti-inflammatory	_	JJ	JJ	_	6	amod	_	_
6	cytokines	_	NNS	NNS	_	7	nsubj	_	_
7	inhibited	_	VBD	VBD	_	0	root	_	_
8	LPS	_	NN	NN	_	12	amod	_	_
9	plus	_	CC	CC	_	8	cc	_	_
10	GM-CSF-stimulated	_	JJ	JJ	_	8	conj	_	_
11	HIV	_	NN	NN	_	12	nn	_	_
12	expression	_	NN	NN	_	7	dobj	_	_
13	,	_	,	,	_	7	punct	_	_
14	and	_	CC	CC	_	7	cc	_	_
15	this	_	DT	DT	_	16	det	_	_
16	effect	_	NN	NN	_	18	nsubj	_	_
17	closely	_	RB	RB	_	18	advmod	_	_
18	correlated	_	VBD	VBD	_	7	conj	_	_
19	with	_	IN	IN	_	18	prep	_	_
20	inhibition	_	NN	NN	_	19	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	IL-1	_	NN	NN	_	23	nn	_	_
23	beta	_	NN	NN	_	24	nn	_	_
24	release	_	NN	NN	_	21	pobj	_	_
25	and	_	CC	CC	_	19	cc	_	_
26	,	_	,	,	_	19	punct	_	_
27	in	_	IN	IN	_	19	conj	_	_
28	particular	_	JJ	JJ	_	27	pobj	_	_
29	,	_	,	,	_	19	punct	_	_
30	with	_	IN	IN	_	19	conj	_	_
31	up-regulation	_	NN	NN	_	30	pobj	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	endogenous	_	JJ	JJ	_	35	amod	_	_
34	IL-1ra	_	NN	NN	_	35	nn	_	_
35	production	_	NN	NN	_	32	pobj	_	_
36	.	_	.	.	_	7	punct	_	_

1	Thus	_	RB	RB	_	22	advmod	_	_
2	,	_	,	,	_	22	punct	_	_
3	the	_	DT	DT	_	4	det	_	_
4	balance	_	NN	NN	_	22	nsubj	_	_
5	between	_	IN	IN	_	4	prep	_	_
6	an	_	DT	DT	_	10	det	_	_
7	endogenously	_	RB	RB	_	10	advmod	_	_
8	produced	_	VBN	VBN	_	10	amod	_	_
9	viral	_	JJ	JJ	_	10	amod	_	_
10	inducer	_	NN	NN	_	5	pobj	_	_
11	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
12	IL-1	_	NN	NN	_	13	nn	_	_
13	beta	_	NN	NN	_	10	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	and	_	CC	CC	_	10	cc	_	_
16	an	_	DT	DT	_	17	det	_	_
17	inhibitor	_	NN	NN	_	10	conj	_	_
18	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
19	IL-1ra	_	NN	NN	_	17	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	may	_	MD	MD	_	22	aux	_	_
22	represent	_	VB	VB	_	0	root	_	_
23	an	_	DT	DT	_	25	det	_	_
24	important	_	JJ	JJ	_	25	amod	_	_
25	pathway	_	NN	NN	_	22	dobj	_	_
26	leading	_	VBG	VBG	_	25	vmod	_	_
27	to	_	TO	TO	_	26	prep	_	_
28	modulation	_	NN	NN	_	27	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	HIV	_	NN	NN	_	31	nn	_	_
31	expression	_	NN	NN	_	29	pobj	_	_
32	from	_	IN	IN	_	31	prep	_	_
33	monocytic	_	JJ	JJ	_	34	amod	_	_
34	cells	_	NNS	NNS	_	32	pobj	_	_
35	.	_	.	.	_	22	punct	_	_

1	Transcriptional	_	JJ	JJ	_	2	amod	_	_
2	regulation	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	interleukin-2	_	NN	NN	_	6	nn	_	_
6	gene	_	NN	NN	_	3	pobj	_	_
7	in	_	IN	IN	_	2	prep	_	_
8	normal	_	JJ	JJ	_	13	amod	_	_
9	human	_	JJ	JJ	_	13	amod	_	_
10	peripheral	_	JJ	JJ	_	13	amod	_	_
11	blood	_	NN	NN	_	13	nn	_	_
12	T	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	7	pobj	_	_
14	.	_	.	.	_	2	punct	_	_

1	Convergence	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	costimulatory	_	JJ	JJ	_	4	amod	_	_
4	signals	_	NNS	NNS	_	2	pobj	_	_
5	and	_	CC	CC	_	1	cc	_	_
6	differences	_	NNS	NNS	_	1	conj	_	_
7	from	_	IN	IN	_	6	prep	_	_
8	transformed	_	VBN	VBN	_	10	amod	_	_
9	T	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	7	pobj	_	_
11	.	_	.	.	_	1	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	study	_	VB	VB	_	0	root	_	_
3	transcriptional	_	JJ	JJ	_	4	amod	_	_
4	regulation	_	NN	NN	_	2	dobj	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	normal	_	JJ	JJ	_	9	amod	_	_
7	human	_	JJ	JJ	_	9	amod	_	_
8	T	_	NN	NN	_	9	nn	_	_
9	cells	_	NNS	NNS	_	5	pobj	_	_
10	,	_	,	,	_	2	punct	_	_
11	we	_	PRP	PRP	_	13	nsubj	_	_
12	have	_	VBP	VBP	_	13	aux	_	_
13	optimized	_	VBN	VBN	_	2	parataxis	_	_
14	conditions	_	NNS	NNS	_	13	dobj	_	_
15	for	_	IN	IN	_	14	prep	_	_
16	transient	_	JJ	JJ	_	17	amod	_	_
17	transfection	_	NN	NN	_	15	pobj	_	_
18	.	_	.	.	_	2	punct	_	_

1	Interleukin-2	_	NN	NN	_	7	nn	_	_
2	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
3	IL-2	_	NN	NN	_	7	nn	_	_
4	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
5	promoter-reporter	_	JJ	JJ	_	7	amod	_	_
6	gene	_	NN	NN	_	7	nn	_	_
7	behavior	_	NN	NN	_	9	nsubj	_	_
8	closely	_	RB	RB	_	9	advmod	_	_
9	parallels	_	VBZ	VBZ	_	0	root	_	_
10	the	_	DT	DT	_	12	det	_	_
11	endogenous	_	JJ	JJ	_	12	amod	_	_
12	gene	_	NN	NN	_	9	dobj	_	_
13	in	_	IN	IN	_	9	prep	_	_
14	response	_	NN	NN	_	13	pobj	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	T	_	NN	NN	_	18	nn	_	_
17	cell	_	NN	NN	_	18	nn	_	_
18	receptor	_	NN	NN	_	15	pobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	costimulatory	_	JJ	JJ	_	21	amod	_	_
21	signals	_	NNS	NNS	_	18	conj	_	_
22	.	_	.	.	_	9	punct	_	_

1	As	_	IN	IN	_	2	mark	_	_
2	assessed	_	VBN	VBN	_	21	advcl	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	mutagenized	_	VBN	VBN	_	5	amod	_	_
5	promoters	_	NNS	NNS	_	3	pobj	_	_
6	,	_	,	,	_	21	punct	_	_
7	the	_	DT	DT	_	12	det	_	_
8	most	_	RBS	RBS	_	9	advmod	_	_
9	important	_	JJ	JJ	_	12	amod	_	_
10	IL-2	_	NN	NN	_	12	nn	_	_
11	cis-regulatory	_	JJ	JJ	_	12	amod	_	_
12	elements	_	NNS	NNS	_	21	nsubj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	normal	_	JJ	JJ	_	16	amod	_	_
15	T	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	13	pobj	_	_
17	are	_	VBP	VBP	_	21	cop	_	_
18	the	_	DT	DT	_	21	det	_	_
19	proximal	_	JJ	JJ	_	21	amod	_	_
20	AP-1	_	NN	NN	_	21	nn	_	_
21	site	_	NN	NN	_	0	root	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	the	_	DT	DT	_	25	det	_	_
24	NF-kappaB	_	NN	NN	_	25	nn	_	_
25	site	_	NN	NN	_	21	conj	_	_
26	.	_	.	.	_	21	punct	_	_

1	Both	_	CC	CC	_	3	preconj	_	_
2	primary	_	JJ	JJ	_	3	amod	_	_
3	activation	_	NN	NN	_	36	nsubjpass	_	_
4	,	_	,	,	_	3	punct	_	_
5	with	_	IN	IN	_	3	prep	_	_
6	phytohemagglutinin	_	NN	NN	_	5	pobj	_	_
7	or	_	CC	CC	_	6	cc	_	_
8	antibodies	_	NNS	NNS	_	10	nn	_	_
9	to	_	TO	TO	_	10	dep	_	_
10	CD3	_	NN	NN	_	6	conj	_	_
11	,	_	,	,	_	3	punct	_	_
12	and	_	CC	CC	_	3	cc	_	_
13	costimulation	_	NN	NN	_	3	conj	_	_
14	,	_	,	,	_	13	punct	_	_
15	provided	_	VBN	VBN	_	13	vmod	_	_
16	by	_	IN	IN	_	15	prep	_	_
17	pairs	_	NNS	NNS	_	16	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	CD2	_	NN	NN	_	20	nn	_	_
20	antibodies	_	NNS	NNS	_	18	pobj	_	_
21	or	_	CC	CC	_	17	cc	_	_
22	B7-positive	_	JJ	JJ	_	25	amod	_	_
23	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
24	B	_	NN	NN	_	25	nn	_	_
25	cells	_	NNS	NNS	_	17	conj	_	_
26	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
27	or	_	CC	CC	_	25	cc	_	_
28	B7-negative	_	JJ	JJ	_	33	amod	_	_
29	-LRB-	_	-LRB-	-LRB-	_	33	punct	_	_
30	endothelial	_	NN	NN	_	33	nn	_	_
31	-RRB-	_	-RRB-	-RRB-	_	33	punct	_	_
32	accessory	_	JJ	JJ	_	33	amod	_	_
33	cells	_	NNS	NNS	_	25	conj	_	_
34	,	_	,	,	_	33	punct	_	_
35	are	_	VBP	VBP	_	36	auxpass	_	_
36	mediated	_	VBN	VBN	_	0	root	_	_
37	through	_	IN	IN	_	36	prep	_	_
38	the	_	DT	DT	_	40	det	_	_
39	same	_	JJ	JJ	_	40	amod	_	_
40	cis-elements	_	NNS	NNS	_	37	pobj	_	_
41	.	_	.	.	_	36	punct	_	_

1	Interestingly	_	RB	RB	_	14	advmod	_	_
2	,	_	,	,	_	14	punct	_	_
3	the	_	DT	DT	_	10	det	_	_
4	nuclear	_	JJ	JJ	_	10	amod	_	_
5	factor	_	NN	NN	_	10	nn	_	_
6	of	_	IN	IN	_	10	amod	_	_
7	activated	_	VBN	VBN	_	10	amod	_	_
8	T	_	NN	NN	_	10	nn	_	_
9	cell	_	NN	NN	_	10	nn	_	_
10	sites	_	NNS	NNS	_	14	nsubj	_	_
11	are	_	VBP	VBP	_	14	cop	_	_
12	much	_	RB	RB	_	13	advmod	_	_
13	less	_	RBR	RBR	_	14	advmod	_	_
14	important	_	JJ	JJ	_	0	root	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	normal	_	JJ	JJ	_	18	amod	_	_
17	T	_	NN	NN	_	18	nn	_	_
18	cells	_	NNS	NNS	_	15	pobj	_	_
19	than	_	IN	IN	_	14	prep	_	_
20	in	_	IN	IN	_	19	pcomp	_	_
21	Jurkat	_	NN	NN	_	23	nn	_	_
22	T	_	NN	NN	_	23	nn	_	_
23	cells	_	NNS	NNS	_	20	pobj	_	_
24	.	_	.	.	_	14	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	conclude	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	7	mark	_	_
4	IL-2	_	NN	NN	_	6	nn	_	_
5	transcriptional	_	JJ	JJ	_	6	amod	_	_
6	regulation	_	NN	NN	_	7	nsubj	_	_
7	differs	_	VBZ	VBZ	_	2	ccomp	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	tumor	_	NN	NN	_	11	nn	_	_
10	cell	_	NN	NN	_	11	nn	_	_
11	lines	_	NNS	NNS	_	8	pobj	_	_
12	compared	_	VBN	VBN	_	7	prep	_	_
13	with	_	IN	IN	_	12	pcomp	_	_
14	normal	_	JJ	JJ	_	16	amod	_	_
15	T	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	13	pobj	_	_
17	and	_	CC	CC	_	7	cc	_	_
18	that	_	IN	IN	_	22	mark	_	_
19	different	_	JJ	JJ	_	21	amod	_	_
20	costimulatory	_	JJ	JJ	_	21	amod	_	_
21	signals	_	NNS	NNS	_	22	nsubj	_	_
22	converge	_	VBP	VBP	_	7	conj	_	_
23	on	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	26	det	_	_
25	same	_	JJ	JJ	_	26	amod	_	_
26	cis-elements	_	NNS	NNS	_	23	pobj	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	30	det	_	_
29	IL-2	_	NN	NN	_	30	nn	_	_
30	promoter	_	NN	NN	_	27	pobj	_	_
31	.	_	.	.	_	2	punct	_	_

1	Monocytic	_	JJ	JJ	_	5	amod	_	_
2	cell	_	NN	NN	_	5	nn	_	_
3	type-specific	_	JJ	JJ	_	5	amod	_	_
4	transcriptional	_	JJ	JJ	_	5	amod	_	_
5	induction	_	NN	NN	_	0	root	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	collagenase	_	NN	NN	_	6	pobj	_	_
8	.	_	.	.	_	5	punct	_	_

1	Interstitial	_	JJ	JJ	_	2	amod	_	_
2	collagenase	_	NN	NN	_	20	nsubj	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	MMP-1	_	NN	NN	_	2	appos	_	_
5	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
6	,	_	,	,	_	2	punct	_	_
7	a	_	DT	DT	_	8	det	_	_
8	metalloproteinase	_	NN	NN	_	2	appos	_	_
9	produced	_	VBN	VBN	_	8	vmod	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	resident	_	JJ	JJ	_	10	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	inflammatory	_	JJ	JJ	_	11	conj	_	_
14	cells	_	NNS	NNS	_	11	dep	_	_
15	during	_	IN	IN	_	9	prep	_	_
16	connective	_	JJ	JJ	_	18	amod	_	_
17	tissue	_	NN	NN	_	18	nn	_	_
18	turnover	_	NN	NN	_	15	pobj	_	_
19	,	_	,	,	_	2	punct	_	_
20	cleaves	_	VBZ	VBZ	_	0	root	_	_
21	type	_	NN	NN	_	24	nn	_	_
22	I	_	CD	CD	_	24	num	_	_
23	collagen	_	NN	NN	_	24	nn	_	_
24	fibrils	_	NNS	NNS	_	20	dobj	_	_
25	.	_	.	.	_	20	punct	_	_

1	This	_	DT	DT	_	3	det	_	_
2	catalytic	_	JJ	JJ	_	3	amod	_	_
3	event	_	NN	NN	_	6	nsubj	_	_
4	is	_	VBZ	VBZ	_	6	cop	_	_
5	rate	_	NN	NN	_	6	dep	_	_
6	limiting	_	VBG	VBG	_	0	root	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	remodeling	_	NN	NN	_	7	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	tissues	_	NNS	NNS	_	9	pobj	_	_
11	rich	_	JJ	JJ	_	10	amod	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	fibrillar	_	JJ	JJ	_	14	amod	_	_
14	collagen	_	NN	NN	_	12	pobj	_	_
15	such	_	JJ	JJ	_	16	mwe	_	_
16	as	_	IN	IN	_	14	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	skin	_	NN	NN	_	16	pobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	lungs	_	NNS	NNS	_	18	conj	_	_
21	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	regulation	_	NN	NN	_	8	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	collagenase	_	NN	NN	_	5	nn	_	_
5	expression	_	NN	NN	_	3	pobj	_	_
6	is	_	VBZ	VBZ	_	8	cop	_	_
7	cell-type	_	NN	NN	_	8	npadvmod	_	_
8	specific	_	JJ	JJ	_	0	root	_	_
9	;	_	:	:	_	8	punct	_	_
10	bacterial	_	JJ	JJ	_	11	amod	_	_
11	LPS	_	NN	NN	_	23	nsubj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	zymosan	_	NN	NN	_	11	conj	_	_
14	,	_	,	,	_	13	punct	_	_
15	a	_	DT	DT	_	19	det	_	_
16	yeast	_	NN	NN	_	19	nn	_	_
17	cell	_	NN	NN	_	19	nn	_	_
18	wall	_	NN	NN	_	19	nn	_	_
19	derivative	_	NN	NN	_	13	appos	_	_
20	,	_	,	,	_	11	punct	_	_
21	are	_	VBP	VBP	_	23	cop	_	_
22	potent	_	JJ	JJ	_	23	amod	_	_
23	inducers	_	NNS	NNS	_	8	parataxis	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	collagenase	_	NN	NN	_	26	nn	_	_
26	expression	_	NN	NN	_	24	pobj	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	macrophages	_	NNS	NNS	_	27	pobj	_	_
29	,	_	,	,	_	23	punct	_	_
30	but	_	CC	CC	_	23	cc	_	_
31	do	_	VBP	VBP	_	33	aux	_	_
32	not	_	RB	RB	_	33	neg	_	_
33	alter	_	VB	VB	_	23	conj	_	_
34	fibroblast	_	NN	NN	_	36	nn	_	_
35	collagenase	_	NN	NN	_	36	nn	_	_
36	expression	_	NN	NN	_	33	dobj	_	_
37	.	_	.	.	_	8	punct	_	_

1	Since	_	IN	IN	_	14	mark	_	_
2	promoter	_	NN	NN	_	3	nn	_	_
3	elements	_	NNS	NNS	_	14	nsubjpass	_	_
4	controlling	_	VBG	VBG	_	3	vmod	_	_
5	collagenase	_	NN	NN	_	6	nn	_	_
6	transcription	_	NN	NN	_	4	dobj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	monocytic	_	JJ	JJ	_	9	amod	_	_
9	cells	_	NNS	NNS	_	7	pobj	_	_
10	have	_	VBP	VBP	_	14	aux	_	_
11	not	_	RB	RB	_	14	neg	_	_
12	been	_	VBN	VBN	_	14	auxpass	_	_
13	previously	_	RB	RB	_	14	advmod	_	_
14	defined	_	VBN	VBN	_	17	advcl	_	_
15	,	_	,	,	_	17	punct	_	_
16	we	_	PRP	PRP	_	17	nsubj	_	_
17	sought	_	VBD	VBD	_	0	root	_	_
18	to	_	TO	TO	_	19	aux	_	_
19	delineate	_	VB	VB	_	17	xcomp	_	_
20	responsive	_	JJ	JJ	_	22	amod	_	_
21	cis-acting	_	JJ	JJ	_	22	amod	_	_
22	elements	_	NNS	NNS	_	19	dobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	26	det	_	_
25	collagenase	_	NN	NN	_	26	nn	_	_
26	promoter	_	NN	NN	_	23	pobj	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	transiently	_	RB	RB	_	29	advmod	_	_
29	transfected	_	VBN	VBN	_	30	amod	_	_
30	human	_	JJ	JJ	_	27	pobj	_	_
31	-LRB-	_	-LRB-	-LRB-	_	32	punct	_	_
32	U937	_	NN	NN	_	30	appos	_	_
33	-RRB-	_	-RRB-	-RRB-	_	32	punct	_	_
34	and	_	CC	CC	_	30	cc	_	_
35	murine	_	JJ	JJ	_	30	conj	_	_
36	-LRB-	_	-LRB-	-LRB-	_	37	punct	_	_
37	J774	_	NN	NN	_	35	appos	_	_
38	-RRB-	_	-RRB-	-RRB-	_	37	punct	_	_
39	monocytic	_	JJ	JJ	_	41	amod	_	_
40	cell	_	NN	NN	_	41	nn	_	_
41	lines	_	NNS	NNS	_	30	dep	_	_
42	.	_	.	.	_	17	punct	_	_

1	Deletion	_	NN	NN	_	2	nn	_	_
2	constructs	_	NNS	NNS	_	17	nsubj	_	_
3	containing	_	VBG	VBG	_	2	vmod	_	_
4	as	_	RB	RB	_	6	advmod	_	_
5	little	_	JJ	JJ	_	6	advmod	_	_
6	as	_	IN	IN	_	7	quantmod	_	_
7	72	_	CD	CD	_	8	num	_	_
8	bp	_	NN	NN	_	3	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	5'-flanking	_	JJ	JJ	_	11	amod	_	_
11	sequence	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	collagenase	_	NN	NN	_	15	nn	_	_
15	promoter	_	NN	NN	_	12	pobj	_	_
16	were	_	VBD	VBD	_	17	cop	_	_
17	sufficient	_	JJ	JJ	_	0	root	_	_
18	for	_	IN	IN	_	17	prep	_	_
19	LPS-	_	NN	NN	_	18	pobj	_	_
20	or	_	CC	CC	_	19	cc	_	_
21	zymosan-mediated	_	JJ	JJ	_	19	conj	_	_
22	transcriptional	_	JJ	JJ	_	23	amod	_	_
23	induction	_	NN	NN	_	19	dep	_	_
24	,	_	,	,	_	17	punct	_	_
25	whereas	_	IN	IN	_	28	mark	_	_
26	phorbol	_	NN	NN	_	27	nn	_	_
27	inducibility	_	NN	NN	_	28	nsubj	_	_
28	exhibited	_	VBD	VBD	_	17	advcl	_	_
29	an	_	DT	DT	_	31	det	_	_
30	absolute	_	JJ	JJ	_	31	amod	_	_
31	requirement	_	NN	NN	_	28	dobj	_	_
32	for	_	IN	IN	_	31	prep	_	_
33	upstream	_	JJ	JJ	_	34	amod	_	_
34	elements	_	NNS	NNS	_	32	pobj	_	_
35	including	_	VBG	VBG	_	34	prep	_	_
36	the	_	DT	DT	_	41	det	_	_
37	polyoma	_	NN	NN	_	41	nn	_	_
38	enhancer	_	NN	NN	_	41	nn	_	_
39	A-binding	_	JJ	JJ	_	41	amod	_	_
40	protein-3	_	NN	NN	_	41	nn	_	_
41	site	_	NN	NN	_	35	pobj	_	_
42	-LRB-	_	-LRB-	-LRB-	_	45	punct	_	_
43	-83	_	CD	CD	_	45	num	_	_
44	to	_	TO	TO	_	45	dep	_	_
45	-91	_	CD	CD	_	41	appos	_	_
46	-RRB-	_	-RRB-	-RRB-	_	45	punct	_	_
47	and	_	CC	CC	_	41	cc	_	_
48	TTCA	_	NN	NN	_	49	nn	_	_
49	sequence	_	NN	NN	_	41	conj	_	_
50	-LRB-	_	-LRB-	-LRB-	_	53	punct	_	_
51	-102	_	CD	CD	_	53	num	_	_
52	to	_	TO	TO	_	53	dep	_	_
53	-105	_	CD	CD	_	49	appos	_	_
54	-RRB-	_	-RRB-	-RRB-	_	53	punct	_	_
55	in	_	IN	IN	_	28	prep	_	_
56	both	_	CC	CC	_	58	preconj	_	_
57	monocytic	_	JJ	JJ	_	58	amod	_	_
58	cells	_	NNS	NNS	_	55	pobj	_	_
59	and	_	CC	CC	_	58	cc	_	_
60	fibroblasts	_	NNS	NNS	_	58	conj	_	_
61	.	_	.	.	_	17	punct	_	_

1	Mutagenesis	_	NN	NN	_	12	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	9	det	_	_
4	activator	_	NN	NN	_	9	nn	_	_
5	protein-1	_	NN	NN	_	9	nn	_	_
6	-LSB-	_	-LRB-	-LRB-	_	9	punct	_	_
7	AP-1	_	NN	NN	_	9	nn	_	_
8	-RSB-	_	-RRB-	-RRB-	_	9	punct	_	_
9	site	_	NN	NN	_	2	pobj	_	_
10	at	_	IN	IN	_	9	prep	_	_
11	-72	_	CD	CD	_	10	pobj	_	_
12	abolished	_	VBD	VBD	_	0	root	_	_
13	basal	_	JJ	JJ	_	14	amod	_	_
14	promoter	_	NN	NN	_	15	nn	_	_
15	activity	_	NN	NN	_	12	dobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	LPS/zymosan	_	NN	NN	_	18	nn	_	_
18	inducibility	_	NN	NN	_	15	conj	_	_
19	,	_	,	,	_	12	punct	_	_
20	while	_	IN	IN	_	30	mark	_	_
21	mutagenesis	_	NN	NN	_	30	nsubj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	an	_	DT	DT	_	25	det	_	_
24	NF-kappaB-like	_	JJ	JJ	_	25	amod	_	_
25	site	_	NN	NN	_	22	pobj	_	_
26	at	_	IN	IN	_	25	prep	_	_
27	-20	_	CD	CD	_	29	number	_	_
28	to	_	TO	TO	_	29	dep	_	_
29	-10	_	CD	CD	_	26	pobj	_	_
30	had	_	VBD	VBD	_	12	advcl	_	_
31	no	_	DT	DT	_	32	neg	_	_
32	effect	_	NN	NN	_	30	dobj	_	_
33	.	_	.	.	_	12	punct	_	_

1	Nuclear	_	JJ	JJ	_	2	amod	_	_
2	extracts	_	NNS	NNS	_	8	nsubj	_	_
3	from	_	IN	IN	_	2	prep	_	_
4	LPS-	_	NN	NN	_	3	pobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	zymosan-treated	_	JJ	JJ	_	7	amod	_	_
7	cells	_	NNS	NNS	_	4	conj	_	_
8	showed	_	VBD	VBD	_	0	root	_	_
9	strong	_	JJ	JJ	_	11	amod	_	_
10	AP-1	_	NN	NN	_	11	nn	_	_
11	activity	_	NN	NN	_	8	dobj	_	_
12	by	_	IN	IN	_	8	prep	_	_
13	gel-shift	_	JJ	JJ	_	14	amod	_	_
14	analysis	_	NN	NN	_	12	pobj	_	_
15	,	_	,	,	_	8	punct	_	_
16	and	_	CC	CC	_	8	cc	_	_
17	supershift	_	NN	NN	_	18	nn	_	_
18	analysis	_	NN	NN	_	19	nsubj	_	_
19	showed	_	VBD	VBD	_	8	conj	_	_
20	the	_	DT	DT	_	22	det	_	_
21	AP-1	_	NN	NN	_	22	nn	_	_
22	complexes	_	NNS	NNS	_	19	dobj	_	_
23	contained	_	VBD	VBD	_	19	dep	_	_
24	specific	_	JJ	JJ	_	25	amod	_	_
25	members	_	NNS	NNS	_	23	dobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	both	_	CC	CC	_	29	preconj	_	_
28	the	_	DT	DT	_	29	dep	_	_
29	jun	_	NN	NN	_	26	pobj	_	_
30	and	_	CC	CC	_	29	cc	_	_
31	fos	_	NN	NN	_	29	conj	_	_
32	gene	_	NN	NN	_	33	nn	_	_
33	families	_	NNS	NNS	_	29	dep	_	_
34	.	_	.	.	_	8	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	20	mark	_	_
5	,	_	,	,	_	20	punct	_	_
6	in	_	IN	IN	_	20	prep	_	_
7	contrast	_	NN	NN	_	6	pobj	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	most	_	JJS	JJS	_	11	amod	_	_
10	LPS	_	NN	NN	_	11	nn	_	_
11	effects	_	NNS	NNS	_	8	pobj	_	_
12	,	_	,	,	_	20	punct	_	_
13	AP-1	_	NN	NN	_	20	nsubj	_	_
14	,	_	,	,	_	13	punct	_	_
15	but	_	CC	CC	_	16	cc	_	_
16	not	_	RB	RB	_	13	cc	_	_
17	nuclear	_	JJ	JJ	_	18	amod	_	_
18	factor-kappaB	_	NN	NN	_	13	conj	_	_
19	,	_	,	,	_	13	punct	_	_
20	mediates	_	VBZ	VBZ	_	3	ccomp	_	_
21	LPS	_	NN	NN	_	22	nn	_	_
22	induction	_	NN	NN	_	20	dobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	collagenase	_	NN	NN	_	25	nn	_	_
25	transcription	_	NN	NN	_	23	pobj	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	macrophagelike	_	JJ	JJ	_	28	amod	_	_
28	cells	_	NNS	NNS	_	26	pobj	_	_
29	.	_	.	.	_	3	punct	_	_

1	Furthermore	_	RB	RB	_	26	advmod	_	_
2	,	_	,	,	_	26	punct	_	_
3	as	_	IN	IN	_	4	dep	_	_
4	compared	_	VBN	VBN	_	26	dep	_	_
5	to	_	TO	TO	_	4	prep	_	_
6	regulation	_	NN	NN	_	5	pobj	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	phorbol	_	NN	NN	_	9	nn	_	_
9	ester	_	NN	NN	_	7	pobj	_	_
10	,	_	,	,	_	26	punct	_	_
11	collagenase	_	NN	NN	_	12	nn	_	_
12	induction	_	NN	NN	_	26	nsubj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	monocytic	_	JJ	JJ	_	15	amod	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	by	_	IN	IN	_	12	prep	_	_
17	cell	_	NN	NN	_	19	nn	_	_
18	wall	_	NN	NN	_	19	nn	_	_
19	derivatives	_	NNS	NNS	_	16	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	bacteria	_	NNS	NNS	_	20	pobj	_	_
22	or	_	CC	CC	_	21	cc	_	_
23	yeast	_	NN	NN	_	21	conj	_	_
24	is	_	VBZ	VBZ	_	26	cop	_	_
25	largely	_	RB	RB	_	26	advmod	_	_
26	independent	_	JJ	JJ	_	0	root	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	upstream	_	JJ	JJ	_	30	amod	_	_
29	promoter	_	NN	NN	_	30	nn	_	_
30	sequences	_	NNS	NNS	_	27	pobj	_	_
31	.	_	.	.	_	26	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	role	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	p16	_	NN	NN	_	3	pobj	_	_
5	in	_	IN	IN	_	2	prep	_	_
6	the	_	DT	DT	_	10	det	_	_
7	E2F-dependent	_	JJ	JJ	_	9	amod	_	_
8	thymidine	_	NN	NN	_	9	nn	_	_
9	kinase	_	NN	NN	_	10	nn	_	_
10	regulation	_	NN	NN	_	5	pobj	_	_
11	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	role	_	NN	NN	_	31	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	alterations	_	NNS	NNS	_	3	pobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	10	det	_	_
7	MTS1	_	NN	NN	_	10	nn	_	_
8	tumor	_	NN	NN	_	10	nn	_	_
9	suppressor	_	NN	NN	_	10	nn	_	_
10	gene	_	NN	NN	_	5	pobj	_	_
11	on	_	IN	IN	_	10	prep	_	_
12	chromosome	_	NN	NN	_	13	nn	_	_
13	9p21	_	NN	NN	_	11	pobj	_	_
14	,	_	,	,	_	10	punct	_	_
15	which	_	WDT	WDT	_	16	nsubj	_	_
16	encodes	_	VBZ	VBZ	_	10	rcmod	_	_
17	p16	_	NN	NN	_	16	dobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	the	_	DT	DT	_	20	det	_	_
20	inhibitor	_	NN	NN	_	17	appos	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	cyclin-dependent-kinase-4	_	NN	NN	_	21	pobj	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	6	_	CD	CD	_	22	conj	_	_
25	,	_	,	,	_	4	punct	_	_
26	in	_	IN	IN	_	4	prep	_	_
27	tumorigenesis	_	NN	NN	_	26	pobj	_	_
28	is	_	VBZ	VBZ	_	31	cop	_	_
29	not	_	RB	RB	_	30	dep	_	_
30	yet	_	RB	RB	_	31	advmod	_	_
31	clear	_	JJ	JJ	_	0	root	_	_
32	.	_	.	.	_	31	punct	_	_

1	Phosphorylation	_	NN	NN	_	12	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	retinoblastoma	_	NN	NN	_	5	nn	_	_
5	protein	_	NN	NN	_	2	pobj	_	_
6	by	_	IN	IN	_	1	prep	_	_
7	cyclin-dependent	_	JJ	JJ	_	8	amod	_	_
8	kinases	_	NNS	NNS	_	6	pobj	_	_
9	4	_	CD	CD	_	8	dep	_	_
10	and	_	CC	CC	_	8	cc	_	_
11	6	_	CD	CD	_	8	conj	_	_
12	prevents	_	VBZ	VBZ	_	0	root	_	_
13	its	_	PRP$	PRP$	_	14	poss	_	_
14	interaction	_	NN	NN	_	12	dobj	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	transcription	_	NN	NN	_	18	nn	_	_
18	factor	_	NN	NN	_	15	pobj	_	_
19	E2F	_	NN	NN	_	18	dep	_	_
20	,	_	,	,	_	18	punct	_	_
21	which	_	WDT	WDT	_	23	nsubj	_	_
22	subsequently	_	RB	RB	_	23	advmod	_	_
23	promotes	_	VBZ	VBZ	_	18	rcmod	_	_
24	the	_	DT	DT	_	25	det	_	_
25	expression	_	NN	NN	_	23	dobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	S	_	NN	NN	_	30	nn	_	_
28	phase	_	NN	NN	_	30	nn	_	_
29	regulated	_	JJ	JJ	_	30	amod	_	_
30	genes	_	NNS	NNS	_	26	pobj	_	_
31	,	_	,	,	_	30	punct	_	_
32	such	_	JJ	JJ	_	33	mwe	_	_
33	as	_	IN	IN	_	30	prep	_	_
34	thymidine	_	NN	NN	_	35	nn	_	_
35	kinase	_	NN	NN	_	33	pobj	_	_
36	.	_	.	.	_	12	punct	_	_

1	Although	_	IN	IN	_	11	mark	_	_
2	a	_	DT	DT	_	3	det	_	_
3	role	_	NN	NN	_	11	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	p16	_	NN	NN	_	4	pobj	_	_
6	in	_	IN	IN	_	3	prep	_	_
7	this	_	DT	DT	_	8	det	_	_
8	regulation	_	NN	NN	_	6	pobj	_	_
9	has	_	VBZ	VBZ	_	11	aux	_	_
10	been	_	VBN	VBN	_	11	auxpass	_	_
11	presumed	_	VBN	VBN	_	14	advcl	_	_
12	,	_	,	,	_	14	punct	_	_
13	there	_	EX	EX	_	14	expl	_	_
14	is	_	VBZ	VBZ	_	0	root	_	_
15	no	_	DT	DT	_	16	neg	_	_
16	proof	_	NN	NN	_	14	nsubj	_	_
17	so	_	RB	RB	_	18	advmod	_	_
18	far	_	RB	RB	_	16	advmod	_	_
19	that	_	IN	IN	_	27	mark	_	_
20	loss	_	NN	NN	_	27	nsubj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	this	_	DT	DT	_	25	det	_	_
23	tumor	_	NN	NN	_	25	nn	_	_
24	suppressor	_	NN	NN	_	25	nn	_	_
25	gene	_	NN	NN	_	21	pobj	_	_
26	really	_	RB	RB	_	27	advmod	_	_
27	affects	_	VBZ	VBZ	_	16	dep	_	_
28	E2F-mediated	_	JJ	JJ	_	29	amod	_	_
29	regulations	_	NNS	NNS	_	27	dobj	_	_
30	.	_	.	.	_	14	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	investigated	_	VBD	VBD	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	regulation	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	thymidine	_	NN	NN	_	7	nn	_	_
7	kinase	_	NN	NN	_	5	pobj	_	_
8	in	_	IN	IN	_	4	prep	_	_
9	phytohemagglutinin-stimulated	_	JJ	JJ	_	12	amod	_	_
10	normal	_	JJ	JJ	_	12	amod	_	_
11	human	_	JJ	JJ	_	12	amod	_	_
12	lymphocytes	_	NNS	NNS	_	8	pobj	_	_
13	and	_	CC	CC	_	8	cc	_	_
14	in	_	IN	IN	_	8	conj	_	_
15	the	_	DT	DT	_	22	det	_	_
16	p16-negative	_	JJ	JJ	_	22	amod	_	_
17	human	_	JJ	JJ	_	22	amod	_	_
18	acute	_	JJ	JJ	_	22	amod	_	_
19	lymphoblastic	_	JJ	JJ	_	22	amod	_	_
20	leukemia	_	NN	NN	_	22	nn	_	_
21	cell	_	NN	NN	_	22	nn	_	_
22	lines	_	NNS	NNS	_	14	pobj	_	_
23	,	_	,	,	_	22	punct	_	_
24	MOLT-4	_	NN	NN	_	22	appos	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	CEM	_	NN	NN	_	24	conj	_	_
27	.	_	.	.	_	2	punct	_	_

1	Compared	_	VBN	VBN	_	10	prep	_	_
2	to	_	TO	TO	_	1	pcomp	_	_
3	normal	_	JJ	JJ	_	4	amod	_	_
4	lymphocytes	_	NNS	NNS	_	2	pobj	_	_
5	,	_	,	,	_	10	punct	_	_
6	MOLT-4	_	NN	NN	_	10	nsubj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	CEM	_	NN	NN	_	6	conj	_	_
9	cells	_	NNS	NNS	_	6	dep	_	_
10	exhibited	_	VBD	VBD	_	0	root	_	_
11	an	_	DT	DT	_	15	det	_	_
12	altered	_	JJ	JJ	_	15	amod	_	_
13	cell	_	NN	NN	_	15	nn	_	_
14	cycle	_	NN	NN	_	15	nn	_	_
15	regulation	_	NN	NN	_	10	dobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	thymidine	_	NN	NN	_	18	nn	_	_
18	kinase	_	NN	NN	_	16	pobj	_	_
19	,	_	,	,	_	15	punct	_	_
20	a	_	DT	DT	_	24	det	_	_
21	much	_	RB	RB	_	23	advmod	_	_
22	higher	_	JJR	JJR	_	23	dep	_	_
23	intracellular	_	JJ	JJ	_	24	amod	_	_
24	activity	_	NN	NN	_	15	conj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	this	_	DT	DT	_	27	det	_	_
27	enzyme	_	NN	NN	_	25	pobj	_	_
28	,	_	,	,	_	15	punct	_	_
29	and	_	CC	CC	_	15	cc	_	_
30	higher	_	JJR	JJR	_	34	amod	_	_
31	thymidine	_	NN	NN	_	33	nn	_	_
32	kinase	_	NN	NN	_	33	nn	_	_
33	mRNA	_	NN	NN	_	34	nn	_	_
34	expression	_	NN	NN	_	15	conj	_	_
35	.	_	.	.	_	10	punct	_	_

1	Transient	_	JJ	JJ	_	2	amod	_	_
2	expression	_	NN	NN	_	9	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	p16	_	NN	NN	_	3	pobj	_	_
5	in	_	IN	IN	_	2	prep	_	_
6	normal	_	JJ	JJ	_	8	amod	_	_
7	human	_	JJ	JJ	_	8	amod	_	_
8	lymphocytes	_	NNS	NNS	_	5	pobj	_	_
9	caused	_	VBD	VBD	_	0	root	_	_
10	arrest	_	NN	NN	_	9	dobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	G1	_	NN	NN	_	11	pobj	_	_
13	,	_	,	,	_	9	punct	_	_
14	but	_	CC	CC	_	9	cc	_	_
15	was	_	VBD	VBD	_	9	conj	_	_
16	without	_	IN	IN	_	15	prep	_	_
17	effect	_	NN	NN	_	16	pobj	_	_
18	on	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	cell	_	NN	NN	_	21	nn	_	_
21	growth	_	NN	NN	_	18	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	MOLT-4	_	NN	NN	_	22	pobj	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	CEM	_	NN	NN	_	23	conj	_	_
26	cells	_	NNS	NNS	_	23	dep	_	_
27	,	_	,	,	_	9	punct	_	_
28	although	_	IN	IN	_	32	mark	_	_
29	all	_	DT	DT	_	32	nsubj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	them	_	PRP	PRP	_	30	pobj	_	_
32	express	_	VBP	VBP	_	9	advcl	_	_
33	functional	_	JJ	JJ	_	35	amod	_	_
34	retinoblastoma	_	NN	NN	_	35	nn	_	_
35	protein	_	NN	NN	_	32	dobj	_	_
36	.	_	.	.	_	9	punct	_	_

1	Nevertheless	_	RB	RB	_	13	advmod	_	_
2	,	_	,	,	_	13	punct	_	_
3	in	_	IN	IN	_	13	prep	_	_
4	the	_	DT	DT	_	8	det	_	_
5	two	_	CD	CD	_	8	num	_	_
6	leukemia	_	NN	NN	_	8	nn	_	_
7	cell	_	NN	NN	_	8	nn	_	_
8	lines	_	NNS	NNS	_	3	pobj	_	_
9	transient	_	JJ	JJ	_	10	amod	_	_
10	overexpression	_	NN	NN	_	13	nsubj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	p16	_	NN	NN	_	11	pobj	_	_
13	reestablished	_	VBD	VBD	_	0	root	_	_
14	the	_	DT	DT	_	16	det	_	_
15	normal	_	JJ	JJ	_	16	amod	_	_
16	regulation	_	NN	NN	_	13	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	thymidine	_	NN	NN	_	19	nn	_	_
19	kinase	_	NN	NN	_	17	pobj	_	_
20	,	_	,	,	_	16	punct	_	_
21	paralleled	_	VBN	VBN	_	16	vmod	_	_
22	by	_	IN	IN	_	21	prep	_	_
23	an	_	DT	DT	_	24	det	_	_
24	increase	_	NN	NN	_	22	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	28	det	_	_
27	underphosphorylated	_	JJ	JJ	_	28	amod	_	_
28	form	_	NN	NN	_	25	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	retinoblastoma	_	NN	NN	_	31	nn	_	_
31	protein	_	NN	NN	_	29	pobj	_	_
32	and	_	CC	CC	_	24	cc	_	_
33	decrease	_	NN	NN	_	24	conj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	free	_	JJ	JJ	_	36	amod	_	_
36	E2F	_	NN	NN	_	34	pobj	_	_
37	bound	_	VBD	VBD	_	36	vmod	_	_
38	to	_	TO	TO	_	37	prep	_	_
39	its	_	PRP$	PRP$	_	40	poss	_	_
40	motif	_	NN	NN	_	38	pobj	_	_
41	in	_	IN	IN	_	40	prep	_	_
42	the	_	DT	DT	_	45	det	_	_
43	thymidine	_	NN	NN	_	45	nn	_	_
44	kinase	_	NN	NN	_	45	nn	_	_
45	promoter	_	NN	NN	_	41	pobj	_	_
46	.	_	.	.	_	13	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	demonstrate	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	7	mark	_	_
4	loss	_	NN	NN	_	7	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	p16	_	NN	NN	_	5	pobj	_	_
7	causes	_	VBZ	VBZ	_	2	ccomp	_	_
8	upregulation	_	NN	NN	_	7	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	this	_	DT	DT	_	13	det	_	_
11	DNA	_	NN	NN	_	13	nn	_	_
12	precursor	_	NN	NN	_	13	nn	_	_
13	pathway	_	NN	NN	_	9	pobj	_	_
14	enzyme	_	NN	NN	_	13	dep	_	_
15	via	_	IN	IN	_	8	prep	_	_
16	activation	_	NN	NN	_	15	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	E2F	_	NN	NN	_	17	pobj	_	_
19	by	_	IN	IN	_	16	prep	_	_
20	a	_	DT	DT	_	21	det	_	_
21	mechanism	_	NN	NN	_	19	pobj	_	_
22	involving	_	VBG	VBG	_	21	vmod	_	_
23	retinoblastoma	_	NN	NN	_	24	nn	_	_
24	protein	_	NN	NN	_	22	dobj	_	_
25	.	_	.	.	_	2	punct	_	_

1	cAMP	_	NN	NN	_	2	nn	_	_
2	inducibility	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	transcriptional	_	JJ	JJ	_	5	amod	_	_
5	repressor	_	NN	NN	_	3	pobj	_	_
6	ICER	_	NN	NN	_	5	dep	_	_
7	in	_	IN	IN	_	2	prep	_	_
8	developing	_	VBG	VBG	_	7	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	mature	_	JJ	JJ	_	13	amod	_	_
11	human	_	JJ	JJ	_	13	amod	_	_
12	T	_	NN	NN	_	13	nn	_	_
13	lymphocytes	_	NNS	NNS	_	8	conj	_	_
14	-LSB-	_	-LRB-	-LRB-	_	17	punct	_	_
15	published	_	VBN	VBN	_	16	amod	_	_
16	erratum	_	NN	NN	_	17	nsubj	_	_
17	appears	_	VBZ	VBZ	_	2	dep	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	Proc	_	NNP	NNP	_	25	nn	_	_
20	Natl	_	NNP	NNP	_	25	nn	_	_
21	Acad	_	NNP	NNP	_	25	nn	_	_
22	Sci	_	NNP	NNP	_	25	nn	_	_
23	U	_	NNP	NNP	_	25	nn	_	_
24	S	_	NNP	NNP	_	25	nn	_	_
25	A	_	NNP	NNP	_	18	pobj	_	_
26	1996	_	CD	CD	_	27	num	_	_
27	Jul	_	NNP	NNP	_	25	dep	_	_
28	23	_	CD	CD	_	27	num	_	_
29	;	_	:	:	_	25	punct	_	_
30	93	_	CD	CD	_	32	num	_	_
31	-LRB-	_	-LRB-	-LRB-	_	32	punct	_	_
32	15	_	CD	CD	_	25	dep	_	_
33	-RRB-	_	-RRB-	-RRB-	_	32	punct	_	_
34	:	_	:	:	_	25	punct	_	_
35	8154	_	CD	CD	_	25	dep	_	_
36	-RSB-	_	-RRB-	-RRB-	_	17	punct	_	_

1	Stimulation	_	NN	NN	_	7	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	6	det	_	_
4	cAMP-dependent	_	JJ	JJ	_	6	amod	_	_
5	signaling	_	NN	NN	_	6	nn	_	_
6	pathway	_	NN	NN	_	2	pobj	_	_
7	exerts	_	VBZ	VBZ	_	0	root	_	_
8	an	_	DT	DT	_	10	det	_	_
9	inhibitory	_	JJ	JJ	_	10	amod	_	_
10	effect	_	NN	NN	_	7	dobj	_	_
11	on	_	IN	IN	_	7	prep	_	_
12	the	_	DT	DT	_	13	dep	_	_
13	proliferation	_	NN	NN	_	11	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	effector	_	NN	NN	_	16	nn	_	_
16	functions	_	NNS	NNS	_	13	conj	_	_
17	of	_	IN	IN	_	13	prep	_	_
18	T	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	17	pobj	_	_
20	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	ability	_	NN	NN	_	14	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	T	_	NN	NN	_	5	nn	_	_
5	cells	_	NNS	NNS	_	3	pobj	_	_
6	to	_	TO	TO	_	7	aux	_	_
7	form	_	VB	VB	_	2	vmod	_	_
8	high	_	JJ	JJ	_	10	amod	_	_
9	intracellular	_	JJ	JJ	_	10	amod	_	_
10	levels	_	NNS	NNS	_	7	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	cAMP	_	NN	NN	_	11	pobj	_	_
13	is	_	VBZ	VBZ	_	14	auxpass	_	_
14	acquired	_	VBN	VBN	_	0	root	_	_
15	during	_	IN	IN	_	14	prep	_	_
16	development	_	NN	NN	_	15	pobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	human	_	JJ	JJ	_	20	amod	_	_
20	thymus	_	NN	NN	_	17	pobj	_	_
21	and	_	CC	CC	_	14	cc	_	_
22	is	_	VBZ	VBZ	_	23	auxpass	_	_
23	retained	_	VBN	VBN	_	14	conj	_	_
24	by	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	26	det	_	_
26	majority	_	NN	NN	_	24	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	mature	_	JJ	JJ	_	31	amod	_	_
29	peripheral	_	JJ	JJ	_	31	amod	_	_
30	T	_	NN	NN	_	31	nn	_	_
31	lymphocytes	_	NNS	NNS	_	27	pobj	_	_
32	.	_	.	.	_	14	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	show	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	11	mark	_	_
5	elevated	_	JJ	JJ	_	7	amod	_	_
6	cAMP	_	NN	NN	_	7	nn	_	_
7	levels	_	NNS	NNS	_	11	nsubj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	T	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	8	pobj	_	_
11	correlate	_	VBP	VBP	_	3	ccomp	_	_
12	with	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	expression	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	19	det	_	_
17	potent	_	JJ	JJ	_	19	amod	_	_
18	transcriptional	_	JJ	JJ	_	19	amod	_	_
19	repressor	_	NN	NN	_	15	pobj	_	_
20	ICER	_	NN	NN	_	19	dep	_	_
21	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
22	inducible	_	JJ	JJ	_	25	amod	_	_
23	cAMP	_	NN	NN	_	25	nn	_	_
24	early	_	JJ	JJ	_	25	amod	_	_
25	repressor	_	NN	NN	_	20	appos	_	_
26	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
27	previously	_	RB	RB	_	14	advmod	_	_
28	described	_	VBN	VBN	_	14	vmod	_	_
29	in	_	IN	IN	_	28	prep	_	_
30	the	_	DT	DT	_	32	det	_	_
31	hypothalamic-pituitary-gonadal	_	JJ	JJ	_	32	amod	_	_
32	axis	_	NN	NN	_	29	pobj	_	_
33	.	_	.	.	_	3	punct	_	_

1	Further	_	RB	RB	_	10	advmod	_	_
2	,	_	,	,	_	10	punct	_	_
3	in	_	IN	IN	_	10	prep	_	_
4	transcriptional	_	JJ	JJ	_	5	amod	_	_
5	assays	_	NNS	NNS	_	3	pobj	_	_
6	in	_	FW	FW	_	5	amod	_	_
7	vivo	_	FW	FW	_	6	dep	_	_
8	,	_	,	,	_	10	punct	_	_
9	ICER	_	NN	NN	_	10	nsubj	_	_
10	inhibits	_	VBZ	VBZ	_	0	root	_	_
11	calcineurin-mediated	_	JJ	JJ	_	12	amod	_	_
12	expression	_	NN	NN	_	10	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	17	det	_	_
15	interleukin	_	NN	NN	_	17	nn	_	_
16	2	_	CD	CD	_	17	num	_	_
17	promoter	_	NN	NN	_	13	pobj	_	_
18	as	_	RB	RB	_	19	advmod	_	_
19	well	_	RB	RB	_	12	cc	_	_
20	as	_	IN	IN	_	19	mwe	_	_
21	Tax-mediated	_	JJ	JJ	_	22	amod	_	_
22	transactivation	_	NN	NN	_	12	conj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	33	det	_	_
25	human	_	JJ	JJ	_	33	amod	_	_
26	T-lymphotropic	_	JJ	JJ	_	33	amod	_	_
27	virus	_	NN	NN	_	33	nn	_	_
28	type	_	NN	NN	_	33	nn	_	_
29	I	_	CD	CD	_	33	num	_	_
30	-LRB-	_	-LRB-	-LRB-	_	33	punct	_	_
31	HTLV-I	_	NN	NN	_	33	nn	_	_
32	-RRB-	_	-RRB-	-RRB-	_	33	punct	_	_
33	promoter	_	NN	NN	_	23	pobj	_	_
34	.	_	.	.	_	10	punct	_	_

1	Thus	_	RB	RB	_	11	advmod	_	_
2	,	_	,	,	_	11	punct	_	_
3	the	_	DT	DT	_	4	det	_	_
4	induction	_	NN	NN	_	11	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	ICER	_	NN	NN	_	5	pobj	_	_
7	in	_	IN	IN	_	4	prep	_	_
8	T	_	NN	NN	_	9	nn	_	_
9	cells	_	NNS	NNS	_	7	pobj	_	_
10	may	_	MD	MD	_	11	aux	_	_
11	play	_	VB	VB	_	0	root	_	_
12	an	_	DT	DT	_	14	det	_	_
13	important	_	JJ	JJ	_	14	amod	_	_
14	role	_	NN	NN	_	11	dobj	_	_
15	in	_	IN	IN	_	11	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	cAMP-induced	_	JJ	JJ	_	18	amod	_	_
18	quiescence	_	NN	NN	_	15	pobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	the	_	DT	DT	_	22	det	_	_
21	persistent	_	JJ	JJ	_	22	amod	_	_
22	latency	_	NN	NN	_	18	conj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	HTLV-I	_	NN	NN	_	23	pobj	_	_
25	.	_	.	.	_	11	punct	_	_

1	Preassociation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	STAT1	_	NN	NN	_	2	pobj	_	_
4	with	_	IN	IN	_	1	prep	_	_
5	STAT2	_	NN	NN	_	4	pobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	STAT3	_	NN	NN	_	5	conj	_	_
8	in	_	IN	IN	_	1	prep	_	_
9	separate	_	JJ	JJ	_	11	amod	_	_
10	signalling	_	NN	NN	_	11	nn	_	_
11	complexes	_	NNS	NNS	_	8	pobj	_	_
12	prior	_	RB	RB	_	1	advmod	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	cytokine	_	NN	NN	_	15	nn	_	_
15	stimulation	_	NN	NN	_	13	pobj	_	_
16	.	_	.	.	_	1	punct	_	_

1	A	_	DT	DT	_	2	det	_	_
2	variety	_	NN	NN	_	8	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	cytokines	_	NNS	NNS	_	3	pobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	growth	_	NN	NN	_	7	nn	_	_
7	factors	_	NNS	NNS	_	4	conj	_	_
8	act	_	VBP	VBP	_	0	root	_	_
9	through	_	IN	IN	_	8	prep	_	_
10	an	_	DT	DT	_	11	det	_	_
11	induction	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	gene	_	NN	NN	_	14	nn	_	_
14	expression	_	NN	NN	_	12	pobj	_	_
15	mediated	_	VBN	VBN	_	14	vmod	_	_
16	by	_	IN	IN	_	15	prep	_	_
17	a	_	DT	DT	_	18	det	_	_
18	family	_	NN	NN	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	latent	_	JJ	JJ	_	22	amod	_	_
21	transcription	_	NN	NN	_	22	nn	_	_
22	factors	_	NNS	NNS	_	19	pobj	_	_
23	called	_	VBN	VBN	_	22	vmod	_	_
24	STAT	_	NN	NN	_	27	nn	_	_
25	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
26	signal	_	NN	NN	_	27	nn	_	_
27	transducers	_	NNS	NNS	_	23	dep	_	_
28	and	_	CC	CC	_	27	cc	_	_
29	activators	_	NNS	NNS	_	33	nn	_	_
30	of	_	IN	IN	_	33	amod	_	_
31	transcription	_	NN	NN	_	33	nn	_	_
32	-RRB-	_	-RRB-	-RRB-	_	33	punct	_	_
33	proteins	_	NNS	NNS	_	27	conj	_	_
34	.	_	.	.	_	8	punct	_	_

1	Ligand-induced	_	JJ	JJ	_	3	amod	_	_
2	tyrosine	_	NN	NN	_	3	nn	_	_
3	phosphorylation	_	NN	NN	_	7	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	6	det	_	_
6	STATs	_	NNS	NNS	_	4	pobj	_	_
7	promotes	_	VBZ	VBZ	_	0	root	_	_
8	their	_	PRP$	PRP$	_	9	poss	_	_
9	homodimer	_	NN	NN	_	7	dobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	heterodimer	_	NN	NN	_	9	conj	_	_
12	formation	_	NN	NN	_	9	dep	_	_
13	and	_	CC	CC	_	9	cc	_	_
14	subsequent	_	JJ	JJ	_	16	amod	_	_
15	nuclear	_	JJ	JJ	_	16	amod	_	_
16	translocation	_	NN	NN	_	9	conj	_	_
17	.	_	.	.	_	7	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	demonstrate	_	VBP	VBP	_	0	root	_	_
3	here	_	RB	RB	_	2	advmod	_	_
4	that	_	IN	IN	_	8	mark	_	_
5	STAT	_	NN	NN	_	7	nn	_	_
6	protein	_	NN	NN	_	7	nn	_	_
7	heterocomplexes	_	NNS	NNS	_	8	nsubj	_	_
8	exist	_	VBP	VBP	_	2	ccomp	_	_
9	prior	_	RB	RB	_	8	advmod	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	cytokine	_	NN	NN	_	12	nn	_	_
12	treatment	_	NN	NN	_	10	pobj	_	_
13	.	_	.	.	_	2	punct	_	_

1	When	_	WRB	WRB	_	6	advmod	_	_
2	unstimulated	_	JJ	JJ	_	4	amod	_	_
3	HeLa	_	NN	NN	_	4	nn	_	_
4	cells	_	NNS	NNS	_	6	nsubjpass	_	_
5	are	_	VBP	VBP	_	6	auxpass	_	_
6	ruptured	_	VBN	VBN	_	25	advcl	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	hypotonic	_	JJ	JJ	_	9	amod	_	_
9	buffer	_	NN	NN	_	7	pobj	_	_
10	without	_	IN	IN	_	6	prep	_	_
11	salt	_	NN	NN	_	10	pobj	_	_
12	or	_	CC	CC	_	11	cc	_	_
13	detergent	_	NN	NN	_	11	conj	_	_
14	,	_	,	,	_	25	punct	_	_
15	immunoadsorption	_	NN	NN	_	25	nsubj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	either	_	CC	CC	_	18	preconj	_	_
18	STAT1	_	NN	NN	_	16	pobj	_	_
19	or	_	CC	CC	_	18	cc	_	_
20	STAT2	_	NN	NN	_	18	conj	_	_
21	from	_	IN	IN	_	15	prep	_	_
22	the	_	DT	DT	_	24	det	_	_
23	resulting	_	VBG	VBG	_	24	amod	_	_
24	cytosol	_	NN	NN	_	21	pobj	_	_
25	yields	_	VBZ	VBZ	_	0	root	_	_
26	coimmunoadsorption	_	NN	NN	_	25	dobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	31	det	_	_
29	other	_	JJ	JJ	_	31	amod	_	_
30	STAT	_	NN	NN	_	31	nn	_	_
31	protein	_	NN	NN	_	27	pobj	_	_
32	.	_	.	.	_	25	punct	_	_

1	Similarly	_	RB	RB	_	6	advmod	_	_
2	,	_	,	,	_	6	punct	_	_
3	STAT1-STAT3	_	NN	NN	_	4	nn	_	_
4	heterocomplexes	_	NNS	NNS	_	6	nsubjpass	_	_
5	are	_	VBP	VBP	_	6	auxpass	_	_
6	coimmunoadsorbed	_	VBN	VBN	_	0	root	_	_
7	from	_	IN	IN	_	6	prep	_	_
8	hypotonic	_	JJ	JJ	_	9	amod	_	_
9	cytosol	_	NN	NN	_	7	pobj	_	_
10	.	_	.	.	_	6	punct	_	_

1	STAT1	_	NN	NN	_	13	nsubj	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	STAT2	_	NN	NN	_	1	conj	_	_
4	or	_	CC	CC	_	1	cc	_	_
5	STAT1	_	NN	NN	_	1	conj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	STAT3	_	NN	NN	_	5	conj	_	_
8	translated	_	VBN	VBN	_	1	vmod	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	reticulocyte	_	NN	NN	_	11	nn	_	_
11	lysate	_	NN	NN	_	9	pobj	_	_
12	spontaneously	_	RB	RB	_	8	advmod	_	_
13	form	_	VBP	VBP	_	0	root	_	_
14	heterocomplexes	_	NNS	NNS	_	13	dobj	_	_
15	when	_	WRB	WRB	_	20	advmod	_	_
16	the	_	DT	DT	_	18	det	_	_
17	translation	_	NN	NN	_	18	nn	_	_
18	lysates	_	NNS	NNS	_	20	nsubjpass	_	_
19	are	_	VBP	VBP	_	20	auxpass	_	_
20	mixed	_	VBN	VBN	_	13	advcl	_	_
21	at	_	IN	IN	_	20	prep	_	_
22	0	_	CD	CD	_	24	num	_	_
23	degrees	_	NNS	NNS	_	24	nn	_	_
24	C	_	NN	NN	_	21	pobj	_	_
25	.	_	.	.	_	13	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	9	mark	_	_
5	interferon-alpha	_	NN	NN	_	8	nn	_	_
6	/beta-induced	_	JJ	JJ	_	8	amod	_	_
7	tyrosine	_	NN	NN	_	8	nn	_	_
8	phosphorylation	_	NN	NN	_	9	nsubj	_	_
9	increases	_	VBZ	VBZ	_	3	ccomp	_	_
10	the	_	DT	DT	_	11	det	_	_
11	stability	_	NN	NN	_	9	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	a	_	DT	DT	_	20	det	_	_
14	preexisting	_	JJ	JJ	_	20	amod	_	_
15	,	_	,	,	_	14	punct	_	_
16	latent	_	JJ	JJ	_	14	dep	_	_
17	,	_	,	,	_	20	punct	_	_
18	STAT1-STAT2	_	JJ	JJ	_	20	amod	_	_
19	signaling	_	NN	NN	_	20	nn	_	_
20	complex	_	NN	NN	_	12	pobj	_	_
21	.	_	.	.	_	3	punct	_	_

1	Newly	_	RB	RB	_	2	advmod	_	_
2	translated	_	VBN	VBN	_	3	amod	_	_
3	STAT1	_	NN	NN	_	4	nsubj	_	_
4	binds	_	VBZ	VBZ	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	equilibrium	_	NN	NN	_	7	nn	_	_
7	fashion	_	NN	NN	_	5	pobj	_	_
8	to	_	TO	TO	_	4	prep	_	_
9	STAT2	_	NN	NN	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	STAT3	_	NN	NN	_	9	conj	_	_
12	,	_	,	,	_	4	punct	_	_
13	but	_	CC	CC	_	4	cc	_	_
14	we	_	PRP	PRP	_	15	nsubj	_	_
15	show	_	VBP	VBP	_	4	conj	_	_
16	that	_	IN	IN	_	20	mark	_	_
17	STAT2	_	NN	NN	_	20	nsubj	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	STAT3	_	NN	NN	_	17	conj	_	_
20	exist	_	VBP	VBP	_	15	ccomp	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	separate	_	JJ	JJ	_	23	amod	_	_
23	heterocomplexes	_	NNS	NNS	_	21	pobj	_	_
24	with	_	IN	IN	_	23	prep	_	_
25	STAT1	_	NN	NN	_	24	pobj	_	_
26	,	_	,	,	_	20	punct	_	_
27	consistent	_	JJ	JJ	_	20	advmod	_	_
28	with	_	IN	IN	_	27	prep	_	_
29	a	_	DT	DT	_	30	det	_	_
30	model	_	NN	NN	_	28	pobj	_	_
31	in	_	IN	IN	_	34	prep	_	_
32	which	_	WDT	WDT	_	31	pobj	_	_
33	STAT1	_	NN	NN	_	34	nsubj	_	_
34	contains	_	VBZ	VBZ	_	30	rcmod	_	_
35	a	_	DT	DT	_	38	det	_	_
36	common	_	JJ	JJ	_	38	amod	_	_
37	binding	_	VBG	VBG	_	38	amod	_	_
38	site	_	NN	NN	_	34	dobj	_	_
39	for	_	IN	IN	_	38	prep	_	_
40	other	_	JJ	JJ	_	42	amod	_	_
41	STAT	_	NN	NN	_	42	nn	_	_
42	proteins	_	NNS	NNS	_	39	pobj	_	_
43	.	_	.	.	_	4	punct	_	_

1	Epstein-Barr	_	JJ	JJ	_	12	amod	_	_
2	virus	_	NN	NN	_	12	nn	_	_
3	nuclear	_	JJ	JJ	_	12	amod	_	_
4	antigen	_	NN	NN	_	12	nn	_	_
5	2	_	CD	CD	_	12	num	_	_
6	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
7	EBNA2	_	NN	NN	_	12	nn	_	_
8	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
9	-oestrogen	_	NN	NN	_	12	nn	_	_
10	receptor	_	NN	NN	_	12	nn	_	_
11	fusion	_	NN	NN	_	12	nn	_	_
12	proteins	_	NNS	NNS	_	13	nsubj	_	_
13	complement	_	VBP	VBP	_	0	root	_	_
14	the	_	DT	DT	_	19	det	_	_
15	EBNA2-deficient	_	JJ	JJ	_	19	amod	_	_
16	Epstein-Barr	_	JJ	JJ	_	19	amod	_	_
17	virus	_	NN	NN	_	19	nn	_	_
18	strain	_	NN	NN	_	19	nn	_	_
19	P3HR1	_	NN	NN	_	13	dobj	_	_
20	in	_	IN	IN	_	13	prep	_	_
21	transformation	_	NN	NN	_	20	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	primary	_	JJ	JJ	_	25	amod	_	_
24	B	_	NN	NN	_	25	nn	_	_
25	cells	_	NNS	NNS	_	22	pobj	_	_
26	but	_	CC	CC	_	13	cc	_	_
27	suppress	_	VBP	VBP	_	13	conj	_	_
28	growth	_	NN	NN	_	27	dobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	human	_	JJ	JJ	_	34	amod	_	_
31	B	_	NN	NN	_	34	nn	_	_
32	cell	_	NN	NN	_	34	nn	_	_
33	lymphoma	_	NN	NN	_	34	nn	_	_
34	lines	_	NNS	NNS	_	29	pobj	_	_
35	.	_	.	.	_	13	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	develop	_	VB	VB	_	0	root	_	_
3	a	_	DT	DT	_	5	det	_	_
4	transformation	_	NN	NN	_	5	nn	_	_
5	system	_	NN	NN	_	2	dobj	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	a	_	DT	DT	_	17	det	_	_
8	conditional	_	JJ	JJ	_	17	amod	_	_
9	Epstein-Barr	_	JJ	JJ	_	17	amod	_	_
10	virus	_	NN	NN	_	17	nn	_	_
11	nuclear	_	JJ	JJ	_	17	amod	_	_
12	antigen	_	NN	NN	_	17	nn	_	_
13	2	_	CD	CD	_	17	num	_	_
14	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
15	EBNA2	_	NN	NN	_	17	nn	_	_
16	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
17	gene	_	NN	NN	_	6	pobj	_	_
18	,	_	,	,	_	2	punct	_	_
19	we	_	PRP	PRP	_	20	nsubj	_	_
20	fused	_	VBD	VBD	_	2	parataxis	_	_
21	the	_	DT	DT	_	24	det	_	_
22	hormone	_	NN	NN	_	24	nn	_	_
23	binding	_	NN	NN	_	24	nn	_	_
24	domain	_	NN	NN	_	20	dobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	28	det	_	_
27	oestrogen	_	NN	NN	_	28	nn	_	_
28	receptor	_	NN	NN	_	25	pobj	_	_
29	to	_	TO	TO	_	20	prep	_	_
30	the	_	DT	DT	_	31	dep	_	_
31	N	_	NN	NN	_	29	pobj	_	_
32	or	_	CC	CC	_	31	cc	_	_
33	C	_	NN	NN	_	31	conj	_	_
34	terminus	_	NN	NN	_	31	dep	_	_
35	of	_	IN	IN	_	31	prep	_	_
36	EBNA2	_	NN	NN	_	35	pobj	_	_
37	.	_	.	.	_	2	punct	_	_

1	In	_	IN	IN	_	17	prep	_	_
2	promoter	_	NN	NN	_	3	nn	_	_
3	transactivation	_	NN	NN	_	1	pobj	_	_
4	as	_	RB	RB	_	5	advmod	_	_
5	well	_	RB	RB	_	3	cc	_	_
6	as	_	IN	IN	_	5	mwe	_	_
7	primary	_	JJ	JJ	_	10	amod	_	_
8	B	_	NN	NN	_	10	nn	_	_
9	cell	_	NN	NN	_	10	nn	_	_
10	transformation	_	NN	NN	_	3	conj	_	_
11	assays	_	NNS	NNS	_	3	dep	_	_
12	these	_	DT	DT	_	15	det	_	_
13	chimeric	_	JJ	JJ	_	15	amod	_	_
14	EBNA2	_	NN	NN	_	15	nn	_	_
15	proteins	_	NNS	NNS	_	17	nsubj	_	_
16	are	_	VBP	VBP	_	17	cop	_	_
17	able	_	JJ	JJ	_	0	root	_	_
18	to	_	TO	TO	_	19	aux	_	_
19	substitute	_	VB	VB	_	17	xcomp	_	_
20	for	_	IN	IN	_	19	prep	_	_
21	wild-type	_	JJ	JJ	_	22	amod	_	_
22	EBNA2	_	NN	NN	_	20	pobj	_	_
23	in	_	IN	IN	_	19	prep	_	_
24	the	_	DT	DT	_	25	det	_	_
25	presence	_	NN	NN	_	23	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	oestrogen	_	NN	NN	_	26	pobj	_	_
28	.	_	.	.	_	17	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	provide	_	VBP	VBP	_	0	root	_	_
4	evidence	_	NN	NN	_	3	dobj	_	_
5	that	_	IN	IN	_	10	mark	_	_
6	this	_	DT	DT	_	7	det	_	_
7	transformation	_	NN	NN	_	10	nsubj	_	_
8	is	_	VBZ	VBZ	_	10	cop	_	_
9	the	_	DT	DT	_	10	det	_	_
10	result	_	NN	NN	_	4	ccomp	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	double	_	JJ	JJ	_	13	amod	_	_
13	infection	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	a	_	DT	DT	_	16	det	_	_
16	cell	_	NN	NN	_	14	pobj	_	_
17	with	_	IN	IN	_	16	prep	_	_
18	two	_	CD	CD	_	19	num	_	_
19	virions	_	NNS	NNS	_	17	pobj	_	_
20	,	_	,	,	_	19	punct	_	_
21	the	_	DT	DT	_	24	det	_	_
22	P3HR1	_	NN	NN	_	24	nn	_	_
23	virus	_	NN	NN	_	24	nn	_	_
24	genome	_	NN	NN	_	19	appos	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	a	_	DT	DT	_	28	det	_	_
27	mini-EBV	_	NN	NN	_	28	nn	_	_
28	plasmid	_	NN	NN	_	24	conj	_	_
29	carrying	_	VBG	VBG	_	28	vmod	_	_
30	the	_	DT	DT	_	33	det	_	_
31	chimeric	_	JJ	JJ	_	33	amod	_	_
32	EBNA2	_	NN	NN	_	33	nn	_	_
33	gene	_	NN	NN	_	29	dobj	_	_
34	.	_	.	.	_	3	punct	_	_

1	Unexpectedly	_	RB	RB	_	18	advmod	_	_
2	,	_	,	,	_	18	punct	_	_
3	expression	_	NN	NN	_	18	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	10	det	_	_
6	same	_	JJ	JJ	_	10	amod	_	_
7	EBNA2-oestrogen	_	NN	NN	_	10	nn	_	_
8	receptor	_	NN	NN	_	10	nn	_	_
9	fusion	_	NN	NN	_	10	nn	_	_
10	protein	_	NN	NN	_	4	pobj	_	_
11	in	_	IN	IN	_	3	prep	_	_
12	established	_	JJ	JJ	_	17	amod	_	_
13	human	_	JJ	JJ	_	17	amod	_	_
14	B	_	NN	NN	_	17	nn	_	_
15	cell	_	NN	NN	_	17	nn	_	_
16	lymphoma	_	NN	NN	_	17	nn	_	_
17	lines	_	NNS	NNS	_	11	pobj	_	_
18	resulted	_	VBD	VBD	_	0	root	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	growth	_	NN	NN	_	21	nn	_	_
21	retardation	_	NN	NN	_	19	pobj	_	_
22	or	_	CC	CC	_	21	cc	_	_
23	growth	_	NN	NN	_	24	nn	_	_
24	arrest	_	NN	NN	_	21	conj	_	_
25	upon	_	IN	IN	_	21	prep	_	_
26	the	_	DT	DT	_	27	det	_	_
27	addition	_	NN	NN	_	25	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	oestrogen	_	NN	NN	_	28	pobj	_	_
30	.	_	.	.	_	18	punct	_	_

1	By	_	IN	IN	_	26	prep	_	_
2	titrating	_	VBG	VBG	_	1	pcomp	_	_
3	the	_	DT	DT	_	5	det	_	_
4	oestrogen	_	NN	NN	_	5	nn	_	_
5	concentration	_	NN	NN	_	2	dobj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	these	_	DT	DT	_	10	det	_	_
8	stably	_	RB	RB	_	10	advmod	_	_
9	transfected	_	VBN	VBN	_	10	amod	_	_
10	cells	_	NNS	NNS	_	6	pobj	_	_
11	,	_	,	,	_	26	punct	_	_
12	the	_	DT	DT	_	14	det	_	_
13	growth	_	NN	NN	_	14	nn	_	_
14	retarding	_	NN	NN	_	26	nsubjpass	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	the	_	DT	DT	_	18	det	_	_
17	transactivating	_	VBG	VBG	_	18	amod	_	_
18	function	_	NN	NN	_	14	conj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	22	det	_	_
21	chimeric	_	JJ	JJ	_	22	amod	_	_
22	proteins	_	NNS	NNS	_	19	pobj	_	_
23	could	_	MD	MD	_	26	aux	_	_
24	not	_	RB	RB	_	26	neg	_	_
25	be	_	VB	VB	_	26	auxpass	_	_
26	dissociated	_	VBN	VBN	_	0	root	_	_
27	.	_	.	.	_	26	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	propose	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	15	mark	_	_
4	growth	_	NN	NN	_	5	nn	_	_
5	inhibition	_	NN	NN	_	15	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	established	_	JJ	JJ	_	11	amod	_	_
8	B	_	NN	NN	_	11	nn	_	_
9	cell	_	NN	NN	_	11	nn	_	_
10	lymphoma	_	NN	NN	_	11	nn	_	_
11	lines	_	NNS	NNS	_	6	pobj	_	_
12	is	_	VBZ	VBZ	_	15	cop	_	_
13	a	_	DT	DT	_	15	det	_	_
14	novel	_	JJ	JJ	_	15	amod	_	_
15	function	_	NN	NN	_	2	ccomp	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	EBNA2	_	NN	NN	_	16	pobj	_	_
18	which	_	WDT	WDT	_	22	nsubjpass	_	_
19	has	_	VBZ	VBZ	_	22	aux	_	_
20	not	_	RB	RB	_	22	neg	_	_
21	been	_	VBN	VBN	_	22	auxpass	_	_
22	detected	_	VBN	VBN	_	15	rcmod	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	25	det	_	_
25	absence	_	NN	NN	_	23	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	an	_	DT	DT	_	29	det	_	_
28	inducible	_	JJ	JJ	_	29	amod	_	_
29	system	_	NN	NN	_	26	pobj	_	_
30	.	_	.	.	_	2	punct	_	_

1	It	_	PRP	PRP	_	2	nsubj	_	_
2	remains	_	VBZ	VBZ	_	0	root	_	_
3	open	_	JJ	JJ	_	2	acomp	_	_
4	whether	_	IN	IN	_	21	mark	_	_
5	the	_	DT	DT	_	8	det	_	_
6	growth	_	NN	NN	_	8	nn	_	_
7	retarding	_	NN	NN	_	8	nn	_	_
8	property	_	NN	NN	_	21	nsubj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	14	det	_	_
11	EBNA2-oestrogen	_	JJ	JJ	_	14	amod	_	_
12	receptor	_	NN	NN	_	14	nn	_	_
13	fusion	_	NN	NN	_	14	nn	_	_
14	protein	_	NN	NN	_	9	pobj	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	B	_	NN	NN	_	19	nn	_	_
17	cell	_	NN	NN	_	19	nn	_	_
18	lymphoma	_	NN	NN	_	19	nn	_	_
19	lines	_	NNS	NNS	_	15	pobj	_	_
20	is	_	VBZ	VBZ	_	21	cop	_	_
21	due	_	JJ	JJ	_	2	ccomp	_	_
22	to	_	TO	TO	_	21	prep	_	_
23	unphysiologically	_	RB	RB	_	24	advmod	_	_
24	high	_	JJ	JJ	_	25	amod	_	_
25	expression	_	NN	NN	_	22	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	29	det	_	_
28	chimeric	_	JJ	JJ	_	29	amod	_	_
29	protein	_	NN	NN	_	26	pobj	_	_
30	or	_	CC	CC	_	22	cc	_	_
31	to	_	TO	TO	_	22	conj	_	_
32	interference	_	NN	NN	_	31	pobj	_	_
33	with	_	IN	IN	_	32	prep	_	_
34	a	_	DT	DT	_	36	det	_	_
35	cellular	_	JJ	JJ	_	36	amod	_	_
36	programme	_	NN	NN	_	33	pobj	_	_
37	driving	_	VBG	VBG	_	36	vmod	_	_
38	proliferation	_	NN	NN	_	37	dobj	_	_
39	in	_	IN	IN	_	38	prep	_	_
40	these	_	DT	DT	_	42	det	_	_
41	cell	_	NN	NN	_	42	nn	_	_
42	lines	_	NNS	NNS	_	39	pobj	_	_
43	.	_	.	.	_	2	punct	_	_

1	Cyclic	_	JJ	JJ	_	4	amod	_	_
2	AMP-responsive	_	JJ	JJ	_	4	amod	_	_
3	element-dependent	_	JJ	JJ	_	4	amod	_	_
4	activation	_	NN	NN	_	0	root	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	Epstein-Barr	_	JJ	JJ	_	7	amod	_	_
7	virus	_	NN	NN	_	5	pobj	_	_
8	zebra	_	NN	NN	_	9	nn	_	_
9	promoter	_	NN	NN	_	7	dep	_	_
10	by	_	IN	IN	_	4	prep	_	_
11	human	_	JJ	JJ	_	12	amod	_	_
12	herpesvirus	_	NN	NN	_	10	pobj	_	_
13	6	_	CD	CD	_	12	num	_	_
14	.	_	.	.	_	4	punct	_	_

1	We	_	PRP	PRP	_	4	nsubj	_	_
2	have	_	VBP	VBP	_	4	aux	_	_
3	recently	_	RB	RB	_	4	advmod	_	_
4	shown	_	VBN	VBN	_	0	root	_	_
5	that	_	IN	IN	_	23	mark	_	_
6	infection	_	NN	NN	_	23	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	Epstein-Barr	_	JJ	JJ	_	15	amod	_	_
9	virus	_	NN	NN	_	15	nn	_	_
10	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
11	EBV	_	NN	NN	_	15	nn	_	_
12	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
13	genome-positive	_	JJ	JJ	_	15	amod	_	_
14	B	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	7	pobj	_	_
16	by	_	IN	IN	_	6	prep	_	_
17	human	_	JJ	JJ	_	18	amod	_	_
18	herpesvirus	_	NN	NN	_	16	pobj	_	_
19	6	_	CD	CD	_	18	num	_	_
20	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	HHV-6	_	NN	NN	_	18	appos	_	_
22	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
23	results	_	VBZ	VBZ	_	4	ccomp	_	_
24	in	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	26	det	_	_
26	expression	_	NN	NN	_	24	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	32	det	_	_
29	immediate-early	_	JJ	JJ	_	32	amod	_	_
30	EBV	_	NN	NN	_	32	nn	_	_
31	Zebra	_	NN	NN	_	32	nn	_	_
32	gene	_	NN	NN	_	27	pobj	_	_
33	,	_	,	,	_	23	punct	_	_
34	followed	_	VBN	VBN	_	23	dep	_	_
35	by	_	IN	IN	_	34	prep	_	_
36	virus	_	NN	NN	_	37	nn	_	_
37	replication	_	NN	NN	_	35	pobj	_	_
38	-LRB-	_	-LRB-	-LRB-	_	39	punct	_	_
39	L.Flamand	_	NNP	NNP	_	4	dep	_	_
40	,	_	,	,	_	39	punct	_	_
41	I.Stefanescu	_	NNP	NNP	_	39	conj	_	_
42	,	_	,	,	_	39	punct	_	_
43	D.V.Ablashi	_	NNP	NNP	_	39	conj	_	_
44	,	_	,	,	_	39	punct	_	_
45	and	_	CC	CC	_	39	cc	_	_
46	J.Menezes	_	NNP	NNP	_	39	conj	_	_
47	,	_	,	,	_	39	punct	_	_
48	J.Virol.67	_	NNP	NNP	_	39	appos	_	_
49	:	_	:	:	_	39	punct	_	_
50	6768-6777	_	CD	CD	_	39	dep	_	_
51	,	_	,	,	_	39	punct	_	_
52	1993	_	CD	CD	_	39	amod	_	_
53	-RRB-	_	-RRB-	-RRB-	_	39	punct	_	_
54	.	_	.	.	_	4	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	show	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	6	mark	_	_
5	HHV-6	_	NN	NN	_	6	nsubj	_	_
6	upregulates	_	VBZ	VBZ	_	3	ccomp	_	_
7	Zebra	_	NN	NN	_	8	nn	_	_
8	gene	_	NN	NN	_	9	nn	_	_
9	transcription	_	NN	NN	_	6	dobj	_	_
10	through	_	IN	IN	_	6	prep	_	_
11	a	_	DT	DT	_	14	det	_	_
12	cyclic	_	JJ	JJ	_	14	amod	_	_
13	AMP-responsive	_	JJ	JJ	_	14	amod	_	_
14	element	_	NN	NN	_	10	pobj	_	_
15	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
16	CRE	_	NN	NN	_	14	appos	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	located	_	JJ	JJ	_	14	amod	_	_
19	within	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	22	det	_	_
21	Zebra	_	NN	NN	_	22	nn	_	_
22	promoter	_	NN	NN	_	19	pobj	_	_
23	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
24	Zp	_	NN	NN	_	22	appos	_	_
25	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
26	.	_	.	.	_	3	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	human	_	JJ	JJ	_	3	amod	_	_
3	B-	_	NN	NN	_	1	dobj	_	_
4	or	_	CC	CC	_	3	cc	_	_
5	T-cell	_	NN	NN	_	3	conj	_	_
6	lines	_	NNS	NNS	_	3	dep	_	_
7	transfected	_	VBN	VBN	_	3	vmod	_	_
8	with	_	IN	IN	_	7	prep	_	_
9	ZpCat	_	NN	NN	_	12	nn	_	_
10	reporter	_	NN	NN	_	12	nn	_	_
11	gene	_	NN	NN	_	12	nn	_	_
12	constructs	_	NNS	NNS	_	8	pobj	_	_
13	,	_	,	,	_	1	punct	_	_
14	we	_	PRP	PRP	_	15	nsubj	_	_
15	demonstrate	_	VBP	VBP	_	1	parataxis	_	_
16	that	_	IN	IN	_	27	mark	_	_
17	a	_	DT	DT	_	18	det	_	_
18	region	_	NN	NN	_	27	nsubj	_	_
19	designated	_	VBN	VBN	_	18	vmod	_	_
20	the	_	DT	DT	_	22	det	_	_
21	ZII	_	NN	NN	_	22	nn	_	_
22	domain	_	NN	NN	_	19	dep	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	Zp	_	NN	NN	_	23	pobj	_	_
25	is	_	VBZ	VBZ	_	27	cop	_	_
26	the	_	DT	DT	_	27	det	_	_
27	target	_	NN	NN	_	15	ccomp	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	HHV-6	_	NN	NN	_	30	nn	_	_
30	transactivation	_	NN	NN	_	28	pobj	_	_
31	.	_	.	.	_	1	punct	_	_

1	Mutation	_	NN	NN	_	9	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	6	det	_	_
4	consensus	_	NN	NN	_	6	nn	_	_
5	AP-1/CRE	_	NN	NN	_	6	nn	_	_
6	site	_	NN	NN	_	2	pobj	_	_
7	within	_	IN	IN	_	6	prep	_	_
8	ZII	_	NN	NN	_	7	pobj	_	_
9	abolished	_	VBD	VBD	_	0	root	_	_
10	the	_	DT	DT	_	11	det	_	_
11	inducibility	_	NN	NN	_	9	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	Zp	_	NN	NN	_	12	pobj	_	_
14	by	_	IN	IN	_	11	prep	_	_
15	HHV-6	_	NN	NN	_	14	pobj	_	_
16	,	_	,	,	_	9	punct	_	_
17	whereas	_	IN	IN	_	29	mark	_	_
18	positioning	_	NN	NN	_	29	nsubj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	21	det	_	_
21	ZII	_	NN	NN	_	19	pobj	_	_
22	domain	_	JJ	JJ	_	21	amod	_	_
23	upstream	_	JJ	JJ	_	18	advmod	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	28	det	_	_
26	beta-globin	_	NN	NN	_	28	nn	_	_
27	minimal	_	JJ	JJ	_	28	amod	_	_
28	promoter	_	NN	NN	_	24	pobj	_	_
29	conferred	_	VBD	VBD	_	9	advcl	_	_
30	responsiveness	_	NN	NN	_	29	dobj	_	_
31	following	_	VBG	VBG	_	30	prep	_	_
32	HHV-6	_	NN	NN	_	33	nn	_	_
33	infection	_	NN	NN	_	31	pobj	_	_
34	.	_	.	.	_	9	punct	_	_

1	Binding	_	NN	NN	_	8	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	these	_	DT	DT	_	4	det	_	_
4	factors	_	NNS	NNS	_	2	pobj	_	_
5	to	_	TO	TO	_	1	prep	_	_
6	ZII	_	NN	NN	_	5	pobj	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	prevented	_	VBN	VBN	_	0	root	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	oligonucleotides	_	NNS	NNS	_	9	pobj	_	_
11	containing	_	VBG	VBG	_	10	vmod	_	_
12	CRE	_	NN	NN	_	11	dobj	_	_
13	but	_	CC	CC	_	9	cc	_	_
14	not	_	RB	RB	_	15	neg	_	_
15	by	_	IN	IN	_	9	conj	_	_
16	AP-1	_	NN	NN	_	18	nn	_	_
17	consensus	_	NN	NN	_	18	nn	_	_
18	sequences	_	NNS	NNS	_	15	pobj	_	_
19	.	_	.	.	_	8	punct	_	_

1	Antibodies	_	NNS	NNS	_	15	nsubj	_	_
2	against	_	IN	IN	_	1	prep	_	_
3	CRE-binding	_	JJ	JJ	_	7	amod	_	_
4	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
5	CREB	_	NN	NN	_	7	nn	_	_
6	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
7	protein	_	NN	NN	_	2	pobj	_	_
8	but	_	CC	CC	_	2	cc	_	_
9	not	_	RB	RB	_	10	neg	_	_
10	against	_	IN	IN	_	2	conj	_	_
11	c-Fos	_	NN	NN	_	10	pobj	_	_
12	or	_	CC	CC	_	11	cc	_	_
13	c-Jun	_	NN	NN	_	11	conj	_	_
14	were	_	VBD	VBD	_	15	cop	_	_
15	able	_	JJ	JJ	_	0	root	_	_
16	to	_	TO	TO	_	17	aux	_	_
17	supershift	_	VB	VB	_	15	xcomp	_	_
18	the	_	DT	DT	_	20	det	_	_
19	DNA-protein	_	JJ	JJ	_	20	amod	_	_
20	complex	_	NN	NN	_	17	dobj	_	_
21	,	_	,	,	_	15	punct	_	_
22	identifying	_	VBG	VBG	_	15	xcomp	_	_
23	the	_	DT	DT	_	24	det	_	_
24	nature	_	NN	NN	_	22	dobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	28	det	_	_
27	transcription	_	NN	NN	_	28	nn	_	_
28	factor	_	NN	NN	_	25	pobj	_	_
29	which	_	WDT	WDT	_	30	nsubj	_	_
30	binds	_	VBZ	VBZ	_	28	rcmod	_	_
31	to	_	TO	TO	_	30	prep	_	_
32	ZII	_	NN	NN	_	31	pobj	_	_
33	as	_	IN	IN	_	30	prep	_	_
34	a	_	DT	DT	_	35	det	_	_
35	member	_	NN	NN	_	33	pobj	_	_
36	of	_	IN	IN	_	35	prep	_	_
37	the	_	DT	DT	_	41	det	_	_
38	CREB	_	NN	NN	_	41	nn	_	_
39	family	_	NN	NN	_	41	nn	_	_
40	of	_	IN	IN	_	41	amod	_	_
41	proteins	_	NNS	NNS	_	36	pobj	_	_
42	.	_	.	.	_	15	punct	_	_

1	Finally	_	RB	RB	_	14	advmod	_	_
2	,	_	,	,	_	14	punct	_	_
3	transfection	_	NN	NN	_	14	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	CREB	_	NN	NN	_	6	nn	_	_
6	protein	_	NN	NN	_	4	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	protein	_	NN	NN	_	12	nn	_	_
9	kinase	_	NN	NN	_	12	nn	_	_
10	A	_	NN	NN	_	12	nn	_	_
11	expression	_	NN	NN	_	12	nn	_	_
12	vectors	_	NNS	NNS	_	6	conj	_	_
13	were	_	VBD	VBD	_	14	auxpass	_	_
14	found	_	VBN	VBN	_	0	root	_	_
15	to	_	TO	TO	_	16	aux	_	_
16	activate	_	VB	VB	_	14	xcomp	_	_
17	Zp	_	NN	NN	_	16	dobj	_	_
18	in	_	IN	IN	_	16	prep	_	_
19	Jurkat	_	NN	NN	_	20	nn	_	_
20	cells	_	NNS	NNS	_	18	pobj	_	_
21	,	_	,	,	_	14	punct	_	_
22	suggesting	_	VBG	VBG	_	14	vmod	_	_
23	that	_	IN	IN	_	30	mark	_	_
24	phosphorylated	_	JJ	JJ	_	25	amod	_	_
25	form	_	NN	NN	_	30	nsubj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	CREB	_	NN	NN	_	28	nn	_	_
28	protein	_	NN	NN	_	26	pobj	_	_
29	can	_	MD	MD	_	30	aux	_	_
30	play	_	VB	VB	_	22	ccomp	_	_
31	a	_	DT	DT	_	33	det	_	_
32	determining	_	JJ	JJ	_	33	amod	_	_
33	role	_	NN	NN	_	30	dobj	_	_
34	in	_	IN	IN	_	30	prep	_	_
35	the	_	DT	DT	_	38	det	_	_
36	EBV	_	NN	NN	_	38	nn	_	_
37	reactivation	_	NN	NN	_	38	nn	_	_
38	process	_	NN	NN	_	34	pobj	_	_
39	.	_	.	.	_	14	punct	_	_

1	Permanent	_	JJ	JJ	_	2	amod	_	_
2	occupancy	_	NN	NN	_	15	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	10	det	_	_
5	human	_	JJ	JJ	_	10	amod	_	_
6	immunodeficiency	_	NN	NN	_	10	nn	_	_
7	virus	_	NN	NN	_	10	nn	_	_
8	type	_	NN	NN	_	10	nn	_	_
9	1	_	CD	CD	_	10	num	_	_
10	enhancer	_	NN	NN	_	3	pobj	_	_
11	by	_	IN	IN	_	2	prep	_	_
12	NF-kappa	_	NN	NN	_	13	nn	_	_
13	B	_	NN	NN	_	11	pobj	_	_
14	is	_	VBZ	VBZ	_	15	auxpass	_	_
15	needed	_	VBN	VBN	_	0	root	_	_
16	for	_	IN	IN	_	15	prep	_	_
17	persistent	_	JJ	JJ	_	19	amod	_	_
18	viral	_	JJ	JJ	_	19	amod	_	_
19	replication	_	NN	NN	_	16	pobj	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	monocytes	_	NNS	NNS	_	20	pobj	_	_
22	.	_	.	.	_	15	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	work	_	NN	NN	_	3	nsubj	_	_
3	aimed	_	VBD	VBD	_	0	root	_	_
4	to	_	TO	TO	_	5	aux	_	_
5	ascertain	_	VB	VB	_	3	xcomp	_	_
6	the	_	DT	DT	_	7	det	_	_
7	role	_	NN	NN	_	5	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	kappaB-responsive	_	JJ	JJ	_	10	amod	_	_
10	elements	_	NNS	NNS	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	21	det	_	_
13	human	_	JJ	JJ	_	21	amod	_	_
14	immunodeficiency	_	NN	NN	_	21	nn	_	_
15	virus	_	NN	NN	_	21	nn	_	_
16	type	_	NN	NN	_	21	nn	_	_
17	1	_	CD	CD	_	21	num	_	_
18	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
19	HIV-1	_	NN	NN	_	21	nn	_	_
20	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
21	enhancer	_	NN	NN	_	11	pobj	_	_
22	not	_	RB	RB	_	23	neg	_	_
23	only	_	RB	RB	_	24	preconj	_	_
24	in	_	IN	IN	_	7	prep	_	_
25	early	_	JJ	JJ	_	26	amod	_	_
26	initiation	_	NN	NN	_	24	pobj	_	_
27	but	_	CC	CC	_	28	cc	_	_
28	also	_	RB	RB	_	24	cc	_	_
29	in	_	IN	IN	_	24	conj	_	_
30	long-term	_	JJ	JJ	_	31	amod	_	_
31	maintenance	_	NN	NN	_	29	pobj	_	_
32	of	_	IN	IN	_	24	dep	_	_
33	proviral	_	JJ	JJ	_	34	amod	_	_
34	transcription	_	NN	NN	_	32	pobj	_	_
35	in	_	IN	IN	_	34	prep	_	_
36	cells	_	NNS	NNS	_	35	pobj	_	_
37	of	_	IN	IN	_	36	prep	_	_
38	the	_	DT	DT	_	40	det	_	_
39	monocytic	_	JJ	JJ	_	40	amod	_	_
40	lineage	_	NN	NN	_	37	pobj	_	_
41	.	_	.	.	_	3	punct	_	_

1	For	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	purpose	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	used	_	VBD	VBD	_	0	root	_	_
7	three	_	CD	CD	_	9	num	_	_
8	main	_	JJ	JJ	_	9	amod	_	_
9	approaches	_	NNS	NNS	_	6	dobj	_	_
10	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	first	_	JJ	JJ	_	3	nsubj	_	_
3	was	_	VBD	VBD	_	0	root	_	_
4	to	_	TO	TO	_	3	prep	_	_
5	abruptly	_	RB	RB	_	4	pcomp	_	_
6	terminate	_	VB	VB	_	4	dep	_	_
7	tumor	_	NN	NN	_	8	nn	_	_
8	necrosis	_	NN	NN	_	6	dobj	_	_
9	factor-induced	_	JJ	JJ	_	8	amod	_	_
10	NF-kappaB	_	NN	NN	_	8	dep	_	_
11	binding	_	VBG	VBG	_	8	vmod	_	_
12	to	_	TO	TO	_	11	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	enhancer	_	NN	NN	_	15	nn	_	_
15	sequences	_	NNS	NNS	_	12	pobj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	U1	_	NN	NN	_	19	nn	_	_
18	monocytic	_	JJ	JJ	_	19	amod	_	_
19	cells	_	NNS	NNS	_	16	pobj	_	_
20	,	_	,	,	_	4	punct	_	_
21	using	_	VBG	VBG	_	4	dep	_	_
22	a	_	DT	DT	_	24	det	_	_
23	short	_	JJ	JJ	_	24	amod	_	_
24	pulse	_	NN	NN	_	21	dobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	exogenous	_	JJ	JJ	_	29	amod	_	_
27	tumor	_	NN	NN	_	29	nn	_	_
28	necrosis	_	NN	NN	_	29	nn	_	_
29	factor	_	NN	NN	_	25	pobj	_	_
30	.	_	.	.	_	3	punct	_	_

1	This	_	DT	DT	_	2	nsubj	_	_
2	resulted	_	VBD	VBD	_	0	root	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	concomitant	_	JJ	JJ	_	5	amod	_	_
5	decrease	_	NN	NN	_	3	pobj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	nuclear	_	JJ	JJ	_	10	amod	_	_
8	NF-kappaB	_	NN	NN	_	10	nn	_	_
9	DNA-binding	_	JJ	JJ	_	10	amod	_	_
10	activity	_	NN	NN	_	6	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	endogenous	_	JJ	JJ	_	15	amod	_	_
13	long	_	JJ	JJ	_	15	amod	_	_
14	terminal	_	JJ	JJ	_	15	amod	_	_
15	repeat	_	NN	NN	_	17	nn	_	_
16	transcriptional	_	JJ	JJ	_	17	amod	_	_
17	activity	_	NN	NN	_	10	conj	_	_
18	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	second	_	JJ	JJ	_	3	nsubj	_	_
3	was	_	VBD	VBD	_	0	root	_	_
4	to	_	TO	TO	_	5	aux	_	_
5	suppress	_	VB	VB	_	3	xcomp	_	_
6	the	_	DT	DT	_	9	det	_	_
7	permanent	_	JJ	JJ	_	9	amod	_	_
8	NF-kappaB	_	NN	NN	_	9	nn	_	_
9	translocation	_	NN	NN	_	5	dobj	_	_
10	induced	_	VBN	VBN	_	9	vmod	_	_
11	by	_	IN	IN	_	10	prep	_	_
12	HIV-1	_	NN	NN	_	13	nn	_	_
13	replication	_	NN	NN	_	11	pobj	_	_
14	itself	_	PRP	PRP	_	13	npadvmod	_	_
15	in	_	IN	IN	_	5	prep	_	_
16	chronically	_	RB	RB	_	19	advmod	_	_
17	infected	_	JJ	JJ	_	19	amod	_	_
18	U937	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	15	pobj	_	_
20	,	_	,	,	_	5	punct	_	_
21	using	_	VBG	VBG	_	5	vmod	_	_
22	a	_	DT	DT	_	25	det	_	_
23	specific	_	JJ	JJ	_	25	amod	_	_
24	proteasome	_	NN	NN	_	25	nn	_	_
25	inhibitor	_	NN	NN	_	21	dobj	_	_
26	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
27	Z-LLL-H	_	NN	NN	_	25	appos	_	_
28	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
29	.	_	.	.	_	3	punct	_	_

1	As	_	RB	RB	_	4	quantmod	_	_
2	early	_	RB	RB	_	4	quantmod	_	_
3	as	_	IN	IN	_	4	quantmod	_	_
4	2	_	CD	CD	_	5	num	_	_
5	h	_	NN	NN	_	6	npadvmod	_	_
6	after	_	IN	IN	_	17	prep	_	_
7	addition	_	NN	NN	_	6	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	inhibitor	_	NN	NN	_	8	pobj	_	_
11	to	_	TO	TO	_	7	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	culture	_	NN	NN	_	14	nn	_	_
14	medium	_	NN	NN	_	11	pobj	_	_
15	,	_	,	,	_	17	punct	_	_
16	there	_	EX	EX	_	17	expl	_	_
17	was	_	VBD	VBD	_	0	root	_	_
18	an	_	DT	DT	_	19	det	_	_
19	inhibition	_	NN	NN	_	17	nsubj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	both	_	CC	CC	_	23	preconj	_	_
22	constitutive	_	JJ	JJ	_	23	amod	_	_
23	activation	_	NN	NN	_	20	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	NF-kappaB	_	NN	NN	_	24	pobj	_	_
26	and	_	CC	CC	_	23	cc	_	_
27	HIV-1	_	NN	NN	_	29	nn	_	_
28	genome	_	NN	NN	_	29	nn	_	_
29	expression	_	NN	NN	_	23	conj	_	_
30	.	_	.	.	_	17	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	third	_	JJ	JJ	_	3	amod	_	_
3	approach	_	NN	NN	_	4	nsubj	_	_
4	was	_	VBD	VBD	_	0	root	_	_
5	to	_	TO	TO	_	6	aux	_	_
6	monitor	_	VB	VB	_	4	xcomp	_	_
7	the	_	DT	DT	_	9	det	_	_
8	replication	_	NN	NN	_	9	nn	_	_
9	competence	_	NN	NN	_	6	dobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	U937	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	an	_	DT	DT	_	17	det	_	_
15	infectious	_	JJ	JJ	_	17	amod	_	_
16	HIV-1	_	NN	NN	_	17	nn	_	_
17	provirus	_	NN	NN	_	13	pobj	_	_
18	carrying	_	VBG	VBG	_	17	vmod	_	_
19	point	_	NN	NN	_	20	nn	_	_
20	mutations	_	NNS	NNS	_	18	dobj	_	_
21	in	_	IN	IN	_	18	prep	_	_
22	the	_	DT	DT	_	24	det	_	_
23	kappaB-responsive	_	JJ	JJ	_	24	amod	_	_
24	elements	_	NNS	NNS	_	21	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	both	_	DT	DT	_	29	dep	_	_
27	long	_	JJ	JJ	_	29	amod	_	_
28	terminal	_	JJ	JJ	_	29	amod	_	_
29	repeats	_	NNS	NNS	_	25	pobj	_	_
30	.	_	.	.	_	4	punct	_	_

1	Compared	_	VBN	VBN	_	10	prep	_	_
2	with	_	IN	IN	_	1	pcomp	_	_
3	its	_	PRP$	PRP$	_	5	poss	_	_
4	wild-type	_	JJ	JJ	_	5	amod	_	_
5	counterpart	_	NN	NN	_	2	pobj	_	_
6	,	_	,	,	_	10	punct	_	_
7	this	_	DT	DT	_	9	det	_	_
8	mutated	_	VBN	VBN	_	9	amod	_	_
9	provirus	_	NN	NN	_	10	nsubj	_	_
10	showed	_	VBD	VBD	_	0	root	_	_
11	a	_	DT	DT	_	19	det	_	_
12	profoundly	_	RB	RB	_	13	advmod	_	_
13	decreased	_	VBN	VBN	_	19	amod	_	_
14	,	_	,	,	_	13	punct	_	_
15	Z-LLL-H-insensitive	_	JJ	JJ	_	13	dep	_	_
16	transcriptional	_	JJ	JJ	_	13	dep	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	replicative	_	JJ	JJ	_	16	conj	_	_
19	activity	_	NN	NN	_	10	dobj	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	U937	_	NN	NN	_	22	nn	_	_
22	monocytes	_	NNS	NNS	_	20	pobj	_	_
23	.	_	.	.	_	10	punct	_	_

1	Together	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	our	_	PRP$	PRP$	_	4	poss	_	_
4	results	_	NNS	NNS	_	5	nsubj	_	_
5	indicate	_	VBP	VBP	_	0	root	_	_
6	that	_	IN	IN	_	19	mark	_	_
7	occupancy	_	NN	NN	_	19	nsubjpass	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	viral	_	JJ	JJ	_	11	amod	_	_
11	enhancer	_	NN	NN	_	8	pobj	_	_
12	by	_	IN	IN	_	7	prep	_	_
13	NF-kappaB	_	NN	NN	_	17	nn	_	_
14	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
15	p50/p65	_	NN	NN	_	17	nn	_	_
16	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
17	heterodimers	_	NNS	NNS	_	12	pobj	_	_
18	is	_	VBZ	VBZ	_	19	auxpass	_	_
19	required	_	VBN	VBN	_	5	ccomp	_	_
20	for	_	IN	IN	_	19	prep	_	_
21	ongoing	_	JJ	JJ	_	22	amod	_	_
22	transcription	_	NN	NN	_	20	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	integrated	_	VBN	VBN	_	26	amod	_	_
25	HIV	_	NN	NN	_	26	nn	_	_
26	provirus	_	NN	NN	_	23	pobj	_	_
27	in	_	IN	IN	_	22	prep	_	_
28	monocytes	_	NNS	NNS	_	27	pobj	_	_
29	,	_	,	,	_	27	punct	_	_
30	even	_	RB	RB	_	31	advmod	_	_
31	in	_	IN	IN	_	27	prep	_	_
32	cells	_	NNS	NNS	_	31	pobj	_	_
33	chronically	_	RB	RB	_	34	advmod	_	_
34	infected	_	VBN	VBN	_	32	dep	_	_
35	and	_	CC	CC	_	34	cc	_	_
36	permanently	_	RB	RB	_	37	advmod	_	_
37	producing	_	VBG	VBG	_	34	conj	_	_
38	functional	_	JJ	JJ	_	41	amod	_	_
39	HIV	_	NN	NN	_	41	nn	_	_
40	Tat	_	NN	NN	_	41	nn	_	_
41	protein	_	NN	NN	_	37	dobj	_	_
42	.	_	.	.	_	5	punct	_	_

1	Thus	_	RB	RB	_	12	advmod	_	_
2	,	_	,	,	_	12	punct	_	_
3	the	_	DT	DT	_	4	det	_	_
4	ability	_	NN	NN	_	12	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	HIV-1	_	NN	NN	_	7	nn	_	_
7	replication	_	NN	NN	_	5	pobj	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	activate	_	VB	VB	_	4	vmod	_	_
10	NF-kappaB	_	NN	NN	_	9	dobj	_	_
11	is	_	VBZ	VBZ	_	12	cop	_	_
12	crucial	_	JJ	JJ	_	0	root	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	the	_	DT	DT	_	18	det	_	_
15	intense	_	JJ	JJ	_	18	amod	_	_
16	self-perpetuated	_	JJ	JJ	_	15	dep	_	_
17	viral	_	JJ	JJ	_	15	dep	_	_
18	transcription	_	NN	NN	_	13	pobj	_	_
19	observed	_	VBN	VBN	_	18	vmod	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	cells	_	NNS	NNS	_	20	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	25	det	_	_
24	monocytic	_	JJ	JJ	_	25	amod	_	_
25	lineage	_	NN	NN	_	22	pobj	_	_
26	.	_	.	.	_	12	punct	_	_

1	Efficient	_	JJ	JJ	_	2	amod	_	_
2	transcription	_	NN	NN	_	0	root	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	replication	_	NN	NN	_	2	conj	_	_
5	of	_	IN	IN	_	2	prep	_	_
6	simian	_	JJ	JJ	_	8	amod	_	_
7	immunodeficiency	_	NN	NN	_	8	nn	_	_
8	virus	_	NN	NN	_	5	pobj	_	_
9	in	_	IN	IN	_	2	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	absence	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	NF-kappaB	_	NN	NN	_	12	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	Sp1	_	NN	NN	_	13	conj	_	_
16	binding	_	NN	NN	_	17	nn	_	_
17	elements	_	NNS	NNS	_	13	dep	_	_
18	.	_	.	.	_	2	punct	_	_

1	Ten	_	CD	CD	_	2	num	_	_
2	mutants	_	NNS	NNS	_	30	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	7	det	_	_
5	simian	_	JJ	JJ	_	7	amod	_	_
6	immunodeficiency	_	NN	NN	_	7	nn	_	_
7	virus	_	NN	NN	_	3	pobj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	SIV	_	NN	NN	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	SIVmac239	_	NN	NN	_	7	dep	_	_
12	bearing	_	VBG	VBG	_	2	vmod	_	_
13	deletions	_	NNS	NNS	_	12	dobj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	delta	_	JJ	JJ	_	13	dep	_	_
16	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
17	or	_	CC	CC	_	13	cc	_	_
18	substitutions	_	NNS	NNS	_	13	conj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	subst	_	JJ	JJ	_	18	dep	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	in	_	IN	IN	_	12	prep	_	_
23	the	_	DT	DT	_	24	det	_	_
24	NF-kappaB	_	NN	NN	_	22	pobj	_	_
25	and/or	_	CC	CC	_	24	cc	_	_
26	Sp1	_	NN	NN	_	28	nn	_	_
27	binding	_	NN	NN	_	28	nn	_	_
28	elements	_	NNS	NNS	_	24	conj	_	_
29	were	_	VBD	VBD	_	30	auxpass	_	_
30	created	_	VBN	VBN	_	0	root	_	_
31	,	_	,	,	_	30	punct	_	_
32	and	_	CC	CC	_	30	cc	_	_
33	the	_	DT	DT	_	35	det	_	_
34	replicative	_	JJ	JJ	_	35	amod	_	_
35	capacities	_	NNS	NNS	_	40	nsubjpass	_	_
36	of	_	IN	IN	_	35	prep	_	_
37	the	_	DT	DT	_	38	det	_	_
38	mutants	_	NNS	NNS	_	36	pobj	_	_
39	were	_	VBD	VBD	_	40	auxpass	_	_
40	analyzed	_	VBN	VBN	_	30	conj	_	_
41	.	_	.	.	_	30	punct	_	_

1	All	_	DT	DT	_	2	det	_	_
2	mutants	_	NNS	NNS	_	19	nsubj	_	_
3	,	_	,	,	_	2	punct	_	_
4	including	_	VBG	VBG	_	2	prep	_	_
5	one	_	CD	CD	_	8	num	_	_
6	extensively	_	RB	RB	_	7	advmod	_	_
7	mutagenized	_	VBN	VBN	_	8	amod	_	_
8	strain	_	NN	NN	_	4	pobj	_	_
9	entirely	_	RB	RB	_	10	advmod	_	_
10	missing	_	VBG	VBG	_	8	vmod	_	_
11	the	_	DT	DT	_	12	det	_	_
12	NF-kappaB	_	NN	NN	_	10	dobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	four	_	CD	CD	_	15	num	_	_
15	Spl	_	NN	NN	_	12	conj	_	_
16	binding	_	NN	NN	_	17	nn	_	_
17	elements	_	NNS	NNS	_	12	dep	_	_
18	,	_	,	,	_	2	punct	_	_
19	replicated	_	VBN	VBN	_	0	root	_	_
20	with	_	IN	IN	_	19	prep	_	_
21	wild-type	_	JJ	JJ	_	22	amod	_	_
22	kinetics	_	NNS	NNS	_	20	pobj	_	_
23	and	_	CC	CC	_	19	cc	_	_
24	to	_	TO	TO	_	19	conj	_	_
25	a	_	DT	DT	_	27	det	_	_
26	wild-type	_	JJ	JJ	_	27	amod	_	_
27	level	_	NN	NN	_	24	pobj	_	_
28	in	_	IN	IN	_	27	prep	_	_
29	peripheral	_	JJ	JJ	_	33	amod	_	_
30	blood	_	NN	NN	_	33	nn	_	_
31	mononuclear	_	JJ	JJ	_	33	amod	_	_
32	cell	_	NN	NN	_	33	nn	_	_
33	cultures	_	NNS	NNS	_	28	pobj	_	_
34	in	_	IN	IN	_	19	prep	_	_
35	50	_	CD	CD	_	37	number	_	_
36	to	_	TO	TO	_	37	dep	_	_
37	100	_	CD	CD	_	38	num	_	_
38	%	_	NN	NN	_	34	pobj	_	_
39	of	_	IN	IN	_	38	prep	_	_
40	the	_	DT	DT	_	41	det	_	_
41	experiments	_	NNS	NNS	_	39	pobj	_	_
42	.	_	.	.	_	19	punct	_	_

1	One	_	CD	CD	_	2	num	_	_
2	group	_	NN	NN	_	5	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	mutants	_	NNS	NNS	_	3	pobj	_	_
5	replicated	_	VBN	VBN	_	0	root	_	_
6	very	_	RB	RB	_	7	advmod	_	_
7	similarly	_	RB	RB	_	5	advmod	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	SIVmac239	_	NN	NN	_	8	pobj	_	_
10	in	_	IN	IN	_	7	prep	_	_
11	kinetics	_	NN	NN	_	10	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	yield	_	NN	NN	_	11	conj	_	_
14	in	_	IN	IN	_	11	prep	_	_
15	CEMxl74	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	14	pobj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	2	_	CD	CD	_	7	dep	_	_
19	x	_	CC	CC	_	18	cc	_	_
20	NFKappaB	_	NN	NN	_	18	conj	_	_
21	&gt;	_	JJ	JJ	_	18	amod	_	_
22	or	_	CC	CC	_	21	cc	_	_
23	=	_	JJ	JJ	_	21	conj	_	_
24	SlVmac239	_	NN	NN	_	21	dep	_	_
25	approximately	_	RB	RB	_	24	advmod	_	_
26	deltaNFkappaB	_	NN	NN	_	24	dep	_	_
27	approximately	_	RB	RB	_	24	advmod	_	_
28	deltaSpl234	_	NN	NN	_	24	dep	_	_
29	approximately	_	RB	RB	_	24	advmod	_	_
30	substNFkappaB	_	NN	NN	_	24	dep	_	_
31	approximately	_	RB	RB	_	24	advmod	_	_
32	substSpl2	_	NN	NN	_	24	dep	_	_
33	approximately	_	RB	RB	_	24	advmod	_	_
34	substSp23	_	NN	NN	_	24	dep	_	_
35	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
36	,	_	,	,	_	5	punct	_	_
37	while	_	IN	IN	_	41	mark	_	_
38	a	_	DT	DT	_	40	det	_	_
39	second	_	JJ	JJ	_	40	amod	_	_
40	group	_	NN	NN	_	41	nsubj	_	_
41	replicated	_	VBD	VBD	_	5	advcl	_	_
42	with	_	IN	IN	_	41	prep	_	_
43	delayed	_	VBN	VBN	_	42	pobj	_	_
44	or	_	CC	CC	_	43	cc	_	_
45	slightly	_	RB	RB	_	46	advmod	_	_
46	delayed	_	VBN	VBN	_	43	conj	_	_
47	kinetics	_	NN	NN	_	43	dep	_	_
48	in	_	IN	IN	_	42	prep	_	_
49	CEMxl74	_	NN	NN	_	50	nn	_	_
50	cells	_	NNS	NNS	_	48	pobj	_	_
51	-LRB-	_	-LRB-	-LRB-	_	52	punct	_	_
52	SIVmac239	_	NN	NN	_	42	dep	_	_
53	&gt;	_	JJ	JJ	_	52	amod	_	_
54	substSp34	_	NN	NN	_	53	dep	_	_
55	&gt;	_	JJ	JJ	_	54	amod	_	_
56	deltaNFkappaBdeltaSpl234	_	NN	NN	_	55	dep	_	_
57	approximately	_	RB	RB	_	56	advmod	_	_
58	deltaNFkappaBdeltaSp1	_	NN	NN	_	56	dep	_	_
59	&gt;	_	JJ	JJ	_	56	amod	_	_
60	substSpl234	_	NN	NN	_	59	dep	_	_
61	-RRB-	_	-RRB-	-RRB-	_	52	punct	_	_
62	.	_	.	.	_	5	punct	_	_

1	Reversions	_	NNS	NNS	_	7	nsubjpass	_	_
2	or	_	CC	CC	_	1	cc	_	_
3	additional	_	JJ	JJ	_	4	amod	_	_
4	mutations	_	NNS	NNS	_	1	conj	_	_
5	were	_	VBD	VBD	_	7	auxpass	_	_
6	not	_	RB	RB	_	7	neg	_	_
7	detected	_	VBN	VBN	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	10	dep	_	_
10	U3	_	NN	NN	_	8	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	R	_	NN	NN	_	10	conj	_	_
13	regions	_	NNS	NNS	_	10	dep	_	_
14	of	_	IN	IN	_	10	prep	_	_
15	proviral	_	JJ	JJ	_	16	amod	_	_
16	DNA	_	NN	NN	_	14	pobj	_	_
17	from	_	IN	IN	_	16	prep	_	_
18	CEMxl74	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	17	pobj	_	_
20	infected	_	VBN	VBN	_	19	vmod	_	_
21	with	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	24	det	_	_
23	SIVmac239	_	NN	NN	_	24	nn	_	_
24	mutants	_	NNS	NNS	_	21	pobj	_	_
25	.	_	.	.	_	7	punct	_	_

1	Similar	_	JJ	JJ	_	2	amod	_	_
2	results	_	NNS	NNS	_	4	nsubjpass	_	_
3	were	_	VBD	VBD	_	4	auxpass	_	_
4	obtained	_	VBN	VBN	_	0	root	_	_
5	when	_	WRB	WRB	_	17	advmod	_	_
6	mutants	_	NNS	NNS	_	17	nsubjpass	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	SIVmacMER	_	NN	NN	_	7	pobj	_	_
9	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
10	a	_	DT	DT	_	12	det	_	_
11	macrophage-competent	_	JJ	JJ	_	12	amod	_	_
12	derivative	_	NN	NN	_	6	dep	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	SIVmac239	_	NN	NN	_	13	pobj	_	_
15	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
16	were	_	VBD	VBD	_	17	auxpass	_	_
17	tested	_	VBN	VBN	_	4	advcl	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	peripheral	_	JJ	JJ	_	22	amod	_	_
20	blood	_	NN	NN	_	22	nn	_	_
21	mononuclear	_	JJ	JJ	_	22	amod	_	_
22	cell	_	NN	NN	_	18	pobj	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	CEMx174	_	NN	NN	_	25	nn	_	_
25	cultures	_	NNS	NNS	_	22	conj	_	_
26	.	_	.	.	_	4	punct	_	_

1	However	_	RB	RB	_	10	advmod	_	_
2	,	_	,	,	_	10	punct	_	_
3	the	_	DT	DT	_	4	det	_	_
4	growth	_	NN	NN	_	10	nsubjpass	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	most	_	JJ	JJ	_	8	amod	_	_
7	mutated	_	VBN	VBN	_	8	amod	_	_
8	viruses	_	NNS	NNS	_	5	pobj	_	_
9	was	_	VBD	VBD	_	10	auxpass	_	_
10	suppressed	_	VBN	VBN	_	0	root	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	primary	_	JJ	JJ	_	16	amod	_	_
13	rhesus	_	NN	NN	_	16	nn	_	_
14	monkey	_	NN	NN	_	16	nn	_	_
15	alveolar	_	JJ	JJ	_	16	amod	_	_
16	macrophages	_	NNS	NNS	_	11	pobj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	SIVmacMER	_	NN	NN	_	10	dep	_	_
19	approximately	_	RB	RB	_	18	advmod	_	_
20	2xNFkappaB	_	NN	NN	_	18	dep	_	_
21	approximately	_	RB	RB	_	18	advmod	_	_
22	substNFkappaB	_	NN	NN	_	18	dep	_	_
23	&gt;	_	JJ	JJ	_	18	amod	_	_
24	deltaNFkappaB	_	NN	NN	_	23	dep	_	_
25	&gt;	_	JJ	JJ	_	24	amod	_	_
26	deltaNFkappaBdeltaSpl234	_	NN	NN	_	25	dep	_	_
27	approximately	_	RB	RB	_	26	advmod	_	_
28	deltaNFkappaBdeltaSpl	_	NN	NN	_	26	dep	_	_
29	&gt;	_	JJ	JJ	_	25	dep	_	_
30	deltaSpl234	_	NN	NN	_	29	dep	_	_
31	approximately	_	RB	RB	_	30	advmod	_	_
32	substSpl2	_	NN	NN	_	30	dep	_	_
33	&gt;	_	JJ	JJ	_	29	dep	_	_
34	substSp23	_	NN	NN	_	33	dep	_	_
35	approximately	_	RB	RB	_	34	advmod	_	_
36	substSp34	_	NN	NN	_	34	dep	_	_
37	approximately	_	RB	RB	_	34	advmod	_	_
38	substSpl234	_	NN	NN	_	34	dep	_	_
39	&gt;	_	JJ	JJ	_	33	dep	_	_
40	or	_	CC	CC	_	39	cc	_	_
41	=	_	JJ	JJ	_	39	conj	_	_
42	SIVmac239	_	NN	NN	_	39	dep	_	_
43	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
44	.	_	.	.	_	10	punct	_	_

1	Thus	_	RB	RB	_	9	advmod	_	_
2	,	_	,	,	_	9	punct	_	_
3	changes	_	NNS	NNS	_	9	nsubj	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	8	det	_	_
6	Sp1	_	NN	NN	_	8	nn	_	_
7	binding	_	NN	NN	_	8	nn	_	_
8	sites	_	NNS	NNS	_	4	pobj	_	_
9	had	_	VBD	VBD	_	0	root	_	_
10	the	_	DT	DT	_	13	det	_	_
11	most	_	RBS	RBS	_	12	advmod	_	_
12	dramatic	_	JJ	JJ	_	13	amod	_	_
13	effects	_	NNS	NNS	_	9	dobj	_	_
14	on	_	IN	IN	_	9	prep	_	_
15	SIVmac	_	NN	NN	_	16	nn	_	_
16	replication	_	NN	NN	_	14	pobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	primary	_	JJ	JJ	_	20	amod	_	_
19	macrophage	_	NN	NN	_	20	nn	_	_
20	cultures	_	NNS	NNS	_	17	pobj	_	_
21	.	_	.	.	_	9	punct	_	_

1	Analysis	_	NN	NN	_	13	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	long	_	JJ	JJ	_	6	amod	_	_
4	terminal	_	JJ	JJ	_	6	amod	_	_
5	repeat-driven	_	JJ	JJ	_	6	amod	_	_
6	secreted	_	VBN	VBN	_	9	amod	_	_
7	alkaline	_	NN	NN	_	8	nn	_	_
8	phosphatase	_	NN	NN	_	9	nn	_	_
9	activity	_	NN	NN	_	2	pobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	transient	_	JJ	JJ	_	12	amod	_	_
12	assays	_	NNS	NNS	_	10	pobj	_	_
13	showed	_	VBD	VBD	_	0	root	_	_
14	that	_	IN	IN	_	28	mark	_	_
15	,	_	,	,	_	28	punct	_	_
16	unlike	_	IN	IN	_	28	prep	_	_
17	human	_	JJ	JJ	_	20	amod	_	_
18	immunodeficiency	_	NN	NN	_	20	nn	_	_
19	virus	_	NN	NN	_	20	nn	_	_
20	type	_	NN	NN	_	16	pobj	_	_
21	1	_	CD	CD	_	20	num	_	_
22	,	_	,	,	_	28	punct	_	_
23	the	_	DT	DT	_	27	det	_	_
24	SIV	_	NN	NN	_	27	nn	_	_
25	long	_	JJ	JJ	_	27	amod	_	_
26	terminal	_	JJ	JJ	_	27	amod	_	_
27	repeat	_	NN	NN	_	28	nsubj	_	_
28	possesses	_	VBZ	VBZ	_	13	ccomp	_	_
29	an	_	DT	DT	_	31	det	_	_
30	enhancer	_	NN	NN	_	31	nn	_	_
31	region	_	NN	NN	_	28	dobj	_	_
32	just	_	RB	RB	_	33	advmod	_	_
33	upstream	_	RB	RB	_	31	advmod	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	the	_	DT	DT	_	37	det	_	_
36	NF-kappaB	_	NN	NN	_	37	nn	_	_
37	element	_	NN	NN	_	34	pobj	_	_
38	which	_	WDT	WDT	_	39	nsubj	_	_
39	maintains	_	VBZ	VBZ	_	37	rcmod	_	_
40	significant	_	JJ	JJ	_	41	amod	_	_
41	levels	_	NNS	NNS	_	39	dobj	_	_
42	of	_	IN	IN	_	41	prep	_	_
43	basal	_	JJ	JJ	_	44	amod	_	_
44	transcription	_	NN	NN	_	42	pobj	_	_
45	in	_	IN	IN	_	39	prep	_	_
46	the	_	DT	DT	_	47	det	_	_
47	absence	_	NN	NN	_	45	pobj	_	_
48	of	_	IN	IN	_	47	prep	_	_
49	NF-kappaB	_	NN	NN	_	48	pobj	_	_
50	and	_	CC	CC	_	49	cc	_	_
51	Sp1	_	NN	NN	_	49	conj	_	_
52	sites	_	NNS	NNS	_	49	dep	_	_
53	.	_	.	.	_	13	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	region	_	NN	NN	_	4	nsubj	_	_
3	is	_	VBZ	VBZ	_	4	cop	_	_
4	responsive	_	JJ	JJ	_	0	root	_	_
5	to	_	TO	TO	_	4	prep	_	_
6	transactivation	_	NN	NN	_	5	pobj	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	Tat	_	NN	NN	_	7	pobj	_	_
9	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	9	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	9	punct	_	_
4	the	_	DT	DT	_	7	det	_	_
5	SIV	_	NN	NN	_	7	nn	_	_
6	TATA	_	NN	NN	_	7	nn	_	_
7	box	_	NN	NN	_	9	nsubjpass	_	_
8	was	_	VBD	VBD	_	9	auxpass	_	_
9	shown	_	VBN	VBN	_	0	root	_	_
10	to	_	TO	TO	_	12	aux	_	_
11	be	_	VB	VB	_	12	cop	_	_
12	stronger	_	JJR	JJR	_	9	xcomp	_	_
13	than	_	IN	IN	_	12	prep	_	_
14	that	_	DT	DT	_	13	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	human	_	JJ	JJ	_	19	amod	_	_
17	immunodeficiency	_	NN	NN	_	19	nn	_	_
18	virus	_	NN	NN	_	19	nn	_	_
19	type	_	NN	NN	_	15	pobj	_	_
20	1	_	CD	CD	_	19	num	_	_
21	.	_	.	.	_	9	punct	_	_

1	Therefore	_	RB	RB	_	18	advmod	_	_
2	,	_	,	,	_	18	punct	_	_
3	the	_	DT	DT	_	7	det	_	_
4	surprisingly	_	RB	RB	_	6	advmod	_	_
5	high	_	JJ	JJ	_	6	amod	_	_
6	replicative	_	JJ	JJ	_	7	amod	_	_
7	capacity	_	NN	NN	_	18	nsubj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	NF-kappaB	_	NN	NN	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	Sp1	_	NN	NN	_	9	conj	_	_
12	binding	_	NN	NN	_	14	nn	_	_
13	site	_	NN	NN	_	14	nn	_	_
14	mutants	_	NNS	NNS	_	9	dep	_	_
15	of	_	IN	IN	_	9	prep	_	_
16	SIVmac	_	NN	NN	_	15	pobj	_	_
17	is	_	VBZ	VBZ	_	18	cop	_	_
18	due	_	JJ	JJ	_	0	root	_	_
19	to	_	TO	TO	_	18	prep	_	_
20	unique	_	JJ	JJ	_	21	amod	_	_
21	features	_	NNS	NNS	_	19	pobj	_	_
22	or	_	CC	CC	_	21	cc	_	_
23	the	_	DT	DT	_	25	det	_	_
24	enhancer/promoter	_	NN	NN	_	25	nn	_	_
25	region	_	NN	NN	_	21	conj	_	_
26	.	_	.	.	_	18	punct	_	_

1	Inactivation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	IkappaBbeta	_	NN	NN	_	2	pobj	_	_
4	by	_	IN	IN	_	1	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	tax	_	NN	NN	_	7	nn	_	_
7	protein	_	NN	NN	_	4	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	human	_	JJ	JJ	_	13	amod	_	_
10	T-cell	_	NN	NN	_	13	nn	_	_
11	leukemia	_	NN	NN	_	13	nn	_	_
12	virus	_	NN	NN	_	13	nn	_	_
13	type	_	NN	NN	_	8	pobj	_	_
14	1	_	CD	CD	_	13	num	_	_
15	:	_	:	:	_	1	punct	_	_
16	a	_	DT	DT	_	18	det	_	_
17	potential	_	JJ	JJ	_	18	amod	_	_
18	mechanism	_	NN	NN	_	1	dep	_	_
19	for	_	IN	IN	_	18	prep	_	_
20	constitutive	_	JJ	JJ	_	21	amod	_	_
21	induction	_	NN	NN	_	19	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	NF-kappaB	_	NN	NN	_	22	pobj	_	_
24	.	_	.	.	_	1	punct	_	_

1	In	_	IN	IN	_	11	prep	_	_
2	resting	_	VBG	VBG	_	4	amod	_	_
3	T	_	NN	NN	_	4	nn	_	_
4	lymphocytes	_	NNS	NNS	_	1	pobj	_	_
5	,	_	,	,	_	11	punct	_	_
6	the	_	DT	DT	_	8	det	_	_
7	transcription	_	NN	NN	_	8	nn	_	_
8	factor	_	NN	NN	_	11	nsubjpass	_	_
9	NF-kappaB	_	NN	NN	_	8	dep	_	_
10	is	_	VBZ	VBZ	_	11	auxpass	_	_
11	sequestered	_	VBN	VBN	_	0	root	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	cytoplasm	_	NN	NN	_	12	pobj	_	_
15	via	_	IN	IN	_	11	prep	_	_
16	interactions	_	NNS	NNS	_	15	pobj	_	_
17	with	_	IN	IN	_	16	prep	_	_
18	members	_	NNS	NNS	_	17	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	24	det	_	_
21	I	_	NN	NN	_	24	nn	_	_
22	kappa	_	NN	NN	_	24	nn	_	_
23	B	_	NN	NN	_	24	nn	_	_
24	family	_	NN	NN	_	19	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	inhibitors	_	NNS	NNS	_	25	pobj	_	_
27	,	_	,	,	_	18	punct	_	_
28	including	_	VBG	VBG	_	18	prep	_	_
29	IkappaBalpha	_	NN	NN	_	28	pobj	_	_
30	and	_	CC	CC	_	29	cc	_	_
31	IkappaBbeta	_	NN	NN	_	29	conj	_	_
32	.	_	.	.	_	11	punct	_	_

1	During	_	IN	IN	_	9	prep	_	_
2	normal	_	JJ	JJ	_	4	amod	_	_
3	T-cell	_	NN	NN	_	4	nn	_	_
4	activation	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	9	punct	_	_
6	IkappaBalpha	_	NN	NN	_	9	nsubjpass	_	_
7	is	_	VBZ	VBZ	_	9	auxpass	_	_
8	rapidly	_	RB	RB	_	9	advmod	_	_
9	phosphorylated	_	VBN	VBN	_	0	root	_	_
10	,	_	,	,	_	9	punct	_	_
11	ubiquitinated	_	VBN	VBN	_	9	conj	_	_
12	,	_	,	,	_	9	punct	_	_
13	and	_	CC	CC	_	9	cc	_	_
14	degraded	_	VBN	VBN	_	9	conj	_	_
15	by	_	IN	IN	_	9	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	26S	_	NN	NN	_	18	nn	_	_
18	proteasome	_	NN	NN	_	15	pobj	_	_
19	,	_	,	,	_	9	punct	_	_
20	thus	_	RB	RB	_	21	advmod	_	_
21	permitting	_	VBG	VBG	_	9	vmod	_	_
22	the	_	DT	DT	_	23	det	_	_
23	release	_	NN	NN	_	21	dobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	functional	_	JJ	JJ	_	26	amod	_	_
26	NF-kappaB	_	NN	NN	_	24	pobj	_	_
27	.	_	.	.	_	9	punct	_	_

1	In	_	IN	IN	_	18	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	to	_	TO	TO	_	2	prep	_	_
4	its	_	PRP$	PRP$	_	6	poss	_	_
5	transient	_	JJ	JJ	_	6	amod	_	_
6	pattern	_	NN	NN	_	3	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	nuclear	_	JJ	JJ	_	9	amod	_	_
9	induction	_	NN	NN	_	7	pobj	_	_
10	during	_	IN	IN	_	6	prep	_	_
11	an	_	DT	DT	_	13	det	_	_
12	immune	_	JJ	JJ	_	13	amod	_	_
13	response	_	NN	NN	_	10	pobj	_	_
14	,	_	,	,	_	18	punct	_	_
15	NF-kappaB	_	NN	NN	_	18	nsubjpass	_	_
16	is	_	VBZ	VBZ	_	18	auxpass	_	_
17	constitutively	_	RB	RB	_	18	advmod	_	_
18	activated	_	VBN	VBN	_	0	root	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	cells	_	NNS	NNS	_	19	pobj	_	_
21	expressing	_	VBG	VBG	_	20	vmod	_	_
22	the	_	DT	DT	_	25	det	_	_
23	Tax	_	NN	NN	_	25	nn	_	_
24	transforming	_	NN	NN	_	25	nn	_	_
25	protein	_	NN	NN	_	21	dobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	human	_	JJ	JJ	_	31	amod	_	_
28	T-cell	_	NN	NN	_	31	nn	_	_
29	leukemia	_	NN	NN	_	31	nn	_	_
30	virus	_	NN	NN	_	31	nn	_	_
31	type	_	NN	NN	_	26	pobj	_	_
32	I	_	CD	CD	_	31	num	_	_
33	-LRB-	_	-LRB-	-LRB-	_	34	punct	_	_
34	HTLV-1	_	NN	NN	_	31	appos	_	_
35	-RRB-	_	-RRB-	-RRB-	_	34	punct	_	_
36	.	_	.	.	_	18	punct	_	_

1	Recent	_	JJ	JJ	_	2	amod	_	_
2	studies	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	7	mark	_	_
5	HTLV-1	_	NN	NN	_	7	nsubj	_	_
6	Tax	_	NN	NN	_	5	dep	_	_
7	targets	_	VBZ	VBZ	_	3	ccomp	_	_
8	IkappaBalpha	_	NN	NN	_	7	dobj	_	_
9	to	_	TO	TO	_	7	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	ubiquitin-proteasome	_	JJ	JJ	_	12	amod	_	_
12	pathway	_	NN	NN	_	9	pobj	_	_
13	.	_	.	.	_	3	punct	_	_

1	However	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	it	_	PRP	PRP	_	4	nsubj	_	_
4	remains	_	VBZ	VBZ	_	0	root	_	_
5	unclear	_	JJ	JJ	_	4	acomp	_	_
6	how	_	WRB	WRB	_	10	advmod	_	_
7	this	_	DT	DT	_	9	det	_	_
8	viral	_	JJ	JJ	_	9	amod	_	_
9	protein	_	NN	NN	_	10	nsubj	_	_
10	induces	_	VBZ	VBZ	_	4	ccomp	_	_
11	a	_	DT	DT	_	17	det	_	_
12	persistent	_	JJ	JJ	_	17	amod	_	_
13	rather	_	RB	RB	_	12	cc	_	_
14	than	_	IN	IN	_	13	mwe	_	_
15	transient	_	JJ	JJ	_	12	conj	_	_
16	NF-kappaB	_	NN	NN	_	17	nn	_	_
17	response	_	NN	NN	_	10	dobj	_	_
18	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	report	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	provide	_	VBP	VBP	_	0	root	_	_
7	evidence	_	NN	NN	_	6	dobj	_	_
8	that	_	IN	IN	_	17	mark	_	_
9	in	_	IN	IN	_	17	prep	_	_
10	addition	_	NN	NN	_	9	pobj	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	acting	_	VBG	VBG	_	11	pcomp	_	_
13	on	_	IN	IN	_	12	prep	_	_
14	IkappaBalpha	_	NN	NN	_	13	pobj	_	_
15	,	_	,	,	_	17	punct	_	_
16	Tax	_	NN	NN	_	17	nsubj	_	_
17	stimulates	_	VBZ	VBZ	_	7	ccomp	_	_
18	the	_	DT	DT	_	19	det	_	_
19	turnover	_	NN	NN	_	17	dobj	_	_
20	Of	_	IN	IN	_	19	prep	_	_
21	IkappaBbeta	_	NN	NN	_	20	pobj	_	_
22	via	_	IN	IN	_	17	prep	_	_
23	a	_	DT	DT	_	26	det	_	_
24	related	_	JJ	JJ	_	26	amod	_	_
25	targeting	_	NN	NN	_	26	nn	_	_
26	mechanism	_	NN	NN	_	22	pobj	_	_
27	.	_	.	.	_	6	punct	_	_

1	Like	_	IN	IN	_	13	prep	_	_
2	IkappaBalpha	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	13	punct	_	_
4	Tax-mediated	_	JJ	JJ	_	5	amod	_	_
5	breakdown	_	NN	NN	_	13	nsubjpass	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	IkappaBbeta	_	NN	NN	_	6	pobj	_	_
8	in	_	IN	IN	_	5	prep	_	_
9	transfected	_	VBN	VBN	_	11	amod	_	_
10	T	_	NN	NN	_	11	nn	_	_
11	lymphocytes	_	NNS	NNS	_	8	pobj	_	_
12	is	_	VBZ	VBZ	_	13	auxpass	_	_
13	blocked	_	VBN	VBN	_	0	root	_	_
14	either	_	CC	CC	_	15	preconj	_	_
15	by	_	IN	IN	_	13	prep	_	_
16	cell-permeable	_	JJ	JJ	_	18	amod	_	_
17	proteasome	_	NN	NN	_	18	nn	_	_
18	inhibitors	_	NNS	NNS	_	15	pobj	_	_
19	or	_	CC	CC	_	15	cc	_	_
20	by	_	IN	IN	_	15	conj	_	_
21	mutation	_	NN	NN	_	20	pobj	_	_
22	Of	_	IN	IN	_	21	prep	_	_
23	IkappaBbeta	_	NN	NN	_	22	pobj	_	_
24	at	_	IN	IN	_	21	prep	_	_
25	two	_	CD	CD	_	27	num	_	_
26	serine	_	NN	NN	_	27	nn	_	_
27	residues	_	NNS	NNS	_	24	pobj	_	_
28	present	_	JJ	JJ	_	27	amod	_	_
29	within	_	IN	IN	_	28	prep	_	_
30	its	_	PRP$	PRP$	_	32	poss	_	_
31	N-terminal	_	JJ	JJ	_	32	amod	_	_
32	region	_	NN	NN	_	29	pobj	_	_
33	.	_	.	.	_	13	punct	_	_

1	Despite	_	IN	IN	_	19	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	dual	_	JJ	JJ	_	4	amod	_	_
4	specificity	_	NN	NN	_	1	pobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	HTLV-1	_	NN	NN	_	5	pobj	_	_
7	Tax	_	NN	NN	_	6	dep	_	_
8	for	_	IN	IN	_	4	prep	_	_
9	IkappaBalpha	_	NN	NN	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	IkappaBbeta	_	NN	NN	_	9	conj	_	_
12	at	_	IN	IN	_	4	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	protein	_	NN	NN	_	15	nn	_	_
15	level	_	NN	NN	_	12	pobj	_	_
16	,	_	,	,	_	19	punct	_	_
17	Tax	_	NN	NN	_	19	nsubj	_	_
18	selectively	_	RB	RB	_	19	advmod	_	_
19	stimulates	_	VBZ	VBZ	_	0	root	_	_
20	NF-kappaB-directed	_	JJ	JJ	_	21	amod	_	_
21	transcription	_	NN	NN	_	19	dobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	25	det	_	_
24	IkappaBalpha	_	NN	NN	_	25	nn	_	_
25	gene	_	NN	NN	_	22	pobj	_	_
26	.	_	.	.	_	19	punct	_	_

1	Consequently	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	IkappaBbeta	_	NN	NN	_	5	nn	_	_
4	protein	_	NN	NN	_	5	nn	_	_
5	expression	_	NN	NN	_	8	nsubjpass	_	_
6	is	_	VBZ	VBZ	_	8	auxpass	_	_
7	chronically	_	RB	RB	_	8	advmod	_	_
8	downregulated	_	VBN	VBN	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	HTLV-1-infected	_	JJ	JJ	_	12	amod	_	_
11	T	_	NN	NN	_	12	nn	_	_
12	lymphocytes	_	NNS	NNS	_	9	pobj	_	_
13	.	_	.	.	_	8	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	findings	_	NNS	NNS	_	5	nsubj	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	IkappaBbeta	_	NN	NN	_	3	pobj	_	_
5	provide	_	VBP	VBP	_	0	root	_	_
6	a	_	DT	DT	_	8	det	_	_
7	potential	_	JJ	JJ	_	8	amod	_	_
8	mechanism	_	NN	NN	_	5	dobj	_	_
9	for	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	constitutive	_	JJ	JJ	_	12	amod	_	_
12	activation	_	NN	NN	_	9	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	NF-kappaB	_	NN	NN	_	13	pobj	_	_
15	in	_	IN	IN	_	12	prep	_	_
16	Tax-expressing	_	JJ	JJ	_	17	amod	_	_
17	cells	_	NNS	NNS	_	15	pobj	_	_
18	.	_	.	.	_	5	punct	_	_

1	Genetic	_	JJ	JJ	_	2	amod	_	_
2	characterization	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	transactivation	_	NN	NN	_	3	pobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	13	det	_	_
7	human	_	JJ	JJ	_	13	amod	_	_
8	T-cell	_	NN	NN	_	13	nn	_	_
9	leukemia	_	NN	NN	_	13	nn	_	_
10	virus	_	NN	NN	_	13	nn	_	_
11	type	_	NN	NN	_	13	nn	_	_
12	1	_	CD	CD	_	13	num	_	_
13	promoter	_	NN	NN	_	5	pobj	_	_
14	:	_	:	:	_	2	punct	_	_
15	Binding	_	NN	NN	_	23	nsubjpass	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	Tax	_	NN	NN	_	16	pobj	_	_
18	to	_	TO	TO	_	15	prep	_	_
19	Tax-responsive	_	JJ	JJ	_	20	amod	_	_
20	element	_	NN	NN	_	18	pobj	_	_
21	1	_	CD	CD	_	20	num	_	_
22	is	_	VBZ	VBZ	_	23	auxpass	_	_
23	mediated	_	VBN	VBN	_	2	dep	_	_
24	by	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	28	det	_	_
26	cyclic	_	JJ	JJ	_	28	amod	_	_
27	AMP-responsive	_	JJ	JJ	_	28	amod	_	_
28	members	_	NNS	NNS	_	24	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	the	_	DT	DT	_	32	det	_	_
31	CREB/ATF	_	NN	NN	_	32	nn	_	_
32	family	_	NN	NN	_	29	pobj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	transcription	_	NN	NN	_	35	nn	_	_
35	factors	_	NNS	NNS	_	33	pobj	_	_
36	.	_	.	.	_	2	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	achieve	_	VB	VB	_	0	root	_	_
3	a	_	DT	DT	_	5	det	_	_
4	better	_	JJR	JJR	_	5	amod	_	_
5	understanding	_	NN	NN	_	2	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	mechanism	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	transactivation	_	NN	NN	_	9	pobj	_	_
11	by	_	IN	IN	_	10	prep	_	_
12	Tax	_	NN	NN	_	11	pobj	_	_
13	of	_	IN	IN	_	10	prep	_	_
14	human	_	JJ	JJ	_	18	amod	_	_
15	T-cell	_	NN	NN	_	18	nn	_	_
16	leukemia	_	NN	NN	_	18	nn	_	_
17	virus	_	NN	NN	_	18	nn	_	_
18	type	_	NN	NN	_	13	pobj	_	_
19	1	_	CD	CD	_	18	num	_	_
20	Tax-responsive	_	JJ	JJ	_	21	amod	_	_
21	element	_	NN	NN	_	18	dep	_	_
22	1	_	CD	CD	_	21	num	_	_
23	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
24	TRE-1	_	NN	NN	_	21	appos	_	_
25	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
26	,	_	,	,	_	2	punct	_	_
27	we	_	PRP	PRP	_	28	nsubj	_	_
28	developed	_	VBD	VBD	_	2	parataxis	_	_
29	a	_	DT	DT	_	31	det	_	_
30	genetic	_	JJ	JJ	_	31	amod	_	_
31	approach	_	NN	NN	_	28	dobj	_	_
32	with	_	IN	IN	_	31	prep	_	_
33	Saccharomyces	_	NN	NN	_	34	nn	_	_
34	cerevisiae	_	NN	NN	_	32	pobj	_	_
35	.	_	.	.	_	2	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	constructed	_	VBD	VBD	_	0	root	_	_
3	a	_	DT	DT	_	6	det	_	_
4	yeast	_	NN	NN	_	6	nn	_	_
5	reporter	_	NN	NN	_	6	nn	_	_
6	strain	_	NN	NN	_	2	dobj	_	_
7	containing	_	VBG	VBG	_	6	vmod	_	_
8	the	_	DT	DT	_	10	det	_	_
9	lacZ	_	NN	NN	_	10	nn	_	_
10	gene	_	NN	NN	_	7	dobj	_	_
11	under	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	control	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	17	det	_	_
16	CYC1	_	NN	NN	_	17	nn	_	_
17	promoter	_	NN	NN	_	14	pobj	_	_
18	associated	_	VBN	VBN	_	17	vmod	_	_
19	with	_	IN	IN	_	18	prep	_	_
20	three	_	CD	CD	_	21	num	_	_
21	copies	_	NNS	NNS	_	19	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	TRE-1	_	NN	NN	_	22	pobj	_	_
24	.	_	.	.	_	2	punct	_	_

1	Expression	_	NN	NN	_	29	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	either	_	CC	CC	_	9	preconj	_	_
4	the	_	DT	DT	_	9	det	_	_
5	cyclic	_	JJ	JJ	_	9	amod	_	_
6	AMP	_	NN	NN	_	9	nn	_	_
7	response	_	NN	NN	_	9	nn	_	_
8	element-binding	_	NN	NN	_	9	nn	_	_
9	protein	_	NN	NN	_	2	pobj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	CREB	_	NN	NN	_	9	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	or	_	CC	CC	_	9	cc	_	_
14	CREB	_	NN	NN	_	9	conj	_	_
15	fused	_	VBN	VBN	_	14	vmod	_	_
16	to	_	TO	TO	_	15	prep	_	_
17	the	_	DT	DT	_	20	det	_	_
18	GAL4	_	NN	NN	_	20	nn	_	_
19	activation	_	NN	NN	_	20	nn	_	_
20	domain	_	NN	NN	_	16	pobj	_	_
21	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
22	GAD	_	NN	NN	_	20	appos	_	_
23	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
24	in	_	IN	IN	_	1	prep	_	_
25	this	_	DT	DT	_	26	det	_	_
26	strain	_	NN	NN	_	24	pobj	_	_
27	did	_	VBD	VBD	_	29	aux	_	_
28	not	_	RB	RB	_	29	neg	_	_
29	modify	_	VB	VB	_	0	root	_	_
30	the	_	DT	DT	_	31	det	_	_
31	expression	_	NN	NN	_	29	dobj	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	the	_	DT	DT	_	35	det	_	_
34	reporter	_	NN	NN	_	35	nn	_	_
35	gene	_	NN	NN	_	32	pobj	_	_
36	.	_	.	.	_	29	punct	_	_

1	Tax	_	NN	NN	_	5	nsubj	_	_
2	alone	_	RB	RB	_	1	advmod	_	_
3	was	_	VBD	VBD	_	5	cop	_	_
4	also	_	RB	RB	_	5	advmod	_	_
5	inactive	_	JJ	JJ	_	0	root	_	_
6	.	_	.	.	_	5	punct	_	_

1	However	_	RB	RB	_	9	advmod	_	_
2	,	_	,	,	_	9	punct	_	_
3	expression	_	NN	NN	_	9	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	reporter	_	NN	NN	_	7	nn	_	_
7	gene	_	NN	NN	_	4	pobj	_	_
8	was	_	VBD	VBD	_	9	auxpass	_	_
9	induced	_	VBN	VBN	_	0	root	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	coexpression	_	NN	NN	_	10	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	Tax	_	NN	NN	_	12	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	CREB	_	NN	NN	_	13	conj	_	_
16	.	_	.	.	_	9	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	effect	_	NN	NN	_	4	nsubj	_	_
3	was	_	VBD	VBD	_	4	cop	_	_
4	stronger	_	JJR	JJR	_	0	root	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	9	det	_	_
7	GAD-CREB	_	NN	NN	_	9	nn	_	_
8	fusion	_	NN	NN	_	9	nn	_	_
9	protein	_	NN	NN	_	5	pobj	_	_
10	.	_	.	.	_	4	punct	_	_

1	Analysis	_	NN	NN	_	10	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	different	_	JJ	JJ	_	5	amod	_	_
4	CREB	_	NN	NN	_	5	nn	_	_
5	mutants	_	NNS	NNS	_	2	pobj	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	this	_	DT	DT	_	9	det	_	_
8	genetic	_	JJ	JJ	_	9	amod	_	_
9	system	_	NN	NN	_	6	pobj	_	_
10	indicated	_	VBD	VBD	_	0	root	_	_
11	that	_	IN	IN	_	30	mark	_	_
12	the	_	DT	DT	_	17	det	_	_
13	C-terminal	_	JJ	JJ	_	17	amod	_	_
14	92	_	CD	CD	_	17	num	_	_
15	amino	_	NN	NN	_	17	nn	_	_
16	acid	_	NN	NN	_	17	nn	_	_
17	residues	_	NNS	NNS	_	30	nsubj	_	_
18	,	_	,	,	_	17	punct	_	_
19	which	_	WDT	WDT	_	20	nsubj	_	_
20	include	_	VBP	VBP	_	17	rcmod	_	_
21	the	_	DT	DT	_	23	det	_	_
22	basic	_	JJ	JJ	_	23	amod	_	_
23	domain	_	NN	NN	_	20	dobj	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	the	_	DT	DT	_	27	det	_	_
26	leucine	_	NN	NN	_	27	nn	_	_
27	zipper	_	NN	NN	_	23	conj	_	_
28	,	_	,	,	_	17	punct	_	_
29	are	_	VBP	VBP	_	30	cop	_	_
30	necessary	_	JJ	JJ	_	10	ccomp	_	_
31	and	_	CC	CC	_	30	cc	_	_
32	sufficient	_	JJ	JJ	_	30	conj	_	_
33	to	_	TO	TO	_	34	aux	_	_
34	mediate	_	VB	VB	_	30	xcomp	_	_
35	transactivation	_	NN	NN	_	34	dobj	_	_
36	by	_	IN	IN	_	35	prep	_	_
37	Tax	_	NN	NN	_	36	pobj	_	_
38	.	_	.	.	_	10	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	identify	_	VB	VB	_	0	root	_	_
3	cellular	_	JJ	JJ	_	4	amod	_	_
4	proteins	_	NNS	NNS	_	2	dobj	_	_
5	binding	_	VBG	VBG	_	4	vmod	_	_
6	to	_	TO	TO	_	5	prep	_	_
7	TRE-1	_	NN	NN	_	6	pobj	_	_
8	in	_	IN	IN	_	5	prep	_	_
9	a	_	DT	DT	_	11	det	_	_
10	Tax-dependent	_	JJ	JJ	_	11	amod	_	_
11	manner	_	NN	NN	_	8	pobj	_	_
12	,	_	,	,	_	2	punct	_	_
13	this	_	DT	DT	_	14	det	_	_
14	strain	_	NN	NN	_	17	nsubjpass	_	_
15	was	_	VBD	VBD	_	17	auxpass	_	_
16	also	_	RB	RB	_	17	advmod	_	_
17	used	_	VBN	VBN	_	2	parataxis	_	_
18	to	_	TO	TO	_	19	aux	_	_
19	screen	_	VB	VB	_	17	xcomp	_	_
20	a	_	DT	DT	_	21	det	_	_
21	library	_	NN	NN	_	19	dobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	human	_	JJ	JJ	_	24	amod	_	_
24	cDNAs	_	NNS	NNS	_	22	pobj	_	_
25	fused	_	VBN	VBN	_	24	vmod	_	_
26	to	_	TO	TO	_	25	prep	_	_
27	GAD	_	NN	NN	_	26	pobj	_	_
28	.	_	.	.	_	2	punct	_	_

1	Of	_	IN	IN	_	15	prep	_	_
2	five	_	CD	CD	_	4	num	_	_
3	positive	_	JJ	JJ	_	4	amod	_	_
4	clones	_	NNS	NNS	_	1	pobj	_	_
5	isolated	_	VBN	VBN	_	4	vmod	_	_
6	from	_	IN	IN	_	5	prep	_	_
7	0.75	_	CD	CD	_	11	num	_	_
8	x	_	CC	CC	_	7	cc	_	_
9	10-LRB-6-RRB-	_	CD	CD	_	7	conj	_	_
10	yeast	_	NN	NN	_	11	nn	_	_
11	colonies	_	NNS	NNS	_	6	pobj	_	_
12	,	_	,	,	_	15	punct	_	_
13	four	_	CD	CD	_	15	nsubj	_	_
14	were	_	VBD	VBD	_	15	cop	_	_
15	members	_	NNS	NNS	_	0	root	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	24	det	_	_
18	CREB/activating	_	JJ	JJ	_	24	amod	_	_
19	transcription	_	NN	NN	_	24	nn	_	_
20	factor	_	NN	NN	_	24	nn	_	_
21	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
22	ATF	_	NN	NN	_	24	nn	_	_
23	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
24	family	_	NN	NN	_	16	pobj	_	_
25	:	_	:	:	_	15	punct	_	_
26	CREB	_	NN	NN	_	15	dep	_	_
27	,	_	,	,	_	26	punct	_	_
28	two	_	CD	CD	_	35	num	_	_
29	isoforms	_	NNS	NNS	_	35	nn	_	_
30	of	_	IN	IN	_	35	amod	_	_
31	the	_	DT	DT	_	35	det	_	_
32	cyclic	_	JJ	JJ	_	35	amod	_	_
33	AMP-responsive	_	JJ	JJ	_	35	amod	_	_
34	element	_	NN	NN	_	35	nn	_	_
35	modulator	_	NN	NN	_	26	conj	_	_
36	-LRB-	_	-LRB-	-LRB-	_	37	punct	_	_
37	CREM	_	NN	NN	_	35	appos	_	_
38	-RRB-	_	-RRB-	-RRB-	_	37	punct	_	_
39	,	_	,	,	_	26	punct	_	_
40	and	_	CC	CC	_	26	cc	_	_
41	ATF-1	_	NN	NN	_	26	conj	_	_
42	.	_	.	.	_	15	punct	_	_

1	Interestingly	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	these	_	DT	DT	_	5	det	_	_
4	three	_	CD	CD	_	5	num	_	_
5	proteins	_	NNS	NNS	_	8	nsubjpass	_	_
6	can	_	MD	MD	_	8	aux	_	_
7	be	_	VB	VB	_	8	auxpass	_	_
8	phosphorylated	_	VBN	VBN	_	0	root	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	protein	_	NN	NN	_	12	nn	_	_
11	kinase	_	NN	NN	_	12	nn	_	_
12	A	_	NN	NN	_	9	pobj	_	_
13	and	_	CC	CC	_	8	cc	_	_
14	thus	_	RB	RB	_	15	advmod	_	_
15	form	_	VB	VB	_	8	conj	_	_
16	a	_	DT	DT	_	18	det	_	_
17	particular	_	JJ	JJ	_	18	amod	_	_
18	subgroup	_	NN	NN	_	15	dobj	_	_
19	within	_	IN	IN	_	15	prep	_	_
20	the	_	DT	DT	_	22	det	_	_
21	CREB/ATF	_	NN	NN	_	22	nn	_	_
22	family	_	NN	NN	_	19	pobj	_	_
23	.	_	.	.	_	8	punct	_	_

1	Expression	_	NN	NN	_	9	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	ATF-2	_	NN	NN	_	2	pobj	_	_
4	in	_	IN	IN	_	1	prep	_	_
5	S.	_	FW	FW	_	6	nn	_	_
6	cerevisiae	_	FW	FW	_	4	pobj	_	_
7	did	_	VBD	VBD	_	9	aux	_	_
8	not	_	RB	RB	_	9	neg	_	_
9	activate	_	VB	VB	_	0	root	_	_
10	TRE-1	_	NN	NN	_	9	dobj	_	_
11	in	_	IN	IN	_	9	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	presence	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	Tax	_	NN	NN	_	14	pobj	_	_
16	.	_	.	.	_	9	punct	_	_

1	This	_	DT	DT	_	2	nsubj	_	_
2	shows	_	VBZ	VBZ	_	0	root	_	_
3	that	_	IN	IN	_	11	mark	_	_
4	in	_	IN	IN	_	11	prep	_	_
5	a	_	DT	DT	_	7	det	_	_
6	eukaryotic	_	JJ	JJ	_	7	amod	_	_
7	nucleus	_	NN	NN	_	4	pobj	_	_
8	,	_	,	,	_	11	punct	_	_
9	Tax	_	NN	NN	_	11	nsubj	_	_
10	specifically	_	RB	RB	_	11	advmod	_	_
11	interacts	_	VBZ	VBZ	_	2	ccomp	_	_
12	with	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	17	det	_	_
14	basic	_	JJ	JJ	_	17	amod	_	_
15	domain-leucine	_	JJ	JJ	_	17	amod	_	_
16	zipper	_	NN	NN	_	17	nn	_	_
17	region	_	NN	NN	_	12	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	ATF-1	_	NN	NN	_	18	pobj	_	_
20	,	_	,	,	_	19	punct	_	_
21	CREB	_	NN	NN	_	19	conj	_	_
22	,	_	,	,	_	19	punct	_	_
23	and	_	CC	CC	_	19	cc	_	_
24	CREM	_	NN	NN	_	19	conj	_	_
25	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	fifth	_	JJ	JJ	_	3	amod	_	_
3	clone	_	NN	NN	_	8	nsubj	_	_
4	identified	_	VBN	VBN	_	3	vmod	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	this	_	DT	DT	_	7	det	_	_
7	screening	_	NN	NN	_	5	pobj	_	_
8	corresponded	_	VBD	VBD	_	0	root	_	_
9	to	_	TO	TO	_	8	prep	_	_
10	the	_	DT	DT	_	14	det	_	_
11	Ku	_	NN	NN	_	14	nn	_	_
12	autoantigen	_	NN	NN	_	14	nn	_	_
13	p70	_	NN	NN	_	14	nn	_	_
14	subunit	_	NN	NN	_	9	pobj	_	_
15	.	_	.	.	_	8	punct	_	_

1	When	_	WRB	WRB	_	2	advmod	_	_
2	fused	_	VBN	VBN	_	12	advcl	_	_
3	to	_	TO	TO	_	2	prep	_	_
4	GAD	_	NN	NN	_	3	pobj	_	_
5	,	_	,	,	_	12	punct	_	_
6	the	_	DT	DT	_	8	det	_	_
7	C-terminal	_	JJ	JJ	_	8	amod	_	_
8	region	_	NN	NN	_	12	nsubj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	Ku	_	NN	NN	_	9	pobj	_	_
11	was	_	VBD	VBD	_	12	cop	_	_
12	able	_	JJ	JJ	_	0	root	_	_
13	to	_	TO	TO	_	14	aux	_	_
14	activate	_	VB	VB	_	12	xcomp	_	_
15	transcription	_	NN	NN	_	14	dobj	_	_
16	via	_	IN	IN	_	14	prep	_	_
17	TRE-1	_	NN	NN	_	16	pobj	_	_
18	but	_	CC	CC	_	12	cc	_	_
19	this	_	DT	DT	_	20	det	_	_
20	activation	_	NN	NN	_	23	nsubj	_	_
21	was	_	VBD	VBD	_	23	cop	_	_
22	not	_	RB	RB	_	23	neg	_	_
23	dependent	_	JJ	JJ	_	12	conj	_	_
24	on	_	IN	IN	_	23	prep	_	_
25	Tax	_	NN	NN	_	24	pobj	_	_
26	.	_	.	.	_	12	punct	_	_

1	Role	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	EGR1	_	NN	NN	_	2	pobj	_	_
4	in	_	IN	IN	_	1	prep	_	_
5	regulation	_	NN	NN	_	4	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	stimulus-dependent	_	JJ	JJ	_	9	amod	_	_
8	CD44	_	NN	NN	_	9	nn	_	_
9	transcription	_	NN	NN	_	6	pobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	B	_	NN	NN	_	12	nn	_	_
12	lymphocytes	_	NNS	NNS	_	10	pobj	_	_
13	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	immediate-early	_	JJ	JJ	_	3	amod	_	_
3	gene	_	NN	NN	_	5	nsubj	_	_
4	egr-1	_	NN	NN	_	3	dep	_	_
5	encodes	_	VBZ	VBZ	_	0	root	_	_
6	a	_	DT	DT	_	8	det	_	_
7	transcription	_	NN	NN	_	8	nn	_	_
8	factor	_	NN	NN	_	5	dobj	_	_
9	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	EGR1	_	NN	NN	_	8	appos	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	that	_	WDT	WDT	_	13	nsubj	_	_
13	links	_	VBZ	VBZ	_	8	rcmod	_	_
14	B-cell	_	NN	NN	_	16	nn	_	_
15	antigen	_	NN	NN	_	16	nn	_	_
16	receptor	_	NN	NN	_	20	nn	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	BCR	_	NN	NN	_	16	appos	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	signals	_	NNS	NNS	_	13	dobj	_	_
21	to	_	TO	TO	_	13	prep	_	_
22	downstream	_	JJ	JJ	_	24	amod	_	_
23	activation	_	NN	NN	_	24	nn	_	_
24	events	_	NNS	NNS	_	21	pobj	_	_
25	through	_	IN	IN	_	13	prep	_	_
26	the	_	DT	DT	_	27	det	_	_
27	regulation	_	NN	NN	_	25	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	previously	_	RB	RB	_	30	advmod	_	_
30	unidentified	_	JJ	JJ	_	32	amod	_	_
31	target	_	NN	NN	_	32	nn	_	_
32	genes	_	NNS	NNS	_	28	pobj	_	_
33	.	_	.	.	_	5	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	identify	_	VBP	VBP	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	gene	_	NN	NN	_	3	dobj	_	_
6	encoding	_	VBG	VBG	_	5	vmod	_	_
7	the	_	DT	DT	_	9	det	_	_
8	lymphocyte	_	NN	NN	_	9	nn	_	_
9	homing	_	NN	NN	_	6	dobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	migration	_	NN	NN	_	12	nn	_	_
12	protein	_	NN	NN	_	9	conj	_	_
13	CD44	_	NN	NN	_	9	dep	_	_
14	as	_	IN	IN	_	3	prep	_	_
15	a	_	DT	DT	_	16	det	_	_
16	target	_	NN	NN	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	EGR1	_	NN	NN	_	19	nn	_	_
19	regulation	_	NN	NN	_	17	pobj	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	B	_	NN	NN	_	22	nn	_	_
22	cells	_	NNS	NNS	_	20	pobj	_	_
23	.	_	.	.	_	3	punct	_	_

1	BCR-induced	_	JJ	JJ	_	2	amod	_	_
2	increases	_	NNS	NNS	_	11	nsubjpass	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	CD44	_	NN	NN	_	5	nn	_	_
5	mRNA	_	NN	NN	_	3	pobj	_	_
6	expression	_	NN	NN	_	5	dep	_	_
7	and	_	CC	CC	_	5	cc	_	_
8	transcription	_	NN	NN	_	5	conj	_	_
9	levels	_	NNS	NNS	_	5	dep	_	_
10	are	_	VBP	VBP	_	11	auxpass	_	_
11	shown	_	VBN	VBN	_	0	root	_	_
12	to	_	TO	TO	_	13	aux	_	_
13	occur	_	VB	VB	_	11	xcomp	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	EGR1-expressing	_	JJ	JJ	_	14	pobj	_	_
16	but	_	CC	CC	_	14	cc	_	_
17	not	_	RB	RB	_	18	neg	_	_
18	in	_	IN	IN	_	14	conj	_	_
19	nonexpressing	_	JJ	JJ	_	20	amod	_	_
20	subclones	_	NNS	NNS	_	18	pobj	_	_
21	of	_	IN	IN	_	14	dep	_	_
22	the	_	DT	DT	_	24	det	_	_
23	B-cell	_	NN	NN	_	24	nn	_	_
24	line	_	NN	NN	_	21	pobj	_	_
25	WEHI-231	_	NN	NN	_	24	dep	_	_
26	.	_	.	.	_	11	punct	_	_

1	Kinetics	_	NNS	NNS	_	12	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	egr-1	_	NN	NN	_	4	nn	_	_
4	transcription	_	NN	NN	_	2	pobj	_	_
5	and	_	CC	CC	_	1	cc	_	_
6	the	_	DT	DT	_	7	det	_	_
7	appearance	_	NN	NN	_	1	conj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	nuclear	_	JJ	JJ	_	11	amod	_	_
10	EGR1	_	NN	NN	_	11	nn	_	_
11	protein	_	NN	NN	_	8	pobj	_	_
12	precede	_	VBP	VBP	_	0	root	_	_
13	CD44	_	NN	NN	_	14	nn	_	_
14	induction	_	NN	NN	_	12	dobj	_	_
15	and	_	CC	CC	_	12	cc	_	_
16	occur	_	VB	VB	_	12	conj	_	_
17	within	_	IN	IN	_	16	prep	_	_
18	30	_	CD	CD	_	19	num	_	_
19	min	_	NN	NN	_	17	pobj	_	_
20	after	_	IN	IN	_	19	prep	_	_
21	stimulation	_	NN	NN	_	20	pobj	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	25	det	_	_
24	EGR1-expressing	_	JJ	JJ	_	25	amod	_	_
25	subclone	_	NN	NN	_	22	pobj	_	_
26	.	_	.	.	_	12	punct	_	_

1	A	_	DT	DT	_	5	det	_	_
2	single	_	JJ	JJ	_	5	amod	_	_
3	EGR1	_	NN	NN	_	5	nn	_	_
4	binding	_	NN	NN	_	5	nn	_	_
5	motif	_	NN	NN	_	7	nsubjpass	_	_
6	is	_	VBZ	VBZ	_	7	auxpass	_	_
7	demonstrated	_	VBN	VBN	_	0	root	_	_
8	at	_	IN	IN	_	7	prep	_	_
9	bp	_	NN	NN	_	8	pobj	_	_
10	-301	_	CD	CD	_	9	num	_	_
11	of	_	IN	IN	_	9	prep	_	_
12	the	_	DT	DT	_	15	det	_	_
13	human	_	JJ	JJ	_	15	amod	_	_
14	CD44	_	NN	NN	_	15	nn	_	_
15	promoter	_	NN	NN	_	11	pobj	_	_
16	.	_	.	.	_	7	punct	_	_

1	Cotransfection	_	NN	NN	_	14	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	a	_	DT	DT	_	8	det	_	_
4	CD44	_	NN	NN	_	8	nn	_	_
5	promoter-chloramphenicol	_	JJ	JJ	_	8	amod	_	_
6	acetyltransferase	_	NN	NN	_	8	nn	_	_
7	reporter	_	NN	NN	_	8	nn	_	_
8	construct	_	NN	NN	_	2	pobj	_	_
9	with	_	IN	IN	_	1	prep	_	_
10	an	_	DT	DT	_	13	det	_	_
11	egr-1	_	NN	NN	_	13	nn	_	_
12	expression	_	NN	NN	_	13	nn	_	_
13	vector	_	NN	NN	_	9	pobj	_	_
14	resulted	_	VBD	VBD	_	0	root	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	a	_	DT	DT	_	20	det	_	_
17	6.5-	_	CD	CD	_	19	number	_	_
18	to	_	TO	TO	_	19	dep	_	_
19	8.5-fold	_	JJ	JJ	_	20	amod	_	_
20	induction	_	NN	NN	_	15	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	transcriptional	_	JJ	JJ	_	23	amod	_	_
23	activity	_	NN	NN	_	21	pobj	_	_
24	relative	_	JJ	JJ	_	23	amod	_	_
25	to	_	TO	TO	_	24	prep	_	_
26	an	_	DT	DT	_	29	det	_	_
27	empty	_	JJ	JJ	_	29	amod	_	_
28	expression	_	NN	NN	_	29	nn	_	_
29	vector	_	NN	NN	_	25	pobj	_	_
30	.	_	.	.	_	14	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	EGR1	_	NN	NN	_	4	nn	_	_
3	binding	_	NN	NN	_	4	nn	_	_
4	motif	_	NN	NN	_	6	nsubjpass	_	_
5	was	_	VBD	VBD	_	6	auxpass	_	_
6	shown	_	VBN	VBN	_	0	root	_	_
7	to	_	TO	TO	_	9	aux	_	_
8	be	_	VB	VB	_	9	cop	_	_
9	necessary	_	JJ	JJ	_	6	xcomp	_	_
10	for	_	IN	IN	_	9	prep	_	_
11	stimulus-induced	_	JJ	JJ	_	12	amod	_	_
12	expression	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	a	_	DT	DT	_	15	det	_	_
15	CD44	_	NN	NN	_	13	pobj	_	_
16	promoter-chloramphenicol	_	JJ	JJ	_	19	amod	_	_
17	acetyltransferase	_	NN	NN	_	19	nn	_	_
18	reporter	_	NN	NN	_	19	nn	_	_
19	construct	_	NN	NN	_	15	dep	_	_
20	in	_	IN	IN	_	12	prep	_	_
21	nontransformed	_	JJ	JJ	_	23	amod	_	_
22	B	_	NN	NN	_	23	nn	_	_
23	lymphocytes	_	NNS	NNS	_	20	pobj	_	_
24	and	_	CC	CC	_	6	cc	_	_
25	was	_	VBD	VBD	_	26	auxpass	_	_
26	required	_	VBN	VBN	_	6	conj	_	_
27	for	_	IN	IN	_	26	prep	_	_
28	transactivation	_	NN	NN	_	27	pobj	_	_
29	by	_	IN	IN	_	28	prep	_	_
30	an	_	DT	DT	_	33	det	_	_
31	EGR1	_	NN	NN	_	33	nn	_	_
32	expression	_	NN	NN	_	33	nn	_	_
33	vector	_	NN	NN	_	29	pobj	_	_
34	in	_	IN	IN	_	28	prep	_	_
35	a	_	DT	DT	_	37	det	_	_
36	B-cell	_	NN	NN	_	37	nn	_	_
37	line	_	NN	NN	_	34	pobj	_	_
38	.	_	.	.	_	6	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	studies	_	NNS	NNS	_	3	nsubj	_	_
3	identify	_	VBP	VBP	_	0	root	_	_
4	EGR1	_	NN	NN	_	3	dobj	_	_
5	as	_	IN	IN	_	3	prep	_	_
6	an	_	DT	DT	_	7	det	_	_
7	intermediary	_	JJ	JJ	_	5	pobj	_	_
8	linking	_	VBG	VBG	_	7	vmod	_	_
9	BCR-derived	_	JJ	JJ	_	10	amod	_	_
10	signals	_	NNS	NNS	_	8	dobj	_	_
11	to	_	TO	TO	_	8	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	induction	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	CD44	_	NN	NN	_	14	pobj	_	_
16	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	relevance	_	NN	NN	_	17	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	these	_	DT	DT	_	6	det	_	_
5	molecular	_	JJ	JJ	_	6	amod	_	_
6	events	_	NNS	NNS	_	3	pobj	_	_
7	to	_	TO	TO	_	2	prep	_	_
8	BCR	_	NN	NN	_	10	nn	_	_
9	signal	_	NN	NN	_	10	nn	_	_
10	transduction	_	NN	NN	_	7	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	antigen-stimulated	_	JJ	JJ	_	15	amod	_	_
13	B-cell-mediated	_	JJ	JJ	_	12	dep	_	_
14	immune	_	JJ	JJ	_	15	amod	_	_
15	responses	_	NNS	NNS	_	10	conj	_	_
16	is	_	VBZ	VBZ	_	17	auxpass	_	_
17	discussed	_	VBN	VBN	_	0	root	_	_
18	.	_	.	.	_	17	punct	_	_

1	Expression	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	Id2	_	NN	NN	_	2	pobj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	Id3	_	NN	NN	_	3	conj	_	_
6	mRNA	_	NN	NN	_	3	dep	_	_
7	in	_	IN	IN	_	1	prep	_	_
8	human	_	JJ	JJ	_	9	amod	_	_
9	lymphocytes	_	NNS	NNS	_	7	pobj	_	_
10	.	_	.	.	_	1	punct	_	_

1	Helix-loop-helix	_	JJ	JJ	_	6	amod	_	_
2	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
3	HLH	_	JJ	JJ	_	6	amod	_	_
4	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
5	transcription	_	NN	NN	_	6	nn	_	_
6	factors	_	NNS	NNS	_	8	nsubjpass	_	_
7	are	_	VBP	VBP	_	8	auxpass	_	_
8	involved	_	VBN	VBN	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	cellular	_	JJ	JJ	_	11	amod	_	_
11	growth	_	NN	NN	_	9	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	differentiation	_	NN	NN	_	11	conj	_	_
14	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	Id	_	NN	NN	_	20	nsubj	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	inhibitor	_	NN	NN	_	2	dep	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	DNA	_	NN	NN	_	5	pobj	_	_
7	binding	_	NN	NN	_	6	dep	_	_
8	and	_	CC	CC	_	6	cc	_	_
9	differentiation	_	NN	NN	_	6	conj	_	_
10	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
11	HLH	_	JJ	JJ	_	12	amod	_	_
12	proteins	_	NNS	NNS	_	2	dep	_	_
13	,	_	,	,	_	2	punct	_	_
14	in	_	IN	IN	_	20	prep	_	_
15	a	_	DT	DT	_	18	det	_	_
16	dominantly	_	RB	RB	_	17	advmod	_	_
17	negative	_	JJ	JJ	_	18	amod	_	_
18	fashion	_	NN	NN	_	14	pobj	_	_
19	,	_	,	,	_	20	punct	_	_
20	regulate	_	VBP	VBP	_	0	root	_	_
21	transcriptional	_	JJ	JJ	_	22	amod	_	_
22	activities	_	NNS	NNS	_	20	dobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	basic	_	JJ	JJ	_	26	amod	_	_
25	HLH	_	JJ	JJ	_	26	amod	_	_
26	proteins	_	NNS	NNS	_	23	pobj	_	_
27	.	_	.	.	_	20	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	examined	_	VBD	VBD	_	0	root	_	_
3	by	_	IN	IN	_	2	prep	_	_
4	northern	_	JJ	JJ	_	5	amod	_	_
5	hybridization	_	NN	NN	_	3	pobj	_	_
6	the	_	DT	DT	_	7	det	_	_
7	expression	_	NN	NN	_	2	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	Id2	_	NN	NN	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	Id3	_	NN	NN	_	9	conj	_	_
12	mRNA	_	NN	NN	_	9	dep	_	_
13	in	_	IN	IN	_	7	prep	_	_
14	human	_	JJ	JJ	_	16	amod	_	_
15	leukemia/lymphoma	_	NN	NN	_	16	nn	_	_
16	lines	_	NNS	NNS	_	13	pobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	patient	_	NN	NN	_	19	nn	_	_
19	samples	_	NNS	NNS	_	16	conj	_	_
20	,	_	,	,	_	16	punct	_	_
21	as	_	RB	RB	_	22	advmod	_	_
22	well	_	RB	RB	_	16	cc	_	_
23	as	_	IN	IN	_	22	mwe	_	_
24	resting	_	VBG	VBG	_	16	conj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	activated	_	VBN	VBN	_	29	amod	_	_
27	normal	_	JJ	JJ	_	29	amod	_	_
28	human	_	JJ	JJ	_	29	amod	_	_
29	lymphocytes	_	NNS	NNS	_	24	conj	_	_
30	from	_	IN	IN	_	24	prep	_	_
31	peripheral	_	JJ	JJ	_	32	amod	_	_
32	blood	_	NN	NN	_	30	pobj	_	_
33	-LRB-	_	-LRB-	-LRB-	_	34	punct	_	_
34	PBL	_	NN	NN	_	32	appos	_	_
35	-RRB-	_	-RRB-	-RRB-	_	34	punct	_	_
36	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	Id2	_	NN	NN	_	3	nn	_	_
3	mRNA	_	NN	NN	_	6	nsubjpass	_	_
4	was	_	VBD	VBD	_	6	auxpass	_	_
5	abundantly	_	RB	RB	_	6	advmod	_	_
6	expressed	_	VBN	VBN	_	0	root	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	5/12	_	CD	CD	_	9	num	_	_
9	T-cell	_	NN	NN	_	7	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	3/4	_	CD	CD	_	13	num	_	_
12	B-cell	_	NN	NN	_	13	nn	_	_
13	lines	_	NNS	NNS	_	9	conj	_	_
14	,	_	,	,	_	6	punct	_	_
15	and	_	CC	CC	_	6	cc	_	_
16	Id3	_	NN	NN	_	17	nn	_	_
17	mRNA	_	NN	NN	_	19	nsubjpass	_	_
18	was	_	VBD	VBD	_	19	auxpass	_	_
19	detected	_	VBN	VBN	_	6	conj	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	4/12	_	CD	CD	_	22	num	_	_
22	T-cell	_	NN	NN	_	20	pobj	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	3/4	_	CD	CD	_	26	num	_	_
25	B-cell	_	NN	NN	_	26	nn	_	_
26	lines	_	NNS	NNS	_	22	conj	_	_
27	.	_	.	.	_	6	punct	_	_

1	Interestingly	_	RB	RB	_	12	advmod	_	_
2	,	_	,	,	_	12	punct	_	_
3	Id2	_	NN	NN	_	12	nsubjpass	_	_
4	,	_	,	,	_	3	punct	_	_
5	but	_	CC	CC	_	6	cc	_	_
6	not	_	RB	RB	_	3	cc	_	_
7	Id3	_	NN	NN	_	3	conj	_	_
8	,	_	,	,	_	3	punct	_	_
9	mRNA	_	NN	NN	_	3	conj	_	_
10	was	_	VBD	VBD	_	12	auxpass	_	_
11	strongly	_	RB	RB	_	12	advmod	_	_
12	expressed	_	VBN	VBN	_	0	root	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	4/5	_	CD	CD	_	16	num	_	_
15	T-cell	_	NN	NN	_	16	nn	_	_
16	lines	_	NNS	NNS	_	13	pobj	_	_
17	infected	_	VBN	VBN	_	16	vmod	_	_
18	with	_	IN	IN	_	17	prep	_	_
19	human	_	JJ	JJ	_	22	amod	_	_
20	T-cell	_	NN	NN	_	22	nn	_	_
21	leukemia	_	NN	NN	_	22	nn	_	_
22	virus	_	NN	NN	_	18	pobj	_	_
23	type	_	NN	NN	_	26	nn	_	_
24	I	_	CD	CD	_	26	num	_	_
25	-LRB-	_	-LRB-	-LRB-	_	26	punct	_	_
26	HTLV-I	_	NN	NN	_	22	dep	_	_
27	-RRB-	_	-RRB-	-RRB-	_	26	punct	_	_
28	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
29	ATL-1k	_	NN	NN	_	16	dep	_	_
30	,	_	,	,	_	29	punct	_	_
31	MT-2	_	NN	NN	_	29	appos	_	_
32	,	_	,	,	_	29	punct	_	_
33	S-LB1	_	NN	NN	_	29	appos	_	_
34	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
35	and	_	CC	CC	_	16	cc	_	_
36	type	_	NN	NN	_	16	conj	_	_
37	II	_	CD	CD	_	36	num	_	_
38	-LRB-	_	-LRB-	-LRB-	_	39	punct	_	_
39	Mo	_	NN	NN	_	36	appos	_	_
40	-RRB-	_	-RRB-	-RRB-	_	39	punct	_	_
41	.	_	.	.	_	12	punct	_	_

1	Another	_	DT	DT	_	3	det	_	_
2	unexpected	_	JJ	JJ	_	3	amod	_	_
3	finding	_	NN	NN	_	4	nsubj	_	_
4	was	_	VBD	VBD	_	0	root	_	_
5	that	_	IN	IN	_	12	mark	_	_
6	T-cell	_	NN	NN	_	7	nn	_	_
7	leukemias	_	NNS	NNS	_	12	nsubj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	T-cell	_	NN	NN	_	10	nn	_	_
10	lines	_	NNS	NNS	_	7	conj	_	_
11	often	_	RB	RB	_	12	advmod	_	_
12	expressed	_	VBD	VBD	_	4	ccomp	_	_
13	either	_	CC	CC	_	14	preconj	_	_
14	Id2	_	NN	NN	_	12	dobj	_	_
15	or	_	CC	CC	_	14	cc	_	_
16	Id3	_	NN	NN	_	17	nn	_	_
17	mRNA	_	NN	NN	_	14	conj	_	_
18	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	7	punct	_	_
4	resting	_	VBG	VBG	_	5	amod	_	_
5	PBL	_	NN	NN	_	7	nsubj	_	_
6	constitutively	_	RB	RB	_	7	advmod	_	_
7	expressed	_	VBD	VBD	_	0	root	_	_
8	prominent	_	JJ	JJ	_	9	amod	_	_
9	levels	_	NNS	NNS	_	7	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	Id2	_	NN	NN	_	12	nn	_	_
12	mRNA	_	NN	NN	_	10	pobj	_	_
13	,	_	,	,	_	12	punct	_	_
14	but	_	CC	CC	_	15	cc	_	_
15	not	_	RB	RB	_	12	cc	_	_
16	Id3	_	NN	NN	_	17	nn	_	_
17	mRNA	_	NN	NN	_	12	conj	_	_
18	.	_	.	.	_	7	punct	_	_

1	Upon	_	IN	IN	_	6	prep	_	_
2	PHA-stimulation	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	6	punct	_	_
4	Id2	_	NN	NN	_	5	nn	_	_
5	expression	_	NN	NN	_	6	nsubj	_	_
6	decreased	_	VBD	VBD	_	0	root	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	Id3	_	NN	NN	_	9	nn	_	_
9	levels	_	NNS	NNS	_	10	nsubj	_	_
10	increased	_	VBD	VBD	_	6	conj	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	biphasic	_	JJ	JJ	_	13	amod	_	_
13	kinetics	_	NNS	NNS	_	11	pobj	_	_
14	.	_	.	.	_	6	punct	_	_

1	Taken	_	VBN	VBN	_	0	root	_	_
2	together	_	RB	RB	_	1	advmod	_	_
3	,	_	,	,	_	1	punct	_	_
4	our	_	PRP$	PRP$	_	5	poss	_	_
5	studies	_	NNS	NNS	_	6	nsubj	_	_
6	revealed	_	VBD	VBD	_	1	parataxis	_	_
7	three	_	CD	CD	_	9	num	_	_
8	unexpected	_	JJ	JJ	_	9	amod	_	_
9	findings	_	NNS	NNS	_	6	dobj	_	_
10	which	_	WDT	WDT	_	11	nsubj	_	_
11	require	_	VBP	VBP	_	9	rcmod	_	_
12	further	_	JJ	JJ	_	13	amod	_	_
13	analysis	_	NN	NN	_	11	dobj	_	_
14	:	_	:	:	_	1	punct	_	_
15	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
16	1	_	LS	LS	_	24	dep	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	expression	_	NN	NN	_	24	nsubjpass	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	Id2	_	NN	NN	_	21	nn	_	_
21	mRNA	_	NN	NN	_	19	pobj	_	_
22	is	_	VBZ	VBZ	_	24	auxpass	_	_
23	often	_	RB	RB	_	24	advmod	_	_
24	associated	_	VBN	VBN	_	1	parataxis	_	_
25	with	_	IN	IN	_	24	prep	_	_
26	lymphocytic	_	JJ	JJ	_	27	amod	_	_
27	transformation	_	NN	NN	_	25	pobj	_	_
28	by	_	IN	IN	_	27	prep	_	_
29	HTLV-I	_	NN	NN	_	28	pobj	_	_
30	or	_	CC	CC	_	29	cc	_	_
31	-II	_	CD	CD	_	29	conj	_	_
32	;	_	:	:	_	24	punct	_	_
33	-LRB-	_	-LRB-	-LRB-	_	34	punct	_	_
34	2	_	LS	LS	_	38	dep	_	_
35	-RRB-	_	-RRB-	-RRB-	_	34	punct	_	_
36	T-cells	_	NNS	NNS	_	38	nsubj	_	_
37	usually	_	RB	RB	_	38	advmod	_	_
38	express	_	VBP	VBP	_	24	parataxis	_	_
39	either	_	CC	CC	_	40	preconj	_	_
40	Id2	_	NN	NN	_	38	dobj	_	_
41	or	_	CC	CC	_	40	cc	_	_
42	Id3	_	NN	NN	_	43	nn	_	_
43	mRNA	_	NN	NN	_	40	conj	_	_
44	,	_	,	,	_	38	punct	_	_
45	but	_	CC	CC	_	38	cc	_	_
46	B-cells	_	NNS	NNS	_	48	nsubj	_	_
47	often	_	RB	RB	_	48	advmod	_	_
48	express	_	VBP	VBP	_	38	conj	_	_
49	both	_	DT	DT	_	48	dobj	_	_
50	simultaneously	_	RB	RB	_	48	advmod	_	_
51	;	_	:	:	_	24	punct	_	_
52	-LRB-	_	-LRB-	-LRB-	_	53	punct	_	_
53	3	_	LS	LS	_	59	dep	_	_
54	-RRB-	_	-RRB-	-RRB-	_	53	punct	_	_
55	non-dividing	_	JJ	JJ	_	58	amod	_	_
56	,	_	,	,	_	55	punct	_	_
57	normal	_	JJ	JJ	_	55	dep	_	_
58	PBL	_	NN	NN	_	59	nsubj	_	_
59	express	_	VBP	VBP	_	24	parataxis	_	_
60	high	_	JJ	JJ	_	61	amod	_	_
61	levels	_	NNS	NNS	_	59	dobj	_	_
62	of	_	IN	IN	_	61	prep	_	_
63	Id2	_	NN	NN	_	62	pobj	_	_
64	and	_	CC	CC	_	61	cc	_	_
65	no	_	DT	DT	_	67	neg	_	_
66	Id3	_	NN	NN	_	67	nn	_	_
67	mRNA	_	NN	NN	_	61	conj	_	_
68	;	_	:	:	_	59	punct	_	_
69	and	_	CC	CC	_	59	cc	_	_
70	with	_	IN	IN	_	81	prep	_	_
71	the	_	DT	DT	_	72	det	_	_
72	onset	_	NN	NN	_	70	pobj	_	_
73	of	_	IN	IN	_	72	prep	_	_
74	cellular	_	JJ	JJ	_	75	amod	_	_
75	proliferation	_	NN	NN	_	73	pobj	_	_
76	,	_	,	,	_	81	punct	_	_
77	levels	_	NNS	NNS	_	81	nsubj	_	_
78	of	_	IN	IN	_	77	prep	_	_
79	Id2	_	NN	NN	_	80	nn	_	_
80	mRNA	_	NN	NN	_	78	pobj	_	_
81	decrease	_	VBP	VBP	_	59	conj	_	_
82	while	_	IN	IN	_	87	mark	_	_
83	levels	_	NNS	NNS	_	87	nsubj	_	_
84	of	_	IN	IN	_	83	prep	_	_
85	Id3	_	NN	NN	_	86	nn	_	_
86	mRNA	_	NN	NN	_	84	pobj	_	_
87	increase	_	VBP	VBP	_	81	advcl	_	_
88	,	_	,	,	_	81	punct	_	_
89	suggesting	_	VBG	VBG	_	81	xcomp	_	_
90	that	_	IN	IN	_	100	mark	_	_
91	regulation	_	NN	NN	_	100	nsubj	_	_
92	of	_	IN	IN	_	91	prep	_	_
93	expression	_	NN	NN	_	92	pobj	_	_
94	of	_	IN	IN	_	93	prep	_	_
95	these	_	DT	DT	_	98	det	_	_
96	closely	_	RB	RB	_	97	advmod	_	_
97	related	_	JJ	JJ	_	98	amod	_	_
98	genes	_	NNS	NNS	_	94	pobj	_	_
99	is	_	VBZ	VBZ	_	100	cop	_	_
100	disparate	_	JJ	JJ	_	89	ccomp	_	_
101	.	_	.	.	_	1	punct	_	_

1	CNI-1493	_	NN	NN	_	2	nsubj	_	_
2	inhibits	_	VBZ	VBZ	_	0	root	_	_
3	monocyte/macrophage	_	JJ	JJ	_	6	amod	_	_
4	tumor	_	NN	NN	_	6	nn	_	_
5	necrosis	_	NN	NN	_	6	nn	_	_
6	factor	_	NN	NN	_	2	dobj	_	_
7	by	_	IN	IN	_	2	prep	_	_
8	suppression	_	NN	NN	_	7	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	translation	_	NN	NN	_	11	nn	_	_
11	efficiency	_	NN	NN	_	9	pobj	_	_
12	.	_	.	.	_	2	punct	_	_

1	Tumor	_	NN	NN	_	3	nn	_	_
2	necrosis	_	NN	NN	_	3	nn	_	_
3	factor	_	NN	NN	_	7	nsubj	_	_
4	-LRB-	_	-LRB-	-LRB-	_	5	punct	_	_
5	TNF	_	NN	NN	_	3	appos	_	_
6	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
7	mediates	_	VBZ	VBZ	_	0	root	_	_
8	a	_	DT	DT	_	10	det	_	_
9	wide	_	JJ	JJ	_	10	amod	_	_
10	variety	_	NN	NN	_	7	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	disease	_	NN	NN	_	13	nn	_	_
13	states	_	NNS	NNS	_	11	pobj	_	_
14	including	_	VBG	VBG	_	10	prep	_	_
15	septic	_	JJ	JJ	_	16	amod	_	_
16	shock	_	NN	NN	_	14	pobj	_	_
17	,	_	,	,	_	16	punct	_	_
18	acute	_	JJ	JJ	_	16	conj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	chronic	_	JJ	JJ	_	18	conj	_	_
21	inflammation	_	NN	NN	_	18	dep	_	_
22	,	_	,	,	_	16	punct	_	_
23	and	_	CC	CC	_	16	cc	_	_
24	cachexia	_	NN	NN	_	16	conj	_	_
25	.	_	.	.	_	7	punct	_	_

1	Recently	_	RB	RB	_	17	advmod	_	_
2	,	_	,	,	_	17	punct	_	_
3	a	_	DT	DT	_	5	det	_	_
4	multivalent	_	JJ	JJ	_	5	amod	_	_
5	guanylhydrazone	_	NN	NN	_	17	nsubjpass	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	CNI-1493	_	NN	NN	_	5	appos	_	_
8	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
9	developed	_	VBN	VBN	_	5	vmod	_	_
10	as	_	IN	IN	_	9	prep	_	_
11	an	_	DT	DT	_	12	det	_	_
12	inhibitor	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	macrophage	_	NN	NN	_	15	nn	_	_
15	activation	_	NN	NN	_	13	pobj	_	_
16	was	_	VBD	VBD	_	17	auxpass	_	_
17	shown	_	VBN	VBN	_	0	root	_	_
18	to	_	TO	TO	_	19	aux	_	_
19	suppress	_	VB	VB	_	17	xcomp	_	_
20	TNF	_	NN	NN	_	21	nn	_	_
21	production	_	NN	NN	_	19	dobj	_	_
22	and	_	CC	CC	_	19	cc	_	_
23	protect	_	NN	NN	_	19	conj	_	_
24	against	_	IN	IN	_	23	prep	_	_
25	tissue	_	NN	NN	_	26	nn	_	_
26	inflammation	_	NN	NN	_	24	pobj	_	_
27	and	_	CC	CC	_	26	cc	_	_
28	endotoxin	_	NN	NN	_	29	nn	_	_
29	lethality	_	NN	NN	_	26	conj	_	_
30	-LSB-	_	-LRB-	-LRB-	_	33	punct	_	_
31	Bianchi	_	NNP	NNP	_	33	nn	_	_
32	,	_	,	,	_	33	punct	_	_
33	M.	_	NNP	NNP	_	17	dep	_	_
34	,	_	,	,	_	33	punct	_	_
35	Ulrich	_	NNP	NNP	_	37	nn	_	_
36	,	_	,	,	_	37	punct	_	_
37	P.	_	NNP	NNP	_	33	conj	_	_
38	,	_	,	,	_	33	punct	_	_
39	Bloom	_	NNP	NNP	_	41	nn	_	_
40	,	_	,	,	_	41	punct	_	_
41	O.	_	NNP	NNP	_	33	conj	_	_
42	,	_	,	,	_	33	punct	_	_
43	Meistrell	_	NNP	NNP	_	45	nn	_	_
44	,	_	,	,	_	45	punct	_	_
45	M.	_	NNP	NNP	_	33	conj	_	_
46	,	_	,	,	_	33	punct	_	_
47	Zimmerman	_	NNP	NNP	_	49	nn	_	_
48	,	_	,	,	_	49	punct	_	_
49	G.A.	_	NNP	NNP	_	33	conj	_	_
50	,	_	,	,	_	33	punct	_	_
51	Schmidtmayerova	_	NNP	NNP	_	53	nn	_	_
52	,	_	,	,	_	53	punct	_	_
53	H.	_	NNP	NNP	_	33	conj	_	_
54	,	_	,	,	_	33	punct	_	_
55	Bukrinsky	_	NNP	NNP	_	57	nn	_	_
56	,	_	,	,	_	57	punct	_	_
57	M.	_	NNP	NNP	_	33	conj	_	_
58	,	_	,	,	_	33	punct	_	_
59	Donnelley	_	NNP	NNP	_	61	nn	_	_
60	,	_	,	,	_	61	punct	_	_
61	T.	_	NNP	NNP	_	33	conj	_	_
62	,	_	,	,	_	33	punct	_	_
63	Bucala	_	NNP	NNP	_	65	nn	_	_
64	,	_	,	,	_	65	punct	_	_
65	R.	_	NNP	NNP	_	33	conj	_	_
66	,	_	,	,	_	33	punct	_	_
67	Sherry	_	NNP	NNP	_	69	nn	_	_
68	,	_	,	,	_	69	punct	_	_
69	B.	_	NNP	NNP	_	33	conj	_	_
70	,	_	,	,	_	33	punct	_	_
71	Manogue	_	NNP	NNP	_	73	nn	_	_
72	,	_	,	,	_	73	punct	_	_
73	K.R.	_	NNP	NNP	_	33	conj	_	_
74	,	_	,	,	_	33	punct	_	_
75	Tortolani	_	NNP	NNP	_	77	nn	_	_
76	,	_	,	,	_	77	punct	_	_
77	A.J.	_	NNP	NNP	_	33	conj	_	_
78	,	_	,	,	_	33	punct	_	_
79	Cerami	_	NNP	NNP	_	81	nn	_	_
80	,	_	,	,	_	81	punct	_	_
81	A.	_	NNP	NNP	_	33	conj	_	_
82	&amp;	_	CC	CC	_	33	cc	_	_
83	Tracey	_	NNP	NNP	_	85	nn	_	_
84	,	_	,	,	_	85	punct	_	_
85	K.J.	_	NNP	NNP	_	33	conj	_	_
86	-LRB-	_	-LRB-	-LRB-	_	87	punct	_	_
87	1995	_	CD	CD	_	33	appos	_	_
88	-RRB-	_	-RRB-	-RRB-	_	87	punct	_	_
89	Mol.Med.1	_	NNP	NNP	_	33	dep	_	_
90	,	_	,	,	_	33	punct	_	_
91	254-266	_	CD	CD	_	33	amod	_	_
92	,	_	,	,	_	33	punct	_	_
93	and	_	CC	CC	_	33	cc	_	_
94	Bianchi	_	NNP	NNP	_	96	nn	_	_
95	,	_	,	,	_	96	punct	_	_
96	M.	_	NNP	NNP	_	33	conj	_	_
97	,	_	,	,	_	96	punct	_	_
98	Bloom	_	NNP	NNP	_	100	nn	_	_
99	,	_	,	,	_	100	punct	_	_
100	O.	_	NNP	NNP	_	96	conj	_	_
101	,	_	,	,	_	96	punct	_	_
102	Raabe	_	NNP	NNP	_	104	nn	_	_
103	,	_	,	,	_	104	punct	_	_
104	T.	_	NNP	NNP	_	96	conj	_	_
105	,	_	,	,	_	96	punct	_	_
106	Cohen	_	NNP	NNP	_	109	nn	_	_
107	,	_	,	,	_	109	punct	_	_
108	P.	_	NNP	NNP	_	109	appos	_	_
109	S.	_	NNP	NNP	_	96	conj	_	_
110	,	_	,	,	_	96	punct	_	_
111	Chesney	_	NNP	NNP	_	113	nn	_	_
112	,	_	,	,	_	113	punct	_	_
113	J.	_	NNP	NNP	_	96	conj	_	_
114	,	_	,	,	_	96	punct	_	_
115	Sherry	_	NNP	NNP	_	117	nn	_	_
116	,	_	,	,	_	117	punct	_	_
117	B.	_	NNP	NNP	_	96	conj	_	_
118	,	_	,	,	_	96	punct	_	_
119	Schmidtmayerova	_	NNP	NNP	_	121	nn	_	_
120	,	_	,	,	_	121	punct	_	_
121	H.	_	NNP	NNP	_	96	conj	_	_
122	,	_	,	,	_	96	punct	_	_
123	Zhang	_	NNP	NNP	_	125	nn	_	_
124	,	_	,	,	_	125	punct	_	_
125	X.	_	NNP	NNP	_	96	conj	_	_
126	,	_	,	,	_	96	punct	_	_
127	Bukrinsky	_	NNP	NNP	_	129	nn	_	_
128	,	_	,	,	_	129	punct	_	_
129	M.	_	NNP	NNP	_	96	conj	_	_
130	,	_	,	,	_	96	punct	_	_
131	Ulrich	_	NNP	NNP	_	133	nn	_	_
132	,	_	,	,	_	133	punct	_	_
133	P.	_	NNP	NNP	_	96	conj	_	_
134	,	_	,	,	_	96	punct	_	_
135	Cerami	_	NNP	NNP	_	137	nn	_	_
136	,	_	,	,	_	137	punct	_	_
137	A.	_	NNP	NNP	_	96	conj	_	_
138	&amp;	_	CC	CC	_	96	cc	_	_
139	Tracey	_	NNP	NNP	_	141	nn	_	_
140	,	_	,	,	_	141	punct	_	_
141	J.	_	NNP	NNP	_	96	conj	_	_
142	-LRB-	_	-LRB-	-LRB-	_	143	punct	_	_
143	1996	_	CD	CD	_	96	appos	_	_
144	-RRB-	_	-RRB-	-RRB-	_	143	punct	_	_
145	J.Exp.Med.	_	NNP	NNP	_	96	dep	_	_
146	,	_	,	,	_	96	punct	_	_
147	in	_	IN	IN	_	96	prep	_	_
148	press	_	NN	NN	_	147	pobj	_	_
149	-RSB-	_	-RRB-	-RRB-	_	33	punct	_	_
150	.	_	.	.	_	17	punct	_	_

1	We	_	PRP	PRP	_	4	nsubj	_	_
2	have	_	VBP	VBP	_	4	aux	_	_
3	now	_	RB	RB	_	4	advmod	_	_
4	elucidated	_	VBN	VBN	_	0	root	_	_
5	the	_	DT	DT	_	6	det	_	_
6	mechanism	_	NN	NN	_	4	dobj	_	_
7	by	_	IN	IN	_	10	prep	_	_
8	which	_	WDT	WDT	_	7	pobj	_	_
9	CNI-1493	_	NN	NN	_	10	nsubj	_	_
10	inhibits	_	VBZ	VBZ	_	6	rcmod	_	_
11	macrophage	_	NN	NN	_	13	nn	_	_
12	TNF	_	NN	NN	_	13	nn	_	_
13	synthesis	_	NN	NN	_	10	dobj	_	_
14	and	_	CC	CC	_	4	cc	_	_
15	show	_	VBP	VBP	_	4	conj	_	_
16	here	_	RB	RB	_	15	advmod	_	_
17	that	_	IN	IN	_	19	mark	_	_
18	it	_	PRP	PRP	_	19	nsubj	_	_
19	acts	_	VBZ	VBZ	_	15	ccomp	_	_
20	through	_	IN	IN	_	19	prep	_	_
21	suppression	_	NN	NN	_	20	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	TNF	_	NN	NN	_	25	nn	_	_
24	translation	_	NN	NN	_	25	nn	_	_
25	efficiency	_	NN	NN	_	22	pobj	_	_
26	.	_	.	.	_	4	punct	_	_

1	CNI-1493	_	NN	NN	_	2	nsubj	_	_
2	blocked	_	VBD	VBD	_	0	root	_	_
3	neither	_	CC	CC	_	10	preconj	_	_
4	the	_	DT	DT	_	10	det	_	_
5	lipopolysaccharide	_	NN	NN	_	10	nn	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	LPS	_	NN	NN	_	5	appos	_	_
8	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
9	-induced	_	JJ	JJ	_	10	amod	_	_
10	increases	_	NNS	NNS	_	2	dobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	expression	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	TNF	_	NN	NN	_	16	nn	_	_
16	mRNA	_	NN	NN	_	14	pobj	_	_
17	nor	_	CC	CC	_	10	cc	_	_
18	the	_	DT	DT	_	19	det	_	_
19	translocation	_	NN	NN	_	10	conj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	nuclear	_	JJ	JJ	_	24	amod	_	_
22	factor	_	NN	NN	_	24	nn	_	_
23	NF-kappa	_	NN	NN	_	24	nn	_	_
24	B	_	NN	NN	_	20	pobj	_	_
25	to	_	TO	TO	_	19	prep	_	_
26	the	_	DT	DT	_	27	det	_	_
27	nucleus	_	NN	NN	_	25	pobj	_	_
28	in	_	IN	IN	_	19	prep	_	_
29	macrophages	_	NNS	NNS	_	28	pobj	_	_
30	activated	_	VBN	VBN	_	29	vmod	_	_
31	by	_	IN	IN	_	30	prep	_	_
32	15	_	CD	CD	_	33	num	_	_
33	min	_	NN	NN	_	31	pobj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	LPS	_	NN	NN	_	36	nn	_	_
36	stimulation	_	NN	NN	_	34	pobj	_	_
37	,	_	,	,	_	2	punct	_	_
38	indicating	_	VBG	VBG	_	2	vmod	_	_
39	that	_	IN	IN	_	43	mark	_	_
40	CNI-1493	_	NN	NN	_	43	nsubj	_	_
41	does	_	VBZ	VBZ	_	43	aux	_	_
42	not	_	RB	RB	_	43	neg	_	_
43	interfere	_	VB	VB	_	38	ccomp	_	_
44	with	_	IN	IN	_	43	prep	_	_
45	early	_	JJ	JJ	_	49	amod	_	_
46	NF-kappa	_	NN	NN	_	49	nn	_	_
47	B-mediated	_	JJ	JJ	_	49	amod	_	_
48	transcriptional	_	JJ	JJ	_	49	amod	_	_
49	regulation	_	NN	NN	_	44	pobj	_	_
50	of	_	IN	IN	_	49	prep	_	_
51	TNF	_	NN	NN	_	50	pobj	_	_
52	.	_	.	.	_	2	punct	_	_

1	However	_	RB	RB	_	13	advmod	_	_
2	,	_	,	,	_	13	punct	_	_
3	synthesis	_	NN	NN	_	13	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	8	det	_	_
6	26-kDa	_	JJ	JJ	_	8	amod	_	_
7	membrane	_	NN	NN	_	8	nn	_	_
8	form	_	NN	NN	_	4	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	TNF	_	NN	NN	_	9	pobj	_	_
11	was	_	VBD	VBD	_	13	auxpass	_	_
12	effectively	_	RB	RB	_	13	advmod	_	_
13	blocked	_	VBN	VBN	_	0	root	_	_
14	by	_	IN	IN	_	13	prep	_	_
15	CNI-1493	_	NN	NN	_	14	pobj	_	_
16	.	_	.	.	_	13	punct	_	_

1	Further	_	RB	RB	_	2	advmod	_	_
2	evidence	_	NN	NN	_	10	nsubjpass	_	_
3	for	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	translational	_	JJ	JJ	_	6	amod	_	_
6	suppression	_	NN	NN	_	3	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	TNF	_	NN	NN	_	7	pobj	_	_
9	is	_	VBZ	VBZ	_	10	auxpass	_	_
10	given	_	VBN	VBN	_	0	root	_	_
11	by	_	IN	IN	_	10	prep	_	_
12	experiments	_	NNS	NNS	_	11	pobj	_	_
13	using	_	VBG	VBG	_	12	vmod	_	_
14	chloram-phenicol	_	NN	NN	_	17	nn	_	_
15	acetyltransferase	_	NN	NN	_	17	nn	_	_
16	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
17	CAT	_	NN	NN	_	13	dobj	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	constructs	_	VBZ	VBZ	_	17	dep	_	_
20	containing	_	VBG	VBG	_	17	vmod	_	_
21	elements	_	NNS	NNS	_	20	dobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	25	det	_	_
24	TNF	_	NN	NN	_	25	nn	_	_
25	gene	_	NN	NN	_	22	pobj	_	_
26	that	_	WDT	WDT	_	28	nsubjpass	_	_
27	are	_	VBP	VBP	_	28	auxpass	_	_
28	involved	_	VBN	VBN	_	21	rcmod	_	_
29	in	_	IN	IN	_	28	prep	_	_
30	TNF	_	NN	NN	_	32	nn	_	_
31	translational	_	JJ	JJ	_	32	amod	_	_
32	regulation	_	NN	NN	_	29	pobj	_	_
33	.	_	.	.	_	10	punct	_	_

1	Both	_	CC	CC	_	3	preconj	_	_
2	the	_	DT	DT	_	3	dep	_	_
3	5'	_	JJ	JJ	_	13	nsubjpass	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	3'	_	JJ	JJ	_	3	conj	_	_
6	untranslated	_	JJ	JJ	_	7	amod	_	_
7	regions	_	NNS	NNS	_	3	dep	_	_
8	of	_	IN	IN	_	3	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	TNF	_	NN	NN	_	11	nn	_	_
11	gene	_	NN	NN	_	8	pobj	_	_
12	were	_	VBD	VBD	_	13	auxpass	_	_
13	required	_	VBN	VBN	_	0	root	_	_
14	to	_	TO	TO	_	15	aux	_	_
15	elicit	_	VB	VB	_	13	xcomp	_	_
16	maximal	_	JJ	JJ	_	18	amod	_	_
17	translational	_	JJ	JJ	_	18	amod	_	_
18	suppression	_	NN	NN	_	15	dobj	_	_
19	by	_	IN	IN	_	18	prep	_	_
20	CNI-1493	_	NN	NN	_	19	pobj	_	_
21	.	_	.	.	_	13	punct	_	_

1	Identification	_	NN	NN	_	13	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	molecular	_	JJ	JJ	_	5	amod	_	_
5	target	_	NN	NN	_	2	pobj	_	_
6	through	_	IN	IN	_	9	prep	_	_
7	which	_	WDT	WDT	_	6	pobj	_	_
8	CNI-1493	_	NN	NN	_	9	nsubj	_	_
9	inhibits	_	VBZ	VBZ	_	5	rcmod	_	_
10	TNF	_	NN	NN	_	11	nn	_	_
11	translation	_	NN	NN	_	9	dobj	_	_
12	should	_	MD	MD	_	13	aux	_	_
13	provide	_	VB	VB	_	0	root	_	_
14	insight	_	NN	NN	_	13	dobj	_	_
15	into	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	17	det	_	_
17	regulation	_	NN	NN	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	macrophage	_	NN	NN	_	20	nn	_	_
20	activation	_	NN	NN	_	18	pobj	_	_
21	and	_	CC	CC	_	17	cc	_	_
22	mechanisms	_	NNS	NNS	_	17	conj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	inflammation	_	NN	NN	_	23	pobj	_	_
25	.	_	.	.	_	13	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	RAR-RXR	_	JJ	JJ	_	10	nsubjpass	_	_
3	as	_	RB	RB	_	4	advmod	_	_
4	well	_	RB	RB	_	2	cc	_	_
5	as	_	IN	IN	_	4	mwe	_	_
6	the	_	DT	DT	_	7	det	_	_
7	RXR-RXR	_	JJ	JJ	_	2	conj	_	_
8	pathway	_	NN	NN	_	2	dep	_	_
9	is	_	VBZ	VBZ	_	10	auxpass	_	_
10	involved	_	VBN	VBN	_	0	root	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	signaling	_	NN	NN	_	14	nn	_	_
13	growth	_	NN	NN	_	14	nn	_	_
14	inhibition	_	NN	NN	_	11	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	human	_	JJ	JJ	_	20	amod	_	_
17	CD34+	_	JJ	JJ	_	20	amod	_	_
18	erythroid	_	JJ	JJ	_	20	amod	_	_
19	progenitor	_	NN	NN	_	20	nn	_	_
20	cells	_	NNS	NNS	_	15	pobj	_	_
21	.	_	.	.	_	10	punct	_	_

1	Previous	_	JJ	JJ	_	2	amod	_	_
2	studies	_	NNS	NNS	_	4	nsubj	_	_
3	have	_	VBP	VBP	_	4	aux	_	_
4	shown	_	VBN	VBN	_	0	root	_	_
5	that	_	IN	IN	_	22	mark	_	_
6	retinoic	_	JJ	JJ	_	7	amod	_	_
7	acid	_	NN	NN	_	22	nsubj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	RA	_	NN	NN	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	,	_	,	,	_	7	punct	_	_
12	similar	_	JJ	JJ	_	7	amod	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	tumor	_	NN	NN	_	16	nn	_	_
15	necrosis	_	NN	NN	_	16	nn	_	_
16	factor-alpha	_	NN	NN	_	13	pobj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	TNF-alpha	_	NN	NN	_	16	appos	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	,	_	,	,	_	7	punct	_	_
21	can	_	MD	MD	_	22	aux	_	_
22	act	_	VB	VB	_	4	ccomp	_	_
23	as	_	IN	IN	_	22	prep	_	_
24	a	_	DT	DT	_	26	det	_	_
25	bifunctional	_	JJ	JJ	_	26	amod	_	_
26	regulator	_	NN	NN	_	23	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	29	det	_	_
29	growth	_	NN	NN	_	27	pobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	bone	_	NN	NN	_	33	nn	_	_
32	marrow	_	NN	NN	_	33	nn	_	_
33	progenitors	_	NNS	NNS	_	30	pobj	_	_
34	,	_	,	,	_	22	punct	_	_
35	in	_	IN	IN	_	22	prep	_	_
36	that	_	IN	IN	_	39	mark	_	_
37	it	_	PRP	PRP	_	39	nsubj	_	_
38	can	_	MD	MD	_	39	aux	_	_
39	stimulate	_	VB	VB	_	35	pcomp	_	_
40	granulocyte-macrophage	_	JJ	JJ	_	42	amod	_	_
41	colony-stimulating	_	JJ	JJ	_	42	amod	_	_
42	factor	_	NN	NN	_	39	dobj	_	_
43	-LRB-	_	-LRB-	-LRB-	_	44	punct	_	_
44	GM-CSF	_	NN	NN	_	42	appos	_	_
45	-RRB-	_	-RRB-	-RRB-	_	44	punct	_	_
46	-	_	:	:	_	42	punct	_	_
47	or	_	CC	CC	_	42	cc	_	_
48	interleukin-3	_	NN	NN	_	42	conj	_	_
49	-LRB-	_	-LRB-	-LRB-	_	50	punct	_	_
50	IL-3	_	NN	NN	_	48	appos	_	_
51	-RRB-	_	-RRB-	-RRB-	_	50	punct	_	_
52	-induced	_	JJ	JJ	_	48	amod	_	_
53	GM	_	NN	NN	_	55	nn	_	_
54	colony	_	NN	NN	_	55	nn	_	_
55	formation	_	NN	NN	_	42	dep	_	_
56	,	_	,	,	_	39	punct	_	_
57	but	_	CC	CC	_	39	cc	_	_
58	potently	_	RB	RB	_	59	advmod	_	_
59	inhibit	_	VBP	VBP	_	39	conj	_	_
60	G-CSF-induced	_	JJ	JJ	_	61	amod	_	_
61	growth	_	NN	NN	_	59	dobj	_	_
62	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	present	_	JJ	JJ	_	3	amod	_	_
3	study	_	NN	NN	_	20	nsubj	_	_
4	,	_	,	,	_	3	punct	_	_
5	using	_	VBG	VBG	_	20	dep	_	_
6	highly	_	RB	RB	_	7	advmod	_	_
7	enriched	_	VBN	VBN	_	9	amod	_	_
8	human	_	JJ	JJ	_	9	amod	_	_
9	CD34+	_	JJ	JJ	_	5	dobj	_	_
10	as	_	RB	RB	_	11	advmod	_	_
11	well	_	RB	RB	_	9	cc	_	_
12	as	_	IN	IN	_	11	mwe	_	_
13	Lin-	_	JJ	JJ	_	18	amod	_	_
14	murine	_	JJ	JJ	_	18	amod	_	_
15	bone	_	NN	NN	_	18	nn	_	_
16	marrow	_	NN	NN	_	18	nn	_	_
17	progenitor	_	NN	NN	_	18	nn	_	_
18	cells	_	NNS	NNS	_	9	conj	_	_
19	,	_	,	,	_	20	punct	_	_
20	demonstrates	_	VBZ	VBZ	_	0	root	_	_
21	a	_	DT	DT	_	24	det	_	_
22	potent	_	JJ	JJ	_	23	amod	_	_
23	inhibitory	_	JJ	JJ	_	24	amod	_	_
24	effect	_	NN	NN	_	20	dobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	9-cis-RA	_	NN	NN	_	25	pobj	_	_
27	on	_	IN	IN	_	24	prep	_	_
28	burst-forming	_	JJ	JJ	_	29	amod	_	_
29	unit-erythroid	_	JJ	JJ	_	34	nn	_	_
30	-LRB-	_	-LRB-	-LRB-	_	31	punct	_	_
31	BFU-E	_	NN	NN	_	29	appos	_	_
32	-RRB-	_	-RRB-	-RRB-	_	31	punct	_	_
33	colony	_	NN	NN	_	34	nn	_	_
34	formation	_	NN	NN	_	27	pobj	_	_
35	regardless	_	RB	RB	_	20	advmod	_	_
36	of	_	IN	IN	_	35	prep	_	_
37	the	_	DT	DT	_	40	det	_	_
38	cytokine	_	NN	NN	_	40	nn	_	_
39	stimulating	_	NN	NN	_	40	nn	_	_
40	growth	_	NN	NN	_	36	pobj	_	_
41	.	_	.	.	_	20	punct	_	_

1	Specifically	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	9-cis-RA	_	NN	NN	_	5	nsubj	_	_
4	potently	_	RB	RB	_	5	advmod	_	_
5	inhibited	_	VBD	VBD	_	0	root	_	_
6	the	_	DT	DT	_	7	det	_	_
7	growth	_	NN	NN	_	5	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	BFU-E	_	NN	NN	_	10	nn	_	_
10	response	_	NN	NN	_	8	pobj	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	erythropoietin	_	NN	NN	_	11	pobj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	Epo	_	NN	NN	_	12	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
17	100	_	CD	CD	_	18	num	_	_
18	%	_	NN	NN	_	7	appos	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	,	_	,	,	_	7	punct	_	_
21	stem	_	NN	NN	_	23	nn	_	_
22	cell	_	NN	NN	_	23	nn	_	_
23	factor	_	NN	NN	_	7	conj	_	_
24	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
25	SCF	_	NN	NN	_	23	appos	_	_
26	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
27	+	_	CC	CC	_	23	cc	_	_
28	Epo	_	NN	NN	_	23	conj	_	_
29	-LRB-	_	-LRB-	-LRB-	_	31	punct	_	_
30	92	_	CD	CD	_	31	num	_	_
31	%	_	NN	NN	_	23	appos	_	_
32	-RRB-	_	-RRB-	-RRB-	_	31	punct	_	_
33	,	_	,	,	_	7	punct	_	_
34	IL-3	_	NN	NN	_	7	conj	_	_
35	+	_	CC	CC	_	34	cc	_	_
36	Epo	_	NN	NN	_	34	conj	_	_
37	-LRB-	_	-LRB-	-LRB-	_	39	punct	_	_
38	97	_	CD	CD	_	39	num	_	_
39	%	_	NN	NN	_	34	appos	_	_
40	-RRB-	_	-RRB-	-RRB-	_	39	punct	_	_
41	,	_	,	,	_	7	punct	_	_
42	IL-4	_	NN	NN	_	7	conj	_	_
43	+	_	CC	CC	_	42	cc	_	_
44	Epo	_	NN	NN	_	42	conj	_	_
45	-LRB-	_	-LRB-	-LRB-	_	47	punct	_	_
46	88	_	CD	CD	_	47	num	_	_
47	%	_	NN	NN	_	42	appos	_	_
48	-RRB-	_	-RRB-	-RRB-	_	47	punct	_	_
49	,	_	,	,	_	7	punct	_	_
50	and	_	CC	CC	_	7	cc	_	_
51	IL-9	_	NN	NN	_	7	conj	_	_
52	+	_	CC	CC	_	51	cc	_	_
53	Epo	_	NN	NN	_	51	conj	_	_
54	-LRB-	_	-LRB-	-LRB-	_	56	punct	_	_
55	100	_	CD	CD	_	56	num	_	_
56	%	_	NN	NN	_	51	appos	_	_
57	-RRB-	_	-RRB-	-RRB-	_	56	punct	_	_
58	.	_	.	.	_	5	punct	_	_

1	Erythroid	_	JJ	JJ	_	3	amod	_	_
2	colony	_	NN	NN	_	3	nn	_	_
3	growth	_	NN	NN	_	6	nsubjpass	_	_
4	was	_	VBD	VBD	_	6	auxpass	_	_
5	also	_	RB	RB	_	6	advmod	_	_
6	inhibited	_	VBN	VBN	_	0	root	_	_
7	when	_	WRB	WRB	_	11	advmod	_	_
8	CD34+	_	JJ	JJ	_	9	amod	_	_
9	progenitors	_	NNS	NNS	_	11	nsubjpass	_	_
10	were	_	VBD	VBD	_	11	auxpass	_	_
11	seeded	_	VBN	VBN	_	6	advcl	_	_
12	at	_	IN	IN	_	11	prep	_	_
13	one	_	CD	CD	_	14	num	_	_
14	cell	_	NN	NN	_	12	pobj	_	_
15	per	_	IN	IN	_	11	prep	_	_
16	well	_	NN	NN	_	15	pobj	_	_
17	,	_	,	,	_	6	punct	_	_
18	suggesting	_	VBG	VBG	_	6	xcomp	_	_
19	a	_	DT	DT	_	21	det	_	_
20	direct	_	JJ	JJ	_	21	amod	_	_
21	action	_	NN	NN	_	18	dobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	RA	_	NN	NN	_	22	pobj	_	_
24	.	_	.	.	_	6	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	synthetic	_	JJ	JJ	_	3	amod	_	_
3	ligands	_	NNS	NNS	_	1	dobj	_	_
4	to	_	TO	TO	_	3	prep	_	_
5	retinoic	_	JJ	JJ	_	7	amod	_	_
6	acid	_	NN	NN	_	7	nn	_	_
7	receptors	_	NNS	NNS	_	4	pobj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	RARs	_	NNS	NNS	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	and	_	CC	CC	_	7	cc	_	_
12	retinoid	_	NN	NN	_	14	nn	_	_
13	X	_	NN	NN	_	14	nn	_	_
14	receptors	_	NNS	NNS	_	7	conj	_	_
15	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
16	RXRs	_	NNS	NNS	_	14	appos	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	that	_	WDT	WDT	_	20	nsubj	_	_
19	selectively	_	RB	RB	_	20	advmod	_	_
20	bind	_	VBP	VBP	_	7	rcmod	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	activate	_	VBP	VBP	_	20	conj	_	_
23	RAR-RXR	_	NN	NN	_	20	dobj	_	_
24	or	_	CC	CC	_	23	cc	_	_
25	RXR-RXR	_	JJ	JJ	_	23	conj	_	_
26	dimers	_	NNS	NNS	_	23	dep	_	_
27	,	_	,	,	_	20	punct	_	_
28	respectively	_	RB	RB	_	20	advmod	_	_
29	,	_	,	,	_	1	punct	_	_
30	we	_	PRP	PRP	_	31	nsubj	_	_
31	dissected	_	VBD	VBD	_	1	parataxis	_	_
32	the	_	DT	DT	_	33	det	_	_
33	involvement	_	NN	NN	_	31	dobj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	the	_	DT	DT	_	39	det	_	_
36	two	_	CD	CD	_	39	num	_	_
37	retinoid	_	NN	NN	_	39	nn	_	_
38	response	_	NN	NN	_	39	nn	_	_
39	pathways	_	NNS	NNS	_	34	pobj	_	_
40	in	_	IN	IN	_	33	prep	_	_
41	the	_	DT	DT	_	42	det	_	_
42	regulation	_	NN	NN	_	40	pobj	_	_
43	of	_	IN	IN	_	42	prep	_	_
44	normal	_	JJ	JJ	_	45	amod	_	_
45	myeloid	_	JJ	JJ	_	43	pobj	_	_
46	and	_	CC	CC	_	45	cc	_	_
47	erythroid	_	JJ	JJ	_	48	amod	_	_
48	progenitor	_	NN	NN	_	45	conj	_	_
49	cell	_	NN	NN	_	50	nn	_	_
50	growth	_	NN	NN	_	45	dep	_	_
51	.	_	.	.	_	1	punct	_	_

1	Transactivation	_	NN	NN	_	2	nn	_	_
2	studies	_	NNS	NNS	_	3	nsubj	_	_
3	showed	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	24	mark	_	_
5	both	_	CC	CC	_	7	preconj	_	_
6	the	_	DT	DT	_	7	det	_	_
7	RAR	_	NN	NN	_	24	nsubj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	Ro	_	NN	NN	_	7	appos	_	_
10	13-7410	_	CD	CD	_	9	num	_	_
11	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
12	and	_	CC	CC	_	7	cc	_	_
13	RXR	_	NN	NN	_	7	conj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	Ro	_	NN	NN	_	13	dep	_	_
16	25-6603	_	CD	CD	_	15	num	_	_
17	and	_	CC	CC	_	15	cc	_	_
18	Ro	_	NN	NN	_	15	conj	_	_
19	25-7386	_	CD	CD	_	18	num	_	_
20	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
21	ligands	_	NNS	NNS	_	7	dep	_	_
22	were	_	VBD	VBD	_	24	cop	_	_
23	highly	_	RB	RB	_	24	advmod	_	_
24	selective	_	JJ	JJ	_	3	ccomp	_	_
25	at	_	IN	IN	_	24	prep	_	_
26	100	_	CD	CD	_	27	num	_	_
27	nmol/L	_	NN	NN	_	25	pobj	_	_
28	.	_	.	.	_	3	punct	_	_

1	At	_	IN	IN	_	8	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	concentration	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	8	punct	_	_
5	Ro	_	NN	NN	_	8	nsubj	_	_
6	13-7410	_	CD	CD	_	5	num	_	_
7	potently	_	RB	RB	_	8	advmod	_	_
8	inhibited	_	VBD	VBD	_	0	root	_	_
9	G-CSF-stimulated	_	JJ	JJ	_	10	amod	_	_
10	myeloid	_	JJ	JJ	_	8	dobj	_	_
11	as	_	RB	RB	_	12	advmod	_	_
12	well	_	RB	RB	_	10	cc	_	_
13	as	_	IN	IN	_	12	mwe	_	_
14	SCF	_	NN	NN	_	10	conj	_	_
15	+	_	CC	CC	_	14	cc	_	_
16	Epo-induced	_	JJ	JJ	_	14	conj	_	_
17	erythroid	_	JJ	JJ	_	14	amod	_	_
18	colony	_	NN	NN	_	19	nn	_	_
19	growth	_	NN	NN	_	10	dep	_	_
20	.	_	.	.	_	8	punct	_	_

1	At	_	IN	IN	_	11	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	same	_	JJ	JJ	_	4	amod	_	_
4	concentration	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	11	punct	_	_
6	Ro	_	NN	NN	_	11	nsubj	_	_
7	25-6603	_	CD	CD	_	6	num	_	_
8	and	_	CC	CC	_	6	cc	_	_
9	Ro	_	NN	NN	_	6	conj	_	_
10	25-7386	_	CD	CD	_	9	num	_	_
11	had	_	VBD	VBD	_	0	root	_	_
12	little	_	JJ	JJ	_	11	dobj	_	_
13	or	_	CC	CC	_	12	cc	_	_
14	no	_	DT	DT	_	12	conj	_	_
15	effect	_	NN	NN	_	12	dep	_	_
16	on	_	IN	IN	_	11	prep	_	_
17	G-CSF-induced	_	JJ	JJ	_	19	amod	_	_
18	colony	_	NN	NN	_	19	nn	_	_
19	formation	_	NN	NN	_	16	pobj	_	_
20	,	_	,	,	_	11	punct	_	_
21	whereas	_	IN	IN	_	23	mark	_	_
22	they	_	PRP	PRP	_	23	nsubj	_	_
23	inhibited	_	VBD	VBD	_	11	advcl	_	_
24	75	_	CD	CD	_	25	num	_	_
25	%	_	NN	NN	_	23	dobj	_	_
26	and	_	CC	CC	_	25	cc	_	_
27	53	_	CD	CD	_	28	num	_	_
28	%	_	NN	NN	_	25	conj	_	_
29	,	_	,	,	_	25	punct	_	_
30	respectively	_	RB	RB	_	25	advmod	_	_
31	,	_	,	,	_	25	punct	_	_
32	of	_	IN	IN	_	25	conj	_	_
33	SCF	_	NN	NN	_	38	amod	_	_
34	+	_	CC	CC	_	33	cc	_	_
35	Epo-stimulated	_	JJ	JJ	_	33	conj	_	_
36	BFU-E	_	NN	NN	_	38	nn	_	_
37	colony	_	NN	NN	_	38	nn	_	_
38	growth	_	NN	NN	_	32	pobj	_	_
39	.	_	.	.	_	11	punct	_	_

1	Thus	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	the	_	DT	DT	_	6	det	_	_
4	RAR-RXR	_	JJ	JJ	_	6	nn	_	_
5	response	_	NN	NN	_	6	nn	_	_
6	pathway	_	NN	NN	_	8	nsubj	_	_
7	can	_	MD	MD	_	8	aux	_	_
8	signal	_	VB	VB	_	0	root	_	_
9	growth	_	NN	NN	_	10	nn	_	_
10	inhibition	_	NN	NN	_	8	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	normal	_	JJ	JJ	_	14	amod	_	_
13	bone	_	NN	NN	_	14	nn	_	_
14	marrow	_	NN	NN	_	11	pobj	_	_
15	myeloid	_	JJ	JJ	_	14	amod	_	_
16	and	_	CC	CC	_	14	cc	_	_
17	erythroid	_	JJ	JJ	_	18	amod	_	_
18	progenitor	_	NN	NN	_	14	conj	_	_
19	cells	_	NNS	NNS	_	14	dep	_	_
20	.	_	.	.	_	8	punct	_	_

1	In	_	IN	IN	_	5	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	5	punct	_	_
4	we	_	PRP	PRP	_	5	nsubj	_	_
5	demonstrate	_	VBP	VBP	_	0	root	_	_
6	a	_	DT	DT	_	8	det	_	_
7	unique	_	JJ	JJ	_	8	amod	_	_
8	involvement	_	NN	NN	_	5	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	RXR-RXR	_	JJ	JJ	_	12	nn	_	_
12	pathway	_	NN	NN	_	9	pobj	_	_
13	in	_	IN	IN	_	8	prep	_	_
14	mediating	_	VBG	VBG	_	13	pcomp	_	_
15	growth	_	NN	NN	_	16	nn	_	_
16	inhibition	_	NN	NN	_	14	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	erythroid	_	JJ	JJ	_	17	pobj	_	_
19	but	_	CC	CC	_	20	cc	_	_
20	not	_	RB	RB	_	18	cc	_	_
21	myeloid	_	JJ	JJ	_	23	amod	_	_
22	progenitor	_	NN	NN	_	23	nn	_	_
23	cells	_	NNS	NNS	_	18	conj	_	_
24	.	_	.	.	_	5	punct	_	_

1	Expression	_	NN	NN	_	12	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	A-myb	_	NN	NN	_	2	pobj	_	_
4	,	_	,	,	_	3	punct	_	_
5	but	_	CC	CC	_	6	cc	_	_
6	not	_	RB	RB	_	3	cc	_	_
7	c-myb	_	NN	NN	_	3	conj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	B-myb	_	NN	NN	_	7	conj	_	_
10	,	_	,	,	_	1	punct	_	_
11	is	_	VBZ	VBZ	_	12	cop	_	_
12	restricted	_	JJ	JJ	_	0	root	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	Burkitt	_	NN	NN	_	16	poss	_	_
15	's	_	POS	POS	_	16	possessive	_	_
16	lymphoma	_	NN	NN	_	13	pobj	_	_
17	,	_	,	,	_	16	punct	_	_
18	sIg+	_	NN	NN	_	21	nn	_	_
19	B-acute	_	JJ	JJ	_	21	amod	_	_
20	lymphoblastic	_	JJ	JJ	_	21	amod	_	_
21	leukemia	_	NN	NN	_	16	conj	_	_
22	,	_	,	,	_	16	punct	_	_
23	and	_	CC	CC	_	16	cc	_	_
24	a	_	DT	DT	_	25	det	_	_
25	subset	_	NN	NN	_	16	conj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	chronic	_	JJ	JJ	_	28	amod	_	_
28	lymphocytic	_	JJ	JJ	_	29	amod	_	_
29	leukemias	_	NNS	NNS	_	26	pobj	_	_
30	.	_	.	.	_	12	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	A-myb	_	NN	NN	_	3	nn	_	_
3	gene	_	NN	NN	_	4	nsubj	_	_
4	encodes	_	VBZ	VBZ	_	0	root	_	_
5	a	_	DT	DT	_	7	det	_	_
6	transcription	_	NN	NN	_	7	nn	_	_
7	factor	_	NN	NN	_	4	dobj	_	_
8	that	_	WDT	WDT	_	10	nsubj	_	_
9	is	_	VBZ	VBZ	_	10	cop	_	_
10	related	_	JJ	JJ	_	7	rcmod	_	_
11	both	_	CC	CC	_	12	preconj	_	_
12	functionally	_	RB	RB	_	10	advmod	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	structurally	_	RB	RB	_	12	conj	_	_
15	to	_	TO	TO	_	10	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	v-myb	_	NN	NN	_	18	nn	_	_
18	oncogene	_	NN	NN	_	15	pobj	_	_
19	.	_	.	.	_	4	punct	_	_

1	Following	_	VBG	VBG	_	31	prep	_	_
2	our	_	PRP$	PRP$	_	3	poss	_	_
3	observations	_	NNS	NNS	_	1	pobj	_	_
4	that	_	IN	IN	_	7	mark	_	_
5	A-myb	_	NN	NN	_	7	nsubjpass	_	_
6	is	_	VBZ	VBZ	_	7	auxpass	_	_
7	expressed	_	VBN	VBN	_	3	ccomp	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	a	_	DT	DT	_	11	det	_	_
10	restricted	_	JJ	JJ	_	11	amod	_	_
11	subset	_	NN	NN	_	8	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	normal	_	JJ	JJ	_	17	amod	_	_
14	mature	_	JJ	JJ	_	17	amod	_	_
15	human	_	JJ	JJ	_	17	amod	_	_
16	B	_	NN	NN	_	17	nn	_	_
17	lymphocytes	_	NNS	NNS	_	12	pobj	_	_
18	,	_	,	,	_	7	punct	_	_
19	with	_	IN	IN	_	7	prep	_	_
20	the	_	DT	DT	_	21	det	_	_
21	phenotype	_	NN	NN	_	19	pobj	_	_
22	CD38+	_	NN	NN	_	21	dep	_	_
23	,	_	,	,	_	21	punct	_	_
24	CD39-	_	NN	NN	_	21	appos	_	_
25	,	_	,	,	_	21	punct	_	_
26	slgM-	_	JJ	JJ	_	21	appos	_	_
27	,	_	,	,	_	31	punct	_	_
28	we	_	PRP	PRP	_	31	nsubj	_	_
29	have	_	VBP	VBP	_	31	aux	_	_
30	now	_	RB	RB	_	31	advmod	_	_
31	investigated	_	VBN	VBN	_	0	root	_	_
32	the	_	DT	DT	_	33	det	_	_
33	pattern	_	NN	NN	_	31	dobj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	A-myb	_	NN	NN	_	36	nn	_	_
36	expression	_	NN	NN	_	34	pobj	_	_
37	in	_	IN	IN	_	36	prep	_	_
38	neoplastic	_	JJ	JJ	_	40	amod	_	_
39	B	_	NN	NN	_	40	nn	_	_
40	cells	_	NNS	NNS	_	37	pobj	_	_
41	representating	_	VBG	VBG	_	40	vmod	_	_
42	the	_	DT	DT	_	44	det	_	_
43	whole	_	JJ	JJ	_	44	amod	_	_
44	spectrum	_	NN	NN	_	41	dobj	_	_
45	of	_	IN	IN	_	44	prep	_	_
46	B-cell	_	NN	NN	_	47	nn	_	_
47	differentiation	_	NN	NN	_	45	pobj	_	_
48	and	_	CC	CC	_	31	cc	_	_
49	compared	_	VBD	VBD	_	31	conj	_	_
50	it	_	PRP	PRP	_	49	dobj	_	_
51	to	_	TO	TO	_	49	prep	_	_
52	that	_	DT	DT	_	51	pobj	_	_
53	of	_	IN	IN	_	52	prep	_	_
54	c-myb	_	NN	NN	_	53	pobj	_	_
55	and	_	CC	CC	_	54	cc	_	_
56	B-myb	_	NN	NN	_	54	conj	_	_
57	.	_	.	.	_	31	punct	_	_

1	In	_	IN	IN	_	10	prep	_	_
2	a	_	DT	DT	_	3	det	_	_
3	panel	_	NN	NN	_	1	pobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	32	_	CD	CD	_	7	num	_	_
6	B-cell	_	NN	NN	_	7	nn	_	_
7	lines	_	NNS	NNS	_	4	pobj	_	_
8	,	_	,	,	_	10	punct	_	_
9	A-myb	_	NN	NN	_	10	nsubj	_	_
10	was	_	VBD	VBD	_	0	root	_	_
11	very	_	RB	RB	_	12	advmod	_	_
12	strongly	_	RB	RB	_	10	advmod	_	_
13	expressed	_	VBN	VBN	_	12	dep	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	most	_	JJS	JJS	_	23	amod	_	_
16	Burkitt	_	NN	NN	_	18	poss	_	_
17	's	_	POS	POS	_	18	possessive	_	_
18	lymphoma	_	NN	NN	_	23	nn	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	BL	_	NN	NN	_	18	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	cell	_	NN	NN	_	23	nn	_	_
23	lines	_	NNS	NNS	_	14	pobj	_	_
24	,	_	,	,	_	12	punct	_	_
25	but	_	CC	CC	_	12	cc	_	_
26	weak	_	JJ	JJ	_	12	conj	_	_
27	or	_	CC	CC	_	26	cc	_	_
28	negative	_	JJ	JJ	_	26	conj	_	_
29	in	_	IN	IN	_	26	prep	_	_
30	2	_	CD	CD	_	31	num	_	_
31	pre-B	_	NN	NN	_	29	pobj	_	_
32	acute	_	JJ	JJ	_	34	amod	_	_
33	lymphoblastic	_	JJ	JJ	_	34	amod	_	_
34	leukemia	_	NN	NN	_	31	dep	_	_
35	-LRB-	_	-LRB-	-LRB-	_	36	punct	_	_
36	ALL	_	NN	NN	_	34	appos	_	_
37	-RRB-	_	-RRB-	-RRB-	_	36	punct	_	_
38	,	_	,	,	_	31	punct	_	_
39	4	_	CD	CD	_	42	num	_	_
40	non-Hodgkin	_	JJ	JJ	_	42	amod	_	_
41	's	_	POS	POS	_	42	possessive	_	_
42	lymphoma	_	NN	NN	_	31	conj	_	_
43	-LRB-	_	-LRB-	-LRB-	_	44	punct	_	_
44	NHL	_	NN	NN	_	42	appos	_	_
45	-RRB-	_	-RRB-	-RRB-	_	44	punct	_	_
46	,	_	,	,	_	31	punct	_	_
47	6	_	CD	CD	_	52	num	_	_
48	Epstein-Barr	_	JJ	JJ	_	52	amod	_	_
49	virus-immortalized	_	JJ	JJ	_	52	amod	_	_
50	lymphoblastoid	_	JJ	JJ	_	52	amod	_	_
51	cell	_	NN	NN	_	52	nn	_	_
52	lines	_	NNS	NNS	_	31	conj	_	_
53	,	_	,	,	_	31	punct	_	_
54	and	_	CC	CC	_	31	cc	_	_
55	6	_	CD	CD	_	57	num	_	_
56	myeloma	_	NN	NN	_	57	nn	_	_
57	lines	_	NNS	NNS	_	31	conj	_	_
58	.	_	.	.	_	10	punct	_	_

1	Protein	_	NN	NN	_	2	nn	_	_
2	expression	_	NN	NN	_	3	nsubj	_	_
3	paralleled	_	VBD	VBD	_	0	root	_	_
4	that	_	DT	DT	_	3	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	RNA	_	NN	NN	_	5	pobj	_	_
8	.	_	.	.	_	3	punct	_	_

1	We	_	PRP	PRP	_	4	nsubj	_	_
2	have	_	VBP	VBP	_	4	aux	_	_
3	also	_	RB	RB	_	4	advmod	_	_
4	investigated	_	VBN	VBN	_	0	root	_	_
5	A-myb	_	NN	NN	_	6	nn	_	_
6	expression	_	NN	NN	_	4	dobj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	49	_	CD	CD	_	10	num	_	_
9	fresh	_	JJ	JJ	_	10	amod	_	_
10	cases	_	NNS	NNS	_	7	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	B	_	NN	NN	_	13	nn	_	_
13	leukemias	_	NN	NN	_	11	pobj	_	_
14	.	_	.	.	_	4	punct	_	_

1	Among	_	IN	IN	_	6	prep	_	_
2	24	_	CD	CD	_	3	num	_	_
3	ALL	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	6	_	CD	CD	_	6	nsubj	_	_
6	were	_	VBD	VBD	_	0	root	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	null	_	JJ	JJ	_	7	pobj	_	_
10	and	_	CC	CC	_	6	cc	_	_
11	11	_	CD	CD	_	6	conj	_	_
12	of	_	IN	IN	_	11	dep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	common	_	JJ	JJ	_	15	amod	_	_
15	type	_	NN	NN	_	12	pobj	_	_
16	and	_	CC	CC	_	6	cc	_	_
17	all	_	DT	DT	_	18	dep	_	_
18	these	_	DT	DT	_	20	nsubj	_	_
19	were	_	VBD	VBD	_	20	cop	_	_
20	negative	_	JJ	JJ	_	6	conj	_	_
21	for	_	IN	IN	_	20	prep	_	_
22	A-myb	_	NN	NN	_	23	nn	_	_
23	expression	_	NN	NN	_	21	pobj	_	_
24	;	_	:	:	_	6	punct	_	_
25	on	_	IN	IN	_	50	prep	_	_
26	the	_	DT	DT	_	28	det	_	_
27	other	_	JJ	JJ	_	28	amod	_	_
28	hand	_	NN	NN	_	25	pobj	_	_
29	,	_	,	,	_	50	punct	_	_
30	all	_	DT	DT	_	33	det	_	_
31	7	_	CD	CD	_	33	num	_	_
32	B-ALL	_	NN	NN	_	33	nn	_	_
33	cases	_	NNS	NNS	_	50	nsubj	_	_
34	-LRB-	_	-LRB-	-LRB-	_	35	punct	_	_
35	slg+	_	JJ	JJ	_	33	dep	_	_
36	-RRB-	_	-RRB-	-RRB-	_	35	punct	_	_
37	,	_	,	,	_	33	punct	_	_
38	as	_	RB	RB	_	39	advmod	_	_
39	well	_	RB	RB	_	33	cc	_	_
40	as	_	IN	IN	_	39	mwe	_	_
41	one	_	CD	CD	_	44	num	_	_
42	fresh	_	JJ	JJ	_	44	amod	_	_
43	BL	_	NN	NN	_	44	nn	_	_
44	case	_	NN	NN	_	33	conj	_	_
45	with	_	IN	IN	_	44	prep	_	_
46	bone	_	NN	NN	_	48	nn	_	_
47	marrow	_	NN	NN	_	48	nn	_	_
48	infiltration	_	NN	NN	_	45	pobj	_	_
49	,	_	,	,	_	33	punct	_	_
50	expressed	_	VBD	VBD	_	6	parataxis	_	_
51	A-myb	_	NN	NN	_	50	dobj	_	_
52	.	_	.	.	_	6	punct	_	_

1	A-myb	_	NN	NN	_	3	nsubj	_	_
2	was	_	VBD	VBD	_	3	cop	_	_
3	undetectable	_	JJ	JJ	_	0	root	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	4	_	CD	CD	_	7	num	_	_
6	prolymphocytic	_	JJ	JJ	_	7	amod	_	_
7	leukemias	_	NNS	NNS	_	4	pobj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	PLL	_	NN	NN	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	but	_	CC	CC	_	3	cc	_	_
12	was	_	VBD	VBD	_	14	auxpass	_	_
13	strongly	_	RB	RB	_	14	advmod	_	_
14	expressed	_	VBN	VBN	_	3	conj	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	5/20	_	CD	CD	_	15	pobj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
18	25	_	CD	CD	_	19	num	_	_
19	%	_	NN	NN	_	16	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	of	_	IN	IN	_	16	prep	_	_
22	chronic	_	JJ	JJ	_	24	amod	_	_
23	lymphocytic	_	JJ	JJ	_	24	amod	_	_
24	leukemia	_	NN	NN	_	28	nn	_	_
25	-LRB-	_	-LRB-	-LRB-	_	26	punct	_	_
26	CLL	_	NN	NN	_	24	appos	_	_
27	-RRB-	_	-RRB-	-RRB-	_	26	punct	_	_
28	samples	_	NNS	NNS	_	21	pobj	_	_
29	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	the	_	DT	DT	_	3	det	_	_
3	latter	_	JJ	JJ	_	1	pobj	_	_
4	A-myb	_	NN	NN	_	7	nsubj	_	_
5	did	_	VBD	VBD	_	7	aux	_	_
6	not	_	RB	RB	_	7	neg	_	_
7	correlate	_	VB	VB	_	0	root	_	_
8	with	_	IN	IN	_	7	prep	_	_
9	phenotype	_	NN	NN	_	8	pobj	_	_
10	or	_	CC	CC	_	9	cc	_	_
11	clinical	_	JJ	JJ	_	12	amod	_	_
12	stage	_	NN	NN	_	9	conj	_	_
13	.	_	.	.	_	7	punct	_	_

1	Finally	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	we	_	PRP	PRP	_	5	nsubj	_	_
4	have	_	VBP	VBP	_	5	aux	_	_
5	studied	_	VBN	VBN	_	0	root	_	_
6	the	_	DT	DT	_	7	det	_	_
7	progression	_	NN	NN	_	5	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	one	_	CD	CD	_	10	num	_	_
10	case	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	CLL	_	NN	NN	_	11	pobj	_	_
13	into	_	IN	IN	_	7	prep	_	_
14	Richter	_	NN	NN	_	16	poss	_	_
15	's	_	POS	POS	_	16	possessive	_	_
16	syndrome	_	NN	NN	_	13	pobj	_	_
17	and	_	CC	CC	_	5	cc	_	_
18	have	_	VBP	VBP	_	19	aux	_	_
19	found	_	VBN	VBN	_	5	conj	_	_
20	that	_	IN	IN	_	25	mark	_	_
21	the	_	DT	DT	_	24	det	_	_
22	Richter	_	NN	NN	_	24	poss	_	_
23	's	_	POS	POS	_	24	possessive	_	_
24	cells	_	NNS	NNS	_	25	nsubj	_	_
25	expressed	_	VBD	VBD	_	19	ccomp	_	_
26	about	_	RB	RB	_	27	advmod	_	_
27	25-fold	_	RB	RB	_	28	npadvmod	_	_
28	less	_	JJR	JJR	_	30	amod	_	_
29	A-myb	_	NN	NN	_	30	nn	_	_
30	RNA	_	NN	NN	_	25	dobj	_	_
31	than	_	IN	IN	_	30	prep	_	_
32	the	_	DT	DT	_	34	det	_	_
33	CLL	_	NN	NN	_	34	nn	_	_
34	cells	_	NNS	NNS	_	31	pobj	_	_
35	from	_	IN	IN	_	34	prep	_	_
36	the	_	DT	DT	_	38	det	_	_
37	same	_	JJ	JJ	_	38	amod	_	_
38	patient	_	NN	NN	_	35	pobj	_	_
39	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	pattern	_	NN	NN	_	9	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	c-myb	_	NN	NN	_	3	pobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	B-myb	_	NN	NN	_	4	conj	_	_
7	was	_	VBD	VBD	_	9	cop	_	_
8	clearly	_	RB	RB	_	9	advmod	_	_
9	distinct	_	JJ	JJ	_	0	root	_	_
10	from	_	IN	IN	_	9	prep	_	_
11	that	_	DT	DT	_	10	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	A-myb	_	NN	NN	_	12	pobj	_	_
14	.	_	.	.	_	9	punct	_	_

1	C-myb	_	NN	NN	_	5	nsubjpass	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	B-myb	_	NN	NN	_	1	conj	_	_
4	were	_	VBD	VBD	_	5	auxpass	_	_
5	expressed	_	VBN	VBN	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	all	_	DT	DT	_	9	det	_	_
8	neoplastic	_	JJ	JJ	_	9	amod	_	_
9	groups	_	NNS	NNS	_	6	pobj	_	_
10	,	_	,	,	_	5	punct	_	_
11	except	_	IN	IN	_	5	prep	_	_
12	in	_	IN	IN	_	11	pcomp	_	_
13	CLL	_	NN	NN	_	14	nn	_	_
14	cells	_	NNS	NNS	_	12	pobj	_	_
15	.	_	.	.	_	5	punct	_	_

1	Thus	_	RB	RB	_	14	advmod	_	_
2	,	_	,	,	_	14	punct	_	_
3	A-myb	_	NN	NN	_	4	nn	_	_
4	expression	_	NN	NN	_	14	nsubj	_	_
5	,	_	,	,	_	4	punct	_	_
6	unlike	_	IN	IN	_	14	prep	_	_
7	that	_	DT	DT	_	6	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	c-myb	_	NN	NN	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	B-myb	_	NN	NN	_	9	conj	_	_
12	,	_	,	,	_	14	punct	_	_
13	is	_	VBZ	VBZ	_	14	cop	_	_
14	restricted	_	JJ	JJ	_	0	root	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	a	_	DT	DT	_	17	det	_	_
17	subset	_	NN	NN	_	28	nn	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	B-cell	_	NN	NN	_	20	nn	_	_
20	neoplasias	_	NN	NN	_	18	pobj	_	_
21	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
22	in	_	IN	IN	_	24	prep	_	_
23	particular	_	JJ	JJ	_	22	pobj	_	_
24	BL	_	NN	NN	_	17	dep	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	slg+B-ALL	_	NN	NN	_	24	conj	_	_
27	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
28	representative	_	NN	NN	_	15	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	a	_	DT	DT	_	32	det	_	_
31	specific	_	JJ	JJ	_	32	amod	_	_
32	stage	_	NN	NN	_	29	pobj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	B-cell	_	NN	NN	_	35	nn	_	_
35	differentiation	_	NN	NN	_	33	pobj	_	_
36	.	_	.	.	_	14	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	expression	_	NN	NN	_	6	nsubj	_	_
3	may	_	NN	NN	_	6	dep	_	_
4	in	_	IN	IN	_	6	prep	_	_
5	part	_	NN	NN	_	4	pobj	_	_
6	reflect	_	VBP	VBP	_	0	root	_	_
7	expression	_	NN	NN	_	6	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	A-myb	_	NN	NN	_	8	pobj	_	_
10	by	_	IN	IN	_	7	prep	_	_
11	the	_	DT	DT	_	14	det	_	_
12	normal	_	JJ	JJ	_	14	amod	_	_
13	germinal	_	JJ	JJ	_	14	amod	_	_
14	center	_	NN	NN	_	10	pobj	_	_
15	B	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	14	dep	_	_
17	that	_	WDT	WDT	_	21	nsubj	_	_
18	are	_	VBP	VBP	_	21	cop	_	_
19	the	_	DT	DT	_	21	det	_	_
20	normal	_	JJ	JJ	_	21	amod	_	_
21	counterpart	_	NN	NN	_	14	rcmod	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	these	_	DT	DT	_	26	det	_	_
24	transformed	_	VBN	VBN	_	26	amod	_	_
25	B	_	NN	NN	_	26	nn	_	_
26	cells	_	NNS	NNS	_	22	pobj	_	_
27	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	5	nsubj	_	_
3	presented	_	VBN	VBN	_	2	vmod	_	_
4	strongly	_	RB	RB	_	5	advmod	_	_
5	support	_	VBP	VBP	_	0	root	_	_
6	a	_	DT	DT	_	7	det	_	_
7	role	_	NN	NN	_	5	dobj	_	_
8	for	_	IN	IN	_	7	prep	_	_
9	this	_	DT	DT	_	11	det	_	_
10	transcription	_	NN	NN	_	11	nn	_	_
11	factor	_	NN	NN	_	8	pobj	_	_
12	in	_	IN	IN	_	7	prep	_	_
13	B-cell	_	NN	NN	_	14	nn	_	_
14	differentiation	_	NN	NN	_	12	pobj	_	_
15	and	_	CC	CC	_	12	cc	_	_
16	perhaps	_	RB	RB	_	17	advmod	_	_
17	in	_	IN	IN	_	12	conj	_	_
18	B-cell	_	NN	NN	_	19	nn	_	_
19	transformation	_	NN	NN	_	17	pobj	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	some	_	DT	DT	_	22	det	_	_
22	neoplasias	_	NNS	NNS	_	20	pobj	_	_
23	.	_	.	.	_	5	punct	_	_

1	Lymphoid	_	JJ	JJ	_	3	amod	_	_
2	cell	_	NN	NN	_	3	nn	_	_
3	resistance	_	NN	NN	_	0	root	_	_
4	to	_	TO	TO	_	3	prep	_	_
5	glucocorticoids	_	NNS	NNS	_	4	pobj	_	_
6	in	_	IN	IN	_	3	prep	_	_
7	HIV	_	NN	NN	_	8	nn	_	_
8	infection	_	NN	NN	_	6	pobj	_	_
9	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	13	prep	_	_
2	humans	_	NNS	NNS	_	1	pobj	_	_
3	infected	_	VBN	VBN	_	2	vmod	_	_
4	with	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	HIV-1	_	NN	NN	_	7	nn	_	_
7	virus	_	NN	NN	_	4	pobj	_	_
8	there	_	EX	EX	_	13	expl	_	_
9	may	_	MD	MD	_	13	aux	_	_
10	be	_	VB	VB	_	13	cop	_	_
11	a	_	DT	DT	_	13	det	_	_
12	disproportionate	_	JJ	JJ	_	13	amod	_	_
13	severity	_	NN	NN	_	0	root	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	signs	_	NNS	NNS	_	14	pobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	symptoms	_	NNS	NNS	_	15	conj	_	_
18	of	_	IN	IN	_	15	prep	_	_
19	illness	_	NN	NN	_	18	pobj	_	_
20	compared	_	VBN	VBN	_	13	prep	_	_
21	to	_	TO	TO	_	20	pcomp	_	_
22	the	_	DT	DT	_	23	det	_	_
23	fraction	_	NN	NN	_	21	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	CD4+	_	JJ	JJ	_	28	amod	_	_
26	infected	_	JJ	JJ	_	28	amod	_	_
27	T-lymphoid	_	NN	NN	_	28	nn	_	_
28	cells	_	NNS	NNS	_	24	pobj	_	_
29	.	_	.	.	_	13	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	part	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	7	punct	_	_
4	this	_	DT	DT	_	7	nsubj	_	_
5	may	_	MD	MD	_	7	aux	_	_
6	be	_	VB	VB	_	7	cop	_	_
7	due	_	JJ	JJ	_	0	root	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	altered	_	JJ	JJ	_	12	amod	_	_
10	intercellular	_	JJ	JJ	_	12	amod	_	_
11	signalling	_	NN	NN	_	12	nn	_	_
12	systems	_	NNS	NNS	_	8	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	intracellular	_	JJ	JJ	_	16	amod	_	_
15	signal	_	NN	NN	_	16	nn	_	_
16	transduction	_	NN	NN	_	12	conj	_	_
17	.	_	.	.	_	7	punct	_	_

1	Glucocorticoids	_	NNS	NNS	_	4	nsubj	_	_
2	are	_	VBP	VBP	_	4	cop	_	_
3	well	_	RB	RB	_	4	advmod	_	_
4	known	_	JJ	JJ	_	0	root	_	_
5	for	_	IN	IN	_	4	prep	_	_
6	their	_	PRP$	PRP$	_	7	poss	_	_
7	effects	_	NNS	NNS	_	5	pobj	_	_
8	on	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	10	dep	_	_
10	vitality	_	NN	NN	_	8	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	function	_	NN	NN	_	10	conj	_	_
13	of	_	IN	IN	_	10	prep	_	_
14	lymphoid	_	JJ	JJ	_	15	amod	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	.	_	.	.	_	4	punct	_	_

1	Patients	_	NNS	NNS	_	6	nsubj	_	_
2	with	_	IN	IN	_	1	prep	_	_
3	HIV	_	NN	NN	_	4	nn	_	_
4	infections	_	NNS	NNS	_	2	pobj	_	_
5	often	_	RB	RB	_	6	advmod	_	_
6	show	_	VBP	VBP	_	0	root	_	_
7	elevated	_	JJ	JJ	_	8	amod	_	_
8	circulating	_	JJ	JJ	_	9	amod	_	_
9	levels	_	NNS	NNS	_	6	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	cortisol	_	NN	NN	_	10	pobj	_	_
12	,	_	,	,	_	6	punct	_	_
13	suggesting	_	VBG	VBG	_	6	vmod	_	_
14	some	_	DT	DT	_	15	det	_	_
15	misfunction	_	NN	NN	_	13	dobj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	regulatory	_	JJ	JJ	_	19	amod	_	_
19	systems	_	NNS	NNS	_	16	pobj	_	_
20	that	_	WDT	WDT	_	21	nsubj	_	_
21	maintain	_	VBP	VBP	_	19	rcmod	_	_
22	the	_	DT	DT	_	23	det	_	_
23	levels	_	NNS	NNS	_	21	dobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	this	_	DT	DT	_	27	det	_	_
26	critical	_	JJ	JJ	_	27	amod	_	_
27	hormone	_	NN	NN	_	24	pobj	_	_
28	.	_	.	.	_	6	punct	_	_

1	At	_	IN	IN	_	8	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	cellular	_	JJ	JJ	_	4	amod	_	_
4	level	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	8	punct	_	_
6	it	_	PRP	PRP	_	8	nsubjpass	_	_
7	is	_	VBZ	VBZ	_	8	auxpass	_	_
8	known	_	VBN	VBN	_	0	root	_	_
9	that	_	IN	IN	_	17	mark	_	_
10	both	_	CC	CC	_	13	preconj	_	_
11	acute	_	JJ	JJ	_	13	amod	_	_
12	HIV	_	NN	NN	_	13	nn	_	_
13	infection	_	NN	NN	_	17	nsubj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	glucocorticoids	_	NNS	NNS	_	13	conj	_	_
16	can	_	MD	MD	_	17	aux	_	_
17	cause	_	VB	VB	_	8	ccomp	_	_
18	apoptotic	_	JJ	JJ	_	20	amod	_	_
19	cell	_	NN	NN	_	20	nn	_	_
20	death	_	NN	NN	_	17	dobj	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	thymic	_	JJ	JJ	_	23	amod	_	_
23	lymphocytes	_	NNS	NNS	_	21	pobj	_	_
24	.	_	.	.	_	8	punct	_	_

1	However	_	RB	RB	_	6	advmod	_	_
2	,	_	,	,	_	6	punct	_	_
3	chronically	_	RB	RB	_	5	advmod	_	_
4	HIV-infected	_	JJ	JJ	_	5	amod	_	_
5	cells	_	NNS	NNS	_	6	nsubj	_	_
6	appear	_	VBP	VBP	_	0	root	_	_
7	to	_	TO	TO	_	9	aux	_	_
8	be	_	VB	VB	_	9	cop	_	_
9	resistant	_	JJ	JJ	_	6	xcomp	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	glucocorticoid-evoked	_	JJ	JJ	_	13	amod	_	_
12	cell	_	NN	NN	_	13	nn	_	_
13	death	_	NN	NN	_	10	pobj	_	_
14	.	_	.	.	_	6	punct	_	_

1	Glucocorticoid	_	NN	NN	_	4	nn	_	_
2	receptor-ligand	_	NN	NN	_	4	nn	_	_
3	binding	_	NN	NN	_	4	nn	_	_
4	studies	_	NNS	NNS	_	10	nsubj	_	_
5	on	_	IN	IN	_	4	prep	_	_
6	patients	_	NNS	NNS	_	8	poss	_	_
7	'	_	POS	POS	_	8	possessive	_	_
8	cells	_	NNS	NNS	_	5	pobj	_	_
9	have	_	VBP	VBP	_	10	aux	_	_
10	shown	_	VBN	VBN	_	0	root	_	_
11	reduced	_	VBN	VBN	_	12	amod	_	_
12	affinity	_	NN	NN	_	10	dobj	_	_
13	between	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	17	dep	_	_
15	receptor	_	NN	NN	_	17	nn	_	_
16	binding	_	NN	NN	_	17	nn	_	_
17	sites	_	NNS	NNS	_	13	pobj	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	test	_	NN	NN	_	20	nn	_	_
20	steroids	_	NNS	NNS	_	17	conj	_	_
21	.	_	.	.	_	10	punct	_	_

1	In	_	FW	FW	_	2	nn	_	_
2	vitro	_	FW	FW	_	12	advmod	_	_
3	,	_	,	,	_	12	punct	_	_
4	chronically	_	RB	RB	_	6	advmod	_	_
5	HIV-infected	_	JJ	JJ	_	6	amod	_	_
6	cells	_	NNS	NNS	_	12	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	11	det	_	_
9	lymphoid	_	JJ	JJ	_	11	amod	_	_
10	CEM	_	NN	NN	_	11	nn	_	_
11	line	_	NN	NN	_	7	pobj	_	_
12	displayed	_	VBD	VBD	_	0	root	_	_
13	resistance	_	NN	NN	_	12	dobj	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	glucocorticoid-induced	_	JJ	JJ	_	16	amod	_	_
16	apoptosis	_	NN	NN	_	14	pobj	_	_
17	.	_	.	.	_	12	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	cells	_	NNS	NNS	_	3	nsubj	_	_
3	showed	_	VBD	VBD	_	0	root	_	_
4	reduced	_	VBN	VBN	_	5	amod	_	_
5	numbers	_	NNS	NNS	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	binding	_	VBG	VBG	_	8	amod	_	_
8	sites	_	NNS	NNS	_	6	pobj	_	_
9	with	_	IN	IN	_	3	prep	_	_
10	little	_	JJ	JJ	_	11	amod	_	_
11	alteration	_	NN	NN	_	9	pobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	apparent	_	JJ	JJ	_	14	amod	_	_
14	affinity	_	NN	NN	_	12	pobj	_	_
15	between	_	IN	IN	_	14	prep	_	_
16	ligand	_	NN	NN	_	15	pobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	receptor	_	NN	NN	_	16	conj	_	_
19	.	_	.	.	_	3	punct	_	_

1	Thus	_	RB	RB	_	3	advmod	_	_
2	it	_	PRP	PRP	_	3	nsubj	_	_
3	appears	_	VBZ	VBZ	_	0	root	_	_
4	that	_	IN	IN	_	9	mark	_	_
5	there	_	EX	EX	_	9	expl	_	_
6	may	_	MD	MD	_	9	aux	_	_
7	often	_	RB	RB	_	9	advmod	_	_
8	be	_	VB	VB	_	9	cop	_	_
9	malfunction	_	NN	NN	_	3	ccomp	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	14	det	_	_
12	normal	_	JJ	JJ	_	14	amod	_	_
13	glucocorticoid	_	NN	NN	_	14	nn	_	_
14	response	_	NN	NN	_	10	pobj	_	_
15	in	_	IN	IN	_	9	prep	_	_
16	HIV-infected	_	JJ	JJ	_	17	amod	_	_
17	cells	_	NNS	NNS	_	15	pobj	_	_
18	probably	_	RB	RB	_	9	advmod	_	_
19	due	_	JJ	JJ	_	9	amod	_	_
20	to	_	TO	TO	_	19	prep	_	_
21	altered	_	JJ	JJ	_	22	amod	_	_
22	interactions	_	NNS	NNS	_	20	pobj	_	_
23	between	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	26	det	_	_
25	glucocorticoid	_	NN	NN	_	26	nn	_	_
26	receptor	_	NN	NN	_	23	pobj	_	_
27	and	_	CC	CC	_	26	cc	_	_
28	its	_	PRP$	PRP$	_	29	poss	_	_
29	hormone	_	NN	NN	_	26	conj	_	_
30	.	_	.	.	_	3	punct	_	_

1	Such	_	JJ	JJ	_	2	amod	_	_
2	alterations	_	NNS	NNS	_	4	nsubj	_	_
3	may	_	MD	MD	_	4	aux	_	_
4	have	_	VB	VB	_	0	root	_	_
5	clinical	_	JJ	JJ	_	6	amod	_	_
6	consequences	_	NNS	NNS	_	4	dobj	_	_
7	,	_	,	,	_	6	punct	_	_
8	including	_	VBG	VBG	_	6	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	possibility	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	a	_	DT	DT	_	16	det	_	_
13	relatively	_	RB	RB	_	14	advmod	_	_
14	longer	_	JJR	JJR	_	16	amod	_	_
15	life	_	NN	NN	_	16	nn	_	_
16	span	_	NN	NN	_	11	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	infected	_	JJ	JJ	_	20	amod	_	_
19	CD4+	_	JJ	JJ	_	20	amod	_	_
20	T-lymphocytes	_	NNS	NNS	_	17	pobj	_	_
21	,	_	,	,	_	10	punct	_	_
22	as	_	RB	RB	_	23	advmod	_	_
23	well	_	RB	RB	_	10	cc	_	_
24	as	_	IN	IN	_	23	mwe	_	_
25	systemic	_	JJ	JJ	_	26	amod	_	_
26	effects	_	NNS	NNS	_	10	conj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	chronically	_	RB	RB	_	29	advmod	_	_
29	elevated	_	JJ	JJ	_	31	amod	_	_
30	cortisol	_	NN	NN	_	31	nn	_	_
31	level	_	NN	NN	_	27	pobj	_	_
32	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	6	det	_	_
2	Epstein-Barr	_	JJ	JJ	_	6	amod	_	_
3	virus-encoded	_	JJ	JJ	_	6	amod	_	_
4	nuclear	_	JJ	JJ	_	6	amod	_	_
5	antigen	_	NN	NN	_	6	nn	_	_
6	EBNA-5	_	NN	NN	_	7	nsubj	_	_
7	accumulates	_	VBZ	VBZ	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	PML-containing	_	JJ	JJ	_	10	amod	_	_
10	bodies	_	NNS	NNS	_	8	pobj	_	_
11	.	_	.	.	_	7	punct	_	_

1	EBNA-5	_	NN	NN	_	3	nsubj	_	_
2	is	_	VBZ	VBZ	_	3	cop	_	_
3	one	_	CD	CD	_	0	root	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	13	det	_	_
6	Epstein-Barr	_	JJ	JJ	_	13	amod	_	_
7	virus	_	NN	NN	_	13	nn	_	_
8	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
9	EBV	_	NN	NN	_	13	nn	_	_
10	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
11	-encoded	_	JJ	JJ	_	13	amod	_	_
12	nuclear	_	JJ	JJ	_	13	amod	_	_
13	proteins	_	NNS	NNS	_	4	pobj	_	_
14	required	_	VBN	VBN	_	13	vmod	_	_
15	for	_	IN	IN	_	14	prep	_	_
16	immortalization	_	NN	NN	_	15	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	human	_	JJ	JJ	_	20	amod	_	_
19	B	_	NN	NN	_	20	nn	_	_
20	lymphocytes	_	NNS	NNS	_	17	pobj	_	_
21	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	12	prep	_	_
2	the	_	DT	DT	_	3	det	_	_
3	nuclei	_	NNS	NNS	_	1	pobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	EBV-transformed	_	JJ	JJ	_	8	amod	_	_
6	lymphoblastoid	_	JJ	JJ	_	8	amod	_	_
7	cell	_	NN	NN	_	8	nn	_	_
8	lines	_	NNS	NNS	_	4	pobj	_	_
9	EBNA-5	_	NN	NN	_	12	nsubjpass	_	_
10	is	_	VBZ	VBZ	_	12	auxpass	_	_
11	preferentially	_	RB	RB	_	12	advmod	_	_
12	targetted	_	VBN	VBN	_	0	root	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	distinct	_	JJ	JJ	_	16	amod	_	_
15	nuclear	_	JJ	JJ	_	16	amod	_	_
16	foci	_	NNS	NNS	_	13	pobj	_	_
17	.	_	.	.	_	12	punct	_	_

1	Previously	_	RB	RB	_	4	advmod	_	_
2	we	_	PRP	PRP	_	4	nsubj	_	_
3	have	_	VBP	VBP	_	4	aux	_	_
4	shown	_	VBN	VBN	_	0	root	_	_
5	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
6	W.Q.	_	NNP	NNP	_	7	nn	_	_
7	Jiang	_	NNP	NNP	_	4	dep	_	_
8	,	_	,	,	_	7	punct	_	_
9	L.Szekely	_	NNP	NNP	_	7	conj	_	_
10	,	_	,	,	_	7	punct	_	_
11	V.Wendel-Hansen	_	NNP	NNP	_	7	conj	_	_
12	,	_	,	,	_	7	punct	_	_
13	N.Ringertz	_	NNP	NNP	_	7	conj	_	_
14	,	_	,	,	_	7	punct	_	_
15	G.Klein	_	NNP	NNP	_	7	conj	_	_
16	,	_	,	,	_	7	punct	_	_
17	and	_	CC	CC	_	7	cc	_	_
18	A.	_	NNP	NNP	_	19	nn	_	_
19	Rosen	_	NNP	NNP	_	7	conj	_	_
20	,	_	,	,	_	7	punct	_	_
21	Exp.Cell	_	NNP	NNP	_	22	nn	_	_
22	Res	_	NNP	NNP	_	7	appos	_	_
23	.	_	.	.	_	4	punct	_	_

1	Heat	_	NN	NN	_	2	nn	_	_
2	shock	_	NN	NN	_	3	nsubj	_	_
3	induces	_	VBZ	VBZ	_	0	root	_	_
4	HIV-1	_	NN	NN	_	5	nn	_	_
5	replication	_	NN	NN	_	3	dobj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	chronically	_	RB	RB	_	8	advmod	_	_
8	infected	_	JJ	JJ	_	12	amod	_	_
9	promyelocyte	_	JJ	JJ	_	12	amod	_	_
10	cell	_	NN	NN	_	12	nn	_	_
11	line	_	NN	NN	_	12	nn	_	_
12	OM10.1	_	NN	NN	_	6	pobj	_	_
13	.	_	.	.	_	3	punct	_	_

1	A	_	DT	DT	_	3	det	_	_
2	long	_	JJ	JJ	_	3	amod	_	_
3	period	_	NN	NN	_	12	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	clinical	_	JJ	JJ	_	6	amod	_	_
6	latency	_	NN	NN	_	4	pobj	_	_
7	before	_	IN	IN	_	6	prep	_	_
8	development	_	NN	NN	_	7	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	symptoms	_	NNS	NNS	_	9	pobj	_	_
11	is	_	VBZ	VBZ	_	12	cop	_	_
12	characteristic	_	JJ	JJ	_	0	root	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	human	_	JJ	JJ	_	17	amod	_	_
15	immunodeficiency	_	NN	NN	_	17	nn	_	_
16	virus	_	NN	NN	_	17	nn	_	_
17	type	_	NN	NN	_	22	nn	_	_
18	1	_	CD	CD	_	17	num	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	HIV-1	_	NN	NN	_	17	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	infection	_	NN	NN	_	13	pobj	_	_
23	.	_	.	.	_	12	punct	_	_

1	OM10.1	_	NN	NN	_	14	nsubjpass	_	_
2	,	_	,	,	_	1	punct	_	_
3	a	_	DT	DT	_	6	det	_	_
4	promyelocyte	_	JJ	JJ	_	6	amod	_	_
5	cell	_	NN	NN	_	6	nn	_	_
6	line	_	NN	NN	_	1	appos	_	_
7	latently	_	RB	RB	_	8	advmod	_	_
8	infected	_	VBN	VBN	_	6	vmod	_	_
9	with	_	IN	IN	_	8	prep	_	_
10	HIV-1	_	NN	NN	_	9	pobj	_	_
11	,	_	,	,	_	1	punct	_	_
12	has	_	VBZ	VBZ	_	14	aux	_	_
13	been	_	VBN	VBN	_	14	auxpass	_	_
14	developed	_	VBN	VBN	_	0	root	_	_
15	as	_	IN	IN	_	14	prep	_	_
16	a	_	DT	DT	_	17	det	_	_
17	model	_	NN	NN	_	15	pobj	_	_
18	for	_	IN	IN	_	17	prep	_	_
19	studying	_	VBG	VBG	_	18	pcomp	_	_
20	the	_	DT	DT	_	21	det	_	_
21	mechanism	_	NN	NN	_	19	dobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	viral	_	JJ	JJ	_	24	amod	_	_
24	latency	_	NN	NN	_	22	pobj	_	_
25	and	_	CC	CC	_	21	cc	_	_
26	the	_	DT	DT	_	27	det	_	_
27	activation	_	NN	NN	_	21	conj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	virus	_	NN	NN	_	30	nn	_	_
30	expression	_	NN	NN	_	28	pobj	_	_
31	.	_	.	.	_	14	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	found	_	VBD	VBD	_	0	root	_	_
3	that	_	IN	IN	_	19	mark	_	_
4	this	_	DT	DT	_	8	det	_	_
5	latently	_	RB	RB	_	6	advmod	_	_
6	infected	_	JJ	JJ	_	8	amod	_	_
7	cell	_	NN	NN	_	8	nn	_	_
8	line	_	NN	NN	_	19	nsubj	_	_
9	with	_	IN	IN	_	8	prep	_	_
10	heat	_	NN	NN	_	11	nn	_	_
11	shock	_	NN	NN	_	9	pobj	_	_
12	at	_	IN	IN	_	11	prep	_	_
13	42	_	CD	CD	_	15	num	_	_
14	degrees	_	NNS	NNS	_	15	nn	_	_
15	C	_	NN	NN	_	12	pobj	_	_
16	for	_	IN	IN	_	11	prep	_	_
17	2	_	CD	CD	_	18	num	_	_
18	h	_	NN	NN	_	16	pobj	_	_
19	resulted	_	VBD	VBD	_	2	ccomp	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	a	_	DT	DT	_	23	det	_	_
22	high	_	JJ	JJ	_	23	amod	_	_
23	level	_	NN	NN	_	20	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	HIV-1	_	NN	NN	_	26	nn	_	_
26	production	_	NN	NN	_	24	pobj	_	_
27	without	_	IN	IN	_	23	prep	_	_
28	addition	_	NN	NN	_	27	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	any	_	DT	DT	_	31	det	_	_
31	cytokines	_	NNS	NNS	_	29	pobj	_	_
32	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	mechanism	_	NN	NN	_	6	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	activation	_	NN	NN	_	3	pobj	_	_
5	was	_	VBD	VBD	_	6	auxpass	_	_
6	analyzed	_	VBN	VBN	_	0	root	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	using	_	VBG	VBG	_	7	pcomp	_	_
9	anti-TNF-alpha	_	JJ	JJ	_	10	amod	_	_
10	antibody	_	NN	NN	_	8	dobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	various	_	JJ	JJ	_	13	amod	_	_
13	inhibitors	_	NNS	NNS	_	10	conj	_	_
14	.	_	.	.	_	6	punct	_	_

1	Although	_	IN	IN	_	8	mark	_	_
2	the	_	DT	DT	_	4	det	_	_
3	TNF-alpha	_	NN	NN	_	4	nn	_	_
4	level	_	NN	NN	_	8	nsubj	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	culture	_	NN	NN	_	7	nn	_	_
7	supernatants	_	NNS	NNS	_	5	pobj	_	_
8	was	_	VBD	VBD	_	27	advcl	_	_
9	below	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	sensitivity	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	an	_	DT	DT	_	16	det	_	_
14	ELISA	_	NN	NN	_	16	nn	_	_
15	assay	_	NN	NN	_	16	nn	_	_
16	system	_	NN	NN	_	12	pobj	_	_
17	,	_	,	,	_	27	punct	_	_
18	addition	_	NN	NN	_	27	nsubj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	anti-TNF-alpha	_	JJ	JJ	_	21	amod	_	_
21	antibody	_	NN	NN	_	19	pobj	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	culture	_	NN	NN	_	24	nn	_	_
24	medium	_	NN	NN	_	22	pobj	_	_
25	could	_	MD	MD	_	27	aux	_	_
26	partially	_	RB	RB	_	27	advmod	_	_
27	suppress	_	VB	VB	_	0	root	_	_
28	the	_	DT	DT	_	33	det	_	_
29	heat	_	NN	NN	_	33	nn	_	_
30	shock	_	NN	NN	_	33	nn	_	_
31	induced	_	JJ	JJ	_	33	amod	_	_
32	HIV-1	_	NN	NN	_	33	nn	_	_
33	production	_	NN	NN	_	27	dobj	_	_
34	.	_	.	.	_	27	punct	_	_

1	Staurosporine	_	NN	NN	_	22	nsubj	_	_
2	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
3	PKC	_	NN	NN	_	4	nn	_	_
4	inhibitor	_	NN	NN	_	1	appos	_	_
5	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
6	,	_	,	,	_	1	punct	_	_
7	pentoxifylline	_	NN	NN	_	1	conj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
9	NF-kappa	_	NN	NN	_	11	nn	_	_
10	B	_	NN	NN	_	11	nn	_	_
11	inhibitor	_	NN	NN	_	7	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	,	_	,	,	_	1	punct	_	_
14	and	_	CC	CC	_	1	cc	_	_
15	Ro5-3335	_	NN	NN	_	1	conj	_	_
16	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
17	HIV-1	_	NN	NN	_	19	nn	_	_
18	Tat	_	NN	NN	_	19	nn	_	_
19	inhibitor	_	NN	NN	_	15	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	also	_	RB	RB	_	22	advmod	_	_
22	inhibited	_	VBD	VBD	_	0	root	_	_
23	significantly	_	RB	RB	_	22	advmod	_	_
24	the	_	DT	DT	_	29	det	_	_
25	heat	_	NN	NN	_	29	nn	_	_
26	shock	_	NN	NN	_	29	nn	_	_
27	induced	_	JJ	JJ	_	29	amod	_	_
28	virus	_	NN	NN	_	29	nn	_	_
29	activation	_	NN	NN	_	22	dobj	_	_
30	.	_	.	.	_	22	punct	_	_

1	In	_	IN	IN	_	5	prep	_	_
2	particular	_	JJ	JJ	_	1	pobj	_	_
3	,	_	,	,	_	5	punct	_	_
4	staurosporine	_	NN	NN	_	5	nsubj	_	_
5	achieved	_	VBD	VBD	_	0	root	_	_
6	approximately	_	RB	RB	_	7	quantmod	_	_
7	90	_	CD	CD	_	8	dep	_	_
8	%	_	NN	NN	_	9	dep	_	_
9	inhibition	_	NN	NN	_	5	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	14	det	_	_
12	HIV-1	_	NN	NN	_	14	nn	_	_
13	antigen	_	NN	NN	_	14	nn	_	_
14	expression	_	NN	NN	_	10	pobj	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	heat	_	NN	NN	_	18	nn	_	_
17	shock-treated	_	JJ	JJ	_	18	amod	_	_
18	OM10.1	_	NN	NN	_	15	pobj	_	_
19	at	_	IN	IN	_	18	prep	_	_
20	a	_	DT	DT	_	22	det	_	_
21	non-toxic	_	JJ	JJ	_	22	amod	_	_
22	concentration	_	NN	NN	_	19	pobj	_	_
23	.	_	.	.	_	5	punct	_	_

1	Although	_	IN	IN	_	14	mark	_	_
2	the	_	DT	DT	_	3	det	_	_
3	mechanism	_	NN	NN	_	14	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	HIV-1	_	NN	NN	_	6	nn	_	_
6	activation	_	NN	NN	_	4	pobj	_	_
7	with	_	IN	IN	_	6	prep	_	_
8	heat	_	NN	NN	_	9	nn	_	_
9	shock	_	NN	NN	_	7	pobj	_	_
10	has	_	VBZ	VBZ	_	14	aux	_	_
11	not	_	RB	RB	_	14	neg	_	_
12	been	_	VBN	VBN	_	14	auxpass	_	_
13	fully	_	RB	RB	_	14	advmod	_	_
14	elucidated	_	VBN	VBN	_	19	advcl	_	_
15	yet	_	RB	RB	_	14	advmod	_	_
16	,	_	,	,	_	19	punct	_	_
17	it	_	PRP	PRP	_	19	nsubjpass	_	_
18	is	_	VBZ	VBZ	_	19	auxpass	_	_
19	presumed	_	VBN	VBN	_	0	root	_	_
20	PKC	_	NN	NN	_	19	dobj	_	_
21	plays	_	VBZ	VBZ	_	19	dep	_	_
22	an	_	DT	DT	_	24	det	_	_
23	important	_	JJ	JJ	_	24	amod	_	_
24	role	_	NN	NN	_	21	dobj	_	_
25	in	_	IN	IN	_	21	prep	_	_
26	HIV-1	_	NN	NN	_	27	nn	_	_
27	activation	_	NN	NN	_	25	pobj	_	_
28	.	_	.	.	_	19	punct	_	_

1	Thus	_	RB	RB	_	7	advmod	_	_
2	,	_	,	,	_	7	punct	_	_
3	the	_	DT	DT	_	5	det	_	_
4	present	_	JJ	JJ	_	5	amod	_	_
5	observations	_	NNS	NNS	_	7	nsubj	_	_
6	will	_	MD	MD	_	7	aux	_	_
7	provide	_	VB	VB	_	0	root	_	_
8	a	_	DT	DT	_	10	det	_	_
9	further	_	JJ	JJ	_	10	amod	_	_
10	insight	_	NN	NN	_	7	dobj	_	_
11	into	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	pathogenesis	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	HIV-1	_	NN	NN	_	16	nn	_	_
16	infections	_	NNS	NNS	_	14	pobj	_	_
17	.	_	.	.	_	7	punct	_	_

1	Expression	_	NN	NN	_	8	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	Retinoid	_	NN	NN	_	6	nn	_	_
4	X	_	NN	NN	_	6	nn	_	_
5	Receptor	_	NN	NN	_	6	nn	_	_
6	alpha	_	NN	NN	_	2	pobj	_	_
7	is	_	VBZ	VBZ	_	8	auxpass	_	_
8	increased	_	VBN	VBN	_	0	root	_	_
9	upon	_	IN	IN	_	8	prep	_	_
10	monocytic	_	JJ	JJ	_	12	amod	_	_
11	cell	_	NN	NN	_	12	nn	_	_
12	differentiation	_	NN	NN	_	9	pobj	_	_
13	.	_	.	.	_	8	punct	_	_

1	1	_	CD	CD	_	3	num	_	_
2	alpha,25-Dihydroxyvitamin	_	NN	NN	_	3	nn	_	_
3	D3	_	NN	NN	_	10	nsubj	_	_
4	-LRB-	_	-LRB-	-LRB-	_	5	punct	_	_
5	VD	_	NN	NN	_	3	appos	_	_
6	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
7	is	_	VBZ	VBZ	_	10	cop	_	_
8	a	_	DT	DT	_	10	det	_	_
9	potent	_	JJ	JJ	_	10	amod	_	_
10	inducer	_	NN	NN	_	0	root	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	monocytic	_	JJ	JJ	_	13	amod	_	_
13	differentiation	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	both	_	CC	CC	_	16	preconj	_	_
16	normal	_	JJ	JJ	_	14	pobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	leukemic	_	JJ	JJ	_	16	conj	_	_
19	cells	_	NNS	NNS	_	16	dep	_	_
20	.	_	.	.	_	10	punct	_	_

1	Its	_	PRP$	PRP$	_	2	poss	_	_
2	effects	_	NNS	NNS	_	4	nsubjpass	_	_
3	are	_	VBP	VBP	_	4	auxpass	_	_
4	mediated	_	VBN	VBN	_	0	root	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	its	_	PRP$	PRP$	_	8	poss	_	_
7	nuclear	_	JJ	JJ	_	8	amod	_	_
8	receptor	_	NN	NN	_	5	pobj	_	_
9	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	VDR	_	NN	NN	_	8	appos	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	.	_	.	.	_	4	punct	_	_

1	Efficient	_	JJ	JJ	_	3	amod	_	_
2	gene	_	NN	NN	_	3	nn	_	_
3	activation	_	NN	NN	_	4	nsubj	_	_
4	requires	_	VBZ	VBZ	_	0	root	_	_
5	the	_	DT	DT	_	6	det	_	_
6	heterodimerization	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	VDR	_	NN	NN	_	7	pobj	_	_
9	with	_	IN	IN	_	6	prep	_	_
10	Retinoid	_	NN	NN	_	12	nn	_	_
11	X	_	NN	NN	_	12	nn	_	_
12	Receptors	_	NNS	NNS	_	9	pobj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	RXR	_	NN	NN	_	12	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	10	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	present	_	JJ	JJ	_	4	amod	_	_
4	study	_	NN	NN	_	1	pobj	_	_
5	using	_	VBG	VBG	_	4	vmod	_	_
6	specific	_	JJ	JJ	_	7	amod	_	_
7	antibodies	_	NNS	NNS	_	5	dobj	_	_
8	,	_	,	,	_	10	punct	_	_
9	we	_	PRP	PRP	_	10	nsubj	_	_
10	analyzed	_	VBD	VBD	_	0	root	_	_
11	the	_	DT	DT	_	12	det	_	_
12	expression	_	NN	NN	_	10	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	17	det	_	_
15	RXR	_	NN	NN	_	17	nn	_	_
16	alpha	_	NN	NN	_	17	nn	_	_
17	protein	_	NN	NN	_	13	pobj	_	_
18	in	_	IN	IN	_	12	prep	_	_
19	blood	_	NN	NN	_	21	nn	_	_
20	mononuclear	_	JJ	JJ	_	21	amod	_	_
21	cells	_	NNS	NNS	_	18	pobj	_	_
22	from	_	IN	IN	_	21	prep	_	_
23	acute	_	JJ	JJ	_	25	amod	_	_
24	myeloid	_	JJ	JJ	_	25	amod	_	_
25	patients	_	NNS	NNS	_	22	pobj	_	_
26	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
27	AML	_	NN	NN	_	25	appos	_	_
28	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
29	-LRB-	_	-LRB-	-LRB-	_	31	punct	_	_
30	10	_	CD	CD	_	31	num	_	_
31	cases	_	NNS	NNS	_	25	appos	_	_
32	-RRB-	_	-RRB-	-RRB-	_	31	punct	_	_
33	and	_	CC	CC	_	22	cc	_	_
34	from	_	IN	IN	_	22	conj	_	_
35	myelomonocytic	_	JJ	JJ	_	37	amod	_	_
36	cell	_	NN	NN	_	37	nn	_	_
37	lines	_	NNS	NNS	_	34	pobj	_	_
38	arrested	_	VBN	VBN	_	37	vmod	_	_
39	at	_	IN	IN	_	38	prep	_	_
40	different	_	JJ	JJ	_	41	amod	_	_
41	stages	_	NNS	NNS	_	39	pobj	_	_
42	of	_	IN	IN	_	41	prep	_	_
43	differentiation	_	NN	NN	_	42	pobj	_	_
44	.	_	.	.	_	10	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	observed	_	VBD	VBD	_	0	root	_	_
3	that	_	IN	IN	_	8	mark	_	_
4	the	_	DT	DT	_	7	det	_	_
5	RXR	_	NN	NN	_	6	nn	_	_
6	alpha	_	NN	NN	_	7	nn	_	_
7	expression	_	NN	NN	_	8	nsubj	_	_
8	increased	_	VBD	VBD	_	2	ccomp	_	_
9	during	_	IN	IN	_	8	prep	_	_
10	myelomonocytic	_	JJ	JJ	_	11	amod	_	_
11	differentiation	_	NN	NN	_	9	pobj	_	_
12	,	_	,	,	_	2	punct	_	_
13	since	_	IN	IN	_	18	mark	_	_
14	the	_	DT	DT	_	16	det	_	_
15	highest	_	JJS	JJS	_	16	amod	_	_
16	levels	_	NNS	NNS	_	18	nsubjpass	_	_
17	were	_	VBD	VBD	_	18	auxpass	_	_
18	found	_	VBN	VBN	_	2	advcl	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	AML	_	NN	NN	_	21	nn	_	_
21	samples	_	NNS	NNS	_	19	pobj	_	_
22	and	_	CC	CC	_	19	cc	_	_
23	in	_	IN	IN	_	19	conj	_	_
24	myelomonocytic	_	JJ	JJ	_	26	amod	_	_
25	cell	_	NN	NN	_	26	nn	_	_
26	lines	_	NNS	NNS	_	23	pobj	_	_
27	having	_	VBG	VBG	_	26	vmod	_	_
28	the	_	DT	DT	_	30	det	_	_
29	highest	_	JJS	JJS	_	30	amod	_	_
30	amounts	_	NNS	NNS	_	27	dobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	monocytic	_	JJ	JJ	_	33	amod	_	_
33	precursors	_	NNS	NNS	_	31	pobj	_	_
34	.	_	.	.	_	2	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	demonstrated	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	22	mark	_	_
5	fresh	_	JJ	JJ	_	7	amod	_	_
6	leukemic	_	JJ	JJ	_	7	amod	_	_
7	cells	_	NNS	NNS	_	22	nsubj	_	_
8	,	_	,	,	_	7	punct	_	_
9	whatever	_	WDT	WDT	_	7	rcmod	_	_
10	their	_	PRP$	PRP$	_	11	poss	_	_
11	stage	_	NN	NN	_	9	dep	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	differentiation	_	NN	NN	_	12	pobj	_	_
14	,	_	,	,	_	7	punct	_	_
15	as	_	RB	RB	_	16	advmod	_	_
16	well	_	RB	RB	_	7	cc	_	_
17	as	_	IN	IN	_	16	mwe	_	_
18	myelomonocytic	_	JJ	JJ	_	20	amod	_	_
19	cell	_	NN	NN	_	20	nn	_	_
20	lines	_	NNS	NNS	_	7	conj	_	_
21	,	_	,	,	_	7	punct	_	_
22	respond	_	VB	VB	_	3	ccomp	_	_
23	to	_	TO	TO	_	22	prep	_	_
24	VD	_	NN	NN	_	23	pobj	_	_
25	by	_	IN	IN	_	22	prep	_	_
26	an	_	DT	DT	_	27	det	_	_
27	increase	_	NN	NN	_	25	pobj	_	_
28	in	_	IN	IN	_	27	prep	_	_
29	RXR	_	NN	NN	_	30	nn	_	_
30	alpha	_	NN	NN	_	31	nn	_	_
31	levels	_	NNS	NNS	_	28	pobj	_	_
32	.	_	.	.	_	3	punct	_	_

1	Combinations	_	NNS	NNS	_	16	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	all-trans	_	JJ	JJ	_	5	amod	_	_
4	retinoic	_	JJ	JJ	_	5	amod	_	_
5	acid	_	NN	NN	_	2	pobj	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	RA	_	NN	NN	_	5	appos	_	_
8	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
9	and	_	CC	CC	_	5	cc	_	_
10	VD	_	NN	NN	_	5	conj	_	_
11	,	_	,	,	_	1	punct	_	_
12	in	_	IN	IN	_	16	prep	_	_
13	some	_	DT	DT	_	14	det	_	_
14	cases	_	NNS	NNS	_	12	pobj	_	_
15	,	_	,	,	_	16	punct	_	_
16	increased	_	VBD	VBD	_	0	root	_	_
17	this	_	DT	DT	_	18	det	_	_
18	effect	_	NN	NN	_	16	dobj	_	_
19	.	_	.	.	_	16	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	response	_	NN	NN	_	3	nsubj	_	_
3	suggests	_	VBZ	VBZ	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	involvement	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	RXR	_	NN	NN	_	8	nn	_	_
8	alpha	_	NN	NN	_	6	pobj	_	_
9	in	_	IN	IN	_	5	prep	_	_
10	monocytic	_	JJ	JJ	_	11	amod	_	_
11	differentiation	_	NN	NN	_	9	pobj	_	_
12	upon	_	IN	IN	_	5	prep	_	_
13	VD	_	NN	NN	_	14	nn	_	_
14	treatment	_	NN	NN	_	12	pobj	_	_
15	.	_	.	.	_	3	punct	_	_

1	Putative	_	JJ	JJ	_	4	amod	_	_
2	steroid	_	NN	NN	_	4	nn	_	_
3	binding	_	NN	NN	_	4	nn	_	_
4	domain	_	NN	NN	_	22	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	9	det	_	_
7	human	_	JJ	JJ	_	9	amod	_	_
8	mineralocorticoid	_	NN	NN	_	9	nn	_	_
9	receptor	_	NN	NN	_	5	pobj	_	_
10	,	_	,	,	_	4	punct	_	_
11	expressed	_	VBN	VBN	_	4	vmod	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	E.	_	FW	FW	_	14	nn	_	_
14	coli	_	FW	FW	_	12	pobj	_	_
15	in	_	IN	IN	_	11	prep	_	_
16	the	_	DT	DT	_	17	det	_	_
17	presence	_	NN	NN	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	heat	_	NN	NN	_	21	nn	_	_
20	shock	_	NN	NN	_	21	nn	_	_
21	proteins	_	NNS	NNS	_	18	pobj	_	_
22	shows	_	VBZ	VBZ	_	0	root	_	_
23	typical	_	JJ	JJ	_	26	amod	_	_
24	native	_	JJ	JJ	_	23	dep	_	_
25	receptor	_	NN	NN	_	26	nn	_	_
26	characteristics	_	NNS	NNS	_	22	dobj	_	_
27	.	_	.	.	_	22	punct	_	_

1	Domain	_	NN	NN	_	2	nn	_	_
2	E	_	NN	NN	_	23	nsubjpass	_	_
3	,	_	,	,	_	2	punct	_	_
4	considered	_	VBN	VBN	_	2	vmod	_	_
5	as	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	10	det	_	_
7	putative	_	JJ	JJ	_	10	amod	_	_
8	hormone	_	NN	NN	_	10	nn	_	_
9	binding	_	NN	NN	_	10	nn	_	_
10	domain	_	NN	NN	_	5	pobj	_	_
11	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
12	HBD	_	NN	NN	_	10	appos	_	_
13	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	of	_	IN	IN	_	10	prep	_	_
15	the	_	DT	DT	_	18	det	_	_
16	human	_	JJ	JJ	_	18	amod	_	_
17	mineralocorticoid	_	NN	NN	_	18	nn	_	_
18	receptor	_	NN	NN	_	14	pobj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	hMR	_	NN	NN	_	18	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	was	_	VBD	VBD	_	23	auxpass	_	_
23	expressed	_	VBN	VBN	_	0	root	_	_
24	in	_	IN	IN	_	23	prep	_	_
25	Escherichia	_	FW	FW	_	26	nn	_	_
26	coli	_	FW	FW	_	24	pobj	_	_
27	as	_	IN	IN	_	23	prep	_	_
28	a	_	DT	DT	_	30	det	_	_
29	fusion	_	NN	NN	_	30	nn	_	_
30	protein	_	NN	NN	_	27	pobj	_	_
31	with	_	IN	IN	_	30	prep	_	_
32	either	_	CC	CC	_	35	preconj	_	_
33	maltose	_	NN	NN	_	35	nn	_	_
34	binding	_	NN	NN	_	35	nn	_	_
35	protein	_	NN	NN	_	31	pobj	_	_
36	-LRB-	_	-LRB-	-LRB-	_	37	punct	_	_
37	MBP	_	NN	NN	_	35	appos	_	_
38	-RRB-	_	-RRB-	-RRB-	_	37	punct	_	_
39	or	_	CC	CC	_	35	cc	_	_
40	glutathione	_	NN	NN	_	41	nn	_	_
41	S-transferase	_	NN	NN	_	35	conj	_	_
42	-LRB-	_	-LRB-	-LRB-	_	43	punct	_	_
43	GST	_	NN	NN	_	41	appos	_	_
44	-RRB-	_	-RRB-	-RRB-	_	43	punct	_	_
45	.	_	.	.	_	23	punct	_	_

1	These	_	DT	DT	_	4	det	_	_
2	bacterially-produced	_	JJ	JJ	_	4	amod	_	_
3	MR	_	NN	NN	_	4	nn	_	_
4	constructs	_	NNS	NNS	_	5	nsubj	_	_
5	had	_	VBD	VBD	_	0	root	_	_
6	no	_	DT	DT	_	9	neg	_	_
7	steroid	_	NN	NN	_	9	nn	_	_
8	binding	_	NN	NN	_	9	nn	_	_
9	activity	_	NN	NN	_	5	dobj	_	_
10	per	_	FW	FW	_	11	nn	_	_
11	se	_	FW	FW	_	5	advmod	_	_
12	.	_	.	.	_	5	punct	_	_

1	In	_	IN	IN	_	12	prep	_	_
2	fact	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	12	punct	_	_
4	heat	_	NN	NN	_	6	nn	_	_
5	shock	_	NN	NN	_	6	nn	_	_
6	protein	_	NN	NN	_	7	nn	_	_
7	association	_	NN	NN	_	12	nsubjpass	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	hsp	_	NN	NN	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	is	_	VBZ	VBZ	_	12	auxpass	_	_
12	required	_	VBN	VBN	_	0	root	_	_
13	for	_	IN	IN	_	12	prep	_	_
14	high	_	JJ	JJ	_	16	amod	_	_
15	affinity	_	NN	NN	_	16	nn	_	_
16	ligand-binding	_	NN	NN	_	13	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	19	det	_	_
19	MR	_	NN	NN	_	17	pobj	_	_
20	.	_	.	.	_	12	punct	_	_

1	After	_	IN	IN	_	23	prep	_	_
2	incubation	_	NN	NN	_	1	pobj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	purified	_	VBN	VBN	_	5	amod	_	_
5	MBP-	_	NN	NN	_	3	pobj	_	_
6	or	_	CC	CC	_	5	cc	_	_
7	GST-HBD	_	NN	NN	_	5	conj	_	_
8	with	_	IN	IN	_	2	prep	_	_
9	rabbit	_	NN	NN	_	11	nn	_	_
10	reticulocyte	_	NN	NN	_	11	nn	_	_
11	lysate	_	NN	NN	_	8	pobj	_	_
12	,	_	,	,	_	11	punct	_	_
13	known	_	VBN	VBN	_	11	vmod	_	_
14	to	_	TO	TO	_	16	aux	_	_
15	be	_	VB	VB	_	16	cop	_	_
16	rich	_	JJ	JJ	_	13	xcomp	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	heat	_	NN	NN	_	20	nn	_	_
19	shock	_	NN	NN	_	20	nn	_	_
20	proteins	_	NNS	NNS	_	17	pobj	_	_
21	,	_	,	,	_	23	punct	_	_
22	we	_	PRP	PRP	_	23	nsubj	_	_
23	obtained	_	VBD	VBD	_	0	root	_	_
24	saturable	_	JJ	JJ	_	25	amod	_	_
25	binding	_	NN	NN	_	23	dobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	-LSB-3H-RSB-aldosterone	_	NN	NN	_	26	pobj	_	_
28	.	_	.	.	_	23	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	Kd	_	NN	NN	_	3	nn	_	_
3	value	_	NN	NN	_	8	nsubj	_	_
4	for	_	IN	IN	_	3	prep	_	_
5	aldosterone	_	NN	NN	_	4	pobj	_	_
6	was	_	VBD	VBD	_	8	cop	_	_
7	0.3	_	CD	CD	_	8	num	_	_
8	nM	_	NN	NN	_	0	root	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	the	_	DT	DT	_	11	det	_	_
11	Bmax	_	NN	NN	_	12	nsubj	_	_
12	=	_	VBD	VBD	_	8	conj	_	_
13	32	_	CD	CD	_	14	num	_	_
14	pmol/mg	_	NN	NN	_	12	dobj	_	_
15	.	_	.	.	_	8	punct	_	_

1	Hormone	_	NN	NN	_	3	nn	_	_
2	binding	_	NN	NN	_	3	nn	_	_
3	specificity	_	NN	NN	_	5	nsubjpass	_	_
4	was	_	VBD	VBD	_	5	auxpass	_	_
5	assessed	_	VBN	VBN	_	0	root	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	competition	_	NN	NN	_	8	nn	_	_
8	studies	_	NNS	NNS	_	6	pobj	_	_
9	with	_	IN	IN	_	8	prep	_	_
10	various	_	JJ	JJ	_	12	amod	_	_
11	steroid	_	NN	NN	_	12	nn	_	_
12	ligands	_	NNS	NNS	_	9	pobj	_	_
13	.	_	.	.	_	5	punct	_	_

1	Sucrose	_	NN	NN	_	3	nn	_	_
2	gradient	_	NN	NN	_	3	nn	_	_
3	assays	_	NNS	NNS	_	7	nsubj	_	_
4	performed	_	VBN	VBN	_	3	vmod	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	-LSB-3H-RSB-aldosterone-MBP-HBD	_	NN	NN	_	5	pobj	_	_
7	revealed	_	VBD	VBD	_	0	root	_	_
8	complex	_	NN	NN	_	7	dobj	_	_
9	sedimenting	_	VBG	VBG	_	8	vmod	_	_
10	at	_	IN	IN	_	9	prep	_	_
11	8.3S	_	NN	NN	_	10	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	4.9S	_	NN	NN	_	11	conj	_	_
14	with	_	IN	IN	_	9	prep	_	_
15	-LSB-3H-RSB-progesterone-MBP-HBD	_	NN	NN	_	14	pobj	_	_
16	.	_	.	.	_	7	punct	_	_

1	Western-blot	_	JJ	JJ	_	2	amod	_	_
2	analysis	_	NN	NN	_	7	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	sedimentation	_	NN	NN	_	6	nn	_	_
6	peak	_	NN	NN	_	3	pobj	_	_
7	showed	_	VBD	VBD	_	0	root	_	_
8	the	_	DT	DT	_	10	det	_	_
9	concomitant	_	JJ	JJ	_	10	amod	_	_
10	presence	_	NN	NN	_	7	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	MBP-HBD	_	NN	NN	_	11	pobj	_	_
13	by	_	IN	IN	_	11	dep	_	_
14	a	_	DT	DT	_	17	det	_	_
15	monoclonal	_	JJ	JJ	_	17	amod	_	_
16	anti-MBP	_	JJ	JJ	_	17	amod	_	_
17	antibody	_	NN	NN	_	13	pobj	_	_
18	,	_	,	,	_	11	punct	_	_
19	and	_	CC	CC	_	11	cc	_	_
20	hsp90	_	NN	NN	_	11	conj	_	_
21	by	_	IN	IN	_	11	dep	_	_
22	a	_	DT	DT	_	25	det	_	_
23	monoclonal	_	JJ	JJ	_	25	amod	_	_
24	anti-hsp	_	JJ	JJ	_	25	amod	_	_
25	antibody	_	NN	NN	_	21	pobj	_	_
26	.	_	.	.	_	7	punct	_	_

1	Moreover	_	RB	RB	_	14	advmod	_	_
2	,	_	,	,	_	14	punct	_	_
3	following	_	VBG	VBG	_	14	prep	_	_
4	incubation	_	NN	NN	_	3	pobj	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	10	det	_	_
7	anti-rabbit	_	JJ	JJ	_	10	amod	_	_
8	hsp90	_	NN	NN	_	10	nn	_	_
9	monoclonal	_	JJ	JJ	_	10	amod	_	_
10	antibody	_	NN	NN	_	5	pobj	_	_
11	the	_	DT	DT	_	13	det	_	_
12	sedimenting	_	NN	NN	_	13	nn	_	_
13	gradient	_	NN	NN	_	14	nsubj	_	_
14	showed	_	VBD	VBD	_	0	root	_	_
15	a	_	DT	DT	_	18	det	_	_
16	10.4S	_	NN	NN	_	18	nn	_	_
17	sedimenting	_	NN	NN	_	18	nn	_	_
18	complex	_	NN	NN	_	14	dobj	_	_
19	.	_	.	.	_	14	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	analyses	_	NNS	NNS	_	3	nsubj	_	_
3	demonstrated	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	11	mark	_	_
5	the	_	DT	DT	_	7	det	_	_
6	-LSB-3H-RSB-aldosterone-MBP-HBD	_	NN	NN	_	7	nn	_	_
7	complex	_	NN	NN	_	11	nsubjpass	_	_
8	is	_	VBZ	VBZ	_	11	auxpass	_	_
9	at	_	IN	IN	_	11	advmod	_	_
10	least	_	JJS	JJS	_	9	pobj	_	_
11	associated	_	VBN	VBN	_	3	ccomp	_	_
12	with	_	IN	IN	_	11	prep	_	_
13	hsp90	_	NN	NN	_	12	pobj	_	_
14	in	_	IN	IN	_	11	prep	_	_
15	reticulocyte	_	NN	NN	_	16	nn	_	_
16	lysate	_	NN	NN	_	14	pobj	_	_
17	and	_	CC	CC	_	11	cc	_	_
18	that	_	IN	IN	_	24	mark	_	_
19	the	_	DT	DT	_	20	det	_	_
20	HBD	_	NN	NN	_	24	nsubj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	hMR	_	NN	NN	_	21	pobj	_	_
23	is	_	VBZ	VBZ	_	24	cop	_	_
24	sufficient	_	JJ	JJ	_	11	conj	_	_
25	to	_	TO	TO	_	26	aux	_	_
26	bind	_	VB	VB	_	24	xcomp	_	_
27	hsp90	_	NN	NN	_	26	dobj	_	_
28	.	_	.	.	_	3	punct	_	_

1	Deletions	_	NNS	NNS	_	20	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	a	_	DT	DT	_	6	det	_	_
4	relatively	_	RB	RB	_	5	advmod	_	_
5	short	_	JJ	JJ	_	6	amod	_	_
6	amino-	_	NN	NN	_	2	pobj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	729-766	_	CD	CD	_	6	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	or	_	CC	CC	_	6	cc	_	_
11	carboxy-terminal	_	JJ	JJ	_	6	conj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	940-984	_	CD	CD	_	11	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	region	_	NN	NN	_	6	dep	_	_
16	of	_	IN	IN	_	6	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	HBD	_	NN	NN	_	19	nn	_	_
19	fragment	_	NN	NN	_	16	pobj	_	_
20	eliminated	_	VBD	VBD	_	0	root	_	_
21	all	_	DT	DT	_	23	det	_	_
22	steroid-binding	_	JJ	JJ	_	23	amod	_	_
23	properties	_	NNS	NNS	_	20	dobj	_	_
24	.	_	.	.	_	20	punct	_	_

1	Overall	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	these	_	DT	DT	_	4	det	_	_
4	results	_	NNS	NNS	_	5	nsubj	_	_
5	indicate	_	VBP	VBP	_	0	root	_	_
6	that	_	IN	IN	_	13	mark	_	_
7	the	_	DT	DT	_	8	det	_	_
8	integrity	_	NN	NN	_	13	nsubj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	domain	_	NN	NN	_	11	nn	_	_
11	E	_	NN	NN	_	9	pobj	_	_
12	is	_	VBZ	VBZ	_	13	cop	_	_
13	necessary	_	JJ	JJ	_	5	ccomp	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	sufficient	_	JJ	JJ	_	13	conj	_	_
16	to	_	TO	TO	_	17	aux	_	_
17	bind	_	VB	VB	_	13	xcomp	_	_
18	steroid	_	NN	NN	_	19	nn	_	_
19	ligands	_	NNS	NNS	_	17	dobj	_	_
20	,	_	,	,	_	19	punct	_	_
21	agonists	_	NNS	NNS	_	19	appos	_	_
22	or	_	CC	CC	_	21	cc	_	_
23	antagonists	_	NNS	NNS	_	21	conj	_	_
24	,	_	,	,	_	17	punct	_	_
25	with	_	IN	IN	_	17	prep	_	_
26	characteristics	_	NNS	NNS	_	25	pobj	_	_
27	similar	_	JJ	JJ	_	26	amod	_	_
28	to	_	TO	TO	_	27	prep	_	_
29	the	_	DT	DT	_	32	det	_	_
30	entire	_	JJ	JJ	_	31	amod	_	_
31	native	_	JJ	JJ	_	32	amod	_	_
32	MR	_	NN	NN	_	28	pobj	_	_
33	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	myeloid-cell-specific	_	JJ	JJ	_	4	amod	_	_
3	c-fes	_	NN	NN	_	4	nn	_	_
4	promoter	_	NN	NN	_	6	nsubjpass	_	_
5	is	_	VBZ	VBZ	_	6	auxpass	_	_
6	regulated	_	VBN	VBN	_	0	root	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	Sp1	_	NN	NN	_	7	pobj	_	_
9	,	_	,	,	_	8	punct	_	_
10	PU.1	_	NN	NN	_	8	conj	_	_
11	,	_	,	,	_	8	punct	_	_
12	and	_	CC	CC	_	8	cc	_	_
13	a	_	DT	DT	_	16	det	_	_
14	novel	_	JJ	JJ	_	16	amod	_	_
15	transcription	_	NN	NN	_	16	nn	_	_
16	factor	_	NN	NN	_	8	conj	_	_
17	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	protein	_	NN	NN	_	3	nn	_	_
3	product	_	NN	NN	_	13	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	10	det	_	_
6	c-fps/fes	_	NN	NN	_	10	nn	_	_
7	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
8	c-fes	_	NN	NN	_	10	nn	_	_
9	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
10	proto-oncogene	_	NN	NN	_	4	pobj	_	_
11	has	_	VBZ	VBZ	_	13	aux	_	_
12	been	_	VBN	VBN	_	13	auxpass	_	_
13	implicated	_	VBN	VBN	_	0	root	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	17	det	_	_
16	normal	_	JJ	JJ	_	17	amod	_	_
17	development	_	NN	NN	_	14	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	myeloid	_	JJ	JJ	_	20	amod	_	_
20	cells	_	NNS	NNS	_	18	pobj	_	_
21	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
22	macrophages	_	NNS	NNS	_	20	dep	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	neutrophils	_	NNS	NNS	_	22	conj	_	_
25	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
26	.	_	.	.	_	13	punct	_	_

1	mRNA	_	NN	NN	_	6	nsubjpass	_	_
2	for	_	IN	IN	_	1	prep	_	_
3	c-fes	_	NN	NN	_	2	pobj	_	_
4	has	_	VBZ	VBZ	_	6	aux	_	_
5	been	_	VBN	VBN	_	6	auxpass	_	_
6	detected	_	VBN	VBN	_	0	root	_	_
7	exclusively	_	RB	RB	_	8	advmod	_	_
8	in	_	IN	IN	_	6	prep	_	_
9	myeloid	_	JJ	JJ	_	10	amod	_	_
10	cells	_	NNS	NNS	_	8	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	vascular	_	JJ	JJ	_	14	amod	_	_
13	endothelial	_	JJ	JJ	_	14	amod	_	_
14	cells	_	NNS	NNS	_	10	conj	_	_
15	in	_	IN	IN	_	10	prep	_	_
16	adult	_	JJ	JJ	_	17	amod	_	_
17	mammals	_	NNS	NNS	_	15	pobj	_	_
18	.	_	.	.	_	6	punct	_	_

1	Although	_	IN	IN	_	10	mark	_	_
2	a	_	DT	DT	_	9	det	_	_
3	13-kilobase-pair	_	NN	NN	_	9	nn	_	_
4	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
5	kb	_	NN	NN	_	9	nn	_	_
6	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
7	human	_	JJ	JJ	_	9	amod	_	_
8	c-fes	_	NN	NN	_	9	nn	_	_
9	transgene	_	NN	NN	_	10	nsubj	_	_
10	exhibits	_	VBZ	VBZ	_	32	advcl	_	_
11	high	_	JJ	JJ	_	12	amod	_	_
12	levels	_	NNS	NNS	_	10	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	expression	_	NN	NN	_	13	pobj	_	_
15	in	_	IN	IN	_	10	prep	_	_
16	mice	_	NNS	NNS	_	15	pobj	_	_
17	,	_	,	,	_	32	punct	_	_
18	the	_	DT	DT	_	19	det	_	_
19	sequences	_	NNS	NNS	_	32	nsubjpass	_	_
20	that	_	WDT	WDT	_	21	nsubj	_	_
21	confer	_	VBP	VBP	_	19	rcmod	_	_
22	myeloid-cell-specific	_	JJ	JJ	_	23	amod	_	_
23	expression	_	NN	NN	_	21	dobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	28	det	_	_
26	human	_	JJ	JJ	_	28	amod	_	_
27	c-fes	_	NN	NN	_	28	nn	_	_
28	gene	_	NN	NN	_	24	pobj	_	_
29	have	_	VBP	VBP	_	32	aux	_	_
30	not	_	RB	RB	_	32	neg	_	_
31	been	_	VBN	VBN	_	32	auxpass	_	_
32	defined	_	VBN	VBN	_	0	root	_	_
33	.	_	.	.	_	32	punct	_	_

1	Transient-transfection	_	NN	NN	_	2	nn	_	_
2	experiments	_	NNS	NNS	_	3	nsubj	_	_
3	demonstrated	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	20	mark	_	_
5	plasmids	_	NNS	NNS	_	20	nsubj	_	_
6	containing	_	VBG	VBG	_	5	vmod	_	_
7	446	_	CD	CD	_	8	num	_	_
8	bp	_	NN	NN	_	6	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	c-fes	_	NN	NN	_	12	nn	_	_
11	5'-flanking	_	JJ	JJ	_	12	amod	_	_
12	sequences	_	NNS	NNS	_	9	pobj	_	_
13	linked	_	VBN	VBN	_	8	vmod	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	a	_	DT	DT	_	18	det	_	_
16	luciferase	_	NN	NN	_	18	nn	_	_
17	reporter	_	NN	NN	_	18	nn	_	_
18	gene	_	NN	NN	_	14	pobj	_	_
19	were	_	VBD	VBD	_	20	cop	_	_
20	active	_	JJ	JJ	_	3	ccomp	_	_
21	exclusively	_	RB	RB	_	22	advmod	_	_
22	in	_	IN	IN	_	20	prep	_	_
23	myeloid	_	JJ	JJ	_	24	amod	_	_
24	cells	_	NNS	NNS	_	22	pobj	_	_
25	.	_	.	.	_	3	punct	_	_

1	No	_	DT	DT	_	4	neg	_	_
2	other	_	JJ	JJ	_	4	amod	_	_
3	DNA	_	NN	NN	_	4	nn	_	_
4	element	_	NN	NN	_	11	nsubj	_	_
5	within	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	10	det	_	_
7	13-kb	_	JJ	JJ	_	10	amod	_	_
8	human	_	JJ	JJ	_	10	amod	_	_
9	c-fes	_	NN	NN	_	10	nn	_	_
10	locus	_	NN	NN	_	5	pobj	_	_
11	contained	_	VBD	VBD	_	0	root	_	_
12	positive	_	JJ	JJ	_	14	amod	_	_
13	cis-acting	_	JJ	JJ	_	14	amod	_	_
14	elements	_	NNS	NNS	_	11	dobj	_	_
15	,	_	,	,	_	11	punct	_	_
16	with	_	IN	IN	_	11	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	exception	_	NN	NN	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	a	_	DT	DT	_	23	det	_	_
21	weakly	_	RB	RB	_	22	advmod	_	_
22	active	_	JJ	JJ	_	23	amod	_	_
23	region	_	NN	NN	_	19	pobj	_	_
24	within	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	27	det	_	_
26	3'-flanking	_	JJ	JJ	_	27	amod	_	_
27	sequences	_	NNS	NNS	_	24	pobj	_	_
28	.	_	.	.	_	11	punct	_	_

1	DNase	_	NN	NN	_	4	nn	_	_
2	I	_	CD	CD	_	4	num	_	_
3	footprinting	_	NN	NN	_	4	nn	_	_
4	assays	_	NNS	NNS	_	5	nsubj	_	_
5	revealed	_	VBD	VBD	_	0	root	_	_
6	four	_	CD	CD	_	8	num	_	_
7	distinct	_	JJ	JJ	_	8	amod	_	_
8	sites	_	NNS	NNS	_	5	dobj	_	_
9	that	_	WDT	WDT	_	10	nsubj	_	_
10	bind	_	VBP	VBP	_	8	rcmod	_	_
11	myeloid	_	JJ	JJ	_	13	amod	_	_
12	nuclear	_	JJ	JJ	_	13	amod	_	_
13	proteins	_	NNS	NNS	_	10	dobj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
15	-408	_	CD	CD	_	17	num	_	_
16	to	_	TO	TO	_	17	dep	_	_
17	-386	_	CD	CD	_	8	dep	_	_
18	,	_	,	,	_	17	punct	_	_
19	-293	_	CD	CD	_	21	num	_	_
20	to	_	TO	TO	_	21	dep	_	_
21	-254	_	CD	CD	_	17	conj	_	_
22	,	_	,	,	_	17	punct	_	_
23	-76	_	CD	CD	_	25	num	_	_
24	to	_	TO	TO	_	25	dep	_	_
25	-65	_	CD	CD	_	17	conj	_	_
26	,	_	,	,	_	17	punct	_	_
27	and	_	CC	CC	_	17	cc	_	_
28	-34	_	CD	CD	_	30	num	_	_
29	to	_	TO	TO	_	30	dep	_	_
30	+3	_	CD	CD	_	17	conj	_	_
31	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
32	.	_	.	.	_	5	punct	_	_

1	However	_	RB	RB	_	7	advmod	_	_
2	,	_	,	,	_	7	punct	_	_
3	the	_	DT	DT	_	6	det	_	_
4	first	_	JJ	JJ	_	6	amod	_	_
5	two	_	CD	CD	_	6	num	_	_
6	footprints	_	NNS	NNS	_	7	nsubj	_	_
7	resided	_	VBD	VBD	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	sequences	_	NNS	NNS	_	8	pobj	_	_
10	that	_	WDT	WDT	_	13	nsubj	_	_
11	were	_	VBD	VBD	_	13	cop	_	_
12	largely	_	RB	RB	_	13	advmod	_	_
13	dispensable	_	JJ	JJ	_	9	rcmod	_	_
14	for	_	IN	IN	_	13	prep	_	_
15	transient	_	JJ	JJ	_	16	amod	_	_
16	activity	_	NN	NN	_	14	pobj	_	_
17	.	_	.	.	_	7	punct	_	_

1	Plasmids	_	NNS	NNS	_	8	nsubj	_	_
2	containing	_	VBG	VBG	_	1	vmod	_	_
3	151	_	CD	CD	_	4	num	_	_
4	bp	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	5'-flanking	_	JJ	JJ	_	7	amod	_	_
7	sequences	_	NNS	NNS	_	5	pobj	_	_
8	confer	_	VBP	VBP	_	0	root	_	_
9	myeloid-cell-specific	_	JJ	JJ	_	11	amod	_	_
10	gene	_	NN	NN	_	11	nn	_	_
11	expression	_	NN	NN	_	8	dobj	_	_
12	.	_	.	.	_	8	punct	_	_

1	Electrophoretic	_	JJ	JJ	_	4	amod	_	_
2	mobility	_	NN	NN	_	4	nn	_	_
3	shift	_	NN	NN	_	4	nn	_	_
4	analyses	_	NNS	NNS	_	5	nsubj	_	_
5	demonstrated	_	VBD	VBD	_	0	root	_	_
6	that	_	IN	IN	_	10	mark	_	_
7	the	_	DT	DT	_	9	det	_	_
8	151-bp	_	JJ	JJ	_	9	amod	_	_
9	region	_	NN	NN	_	10	nsubj	_	_
10	contains	_	VBZ	VBZ	_	5	ccomp	_	_
11	nuclear	_	JJ	JJ	_	14	amod	_	_
12	protein	_	NN	NN	_	14	nn	_	_
13	binding	_	NN	NN	_	14	nn	_	_
14	sites	_	NNS	NNS	_	10	dobj	_	_
15	for	_	IN	IN	_	14	prep	_	_
16	Sp1	_	NN	NN	_	15	pobj	_	_
17	,	_	,	,	_	16	punct	_	_
18	PU.1	_	NN	NN	_	16	conj	_	_
19	,	_	,	,	_	16	punct	_	_
20	and/or	_	CC	CC	_	16	cc	_	_
21	Elf-1	_	NN	NN	_	16	conj	_	_
22	,	_	,	,	_	16	punct	_	_
23	and	_	CC	CC	_	16	cc	_	_
24	a	_	DT	DT	_	26	det	_	_
25	novel	_	JJ	JJ	_	26	amod	_	_
26	factor	_	NN	NN	_	16	conj	_	_
27	.	_	.	.	_	5	punct	_	_

1	This	_	DT	DT	_	3	det	_	_
2	unidentified	_	JJ	JJ	_	3	amod	_	_
3	factor	_	NN	NN	_	4	nsubj	_	_
4	binds	_	VBZ	VBZ	_	0	root	_	_
5	immediately	_	RB	RB	_	6	advmod	_	_
6	3'	_	JJ	JJ	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	PU.1/Elf-1	_	JJ	JJ	_	10	amod	_	_
10	sites	_	NNS	NNS	_	7	pobj	_	_
11	and	_	CC	CC	_	4	cc	_	_
12	appears	_	VBZ	VBZ	_	4	conj	_	_
13	to	_	TO	TO	_	17	aux	_	_
14	be	_	VB	VB	_	17	cop	_	_
15	myeloid	_	JJ	JJ	_	17	amod	_	_
16	cell	_	NN	NN	_	17	npadvmod	_	_
17	specific	_	JJ	JJ	_	12	xcomp	_	_
18	.	_	.	.	_	4	punct	_	_

1	Mutation	_	NN	NN	_	20	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	PU.1/Elf-1	_	JJ	JJ	_	5	nn	_	_
5	site	_	NN	NN	_	2	pobj	_	_
6	or	_	CC	CC	_	5	cc	_	_
7	the	_	DT	DT	_	9	det	_	_
8	3'	_	JJ	JJ	_	9	amod	_	_
9	site	_	NN	NN	_	5	conj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	FP4-3'	_	NN	NN	_	9	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	within	_	IN	IN	_	1	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	context	_	NN	NN	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	c-fes	_	NN	NN	_	19	nn	_	_
19	promoter	_	NN	NN	_	16	pobj	_	_
20	resulted	_	VBD	VBD	_	0	root	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	substantially	_	RB	RB	_	23	advmod	_	_
23	reduced	_	VBN	VBN	_	24	amod	_	_
24	activity	_	NN	NN	_	21	pobj	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	transient	_	JJ	JJ	_	27	amod	_	_
27	transfections	_	NNS	NNS	_	25	pobj	_	_
28	.	_	.	.	_	20	punct	_	_

1	Furthermore	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	transient-cotransfection	_	JJ	JJ	_	4	amod	_	_
4	assay	_	NN	NN	_	5	nsubj	_	_
5	demonstrated	_	VBD	VBD	_	0	root	_	_
6	that	_	IN	IN	_	14	mark	_	_
7	PU.1	_	NN	NN	_	14	nsubj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
9	and	_	CC	CC	_	11	cc	_	_
10	not	_	RB	RB	_	11	dep	_	_
11	Elf-1	_	NN	NN	_	7	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	can	_	MD	MD	_	14	aux	_	_
14	transactivate	_	VB	VB	_	5	ccomp	_	_
15	the	_	DT	DT	_	17	det	_	_
16	c-fes	_	NN	NN	_	17	nn	_	_
17	promoter	_	NN	NN	_	14	dobj	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	nonmyeloid	_	JJ	JJ	_	21	amod	_	_
20	cell	_	NN	NN	_	21	nn	_	_
21	lines	_	NNS	NNS	_	18	pobj	_	_
22	.	_	.	.	_	5	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	conclude	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	8	mark	_	_
4	the	_	DT	DT	_	7	det	_	_
5	human	_	JJ	JJ	_	7	amod	_	_
6	c-fes	_	NN	NN	_	7	nn	_	_
7	gene	_	NN	NN	_	8	nsubj	_	_
8	contains	_	VBZ	VBZ	_	2	ccomp	_	_
9	a	_	DT	DT	_	12	det	_	_
10	strong	_	JJ	JJ	_	12	amod	_	_
11	myeloid-cell-specific	_	JJ	JJ	_	12	amod	_	_
12	promoter	_	NN	NN	_	8	dobj	_	_
13	that	_	WDT	WDT	_	15	nsubjpass	_	_
14	is	_	VBZ	VBZ	_	15	auxpass	_	_
15	regulated	_	VBN	VBN	_	12	rcmod	_	_
16	by	_	IN	IN	_	15	prep	_	_
17	Sp1	_	NN	NN	_	16	pobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	PU.1	_	NN	NN	_	17	conj	_	_
20	,	_	,	,	_	17	punct	_	_
21	and	_	CC	CC	_	17	cc	_	_
22	a	_	DT	DT	_	25	det	_	_
23	novel	_	JJ	JJ	_	25	amod	_	_
24	transcription	_	NN	NN	_	25	nn	_	_
25	factor	_	NN	NN	_	17	conj	_	_
26	.	_	.	.	_	2	punct	_	_

1	DNA	_	NN	NN	_	3	nn	_	_
2	triplex	_	NN	NN	_	3	nn	_	_
3	formation	_	NN	NN	_	5	nsubj	_	_
4	selectively	_	RB	RB	_	5	advmod	_	_
5	inhibits	_	VBZ	VBZ	_	0	root	_	_
6	granulocyte-macrophage	_	JJ	JJ	_	9	amod	_	_
7	colony-stimulating	_	JJ	JJ	_	9	amod	_	_
8	factor	_	NN	NN	_	9	nn	_	_
9	gene	_	NN	NN	_	10	nn	_	_
10	expression	_	NN	NN	_	5	dobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	human	_	JJ	JJ	_	14	amod	_	_
13	T	_	NN	NN	_	14	nn	_	_
14	cells	_	NNS	NNS	_	11	pobj	_	_
15	.	_	.	.	_	5	punct	_	_

1	Granulocyte-macrophage	_	JJ	JJ	_	3	amod	_	_
2	colony-stimulating	_	JJ	JJ	_	3	amod	_	_
3	factor	_	NN	NN	_	11	nsubj	_	_
4	-LRB-	_	-LRB-	-LRB-	_	5	punct	_	_
5	GM-CSF	_	NN	NN	_	3	appos	_	_
6	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
7	is	_	VBZ	VBZ	_	11	cop	_	_
8	a	_	DT	DT	_	11	det	_	_
9	hemopoietic	_	JJ	JJ	_	11	amod	_	_
10	growth	_	NN	NN	_	11	nn	_	_
11	factor	_	NN	NN	_	0	root	_	_
12	that	_	WDT	WDT	_	14	nsubjpass	_	_
13	is	_	VBZ	VBZ	_	14	auxpass	_	_
14	expressed	_	VBN	VBN	_	11	rcmod	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	activated	_	VBN	VBN	_	18	amod	_	_
17	T	_	NN	NN	_	18	nn	_	_
18	cells	_	NNS	NNS	_	15	pobj	_	_
19	,	_	,	,	_	18	punct	_	_
20	fibroblasts	_	NNS	NNS	_	18	conj	_	_
21	,	_	,	,	_	18	punct	_	_
22	macrophages	_	NNS	NNS	_	18	conj	_	_
23	,	_	,	,	_	18	punct	_	_
24	and	_	CC	CC	_	18	cc	_	_
25	endothelial	_	JJ	JJ	_	26	amod	_	_
26	cells	_	NNS	NNS	_	18	conj	_	_
27	.	_	.	.	_	11	punct	_	_

1	Although	_	IN	IN	_	5	mark	_	_
2	GM-CSF	_	NN	NN	_	5	nsubj	_	_
3	does	_	VBZ	VBZ	_	5	aux	_	_
4	not	_	RB	RB	_	5	neg	_	_
5	appear	_	VB	VB	_	18	advcl	_	_
6	to	_	TO	TO	_	8	aux	_	_
7	be	_	VB	VB	_	8	cop	_	_
8	essential	_	JJ	JJ	_	5	xcomp	_	_
9	for	_	IN	IN	_	8	prep	_	_
10	normal	_	JJ	JJ	_	11	amod	_	_
11	hemopoiesis	_	NN	NN	_	9	pobj	_	_
12	,	_	,	,	_	18	punct	_	_
13	overexpression	_	NN	NN	_	18	nsubjpass	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	GM-CSF	_	NN	NN	_	14	pobj	_	_
16	has	_	VBZ	VBZ	_	18	aux	_	_
17	been	_	VBN	VBN	_	18	auxpass	_	_
18	implicated	_	VBN	VBN	_	0	root	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	21	det	_	_
21	pathogenesis	_	NN	NN	_	19	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	some	_	DT	DT	_	24	det	_	_
24	diseases	_	NNS	NNS	_	22	pobj	_	_
25	such	_	JJ	JJ	_	26	mwe	_	_
26	as	_	IN	IN	_	24	prep	_	_
27	myeloid	_	JJ	JJ	_	28	amod	_	_
28	leukemia	_	NN	NN	_	26	pobj	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	chronic	_	JJ	JJ	_	31	amod	_	_
31	inflammation	_	NN	NN	_	28	conj	_	_
32	.	_	.	.	_	18	punct	_	_

1	An	_	DT	DT	_	4	det	_	_
2	NF-kappaB/Rel	_	NN	NN	_	4	nn	_	_
3	binding	_	NN	NN	_	4	nn	_	_
4	site	_	NN	NN	_	14	nsubj	_	_
5	within	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	GM-CSF	_	NN	NN	_	8	nn	_	_
8	promoter	_	NN	NN	_	5	pobj	_	_
9	,	_	,	,	_	4	punct	_	_
10	termed	_	VBN	VBN	_	4	vmod	_	_
11	the	_	DT	DT	_	13	det	_	_
12	kappaB	_	NN	NN	_	13	nn	_	_
13	element	_	NN	NN	_	10	dep	_	_
14	appears	_	VBZ	VBZ	_	0	root	_	_
15	to	_	TO	TO	_	17	aux	_	_
16	be	_	VB	VB	_	17	cop	_	_
17	important	_	JJ	JJ	_	14	xcomp	_	_
18	for	_	IN	IN	_	17	prep	_	_
19	controlling	_	VBG	VBG	_	18	pcomp	_	_
20	expression	_	NN	NN	_	19	dobj	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	reporter	_	NN	NN	_	23	nn	_	_
23	gene	_	NN	NN	_	24	nn	_	_
24	assays	_	NNS	NNS	_	21	pobj	_	_
25	in	_	IN	IN	_	20	prep	_	_
26	response	_	NN	NN	_	25	pobj	_	_
27	to	_	TO	TO	_	26	prep	_	_
28	a	_	DT	DT	_	29	det	_	_
29	number	_	NN	NN	_	27	pobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	stimuli	_	NNS	NNS	_	30	pobj	_	_
32	in	_	IN	IN	_	29	prep	_	_
33	T	_	NN	NN	_	34	nn	_	_
34	cells	_	NNS	NNS	_	32	pobj	_	_
35	.	_	.	.	_	14	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	investigated	_	VBD	VBD	_	0	root	_	_
3	oligonucleotide-directed	_	JJ	JJ	_	6	amod	_	_
4	triple	_	JJ	JJ	_	3	dep	_	_
5	helix	_	NN	NN	_	6	nn	_	_
6	formation	_	NN	NN	_	2	dobj	_	_
7	across	_	IN	IN	_	6	prep	_	_
8	this	_	DT	DT	_	10	det	_	_
9	regulatory	_	JJ	JJ	_	10	amod	_	_
10	sequence	_	NN	NN	_	7	pobj	_	_
11	as	_	IN	IN	_	2	prep	_	_
12	a	_	DT	DT	_	14	det	_	_
13	potential	_	JJ	JJ	_	14	amod	_	_
14	tool	_	NN	NN	_	11	pobj	_	_
15	to	_	TO	TO	_	16	aux	_	_
16	inhibit	_	VB	VB	_	14	vmod	_	_
17	GM-CSF	_	NN	NN	_	19	nn	_	_
18	gene	_	NN	NN	_	19	nn	_	_
19	transcription	_	NN	NN	_	16	dobj	_	_
20	.	_	.	.	_	2	punct	_	_

1	A	_	DT	DT	_	3	det	_	_
2	15-base	_	NN	NN	_	3	nn	_	_
3	oligonucleotide	_	NN	NN	_	8	nsubjpass	_	_
4	,	_	,	,	_	3	punct	_	_
5	GM3	_	NN	NN	_	3	appos	_	_
6	,	_	,	,	_	3	punct	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	targeted	_	VBN	VBN	_	0	root	_	_
9	to	_	TO	TO	_	8	prep	_	_
10	a	_	DT	DT	_	12	det	_	_
11	purine-rich	_	JJ	JJ	_	12	amod	_	_
12	region	_	NN	NN	_	9	pobj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	17	det	_	_
15	GM-CSF	_	NN	NN	_	17	nn	_	_
16	proximal	_	JJ	JJ	_	17	amod	_	_
17	promoter	_	NN	NN	_	13	pobj	_	_
18	,	_	,	,	_	12	punct	_	_
19	which	_	WDT	WDT	_	20	nsubj	_	_
20	overlaps	_	VBZ	VBZ	_	12	rcmod	_	_
21	the	_	DT	DT	_	23	det	_	_
22	kappaB	_	NN	NN	_	23	nn	_	_
23	element	_	NN	NN	_	20	dobj	_	_
24	.	_	.	.	_	8	punct	_	_

1	Gel	_	NN	NN	_	4	nn	_	_
2	mobility	_	NN	NN	_	4	nn	_	_
3	shift	_	NN	NN	_	4	nn	_	_
4	assays	_	NNS	NNS	_	9	nsubj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	DNase	_	NN	NN	_	8	nn	_	_
7	I	_	CD	CD	_	6	num	_	_
8	footprinting	_	NN	NN	_	4	conj	_	_
9	demonstrated	_	VBD	VBD	_	0	root	_	_
10	that	_	IN	IN	_	12	mark	_	_
11	GM3	_	NN	NN	_	12	nsubj	_	_
12	formed	_	VBD	VBD	_	9	ccomp	_	_
13	a	_	DT	DT	_	16	det	_	_
14	sequence-specific	_	JJ	JJ	_	16	amod	_	_
15	collinear	_	NN	NN	_	16	nn	_	_
16	triplex	_	NN	NN	_	12	dobj	_	_
17	with	_	IN	IN	_	12	prep	_	_
18	its	_	PRP$	PRP$	_	21	poss	_	_
19	double-stranded	_	JJ	JJ	_	21	amod	_	_
20	DNA	_	NN	NN	_	21	nn	_	_
21	target	_	NN	NN	_	17	pobj	_	_
22	.	_	.	.	_	9	punct	_	_

1	Triplex	_	JJ	JJ	_	2	amod	_	_
2	formation	_	NN	NN	_	5	nsubj	_	_
3	by	_	IN	IN	_	2	prep	_	_
4	GM3	_	NN	NN	_	3	pobj	_	_
5	blocked	_	VBD	VBD	_	0	root	_	_
6	recombinant	_	JJ	JJ	_	5	dobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	nuclear	_	JJ	JJ	_	6	conj	_	_
9	NF-kappaB	_	NN	NN	_	10	nn	_	_
10	proteins	_	NNS	NNS	_	6	dep	_	_
11	binding	_	VBG	VBG	_	10	amod	_	_
12	to	_	TO	TO	_	6	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	GM-CSF	_	NN	NN	_	15	nn	_	_
15	element	_	NN	NN	_	12	pobj	_	_
16	.	_	.	.	_	5	punct	_	_

1	GM3	_	NN	NN	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	caused	_	VBD	VBD	_	0	root	_	_
4	selective	_	JJ	JJ	_	5	amod	_	_
5	inhibition	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	15	det	_	_
8	human	_	JJ	JJ	_	12	amod	_	_
9	T-cell	_	NN	NN	_	12	nn	_	_
10	lymphotrophic	_	JJ	JJ	_	12	amod	_	_
11	virus-1	_	NN	NN	_	12	nn	_	_
12	Tax	_	NN	NN	_	15	nn	_	_
13	transactivator-induced	_	JJ	JJ	_	15	amod	_	_
14	luciferase	_	NN	NN	_	15	nn	_	_
15	activity	_	NN	NN	_	6	pobj	_	_
16	from	_	IN	IN	_	15	prep	_	_
17	a	_	DT	DT	_	19	det	_	_
18	reporter	_	NN	NN	_	19	nn	_	_
19	construct	_	NN	NN	_	16	pobj	_	_
20	driven	_	VBN	VBN	_	19	vmod	_	_
21	by	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	24	det	_	_
23	GM-CSF	_	NN	NN	_	24	nn	_	_
24	promoter	_	NN	NN	_	21	pobj	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	Jurkat	_	NN	NN	_	28	nn	_	_
27	T	_	NN	NN	_	28	nn	_	_
28	cells	_	NNS	NNS	_	25	pobj	_	_
29	.	_	.	.	_	3	punct	_	_

1	Finally	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	GM3	_	NN	NN	_	5	nsubj	_	_
4	greatly	_	RB	RB	_	5	advmod	_	_
5	reduced	_	VBD	VBD	_	0	root	_	_
6	the	_	DT	DT	_	7	det	_	_
7	concentration	_	NN	NN	_	5	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	endogenous	_	JJ	JJ	_	11	amod	_	_
10	GM-CSF	_	NN	NN	_	11	nn	_	_
11	mRNA	_	NN	NN	_	8	pobj	_	_
12	induced	_	VBN	VBN	_	11	vmod	_	_
13	by	_	IN	IN	_	12	prep	_	_
14	different	_	JJ	JJ	_	15	amod	_	_
15	stimuli	_	NNS	NNS	_	13	pobj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	Jurkat	_	NN	NN	_	19	nn	_	_
18	T	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	16	pobj	_	_
20	but	_	CC	CC	_	5	cc	_	_
21	did	_	VBD	VBD	_	23	aux	_	_
22	not	_	RB	RB	_	23	neg	_	_
23	affect	_	VB	VB	_	5	conj	_	_
24	interleukin	_	NN	NN	_	26	nn	_	_
25	3	_	CD	CD	_	26	num	_	_
26	mRNA	_	NN	NN	_	27	nn	_	_
27	levels	_	NNS	NNS	_	23	dobj	_	_
28	in	_	IN	IN	_	27	prep	_	_
29	the	_	DT	DT	_	31	det	_	_
30	same	_	JJ	JJ	_	31	amod	_	_
31	cells	_	NNS	NNS	_	28	pobj	_	_
32	.	_	.	.	_	5	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	conclude	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	11	mark	_	_
4	the	_	DT	DT	_	6	det	_	_
5	kappaB	_	NN	NN	_	6	nn	_	_
6	element	_	NN	NN	_	11	nsubj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	GM-CSF	_	NN	NN	_	10	nn	_	_
10	promoter	_	NN	NN	_	7	pobj	_	_
11	plays	_	VBZ	VBZ	_	2	ccomp	_	_
12	a	_	DT	DT	_	14	det	_	_
13	central	_	JJ	JJ	_	14	amod	_	_
14	role	_	NN	NN	_	11	dobj	_	_
15	in	_	IN	IN	_	11	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	transcriptional	_	JJ	JJ	_	18	amod	_	_
18	activation	_	NN	NN	_	15	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	23	det	_	_
21	endogenous	_	JJ	JJ	_	23	amod	_	_
22	GM-CSF	_	NN	NN	_	23	nn	_	_
23	gene	_	NN	NN	_	19	pobj	_	_
24	.	_	.	.	_	2	punct	_	_

1	Colinear	_	JJ	JJ	_	3	amod	_	_
2	triplex	_	NN	NN	_	3	nn	_	_
3	formation	_	NN	NN	_	4	nsubj	_	_
4	acts	_	VBZ	VBZ	_	0	root	_	_
5	as	_	IN	IN	_	4	prep	_	_
6	a	_	DT	DT	_	9	det	_	_
7	selective	_	JJ	JJ	_	9	amod	_	_
8	transcriptional	_	JJ	JJ	_	9	amod	_	_
9	repressor	_	NN	NN	_	5	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	GM-CSF	_	NN	NN	_	13	nn	_	_
13	gene	_	NN	NN	_	10	pobj	_	_
14	and	_	CC	CC	_	4	cc	_	_
15	may	_	MD	MD	_	16	aux	_	_
16	have	_	VB	VB	_	4	conj	_	_
17	potential	_	JJ	JJ	_	18	amod	_	_
18	therapeutic	_	JJ	JJ	_	19	amod	_	_
19	application	_	NN	NN	_	16	dobj	_	_
20	in	_	IN	IN	_	16	prep	_	_
21	cases	_	NNS	NNS	_	20	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	undesirable	_	JJ	JJ	_	24	amod	_	_
24	overexpression	_	NN	NN	_	22	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	this	_	DT	DT	_	27	det	_	_
27	protein	_	NN	NN	_	25	pobj	_	_
28	.	_	.	.	_	4	punct	_	_

1	Induction	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	CIITA	_	NN	NN	_	2	pobj	_	_
4	and	_	CC	CC	_	1	cc	_	_
5	modification	_	NN	NN	_	1	conj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	in	_	FW	FW	_	11	amod	_	_
8	vivo	_	FW	FW	_	7	dep	_	_
9	HLA-DR	_	NN	NN	_	10	nn	_	_
10	promoter	_	NN	NN	_	11	nn	_	_
11	occupancy	_	NN	NN	_	6	pobj	_	_
12	in	_	IN	IN	_	1	prep	_	_
13	normal	_	JJ	JJ	_	16	amod	_	_
14	thymic	_	JJ	JJ	_	16	amod	_	_
15	epithelial	_	JJ	JJ	_	16	amod	_	_
16	cells	_	NNS	NNS	_	12	pobj	_	_
17	treated	_	VBN	VBN	_	16	vmod	_	_
18	with	_	IN	IN	_	17	prep	_	_
19	IFN-gamma	_	NN	NN	_	18	pobj	_	_
20	:	_	:	:	_	1	punct	_	_
21	similarities	_	NNS	NNS	_	1	dep	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	distinctions	_	NNS	NNS	_	21	conj	_	_
24	with	_	IN	IN	_	21	prep	_	_
25	respect	_	NN	NN	_	24	pobj	_	_
26	to	_	TO	TO	_	25	prep	_	_
27	HLA-DR-constitutive	_	JJ	JJ	_	29	amod	_	_
28	B	_	NN	NN	_	29	nn	_	_
29	cells	_	NNS	NNS	_	26	pobj	_	_
30	.	_	.	.	_	1	punct	_	_

1	In	_	IN	IN	_	25	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	study	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	25	punct	_	_
5	the	_	DT	DT	_	7	det	_	_
6	IFN-gamma	_	NN	NN	_	7	nn	_	_
7	induction	_	NN	NN	_	25	nsubjpass	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	MHC	_	NN	NN	_	12	nn	_	_
10	class	_	NN	NN	_	12	nn	_	_
11	II	_	CD	CD	_	12	num	_	_
12	gene	_	NN	NN	_	13	nn	_	_
13	expression	_	NN	NN	_	8	pobj	_	_
14	in	_	IN	IN	_	7	prep	_	_
15	primary	_	JJ	JJ	_	16	amod	_	_
16	cultures	_	NNS	NNS	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	thymic	_	JJ	JJ	_	20	amod	_	_
19	epithelial	_	JJ	JJ	_	20	amod	_	_
20	cells	_	NNS	NNS	_	17	pobj	_	_
21	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
22	TEC	_	NN	NN	_	20	appos	_	_
23	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
24	was	_	VBD	VBD	_	25	auxpass	_	_
25	analyzed	_	VBN	VBN	_	0	root	_	_
26	.	_	.	.	_	25	punct	_	_

1	This	_	DT	DT	_	3	det	_	_
2	cellular	_	JJ	JJ	_	3	amod	_	_
3	system	_	NN	NN	_	4	nsubj	_	_
4	offers	_	VBZ	VBZ	_	0	root	_	_
5	the	_	DT	DT	_	6	det	_	_
6	advantage	_	NN	NN	_	4	dobj	_	_
7	that	_	IN	IN	_	13	mark	_	_
8	MHC	_	NN	NN	_	9	nn	_	_
9	class	_	NN	NN	_	11	nn	_	_
10	II	_	CD	CD	_	9	num	_	_
11	induction	_	NN	NN	_	13	nsubjpass	_	_
12	is	_	VBZ	VBZ	_	13	auxpass	_	_
13	studied	_	VBN	VBN	_	6	ccomp	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	a	_	DT	DT	_	19	det	_	_
16	``	_	``	``	_	19	punct	_	_
17	physiologic	_	JJ	JJ	_	19	amod	_	_
18	cell	_	NN	NN	_	19	nn	_	_
19	lineage	_	NN	NN	_	14	pobj	_	_
20	that	_	WDT	WDT	_	33	nsubjpass	_	_
21	,	_	,	,	_	33	punct	_	_
22	as	_	IN	IN	_	33	prep	_	_
23	a	_	DT	DT	_	24	det	_	_
24	result	_	NN	NN	_	22	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	this	_	DT	DT	_	27	det	_	_
27	expression	_	NN	NN	_	25	pobj	_	_
28	within	_	IN	IN	_	27	prep	_	_
29	the	_	DT	DT	_	30	det	_	_
30	thymus	_	NN	NN	_	28	pobj	_	_
31	,	_	,	,	_	33	punct	_	_
32	is	_	VBZ	VBZ	_	33	auxpass	_	_
33	thought	_	VBN	VBN	_	19	rcmod	_	_
34	to	_	TO	TO	_	35	aux	_	_
35	participate	_	VB	VB	_	33	xcomp	_	_
36	to	_	TO	TO	_	35	prep	_	_
37	the	_	DT	DT	_	38	dep	_	_
38	selection	_	NN	NN	_	36	pobj	_	_
39	and	_	CC	CC	_	38	cc	_	_
40	maturation	_	NN	NN	_	38	conj	_	_
41	of	_	IN	IN	_	38	prep	_	_
42	the	_	DT	DT	_	44	det	_	_
43	T	_	NN	NN	_	44	nn	_	_
44	cells	_	NNS	NNS	_	41	pobj	_	_
45	.	_	.	.	_	4	punct	_	_

1	It	_	PRP	PRP	_	3	nsubjpass	_	_
2	was	_	VBD	VBD	_	3	auxpass	_	_
3	found	_	VBN	VBN	_	0	root	_	_
4	that	_	IN	IN	_	12	mark	_	_
5	the	_	DT	DT	_	10	det	_	_
6	MHC	_	NN	NN	_	9	nn	_	_
7	class	_	NN	NN	_	9	nn	_	_
8	II	_	CD	CD	_	9	num	_	_
9	gene	_	NN	NN	_	10	nn	_	_
10	expression	_	NN	NN	_	12	nsubjpass	_	_
11	was	_	VBD	VBD	_	12	auxpass	_	_
12	associated	_	VBN	VBN	_	3	ccomp	_	_
13	with	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	17	det	_	_
15	de	_	FW	FW	_	17	amod	_	_
16	novo	_	FW	FW	_	15	dep	_	_
17	transcription	_	NN	NN	_	13	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	20	det	_	_
20	gene	_	NN	NN	_	18	pobj	_	_
21	encoding	_	VBG	VBG	_	20	vmod	_	_
22	the	_	DT	DT	_	24	det	_	_
23	CIITA	_	NN	NN	_	24	nn	_	_
24	trans-activator	_	NN	NN	_	21	dobj	_	_
25	,	_	,	,	_	24	punct	_	_
26	a	_	DT	DT	_	33	det	_	_
27	crucial	_	JJ	JJ	_	33	amod	_	_
28	MHC	_	NN	NN	_	33	nn	_	_
29	class	_	NN	NN	_	33	nn	_	_
30	II	_	CD	CD	_	33	num	_	_
31	gene	_	NN	NN	_	33	nn	_	_
32	regulatory	_	JJ	JJ	_	33	amod	_	_
33	factor	_	NN	NN	_	24	appos	_	_
34	.	_	.	.	_	3	punct	_	_

1	Furthermore	_	RB	RB	_	19	advmod	_	_
2	,	_	,	,	_	19	punct	_	_
3	the	_	DT	DT	_	4	det	_	_
4	anatomy	_	NN	NN	_	19	nsubjpass	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	interaction	_	NN	NN	_	5	pobj	_	_
7	between	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	13	dep	_	_
9	MHC	_	NN	NN	_	13	nn	_	_
10	class	_	NN	NN	_	13	nn	_	_
11	II	_	CD	CD	_	13	num	_	_
12	DRA	_	NN	NN	_	13	nn	_	_
13	promoter	_	NN	NN	_	7	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	corresponding	_	JJ	JJ	_	17	amod	_	_
16	binding	_	VBG	VBG	_	17	amod	_	_
17	factors	_	NNS	NNS	_	13	conj	_	_
18	was	_	VBD	VBD	_	19	auxpass	_	_
19	analyzed	_	VBN	VBN	_	0	root	_	_
20	by	_	IN	IN	_	19	prep	_	_
21	in	_	FW	FW	_	25	amod	_	_
22	vivo	_	FW	FW	_	21	dep	_	_
23	DNAse	_	NN	NN	_	24	nn	_	_
24	I	_	NN	NN	_	25	nn	_	_
25	footprint	_	NN	NN	_	20	pobj	_	_
26	.	_	.	.	_	19	punct	_	_

1	It	_	PRP	PRP	_	3	nsubjpass	_	_
2	was	_	VBD	VBD	_	3	auxpass	_	_
3	found	_	VBN	VBN	_	0	root	_	_
4	that	_	IN	IN	_	8	mark	_	_
5	treatment	_	NN	NN	_	8	nsubj	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	IFN-gamma	_	NN	NN	_	6	pobj	_	_
8	induces	_	VBZ	VBZ	_	3	ccomp	_	_
9	changes	_	NNS	NNS	_	8	dobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	occupancy	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	18	det	_	_
15	DRA	_	NN	NN	_	18	nn	_	_
16	gene	_	NN	NN	_	18	nn	_	_
17	regulatory	_	JJ	JJ	_	18	amod	_	_
18	sequences	_	NNS	NNS	_	13	pobj	_	_
19	by	_	IN	IN	_	12	prep	_	_
20	nuclear	_	JJ	JJ	_	21	amod	_	_
21	factors	_	NNS	NNS	_	19	pobj	_	_
22	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	resulting	_	VBG	VBG	_	3	amod	_	_
3	occupancy	_	NN	NN	_	4	nsubj	_	_
4	displays	_	VBZ	VBZ	_	0	root	_	_
5	strong	_	JJ	JJ	_	6	amod	_	_
6	similarities	_	NNS	NNS	_	4	dobj	_	_
7	with	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	one	_	CD	CD	_	7	pobj	_	_
10	observed	_	VBN	VBN	_	9	vmod	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	17	det	_	_
13	MHC	_	NN	NN	_	17	nn	_	_
14	class	_	NN	NN	_	17	nn	_	_
15	II-constitutive	_	JJ	JJ	_	17	amod	_	_
16	B	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	11	pobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	represented	_	VBN	VBN	_	17	vmod	_	_
20	by	_	IN	IN	_	19	prep	_	_
21	both	_	CC	CC	_	26	preconj	_	_
22	the	_	DT	DT	_	26	dep	_	_
23	Burkitt	_	NN	NN	_	26	nn	_	_
24	lymphoma	_	NN	NN	_	26	nn	_	_
25	line	_	NN	NN	_	26	nn	_	_
26	Raji	_	NN	NN	_	20	pobj	_	_
27	and	_	CC	CC	_	26	cc	_	_
28	normal	_	JJ	JJ	_	31	amod	_	_
29	tonsil-derived	_	JJ	JJ	_	31	amod	_	_
30	B	_	NN	NN	_	31	nn	_	_
31	cells	_	NNS	NNS	_	26	conj	_	_
32	.	_	.	.	_	4	punct	_	_

1	However	_	RB	RB	_	7	advmod	_	_
2	,	_	,	,	_	7	punct	_	_
3	some	_	DT	DT	_	5	det	_	_
4	peculiar	_	JJ	JJ	_	5	amod	_	_
5	differences	_	NNS	NNS	_	7	nsubjpass	_	_
6	were	_	VBD	VBD	_	7	auxpass	_	_
7	observed	_	VBN	VBN	_	0	root	_	_
8	between	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	TEC	_	NN	NN	_	8	pobj	_	_
11	,	_	,	,	_	10	punct	_	_
12	either	_	CC	CC	_	13	preconj	_	_
13	IFN-gamma-induced	_	JJ	JJ	_	10	amod	_	_
14	or	_	CC	CC	_	13	cc	_	_
15	not	_	RB	RB	_	13	conj	_	_
16	,	_	,	,	_	10	punct	_	_
17	and	_	CC	CC	_	10	cc	_	_
18	the	_	DT	DT	_	21	det	_	_
19	constitutive	_	JJ	JJ	_	21	amod	_	_
20	B	_	NN	NN	_	21	nn	_	_
21	cells	_	NNS	NNS	_	10	conj	_	_
22	.	_	.	.	_	7	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	23	mark	_	_
5	both	_	CC	CC	_	7	preconj	_	_
6	common	_	JJ	JJ	_	7	amod	_	_
7	mechanisms	_	NNS	NNS	_	23	nsubj	_	_
8	,	_	,	,	_	7	punct	_	_
9	such	_	JJ	JJ	_	10	mwe	_	_
10	as	_	IN	IN	_	7	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	one	_	CD	CD	_	10	pobj	_	_
13	mediated	_	VBN	VBN	_	12	vmod	_	_
14	by	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	17	det	_	_
16	CIITA	_	NN	NN	_	17	nn	_	_
17	trans-activator	_	NN	NN	_	14	pobj	_	_
18	,	_	,	,	_	7	punct	_	_
19	and	_	CC	CC	_	7	cc	_	_
20	distinct	_	JJ	JJ	_	21	amod	_	_
21	tissue-specific	_	JJ	JJ	_	22	amod	_	_
22	constraints	_	NNS	NNS	_	7	conj	_	_
23	contribute	_	VBP	VBP	_	3	ccomp	_	_
24	to	_	TO	TO	_	23	prep	_	_
25	the	_	DT	DT	_	27	det	_	_
26	transcriptional	_	JJ	JJ	_	27	amod	_	_
27	control	_	NN	NN	_	24	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	constitutive	_	JJ	JJ	_	36	amod	_	_
30	and	_	CC	CC	_	29	cc	_	_
31	IFN-gamma-induced	_	JJ	JJ	_	29	conj	_	_
32	MHC	_	NN	NN	_	35	nn	_	_
33	class	_	NN	NN	_	35	nn	_	_
34	II	_	CD	CD	_	35	num	_	_
35	gene	_	NN	NN	_	36	nn	_	_
36	expression	_	NN	NN	_	28	pobj	_	_
37	.	_	.	.	_	3	punct	_	_

1	Antisense	_	JJ	JJ	_	2	amod	_	_
2	inhibition	_	NN	NN	_	8	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	vitamin	_	NN	NN	_	6	nn	_	_
5	D	_	NN	NN	_	6	nn	_	_
6	receptor	_	NN	NN	_	7	nn	_	_
7	expression	_	NN	NN	_	3	pobj	_	_
8	induces	_	VBZ	VBZ	_	0	root	_	_
9	apoptosis	_	NN	NN	_	8	dobj	_	_
10	in	_	IN	IN	_	8	prep	_	_
11	monoblastoid	_	JJ	JJ	_	13	amod	_	_
12	U937	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	10	pobj	_	_
14	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	6	det	_	_
2	active	_	JJ	JJ	_	6	amod	_	_
3	vitamin	_	NN	NN	_	6	nn	_	_
4	D3	_	NN	NN	_	6	nn	_	_
5	metabolite	_	NN	NN	_	6	nn	_	_
6	1,25-dihydroxycholecalciferol	_	NN	NN	_	10	nsubj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	1,25-LRB-OH-RRB-2D3	_	NN	NN	_	6	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	acts	_	VBZ	VBZ	_	0	root	_	_
11	as	_	IN	IN	_	10	prep	_	_
12	an	_	DT	DT	_	16	det	_	_
13	antiproliferative	_	JJ	JJ	_	16	amod	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	differentiating	_	VBG	VBG	_	13	conj	_	_
16	agent	_	NN	NN	_	11	pobj	_	_
17	for	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	22	det	_	_
19	monoblastoid	_	JJ	JJ	_	22	amod	_	_
20	cell	_	NN	NN	_	22	nn	_	_
21	line	_	NN	NN	_	22	nn	_	_
22	U937	_	NN	NN	_	17	pobj	_	_
23	and	_	CC	CC	_	11	cc	_	_
24	as	_	IN	IN	_	11	conj	_	_
25	an	_	DT	DT	_	28	det	_	_
26	important	_	JJ	JJ	_	28	amod	_	_
27	immunologic	_	JJ	JJ	_	26	dep	_	_
28	mediator	_	NN	NN	_	24	pobj	_	_
29	implicated	_	VBN	VBN	_	28	vmod	_	_
30	particularly	_	RB	RB	_	31	advmod	_	_
31	in	_	IN	IN	_	29	prep	_	_
32	the	_	DT	DT	_	33	det	_	_
33	function	_	NN	NN	_	31	pobj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	cells	_	NNS	NNS	_	34	pobj	_	_
36	belonging	_	VBG	VBG	_	35	vmod	_	_
37	to	_	TO	TO	_	36	prep	_	_
38	the	_	DT	DT	_	40	det	_	_
39	monocyte/macrophage	_	NN	NN	_	40	nn	_	_
40	lineage	_	NN	NN	_	37	pobj	_	_
41	.	_	.	.	_	10	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	effects	_	NNS	NNS	_	4	nsubjpass	_	_
3	are	_	VBP	VBP	_	4	auxpass	_	_
4	controlled	_	VBN	VBN	_	0	root	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	9	det	_	_
7	vitamin	_	NN	NN	_	9	nn	_	_
8	D	_	NN	NN	_	9	nn	_	_
9	receptor	_	NN	NN	_	5	pobj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	VDR	_	NN	NN	_	9	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	,	_	,	,	_	9	punct	_	_
14	a	_	DT	DT	_	15	det	_	_
15	member	_	NN	NN	_	9	appos	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	21	det	_	_
18	steroid	_	NN	NN	_	21	nn	_	_
19	hormone	_	NN	NN	_	21	nn	_	_
20	receptor	_	NN	NN	_	21	nn	_	_
21	family	_	NN	NN	_	16	pobj	_	_
22	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	objective	_	NN	NN	_	6	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	this	_	DT	DT	_	5	det	_	_
5	study	_	NN	NN	_	3	pobj	_	_
6	was	_	VBD	VBD	_	0	root	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	develop	_	VB	VB	_	6	ccomp	_	_
9	U937	_	NN	NN	_	10	nn	_	_
10	transfectants	_	NNS	NNS	_	8	dobj	_	_
11	expressing	_	VBG	VBG	_	10	vmod	_	_
12	antisense	_	JJ	JJ	_	14	amod	_	_
13	VDR	_	NN	NN	_	14	nn	_	_
14	mRNA	_	NN	NN	_	11	dobj	_	_
15	,	_	,	,	_	8	punct	_	_
16	and	_	CC	CC	_	8	cc	_	_
17	to	_	TO	TO	_	18	aux	_	_
18	use	_	VB	VB	_	8	conj	_	_
19	these	_	DT	DT	_	18	dobj	_	_
20	to	_	TO	TO	_	21	aux	_	_
21	examine	_	VB	VB	_	18	xcomp	_	_
22	the	_	DT	DT	_	23	det	_	_
23	role	_	NN	NN	_	21	dobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	1,25-LRB-OH-RRB-2D3-VDR	_	JJ	JJ	_	26	amod	_	_
26	interaction	_	NN	NN	_	24	pobj	_	_
27	in	_	IN	IN	_	23	prep	_	_
28	this	_	DT	DT	_	29	det	_	_
29	lineage	_	NN	NN	_	27	pobj	_	_
30	.	_	.	.	_	6	punct	_	_

1	A	_	DT	DT	_	5	det	_	_
2	2-kb	_	JJ	JJ	_	5	amod	_	_
3	VDR	_	NN	NN	_	5	nn	_	_
4	cDNA	_	NN	NN	_	5	nn	_	_
5	insert	_	NN	NN	_	15	nsubjpass	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	including	_	VBG	VBG	_	5	prep	_	_
8	the	_	DT	DT	_	12	det	_	_
9	complete	_	JJ	JJ	_	12	amod	_	_
10	VDR	_	NN	NN	_	12	nn	_	_
11	coding	_	NN	NN	_	12	nn	_	_
12	region	_	NN	NN	_	7	pobj	_	_
13	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
14	was	_	VBD	VBD	_	15	auxpass	_	_
15	cloned	_	VBN	VBN	_	0	root	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	an	_	DT	DT	_	19	det	_	_
18	antisense	_	JJ	JJ	_	19	amod	_	_
19	orientation	_	NN	NN	_	16	pobj	_	_
20	into	_	IN	IN	_	15	prep	_	_
21	the	_	DT	DT	_	25	det	_	_
22	EBV	_	NN	NN	_	25	nn	_	_
23	episomal	_	NN	NN	_	25	nn	_	_
24	vector	_	NN	NN	_	25	nn	_	_
25	pMEP4	_	NN	NN	_	20	pobj	_	_
26	under	_	IN	IN	_	15	prep	_	_
27	the	_	DT	DT	_	28	det	_	_
28	control	_	NN	NN	_	26	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	an	_	DT	DT	_	32	det	_	_
31	inducible	_	JJ	JJ	_	32	amod	_	_
32	promoter	_	NN	NN	_	29	pobj	_	_
33	and	_	CC	CC	_	15	cc	_	_
34	transfected	_	VBN	VBN	_	15	conj	_	_
35	into	_	IN	IN	_	34	prep	_	_
36	U937	_	NN	NN	_	35	pobj	_	_
37	.	_	.	.	_	15	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	resultant	_	JJ	JJ	_	4	amod	_	_
3	cell	_	NN	NN	_	4	nn	_	_
4	line	_	NN	NN	_	10	nsubj	_	_
5	,	_	,	,	_	4	punct	_	_
6	DH42	_	NN	NN	_	4	appos	_	_
7	,	_	,	,	_	4	punct	_	_
8	was	_	VBD	VBD	_	10	cop	_	_
9	hygromycin	_	NN	NN	_	10	npadvmod	_	_
10	resistant	_	JJ	JJ	_	0	root	_	_
11	,	_	,	,	_	10	punct	_	_
12	contained	_	VBD	VBD	_	10	conj	_	_
13	VDR	_	NN	NN	_	14	nn	_	_
14	cDNA	_	NN	NN	_	12	dobj	_	_
15	,	_	,	,	_	10	punct	_	_
16	expressed	_	VBD	VBD	_	10	conj	_	_
17	fewer	_	JJR	JJR	_	16	dobj	_	_
18	VDRs	_	NNS	NNS	_	17	dep	_	_
19	than	_	IN	IN	_	20	mark	_	_
20	controls	_	NNS	NNS	_	17	dep	_	_
21	,	_	,	,	_	10	punct	_	_
22	and	_	CC	CC	_	10	cc	_	_
23	showed	_	VBD	VBD	_	10	conj	_	_
24	a	_	DT	DT	_	26	det	_	_
25	substantial	_	JJ	JJ	_	26	amod	_	_
26	decrease	_	NN	NN	_	23	dobj	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	antiproliferative	_	JJ	JJ	_	29	amod	_	_
29	response	_	NN	NN	_	27	pobj	_	_
30	to	_	TO	TO	_	29	prep	_	_
31	1,25-LRB-OH-RRB-2D3	_	NN	NN	_	30	pobj	_	_
32	.	_	.	.	_	10	punct	_	_

1	However	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	1,25-LRB-OH-RRB-2D3	_	NN	NN	_	4	nsubj	_	_
4	increased	_	VBD	VBD	_	0	root	_	_
5	the	_	DT	DT	_	6	det	_	_
6	number	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	cells	_	NNS	NNS	_	7	pobj	_	_
9	expressing	_	VBG	VBG	_	8	vmod	_	_
10	macrophage	_	NN	NN	_	13	nn	_	_
11	cell	_	NN	NN	_	13	nn	_	_
12	surface	_	NN	NN	_	13	nn	_	_
13	Ags	_	NN	NN	_	9	dobj	_	_
14	,	_	,	,	_	13	punct	_	_
15	including	_	VBG	VBG	_	13	prep	_	_
16	CD14	_	NN	NN	_	15	pobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	CD11b	_	NN	NN	_	16	conj	_	_
19	.	_	.	.	_	4	punct	_	_

1	A	_	DT	DT	_	2	det	_	_
2	subpopulation	_	NN	NN	_	8	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	smaller	_	JJR	JJR	_	5	amod	_	_
5	cells	_	NNS	NNS	_	3	pobj	_	_
6	did	_	VBD	VBD	_	8	aux	_	_
7	not	_	RB	RB	_	8	neg	_	_
8	express	_	VB	VB	_	0	root	_	_
9	the	_	DT	DT	_	11	det	_	_
10	differentiation	_	NN	NN	_	11	nn	_	_
11	markers	_	NNS	NNS	_	8	dobj	_	_
12	after	_	IN	IN	_	8	prep	_	_
13	cadmium	_	NN	NN	_	14	nn	_	_
14	stimulation	_	NN	NN	_	12	pobj	_	_
15	.	_	.	.	_	8	punct	_	_

1	Cell	_	NN	NN	_	3	nn	_	_
2	cycle	_	NN	NN	_	3	nn	_	_
3	analysis	_	NN	NN	_	4	nsubj	_	_
4	showed	_	VBD	VBD	_	0	root	_	_
5	shifts	_	NNS	NNS	_	4	dobj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	distribution	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	cells	_	NNS	NNS	_	9	pobj	_	_
11	from	_	IN	IN	_	8	prep	_	_
12	G1	_	NN	NN	_	11	pobj	_	_
13	to	_	TO	TO	_	8	prep	_	_
14	S	_	NN	NN	_	15	nn	_	_
15	phase	_	NN	NN	_	13	pobj	_	_
16	,	_	,	,	_	5	punct	_	_
17	which	_	WDT	WDT	_	20	nsubj	_	_
18	were	_	VBD	VBD	_	20	cop	_	_
19	more	_	RBR	RBR	_	20	advmod	_	_
20	pronounced	_	JJ	JJ	_	5	rcmod	_	_
21	after	_	IN	IN	_	20	prep	_	_
22	cadmium	_	NN	NN	_	23	nn	_	_
23	treatment	_	NN	NN	_	21	pobj	_	_
24	.	_	.	.	_	4	punct	_	_

1	A	_	DT	DT	_	3	det	_	_
2	considerable	_	JJ	JJ	_	3	amod	_	_
3	proportion	_	NN	NN	_	6	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	cells	_	NNS	NNS	_	4	pobj	_	_
6	were	_	VBD	VBD	_	0	root	_	_
7	outside	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	cycle	_	NN	NN	_	7	pobj	_	_
10	and	_	CC	CC	_	6	cc	_	_
11	DNA	_	NN	NN	_	12	nn	_	_
12	fragmentation	_	NN	NN	_	13	nsubj	_	_
13	confirmed	_	VBD	VBD	_	6	conj	_	_
14	apoptosis	_	NN	NN	_	13	dobj	_	_
15	.	_	.	.	_	6	punct	_	_

1	Thus	_	RB	RB	_	11	advmod	_	_
2	,	_	,	,	_	11	punct	_	_
3	the	_	DT	DT	_	5	det	_	_
4	functional	_	JJ	JJ	_	5	amod	_	_
5	outcome	_	NN	NN	_	11	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	10	det	_	_
8	VDR	_	NN	NN	_	10	nn	_	_
9	antisense	_	JJ	JJ	_	10	amod	_	_
10	transfection	_	NN	NN	_	6	pobj	_	_
11	suggests	_	VBZ	VBZ	_	0	root	_	_
12	that	_	IN	IN	_	21	mark	_	_
13	in	_	IN	IN	_	21	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	myelomonocytic	_	JJ	JJ	_	16	amod	_	_
16	lineage	_	NN	NN	_	13	pobj	_	_
17	,	_	,	,	_	21	punct	_	_
18	VDR	_	NN	NN	_	19	nn	_	_
19	expression	_	NN	NN	_	21	nsubj	_	_
20	may	_	MD	MD	_	21	aux	_	_
21	act	_	VB	VB	_	11	ccomp	_	_
22	as	_	IN	IN	_	21	prep	_	_
23	a	_	DT	DT	_	25	det	_	_
24	protective	_	JJ	JJ	_	25	amod	_	_
25	mechanism	_	NN	NN	_	22	pobj	_	_
26	against	_	IN	IN	_	25	prep	_	_
27	programmed	_	VBN	VBN	_	29	amod	_	_
28	cell	_	NN	NN	_	29	nn	_	_
29	death	_	NN	NN	_	26	pobj	_	_
30	.	_	.	.	_	11	punct	_	_

1	Binding	_	NN	NN	_	0	root	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	cooperative	_	JJ	JJ	_	4	amod	_	_
4	interactions	_	NNS	NNS	_	1	conj	_	_
5	between	_	IN	IN	_	1	prep	_	_
6	two	_	CD	CD	_	10	num	_	_
7	B	_	NN	NN	_	10	nn	_	_
8	cell-specific	_	JJ	JJ	_	10	amod	_	_
9	transcriptional	_	JJ	JJ	_	10	amod	_	_
10	coactivators	_	NNS	NNS	_	5	pobj	_	_
11	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	class	_	NN	NN	_	4	nn	_	_
3	II	_	CD	CD	_	4	num	_	_
4	transactivator	_	NN	NN	_	23	nsubj	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	CIITA	_	NN	NN	_	4	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	and	_	CC	CC	_	4	cc	_	_
9	B	_	NN	NN	_	16	nn	_	_
10	cell	_	NN	NN	_	16	nn	_	_
11	octamer-binding	_	JJ	JJ	_	16	amod	_	_
12	protein	_	NN	NN	_	16	nn	_	_
13	1/octamer-binding	_	JJ	JJ	_	16	amod	_	_
14	factor	_	NN	NN	_	16	nn	_	_
15	1/Oct	_	NN	NN	_	16	nn	_	_
16	coactivator	_	NN	NN	_	4	conj	_	_
17	from	_	IN	IN	_	16	prep	_	_
18	B	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	17	pobj	_	_
20	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	Bob1/OBF-1/OCA-B	_	NN	NN	_	16	appos	_	_
22	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
23	represent	_	VBP	VBP	_	0	root	_	_
24	two	_	CD	CD	_	28	num	_	_
25	B	_	NN	NN	_	28	nn	_	_
26	cell-specific	_	JJ	JJ	_	28	amod	_	_
27	transcriptional	_	JJ	JJ	_	28	amod	_	_
28	coactivators	_	NNS	NNS	_	23	dobj	_	_
29	.	_	.	.	_	23	punct	_	_

1	CIITA	_	NN	NN	_	4	nsubj	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	Bob1	_	NN	NN	_	1	conj	_	_
4	interact	_	VBP	VBP	_	0	root	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	proteins	_	NNS	NNS	_	5	pobj	_	_
7	that	_	WDT	WDT	_	8	nsubj	_	_
8	bind	_	VBP	VBP	_	6	rcmod	_	_
9	to	_	TO	TO	_	8	prep	_	_
10	conserved	_	VBN	VBN	_	12	amod	_	_
11	upstream	_	JJ	JJ	_	12	amod	_	_
12	sequences	_	NNS	NNS	_	9	pobj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	promoters	_	NNS	NNS	_	13	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	class	_	NN	NN	_	20	nn	_	_
17	II	_	CD	CD	_	20	num	_	_
18	major	_	JJ	JJ	_	20	amod	_	_
19	histocompatibility	_	NN	NN	_	20	nn	_	_
20	genes	_	NNS	NNS	_	15	pobj	_	_
21	and	_	CC	CC	_	12	cc	_	_
22	octamer-binding	_	JJ	JJ	_	24	amod	_	_
23	transcription	_	NN	NN	_	24	nn	_	_
24	factors	_	NNS	NNS	_	12	conj	_	_
25	Oct-1	_	NN	NN	_	24	dep	_	_
26	and	_	CC	CC	_	25	cc	_	_
27	Oct-2	_	NN	NN	_	25	conj	_	_
28	,	_	,	,	_	8	punct	_	_
29	respectively	_	RB	RB	_	8	advmod	_	_
30	.	_	.	.	_	4	punct	_	_

1	Both	_	CC	CC	_	2	preconj	_	_
2	CIITA	_	NN	NN	_	5	nsubj	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	Bob1	_	NN	NN	_	2	conj	_	_
5	increase	_	VBP	VBP	_	0	root	_	_
6	the	_	DT	DT	_	7	det	_	_
7	expression	_	NN	NN	_	5	dobj	_	_
8	from	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	DRA	_	NN	NN	_	11	nn	_	_
11	promoter	_	NN	NN	_	8	pobj	_	_
12	,	_	,	,	_	11	punct	_	_
13	which	_	WDT	WDT	_	19	nsubj	_	_
14	is	_	VBZ	VBZ	_	19	cop	_	_
15	a	_	DT	DT	_	19	det	_	_
16	prototypic	_	JJ	JJ	_	19	amod	_	_
17	class	_	NN	NN	_	19	nn	_	_
18	II	_	CD	CD	_	19	num	_	_
19	promoter	_	NN	NN	_	11	rcmod	_	_
20	.	_	.	.	_	5	punct	_	_

1	Moreover	_	RB	RB	_	17	advmod	_	_
2	,	_	,	,	_	17	punct	_	_
3	in	_	IN	IN	_	17	prep	_	_
4	the	_	DT	DT	_	5	det	_	_
5	presence	_	NN	NN	_	3	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	CIITA	_	NN	NN	_	6	pobj	_	_
8	,	_	,	,	_	17	punct	_	_
9	interactions	_	NNS	NNS	_	17	nsubj	_	_
10	between	_	IN	IN	_	9	prep	_	_
11	class	_	NN	NN	_	13	nn	_	_
12	II	_	CD	CD	_	13	num	_	_
13	promoters	_	NNS	NNS	_	10	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	Bob1	_	NN	NN	_	13	conj	_	_
16	are	_	VBP	VBP	_	17	cop	_	_
17	independent	_	JJ	JJ	_	0	root	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	octamer-binding	_	JJ	JJ	_	21	amod	_	_
21	site	_	NN	NN	_	18	pobj	_	_
22	.	_	.	.	_	17	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	in	_	FW	FW	_	1	dobj	_	_
3	vivo	_	FW	FW	_	2	dep	_	_
4	and	_	CC	CC	_	2	cc	_	_
5	in	_	FW	FW	_	2	conj	_	_
6	vitro	_	FW	FW	_	5	dep	_	_
7	binding	_	NN	NN	_	8	nn	_	_
8	assays	_	NNS	NNS	_	2	dep	_	_
9	,	_	,	,	_	1	punct	_	_
10	we	_	PRP	PRP	_	11	nsubj	_	_
11	confirm	_	VBP	VBP	_	1	parataxis	_	_
12	that	_	IN	IN	_	14	mark	_	_
13	Bob1	_	NN	NN	_	14	nsubj	_	_
14	binds	_	VBZ	VBZ	_	11	ccomp	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	CIITA	_	NN	NN	_	15	pobj	_	_
17	.	_	.	.	_	1	punct	_	_

1	Thus	_	RB	RB	_	6	advmod	_	_
2	,	_	,	,	_	6	punct	_	_
3	CIITA	_	NN	NN	_	6	nsubj	_	_
4	not	_	RB	RB	_	5	neg	_	_
5	only	_	RB	RB	_	6	preconj	_	_
6	activates	_	VBZ	VBZ	_	0	root	_	_
7	the	_	DT	DT	_	8	det	_	_
8	expression	_	NN	NN	_	6	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	class	_	NN	NN	_	12	nn	_	_
11	II	_	CD	CD	_	12	num	_	_
12	genes	_	NNS	NNS	_	9	pobj	_	_
13	but	_	CC	CC	_	6	cc	_	_
14	recruits	_	VBZ	VBZ	_	6	conj	_	_
15	another	_	DT	DT	_	18	det	_	_
16	B	_	NN	NN	_	18	nn	_	_
17	cell-specific	_	JJ	JJ	_	18	amod	_	_
18	coactivator	_	NN	NN	_	14	dobj	_	_
19	to	_	TO	TO	_	20	aux	_	_
20	increase	_	VB	VB	_	6	xcomp	_	_
21	transcriptional	_	JJ	JJ	_	22	amod	_	_
22	activity	_	NN	NN	_	20	dobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	class	_	NN	NN	_	26	nn	_	_
25	II	_	CD	CD	_	26	num	_	_
26	promoters	_	NNS	NNS	_	23	pobj	_	_
27	in	_	IN	IN	_	22	prep	_	_
28	B	_	NN	NN	_	29	nn	_	_
29	cells	_	NNS	NNS	_	27	pobj	_	_
30	.	_	.	.	_	6	punct	_	_

1	Activation	_	NN	NN	_	3	npadvmod	_	_
2	protein	_	NN	NN	_	3	npadvmod	_	_
3	1-dependent	_	JJ	JJ	_	5	amod	_	_
4	transcriptional	_	JJ	JJ	_	3	dep	_	_
5	activation	_	NN	NN	_	0	root	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	interleukin	_	NN	NN	_	9	nn	_	_
8	2	_	CD	CD	_	9	num	_	_
9	gene	_	NN	NN	_	6	pobj	_	_
10	by	_	IN	IN	_	5	prep	_	_
11	Ca2+/calmodulin	_	NN	NN	_	14	nn	_	_
12	kinase	_	NN	NN	_	14	nn	_	_
13	type	_	NN	NN	_	14	nn	_	_
14	IV/Gr	_	NN	NN	_	10	pobj	_	_
15	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	9	det	_	_
2	Ca2+/calmodulin-dependent	_	JJ	JJ	_	9	amod	_	_
3	protein	_	NN	NN	_	9	nn	_	_
4	kinase	_	NN	NN	_	9	nn	_	_
5	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
6	CaMK	_	NN	NN	_	9	nn	_	_
7	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
8	type	_	NN	NN	_	9	nn	_	_
9	IV/Gr	_	NN	NN	_	12	nsubjpass	_	_
10	is	_	VBZ	VBZ	_	12	auxpass	_	_
11	selectively	_	RB	RB	_	12	advmod	_	_
12	expressed	_	VBN	VBN	_	0	root	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	T	_	NN	NN	_	15	nn	_	_
15	lymphocytes	_	NNS	NNS	_	13	pobj	_	_
16	and	_	CC	CC	_	12	cc	_	_
17	is	_	VBZ	VBZ	_	18	auxpass	_	_
18	activated	_	VBN	VBN	_	12	conj	_	_
19	after	_	IN	IN	_	18	prep	_	_
20	signaling	_	VBG	VBG	_	19	pobj	_	_
21	via	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	26	det	_	_
23	T	_	NN	NN	_	26	nn	_	_
24	cell	_	NN	NN	_	26	nn	_	_
25	antigen	_	NN	NN	_	26	nn	_	_
26	receptor	_	NN	NN	_	21	pobj	_	_
27	-LRB-	_	-LRB-	-LRB-	_	28	punct	_	_
28	TCR	_	NN	NN	_	26	appos	_	_
29	-RRB-	_	-RRB-	-RRB-	_	28	punct	_	_
30	,	_	,	,	_	12	punct	_	_
31	indicating	_	VBG	VBG	_	12	vmod	_	_
32	that	_	IN	IN	_	34	mark	_	_
33	it	_	PRP	PRP	_	34	nsubj	_	_
34	mediates	_	VBZ	VBZ	_	31	ccomp	_	_
35	some	_	DT	DT	_	34	dobj	_	_
36	of	_	IN	IN	_	35	prep	_	_
37	the	_	DT	DT	_	40	det	_	_
38	Ca-LRB-2+-RRB--dependent	_	JJ	JJ	_	40	amod	_	_
39	transcriptional	_	JJ	JJ	_	38	dep	_	_
40	events	_	NNS	NNS	_	36	pobj	_	_
41	that	_	WDT	WDT	_	42	nsubj	_	_
42	follow	_	VBP	VBP	_	40	rcmod	_	_
43	TCR	_	NN	NN	_	44	nn	_	_
44	engagement	_	NN	NN	_	42	dobj	_	_
45	.	_	.	.	_	12	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	show	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	6	mark	_	_
5	CaMKIV/Gr	_	NN	NN	_	6	nsubj	_	_
6	induces	_	VBZ	VBZ	_	3	ccomp	_	_
7	the	_	DT	DT	_	11	det	_	_
8	transcription	_	NN	NN	_	11	nn	_	_
9	factor	_	NN	NN	_	11	nn	_	_
10	activation	_	NN	NN	_	11	nn	_	_
11	protein	_	NN	NN	_	6	dobj	_	_
12	1	_	CD	CD	_	11	num	_	_
13	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	AP-1	_	NN	NN	_	11	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	alone	_	RB	RB	_	6	advmod	_	_
17	or	_	CC	CC	_	16	cc	_	_
18	in	_	IN	IN	_	16	conj	_	_
19	synergy	_	NN	NN	_	18	pobj	_	_
20	with	_	IN	IN	_	19	prep	_	_
21	T	_	NN	NN	_	23	nn	_	_
22	cell	_	NN	NN	_	23	nn	_	_
23	mitogens	_	NNS	NNS	_	20	pobj	_	_
24	and	_	CC	CC	_	20	cc	_	_
25	with	_	IN	IN	_	20	conj	_	_
26	the	_	DT	DT	_	28	det	_	_
27	p21ras	_	NN	NN	_	28	nn	_	_
28	oncoprotein	_	NN	NN	_	25	pobj	_	_
29	.	_	.	.	_	3	punct	_	_

1	CaMKIV/	_	NN	NN	_	2	nn	_	_
2	Gr	_	NN	NN	_	3	nn	_	_
3	signaling	_	NN	NN	_	5	nsubjpass	_	_
4	is	_	VBZ	VBZ	_	5	auxpass	_	_
5	associated	_	VBN	VBN	_	0	root	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	transcriptional	_	JJ	JJ	_	8	amod	_	_
8	activation	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	c-fos	_	NN	NN	_	9	pobj	_	_
11	but	_	CC	CC	_	5	cc	_	_
12	is	_	VBZ	VBZ	_	13	cop	_	_
13	independent	_	JJ	JJ	_	5	conj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	p21ras	_	NN	NN	_	14	pobj	_	_
16	or	_	CC	CC	_	15	cc	_	_
17	calcineurin	_	NN	NN	_	15	conj	_	_
18	.	_	.	.	_	5	punct	_	_

1	AP-1	_	NN	NN	_	5	nsubj	_	_
2	is	_	VBZ	VBZ	_	5	cop	_	_
3	an	_	DT	DT	_	5	det	_	_
4	integral	_	JJ	JJ	_	5	amod	_	_
5	component	_	NN	NN	_	0	root	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	18	det	_	_
8	nuclear	_	JJ	JJ	_	18	amod	_	_
9	factor	_	NN	NN	_	18	nn	_	_
10	of	_	IN	IN	_	18	amod	_	_
11	activated	_	VBN	VBN	_	18	amod	_	_
12	T	_	NN	NN	_	18	nn	_	_
13	cells	_	NNS	NNS	_	18	nn	_	_
14	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
15	NFAT	_	NN	NN	_	18	nn	_	_
16	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
17	transcriptional	_	JJ	JJ	_	18	amod	_	_
18	complex	_	NN	NN	_	6	pobj	_	_
19	,	_	,	,	_	5	punct	_	_
20	which	_	WDT	WDT	_	22	nsubjpass	_	_
21	is	_	VBZ	VBZ	_	22	auxpass	_	_
22	required	_	VBN	VBN	_	5	rcmod	_	_
23	for	_	IN	IN	_	22	prep	_	_
24	interleukin	_	NN	NN	_	26	nn	_	_
25	2	_	CD	CD	_	26	num	_	_
26	gene	_	NN	NN	_	27	nn	_	_
27	expression	_	NN	NN	_	23	pobj	_	_
28	in	_	IN	IN	_	27	prep	_	_
29	T	_	NN	NN	_	30	nn	_	_
30	cells	_	NNS	NNS	_	28	pobj	_	_
31	.	_	.	.	_	5	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	demonstrate	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	5	mark	_	_
4	CaMKIV/Gr	_	NN	NN	_	5	nsubj	_	_
5	reconstitutes	_	VBZ	VBZ	_	2	ccomp	_	_
6	the	_	DT	DT	_	7	det	_	_
7	capacity	_	NN	NN	_	5	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	cytosolic	_	JJ	JJ	_	11	amod	_	_
11	component	_	NN	NN	_	8	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	NFAT	_	NN	NN	_	12	pobj	_	_
14	to	_	TO	TO	_	15	aux	_	_
15	direct	_	VB	VB	_	7	vmod	_	_
16	transcription	_	NN	NN	_	15	dobj	_	_
17	from	_	IN	IN	_	16	prep	_	_
18	NFAT	_	NN	NN	_	19	nn	_	_
19	sites	_	NNS	NNS	_	17	pobj	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	non-T	_	NN	NN	_	22	nn	_	_
22	cells	_	NNS	NNS	_	20	pobj	_	_
23	.	_	.	.	_	2	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	reveal	_	VBP	VBP	_	0	root	_	_
4	a	_	DT	DT	_	6	det	_	_
5	central	_	JJ	JJ	_	6	amod	_	_
6	role	_	NN	NN	_	3	dobj	_	_
7	for	_	IN	IN	_	6	prep	_	_
8	CaMKIV/Gr	_	NN	NN	_	7	pobj	_	_
9	as	_	IN	IN	_	6	prep	_	_
10	a	_	DT	DT	_	12	det	_	_
11	Ca-LRB-2+-RRB--regulated	_	JJ	JJ	_	12	amod	_	_
12	activator	_	NN	NN	_	9	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	gene	_	NN	NN	_	15	nn	_	_
15	transcription	_	NN	NN	_	13	pobj	_	_
16	in	_	IN	IN	_	12	prep	_	_
17	T	_	NN	NN	_	18	nn	_	_
18	lymphocytes	_	NNS	NNS	_	16	pobj	_	_
19	.	_	.	.	_	3	punct	_	_

1	Cytokine-modulating	_	JJ	JJ	_	2	amod	_	_
2	activity	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	tepoxalin	_	NN	NN	_	3	pobj	_	_
5	,	_	,	,	_	4	punct	_	_
6	a	_	DT	DT	_	9	det	_	_
7	new	_	JJ	JJ	_	9	amod	_	_
8	potential	_	JJ	JJ	_	7	dep	_	_
9	antirheumatic	_	NN	NN	_	4	appos	_	_
10	.	_	.	.	_	2	punct	_	_

1	Tepoxalin	_	NN	NN	_	8	nsubj	_	_
2	is	_	VBZ	VBZ	_	8	cop	_	_
3	a	_	DT	DT	_	8	det	_	_
4	new	_	JJ	JJ	_	8	amod	_	_
5	dual	_	JJ	JJ	_	8	amod	_	_
6	cyclooxygenase/5-lipoxygenase	_	NN	NN	_	8	nn	_	_
7	anti-inflammatory	_	JJ	JJ	_	8	amod	_	_
8	compound	_	NN	NN	_	0	root	_	_
9	currently	_	RB	RB	_	10	advmod	_	_
10	under	_	IN	IN	_	8	prep	_	_
11	clinical	_	JJ	JJ	_	12	amod	_	_
12	investigation	_	NN	NN	_	10	pobj	_	_
13	.	_	.	.	_	8	punct	_	_

1	It	_	PRP	PRP	_	4	nsubjpass	_	_
2	has	_	VBZ	VBZ	_	4	aux	_	_
3	been	_	VBN	VBN	_	4	auxpass	_	_
4	shown	_	VBN	VBN	_	0	root	_	_
5	to	_	TO	TO	_	6	aux	_	_
6	possess	_	VB	VB	_	4	ccomp	_	_
7	anti-inflammatory	_	JJ	JJ	_	8	amod	_	_
8	activity	_	NN	NN	_	6	dobj	_	_
9	in	_	IN	IN	_	6	prep	_	_
10	a	_	DT	DT	_	11	det	_	_
11	variety	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	animal	_	NN	NN	_	14	nn	_	_
14	models	_	NNS	NNS	_	12	pobj	_	_
15	and	_	CC	CC	_	6	cc	_	_
16	more	_	RBR	RBR	_	17	advmod	_	_
17	recently	_	RB	RB	_	19	advmod	_	_
18	to	_	TO	TO	_	19	aux	_	_
19	inhibit	_	VB	VB	_	6	conj	_	_
20	IL-2	_	NN	NN	_	23	nn	_	_
21	induced	_	JJ	JJ	_	23	amod	_	_
22	signal	_	NN	NN	_	23	nn	_	_
23	transduction	_	NN	NN	_	19	dobj	_	_
24	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	current	_	JJ	JJ	_	3	amod	_	_
3	study	_	NN	NN	_	5	nsubjpass	_	_
4	was	_	VBD	VBD	_	5	auxpass	_	_
5	conducted	_	VBN	VBN	_	0	root	_	_
6	to	_	TO	TO	_	7	aux	_	_
7	evaluate	_	VB	VB	_	5	xcomp	_	_
8	the	_	DT	DT	_	11	det	_	_
9	cytokine	_	NN	NN	_	11	nn	_	_
10	modulating	_	NN	NN	_	11	nn	_	_
11	activity	_	NN	NN	_	7	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	tepoxalin	_	NN	NN	_	12	pobj	_	_
14	and	_	CC	CC	_	11	cc	_	_
15	the	_	DT	DT	_	16	det	_	_
16	role	_	NN	NN	_	11	conj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	iron	_	NN	NN	_	17	pobj	_	_
19	in	_	IN	IN	_	16	prep	_	_
20	these	_	DT	DT	_	21	det	_	_
21	effects	_	NNS	NNS	_	19	pobj	_	_
22	.	_	.	.	_	5	punct	_	_

1	In	_	IN	IN	_	15	prep	_	_
2	human	_	JJ	JJ	_	6	amod	_	_
3	peripheral	_	JJ	JJ	_	6	amod	_	_
4	blood	_	NN	NN	_	6	nn	_	_
5	mononuclear	_	JJ	JJ	_	6	amod	_	_
6	cells	_	NNS	NNS	_	1	pobj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	PBMC	_	NN	NN	_	6	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	stimulated	_	VBN	VBN	_	6	vmod	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	OKT3/PMA	_	NN	NN	_	11	pobj	_	_
13	,	_	,	,	_	15	punct	_	_
14	tepoxalin	_	NN	NN	_	15	nsubj	_	_
15	inhibited	_	VBD	VBD	_	0	root	_	_
16	lymphocyte	_	NN	NN	_	17	nn	_	_
17	proliferation	_	NN	NN	_	15	dobj	_	_
18	with	_	IN	IN	_	17	prep	_	_
19	an	_	DT	DT	_	20	det	_	_
20	IC50	_	NN	NN	_	18	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	6	_	CD	CD	_	23	num	_	_
23	microM	_	NN	NN	_	21	pobj	_	_
24	.	_	.	.	_	15	punct	_	_

1	Additionally	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	it	_	PRP	PRP	_	4	nsubj	_	_
4	inhibited	_	VBD	VBD	_	0	root	_	_
5	the	_	DT	DT	_	6	det	_	_
6	production	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	LTB4	_	NN	NN	_	7	pobj	_	_
9	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	IC50	_	NN	NN	_	8	dep	_	_
11	=	_	JJ	JJ	_	10	amod	_	_
12	0.5	_	CD	CD	_	13	num	_	_
13	microM	_	NN	NN	_	11	dep	_	_
14	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
15	and	_	CC	CC	_	8	cc	_	_
16	the	_	DT	DT	_	17	det	_	_
17	cytokines	_	NNS	NNS	_	8	conj	_	_
18	IL-2	_	NN	NN	_	17	dep	_	_
19	,	_	,	,	_	18	punct	_	_
20	IL-6	_	NN	NN	_	18	conj	_	_
21	and	_	CC	CC	_	18	cc	_	_
22	TNF	_	NN	NN	_	23	nn	_	_
23	alpha	_	NN	NN	_	18	conj	_	_
24	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
25	IC50	_	NN	NN	_	23	dep	_	_
26	=	_	JJ	JJ	_	25	amod	_	_
27	10-12	_	CD	CD	_	28	num	_	_
28	microM	_	NN	NN	_	26	dep	_	_
29	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
30	.	_	.	.	_	4	punct	_	_

1	Cytotoxicity	_	NN	NN	_	4	nsubjpass	_	_
2	was	_	VBD	VBD	_	4	auxpass	_	_
3	not	_	RB	RB	_	4	neg	_	_
4	demonstrated	_	VBN	VBN	_	0	root	_	_
5	at	_	IN	IN	_	4	prep	_	_
6	these	_	DT	DT	_	7	det	_	_
7	concentrations	_	NNS	NNS	_	5	pobj	_	_
8	.	_	.	.	_	4	punct	_	_

1	Add-back	_	JJ	JJ	_	2	amod	_	_
2	experiments	_	NNS	NNS	_	16	nsubj	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	either	_	CC	CC	_	5	preconj	_	_
5	cytokines	_	NNS	NNS	_	3	pobj	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	IL-2	_	NN	NN	_	5	dep	_	_
8	or	_	CC	CC	_	7	cc	_	_
9	IL-6	_	NN	NN	_	7	conj	_	_
10	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
11	,	_	,	,	_	5	punct	_	_
12	LTB4	_	NN	NN	_	5	conj	_	_
13	or	_	CC	CC	_	5	cc	_	_
14	conditioned	_	JJ	JJ	_	15	amod	_	_
15	media	_	NNS	NNS	_	5	conj	_	_
16	failed	_	VBD	VBD	_	0	root	_	_
17	to	_	TO	TO	_	18	aux	_	_
18	restore	_	VB	VB	_	16	xcomp	_	_
19	the	_	DT	DT	_	21	det	_	_
20	proliferative	_	JJ	JJ	_	21	amod	_	_
21	response	_	NN	NN	_	18	dobj	_	_
22	in	_	IN	IN	_	18	prep	_	_
23	the	_	DT	DT	_	24	det	_	_
24	presence	_	NN	NN	_	22	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	tepoxalin	_	NN	NN	_	25	pobj	_	_
27	.	_	.	.	_	16	punct	_	_

1	However	_	RB	RB	_	22	advmod	_	_
2	,	_	,	,	_	22	punct	_	_
3	the	_	DT	DT	_	5	det	_	_
4	concurrent	_	JJ	JJ	_	5	amod	_	_
5	addition	_	NN	NN	_	22	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	iron	_	NN	NN	_	6	pobj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	in	_	IN	IN	_	7	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	form	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	ferrous	_	JJ	JJ	_	12	pobj	_	_
14	or	_	CC	CC	_	13	cc	_	_
15	ferric	_	JJ	JJ	_	13	conj	_	_
16	chloride	_	NN	NN	_	13	dep	_	_
17	and	_	CC	CC	_	13	cc	_	_
18	other	_	JJ	JJ	_	20	amod	_	_
19	iron	_	NN	NN	_	20	nn	_	_
20	salts	_	NNS	NNS	_	13	conj	_	_
21	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
22	reversed	_	VBD	VBD	_	0	root	_	_
23	the	_	DT	DT	_	24	det	_	_
24	inhibition	_	NN	NN	_	22	dobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	proliferation	_	NN	NN	_	25	pobj	_	_
27	caused	_	VBN	VBN	_	24	vmod	_	_
28	by	_	IN	IN	_	27	prep	_	_
29	tepoxalin	_	NN	NN	_	28	pobj	_	_
30	.	_	.	.	_	22	punct	_	_

1	Tepoxalin	_	NN	NN	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	inhibits	_	VBZ	VBZ	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	activation	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	NF	_	NN	NN	_	9	nn	_	_
8	kappa	_	NN	NN	_	9	nn	_	_
9	B	_	NN	NN	_	6	pobj	_	_
10	,	_	,	,	_	9	punct	_	_
11	a	_	DT	DT	_	13	det	_	_
12	transcription	_	NN	NN	_	13	nn	_	_
13	factor	_	NN	NN	_	9	appos	_	_
14	which	_	WDT	WDT	_	15	nsubj	_	_
15	acts	_	VBZ	VBZ	_	13	rcmod	_	_
16	on	_	IN	IN	_	15	prep	_	_
17	several	_	JJ	JJ	_	19	amod	_	_
18	cytokine	_	NN	NN	_	19	nn	_	_
19	genes	_	NNS	NNS	_	16	pobj	_	_
20	.	_	.	.	_	3	punct	_	_

1	Tepoxalin	_	NN	NN	_	3	poss	_	_
2	's	_	POS	POS	_	3	possessive	_	_
3	effect	_	NN	NN	_	10	nsubjpass	_	_
4	on	_	IN	IN	_	3	prep	_	_
5	NF	_	NN	NN	_	7	nn	_	_
6	kappa	_	NN	NN	_	7	nn	_	_
7	B	_	NN	NN	_	4	pobj	_	_
8	is	_	VBZ	VBZ	_	10	auxpass	_	_
9	also	_	RB	RB	_	10	advmod	_	_
10	reversed	_	VBN	VBN	_	0	root	_	_
11	by	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	addition	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	iron	_	NN	NN	_	16	nn	_	_
16	salts	_	NNS	NNS	_	14	pobj	_	_
17	.	_	.	.	_	10	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	20	mark	_	_
5	the	_	DT	DT	_	6	det	_	_
6	action	_	NN	NN	_	20	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	tepoxalin	_	NN	NN	_	7	pobj	_	_
9	to	_	TO	TO	_	10	aux	_	_
10	inhibit	_	VB	VB	_	6	vmod	_	_
11	proliferation	_	NN	NN	_	10	dobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	PBMC	_	NN	NN	_	12	pobj	_	_
14	may	_	MD	MD	_	20	aux	_	_
15	be	_	VB	VB	_	20	cop	_	_
16	at	_	IN	IN	_	18	advmod	_	_
17	least	_	JJS	JJS	_	16	pobj	_	_
18	in	_	IN	IN	_	20	prep	_	_
19	part	_	NN	NN	_	18	pobj	_	_
20	due	_	JJ	JJ	_	3	ccomp	_	_
21	to	_	TO	TO	_	20	prep	_	_
22	its	_	PRP$	PRP$	_	23	poss	_	_
23	ability	_	NN	NN	_	31	nsubj	_	_
24	to	_	TO	TO	_	25	aux	_	_
25	reduce	_	VB	VB	_	23	vmod	_	_
26	the	_	DT	DT	_	27	det	_	_
27	amount	_	NN	NN	_	25	dobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	available	_	JJ	JJ	_	30	amod	_	_
30	iron	_	NN	NN	_	28	pobj	_	_
31	resulting	_	VBG	VBG	_	21	pcomp	_	_
32	in	_	IN	IN	_	31	prep	_	_
33	decreased	_	VBN	VBN	_	34	amod	_	_
34	activation	_	NN	NN	_	32	pobj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	NF	_	NN	NN	_	38	nn	_	_
37	kappa	_	NN	NN	_	38	nn	_	_
38	B	_	NN	NN	_	35	pobj	_	_
39	and	_	CC	CC	_	34	cc	_	_
40	subsequent	_	JJ	JJ	_	41	amod	_	_
41	inhibition	_	NN	NN	_	34	conj	_	_
42	of	_	IN	IN	_	41	prep	_	_
43	cytokine	_	NN	NN	_	44	nn	_	_
44	production	_	NN	NN	_	42	pobj	_	_
45	.	_	.	.	_	3	punct	_	_

1	Interleukin-7	_	NN	NN	_	2	nn	_	_
2	signaling	_	NN	NN	_	16	nsubj	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	human	_	JJ	JJ	_	11	amod	_	_
5	B	_	NN	NN	_	11	nn	_	_
6	cell	_	NN	NN	_	11	nn	_	_
7	precursor	_	NN	NN	_	11	nn	_	_
8	acute	_	JJ	JJ	_	11	amod	_	_
9	lymphoblastic	_	JJ	JJ	_	11	amod	_	_
10	leukemia	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	3	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	murine	_	JJ	JJ	_	15	amod	_	_
14	BAF3	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	11	conj	_	_
16	involves	_	VBZ	VBZ	_	0	root	_	_
17	activation	_	NN	NN	_	16	dobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	STAT1	_	NN	NN	_	18	pobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	STAT5	_	NN	NN	_	19	conj	_	_
22	mediated	_	VBN	VBN	_	17	vmod	_	_
23	via	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	28	det	_	_
25	interleukin-7	_	NN	NN	_	28	nn	_	_
26	receptor	_	NN	NN	_	28	nn	_	_
27	alpha	_	NN	NN	_	28	nn	_	_
28	chain	_	NN	NN	_	23	pobj	_	_
29	.	_	.	.	_	16	punct	_	_

1	Interleukin-7	_	NN	NN	_	5	nsubj	_	_
2	-LRB-	_	-LRB-	-LRB-	_	3	punct	_	_
3	IL-7	_	NN	NN	_	1	appos	_	_
4	-RRB-	_	-RRB-	-RRB-	_	3	punct	_	_
5	stimulates	_	VBZ	VBZ	_	0	root	_	_
6	the	_	DT	DT	_	7	det	_	_
7	proliferation	_	NN	NN	_	5	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	normal	_	JJ	JJ	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	leukemic	_	JJ	JJ	_	9	conj	_	_
12	B	_	NN	NN	_	9	dep	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	T	_	NN	NN	_	12	conj	_	_
15	cell	_	NN	NN	_	16	nn	_	_
16	precursors	_	NNS	NNS	_	12	dep	_	_
17	and	_	CC	CC	_	12	cc	_	_
18	T	_	NN	NN	_	19	nn	_	_
19	lymphocytes	_	NNS	NNS	_	12	conj	_	_
20	.	_	.	.	_	5	punct	_	_

1	Activation	_	NN	NN	_	8	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	JAK/STAT	_	NN	NN	_	5	nn	_	_
5	pathway	_	NN	NN	_	2	pobj	_	_
6	has	_	VBZ	VBZ	_	8	aux	_	_
7	been	_	VBN	VBN	_	8	auxpass	_	_
8	implicated	_	VBN	VBN	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	IL-7R	_	NN	NN	_	11	nn	_	_
11	signaling	_	NN	NN	_	9	pobj	_	_
12	.	_	.	.	_	8	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	investigated	_	VBD	VBD	_	0	root	_	_
3	which	_	WDT	WDT	_	5	det	_	_
4	STAT	_	NN	NN	_	5	nn	_	_
5	complexes	_	NNS	NNS	_	7	nsubjpass	_	_
6	are	_	VBP	VBP	_	7	auxpass	_	_
7	formed	_	VBN	VBN	_	2	ccomp	_	_
8	upon	_	IN	IN	_	7	prep	_	_
9	stimulation	_	NN	NN	_	8	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	B	_	NN	NN	_	20	nn	_	_
12	cell	_	NN	NN	_	20	nn	_	_
13	precursor	_	NN	NN	_	20	nn	_	_
14	acute	_	JJ	JJ	_	20	amod	_	_
15	lymphoblastic	_	JJ	JJ	_	20	amod	_	_
16	leukemia	_	NN	NN	_	20	nn	_	_
17	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
18	BCP-ALL	_	NN	NN	_	20	nn	_	_
19	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
20	cells	_	NNS	NNS	_	10	pobj	_	_
21	with	_	IN	IN	_	9	prep	_	_
22	IL-7	_	NN	NN	_	21	pobj	_	_
23	.	_	.	.	_	2	punct	_	_

1	Gel	_	NN	NN	_	3	nn	_	_
2	retardation	_	NN	NN	_	3	nn	_	_
3	assays	_	NNS	NNS	_	7	nsubj	_	_
4	with	_	IN	IN	_	3	prep	_	_
5	STAT-binding	_	JJ	JJ	_	6	amod	_	_
6	oligonucleotides	_	NNS	NNS	_	4	pobj	_	_
7	showed	_	VBD	VBD	_	0	root	_	_
8	that	_	IN	IN	_	10	mark	_	_
9	IL-7	_	NN	NN	_	10	nsubj	_	_
10	induces	_	VBZ	VBZ	_	7	ccomp	_	_
11	the	_	DT	DT	_	12	det	_	_
12	formation	_	NN	NN	_	10	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	two	_	CD	CD	_	17	num	_	_
15	major	_	JJ	JJ	_	17	amod	_	_
16	STAT	_	NN	NN	_	17	nn	_	_
17	complexes	_	NNS	NNS	_	13	pobj	_	_
18	in	_	IN	IN	_	10	prep	_	_
19	BCP-ALL	_	NN	NN	_	20	nn	_	_
20	cells	_	NNS	NNS	_	18	pobj	_	_
21	.	_	.	.	_	7	punct	_	_

1	Supershifts	_	NNS	NNS	_	5	nsubj	_	_
2	with	_	IN	IN	_	1	prep	_	_
3	anti-STAT	_	JJ	JJ	_	4	amod	_	_
4	antibodies	_	NNS	NNS	_	2	pobj	_	_
5	identified	_	VBD	VBD	_	0	root	_	_
6	these	_	DT	DT	_	5	dobj	_	_
7	as	_	IN	IN	_	5	prep	_	_
8	STAT1	_	NN	NN	_	7	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	STAT5	_	NN	NN	_	11	nn	_	_
11	complexes	_	NNS	NNS	_	8	conj	_	_
12	.	_	.	.	_	5	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	pattern	_	NN	NN	_	7	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	STAT	_	NN	NN	_	5	nn	_	_
5	activation	_	NN	NN	_	3	pobj	_	_
6	was	_	VBD	VBD	_	7	auxpass	_	_
7	seen	_	VBN	VBN	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	all	_	DT	DT	_	11	det	_	_
10	BCP-ALL	_	NN	NN	_	11	nn	_	_
11	cases	_	NNS	NNS	_	8	pobj	_	_
12	that	_	WDT	WDT	_	13	nsubj	_	_
13	respond	_	VBP	VBP	_	11	rcmod	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	IL-7	_	NN	NN	_	14	pobj	_	_
16	in	_	IN	IN	_	13	prep	_	_
17	proliferation	_	NN	NN	_	18	nn	_	_
18	assays	_	NNS	NNS	_	16	pobj	_	_
19	.	_	.	.	_	7	punct	_	_

1	IL-7	_	NN	NN	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	induced	_	VBD	VBD	_	0	root	_	_
4	STAT/DNA	_	NN	NN	_	5	nn	_	_
5	binding	_	NN	NN	_	3	dobj	_	_
6	in	_	IN	IN	_	3	prep	_	_
7	BCP-ALL	_	NN	NN	_	8	nn	_	_
8	cases	_	NNS	NNS	_	6	pobj	_	_
9	that	_	WDT	WDT	_	10	nsubj	_	_
10	failed	_	VBD	VBD	_	8	rcmod	_	_
11	to	_	TO	TO	_	12	aux	_	_
12	proliferate	_	VB	VB	_	10	xcomp	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	response	_	NN	NN	_	13	pobj	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	IL-7	_	NN	NN	_	15	pobj	_	_
17	,	_	,	,	_	3	punct	_	_
18	suggesting	_	VBG	VBG	_	3	vmod	_	_
19	that	_	IN	IN	_	33	mark	_	_
20	the	_	DT	DT	_	21	det	_	_
21	ability	_	NN	NN	_	33	nsubj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	IL-7R	_	NN	NN	_	22	pobj	_	_
24	to	_	TO	TO	_	25	aux	_	_
25	activate	_	VB	VB	_	21	vmod	_	_
26	the	_	DT	DT	_	28	det	_	_
27	JAK/STAT	_	NN	NN	_	28	nn	_	_
28	pathway	_	NN	NN	_	25	dobj	_	_
29	per	_	FW	FW	_	30	nn	_	_
30	se	_	FW	FW	_	25	advmod	_	_
31	is	_	VBZ	VBZ	_	33	cop	_	_
32	not	_	RB	RB	_	33	neg	_	_
33	sufficient	_	JJ	JJ	_	18	ccomp	_	_
34	for	_	IN	IN	_	33	prep	_	_
35	proliferation	_	NN	NN	_	36	nn	_	_
36	induction	_	NN	NN	_	34	pobj	_	_
37	.	_	.	.	_	3	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	determine	_	VB	VB	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	contribution	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	cytoplasmic	_	JJ	JJ	_	8	amod	_	_
8	domain	_	NN	NN	_	5	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	14	det	_	_
11	IL-7	_	NN	NN	_	14	nn	_	_
12	receptor	_	NN	NN	_	14	nn	_	_
13	alpha	_	NN	NN	_	14	nn	_	_
14	chain	_	NN	NN	_	9	pobj	_	_
15	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
16	IL-7R	_	NN	NN	_	17	nn	_	_
17	alpha	_	NN	NN	_	14	appos	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	to	_	TO	TO	_	4	prep	_	_
20	activation	_	NN	NN	_	19	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	STAT	_	NN	NN	_	23	nn	_	_
23	proteins	_	NNS	NNS	_	21	pobj	_	_
24	,	_	,	,	_	2	punct	_	_
25	transfectants	_	NNS	NNS	_	34	nsubjpass	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	32	det	_	_
28	murine	_	JJ	JJ	_	32	amod	_	_
29	pro-B	_	NN	NN	_	32	nn	_	_
30	cell	_	NN	NN	_	32	nn	_	_
31	line	_	NN	NN	_	32	nn	_	_
32	BAF3	_	NNS	NNS	_	26	pobj	_	_
33	were	_	VBD	VBD	_	34	auxpass	_	_
34	made	_	VBN	VBN	_	2	parataxis	_	_
35	that	_	WDT	WDT	_	36	nsubj	_	_
36	express	_	NN	NN	_	34	dep	_	_
37	chimeric	_	JJ	JJ	_	38	amod	_	_
38	receptors	_	NNS	NNS	_	36	dobj	_	_
39	consisting	_	VBG	VBG	_	38	vmod	_	_
40	of	_	IN	IN	_	39	prep	_	_
41	the	_	DT	DT	_	43	det	_	_
42	extracellular	_	JJ	JJ	_	43	amod	_	_
43	domain	_	NN	NN	_	40	pobj	_	_
44	of	_	IN	IN	_	43	prep	_	_
45	human	_	JJ	JJ	_	49	amod	_	_
46	granulocyte	_	NN	NN	_	49	nn	_	_
47	colony-stimulating	_	JJ	JJ	_	49	amod	_	_
48	factor	_	NN	NN	_	49	nn	_	_
49	receptor	_	NN	NN	_	44	pobj	_	_
50	-LRB-	_	-LRB-	-LRB-	_	51	punct	_	_
51	G-CSF-R	_	NN	NN	_	49	appos	_	_
52	-RRB-	_	-RRB-	-RRB-	_	51	punct	_	_
53	and	_	CC	CC	_	43	cc	_	_
54	the	_	DT	DT	_	55	dep	_	_
55	transmembrane	_	NN	NN	_	43	conj	_	_
56	and	_	CC	CC	_	55	cc	_	_
57	intracellular	_	JJ	JJ	_	55	conj	_	_
58	domains	_	NNS	NNS	_	55	dep	_	_
59	of	_	IN	IN	_	55	prep	_	_
60	human	_	JJ	JJ	_	62	amod	_	_
61	IL-7R	_	NN	NN	_	62	nn	_	_
62	alpha	_	NN	NN	_	59	pobj	_	_
63	.	_	.	.	_	2	punct	_	_

1	Activation	_	NN	NN	_	9	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	6	det	_	_
4	chimeric	_	JJ	JJ	_	6	amod	_	_
5	G-CSF-R/IL-7R	_	NN	NN	_	6	nn	_	_
6	alpha	_	NN	NN	_	2	pobj	_	_
7	with	_	IN	IN	_	6	prep	_	_
8	G-CSF	_	NN	NN	_	7	pobj	_	_
9	resulted	_	VBD	VBD	_	0	root	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	a	_	DT	DT	_	14	det	_	_
12	full	_	JJ	JJ	_	14	amod	_	_
13	proliferative	_	JJ	JJ	_	12	dep	_	_
14	response	_	NN	NN	_	10	pobj	_	_
15	and	_	CC	CC	_	9	cc	_	_
16	induced	_	VBD	VBD	_	9	conj	_	_
17	the	_	DT	DT	_	18	det	_	_
18	phosphorylation	_	NN	NN	_	16	dobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	JAK1	_	NN	NN	_	19	pobj	_	_
21	but	_	CC	CC	_	22	cc	_	_
22	not	_	RB	RB	_	20	cc	_	_
23	JAK2	_	NN	NN	_	20	conj	_	_
24	.	_	.	.	_	9	punct	_	_

1	Major	_	JJ	JJ	_	3	amod	_	_
2	STAT	_	NN	NN	_	3	nn	_	_
3	complexes	_	NNS	NNS	_	8	nsubj	_	_
4	activated	_	VBN	VBN	_	3	vmod	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	G-CSF-R/IL-7R	_	NN	NN	_	7	nn	_	_
7	alpha	_	NN	NN	_	5	pobj	_	_
8	contained	_	VBD	VBD	_	0	root	_	_
9	STAT1	_	NN	NN	_	8	dobj	_	_
10	or	_	CC	CC	_	9	cc	_	_
11	STAT5	_	NN	NN	_	9	conj	_	_
12	,	_	,	,	_	8	punct	_	_
13	while	_	IN	IN	_	21	mark	_	_
14	some	_	DT	DT	_	15	det	_	_
15	formation	_	NN	NN	_	21	nsubjpass	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	STAT3-containing	_	JJ	JJ	_	18	amod	_	_
18	complexes	_	NNS	NNS	_	16	pobj	_	_
19	was	_	VBD	VBD	_	21	auxpass	_	_
20	also	_	RB	RB	_	21	advmod	_	_
21	seen	_	VBN	VBN	_	8	advcl	_	_
22	.	_	.	.	_	8	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	findings	_	NNS	NNS	_	3	nsubj	_	_
3	establish	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	14	mark	_	_
5	STAT1	_	NN	NN	_	14	nsubjpass	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	STAT5	_	NN	NN	_	5	conj	_	_
8	,	_	,	,	_	5	punct	_	_
9	and	_	CC	CC	_	5	cc	_	_
10	possibly	_	RB	RB	_	11	advmod	_	_
11	STAT3	_	NN	NN	_	5	conj	_	_
12	,	_	,	,	_	5	punct	_	_
13	are	_	VBP	VBP	_	14	auxpass	_	_
14	activated	_	VBN	VBN	_	3	ccomp	_	_
15	upon	_	IN	IN	_	14	prep	_	_
16	stimulation	_	NN	NN	_	15	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	precursor	_	JJ	JJ	_	20	amod	_	_
19	B	_	NN	NN	_	20	nn	_	_
20	cells	_	NNS	NNS	_	17	pobj	_	_
21	with	_	IN	IN	_	16	prep	_	_
22	IL-7	_	NN	NN	_	21	pobj	_	_
23	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	4	nsubj	_	_
3	further	_	RB	RB	_	4	advmod	_	_
4	indicate	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	12	mark	_	_
6	the	_	DT	DT	_	9	det	_	_
7	IL-7R	_	NN	NN	_	9	nn	_	_
8	alpha	_	NN	NN	_	9	nn	_	_
9	chains	_	NNS	NNS	_	12	nsubjpass	_	_
10	are	_	VBP	VBP	_	12	auxpass	_	_
11	directly	_	RB	RB	_	12	advmod	_	_
12	involved	_	VBN	VBN	_	4	ccomp	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	activation	_	NN	NN	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	JAKs	_	NNS	NNS	_	16	pobj	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	STATs	_	NNS	NNS	_	17	conj	_	_
20	and	_	CC	CC	_	12	cc	_	_
21	have	_	VB	VB	_	12	conj	_	_
22	a	_	DT	DT	_	24	det	_	_
23	major	_	JJ	JJ	_	24	amod	_	_
24	role	_	NN	NN	_	21	dobj	_	_
25	in	_	IN	IN	_	21	prep	_	_
26	proliferative	_	JJ	JJ	_	27	amod	_	_
27	signaling	_	NN	NN	_	25	pobj	_	_
28	in	_	IN	IN	_	27	prep	_	_
29	precursor	_	NN	NN	_	31	nn	_	_
30	B	_	NN	NN	_	31	nn	_	_
31	cells	_	NNS	NNS	_	28	pobj	_	_
32	.	_	.	.	_	4	punct	_	_

